Psyllid ID: psy6593
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 433 | 2.2.26 [Sep-21-2011] | |||||||
| Q8IR79 | 1257 | LIM domain kinase 1 OS=Dr | no | N/A | 0.577 | 0.198 | 0.605 | 4e-89 | |
| Q8QFP8 | 662 | LIM domain kinase 1 OS=Ga | yes | N/A | 0.549 | 0.359 | 0.597 | 4e-81 | |
| P53666 | 642 | LIM domain kinase 2 OS=Ga | no | N/A | 0.561 | 0.378 | 0.607 | 6e-80 | |
| P53667 | 647 | LIM domain kinase 1 OS=Ho | yes | N/A | 0.549 | 0.367 | 0.589 | 2e-79 | |
| P53668 | 647 | LIM domain kinase 1 OS=Mu | yes | N/A | 0.547 | 0.366 | 0.595 | 5e-79 | |
| P53669 | 647 | LIM domain kinase 1 OS=Ra | yes | N/A | 0.549 | 0.367 | 0.581 | 2e-78 | |
| Q32L23 | 638 | LIM domain kinase 2 OS=Bo | no | N/A | 0.561 | 0.380 | 0.595 | 6e-78 | |
| P53670 | 638 | LIM domain kinase 2 OS=Ra | no | N/A | 0.561 | 0.380 | 0.595 | 1e-77 | |
| P53671 | 638 | LIM domain kinase 2 OS=Ho | no | N/A | 0.558 | 0.379 | 0.592 | 3e-77 | |
| O54785 | 638 | LIM domain kinase 2 OS=Mu | no | N/A | 0.561 | 0.380 | 0.591 | 4e-77 |
| >sp|Q8IR79|LIMK1_DROME LIM domain kinase 1 OS=Drosophila melanogaster GN=LIMK1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 328 bits (842), Expect = 4e-89, Method: Compositional matrix adjust.
Identities = 161/266 (60%), Positives = 196/266 (73%), Gaps = 16/266 (6%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+VAVLR L H +V++FIGVLYKD+KL++VTEY+AGG LKEL+ DP Q LPW QRV ARD
Sbjct: 446 EVAVLRLLDHRHVLKFIGVLYKDKKLHMVTEYVAGGCLKELIHDPAQVLPWPQRVRLARD 505
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
IA GM+YLHSMN+IHRDLNS NCLVRED++V+VADFGLAR + PR P+ M +
Sbjct: 506 IACGMSYLHSMNIIHRDLNSMNCLVREDRSVIVADFGLARSV-DAPRLPSGNMTPGGYGS 564
Query: 268 AQRRGA---------------RKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE 312
A R++RYTVVGNPYWMAPEMM G +YDE VDVFS+GI+LCE
Sbjct: 565 GANSDAPMSPSGTLRRSKSRQRRQRYTVVGNPYWMAPEMMKGLKYDEKVDVFSFGIMLCE 624
Query: 313 IIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372
IIGRV ADPD++PR+ DF L+Q +FR KFCA CPEPFV++AF+CCDLNPD RP FE L V
Sbjct: 625 IIGRVEADPDFMPRNSDFSLNQQEFREKFCAQCPEPFVKVAFVCCDLNPDMRPCFETLHV 684
Query: 373 WLEGLSMHLSVDKPLPSDLEADIYQF 398
WL+ L+ L+ D+ P L +I F
Sbjct: 685 WLQRLADDLAADRVPPERLLHEIETF 710
|
Protein kinase which regulates actin filament dynamics. Phosphorylates and inactivates the actin binding/depolymerizing factor tsr/cofilin, thereby stabilizing the actin cytoskeleton. Modulation of actin cytoskeleton dynamics may be essential for imaginal disk morphogenesis and axon guidance. Drosophila melanogaster (taxid: 7227) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8QFP8|LIMK1_CHICK LIM domain kinase 1 OS=Gallus gallus GN=LIMK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 302 bits (773), Expect = 4e-81, Method: Compositional matrix adjust.
Identities = 147/246 (59%), Positives = 181/246 (73%), Gaps = 8/246 (3%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+V V+R L H NV++FIGVLYK+++LN +TEYI GGTL+ L++ PW QRV+FA+D
Sbjct: 391 EVKVMRCLEHPNVLKFIGVLYKEKRLNFITEYIKGGTLRGLIKSMDSHYPWSQRVSFAKD 450
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
IAAGM YLHSMN+IHRDLNS NCLVRE+K+VVVADFGLAR++ P +
Sbjct: 451 IAAGMAYLHSMNIIHRDLNSHNCLVRENKSVVVADFGLARLMVDEKNQPEHLQ------- 503
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
++ RKKRYTVVGNPYWMAPEM+ G+ YDE VD+FS+GIVLCEIIGRV ADPDYLPR+
Sbjct: 504 NLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDIFSFGIVLCEIIGRVSADPDYLPRT 563
Query: 328 PDFGLDQTDFRNKFC-ASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKP 386
DFGL+ F ++C +CP F IA CCDL+P++RP F LE WLE L MHL + P
Sbjct: 564 TDFGLNVRGFLERYCPPACPPSFFPIAACCCDLDPEKRPSFSKLEQWLETLRMHLDIRLP 623
Query: 387 LPSDLE 392
L S LE
Sbjct: 624 LSSQLE 629
|
Protein kinase which regulates actin filament dynamics. Phosphorylates and inactivates the actin binding/depolymerizing factor cofilin, thereby stabilizing the actin cytoskeleton. Required for motility of the axon growth cone. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P53666|LIMK2_CHICK LIM domain kinase 2 OS=Gallus gallus GN=LIMK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 298 bits (763), Expect = 6e-80, Method: Compositional matrix adjust.
Identities = 150/247 (60%), Positives = 186/247 (75%), Gaps = 4/247 (1%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+V V+RSL H NV++FIGVLYKD+KLNL+TEYI GGTLK+ L++ P PW Q+V+FA+
Sbjct: 376 EVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRN-ADPFPWQQKVSFAKG 434
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
IA+GM YLHSM +IHRDLNS NCL++ DKTVVVADFGL+R+I + + PT + +K
Sbjct: 435 IASGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKKPT-LEKPSAKKR 493
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
R+ RKKRYTVVGNPYWMAPEM+ GQ YDETVD+FS+GIVLCEIIG+V ADPD LPR+
Sbjct: 494 TLRKSDRKKRYTVVGNPYWMAPEMLNGQSYDETVDIFSFGIVLCEIIGQVYADPDCLPRT 553
Query: 328 PDFGLDQTDFRNKFC-ASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL-SVDK 385
DFGL+ F KF A CP F +A +CC L P+ RPPF LE E LS++L +
Sbjct: 554 LDFGLNVKLFWEKFVPADCPPAFFPLAAICCRLEPESRPPFSKLEDSFEALSLYLGELAI 613
Query: 386 PLPSDLE 392
PLPS+LE
Sbjct: 614 PLPSELE 620
|
Displays serine/threonine-specific phosphorylation of myelin basic protein and histone (MBP) in vitro. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P53667|LIMK1_HUMAN LIM domain kinase 1 OS=Homo sapiens GN=LIMK1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 296 bits (758), Expect = 2e-79, Method: Compositional matrix adjust.
Identities = 145/246 (58%), Positives = 180/246 (73%), Gaps = 8/246 (3%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+V V+R L H NV++FIGVLYKD++LN +TEYI GGTL+ +++ PW QRV+FA+D
Sbjct: 384 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 443
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
IA+GM YLHSMN+IHRDLNS NCLVRE+K VVVADFGLAR++ P +
Sbjct: 444 IASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL-------R 496
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
+ ++ RKKRYTVVGNPYWMAPEM+ G+ YDE VDVFS+GIVLCEIIGRV ADPDYLPR+
Sbjct: 497 SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 556
Query: 328 PDFGLDQTDFRNKFC-ASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKP 386
DFGL+ F +++C +CP F I CCDL+P++RP F LE WLE L MHL+ P
Sbjct: 557 MDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLP 616
Query: 387 LPSDLE 392
L LE
Sbjct: 617 LGPQLE 622
|
Serine/threonine-protein kinase that plays an essential role in the regulation of actin filament dynamics. Acts downstream of several Rho family GTPase signal transduction pathways. Activated by upstream kinases including ROCK1, PAK1 and PAK4, which phosphorylate LIMK1 on a threonine residue located in its activation loop. LIMK1 subsequently phosphorylates and inactivates the actin binding/depolymerizing factors cofilin-1/CFL1, cofilin-2/CFL2 and destrin/DSTN, thereby preventing the cleavage of filamentous actin (F-actin), and stabilizing the actin cytoskeleton. In this way LIMK1 regulates several actin-dependent biological processes including cell motility, cell cycle progression, and differentiation. Phosphorylates TPPP on serine residues, thereby promoting microtubule disassembly. Stimulates axonal outgrowth and may be involved in brain development. Isoform 3 has a dominant negative effect on actin cytoskeletal changes. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P53668|LIMK1_MOUSE LIM domain kinase 1 OS=Mus musculus GN=Limk1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (755), Expect = 5e-79, Method: Compositional matrix adjust.
Identities = 147/247 (59%), Positives = 181/247 (73%), Gaps = 10/247 (4%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+V V+R L H NV++FIGVLYKD++LN +TEYI GGTL+ ++++ PW QRV+FA+D
Sbjct: 384 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKNMDSQYPWSQRVSFAKD 443
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARI-IHQGPRAPTTVMAKVPRK 266
IA+GM YLHSMN+IHRDLNS NCLVRE++ VVVADFGLAR+ I + ++ K P
Sbjct: 444 IASGMAYLHSMNIIHRDLNSHNCLVRENRNVVVADFGLARLMIDEKNQSEDLRSLKKP-- 501
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326
RKKRYTVVGNPYWMAPEM+ G+ YDE VDVFS+GIVLCEIIGRV ADPDYLPR
Sbjct: 502 ------DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR 555
Query: 327 SPDFGLDQTDFRNKFC-ASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDK 385
+ DFGL+ F +++C +CP F I CCDL+P++RP F LE WLE L MHLS
Sbjct: 556 TMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEQWLETLRMHLSGHL 615
Query: 386 PLPSDLE 392
PL LE
Sbjct: 616 PLGPQLE 622
|
Serine/threonine-protein kinase that plays an essential role in the regulation of actin filament dynamics. Acts downstream of several Rho family GTPase signal transduction pathways. Activated by upstream kinases including ROCK1, PAK1 and PAK4, which phosphorylate LIMK1 on a threonine residue located in its activation loop. LIMK1 subsequently phosphorylates and inactivates the actin binding/depolymerizing factors cofilin-1/CFL1, cofilin-2/CFL2 and destrin/DSTN, thereby preventing the cleavage of filamentous actin (F-actin), and stabilizing the actin cytoskeleton. In this way LIMK1 regulates several actin-dependent biological processes including cell motility, cell cycle progression, and differentiation. Phosphorylates TPPP on serine residues, thereby promoting microtubule disassembly. Stimulates axonal outgrowth and may be involved in brain development. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P53669|LIMK1_RAT LIM domain kinase 1 OS=Rattus norvegicus GN=Limk1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 293 bits (750), Expect = 2e-78, Method: Compositional matrix adjust.
Identities = 143/246 (58%), Positives = 179/246 (72%), Gaps = 8/246 (3%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+V V+R L H NV++FIGVLYKD++LN +TEYI GGTL+ +++ PW QRV+FA+D
Sbjct: 384 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 443
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
IA+GM YLHSMN+IHRDLNS NCLVRE++ VVVADFGLAR++ +
Sbjct: 444 IASGMAYLHSMNIIHRDLNSHNCLVRENRNVVVADFGLARLM-------IDEKGQSEDLR 496
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
+ ++ RKKRYTVVGNPYWMAPEM+ G+ YDE VDVFS+GIVLCEIIGRV ADPDYLPR+
Sbjct: 497 SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 556
Query: 328 PDFGLDQTDFRNKFC-ASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKP 386
DFGL+ F +++C +CP F I CCDL+P++RP F LE WLE L MHL+ P
Sbjct: 557 MDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEQWLETLRMHLAGHLP 616
Query: 387 LPSDLE 392
L LE
Sbjct: 617 LGPQLE 622
|
Serine/threonine-protein kinase that plays an essential role in the regulation of actin filament dynamics. Acts downstream of several Rho family GTPase signal transduction pathways. Activated by upstream kinases including ROCK1, PAK1 and PAK4, which phosphorylate LIMK1 on a threonine residue located in its activation loop. LIMK1 subsequently phosphorylates and inactivates the actin binding/depolymerizing factors cofilin-1/CFL1, cofilin-2/CFL2 and destrin/DSTN, thereby preventing the cleavage of filamentous actin (F-actin), and stabilizing the actin cytoskeleton. In this way LIMK1 regulates several actin-dependent biological processes including cell motility, cell cycle progression, and differentiation. Phosphorylates TPPP on serine residues, thereby promoting microtubule disassembly. Stimulates axonal outgrowth and may be involved in brain development. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q32L23|LIMK2_BOVIN LIM domain kinase 2 OS=Bos taurus GN=LIMK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 291 bits (746), Expect = 6e-78, Method: Compositional matrix adjust.
Identities = 147/247 (59%), Positives = 183/247 (74%), Gaps = 4/247 (1%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+V V+RSL H NV++FIGVLYKD+KLNL+TEYI GGTLK+ L++ P PW Q+V FA+
Sbjct: 376 EVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRNV-DPFPWQQKVRFAKG 434
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
IA+GM YLHSM +IHRDLNS NCL++ DKTVVVADFGL+R+I + + P A +K
Sbjct: 435 IASGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKKPPVEKATT-KKR 493
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
R+ RKKRYTVVGNPYWMAPEM+ G+ YDETVDVFS+GIVLCEIIG+V ADPD LPR+
Sbjct: 494 TLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRT 553
Query: 328 PDFGLDQTDFRNKFC-ASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL-SVDK 385
DFGL+ F KF CP F +A +CC L P+ RP F LE + E LS++L +
Sbjct: 554 LDFGLNVKLFWEKFVPEECPPAFFPLAAICCRLEPESRPAFSKLEDFFEALSLYLGELGI 613
Query: 386 PLPSDLE 392
PLP++LE
Sbjct: 614 PLPTELE 620
|
Displays serine/threonine-specific phosphorylation of myelin basic protein and histone (MBP) in vitro. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P53670|LIMK2_RAT LIM domain kinase 2 OS=Rattus norvegicus GN=Limk2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 290 bits (743), Expect = 1e-77, Method: Compositional matrix adjust.
Identities = 147/247 (59%), Positives = 182/247 (73%), Gaps = 4/247 (1%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+V V+RSL H NV++FIGVLYKD+KLNL+TEYI GGTLK+ L++ P PW Q+V FA+
Sbjct: 376 EVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRNV-DPFPWQQKVRFAKG 434
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
IA+GM YLHSM +IHRDLNS NCL++ DKTVVVADFGL+R+I + + P A +K
Sbjct: 435 IASGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKAAT-KKR 493
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
R+ RKKRYTVVGNPYWMAPEM+ G+ YDETVDVFS+GIVLCEIIG+V ADPD LPR+
Sbjct: 494 TLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRT 553
Query: 328 PDFGLDQTDFRNKFCAS-CPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL-SVDK 385
DFGL+ F KF + CP F +A +CC L P+ RP F LE E LS+ L +
Sbjct: 554 LDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSLFLGELAI 613
Query: 386 PLPSDLE 392
PLP++LE
Sbjct: 614 PLPAELE 620
|
Displays serine/threonine-specific phosphorylation of myelin basic protein and histone (MBP) in vitro. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P53671|LIMK2_HUMAN LIM domain kinase 2 OS=Homo sapiens GN=LIMK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 289 bits (739), Expect = 3e-77, Method: Compositional matrix adjust.
Identities = 147/248 (59%), Positives = 183/248 (73%), Gaps = 6/248 (2%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+V V+RSL H NV++FIGVLYKD+KLNL+TEYI GGTLK+ L+ P PW Q+V FA+
Sbjct: 376 EVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRS-MDPFPWQQKVRFAKG 434
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLAR-IIHQGPRAPTTVMAKVPRK 266
IA+GM YLHSM +IHRDLNS NCL++ DKTVVVADFGL+R I+ + RAP + +K
Sbjct: 435 IASGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRAP--MEKATTKK 492
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326
R+ RKKRYTVVGNPYWMAPEM+ G+ YDETVD+FS+GIVLCEIIG+V ADPD LPR
Sbjct: 493 RTLRKNDRKKRYTVVGNPYWMAPEMLNGKSYDETVDIFSFGIVLCEIIGQVYADPDCLPR 552
Query: 327 SPDFGLDQTDFRNKFCAS-CPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL-SVD 384
+ DFGL+ F KF + CP F +A +CC L P+ RP F LE E LS++L +
Sbjct: 553 TLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCRLEPESRPAFSKLEDSFEALSLYLGELG 612
Query: 385 KPLPSDLE 392
PLP++LE
Sbjct: 613 IPLPAELE 620
|
Displays serine/threonine-specific phosphorylation of myelin basic protein and histone (MBP) in vitro. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O54785|LIMK2_MOUSE LIM domain kinase 2 OS=Mus musculus GN=Limk2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 288 bits (738), Expect = 4e-77, Method: Compositional matrix adjust.
Identities = 146/247 (59%), Positives = 181/247 (73%), Gaps = 4/247 (1%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+V V+RSL H NV++FIGVLYKD+KLNL+TEYI GGTLK+ L+ P PW Q+V FA+
Sbjct: 376 EVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV-DPFPWQQKVRFAKG 434
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
I++GM YLHSM +IHRDLNS NCL++ DKTVVVADFGL+R+I + + P A +K
Sbjct: 435 ISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATT-KKR 493
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
R+ RKKRYTVVGNPYWMAPEM+ G+ YDETVDVFS+GIVLCEIIG+V ADPD LPR+
Sbjct: 494 TLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRT 553
Query: 328 PDFGLDQTDFRNKFCAS-CPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL-SVDK 385
DFGL+ F KF + CP F +A +CC L P+ RP F LE E LS+ L +
Sbjct: 554 LDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSLFLGELAI 613
Query: 386 PLPSDLE 392
PLP++LE
Sbjct: 614 PLPAELE 620
|
Displays serine/threonine-specific phosphorylation of myelin basic protein and histone (MBP) in vitro. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 433 | ||||||
| 345487720 | 1112 | PREDICTED: LIM domain kinase 1-like isof | 0.598 | 0.232 | 0.708 | 1e-109 | |
| 345487718 | 1143 | PREDICTED: LIM domain kinase 1-like isof | 0.598 | 0.226 | 0.708 | 1e-109 | |
| 91085311 | 819 | PREDICTED: similar to LIM domain kinase | 0.655 | 0.346 | 0.641 | 1e-104 | |
| 332025854 | 1225 | LIM domain kinase 1 [Acromyrmex echinati | 0.579 | 0.204 | 0.710 | 1e-104 | |
| 270009126 | 846 | hypothetical protein TcasGA2_TC015763 [T | 0.655 | 0.335 | 0.641 | 1e-104 | |
| 383855916 | 1190 | PREDICTED: LIM domain kinase 1-like [Meg | 0.581 | 0.211 | 0.707 | 1e-104 | |
| 322792342 | 1153 | hypothetical protein SINV_06854 [Solenop | 0.639 | 0.240 | 0.658 | 1e-104 | |
| 242011461 | 664 | LIM domain kinase, putative [Pediculus h | 0.551 | 0.359 | 0.721 | 1e-104 | |
| 380030744 | 1186 | PREDICTED: LIM domain kinase 1-like isof | 0.579 | 0.211 | 0.698 | 1e-104 | |
| 307177067 | 1316 | LIM domain kinase 1 [Camponotus floridan | 0.639 | 0.210 | 0.654 | 1e-104 |
| >gi|345487720|ref|XP_003425744.1| PREDICTED: LIM domain kinase 1-like isoform 2 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 400 bits (1028), Expect = e-109, Method: Compositional matrix adjust.
Identities = 187/264 (70%), Positives = 217/264 (82%), Gaps = 5/264 (1%)
Query: 141 EACQN-CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 199
EA +N +VAVLRSLHH+NV+RFIGVLYKD+KL+LVTE+I+GGTL+ LL D + LPW
Sbjct: 393 EAQKNFLKEVAVLRSLHHNNVLRFIGVLYKDKKLHLVTEFISGGTLRALLHDTSETLPWE 452
Query: 200 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG----PRA 255
QR +FA+DIAAGM YLHSMN+IHRDLNS NCLVREDKTVVVADFGLARII G ++
Sbjct: 453 QRTSFAKDIAAGMAYLHSMNIIHRDLNSHNCLVREDKTVVVADFGLARIIQNGNAPDKQS 512
Query: 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG 315
P + + R RKKRYTVVGNPYWMAPEMM G +YDE VD+FS+GIV+CEIIG
Sbjct: 513 PGKYTRRSDGEVRTSRKERKKRYTVVGNPYWMAPEMMKGNKYDEKVDIFSFGIVMCEIIG 572
Query: 316 RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375
RV ADPDYLPRS DFGL++ F++KFCA+CPE F IAFLCCDLNPD+RPPFEV+EVWLE
Sbjct: 573 RVQADPDYLPRSSDFGLNKKAFKDKFCANCPECFYTIAFLCCDLNPDKRPPFEVMEVWLE 632
Query: 376 GLSMHLSVDKPLPSDLEADIYQFA 399
GL+MHLSVD PLPSDLEADI +A
Sbjct: 633 GLAMHLSVDAPLPSDLEADIKNYA 656
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|345487718|ref|XP_003425743.1| PREDICTED: LIM domain kinase 1-like isoform 1 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 400 bits (1027), Expect = e-109, Method: Compositional matrix adjust.
Identities = 187/264 (70%), Positives = 217/264 (82%), Gaps = 5/264 (1%)
Query: 141 EACQN-CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 199
EA +N +VAVLRSLHH+NV+RFIGVLYKD+KL+LVTE+I+GGTL+ LL D + LPW
Sbjct: 424 EAQKNFLKEVAVLRSLHHNNVLRFIGVLYKDKKLHLVTEFISGGTLRALLHDTSETLPWE 483
Query: 200 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG----PRA 255
QR +FA+DIAAGM YLHSMN+IHRDLNS NCLVREDKTVVVADFGLARII G ++
Sbjct: 484 QRTSFAKDIAAGMAYLHSMNIIHRDLNSHNCLVREDKTVVVADFGLARIIQNGNAPDKQS 543
Query: 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG 315
P + + R RKKRYTVVGNPYWMAPEMM G +YDE VD+FS+GIV+CEIIG
Sbjct: 544 PGKYTRRSDGEVRTSRKERKKRYTVVGNPYWMAPEMMKGNKYDEKVDIFSFGIVMCEIIG 603
Query: 316 RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375
RV ADPDYLPRS DFGL++ F++KFCA+CPE F IAFLCCDLNPD+RPPFEV+EVWLE
Sbjct: 604 RVQADPDYLPRSSDFGLNKKAFKDKFCANCPECFYTIAFLCCDLNPDKRPPFEVMEVWLE 663
Query: 376 GLSMHLSVDKPLPSDLEADIYQFA 399
GL+MHLSVD PLPSDLEADI +A
Sbjct: 664 GLAMHLSVDAPLPSDLEADIKNYA 687
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|91085311|ref|XP_968975.1| PREDICTED: similar to LIM domain kinase 1 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 386 bits (992), Expect = e-104, Method: Compositional matrix adjust.
Identities = 188/293 (64%), Positives = 224/293 (76%), Gaps = 9/293 (3%)
Query: 141 EACQN-CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 199
EA +N +VAVLRSLHH+NV+RFIGVLYK+R+L+LVTEYI+GGTL EL+ D QPLPW
Sbjct: 369 EAQKNFLKEVAVLRSLHHNNVLRFIGVLYKERRLHLVTEYISGGTLTELIHDTSQPLPWE 428
Query: 200 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259
QRV+FA+DIAAGM YLHSMN+IHRDLNS NCLVREDKTV+VADFGLARI+ + T
Sbjct: 429 QRVSFAKDIAAGMAYLHSMNIIHRDLNSHNCLVREDKTVIVADFGLARIVSHTTNSAT-- 486
Query: 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPA 319
+ + +R RKKRYTVVGNPYWMAPEMM G +YDE VD+FS+GI+LCEIIGRV A
Sbjct: 487 ------RMSPKRQERKKRYTVVGNPYWMAPEMMKGNKYDEKVDIFSFGIILCEIIGRVLA 540
Query: 320 DPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379
DPD+LPRS DFGL+Q F+ KFCASCPE F +IAFLC DLNPD+RPPFEV+EVWLE LSM
Sbjct: 541 DPDFLPRSNDFGLNQMTFKEKFCASCPEAFYKIAFLCTDLNPDKRPPFEVMEVWLESLSM 600
Query: 380 HLSVDKPLPSDLEADIYQFATRKSASPLTEPECTAPTPADGALRPILETQSSK 432
HLSV PLP DL DI + +S + + AL PI E ++++
Sbjct: 601 HLSVGMPLPPDLLFDIQHYRGISPSSSGSNTPDSISGHRSPALEPIKEGKTTE 653
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332025854|gb|EGI66010.1| LIM domain kinase 1 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 386 bits (991), Expect = e-104, Method: Compositional matrix adjust.
Identities = 179/252 (71%), Positives = 205/252 (81%), Gaps = 1/252 (0%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+VAVLRSLHH+NV+RFIGVLYKD+KL+LVTEYIAGGTL+ LL D +PLPW QR +FA+D
Sbjct: 467 EVAVLRSLHHNNVLRFIGVLYKDKKLHLVTEYIAGGTLRALLHDTNEPLPWEQRTSFAKD 526
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR-K 266
IAAGM YLHSMN+IHRDLNS NCLVREDKTVVVADFGLARII G + +
Sbjct: 527 IAAGMAYLHSMNIIHRDLNSHNCLVREDKTVVVADFGLARIIQNGSSPDNRKYNRHSNGE 586
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326
+ RKKRYTVVGNPYWMAPEMM G +YDE VD+FS+GIV+CEIIGRV ADPDYLPR
Sbjct: 587 VKTSKKERKKRYTVVGNPYWMAPEMMKGNKYDEKVDIFSFGIVVCEIIGRVQADPDYLPR 646
Query: 327 SPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKP 386
S DFGL+Q F+ KFC++CPE F IAFLCCDLNPD+RPPFEV+EVWLEGL+MHLSV
Sbjct: 647 SSDFGLNQNVFKEKFCSNCPETFYMIAFLCCDLNPDKRPPFEVMEVWLEGLAMHLSVGAE 706
Query: 387 LPSDLEADIYQF 398
LP DL+ DI +
Sbjct: 707 LPVDLDFDIRNY 718
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270009126|gb|EFA05574.1| hypothetical protein TcasGA2_TC015763 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 385 bits (990), Expect = e-104, Method: Compositional matrix adjust.
Identities = 188/293 (64%), Positives = 224/293 (76%), Gaps = 9/293 (3%)
Query: 141 EACQN-CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 199
EA +N +VAVLRSLHH+NV+RFIGVLYK+R+L+LVTEYI+GGTL EL+ D QPLPW
Sbjct: 396 EAQKNFLKEVAVLRSLHHNNVLRFIGVLYKERRLHLVTEYISGGTLTELIHDTSQPLPWE 455
Query: 200 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259
QRV+FA+DIAAGM YLHSMN+IHRDLNS NCLVREDKTV+VADFGLARI+ + T
Sbjct: 456 QRVSFAKDIAAGMAYLHSMNIIHRDLNSHNCLVREDKTVIVADFGLARIVSHTTNSAT-- 513
Query: 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPA 319
+ + +R RKKRYTVVGNPYWMAPEMM G +YDE VD+FS+GI+LCEIIGRV A
Sbjct: 514 ------RMSPKRQERKKRYTVVGNPYWMAPEMMKGNKYDEKVDIFSFGIILCEIIGRVLA 567
Query: 320 DPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379
DPD+LPRS DFGL+Q F+ KFCASCPE F +IAFLC DLNPD+RPPFEV+EVWLE LSM
Sbjct: 568 DPDFLPRSNDFGLNQMTFKEKFCASCPEAFYKIAFLCTDLNPDKRPPFEVMEVWLESLSM 627
Query: 380 HLSVDKPLPSDLEADIYQFATRKSASPLTEPECTAPTPADGALRPILETQSSK 432
HLSV PLP DL DI + +S + + AL PI E ++++
Sbjct: 628 HLSVGMPLPPDLLFDIQHYRGISPSSSGSNTPDSISGHRSPALEPIKEGKTTE 680
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383855916|ref|XP_003703456.1| PREDICTED: LIM domain kinase 1-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 385 bits (989), Expect = e-104, Method: Compositional matrix adjust.
Identities = 179/253 (70%), Positives = 207/253 (81%), Gaps = 1/253 (0%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+VAVLRSLHH+NV+RFIGVLYKD+KL+LVTEYIAGGTL+ LL D + LPW QR++FA+D
Sbjct: 422 EVAVLRSLHHNNVLRFIGVLYKDKKLHLVTEYIAGGTLRALLHDTSETLPWEQRMSFAKD 481
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR-K 266
IAAGM YLHSMN+IHRDLNS NCLVREDKTVVVADFGLARII G ++ +
Sbjct: 482 IAAGMAYLHSMNIIHRDLNSHNCLVREDKTVVVADFGLARIIQNGNSPDNRKYSRHSDGE 541
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326
+ RKKRYTVVGNPYWMAPEMM G +YDE VD+FS+GIV+CEIIGRV ADPDYLPR
Sbjct: 542 VKTSKKERKKRYTVVGNPYWMAPEMMKGNKYDEKVDIFSFGIVVCEIIGRVQADPDYLPR 601
Query: 327 SPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKP 386
S DFGL+Q F+ KFCA+CPE F RIAFLCCDLNPD+RPPFEV++VWL+GL MHLS+
Sbjct: 602 SSDFGLNQNVFKEKFCANCPEMFYRIAFLCCDLNPDKRPPFEVMQVWLDGLVMHLSMGIE 661
Query: 387 LPSDLEADIYQFA 399
LPSDLE DI +
Sbjct: 662 LPSDLEIDIKNYT 674
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|322792342|gb|EFZ16326.1| hypothetical protein SINV_06854 [Solenopsis invicta] | Back alignment and taxonomy information |
|---|
Score = 384 bits (987), Expect = e-104, Method: Compositional matrix adjust.
Identities = 183/278 (65%), Positives = 214/278 (76%), Gaps = 1/278 (0%)
Query: 122 YFEKDGLLFCKEDYNGKYGEACQNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIA 181
+ + D ++ KE Y +VAVLRSLHH+NV+RFIGVLYKD+KL+LVTEYIA
Sbjct: 357 HRDTDEVMVLKELYRVDEDAQKNFLKEVAVLRSLHHNNVLRFIGVLYKDKKLHLVTEYIA 416
Query: 182 GGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVA 241
GGTL+ LL D +PLPW QR +FA+DIAAGM YLHSMN+IHRDLNS NCLVREDKTVVVA
Sbjct: 417 GGTLRALLHDTNEPLPWEQRTSFAKDIAAGMAYLHSMNIIHRDLNSHNCLVREDKTVVVA 476
Query: 242 DFGLARIIHQGPRAPTTVMAKVPR-KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDET 300
DFGLARII G + + + RKKRYTVVGNPYWMAPEMM G +YDE
Sbjct: 477 DFGLARIIQNGSSPDNRKYNRHSDGEVKTSKKERKKRYTVVGNPYWMAPEMMKGNKYDEK 536
Query: 301 VDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLN 360
VD+FS+GIV+CEIIGRV ADPDYLPRS DFGL+Q F+ KFC++CPE F IAFLCCDLN
Sbjct: 537 VDLFSFGIVVCEIIGRVQADPDYLPRSSDFGLNQNVFKEKFCSNCPETFYMIAFLCCDLN 596
Query: 361 PDQRPPFEVLEVWLEGLSMHLSVDKPLPSDLEADIYQF 398
PD+RPPFEV+EVWLEGL+MHLSV LP+DL+ DI +
Sbjct: 597 PDKRPPFEVMEVWLEGLAMHLSVGAELPADLDFDIRNY 634
|
Source: Solenopsis invicta Species: Solenopsis invicta Genus: Solenopsis Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242011461|ref|XP_002426468.1| LIM domain kinase, putative [Pediculus humanus corporis] gi|212510580|gb|EEB13730.1| LIM domain kinase, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 384 bits (985), Expect = e-104, Method: Compositional matrix adjust.
Identities = 181/251 (72%), Positives = 208/251 (82%), Gaps = 12/251 (4%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+VAVLRSLHH NV+RFIGVL KD+KL+LVTE+I+GGTLK+L+ D +PLPW QRVNFA++
Sbjct: 375 EVAVLRSLHHCNVLRFIGVLCKDKKLHLVTEFISGGTLKDLIHDMNEPLPWEQRVNFAKN 434
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
IA+GM+YLH+ N+IHRDLNS NCLVREDKTVVVADFGLARI+ Q +
Sbjct: 435 IASGMSYLHARNIIHRDLNSHNCLVREDKTVVVADFGLARIVSQNT------------GS 482
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
+R RKKRYTVVGNPYWMAPEMM G +YDE VD+FS+GIVLCEIIGRV ADPDYLPRS
Sbjct: 483 GSKRCERKKRYTVVGNPYWMAPEMMKGYKYDEKVDIFSFGIVLCEIIGRVQADPDYLPRS 542
Query: 328 PDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPL 387
DFGL+Q+ FR KFC +CPE F R+AFLCCDLNPDQRPPFEV+EVWLEGLSMHLSV PL
Sbjct: 543 KDFGLNQSVFREKFCTNCPESFYRLAFLCCDLNPDQRPPFEVMEVWLEGLSMHLSVGIPL 602
Query: 388 PSDLEADIYQF 398
P DLE DIY +
Sbjct: 603 PHDLEYDIYNY 613
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380030744|ref|XP_003699002.1| PREDICTED: LIM domain kinase 1-like isoform 2 [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 383 bits (984), Expect = e-104, Method: Compositional matrix adjust.
Identities = 176/252 (69%), Positives = 207/252 (82%), Gaps = 1/252 (0%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+VAVLRSLHH+NV+RFIGVLYKD+KL+LVTEYIAGGTL+ LL D + LPW QR +FA+D
Sbjct: 422 EVAVLRSLHHNNVLRFIGVLYKDKKLHLVTEYIAGGTLRALLHDTNEILPWEQRTSFAKD 481
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR-K 266
IAAGM YLHSMN+IHRDLNS NCLVREDKTVVVADFGLARII G ++ +
Sbjct: 482 IAAGMAYLHSMNIIHRDLNSHNCLVREDKTVVVADFGLARIIQNGNSPDNRKYSRHSEGE 541
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326
A + RKKRYTVVGNPYWMAPEMM G +YDE VD+FS+GIV+CEIIGRV ADPDYLPR
Sbjct: 542 AKTSKKERKKRYTVVGNPYWMAPEMMKGNKYDEKVDIFSFGIVVCEIIGRVQADPDYLPR 601
Query: 327 SPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKP 386
S DFGL+Q F+ KFC++CPE F IAFLCCDLNPD+RPPFE++++WLEGL+MHLS+
Sbjct: 602 SSDFGLNQNVFKEKFCSNCPEMFYMIAFLCCDLNPDKRPPFEIMQLWLEGLAMHLSMGAE 661
Query: 387 LPSDLEADIYQF 398
LPS+LE DI +
Sbjct: 662 LPSNLEYDIRNY 673
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307177067|gb|EFN66335.1| LIM domain kinase 1 [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 383 bits (984), Expect = e-104, Method: Compositional matrix adjust.
Identities = 182/278 (65%), Positives = 214/278 (76%), Gaps = 1/278 (0%)
Query: 122 YFEKDGLLFCKEDYNGKYGEACQNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIA 181
+ + D ++ KE Y +VAVLRSLHH+NV+RFIGVLYKD+KL+LVTEYIA
Sbjct: 529 HRDTDEVMVLKELYRVDEDAQKNFLKEVAVLRSLHHNNVLRFIGVLYKDKKLHLVTEYIA 588
Query: 182 GGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVA 241
GGTL+ LL D +PLPW QR +FA+DIAAGM YLHSMN+IHRDLNS NCLVREDKTVVVA
Sbjct: 589 GGTLRALLHDTNEPLPWEQRTSFAKDIAAGMAYLHSMNIIHRDLNSHNCLVREDKTVVVA 648
Query: 242 DFGLARIIHQGPRAPTTVMAKVPR-KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDET 300
DFGLARII G + + + RKKRYTVVGNPYWMAPEMM G +YDE
Sbjct: 649 DFGLARIIQNGSSPDNRKYNRHSDGEVKTSKKERKKRYTVVGNPYWMAPEMMKGNKYDEK 708
Query: 301 VDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLN 360
VD+FS+GIV+CEIIGRV ADPDYLPRS DFGL+Q F+ KFC++CPE F IAFLCCDLN
Sbjct: 709 VDIFSFGIVVCEIIGRVQADPDYLPRSSDFGLNQNVFKEKFCSNCPETFYMIAFLCCDLN 768
Query: 361 PDQRPPFEVLEVWLEGLSMHLSVDKPLPSDLEADIYQF 398
PD+RPPFEV+EVWLEGL+MHLSV LP++L+ DI +
Sbjct: 769 PDKRPPFEVMEVWLEGLAMHLSVGAELPANLDFDIRNY 806
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 433 | ||||||
| FB|FBgn0041203 | 1257 | LIMK1 "LIM-kinase1" [Drosophil | 0.618 | 0.213 | 0.572 | 5.3e-113 | |
| UNIPROTKB|P53666 | 642 | LIMK2 "LIM domain kinase 2" [G | 0.561 | 0.378 | 0.582 | 3.2e-100 | |
| UNIPROTKB|F1NVM7 | 648 | LIMK1 "LIM domain kinase 1" [G | 0.547 | 0.365 | 0.587 | 3.7e-99 | |
| UNIPROTKB|Q8QFP8 | 662 | LIMK1 "LIM domain kinase 1" [G | 0.547 | 0.358 | 0.587 | 3.7e-99 | |
| UNIPROTKB|F1NXY2 | 643 | LIMK1 "LIM domain kinase 1" [G | 0.547 | 0.368 | 0.582 | 9.7e-99 | |
| UNIPROTKB|F1PAG0 | 637 | LIMK2 "Uncharacterized protein | 0.561 | 0.381 | 0.574 | 6.8e-98 | |
| UNIPROTKB|F1MGL9 | 638 | LIMK2 "LIM domain kinase 2" [B | 0.561 | 0.380 | 0.570 | 1.8e-97 | |
| UNIPROTKB|Q32L23 | 638 | LIMK2 "LIM domain kinase 2" [B | 0.561 | 0.380 | 0.570 | 1.8e-97 | |
| ZFIN|ZDB-GENE-061212-3 | 648 | limk1a "LIM domain kinase 1a" | 0.565 | 0.378 | 0.555 | 2.9e-97 | |
| UNIPROTKB|F1RPC2 | 617 | LIMK2 "Uncharacterized protein | 0.561 | 0.393 | 0.570 | 6e-97 |
| FB|FBgn0041203 LIMK1 "LIM-kinase1" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 822 (294.4 bits), Expect = 5.3e-113, Sum P(2) = 5.3e-113
Identities = 166/290 (57%), Positives = 206/290 (71%)
Query: 141 EACQN-CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 199
EA +N +VAVLR L H +V++FIGVLYKD+KL++VTEY+AGG LKEL+ DP Q LPW
Sbjct: 438 EAQRNFIKEVAVLRLLDHRHVLKFIGVLYKDKKLHMVTEYVAGGCLKELIHDPAQVLPWP 497
Query: 200 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259
QRV ARDIA GM+YLHSMN+IHRDLNS NCLVRED++V+VADFGLAR + PR P+
Sbjct: 498 QRVRLARDIACGMSYLHSMNIIHRDLNSMNCLVREDRSVIVADFGLARSV-DAPRLPSGN 556
Query: 260 M----------AKVPXXXXXXXXXXXXX-----YTVVGNPYWMAPEMMTGQEYDETVDVF 304
M + P YTVVGNPYWMAPEMM G +YDE VDVF
Sbjct: 557 MTPGGYGSGANSDAPMSPSGTLRRSKSRQRRQRYTVVGNPYWMAPEMMKGLKYDEKVDVF 616
Query: 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQR 364
S+GI+LCEIIGRV ADPD++PR+ DF L+Q +FR KFCA CPEPFV++AF+CCDLNPD R
Sbjct: 617 SFGIMLCEIIGRVEADPDFMPRNSDFSLNQQEFREKFCAQCPEPFVKVAFVCCDLNPDMR 676
Query: 365 PPFEVLEVWLEGLSMHLSVDKPLPSDL--EADIYQ--FATRKSA-SPLTE 409
P FE L VWL+ L+ L+ D+ P L E + +Q +A+ + A SP ++
Sbjct: 677 PCFETLHVWLQRLADDLAADRVPPERLLHEIETFQEWYASSEDALSPTSQ 726
|
|
| UNIPROTKB|P53666 LIMK2 "LIM domain kinase 2" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 723 (259.6 bits), Expect = 3.2e-100, Sum P(2) = 3.2e-100
Identities = 144/247 (58%), Positives = 177/247 (71%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+V V+RSL H NV++FIGVLYKD+KLNL+TEYI GGTLK+ L++ P PW Q+V+FA+
Sbjct: 376 EVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRN-ADPFPWQQKVSFAKG 434
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPXXX 267
IA+GM YLHSM +IHRDLNS NCL++ DKTVVVADFGL+R+I + + PT
Sbjct: 435 IASGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKKPTLEKPSAKKRT 494
Query: 268 XXXXXXXXXXYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
YTVVGNPYWMAPEM+ GQ YDETVD+FS+GIVLCEIIG+V ADPD LPR+
Sbjct: 495 LRKSDRKKR-YTVVGNPYWMAPEMLNGQSYDETVDIFSFGIVLCEIIGQVYADPDCLPRT 553
Query: 328 PDFGLDQTDFRNKFC-ASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLS-VDK 385
DFGL+ F KF A CP F +A +CC L P+ RPPF LE E LS++L +
Sbjct: 554 LDFGLNVKLFWEKFVPADCPPAFFPLAAICCRLEPESRPPFSKLEDSFEALSLYLGELAI 613
Query: 386 PLPSDLE 392
PLPS+LE
Sbjct: 614 PLPSELE 620
|
|
| UNIPROTKB|F1NVM7 LIMK1 "LIM domain kinase 1" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 748 (268.4 bits), Expect = 3.7e-99, Sum P(2) = 3.7e-99
Identities = 145/247 (58%), Positives = 177/247 (71%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+V V+R L H NV++FIGVLYK+++LN +TEYI GGTL+ L++ PW QRV+FA+D
Sbjct: 377 EVKVMRCLEHPNVLKFIGVLYKEKRLNFITEYIKGGTLRGLIKSMDSHYPWSQRVSFAKD 436
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM-AKVPXX 266
IAAGM YLHSMN+IHRDLNS NCLVRE+K+VVVADFGLAR++ P + K P
Sbjct: 437 IAAGMAYLHSMNIIHRDLNSHNCLVRENKSVVVADFGLARLMVDEKNQPEHLQNLKKPDR 496
Query: 267 XXXXXXXXXXXYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326
YTVVGNPYWMAPEM+ G+ YDE VD+FS+GIVLCEIIGRV ADPDYLPR
Sbjct: 497 KKR--------YTVVGNPYWMAPEMINGRSYDEKVDIFSFGIVLCEIIGRVSADPDYLPR 548
Query: 327 SPDFGLDQTDFRNKFCA-SCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDK 385
+ DFGL+ F ++C +CP F IA CCDL+P++RP F LE WLE L MHL +
Sbjct: 549 TTDFGLNVRGFLERYCPPACPPSFFPIAACCCDLDPEKRPSFSKLEQWLETLRMHLDIRL 608
Query: 386 PLPSDLE 392
PL S LE
Sbjct: 609 PLSSQLE 615
|
|
| UNIPROTKB|Q8QFP8 LIMK1 "LIM domain kinase 1" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 748 (268.4 bits), Expect = 3.7e-99, Sum P(2) = 3.7e-99
Identities = 145/247 (58%), Positives = 177/247 (71%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+V V+R L H NV++FIGVLYK+++LN +TEYI GGTL+ L++ PW QRV+FA+D
Sbjct: 391 EVKVMRCLEHPNVLKFIGVLYKEKRLNFITEYIKGGTLRGLIKSMDSHYPWSQRVSFAKD 450
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM-AKVPXX 266
IAAGM YLHSMN+IHRDLNS NCLVRE+K+VVVADFGLAR++ P + K P
Sbjct: 451 IAAGMAYLHSMNIIHRDLNSHNCLVRENKSVVVADFGLARLMVDEKNQPEHLQNLKKPDR 510
Query: 267 XXXXXXXXXXXYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326
YTVVGNPYWMAPEM+ G+ YDE VD+FS+GIVLCEIIGRV ADPDYLPR
Sbjct: 511 KKR--------YTVVGNPYWMAPEMINGRSYDEKVDIFSFGIVLCEIIGRVSADPDYLPR 562
Query: 327 SPDFGLDQTDFRNKFCA-SCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDK 385
+ DFGL+ F ++C +CP F IA CCDL+P++RP F LE WLE L MHL +
Sbjct: 563 TTDFGLNVRGFLERYCPPACPPSFFPIAACCCDLDPEKRPSFSKLEQWLETLRMHLDIRL 622
Query: 386 PLPSDLE 392
PL S LE
Sbjct: 623 PLSSQLE 629
|
|
| UNIPROTKB|F1NXY2 LIMK1 "LIM domain kinase 1" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 744 (267.0 bits), Expect = 9.7e-99, Sum P(2) = 9.7e-99
Identities = 144/247 (58%), Positives = 176/247 (71%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+ V+R L H NV++FIGVLYK+++LN +TEYI GGTL+ L++ PW QRV+FA+D
Sbjct: 372 EAMVMRCLEHPNVLKFIGVLYKEKRLNFITEYIKGGTLRGLIKSMDSHYPWSQRVSFAKD 431
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM-AKVPXX 266
IAAGM YLHSMN+IHRDLNS NCLVRE+K+VVVADFGLAR++ P + K P
Sbjct: 432 IAAGMAYLHSMNIIHRDLNSHNCLVRENKSVVVADFGLARLMVDEKNQPEHLQNLKKPDR 491
Query: 267 XXXXXXXXXXXYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326
YTVVGNPYWMAPEM+ G+ YDE VD+FS+GIVLCEIIGRV ADPDYLPR
Sbjct: 492 KKR--------YTVVGNPYWMAPEMINGRSYDEKVDIFSFGIVLCEIIGRVSADPDYLPR 543
Query: 327 SPDFGLDQTDFRNKFCA-SCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDK 385
+ DFGL+ F ++C +CP F IA CCDL+P++RP F LE WLE L MHL +
Sbjct: 544 TTDFGLNVRGFLERYCPPACPPSFFPIAACCCDLDPEKRPSFSKLEQWLETLRMHLDIRL 603
Query: 386 PLPSDLE 392
PL S LE
Sbjct: 604 PLSSQLE 610
|
|
| UNIPROTKB|F1PAG0 LIMK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 706 (253.6 bits), Expect = 6.8e-98, Sum P(2) = 6.8e-98
Identities = 142/247 (57%), Positives = 175/247 (70%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+V V+RSL H NV++FIGVLYKD+KLNL+TEYI GGTLK+ L+ P PW Q+V FA+
Sbjct: 376 EVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV-DPFPWQQKVRFAKG 434
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPXXX 267
IA+GM YLHSM +IHRDLNS NCL++ DKTVVVADFGL+R+I + + P T A
Sbjct: 435 IASGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKKPPTEKA-TSKKR 493
Query: 268 XXXXXXXXXXYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
YTVVGNPYWMAPEM+ G+ YDETVDVFS+GIVLCEIIG+V ADPD LPR+
Sbjct: 494 TLRKNDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRT 553
Query: 328 PDFGLDQTDFRNKFCAS-CPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLS-VDK 385
DFGL+ F KF + CP F +A +CC L P+ RP F LE E LS++L +
Sbjct: 554 LDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSLYLGELGI 613
Query: 386 PLPSDLE 392
PLP++LE
Sbjct: 614 PLPAELE 620
|
|
| UNIPROTKB|F1MGL9 LIMK2 "LIM domain kinase 2" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 705 (253.2 bits), Expect = 1.8e-97, Sum P(2) = 1.8e-97
Identities = 141/247 (57%), Positives = 175/247 (70%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+V V+RSL H NV++FIGVLYKD+KLNL+TEYI GGTLK+ L++ P PW Q+V FA+
Sbjct: 376 EVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRNV-DPFPWQQKVRFAKG 434
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPXXX 267
IA+GM YLHSM +IHRDLNS NCL++ DKTVVVADFGL+R+I + + P A
Sbjct: 435 IASGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKKPPVEKATTKKRT 494
Query: 268 XXXXXXXXXXYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
YTVVGNPYWMAPEM+ G+ YDETVDVFS+GIVLCEIIG+V ADPD LPR+
Sbjct: 495 LRKSDRKKR-YTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRT 553
Query: 328 PDFGLDQTDFRNKFCAS-CPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLS-VDK 385
DFGL+ F KF CP F +A +CC L P+ RP F LE + E LS++L +
Sbjct: 554 LDFGLNVKLFWEKFVPEECPPAFFPLAAICCRLEPESRPAFSKLEDFFEALSLYLGELGI 613
Query: 386 PLPSDLE 392
PLP++LE
Sbjct: 614 PLPTELE 620
|
|
| UNIPROTKB|Q32L23 LIMK2 "LIM domain kinase 2" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 705 (253.2 bits), Expect = 1.8e-97, Sum P(2) = 1.8e-97
Identities = 141/247 (57%), Positives = 175/247 (70%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+V V+RSL H NV++FIGVLYKD+KLNL+TEYI GGTLK+ L++ P PW Q+V FA+
Sbjct: 376 EVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRNV-DPFPWQQKVRFAKG 434
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPXXX 267
IA+GM YLHSM +IHRDLNS NCL++ DKTVVVADFGL+R+I + + P A
Sbjct: 435 IASGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKKPPVEKATTKKRT 494
Query: 268 XXXXXXXXXXYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
YTVVGNPYWMAPEM+ G+ YDETVDVFS+GIVLCEIIG+V ADPD LPR+
Sbjct: 495 LRKSDRKKR-YTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRT 553
Query: 328 PDFGLDQTDFRNKFCAS-CPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLS-VDK 385
DFGL+ F KF CP F +A +CC L P+ RP F LE + E LS++L +
Sbjct: 554 LDFGLNVKLFWEKFVPEECPPAFFPLAAICCRLEPESRPAFSKLEDFFEALSLYLGELGI 613
Query: 386 PLPSDLE 392
PLP++LE
Sbjct: 614 PLPTELE 620
|
|
| ZFIN|ZDB-GENE-061212-3 limk1a "LIM domain kinase 1a" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 716 (257.1 bits), Expect = 2.9e-97, Sum P(2) = 2.9e-97
Identities = 144/259 (55%), Positives = 184/259 (71%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+V V+R L H NV++FIGVLYKD++LN + EYI GGTL++++++ PWGQRV+FA+D
Sbjct: 388 EVKVMRCLDHPNVLKFIGVLYKDKRLNFIAEYIKGGTLRDIIKNMDSNYPWGQRVSFAKD 447
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPXXX 267
IA+GM YLHSMN+IHRDLNS NCLVRE+K+VVVADFGL+R++ + R+ A
Sbjct: 448 IASGMAYLHSMNIIHRDLNSHNCLVRENKSVVVADFGLSRLMVED-RSVERRKAD----- 501
Query: 268 XXXXXXXXXXYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
YTVVGNPYWMAPEM+ G+ YDE VD+FS+GI+LCEIIGRV ADPDYLPR+
Sbjct: 502 ------RRKRYTVVGNPYWMAPEMIHGKSYDEKVDLFSFGIMLCEIIGRVNADPDYLPRA 555
Query: 328 PDFGLDQTDFRNKFC-ASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKP 386
DFGL+ F + C A CP F IA LCCDL+ ++RP F LE WLE L MHL +
Sbjct: 556 LDFGLNTAVFLEEHCPADCPAAFFPIAALCCDLDAEKRPAFTKLESWLEDLKMHLELGLH 615
Query: 387 LPSDLEADIYQFATRKSAS 405
L S+LE ++Q +K S
Sbjct: 616 LVSELEL-LHQDFMQKHTS 633
|
|
| UNIPROTKB|F1RPC2 LIMK2 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 704 (252.9 bits), Expect = 6.0e-97, Sum P(2) = 6.0e-97
Identities = 141/247 (57%), Positives = 175/247 (70%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+V V+RSL H NV++FIGVLYKD+KLNL+TEYI GGTLK+ L+ P PW Q+V FA+
Sbjct: 355 EVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV-DPFPWQQKVRFAKG 413
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPXXX 267
IA+GM YLHSM +IHRDLNS NCL++ DKTVVVADFGL+R+I + + P+ A
Sbjct: 414 IASGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKKPSVEKAATKKRT 473
Query: 268 XXXXXXXXXXYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
YTVVGNPYWMAPEM+ G+ YDETVDVFS+GIVLCEIIG+V ADPD LPR+
Sbjct: 474 LRKSDRKKR-YTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRT 532
Query: 328 PDFGLDQTDFRNKFCAS-CPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLS-VDK 385
DFGL+ F KF + CP F +A +CC L P+ RP F LE E LS++L +
Sbjct: 533 LDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSLYLGELGI 592
Query: 386 PLPSDLE 392
PLP++LE
Sbjct: 593 PLPAELE 599
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P53667 | LIMK1_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.5894 | 0.5496 | 0.3678 | yes | N/A |
| P53668 | LIMK1_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.5951 | 0.5473 | 0.3663 | yes | N/A |
| P53669 | LIMK1_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.5813 | 0.5496 | 0.3678 | yes | N/A |
| Q8QFP8 | LIMK1_CHICK | 2, ., 7, ., 1, 1, ., 1 | 0.5975 | 0.5496 | 0.3595 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 433 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-53 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-53 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-38 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-37 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-36 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-32 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-32 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-31 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-31 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-30 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-29 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-28 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-28 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-27 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-27 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-26 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-26 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-26 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-25 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-25 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-25 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-24 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-24 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-24 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-24 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-24 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-24 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-24 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-23 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-23 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-23 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-23 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-22 | |
| cd09365 | 54 | cd09365, LIM2_LIMK, The second LIM domain of LIMK | 2e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-22 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-21 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-21 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-21 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-21 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-19 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-18 | |
| cd09465 | 59 | cd09465, LIM2_LIMK2, The second LIM domain of LIMK | 7e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-17 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-17 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-16 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-16 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-16 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-15 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-14 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-14 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-14 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-14 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-13 | |
| cd09464 | 55 | cd09464, LIM2_LIMK1, The second LIM domain of LIMK | 5e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-09 | |
| cd09364 | 53 | cd09364, LIM1_LIMK, The first LIM domain of LIMK ( | 2e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-09 | |
| cd08368 | 53 | cd08368, LIM, LIM is a small protein-protein inter | 4e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-08 | |
| cd09364 | 53 | cd09364, LIM1_LIMK, The first LIM domain of LIMK ( | 2e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-08 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 4e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-08 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 8e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-07 | |
| pfam00412 | 58 | pfam00412, LIM, LIM domain | 2e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-07 | |
| cd09463 | 53 | cd09463, LIM1_LIMK2, The first LIM domain of LIMK2 | 4e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-07 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 1e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd09327 | 52 | cd09327, LIM1_abLIM, The first LIM domain of actin | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| smart00132 | 54 | smart00132, LIM, Zinc-binding domain present in Li | 2e-06 | |
| cd09330 | 56 | cd09330, LIM4_abLIM, The fourth LIM domain of acti | 5e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-06 | |
| cd09463 | 53 | cd09463, LIM1_LIMK2, The first LIM domain of LIMK2 | 1e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-05 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 1e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| cd09462 | 74 | cd09462, LIM1_LIMK1, The first LIM domain of LIMK1 | 2e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 2e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-05 | |
| cd09328 | 56 | cd09328, LIM2_abLIM, The second LIM domain on acti | 3e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| cd09392 | 53 | cd09392, LIM2_Lrg1p_like, The second LIM domain of | 3e-05 | |
| cd09462 | 74 | cd09462, LIM1_LIMK1, The first LIM domain of LIMK1 | 4e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-05 | |
| cd09387 | 55 | cd09387, LIM2_LMO4, The second LIM domain of LMO4 | 7e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-04 | |
| cd09372 | 53 | cd09372, LIM2_FBLP-1, The second LIM domain of the | 1e-04 | |
| cd09471 | 55 | cd09471, LIM2_Isl2, The second LIM domain of Isl2 | 2e-04 | |
| cd09374 | 55 | cd09374, LIM2_Isl, The second LIM domain of Isl, a | 2e-04 | |
| cd09400 | 61 | cd09400, LIM_like_1, LIM domain in proteins of unk | 2e-04 | |
| cd09371 | 53 | cd09371, LIM1_Lmx1b, The first LIM domain of Lmx1b | 4e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-04 | |
| cd09360 | 52 | cd09360, LIM_ALP_like, The LIM domain of ALP (acti | 6e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-04 | |
| cd09395 | 53 | cd09395, LIM2_Rga, The second LIM domain of Rga GT | 0.001 | |
| cd09332 | 52 | cd09332, LIM2_PINCH, The second LIM domain of prot | 0.001 | |
| cd09329 | 52 | cd09329, LIM3_abLIM, The third LIM domain of actin | 0.002 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 | |
| cd09379 | 55 | cd09379, LIM2_AWH, The second LIM domain of Arrowh | 0.002 | |
| cd09406 | 55 | cd09406, LIM1_Leupaxin, The first LIM domain of Le | 0.002 | |
| cd09336 | 53 | cd09336, LIM1_Paxillin_like, The first LIM domain | 0.003 | |
| cd09383 | 55 | cd09383, LIM2_Lhx7_Lhx8, The second LIM domain of | 0.003 | |
| cd09382 | 55 | cd09382, LIM2_Lhx6, The second LIM domain of Lhx6 | 0.003 | |
| cd09340 | 58 | cd09340, LIM1_Testin_like, The first LIM domain of | 0.004 | |
| cd09361 | 52 | cd09361, LIM1_Enigma_like, The first LIM domain of | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 3e-53
Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 35/228 (15%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
++++ L H N++R +GV + L +VTEY+ GG L + L+ G+ L + A I
Sbjct: 52 ASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQI 111
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
A GM YL S N +HRDL ++NCLV E+ V ++DFGL+R I++ K+P K
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK-- 169
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328
WMAPE + ++ DV+S+G++L EI L P
Sbjct: 170 -----------------WMAPESLKDGKFTSKSDVWSFGVLLWEIF--------TLGEQP 204
Query: 329 DFGLDQTDFRNKFCA--------SCPEPFVRIAFLCCDLNPDQRPPFE 368
G+ + +CP+ + C +P+ RP F
Sbjct: 205 YPGMSNEEVLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFS 252
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 7e-53
Identities = 70/232 (30%), Positives = 104/232 (44%), Gaps = 36/232 (15%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
++R L H NV++ +GV ++ L +V EY+ GG L L+ L ++FA IA
Sbjct: 54 IMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIAR 113
Query: 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQR 270
GM YL S N IHRDL ++NCLV E+ V ++DFGL+R ++
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-------------------- 153
Query: 271 RGARKKRYTVVGN---PY-WMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYL 324
Y P WMAPE + ++ DV+S+G++L EI G P Y
Sbjct: 154 ----DDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP----YP 205
Query: 325 PRSPD--FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWL 374
S + + +R +CP + C +P+ RP F L L
Sbjct: 206 GMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 4e-52
Identities = 70/233 (30%), Positives = 107/233 (45%), Gaps = 37/233 (15%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIA 209
++R L H N+++ +GV ++ L +V EY+ GG L + L+ + L ++FA IA
Sbjct: 54 IMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIA 113
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
GM YL S N IHRDL ++NCLV E+ V ++DFGL+R ++
Sbjct: 114 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD----------------- 156
Query: 270 RRGARKKRYTVVGN---PY-WMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDY 323
Y V P WMAPE + ++ DV+S+G++L EI G P Y
Sbjct: 157 -------DYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP----Y 205
Query: 324 LPRSPD--FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWL 374
S + +R +CP ++ C +P+ RP F L L
Sbjct: 206 PGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 1e-47
Identities = 71/237 (29%), Positives = 105/237 (44%), Gaps = 43/237 (18%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ--------DPGQPLPWGQR 201
V++ L H NV+R +GV ++ L LV EY+ GG L + L+ L
Sbjct: 48 RVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDL 107
Query: 202 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA 261
++FA IA GM YL S +HRDL ++NCLV ED V ++DFGL+R ++
Sbjct: 108 LSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGG 167
Query: 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPA 319
K+P + WMAPE + + DV+S+G++L EI G P
Sbjct: 168 KLPIR-------------------WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP- 207
Query: 320 DPDYLPRSPDFGLDQT------DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
Y P ++ +R CP+ + C L+P+ RP F L
Sbjct: 208 ---Y----PGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 4e-46
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 57/226 (25%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ +L+ L+H N+++ GV + L LV EY GG+LK+LL++ L + + I
Sbjct: 42 IEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQI 101
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDK-TVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
G+ YLHS +IHRDL +N L+ D V +ADFGL++++
Sbjct: 102 LEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK-------------- 147
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326
T+VG P +MAPE++ G+ Y E D++S G++L E+
Sbjct: 148 -------SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------- 187
Query: 327 SPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-PFEVLE 371
+ +P++RP E+LE
Sbjct: 188 --------------------PELKDLIRKMLQKDPEKRPSAKEILE 213
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 6e-43
Identities = 67/235 (28%), Positives = 108/235 (45%), Gaps = 51/235 (21%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ +L+ L H N++R V + KL LV EY GG L +LL+ G L + + R I
Sbjct: 48 IKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQI 106
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
+ + YLHS ++HRDL +N L+ ED V +ADFGLAR + G
Sbjct: 107 LSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPG---------------- 150
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVP--------- 318
+K T VG P +MAPE++ G+ Y + VD++S G++L E++ G+ P
Sbjct: 151 ------EKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLE 204
Query: 319 -----ADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFE 368
P P++ + + ++ +R +P++R E
Sbjct: 205 LFKKIGKPKPPFPPPEWDISP-EAKD---------LIR---KLLVKDPEKRLTAE 246
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 69/230 (30%), Positives = 100/230 (43%), Gaps = 42/230 (18%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ +LR L H N++R I L LV EY GG L + L G PL + A I
Sbjct: 49 IRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQI 107
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G+ YLHS +IHRDL +N L+ E+ V +ADFGLA+ +
Sbjct: 108 LRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLL------------------ 149
Query: 269 QRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEII-GRVP------AD 320
+ T VG P++MAPE ++ G Y VDV+S G++L E++ G+ P D
Sbjct: 150 ---KSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILD 206
Query: 321 PDY-----LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
L +F + S E + C + +P +RP
Sbjct: 207 QLQLIRRILGPPLEFDEPKWS-------SGSEEAKDLIKKCLNKDPSKRP 249
|
Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 5e-37
Identities = 67/246 (27%), Positives = 109/246 (44%), Gaps = 46/246 (18%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ +++ H N++ + +L +V EY+ GG+L +++ + Q R++
Sbjct: 66 ILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREV 125
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G+ YLHS N+IHRD+ S N L+ +D +V +ADFG A A
Sbjct: 126 LQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFA---------------------A 164
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDYLPRS 327
Q + KR +VVG PYWMAPE++ ++Y VD++S GI+ E+ G +P YL
Sbjct: 165 QLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG----EPPYLREP 220
Query: 328 P--------DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP--------PFEVLE 371
P G+ K+ + F+ C +P++RP PF
Sbjct: 221 PLRALFLITTKGIPPLKNPEKWSPEFKD-FLN---KCLVKDPEKRPSAEELLQHPFLKKA 276
Query: 372 VWLEGL 377
E
Sbjct: 277 CPKEEF 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 8e-37
Identities = 77/230 (33%), Positives = 115/230 (50%), Gaps = 29/230 (12%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIA 209
+++ L H +++ V ++ + +VTEY++ G+L + L+ G+ L Q V+ A IA
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIA 113
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
GM YL S N IHRDL ++N LV E+ +ADFGLAR+I AK P K
Sbjct: 114 EGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE-GAKFPIK--- 169
Query: 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYLPRS 327
W APE + DV+S+GI+L EI+ GRVP Y +
Sbjct: 170 ----------------WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP----YPGMT 209
Query: 328 PDFGLDQTD--FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375
L+Q + +R +CPE + C D +P++RP FE L+ +LE
Sbjct: 210 NREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 2e-36
Identities = 68/224 (30%), Positives = 104/224 (46%), Gaps = 35/224 (15%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ +L+ H N++++ G K +L +V E+ +GG+LK+LL+ Q L Q +++
Sbjct: 48 IQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKEL 107
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G+ YLHS +IHRD+ + N L+ D V + DFGL+ +
Sbjct: 108 LKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT---------------- 151
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDYLPRS 327
K R T+VG PYWMAPE++ G+ YD D++S GI E+ G+ P Y
Sbjct: 152 ------KARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP----YSELP 201
Query: 328 PDFGL------DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
P L RN S + F C NP++RP
Sbjct: 202 PMKALFKIATNGPPGLRNPEKWS--DEFKDFLKKCLQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 6e-34
Identities = 74/232 (31%), Positives = 106/232 (45%), Gaps = 30/232 (12%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFAR 206
+V L+ L H ++I V + ++TE + G+L L+ P GQ LP ++ A
Sbjct: 52 EVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMAC 111
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
+A GM YL N IHRDL ++N LV ED VADFGLAR+I + + K+P K
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSD--KKIPYK 169
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYL 324
W APE + + DV+S+GI+L E+ G+VP Y
Sbjct: 170 -------------------WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVP----YP 206
Query: 325 PRSPDFGLDQTD--FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWL 374
+ DQ +R A CP+ +I C P+ RP F+ L L
Sbjct: 207 GMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-33
Identities = 76/235 (32%), Positives = 117/235 (49%), Gaps = 41/235 (17%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDI 208
+V+ +L H N+++ +GV+ + L +VTEY+A G+L + L+ G + Q++ FA D+
Sbjct: 52 SVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDV 111
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
GM YL N +HRDL ++N LV ED V+DFGLA+ QG + K+P K
Sbjct: 112 CEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS-----GKLPVK-- 164
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI--IGRVPADPDYLPR 326
W APE + +++ DV+S+GI+L EI GRVP PR
Sbjct: 165 -----------------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP-----YPR 202
Query: 327 SPDFGLD------QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375
P L + +R + CP ++ C +L+P +RP F+ L L
Sbjct: 203 IP---LKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 68/235 (28%), Positives = 101/235 (42%), Gaps = 53/235 (22%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRK--LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
+ +L SL H N++R+ G + K LN+ EY++GG+L LL+ G LP + R
Sbjct: 50 IRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTR 108
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
I G+ YLHS ++HRD+ N LV D V +ADFG A+ + T
Sbjct: 109 QILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT-------- 160
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVP------- 318
+V G PYWMAPE++ G+EY D++S G + E+ G+ P
Sbjct: 161 -----------GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP 209
Query: 319 -------ADPDYLPRSPDFGLDQ-TDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
P P+ ++ DF K C +P +RP
Sbjct: 210 MAALYKIGSSGEPPEIPEHLSEEAKDFLRK---------------CLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 77/230 (33%), Positives = 109/230 (47%), Gaps = 29/230 (12%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-DPGQPLPWGQRVNFARDIA 209
+++ L H +I+ V + + +VTE + G+L E LQ G+ L Q ++ A +A
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVA 113
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
+GM YL + N IHRDL ++N LV E+ VADFGLAR+I + AK P K
Sbjct: 114 SGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE-GAKFPIK--- 169
Query: 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYLPRS 327
W APE + DV+S+GI+L EI+ GR+P Y +
Sbjct: 170 ----------------WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP----YPGMT 209
Query: 328 PDFGLDQTD--FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375
L Q D +R CP+ I C +PD RP FE L+ LE
Sbjct: 210 NAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-31
Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 27/221 (12%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
+L+ H N+++ IGV + + + +V E + GG+L L+ L + + + D AA
Sbjct: 45 ILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAA 104
Query: 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQR 270
GM YL S N IHRDL ++NCLV E+ + ++DFG++R G + + ++P K
Sbjct: 105 GMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK---- 160
Query: 271 RGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI--IGRVPADPDYLPRSP 328
W APE + Y DV+SYGI+L E +G P Y S
Sbjct: 161 ---------------WTAPEALNYGRYTSESDVWSYGILLWETFSLGDTP----YPGMSN 201
Query: 329 DFGLDQTD--FRNKFCASCPEPFVRIAFLCCDLNPDQRPPF 367
++ + +R CPE R+ C +P+ RP F
Sbjct: 202 QQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSF 242
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 80/270 (29%), Positives = 125/270 (46%), Gaps = 45/270 (16%)
Query: 115 DVMLDNWYFEKDGLLFCKEDYNGKYGEACQNCGQVAVLRSLHHHNVIRFIGVLYKDR-KL 173
DVML ++ K + K D + A + +V+ L H N+++ +GV+ +++ L
Sbjct: 21 DVMLGDYRGNKVAVKCIKNDATAQAFLA-----EASVMTQLRHSNLVQLLGVIVEEKGGL 75
Query: 174 NLVTEYIAGGTLKELLQDPGQPLPWGQR-VNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 232
+VTEY+A G+L + L+ G+ + G + F+ D+ M YL + N +HRDL ++N LV
Sbjct: 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV 135
Query: 233 REDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMM 292
ED V+DFGL + + T K+P K W APE +
Sbjct: 136 SEDNVAKVSDFGLTK-----EASSTQDTGKLPVK-------------------WTAPEAL 171
Query: 293 TGQEYDETVDVFSYGIVLCEI--IGRVP----ADPDYLPR-SPDFGLDQTDFRNKFCASC 345
+++ DV+S+GI+L EI GRVP D +PR + +D D C
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD-------GC 224
Query: 346 PEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375
P + C L+ RP F L LE
Sbjct: 225 PPVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-31
Identities = 64/226 (28%), Positives = 97/226 (42%), Gaps = 39/226 (17%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++ L + ++ G K KL ++ EY GG+ +LL+ PG L R+
Sbjct: 49 EIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK-PG-KLDETYIAFILRE 106
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ G+ YLH IHRD+ + N L+ E+ V +ADFG++
Sbjct: 107 VLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVS--------------------- 145
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDY---- 323
Q KR T VG P+WMAPE++ YDE D++S GI E+ P D
Sbjct: 146 GQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR 205
Query: 324 ----LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
+P++ L+ F F FV LC + +P +RP
Sbjct: 206 VLFLIPKNNPPSLEGNKFSKPFKD-----FVS---LCLNKDPKERP 243
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 49/167 (29%), Positives = 86/167 (51%), Gaps = 24/167 (14%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFA 205
V +L+ L+H N+I++ + KL +V EY GG L + ++ G+P P Q +++
Sbjct: 50 VKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF 109
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
+ + YLHS ++HRD+ QN + + V + DFG+++++ T +AK
Sbjct: 110 VQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS-----TVDLAK--- 161
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE 312
TVVG PY+++PE+ + Y+ D++S G VL E
Sbjct: 162 -------------TVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYE 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 67/247 (27%), Positives = 105/247 (42%), Gaps = 50/247 (20%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFA 205
++ +LR+L H N++++ GV K R L L+ EY+ G+L++ LQ + + + F+
Sbjct: 56 EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS 115
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
I GM YL S IHRDL ++N LV + V ++DFGLA+++ +
Sbjct: 116 SQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE-------------- 161
Query: 266 KAAQRRGARKKRYTVVGNP-----YWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPAD 320
K Y V P +W APE + ++ DV+S+G+ L E+ D
Sbjct: 162 ---------DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTY--GD 210
Query: 321 PDYLPRSPDFGLD---------QTDFRNKFC--------ASCPEPFVRIAFLCCDLNPDQ 363
P P +F T SCP+ + LC + P
Sbjct: 211 PSQSP-PAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQD 269
Query: 364 RPPFEVL 370
RP F L
Sbjct: 270 RPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-29
Identities = 74/237 (31%), Positives = 110/237 (46%), Gaps = 42/237 (17%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPL-PWGQRVNFAR 206
+ AV+ LHH N++R +GV+ + L +V E ++ G L L+ G+ L Q + F+
Sbjct: 49 ETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL 107
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
D+A GM YL S L+HRDL ++N LV ED V+DFGLAR+ G +K+P K
Sbjct: 108 DVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDN--SKLPVK 162
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYL 324
W APE + +++ DV+SYG++L E+ GR P
Sbjct: 163 -------------------WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP------ 197
Query: 325 PRSPDFGLDQTD------FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375
P L + +R + CP + C + P +RP F L LE
Sbjct: 198 --YPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 8e-29
Identities = 65/221 (29%), Positives = 102/221 (46%), Gaps = 35/221 (15%)
Query: 156 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYL 215
H N+IR GV+ K R + ++TEY+ G+L + L++ GQ V R IA+GM YL
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL 122
Query: 216 HSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARK 275
MN +HRDL ++N LV + V+DFGL+R + TT K+P +
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR--------- 173
Query: 276 KRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT 335
W APE + +++ DV+S+GIV+ E++ Y R P + +
Sbjct: 174 ----------WTAPEAIAYRKFTSASDVWSFGIVMWEVMS-------YGER-PYWDMSNQ 215
Query: 336 D--------FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFE 368
D +R CP ++ C + ++RP F
Sbjct: 216 DVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFS 256
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-28
Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 21/231 (9%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFAR 206
+ AV++ + H N+++ +GV ++ ++TE++ G L + L++ Q + + A
Sbjct: 52 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 111
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
I++ M YL N IHRDL ++NCLV E+ V VADFGL+R++ G AK P K
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIK 170
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326
W APE + ++ DV+++G++L EI + +
Sbjct: 171 -------------------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 211
Query: 327 SPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377
S + L + +R + CP + C NP RP F + E +
Sbjct: 212 SQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 69/247 (27%), Positives = 109/247 (44%), Gaps = 46/247 (18%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLN------LVTEYIAGGTLKELL-----QDPGQPLPW 198
A ++ H NV++ IGV ++ L ++ ++ G L L + LP
Sbjct: 53 ACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL 112
Query: 199 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTT 258
+ F DIA GM YL + N IHRDL ++NC++RED TV VADFGL++ I+ G
Sbjct: 113 QTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG 172
Query: 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVP 318
+AK+P K W+A E + + Y DV+++G+ + EI R
Sbjct: 173 RIAKMPVK-------------------WIAIESLADRVYTSKSDVWAFGVTMWEIATR-- 211
Query: 319 ADPDYLPRSPDFGLDQTDF--------RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
++P G++ + R K C + + + C +P RP F L
Sbjct: 212 ------GQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKL 265
Query: 371 EVWLEGL 377
LE +
Sbjct: 266 REVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 64/237 (27%), Positives = 99/237 (41%), Gaps = 43/237 (18%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++ +L H N++ + + KL ++ E+ GG L ++ + + L Q R
Sbjct: 52 EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ + +LHS +IHRDL + N L+ D V +ADFG V AK
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFG--------------VSAKNKST- 156
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMM-----TGQEYDETVDVFSYGIVLCEIIGRVPADPD 322
+KR T +G PYWMAPE++ YD D++S GI L E+ P +
Sbjct: 157 ------LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210
Query: 323 YLP--------RSPDFGLDQTD-FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
P +S LDQ + + F F++ C +PD RP L
Sbjct: 211 LNPMRVLLKILKSEPPTLDQPSKWSSSF-----NDFLKS---CLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 62/242 (25%), Positives = 102/242 (42%), Gaps = 58/242 (23%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ---------DPGQPLPWGQR 201
V++ + H+V+R +GV+ + +V E +A G LK L+ P +
Sbjct: 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 202 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA 261
+ A +IA GM YL + +HRDL ++NC+V ED TV + DFG+ R I++
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE---------T 172
Query: 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI-------- 313
RK + + WMAPE + + DV+S+G+VL E+
Sbjct: 173 DYYRKGGKGLLPVR----------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222
Query: 314 -------IGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP 366
+ + D +L P+ +CP+ + + +C NP RP
Sbjct: 223 QGLSNEEVLKFVIDGGHLDL-PE--------------NCPDKLLELMRMCWQYNPKMRPT 267
Query: 367 FE 368
F
Sbjct: 268 FL 269
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 48/221 (21%)
Query: 159 NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM 218
++++ G +K+ L +V EY G++ ++++ + L + G+ YLHS
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 219 NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRY 278
IHRD+ + N L+ E+ +ADFG++ Q KR
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVS---------------------GQLTDTMAKRN 157
Query: 279 TVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPAD--PDY-----------LP 325
TV+G P+WMAPE++ Y+ D++S GI E+ A+ P Y +P
Sbjct: 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEM-----AEGKPPYSDIHPMRAIFMIP 212
Query: 326 RSPDFGL-DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
P L D + +F FV+ C +P++RP
Sbjct: 213 NKPPPTLSDPEKWSPEFND-----FVK---KCLVKDPEERP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 71/232 (30%), Positives = 112/232 (48%), Gaps = 34/232 (14%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIA 209
+++ L H ++R V+ ++ + ++TEY+ G+L + L+ P G L + ++ A IA
Sbjct: 54 LMKQLQHPRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIA 112
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
GM ++ N IHRDL + N LV E +ADFGLAR+I AK P K
Sbjct: 113 EGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE-GAKFPIK--- 168
Query: 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVP----ADPDY 323
W APE + + DV+S+GI+L EI+ GR+P +P+
Sbjct: 169 ----------------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV 212
Query: 324 LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375
+ ++ + G +R +CPE + LC P++RP FE L LE
Sbjct: 213 I-QNLERG-----YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 8e-27
Identities = 56/169 (33%), Positives = 87/169 (51%), Gaps = 20/169 (11%)
Query: 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
+ +++ HHN+IR GV+ K + ++TEY+ G L + L+D Q V R
Sbjct: 55 SEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR 114
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP-TTVMAKVPR 265
IAAGM YL MN +HRDL ++N LV + V+DFGL+R++ P TT K+P
Sbjct: 115 GIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII 314
+ W APE + +++ DV+S+GIV+ E++
Sbjct: 175 R-------------------WTAPEAIAYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-27
Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 33/221 (14%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-DPGQPLPWGQRVNFARDIA 209
VL L +IR+ KLN+V EY G L +LL+ G+PLP Q F I
Sbjct: 52 VLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQIL 111
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
G+ +LHS ++HRD+ S N + V + D G+A+++ + T A
Sbjct: 112 LGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-----SDNTNFAN------- 159
Query: 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI-IGRVPADPDYLPRSP 328
T+VG PY+++PE+ + Y+E DV++ G+VL E G+ P D +
Sbjct: 160 ---------TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-----N 205
Query: 329 DFGLDQTDFRNKFCASCPEPF----VRIAFLCCDLNPDQRP 365
L R F + + ++ C + QRP
Sbjct: 206 QGALILKIIRGVF-PPVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 67/222 (30%), Positives = 104/222 (46%), Gaps = 23/222 (10%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
+L+ H N++R IGV + + + +V E + GG L+ G L + + + AA
Sbjct: 46 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAA 105
Query: 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQR 270
GM YL S + IHRDL ++NCLV E + ++DFG++R G A T M ++P K
Sbjct: 106 GMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK---- 161
Query: 271 RGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI--IGRVPADPDYLPRSP 328
W APE + Y DV+S+GI+L E +G VP + +
Sbjct: 162 ---------------WTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPY-ANLSNQQT 205
Query: 329 DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
++Q R CP+ R+ C + +P QRP F +
Sbjct: 206 REAIEQ-GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 28/227 (12%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+ V+ L H N+++ GV K R + +VTEY+A G L L++ L ++ D
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD 108
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ M YL S IHRDL ++NCLV ED V V+DFGLAR + + ++ K P K
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD-QYTSSQGTKFPVK- 166
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYLP 325
W PE+ + DV+S+G+++ E+ G++P Y
Sbjct: 167 ------------------WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMP----YER 204
Query: 326 RSPDFGLD--QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
S ++ +R P I + C P+ RP F+ L
Sbjct: 205 FSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 70/232 (30%), Positives = 115/232 (49%), Gaps = 34/232 (14%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-DPGQPLPWGQRVNFARDIA 209
V+++L H +++ V+ K+ + ++TE++A G+L + L+ D G P + ++F+ IA
Sbjct: 54 VMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 112
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
GM ++ N IHRDL + N LV +ADFGLAR+I AK P K
Sbjct: 113 EGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE-GAKFPIK--- 168
Query: 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVP----ADPDY 323
W APE + + DV+S+GI+L EI+ GR+P ++P+
Sbjct: 169 ----------------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV 212
Query: 324 LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375
+ R+ + G +R +CPE I C P++RP FE ++ L+
Sbjct: 213 I-RALERG-----YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-26
Identities = 73/245 (29%), Positives = 114/245 (46%), Gaps = 30/245 (12%)
Query: 131 CKEDYNGKYGEACQNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ 190
CKED + + + +L+ H N+++ IGV + + + +V E + GG L+
Sbjct: 27 CKEDLPQEL--KIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLR 84
Query: 191 DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIH 250
L Q V FA D AAGM YL S N IHRDL ++NCLV E+ + ++DFG++R
Sbjct: 85 KKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQED 144
Query: 251 QGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310
G + ++ + ++P K W APE + Y DV+SYGI+L
Sbjct: 145 DGIYS-SSGLKQIPIK-------------------WTAPEALNYGRYSSESDVWSYGILL 184
Query: 311 CEI--IGRVPADPDYLPRSPDFGLDQTD--FRNKFCASCPEPFVRIAFLCCDLNPDQRPP 366
E +G P Y + +Q + +R CP+ ++ C D P+ RP
Sbjct: 185 WETFSLGVCP----YPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPK 240
Query: 367 FEVLE 371
F L+
Sbjct: 241 FSELQ 245
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 74/233 (31%), Positives = 112/233 (48%), Gaps = 30/233 (12%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFAR 206
+ +++ L H +++ V+ + + +VTEY++ G+L + L+D G+ L V+ A
Sbjct: 51 EAQIMKKLRHDKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAA 109
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
+AAGM Y+ MN IHRDL S N LV + +ADFGLAR+I AK P K
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ-GAKFPIK 168
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYL 324
W APE + DV+S+GI+L E++ GRVP P
Sbjct: 169 -------------------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY-PGMN 208
Query: 325 PRSPDFGLDQTD--FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375
R L+Q + +R CP + C +P++RP FE L+ +LE
Sbjct: 209 NREV---LEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 76/233 (32%), Positives = 118/233 (50%), Gaps = 30/233 (12%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-DPGQPLPWGQRVNFAR 206
+ V++ L H +++ V+ + + +VTEY++ G+L + L+ + G+ L Q V+ A
Sbjct: 51 EAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 109
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
IA+GM Y+ MN +HRDL + N LV E+ VADFGLAR+I +
Sbjct: 110 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-------------E 156
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYL 324
R+GA ++ + W APE + DV+S+GI+L E+ GRVP P +
Sbjct: 157 YTARQGA---KFPI----KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY-PGMV 208
Query: 325 PRSPDFGLDQTD--FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375
R LDQ + +R CPE + C P++RP FE L+ +LE
Sbjct: 209 NREV---LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 73/233 (31%), Positives = 118/233 (50%), Gaps = 30/233 (12%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFAR 206
+ +++ L H ++ V+ + + +VTE++ G+L + L++ G+ L Q V+ A
Sbjct: 51 EAQIMKKLRHDKLVPLYAVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA 109
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
IA GM Y+ MN IHRDL + N LV ++ +ADFGLAR+I +
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN-------------E 156
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYL 324
R+GA ++ + W APE + DV+S+GI+L E++ GRVP P +
Sbjct: 157 YTARQGA---KFPI----KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY-PGMV 208
Query: 325 PRSPDFGLDQTD--FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375
R L+Q + +R CPE + LC +PD+RP FE ++ +LE
Sbjct: 209 NREV---LEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 107 bits (266), Expect = 1e-25
Identities = 56/233 (24%), Positives = 94/233 (40%), Gaps = 33/233 (14%)
Query: 151 VLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ--PLPWGQRVNFARD 207
+L SL+H N+++ + L LV EY+ GG+L++LL+ G+ PL + +
Sbjct: 50 ILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQ 109
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVV-ADFGLARIIHQGPRAPTTVMAKVPRK 266
I + + YLHS +IHRD+ +N L+ D VV DFGLA+++
Sbjct: 110 ILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL---------------PD 154
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQE---YDETVDVFSYGIVLCEII-GRVPADPD 322
T VG P +MAPE++ G + D++S GI L E++ G P + +
Sbjct: 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE 214
Query: 323 YLPRSPD----------FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
+ + + + +P R
Sbjct: 215 KNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL 267
|
Length = 384 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 77/281 (27%), Positives = 124/281 (44%), Gaps = 48/281 (17%)
Query: 121 WYFEKDGLLFCKEDYNGKYGEAC----QNCGQVAV-------------------LRSLHH 157
W ++ + K+ G++GE N +VAV +++L H
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQH 60
Query: 158 HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-DPGQPLPWGQRVNFARDIAAGMTYLH 216
++R V+ K+ + ++TEY+A G+L + L+ D G + + ++F+ IA GM Y+
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 217 SMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKK 276
N IHRDL + N LV E +ADFGLAR+I AK P K
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE-GAKFPIK---------- 169
Query: 277 RYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYLPRSPDFGLDQ 334
W APE + + DV+S+GI+L EI+ G++P + S Q
Sbjct: 170 ---------WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG--MSNSDVMSALQ 218
Query: 335 TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375
+R +CP+ I C ++RP F+ L+ L+
Sbjct: 219 RGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 24/170 (14%)
Query: 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFA 205
++++L+ H N++ + G + KL +V EY GG+L+++ Q PL Q
Sbjct: 48 QQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVC 107
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
R+ G+ YLH IHRD+ N L+ ED V +ADFG++ + T +A
Sbjct: 108 RETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQL-------TATIA---- 156
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMM---TGQEYDETVDVFSYGIVLCE 312
KR + +G PYWMAPE+ YD D+++ GI E
Sbjct: 157 ----------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 70/229 (30%), Positives = 103/229 (44%), Gaps = 34/229 (14%)
Query: 157 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---------------PGQPLPWGQR 201
H N+I +GV ++ L +V EY A G L++ L+ P + L
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 202 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA 261
V+FA +A GM +L S IHRDL ++N LV ED + +ADFGLAR IH T
Sbjct: 135 VSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADP 321
++P K WMAPE + + Y DV+S+G++L EI +
Sbjct: 195 RLPVK-------------------WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235
Query: 322 DYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
+P F L + +R + +C + + C P QRP F+ L
Sbjct: 236 PGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQL 284
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 55/175 (31%), Positives = 85/175 (48%), Gaps = 21/175 (12%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD--PGQPLPWGQRVNFA 205
+V + +H NV+++ +L LV Y++GG+L ++++ P L
Sbjct: 49 EVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL 108
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
+++ G+ YLHS IHRD+ + N L+ ED +V +ADFG++ + G
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG------------- 155
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMT-GQEYDETVDVFSYGIVLCE-IIGRVP 318
R RK R T VG P WMAPE+M YD D++S+GI E G P
Sbjct: 156 --GDRT--RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 46/207 (22%)
Query: 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
++A+L L H N+++++G ++ L + E + GG+L +LL+ G P + R
Sbjct: 51 QEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTR 109
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
I G+ YLH N +HRD+ N LV + V +ADFG+A+ + AK
Sbjct: 110 QILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV------EFSFAK---- 159
Query: 267 AAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEI------------ 313
+ G+PYWMAPE + Y D++S G + E+
Sbjct: 160 ------------SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG 207
Query: 314 ------IGR---VPADPDYL-PRSPDF 330
IGR +P PD+L + DF
Sbjct: 208 VAAVFKIGRSKELPPIPDHLSDEAKDF 234
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 51/171 (29%), Positives = 85/171 (49%), Gaps = 27/171 (15%)
Query: 148 QVAVLRSLHHH---NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF 204
+VA+L L N+ ++ G K +L ++ EY GG+++ L++ P+
Sbjct: 49 EVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK--AGPIAEKYISVI 106
Query: 205 ARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVP 264
R++ + Y+H + +IHRD+ + N LV V + DFG+A +++Q
Sbjct: 107 IREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN------------ 154
Query: 265 RKAAQRRGARKKRYTVVGNPYWMAPEMMT-GQEYDETVDVFSYGIVLCEII 314
KR T VG PYWMAPE++T G+ YD D++S GI + E+
Sbjct: 155 ---------SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 69/252 (27%), Positives = 116/252 (46%), Gaps = 46/252 (18%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD------------------- 191
+L+ ++H +VI+ G +D L L+ EY G+L+ L++
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 192 ---PG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLAR 247
P + L G ++FA I+ GM YL M L+HRDL ++N LV E + + ++DFGL+R
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 248 IIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYG 307
+++ ++P K WMA E + Y DV+S+G
Sbjct: 176 DVYEEDSYVKRSKGRIPVK-------------------WMAIESLFDHIYTTQSDVWSFG 216
Query: 308 IVLCEIIGRVPADPDYLPRSPD--FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
++L EI+ + +P Y +P+ F L +T +R + +C E + C PD+RP
Sbjct: 217 VLLWEIV-TLGGNP-YPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRP 274
Query: 366 PFEVLEVWLEGL 377
F + LE +
Sbjct: 275 TFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 54/169 (31%), Positives = 85/169 (50%), Gaps = 20/169 (11%)
Query: 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
+ +++ H N+I GV+ K + + +VTEY+ G+L L+ Q V R
Sbjct: 54 SEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR 113
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP-TTVMAKVPR 265
IA+GM YL M +HRDL ++N LV + V+DFGL+R++ P A TT K+P
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 173
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII 314
+ W APE + +++ DV+SYGIV+ E++
Sbjct: 174 R-------------------WTAPEAIAYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 54/174 (31%), Positives = 91/174 (52%), Gaps = 26/174 (14%)
Query: 142 ACQNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP-LPWGQ 200
A QN + VL+ L H N+I + +D+ L +V EY GGTL E +Q L
Sbjct: 45 AAQN--ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT 102
Query: 201 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVV-VADFGLARIIHQGPRAPTTV 259
++F I + ++H+ ++HRDL +QN L+ + K VV + DFG+++I+
Sbjct: 103 ILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---------- 152
Query: 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI 313
++ K YTVVG P +++PE+ G+ Y++ D+++ G VL E+
Sbjct: 153 ------------SSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 75/247 (30%), Positives = 120/247 (48%), Gaps = 43/247 (17%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ--------DPGQPLP-W 198
+ +V++ H+V+R +GV+ K + +V E +A G LK L+ +PG+P P
Sbjct: 59 EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 118
Query: 199 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTT 258
+ + A +IA GM YL++ +HRDL ++NC+V D TV + DFG+ R I++
Sbjct: 119 QEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE------- 171
Query: 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI--IGR 316
RK +G R WMAPE + + + D++S+G+VL EI +
Sbjct: 172 --TDYYRKGG--KGLLPVR--------WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 219
Query: 317 VP----ADPDYLPRSPDFG-LDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF-EVL 370
P ++ L D G LDQ D +CPE + +C NP RP F E++
Sbjct: 220 QPYQGLSNEQVLKFVMDGGYLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIV 272
Query: 371 EVWLEGL 377
+ + L
Sbjct: 273 NLLKDDL 279
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 71/242 (29%), Positives = 105/242 (43%), Gaps = 30/242 (12%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLN------LVTEYIAGGTLKELL-----QDPGQPL 196
+ ++ H NV+R IGV + + ++ ++ G L L D Q L
Sbjct: 50 EAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYL 109
Query: 197 PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256
P V F DIA+GM YL S + IHRDL ++NC++ E+ V VADFGL++ I+ G
Sbjct: 110 PTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR 169
Query: 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGR 316
+AK+P K W+A E + + Y DV+S+G+ + EI R
Sbjct: 170 QGRIAKMPVK-------------------WIAIESLADRVYTTKSDVWSFGVTMWEIATR 210
Query: 317 VPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376
+ S + + R K C + + C LNP RP FE L LE
Sbjct: 211 GQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270
Query: 377 LS 378
Sbjct: 271 AL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 79/273 (28%), Positives = 117/273 (42%), Gaps = 39/273 (14%)
Query: 157 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---------------PGQPLPWGQR 201
H N+I +G +D L ++ EY + G L+E L+ P + L +
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 202 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA 261
V+ A +A GM YL S IHRDL ++N LV ED + +ADFGLAR +H T
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADP 321
++P K WMAPE + + Y DV+S+G++L EI +
Sbjct: 197 RLPVK-------------------WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
Query: 322 DYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381
+P F L + R A+C I C P QRP F+ L L+ +
Sbjct: 238 PGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297
Query: 382 SVDKPLPSDLEADIYQFATRKSASPLTEPECTA 414
S D+ L DL Q++ P + C++
Sbjct: 298 STDEYL--DLSVPFEQYS---PGCPDSPSSCSS 325
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 71/241 (29%), Positives = 106/241 (43%), Gaps = 34/241 (14%)
Query: 157 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---------------PGQPLPWGQR 201
H N+I +GV ++ L ++ EY A G L+E L+ P + L +
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 202 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA 261
V+ A +A GM YL S IHRDL ++N LV ED + +ADFGLAR +H T
Sbjct: 137 VSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADP 321
++P K WMAPE + + Y DV+S+GI++ EI +
Sbjct: 197 RLPVK-------------------WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
Query: 322 DYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381
+P F L + R ++C + C P QRP F+ L L+ + +
Sbjct: 238 PGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297
Query: 382 S 382
S
Sbjct: 298 S 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 25/168 (14%)
Query: 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
++ +L++L H N++++IG + L ++ EY G+L+++++ G P P +
Sbjct: 48 QEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG-PFPESLVAVYVY 106
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
+ G+ YLH +IHRD+ + N L +D V +ADFG+A +
Sbjct: 107 QVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKL----------------- 149
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII 314
K +VVG PYWMAPE++ D++S G C +I
Sbjct: 150 ----NDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLG---CTVI 190
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 69/241 (28%), Positives = 104/241 (43%), Gaps = 54/241 (22%)
Query: 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL-QDPGQPLPWGQRVNFA 205
+ +++ H N+I GV+ K R + ++TE++ G L L Q+ GQ Q V
Sbjct: 54 SEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ-FTVIQLVGML 112
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA---K 262
R IAAGM YL MN +HRDL ++N LV + V+DFGL+R + PT + K
Sbjct: 113 RGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172
Query: 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVP-- 318
+P + W APE + +++ DV+SYGIV+ E++ G P
Sbjct: 173 IPIR-------------------WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 213
Query: 319 ----------ADPDY-LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF 367
+ DY LP D CP ++ C + + RP F
Sbjct: 214 DMSNQDVINAIEQDYRLPPPMD---------------CPTALHQLMLDCWQKDRNARPKF 258
Query: 368 E 368
Sbjct: 259 G 259
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 57/181 (31%), Positives = 92/181 (50%), Gaps = 26/181 (14%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++ V+R H N++ ++ +L +V EY+AGG+L +++ + + GQ R+
Sbjct: 66 EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRE 123
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ +LHS +IHRD+ S N L+ D +V + DFG
Sbjct: 124 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC--------------------- 162
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
AQ + KR T+VG PYWMAPE++T + Y VD++S GI+ E+ V +P YL +
Sbjct: 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM---VEGEPPYLNEN 219
Query: 328 P 328
P
Sbjct: 220 P 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 7e-24
Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
V+ L H +++ GV K R + +VTEY++ G L L++ G+ Q + +D+
Sbjct: 52 VMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCE 111
Query: 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQR 270
GM YL S IHRDL ++NCLV + V V+DFGL+R + ++V +K P +
Sbjct: 112 GMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-EYTSSVGSKFPVR---- 166
Query: 271 RGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI--IGRVPADPDYLPRSP 328
W PE++ ++ DV+++G+++ E+ +G++P + +
Sbjct: 167 ---------------WSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV 211
Query: 329 DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
+ AS E I + C ++RP F+ L
Sbjct: 212 EKVSQGLRLYRPHLAS--EKVYAIMYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 1e-23
Identities = 55/173 (31%), Positives = 87/173 (50%), Gaps = 30/173 (17%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFA 205
++ +L+SL H N++++ GV Y R L LV EY+ G+L++ LQ + L + + +A
Sbjct: 55 EIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYA 114
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
I GM YL S +HRDL ++N LV + V + DFGL +++ Q
Sbjct: 115 SQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-------------- 160
Query: 266 KAAQRRGARKKRYTVVGNP-----YWMAPEMMTGQEYDETVDVFSYGIVLCEI 313
K Y V P +W APE +T ++ DV+S+G+VL E+
Sbjct: 161 ---------DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 62/238 (26%), Positives = 91/238 (38%), Gaps = 53/238 (22%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP-LPWGQRVNFAR 206
+ A++ SL H N+IR GV+ L +VTE G+L + L+ ++A
Sbjct: 46 EAAIMHSLDHENLIRLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV 104
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM-AKVPR 265
IA GM YL S IHRDL ++N L+ D V + DFGL R + Q KVP
Sbjct: 105 QIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF 164
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE------------- 312
W APE + + + DV+ +G+ L E
Sbjct: 165 A-------------------WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS 205
Query: 313 ---IIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF 367
I+ ++ + + L R CP+ + C NP RP F
Sbjct: 206 GSQILKKIDKEGERLERPEA---------------CPQDIYNVMLQCWAHNPADRPTF 248
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 2e-23
Identities = 70/250 (28%), Positives = 109/250 (43%), Gaps = 48/250 (19%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLN------LVTEYIAGGTLKELL------QDPGQP 195
+ A ++ H NVI+ IGV + R ++ ++ G L L ++P
Sbjct: 51 EAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT- 109
Query: 196 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255
LP V F DIA+GM YL S N IHRDL ++NC++ E+ TV VADFGL++ I+ G
Sbjct: 110 LPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYY 169
Query: 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG 315
+K+P K W+A E + Y DV+++G+ + EI+
Sbjct: 170 RQGCASKLPVK-------------------WLALESLADNVYTTHSDVWAFGVTMWEIMT 210
Query: 316 RVPADPDYLPRSPDFGLDQTDFRNKFCA--------SCPEPFVRIAFLCCDLNPDQRPPF 367
R ++P G++ ++ N C E + C P RP F
Sbjct: 211 R--------GQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSF 262
Query: 368 EVLEVWLEGL 377
+ L LE +
Sbjct: 263 QHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 3e-23
Identities = 66/231 (28%), Positives = 100/231 (43%), Gaps = 38/231 (16%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVT-EYIAGGTLKELLQDPGQPLPWGQRVNFARDIA 209
+++ H NV+ +G+ LV Y+ G L+ ++ + F +A
Sbjct: 49 IMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVA 108
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
GM YL S +HRDL ++NC++ E TV VADFGLAR I+ K
Sbjct: 109 KGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYD----------KEYYSVHN 158
Query: 270 RRGARKKRYTVVGNPY-WMAPEMMTGQEYDETVDVFSYGIVLCEIIGR-VPADPD----- 322
GA+ P WMA E + Q++ DV+S+G++L E++ R P PD
Sbjct: 159 HTGAKL--------PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD 210
Query: 323 ---YLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
YL + L Q ++ CP+P + C P+ RP F L
Sbjct: 211 ITVYLLQGRR--LLQPEY-------CPDPLYEVMLSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 3e-23
Identities = 50/174 (28%), Positives = 82/174 (47%), Gaps = 33/174 (18%)
Query: 151 VLRSLHHHNVIRFIGVLYK----DRKLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNFA 205
+L ++H FI L+ + KL LV EY GG L L G+ + +A
Sbjct: 46 ILSRINH----PFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF--YA 99
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
+I + YLHS+ +I+RDL +N L+ D + + DFGLA+ +
Sbjct: 100 AEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE------------- 146
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVP 318
+ T G P ++APE++ G+ Y + VD +S G++L E++ G+ P
Sbjct: 147 --------GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 5e-23
Identities = 71/247 (28%), Positives = 101/247 (40%), Gaps = 59/247 (23%)
Query: 151 VLRSL-HHHNVIRFIGVLYK------DRKLNLVTEYIAGGTLKEL---LQDPGQPLPWGQ 200
+LR +H N+ F G K D +L LV E GG++ +L L+ G+ L
Sbjct: 55 ILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW 114
Query: 201 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260
R+ G+ YLH +IHRD+ QN L+ ++ V + DFG+
Sbjct: 115 IAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV--------------- 159
Query: 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE-----YDETVDVFSYGIVLCEIIG 315
+AQ +R T +G PYWMAPE++ E YD DV+S GI E+
Sbjct: 160 ------SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELAD 213
Query: 316 RVP--AD--PD----YLPRSPDFGLDQ----TDFRNKFCASCPEPFVRIAFLCCDLNPDQ 363
P D P +PR+P L + N F + C N +Q
Sbjct: 214 GKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIK-----------NYEQ 262
Query: 364 RPPFEVL 370
RP E L
Sbjct: 263 RPFMEEL 269
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 5e-23
Identities = 67/218 (30%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++ VL + R+ G K KL ++ EY+ GG+ +LL+ PG PL R+
Sbjct: 52 EITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PG-PLEETYIATILRE 109
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
I G+ YLHS IHRD+ + N L+ E V +ADFG+A
Sbjct: 110 ILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVA--------------------- 148
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
Q + KR T VG P+WMAPE++ YD D++S GI E+ P + D P
Sbjct: 149 GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR 208
Query: 328 PDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
F L + +PF C + +P RP
Sbjct: 209 VLF-LIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRP 245
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 6e-23
Identities = 69/229 (30%), Positives = 100/229 (43%), Gaps = 34/229 (14%)
Query: 157 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ---------------DPGQPLPWGQR 201
H N+I +G +D L ++ EY + G L+E L+ P + L +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 202 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA 261
V+ A +A GM YL S IHRDL ++N LV ED + +ADFGLAR IH T
Sbjct: 143 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADP 321
++P K WMAPE + + Y DV+S+G++L EI +
Sbjct: 203 RLPVK-------------------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
Query: 322 DYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
+P F L + R ++C + C P QRP F+ L
Sbjct: 244 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 7e-23
Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 25/172 (14%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+++L+ L H N+++ + V++ +RKL LV EY LK+ L PL + +
Sbjct: 49 ISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQL 107
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G+ Y HS ++HRDL QN L+ D + +ADFGLAR +P
Sbjct: 108 LRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFG------------IP---- 151
Query: 269 QRRGARKKRYT-VVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVP 318
+ YT V ++ APE++ G Y VD++S G + E+I P
Sbjct: 152 ------LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 9e-23
Identities = 60/178 (33%), Positives = 85/178 (47%), Gaps = 23/178 (12%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++ VL V ++ G KD KL ++ EY+ GG+ +LL+ PG PL Q R+
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PG-PLDETQIATILRE 109
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
I G+ YLHS IHRD+ + N L+ E V +ADFG+ A
Sbjct: 110 ILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGV---------------------A 148
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLP 325
Q + KR T VG P+WMAPE++ YD D++S GI E+ P + P
Sbjct: 149 GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 47/173 (27%), Positives = 84/173 (48%), Gaps = 24/173 (13%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++ L++ H V++ + V LV EY+ L E+L+D +PLP Q ++ R
Sbjct: 49 EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRM 107
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ G+ Y+H+ ++HRDL N L+ D + +ADFGLAR+ +
Sbjct: 108 LLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL----------- 156
Query: 268 AQRRGARKKRYT-VVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVP 318
Y+ V ++ APE++ G ++YD VD+++ G + E++ P
Sbjct: 157 ----------YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 67/264 (25%), Positives = 106/264 (40%), Gaps = 75/264 (28%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-----DPG-----QPLP 197
+V +L L N+ R +GV D L ++ EY+ G L + LQ G + L
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 198 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPT 257
+ + A IA+GM YL S+N +HRDL ++NCLV ++ T+ +ADFG++R ++
Sbjct: 129 FSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS----- 183
Query: 258 TVMAKVPRKAAQRRGARKKRYTVVGNP----YWMAPEMMTGQEYDETVDVFSYGIVLCEI 313
Y V G WMA E + ++ DV+++G+ L EI
Sbjct: 184 ------------------DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225
Query: 314 --------------------IGRVPADPD---YLPRSPDFGLDQTDFRNKFCASCPEPFV 350
G D YLPR P +CP+
Sbjct: 226 LTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPP---------------NCPKDIY 270
Query: 351 RIAFLCCDLNPDQRPPFEVLEVWL 374
+ C + + RP F + ++L
Sbjct: 271 ELMLECWRRDEEDRPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 34/202 (16%)
Query: 125 KDGLLFC-KE-DYNG-KYGEACQNCGQVAVLRSLHHHNVIRFIG--VLYKDRKLNLVTEY 179
DG + KE DY E Q +V +LR L H N++R+ + ++ L +V EY
Sbjct: 23 SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY 82
Query: 180 IAGGTLKELLQ---DPGQPLPWGQRVNFARDIAAGMTYLH-----SMNLIHRDLNSQNCL 231
GG L +L+Q + + + + H ++HRDL N
Sbjct: 83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIF 142
Query: 232 VREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM 291
+ + V + DFGLA+I+ + AK T VG PY+M+PE
Sbjct: 143 LDANNNVKLGDFGLAKILGHD-----SSFAK----------------TYVGTPYYMSPEQ 181
Query: 292 MTGQEYDETVDVFSYGIVLCEI 313
+ YDE D++S G ++ E+
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|188751 cd09365, LIM2_LIMK, The second LIM domain of LIMK (LIM domain Kinase ) | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 2e-22
Identities = 35/53 (66%), Positives = 41/53 (77%), Gaps = 1/53 (1%)
Query: 63 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERS-ILCSAC 114
C C Q+++GPVMV GDHKFHPECF C+SC IGDG+SYALVERS + C C
Sbjct: 1 CHGCSQIITGPVMVAGDHKFHPECFSCSSCKAFIGDGDSYALVERSKLYCGVC 53
|
The second LIM domain of LIMK (LIM domain Kinase ): LIMK protein family is comprised of two members LIMK1 and LIMK2. LIMK contains two LIM domains, a PDZ domain and a kinase domain. LIMK is involved in the regulation of actin polymerization and microtubule disassembly. LIMK influences architecture of the actin cytoskeleton by regulating the activity of the cofilin family proteins cofilin1, cofilin2, and destrin. The mechanism of the activation is to phosphorylates cofilin on serine 3 and inactivates its actin-severing activity, and altering the rate of actin depolymerization. LIMKs can function in both cytoplasm and nucleus and are expressed in all tissues. Both LIMK1 and LIMK2 can act in the nucleus to suppress Rac/Cdc42-dependent cyclin D1 expression. However, LIMK1 and LIMk2 have different cellular locations. While LIMK1 localizes mainly at focal adhesions, LIMK2 is found in cytoplasmic punctae, suggesting that they may have different cellular functions. The LIM domains of LIMK have been shown to play an important role in regulating kinase activity and likely also contribute to LIMK function by acting as sites of protein-to-protein interactions. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 54 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 2e-22
Identities = 46/168 (27%), Positives = 84/168 (50%), Gaps = 16/168 (9%)
Query: 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
++A+L+ L H N+++++G LN+ EY+ GG++ LL + G NF R
Sbjct: 55 REIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA-FEETLVRNFVR 113
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
I G+ YLH+ +IHRD+ N LV + ++DFG+++ + A +
Sbjct: 114 QILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKL----EANSLSTKT---- 165
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII 314
R ++ G+ +WMAPE++ Y D++S G ++ E++
Sbjct: 166 -------NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-22
Identities = 69/251 (27%), Positives = 110/251 (43%), Gaps = 52/251 (20%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL------QDPG-------- 193
+ ++ L H N++ +GV K++ ++ EY+A G L E L D G
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 194 -QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252
L ++ A IAAGM YL S + +HRDL ++NCLV E TV ++DFGL+R I+
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
Query: 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLC 311
+ +P + WM PE ++ G+ E+ D++S+G+VL
Sbjct: 178 DYYRVQSKSLLPVR-------------------WMPPEAILYGKFTTES-DIWSFGVVLW 217
Query: 312 EIIGRVPADPDYLPRSPDFGLDQTD----FRNKFCASCPE---PFV-RIAFLCCDLNPDQ 363
EI P +G + R++ CPE V + C + P +
Sbjct: 218 EIFS--------YGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPAR 269
Query: 364 RPPFEVLEVWL 374
RP F+ + L
Sbjct: 270 RPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 3e-22
Identities = 58/237 (24%), Positives = 105/237 (44%), Gaps = 40/237 (16%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKE-LLQDPGQPLPWGQRVNFAR 206
++ +L L H N+I + D L + EY GGTL + +++ GQ + +
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
I + ++Y+H ++HRD+ + N + + + + DFG+++I+ MA+
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS-----EYSMAE---- 159
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326
TVVG PY+M+PE+ G +Y+ D+++ G VL E++ L R
Sbjct: 160 ------------TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL--------TLKR 199
Query: 327 SPDFGLDQTDFRNKF--CASCPEPFVRIAFL------CCDLNPDQRPPF-EVLEVWL 374
+ D + + K P V + L +P++RP EVL+ L
Sbjct: 200 TFD-ATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 4e-22
Identities = 67/255 (26%), Positives = 111/255 (43%), Gaps = 49/255 (19%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ---------------DP 192
+V +L L N+IR +GV + L ++TEY+ G L + L P
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 193 GQPLP---WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARII 249
LP + ++ A IA+GM YL S+N +HRDL ++NCLV E+ T+ +ADFG++R +
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIV 309
+ G A +P + WMA E + ++ DV+++G+
Sbjct: 189 YAGDYYRIQGRAVLPIR-------------------WMAWECILMGKFTTASDVWAFGVT 229
Query: 310 LCEIIGRVPADP-------DYLPRSPDFGLDQTDFRNKFC---ASCPEPFVRIAFLCCDL 359
L EI+ P + + +F DQ R + CP+ + C
Sbjct: 230 LWEILMLCKEQPYGELTDEQVIENAGEFFRDQG--RQVYLFRPPPCPQGLYELMLQCWSR 287
Query: 360 NPDQRPPFEVLEVWL 374
+ +RP F + +L
Sbjct: 288 DCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 9e-22
Identities = 56/178 (31%), Positives = 82/178 (46%), Gaps = 23/178 (12%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++ VL V ++ G K KL ++ EY+ GG+ +LL+ P Q ++
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR--AGPFDEFQIATMLKE 109
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
I G+ YLHS IHRD+ + N L+ E V +ADFG+A
Sbjct: 110 ILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVA--------------------- 148
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLP 325
Q + KR T VG P+WMAPE++ YD D++S GI E+ P + D P
Sbjct: 149 GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 36/186 (19%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKEL-----LQDPGQPLPWGQRV 202
+V ++R H N++ +L +V E++ GG L ++ + + Q
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIA 118
Query: 203 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAK 262
+ +++LH+ +IHRD+ S + L+ D V ++DFG V +
Sbjct: 119 TVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFC----------AQVSKE 168
Query: 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPD 322
VPR R ++VG PYWMAPE+++ Y VD++S GI++ E+ V +P
Sbjct: 169 VPR-----------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM---VDGEPP 214
Query: 323 YLPRSP 328
Y P
Sbjct: 215 YFNEPP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 2e-21
Identities = 56/181 (30%), Positives = 92/181 (50%), Gaps = 26/181 (14%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++ V+R + N++ ++ +L +V EY+AGG+L +++ + + GQ R+
Sbjct: 66 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRE 123
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ +LHS +IHRD+ S N L+ D +V + DFG
Sbjct: 124 CLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC--------------------- 162
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
AQ + KR T+VG PYWMAPE++T + Y VD++S GI+ E+ V +P YL +
Sbjct: 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM---VEGEPPYLNEN 219
Query: 328 P 328
P
Sbjct: 220 P 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 67/236 (28%), Positives = 112/236 (47%), Gaps = 42/236 (17%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ--------DPGQ-PLPW 198
+ +V++ + H+V+R +GV+ + + ++ E + G LK L+ +P Q P
Sbjct: 59 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118
Query: 199 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTT 258
+ + A +IA GM YL++ +HRDL ++NC+V ED TV + DFG+ R I++
Sbjct: 119 KKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE------- 171
Query: 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI--IGR 316
RK +G R WM+PE + + DV+S+G+VL EI +
Sbjct: 172 --TDYYRKGG--KGLLPVR--------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 219
Query: 317 VP----ADPDYLPRSPDFG-LDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF 367
P ++ L + G LD+ D +CP+ + +C NP RP F
Sbjct: 220 QPYQGMSNEQVLRFVMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSF 268
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 4e-21
Identities = 65/233 (27%), Positives = 109/233 (46%), Gaps = 36/233 (15%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++ +++ H N++ + G KL + EY GG+L+++ G PL Q R+
Sbjct: 56 EIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRE 114
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
G+ YLHS +HRD+ N L+ ++ V +ADFG+A I T +A
Sbjct: 115 TLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKI-------TATIA------ 161
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQE---YDETVDVFSYGIVLCEIIGRVPADPDYL 324
KR + +G PYWMAPE+ ++ Y++ D+++ GI E+ P D
Sbjct: 162 --------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213
Query: 325 PRSPDFGLDQTDF-------RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
P F + +++F + K+ +S FV+I+ NP +RP E L
Sbjct: 214 PMRALFLMSKSNFQPPKLKDKTKW-SSTFHNFVKISLT---KNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 4e-21
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 34/229 (14%)
Query: 157 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---------------PGQPLPWGQR 201
H N+I +G +D L ++ EY + G L+E L+ P + + +
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 202 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA 261
V+ +A GM YL S IHRDL ++N LV E+ + +ADFGLAR ++ T
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADP 321
++P K WMAPE + + Y DV+S+G+++ EI +
Sbjct: 200 RLPVK-------------------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
Query: 322 DYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
+P F L + R A+C + C P RP F+ L
Sbjct: 241 PGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQL 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 4e-21
Identities = 62/246 (25%), Positives = 106/246 (43%), Gaps = 48/246 (19%)
Query: 147 GQVAVLRSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF 204
++ +L++L+H N++++ G + + L L+ EY+ G+L++ L P L Q + F
Sbjct: 55 KEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLF 112
Query: 205 ARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVP 264
A+ I GM YLHS + IHRDL ++N L+ D+ V + DFGLA+ + +G
Sbjct: 113 AQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG------------ 160
Query: 265 RKAAQRRGARKKRYTVV---GNP-YWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPAD 320
+ Y V +P +W A E + ++ DV+S+G+ L E++ D
Sbjct: 161 ----------HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTH--CD 208
Query: 321 PDYLPRS----------------PDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQR 364
P L + R +CP+ + C + R
Sbjct: 209 SKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFR 268
Query: 365 PPFEVL 370
P F L
Sbjct: 269 PTFRSL 274
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 5e-21
Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 33/227 (14%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++ +L + +H +++ +G Y D KL ++ E+ GG + ++ + + L Q R
Sbjct: 59 EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ + YLHSM +IHRDL + N L+ D + +ADFG+ +
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGV---------------------S 157
Query: 268 AQRRGARKKRYTVVGNPYWMAPEM-----MTGQEYDETVDVFSYGIVLCEIIGRVPADPD 322
A+ ++R + +G PYWMAPE+ M YD D++S GI L E+ P +
Sbjct: 158 AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217
Query: 323 YLPRSPDFGLDQTDFRNKFCASCPEP----FVRIAFLCCDLNPDQRP 365
P + +++ S F++ A D +P+ RP
Sbjct: 218 LNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTAL---DKHPETRP 261
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 7e-21
Identities = 55/181 (30%), Positives = 92/181 (50%), Gaps = 26/181 (14%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++ V++ L + N++ F+ +L +V EY+AGG+L +++ + + Q R+
Sbjct: 66 EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRE 123
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ +LH+ +IHRD+ S N L+ D +V + DFG
Sbjct: 124 CLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFC--------------------- 162
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
AQ + KR T+VG PYWMAPE++T + Y VD++S GI+ E+ V +P YL +
Sbjct: 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM---VEGEPPYLNEN 219
Query: 328 P 328
P
Sbjct: 220 P 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 8e-21
Identities = 48/173 (27%), Positives = 85/173 (49%), Gaps = 22/173 (12%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIA 209
V+ S+ H +V+R +G+ + + L+T+ + G L + +++ + +N+ IA
Sbjct: 61 YVMASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIA 119
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
GM+YL L+HRDL ++N LV+ + V + DFGLA+++ + KVP K
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK--- 176
Query: 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPAD 320
WMA E + + Y DV+SYG+ + E++ G P +
Sbjct: 177 ----------------WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 9e-21
Identities = 56/181 (30%), Positives = 92/181 (50%), Gaps = 26/181 (14%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++ V+R + N++ ++ +L +V EY+AGG+L +++ + + GQ R+
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRE 124
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ +LHS +IHRD+ S N L+ D +V + DFG
Sbjct: 125 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC--------------------- 163
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
AQ + KR T+VG PYWMAPE++T + Y VD++S GI+ E+I +P YL +
Sbjct: 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI---EGEPPYLNEN 220
Query: 328 P 328
P
Sbjct: 221 P 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 9e-21
Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 19/179 (10%)
Query: 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
++ +L++L H ++++ G L D L++ EY+ GG++K+ L+ G L + R
Sbjct: 53 CEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTRKYTR 111
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
I G+ YLHS ++HRD+ N L V + DFG ++ + Q + T M
Sbjct: 112 QILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICSSGTGMK----- 165
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLP 325
+V G PYWM+PE+++G+ Y DV+S G + E++ P ++
Sbjct: 166 ------------SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-20
Identities = 63/245 (25%), Positives = 111/245 (45%), Gaps = 46/245 (18%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFA 205
++ +LR+L+H N++++ G+ +D + L+ E++ G+LKE L + Q++ +A
Sbjct: 56 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYA 115
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
I GM YL S +HRDL ++N LV + V + DFGL + I
Sbjct: 116 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD------------- 162
Query: 266 KAAQRRGARKKRYTV---VGNP-YWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADP 321
K+ YTV + +P +W APE + ++ DV+S+G+ L E++ D
Sbjct: 163 ---------KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL--TYCDS 211
Query: 322 DYLPRS-------PDFG---------LDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
+ P + P G + + R +CPE ++ C + P +R
Sbjct: 212 ESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRT 271
Query: 366 PFEVL 370
F+ L
Sbjct: 272 TFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 59/237 (24%), Positives = 100/237 (42%), Gaps = 39/237 (16%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ--------DPGQPLPWG 199
++ + R L H NV+R +G+ + ++ EY G LK+ L+ PL
Sbjct: 58 ELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTK 117
Query: 200 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259
Q+V IA GM +L + +HRDL ++NCLV + V V+ L++ ++
Sbjct: 118 QKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYK-LR 176
Query: 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRV 317
A +P + W+APE + ++ DV+S+G+++ E+ G +
Sbjct: 177 NALIPLR-------------------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGEL 217
Query: 318 P----ADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
P +D + L R L CP ++ C +NP RP F L
Sbjct: 218 PFYGLSDEEVLNR-----LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-20
Identities = 53/178 (29%), Positives = 90/178 (50%), Gaps = 21/178 (11%)
Query: 148 QVAVLRSLHHHNVIRFIGVL--YKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFA 205
++ +L++L H ++++ G L ++ L + EY+ GG++K+ L+ G L +
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYT 112
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
R I GM+YLHS ++HRD+ N L V + DFG ++ R T M+
Sbjct: 113 RQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK------RLQTICMSGT-- 164
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDY 323
G R +V G PYWM+PE+++G+ Y DV+S G + E++ P +Y
Sbjct: 165 ------GIR----SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 72/239 (30%), Positives = 100/239 (41%), Gaps = 31/239 (12%)
Query: 132 KEDYNGK-YGEACQNC-GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL 189
K Y+GK E Q+ +V L+ L H N I + G K+ LV EY G + +LL
Sbjct: 53 KMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLL 111
Query: 190 QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARII 249
+ +PL + G+ YLHS N+IHRD+ + N L+ E V +ADFG A
Sbjct: 112 EVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS 171
Query: 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM---MTGQEYDETVDVFSY 306
+P + VG PYWMAPE+ M +YD VDV+S
Sbjct: 172 -----SPAN--------------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 206
Query: 307 GIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
GI E+ R P + S + + Q D + F C P +RP
Sbjct: 207 GITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERP 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 3e-20
Identities = 63/248 (25%), Positives = 109/248 (43%), Gaps = 42/248 (16%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD--------PGQPLPWG 199
++ ++ L + N+IR +GV D L ++TEY+ G L + L +P
Sbjct: 67 EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 200 QRVNF---ARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256
N A IA+GM YL S+N +HRDL ++NCLV T+ +ADFG++R ++ G
Sbjct: 127 SIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186
Query: 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG- 315
A +P + WMA E + ++ DV+++G+ L E+
Sbjct: 187 IQGRAVLPIR-------------------WMAWESILLGKFTTASDVWAFGVTLWEMFTL 227
Query: 316 ------RVPADPDYLPRSPDFGLDQTDFRNKFCAS---CPEPFVRIAFLCCDLNPDQRPP 366
+ +D + + +F +Q R + + CP P ++ C + RP
Sbjct: 228 CKEQPYSLLSDEQVIENTGEFFRNQG--RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT 285
Query: 367 FEVLEVWL 374
F + +L
Sbjct: 286 FNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 4e-20
Identities = 67/257 (26%), Positives = 106/257 (41%), Gaps = 56/257 (21%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---------------- 191
+ A++ H N+++ +GV + + L+ EY+A G L E L+
Sbjct: 58 EAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSA 117
Query: 192 ---PGQPLPWG--QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLA 246
PLP +++ A+ +AAGM YL +HRDL ++NCLV E+ V +ADFGL+
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 247 RIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306
R I+ + +P + WM PE + Y DV++Y
Sbjct: 178 RNIYSADYYKASENDAIPIR-------------------WMPPESIFYNRYTTESDVWAY 218
Query: 307 GIVLCEIIGRVPADPDYLPRSPDFGLDQTD----FRNKFCASCPE----PFVRIAFLCCD 358
G+VL EI P +G+ + R+ SCP+ + LC
Sbjct: 219 GVVLWEIFS--------YGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWS 270
Query: 359 LNPDQRPPFEVLEVWLE 375
P RP F + L+
Sbjct: 271 KLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 36/228 (15%)
Query: 96 IGDGESYALVERSILCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQNCGQVAVLRSL 155
IG+G +Y +V A D + K L + + G ++ +L+ L
Sbjct: 7 IGEG-TYGVV-----YKARDKLTGEIVAIKKIKLRFESE-----GIPKTALREIKLLKEL 55
Query: 156 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYL 215
+H N+I+ + V L LV E++ L +L++D + LP ++ + G+ +
Sbjct: 56 NHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC 114
Query: 216 HSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARK 275
HS ++HRDL +N L+ + + +ADFGLAR R
Sbjct: 115 HSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP-------------------- 154
Query: 276 KRYT-VVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADP 321
YT V ++ APE++ G + Y VD++S G + E++ R P P
Sbjct: 155 --YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFP 200
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 4e-20
Identities = 65/227 (28%), Positives = 109/227 (48%), Gaps = 30/227 (13%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++ ++ L+H ++IR +G +D NL E++AGG++ LL G +N+
Sbjct: 53 EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQ 111
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKT---VVVADFGLARIIHQGPRAPTTVMAKVP 264
+ G++YLH +IHRD+ N L+ D T + +ADFG A
Sbjct: 112 LLRGLSYLHENQIIHRDVKGANLLI--DSTGQRLRIADFGAA-----------------A 152
Query: 265 RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDY 323
R AA+ GA + + ++G +MAPE++ G++Y + DV+S G V+ E+ + P + +
Sbjct: 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212
Query: 324 LPRSPDFGLDQTDFRNKFCASCPE---PFVR-IAFLCCDLNPDQRPP 366
S L S PE P +R + C +L P+ RPP
Sbjct: 213 H--SNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPP 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 4e-20
Identities = 61/233 (26%), Positives = 102/233 (43%), Gaps = 53/233 (22%)
Query: 152 LRSLH---HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV--NFAR 206
L++L V++ G YK+ ++++V EY+ GG+L +LL+ G + V AR
Sbjct: 50 LKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG---KIPEPVLAYIAR 106
Query: 207 DIAAGMTYLHSM-NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
I G+ YLH+ ++IHRD+ N L+ V +ADFG+++++
Sbjct: 107 QILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT------------- 153
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE-IIGRVPADPDYL 324
+ T VG +M+PE + G+ Y D++S G+ L E +G+ P +L
Sbjct: 154 --------LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP----FL 201
Query: 325 PRSPDFGLDQTDFRNKFCA--SCPEPFVR--------IAFL--CCDLNPDQRP 365
P Q F A P P + F+ C +P +RP
Sbjct: 202 P------PGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 5e-20
Identities = 51/230 (22%), Positives = 89/230 (38%), Gaps = 45/230 (19%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL---QDPGQPLPWGQRVNF 204
++ +L S++H N+I + KL +V EY G L + + + + +P +
Sbjct: 49 EIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108
Query: 205 ARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVP 264
+ G+ LH ++HRDL S N L+ + V + D G+++++ + MAK
Sbjct: 109 FIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-------MAK-- 159
Query: 265 RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDY 323
T +G P++MAPE+ G+ Y D++S G +L E+ P +
Sbjct: 160 --------------TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE--- 202
Query: 324 LPRSPDFGLDQTDFRNKFCASCPEP--------FVRIAFLCCDLNPDQRP 365
D R K P + P RP
Sbjct: 203 -------ARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 6e-20
Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
V+ L H +++ GV + + LV E++ G L + L+ + D+
Sbjct: 52 VMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCE 111
Query: 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQR 270
GM YL S N+IHRDL ++NCLV E++ V V+DFG+ R + +T K P K
Sbjct: 112 GMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST-GTKFPVK---- 166
Query: 271 RGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYLPRSP 328
W +PE+ + +Y DV+S+G+++ E+ G+ P Y RS
Sbjct: 167 ---------------WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTP----YENRSN 207
Query: 329 DFGLDQ--TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
++ FR + + C P+ RP F +L
Sbjct: 208 SEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLL 251
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 7e-20
Identities = 55/187 (29%), Positives = 87/187 (46%), Gaps = 35/187 (18%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ------------- 194
+ +L L H +++RF GV + R L +V EY+ G L L+ G
Sbjct: 57 EAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAP 116
Query: 195 -PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253
L GQ + A IA+GM YL S++ +HRDL ++NCLV + V + DFG++R I+
Sbjct: 117 GQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176
Query: 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI 313
+P + WM PE + +++ D++S+G+VL EI
Sbjct: 177 YYRVGGRTMLPIR-------------------WMPPESILYRKFTTESDIWSFGVVLWEI 217
Query: 314 I--GRVP 318
G+ P
Sbjct: 218 FTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 8e-20
Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 24/173 (13%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFAR 206
+V VLR L H N++ + +L LV EY+ L+ L P G P + +
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIW-- 107
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
+ + Y HS N+IHRD+ +N LV E + + DFG AR + P +P T
Sbjct: 108 QLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT-------- 159
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVP 318
V ++ APE++ G Y + VDV++ G ++ E++ P
Sbjct: 160 ------------DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 8e-20
Identities = 82/275 (29%), Positives = 112/275 (40%), Gaps = 46/275 (16%)
Query: 132 KEDYNGKYG-EACQN-CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL 189
K Y+GK E Q+ +V L+ L H N I + G ++ LV EY G + ++L
Sbjct: 47 KMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDIL 105
Query: 190 QDPGQPLPWGQRVNFA---RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLA 246
+ +PL Q V A G+ YLHS IHRD+ + N L+ E TV +ADFG A
Sbjct: 106 EVHKKPL---QEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSA 162
Query: 247 RIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPE----MMTGQEYDETVD 302
++ +P + VG PYWMAPE M GQ YD VD
Sbjct: 163 SLV-----SPAN--------------------SFVGTPYWMAPEVILAMDEGQ-YDGKVD 196
Query: 303 VFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPD 362
V+S GI E+ R P + S + + Q D + F C P
Sbjct: 197 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQ 256
Query: 363 QRPPFEVLEVWLEGLSMHLSVDKPLPSDLEADIYQ 397
RP E L H V + P + D+ Q
Sbjct: 257 DRPSSEE-------LLKHRFVLRERPPTVIIDLIQ 284
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 66/222 (29%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 157 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP-LPWGQRVNFARDIAAGMTYL 215
H N++ +G + ++TEY G L L+ + L ++F+ +A GM +L
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 216 HSMNLIHRDLNSQNCLVREDKTVVVADFGLAR-IIHQGPRAPTTVMAKVPRKAAQRRGAR 274
S N IHRDL ++N L+ K V + DFGLAR I++
Sbjct: 158 ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND----------------------- 194
Query: 275 KKRYTVVGNPY----WMAPEMMTGQEYDETVDVFSYGIVLCEI--IGRVPADPDYLPRSP 328
Y V GN WMAPE + Y DV+SYGI+L EI +G P P S
Sbjct: 195 -SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY-PGMPVDSK 252
Query: 329 DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
+ L + +R P I C D +P +RP F+ +
Sbjct: 253 FYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 69/241 (28%), Positives = 109/241 (45%), Gaps = 39/241 (16%)
Query: 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD----PGQPLPWGQR 201
+ ++ +H N++R IGV ++ ++ E +AGG LK L++ P +P +
Sbjct: 57 LMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMK 116
Query: 202 --VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAP 256
+ ARD+A G YL + IHRD+ ++NCL+ + +ADFG+AR I+
Sbjct: 117 DLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY------ 170
Query: 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPY-WMAPEMMTGQEYDETVDVFSYGIVLCEI-- 313
R + R+G R P WM PE + DV+S+G++L EI
Sbjct: 171 --------RASYYRKGGRAML------PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
Query: 314 IGRVPADPDYLPRSPDFGLDQTDF--RNKFCASCPEPFVRIAFLCCDLNPDQRPPF-EVL 370
+G +P Y R+ ++ R CP P RI C P+ RP F +L
Sbjct: 217 LGYMP----YPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATIL 272
Query: 371 E 371
E
Sbjct: 273 E 273
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 62/237 (26%), Positives = 106/237 (44%), Gaps = 44/237 (18%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++ +++ H N++ + G + KL + E+ GG+L+++ G PL Q +R+
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRE 114
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
G+ YLHS +HRD+ N L+ ++ V +ADFG+ +
Sbjct: 115 TLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGV---------------------S 153
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQE---YDETVDVFSYGIVLCEIIGRVPADPDYL 324
AQ KR + +G PYWMAPE+ + Y++ D+++ GI E+ P D
Sbjct: 154 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213
Query: 325 PRSPDFGLDQTDFR-----------NKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
P F + +++F+ N F FV++A NP +RP E L
Sbjct: 214 PMRALFLMTKSNFQPPKLKDKMKWSNSF-----HHFVKMAL---TKNPKKRPTAEKL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 53/196 (27%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRK-LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIA 209
+L +H +++ +KD+K + ++ EY GG L +L+D R F A
Sbjct: 46 ILEECNHPFIVKLYRT-FKDKKYIYMLMEYCLGGELWTILRD---------RGLFDEYTA 95
Query: 210 ----AGMT----YLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA 261
A + YLH+ +I+RDL +N L+ + V + DFG A+ +
Sbjct: 96 RFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL------------ 143
Query: 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPAD 320
+ +K +T G P ++APE++ + YD +VD +S GI+L E++ GR P
Sbjct: 144 ----------KSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP-- 191
Query: 321 PDYLPRSPDFGLDQTD 336
FG D D
Sbjct: 192 ---------FGEDDED 198
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-19
Identities = 60/239 (25%), Positives = 108/239 (45%), Gaps = 38/239 (15%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD------PGQPLPWGQR 201
+ ++ + +H N+++ +GV + ++ E + GG L L+D L +
Sbjct: 49 EAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKEL 108
Query: 202 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE-----DKTVVVADFGLARIIHQGPRAP 256
++ D+A G YL M+ IHRDL ++NCLV E D+ V + DFGLAR I++
Sbjct: 109 LDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS---- 164
Query: 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-- 314
++ G WMAPE + ++ DV+S+G+++ EI+
Sbjct: 165 ---------DYYRKEGEGLL------PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTL 209
Query: 315 GRVPADPDYLPRSPDFGLD--QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371
G+ P Y + L R + +CP+ ++ C +P +RP F+ ++
Sbjct: 210 GQQP----YPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQ 264
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 4e-19
Identities = 49/176 (27%), Positives = 79/176 (44%), Gaps = 26/176 (14%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLN-----LVTEYIAGGTLKELLQDPGQPLPWGQRVN 203
+ +LR L H N+I + +L + +VTE L ++++ P QPL
Sbjct: 50 IKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL-METDLHKVIKSP-QPLTDDHIQY 107
Query: 204 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263
F I G+ YLHS N+IHRDL N LV + + + DFGLAR + + V
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 264 PRKAAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEIIGRVP 318
R ++ APE +++ Y + +D++S G + E++ R P
Sbjct: 168 ----VTR--------------WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 6e-19
Identities = 68/235 (28%), Positives = 101/235 (42%), Gaps = 49/235 (20%)
Query: 156 HHHNVIRFIGVLYK------DRKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDI 208
HH N+ + G K D +L LV E+ G++ +L+++ G L R+I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 120
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G+++LH +IHRD+ QN L+ E+ V + DFG V A++ R
Sbjct: 121 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG--------------VSAQLDRTVG 166
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQE-----YDETVDVFSYGIVLCEIIGRVPADPDY 323
+R T +G PYWMAPE++ E YD D++S GI E+ P D
Sbjct: 167 RRN-------TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
Query: 324 --------LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
+PR+P L + KF + F+ C N QRP E L
Sbjct: 220 HPMRALFLIPRNPAPRLKSKKWSKKF-----QSFIES---CLVKNHSQRPTTEQL 266
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 7e-19
Identities = 49/169 (28%), Positives = 80/169 (47%), Gaps = 15/169 (8%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
+L V++ + L LV EY+ GG L LL++ G L + +I
Sbjct: 46 ILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVL 104
Query: 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQR 270
+ YLHS +IHRDL N L+ + + + DFGL+++ + K +R
Sbjct: 105 ALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR----RQINLNDDEKEDKR 160
Query: 271 RGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
+VG P ++APE++ GQ + +TVD +S G +L E ++G P
Sbjct: 161 ---------IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 7e-19
Identities = 61/240 (25%), Positives = 109/240 (45%), Gaps = 39/240 (16%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL---QDPGQP-------LP 197
++ ++ L N+IR + V L ++TEY+ G L + L + +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 198 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPT 257
+ + A IA+GM YL S+N +HRDL ++NCLV ++ T+ +ADFG++R ++ G
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRV 317
A +P + WM+ E + ++ DV+++G+ L EI+
Sbjct: 189 QGRAVLPIR-------------------WMSWESILLGKFTTASDVWAFGVTLWEILTLC 229
Query: 318 PADPDYLPRSPDFGLDQTD--FRNK-------FCASCPEPFVRIAFLCCDLNPDQRPPFE 368
P Y S + ++ T FR++ A CP+ ++ C N +RP F+
Sbjct: 230 KEQP-YSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQ 288
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 8e-19
Identities = 68/237 (28%), Positives = 100/237 (42%), Gaps = 53/237 (22%)
Query: 156 HHHNVIRFIGVLYK------DRKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDI 208
HH N+ + G K D +L LV E+ G++ +L+++ G L R+I
Sbjct: 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREI 130
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G+ +LH+ +IHRD+ QN L+ E+ V + DFG V A++ R
Sbjct: 131 LRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG--------------VSAQLDRTVG 176
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQE-----YDETVDVFSYGIVLCEIIGRVPADPDY 323
+R T +G PYWMAPE++ E YD D++S GI E+ P D
Sbjct: 177 RRN-------TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
Query: 324 --------LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFL--CCDLNPDQRPPFEVL 370
+PR+P L + KF I F+ C N RP E L
Sbjct: 230 HPMRALFLIPRNPPPKLKSKKWSKKF----------IDFIEGCLVKNYLSRPSTEQL 276
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 8e-19
Identities = 51/178 (28%), Positives = 91/178 (51%), Gaps = 21/178 (11%)
Query: 148 QVAVLRSLHHHNVIRFIGVL--YKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFA 205
++ +L++L H ++++ G L +++KL++ EY+ GG++K+ L+ G L +
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA-LTENVTRRYT 112
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
R I G++YLHS ++HRD+ N L V + DFG ++ R T M+
Sbjct: 113 RQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK------RIQTICMSGTGI 166
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDY 323
K +V G PYWM+PE+++G+ Y DV+S + E++ P +Y
Sbjct: 167 K------------SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 8e-19
Identities = 64/192 (33%), Positives = 88/192 (45%), Gaps = 31/192 (16%)
Query: 132 KEDYNGKY-GEACQNC-GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL 189
K Y+GK E Q+ +V L+ L H N I++ G ++ LV EY G + +LL
Sbjct: 47 KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLL 105
Query: 190 QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARII 249
+ +PL + G+ YLHS N+IHRD+ + N L+ E V + DFG A I+
Sbjct: 106 EVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165
Query: 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM---MTGQEYDETVDVFSY 306
AP VG PYWMAPE+ M +YD VDV+S
Sbjct: 166 -----APAN--------------------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200
Query: 307 GIVLCEIIGRVP 318
GI E+ R P
Sbjct: 201 GITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 36/229 (15%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++ L+ L H N+++++G + L++ EY+ GG++ L+ G+ R F
Sbjct: 58 EIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-FFTEQ 116
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ G+ YLHS ++HRDL + N LV D ++DFG++ + + +
Sbjct: 117 VLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGIS-------KKSDDIYDNDQNMS 169
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMM--TGQEYDETVDVFSYGIVLCEII-GRVPADPDYL 324
Q G+ +WMAPE++ Q Y VD++S G V+ E+ GR P
Sbjct: 170 MQ------------GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-----W 212
Query: 325 PRSPDFGLDQTDFRNKFCASCPEPFVR------IAFL--CCDLNPDQRP 365
+ P + FL C +NPD RP
Sbjct: 213 SDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 45/183 (24%), Positives = 85/183 (46%), Gaps = 14/183 (7%)
Query: 150 AVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
VL L+ H +I+ + L V EY G L + ++ G L R
Sbjct: 53 EVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS-LD----EKCTRFY 107
Query: 209 AA----GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVP 264
AA + YLHS +IHRDL +N L+ +D + + DFG A+++ P +
Sbjct: 108 AAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS-PESNKGDAT 166
Query: 265 RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVP--ADP 321
+Q R++ + VG +++PE++ + ++ D+++ G ++ +++ G+ P
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226
Query: 322 DYL 324
+YL
Sbjct: 227 EYL 229
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 53/185 (28%), Positives = 88/185 (47%), Gaps = 33/185 (17%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ------------DPGQP 195
+ +L +L H ++++F GV + L +V EY+ G L + L+ +
Sbjct: 57 EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE 116
Query: 196 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255
L Q ++ A+ IAAGM YL S + +HRDL ++NCLV E+ V + DFG++R ++
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176
Query: 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII- 314
+P + WM PE + +++ DV+S G+VL EI
Sbjct: 177 RVGGHTMLPIR-------------------WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
Query: 315 -GRVP 318
G+ P
Sbjct: 218 YGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 48/173 (27%), Positives = 87/173 (50%), Gaps = 19/173 (10%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+V +L+SL H N+++++G D +++ E++ GG++ +L G PLP + +
Sbjct: 52 EVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG-PLPEPVFCKYTKQ 110
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLA-RIIHQGPRAPTTVMAKVPRK 266
I G+ YLH+ ++HRD+ N ++ + + + DFG A R+ G + M K
Sbjct: 111 ILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK---- 166
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI-IGRVP 318
++ G PYWMAPE++ Y D++S G + E+ G+ P
Sbjct: 167 ------------SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 63/192 (32%), Positives = 88/192 (45%), Gaps = 31/192 (16%)
Query: 132 KEDYNGKYG-EACQNC-GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL 189
K Y+GK E Q+ +V L+ + H N I + G ++ LV EY G + +LL
Sbjct: 57 KMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLL 115
Query: 190 QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARII 249
+ +PL + G+ YLHS N+IHRD+ + N L+ E V +ADFG A I
Sbjct: 116 EVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA 175
Query: 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM---MTGQEYDETVDVFSY 306
+P + VG PYWMAPE+ M +YD VDV+S
Sbjct: 176 -----SPAN--------------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 210
Query: 307 GIVLCEIIGRVP 318
GI E+ R P
Sbjct: 211 GITCIELAERKP 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 3e-18
Identities = 50/176 (28%), Positives = 87/176 (49%), Gaps = 22/176 (12%)
Query: 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
++ VL L H N++++ GV K+ + EY +GGTL+ELL+ G+ L +
Sbjct: 48 DEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTL 106
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
+ G+ YLHS ++HRD+ N + + + + DFG A + + TT M
Sbjct: 107 QLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL----KNNTTTM------ 156
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDE---TVDVFSYGIVLCEII-GRVP 318
++ ++ G P +MAPE++TG + D++S G V+ E+ G+ P
Sbjct: 157 -------GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 51/181 (28%), Positives = 86/181 (47%), Gaps = 26/181 (14%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+V ++R HH NV+ +L +V E++ GG L +++ + Q
Sbjct: 69 EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLS 126
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ ++YLH+ +IHRD+ S + L+ D + ++DFG V +VP
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFC----------AQVSKEVP--- 173
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
KR ++VG PYWMAPE+++ Y VD++S GI++ E+I +P Y
Sbjct: 174 --------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMID---GEPPYFNEP 222
Query: 328 P 328
P
Sbjct: 223 P 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 53/181 (29%), Positives = 85/181 (46%), Gaps = 26/181 (14%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+V ++R H NV+ +L ++ E++ GG L +++ L Q
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCES 125
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ + YLHS +IHRD+ S + L+ D V ++DFG I + VP
Sbjct: 126 VLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK----------DVP--- 172
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
KR ++VG PYWMAPE+++ Y VD++S GI++ E+ V +P Y S
Sbjct: 173 --------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEM---VDGEPPYFSDS 221
Query: 328 P 328
P
Sbjct: 222 P 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 35/190 (18%)
Query: 148 QVAVLRSLHHHNVIRFIGVLY--KDRKLNLVTEYIAGGTL----KELLQDPGQPLPWGQR 201
++ + +S ++++ G + + EY GG+L K++ + G+ G++
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRI---GEK 105
Query: 202 V--NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259
V A + G++YLHS +IHRD+ N L+ V + DFG V
Sbjct: 106 VLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG--------------V 151
Query: 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVP 318
++ A T G ++MAPE + G+ Y T DV+S G+ L E+ R P
Sbjct: 152 SGELVNSLAG---------TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
Query: 319 ADPDYLPRSP 328
P+ P
Sbjct: 203 FPPEGEPPLG 212
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 5e-18
Identities = 56/190 (29%), Positives = 87/190 (45%), Gaps = 42/190 (22%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-------------Q 194
+ +L + H N+++F GV + +V EY+ G L + L+ G
Sbjct: 58 EAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMG 117
Query: 195 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254
L Q + A IA+GM YL S + +HRDL ++NCLV D V + DFG++R ++
Sbjct: 118 ELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY---- 173
Query: 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPY----WMAPEMMTGQEYDETVDVFSYGIVL 310
TT Y V G+ WM PE + +++ DV+S+G+VL
Sbjct: 174 --TT-----------------DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVL 214
Query: 311 CEII--GRVP 318
EI G+ P
Sbjct: 215 WEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 6e-18
Identities = 47/170 (27%), Positives = 85/170 (50%), Gaps = 28/170 (16%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNFARDIA 209
+L+S+ H ++ G D L LV EY+ GG L L+ G+ P P + +A +
Sbjct: 54 ILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARF--YAAQVV 111
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
+ YLHS+++++RDL +N L+ D + + DFG A+ +
Sbjct: 112 LALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV-------------------- 151
Query: 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVP 318
+ + YT+ G P ++APE++ + Y + VD ++ GI++ E++ G P
Sbjct: 152 ----KGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|188849 cd09465, LIM2_LIMK2, The second LIM domain of LIMK2 (LIM domain Kinase 2) | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 7e-18
Identities = 30/58 (51%), Positives = 40/58 (68%), Gaps = 1/58 (1%)
Query: 58 KYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSIL-CSAC 114
K+GE C C +M+GP MV G++K+HPECF C SC I DG++YALV+ + L C C
Sbjct: 1 KFGELCHGCSLLMTGPAMVAGEYKYHPECFACMSCKVIIEDGDTYALVQHTTLYCGKC 58
|
The second LIM domain of LIMK2 (LIM domain Kinase 2): LIMK2 is a member of the LIMK protein family, which comprises LIMK1 and LIMK2. LIMK contains two LIM domains, a PDZ domain, and a kinase domain. LIMK is involved in the regulation of actin polymerization and microtubule disassembly. LIMK influences architecture of the actin cytoskeleton by regulating the activity of the cofilin family proteins cofilin1, cofilin2, and destrin. The mechanism of the activation is to phosphorylates cofilin on serine 3 and inactivates its actin-severing activity, altering the rate of actin depolymerisation. LIMK activity is activated by phosphorylation of a threonine residue within the activation loop of the kinase by p21-activated kinases 1 and 4 and by Rho kinase. LIMKs can function in both cytoplasm and nucleus. Both LIMK1 and LIMK2 can act in the nucleus to suppress Rac/Cdc42-dependent cyclin D1 expression. LIMK2 is expressed in all tissues. While LIMK1 localizes mainly at focal adhesions, LIMK2 is found in cytoplasmic punctae, suggesting that they may have different cellular functions. The activity of LIM kinase 2 to regulate cofilin phosphorylation is inhibited by the direct binding of Par-3. LIMK2 activation promotes cell cycle progression. The phenotype of Limk2 knockout mice shows a defect in spermatogenesis. The LIM domains have been shown to play an important role in regulating kinase activity and likely also contribute to LIMK function by acting as sites of protein-to-protein interactions. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 59 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 26/181 (14%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+V ++R H NV+ +L +V E++ GG L +++ + Q
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLA 124
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ ++ LH+ +IHRD+ S + L+ D V ++DFG V +VPR
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC----------AQVSKEVPR-- 172
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
R ++VG PYWMAPE+++ Y VD++S GI++ E+ V +P Y
Sbjct: 173 ---------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM---VDGEPPYFNEP 220
Query: 328 P 328
P
Sbjct: 221 P 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 48/173 (27%), Positives = 88/173 (50%), Gaps = 21/173 (12%)
Query: 148 QVAVLRSLHHHNVIRFIGVLY--KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFA 205
++ +L++L H ++++ G L +R L++ E++ GG++K+ L+ G L +
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTENVTRKYT 112
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
R I G++YLHS ++HRD+ N L V + DFG ++ R T ++
Sbjct: 113 RQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASK------RLQTICLSGTGM 166
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVP 318
K +V G PYWM+PE+++G+ Y D++S G + E++ P
Sbjct: 167 K------------SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 45/167 (26%), Positives = 88/167 (52%), Gaps = 22/167 (13%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTL-KELLQDPGQPLPWGQRVNFAR 206
+VAVL ++ H N++++ ++ L +V +Y GG L K++ G P Q +++
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
I + ++H ++HRD+ SQN + +D T+ + DFG+AR+++ T +A+
Sbjct: 109 QICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-----TVELAR---- 159
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI 313
T +G PY+++PE+ + Y+ D+++ G VL E+
Sbjct: 160 ------------TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 52/171 (30%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++ +L S H N+++ + Y + L ++ E+ AGG + ++ + +PL Q +
Sbjct: 52 EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQ 111
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ YLH +IHRDL + N L D + +ADFG V AK R
Sbjct: 112 TLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFG--------------VSAKNTR-T 156
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMM-----TGQEYDETVDVFSYGIVLCEI 313
QRR + +G PYWMAPE++ + YD DV+S GI L E+
Sbjct: 157 IQRRD------SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 54/187 (28%), Positives = 89/187 (47%), Gaps = 33/187 (17%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
+L+ L H N+I + V +NLV E++ L+++++D L ++
Sbjct: 55 LLQELKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLR 113
Query: 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQR 270
G+ YLHS ++HRDL N L+ D + +ADFGLAR
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSF--------------------- 152
Query: 271 RGARKKRYT--VVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
G+ ++ T VV ++ APE++ G + Y VD++S G + E++ RVP +LP
Sbjct: 153 -GSPNRKMTHQVV-TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVP----FLPGD 206
Query: 328 PDFGLDQ 334
D +DQ
Sbjct: 207 SD--IDQ 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 47/170 (27%), Positives = 86/170 (50%), Gaps = 22/170 (12%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++++L+ L+H N+++ + V++ + KL LV E++ K + P +P ++
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQ 108
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ G+ + HS ++HRDL QN L+ + + +ADFGLAR VP
Sbjct: 109 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF------------GVP--- 153
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDET-VDVFSYGIVLCEIIGR 316
R + VV ++ APE++ G +Y T VD++S G + E++ R
Sbjct: 154 -----VRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 58/180 (32%), Positives = 88/180 (48%), Gaps = 41/180 (22%)
Query: 151 VLRSLHHH-NVIRFIGVLYKDRKLN-----LVTEYIAGGTLKELLQDPGQPLPWGQRVNF 204
+L+SL +H NV++F G+ YK KL LV E GG++ EL++ L GQR++
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL---LICGQRLDE 127
Query: 205 A------RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTT 258
A G+ +LH+ +IHRD+ N L+ + V + DFG++
Sbjct: 128 AMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS------------ 175
Query: 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE-----YDETVDVFSYGIVLCEI 313
AQ R +R T VG P+WMAPE++ ++ YD DV+S GI E+
Sbjct: 176 ---------AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 42/176 (23%), Positives = 82/176 (46%), Gaps = 25/176 (14%)
Query: 142 ACQNC-GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL---QDPGQPLP 197
A Q+C ++ +L+ L H NVI+++ ++ +LN+V E G L ++ + + +P
Sbjct: 45 ARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIP 104
Query: 198 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPT 257
+ + + + ++HS ++HRD+ N + V + D GL R +
Sbjct: 105 ERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSK 159
Query: 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI 313
T A +++VG PY+M+PE + Y+ D++S G +L E+
Sbjct: 160 TTAA----------------HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 7e-17
Identities = 53/188 (28%), Positives = 88/188 (46%), Gaps = 36/188 (19%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---------PGQP--- 195
+ +L +L H ++++F GV L +V EY+ G L + L+ GQP
Sbjct: 57 EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116
Query: 196 ---LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252
L Q ++ A IA+GM YL S + +HRDL ++NCLV + V + DFG++R ++
Sbjct: 117 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 176
Query: 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE 312
+P + WM PE + +++ DV+S+G++L E
Sbjct: 177 DYYRVGGHTMLPIR-------------------WMPPESIMYRKFTTESDVWSFGVILWE 217
Query: 313 II--GRVP 318
I G+ P
Sbjct: 218 IFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 8e-17
Identities = 43/162 (26%), Positives = 68/162 (41%), Gaps = 18/162 (11%)
Query: 170 DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMT----YLHSMNLIHRDL 225
+ L LV EY+ GG L LL AR A + +H + IHRD+
Sbjct: 73 EEHLYLVMEYMPGGDLMNLLIRKDV-----FPEETARFYIAELVLALDSVHKLGFIHRDI 127
Query: 226 NSQNCLVREDKTVVVADFGLARIIHQG--------PRAPTTVMAKVPRKAAQRRGARKKR 277
N L+ D + +ADFGL + +++ V + + R +
Sbjct: 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRA 187
Query: 278 YTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
+ VG P ++APE++ G Y D +S G++L E + G P
Sbjct: 188 NSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 55/225 (24%)
Query: 151 VLRSLHHH-NVIRFIGVLYKDRKLN-----LVTEYIAGGTLKELLQDPGQPLPWGQRVN- 203
+L++L H NV++F G+ YK N LV E GG++ +L++ L G+R+
Sbjct: 67 ILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGF---LKRGERMEE 123
Query: 204 -----FARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTT 258
+ G+ +LH IHRD+ N L+ + V + DFG++
Sbjct: 124 PIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS------------ 171
Query: 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE-----YDETVDVFSYGIVLCEI 313
AQ R +R T VG P+WMAPE++ ++ YD DV+S GI E+
Sbjct: 172 ---------AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
Query: 314 IGRVPADPDY--------LPRSPDFGLDQ-----TDFRNKFCASC 345
P D +PR+P L Q +F N F C
Sbjct: 223 GDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEF-NDFIRKC 266
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 56/253 (22%), Positives = 100/253 (39%), Gaps = 39/253 (15%)
Query: 131 CKEDYNGKYGEACQNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ 190
CK + E + + ++R H ++++ IGV+ + + +V E G L+ LQ
Sbjct: 42 CKNCTSPSVRE--KFLQEAYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQ 98
Query: 191 DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIH 250
L + ++ ++ + YL S +HRD+ ++N LV V + DFGL+R +
Sbjct: 99 VNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158
Query: 251 QGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310
+ K+P K WMAPE + + + DV+ +G+ +
Sbjct: 159 DESYYKASK-GKLPIK-------------------WMAPESINFRRFTSASDVWMFGVCM 198
Query: 311 CEIIGRVPADPDYLPRSPDFGLDQTDFRNKF--------CASCPEPFVRIAFLCCDLNPD 362
EI+ L P G+ D + +CP + C +P
Sbjct: 199 WEILM--------LGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPS 250
Query: 363 QRPPFEVLEVWLE 375
+RP F L+ L
Sbjct: 251 KRPRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 50/174 (28%), Positives = 85/174 (48%), Gaps = 26/174 (14%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++++L+ L+H N++R + V++ + KL LV E++ K + P L ++
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ 107
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ G+ Y HS ++HRDL QN L+ + + +ADFGLAR VP +
Sbjct: 108 LLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF------------GVPVRT 155
Query: 268 AQRRGARKKRYT--VVGNPYWMAPEMMTGQEYDET-VDVFSYGIVLCEIIGRVP 318
YT VV ++ APE++ G T VD++S G + E++ R P
Sbjct: 156 ----------YTHEVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 2e-16
Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 22/170 (12%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
V+ L H +++ GV + + L +VTE++ G L L+ L ++ +D+
Sbjct: 52 VMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCE 111
Query: 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQR 270
GM YL + IHRDL ++NCLV V V+DFG+ R + ++ AK P K
Sbjct: 112 GMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD-EYTSSSGAKFPVK---- 166
Query: 271 RGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVP 318
W PE+ +Y DV+S+G+++ E+ G++P
Sbjct: 167 ---------------WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 59/233 (25%), Positives = 98/233 (42%), Gaps = 41/233 (17%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
+L + ++ F G Y + +++ EY+ GG+L ++L++ +P A +
Sbjct: 52 ILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLK 111
Query: 211 GMTYLHS-MNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
G+TYLH +IHRD+ N LV + + DFG++ + +AK
Sbjct: 112 GLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-------VNSLAK------- 157
Query: 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI-IGRVPADPDYLPRSP 328
T VG +MAPE + G +Y D++S G+ L E+ GR P P+ P P
Sbjct: 158 ---------TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP--P 206
Query: 329 DFGLDQTDF----------RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371
D + + KF F LC +P +RP ++ L
Sbjct: 207 DGIFELLQYIVNEPPPRLPSGKF----SPDFQDFVNLCLIKDPRERPSYKELL 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 56/197 (28%), Positives = 83/197 (42%), Gaps = 36/197 (18%)
Query: 181 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVV 240
+ + E + PL + F+ +A GM +L S N IHRD+ ++N L+ + + +
Sbjct: 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKI 253
Query: 241 ADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDET 300
DFGLAR I A++P K WMAPE + Y
Sbjct: 254 CDFGLARDIMNDSNYVVKGNARLPVK-------------------WMAPESIFDCVYTVQ 294
Query: 301 VDVFSYGIVLCEI--IGRVPADPDYLPRSP-------DFGLDQTDFRNKFCASCPEPFVR 351
DV+SYGI+L EI +G+ P P L S + + + DF P
Sbjct: 295 SDVWSYGILLWEIFSLGKSPY-PGILVNSKFYKMVKRGYQMSRPDF-------APPEIYS 346
Query: 352 IAFLCCDLNPDQRPPFE 368
I +C +L P +RP F
Sbjct: 347 IMKMCWNLEPTERPTFS 363
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 4e-16
Identities = 49/178 (27%), Positives = 89/178 (50%), Gaps = 25/178 (14%)
Query: 138 KYGEACQNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTL-KELLQDPGQPL 196
K EA + +V +L + H N++ F ++ +L +V EY GG L K + + G
Sbjct: 41 KEKEASKK--EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF 98
Query: 197 PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVV-VADFGLARIIHQGPRA 255
Q +++ I+ G+ ++H ++HRD+ SQN + ++ V + DFG+AR ++
Sbjct: 99 SEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND---- 154
Query: 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI 313
+ +A YT VG PY+++PE+ + Y+ D++S G VL E+
Sbjct: 155 -SMELA----------------YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 5e-16
Identities = 66/268 (24%), Positives = 113/268 (42%), Gaps = 56/268 (20%)
Query: 133 EDYNG--KYGEACQNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL- 189
+D N ++GE Q + +++ LHH N++ +GV+ +++ + ++ EY+ G L E L
Sbjct: 43 KDINNPQQWGEFQQ---EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLI 99
Query: 190 -----QDPG----------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 234
D G L G ++ A IAAGM YL S +H+DL ++N L+ E
Sbjct: 100 MRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159
Query: 235 DKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG 294
V ++D GL+R I+ + +P + WM PE +
Sbjct: 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIR-------------------WMPPEAIMY 200
Query: 295 QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD----FRNKFCASCPE--P 348
++ D++S+G+VL EI P +G + R + C E P
Sbjct: 201 GKFSSDSDIWSFGVVLWEIFS--------FGLQPYYGFSNQEVIEMVRKRQLLPCSEDCP 252
Query: 349 FVRIAFL--CCDLNPDQRPPFEVLEVWL 374
+ + C P +RP F+ + L
Sbjct: 253 PRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 6e-16
Identities = 66/245 (26%), Positives = 104/245 (42%), Gaps = 55/245 (22%)
Query: 152 LRSLHHHNVIRFIGVLYKDRKLNLVTE-YIAGGTLKELLQDP-------GQPLPWGQRVN 203
L L H N++ + V +D + V Y+ G LK LQ Q L Q V+
Sbjct: 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH 121
Query: 204 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263
A IA GM+YLH +IH+D+ ++NC++ E+ V + D L+R +
Sbjct: 122 MAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD---------- 171
Query: 264 PRKAAQRRGARKKRYTVVG-NPY----WMAPEMMTGQEYDETVDVFSYGIVLCEI--IGR 316
Y +G N WMA E + +EY DV+S+G++L E+ +G+
Sbjct: 172 --------------YHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQ 217
Query: 317 VP-ADPD------YLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEV 369
P + D YL + +R +CP+ + C L+P++RP F
Sbjct: 218 TPYVEIDPFEMAAYL---------KDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQ 268
Query: 370 LEVWL 374
L L
Sbjct: 269 LVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 6e-16
Identities = 40/156 (25%), Positives = 62/156 (39%), Gaps = 40/156 (25%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD--------IAAGMTYLHSMNLIHR 223
+ LV + + GG L+ L Q+V F+ + I + YLHS +IHR
Sbjct: 74 NMYLVVDLLLGGDLRYHLS---------QKVKFSEEQVKFWICEIVLALEYLHSKGIIHR 124
Query: 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGN 283
D+ N L+ E V + DF +A + + G
Sbjct: 125 DIKPDNILLDEQGHVHITDFNIATKVTPD----------------------TLTTSTSGT 162
Query: 284 PYWMAPEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
P +MAPE++ Q Y VD +S G+ E + G+ P
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 6e-16
Identities = 50/186 (26%), Positives = 86/186 (46%), Gaps = 43/186 (23%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++++L+ + H N++R V++ +++L LV EY+ K + P +FA++
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSP----------DFAKN 100
Query: 208 ----------IAAGMTYLHSMNLIHRDLNSQNCLV-REDKTVVVADFGLARIIHQGPRAP 256
I G+ Y HS ++HRDL QN L+ R + +ADFGLAR R
Sbjct: 101 PRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160
Query: 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIG 315
T + VV ++ APE++ G + Y VD++S G + E++
Sbjct: 161 T--------------------HEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
Query: 316 RVPADP 321
+ P P
Sbjct: 200 QKPLFP 205
|
Length = 294 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 26/186 (13%)
Query: 151 VLRSLHHHNVIRFIGVLY----KDRKLNLVTEYIAGGTLKELLQ-DPGQPLPWGQRVNF- 204
+L +L H F+ LY + L LV +Y GG L LLQ PG+ L + F
Sbjct: 54 ILATLDH----PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLS-EEVARFY 108
Query: 205 ARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVP 264
A ++ + YLH + +++RDL +N L+ E ++++DF L++ Q P V +
Sbjct: 109 AAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSK---QSDVEPPPVSKALR 165
Query: 265 RKAAQRRGARKKRYTV-----------VGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI 313
+ + + T VG ++APE+++G + VD ++ GI+L E+
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225
Query: 314 I-GRVP 318
+ G P
Sbjct: 226 LYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 7e-16
Identities = 56/186 (30%), Positives = 83/186 (44%), Gaps = 38/186 (20%)
Query: 195 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254
PL ++++ +A GM +L S IHRDL ++N L+ E+ V + DFGLAR I++ P
Sbjct: 169 PLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD 228
Query: 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII 314
A++P K WMAPE + + Y DV+S+G++L EI
Sbjct: 229 YVRKGDARLPLK-------------------WMAPESIFDKVYTTQSDVWSFGVLLWEIF 269
Query: 315 GRVPADPDYLPRSPDFGLD-QTDFRNKF------CA---SCPEPFVRIAFLCCDLNPDQR 364
L SP G+ +F + A + PE + I C NP+ R
Sbjct: 270 S--------LGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIY-SIMLDCWHNNPEDR 320
Query: 365 PPFEVL 370
P F L
Sbjct: 321 PTFSEL 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 8e-16
Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 25/176 (14%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++ +L+ L H N++ I V + RKL+LV EY L EL ++P + +P
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQ 108
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ + H N IHRD+ +N L+ + + + DFG ARI+
Sbjct: 109 TLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD------------ 156
Query: 268 AQRRGARKKRYT-VVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVPADP 321
YT V ++ APE++ G +Y VDV++ G V E++ P P
Sbjct: 157 ----------YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 9e-16
Identities = 48/175 (27%), Positives = 83/175 (47%), Gaps = 27/175 (15%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFAR 206
++++L+ L H N++ VL ++ +L L+ E+++ K L P GQ + ++
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLY 108
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
I G+ + HS ++HRDL QN L+ + +ADFGLAR +P +
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF------------GIPVR 156
Query: 267 AAQRRGARKKRYT--VVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVP 318
YT VV ++ APE++ G Y VD++S G + E+ + P
Sbjct: 157 V----------YTHEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 9e-16
Identities = 54/181 (29%), Positives = 80/181 (44%), Gaps = 34/181 (18%)
Query: 148 QVAVLRSL---HHHNVIRFIGVLYKDR-----KLNLVTEYIAG--GTLKELLQDPGQPLP 197
++A+L+ L H N++R + V + R KL LV E++ T PG LP
Sbjct: 48 EIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG--LP 105
Query: 198 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPT 257
+ R + G+ +LHS ++HRDL QN LV D V +ADFGLARI
Sbjct: 106 PETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY-------- 157
Query: 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRV 317
+VV ++ APE++ Y VD++S G + E+ R
Sbjct: 158 --------------SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203
Query: 318 P 318
P
Sbjct: 204 P 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 54/229 (23%), Positives = 87/229 (37%), Gaps = 38/229 (16%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+ L H N++R GV+ + + +VTEY++ G L L+ L GQ +
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPG 115
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+A+GM YL M +H+ L + LV D ++ F R +
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR---------RLQEDKSEAI---- 162
Query: 268 AQRRGARKKRYTVVGNP---YWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVP---- 318
YT + W APE + + DV+S+GIV+ E++ G P
Sbjct: 163 ----------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212
Query: 319 ADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF 367
+ D + D FR +CP ++ C +RP F
Sbjct: 213 SGQDVIKAVED------GFRLPAPRNCPNLLHQLMLDCWQKERGERPRF 255
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 49/176 (27%), Positives = 78/176 (44%), Gaps = 26/176 (14%)
Query: 141 EACQNCGQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 199
E C N +V LR L+ H N+++ V ++ +L V EY+ G + + G+P
Sbjct: 40 EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSES 99
Query: 200 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259
+ I G+ ++H HRDL +N LV + V +ADFGLAR I R P
Sbjct: 100 VIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIR--SRPP--- 154
Query: 260 MAKVPRKAAQRRGARKKRYTV-VGNPYWMAPEM-MTGQEYDETVDVFSYGIVLCEI 313
YT V ++ APE+ + Y VD+++ G ++ E+
Sbjct: 155 ------------------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAEL 192
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 56/205 (27%), Positives = 85/205 (41%), Gaps = 32/205 (15%)
Query: 171 RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 230
R+ YI E+L++ L ++F+ +A GM++L S N IHRDL ++N
Sbjct: 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNI 245
Query: 231 LVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPE 290
L+ + + DFGLAR I A++P K WMAPE
Sbjct: 246 LLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK-------------------WMAPE 286
Query: 291 MMTGQEYDETVDVFSYGIVLCEIIG-------RVPADPDYLPRSPDFGLDQTDFRNKFCA 343
+ Y DV+SYGI+L EI +P D + + + + +R
Sbjct: 287 SIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF------YKMIKEGYRMLSPE 340
Query: 344 SCPEPFVRIAFLCCDLNPDQRPPFE 368
P I C D +P +RP F+
Sbjct: 341 CAPSEMYDIMKSCWDADPLKRPTFK 365
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 70/253 (27%), Positives = 103/253 (40%), Gaps = 56/253 (22%)
Query: 147 GQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-------DPG----- 193
G++ VL L HH N+I +G L + EY G L + L+ DP
Sbjct: 51 GELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEH 110
Query: 194 ---QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIH 250
L Q + FA D+A GM YL IHRDL ++N LV E+ +ADFGL+R
Sbjct: 111 GTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--- 167
Query: 251 QGPRAPTT-VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIV 309
G M ++P + WMA E + Y DV+S+G++
Sbjct: 168 -GEEVYVKKTMGRLPVR-------------------WMAIESLNYSVYTTKSDVWSFGVL 207
Query: 310 LCEIIGRVPADPDYLPRSPDFGLDQTD--------FRNKFCASCPEPFVRIAFLCCDLNP 361
L EI+ L +P G+ + +R + +C + + C P
Sbjct: 208 LWEIVS--------LGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRP 259
Query: 362 DQRPPFEVLEVWL 374
+RPPF + V L
Sbjct: 260 YERPPFAQISVQL 272
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 47/153 (30%), Positives = 67/153 (43%), Gaps = 33/153 (21%)
Query: 170 DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGM----TYLHSMNLIHRDL 225
D L L EY+ GG + LL + G + AR A M LH + IHRDL
Sbjct: 73 DEYLYLAMEYVPGGDFRTLLNNLGV-----LSEDHARFYMAEMFEAVDALHELGYIHRDL 127
Query: 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPY 285
+N L+ + + DFGL++ G +VVG+P
Sbjct: 128 KPENFLIDASGHIKLTDFGLSK------------------------GIVTYANSVVGSPD 163
Query: 286 WMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVP 318
+MAPE++ G+ YD TVD +S G +L E + P
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFP 196
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 53/176 (30%), Positives = 81/176 (46%), Gaps = 29/176 (16%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRK-LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
++ +L+ L H N+I + + + VTE + G L LL +PL F
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDIYFVTE-LLGTDLHRLLT--SRPLEKQFIQYFLY 115
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
I G+ Y+HS ++HRDL N L+ E+ + + DFGLARI Q P+ V +
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--QDPQMTGYVSTR---- 169
Query: 267 AAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEIIGRVPADP 321
Y+ APE M+T Q+YD VD++S G + E++ P P
Sbjct: 170 ------------------YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 24/225 (10%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+ ++ S+ H +++R +GV + LVT+ + G L + + + + +N+
Sbjct: 59 EALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ 117
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
IA GM YL L+HRDL ++N LV+ V + DFGLAR++ + K+P K
Sbjct: 118 IAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK- 176
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYLP 325
WMA E + +++ DV+SYG+ + E++ G P D
Sbjct: 177 ------------------WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR 218
Query: 326 RSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
PD L + R C + C ++ D RP F+ L
Sbjct: 219 EIPD--LLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 60/184 (32%), Positives = 82/184 (44%), Gaps = 38/184 (20%)
Query: 147 GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-------DPG----- 193
G++ VL L HH N+I +G L L EY G L + L+ DP
Sbjct: 56 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 115
Query: 194 ---QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIH 250
L Q ++FA D+A GM YL IHRDL ++N LV E+ +ADFGL+R
Sbjct: 116 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--G 173
Query: 251 QGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310
Q T M ++P + WMA E + Y DV+SYG++L
Sbjct: 174 QEVYVKKT-MGRLPVR-------------------WMAIESLNYSVYTTNSDVWSYGVLL 213
Query: 311 CEII 314
EI+
Sbjct: 214 WEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 71/225 (31%)
Query: 145 NCGQVAVLRSLHHHNVIRFIGVL--YKDRKLNLVTEY-------------------IAGG 183
C ++A+LR L H NV+ + V + D+ + L+ +Y I
Sbjct: 49 ACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPS 108
Query: 184 TLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV----REDKTVV 239
+K LL W Q +N G+ YLHS ++HRDL N LV E V
Sbjct: 109 MVKSLL--------W-QILN-------GVHYLHSNWVLHRDLKPANILVMGEGPERGVVK 152
Query: 240 VADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWM-APEMMTG-QEY 297
+ D GLAR+ + + + V VV W APE++ G + Y
Sbjct: 153 IGDLGLARLFNAPLKPLADL-DPV----------------VV--TIWYRAPELLLGARHY 193
Query: 298 DETVDVFSYGIVLCEIIGRVP------ADPDYLPRSPDFGLDQTD 336
+ +D+++ G + E++ P A +P F DQ +
Sbjct: 194 TKAIDIWAIGCIFAELLTLEPIFKGREAKIK--KSNP-FQRDQLE 235
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 20/220 (9%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
V+ S+ + +V R +G+ + L+T+ + G L + +++ + +N+ IA
Sbjct: 62 VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 120
Query: 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQR 270
GM YL L+HRDL ++N LV+ + V + DFGLA+++ + KVP K
Sbjct: 121 GMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK---- 176
Query: 271 RGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF 330
WMA E + + Y DV+SYG+ + E++ D +P S
Sbjct: 177 ---------------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 221
Query: 331 GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
+ + R C I C ++ D RP F L
Sbjct: 222 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL 261
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 33/173 (19%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYK------DRKLNLVTEYIAGGTL-KELLQDPGQPLPWGQ 200
+ +L L H N+ V Y+ D L +V + GG L +L + G+ LP Q
Sbjct: 49 EAQLLSQLKHPNI-----VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQ 103
Query: 201 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260
V + IA + YLH +++HRDL +QN + + V D G+AR++ M
Sbjct: 104 VVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN-----QCDM 158
Query: 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI 313
A T++G PY+M+PE+ + + Y+ DV++ G + E+
Sbjct: 159 AS----------------TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 59/198 (29%), Positives = 87/198 (43%), Gaps = 23/198 (11%)
Query: 183 GTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVA 241
+K LL D G + L ++F +A GM +L S N +HRDL ++N L+ + K V +
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKIC 279
Query: 242 DFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETV 301
DFGLAR I + +P K WMAPE + Y
Sbjct: 280 DFGLARDIMHDSNYVSKGSTFLPVK-------------------WMAPESIFDNLYTTLS 320
Query: 302 DVFSYGIVLCEI--IGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDL 359
DV+SYGI+L EI +G P P + S + ++ +R + I C +
Sbjct: 321 DVWSYGILLWEIFSLGGTPY-PGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNS 379
Query: 360 NPDQRPPFEVLEVWLEGL 377
P++RP F L +E L
Sbjct: 380 EPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 1e-14
Identities = 47/177 (26%), Positives = 73/177 (41%), Gaps = 36/177 (20%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLN--LVTEYI----AGGTLKELLQDPGQPLPWGQRVNF 204
+L+ L H N++R ++ K + +V EY+ G LL P Q +
Sbjct: 51 LLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG-----LLDSPEVKFTESQIKCY 105
Query: 205 ARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVP 264
+ + G+ YLHS ++HRD+ N L+ D + +ADFGLAR
Sbjct: 106 MKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYT-------------- 151
Query: 265 RKAAQRRGARKKRYT--VVGNPYWMAPEMMTGQE-YDETVDVFSYGIVLCEIIGRVP 318
YT V+ Y PE++ G Y VD++S G +L E+ P
Sbjct: 152 -------KRNSADYTNRVITLWY-RPPELLLGATRYGPEVDMWSVGCILAELFLGKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 44/127 (34%), Positives = 62/127 (48%), Gaps = 18/127 (14%)
Query: 193 GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252
GQPL +F I G+ Y+HS N++HRDL N LV D + + DFGLAR +
Sbjct: 99 GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158
Query: 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLC 311
P M Y V ++ APE M++ Q Y + +DV+S G +L
Sbjct: 159 PGENAGFM---------------TEY--VATRWYRAPEIMLSFQSYTKAIDVWSVGCILA 201
Query: 312 EIIGRVP 318
E++GR P
Sbjct: 202 ELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 63/229 (27%), Positives = 90/229 (39%), Gaps = 36/229 (15%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
V+ L H ++R IGV K L LV E G L + L+ + +P A +A
Sbjct: 49 VMAQLDHPCIVRLIGVC-KGEPLMLVMELAPLGPLLKYLKKRRE-IPVSDLKELAHQVAM 106
Query: 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP---RAPTTVMAKVPRKA 267
GM YL S + +HRDL ++N L+ ++DFG++R + G RA T + P K
Sbjct: 107 GMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA--GRWPLK- 163
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
W APE + ++ DV+SYG+ L E Y
Sbjct: 164 ------------------WYAPECINYGKFSSKSDVWSYGVTLWEAFSY--GAKPYGEMK 203
Query: 328 PDFGLDQTDF-----RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371
G + R CP+ I C P+ RP F LE
Sbjct: 204 ---GAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELE 249
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 59/203 (29%), Positives = 86/203 (42%), Gaps = 32/203 (15%)
Query: 182 GGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVA 241
T ++ L + L + V F+ +A GM +L S N +HRDL ++N L+ E K V +
Sbjct: 222 ERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKIC 281
Query: 242 DFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPY----WMAPEMMTGQEY 297
DFGLAR I R Y G+ + WMAPE + Y
Sbjct: 282 DFGLARDI-----------------------MRDSNYISKGSTFLPLKWMAPESIFNNLY 318
Query: 298 DETVDVFSYGIVLCEI--IGRVPADPDYLPRSPDF-GLDQTDFRNKFCASCPEPFVRIAF 354
DV+S+GI+L EI +G P P+ LP + F + +R A + I
Sbjct: 319 TTLSDVWSFGILLWEIFTLGGTPY-PE-LPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQ 376
Query: 355 LCCDLNPDQRPPFEVLEVWLEGL 377
C + + RP F L + L
Sbjct: 377 KCWEEKFEIRPDFSQLVHLVGDL 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 57/183 (31%), Positives = 85/183 (46%), Gaps = 32/183 (17%)
Query: 195 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254
PL + ++ +A GM +L S IHRDL ++N L+ E+ V + DFGLAR I++ P
Sbjct: 170 PLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD 229
Query: 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI- 313
A++P K WMAPE + + Y DV+S+G++L EI
Sbjct: 230 YVRKGSARLPLK-------------------WMAPESIFDKVYTTQSDVWSFGVLLWEIF 270
Query: 314 -IGRVP-----ADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF 367
+G P + ++ R D T R A+ PE + RI C +P +RP F
Sbjct: 271 SLGASPYPGVQINEEFCQRLK----DGTRMRAPENAT-PEIY-RIMLACWQGDPKERPTF 324
Query: 368 EVL 370
L
Sbjct: 325 SAL 327
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 52/150 (34%), Positives = 81/150 (54%), Gaps = 10/150 (6%)
Query: 171 RKLNLVTEYIAGGTLKELLQDPGQPLPWGQ-RVNFARDIAAGMTYLHSMNLIHRDLNSQN 229
R L +V EY+ GG LL++ G LP R+ FA + A + YLH+ ++HRDL N
Sbjct: 74 RHLCMVMEYVEGGDCATLLKNIG-ALPVDMARMYFAETVLA-LEYLHNYGIVHRDLKPDN 131
Query: 230 CLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAP 289
L+ + + DFGL++I G + TT + + + R K+ V G P ++AP
Sbjct: 132 LLITSMGHIKLTDFGLSKI---GLMSLTTNLYEGHIEKDTREFLDKQ---VCGTPEYIAP 185
Query: 290 EMMTGQEYDETVDVFSYGIVLCEI-IGRVP 318
E++ Q Y + VD ++ GI+L E +G VP
Sbjct: 186 EVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 49/179 (27%), Positives = 80/179 (44%), Gaps = 22/179 (12%)
Query: 154 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMT 213
SL H ++R +G+ L LVT+ G+L + ++ L + +N+ IA GM
Sbjct: 65 SLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMY 123
Query: 214 YLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGA 273
YL ++HR+L ++N L++ D V +ADFG+A +++ + K P K
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK------- 176
Query: 274 RKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYLPRSPDF 330
WMA E + Y DV+SYG+ + E++ G P PD
Sbjct: 177 ------------WMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL 223
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 49/147 (33%), Positives = 73/147 (49%), Gaps = 22/147 (14%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 231
KL V +Y+ GG L LQ + P + +A +IA+ + YLHS+N+I+RDL +N L
Sbjct: 70 KLYFVLDYVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENIL 128
Query: 232 VREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM 291
+ VV+ DFGL + +G T T G P ++APE+
Sbjct: 129 LDSQGHVVLTDFGLCK---EGIEHSKTTS------------------TFCGTPEYLAPEV 167
Query: 292 MTGQEYDETVDVFSYGIVLCEIIGRVP 318
+ Q YD TVD + G VL E++ +P
Sbjct: 168 LRKQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 71/253 (28%), Positives = 101/253 (39%), Gaps = 56/253 (22%)
Query: 147 GQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-------DPG----- 193
G++ VL L HH N+I +G L L EY G L + L+ DP
Sbjct: 44 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 103
Query: 194 ---QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIH 250
L Q ++FA D+A GM YL IHRDL ++N LV E+ +ADFGL+R
Sbjct: 104 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--- 160
Query: 251 QGPRAPT-TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIV 309
G M ++P + WMA E + Y DV+SYG++
Sbjct: 161 -GQEVYVKKTMGRLPVR-------------------WMAIESLNYSVYTTNSDVWSYGVL 200
Query: 310 LCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCA--------SCPEPFVRIAFLCCDLNP 361
L EI+ L +P G+ + K +C + + C P
Sbjct: 201 LWEIVS--------LGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKP 252
Query: 362 DQRPPFEVLEVWL 374
+RP F + V L
Sbjct: 253 YERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 55/234 (23%), Positives = 102/234 (43%), Gaps = 31/234 (13%)
Query: 140 GEACQNC-GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL---QDPGQP 195
+A Q+C ++ +L+ L+H NVI+++ +D +LN+V E G L +++ + +
Sbjct: 43 AKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL 102
Query: 196 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255
+P + + + + ++HS ++HRD+ N + V + D GL R A
Sbjct: 103 IPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162
Query: 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG 315
+++VG PY+M+PE + Y+ D++S G +L E+
Sbjct: 163 A---------------------HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA- 200
Query: 316 RVPADPDYLPRSPDFGL----DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
P Y + F L +Q D+ E + +C +PDQRP
Sbjct: 201 -ALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 50/183 (27%), Positives = 80/183 (43%), Gaps = 23/183 (12%)
Query: 140 GEACQNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 199
G C +V++L+ L H N++ +++ D+ L LV EY+ LK+ + D G +
Sbjct: 46 GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMH 104
Query: 200 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259
F I G+ Y H ++HRDL QN L+ E + +ADFGLAR
Sbjct: 105 NVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR------------ 152
Query: 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVP 318
VP K V ++ P+++ G EY +D++ G + E+ P
Sbjct: 153 AKSVPTKTYSNE---------VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRP 203
Query: 319 ADP 321
P
Sbjct: 204 LFP 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-14
Identities = 40/142 (28%), Positives = 64/142 (45%), Gaps = 26/142 (18%)
Query: 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 232
L LV EY+ GG L++ G LP + ++ G+ LH +IHRD+ +N L+
Sbjct: 72 LYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI 130
Query: 233 REDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMM 292
+ + + DFGL+R G K++ VG P ++APE +
Sbjct: 131 DQTGHLKLTDFGLSRN-----------------------GLENKKF--VGTPDYLAPETI 165
Query: 293 TGQEYDETVDVFSYGIVLCEII 314
G D+ D +S G V+ E +
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 52/170 (30%), Positives = 82/170 (48%), Gaps = 26/170 (15%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
+L++L H ++ KL V +Y+ GG L LQ L R +A ++A+
Sbjct: 49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVAS 107
Query: 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG--PRAPTTVMAKVPRKAA 268
+ YLHS+N+I+RDL +N L+ VV+ DFGL + +G P T+
Sbjct: 108 AIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTS---------- 154
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVP 318
T G P ++APE++ + YD TVD + G VL E++ +P
Sbjct: 155 ----------TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 50/181 (27%), Positives = 82/181 (45%), Gaps = 22/181 (12%)
Query: 148 QVAVLRSLHHHNVIRFIGVLY-----KDRKLN---LVTEYIAGGTLKELLQDPGQPLPWG 199
++ +L+ L H NV+ I + RK +VT Y+ L LL++P L
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTES 115
Query: 200 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259
Q + + G+ YLH +++HRD+ + N L+ + +ADFGLAR P P
Sbjct: 116 QIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG- 174
Query: 260 MAKVPRKAAQRRGARKKRYT-VVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRV 317
G ++YT +V ++ PE++ G + Y VD++ G V E+ R
Sbjct: 175 ----------GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
Query: 318 P 318
P
Sbjct: 225 P 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 5e-14
Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 24/149 (16%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQP-LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 230
L LV + GG LK + + G+P P + + +A I G+ +LH +++RDL +N
Sbjct: 67 DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENV 126
Query: 231 LVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPE 290
L+ + V ++D GLA V K +K R G P +MAPE
Sbjct: 127 LLDDHGNVRISDLGLA------------VELKGGKKIKGR----------AGTPGYMAPE 164
Query: 291 MMTGQEYDETVDVFSYGIVLCEII-GRVP 318
++ G+ YD +VD F+ G L E+I GR P
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-14
Identities = 50/183 (27%), Positives = 83/183 (45%), Gaps = 23/183 (12%)
Query: 140 GEACQNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 199
G C +V++L++L H N++ +++ +R L LV EY+ LK+ L + G +
Sbjct: 45 GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMH 103
Query: 200 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259
F + G++Y H ++HRDL QN L+ E + +ADFGLAR
Sbjct: 104 NVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLAR------------ 151
Query: 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVP 318
VP K V ++ P+++ G EY +D++ G +L E+ P
Sbjct: 152 AKSVPTKTYSNE---------VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRP 202
Query: 319 ADP 321
P
Sbjct: 203 MFP 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 24/213 (11%)
Query: 160 VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN 219
V R +G+ + LVT+ + G L + +++ + +N+ IA GM+YL +
Sbjct: 71 VCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 220 LIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYT 279
L+HRDL ++N LV+ V + DFGLAR++ KVP K
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK------------- 176
Query: 280 VVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYLPRSPDFGLDQTDF 337
WMA E + + + DV+SYG+ + E++ G P D PD L++ +
Sbjct: 177 ------WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL-LEKGER 229
Query: 338 RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
+ C I C ++ + RP F L
Sbjct: 230 LPQPP-ICTIDVYMIMVKCWMIDSECRPRFREL 261
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 9e-14
Identities = 63/246 (25%), Positives = 105/246 (42%), Gaps = 67/246 (27%)
Query: 144 QNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 203
Q C ++ +LR ++H NV++ + + ++ ++ E++ GG+L+ G +
Sbjct: 118 QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE------------GTHIA 165
Query: 204 -------FARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256
AR I +G+ YLH +++HRD+ N L+ K V +ADFG++RI+ Q
Sbjct: 166 DEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ----- 220
Query: 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ----EYDETV-DVFSYGIVLC 311
M P ++ VG +M+PE + YD D++S G+ +
Sbjct: 221 --TMD--PCNSS------------VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSIL 264
Query: 312 EIIGRVPADPDYLPRSPDFGLD-QTDFRNKFCASC----PEP-------FVRIAFLCCDL 359
E YL R P FG+ Q D+ + CA C PE F C
Sbjct: 265 EF---------YLGRFP-FGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQR 314
Query: 360 NPDQRP 365
P +R
Sbjct: 315 EPAKRW 320
|
Length = 353 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 50/149 (33%), Positives = 73/149 (48%), Gaps = 26/149 (17%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 231
KL V +YI GG L LQ L R +A +IA+ + YLHS+N+++RDL +N L
Sbjct: 70 KLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHSLNIVYRDLKPENIL 128
Query: 232 VREDKTVVVADFGLAR--IIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAP 289
+ +V+ DFGL + I H G + T G P ++AP
Sbjct: 129 LDSQGHIVLTDFGLCKENIEHNGTTS-----------------------TFCGTPEYLAP 165
Query: 290 EMMTGQEYDETVDVFSYGIVLCEIIGRVP 318
E++ Q YD TVD + G VL E++ +P
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 46/147 (31%), Positives = 75/147 (51%), Gaps = 23/147 (15%)
Query: 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 232
L V EY+ GG L +Q G+ R +A +I G+ +LH +I+RDL N L+
Sbjct: 71 LFFVMEYLNGGDLMFHIQSSGRFDEARARF-YAAEIICGLQFLHKKGIIYRDLKLDNVLL 129
Query: 233 REDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMM 292
+D + +ADFG+ + + K T G P ++APE++
Sbjct: 130 DKDGHIKIADFGMCK---------------------ENMNGEGKASTFCGTPDYIAPEIL 168
Query: 293 TGQEYDETVDVFSYGIVLCE-IIGRVP 318
GQ+Y+E+VD +S+G++L E +IG+ P
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 53/190 (27%), Positives = 88/190 (46%), Gaps = 33/190 (17%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFAR 206
++ +L+ L H N++ I V + ++L LV E++ L +L + P G ++ F
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLF-- 107
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
I G+ + HS N+IHRD+ +N LV + V + DFG AR + AP V
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA----APGEV------- 156
Query: 267 AAQRRGARKKRYT-VVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVPADPDYL 324
YT V ++ APE++ G +Y VD+++ G C + + +P
Sbjct: 157 -----------YTDYVATRWYRAPELLVGDTKYGRAVDIWAVG---CLVTEMLTGEP-LF 201
Query: 325 PRSPDFGLDQ 334
P D +DQ
Sbjct: 202 PGDSD--IDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 64/235 (27%), Positives = 95/235 (40%), Gaps = 44/235 (18%)
Query: 136 NGKYGEACQNCGQVAVLRSLH---HHNVIRFIGVLYKDR-----KLNLVTEYIAGGTLKE 187
+ G +VA+L+ L H N++R + V R K+ LV E++
Sbjct: 37 TNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTY 96
Query: 188 LLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLAR 247
L + P LP + R G+ +LH+ ++HRDL +N LV V +ADFGLAR
Sbjct: 97 LDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR 156
Query: 248 IIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYG 307
I + MA P VV ++ APE++ Y VD++S G
Sbjct: 157 IY-------SCQMALTP---------------VVVTLWYRAPEVLLQSTYATPVDMWSVG 194
Query: 308 IVLCEIIGRVP-----ADPDY---------LPRSPDFGLDQTDFRNKFCASCPEP 348
+ E+ R P ++ D LP D+ D T R F P P
Sbjct: 195 CIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRP 249
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 54/186 (29%), Positives = 85/186 (45%), Gaps = 30/186 (16%)
Query: 148 QVAVLRSLHHHNV--IRFI----GVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQR 201
++ +LR H N+ IR I G +KD + +V + + L ++ QPL
Sbjct: 54 ELKILRHFKHDNIIAIRDILRPPGADFKD--VYVVMD-LMESDLHHIIHS-DQPLTEEHI 109
Query: 202 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA 261
F + G+ Y+HS N+IHRDL N LV ED + + DFG+AR + P M
Sbjct: 110 RYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT 169
Query: 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMM-TGQEYDETVDVFSYGIVLCEIIGRVPAD 320
+ Y V Y APE++ + EY +D++S G + E++GR
Sbjct: 170 E---------------Y-VATRWY-RAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF 212
Query: 321 P--DYL 324
P +Y+
Sbjct: 213 PGKNYV 218
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 1/100 (1%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++ +L+ L H N++R VL+ D+KL LV EY K G P + +F
Sbjct: 49 EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK-SFMFQ 107
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLAR 247
+ G+ + HS N++HRDL QN L+ ++ + +ADFGLAR
Sbjct: 108 LLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 41/168 (24%), Positives = 83/168 (49%), Gaps = 25/168 (14%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
VL+ + H +IR + R L ++ EY+ GG L L++ G+ + +A +I
Sbjct: 54 VLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR-FSNSTGLFYASEIVC 112
Query: 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQR 270
+ YLHS +++RDL +N L+ ++ + + DFG A+ +
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD------------------- 153
Query: 271 RGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVP 318
+ +T+ G P ++APE++ + +++ VD ++ GI++ E++ P
Sbjct: 154 -----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 24/155 (15%)
Query: 169 KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 228
KDR L V EY+ GG L +Q G+ + +A +I G+ +LH +I+RDL
Sbjct: 68 KDR-LFFVMEYVNGGDLMFHIQRSGR-FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLD 125
Query: 229 NCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMA 288
N L+ + + +ADFG+ K G T G P ++A
Sbjct: 126 NVLLDSEGHIKIADFGMC-------------------KEGILGGVTTS--TFCGTPDYIA 164
Query: 289 PEMMTGQEYDETVDVFSYGIVLCE-IIGRVPADPD 322
PE+++ Q Y VD ++ G++L E + G+ P + D
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 48/147 (32%), Positives = 74/147 (50%), Gaps = 28/147 (19%)
Query: 173 LNLVTEYIAGGTLKELL-----QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 227
L LV + GG L+ + ++PG P P + + I +G+ +LH +I+RDL
Sbjct: 68 LCLVMTIMNGGDLRYHIYNVDEENPGFPEP--RACFYTAQIISGLEHLHQRRIIYRDLKP 125
Query: 228 QNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWM 287
+N L+ D V ++D GLA V K Q ++ K Y G P +M
Sbjct: 126 ENVLLDNDGNVRISDLGLA----------------VELKDGQ---SKTKGYA--GTPGFM 164
Query: 288 APEMMTGQEYDETVDVFSYGIVLCEII 314
APE++ G+EYD +VD F+ G+ L E+I
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 54/179 (30%), Positives = 77/179 (43%), Gaps = 30/179 (16%)
Query: 148 QVAVLRSLH---HHNVIRFIGVLYKDR-----KLNLVTEYIAGGTLKELLQDPGQPLPWG 199
+VAVLR L H NV+R V R KL LV E++ L + P +P
Sbjct: 51 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 110
Query: 200 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259
+ + G+ +LHS ++HRDL QN LV + +ADFGLARI + T
Sbjct: 111 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTS 168
Query: 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVP 318
VV ++ APE++ Y VD++S G + E+ R P
Sbjct: 169 --------------------VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 62/249 (24%), Positives = 103/249 (41%), Gaps = 59/249 (23%)
Query: 148 QVAVLRS-LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL------QDPGQ------ 194
A++RS L H N++ +GV+ K++ L+++ Y + L E L D G
Sbjct: 57 HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116
Query: 195 ---PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251
L V+ IAAGM +L S +++H+DL ++N LV + V ++D GL R ++
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPY----WMAPEMMTGQEYDETVDVFSYG 307
Y ++GN WM+PE + ++ D++SYG
Sbjct: 177 A-----------------------DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYG 213
Query: 308 IVLCEIIGRVPADPDYLPRSPDFGLDQTD----FRNKFCASCPEP----FVRIAFLCCDL 359
+VL E+ P G D RN+ CP+ + C +
Sbjct: 214 VVLWEVFS--------YGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNE 265
Query: 360 NPDQRPPFE 368
P +RP F+
Sbjct: 266 FPSRRPRFK 274
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|188848 cd09464, LIM2_LIMK1, The second LIM domain of LIMK1 (LIM domain Kinase 1) | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-13
Identities = 28/54 (51%), Positives = 35/54 (64%), Gaps = 2/54 (3%)
Query: 63 CQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSIL-CSAC 114
C C + ++ G VMV G+ K+HPECF C C IGDG++YALVE S L C C
Sbjct: 1 CHGCSETITTGLVMVAGEQKYHPECFSCLRCGAFIGDGDTYALVEHSKLYCGHC 54
|
The second LIM domain of LIMK1 (LIM domain Kinase 1): LIMK1 belongs to the LIMK protein family, which comprises LIMK1 and LIMK2. LIMK contains two LIM domains, a PDZ domain, and a kinase domain. LIMK is involved in the regulation of actin polymerization and microtubule disassembly. LIMK influences architecture of the actin cytoskeleton by regulating the activity of the cofilin family proteins cofilin1, cofilin2, and destrin. The mechanism of the activation is to phosphorylates cofilin on serine 3 and inactivates its actin-severing activity, and altering the rate of actin depolymerization. LIMKs can function in both cytoplasm and nucleus. Both LIMK1 and LIMK2 can act in the nucleus to suppress Rac/Cdc42-dependent cyclin D1 expression. LIMK1 is expressed in all tissues and is localized to focal adhesions in the cell. LIMK1 can form homodimers upon binding of HSP90 and is activated by Rho effector Rho kinase and MAPKAPK2. LIMK1 is important for normal central nervous system development, and its deletion has been implicated in the development of the human genetic disorder Williams syndrome. Moreover, LIMK1 up-regulates the promoter activity of urokinase type plasminogen activator and induces its mRNA and protein expression in breast cancer cells. The LIM domains have been shown to play an important role in regulating kinase activity and likely also contribute to LIMK function by acting as sites of protein-to-protein interactions. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 55 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 47/183 (25%), Positives = 80/183 (43%), Gaps = 23/183 (12%)
Query: 140 GEACQNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 199
G C +V++L+ L H N++ +++ ++ L LV EY+ LK+ L D G +
Sbjct: 46 GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH 104
Query: 200 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259
F + G+ Y H ++HRDL QN L+ E + +ADFGLAR
Sbjct: 105 NVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR------------ 152
Query: 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVP 318
+P K V ++ P+++ G +Y +D++ G + E+ P
Sbjct: 153 AKSIPTKTYSNE---------VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRP 203
Query: 319 ADP 321
P
Sbjct: 204 LFP 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 48/148 (32%), Positives = 76/148 (51%), Gaps = 24/148 (16%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 231
KL V +++ GG L LQ + P + +A +IA+ + YLHS+N+++RDL +N L
Sbjct: 70 KLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENIL 128
Query: 232 VREDKTVVVADFGLARIIHQG-PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPE 290
+ VV+ DFGL + +G ++ TT T G P ++APE
Sbjct: 129 LDSQGHVVLTDFGLCK---EGIAQSDTTT-------------------TFCGTPEYLAPE 166
Query: 291 MMTGQEYDETVDVFSYGIVLCEIIGRVP 318
++ Q YD TVD + G VL E++ +P
Sbjct: 167 VIRKQPYDNTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 8e-13
Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 29/160 (18%)
Query: 160 VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN 219
+I F G + + ++++ TE++ GG+L + P L R+ A + G+TYL S+
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVL---GRIAVA--VVKGLTYLWSLK 115
Query: 220 LIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYT 279
++HRD+ N LV V + DFG++ + +AK T
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-------VNSIAK----------------T 152
Query: 280 VVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI-IGRVP 318
VG +MAPE ++G++Y DV+S GI E+ +GR P
Sbjct: 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 8e-13
Identities = 45/152 (29%), Positives = 76/152 (50%), Gaps = 24/152 (15%)
Query: 170 DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 229
DR L V EY+ GG L +Q G+ V +A +IA G+ +LHS +I+RDL N
Sbjct: 74 DR-LYFVMEYVNGGDLMYHIQQVGK-FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDN 131
Query: 230 CLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAP 289
++ + + +ADFG+ + + T T G P ++AP
Sbjct: 132 VMLDAEGHIKIADFGMCK---ENIFGGKTTR------------------TFCGTPDYIAP 170
Query: 290 EMMTGQEYDETVDVFSYGIVLCEII-GRVPAD 320
E++ Q Y ++VD +++G++L E++ G+ P D
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 49/199 (24%), Positives = 87/199 (43%), Gaps = 35/199 (17%)
Query: 128 LLFCKEDYNGKYG----------EACQNCGQVAVLRS-LHHHNVIRFIGVLYKDRKLNLV 176
LL + + KY A ++ + AVL + + H N++ F D L +V
Sbjct: 17 LLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV 76
Query: 177 TEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRED 235
EY GG L + ++ G+ P + + + G+ ++H ++HRD+ S+N + ++
Sbjct: 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN 136
Query: 236 KTVVVADFGLARII-HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG 294
V + DFG AR++ G A T VG PY++ PE+
Sbjct: 137 GKVKLGDFGSARLLTSPGAYA----------------------CTYVGTPYYVPPEIWEN 174
Query: 295 QEYDETVDVFSYGIVLCEI 313
Y+ D++S G +L E+
Sbjct: 175 MPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 54/256 (21%), Positives = 108/256 (42%), Gaps = 47/256 (18%)
Query: 140 GEACQNC-GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL---QDPGQP 195
+A +C ++ +L+ L+H NVI++ +D +LN+V E G L ++ + +
Sbjct: 43 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL 102
Query: 196 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255
+P + + + + ++HS ++HRD+ N + V + D GL R A
Sbjct: 103 IPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162
Query: 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG 315
+++VG PY+M+PE + Y+ D++S G +L E+
Sbjct: 163 A---------------------HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201
Query: 316 RVPADPDYLPRSPDFG-----------LDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQR 364
+SP +G ++Q D+ E ++ +C + +P++R
Sbjct: 202 L---------QSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252
Query: 365 PPFEVLEVWLEGLSMH 380
P ++ V+ MH
Sbjct: 253 P--DITYVYDVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 46/179 (25%), Positives = 73/179 (40%), Gaps = 29/179 (16%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDR--KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFA 205
++ +L +L H N++ V+ + LV EY L LL + P Q
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLM 114
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIH--QGPRAPTTVMAKV 263
+ G+ YLH +IHRDL N L+ + + +ADFGLAR P P V
Sbjct: 115 LQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTL-- 172
Query: 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADP 321
++ APE++ G Y +D+++ G +L E++ P P
Sbjct: 173 ---------------------WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 23/151 (15%)
Query: 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 232
L V E++ GG L +QD G+ + +A +I G+ +LHS +I+RDL N ++
Sbjct: 71 LFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129
Query: 233 REDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMM 292
D + +ADFG+ + + + T G P ++APE++
Sbjct: 130 DRDGHIKIADFGMCK---------------------ENVFGDNRASTFCGTPDYIAPEIL 168
Query: 293 TGQEYDETVDVFSYGIVLCE-IIGRVPADPD 322
G +Y +VD +S+G++L E +IG+ P D
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 43/176 (24%), Positives = 79/176 (44%), Gaps = 25/176 (14%)
Query: 141 EACQNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLP 197
E Q + +L L H +++F + ++TEY G L L++ G+ L
Sbjct: 45 ETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLS 104
Query: 198 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPT 257
Q + + G+ Y+H ++HRDL ++N ++ + + + DFG++R++
Sbjct: 105 ENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLL-------- 155
Query: 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI 313
G+ T G PY+M+PE + Q YD D++S G +L E+
Sbjct: 156 -------------MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 32/184 (17%)
Query: 141 EACQNCGQVAVLRSLHHH-NVIRFIGVLYKDRK---LNLVTEYIAGGTLKELLQDPGQPL 196
E N ++ LR L H N++R I VL+ DRK L LV E + L EL++ +PL
Sbjct: 40 EQVNNLREIQALRRLSPHPNILRLIEVLF-DRKTGRLALVFE-LMDMNLYELIKGRKRPL 97
Query: 197 PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256
P + ++ + + ++H + HRD+ +N L+++D + +ADFG R I+
Sbjct: 98 PEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYS----- 151
Query: 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWM-APE-MMTGQEYDETVDVFSYGIVLCEII 314
K YT + W APE ++T Y +D+++ G V EI+
Sbjct: 152 ------------------KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193
Query: 315 GRVP 318
P
Sbjct: 194 SLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 44/176 (25%), Positives = 77/176 (43%), Gaps = 41/176 (23%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
+L L H ++ + + ++ + E++ GG L L+ G+ F D+A
Sbjct: 71 ILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR---------FPNDVAK 121
Query: 211 --------GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAK 262
YLHS ++I+RDL +N L+ V V DFG A+ K
Sbjct: 122 FYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK--------------K 167
Query: 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVP 318
VP + +T+ G P ++APE++ + + + VD ++ G++L E I P
Sbjct: 168 VPDRT----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 54/190 (28%), Positives = 82/190 (43%), Gaps = 44/190 (23%)
Query: 194 QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253
+ L + ++ +A GM +L S IHRDL ++N L+ E+ V + DFGLAR I++ P
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP 233
Query: 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI 313
A++P K WMAPE + + Y DV+S+G++L EI
Sbjct: 234 DYVRKGDARLPLK-------------------WMAPETIFDRVYTIQSDVWSFGVLLWEI 274
Query: 314 IGRVPADPDYLPRSPDFGLDQTDFRNKFCA-------------SCPEPFVRIAFLCCDLN 360
+ A P P +D+ +FC + PE + + C
Sbjct: 275 FS-LGASP-----YPGVKIDE-----EFCRRLKEGTRMRAPDYTTPEMY-QTMLDCWHGE 322
Query: 361 PDQRPPFEVL 370
P QRP F L
Sbjct: 323 PSQRPTFSEL 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 41/163 (25%), Positives = 73/163 (44%), Gaps = 26/163 (15%)
Query: 155 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKEL---LQDPGQPLPWGQRVNFARDIAAG 211
L H N++R+ ++ +L +V + I G L E L++ Q + N +
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 212 MTYLH-SMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQR 270
+ YLH ++HRDL N ++ ED V + DFGLA+ +
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK----------------------Q 163
Query: 271 RGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI 313
+ K +VVG + PE++ + Y E DV+++G +L ++
Sbjct: 164 KQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 44/184 (23%), Positives = 77/184 (41%), Gaps = 27/184 (14%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
+L++++H +VIR L +V + + L L +PLP Q + + I
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILE 168
Query: 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQR 270
G+ YLH+ +IHRD+ ++N + + V + D G AAQ
Sbjct: 169 GLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLG----------------------AAQF 206
Query: 271 RGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF 330
+ G APE++ +Y+ D++S GIVL E++ A P + P
Sbjct: 207 PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML----AYPSTIFEDPPS 262
Query: 331 GLDQ 334
++
Sbjct: 263 TPEE 266
|
Length = 357 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 23/150 (15%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 231
+L V EY+ GG L +Q G+ Q V +A +I+ G+ +LH +I+RDL N +
Sbjct: 75 RLYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVM 133
Query: 232 VREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM 291
+ + + +ADFG+ K G + T G P ++APE+
Sbjct: 134 LDSEGHIKIADFGMC-------------------KEHMVDGVTTR--TFCGTPDYIAPEI 172
Query: 292 MTGQEYDETVDVFSYGIVLCEII-GRVPAD 320
+ Q Y ++VD ++YG++L E++ G+ P D
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 35/178 (19%)
Query: 152 LRSLHHHN---VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNFARD 207
L+ LH N ++ F G Y D ++++ E++ GG+L ++L+ G+ P +++ A
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA-- 107
Query: 208 IAAGMTYL---HSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVP 264
+ G+TYL H ++HRD+ N LV + + DFG++ + MA
Sbjct: 108 VLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-------MAN-- 156
Query: 265 RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI-IGRVPADP 321
+ VG +M+PE + G Y D++S G+ L E+ IGR P P
Sbjct: 157 --------------SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 47/149 (31%), Positives = 75/149 (50%), Gaps = 27/149 (18%)
Query: 173 LNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNC 230
L V EY+ GG L +Q + LP R F A +I G+ +LHS +++RDL N
Sbjct: 71 LFFVMEYLNGGDLMFHIQSCHKFDLP---RATFYAAEIICGLQFLHSKGIVYRDLKLDNI 127
Query: 231 LVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPE 290
L+ D + +ADFG+ + + K T G P ++APE
Sbjct: 128 LLDTDGHIKIADFGMCK---------------------ENMLGDAKTCTFCGTPDYIAPE 166
Query: 291 MMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
++ GQ+Y+ +VD +S+G++L E +IG+ P
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 34/174 (19%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLN------LVTEYIAGGTLKELLQDPGQPLPWGQR 201
++ +L+ ++H N+I + V + L LV E + + + + +R
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDH-----ER 124
Query: 202 VNFA-RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260
+++ + G+ +LHS +IHRDL N +V+ D T+ + DFGLAR A T M
Sbjct: 125 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART------ACTNFM 178
Query: 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII 314
P Y V Y+ APE++ G Y E VD++S G ++ E++
Sbjct: 179 M-TP-------------YVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 44/185 (23%), Positives = 79/185 (42%), Gaps = 30/185 (16%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFA-- 205
++ ++ + H N++ + V + +NLV + +A LK+++ ++
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDR---------KIRLTES 119
Query: 206 ------RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259
I G+ LH +HRDL+ N + +ADFGLAR P + T
Sbjct: 120 QVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL- 178
Query: 260 MAKVPRKAAQRRGARKKRYT--VVGNPYWMAPEMMTGQE-YDETVDVFSYGIVLCEIIGR 316
+ R++ T VV ++ APE++ G E Y VD++S G + E++
Sbjct: 179 -------SKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
Query: 317 VPADP 321
P P
Sbjct: 231 KPLFP 235
|
Length = 335 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 59/257 (22%), Positives = 104/257 (40%), Gaps = 55/257 (21%)
Query: 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVN 203
++ R L H N++ ++ D +L +V+ +A G+ ++LL+ G LP
Sbjct: 48 QEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG--LPELAIAF 105
Query: 204 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLAR-IIHQGPRAPTTVMAK 262
+D+ + Y+HS IHR + + + L+ D VV++ + +I G R V+
Sbjct: 106 ILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR--QRVVHD 163
Query: 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG--QEYDETVDVFSYGIVLCEII-GRVP- 318
P+ + + N W++PE++ Q Y+E D++S GI CE+ G VP
Sbjct: 164 FPKSSVK-------------NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF 210
Query: 319 AD---------------PDYLPRS--PDFGLDQTDFRNKFCASCP-------------EP 348
D P L +S P + + R+ E
Sbjct: 211 KDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEH 270
Query: 349 FVRIAFLCCDLNPDQRP 365
F + LC +P+ RP
Sbjct: 271 FHQFVELCLQRDPESRP 287
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 44/174 (25%), Positives = 78/174 (44%), Gaps = 21/174 (12%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
++ +LR+L N++ + KL LV EY+ L+ L + P P R +
Sbjct: 50 ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL 109
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
I A + + H +++HRD+ +N L+ + + + DFG AR + +G A T
Sbjct: 110 IKA-IHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT--------- 159
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADP 321
V ++ +PE++ G Y + VD++S G +L E+ P P
Sbjct: 160 -----------EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 25/168 (14%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 231
+L LV EY+ GG L +Q + LP +A +I + +LH +I+RDL N L
Sbjct: 70 RLFLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVL 128
Query: 232 VREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM 291
+ D + + D+G+ + +G T T G P ++APE+
Sbjct: 129 LDADGHIKLTDYGMCK---EGLGPGDTTS------------------TFCGTPNYIAPEI 167
Query: 292 MTGQEYDETVDVFSYGIVLCEII-GRVPADPDYLPRSPDFGLDQTDFR 338
+ G+EY +VD ++ G+++ E++ GR P D + +PD + F+
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPF--DIITDNPDMNTEDYLFQ 213
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 44/174 (25%), Positives = 82/174 (47%), Gaps = 25/174 (14%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ--PLPWGQRVNFA 205
++++++ L H N++R V++ + KL LV EY+ LK+ + G L +F
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT 106
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
+ G+ + H ++HRDL QN L+ + + +ADFGLAR +P
Sbjct: 107 YQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAF------------GIPV 154
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVP 318
V ++ AP+++ G + Y ++D++S G ++ E+I P
Sbjct: 155 NTFSNE---------VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 63/230 (27%), Positives = 103/230 (44%), Gaps = 38/230 (16%)
Query: 152 LRSLHHHN---VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNFARD 207
L+ LH N ++ F G Y D ++++ E++ GG+L ++L+ G+ P +V+ A
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA-- 111
Query: 208 IAAGMTYLHSMN-LIHRDLNSQNCLVREDKTVVVADFGLA-RIIHQGPRAPTTVMAKVPR 265
+ G+TYL + ++HRD+ N LV + + DFG++ ++I MA
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--------MAN--- 160
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI-IGRVP-ADPDY 323
+ VG +M+PE + G Y D++S G+ L E+ IGR P PD
Sbjct: 161 -------------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207
Query: 324 LPRSPDFGLD-QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372
FG + D + P P R PD RPP + E+
Sbjct: 208 KELELMFGCPVEGDPAESETSPRPRPPGRPL---SSYGPDSRPPMAIFEL 254
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 27/175 (15%)
Query: 148 QVAVLRSLHHHNV--IRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFA 205
++ +L L H N+ ++ + V K+ +V EY+ LK L++ QP +
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM 112
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
+ +G+ +LH ++HRDL + N L+ + + DFGLAR
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR------------------ 154
Query: 266 KAAQRRGARKKRYT-VVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVP 318
G+ K YT +V ++ APE++ G EY +D++S G + E++ + P
Sbjct: 155 ----EYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 32/182 (17%)
Query: 148 QVAVLRSLHHHNVIRFIGVL--------YKDRKLN--LVTEYIAGGTLKELLQDPGQPLP 197
++ +LR L+H N++ ++ +K K LV EY+ L LL+
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFS 114
Query: 198 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPT 257
+F + + G+ Y H N +HRD+ N L+ + +ADFGLAR+ + P
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE-YDETVDVFSYGIVLCEIIGR 316
T K T+ ++ PE++ G+E Y +DV+S G +L E+ +
Sbjct: 175 T----------------NKVITL----WYRPPELLLGEERYGPAIDVWSCGCILGELFTK 214
Query: 317 VP 318
P
Sbjct: 215 KP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 43/150 (28%), Positives = 76/150 (50%), Gaps = 23/150 (15%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 231
+L V EY+ GG L +Q G+ V +A +IA G+ +LHS +I+RDL N +
Sbjct: 75 RLYFVMEYVNGGDLMYQIQQVGR-FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVM 133
Query: 232 VREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM 291
+ + + +ADFG+ + + V K T G P ++APE+
Sbjct: 134 LDSEGHIKIADFGMCK---------ENMWDGVTTK------------TFCGTPDYIAPEI 172
Query: 292 MTGQEYDETVDVFSYGIVLCEII-GRVPAD 320
+ Q Y ++VD +++G++L E++ G+ P +
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 58/224 (25%), Positives = 90/224 (40%), Gaps = 25/224 (11%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
++ L + ++R IGV + L LV E +GG L + L + V ++
Sbjct: 48 IMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSM 106
Query: 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA-KVPRKAAQ 269
GM YL N +HRDL ++N L+ ++DFGL++ + A K P K
Sbjct: 107 GMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK--- 163
Query: 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYLPRS 327
W APE + +++ DV+SYGI + E G+ P P
Sbjct: 164 ----------------WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV 207
Query: 328 PDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371
F ++Q R A CP + C + RP F +E
Sbjct: 208 MSF-IEQGK-RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVE 249
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 23/175 (13%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+ ++L+ L H N++ +++ L LV EY+ + + + PG P ++ F
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL-FLFQ 111
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ G++Y+H ++HRDL QN L+ + + +ADFGLAR VP
Sbjct: 112 LLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLAR------------AKSVPSHT 159
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVPADP 321
V ++ P+++ G EY +D++ G + E+I V A P
Sbjct: 160 YSNE---------VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 40/108 (37%), Positives = 56/108 (51%), Gaps = 23/108 (21%)
Query: 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQR 270
G+ +LHS +IHRDL N +V+ D T+ + DFGLAR A T+ M P
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART------AGTSFMM-TP------ 176
Query: 271 RGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRV 317
Y V Y+ APE++ G Y E VD++S G ++ E+I G V
Sbjct: 177 -------YVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 39/155 (25%)
Query: 170 DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR--------DIAAGMTYLHSMNLI 221
D KL+L+ +YI GG L L QR F +I + +LH + +I
Sbjct: 77 DTKLHLILDYINGGELFTHLS---------QRERFKEQEVQIYSGEIVLALEHLHKLGII 127
Query: 222 HRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVV 281
+RD+ +N L+ + VV+ DFGL++ H+ ++ Y+
Sbjct: 128 YRDIKLENILLDSNGHVVLTDFGLSKEFHEDE--------------------VERAYSFC 167
Query: 282 GNPYWMAPEMMTGQE--YDETVDVFSYGIVLCEII 314
G +MAP+++ G + +D+ VD +S G+++ E++
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 40/168 (23%), Positives = 74/168 (44%), Gaps = 25/168 (14%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
+L ++H + G + L LV E++ GG L+ + P +A I
Sbjct: 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVL 142
Query: 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQR 270
YL S+N+++RDL +N L+ +D + + DFG A+++
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-------------------- 182
Query: 271 RGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVP 318
+ YT+ G P ++APE++ + + D ++ GI + EI+ P
Sbjct: 183 ----TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 40/144 (27%), Positives = 64/144 (44%), Gaps = 24/144 (16%)
Query: 176 VTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRED 235
V EY AGG L + P + V +A + G+ YLH +++RDL N L+ +
Sbjct: 80 VMEYAAGGDLMMHIHTDVFSEP--RAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE 137
Query: 236 KTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ 295
V +ADFGL + + G + T G P ++APE++T
Sbjct: 138 GFVKIADFGLCK---------------------EGMGFGDRTSTFCGTPEFLAPEVLTET 176
Query: 296 EYDETVDVFSYGIVLCE-IIGRVP 318
Y VD + G+++ E ++G P
Sbjct: 177 SYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 39/215 (18%)
Query: 107 RSILCSACDVMLD-NWYFEKDGLLFCKEDYNGKYGEACQNCGQVAVLRSLHHHNVIRFIG 165
+ I+C+A D +LD N +K F + + A + ++ +++ ++H N+I +
Sbjct: 30 QGIVCAAYDAVLDRNVAIKKLSRPFQNQTH------AKRAYRELVLMKCVNHKNIISLLN 83
Query: 166 VLYKDRKLN------LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN 219
V + L LV E + L +++Q L + + G+ +LHS
Sbjct: 84 VFTPQKSLEEFQDVYLVME-LMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG 139
Query: 220 LIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYT 279
+IHRDL N +V+ D T+ + DFGLAR A T+ M
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLART------AGTSFMMT----------------P 177
Query: 280 VVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII 314
V Y+ APE++ G Y E VD++S G ++ E++
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 50/187 (26%), Positives = 87/187 (46%), Gaps = 36/187 (19%)
Query: 148 QVAVLRSLHHHN-VIRFIGVLYKDRK-----LNLVTEYIAGGTLKELL----QDPGQPLP 197
++++L+ L ++R + V + + K L LV EY+ LK+ + + PG+PLP
Sbjct: 50 EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLP 108
Query: 198 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVV-VADFGLARIIHQGPRAP 256
+F + G+ + H ++HRDL QN LV + K ++ +AD GL R
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF------- 161
Query: 257 TTVMAKVPRKAAQRRGARKKRYT-VVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEII 314
+P K+ YT + ++ APE++ G Y VD++S G + E+
Sbjct: 162 -----SIPVKS----------YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
Query: 315 GRVPADP 321
+ P P
Sbjct: 207 RKQPLFP 213
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 42/176 (23%), Positives = 78/176 (44%), Gaps = 25/176 (14%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+ ++L+ L H N++ +++ L V EY+ + ++Q PG P+ R+ F
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-FMFQ 111
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ G+ Y+H +++HRDL QN L+ + +ADFGLAR +P +
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLAR------------AKSIPSQT 159
Query: 268 AQRRGARKKRYTVVGNPYWMAPE--MMTGQEYDETVDVFSYGIVLCEIIGRVPADP 321
Y+ W P ++ +Y +D++ G + E++ PA P
Sbjct: 160 ----------YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 49/180 (27%), Positives = 77/180 (42%), Gaps = 40/180 (22%)
Query: 170 DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIA----AGMT----YLHSMNLI 221
L V +YI GG + LL G F D+A A +T +H M I
Sbjct: 73 KDNLYFVMDYIPGGDMMSLLIRLGI---------FEEDLARFYIAELTCAIESVHKMGFI 123
Query: 222 HRDLNSQNCLVREDKTVVVADFGLA---RIIH------------QGPRAPTTVMA---KV 263
HRD+ N L+ D + + DFGL R H Q P+ + +
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 264 PRKAAQRRGARK----KRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
K +RR R+ +++VG P ++APE++ Y + D +S G++L E ++G+ P
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 39/150 (26%), Positives = 75/150 (50%), Gaps = 23/150 (15%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 231
+L V E+++GG L +Q + LP ++ +I+ + +LH +I+RDL N L
Sbjct: 70 RLFFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVL 128
Query: 232 VREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM 291
+ + + + D+G+ + +G R T T G P ++APE+
Sbjct: 129 LDAEGHIKLTDYGMCK---EGIRPGDTTS------------------TFCGTPNYIAPEI 167
Query: 292 MTGQEYDETVDVFSYGIVLCEII-GRVPAD 320
+ G++Y +VD ++ G+++ E++ GR P D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 59/234 (25%), Positives = 95/234 (40%), Gaps = 40/234 (17%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
V++ L + ++R IG+ + LV E G L + LQ + + ++
Sbjct: 49 VMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFLQK-NKHVTEKNITELVHQVSM 106
Query: 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP---RAPTTVMAKVPRKA 267
GM YL N +HRDL ++N L+ ++DFGL++ + +A T K P K
Sbjct: 107 GMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH--GKWPVK- 163
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYLP 325
W APE M ++ DV+S+G+++ E G+ P Y
Sbjct: 164 ------------------WYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP----YKG 201
Query: 326 RSPDFGLDQTDF-----RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWL 374
G + T R + CP + LC D+RP F V+E+ L
Sbjct: 202 MK---GNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRL 252
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 45/182 (24%), Positives = 80/182 (43%), Gaps = 31/182 (17%)
Query: 148 QVAVLRSLHHHNVIRFIGVLY-KDRKLN-------LVTEYIAGGTLKELLQDPGQPLPWG 199
++ +L+ L H NV+ I + K N LV E+ L LL +
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS 119
Query: 200 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259
+ + + G+ Y+H ++HRD+ + N L+ +D + +ADFGLAR
Sbjct: 120 EIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSL-------- 171
Query: 260 MAKVPRKAAQRRGARKKRYT--VVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGR 316
K ++ RYT VV ++ PE++ G ++Y +D++ G ++ E+ R
Sbjct: 172 -----SKNSKP-----NRYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220
Query: 317 VP 318
P
Sbjct: 221 SP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 4e-10
Identities = 41/152 (26%), Positives = 75/152 (49%), Gaps = 23/152 (15%)
Query: 170 DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 229
+ +L V EY+ GG L +Q + LP ++ +I+ + YLH +I+RDL N
Sbjct: 68 ESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDN 126
Query: 230 CLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAP 289
L+ + + + D+G+ + +G R T T G P ++AP
Sbjct: 127 VLLDSEGHIKLTDYGMCK---EGLRPGDTTS------------------TFCGTPNYIAP 165
Query: 290 EMMTGQEYDETVDVFSYGIVLCEII-GRVPAD 320
E++ G++Y +VD ++ G+++ E++ GR P D
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 5e-10
Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 34/194 (17%)
Query: 140 GEACQNCGQVAVLRSLHHHNVIRFIGVL--YKDRKLNLVTEY--------IAGGTLKELL 189
G + C ++A+LR L H NVI V + DRK+ L+ +Y I +
Sbjct: 40 GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN 99
Query: 190 QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR----EDKTVVVADFGL 245
+ P Q LP G + I G+ YLH+ ++HRDL N LV E V +AD G
Sbjct: 100 KKPVQ-LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158
Query: 246 ARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVF 304
AR+ + +P +A + VV ++ APE++ G + Y + +D++
Sbjct: 159 ARLFN----SPLKPLADLD--------------PVVVTFWYRAPELLLGARHYTKAIDIW 200
Query: 305 SYGIVLCEIIGRVP 318
+ G + E++ P
Sbjct: 201 AIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 47/179 (26%), Positives = 72/179 (40%), Gaps = 45/179 (25%)
Query: 152 LRSLHHHNVIRFIGVLYKDRKLN------LVTEYIA---GGTLK-ELLQDPGQPLPWGQR 201
L+ + H NVI + V L LVT + +K + L D
Sbjct: 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSD--------DH 119
Query: 202 VNF-ARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260
+ F I G+ Y+HS +IHRDL N V ED + + DFGLAR
Sbjct: 120 IQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH------------ 167
Query: 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEII-GRV 317
+ V ++ APE M+ Y++TVD++S G ++ E++ G+
Sbjct: 168 ------------TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 38/124 (30%), Positives = 58/124 (46%), Gaps = 21/124 (16%)
Query: 204 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263
F I G+ Y+HS N++HRDL N L+ + + + DFGLARI + V
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 264 PRKAAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEIIGRVPADP- 321
A R ++ APE M+ + Y + +D++S G +L E++ P P
Sbjct: 171 ----ATR--------------WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212
Query: 322 -DYL 324
DYL
Sbjct: 213 KDYL 216
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 46/169 (27%), Positives = 79/169 (46%), Gaps = 24/169 (14%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTE-YIAGGTLKELLQDPGQPLPWGQRVNFA- 205
++ +++ ++H N+I + V + L + YI + L Q +R+++
Sbjct: 73 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL 132
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
+ G+ +LHS +IHRDL N +V+ D T+ + DFGLAR A T+ M
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART------AGTSFMMT--- 183
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII 314
V Y+ APE++ G Y E VD++S G ++ E+I
Sbjct: 184 -------------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 42/147 (28%), Positives = 67/147 (45%), Gaps = 22/147 (14%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 231
KL LV +I GG L LQ G+ R A + A + LH N+I+RDL +N L
Sbjct: 67 KLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCA-LENLHKFNVIYRDLKPENIL 125
Query: 232 VREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM 291
+ + + DFGL ++ M + T G P ++APE+
Sbjct: 126 LDYQGHIALCDFGLCKL----------NMKDDDKTN-----------TFCGTPEYLAPEL 164
Query: 292 MTGQEYDETVDVFSYGIVLCEIIGRVP 318
+ G Y + VD ++ G++L E++ +P
Sbjct: 165 LLGHGYTKAVDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 41/146 (28%), Positives = 62/146 (42%), Gaps = 13/146 (8%)
Query: 179 YIAGGTLKELLQDPGQ------PLPWGQRV-NFAR---DIAAGMTYLHSMNLIHRDLNSQ 228
YI G TLK LL+ Q L V F I A + Y+HS ++HRDL
Sbjct: 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPD 142
Query: 229 NCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMA 288
N L+ VV+ D+G A + K +VG P +MA
Sbjct: 143 NILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGK---IVGTPDYMA 199
Query: 289 PEMMTGQEYDETVDVFSYGIVLCEII 314
PE + G E+ D+++ G++L +++
Sbjct: 200 PERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 21/170 (12%)
Query: 148 QVAVLRSLHHHNVIRFI--GVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFA 205
+ A+ L+H N++ + G L V EY+ G TL+E+L G LP G+
Sbjct: 28 ETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYVPGRTLREVLAADG-ALPAGETGRLM 85
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVRE---DKTVVVADFGLARIIHQGPRAPTTVMAK 262
+ + H+ ++HRDL QN +V + V DFG+ + P
Sbjct: 86 LQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTL---LPGV------- 135
Query: 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE 312
R A R +G P + APE + G+ D++++G++ E
Sbjct: 136 --RDADVATLTRTTEV--LGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 39/155 (25%)
Query: 170 DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD--------IAAGMTYLHSMNLI 221
D KL+L+ +Y+ GG L L QR +F I + +LH + +I
Sbjct: 77 DTKLHLILDYVNGGELFTHLY---------QREHFTESEVRVYIAEIVLALDHLHQLGII 127
Query: 222 HRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVV 281
+RD+ +N L+ + VV+ DFGL++ A A Y+
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGLSKEF----LAEEEERA----------------YSFC 167
Query: 282 GNPYWMAPEMMTGQE--YDETVDVFSYGIVLCEII 314
G +MAPE++ G +D+ VD +S G++ E++
Sbjct: 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 48/177 (27%), Positives = 85/177 (48%), Gaps = 33/177 (18%)
Query: 152 LRSLHHHN---VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNFARD 207
L+ LH N ++ F G Y D ++++ E++ GG+L ++L++ + P +V+ A
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA-- 111
Query: 208 IAAGMTYLHSMN-LIHRDLNSQNCLVREDKTVVVADFGLA-RIIHQGPRAPTTVMAKVPR 265
+ G+ YL + ++HRD+ N LV + + DFG++ ++I MA
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--------MAN--- 160
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI-IGRVPADP 321
+ VG +M+PE + G Y D++S G+ L E+ IGR P P
Sbjct: 161 -------------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 39/182 (21%), Positives = 73/182 (40%), Gaps = 30/182 (16%)
Query: 148 QVAVLRSLHHHNVIRFIGVL-YKDRKLNLVTEY---IAGGTLKELLQDPGQPLPWGQRVN 203
++ L L+H N+++ +L + + +Y + E +PL R
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-A 271
Query: 204 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263
+ + + Y+H LIHRD+ +N + D +V+ DFG A + + R
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA-MPFEKEREA------- 323
Query: 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDY 323
Y VG +PE++ G Y E D++S G++L +++ D+
Sbjct: 324 ------------FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH-----DF 366
Query: 324 LP 325
P
Sbjct: 367 CP 368
|
Length = 501 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 35/114 (30%), Positives = 52/114 (45%), Gaps = 21/114 (18%)
Query: 204 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263
F I G+ YLHS ++HRD+ N LV + + + DFGLAR+ T
Sbjct: 108 FLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT----- 162
Query: 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGR 316
VV Y+ APE++ G + Y VD++S G + E++GR
Sbjct: 163 --------------QEVV-TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 27/170 (15%)
Query: 160 VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN 219
V++ D+ L +V EY+ GG L L+ + P W + + ++ + +HSM
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF--YTAEVVLALDAIHSMG 162
Query: 220 LIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYT 279
LIHRD+ N L+ + + +ADFG + + T M + T
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE------TGMVRCD--------------T 202
Query: 280 VVGNPYWMAPEMMTGQ----EYDETVDVFSYGIVLCE-IIGRVPADPDYL 324
VG P +++PE++ Q Y D +S G+ L E ++G P D L
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 41/148 (27%), Positives = 71/148 (47%), Gaps = 24/148 (16%)
Query: 173 LNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 231
L LV + GG LK + + G+ L + ++++ I G+ +LHSM++++RD+ +N L
Sbjct: 68 LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVL 127
Query: 232 VREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM 291
+ + ++D GLA + G T QR G +MAPE+
Sbjct: 128 LDDQGNCRLSDLGLAVELKDG--KTIT----------QRAGTNG----------YMAPEI 165
Query: 292 MTGQEYDETVDVFSYGIVLCEII-GRVP 318
+ + Y VD F+ G + E++ GR P
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 49/184 (26%), Positives = 79/184 (42%), Gaps = 29/184 (15%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIA----GGTLKELLQDPGQPLPWGQRVN 203
++ +LR L H NVI ++ + YI L ++++ Q L
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSS-QTLSDDHCQY 112
Query: 204 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263
F + G+ Y+HS N++HRDL N L+ + + + DFGLAR + T
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE----- 167
Query: 264 PRKAAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEIIGRVPADP- 321
Y V ++ APE ++ EY +DV+S G + E++GR P P
Sbjct: 168 --------------YVVT--RWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211
Query: 322 -DYL 324
DY+
Sbjct: 212 KDYV 215
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 55/237 (23%), Positives = 91/237 (38%), Gaps = 46/237 (19%)
Query: 153 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-----PGQPLPWGQRVNFARD 207
R L+H NV++ +G + LV E+ G LK L+ + A +
Sbjct: 50 RELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ-RMACE 108
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+A+G+ +LH + IH DL +NC + D +V + D+GLA + T VP +
Sbjct: 109 VASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR- 167
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYD-ETVD------VFSYGIVLCEI--IGRVP 318
W+APE++ + D D ++S G+ + E+ P
Sbjct: 168 ------------------WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
Query: 319 ----ADPD---YLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFE 368
+D + R D L + K+ E C L+P+ RP E
Sbjct: 210 YPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE-----VMQFCWLDPETRPTAE 261
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 40/177 (22%), Positives = 83/177 (46%), Gaps = 39/177 (22%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD--- 207
+L ++H +++ + KL L+ +++ GG L L + V F +
Sbjct: 51 ILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS---------KEVMFTEEDVK 101
Query: 208 -----IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAK 262
+A + +LHS+ +I+RDL +N L+ E+ + + DFGL++
Sbjct: 102 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--------------- 146
Query: 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVP 318
+ KK Y+ G +MAPE++ + + ++ D +S+G+++ E++ G +P
Sbjct: 147 ------ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 35/177 (19%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLN------LVTEYIAGGTLKELLQDPGQPLPWGQR 201
++ +L+ + H NVI + V R L LVT ++ G L +++ Q L
Sbjct: 66 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVK--CQKLTDDHV 122
Query: 202 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA 261
I G+ Y+HS ++IHRDL N V ED + + DFGLAR
Sbjct: 123 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------------- 168
Query: 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEII-GR 316
+ G V ++ APE+M Y++TVD++S G ++ E++ GR
Sbjct: 169 ---HTDDEMTG-------YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 26/152 (17%)
Query: 169 KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNS 227
KDR L V EY+ GG L + + R F +I + + YLHS +++RDL
Sbjct: 67 KDR-LCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKL 123
Query: 228 QNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWM 287
+N ++ +D + + DFGL + +G T+ T G P ++
Sbjct: 124 ENLMLDKDGHIKITDFGLCK---EGITDAATMK------------------TFCGTPEYL 162
Query: 288 APEMMTGQEYDETVDVFSYGIVLCEII-GRVP 318
APE++ +Y VD + G+V+ E++ GR+P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 50/181 (27%), Positives = 80/181 (44%), Gaps = 35/181 (19%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG-QRVNF-A 205
++A+ L H N+++++G ++ + E + GG+L LL+ PL Q + F
Sbjct: 55 EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT 114
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVV-VADFG----LARIIHQGPRAPTTVM 260
+ I G+ YLH ++HRD+ N LV VV ++DFG LA I P T
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI------NPCT-- 166
Query: 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMM-TGQE-YDETVDVFSYGIVLCEI-IGRV 317
T G +MAPE++ G Y D++S G + E+ G+
Sbjct: 167 -----------------ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKP 209
Query: 318 P 318
P
Sbjct: 210 P 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 1/108 (0%)
Query: 140 GEACQNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 199
G + ++L+ L H N++ +++ + L LV EY+ LK+ + D G L
Sbjct: 45 GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMH 103
Query: 200 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLAR 247
F + G+ Y H ++HRDL QN L+ E + +ADFGLAR
Sbjct: 104 NVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 47/170 (27%), Positives = 76/170 (44%), Gaps = 27/170 (15%)
Query: 160 VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN 219
V++ DR L +V EY+ GG L L+ + P W + + ++ + +HSM
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF--YTAEVVLALDAIHSMG 162
Query: 220 LIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYT 279
IHRD+ N L+ + + +ADFG T M K+ ++ R T
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFG-------------TCM-KMNKEGMVRCD------T 202
Query: 280 VVGNPYWMAPEMMTGQ----EYDETVDVFSYGIVLCE-IIGRVPADPDYL 324
VG P +++PE++ Q Y D +S G+ L E ++G P D L
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 26/152 (17%)
Query: 169 KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNS 227
DR L V EY GG L L + R F +I + + YLHS ++++RDL
Sbjct: 67 HDR-LCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKL 123
Query: 228 QNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWM 287
+N ++ +D + + DFGL K GA K T G P ++
Sbjct: 124 ENLMLDKDGHIKITDFGLC-------------------KEGISDGATMK--TFCGTPEYL 162
Query: 288 APEMMTGQEYDETVDVFSYGIVLCEII-GRVP 318
APE++ +Y VD + G+V+ E++ GR+P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 49/195 (25%), Positives = 80/195 (41%), Gaps = 30/195 (15%)
Query: 160 VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN 219
V+R L V +YI GG + LL G P + ++ + +H M
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVESVHKMG 121
Query: 220 LIHRDLNSQNCLVREDKTVVVADFGLA---RIIHQG--------PRA-----------PT 257
IHRD+ N L+ D + + DFGL R H R P
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPA 181
Query: 258 TVMAKVPRKAAQRRGARKKR----YTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI 313
K +RR AR+ + +++VG P ++APE++ Y + D +S G++L E+
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241
Query: 314 IGRVPADPDYLPRSP 328
+ P +L ++P
Sbjct: 242 ---LVGQPPFLAQTP 253
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|188750 cd09364, LIM1_LIMK, The first LIM domain of LIMK (LIM domain Kinase ) | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-09
Identities = 20/52 (38%), Positives = 26/52 (50%), Gaps = 5/52 (9%)
Query: 89 CTSCSCCIGDGESYALVERS-----ILCSACDVMLDNWYFEKDGLLFCKEDY 135
C C I D + + + CS C L NWYFEKDG L+C++DY
Sbjct: 1 CAGCRGKILDSQYVQALNQDWHCDCFRCSVCSDSLSNWYFEKDGKLYCRKDY 52
|
The first LIM domain of LIMK (LIM domain Kinase ): LIMK protein family is comprised of two members LIMK1 and LIMK2. LIMK contains two LIM domains, a PDZ domain and a kinase domain. LIMK is involved in the regulation of actin polymerization and microtubule disassembly. LIMK influences architecture of the actin cytoskeleton by regulating the activity of the cofilin family proteins cofilin1, cofilin2, and destrin. The mechanism of the activation is to phosphorylates cofilin on serine 3 and inactivates its actin-severing activity, and altering the rate of actin depolymerisation. LIMKs can function in both cytoplasm and nucleus and are expressed in all tissues. Both LIMK1 and LIMK2 can act in the nucleus to suppress Rac/Cdc42-dependent cyclin D1 expression. However, LIMK1 and LIMk2 have different cellular locations. While LIMK1 localizes mainly at focal adhesions, LIMK2 is found in cytoplasmic punctae, suggesting that they may have different cellular functions. The LIM domains of LIMK have been shown to play an important role in regulating kinase activity and likely also contribute to LIMK function by acting as sites of protein-to-protein interactions. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 53 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 3e-09
Identities = 53/194 (27%), Positives = 87/194 (44%), Gaps = 34/194 (17%)
Query: 140 GEACQNCGQVAVLRSLHHHNVIRFIGVL--YKDRKLNLVTEY--------IAGGTLKELL 189
G + C ++A+LR L H NVI V + DRK+ L+ +Y I +
Sbjct: 40 GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN 99
Query: 190 QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR----EDKTVVVADFGL 245
+ P Q LP + I G+ YLH+ ++HRDL N LV E V +AD G
Sbjct: 100 KKPMQ-LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158
Query: 246 ARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVF 304
AR+ + +P +A + VV ++ APE++ G + Y + +D++
Sbjct: 159 ARLFN----SPLKPLADLD--------------PVVVTFWYRAPELLLGARHYTKAIDIW 200
Query: 305 SYGIVLCEIIGRVP 318
+ G + E++ P
Sbjct: 201 AIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|188711 cd08368, LIM, LIM is a small protein-protein interaction domain, containing two zinc fingers | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 4e-09
Identities = 20/74 (27%), Positives = 32/74 (43%), Gaps = 22/74 (29%)
Query: 63 CQNCGQMMSG-PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVMLDNW 121
C CG+ + G ++ K+HPECFKC+ C +G
Sbjct: 1 CAGCGKPIEGRELLRALGKKWHPECFKCSVCGKPLGGDS--------------------- 39
Query: 122 YFEKDGLLFCKEDY 135
++EKDG +C++ Y
Sbjct: 40 FYEKDGKPYCEKCY 53
|
LIM domains are identified in a diverse group of proteins with wide variety of biological functions, including gene expression regulation, cell fate determination, cytoskeleton organization, tumor formation and development. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. They perform their functions through interactions with other protein partners. LIM domains are 50-60 amino acids in size and share two characteristic highly conserved zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. The consensus sequence of LIM domain has been defined as C-x(2)-C-x(16,23)-H-x(2)-[CH]-x(2)-C-x(2)-C-x(16, 21)-C-x(2,3)-[CHD] (where X denotes any amino acid). Length = 53 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 4e-09
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 43/178 (24%)
Query: 152 LRSLHHH-NVIRFIGVLYK---DRKLNLVTEY--------IAGGTLKELLQDPGQPLPWG 199
L+ L H N+++ + V K D+ + LV EY I L+++
Sbjct: 60 LQELGDHPNIVKLLNV-IKAENDKDIYLVFEYMETDLHAVIRANILEDV----------- 107
Query: 200 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTT- 258
+ + + Y+HS N+IHRDL N L+ D V +ADFGLAR + + P
Sbjct: 108 HKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167
Query: 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIG 315
V+ Y V ++ APE++ G Y + VD++S G +L E++
Sbjct: 168 VLTD---------------Y--VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 41/149 (27%), Positives = 70/149 (46%), Gaps = 25/149 (16%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNC 230
+L V EY GG L + + +R F +I + + YLHS ++++RD+ +N
Sbjct: 69 RLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL 126
Query: 231 LVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPE 290
++ +D + + DFGL K GA K T G P ++APE
Sbjct: 127 MLDKDGHIKITDFGLC-------------------KEGISDGATMK--TFCGTPEYLAPE 165
Query: 291 MMTGQEYDETVDVFSYGIVLCEII-GRVP 318
++ +Y VD + G+V+ E++ GR+P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 38/154 (24%)
Query: 170 DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD--------IAAGMTYLHSMNLI 221
+ KL+L+ +Y++GG + L QR NF+ D I + +LH + ++
Sbjct: 77 EAKLHLILDYVSGGEMFTHLY---------QRDNFSEDEVRFYSGEIILALEHLHKLGIV 127
Query: 222 HRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVV 281
+RD+ +N L+ + VV+ DFGL++ + T Y+
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT--------------------YSFC 167
Query: 282 GNPYWMAPEMMTGQE-YDETVDVFSYGIVLCEII 314
G +MAPE++ G+ + + VD +S GI++ E++
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 7e-09
Identities = 37/100 (37%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 153 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-----DPGQPLPWG-QRVNFAR 206
RSL H N+++ +G + LV E+ G LK L+ + P P QR+ A
Sbjct: 50 RSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--AC 107
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLA 246
+IA G+ +LH N IH DL +NCL+ D TV + D+GL+
Sbjct: 108 EIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 8e-09
Identities = 44/174 (25%), Positives = 75/174 (43%), Gaps = 16/174 (9%)
Query: 160 VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN 219
V++ R L L+ E++ GG + LL + A + A + +H +
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLA-IDAIHQLG 121
Query: 220 LIHRDLNSQNCLVREDKTVVVADFGLA-------------RIIHQGPRAPTTVMAKVPRK 266
IHRD+ N L+ V ++DFGL + H P + RK
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 267 AAQ-RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
A ++ R+ Y+ VG P ++APE+ Y++ D +S G+++ E +IG P
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 44/167 (26%), Positives = 75/167 (44%), Gaps = 17/167 (10%)
Query: 168 YKDR-KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226
++D+ L L+ E++ GG + LL + A + A + +H + IHRD+
Sbjct: 70 FQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLA-IDSIHQLGFIHRDIK 128
Query: 227 SQNCLVREDKTVVVADFGLA-------------RIIHQGPRAPTTVMAKVPRKAAQ-RRG 272
N L+ V ++DFGL + H P T RKA +R
Sbjct: 129 PDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRN 188
Query: 273 ARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
R+ ++ VG P ++APE+ Y++ D +S G+++ E +IG P
Sbjct: 189 RRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 55/221 (24%)
Query: 109 ILCSACD------VMLDNWY--FEKDGLLFCKEDYNGKYGEACQNCGQVAVLRSLHHHNV 160
+CSA D V + Y F+ + LF K Y ++ +L+ + H NV
Sbjct: 30 TVCSALDRRTGAKVAIKKLYRPFQSE--LFAKRAYR-----------ELRLLKHMKHENV 76
Query: 161 IRFIGVLYKDRKLNLVTEY-----IAGGTLKELLQDPGQPLPWGQRVNF-ARDIAAGMTY 214
I + V D L+ ++ G L +L++ + L R+ F + G+ Y
Sbjct: 77 IGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--EKLS-EDRIQFLVYQMLKGLKY 133
Query: 215 LHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGAR 274
+H+ +IHRDL N V ED + + DFGLAR V+ +
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYVVTR------------ 179
Query: 275 KKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEII 314
++ APE ++ Y +TVD++S G ++ E++
Sbjct: 180 ----------WYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 28/159 (17%)
Query: 168 YKDRK-LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226
++D+ L LV EY GG L LL + ++ + +H M +HRD+
Sbjct: 70 FQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIK 129
Query: 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYW 286
+N L+ + +ADFG A + A V +K+P VG P +
Sbjct: 130 PENVLIDRTGHIKLADFGSAARLT----ANKMVNSKLP----------------VGTPDY 169
Query: 287 MAPEMMTGQE------YDETVDVFSYGIVLCEII-GRVP 318
+APE++T Y D +S G++ E+I GR P
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|188750 cd09364, LIM1_LIMK, The first LIM domain of LIMK (LIM domain Kinase ) | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-08
Identities = 16/25 (64%), Positives = 19/25 (76%)
Query: 31 CSACDVMLDNWYFEKDGLLFCKEDY 55
CS C L NWYFEKDG L+C++DY
Sbjct: 28 CSVCSDSLSNWYFEKDGKLYCRKDY 52
|
The first LIM domain of LIMK (LIM domain Kinase ): LIMK protein family is comprised of two members LIMK1 and LIMK2. LIMK contains two LIM domains, a PDZ domain and a kinase domain. LIMK is involved in the regulation of actin polymerization and microtubule disassembly. LIMK influences architecture of the actin cytoskeleton by regulating the activity of the cofilin family proteins cofilin1, cofilin2, and destrin. The mechanism of the activation is to phosphorylates cofilin on serine 3 and inactivates its actin-severing activity, and altering the rate of actin depolymerisation. LIMKs can function in both cytoplasm and nucleus and are expressed in all tissues. Both LIMK1 and LIMK2 can act in the nucleus to suppress Rac/Cdc42-dependent cyclin D1 expression. However, LIMK1 and LIMk2 have different cellular locations. While LIMK1 localizes mainly at focal adhesions, LIMK2 is found in cytoplasmic punctae, suggesting that they may have different cellular functions. The LIM domains of LIMK have been shown to play an important role in regulating kinase activity and likely also contribute to LIMK function by acting as sites of protein-to-protein interactions. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 53 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 26/150 (17%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF-ARDIAAGMTYLHS-MNLIHRDLNSQN 229
+L V EY GG L + + R F +I + + YLHS N+++RDL +N
Sbjct: 69 RLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLEN 126
Query: 230 CLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAP 289
++ +D + + DFGL K + GA K T G P ++AP
Sbjct: 127 LMLDKDGHIKITDFGLC-------------------KEGIKDGATMK--TFCGTPEYLAP 165
Query: 290 EMMTGQEYDETVDVFSYGIVLCEII-GRVP 318
E++ +Y VD + G+V+ E++ GR+P
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 35/132 (26%), Positives = 59/132 (44%), Gaps = 23/132 (17%)
Query: 148 QVAVLRSLHHHNVIRF--------------IGVLYKDRKLNLVTEYIAGGTLKELLQDPG 193
++ ++R L H N+++ +G L + + +V EY+ L Q
Sbjct: 52 EIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ--- 108
Query: 194 QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVV-VADFGLARII--- 249
PL F + G+ Y+HS N++HRDL N + + V+ + DFGLARI+
Sbjct: 109 GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPH 168
Query: 250 --HQGPRAPTTV 259
H+G + V
Sbjct: 169 YSHKGYLSEGLV 180
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 36/118 (30%), Positives = 56/118 (47%), Gaps = 29/118 (24%)
Query: 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQR 270
G+ Y+HS +IHRDL N V ED + + DFGLAR
Sbjct: 130 GLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR----------------------- 166
Query: 271 RGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEII-GRV--PADPDYL 324
A + V ++ APE+M Y++TVD++S G ++ E++ G+ P + DY+
Sbjct: 167 -QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN-DYI 222
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 41/170 (24%), Positives = 77/170 (45%), Gaps = 22/170 (12%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTL-KELLQDPGQPLPWGQRVN--F 204
++ L + H +++ D KL L+ EY +GG L K++ Q + LP+ +
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174
Query: 205 ARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVP 264
I + +HS ++HRDL S N + + + DFG ++ + +V V
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK------QYSDSVSLDVA 228
Query: 265 RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII 314
+ G PY++APE+ + Y + D++S G++L E++
Sbjct: 229 S-------------SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265
|
Length = 478 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 24/148 (16%)
Query: 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCL 231
L LV + GG LK + + G P +R F A +I G+ LH N ++RDL +N L
Sbjct: 75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENIL 134
Query: 232 VREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM 291
+ + + ++D GLA K+P + R R VG +MAPE+
Sbjct: 135 LDDYGHIRISDLGLA--------------VKIPEGESIR-----GRVGTVG---YMAPEV 172
Query: 292 MTGQEYDETVDVFSYGIVLCEII-GRVP 318
+ Q Y + D + G ++ E+I G+ P
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 4e-08
Identities = 25/74 (33%), Positives = 37/74 (50%), Gaps = 6/74 (8%)
Query: 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 234
+V EYI G LK+L+ G +R+I + LHS +IH DL + N ++
Sbjct: 76 IVMEYIEGEPLKDLINSNGMEELE-----LSREIGRLVGKLHSAGIIHGDLTTSNMILSG 130
Query: 235 DKTVVVADFGLARI 248
K ++ DFGLA
Sbjct: 131 GKIYLI-DFGLAEF 143
|
Length = 211 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 5e-08
Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 24/148 (16%)
Query: 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCL 231
L LV + GG LK + + G P +R F A +I G+ LH +++RDL +N L
Sbjct: 75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENIL 134
Query: 232 VREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM 291
+ + + ++D GLA I +G + R VG +MAPE+
Sbjct: 135 LDDYGHIRISDLGLAVEIPEGETI-------------------RGRVGTVG---YMAPEV 172
Query: 292 MTGQEYDETVDVFSYGIVLCEII-GRVP 318
+ + Y + D + G ++ E+I G+ P
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 40/164 (24%), Positives = 69/164 (42%), Gaps = 19/164 (11%)
Query: 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 232
L L+ EY+ GG + LL R A I A + +H + IHRD+ N L+
Sbjct: 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILA-IDSIHKLGYIHRDIKPDNLLL 134
Query: 233 REDKTVVVADFGLARIIHQ-----------------GPRAPTTVMAKVPRKAAQRRGARK 275
+ ++DFGL + + + M+ + +R R
Sbjct: 135 DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRA 194
Query: 276 KRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
Y+ VG P ++APE+ Y++ D +S G+++ E ++G P
Sbjct: 195 LAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 44/176 (25%), Positives = 78/176 (44%), Gaps = 32/176 (18%)
Query: 151 VLRSLH--HH----NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF 204
+LR L H ++ F G + + + E++ G+L + + G P+P
Sbjct: 50 ILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG-PIPVEILGKI 108
Query: 205 ARDIAAGMTYLHSMN-LIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263
A + G+TYL++++ ++HRD+ N LV + + DFG V ++
Sbjct: 109 AVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFG--------------VSGEL 154
Query: 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI-IGRVP 318
A T VG +M+PE + G +Y DV+S GI + E+ +G+ P
Sbjct: 155 INSIAD---------TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 27/154 (17%)
Query: 170 DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 229
D+ L +V EY+ GG L L+ + P W + + ++ + +HSM IHRD+ N
Sbjct: 115 DKYLYMVMEYMPGGDLVNLMSNYDIPEKWARF--YTAEVVLALDAIHSMGFIHRDVKPDN 172
Query: 230 CLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAP 289
L+ + + +ADFG T M K+ R T VG P +++P
Sbjct: 173 MLLDKSGHLKLADFG-------------TCM-KMDANGMVRCD------TAVGTPDYISP 212
Query: 290 EMMTGQ----EYDETVDVFSYGIVLCE-IIGRVP 318
E++ Q Y D +S G+ L E ++G P
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 8e-08
Identities = 51/194 (26%), Positives = 87/194 (44%), Gaps = 36/194 (18%)
Query: 141 EACQN------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL----Q 190
EAC N G++ V + +H N++ + D +L +VT ++A G+ K+L+
Sbjct: 36 EACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM 95
Query: 191 DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARI-- 248
D L + + + Y+H M +HR + + + L+ D V ++ GL
Sbjct: 96 DGMSELAIAY---ILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLS 150
Query: 249 -IHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG--QEYDETVDVFS 305
I+ G R V+ P +Y+V P W++PE++ Q YD D++S
Sbjct: 151 MINHGQRL--RVVHDFP------------KYSVKVLP-WLSPEVLQQNLQGYDAKSDIYS 195
Query: 306 YGIVLCEII-GRVP 318
GI CE+ G VP
Sbjct: 196 VGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 28/176 (15%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+A + L H N+++ IG+ ++ L+ EYI G L E+L++ L W +R A I
Sbjct: 734 IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGI 789
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
A + +LH C VVV + +II G P ++ +P
Sbjct: 790 AKALRFLHC-----------RC----SPAVVVGNLSPEKIIIDGKDEPHLRLS-LP---- 829
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDY 323
G + ++APE ++ E D++ +G++L E++ G+ PAD ++
Sbjct: 830 ---GLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882
|
Length = 968 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 3/96 (3%)
Query: 153 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR---DIA 209
R L H N+++ +G + LV EY G LK L Q + R +IA
Sbjct: 50 RILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIA 109
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGL 245
AG+T++H N +H DL +NC + D TV V D+G+
Sbjct: 110 AGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 46/174 (26%), Positives = 76/174 (43%), Gaps = 35/174 (20%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDRKLN------LVTEYIAGGTLKELLQDPGQPLPWGQR 201
++ +L+ + H NVI + V + LV Y+ +L + G PL +
Sbjct: 64 ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM----QTDLQKIMGHPLSEDKV 119
Query: 202 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA 261
+ G+ Y+HS +IHRDL N V ED + + DFGLAR
Sbjct: 120 QYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------- 165
Query: 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEII 314
A+ G Y V ++ APE ++ Y++TVD++S G ++ E++
Sbjct: 166 ---HADAEMTG-----YVV--TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 44/188 (23%), Positives = 79/188 (42%), Gaps = 31/188 (16%)
Query: 168 YKDRK-LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226
++D+ L V +YI GG + LL P + ++ + +H M IHRD+
Sbjct: 70 FQDKDNLYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHKMGFIHRDIK 128
Query: 227 SQNCLVREDKTVVVADFGL---------------ARIIHQGPRAPTTVMAKVP------- 264
N L+ D + + DFGL I Q P+ + V
Sbjct: 129 PDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDR 188
Query: 265 ----RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPAD 320
+ A ++ R +++VG P ++APE++ + Y + D +S G++L E++
Sbjct: 189 LKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML---VGQ 245
Query: 321 PDYLPRSP 328
P +L +P
Sbjct: 246 PPFLAPTP 253
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 43/179 (24%), Positives = 81/179 (45%), Gaps = 34/179 (18%)
Query: 148 QVAVLRSLHHHNVIRFIGVLY-----KDRK---LNLVTEYIAGGTLKEL--LQDPGQPLP 197
++ ++++L+H N+I Y K+ K LN+V E+I K + LP
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALP 168
Query: 198 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDK-TVVVADFGLARIIHQGPRAP 256
++ + + Y+HS + HRDL QN L+ + T+ + DFG A+ + G R+
Sbjct: 169 LFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV 228
Query: 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEII 314
+ + ++ ++ APE+M G Y +D++S G ++ E+I
Sbjct: 229 SYICSR----------------------FYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 32/131 (24%), Positives = 54/131 (41%), Gaps = 27/131 (20%)
Query: 215 LHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIH--------QGPRAPTTV------- 259
+H + IHRD+ N L+ + ++DFGL+ H Q +
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 260 -----------MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGI 308
M+ + A ++ R Y+ VG P ++APE+ Q Y + D +S G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236
Query: 309 VLCE-IIGRVP 318
++ E +IG P
Sbjct: 237 IMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215907 pfam00412, LIM, LIM domain | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-07
Identities = 23/79 (29%), Positives = 32/79 (40%), Gaps = 23/79 (29%)
Query: 63 CQNCGQMMSGP--VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVMLDN 120
C CG+ + V +HPECF+C C +G G+
Sbjct: 1 CAGCGKPIYDRELVRRALGKVWHPECFRCAVCGKPLGPGD-------------------- 40
Query: 121 WYFEKDGLLFCKEDYNGKY 139
+FEKDG L+CK DY +
Sbjct: 41 -FFEKDGKLYCKHDYFKLF 58
|
This family represents two copies of the LIM structural domain. Length = 58 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 31/101 (30%), Positives = 52/101 (51%), Gaps = 19/101 (18%)
Query: 214 YLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGA 273
++HS ++IHRD+ S N L+ + V + DFG +++ TV V R
Sbjct: 158 HVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY------AATVSDDVGR-------- 203
Query: 274 RKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII 314
T G PY++APE+ + Y + D+FS G++L E++
Sbjct: 204 -----TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELL 239
|
Length = 496 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 48/186 (25%), Positives = 69/186 (37%), Gaps = 60/186 (32%)
Query: 208 IAAGMTYLHS-MNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
I + YLHS +++IHRD+ N L+ + V + DFG++ + +AK
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL-------VDSVAK---- 160
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEM----MTGQEYDETVDVFSYGIVLCEI-IGRVPAD- 320
G + PY MAPE + + YD DV+S GI + E+ GR P D
Sbjct: 161 -TIDAGCK---------PY-MAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209
Query: 321 ---------------PDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
LP F + DF NK C N +RP
Sbjct: 210 WKTPFQQLKQVVEEPSPQLPAEK-FSPEFQDFVNK---------------CLKKNYKERP 253
Query: 366 PFEVLE 371
+ L
Sbjct: 254 NYPELL 259
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|188847 cd09463, LIM1_LIMK2, The first LIM domain of LIMK2 (LIM domain Kinase 2) | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-07
Identities = 21/52 (40%), Positives = 28/52 (53%), Gaps = 5/52 (9%)
Query: 89 CTSCSCCIGDGESYALVERS-----ILCSACDVMLDNWYFEKDGLLFCKEDY 135
CT C I D Y +V+ + CS C +L NWY+EKDG L+C + Y
Sbjct: 1 CTGCGGRIQDSFHYRVVQEAWHNSCFQCSVCQDLLTNWYYEKDGKLYCHKHY 52
|
The first LIM domain of LIMK2 (LIM domain Kinase 2): LIMK2 is a member of the LIMK protein family, which comprises LIMK1 and LIMK2. LIMK contains two LIM domains, a PDZ domain, and a kinase domain. LIMK is involved in the regulation of actin polymerization and microtubule disassembly. LIMK influences architecture of the actin cytoskeleton by regulating the activity of the cofilin family proteins cofilin1, cofilin2, and destrin. The mechanism of the activation is to phosphorylates cofilin on serine 3 and inactivates its actin-severing activity, altering the rate of actin depolymerization. LIMK activity is activated by phosphorylation of a threonine residue within the activation loop of the kinase by p21-activated kinases 1 and 4 and by Rho kinase. LIMKs can function in both cytoplasm and nucleus. Both LIMK1 and LIMK2 can act in the nucleus to suppress Rac/Cdc42-dependent cyclin D1 expression. LIMK2 is expressed in all tissues. While LIMK1 localizes mainly at focal adhesions, LIMK2 is found in cytoplasmic punctae, suggesting that they may have different cellular functions. The activity of LIM kinase 2 to regulate cofilin phosphorylation is inhibited by the direct binding of Par-3. LIMK2 activation promotes cell cycle progression. The phenotype of Limk2 knockout mice shows a defect in spermatogenesis. The LIM domains have been shown to play an important role in regulating kinase activity and likely also contribute to LIMK function by acting as sites of protein-to-protein interactions. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 53 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 42/157 (26%), Positives = 73/157 (46%), Gaps = 28/157 (17%)
Query: 169 KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 228
KDR L V EY+ GG L +Q + + +A ++ + +LH +I+RDL
Sbjct: 68 KDR-LFFVMEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLD 125
Query: 229 NCLVREDKTVVVADFGLARIIHQG--PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYW 286
N L+ + +ADFG+ + +G TT T G P +
Sbjct: 126 NILLDAEGHCKLADFGMCK---EGILNGVTTT--------------------TFCGTPDY 162
Query: 287 MAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPD 322
+APE++ EY +VD ++ G+++ E++ G+ P + D
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 33/121 (27%), Positives = 54/121 (44%), Gaps = 23/121 (19%)
Query: 194 QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253
+PL Q AR + + + Y+H +IHRD+ ++N LV + + + DFG A
Sbjct: 255 RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA---- 310
Query: 254 RAPTTVMAKVPRKAAQRRGARKK--RYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLC 311
RG+ Y + G APE++ G Y +VD++S G+V+
Sbjct: 311 -----------------RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
Query: 312 E 312
E
Sbjct: 354 E 354
|
Length = 461 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 7e-07
Identities = 38/151 (25%), Positives = 65/151 (43%), Gaps = 28/151 (18%)
Query: 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL-VR 233
L+ +YI G L +LL+ G L + R + + LH N+IH D+ +N L R
Sbjct: 86 LIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR 144
Query: 234 EDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT 293
+ + D+GL +II P+ G T+ + +PE +
Sbjct: 145 AKDRIYLCDYGLCKIIGT----PSC-----------YDG------TLD----YFSPEKIK 179
Query: 294 GQEYDETVDVFSYGIVLCEII-GRVPADPDY 323
G YD + D ++ G++ E++ G+ P D
Sbjct: 180 GHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 9e-07
Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 24/148 (16%)
Query: 173 LNLVTEYIAGGTLKELLQDPGQP-LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 231
L LV + GG LK + G+ G+ V +A +I G+ LH +++RDL +N L
Sbjct: 75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENIL 134
Query: 232 VREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM 291
+ + + ++D GLA + +G T+ K R VG +MAPE+
Sbjct: 135 LDDHGHIRISDLGLAVHVPEG----QTI---------------KGRVGTVG---YMAPEV 172
Query: 292 MTGQEYDETVDVFSYGIVLCEII-GRVP 318
+ + Y + D ++ G +L E+I G+ P
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 23/74 (31%), Positives = 39/74 (52%), Gaps = 9/74 (12%)
Query: 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 234
+V EYI G LK+++++ R+I + LH ++H DL + N +VR+
Sbjct: 74 IVMEYIEGKPLKDVIEE--------GNDELLREIGRLVGKLHKAGIVHGDLTTSNIIVRD 125
Query: 235 DKTVVVADFGLARI 248
DK ++ DFGL +
Sbjct: 126 DKLYLI-DFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 29/112 (25%), Positives = 50/112 (44%), Gaps = 16/112 (14%)
Query: 149 VAVLRSLHHHNVI--RFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
VA+L+ L + + + D L+ E+I G TL E+ ++ ++ + A
Sbjct: 42 VAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEE--------EKEDIAE 93
Query: 207 DIAAGMTYLHSMN---LIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255
+A + LH + L H DL+ N LV + K + + D+ A GP A
Sbjct: 94 QLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY---GPPA 142
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 129 LFCKE--DYNG-KYGEACQNCGQVAVLRSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGG 183
FC + Y G K E Q +V V+R L H N++R+I ++KL ++ E+ G
Sbjct: 40 FFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAG 99
Query: 184 TLKELLQDPGQPLPWGQR---VNFARDIAAGMTYLHSMN-------LIHRDLNSQNCLVR 233
L +Q + + V+ R + + Y H++ ++HRDL QN +
Sbjct: 100 DLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL- 158
Query: 234 EDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRR-GARKKRYTVVGNPYWMAPEMM 292
+ + G +I Q +AK+ + G ++ VG PY+ +PE++
Sbjct: 159 ---STGIRHIG--KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELL 213
Query: 293 --TGQEYDETVDVFSYGIVLCEII-GRVP 318
+ YD+ D+++ G ++ E+ G+ P
Sbjct: 214 LHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 37/145 (25%), Positives = 69/145 (47%), Gaps = 23/145 (15%)
Query: 170 DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 229
D L LVT+Y++GG L LQ G+ + + ++ + +LH ++++RDL +N
Sbjct: 68 DSDLYLVTDYMSGGELFWHLQKEGR-FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPEN 126
Query: 230 CLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAP 289
L+ + + DFGL+ +A T K T G ++AP
Sbjct: 127 ILLDATGHIALCDFGLS-------KANLT--------------DNKTTNTFCGTTEYLAP 165
Query: 290 EMMTGQE-YDETVDVFSYGIVLCEI 313
E++ ++ Y + VD +S G+++ E+
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 50/231 (21%), Positives = 88/231 (38%), Gaps = 52/231 (22%)
Query: 152 LRSLHHHNVIRFIGVLYKDR----KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
LR + +N+++ G + +L+L+ EY G L+E+L D + L + +++ A D
Sbjct: 72 LRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-DKEKDLSFKTKLDMAID 130
Query: 208 IAAGMTYLH-SMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
G+ L+ N +++L S + LV E+ + + GL +I+ P M K
Sbjct: 131 CCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYK 190
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTG--QEYDETVDVFSYGIVLCEII-GRVPADPDY 323
M+ EY D++S G+VL EI G++P +
Sbjct: 191 ------------------------MLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE--- 223
Query: 324 LPRSPDFGLDQTDFRN---------KFCASCPEPFVRIAFLCCDLNPDQRP 365
L + + K CP I C + +RP
Sbjct: 224 -------NLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRP 267
|
Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 43/177 (24%), Positives = 73/177 (41%), Gaps = 40/177 (22%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
+L ++ H ++ I KL L+ EY++GG L L+ G F D A
Sbjct: 53 ILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGI---------FMEDTAC 103
Query: 211 --------GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLAR-IIHQGPRAPTTVMA 261
+ +LH +I+RDL +N L+ V + DFGL + IH+G
Sbjct: 104 FYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--------- 154
Query: 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVP 318
+T G +MAPE++ + + VD +S G ++ +++ P
Sbjct: 155 -------------TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAP 198
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 47/221 (21%), Positives = 80/221 (36%), Gaps = 23/221 (10%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+++ L H ++++ GV +D + +V EY+ G L L + +++ A+ +
Sbjct: 52 ASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQL 110
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
A+ + YL L+H ++ +N LV G K+
Sbjct: 111 ASALHYLEDKKLVHGNVCGKNILV----------------ARYGLNEGYVPFIKLSDPGI 154
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETV--DVFSYGIVLCEIIGRVPADPDYLPR 326
+ V P W+APE + + T+ D +S+G L EI L
Sbjct: 155 -PITVLSREERVERIP-WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212
Query: 327 SPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF 367
S Q R C E I C +P +RP F
Sbjct: 213 SEKERFYQDQHRLPM-PDCAELANLIN-QCWTYDPTKRPSF 251
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 41/176 (23%), Positives = 70/176 (39%), Gaps = 22/176 (12%)
Query: 138 KYGEACQNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLP 197
K G+ + +LR+++H ++I+ G ++ L+ L L + +
Sbjct: 123 KAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAK-RNIA 180
Query: 198 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPT 257
+ R + + YLH +IHRD+ ++N + V + DFG A P
Sbjct: 181 ICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACF-------PV 233
Query: 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI 313
+ A K Y G APE++ Y VD++S GIVL E+
Sbjct: 234 DINA-------------NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 26/77 (33%), Positives = 42/77 (54%), Gaps = 7/77 (9%)
Query: 175 LVTEYIAGGTLKELLQDPG---QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 231
LV EY+ GG +K LL G + + V + ++A + YLH +IHRDL N L
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMA----VKYISEVALALDYLHRHGIIHRDLKPDNML 136
Query: 232 VREDKTVVVADFGLARI 248
+ + + + DFGL+++
Sbjct: 137 ISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|188713 cd09327, LIM1_abLIM, The first LIM domain of actin binding LIM (abLIM) proteins | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 2e-06
Identities = 21/73 (28%), Positives = 29/73 (39%), Gaps = 21/73 (28%)
Query: 63 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVMLDNWY 122
C CG+ G V+ V D FH +CF C C C + G +
Sbjct: 1 CYKCGKKCKGEVLRVQDKYFHIKCFTCKVCGCDLAQG---------------------GF 39
Query: 123 FEKDGLLFCKEDY 135
F K+G +C +DY
Sbjct: 40 FVKEGEYYCTDDY 52
|
The first LIM domain of actin binding LIM (abLIM) proteins: Three homologous members of the abLIM protein family have been identified; abLIM-1, abLIM-2 and abLIM-3. The N-terminal of abLIM consists of four tandem repeats of LIM domains and the C-terminal of acting binding LIM protein is a villin headpiece domain, which has strong actin binding activity. The abLIM-1, which is expressed in retina, brain, and muscle tissue, has been indicated to function as a tumor suppressor. AbLIM-2 and -3, mainly expressed in muscle and neuronal tissue, bind to F-actin strongly. They may serve as a scaffold for signaling modules of the actin cytoskeleton and thereby modulate transcription. It has shown that LIM domains of abLIMs interact with STARS (striated muscle activator of Rho signaling), which directly binds actin and stimulates serum-response factor (SRF)-dependent transcription. All LIM domains are 50-60 amino acids in size and share two characteristic highly conserved zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 52/226 (23%), Positives = 94/226 (41%), Gaps = 29/226 (12%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPL--PWGQRVNFARD 207
+++R + H +++ GV +D + +V E++ G L + L PW + A+
Sbjct: 56 SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQ 113
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+A+ ++YL +L+H ++ ++N L+ + + + G I P P TV++
Sbjct: 114 LASALSYLEDKDLVHGNVCTKNILLAREG--IDGECG-PFIKLSDPGIPITVLS------ 164
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMT-GQEYDETVDVFSYGIVLCEII--GRVPADPDYL 324
R V W+APE + + D +S+G L EI G +P L
Sbjct: 165 ---------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215
Query: 325 PRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
F Q SC E + C + +P+QRP F +
Sbjct: 216 AEKERFYEGQCML---VTPSCKE-LADLMTHCMNYDPNQRPFFRAI 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|214528 smart00132, LIM, Zinc-binding domain present in Lin-11, Isl-1, Mec-3 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-06
Identities = 16/54 (29%), Positives = 27/54 (50%), Gaps = 3/54 (5%)
Query: 63 CQNCGQMMSG--PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSAC 114
C CG+ + G V+ +HPECFKC +C + G+++ + + C C
Sbjct: 2 CAGCGKPIYGTERVLRALGKVWHPECFKCATCGKPLS-GDTFFEKDGKLYCKDC 54
|
Zinc-binding domain family. Some LIM domains bind protein partners via tyrosine-containing motifs. LIM domains are found in many key regulators of developmental pathways. Length = 54 |
| >gnl|CDD|188716 cd09330, LIM4_abLIM, The fourth LIM domain of actin binding LIM (abLIM) proteins | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 5e-06
Identities = 13/38 (34%), Positives = 22/38 (57%)
Query: 63 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGE 100
C+ C + ++G V+ G +HP C +C+ C G+GE
Sbjct: 1 CEACDKFITGKVLEAGGKHYHPTCARCSRCGQMFGEGE 38
|
The fourth LIM domain of actin binding LIM (abLIM) proteins: Three homologous members of the abLIM protein family have been identified; abLIM-1, abLIM-2 and abLIM-3. The N-terminal of abLIM consists of four tandem repeats of LIM domains and the C-terminal of acting binding LIM protein is a villin headpiece domain, which has strong actin binding activity. The abLIM-1, which is expressed in retina, brain, and muscle tissue, has been indicated to function as a tumor suppressor. AbLIM-2 and -3, mainly expressed in muscle and neuronal tissue, bind to F-actin strongly. They may serve as a scaffold for signaling modules of the actin cytoskeleton and thereby modulate transcription. It has shown that LIM domains of abLIMs interact with STARS (striated muscle activator of Rho signaling), which directly binds actin and stimulates serum-response factor (SRF)-dependent transcription. All LIM domains are 50-60 amino acids in size and share two characteristic highly conserved zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 56 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 54/241 (22%), Positives = 93/241 (38%), Gaps = 72/241 (29%)
Query: 160 VIRFIGVLYKDRKLNLVTEYIAGGTLKEL----LQDPGQPLPWGQRVNFARDIAAGMTYL 215
++ F G + + + + EY+ G+L +L + G P +R+ +A + G+ +L
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA--VVKGLKFL 118
Query: 216 -HSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGAR 274
N+IHRD+ N LV + V + DFG++ ++A + +
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS----------GNLVASLAK--------- 159
Query: 275 KKRYTVVGNPYWMAPEMMTGQ------EYDETVDVFSYGIVLCEI-IGRVP--------- 318
T +G +MAPE + Y DV+S G+ + E+ +GR P
Sbjct: 160 ----TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI 215
Query: 319 ---------ADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEV 369
DP LP + D DF K C + P++RP +
Sbjct: 216 FAQLSAIVDGDPPTLP--SGYSDDAQDFVAK---------------CLNKIPNRRPTYAQ 258
Query: 370 L 370
L
Sbjct: 259 L 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 39/144 (27%), Positives = 65/144 (45%), Gaps = 25/144 (17%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 231
KL + + + GG L L G R +A +I G+ ++H+ +++RDL N L
Sbjct: 71 KLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMHNRFVVYRDLKPANIL 129
Query: 232 VREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM 291
+ E V ++D GLA ++KK + VG +MAPE+
Sbjct: 130 LDEHGHVRISDLGLACDF-----------------------SKKKPHASVGTHGYMAPEV 166
Query: 292 M-TGQEYDETVDVFSYGIVLCEII 314
+ G YD + D FS G +L +++
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 8e-06
Identities = 38/149 (25%), Positives = 67/149 (44%), Gaps = 25/149 (16%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 231
+L V E++ GG L +Q + + +A +I + + +LH +I+RDL N L
Sbjct: 70 RLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVL 128
Query: 232 VREDKTVVVADFGLARI-IHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPE 290
+ + +ADFG+ + I G K T G P ++APE
Sbjct: 129 LDHEGHCKLADFGMCKEGIFNG----------------------KTTSTFCGTPDYIAPE 166
Query: 291 MMTGQEYDETVDVFSYGIVLCEII-GRVP 318
++ Y +VD ++ G++L E++ G P
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|188847 cd09463, LIM1_LIMK2, The first LIM domain of LIMK2 (LIM domain Kinase 2) | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 1e-05
Identities = 14/25 (56%), Positives = 18/25 (72%)
Query: 31 CSACDVMLDNWYFEKDGLLFCKEDY 55
CS C +L NWY+EKDG L+C + Y
Sbjct: 28 CSVCQDLLTNWYYEKDGKLYCHKHY 52
|
The first LIM domain of LIMK2 (LIM domain Kinase 2): LIMK2 is a member of the LIMK protein family, which comprises LIMK1 and LIMK2. LIMK contains two LIM domains, a PDZ domain, and a kinase domain. LIMK is involved in the regulation of actin polymerization and microtubule disassembly. LIMK influences architecture of the actin cytoskeleton by regulating the activity of the cofilin family proteins cofilin1, cofilin2, and destrin. The mechanism of the activation is to phosphorylates cofilin on serine 3 and inactivates its actin-severing activity, altering the rate of actin depolymerization. LIMK activity is activated by phosphorylation of a threonine residue within the activation loop of the kinase by p21-activated kinases 1 and 4 and by Rho kinase. LIMKs can function in both cytoplasm and nucleus. Both LIMK1 and LIMK2 can act in the nucleus to suppress Rac/Cdc42-dependent cyclin D1 expression. LIMK2 is expressed in all tissues. While LIMK1 localizes mainly at focal adhesions, LIMK2 is found in cytoplasmic punctae, suggesting that they may have different cellular functions. The activity of LIM kinase 2 to regulate cofilin phosphorylation is inhibited by the direct binding of Par-3. LIMK2 activation promotes cell cycle progression. The phenotype of Limk2 knockout mice shows a defect in spermatogenesis. The LIM domains have been shown to play an important role in regulating kinase activity and likely also contribute to LIMK function by acting as sites of protein-to-protein interactions. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 53 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 31/112 (27%), Positives = 54/112 (48%), Gaps = 24/112 (21%)
Query: 204 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263
+A +I G+ ++H+ +++RDL N L+ E V ++D GLA
Sbjct: 102 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF-------------- 147
Query: 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMT-GQEYDETVDVFSYGIVLCEII 314
++KK + VG +MAPE++ G YD + D FS G +L +++
Sbjct: 148 ---------SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 22/74 (29%), Positives = 37/74 (50%), Gaps = 10/74 (13%)
Query: 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 234
+V EYI G LK++L+ R + + LH ++H DL + N +VR+
Sbjct: 413 IVMEYIGGKDLKDVLEG---------NPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVRD 463
Query: 235 DKTVVVADFGLARI 248
D+ ++ DFGL +
Sbjct: 464 DRLYLI-DFGLGKY 476
|
Length = 535 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 38/156 (24%), Positives = 67/156 (42%), Gaps = 28/156 (17%)
Query: 170 DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 229
+ L LV +Y GG L LL LP + ++ + +H ++ +HRD+ N
Sbjct: 73 ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDN 132
Query: 230 CLVREDKTVVVADFG-LARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMA 288
L+ + + +ADFG +++ G TV + V VG P +++
Sbjct: 133 ILMDMNGHIRLADFGSCLKLMEDG-----TVQSSV----------------AVGTPDYIS 171
Query: 289 PEMMTGQE-----YDETVDVFSYGIVLCEII-GRVP 318
PE++ E Y D +S G+ + E++ G P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 43/182 (23%), Positives = 74/182 (40%), Gaps = 42/182 (23%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDR----------KLNLVTEYIAGGTLKELLQDPGQPLP 197
++ +L+++ H +I I Y+ + K +L T Y+ D PLP
Sbjct: 136 EIDILKTISHRAIINLIHA-YRWKSTVCMVMPKYKCDLFT-YV----------DRSGPLP 183
Query: 198 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPT 257
Q + R + + YLH +IHRD+ ++N + E + V+ DFG A + P P
Sbjct: 184 LEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP- 242
Query: 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI-IGR 316
+ Y G +PE++ Y D++S G+VL E+ +
Sbjct: 243 ------------------QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKN 284
Query: 317 VP 318
V
Sbjct: 285 VT 286
|
Length = 392 |
| >gnl|CDD|188846 cd09462, LIM1_LIMK1, The first LIM domain of LIMK1 (LIM domain Kinase 1) | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-05
Identities = 23/55 (41%), Positives = 28/55 (50%), Gaps = 11/55 (20%)
Query: 89 CTSCSCCIGDGES--------YALVERSILCSACDVMLDNWYFEKDGLLFCKEDY 135
C SC I DG+ +A R C C L +WY+EKDG LFCK+DY
Sbjct: 22 CASCGQSIYDGQYLQALNSDWHADCFR---CCECGASLSHWYYEKDGRLFCKKDY 73
|
The first LIM domain of LIMK1 (LIM domain Kinase 1): LIMK1 belongs to the LIMK protein family, which comprises LIMK1 and LIMK2. LIMK contains two LIM domains, a PDZ domain, and a kinase domain. LIMK is involved in the regulation of actin polymerization and microtubule disassembly. LIMK influences architecture of the actin cytoskeleton by regulating the activity of the cofilin family proteins cofilin1, cofilin2, and destrin. The mechanism of the activation is to phosphorylates cofilin on serine 3 and inactivates its actin-severing activity, and altering the rate of actin depolymerization. LIMKs can function in both cytoplasm and nucleus. Both LIMK1 and LIMK2 can act in the nucleus to suppress Rac/Cdc42-dependent cyclin D1 expression. LIMK1 is expressed in all tissues and is localized to focal adhesions in the cell. LIMK1 can form homodimers upon binding of HSP90 and is activated by Rho effector Rho kinase and MAPKAPK2. LIMK1 is important for normal central nervous system development, and its deletion has been implicated in the development of the human genetic disorder Williams syndrome. Moreover, LIMK1 up-regulates the promoter activity of urokinase type plasminogen activator and induces its mRNA and protein expression in breast cancer cells. The LIM domains have been shown to play an important role in regulating kinase activity and likely also contribute to LIMK function by acting as sites of protein-to-protein interactions. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 74 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 20/74 (27%), Positives = 35/74 (47%), Gaps = 9/74 (12%)
Query: 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 234
+V EYI G LK+ L++ R + R++ + LH ++H DL + N ++
Sbjct: 76 IVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSG 127
Query: 235 DKTVVVADFGLARI 248
+ + DFGL
Sbjct: 128 GRIYFI-DFGLGEF 140
|
Length = 204 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 24/148 (16%)
Query: 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQR-VNFARDIAAGMTYLHSMNLIHRDLNSQNCL 231
L LV + GG LK + + G P QR + +A ++ G+ L +++RDL +N L
Sbjct: 75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENIL 134
Query: 232 VREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM 291
+ + + ++D GLA I +G RG VG +MAPE+
Sbjct: 135 LDDRGHIRISDLGLAVQIPEGETV---------------RGR-------VGTVGYMAPEV 172
Query: 292 MTGQEYDETVDVFSYGIVLCEII-GRVP 318
+ ++Y + D + G ++ E+I G+ P
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 30/114 (26%), Positives = 50/114 (43%), Gaps = 22/114 (19%)
Query: 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQR 270
+ Y+H+ N+ HRDL +N L D + + DFGLAR+ PT +
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN--DTPTAIF---------- 162
Query: 271 RGARKKRYT-VVGNPYWMAPEMMTG--QEYDETVDVFSYGIVLCEIIGRVPADP 321
+T V ++ APE+ +Y +D++S G + E++ P P
Sbjct: 163 -------WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 209
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|188714 cd09328, LIM2_abLIM, The second LIM domain on actin binding LIM (abLIM) proteins | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 3e-05
Identities = 15/55 (27%), Positives = 23/55 (41%)
Query: 60 GEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSAC 114
G C +C + G V+ +HP+CF C+ C G+ + LC C
Sbjct: 1 GTKCDSCQDFVEGEVVSALGKTYHPKCFVCSVCRQPFPPGDRVTFNGKECLCQKC 55
|
The second LIM domain of actin binding LIM (abLIM) proteins: Three homologous members of the abLIM protein family have been identified; abLIM-1, abLIM-2 and abLIM-3. The N-terminal of abLIM consists of four tandem repeats of LIM domains and the C-terminal of acting binding LIM protein is a villin headpiece domain, which has strong actin binding activity. The abLIM-1, which is expressed in retina, brain, and muscle tissue, has been indicated to function as a tumor suppressor. AbLIM-2 and -3, mainly expressed in muscle and neuronal tissue, bind to F-actin strongly. They may serve as a scaffold for signaling modules of the actin cytoskeleton and thereby modulate transcription. It has shown that LIM domains of abLIMs interact with STARS (striated muscle activator of Rho signaling), which directly binds actin and stimulates serum-response factor (SRF)-dependent transcription. All LIM domains are 50-60 amino acids in size and share two characteristic highly conserved zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 56 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 55/232 (23%), Positives = 90/232 (38%), Gaps = 36/232 (15%)
Query: 148 QVAVLRSLHHHNVIRFI-GVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
+ A L S H + F+ GV + + +V E++ G L L+ +P ++ A+
Sbjct: 65 ETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQ 124
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLAR-----IIHQGPRAPTTVMA 261
+A+ ++YL NL+H ++ ++N +++A GLA I P T ++
Sbjct: 125 QLASALSYLEDKNLVHGNVCAKN--------ILLARLGLAEGTSPFIKLSDPGVSFTALS 176
Query: 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMM-TGQEYDETVDVFSYGIVLCEII--GRVP 318
+ R V W+APE + G D +S+G L EI G VP
Sbjct: 177 REER---------------VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP 221
Query: 319 ADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
F + SC E I+ C P QRP F +
Sbjct: 222 LKERTPSEKERFYEKKHRLPE---PSCKELATLIS-QCLTYEPTQRPSFRTI 269
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|188778 cd09392, LIM2_Lrg1p_like, The second LIM domain of Lrg1p, a LIM and RhoGap domain containing protein | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 3e-05
Identities = 16/50 (32%), Positives = 21/50 (42%)
Query: 63 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCS 112
C CG + G + K+H E F C+ C G +SY E I C
Sbjct: 1 CFKCGGALRGSYITALGRKYHVEHFTCSVCPTVFGPNDSYYEHEGKIYCH 50
|
The second LIM domain of Lrg1p, a LIM and RhoGap domain containing protein: The members of this family contain three tandem repeats of LIM domains and a Rho-type GTPase activating protein (RhoGap) domain. Lrg1p is a Rho1 GTPase-activating protein required for efficient cell fusion in yeast. Lrg1p-GAP domain strongly and specifically stimulates the GTPase activity of Rho1p, a regulator of beta (1-3)-glucan synthase in vitro. The LIM domain is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 53 |
| >gnl|CDD|188846 cd09462, LIM1_LIMK1, The first LIM domain of LIMK1 (LIM domain Kinase 1) | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-05
Identities = 15/25 (60%), Positives = 18/25 (72%)
Query: 31 CSACDVMLDNWYFEKDGLLFCKEDY 55
C C L +WY+EKDG LFCK+DY
Sbjct: 49 CCECGASLSHWYYEKDGRLFCKKDY 73
|
The first LIM domain of LIMK1 (LIM domain Kinase 1): LIMK1 belongs to the LIMK protein family, which comprises LIMK1 and LIMK2. LIMK contains two LIM domains, a PDZ domain, and a kinase domain. LIMK is involved in the regulation of actin polymerization and microtubule disassembly. LIMK influences architecture of the actin cytoskeleton by regulating the activity of the cofilin family proteins cofilin1, cofilin2, and destrin. The mechanism of the activation is to phosphorylates cofilin on serine 3 and inactivates its actin-severing activity, and altering the rate of actin depolymerization. LIMKs can function in both cytoplasm and nucleus. Both LIMK1 and LIMK2 can act in the nucleus to suppress Rac/Cdc42-dependent cyclin D1 expression. LIMK1 is expressed in all tissues and is localized to focal adhesions in the cell. LIMK1 can form homodimers upon binding of HSP90 and is activated by Rho effector Rho kinase and MAPKAPK2. LIMK1 is important for normal central nervous system development, and its deletion has been implicated in the development of the human genetic disorder Williams syndrome. Moreover, LIMK1 up-regulates the promoter activity of urokinase type plasminogen activator and induces its mRNA and protein expression in breast cancer cells. The LIM domains have been shown to play an important role in regulating kinase activity and likely also contribute to LIMK function by acting as sites of protein-to-protein interactions. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 74 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 56/217 (25%), Positives = 80/217 (36%), Gaps = 77/217 (35%)
Query: 185 LKELLQDPGQPLPWGQRVNFARDIAAGMTY-----LHSM----NLIHRDLNSQNCLVRED 235
L +LL+ P+P DI MT LH + +IHRD+ N L+
Sbjct: 100 LDKLLKRIQGPIP--------EDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDAS 151
Query: 236 KTVVVADFGLA-RIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG 294
V + DFG++ R++ AK R A G +MAPE +
Sbjct: 152 GNVKLCDFGISGRLVDS--------KAKT-------RSA--------GCAAYMAPERIDP 188
Query: 295 Q----EYDETVDVFSYGIVLCEII-GRVP----------------ADPDYLPRSPDFGLD 333
+YD DV+S GI L E+ G+ P +P LP + F D
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD 248
Query: 334 QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
FC+ FV LC + +RP + L
Sbjct: 249 -------FCS-----FVD---LCLTKDHRKRPKYREL 270
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|188773 cd09387, LIM2_LMO4, The second LIM domain of LMO4 (LIM domain only protein 4) | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 7e-05
Identities = 16/51 (31%), Positives = 26/51 (50%), Gaps = 2/51 (3%)
Query: 63 CQNCGQMM--SGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILC 111
C CGQ + S VM + +H +CF C++C + G+ + V S+ C
Sbjct: 1 CSACGQSIPASELVMRAQGNVYHLKCFTCSTCHNQLVPGDRFHYVNGSLFC 51
|
The second LIM domain of LMO4 (LIM domain only protein 4): LMO4 is a nuclear protein that plays important roles in transcriptional regulation and development. LMO4 is involved in various functions in tumorigenesis and cellular differentiation. LMO4 proteins regulate gene expression by interacting with a wide variety of transcription factors and cofactors to form large transcription complexes. It can interact with Smad proteins, and associate with the promoter of the PAI-1 (plasminogen activator inhibitor-1) gene in a TGFbeta (transforming growth factor beta)-dependent manner. LMO4 can also form a complex with transcription regulator CREB (cAMP response element-binding protein) and interact with CLIM1 and CLIM2. In breast tissue, LMO4 interacts with multiple proteins, including the cofactor CtIP [CtBP (C-terminal binding protein)-interacting protein], the breast and ovarian tumor suppressor BRCA1 (breast-cancer susceptibility gene 1) and the LIM-domain-binding protein LDB1. Functionally, LMO4 is shown to repress BRCA1-mediated transcription activation, thus invoking a potential role for LMO4 as a negative regulator of BRCA1 in sporadic breast cancer. LMO4 also forms complex to both ERa (oestrogen receptor alpha), MTA1 (metastasis tumor antigen 1), and HDACs (histone deacetylases), implying that LMO4 is also a component of the MTA1 corepressor complex. Over-expressed LMO4 represses ERa transactivation functions in an HDAC-dependent manner, and contributes to the process of breast cancer progression by allowing the development of Era-negative phenotypes. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 55 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 36/155 (23%), Positives = 65/155 (41%), Gaps = 26/155 (16%)
Query: 170 DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 229
+ L LV +Y GG L LL LP + ++ + +H ++ +HRD+ N
Sbjct: 73 ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDN 132
Query: 230 CLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAP 289
L+ + + +ADFG ++Q ++V VG P +++P
Sbjct: 133 VLLDMNGHIRLADFGSCLKMNQDGTVQSSV--------------------AVGTPDYISP 172
Query: 290 EMMTGQE-----YDETVDVFSYGIVLCEII-GRVP 318
E++ E Y D +S G+ + E++ G P
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 17/47 (36%), Positives = 24/47 (51%)
Query: 284 PYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF 330
PY+MAPE++ GQ Y E D++S GI L E + + S
Sbjct: 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAIL 114
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|188758 cd09372, LIM2_FBLP-1, The second LIM domain of the filamin-binding LIM protein-1 (FBLP-1) | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 1e-04
Identities = 15/44 (34%), Positives = 24/44 (54%), Gaps = 1/44 (2%)
Query: 63 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVE 106
C C +++ ++ +HP CF C +C IGD ES+A+ E
Sbjct: 1 CAKCQGVITEHIIRALGKGYHPPCFTCVTCGRRIGD-ESFAVDE 43
|
The second LIM domain of the filamin-binding LIM protein-1 (FBLP-1): Fblp-1 contains a proline-rich domain near its N terminus and two LIM domains at its C terminus. FBLP-1 mRNA was detected in a variety of tissues and cells including platelets and endothelial cells. FBLP-1 binds to Filamins. The association between filamin B and FBLP-1 may play an unknown role in cytoskeletal function, cell adhesion, and cell motility. As in other LIM domains, this domain family is 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 53 |
| >gnl|CDD|188855 cd09471, LIM2_Isl2, The second LIM domain of Isl2 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 2e-04
Identities = 19/53 (35%), Positives = 26/53 (49%), Gaps = 2/53 (3%)
Query: 63 CQNCGQMMSGP--VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSA 113
C C S VM D +H ECF+C+ CS + G+ + L E +LC A
Sbjct: 1 CAQCRLGFSSSDLVMRARDSVYHIECFRCSVCSRQLLPGDEFCLREHELLCRA 53
|
The second LIM domain of Isl2: Isl is a member of LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs, such as the pituitary gland and the pancreas. Isl proteins are found in the nucleus and act as transcription factors or cofactors. Isl1 and Isl2 are the two conserved members of this family. Mouse Isl2 is expressed in the retinal ganglion cells and the developing spinal cord where it plays a role in motor neuron development. Isl2 may be able to bind to the insulin gene enhancer to promote gene activation. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 55 |
| >gnl|CDD|188760 cd09374, LIM2_Isl, The second LIM domain of Isl, a member of LHX protein family | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 2e-04
Identities = 18/53 (33%), Positives = 27/53 (50%), Gaps = 2/53 (3%)
Query: 63 CQNCGQMMSGP--VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSA 113
C C Q S VM +H ECF+C++CS + G+ +AL + + C A
Sbjct: 1 CAKCQQSFSKNDFVMRARTKIYHIECFRCSACSRQLIPGDEFALRDDGLFCKA 53
|
The second LIM domain of Isl: Isl is a member of LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Isl1 and Isl2 are the two conserved members of this family. Proteins in this group are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs, such as the pituitary gland and the pancreas. Isl-1 is one of the LHX proteins isolated originally by virtue of its ability to bind DNA sequences from the 5'-flanking region of the rat insulin gene in pancreatic insulin-producing cells. Mice deficient in Isl-1 fail to form the dorsal exocrine pancreas and islet cells fail to differentiate. On the other hand, Isl-1 takes part in the pituitary development by activating the gonadotropin-releasing hormone receptor gene together with LHX3 and steroidogenic factor 1. Mouse Isl2 is expressed in the retinal ganglion cells and the developing spinal cord where it plays a role in motor neuron development. Same as Isl1, Isl2 may also be able to bind to the insulin gene enhancer to promote gene activation. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 55 |
| >gnl|CDD|188784 cd09400, LIM_like_1, LIM domain in proteins of unknown function | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 2e-04
Identities = 15/55 (27%), Positives = 22/55 (40%), Gaps = 1/55 (1%)
Query: 61 EACQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSAC 114
E C +CG + +++ +H CFKC C + G Y S C C
Sbjct: 3 EPCASCGLPVFLAERLLIEGKVYHRTCFKCARCGVQLTPGSFYETEYGSYCCETC 57
|
LIM domain in proteins of unknown function: LIM domains are identified in a diverse group of proteins with wide variety of biological functions, including gene expression regulation, cell fate determination, cytoskeleton organization, tumor formation, and development. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. They perform their functions through interactions with other protein partners. The LIM domains are 50-60 amino acids in size and share two characteristic highly conserved zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. The consensus sequence of LIM domain has been defined as C-x(2)-C-x(16,23)-H-x(2)-[CH]-x(2)-C-x(2)-C-x(16, 21)-C-x(2,3)-[CHD] (where X denotes any amino acid). Length = 61 |
| >gnl|CDD|188757 cd09371, LIM1_Lmx1b, The first LIM domain of Lmx1b | Back alignment and domain information |
|---|
Score = 37.7 bits (88), Expect = 4e-04
Identities = 17/74 (22%), Positives = 32/74 (43%), Gaps = 23/74 (31%)
Query: 63 CQNCGQMMSGP-VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVMLDNW 121
C C + +S ++ V + +H EC +C+ C + L ++C
Sbjct: 1 CAGCQRPISDRYLLRVNERSWHEECLQCSVC--------------QQPLTTSC------- 39
Query: 122 YFEKDGLLFCKEDY 135
+ +D L+CK+DY
Sbjct: 40 -YFRDRKLYCKQDY 52
|
The first LIM domain of Lmx1b: Lmx1b belongs to the LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Members of LHX family are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs, such as the pituitary gland and the pancreas. In mouse, Lmx1b functions in the developing limbs and eyes, the kidneys, the brain, and in cranial mesenchyme. The disruption of Lmx1b gene results kidney and limb defects. In the brain, Lmx1b is important for generation of mesencephalic dopamine neurons and the differentiation of serotonergic neurons. In the mouse eye, Lmx1b regulates anterior segment (cornea, iris, ciliary body, trabecular meshwork, and lens) development. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 53 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 39/156 (25%), Positives = 67/156 (42%), Gaps = 28/156 (17%)
Query: 170 DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 229
+ L LV +Y GG L LL LP + ++ + +H + +HRD+ N
Sbjct: 73 ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDN 132
Query: 230 CLVREDKTVVVADFG-LARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMA 288
L+ ++ + +ADFG R++ G TV + V VG P +++
Sbjct: 133 VLLDKNGHIRLADFGSCLRLLADG-----TVQSNV----------------AVGTPDYIS 171
Query: 289 PEMMTGQE-----YDETVDVFSYGIVLCEII-GRVP 318
PE++ E Y D +S G+ + E++ G P
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|188746 cd09360, LIM_ALP_like, The LIM domain of ALP (actinin-associated LIM protein) family | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 6e-04
Identities = 13/30 (43%), Positives = 15/30 (50%)
Query: 63 CQNCGQMMSGPVMVVGDHKFHPECFKCTSC 92
C CG + G V+ D HPECF C C
Sbjct: 1 CDKCGNGIVGVVVKARDKNRHPECFVCADC 30
|
This family represents the LIM domain of ALP (actinin-associated LIM protein) family. Four proteins: ALP, CLP36, RIL, and Mystique have been classified into the ALP subfamily of LIM domain proteins. Each member of the subfamily contains an N-terminal PDZ domain and a C-terminal LIM domain. Functionally, these proteins bind to alpha-actinin through their PDZ domains and bind or other signaling molecules through their LIM domains. ALP proteins have been implicated in cardiac and skeletal muscle structure, function and disease, platelet, and epithelial cell motility. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 47/194 (24%), Positives = 85/194 (43%), Gaps = 28/194 (14%)
Query: 133 EDYNGKYGEACQNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP 192
E+ ++ +A QN +V + H N++ V L +++ ++A G+ LL+
Sbjct: 36 ENCTEEHLKALQN--EVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTY 93
Query: 193 GQPLPWGQRVNFARDI----AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFG-LAR 247
P G +I G+ YLH IHR++ + + L+ D V ++ L
Sbjct: 94 ---FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYS 150
Query: 248 IIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETV--DVFS 305
++ G +A V+ P +++ P W++PE++ Y V D++S
Sbjct: 151 LVRNGQKA--KVVYDFP------------QFSTSVLP-WLSPELLRQDLYGYNVKSDIYS 195
Query: 306 YGIVLCEII-GRVP 318
GI CE+ GRVP
Sbjct: 196 VGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|188781 cd09395, LIM2_Rga, The second LIM domain of Rga GTPase-Activating Proteins | Back alignment and domain information |
|---|
Score = 36.7 bits (85), Expect = 0.001
Identities = 17/53 (32%), Positives = 29/53 (54%), Gaps = 2/53 (3%)
Query: 63 CQNCGQMMSG-PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSAC 114
C+NCG+ + +++ D + +CF+C CS I D YA +R + C +C
Sbjct: 1 CKNCGKKIDDTAILLSSDEAYCSDCFRCRRCSRDITD-LKYAKTKRGLFCMSC 52
|
The second LIM domain of Rga GTPase-Activating Proteins: The members of this family contain two tandem repeats of LIM domains and a Rho-type GTPase activating protein (RhoGap) domain. Rga activates GTPases during polarized morphogenesis. In yeast, a known regulating target of Rga is CDC42p, a small GTPase. The LIM domain is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 53 |
| >gnl|CDD|188718 cd09332, LIM2_PINCH, The second LIM domain of protein PINCH | Back alignment and domain information |
|---|
Score = 36.2 bits (84), Expect = 0.001
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 63 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGD 98
C CG+ + G V+ ++ +HP+CF+C C+ + D
Sbjct: 1 CGKCGEFVIGRVIKAMNNNWHPDCFRCEICNKELAD 36
|
The second LIM domain of protein PINCH: PINCH plays a pivotal role in the assembly of focal adhesions (FAs), regulating diverse functions in cell adhesion, growth, and differentiation through LIM-mediated protein-protein interactions. PINCH comprises an array of five LIM domains that interact with integrin-linked kinase (ILK), Nck2 (also called Nckbeta or Grb4) and other interaction partners. These interactions are essential for triggering the FA assembly and for relaying diverse mechanical and biochemical signals between Cell-extracellular matrix and the actin cytoskeleton. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
| >gnl|CDD|188715 cd09329, LIM3_abLIM, The third LIM domain of actin binding LIM (abLIM) proteins | Back alignment and domain information |
|---|
Score = 36.1 bits (84), Expect = 0.002
Identities = 20/74 (27%), Positives = 29/74 (39%), Gaps = 23/74 (31%)
Query: 63 CQNCGQMM-SGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVMLDNW 121
C CGQ + +G ++ D ++H CFKC C +L
Sbjct: 1 CAGCGQEIKNGQALLALDKQWHVWCFKCKECGK----------------------VLTGE 38
Query: 122 YFEKDGLLFCKEDY 135
Y KDG +C+ DY
Sbjct: 39 YMGKDGKPYCERDY 52
|
The third LIM domain of actin binding LIM (abLIM) proteins: Three homologous members of the abLIM protein family have been identified; abLIM-1, abLIM-2 and abLIM-3. The N-terminal of abLIM consists of four tandem repeats of LIM domains and the C-terminal of acting binding LIM protein is a villin headpiece domain, which has strong actin binding activity. The abLIM-1, which is expressed in retina, brain, and muscle tissue, has been indicated to function as a tumor suppressor. AbLIM-2 and -3, mainly expressed in muscle and neuronal tissue, bind to F-actin strongly. They may serve as a scaffold for signaling modules of the actin cytoskeleton and thereby modulate transcription. It has shown that LIM domains of abLIMs interact with STARS (striated muscle activator of Rho signaling), which directly binds actin and stimulates serum-response factor (SRF)-dependent transcription. All LIM domains are 50-60 amino acids in size and share two characteristic highly conserved zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 16/41 (39%), Positives = 24/41 (58%)
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLA 246
R + G+ LH + ++HRD+ +N LV D V + DFG A
Sbjct: 316 RQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|188765 cd09379, LIM2_AWH, The second LIM domain of Arrowhead (AWH) | Back alignment and domain information |
|---|
Score = 35.9 bits (83), Expect = 0.002
Identities = 15/35 (42%), Positives = 21/35 (60%)
Query: 79 DHKFHPECFKCTSCSCCIGDGESYALVERSILCSA 113
DH +H CF C +C + GE +AL+E +LC A
Sbjct: 19 DHVYHLACFACDACKRQLSTGEEFALIEDRVLCKA 53
|
The second LIM domain of Arrowhead (AWH): Arrowhead belongs to the LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Members of LHX family are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs such as the pituitary gland and the pancreas. During embryogenesis of Drosophila, Arrowhead is expressed in each abdominal segment and in the labial segment. Late in embryonic development, expression of arrowhead is refined to the abdominal histoblasts and salivary gland imaginal ring cells themselves. The Arrowhead gene required for establishment of a subset of imaginal tissues: the abdominal histoblasts and the salivary gland imaginal rings. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 55 |
| >gnl|CDD|188790 cd09406, LIM1_Leupaxin, The first LIM domain of Leupaxin | Back alignment and domain information |
|---|
Score = 36.0 bits (83), Expect = 0.002
Identities = 18/74 (24%), Positives = 31/74 (41%), Gaps = 21/74 (28%)
Query: 63 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVMLDNWY 122
C +C + ++G V+ +HPE F C C +G +
Sbjct: 3 CASCQKPIAGQVVTALGQTWHPEHFVCCQCGKELGSRP---------------------F 41
Query: 123 FEKDGLLFCKEDYN 136
FE++G +C+EDY+
Sbjct: 42 FERNGQAYCEEDYH 55
|
The first LIM domain of Leupaxin: Leupaxin is a cytoskeleton adaptor protein, which is preferentially expressed in hematopoietic cells. Leupaxin belongs to the paxillin focal adhesion protein family. Same as other members of the family, it has four leucine-rich LD-motifs in the N-terminus and four LIM domains in the C-terminus. It may function in cell type-specific signaling by associating with interaction partners PYK2, FAK, PEP and p95PKL. When expressed in human leukocytic cells, leupaxin significantly suppressed integrin-mediated cell adhesion to fibronectin and the tyrosine phosphorylation of paxillin. These findings indicate that leupaxin may negatively regulate the functions of paxillin during integrin signaling. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 55 |
| >gnl|CDD|188722 cd09336, LIM1_Paxillin_like, The first LIM domain of the paxillin like protein family | Back alignment and domain information |
|---|
Score = 35.4 bits (82), Expect = 0.003
Identities = 18/74 (24%), Positives = 29/74 (39%), Gaps = 21/74 (28%)
Query: 63 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVMLDNWY 122
C C + + G V+ +HPE F C C +G +
Sbjct: 1 CAACKKPIVGQVVTALGKTWHPEHFVCAECKTELG---------------------TKNF 39
Query: 123 FEKDGLLFCKEDYN 136
FE+DG +C++DY+
Sbjct: 40 FERDGQPYCEKDYH 53
|
The first LIM domain of the paxillin like protein family: This family consists of paxillin, leupaxin, Hic-5 (ARA55), and other related proteins. There are four LIM domains in the C-terminal of the proteins and leucine-rich LD-motifs in the N-terminal region. Members of this family are adaptor proteins to recruit key components of signal-transduction machinery to specific sub-cellular locations. Paxillin is found at the interface between the plasma membrane and the actin cytoskeleton. Paxillin serves as a platform for the recruitment of numerous regulatory and structural proteins that together control the dynamic changes in cell adhesion, cytoskeletal reorganization and gene expression that are necessary for cell migration and survival. Leupaxin is a cytoskeleton adaptor protein, which is preferentially expressed in hematopoietic cells. It associates with focal adhesion kinases PYK2 and pp125FAK and identified to be a component of the osteoclast pososomal signaling complex. Hic-5 controls cell proliferation, migration and senescence by functioning as coactivator for steroid receptors such as androgen receptor, glucocorticoid receptor and progesterone receptor. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 53 |
| >gnl|CDD|188769 cd09383, LIM2_Lhx7_Lhx8, The second LIM domain of Lhx7 and Lhx8 | Back alignment and domain information |
|---|
Score = 35.8 bits (82), Expect = 0.003
Identities = 18/51 (35%), Positives = 25/51 (49%), Gaps = 2/51 (3%)
Query: 63 CQNCGQMMSGP--VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILC 111
C CG+ + V + +H CF C SC + GE +ALVE +LC
Sbjct: 1 CSRCGRHIHSTDWVRRAKGNVYHLACFACFSCKRQLSTGEEFALVEEKVLC 51
|
The second LIM domain of Lhx7 and Lhx8: Lhx7 and Lhx8 belong to the LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Members of LHX family are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs such as the pituitary gland and the pancreas. Studies using mutant mice have revealed roles for Lhx7 and Lhx8 in the development of cholinergic neurons in the telencephalon and in basal forebrain development. Mice lacking alleles of the LIM-homeobox gene Lhx7 or Lhx8 display dramatically reduced number of forebrain cholinergic neurons. In addition, Lhx7 mutation affects male and female mice differently, with females appearing more affected than males. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 55 |
| >gnl|CDD|188768 cd09382, LIM2_Lhx6, The second LIM domain of Lhx6 | Back alignment and domain information |
|---|
Score = 35.4 bits (81), Expect = 0.003
Identities = 18/51 (35%), Positives = 25/51 (49%), Gaps = 2/51 (3%)
Query: 63 CQNCGQMM--SGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILC 111
C CG+ + S V + +H CF C SC + GE + LVE +LC
Sbjct: 1 CARCGRQIYASDWVRRARGNAYHLACFACFSCKRQLSTGEEFGLVEEKVLC 51
|
The second LIM domain of Lhx6. Lhx6 is a member of LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Members of LHX family are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs such as the pituitary gland and the pancreas. Lhx6 functions in brain and nervous system. It is expressed at high levels in several regions of the embryonic mouse CNS, including the telencephalon and hypothalamus, and the first branchial arch. Lhx6 is proposed to have a role in patterning of the mandible and maxilla, and in signaling during odontogenesis. In brain sections, knockdown of Lhx6 gene blocks the normal migration of neurons to the cortex. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 55 |
| >gnl|CDD|188726 cd09340, LIM1_Testin_like, The first LIM domain of Testin-like family | Back alignment and domain information |
|---|
Score = 35.3 bits (82), Expect = 0.004
Identities = 20/79 (25%), Positives = 30/79 (37%), Gaps = 27/79 (34%)
Query: 63 CQNCGQMMS-GPVMVVGDHK-----FHPECFKCTSCSCCIGDGESYALVERSILCSACDV 116
C+ C + ++ G V V + +HP CF C +C + LV
Sbjct: 1 CEKCKEPINPGEVAVFAERAGEDACWHPGCFVCETC--------NELLV----------- 41
Query: 117 MLDNWYFEKDGLLFCKEDY 135
D YF DG ++C Y
Sbjct: 42 --DLIYFYHDGKIYCGRHY 58
|
The first LIM domain of Testin_like family: This family includes testin, prickle, dyxin and LIMPETin. Structurally, testin and prickle proteins contain three LIM domains at C-terminal; LIMPETin has six LIM domains; and dyxin presents only two LIM domains. However, all members of the family contain a PET protein-protein interaction domain. Testin is a cytoskeleton associated focal adhesion protein that localizes along actin stress fibers, at cell-cell-contact areas, and at focal adhesion plaques. Testin interacts with a variety of cytoskeletal proteins, including zyxin, mena, VASP, talin, and actin and it is involved in cell motility and adhesion events. Prickles have been implicated in roles of regulating tissue polarity or planar cell polarity (PCP). Dyxin involves in lung and heart development by interaction with GATA6 and blocking GATA6 activated target genes. LIMPETin might be the recombinant product of genes coding testin and four and half LIM proteins and its function is not well understood. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 58 |
| >gnl|CDD|188747 cd09361, LIM1_Enigma_like, The first LIM domain of Enigma-like family | Back alignment and domain information |
|---|
Score = 35.0 bits (81), Expect = 0.004
Identities = 18/54 (33%), Positives = 27/54 (50%), Gaps = 5/54 (9%)
Query: 63 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVER--SILCSAC 114
C +C Q++ GP +V +HPE F C+ C C + + VE S+ C C
Sbjct: 1 CAHCNQVIRGPFLVALGRSWHPEEFTCSHCHCSLAEI---GFVEEKGSLYCELC 51
|
The first LIM domain of Enigma-like family: The Enigma LIM domain family is comprised of three members: Enigma, ENH, and Cypher (mouse)/ZASP (human). These subfamily members contain a single PDZ domain at the N-terminus and three LIM domains at the C-terminus. Enigma was initially characterized in humans and is expressed in multiple tissues, such as skeletal muscle, heart, bone, and brain. The third LIM domain specifically interacts with the insulin receptor and the second LIM domain interacts with the receptor tyrosine kinase Ret and the adaptor protein APS. Thus Enigma is implicated in signal transduction processes, such as mitogenic activity, insulin related actin organization, and glucose metabolism. The second member, ENH protein, was first identified in rat brain. It has been shown that ENH interacts with protein kinase D1 (PKD1) via its LIM domains and forms a complex with PKD1 and the alpha1C subunit of cardiac L-type voltage-gated calcium channel in rat neonatal cardiomyocytes. The N-terminal PDZ domain interacts with alpha-actinin at the Z-line. ZASP/Cypher is required for maintenance of Z-line structure during muscle contraction, but not required for Z-line assembly. In heart, Cypher/ZASP plays a structural role through its interaction with cytoskeletal Z-line proteins. In addition, there is increasing evidence that Cypher/ZASP also performs signaling functions. Studies reveal that Cypher/ZASP interacts with and directs PKC to the Z-line, where PKC phosphorylates downstream signaling targets. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 433 | |||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0659|consensus | 318 | 100.0 | ||
| KOG1026|consensus | 774 | 100.0 | ||
| KOG0201|consensus | 467 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0589|consensus | 426 | 100.0 | ||
| KOG4721|consensus | 904 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0597|consensus | 808 | 100.0 | ||
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0694|consensus | 694 | 100.0 | ||
| KOG1095|consensus | 1025 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257|consensus | 974 | 100.0 | ||
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196|consensus | 996 | 100.0 | ||
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4278|consensus | 1157 | 100.0 | ||
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG1094|consensus | 807 | 100.0 | ||
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| KOG0666|consensus | 438 | 100.0 | ||
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG0669|consensus | 376 | 100.0 | ||
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0199|consensus | 1039 | 100.0 | ||
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0200|consensus | 609 | 99.98 | ||
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| KOG4236|consensus | 888 | 99.98 | ||
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG0607|consensus | 463 | 99.97 | ||
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| KOG4250|consensus | 732 | 99.97 | ||
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| KOG0696|consensus | 683 | 99.97 | ||
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG1035|consensus | 1351 | 99.97 | ||
| KOG0587|consensus | 953 | 99.97 | ||
| KOG1151|consensus | 775 | 99.97 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0671|consensus | 415 | 99.97 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1006|consensus | 361 | 99.97 | ||
| KOG1025|consensus | 1177 | 99.97 | ||
| KOG2052|consensus | 513 | 99.97 | ||
| KOG0695|consensus | 593 | 99.96 | ||
| KOG3653|consensus | 534 | 99.96 | ||
| KOG1163|consensus | 341 | 99.96 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0668|consensus | 338 | 99.96 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0984|consensus | 282 | 99.96 | ||
| KOG1027|consensus | 903 | 99.96 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1152|consensus | 772 | 99.95 | ||
| KOG0664|consensus | 449 | 99.95 | ||
| KOG0576|consensus | 829 | 99.95 | ||
| KOG0665|consensus | 369 | 99.95 | ||
| KOG1024|consensus | 563 | 99.95 | ||
| KOG1165|consensus | 449 | 99.95 | ||
| KOG1290|consensus | 590 | 99.95 | ||
| KOG1164|consensus | 322 | 99.95 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG0670|consensus | 752 | 99.94 | ||
| KOG1167|consensus | 418 | 99.94 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1345|consensus | 378 | 99.92 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG0590|consensus | 601 | 99.87 | ||
| KOG1701|consensus | 468 | 99.86 | ||
| KOG1044|consensus | 670 | 99.86 | ||
| KOG0195|consensus | 448 | 99.85 | ||
| KOG4158|consensus | 598 | 99.85 | ||
| KOG4577|consensus | 383 | 99.84 | ||
| KOG0603|consensus | 612 | 99.83 | ||
| KOG1240|consensus | 1431 | 99.83 | ||
| KOG1701|consensus | 468 | 99.82 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| KOG1023|consensus | 484 | 99.8 | ||
| KOG1033|consensus | 516 | 99.77 | ||
| KOG2272|consensus | 332 | 99.76 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.75 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.72 | |
| KOG2272|consensus | 332 | 99.71 | ||
| KOG0606|consensus | 1205 | 99.71 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.69 | |
| KOG1166|consensus | 974 | 99.69 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.62 | |
| KOG1703|consensus | 479 | 99.61 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.59 | |
| KOG0590|consensus | 601 | 99.58 | ||
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.58 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.56 | |
| KOG1703|consensus | 479 | 99.54 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG0601|consensus | 524 | 99.45 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.45 | |
| KOG1044|consensus | 670 | 99.42 | ||
| KOG1266|consensus | 458 | 99.41 | ||
| PF00412 | 58 | LIM: LIM domain; InterPro: IPR001781 Zinc finger ( | 99.39 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.33 | |
| KOG0606|consensus | 1205 | 99.3 | ||
| KOG1243|consensus | 690 | 99.28 | ||
| KOG0601|consensus | 524 | 99.22 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.17 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.06 | |
| KOG3087|consensus | 229 | 99.04 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.01 | |
| KOG3741|consensus | 655 | 99.01 | ||
| KOG1700|consensus | 200 | 98.98 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.95 | |
| KOG2137|consensus | 700 | 98.93 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.88 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.87 | |
| PF00412 | 58 | LIM: LIM domain; InterPro: IPR001781 Zinc finger ( | 98.81 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.59 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.54 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.45 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.39 | |
| smart00132 | 39 | LIM Zinc-binding domain present in Lin-11, Isl-1, | 98.32 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.3 | |
| smart00132 | 39 | LIM Zinc-binding domain present in Lin-11, Isl-1, | 98.29 | |
| KOG0576|consensus | 829 | 98.06 | ||
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.04 | |
| KOG4577|consensus | 383 | 97.98 | ||
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.97 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.93 | |
| KOG0490|consensus | 235 | 97.85 | ||
| KOG1035|consensus | 1351 | 97.81 | ||
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.65 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.45 | |
| KOG1700|consensus | 200 | 97.38 | ||
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.26 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.22 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.21 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.2 | |
| KOG1235|consensus | 538 | 97.09 | ||
| KOG1826|consensus | 2724 | 96.98 | ||
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.95 | |
| KOG1702|consensus | 264 | 96.83 | ||
| PRK14559 | 645 | putative protein serine/threonine phosphatase; Pro | 96.52 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.48 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.4 | |
| KOG2268|consensus | 465 | 96.3 | ||
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.17 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.11 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.0 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.94 | |
| PLN02236 | 344 | choline kinase | 95.81 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.63 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.88 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.81 | |
| KOG1093|consensus | 725 | 94.7 |
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=345.17 Aligned_cols=232 Identities=22% Similarity=0.362 Sum_probs=195.6
Q ss_pred ccCCeeeeeccCCCcchhhhhcc--------------------------------chHHHHhhcCCcceeeEEEEEEeCC
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC--------------------------------GQVAVLRSLHHHNVIRFIGVLYKDR 171 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~--------------------------------~E~~~l~~l~h~~iv~~~~~~~~~~ 171 (433)
.++.+++.+.+|.|+||.|..++ +|++||++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45668889999999999887522 7999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccC---CceEEeccccchh
Q psy6593 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRED---KTVVVADFGLARI 248 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~ 248 (433)
..||||||++||+|.+.+..++ .+.+..-..+++|++.||.|||++||+||||||+|||++.+ -.+||+|||+|+.
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 9999999999999999987755 48899999999999999999999999999999999999865 7899999999998
Q ss_pred ccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCC---CcccCeEehhHHHHHHhcCCCCCCCCCC
Q psy6593 249 IHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY---DETVDVFSYGIVLCEIIGRVPADPDYLP 325 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~ell~~~~~~~~~~~ 325 (433)
.+... .-.+.+|||.|.|||++.+... ..++|||||||+||-+++|.|||.+...
T Consensus 329 ~g~~s----------------------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~ 386 (475)
T KOG0615|consen 329 SGEGS----------------------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT 386 (475)
T ss_pred cccce----------------------ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC
Confidence 75322 1127899999999999987543 3478999999999999999999987655
Q ss_pred CC-CCCCCchh--hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhc
Q psy6593 326 RS-PDFGLDQT--DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 326 ~~-~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
.. ....+... .+....+..++++..+||.+||..||++||++.|++ .||+...
T Consensus 387 ~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 387 DPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred CccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 44 11222222 222334578899999999999999999999999998 5888643
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=337.36 Aligned_cols=232 Identities=25% Similarity=0.415 Sum_probs=196.6
Q ss_pred cccCCeeeeeccCCCcchhhhhcc--------------------------chHHHHhhcCCcceeeEEEEEEeCCe-eeE
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSLHHHNVIRFIGVLYKDRK-LNL 175 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~-~~l 175 (433)
+..+++.....+|+|..|+|+|.. +|++++++.+||+||++||+|..+.. ++|
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 344468888899999999999722 89999999999999999999999994 999
Q ss_pred EEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhc-CCccccCCCCcceEEccCCceEEeccccchhccCCCC
Q psy6593 176 VTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
+||||+||||++++...+ .+++...-+|+.++++||.|||+ .+|+||||||+|||++..|.|||+|||.+..+..+..
T Consensus 156 ~mEYMDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a 234 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIA 234 (364)
T ss_pred ehhhcCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhc
Confidence 999999999999998764 59999999999999999999995 8999999999999999999999999999998876522
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC---
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG--- 331 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~--- 331 (433)
. +++||..|||||.+.+..|+.++||||||++++|+.+|.-|+....+......
T Consensus 235 ~-----------------------tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll 291 (364)
T KOG0581|consen 235 N-----------------------TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELL 291 (364)
T ss_pred c-----------------------cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHH
Confidence 2 78999999999999999999999999999999999988877765311111100
Q ss_pred -CchhhhccccCCC-CcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhc
Q psy6593 332 -LDQTDFRNKFCAS-CPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 332 -~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
..-....+.++.+ ++++|++++..||++||.+||++++++ .|+.+..
T Consensus 292 ~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 292 CAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 0111223344554 889999999999999999999999998 5887654
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=345.70 Aligned_cols=243 Identities=33% Similarity=0.510 Sum_probs=208.6
Q ss_pred ccccccCCeeeeeccCCCcchhhhhcc--------------------------chHHHHhhcCCcceeeEEEEEEeCC-e
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSLHHHNVIRFIGVLYKDR-K 172 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l~h~~iv~~~~~~~~~~-~ 172 (433)
.+.+..+++.+...++.|+||+||++. +|+.+|++++|||||+++|++.+.. .
T Consensus 35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 35 EEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGS 114 (362)
T ss_pred ceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 344455556666678888888888622 7999999999999999999999887 7
Q ss_pred eeEEEeccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCC-ccccCCCCcceEEccCC-ceEEeccccchhc
Q psy6593 173 LNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMN-LIHRDLNSQNCLVREDK-TVVVADFGLARII 249 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~-i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 249 (433)
+.|||||+++|+|.+++.+ .+..++...+++|+.+|+.|+.|||+.+ ||||||||+|||++.++ ++||+|||+++..
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 9999999999999999987 4667999999999999999999999999 99999999999999997 9999999999876
Q ss_pred cCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec--CCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCC
Q psy6593 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT--GQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~ 327 (433)
....... ....||+.|||||++. ...++.++||||||+++|||+|+..||....+..
T Consensus 195 ~~~~~~~---------------------~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~ 253 (362)
T KOG0192|consen 195 VISKTSM---------------------TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ 253 (362)
T ss_pred ccccccc---------------------cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH
Confidence 5432110 1367999999999999 5689999999999999999999998888876645
Q ss_pred CCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccccC
Q psy6593 328 PDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSV 383 (433)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~~ 383 (433)
....+.....+..++..+++.+..+|.+||+.||+.||++.+|+..|+.+......
T Consensus 254 ~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 254 VASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 55555566777777888999999999999999999999999999999988765543
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=329.30 Aligned_cols=223 Identities=22% Similarity=0.401 Sum_probs=184.5
Q ss_pred CCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEE-EEEeCCe-eeEE
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIG-VLYKDRK-LNLV 176 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~-~~~~~~~-~~lv 176 (433)
.++.+.+++|+|+||+|||.. .|+.+|++|+|||||++++ .|.+++. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 347778899999999999822 7999999999999999999 5555555 9999
Q ss_pred EeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhc--CC--ccccCCCCcceEEccCCceEEeccccchhc
Q psy6593 177 TEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHS--MN--LIHRDLNSQNCLVREDKTVVVADFGLARII 249 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~--~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 249 (433)
||++++|+|.++++. .++.+++..+++++.|++.||..+|+ .. ++||||||.||+++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999853 56679999999999999999999999 45 999999999999999999999999999988
Q ss_pred cCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCC
Q psy6593 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPD 329 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~ 329 (433)
...... ..+.+|||.||+||.+.+.+|+.+|||||+||++|||..-.+||....-....
T Consensus 179 ~s~~tf---------------------A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~ 237 (375)
T KOG0591|consen 179 SSKTTF---------------------AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLC 237 (375)
T ss_pred cchhHH---------------------HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHH
Confidence 664432 22789999999999999999999999999999999999988888764211111
Q ss_pred CCCchhhhccccC-CCCcHHHHHHHHHhcccCCCCCCChhHH
Q psy6593 330 FGLDQTDFRNKFC-ASCPEPFVRIAFLCCDLNPDQRPPFEVL 370 (433)
Q Consensus 330 ~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~RPs~~~i 370 (433)
..+....+.+ +| ..++.++..||..|+..||+.||+...+
T Consensus 238 ~KI~qgd~~~-~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~ 278 (375)
T KOG0591|consen 238 KKIEQGDYPP-LPDEHYSTDLRELINMCIAVDPEQRPDTVPY 278 (375)
T ss_pred HHHHcCCCCC-CcHHHhhhHHHHHHHHHccCCcccCCCcchH
Confidence 1112222211 22 5667899999999999999999984333
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=331.62 Aligned_cols=234 Identities=26% Similarity=0.354 Sum_probs=196.8
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCee
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~ 173 (433)
....+++.+.+.+|+|+||+|++.. .|..||.+++||+||+++-.|++.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 4567778899999999999998611 799999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 174 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
|+|+||+.||.|.-+|++++ .|++..++-++.+|+.||.|||++|||||||||+|||++.+|+++|+|||+++......
T Consensus 101 ylVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 99999999999999998766 49999999999999999999999999999999999999999999999999999654432
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~ 333 (433)
.. ..+++||+.|||||++.+..|+.++|+||||+++|||++|.|||...........+.
T Consensus 180 ~~---------------------t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~ 238 (357)
T KOG0598|consen 180 DA---------------------TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKIL 238 (357)
T ss_pred Cc---------------------cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHh
Confidence 22 226899999999999999999999999999999999999999997644332222222
Q ss_pred hhhhccccCCCCcHHHHHHHHHhcccCCCCCC----ChhHHH--HHHHhhc
Q psy6593 334 QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP----PFEVLE--VWLEGLS 378 (433)
Q Consensus 334 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP----s~~~i~--~~l~~~~ 378 (433)
... ....+..++.+.+++++++|+.||++|. ++++|. .++..+.
T Consensus 239 ~~k-~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 239 KGK-LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred cCc-CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 221 1223355889999999999999999995 566765 3454443
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=344.06 Aligned_cols=204 Identities=25% Similarity=0.447 Sum_probs=182.2
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+||+|.++|+|||||+++++|++.++.|||+|+|..++|..++++ .+.+++.+++.++.||+.||.|||+.+|+|||||
T Consensus 67 ~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLK 145 (592)
T KOG0575|consen 67 NEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLK 145 (592)
T ss_pred HHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccc
Confidence 899999999999999999999999999999999999999999985 4579999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
..|++++++.+|||+|||+|..+.... .+.++.+|||.|.|||++.....+..+||||+
T Consensus 146 LGNlfL~~~~~VKIgDFGLAt~le~~~---------------------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSl 204 (592)
T KOG0575|consen 146 LGNLFLNENMNVKIGDFGLATQLEYDG---------------------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSL 204 (592)
T ss_pred hhheeecCcCcEEecccceeeeecCcc---------------------cccceecCCCcccChhHhccCCCCCchhhhhh
Confidence 999999999999999999999875432 34458999999999999999999999999999
Q ss_pred hHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHH
Q psy6593 307 GIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWL 374 (433)
Q Consensus 307 G~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l 374 (433)
||+||.||.|.|||....-......+....+ .+|..++.+..+||.++|+.||.+|||+++|+ .+|
T Consensus 205 GcvmYtLL~G~PPFetk~vkety~~Ik~~~Y--~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 205 GCVMYTLLVGRPPFETKTVKETYNKIKLNEY--SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred hhHHHhhhhCCCCcccchHHHHHHHHHhcCc--ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 9999999999999977544333333333333 34578899999999999999999999999998 577
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=329.65 Aligned_cols=225 Identities=28% Similarity=0.501 Sum_probs=188.6
Q ss_pred ccCCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEE
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 176 (433)
..+++.+.+++|+|+|++||++- .|+.+|+.++|||||+++++...++.+|||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 45568888899999999999722 799999999999999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccC------CceEEeccccchhcc
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRED------KTVVVADFGLARIIH 250 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~------~~~kl~Dfg~~~~~~ 250 (433)
||||.||+|.+++++.+ .+++..++.++.||+.||++||+++||||||||+|||++.. -.+||+|||+|+.+.
T Consensus 88 MEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999999865 59999999999999999999999999999999999999864 468999999999887
Q ss_pred CCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC
Q psy6593 251 QGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF 330 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~ 330 (433)
..... .+.+|+|.|||||++....|+.|+|+||+|+|+|++++|.+||..........
T Consensus 167 ~~~~a----------------------~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~ 224 (429)
T KOG0595|consen 167 PGSMA----------------------ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL 224 (429)
T ss_pred chhHH----------------------HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 54322 16789999999999999999999999999999999999999987543333222
Q ss_pred CCch-hhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 331 GLDQ-TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 331 ~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
.+.. ......++..+++.+.+++...++.++.+|-++.+-.
T Consensus 225 ~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 225 YIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred HHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 2221 2222333455666778888899999998887766543
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=339.82 Aligned_cols=241 Identities=31% Similarity=0.531 Sum_probs=206.6
Q ss_pred ccccccccCCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCCcceeeEEEEEEeCCeee
Q psy6593 118 LDNWYFEKDGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 118 l~~~~~~~~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 174 (433)
.+.|.++.+.+.+++++|+|.||+|+... +|+++|++|+|+|||++++++..++.+|
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence 56788888899999999999999999611 7999999999999999999999988999
Q ss_pred EEEeccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 175 LVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
|||||++.|+|.++|+. .+..++..+.+.++.||++|++||+++++|||||...||||+++..+||+|||+++......
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 99999999999999987 66789999999999999999999999999999999999999999999999999999544433
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCC
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGL 332 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~ 332 (433)
+.... .. --...|.|||++....++.+|||||||++||||+| |..|++. .........
T Consensus 358 Y~~~~-~~-------------------kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~-msn~ev~~~ 416 (468)
T KOG0197|consen 358 YTASE-GG-------------------KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG-MSNEEVLEL 416 (468)
T ss_pred eeecC-CC-------------------CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC-CCHHHHHHH
Confidence 32211 11 12345999999999999999999999999999994 4444443 333334445
Q ss_pred chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 333 DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 333 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
.....+..-|..+|+++.+||..||+.+|++|||++.+...|+++..
T Consensus 417 le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 417 LERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred HhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 56667777789999999999999999999999999999999988653
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=332.59 Aligned_cols=248 Identities=21% Similarity=0.338 Sum_probs=207.0
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhc-CCcceeeEEEEEEeCCe
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSL-HHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~ 172 (433)
.....++++.+.+|+|+|.+|+.+- .|-++|.+| .||.|++|+--|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 4456679999999999999999622 799999999 89999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
+|+|+||+++|+|.++|.+.+ .|++..++-++.||++||+|||+.|||||||||+|||++.+++++|.|||.|+.+...
T Consensus 149 LYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 999999999999999998875 5999999999999999999999999999999999999999999999999999988764
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL 332 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~ 332 (433)
......... ..........++||..|.+||++.+...+..+|||+||||+|.|+.|.|||....+-.....+
T Consensus 228 ~~~~~~~~~--------~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI 299 (604)
T KOG0592|consen 228 QKSQENPVD--------PNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI 299 (604)
T ss_pred hccccCccC--------cccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence 433111000 000111235899999999999999999999999999999999999999999764332222222
Q ss_pred chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhccc
Q psy6593 333 DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLSMH 380 (433)
Q Consensus 333 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~~~ 380 (433)
. .+.-.++.+.|+...+|++++|..||.+|++.++|.+ +|+.+.+.
T Consensus 300 ~--~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 300 Q--ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred H--HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 2 2334567899999999999999999999999999974 66665543
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=308.01 Aligned_cols=218 Identities=24% Similarity=0.425 Sum_probs=178.3
Q ss_pred eeccCCCcchhhhh---------------------------ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCC
Q psy6593 131 CKEDYNGKYGEACQ---------------------------NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGG 183 (433)
Q Consensus 131 ~~~~~~g~fg~v~~---------------------------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 183 (433)
..+.|+|+||+|+| +++|+..|++|+|+|+|.++++|...+.++|||||++.
T Consensus 7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh- 85 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH- 85 (396)
T ss_pred hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-
Confidence 34667788887776 33999999999999999999999999999999999987
Q ss_pred CHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccc
Q psy6593 184 TLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263 (433)
Q Consensus 184 sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 263 (433)
++.+-++.....++.+.+.+++.|++.|+.|+|+.+++||||||+||||+.+|.+||+|||+|+.+......
T Consensus 86 TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~-------- 157 (396)
T KOG0593|consen 86 TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN-------- 157 (396)
T ss_pred HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch--------
Confidence 555555554556999999999999999999999999999999999999999999999999999988642221
Q ss_pred hhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC----------
Q psy6593 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL---------- 332 (433)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~---------- 332 (433)
...++.|++|+|||.+.+ ..|+..+||||+||++.||++|.|.|+....-.....+
T Consensus 158 -------------YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~pr 224 (396)
T KOG0593|consen 158 -------------YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPR 224 (396)
T ss_pred -------------hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHH
Confidence 226789999999999988 78999999999999999999999999765332111110
Q ss_pred --------------c------hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 333 --------------D------QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 333 --------------~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
. ...+... ..+++..+.++++.||+.||++|++-++++
T Consensus 225 hq~iF~~N~~F~Gv~lP~~~~~epLe~k-~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 225 HQSIFSSNPFFHGVRLPEPEHPEPLERK-YPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred HHHHhccCCceeeeecCCCCCccchhhh-cccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 0 0001111 144566789999999999999999999997
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=319.63 Aligned_cols=229 Identities=24% Similarity=0.413 Sum_probs=186.0
Q ss_pred CCeeeeeccCCCcchhhhhc-------------------------cchHHHHhhcCCcceeeEEEEEEeCC--eeeEEEe
Q psy6593 126 DGLLFCKEDYNGKYGEACQN-------------------------CGQVAVLRSLHHHNVIRFIGVLYKDR--KLNLVTE 178 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~-------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e 178 (433)
......+-+|+|.||.|+.. .+|+.+|++|+|||||+++|...... .++|+||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 33555566777777777741 27999999999999999999855444 6999999
Q ss_pred ccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc-CCceEEeccccchhccCCCCCCc
Q psy6593 179 YIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE-DKTVVVADFGLARIIHQGPRAPT 257 (433)
Q Consensus 179 ~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~ 257 (433)
|+++|||.+++.+.+..+++..++.++.|++.||+|||++||+|+||||+|||++. ++.+||+|||+++.........
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~- 175 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS- 175 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc-
Confidence 99999999999986657999999999999999999999999999999999999999 7999999999998766411110
Q ss_pred cccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeEehhHHHHHHhcCCCCCCCC-CCCCCCCCCchh
Q psy6593 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVPADPDY-LPRSPDFGLDQT 335 (433)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~~~~~~~~~-~~~~~~~~~~~~ 335 (433)
.......||+.|||||++..+ ...+++|||||||++.||+||.+||... ........+...
T Consensus 176 -----------------~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~ 238 (313)
T KOG0198|consen 176 -----------------DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE 238 (313)
T ss_pred -----------------cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc
Confidence 112267899999999999953 3445999999999999999999998873 222222222223
Q ss_pred hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 336 DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 336 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
...+.++..++.+.++++.+|+..+|++|||++++++
T Consensus 239 ~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 239 DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 3345778889999999999999999999999999985
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=323.26 Aligned_cols=228 Identities=22% Similarity=0.368 Sum_probs=190.7
Q ss_pred CCeeeeeccCCCcchhhhh--------------------------ccchHHHHhhcC-CcceeeEEEEEEeCC-eeeEEE
Q psy6593 126 DGLLFCKEDYNGKYGEACQ--------------------------NCGQVAVLRSLH-HHNVIRFIGVLYKDR-KLNLVT 177 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~--------------------------~~~E~~~l~~l~-h~~iv~~~~~~~~~~-~~~lv~ 177 (433)
+.+...+++|.|.||.|+. +++|+..|++|+ ||||+++.+++.+.+ .+|+||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 4467778999999999996 228999999998 999999999999887 999999
Q ss_pred eccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCc
Q psy6593 178 EYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPT 257 (433)
Q Consensus 178 e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 257 (433)
|||+ .+|++++++.++.|++..++.|+.||++||+|+|..|+.|||+||+|||+.....+||+|||+|+.+...+...
T Consensus 90 E~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYT- 167 (538)
T KOG0661|consen 90 EFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYT- 167 (538)
T ss_pred Hhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCcc-
Confidence 9995 59999999988999999999999999999999999999999999999999999999999999999887655432
Q ss_pred cccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC----
Q psy6593 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL---- 332 (433)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~---- 332 (433)
.++.|++|+|||++.. ..|+.+.|||++|||++|+.+-+|.|+..........+
T Consensus 168 ---------------------eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VL 226 (538)
T KOG0661|consen 168 ---------------------EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVL 226 (538)
T ss_pred ---------------------hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHh
Confidence 6789999999998765 67899999999999999999998888754221111000
Q ss_pred -------ch------hh-----------hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 333 -------DQ------TD-----------FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 333 -------~~------~~-----------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
.. .. -...+....+.+..++|.+|++.||.+||++.+.++ +++.
T Consensus 227 GtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~ 296 (538)
T KOG0661|consen 227 GTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQV 296 (538)
T ss_pred CCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccc
Confidence 00 00 001112457889999999999999999999999985 5554
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=323.49 Aligned_cols=267 Identities=20% Similarity=0.312 Sum_probs=213.6
Q ss_pred ccccccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEe
Q psy6593 118 LDNWYFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYK 169 (433)
Q Consensus 118 l~~~~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~ 169 (433)
+.+-.+..+++...+.+|+|+||+|+-+- .|-++|...++++||+|+-.|++
T Consensus 133 ~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD 212 (550)
T KOG0605|consen 133 LRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD 212 (550)
T ss_pred hccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC
Confidence 34445678889999999999999999511 68889999999999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhc
Q psy6593 170 DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARII 249 (433)
Q Consensus 170 ~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 249 (433)
.+++||||||++||++..+|.+.+ .|++..++.++.+++.||+.||+.|++||||||+|+||+..|++||+||||+.-+
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred CCeeEEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999999999998865 5999999999999999999999999999999999999999999999999999755
Q ss_pred cCCCCCC-----------------ccccc---------cchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 250 HQGPRAP-----------------TTVMA---------KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 250 ~~~~~~~-----------------~~~~~---------~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
....... ..... .......+....+.-.+..+|||.|+|||++.+..|+...|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 4321111 11110 001111334455556678899999999999999999999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccC--CCCcHHHHHHHHHhcccCCCCCC---ChhHHH--HHHHh
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFC--ASCPEPFVRIAFLCCDLNPDQRP---PFEVLE--VWLEG 376 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~RP---s~~~i~--~~l~~ 376 (433)
|||||||||||.|.|||....+......+..-.....+| ..++++..+||.++|. ||++|. .++||. .||+.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 999999999999999998876655544443333222333 5567899999999999 999997 578887 48888
Q ss_pred hcccccCCCC
Q psy6593 377 LSMHLSVDKP 386 (433)
Q Consensus 377 ~~~~~~~~~~ 386 (433)
+.++.-...+
T Consensus 451 v~W~~l~~~~ 460 (550)
T KOG0605|consen 451 VDWDHLREMP 460 (550)
T ss_pred CCcchhhcCC
Confidence 7775533333
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=301.66 Aligned_cols=215 Identities=23% Similarity=0.423 Sum_probs=191.1
Q ss_pred cccCCeeeeeccCCCcchhhhh----------------------------ccchHHHHhhcCCcceeeEEEEEEeCCeee
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQ----------------------------NCGQVAVLRSLHHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~----------------------------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 174 (433)
+..+++...+.+|.|+||.|-- -.+|..+|+.+.||+++++++.+.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 6677788999999999997763 118999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCC
Q psy6593 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
+||||++||.|..++++.+ +|++..++-++.||+.||+|||+.+|++|||||+|||++.+|.+||+|||+|+....
T Consensus 121 mvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--- 196 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--- 196 (355)
T ss_pred EEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence 9999999999999999866 499999999999999999999999999999999999999999999999999998643
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCch
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQ 334 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~ 334 (433)
..++.+|||.|+|||.+...+++.++|+||||+++|||+.|.|||....+......+.
T Consensus 197 ---------------------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~- 254 (355)
T KOG0616|consen 197 ---------------------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL- 254 (355)
T ss_pred ---------------------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH-
Confidence 2458899999999999999999999999999999999999999998765533222222
Q ss_pred hhhccccCCCCcHHHHHHHHHhcccCCCCC
Q psy6593 335 TDFRNKFCASCPEPFVRIAFLCCDLNPDQR 364 (433)
Q Consensus 335 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 364 (433)
.-.-.+|..++.++++|++.+|+.|-.+|
T Consensus 255 -~~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 255 -EGKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -hCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 22334678889999999999999999999
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=317.10 Aligned_cols=242 Identities=25% Similarity=0.425 Sum_probs=195.9
Q ss_pred ccccccccccccc-ccCCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceee
Q psy6593 111 CSACDVMLDNWYF-EKDGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIR 162 (433)
Q Consensus 111 C~~c~~~l~~~~~-~~~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~ 162 (433)
+..+...+..|.- ..+.+..+.++|+|.||.||++. +||.||++|+||||++
T Consensus 101 ~~~~ge~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIik 180 (560)
T KOG0600|consen 101 SSVAGEALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIK 180 (560)
T ss_pred ccccccccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccc
Confidence 3444444443322 22336667799999999999832 8999999999999999
Q ss_pred EEEEEEeC--CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEE
Q psy6593 163 FIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVV 240 (433)
Q Consensus 163 ~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl 240 (433)
|.+..... ..+|||||||+. +|.-++...+-.|++.++..+++||+.||+|+|.+||+|||||.+||||+.+|.+||
T Consensus 181 L~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKi 259 (560)
T KOG0600|consen 181 LEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKI 259 (560)
T ss_pred eeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEe
Confidence 99999877 689999999976 999999998888999999999999999999999999999999999999999999999
Q ss_pred eccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCC
Q psy6593 241 ADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPA 319 (433)
Q Consensus 241 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~ 319 (433)
+|||+|+++........ ...+-|.+|+|||.+.| ..|+.++|+||.||||.||+.|+|.
T Consensus 260 aDFGLAr~y~~~~~~~~--------------------T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI 319 (560)
T KOG0600|consen 260 ADFGLARFYTPSGSAPY--------------------TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPI 319 (560)
T ss_pred ccccceeeccCCCCccc--------------------ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCC
Confidence 99999998765543322 25678999999999988 5799999999999999999999998
Q ss_pred CCCCC--------------CCCCCCCCc--------------hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 320 DPDYL--------------PRSPDFGLD--------------QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 320 ~~~~~--------------~~~~~~~~~--------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
+.... +....+... .+.+. +....+|....+|+..+|.+||.+|.|+.+.+
T Consensus 320 ~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~-E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 320 LQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLR-ETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred cCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHH-HHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 85431 111111100 00111 12367788999999999999999999999988
Q ss_pred --HHH
Q psy6593 372 --VWL 374 (433)
Q Consensus 372 --~~l 374 (433)
++|
T Consensus 399 ~seyF 403 (560)
T KOG0600|consen 399 QSEYF 403 (560)
T ss_pred cCccc
Confidence 467
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=325.32 Aligned_cols=225 Identities=29% Similarity=0.477 Sum_probs=195.3
Q ss_pred eeeeeccCCCcchhhhh-------------------------ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCC
Q psy6593 128 LLFCKEDYNGKYGEACQ-------------------------NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAG 182 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~-------------------------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 182 (433)
+..-+++++|..|.||- .++|+.+|+.++|+|||++++.|..++.+|+||||++|
T Consensus 275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~g 354 (550)
T KOG0578|consen 275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEG 354 (550)
T ss_pred hcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCC
Confidence 44556888999998885 22899999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcccccc
Q psy6593 183 GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAK 262 (433)
Q Consensus 183 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 262 (433)
|+|.+.+.. ..+++.++..|.++++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 355 gsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-------- 424 (550)
T KOG0578|consen 355 GSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-------- 424 (550)
T ss_pred Cchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--------
Confidence 999999987 3499999999999999999999999999999999999999999999999999988765432
Q ss_pred chhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc-hhhhcccc
Q psy6593 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD-QTDFRNKF 341 (433)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 341 (433)
++.+.+|||+|||||+.....|+++.||||||++++||+-|.|||-...+......+. ........
T Consensus 425 -------------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~ 491 (550)
T KOG0578|consen 425 -------------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKN 491 (550)
T ss_pred -------------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCC
Confidence 3448899999999999999999999999999999999999999987544433333222 22333345
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHH
Q psy6593 342 CASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLE 375 (433)
Q Consensus 342 ~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~ 375 (433)
+..+++.|++++.+||+.|+++|+++.+|++ +|+
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence 6889999999999999999999999999984 774
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=317.88 Aligned_cols=240 Identities=28% Similarity=0.452 Sum_probs=187.8
Q ss_pred cccccCCeeeeeccCCCcchhhhhc-------------------------------cchHHHHhhc-CCcceeeEEEEEE
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQN-------------------------------CGQVAVLRSL-HHHNVIRFIGVLY 168 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~-------------------------------~~E~~~l~~l-~h~~iv~~~~~~~ 168 (433)
|.+..+++.+.+.++.|+||.||++ .+|+.+|+++ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 3445566777777888888888642 1689999999 8999999999887
Q ss_pred eC-CeeeEEEeccCCCCHHHHhcCCC------------------------------------------------------
Q psy6593 169 KD-RKLNLVTEYIAGGTLKELLQDPG------------------------------------------------------ 193 (433)
Q Consensus 169 ~~-~~~~lv~e~~~g~sL~~~l~~~~------------------------------------------------------ 193 (433)
.. ..+++||||+++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 64 46899999999999999986421
Q ss_pred -------CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhh
Q psy6593 194 -------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266 (433)
Q Consensus 194 -------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 266 (433)
.++++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||+++..........
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~--------- 232 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR--------- 232 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhc---------
Confidence 2477889999999999999999999999999999999999999999999999986533221100
Q ss_pred hhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCC
Q psy6593 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASC 345 (433)
Q Consensus 267 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (433)
.....+++.|+|||++.+..++.++||||||+++|||++ |.+||.....................+..+
T Consensus 233 ----------~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (338)
T cd05102 233 ----------KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENA 302 (338)
T ss_pred ----------ccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCC
Confidence 012345678999999999899999999999999999995 888876532211111111111122334677
Q ss_pred cHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 346 PEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 346 ~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
++.+.+++.+||+.||.+||++.+|++.|+++..
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=287.69 Aligned_cols=210 Identities=25% Similarity=0.406 Sum_probs=175.3
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
+++||+.|+.++|+||+.++++|.+.+.+.||+||++ .+|+..+++....++...+..++.+++.||+|+|++.|+|||
T Consensus 48 alREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRD 126 (318)
T KOG0659|consen 48 ALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRD 126 (318)
T ss_pred HHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhccc
Confidence 5599999999999999999999999999999999996 699999999888999999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCe
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDV 303 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 303 (433)
|||.|+|++++|.+||+|||+++.+........ ..+-|.+|+|||.+.| ..|+..+||
T Consensus 127 lKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~---------------------~~V~TRWYRAPELLfGsr~Yg~~VDm 185 (318)
T KOG0659|consen 127 LKPNNLLISSDGQLKIADFGLARFFGSPNRIQT---------------------HQVVTRWYRAPELLFGSRQYGTGVDM 185 (318)
T ss_pred CCccceEEcCCCcEEeecccchhccCCCCcccc---------------------cceeeeeccChHHhccchhcCCcchh
Confidence 999999999999999999999998876543321 3478999999999887 679999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCC--------------CCCC----CCc--------hhhhccccCCCCcHHHHHHHHHhc
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPR--------------SPDF----GLD--------QTDFRNKFCASCPEPFVRIAFLCC 357 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~--------------~~~~----~~~--------~~~~~~~~~~~~~~~l~~li~~~l 357 (433)
||.|||+.||+-+.|.++....- ...+ .+. .......+....+++..+|+..|+
T Consensus 186 WavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~ 265 (318)
T KOG0659|consen 186 WAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKML 265 (318)
T ss_pred hhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhh
Confidence 99999999999999988654221 0000 000 001111133556778899999999
Q ss_pred ccCCCCCCChhHHHH--HHHh
Q psy6593 358 DLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 358 ~~~p~~RPs~~~i~~--~l~~ 376 (433)
.+||.+|+++.|.++ +|..
T Consensus 266 ~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 266 TYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred ccCchhcccHHHHhcchhhhc
Confidence 999999999999873 5554
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=329.25 Aligned_cols=240 Identities=29% Similarity=0.477 Sum_probs=206.3
Q ss_pred cccccCCeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhcCCcceeeEEEEEEe
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSLHHHNVIRFIGVLYK 169 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l~h~~iv~~~~~~~~ 169 (433)
..+...++++..++|+|.||+|+++. +|+++|..|+|||||+|+|++..
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 45677789999999999999999722 89999999999999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhcCC---------CC----CCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCC
Q psy6593 170 DRKLNLVTEYIAGGTLKELLQDP---------GQ----PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDK 236 (433)
Q Consensus 170 ~~~~~lv~e~~~g~sL~~~l~~~---------~~----~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~ 236 (433)
++.+++|+|||..|||.++|+.. +. +++..+.+.|+.||+.|+.||-+..+|||||...|+||.++.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 99999999999999999999641 22 388999999999999999999999999999999999999999
Q ss_pred ceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHh-c
Q psy6593 237 TVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-G 315 (433)
Q Consensus 237 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~ 315 (433)
.|||+|||+++.....+++.... ...-..+|||||.+..++++.+|||||+||+|||++ -
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~-------------------~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsy 701 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRG-------------------NTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSY 701 (774)
T ss_pred EEEecccccchhhhhhhhhcccC-------------------CceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhcc
Confidence 99999999999887766554322 122356799999999999999999999999999999 4
Q ss_pred CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccc
Q psy6593 316 RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMH 380 (433)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~ 380 (433)
|+.|+...........+..... ..-+.++|.++..||..||+.+|.+||++++|...|+.....
T Consensus 702 G~QPy~glSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 702 GKQPYYGLSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred ccCcccccchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 6666666555544444444444 455799999999999999999999999999999999987643
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=310.83 Aligned_cols=220 Identities=30% Similarity=0.500 Sum_probs=194.5
Q ss_pred eeeeccCCCcchhhhhcc--------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCC
Q psy6593 129 LFCKEDYNGKYGEACQNC--------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAG 182 (433)
Q Consensus 129 ~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 182 (433)
.....+++|+||.||+++ +|+.+|.+++++||.++|+.+..+..+|++|||+.|
T Consensus 16 ~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~g 95 (467)
T KOG0201|consen 16 TKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGG 95 (467)
T ss_pred ccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcC
Confidence 334678999999999854 699999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcccccc
Q psy6593 183 GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAK 262 (433)
Q Consensus 183 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 262 (433)
|++.++++..+ .+.+..+.-++++++.||.|||..+.+|||||+.||++..+|.+||.|||++-.+.....
T Consensus 96 Gsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~-------- 166 (467)
T KOG0201|consen 96 GSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK-------- 166 (467)
T ss_pred cchhhhhccCC-CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh--------
Confidence 99999998733 358999999999999999999999999999999999999999999999999987755432
Q ss_pred chhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccC
Q psy6593 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFC 342 (433)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (433)
++.+++|||.|||||++....|+.++||||||++++||.+|.||+.+..+....+.+.... .+.+.
T Consensus 167 -------------rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~-PP~L~ 232 (467)
T KOG0201|consen 167 -------------RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA-PPRLD 232 (467)
T ss_pred -------------ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC-CCccc
Confidence 2248999999999999999899999999999999999999999999988866555544433 33344
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 343 ASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 343 ~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
..+++.+++++..||++||+.||+|.+++
T Consensus 233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LL 261 (467)
T KOG0201|consen 233 GDFSPPFKEFVEACLDKNPEFRPSAKELL 261 (467)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 68889999999999999999999999987
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=313.83 Aligned_cols=206 Identities=24% Similarity=0.375 Sum_probs=175.8
Q ss_pred chHHHHhhcC-CcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+.++++++ ||||+++++++.....+|+||||+.||+|.+++.+ .+++.+..+..++.|+++|++|+|+.||+||||
T Consensus 68 rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDL 146 (370)
T KOG0583|consen 68 REISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDL 146 (370)
T ss_pred HHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCC
Confidence 6999999998 99999999999999999999999999999999988 557999999999999999999999999999999
Q ss_pred CCcceEEccC-CceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC-CC-cccC
Q psy6593 226 NSQNCLVRED-KTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE-YD-ETVD 302 (433)
Q Consensus 226 kp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~D 302 (433)
||+|||++.+ +.+||+|||++........ ...+.+||+.|+|||++.+.. |+ .++|
T Consensus 147 K~ENilld~~~~~~Kl~DFG~s~~~~~~~~---------------------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aD 205 (370)
T KOG0583|consen 147 KPENILLDGNEGNLKLSDFGLSAISPGEDG---------------------LLKTFCGSPAYAAPEVLSGKGTYSGKAAD 205 (370)
T ss_pred CHHHEEecCCCCCEEEeccccccccCCCCC---------------------cccCCCCCcccCCHHHhCCCCCcCCchhh
Confidence 9999999999 9999999999987631111 122789999999999999977 75 7899
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCC-cHHHHHHHHHhcccCCCCCCChhHHH--HHHHh
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASC-PEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEG 376 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~ 376 (433)
|||+|++||.|++|..||.+......... .......++..+ +.++..|+.+||..+|.+|+++.+|+ .||+.
T Consensus 206 vWS~GViLy~ml~G~~PF~d~~~~~l~~k--i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 206 VWSLGVILYVLLCGRLPFDDSNVPNLYRK--IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred hhhhHHHHHHHHhCCCCCCCccHHHHHHH--HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 99999999999999988876322111111 222223445666 99999999999999999999999998 47775
|
|
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=312.68 Aligned_cols=206 Identities=27% Similarity=0.449 Sum_probs=179.3
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCe-eeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccc
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRK-LNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIH 222 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H 222 (433)
+.+|+.++++++|||||.+.+.|..++. ++|||+|++||+|.+.+.+. +..|+++.+..|+.|++.||.|||+++|+|
T Consensus 50 A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLH 129 (426)
T KOG0589|consen 50 AIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLH 129 (426)
T ss_pred HHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhc
Confidence 3489999999999999999999999987 99999999999999999764 467999999999999999999999999999
Q ss_pred cCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccC
Q psy6593 223 RDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVD 302 (433)
Q Consensus 223 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 302 (433)
||||+.||+++.++.|+|+|||+++........ ..+.+|||.|++||++.+.+|+.++|
T Consensus 130 RDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~---------------------a~tvvGTp~YmcPEil~d~pYn~KSD 188 (426)
T KOG0589|consen 130 RDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL---------------------ASTVVGTPYYMCPEILSDIPYNEKSD 188 (426)
T ss_pred ccchhhhhhccccCceeecchhhhhhcCCchhh---------------------hheecCCCcccCHHHhCCCCCCccCc
Confidence 999999999999999999999999988765321 12789999999999999999999999
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
||||||++|||++-++.|...........+.... ...++..++.++..+++.||..+|+.||++.+++.
T Consensus 189 iWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~ 257 (426)
T KOG0589|consen 189 IWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLR 257 (426)
T ss_pred chhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhh
Confidence 9999999999999999886543322222222221 34456888999999999999999999999999985
|
|
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=308.65 Aligned_cols=230 Identities=28% Similarity=0.488 Sum_probs=205.6
Q ss_pred CCeeeeeccCCCcchhhhhcc----------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHh
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC----------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL 189 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~----------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l 189 (433)
+...-..=+|.|+.|.||..- .+|+-|++|+|+||+.|.|+|....-++||||||..|-|.+.|
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VL 203 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVL 203 (904)
T ss_pred HHhhhhhhhccCcccceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHH
Confidence 333344457788899888522 5788899999999999999999999999999999999999999
Q ss_pred cCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhh
Q psy6593 190 QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269 (433)
Q Consensus 190 ~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (433)
+.. +.+.......|.++|+.|+.|||...|||||||.-||||+.+..|||+|||-++.+....+
T Consensus 204 ka~-~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST--------------- 267 (904)
T KOG4721|consen 204 KAG-RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST--------------- 267 (904)
T ss_pred hcc-CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhh---------------
Confidence 874 4699999999999999999999999999999999999999999999999999987755322
Q ss_pred hcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHH
Q psy6593 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPF 349 (433)
Q Consensus 270 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 349 (433)
...++||..|||||++...+.+.|+|||||||+|||||||.-|+.+.......+.+-...+....+..+|+.|
T Consensus 268 -------kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gf 340 (904)
T KOG4721|consen 268 -------KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGF 340 (904)
T ss_pred -------hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHH
Confidence 2278999999999999999999999999999999999999999998888888888888888888899999999
Q ss_pred HHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 350 VRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 350 ~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
.-|+++||+..|.+||+|.+|+..|+-..
T Consensus 341 klL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 341 KLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred HHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 99999999999999999999998877543
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=289.80 Aligned_cols=233 Identities=24% Similarity=0.338 Sum_probs=191.6
Q ss_pred ccccCCeeeeeccCCCcchhhhhc---------------------------cchHHHHhhcCCcceeeEEEEEEeC--Ce
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQN---------------------------CGQVAVLRSLHHHNVIRFIGVLYKD--RK 172 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~---------------------------~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 172 (433)
.-.++++....++.+|.||.||++ ++||.+|.+++|||||.+.++.... +.
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 445666778889999999999972 2899999999999999999998754 57
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
+||||||++. +|..++...+++|...++..++.|++.||+|||...|+||||||+|+|++..|.+||+|||+|+.++..
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999999975 999999888888999999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCC---
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP--- 328 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~--- 328 (433)
... ....+-|.+|+|||.+.+ ..|+.+.|+||+|||+.||+++.|.++....-..
T Consensus 231 ~k~---------------------~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~ 289 (419)
T KOG0663|consen 231 LKP---------------------YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK 289 (419)
T ss_pred ccc---------------------CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH
Confidence 322 225678999999999987 5799999999999999999999988764321100
Q ss_pred --------------------------CCCCchhhhccccCC-CCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHh
Q psy6593 329 --------------------------DFGLDQTDFRNKFCA-SCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEG 376 (433)
Q Consensus 329 --------------------------~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~ 376 (433)
.....-..++..+.. .+++.-.+|+..+|.+||.+|.|+++.+ .|+.+
T Consensus 290 If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 290 IFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred HHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 000111122233332 2668889999999999999999999987 47765
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=299.52 Aligned_cols=258 Identities=21% Similarity=0.296 Sum_probs=205.7
Q ss_pred ccCCeeeeeccCCCcchhhhh----------------------------ccchHHHHhhcCCcceeeEEEEEEeCCeeeE
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQ----------------------------NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~----------------------------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 175 (433)
.-+.+...+.+|.|.-|.||- +..|.+||+.++||.++.+|..|+.++..|+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 344466667777777777774 2279999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCC
Q psy6593 176 VTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
|||||+||+|..++++ +++.|++..++-++.+++.||+|||.+|||+|||||+||||.++|++.|+||.++......+.
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 9999999999999876 566799999999999999999999999999999999999999999999999999987643222
Q ss_pred CCccc----------------cccchh---hhhh----------------hcccccceeeeccCccccccceecCCCCCc
Q psy6593 255 APTTV----------------MAKVPR---KAAQ----------------RRGARKKRYTVVGNPYWMAPEMMTGQEYDE 299 (433)
Q Consensus 255 ~~~~~----------------~~~~~~---~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 299 (433)
..... ....++ .... ..+...+...++||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 11100 000001 0000 122334556789999999999999999999
Q ss_pred ccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCC----hhHHH--HH
Q psy6593 300 TVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP----FEVLE--VW 373 (433)
Q Consensus 300 ~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs----~~~i~--~~ 373 (433)
++|+|+||+++|||+.|..||...........+........-...++..+++||+++|.+||.+|.. +.||. .+
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpF 394 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPF 394 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCcc
Confidence 9999999999999999999998776666555554444333223467789999999999999999997 88887 58
Q ss_pred HHhhcccc
Q psy6593 374 LEGLSMHL 381 (433)
Q Consensus 374 l~~~~~~~ 381 (433)
|+.+.+.+
T Consensus 395 F~gVnWaL 402 (459)
T KOG0610|consen 395 FEGVNWAL 402 (459)
T ss_pred ccCCChhh
Confidence 88888765
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=299.99 Aligned_cols=212 Identities=26% Similarity=0.460 Sum_probs=174.7
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+..|+.++||||++++..|..++.+|+||.||.+||+.++++. -...+++..+..|+++++.||.|||++|.|||||
T Consensus 73 kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdv 152 (516)
T KOG0582|consen 73 KEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDV 152 (516)
T ss_pred HHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceeccc
Confidence 799999999999999999999999999999999999999999976 2334999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccce-eeeccCccccccceecC--CCCCcccC
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKR-YTVVGNPYWMAPEMMTG--QEYDETVD 302 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~~D 302 (433)
|+.||||+.+|.|||+|||.+..+....... ..+ .+++||+.|||||++.. ..|+.|+|
T Consensus 153 KAgnILi~~dG~VkLadFgvsa~l~~~G~R~------------------~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaD 214 (516)
T KOG0582|consen 153 KAGNILIDSDGTVKLADFGVSASLFDSGDRQ------------------VTRFNTFVGTPCWMAPEVLMQQLHGYDFKAD 214 (516)
T ss_pred ccccEEEcCCCcEEEcCceeeeeecccCcee------------------eEeeccccCcccccChHHhhhcccCccchhh
Confidence 9999999999999999999988765533111 111 37799999999999654 57999999
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCCCCCCCc--------hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--H
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRSPDFGLD--------QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--V 372 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~ 372 (433)
|||||++..||.+|..||..+.+.......- ............+..+++++..||+.||.+||++++++ .
T Consensus 215 IwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 215 IWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred hhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 9999999999999999998765433211110 01111122245667899999999999999999999997 3
Q ss_pred HHHh
Q psy6593 373 WLEG 376 (433)
Q Consensus 373 ~l~~ 376 (433)
||..
T Consensus 295 FFk~ 298 (516)
T KOG0582|consen 295 FFKK 298 (516)
T ss_pred HHhh
Confidence 6654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=312.16 Aligned_cols=208 Identities=20% Similarity=0.256 Sum_probs=172.3
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..+|+.+|++++||||+++++++..++..++||||+++++|.+++...+ .+++..+..++.||+.||+|||+.||+|||
T Consensus 42 ~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~ivHrD 120 (323)
T cd05571 42 TLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALGYLHSCDVVYRD 120 (323)
T ss_pred HHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCC
Confidence 4479999999999999999999999999999999999999999987643 599999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|||+||+++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||
T Consensus 121 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 179 (323)
T cd05571 121 LKLENLMLDKDGHIKITDFGLCKEGISDGA---------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179 (323)
T ss_pred CCHHHEEECCCCCEEEeeCCCCcccccCCC---------------------cccceecCccccChhhhcCCCCCccccCc
Confidence 999999999999999999999875322111 11256799999999999999999999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHHH--HHHh
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLEV--WLEG 376 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~~--~l~~ 376 (433)
|||+++|||++|.+||...........+ ......++..+++++.+++.+||+.||++|| ++.++++ |+..
T Consensus 180 SlG~il~elltg~~Pf~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 180 GLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred ccchhhhhhhcCCCCCCCCCHHHHHHHH--HcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999999999887543211110000 0112234567889999999999999999999 7888873 5554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=311.99 Aligned_cols=220 Identities=29% Similarity=0.401 Sum_probs=186.0
Q ss_pred CeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 127 GLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
++.+...+|+|+||.|||.- +|++|+++|+||||+.++++|+...++|+|.||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 34555678899999999721 899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccc
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
+.| +|..++...+ .++++.++.|+.+++.||.|||+.+|+|||+||+|||++.+|.+|++|||+++.........
T Consensus 83 a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl--- 157 (808)
T KOG0597|consen 83 AVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL--- 157 (808)
T ss_pred hhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceee---
Confidence 976 9999998855 59999999999999999999999999999999999999999999999999999876644322
Q ss_pred cccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhcc
Q psy6593 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRN 339 (433)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (433)
..+-|||.|||||.+.+.+|+..+|+||||||+||++.|.|||....-......+. .-..
T Consensus 158 ------------------tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~--~d~v 217 (808)
T KOG0597|consen 158 ------------------TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL--KDPV 217 (808)
T ss_pred ------------------eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh--cCCC
Confidence 26789999999999999999999999999999999999999985321100000000 0111
Q ss_pred ccCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 340 KFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 340 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
..+...+..+..+++.+|.+||..|.+..+++
T Consensus 218 ~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 218 KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLL 249 (808)
T ss_pred CCcccccHHHHHHHHHHhhcChhhcccHHHHh
Confidence 23457788999999999999999999999887
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=316.29 Aligned_cols=241 Identities=28% Similarity=0.492 Sum_probs=194.4
Q ss_pred cccccccCCeeeeeccCCCcchhhhhc-------------------------------cchHHHHhhc-CCcceeeEEEE
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQN-------------------------------CGQVAVLRSL-HHHNVIRFIGV 166 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~-------------------------------~~E~~~l~~l-~h~~iv~~~~~ 166 (433)
+.|.+..+++.+.+.+++|+||.||+. .+|+++|+.+ +|+||++++++
T Consensus 31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 456778888999999999999998731 1699999999 89999999999
Q ss_pred EEeCCeeeEEEeccCCCCHHHHhcCC------------------------------------------------------
Q psy6593 167 LYKDRKLNLVTEYIAGGTLKELLQDP------------------------------------------------------ 192 (433)
Q Consensus 167 ~~~~~~~~lv~e~~~g~sL~~~l~~~------------------------------------------------------ 192 (433)
+...+..++||||+++|+|.++++..
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 99999999999999999999988532
Q ss_pred ---------------CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCc
Q psy6593 193 ---------------GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPT 257 (433)
Q Consensus 193 ---------------~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 257 (433)
..++++..+++++.||+.||.|||+.||+||||||+||+++.++.++|+|||+++..........
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 12478889999999999999999999999999999999999999999999999876543221100
Q ss_pred cccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhh
Q psy6593 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTD 336 (433)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~ 336 (433)
.....++..|+|||++.+..++.++||||||+++|+|++ |.+||................
T Consensus 271 -------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~ 331 (374)
T cd05106 271 -------------------KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG 331 (374)
T ss_pred -------------------ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc
Confidence 002234567999999998899999999999999999996 888876543322211222222
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
.....+..+|+++.+++.+||+.+|.+||++.+|++.|+++.
T Consensus 332 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 332 YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 233334567899999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=314.10 Aligned_cols=244 Identities=28% Similarity=0.480 Sum_probs=208.7
Q ss_pred ccccccccCCeeeeeccCCCcchhhhh--------------------------------ccchHHHHhhcCCcceeeEEE
Q psy6593 118 LDNWYFEKDGLLFCKEDYNGKYGEACQ--------------------------------NCGQVAVLRSLHHHNVIRFIG 165 (433)
Q Consensus 118 l~~~~~~~~~~~~~~~~~~g~fg~v~~--------------------------------~~~E~~~l~~l~h~~iv~~~~ 165 (433)
.+.|.+..++..+.+++|+|.||+|++ .++|+++|++++|||||++||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 366888999999999999999999996 118999999999999999999
Q ss_pred EEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEecccc
Q psy6593 166 VLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGL 245 (433)
Q Consensus 166 ~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 245 (433)
+......++||||++.||+|.++|++.+..++..+...++.+.+.||+|||+++++||||..+|+|++.++.+||+|||+
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccc
Confidence 99999999999999999999999999777799999999999999999999999999999999999999999999999999
Q ss_pred chhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHh-cCCCCCCCCC
Q psy6593 246 ARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDYL 324 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~~~~~~~~~~ 324 (433)
++.-........ ..--...|+|||.+....++.++||||||+++||++ .|..|++...
T Consensus 309 s~~~~~~~~~~~---------------------~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~ 367 (474)
T KOG0194|consen 309 SRAGSQYVMKKF---------------------LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK 367 (474)
T ss_pred ccCCcceeeccc---------------------cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC
Confidence 876431111100 001235699999999999999999999999999999 4677776655
Q ss_pred CCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccccc
Q psy6593 325 PRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLS 382 (433)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~ 382 (433)
.......+....++...+...|..+..++.+||..+|++||++.++.++|+.+.....
T Consensus 368 ~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 368 NYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 4444344445566667778889999999999999999999999999999999876544
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=310.45 Aligned_cols=228 Identities=21% Similarity=0.341 Sum_probs=188.3
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCee
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~ 173 (433)
.+..+++.+.+.++.|+||.||+.. +|+.+|++++||||+++++++..++..
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 3456678888889999999888511 689999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 174 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
++||||++|++|.+++.+.+ .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EEEEcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 99999999999999997644 58999999999999999999999999999999999999999999999999987653211
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~ 333 (433)
....||+.|+|||++.+..++.++||||||+++|+|++|.+||....+......+
T Consensus 173 ------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i- 227 (329)
T PTZ00263 173 ------------------------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI- 227 (329)
T ss_pred ------------------------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHH-
Confidence 1457899999999999988999999999999999999999988653221111111
Q ss_pred hhhhccccCCCCcHHHHHHHHHhcccCCCCCCC-----hhHHH--HHHHh
Q psy6593 334 QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP-----FEVLE--VWLEG 376 (433)
Q Consensus 334 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~i~--~~l~~ 376 (433)
......++..++..+.+|+.+||+.||.+||+ +++|+ .|+..
T Consensus 228 -~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 228 -LAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred -hcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 11122345567889999999999999999997 57776 35544
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=315.35 Aligned_cols=233 Identities=21% Similarity=0.311 Sum_probs=197.4
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhc-CCcceeeEEEEEEeCCe
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSL-HHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~ 172 (433)
.+..+++.+.+-+|+|+||.|..+- .|..|+... +||.+++++..|+++++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 5677889999999999999998521 678888888 59999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
+|+||||+.||++..+.+. +.|++..++-++..++.||.|||+.||||||||.+|||+|.+|++||+|||+++.....
T Consensus 444 l~fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 9999999999996665554 46999999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL 332 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~ 332 (433)
.. ...+++|||.|+|||++.+..|+.++|+|||||+|||||.|.+||+..........+
T Consensus 522 g~---------------------~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI 580 (694)
T KOG0694|consen 522 GD---------------------RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI 580 (694)
T ss_pred CC---------------------ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 22 223899999999999999999999999999999999999999999876555444433
Q ss_pred chhhhccccCCCCcHHHHHHHHHhcccCCCCCCC-----hhHHH--HHHHhhcc
Q psy6593 333 DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP-----FEVLE--VWLEGLSM 379 (433)
Q Consensus 333 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~i~--~~l~~~~~ 379 (433)
... ...+|..++.+...|++++|..+|++|.- +++|. .+++.+.+
T Consensus 581 ~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 581 VND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred hcC--CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence 333 23356788999999999999999999974 45665 35555443
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=329.05 Aligned_cols=244 Identities=26% Similarity=0.430 Sum_probs=206.9
Q ss_pred cccCCeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhcCCcceeeEEEEEEeCC
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSLHHHNVIRFIGVLYKDR 171 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l~h~~iv~~~~~~~~~~ 171 (433)
++.+.+....-+|+|.||+||... +|+.+|+.++|||||+++|++.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 446778888899999999999721 8999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhcCC------CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEecccc
Q psy6593 172 KLNLVTEYIAGGTLKELLQDP------GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGL 245 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~------~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 245 (433)
..+|++|||+||+|..+|++. ...++..+.+.++.+|+.|..||+++++|||||...|+|++....+||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999999986 56799999999999999999999999999999999999999999999999999
Q ss_pred chhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHh-cCCCCCCCCC
Q psy6593 246 ARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDYL 324 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~~~~~~~~~~ 324 (433)
|+.+....++..... ..-...|||||.+..+.++.++|||||||++||++ -|.+|++...
T Consensus 849 ArDiy~~~yyr~~~~-------------------a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~ 909 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGE-------------------AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS 909 (1025)
T ss_pred hHhhhhchheeccCc-------------------cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc
Confidence 997665554433211 12235699999999999999999999999999999 5777887765
Q ss_pred CCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccccCCCC
Q psy6593 325 PRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKP 386 (433)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~~~~~ 386 (433)
+........... +...+..+|+.+.++|..||+.+|++||++..|++.+..+.........
T Consensus 910 n~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~ 970 (1025)
T KOG1095|consen 910 NFEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIY 970 (1025)
T ss_pred hHHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcc
Confidence 554433233333 6777899999999999999999999999999999988777655444333
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=308.92 Aligned_cols=206 Identities=28% Similarity=0.470 Sum_probs=180.1
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.+|+.+.||||+++|+++.++.++|+|.||++||-|.+++..++ ++++.++.+++.||+.|+.|+|..+|+|||||
T Consensus 61 rEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLK 139 (786)
T KOG0588|consen 61 REIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFNICHRDLK 139 (786)
T ss_pred hhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhcceeccCC
Confidence 89999999999999999999999999999999999999999998765 59999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCC-CcccCeEe
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY-DETVDVFS 305 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Diws 305 (433)
|+|+|++..+.+||+|||+|.....+.-. .+.+|+|.|++||++.|.+| +.++||||
T Consensus 140 pENlLLd~~~nIKIADFGMAsLe~~gklL----------------------eTSCGSPHYA~PEIV~G~pYdG~~sDVWS 197 (786)
T KOG0588|consen 140 PENLLLDVKNNIKIADFGMASLEVPGKLL----------------------ETSCGSPHYAAPEIVSGRPYDGRPSDVWS 197 (786)
T ss_pred chhhhhhcccCEeeeccceeecccCCccc----------------------cccCCCcccCCchhhcCCCCCCCccccch
Confidence 99999999888999999999876543322 26799999999999999887 57899999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
-|+|||.||+|..||.++.-+.....+.. ..-++|..++.+.++||.+||..||+.|.+.++|++ ||...
T Consensus 198 CGVILfALLtG~LPFdDdNir~LLlKV~~--G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 198 CGVILFALLTGKLPFDDDNIRVLLLKVQR--GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred hHHHHHHHHhCCCCCCCccHHHHHHHHHc--CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 99999999999999875433332222222 233467999999999999999999999999999985 77654
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=311.25 Aligned_cols=241 Identities=28% Similarity=0.430 Sum_probs=191.1
Q ss_pred ccccccccCCeeeeeccCCCcchhhhhc-------------------------------cchHHHHhhc-CCcceeeEEE
Q psy6593 118 LDNWYFEKDGLLFCKEDYNGKYGEACQN-------------------------------CGQVAVLRSL-HHHNVIRFIG 165 (433)
Q Consensus 118 l~~~~~~~~~~~~~~~~~~g~fg~v~~~-------------------------------~~E~~~l~~l-~h~~iv~~~~ 165 (433)
..++.+..+++.+.+.+++|+||+||+. .+|+.+|+.+ +||||+++++
T Consensus 27 ~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 27 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred ccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 3455666777888888899999988641 1699999999 8999999999
Q ss_pred EEEeCCeeeEEEeccCCCCHHHHhcCCC----------------------------------------------------
Q psy6593 166 VLYKDRKLNLVTEYIAGGTLKELLQDPG---------------------------------------------------- 193 (433)
Q Consensus 166 ~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------------------------------------------------- 193 (433)
++...+..++||||++||+|.+++++..
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 9999999999999999999999885421
Q ss_pred ----------------------CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 194 ----------------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 194 ----------------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
..+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||+++....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 2477888999999999999999999999999999999999999999999999976543
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDF 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~ 330 (433)
....... ....++..|+|||.+.+..++.++||||||+++|||++ |.+|+..........
T Consensus 267 ~~~~~~~-------------------~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~ 327 (375)
T cd05104 267 DSNYVVK-------------------GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY 327 (375)
T ss_pred ccccccc-------------------CCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHH
Confidence 2211000 02234567999999999999999999999999999996 777775432221111
Q ss_pred CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 331 GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
...........+...+.++.+|+.+||+.||++||++.+|++.|+..
T Consensus 328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 328 KMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11112222233455688999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=276.78 Aligned_cols=227 Identities=22% Similarity=0.323 Sum_probs=198.8
Q ss_pred cccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCe
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~ 172 (433)
..+..+++-+.+.+++|.||.||.+. +|++|-+.|+||||+++|++|.++..
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 46778889999999999999999633 89999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 173 LNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
.||++||..+|+|.+.+++ ...++++..+..++.|++.||.|+|.++++||||||+|+|++..+.+||+|||.+.....
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 9999999999999999974 345699999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG 331 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~ 331 (433)
.++.+.+||..|.+||+..+..++..+|+|++|++.||++.|.|||...........
T Consensus 177 -----------------------~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkr 233 (281)
T KOG0580|consen 177 -----------------------NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKR 233 (281)
T ss_pred -----------------------CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHH
Confidence 234488999999999999999999999999999999999999999976543322222
Q ss_pred CchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 332 LDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
.......++..++....++|.+|+.++|.+|.+..++..
T Consensus 234 --I~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 234 --IRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred --HHHccccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 223334566889999999999999999999999999874
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=288.75 Aligned_cols=229 Identities=24% Similarity=0.403 Sum_probs=187.6
Q ss_pred eeeeeccCCCcchhhhhcc---------------------chHHHHhhcCCcceeeEEEEEEeCC-----eeeEEEeccC
Q psy6593 128 LLFCKEDYNGKYGEACQNC---------------------GQVAVLRSLHHHNVIRFIGVLYKDR-----KLNLVTEYIA 181 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~~---------------------~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~ 181 (433)
+...+-+|.|+||.|+++. +|+++|+.++|||||++.-+|.... ...+||||++
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 4445577899999999843 8999999999999999999987542 4668999996
Q ss_pred CCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccC-CceEEeccccchhccCCCCCCc
Q psy6593 182 GGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRED-KTVVVADFGLARIIHQGPRAPT 257 (433)
Q Consensus 182 g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~ 257 (433)
.+|.+.++. .+..++...+.-+..||++||+|||+.||+||||||+|+|++.+ |.+||+|||.|+.+..+....
T Consensus 106 -~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epni- 183 (364)
T KOG0658|consen 106 -ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNI- 183 (364)
T ss_pred -HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCce-
Confidence 699999874 34669999999999999999999999999999999999999965 999999999999987655432
Q ss_pred cccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCC--------
Q psy6593 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP-------- 328 (433)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~-------- 328 (433)
++..|+.|+|||.+.+ ..|+.+.||||.||++.||+-|.|.|+.......
T Consensus 184 ---------------------SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~l 242 (364)
T KOG0658|consen 184 ---------------------SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVL 242 (364)
T ss_pred ---------------------eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHh
Confidence 7789999999999887 6799999999999999999999998875422111
Q ss_pred -------------------CCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhcc
Q psy6593 329 -------------------DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLSM 379 (433)
Q Consensus 329 -------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~~ 379 (433)
...+....+...+....+++..+|+.++|.++|.+|.++.+++ .+++.+..
T Consensus 243 G~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 243 GTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred CCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 1111122222224477899999999999999999999999997 57776653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=304.90 Aligned_cols=203 Identities=23% Similarity=0.389 Sum_probs=169.6
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+++|++++||||+++++++.+++..++||||+++++|.+++...+ .+++..+..++.|++.||+|||+.|++|||||
T Consensus 50 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 128 (291)
T cd05612 50 NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKEIVYRDLK 128 (291)
T ss_pred HHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence 68999999999999999999999999999999999999999997644 59999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.++|+|||++....... ....||+.|+|||.+.+..++.++|||||
T Consensus 129 p~NIli~~~~~~kl~Dfg~~~~~~~~~------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 184 (291)
T cd05612 129 PENILLDKEGHIKLTDFGFAKKLRDRT------------------------WTLCGTPEYLAPEVIQSKGHNKAVDWWAL 184 (291)
T ss_pred HHHeEECCCCCEEEEecCcchhccCCc------------------------ccccCChhhcCHHHHcCCCCCchhhHHHH
Confidence 999999999999999999987653211 14568999999999999889999999999
Q ss_pred hHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCC-----hhHHH--HHHHh
Q psy6593 307 GIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP-----FEVLE--VWLEG 376 (433)
Q Consensus 307 G~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~i~--~~l~~ 376 (433)
|+++|+|++|.+||...........+ ......++..++..+.+++++||+.||.+||+ +++++ .|+..
T Consensus 185 G~il~~l~~g~~pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 185 GILIYEMLVGYPPFFDDNPFGIYEKI--LAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHH--HhCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 99999999999887653221111111 11122345667889999999999999999995 77776 35543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=296.06 Aligned_cols=210 Identities=23% Similarity=0.410 Sum_probs=172.1
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.+|++++||||+++++++..++..++||||+++++|.+++......+++..++.++.|++.||+|||+.|++|||||
T Consensus 55 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dik 134 (266)
T cd05064 55 AEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLA 134 (266)
T ss_pred HHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccc
Confidence 79999999999999999999999999999999999999999997755679999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.++++|||.+......... ......++..|+|||.+.+..++.++|||||
T Consensus 135 p~nili~~~~~~~l~dfg~~~~~~~~~~~--------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 194 (266)
T cd05064 135 AHKVLVNSDLVCKISGFRRLQEDKSEAIY--------------------TTMSGKSPVLWAAPEAIQYHHFSSASDVWSF 194 (266)
T ss_pred HhhEEEcCCCcEEECCCcccccccccchh--------------------cccCCCCceeecCHHHHhhCCccchhHHHHH
Confidence 99999999999999999987653221110 0012234678999999999999999999999
Q ss_pred hHHHHHHh-cCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 307 GIVLCEII-GRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 307 G~il~ell-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
|+++||++ +|.+||...........+ ........+..+|..+.+++.+||+.+|++||++++|.+.|+++
T Consensus 195 G~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 195 GIVMWEVMSYGERPYWDMSGQDVIKAV-EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 99999987 588877553222111111 11122234567889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=305.73 Aligned_cols=228 Identities=21% Similarity=0.335 Sum_probs=188.4
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc-----------------------------chHHHHhhcCCcceeeEEEEEEeCCe
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC-----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~-----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~ 172 (433)
....+++.+.+.+++|+||+||++. +|+.+++.++||||+++++++.+++.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 3455667778888888888887521 58999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
.++||||++|++|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 999999999999999997644 5999999999999999999999999999999999999999999999999998764321
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL 332 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~ 332 (433)
.....||+.|+|||++.+..++.++||||||+++|||++|.+||....+......+
T Consensus 185 ------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i 240 (340)
T PTZ00426 185 ------------------------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI 240 (340)
T ss_pred ------------------------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 11567999999999999988999999999999999999999988653321111111
Q ss_pred chhhhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHHH--HHHh
Q psy6593 333 DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLEV--WLEG 376 (433)
Q Consensus 333 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~~--~l~~ 376 (433)
......++..+++.+.+++++||+.+|++|+ +++++++ |++.
T Consensus 241 --~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 241 --LEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred --hcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 1112234567789999999999999999995 7888864 5554
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=296.79 Aligned_cols=207 Identities=22% Similarity=0.324 Sum_probs=172.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEe----CCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC-Ccc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYK----DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM-NLI 221 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~ 221 (433)
+|+.+|++++||||+++++++.+ ...+++||||+++|+|.+++.+.+ .+++...+.++.|++.||.+||+. +++
T Consensus 67 ~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~ 145 (283)
T PHA02988 67 NEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNKP 145 (283)
T ss_pred HHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhcCCCC
Confidence 89999999999999999999877 347899999999999999997744 589999999999999999999984 999
Q ss_pred ccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC--CCCCc
Q psy6593 222 HRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG--QEYDE 299 (433)
Q Consensus 222 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ 299 (433)
||||||+||+++.++.+||+|||+++....... ...|+..|+|||.+.+ ..++.
T Consensus 146 Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~------------------------~~~~~~~y~aPE~~~~~~~~~~~ 201 (283)
T PHA02988 146 YKNLTSVSFLVTENYKLKIICHGLEKILSSPPF------------------------KNVNFMVYFSYKMLNDIFSEYTI 201 (283)
T ss_pred CCcCChhhEEECCCCcEEEcccchHhhhccccc------------------------cccCcccccCHHHhhhccccccc
Confidence 999999999999999999999999886533211 3467889999999976 67899
Q ss_pred ccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 300 TVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 300 ~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
++||||||+++|||++|..||....................++...|+.+.+++.+||+.||++||++++|+..|+.+.
T Consensus 202 k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 202 KDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred hhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 9999999999999999998886543221111111122233344568899999999999999999999999999998764
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=305.07 Aligned_cols=242 Identities=27% Similarity=0.466 Sum_probs=202.7
Q ss_pred ccccccccCCeeeeeccCCCcchhhhhcc------------------------chHHHHhhcCCcceeeEEEEEEeCCee
Q psy6593 118 LDNWYFEKDGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 118 l~~~~~~~~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~ 173 (433)
+..|.+..+.+.+..++|.|+||+|++.. +||.++++-+|.||+-+.|++.....
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 35577778889999999999999999843 89999999999999999999987766
Q ss_pred eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 174 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
.||..+|+|.+|+.+++.....|.....+.|++||++|+.|||.++|||||||..||++.+++.|||+|||++..-....
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 89999999999999998766789999999999999999999999999999999999999999999999999987533221
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecC---CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG---QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF 330 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~ 330 (433)
.. .....-.|...|||||++.. .+|+..+||||||+++|||++|..|+.........+
T Consensus 543 g~-------------------~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif 603 (678)
T KOG0193|consen 543 GE-------------------QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF 603 (678)
T ss_pred cc-------------------cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE
Confidence 00 00112347788999999875 478999999999999999999999998544444444
Q ss_pred CCchhhhcc---ccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 331 GLDQTDFRN---KFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 331 ~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
.+-..-+.+ ....++|+++.+|+..||.+++++||.+.+|+..|+.+..
T Consensus 604 mVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 604 MVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred EecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 444332222 2337788999999999999999999999999998888765
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=276.04 Aligned_cols=228 Identities=21% Similarity=0.323 Sum_probs=189.8
Q ss_pred CCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEe
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTE 178 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 178 (433)
+.+.++..+++|.|..|+.-. +|+.|-+.|+||||+++.+........|||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 346667788899999988611 79999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc---CCceEEeccccchhccCCCCC
Q psy6593 179 YIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE---DKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 179 ~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
++.|++|..-+-+. ..+++..+...+.||++||.|+|.+||||||+||+|+++.+ .--+||+|||++..+.....
T Consensus 91 ~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~- 168 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA- 168 (355)
T ss_pred cccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc-
Confidence 99999996544331 45899999999999999999999999999999999999963 34699999999998763222
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~ 335 (433)
...++|||.|+|||++...+|+..+|||+-|+|||-|+.|.+||.+.........+...
T Consensus 169 ---------------------~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g 227 (355)
T KOG0033|consen 169 ---------------------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG 227 (355)
T ss_pred ---------------------cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc
Confidence 12678999999999999999999999999999999999999998775444433333333
Q ss_pred --hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHh
Q psy6593 336 --DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEG 376 (433)
Q Consensus 336 --~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~ 376 (433)
.+....++.++++.++|+++||..||.+|.|+.|.+ .|+.+
T Consensus 228 ~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 228 AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 233334588899999999999999999999999987 36653
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=296.59 Aligned_cols=209 Identities=20% Similarity=0.290 Sum_probs=171.3
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+.+|++++|+||+++++++.+++..++||||+++++|.+++... ...+++..+..++.|++.||+|||+.||+||||
T Consensus 49 ~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~di 128 (285)
T cd05631 49 NEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDL 128 (285)
T ss_pred HHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCC
Confidence 6999999999999999999999999999999999999999887542 346899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||+++.++.++|+|||++........ .....||+.|+|||++.+..++.++||||
T Consensus 129 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~----------------------~~~~~g~~~y~aPE~~~~~~~~~~~Dvws 186 (285)
T cd05631 129 KPENILLDDRGHIRISDLGLAVQIPEGET----------------------VRGRVGTVGYMAPEVINNEKYTFSPDWWG 186 (285)
T ss_pred CHHHEEECCCCCEEEeeCCCcEEcCCCCe----------------------ecCCCCCCCccCHhhhcCCCCCcccCchh
Confidence 99999999999999999999876432111 11346899999999999999999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCc--hhhhccccCCCCcHHHHHHHHHhcccCCCCCCC-----hhHHHH--HHHh
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLD--QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP-----FEVLEV--WLEG 376 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~i~~--~l~~ 376 (433)
||+++|+|++|.+||............. .......++..++..+.+|+.+||+.||.+||+ ++++++ |++.
T Consensus 187 lGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 187 LGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 9999999999999886543221111111 011122345678899999999999999999997 677773 6655
Q ss_pred h
Q psy6593 377 L 377 (433)
Q Consensus 377 ~ 377 (433)
+
T Consensus 267 ~ 267 (285)
T cd05631 267 I 267 (285)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=297.53 Aligned_cols=232 Identities=27% Similarity=0.386 Sum_probs=182.8
Q ss_pred cccCCeeeeeccCCCcchhhhhcc---------------------------------------chHHHHhhcCCcceeeE
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC---------------------------------------GQVAVLRSLHHHNVIRF 163 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~---------------------------------------~E~~~l~~l~h~~iv~~ 163 (433)
...+.+.+.+++|+|.||.|..+. +||+||++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 344558888899999999887511 89999999999999999
Q ss_pred EEEEEeC--CeeeEEEeccCCCCHHHHhcCCCCC-CChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEE
Q psy6593 164 IGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQP-LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVV 240 (433)
Q Consensus 164 ~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~~-~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl 240 (433)
+++..+. +.+|||+||+..|.+...-.. .. +++.++++++..++.||+|||.+||+||||||+|+|++++|++||
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d--~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD--KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCC--cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 9998754 589999999988877544322 34 999999999999999999999999999999999999999999999
Q ss_pred eccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC----CCcccCeEehhHHHHHHhcC
Q psy6593 241 ADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE----YDETVDVFSYGIVLCEIIGR 316 (433)
Q Consensus 241 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~~ 316 (433)
+|||.+..+........+ ......+|||.|+|||...++. .+.+.||||+|++||.|+-|
T Consensus 252 sDFGVs~~~~~~~~~~~d----------------~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG 315 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSD----------------DQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFG 315 (576)
T ss_pred eccceeeecccCCccccH----------------HHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhc
Confidence 999999876544222111 1112478999999999987732 35789999999999999977
Q ss_pred CCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 317 VPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
..||.+.........+....+.......+.+.+++||++||.+||+.|.+..+|..
T Consensus 316 ~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 316 QLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred cCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 77665543333333333333332223456789999999999999999999988863
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=308.06 Aligned_cols=257 Identities=28% Similarity=0.466 Sum_probs=200.6
Q ss_pred CCCcccccCCccccccccccccccccccCCeeeeeccCCCcchhhhhc-------------------------------c
Q psy6593 98 DGESYALVERSILCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQN-------------------------------C 146 (433)
Q Consensus 98 ~g~~~~~~~~~~~C~~c~~~l~~~~~~~~~~~~~~~~~~g~fg~v~~~-------------------------------~ 146 (433)
+|..|..++...+- ..+++.+..+++++.+.++.|+||.||+. .
T Consensus 14 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~ 88 (400)
T cd05105 14 DGHEYIYVDPMQLP-----YDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALM 88 (400)
T ss_pred CCceeeeeccccCC-----CCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHH
Confidence 45556555544331 12466777888999999999999999641 0
Q ss_pred chHHHHhhcC-CcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC---------------------------------
Q psy6593 147 GQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP--------------------------------- 192 (433)
Q Consensus 147 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--------------------------------- 192 (433)
+|+++|++++ ||||+++++++......||||||+++|+|.+++.+.
T Consensus 89 ~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (400)
T cd05105 89 SELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVI 168 (400)
T ss_pred HHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhh
Confidence 6999999996 999999999999999999999999999999887531
Q ss_pred --------------------------------------------------------------CCCCChHHHHHHHHHHHH
Q psy6593 193 --------------------------------------------------------------GQPLPWGQRVNFARDIAA 210 (433)
Q Consensus 193 --------------------------------------------------------------~~~~~~~~~~~i~~qi~~ 210 (433)
...+++..++.++.|++.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~ 248 (400)
T cd05105 169 LSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVAR 248 (400)
T ss_pred hhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHH
Confidence 124778888999999999
Q ss_pred HHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccc
Q psy6593 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPE 290 (433)
Q Consensus 211 ~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 290 (433)
||+|||+.+|+|+||||+||+++.++.++|+|||+++.......... .....+++.|+|||
T Consensus 249 aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~-------------------~~~~~~~~~y~aPE 309 (400)
T cd05105 249 GMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS-------------------KGSTFLPVKWMAPE 309 (400)
T ss_pred HHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccc-------------------cCCcCCCcceEChh
Confidence 99999999999999999999999999999999999886543221110 11335677899999
Q ss_pred eecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhH
Q psy6593 291 MMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEV 369 (433)
Q Consensus 291 ~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 369 (433)
.+.+..++.++||||||+++|+|++ |..|+.....................+..++..+.+++.+||+.+|++||++.+
T Consensus 310 ~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~ 389 (400)
T cd05105 310 SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLH 389 (400)
T ss_pred hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHH
Confidence 9998889999999999999999984 766665432211111111112222344678899999999999999999999999
Q ss_pred HHHHHHhhc
Q psy6593 370 LEVWLEGLS 378 (433)
Q Consensus 370 i~~~l~~~~ 378 (433)
|.+.|+.+.
T Consensus 390 l~~~l~~l~ 398 (400)
T cd05105 390 LSDIVESLL 398 (400)
T ss_pred HHHHHHHHc
Confidence 999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=301.42 Aligned_cols=202 Identities=22% Similarity=0.334 Sum_probs=167.3
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..+|+.+|++++||||+++++++..++..++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.||+|||
T Consensus 40 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~HrD 118 (312)
T cd05585 40 TLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREG-RFDLSRARFYTAELLCALENLHKFNVIYRD 118 (312)
T ss_pred HHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCC
Confidence 4479999999999999999999999999999999999999999997644 599999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|||+||+++.++.++|+|||+++........ .....||+.|+|||.+.+..++.++|||
T Consensus 119 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~---------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 177 (312)
T cd05585 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDK---------------------TNTFCGTPEYLAPELLLGHGYTKAVDWW 177 (312)
T ss_pred CCHHHeEECCCCcEEEEECcccccCccCCCc---------------------cccccCCcccCCHHHHcCCCCCCcccee
Confidence 9999999999999999999998753221111 1145789999999999999999999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i 370 (433)
|||+++|+|++|.+||........... .......++..+++.+.+++.+||+.||.+||++..+
T Consensus 178 slGvil~el~tg~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 178 TLGVLLYEMLTGLPPFYDENVNEMYRK--ILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred chhHHHHHHHhCCCCcCCCCHHHHHHH--HHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 999999999999998865322111000 0111223456788999999999999999999865433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=287.16 Aligned_cols=230 Identities=23% Similarity=0.365 Sum_probs=184.0
Q ss_pred eeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEe-----CCeeeE
Q psy6593 128 LLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYK-----DRKLNL 175 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 175 (433)
++..+.+|.|.||.|+++. +|+.+|+.++|+||+.+++++.. -+.+|+
T Consensus 24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYi 103 (359)
T KOG0660|consen 24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYL 103 (359)
T ss_pred ecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEE
Confidence 3336788999999888622 89999999999999999999875 257999
Q ss_pred EEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCC
Q psy6593 176 VTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
|+|+| +.+|.+.++... .+++..+.-++.|++.||+|+|+.|++||||||.|++++.+..+||+|||+|+........
T Consensus 104 V~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 104 VFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred ehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 99999 679999998743 4999999999999999999999999999999999999999999999999999987643110
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCC-----
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPD----- 329 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~----- 329 (433)
..-..++.|.+|+|||.+.. ..|+.+.||||.|||+.||++|+|.|+........
T Consensus 182 -------------------~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~ 242 (359)
T KOG0660|consen 182 -------------------GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILE 242 (359)
T ss_pred -------------------cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHH
Confidence 01126788999999998754 78999999999999999999999998754221100
Q ss_pred ----------CCCc---hhhhcc-----------ccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 330 ----------FGLD---QTDFRN-----------KFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 330 ----------~~~~---~~~~~~-----------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
..+. ...+.. ....+.++...+|+.+||..||.+|+|+++.++ .|..+.
T Consensus 243 ~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 243 LLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred hcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 0000 001111 112567788999999999999999999999984 665543
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=301.43 Aligned_cols=209 Identities=19% Similarity=0.330 Sum_probs=168.7
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.|+.+|+++ +|+||+++++++..++.+++||||+++++|.+++.+.+ .+++..+..++.||+.||+|||+.||+||||
T Consensus 53 ~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDl 131 (332)
T cd05614 53 TERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKLGIVYRDI 131 (332)
T ss_pred HHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Confidence 689999999 59999999999999999999999999999999987643 5999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeE
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVF 304 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diw 304 (433)
||+|||++.++.++|+|||+++........ ......||+.|+|||++.+. .++.++|||
T Consensus 132 kp~Nili~~~~~~kl~DfG~~~~~~~~~~~--------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 191 (332)
T cd05614 132 KLENILLDSEGHVVLTDFGLSKEFLSEEKE--------------------RTYSFCGTIEYMAPEIIRGKGGHGKAVDWW 191 (332)
T ss_pred CHHHeEECCCCCEEEeeCcCCccccccCCC--------------------ccccccCCccccCHHHhcCCCCCCCccccc
Confidence 999999999999999999998765332211 11245799999999998864 478899999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCch--hhhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHHH--HHH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLDQ--TDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLEV--WLE 375 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~~--~l~ 375 (433)
|||+++|||++|.+||.............. ......++..++..+.+++.+||+.||++|| +++++++ |++
T Consensus 192 slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 271 (332)
T cd05614 192 SLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271 (332)
T ss_pred cchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcC
Confidence 999999999999998854322211111111 1112234467889999999999999999999 6667763 554
Q ss_pred h
Q psy6593 376 G 376 (433)
Q Consensus 376 ~ 376 (433)
+
T Consensus 272 ~ 272 (332)
T cd05614 272 G 272 (332)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=301.93 Aligned_cols=202 Identities=20% Similarity=0.269 Sum_probs=168.5
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.+|++++||||+++++++..++..|+||||++|++|.+++...+ .+++..+..++.|++.||+|||+.||+|||||
T Consensus 49 ~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 127 (323)
T cd05584 49 AERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQGIIYRDLK 127 (323)
T ss_pred HHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 69999999999999999999999999999999999999999987644 58899999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||
T Consensus 128 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 186 (323)
T cd05584 128 PENILLDAQGHVKLTDFGLCKESIHEGT---------------------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSL 186 (323)
T ss_pred HHHeEECCCCCEEEeeCcCCeecccCCC---------------------cccccCCCccccChhhccCCCCCCcceeccc
Confidence 9999999999999999999875322111 1114568999999999999889999999999
Q ss_pred hHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHHH
Q psy6593 307 GIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLEV 372 (433)
Q Consensus 307 G~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~~ 372 (433)
|+++|||++|.+||...........+ ......++..+++.+.+++.+||+.+|++|| +++++++
T Consensus 187 G~il~ell~G~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 187 GALMYDMLTGAPPFTAENRKKTIDKI--LKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHH--HcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 99999999999988653221111000 0112234567789999999999999999999 7888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=302.20 Aligned_cols=200 Identities=19% Similarity=0.272 Sum_probs=166.9
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.+|+++|++++||||+++++++..++..|+||||+++++|.+++.+.. .+++..++.++.||+.||+|||+.||+||||
T Consensus 46 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 124 (318)
T cd05582 46 KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDL 124 (318)
T ss_pred HHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCC
Confidence 379999999999999999999999999999999999999999986643 5999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||+++.++.++|+|||++........ ......||+.|+|||.+.+..++.++||||
T Consensus 125 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Diws 183 (318)
T cd05582 125 KPENILLDEEGHIKLTDFGLSKESIDHEK---------------------KAYSFCGTVEYMAPEVVNRRGHTQSADWWS 183 (318)
T ss_pred CHHHeEECCCCcEEEeeccCCcccCCCCC---------------------ceecccCChhhcCHHHHcCCCCCCccceec
Confidence 99999999999999999999876433211 112457899999999999888999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhH
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEV 369 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 369 (433)
||+++|+|++|..||...........+ ......++..+++.+.+++.+||+.||++||++.+
T Consensus 184 lG~il~el~tg~~p~~~~~~~~~~~~i--~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 184 FGVLMFEMLTGSLPFQGKDRKETMTMI--LKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred cceEeeeeccCCCCCCCCCHHHHHHHH--HcCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 999999999999887543221111000 01112345667899999999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=298.28 Aligned_cols=203 Identities=20% Similarity=0.246 Sum_probs=168.4
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.+|+.++++++||||+++++++..++..++||||+++++|.+++...+ .+++..++.++.||+.||+|||+.||+||||
T Consensus 43 ~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dl 121 (323)
T cd05595 43 VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDI 121 (323)
T ss_pred HHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCC
Confidence 379999999999999999999999999999999999999998887643 5999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||+++.++.+||+|||++........ ......||+.|+|||.+.+..++.++||||
T Consensus 122 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 180 (323)
T cd05595 122 KLENLMLDKDGHIKITDFGLCKEGISDGA---------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 180 (323)
T ss_pred CHHHEEEcCCCCEEecccHHhccccCCCC---------------------ccccccCCcCcCCcccccCCCCCchhchhh
Confidence 99999999999999999999875322111 111456899999999999989999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHHH
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLEV 372 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~~ 372 (433)
||+++|+|++|..||............. .....++..+++.+.+++.+||+.||.+|| ++.++++
T Consensus 181 lGvil~ell~g~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 181 LGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred hHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 9999999999988875432211111111 111234567889999999999999999998 7888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=294.16 Aligned_cols=204 Identities=25% Similarity=0.405 Sum_probs=164.3
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++++++||||+++++++..++..++||||+++ +|.+++...+..+++..+..++.||+.||+|||+.||+|||||
T Consensus 52 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlk 130 (288)
T cd07871 52 REVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLK 130 (288)
T ss_pred HHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 799999999999999999999999999999999964 9999987766668999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEe
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFS 305 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws 305 (433)
|+||+++.++.+||+|||+++........ .....+++.|+|||.+.+ ..++.++||||
T Consensus 131 p~Nil~~~~~~~kl~DfG~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Diws 189 (288)
T cd07871 131 PQNLLINEKGELKLADFGLARAKSVPTKT---------------------YSNEVVTLWYRPPDVLLGSTEYSTPIDMWG 189 (288)
T ss_pred HHHEEECCCCCEEECcCcceeeccCCCcc---------------------ccCceecccccChHHhcCCcccCcHHHHHH
Confidence 99999999999999999998754322111 113467899999998865 56899999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCC---------------CC-chhhhc------------cccCCCCcHHHHHHHHHhc
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDF---------------GL-DQTDFR------------NKFCASCPEPFVRIAFLCC 357 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~---------------~~-~~~~~~------------~~~~~~~~~~l~~li~~~l 357 (433)
||+++|+|++|.++|.......... .. ....+. ......++.++.+++.+||
T Consensus 190 lG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL 269 (288)
T cd07871 190 VGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLL 269 (288)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhc
Confidence 9999999999998885432110000 00 000000 0112356788999999999
Q ss_pred ccCCCCCCChhHHHH
Q psy6593 358 DLNPDQRPPFEVLEV 372 (433)
Q Consensus 358 ~~~p~~RPs~~~i~~ 372 (433)
+.||.+|||++++++
T Consensus 270 ~~dp~~R~t~~~~l~ 284 (288)
T cd07871 270 LYETKSRISAEAALR 284 (288)
T ss_pred CcCcccCCCHHHHhc
Confidence 999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=290.62 Aligned_cols=234 Identities=29% Similarity=0.517 Sum_probs=187.8
Q ss_pred cccCCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
+..+++.+.+++++|+||.||++. +|+.++++++|+||+++++.+...+..++||||
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 445567777777788887776521 699999999999999999999999999999999
Q ss_pred cCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcc
Q psy6593 180 IAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTT 258 (433)
Q Consensus 180 ~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 258 (433)
+++++|.+++.. .+..+++..++.++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~-- 160 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA-- 160 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceec--
Confidence 999999999865 34568999999999999999999999999999999999999999999999999998654321110
Q ss_pred ccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhh
Q psy6593 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDF 337 (433)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~ 337 (433)
.....++..|+|||.+.+..++.++||||||+++|+|++ |.+|+...........+ ....
T Consensus 161 ------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~ 221 (261)
T cd05072 161 ------------------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-QRGY 221 (261)
T ss_pred ------------------cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH-HcCC
Confidence 002235667999999988889999999999999999997 88887653222111111 1111
Q ss_pred ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 338 RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 338 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
.......+|.++.+++.+||+.+|++||++++|.++|+++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 222 RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 2223356789999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=304.05 Aligned_cols=232 Identities=22% Similarity=0.295 Sum_probs=183.8
Q ss_pred cccCCeeeeeccCCCcchhhhhcc-------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCC
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC-------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGG 183 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~-------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 183 (433)
+...++.+.+.+++|+||.||+.. +|+++|++|+||||+++++++..+...++|||++ ++
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~ 167 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KT 167 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CC
Confidence 355678888999999999998632 6999999999999999999999999999999999 46
Q ss_pred CHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccc
Q psy6593 184 TLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263 (433)
Q Consensus 184 sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 263 (433)
+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.........
T Consensus 168 ~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~-------- 238 (391)
T PHA03212 168 DLYCYLAAKR-NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN-------- 238 (391)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc--------
Confidence 8988886643 5899999999999999999999999999999999999999999999999998753221110
Q ss_pred hhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCC--------------
Q psy6593 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPD-------------- 329 (433)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~-------------- 329 (433)
......||+.|+|||++.+..++.++||||||+++|||++|.+++.........
T Consensus 239 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~ 306 (391)
T PHA03212 239 ------------KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRS 306 (391)
T ss_pred ------------ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHh
Confidence 112567999999999999989999999999999999999887654321110000
Q ss_pred ------CCCch----h-hh--------cc-------ccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHh
Q psy6593 330 ------FGLDQ----T-DF--------RN-------KFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEG 376 (433)
Q Consensus 330 ------~~~~~----~-~~--------~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~ 376 (433)
..... . .+ .. .....+|.++.+||.+||+.||++|||+++++ .||..
T Consensus 307 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 307 GTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred cCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 00000 0 00 00 00023567899999999999999999999998 57765
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=296.77 Aligned_cols=204 Identities=20% Similarity=0.250 Sum_probs=169.5
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..+|+.+|++++||||+++++++..++..++||||+++++|.+++...+ .+++..++.++.||+.||+|||+.||+|||
T Consensus 42 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrD 120 (328)
T cd05593 42 TLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120 (328)
T ss_pred HHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecc
Confidence 3479999999999999999999999999999999999999999887643 599999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|||+|||++.++.+||+|||+++........ .....||+.|+|||.+.+..++.++|||
T Consensus 121 ikp~NIll~~~~~~kL~DfG~~~~~~~~~~~---------------------~~~~~gt~~y~aPE~~~~~~~~~~~Diw 179 (328)
T cd05593 121 LKLENLMLDKDGHIKITDFGLCKEGITDAAT---------------------MKTFCGTPEYLAPEVLEDNDYGRAVDWW 179 (328)
T ss_pred cCHHHeEECCCCcEEEecCcCCccCCCcccc---------------------cccccCCcCccChhhhcCCCCCccCCcc
Confidence 9999999999999999999998753221110 1145689999999999998999999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHHH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLEV 372 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~~ 372 (433)
|||+++|+|++|.+||...........+. .....++..++.++.+++.+||+.||++|+ +++++++
T Consensus 180 slGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 180 GLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred ccchHHHHHhhCCCCCCCCCHHHHHHHhc--cCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 99999999999998885432211111110 112234567889999999999999999997 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=300.62 Aligned_cols=197 Identities=22% Similarity=0.310 Sum_probs=161.1
Q ss_pred HHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcce
Q psy6593 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 230 (433)
Q Consensus 151 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Ni 230 (433)
++++++||||+++++++..++..|+||||++|++|..++.. ..+++..++.++.||+.||+|||+.|++||||||+||
T Consensus 55 ~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Ni 132 (324)
T cd05589 55 TANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNL 132 (324)
T ss_pred hccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHe
Confidence 34567899999999999999999999999999999998865 4699999999999999999999999999999999999
Q ss_pred EEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHH
Q psy6593 231 LVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310 (433)
Q Consensus 231 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 310 (433)
+++.++.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++
T Consensus 133 ll~~~~~~kL~Dfg~~~~~~~~~~---------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il 191 (324)
T cd05589 133 LLDTEGFVKIADFGLCKEGMGFGD---------------------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLI 191 (324)
T ss_pred EECCCCcEEeCcccCCccCCCCCC---------------------cccccccCccccCHhHhcCCCCCcccchhhHHHHH
Confidence 999999999999999864322111 11246789999999999998999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHHH
Q psy6593 311 CEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLEV 372 (433)
Q Consensus 311 ~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~~ 372 (433)
|+|++|.+||........... .......++..++..+.+++.+||+.||.+|| ++.++++
T Consensus 192 ~el~~G~~pf~~~~~~~~~~~--i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 192 YEMLVGESPFPGDDEEEVFDS--IVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHHhCCCCCCCCCHHHHHHH--HHhCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 999999988864322111110 11112234567889999999999999999999 4566653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=298.30 Aligned_cols=197 Identities=24% Similarity=0.309 Sum_probs=162.3
Q ss_pred HHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcc
Q psy6593 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 229 (433)
Q Consensus 150 ~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~N 229 (433)
.+++.++|+||+++++++..++..++||||++|++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 48 ~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~N 126 (325)
T cd05602 48 VLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPEN 126 (325)
T ss_pred HHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHH
Confidence 35677899999999999999999999999999999999997644 58899999999999999999999999999999999
Q ss_pred eEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHH
Q psy6593 230 CLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIV 309 (433)
Q Consensus 230 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 309 (433)
|+++.++.++|+|||+++....... ......||+.|+|||++.+..++.++||||||++
T Consensus 127 ili~~~~~~kl~DfG~a~~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 185 (325)
T cd05602 127 ILLDSQGHIVLTDFGLCKENIEHNG---------------------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAV 185 (325)
T ss_pred eEECCCCCEEEccCCCCcccccCCC---------------------CcccccCCccccCHHHHcCCCCCCccccccccHH
Confidence 9999999999999999875322111 1114579999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHH
Q psy6593 310 LCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370 (433)
Q Consensus 310 l~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i 370 (433)
+|+|++|.+||...........+ ......+...+++.+.+++.+||+.+|.+||++.+.
T Consensus 186 l~el~~g~~pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 186 LYEMLYGLPPFYSRNTAEMYDNI--LNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred HHHHhcCCCCCCCCCHHHHHHHH--HhCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 99999999988653221111111 011122345788999999999999999999988743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=304.22 Aligned_cols=250 Identities=20% Similarity=0.302 Sum_probs=182.1
Q ss_pred eeeeeccCCCcchhhhhc----------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 128 LLFCKEDYNGKYGEACQN----------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~----------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
+...+.+|+|+||+||++ .+|+++|++++|+||+++++++.+++.+++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 456667778888877752 1688999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcc-
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTT- 258 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~- 258 (433)
++|++|.+++.+.+ .+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++..+.........
T Consensus 83 ~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 83 IPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 99999999987644 5899999999999999999999999999999999999999999999999998654211100000
Q ss_pred --------cccc---------------chhh--hhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHH
Q psy6593 259 --------VMAK---------------VPRK--AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI 313 (433)
Q Consensus 259 --------~~~~---------------~~~~--~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 313 (433)
.... .... ...............||+.|+|||.+.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el 241 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence 0000 0000 00000000111246799999999999988899999999999999999
Q ss_pred hcCCCCCCCCCCCCCCCCCch--hhhccccCCCCcHHHHHHHHHhc--ccCCCCCCChhHHHH--HHHhhc
Q psy6593 314 IGRVPADPDYLPRSPDFGLDQ--TDFRNKFCASCPEPFVRIAFLCC--DLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 314 l~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l--~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
++|.+||...........+.. ..........+++++.+++.+|+ ..++..||++++|++ |++...
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 242 LVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred HhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 999998865432221111110 01111112357899999999965 445556999999984 666543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=300.31 Aligned_cols=205 Identities=23% Similarity=0.383 Sum_probs=169.7
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+++|.+++||||+++++++..++..|+||||++|++|.+++...+ .+++..++.++.||+.||.|||+.||+|||||
T Consensus 50 ~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 128 (333)
T cd05600 50 TERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128 (333)
T ss_pred HHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 68999999999999999999999999999999999999999997643 58999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||
T Consensus 129 p~Nil~~~~~~~kL~Dfg~a~~~~~~------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 184 (333)
T cd05600 129 PENFLIDASGHIKLTDFGLSKGIVTY------------------------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSL 184 (333)
T ss_pred HHHEEECCCCCEEEEeCcCCcccccc------------------------cCCcccCccccChhHhcCCCCCCccceecc
Confidence 99999999999999999998765331 114578999999999999899999999999
Q ss_pred hHHHHHHhcCCCCCCCCCCCCCCCCCch--hhhcc-cc---CCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 307 GIVLCEIIGRVPADPDYLPRSPDFGLDQ--TDFRN-KF---CASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 307 G~il~ell~~~~~~~~~~~~~~~~~~~~--~~~~~-~~---~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
|+++|||++|.+||...........+.. ..... .. ...+++++.+++.+||+.+|.+||+++++++ |+..
T Consensus 185 G~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 185 GCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred hHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 9999999999998865332111100000 00000 00 1256889999999999999999999999984 5554
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=305.45 Aligned_cols=228 Identities=18% Similarity=0.253 Sum_probs=167.4
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+++|++++||||+++++++.+++.+|+||||++|++|.+++... ..+++..++.++.|++.||+|||+.||+|||||
T Consensus 50 ~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlk 128 (377)
T cd05629 50 AERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIK 128 (377)
T ss_pred HHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence 5899999999999999999999999999999999999999998764 458999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCcc-----ccccc---------------------hhhhhhhcccccceeee
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTT-----VMAKV---------------------PRKAAQRRGARKKRYTV 280 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~-----~~~~~---------------------~~~~~~~~~~~~~~~~~ 280 (433)
|+||+++.++.++|+|||+++.+......... ..... .....+...........
T Consensus 129 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (377)
T cd05629 129 PDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYST 208 (377)
T ss_pred HHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc
Confidence 99999999999999999999744221100000 00000 00000000000011135
Q ss_pred ccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccC--CCCcHHHHHHHHHhcc
Q psy6593 281 VGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFC--ASCPEPFVRIAFLCCD 358 (433)
Q Consensus 281 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~ 358 (433)
.||+.|+|||++.+..++.++|||||||++|||++|.+||...........+........++ ..++.++.+++.+||.
T Consensus 209 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~ 288 (377)
T cd05629 209 VGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT 288 (377)
T ss_pred CCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc
Confidence 79999999999999899999999999999999999999986533211111110000011122 2467899999999997
Q ss_pred cCCCCC---CChhHHHH--HHHh
Q psy6593 359 LNPDQR---PPFEVLEV--WLEG 376 (433)
Q Consensus 359 ~~p~~R---Ps~~~i~~--~l~~ 376 (433)
+|.+| +++.+++. ||..
T Consensus 289 -~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 289 -NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred -CHhhcCCCCCHHHHhcCCCcCC
Confidence 67665 58888874 6654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=296.13 Aligned_cols=211 Identities=27% Similarity=0.483 Sum_probs=166.1
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC------------------CCCChHHHHHHHHHH
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG------------------QPLPWGQRVNFARDI 208 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~------------------~~~~~~~~~~i~~qi 208 (433)
+|+++|.+++||||+++++++.+.+..++||||+++++|.+++.... ..+++..++.++.||
T Consensus 68 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i 147 (304)
T cd05096 68 KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQI 147 (304)
T ss_pred HHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHH
Confidence 79999999999999999999999999999999999999999885421 236778899999999
Q ss_pred HHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccc
Q psy6593 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMA 288 (433)
Q Consensus 209 ~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 288 (433)
+.||.|||+.||+||||||+||+++.++.+||+|||+++.......... .....++..|+|
T Consensus 148 ~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~-------------------~~~~~~~~~y~a 208 (304)
T cd05096 148 ASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRI-------------------QGRAVLPIRWMA 208 (304)
T ss_pred HHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEe-------------------cCcCCCCccccC
Confidence 9999999999999999999999999999999999999876533221100 002345778999
Q ss_pred cceecCCCCCcccCeEehhHHHHHHhc--CCCCCCCCCCCCCCCCCc------hhhhccccCCCCcHHHHHHHHHhcccC
Q psy6593 289 PEMMTGQEYDETVDVFSYGIVLCEIIG--RVPADPDYLPRSPDFGLD------QTDFRNKFCASCPEPFVRIAFLCCDLN 360 (433)
Q Consensus 289 PE~~~~~~~~~~~DiwslG~il~ell~--~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~ 360 (433)
||.+.+..++.++||||||+++|+|++ +..|+............. ........+..+|..+.+++.+||+.+
T Consensus 209 PE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 288 (304)
T cd05096 209 WECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRD 288 (304)
T ss_pred HHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCC
Confidence 999988889999999999999999985 444554322111100000 000111223567899999999999999
Q ss_pred CCCCCChhHHHHHHHh
Q psy6593 361 PDQRPPFEVLEVWLEG 376 (433)
Q Consensus 361 p~~RPs~~~i~~~l~~ 376 (433)
|++||++++|.++|++
T Consensus 289 p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 289 CRERPSFSDIHAFLTE 304 (304)
T ss_pred chhCcCHHHHHHHHhC
Confidence 9999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=304.60 Aligned_cols=228 Identities=27% Similarity=0.467 Sum_probs=196.7
Q ss_pred ccCCeeeeeccCCCcchhhhhcc-------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEe
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTE 178 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 178 (433)
..+-.-++.++|.|.||.|||+. -||+||...+||+||++++.|..++.+||+.|
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 34445567789999999999843 58999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcc
Q psy6593 179 YIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTT 258 (433)
Q Consensus 179 ~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 258 (433)
||.||-+..++-.-+..+.+.++.-+.+|++.||.|||+++|+|||||..|||++-+|.++|+|||.+.....
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~------- 182 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS------- 182 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh-------
Confidence 9999999999888778899999999999999999999999999999999999999999999999999865322
Q ss_pred ccccchhhhhhhcccccceeeeccCccccccceec-----CCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc
Q psy6593 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT-----GQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~ 333 (433)
..+++.+++|||+|||||+.. ..+|+.++||||||++|.||..+.||-....+......+.
T Consensus 183 --------------t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia 248 (1187)
T KOG0579|consen 183 --------------TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA 248 (1187)
T ss_pred --------------HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh
Confidence 334556899999999999874 4689999999999999999999999988776655544443
Q ss_pred hhhh-ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 334 QTDF-RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 334 ~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
.... ....|..++..|.+++++||.+||+.||++.+|++
T Consensus 249 KSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 249 KSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 3322 22345788899999999999999999999999873
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=288.62 Aligned_cols=210 Identities=28% Similarity=0.500 Sum_probs=172.7
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|++++++++|+||+++++++..+..+++||||+++++|.+++... ...+++..++.++.|++.||++||+.|++|+||
T Consensus 51 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dl 130 (263)
T cd05052 51 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 130 (263)
T ss_pred HHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeeccc
Confidence 6999999999999999999999999999999999999999998653 345899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||++++++.++|+|||++........... ....++..|+|||.+.+..++.++||||
T Consensus 131 kp~nil~~~~~~~kl~df~~~~~~~~~~~~~~--------------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 190 (263)
T cd05052 131 AARNCLVGENHLVKVADFGLSRLMTGDTYTAH--------------------AGAKFPIKWTAPESLAYNKFSIKSDVWA 190 (263)
T ss_pred CcceEEEcCCCcEEeCCCccccccccceeecc--------------------CCCCCccccCCHHHhccCCCCchhHHHH
Confidence 99999999999999999999876543221100 0122356799999999889999999999
Q ss_pred hhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 306 YGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 306 lG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
||+++|||++ |.+|+........ ............+..+|..+.+++.+||+.+|++||++.++.+.|+.+
T Consensus 191 lG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 191 FGVLLWEIATYGMSPYPGIDLSQV-YELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 9999999997 8887754322111 111111223344577889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=295.29 Aligned_cols=228 Identities=21% Similarity=0.365 Sum_probs=180.5
Q ss_pred cCCeeeeeccCCCcchhhhh--------------------------ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEe
Q psy6593 125 KDGLLFCKEDYNGKYGEACQ--------------------------NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTE 178 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~--------------------------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 178 (433)
.+++...+.+++|+||.|++ ..+|+++|++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 34455566667777776664 1179999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC-CccccCCCCcceEEccCCceEEeccccchhccCCCCCCc
Q psy6593 179 YIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPT 257 (433)
Q Consensus 179 ~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 257 (433)
|+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 159 (331)
T cd06649 84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--- 159 (331)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccccc---
Confidence 999999999997644 589999999999999999999986 699999999999999999999999999876532211
Q ss_pred cccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCC---------
Q psy6593 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP--------- 328 (433)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~--------- 328 (433)
....||+.|+|||.+.+..++.++||||||+++|||++|..|+........
T Consensus 160 --------------------~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 219 (331)
T cd06649 160 --------------------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVV 219 (331)
T ss_pred --------------------ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccccc
Confidence 144689999999999998999999999999999999999888753211000
Q ss_pred ------CCCCc------------------------------hhhhcccc-CCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 329 ------DFGLD------------------------------QTDFRNKF-CASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 329 ------~~~~~------------------------------~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
..... ........ ...+++++.+|+.+||+.||++||++++|+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell 299 (331)
T cd06649 220 DGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLM 299 (331)
T ss_pred ccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHh
Confidence 00000 00000011 124678999999999999999999999998
Q ss_pred H--HHHh
Q psy6593 372 V--WLEG 376 (433)
Q Consensus 372 ~--~l~~ 376 (433)
+ ||..
T Consensus 300 ~h~~~~~ 306 (331)
T cd06649 300 NHTFIKR 306 (331)
T ss_pred cChHHhh
Confidence 4 7765
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=303.22 Aligned_cols=229 Identities=18% Similarity=0.329 Sum_probs=170.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.+|..++|+||+++++++.+++.+++||||++|++|.+++...+ .+++..+..++.|++.||+|||+.||+|||||
T Consensus 50 ~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlk 128 (364)
T cd05599 50 AERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLGYIHRDIK 128 (364)
T ss_pred HHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCC
Confidence 59999999999999999999999999999999999999999987644 59999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccc-----------------cchhhhhhhcccccceeeeccCcccccc
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA-----------------KVPRKAAQRRGARKKRYTVVGNPYWMAP 289 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~gt~~y~aP 289 (433)
|+|||++.++.++|+|||++..+............ ....................||+.|+||
T Consensus 129 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 208 (364)
T cd05599 129 PDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAP 208 (364)
T ss_pred HHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCH
Confidence 99999999999999999998765332111000000 0000000000011112245799999999
Q ss_pred ceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccC--CCCcHHHHHHHHHhcccCCCCCCC-
Q psy6593 290 EMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFC--ASCPEPFVRIAFLCCDLNPDQRPP- 366 (433)
Q Consensus 290 E~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~RPs- 366 (433)
|++.+..++.++|||||||++|||++|.+||...........+........++ ..+++.+.++|.+|+. +|.+|++
T Consensus 209 E~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~ 287 (364)
T cd05599 209 EVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGN 287 (364)
T ss_pred HHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCC
Confidence 99999899999999999999999999999886543221111000000001111 3468899999999996 9999998
Q ss_pred --hhHHHH--HHHhh
Q psy6593 367 --FEVLEV--WLEGL 377 (433)
Q Consensus 367 --~~~i~~--~l~~~ 377 (433)
+++++. |+...
T Consensus 288 ~~~~~ll~h~~~~~~ 302 (364)
T cd05599 288 NGVNEIKSHPFFKGV 302 (364)
T ss_pred CCHHHHhcCCCcCCC
Confidence 888874 55543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=298.80 Aligned_cols=198 Identities=25% Similarity=0.344 Sum_probs=161.9
Q ss_pred chHH-HHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVA-VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.|.. +++.++||||+++++.+..++..++||||++|++|.+++...+ .+++..+..++.||+.||+|||+.||+||||
T Consensus 44 ~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~givH~di 122 (323)
T cd05575 44 AERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLHSLNIIYRDL 122 (323)
T ss_pred HHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCC
Confidence 4444 4677899999999999999999999999999999999987643 5999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||+++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||
T Consensus 123 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws 181 (323)
T cd05575 123 KPENILLDSQGHVVLTDFGLCKEGIEHSK---------------------TTSTFCGTPEYLAPEVLRKQPYDRTVDWWC 181 (323)
T ss_pred CHHHeEECCCCcEEEeccCCCcccccCCC---------------------ccccccCChhhcChhhhcCCCCCccccccc
Confidence 99999999999999999999875322111 111456899999999999989999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChh
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFE 368 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~ 368 (433)
||+++|+|++|.+||...........+ ......++..++..+.+++.+||+.+|.+||++.
T Consensus 182 lG~il~ell~g~~pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 182 LGAVLYEMLYGLPPFYSRDTAEMYDNI--LNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHH--HcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 999999999999888643211110000 0111223466789999999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=313.19 Aligned_cols=205 Identities=21% Similarity=0.322 Sum_probs=169.1
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
+|+.+|+.++||||+++++++..++..||||||++|++|.+++.+ ...++++..+..++.|++.||.|||+.||+||
T Consensus 114 ~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHr 193 (478)
T PTZ00267 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHR 193 (478)
T ss_pred HHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEEC
Confidence 699999999999999999999999999999999999999988753 23468999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
||||+||+++.++.+||+|||+++......... ......||+.|+|||++.+..++.++||
T Consensus 194 Dlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 254 (478)
T PTZ00267 194 DLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD-------------------VASSFCGTPYYLAPELWERKRYSKKADM 254 (478)
T ss_pred CcCHHhEEECCCCcEEEEeCcCceecCCccccc-------------------cccccCCCccccCHhHhCCCCCCcHHhH
Confidence 999999999999999999999998654322110 1124579999999999999899999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
||||+++|+|++|.+|+............. ......++..++..+.++|.+||+.+|++||++++++
T Consensus 255 ~slG~~l~el~tg~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l 321 (478)
T PTZ00267 255 WSLGVILYELLTLHRPFKGPSQREIMQQVL-YGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321 (478)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 999999999999988875432111000000 0111123456789999999999999999999999986
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=287.95 Aligned_cols=222 Identities=23% Similarity=0.423 Sum_probs=186.3
Q ss_pred cCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEE
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 176 (433)
+..+.+.+++|+|.||.|-++. +||+||+.|+||||+.+|++|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3446667788899999876522 899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCC
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
|||..+|.|++++.+.+ .+++.+++.+++||++|+.|+|..+++|||||.+|||++.++.+||+|||++-.+.....
T Consensus 132 MEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf-- 208 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF-- 208 (668)
T ss_pred EEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccH--
Confidence 99999999999998865 499999999999999999999999999999999999999999999999999987654321
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCC-CcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY-DETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~ 335 (433)
..+++|+|-|.+||++.+.+| ++.+|-||||++||.|+.|.-||....-......+...
T Consensus 209 --------------------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G 268 (668)
T KOG0611|consen 209 --------------------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG 268 (668)
T ss_pred --------------------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc
Confidence 227899999999999999887 57899999999999999777776543322222222222
Q ss_pred hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 336 DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 336 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
.++. ..-|....-||++||-.||++|.++++|..
T Consensus 269 aYrE---P~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 269 AYRE---PETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred cccC---CCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 2221 445778899999999999999999999975
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=298.32 Aligned_cols=198 Identities=24% Similarity=0.318 Sum_probs=161.3
Q ss_pred chH-HHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQV-AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.|. .+++.++||||+++++++.+.+..++||||++|++|.+.+... ..+++..+..++.||+.||.|||+.||+||||
T Consensus 44 ~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dl 122 (321)
T cd05603 44 AERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122 (321)
T ss_pred HHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccC
Confidence 344 3678889999999999999999999999999999999888654 35899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||+++.++.+||+|||++........ ......||+.|+|||.+.+..++.++||||
T Consensus 123 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 181 (321)
T cd05603 123 KPENILLDSQGHVVLTDFGLCKEGVEPEE---------------------TTSTFCGTPEYLAPEVLRKEPYDRTVDWWC 181 (321)
T ss_pred CHHHeEECCCCCEEEccCCCCccCCCCCC---------------------ccccccCCcccCCHHHhcCCCCCCcCcccc
Confidence 99999999999999999999875322111 011457899999999999988999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChh
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFE 368 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~ 368 (433)
||+++|||++|.+||...........+ ......++...+..+.+++.+||+.+|.+||++.
T Consensus 182 lG~il~el~~g~~pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 182 LGAVLYEMLYGLPPFYSRDVSQMYDNI--LHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHH--hcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 999999999999988653211110000 0112234466788999999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=294.91 Aligned_cols=201 Identities=19% Similarity=0.304 Sum_probs=164.1
Q ss_pred ccchHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 145 NCGQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 145 ~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
..+|+.++.++ +||||+++++++..++..++||||+++++|..++...+ .+++..++.++.|++.||+|||+.||+||
T Consensus 42 ~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~ivH~ 120 (329)
T cd05618 42 VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYR 120 (329)
T ss_pred HHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence 33688888877 89999999999999999999999999999998886643 59999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
||||+||+++.++.++|+|||+++....... ......||+.|+|||++.+..++.++||
T Consensus 121 Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di 179 (329)
T cd05618 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---------------------TTSTFCGTPNYIAPEILRGEDYGFSVDW 179 (329)
T ss_pred CCCHHHEEECCCCCEEEeeCCccccccCCCC---------------------ccccccCCccccCHHHHcCCCCCCccce
Confidence 9999999999999999999999875322111 1114578999999999999999999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCc-------hhhhccccCCCCcHHHHHHHHHhcccCCCCCCCh
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLD-------QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF 367 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~ 367 (433)
||||+++|+|++|.+||............. .......++..++..+.+++.+||+.||.+||++
T Consensus 180 wslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 999999999999998885321111100000 0111223456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=300.09 Aligned_cols=210 Identities=20% Similarity=0.268 Sum_probs=169.7
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.+++.++|+||+++++++..++..++||||+++++|.+++.+....+++..+..++.|++.||+|||+.||+|||||
T Consensus 50 ~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlk 129 (330)
T cd05601 50 EERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIK 129 (330)
T ss_pred HHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCc
Confidence 68889999999999999999999999999999999999999998765679999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec------CCCCCcc
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT------GQEYDET 300 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~ 300 (433)
|+||+++.++.+||+|||++......... ......||+.|+|||++. ...++.+
T Consensus 130 p~NIll~~~~~~kL~Dfg~a~~~~~~~~~--------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 189 (330)
T cd05601 130 PENVLIDRTGHIKLADFGSAARLTANKMV--------------------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVE 189 (330)
T ss_pred hHheEECCCCCEEeccCCCCeECCCCCce--------------------eeecccCCccccCHHHhccccccccCCCCCc
Confidence 99999999999999999999865432211 011346899999999986 4567889
Q ss_pred cCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccC--CCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHh
Q psy6593 301 VDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFC--ASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEG 376 (433)
Q Consensus 301 ~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~ 376 (433)
+||||||+++|+|++|.+||...........+........++ ..++..+.+|+..||+ +|.+||++++++ .|+..
T Consensus 190 ~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 190 CDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred ceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 999999999999999998886533211111100000011112 3578899999999998 999999999998 46665
Q ss_pred h
Q psy6593 377 L 377 (433)
Q Consensus 377 ~ 377 (433)
+
T Consensus 269 ~ 269 (330)
T cd05601 269 I 269 (330)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=273.48 Aligned_cols=209 Identities=22% Similarity=0.358 Sum_probs=176.9
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+.||+++ -||+|+++.++++.+..+++|+|.++.|.|.+++.+. -.+++...++|++|+++|+.|||..+||||||
T Consensus 71 ~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDL 149 (411)
T KOG0599|consen 71 QEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDL 149 (411)
T ss_pred HHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhccc
Confidence 899999999 6999999999999999999999999999999999774 35999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC------CCCCc
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG------QEYDE 299 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ 299 (433)
||+|||++++..++|+|||++..+..+ .+.+..+|||+|+|||.+.- ..|+.
T Consensus 150 KpENILlddn~~i~isDFGFa~~l~~G----------------------ekLrelCGTPgYLAPEtikC~m~e~~pGYs~ 207 (411)
T KOG0599|consen 150 KPENILLDDNMNIKISDFGFACQLEPG----------------------EKLRELCGTPGYLAPETIKCSMYENHPGYSK 207 (411)
T ss_pred ChhheeeccccceEEeccceeeccCCc----------------------hhHHHhcCCCcccChhheeeecccCCCCccc
Confidence 999999999999999999999887543 23447799999999998853 46888
Q ss_pred ccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc--hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHH
Q psy6593 300 TVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD--QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLE 375 (433)
Q Consensus 300 ~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~ 375 (433)
.+|+|+.|+|||.|+.|.|||....+......+. .-.+....+.+++...++||.++|+.||.+|.|++|.+ .|+.
T Consensus 208 EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 208 EVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred hhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 9999999999999999999886432211111111 11233444578889999999999999999999999998 4776
Q ss_pred hhc
Q psy6593 376 GLS 378 (433)
Q Consensus 376 ~~~ 378 (433)
.+.
T Consensus 288 q~~ 290 (411)
T KOG0599|consen 288 QIA 290 (411)
T ss_pred HHH
Confidence 554
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=293.41 Aligned_cols=209 Identities=23% Similarity=0.372 Sum_probs=165.4
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++++++||||+++++++.++...++||||+. ++|.+++......+++..+..++.|++.||+|||+.||+|||||
T Consensus 52 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlk 130 (303)
T cd07869 52 REASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLK 130 (303)
T ss_pred HHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 79999999999999999999999999999999995 68888887665679999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEe
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFS 305 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws 305 (433)
|+||+++.++.+||+|||++......... .....+|+.|+|||++.+ ..++.++||||
T Consensus 131 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Diws 189 (303)
T cd07869 131 PQNLLISDTGELKLADFGLARAKSVPSHT---------------------YSNEVVTLWYRPPDVLLGSTEYSTCLDMWG 189 (303)
T ss_pred HHHEEECCCCCEEECCCCcceeccCCCcc---------------------CCCCcccCCCCChHHHcCCCCCCcHHHHHH
Confidence 99999999999999999998754321111 113467899999999865 45788999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCC---------------CC-------Cchhhh--------cccc-CCCCcHHHHHHHH
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPD---------------FG-------LDQTDF--------RNKF-CASCPEPFVRIAF 354 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~---------------~~-------~~~~~~--------~~~~-~~~~~~~l~~li~ 354 (433)
||+++|+|++|.+||......... .. .....+ .... ....++.+.+++.
T Consensus 190 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 269 (303)
T cd07869 190 VGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLAS 269 (303)
T ss_pred HHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHH
Confidence 999999999999988653211000 00 000000 0000 0134578899999
Q ss_pred HhcccCCCCCCChhHHHH--HHHhh
Q psy6593 355 LCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 355 ~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
+||+.||++|||++++++ ||+.+
T Consensus 270 ~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 270 KLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred HHhccCchhccCHHHHhcCcccccC
Confidence 999999999999999984 77654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=290.39 Aligned_cols=205 Identities=22% Similarity=0.385 Sum_probs=164.7
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|++++++++|+||+++++++..++..++||||+++++|..+... ...+++..++.++.|++.||.|||+.|++|||||
T Consensus 49 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlk 127 (287)
T cd07848 49 RELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIK 127 (287)
T ss_pred HHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 799999999999999999999999999999999988766655443 3469999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.++|+|||++.......... .....||+.|+|||++.+..++.++|||||
T Consensus 128 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--------------------~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 187 (287)
T cd07848 128 PENLLISHNDVLKLCDFGFARNLSEGSNAN--------------------YTEYVATRWYRSPELLLGAPYGKAVDMWSV 187 (287)
T ss_pred HHHEEEcCCCcEEEeeccCccccccccccc--------------------ccccccccccCCcHHHcCCCCCCchhHHhH
Confidence 999999999999999999998754322111 114568999999999998889999999999
Q ss_pred hHHHHHHhcCCCCCCCCCCCCCCCC------------------------C------chhhhccccCCCCcHHHHHHHHHh
Q psy6593 307 GIVLCEIIGRVPADPDYLPRSPDFG------------------------L------DQTDFRNKFCASCPEPFVRIAFLC 356 (433)
Q Consensus 307 G~il~ell~~~~~~~~~~~~~~~~~------------------------~------~~~~~~~~~~~~~~~~l~~li~~~ 356 (433)
|+++|||++|.+||........... . ............++..+.+|+.+|
T Consensus 188 Gvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~ 267 (287)
T cd07848 188 GCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNL 267 (287)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHH
Confidence 9999999999998865321110000 0 000000111234678899999999
Q ss_pred cccCCCCCCChhHHHH
Q psy6593 357 CDLNPDQRPPFEVLEV 372 (433)
Q Consensus 357 l~~~p~~RPs~~~i~~ 372 (433)
|+.||++||+++++++
T Consensus 268 L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 268 LKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccCCcccCCCHHHHhc
Confidence 9999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=301.45 Aligned_cols=229 Identities=20% Similarity=0.360 Sum_probs=173.7
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+++|..++|+||+++++++.+++..++||||+++++|.+++.+. ..+++..++.++.||+.||+|||+.||+|||||
T Consensus 50 ~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlk 128 (350)
T cd05573 50 AERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIK 128 (350)
T ss_pred HHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 6889999999999999999999999999999999999999999775 469999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccch--------hhhhhhcccccceeeeccCccccccceecCCCCC
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVP--------RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYD 298 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 298 (433)
|+||+++.++.++|+|||++.................. .................||+.|+|||++.+..++
T Consensus 129 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 208 (350)
T cd05573 129 PDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG 208 (350)
T ss_pred HHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC
Confidence 99999999999999999999876543210000000000 0000000001122256799999999999999999
Q ss_pred cccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCch--hhhccccCCCCcHHHHHHHHHhcccCCCCCCC-hhHHHH--H
Q psy6593 299 ETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQ--TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP-FEVLEV--W 373 (433)
Q Consensus 299 ~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-~~~i~~--~ 373 (433)
.++||||||+++|+|++|.+||...........+.. ..........+++.+.++|.+||. +|.+||+ ++++++ |
T Consensus 209 ~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 209 LECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred CceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 999999999999999999998865432211111111 111111123468999999999997 9999999 999984 5
Q ss_pred HHhh
Q psy6593 374 LEGL 377 (433)
Q Consensus 374 l~~~ 377 (433)
++..
T Consensus 288 ~~~~ 291 (350)
T cd05573 288 FKGI 291 (350)
T ss_pred cCCC
Confidence 6543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=291.67 Aligned_cols=210 Identities=28% Similarity=0.467 Sum_probs=171.9
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC---------------CCCChHHHHHHHHHHHHH
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQRVNFARDIAAG 211 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~ 211 (433)
+|+.++++++||||+++++++...+..+++|||+++++|.+++.... ..+++..++.++.|++.|
T Consensus 57 ~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~a 136 (283)
T cd05048 57 QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAG 136 (283)
T ss_pred HHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHH
Confidence 79999999999999999999999899999999999999999986521 358889999999999999
Q ss_pred HhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccce
Q psy6593 212 MTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM 291 (433)
Q Consensus 212 L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 291 (433)
|.|||+.|++|+||||+||++++++.++|+|||++........... .....+++.|+|||.
T Consensus 137 l~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~-------------------~~~~~~~~~y~aPE~ 197 (283)
T cd05048 137 MEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV-------------------QSKSLLPVRWMPPEA 197 (283)
T ss_pred HHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccc-------------------cCCCcccccccCHHH
Confidence 9999999999999999999999999999999999876533221100 013346788999999
Q ss_pred ecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHH
Q psy6593 292 MTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370 (433)
Q Consensus 292 ~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i 370 (433)
+.+..++.++||||||+++|||++ |.+|+...........+. .......+..+|+++.+|+.+||+.+|.+||++.+|
T Consensus 198 ~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i 276 (283)
T cd05048 198 ILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDI 276 (283)
T ss_pred hccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 988889999999999999999996 877765433221111111 112223456789999999999999999999999999
Q ss_pred HHHHHh
Q psy6593 371 EVWLEG 376 (433)
Q Consensus 371 ~~~l~~ 376 (433)
++.|++
T Consensus 277 ~~~l~~ 282 (283)
T cd05048 277 HTRLRS 282 (283)
T ss_pred HHHHhc
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=301.83 Aligned_cols=223 Identities=23% Similarity=0.422 Sum_probs=191.8
Q ss_pred cCCCcchhhhhcc-------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHH
Q psy6593 134 DYNGKYGEACQNC-------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKEL 188 (433)
Q Consensus 134 ~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~ 188 (433)
+|+|.||+||.+- .||.+-++|+|.|||+++|.+.+++++-|.||-++||||.++
T Consensus 583 LGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsL 662 (1226)
T KOG4279|consen 583 LGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSL 662 (1226)
T ss_pred eecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHH
Confidence 6889999998622 799999999999999999999999999999999999999999
Q ss_pred hcCCCCCC--ChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEc-cCCceEEeccccchhccCCCCCCccccccchh
Q psy6593 189 LQDPGQPL--PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR-EDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265 (433)
Q Consensus 189 l~~~~~~~--~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 265 (433)
++..-+++ ++..+--+.+||++||.|||++.|||||||-+|+|++ -.|.+||+|||-++.+..-..-.
T Consensus 663 LrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T--------- 733 (1226)
T KOG4279|consen 663 LRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT--------- 733 (1226)
T ss_pred HHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccc---------
Confidence 99877777 8888999999999999999999999999999999997 57999999999999876543322
Q ss_pred hhhhhcccccceeeeccCccccccceecCC--CCCcccCeEehhHHHHHHhcCCCCCCCCC-CCCCCCCCchhhhccccC
Q psy6593 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQ--EYDETVDVFSYGIVLCEIIGRVPADPDYL-PRSPDFGLDQTDFRNKFC 342 (433)
Q Consensus 266 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 342 (433)
-++.||..|||||++..+ .|+.++|||||||++.||.||+|||.... +....+.+..-...+.+|
T Consensus 734 ------------ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iP 801 (1226)
T KOG4279|consen 734 ------------ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIP 801 (1226)
T ss_pred ------------cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCc
Confidence 177899999999999764 68999999999999999999999996542 222334444445566677
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhh
Q psy6593 343 ASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGL 377 (433)
Q Consensus 343 ~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~ 377 (433)
..++.+.+.+|.+|+..+|.+||++.+++ .+|+.-
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 88889999999999999999999999998 366654
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=295.98 Aligned_cols=208 Identities=18% Similarity=0.310 Sum_probs=168.3
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.|+.++.++ +||||+++++++..++.+|+||||++|++|.+++... +.+++..++.++.|++.||.|||+.|++||||
T Consensus 44 ~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dl 122 (329)
T cd05588 44 TEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDL 122 (329)
T ss_pred HHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCC
Confidence 688899898 7999999999999999999999999999999988664 35999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||+++.++.++|+|||+++....... ......||+.|+|||++.+..++.++||||
T Consensus 123 kp~Nili~~~~~~kL~Dfg~~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 181 (329)
T cd05588 123 KLDNVLLDAEGHIKLTDYGMCKEGIRPGD---------------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWA 181 (329)
T ss_pred CHHHeEECCCCCEEECcCccccccccCCC---------------------ccccccCCccccCHHHHcCCCCCCccceec
Confidence 99999999999999999999874321111 112467899999999999999999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCC----Cc---hhhhccccCCCCcHHHHHHHHHhcccCCCCCCC------hhHHH-
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFG----LD---QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP------FEVLE- 371 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~----~~---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs------~~~i~- 371 (433)
||+++|+|++|.+||........... .. .......++..++..+.+++++||+.||.+|++ +++++
T Consensus 182 lG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 182 LGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred hHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 99999999999988853221110000 00 011122345678899999999999999999997 56665
Q ss_pred -HHHHh
Q psy6593 372 -VWLEG 376 (433)
Q Consensus 372 -~~l~~ 376 (433)
.|+..
T Consensus 262 hp~~~~ 267 (329)
T cd05588 262 HPFFRN 267 (329)
T ss_pred CCCCCC
Confidence 35543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=295.78 Aligned_cols=204 Identities=21% Similarity=0.255 Sum_probs=168.5
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhc-CCcccc
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHR 223 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~ 223 (433)
..+|++++++++||||+++++++..++..++||||+++++|.+++...+ .+++..+..++.||+.||+|||+ .||+||
T Consensus 42 ~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~~ivHr 120 (325)
T cd05594 42 TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYR 120 (325)
T ss_pred HHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEec
Confidence 3478999999999999999999999999999999999999999887643 59999999999999999999997 799999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
||||+||+++.++.+||+|||+++........ .....||+.|+|||++.+..++.++||
T Consensus 121 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~---------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di 179 (325)
T cd05594 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---------------------MKTFCGTPEYLAPEVLEDNDYGRAVDW 179 (325)
T ss_pred CCCCCeEEECCCCCEEEecCCCCeecCCCCcc---------------------cccccCCcccCCHHHHccCCCCCcccc
Confidence 99999999999999999999998753221111 114568999999999999899999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHHH
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLEV 372 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~~ 372 (433)
||||+++|+|++|.+||...........+ ......++..+++++.+++.+||+.||++|+ ++.++++
T Consensus 180 wslG~il~el~tG~~Pf~~~~~~~~~~~i--~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 180 WGLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred ccccceeeeeccCCCCCCCCCHHHHHHHH--hcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 99999999999999887543221110000 0112234567889999999999999999997 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=301.42 Aligned_cols=234 Identities=18% Similarity=0.258 Sum_probs=186.8
Q ss_pred cccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCe
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~ 172 (433)
.....+++.+.+.+++|+||+||+.. +|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 34456678888889999999988411 58899999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
.++||||++|++|.+++.+ ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999999876 35899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCC----CCCcccCeEehhHHHHHHhcCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ----EYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~ 328 (433)
.... .....||+.|+|||++.+. .++.++||||||+++|||++|.+||........
T Consensus 196 ~~~~--------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 255 (370)
T cd05596 196 GMVR--------------------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 255 (370)
T ss_pred Cccc--------------------CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH
Confidence 1110 1145799999999998653 478899999999999999999998865432211
Q ss_pred CCCCchhhhccccC--CCCcHHHHHHHHHhcccCCCC--CCChhHHHH--HHHh
Q psy6593 329 DFGLDQTDFRNKFC--ASCPEPFVRIAFLCCDLNPDQ--RPPFEVLEV--WLEG 376 (433)
Q Consensus 329 ~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~--RPs~~~i~~--~l~~ 376 (433)
...+........++ ..++.++.+++.+||+.+|.+ |++++++++ ||+.
T Consensus 256 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 256 YSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 11111111111122 357899999999999999988 999999974 5654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=293.11 Aligned_cols=210 Identities=30% Similarity=0.525 Sum_probs=167.6
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCC-eeeEEEeccCCCCHHHHhcCCCC-CCChHHHHHHHHHHHHHHhhhhcCC---cc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDR-KLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNFARDIAAGMTYLHSMN---LI 221 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~g~sL~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~---i~ 221 (433)
+|+++|.+++|||+|+++|||.+.+ +..||+||+++|||.+++..... .++|...++|+.+++.||+|||... |+
T Consensus 120 ~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~ii 199 (361)
T KOG1187|consen 120 NEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPII 199 (361)
T ss_pred HHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEe
Confidence 7999999999999999999999998 59999999999999999988655 8999999999999999999999864 99
Q ss_pred ccCCCCcceEEccCCceEEeccccchhccC-CCCCCccccccchhhhhhhcccccceeee-ccCccccccceecCCCCCc
Q psy6593 222 HRDLNSQNCLVREDKTVVVADFGLARIIHQ-GPRAPTTVMAKVPRKAAQRRGARKKRYTV-VGNPYWMAPEMMTGQEYDE 299 (433)
Q Consensus 222 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~ 299 (433)
||||||+|||+|++..+||+|||+++.... ... .... .||.+|++||++..+..+.
T Consensus 200 HrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~----------------------~~~~~~gt~gY~~PEy~~~g~lt~ 257 (361)
T KOG1187|consen 200 HRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTS----------------------VSTTVMGTFGYLAPEYASTGKLTE 257 (361)
T ss_pred cCCCCHHHeeECCCCCEEccCccCcccCCccccc----------------------eeeecCCCCccCChhhhccCCcCc
Confidence 999999999999999999999999965432 111 0122 7999999999999999999
Q ss_pred ccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCch--h-----hhcc----ccC-CCCc-----HHHHHHHHHhcccCCC
Q psy6593 300 TVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQ--T-----DFRN----KFC-ASCP-----EPFVRIAFLCCDLNPD 362 (433)
Q Consensus 300 ~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~--~-----~~~~----~~~-~~~~-----~~l~~li~~~l~~~p~ 362 (433)
++||||||++++||++|+++.....+........+ . .+.. .+. ...+ ..+..+..+|++.+|.
T Consensus 258 KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~ 337 (361)
T KOG1187|consen 258 KSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPK 337 (361)
T ss_pred ccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCC
Confidence 99999999999999998865543221111111110 0 0000 111 1222 2367788899999999
Q ss_pred CCCChhHHHHHHHhhc
Q psy6593 363 QRPPFEVLEVWLEGLS 378 (433)
Q Consensus 363 ~RPs~~~i~~~l~~~~ 378 (433)
+||++.+|++.|+.+.
T Consensus 338 ~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 338 ERPTMSQVVKELEGIL 353 (361)
T ss_pred cCcCHHHHHHHHHhhc
Confidence 9999999999886654
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=296.11 Aligned_cols=201 Identities=25% Similarity=0.361 Sum_probs=164.9
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.|..++..+ +||||+++++++..++..++||||++|++|.+++...+ .+++..+..++.|++.||+|||+.||+||||
T Consensus 44 ~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl 122 (316)
T cd05592 44 VERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGIIYRDL 122 (316)
T ss_pred HHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 566677655 89999999999999999999999999999999987644 5999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||+++.++.+||+|||+++....... ......||+.|+|||.+.+..++.++||||
T Consensus 123 kp~Nill~~~~~~kL~Dfg~a~~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws 181 (316)
T cd05592 123 KLDNVLLDKDGHIKIADFGMCKENMNGEG---------------------KASTFCGTPDYIAPEILKGQKYNESVDWWS 181 (316)
T ss_pred CHHHeEECCCCCEEEccCcCCeECCCCCC---------------------ccccccCCccccCHHHHcCCCCCCcccchh
Confidence 99999999999999999999875432211 111457899999999999988999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChh-HHH
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFE-VLE 371 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~-~i~ 371 (433)
||+++|+|++|.+||........... .......++..++.++.+++.+||+.+|.+||++. +++
T Consensus 182 lG~il~ell~G~~Pf~~~~~~~~~~~--i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 182 FGVLLYEMLIGQSPFHGEDEDELFDS--ILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHH--HHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 99999999999988864322111110 11122334566789999999999999999999875 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=288.57 Aligned_cols=209 Identities=23% Similarity=0.350 Sum_probs=169.3
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
.|+++|++++|+||+++.+++..+...++||||++|++|.+++.. ....+++..++.++.||+.||+|||+.||+||
T Consensus 42 ~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~ 121 (280)
T cd05608 42 VEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYR 121 (280)
T ss_pred HHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 699999999999999999999999999999999999999887743 33469999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
||||+||+++.++.++|+|||++......... .....||+.|+|||.+.+..++.++||
T Consensus 122 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~---------------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv 180 (280)
T cd05608 122 DLKPENVLLDNDGNVRISDLGLAVELKDGQSK---------------------TKGYAGTPGFMAPELLQGEEYDFSVDY 180 (280)
T ss_pred CCCHHHEEECCCCCEEEeeCccceecCCCCcc---------------------ccccCCCcCccCHHHhcCCCCCccccH
Confidence 99999999999999999999998765432211 114568999999999999999999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCchh--hhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHH--HHH
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT--DFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLE--VWL 374 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~--~~l 374 (433)
||||+++|+|++|..||............... .....++..++..+.+++.+||+.||++|| ++++++ .|+
T Consensus 181 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~ 260 (280)
T cd05608 181 FALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260 (280)
T ss_pred HHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhh
Confidence 99999999999999888653221111111111 111223456789999999999999999999 556666 356
Q ss_pred Hh
Q psy6593 375 EG 376 (433)
Q Consensus 375 ~~ 376 (433)
+.
T Consensus 261 ~~ 262 (280)
T cd05608 261 RD 262 (280)
T ss_pred hc
Confidence 54
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=296.83 Aligned_cols=214 Identities=29% Similarity=0.439 Sum_probs=170.5
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeC-CeeeEEEeccCCCCHHHHhcCCC-------------------------------
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKD-RKLNLVTEYIAGGTLKELLQDPG------------------------------- 193 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~lv~e~~~g~sL~~~l~~~~------------------------------- 193 (433)
+|+++++++ +|+||+++++++... ..+++||||+++++|.+++....
T Consensus 59 ~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (337)
T cd05054 59 TELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSS 138 (337)
T ss_pred HHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCc
Confidence 699999999 899999999988654 57889999999999999885311
Q ss_pred -----------------------------CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccc
Q psy6593 194 -----------------------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFG 244 (433)
Q Consensus 194 -----------------------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 244 (433)
..+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG 218 (337)
T cd05054 139 SQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 218 (337)
T ss_pred cccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccc
Confidence 257899999999999999999999999999999999999999999999999
Q ss_pred cchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCC
Q psy6593 245 LARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDY 323 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~ 323 (433)
++..+........ .....++..|+|||++.+..++.++||||||+++|||++ |.+|+...
T Consensus 219 ~a~~~~~~~~~~~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~ 279 (337)
T cd05054 219 LARDIYKDPDYVR-------------------KGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279 (337)
T ss_pred cchhcccCcchhh-------------------ccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCC
Confidence 9987643221110 002345677999999999999999999999999999996 88887543
Q ss_pred CCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 324 LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
..................+...++++.+++.+||+.+|++||++++|++.|+.+..
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 280 QIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 22111111111111222345677899999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=290.94 Aligned_cols=214 Identities=28% Similarity=0.434 Sum_probs=173.5
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC------------CCCChHHHHHHHHHHHHHHhh
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG------------QPLPWGQRVNFARDIAAGMTY 214 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~------------~~~~~~~~~~i~~qi~~~L~~ 214 (433)
+|++++++++|+||+++++++...+..++||||+++++|.+++...+ ..+++..++.++.|++.||+|
T Consensus 56 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~ 135 (288)
T cd05093 56 REAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVY 135 (288)
T ss_pred HHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 79999999999999999999999999999999999999999986432 248999999999999999999
Q ss_pred hhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC
Q psy6593 215 LHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG 294 (433)
Q Consensus 215 lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 294 (433)
||+.|++||||||+||++++++.++|+|||++........... .....++..|+|||.+.+
T Consensus 136 lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~-------------------~~~~~~~~~y~aPE~~~~ 196 (288)
T cd05093 136 LASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV-------------------GGHTMLPIRWMPPESIMY 196 (288)
T ss_pred HHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeec-------------------CCCCCccccccCHHHhcc
Confidence 9999999999999999999999999999999876533211100 002234678999999998
Q ss_pred CCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHH
Q psy6593 295 QEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVW 373 (433)
Q Consensus 295 ~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~ 373 (433)
..++.++||||||+++|+|++ |.+|+...........+.. ......+..++.++.+++.+||+.+|.+||++.++.+.
T Consensus 197 ~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~ 275 (288)
T cd05093 197 RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ-GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSL 275 (288)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 889999999999999999997 8887754332111111111 11122345678899999999999999999999999999
Q ss_pred HHhhccc
Q psy6593 374 LEGLSMH 380 (433)
Q Consensus 374 l~~~~~~ 380 (433)
|+++...
T Consensus 276 l~~~~~~ 282 (288)
T cd05093 276 LQNLAKA 282 (288)
T ss_pred HHHHHHh
Confidence 9987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=285.03 Aligned_cols=210 Identities=32% Similarity=0.508 Sum_probs=171.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+.++++++|+||+++++++...+..++||||+++++|.+++... +..+++..+..++.|++.||.+||+.|++|+||
T Consensus 50 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 129 (261)
T cd05068 50 AEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDL 129 (261)
T ss_pred HHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 6899999999999999999999999999999999999999999763 346899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||+++.++.++|+|||++........... .....+..|+|||.+.+..++.++||||
T Consensus 130 ~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~--------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~s 189 (261)
T cd05068 130 AARNVLVGENNICKVADFGLARVIKEDIYEAR--------------------EGAKFPIKWTAPEAALYNRFSIKSDVWS 189 (261)
T ss_pred CcceEEEcCCCCEEECCcceEEEccCCccccc--------------------CCCcCceeccCccccccCCCCchhhHHH
Confidence 99999999999999999999987653211100 0112245799999999888999999999
Q ss_pred hhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 306 YGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 306 lG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
||+++|+|++ |.+|+...........+ ........+..++..+.+++.+|++.+|++||++++|...|+++
T Consensus 190 lG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 190 FGILLTEIVTYGRMPYPGMTNAEVLQQV-DQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 9999999997 88887553322111111 11112223456789999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=277.56 Aligned_cols=228 Identities=26% Similarity=0.406 Sum_probs=179.6
Q ss_pred eeeeeccCCCcchhhhh---------------------------ccchHHHHhhcCCcc-eeeEEEEEEeCC------ee
Q psy6593 128 LLFCKEDYNGKYGEACQ---------------------------NCGQVAVLRSLHHHN-VIRFIGVLYKDR------KL 173 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~---------------------------~~~E~~~l~~l~h~~-iv~~~~~~~~~~------~~ 173 (433)
+....++|+|.||+||+ +.+|+.+|++|+|+| |+++++++.+.+ .+
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 34445677777777776 338999999999999 999999999887 89
Q ss_pred eEEEeccCCCCHHHHhcCCC---CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhcc
Q psy6593 174 NLVTEYIAGGTLKELLQDPG---QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIH 250 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 250 (433)
++||||++ .+|.+++...+ ..++...+..++.||+.||+|||+.+|+||||||+||+|+++|.+||+|||+|+...
T Consensus 93 ~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 93 YLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFS 171 (323)
T ss_pred EEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence 99999995 69999997754 458889999999999999999999999999999999999999999999999999665
Q ss_pred CCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeEehhHHHHHHhcCCCCCCCCCC----
Q psy6593 251 QGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVPADPDYLP---- 325 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~~~~~~~~~~~---- 325 (433)
.+... ....++|.+|+|||++.+. .|+...||||+|||++||+++.|.|+....
T Consensus 172 ip~~~---------------------yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql 230 (323)
T KOG0594|consen 172 IPMRT---------------------YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQL 230 (323)
T ss_pred CCccc---------------------ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 33221 2256789999999999885 799999999999999999999988865422
Q ss_pred ----------CCCCCCCch--h----hhcc-----cc---CCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 326 ----------RSPDFGLDQ--T----DFRN-----KF---CASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 326 ----------~~~~~~~~~--~----~~~~-----~~---~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
....+.... . .+.. .+ .....+...+++.+||+.+|.+|.|++..+. +|..+
T Consensus 231 ~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 231 FRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred HHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 111111000 0 0000 00 1223357899999999999999999998885 35543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=299.91 Aligned_cols=229 Identities=20% Similarity=0.352 Sum_probs=169.0
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++.+++|+||+++++.+.++..+|+||||++|++|.+++.+.+ .+++..+..++.|++.||+|||+.||+|||||
T Consensus 50 ~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~givHrDlK 128 (363)
T cd05628 50 AERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQLGFIHRDIK 128 (363)
T ss_pred HHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCC
Confidence 58899999999999999999999999999999999999999997644 59999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCcccc--ccch------------hhhhhhcccccceeeeccCcccccccee
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM--AKVP------------RKAAQRRGARKKRYTVVGNPYWMAPEMM 292 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~--~~~~------------~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 292 (433)
|+|||++.++.++|+|||+++............. ...+ ................+||+.|+|||++
T Consensus 129 p~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~ 208 (363)
T cd05628 129 PDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF 208 (363)
T ss_pred HHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHH
Confidence 9999999999999999999886543211000000 0000 0000000111122356899999999999
Q ss_pred cCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccC--CCCcHHHHHHHHHhcccCCC---CCCCh
Q psy6593 293 TGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFC--ASCPEPFVRIAFLCCDLNPD---QRPPF 367 (433)
Q Consensus 293 ~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~---~RPs~ 367 (433)
.+..++.++||||||+++|||++|.+||...........+........++ ..+++++.+++.+++. +|. .||++
T Consensus 209 ~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~ 287 (363)
T cd05628 209 MQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGV 287 (363)
T ss_pred cCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCH
Confidence 99899999999999999999999999986543222111111100111122 3467899999998765 444 46899
Q ss_pred hHHHH--HHHhh
Q psy6593 368 EVLEV--WLEGL 377 (433)
Q Consensus 368 ~~i~~--~l~~~ 377 (433)
++|++ ||+..
T Consensus 288 ~ei~~hp~f~~~ 299 (363)
T cd05628 288 EEIKTNPFFEGV 299 (363)
T ss_pred HHHhCCCCCCCC
Confidence 99984 56543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=284.74 Aligned_cols=207 Identities=24% Similarity=0.405 Sum_probs=169.0
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+++|++++||||+++++++..++..++||||+++++|.+++......+++..+..++.|++.||+|||+.|++|+||+
T Consensus 48 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 127 (256)
T cd05114 48 EEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA 127 (256)
T ss_pred HHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccC
Confidence 69999999999999999999999999999999999999999997644568999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.++|+|||.+.......... .....++..|+|||.+.+..++.++|||||
T Consensus 128 p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~--------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~ 187 (256)
T cd05114 128 ARNCLVSSTGVVKVSDFGMTRYVLDDEYTS--------------------SSGAKFPVKWSPPEVFNFSKYSSKSDVWSF 187 (256)
T ss_pred cceEEEcCCCeEEECCCCCccccCCCceec--------------------cCCCCCchhhCChhhcccCccchhhhhHHH
Confidence 999999999999999999987653221110 002234567999999998889999999999
Q ss_pred hHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHH
Q psy6593 307 GIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWL 374 (433)
Q Consensus 307 G~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 374 (433)
|+++|+|++ |.+|+...........+. .......+...+..+.+++.+||+.+|++||+++++++.|
T Consensus 188 G~~l~el~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 188 GVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 999999998 888775432211111111 1112223455678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=296.37 Aligned_cols=199 Identities=20% Similarity=0.270 Sum_probs=164.6
Q ss_pred ccchHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 145 NCGQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 145 ~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
...|+.++..+ +||||+++++++...+.+|+||||++|++|.+++.+.+ .+++..+..++.|++.||+|||+.|++||
T Consensus 42 ~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~~ivH~ 120 (320)
T cd05590 42 TMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDKGIIYR 120 (320)
T ss_pred HHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence 34788888877 69999999999999999999999999999999887644 59999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
||||+||+++.++.++|+|||+++........ .....||+.|+|||++.+..++.++||
T Consensus 121 dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~---------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di 179 (320)
T cd05590 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT---------------------TSTFCGTPDYIAPEILQEMLYGPSVDW 179 (320)
T ss_pred CCCHHHeEECCCCcEEEeeCCCCeecCcCCCc---------------------ccccccCccccCHHHHcCCCCCCccch
Confidence 99999999999999999999998753221111 114578999999999999899999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCCh
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF 367 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~ 367 (433)
||||+++|+|++|.+||...........+ .......+..++.++.+++++||+.||.+||++
T Consensus 180 wslG~il~el~~g~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAI--LNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred hhhHHHHHHHhhCCCCCCCCCHHHHHHHH--hcCCCCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 99999999999999988653221111111 011123345678999999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=284.73 Aligned_cols=211 Identities=28% Similarity=0.502 Sum_probs=173.2
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++++++|+||+++++++..++..++||||+++++|.+++......+++..++.++.|++.||+|||+.||+|+||+
T Consensus 54 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~ 133 (266)
T cd05033 54 TEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLA 133 (266)
T ss_pred HHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 69999999999999999999999999999999999999999997766679999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||++++++.++|+|||++........... .....++..|+|||.+.+..++.++|||||
T Consensus 134 p~nili~~~~~~~l~dfg~~~~~~~~~~~~~-------------------~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~sl 194 (266)
T cd05033 134 ARNILVNSNLVCKVSDFGLSRRLEDSEATYT-------------------TKGGKIPIRWTAPEAIAYRKFTSASDVWSF 194 (266)
T ss_pred cceEEEcCCCCEEECccchhhccccccccee-------------------ccCCCCCccccChhhhccCCCccccchHHH
Confidence 9999999999999999999987752111100 002234577999999998899999999999
Q ss_pred hHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 307 GIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 307 G~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
|+++|+|++ |.+|+...........+ ........+..++..+.+++.+||+.+|++||++++|++.|+++
T Consensus 195 G~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 195 GIVMWEVMSYGERPYWDMSNQDVIKAV-EDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999986 77776443221111000 11112233456789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=294.33 Aligned_cols=202 Identities=20% Similarity=0.275 Sum_probs=166.0
Q ss_pred cchHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 146 CGQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 146 ~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..|++++..+ +||||+++++++..++..|+||||+++++|.+.+.+.+ .+++..+..++.||+.||.|||+.||+|||
T Consensus 43 ~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrD 121 (321)
T cd05591 43 MTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121 (321)
T ss_pred HHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 3688888876 79999999999999999999999999999999887644 589999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|||+||+++.++.++|+|||++........ ......||+.|+|||++.+..++.++|||
T Consensus 122 ikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 180 (321)
T cd05591 122 LKLDNILLDAEGHCKLADFGMCKEGILNGV---------------------TTTTFCGTPDYIAPEILQELEYGPSVDWW 180 (321)
T ss_pred CCHHHeEECCCCCEEEeecccceecccCCc---------------------cccccccCccccCHHHHcCCCCCCcccee
Confidence 999999999999999999999875322111 11145689999999999998999999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCC-------ChhHHH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-------PFEVLE 371 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-------s~~~i~ 371 (433)
|||+++|+|++|.+||...........+. .....++..++.++.+++.+||+.+|++|| ++++++
T Consensus 181 slG~il~el~tg~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~ 252 (321)
T cd05591 181 ALGVLMYEMMAGQPPFEADNEDDLFESIL--HDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIK 252 (321)
T ss_pred chhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHh
Confidence 99999999999999886533211111110 111123455789999999999999999999 667776
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=293.18 Aligned_cols=210 Identities=18% Similarity=0.250 Sum_probs=165.7
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++..++|+||+++++.+.+.+.+++||||+++|+|.+++.+.+..+++..+..++.||+.||+|||+.||+|||||
T Consensus 50 ~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlk 129 (332)
T cd05623 50 EERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIK 129 (332)
T ss_pred HHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence 57888899999999999999999999999999999999999998755579999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec-----CCCCCccc
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT-----GQEYDETV 301 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~ 301 (433)
|+||+++.++.++|+|||++......... ......||+.|+|||++. ...++.++
T Consensus 130 p~Nili~~~~~~kL~DfG~a~~~~~~~~~--------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 189 (332)
T cd05623 130 PDNILMDMNGHIRLADFGSCLKLMEDGTV--------------------QSSVAVGTPDYISPEILQAMEDGKGKYGPEC 189 (332)
T ss_pred HHHEEECCCCCEEEeecchheecccCCcc--------------------eecccccCccccCHHHHhccccCCCCCCCcC
Confidence 99999999999999999998754322111 011356999999999986 34678899
Q ss_pred CeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhc---cccCCCCcHHHHHHHHHhcccCCCC--CCChhHHHH--HH
Q psy6593 302 DVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFR---NKFCASCPEPFVRIAFLCCDLNPDQ--RPPFEVLEV--WL 374 (433)
Q Consensus 302 DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~--RPs~~~i~~--~l 374 (433)
||||||+++|||++|.+||...........+...... ......+++.+.+++.+|+..++.+ |++++++++ ||
T Consensus 190 DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f 269 (332)
T cd05623 190 DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF 269 (332)
T ss_pred CEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCc
Confidence 9999999999999999888653221111111111111 1122467899999999999765544 678888874 55
Q ss_pred Hh
Q psy6593 375 EG 376 (433)
Q Consensus 375 ~~ 376 (433)
..
T Consensus 270 ~~ 271 (332)
T cd05623 270 TG 271 (332)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=300.81 Aligned_cols=228 Identities=21% Similarity=0.361 Sum_probs=169.4
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+++|++++|+||+++++.+.+++.+++||||++|++|.+++.+.+ .+++..+..++.||+.||+|||+.||+|||||
T Consensus 50 ~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlk 128 (376)
T cd05598 50 AERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIK 128 (376)
T ss_pred HHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCC
Confidence 68999999999999999999999999999999999999999997744 58999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCc---------cccccc------------h-hhhhhhcccccceeeeccCc
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPT---------TVMAKV------------P-RKAAQRRGARKKRYTVVGNP 284 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~---------~~~~~~------------~-~~~~~~~~~~~~~~~~~gt~ 284 (433)
|+||+++.++.++|+|||++..+........ ...... . .................||+
T Consensus 129 p~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 208 (376)
T cd05598 129 PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTP 208 (376)
T ss_pred HHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCc
Confidence 9999999999999999999864321100000 000000 0 00000000011122457999
Q ss_pred cccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCch--hhhccccCCCCcHHHHHHHHHhcccCCC
Q psy6593 285 YWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQ--TDFRNKFCASCPEPFVRIAFLCCDLNPD 362 (433)
Q Consensus 285 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~ 362 (433)
.|+|||++.+..++.++|||||||++|||++|.+||....+......+.. ..........++..+.+++.+|+ .+|.
T Consensus 209 ~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~ 287 (376)
T cd05598 209 NYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAE 287 (376)
T ss_pred cccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHh
Confidence 99999999999999999999999999999999998865432211111110 01111112457889999999976 5999
Q ss_pred CCC---ChhHHHH--HHHh
Q psy6593 363 QRP---PFEVLEV--WLEG 376 (433)
Q Consensus 363 ~RP---s~~~i~~--~l~~ 376 (433)
+|+ ++.++++ |++.
T Consensus 288 ~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 288 DRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred hcCCCCCHHHHhCCCCcCC
Confidence 999 8888873 5554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=288.76 Aligned_cols=213 Identities=27% Similarity=0.416 Sum_probs=173.7
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC---------------CCCChHHHHHHHHHHHHH
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQRVNFARDIAAG 211 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~ 211 (433)
+|++++++++|+||+++++++...+..++||||+++++|.+++...+ ..+++..++.++.||+.|
T Consensus 56 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a 135 (291)
T cd05094 56 REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASG 135 (291)
T ss_pred HHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHH
Confidence 79999999999999999999999999999999999999999986422 348899999999999999
Q ss_pred HhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccce
Q psy6593 212 MTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM 291 (433)
Q Consensus 212 L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 291 (433)
|+|||+.|++||||||+||+++.++.++|+|||++........... .....++..|+|||.
T Consensus 136 l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~-------------------~~~~~~~~~y~aPE~ 196 (291)
T cd05094 136 MVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV-------------------GGHTMLPIRWMPPES 196 (291)
T ss_pred HHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeec-------------------CCCCCcceeecChHH
Confidence 9999999999999999999999999999999999876543221100 013346778999999
Q ss_pred ecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHH
Q psy6593 292 MTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370 (433)
Q Consensus 292 ~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i 370 (433)
+.+..++.++||||||+++|+|++ |.+|+...........+ ........+...|..+.+++.+||+.+|++||++++|
T Consensus 197 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v 275 (291)
T cd05094 197 IMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI-TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275 (291)
T ss_pred hccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 998889999999999999999997 88887543321111101 1111122335578899999999999999999999999
Q ss_pred HHHHHhhcc
Q psy6593 371 EVWLEGLSM 379 (433)
Q Consensus 371 ~~~l~~~~~ 379 (433)
++.|+++..
T Consensus 276 ~~~l~~~~~ 284 (291)
T cd05094 276 YKILHALGK 284 (291)
T ss_pred HHHHHHHHh
Confidence 999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=296.01 Aligned_cols=198 Identities=25% Similarity=0.320 Sum_probs=161.7
Q ss_pred chHH-HHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVA-VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.|.. +++.++||||+++++++..++..++||||++|++|..++... ..+++..+..++.||+.||+|||+.||+||||
T Consensus 44 ~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~givH~Dl 122 (325)
T cd05604 44 AERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSINIVYRDL 122 (325)
T ss_pred HHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCC
Confidence 4444 467789999999999999999999999999999999888764 35999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||+++.++.++|+|||+++........ .....||+.|+|||++.+..++.++||||
T Consensus 123 kp~NIll~~~~~~kL~DfG~~~~~~~~~~~---------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dvws 181 (325)
T cd05604 123 KPENILLDSQGHVVLTDFGLCKEGIAQSDT---------------------TTTFCGTPEYLAPEVIRKQPYDNTVDWWC 181 (325)
T ss_pred CHHHeEECCCCCEEEeecCCcccCCCCCCC---------------------cccccCChhhCCHHHHcCCCCCCcCcccc
Confidence 999999999999999999998753221111 11457899999999999999999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChh
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFE 368 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~ 368 (433)
||+++|+|++|.+||............. ..........+..+.+++.+||+.+|.+||++.
T Consensus 182 lG~il~el~~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 182 LGAVLYEMLYGLPPFYCRDVAEMYDNIL--HKPLVLRPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred ccceehhhhcCCCCCCCCCHHHHHHHHH--cCCccCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 9999999999999886532211111000 111123356788999999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=291.88 Aligned_cols=235 Identities=23% Similarity=0.423 Sum_probs=197.9
Q ss_pred cccCCeeeeeccCCCcchhhhhcc------------------------------chHHHHhhcCCcceeeEEEEEEeCCe
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC------------------------------GQVAVLRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~------------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~ 172 (433)
+.++.......+|.|.||.||+.. +|+.+|++++||||++++|++. +..
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccc
Confidence 344446666789999999999722 7999999999999999999996 468
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
.|||||+++-|.|..+++.+...++......++.||..||.|||+.++|||||...|||+.+..-|||+|||+++.+...
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 99999999999999999988778999999999999999999999999999999999999999999999999999998776
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHh-cCCCCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDYLPRSPDFG 331 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~~~~~~~~~~~~~~~~~ 331 (433)
.++... ...-..-|||||.+.-..++.++|||.||+.|||++ -|..||......... .
T Consensus 545 ~yYkaS--------------------~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-~ 603 (974)
T KOG4257|consen 545 AYYKAS--------------------RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-G 603 (974)
T ss_pred chhhcc--------------------ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-E
Confidence 655432 112234599999999999999999999999999998 566666544333322 2
Q ss_pred CchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 332 LDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
.....-+...|.++|+.+..|+.+||+++|.+||.+.+|...|.++..
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 233344555679999999999999999999999999999988887664
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=295.09 Aligned_cols=207 Identities=22% Similarity=0.306 Sum_probs=169.3
Q ss_pred cchHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 146 CGQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 146 ~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
.+|+.+++.+ +||||+++++++...+.+++||||++|++|.+++.+.+ .+++..+..++.|++.||.|||+.||+|||
T Consensus 43 ~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivH~d 121 (318)
T cd05570 43 MTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERGIIYRD 121 (318)
T ss_pred HHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEccC
Confidence 3788888888 79999999999999999999999999999999887643 599999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|||+||+++.++.++|+|||++........ ......||+.|+|||++.+..++.++|||
T Consensus 122 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Diw 180 (318)
T cd05570 122 LKLDNVLLDSEGHIKIADFGMCKEGILGGV---------------------TTSTFCGTPDYIAPEILSYQPYGPAVDWW 180 (318)
T ss_pred CCHHHeEECCCCcEEecccCCCeecCcCCC---------------------cccceecCccccCHHHhcCCCCCcchhhh
Confidence 999999999999999999999864322111 11145689999999999999999999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCCh-----hHHHH--HHHh
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF-----EVLEV--WLEG 376 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~-----~~i~~--~l~~ 376 (433)
|||+++|+|++|.+||........... .......++..++..+.++|.+||+.||.+||++ .+++. |+..
T Consensus 181 slGvil~~l~~G~~pf~~~~~~~~~~~--i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 181 ALGVLLYEMLAGQSPFEGDDEDELFQS--ILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred hHHHHHHHHhhCCCCCCCCCHHHHHHH--HHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999999999988854321111000 0111223456788999999999999999999999 77763 4443
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=290.75 Aligned_cols=206 Identities=18% Similarity=0.252 Sum_probs=163.1
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++..++|+||+++++++..++..|+||||++||+|.+++.+....+++..+..++.|++.||+|||+.||+|||||
T Consensus 50 ~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlk 129 (331)
T cd05624 50 EERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIK 129 (331)
T ss_pred HHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCc
Confidence 57888999999999999999999999999999999999999998755579999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-----CCCCccc
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-----QEYDETV 301 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~ 301 (433)
|+||+++.++.+||+|||++.......... .....||+.|+|||++.+ ..++.++
T Consensus 130 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~--------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 189 (331)
T cd05624 130 PDNVLLDMNGHIRLADFGSCLKMNQDGTVQ--------------------SSVAVGTPDYISPEILQAMEDGMGKYGPEC 189 (331)
T ss_pred hHHEEEcCCCCEEEEeccceeeccCCCcee--------------------eccccCCcccCCHHHHhccccCCCCCCCcc
Confidence 999999999999999999987654322110 113568999999999875 4678899
Q ss_pred CeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhcccc---CCCCcHHHHHHHHHhcccCCCC--CCChhHHHH
Q psy6593 302 DVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKF---CASCPEPFVRIAFLCCDLNPDQ--RPPFEVLEV 372 (433)
Q Consensus 302 DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~--RPs~~~i~~ 372 (433)
||||||+++|+|++|.+||...........+........+ ...++.++.+++.+||..++.+ |++++++++
T Consensus 190 DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 190 DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred cEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 9999999999999999888643221111111111111111 2456899999999999876544 457777763
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=286.35 Aligned_cols=203 Identities=21% Similarity=0.320 Sum_probs=166.0
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.|++++++++||||+++++++..+...++||||++|++|.+++... ...+++..+..++.|++.||+|||+.|++||||
T Consensus 42 ~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~di 121 (277)
T cd05607 42 LEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDM 121 (277)
T ss_pred HHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccC
Confidence 5999999999999999999999999999999999999999887542 335889999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||+++.++.++|+|||++........ .....|++.|+|||++.+..++.++||||
T Consensus 122 kp~Nili~~~~~~~l~Dfg~~~~~~~~~~----------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 179 (277)
T cd05607 122 KPENVLLDDQGNCRLSDLGLAVELKDGKT----------------------ITQRAGTNGYMAPEILKEEPYSYPVDWFA 179 (277)
T ss_pred ChHhEEEcCCCCEEEeeceeeeecCCCce----------------------eeccCCCCCccCHHHHccCCCCCchhHHH
Confidence 99999999999999999999876533211 11346889999999999988999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccc---cCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNK---FCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
||+++|+|++|.+|+...........+........ ....+++++.+++.+||+.||++||+++++.
T Consensus 180 lGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 180 MGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccch
Confidence 99999999999988765322111111111111111 1246789999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=283.52 Aligned_cols=208 Identities=26% Similarity=0.465 Sum_probs=168.9
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++++++||||+++++++...+..++||||+.+++|.+++......+++..++.++.|++.||+|||+.|++|+|||
T Consensus 48 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 127 (256)
T cd05113 48 EEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLA 127 (256)
T ss_pred HHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccC
Confidence 79999999999999999999998889999999999999999997755579999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.+||+|||.++......... .....++..|+|||.+.+..++.++|||||
T Consensus 128 p~nili~~~~~~kl~d~g~~~~~~~~~~~~--------------------~~~~~~~~~y~~pe~~~~~~~~~~~Di~sl 187 (256)
T cd05113 128 ARNCLVDDQGCVKVSDFGLSRYVLDDEYTS--------------------SVGSKFPVRWSPPEVLLYSKFSSKSDVWAF 187 (256)
T ss_pred cceEEEcCCCCEEECCCccceecCCCceee--------------------cCCCccChhhCCHHHHhcCcccchhHHHHH
Confidence 999999999999999999987653321110 002234567999999988889999999999
Q ss_pred hHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHH
Q psy6593 307 GIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375 (433)
Q Consensus 307 G~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 375 (433)
|+++|+|++ |.+|+............ ........+...+..+.+++.+||+.+|.+||++.+|+..|+
T Consensus 188 G~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 188 GVLMWEVYSLGKMPYERFNNSETVEKV-SQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHHHhcCCCCCcCcCCHHHHHHHH-hcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 999999997 87776543221111111 111122233556789999999999999999999999987663
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=286.90 Aligned_cols=209 Identities=29% Similarity=0.457 Sum_probs=169.5
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC--------------CCCChHHHHHHHHHHHHHH
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG--------------QPLPWGQRVNFARDIAAGM 212 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--------------~~~~~~~~~~i~~qi~~~L 212 (433)
+|++++++++|+||+++++++......++||||+++++|.+++...+ ..+++..++.++.|++.||
T Consensus 56 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al 135 (280)
T cd05092 56 REAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGM 135 (280)
T ss_pred HHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHH
Confidence 68999999999999999999999999999999999999999986532 2488999999999999999
Q ss_pred hhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCcccccccee
Q psy6593 213 TYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMM 292 (433)
Q Consensus 213 ~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 292 (433)
+|||+.|++|+||||+||++++++.++|+|||++........... .....+++.|+|||.+
T Consensus 136 ~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~-------------------~~~~~~~~~y~aPE~~ 196 (280)
T cd05092 136 VYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV-------------------GGRTMLPIRWMPPESI 196 (280)
T ss_pred HHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeec-------------------CCCccccccccCHHHh
Confidence 999999999999999999999999999999999875432211000 0123356789999999
Q ss_pred cCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 293 TGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 293 ~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
.+..++.++||||||+++|+|++ |.+|+............ ........+..+|+.+.+++.+||+.+|.+||++++|+
T Consensus 197 ~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~ 275 (280)
T cd05092 197 LYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI-TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIH 275 (280)
T ss_pred ccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH-HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 98889999999999999999997 88877543221111111 11111233466889999999999999999999999999
Q ss_pred HHHH
Q psy6593 372 VWLE 375 (433)
Q Consensus 372 ~~l~ 375 (433)
..|+
T Consensus 276 ~~l~ 279 (280)
T cd05092 276 SRLQ 279 (280)
T ss_pred HHHh
Confidence 8876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=298.44 Aligned_cols=247 Identities=22% Similarity=0.362 Sum_probs=180.3
Q ss_pred eeeeeccCCCcchhhhhc----------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 128 LLFCKEDYNGKYGEACQN----------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~----------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
+...+.+|+|+||+||++ .+|+.+|++++|+||+++++.+.+++.+|+||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 445666777777777652 1689999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccc
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
++||+|.+++.+.+ .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++..+..........
T Consensus 83 ~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 83 IPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 99999999987643 58999999999999999999999999999999999999999999999999986432111000000
Q ss_pred cc--------cc-----------------h-hhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHH
Q psy6593 260 MA--------KV-----------------P-RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI 313 (433)
Q Consensus 260 ~~--------~~-----------------~-~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 313 (433)
.. .. . .................||+.|+|||++.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence 00 00 0 0000000111112346799999999999998999999999999999999
Q ss_pred hcCCCCCCCCCCCCCCCCCch--hhhccccCCCCcHHHHHHHHHhcccCCCCCCC---hhHHHH--HHHh
Q psy6593 314 IGRVPADPDYLPRSPDFGLDQ--TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP---FEVLEV--WLEG 376 (433)
Q Consensus 314 l~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs---~~~i~~--~l~~ 376 (433)
++|.+||....+......+.. ..........+++++.+++.+|+ .+|.+|++ +++++. |++.
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 242 LVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 999999865432211111110 01111112457889999999987 59999987 777763 5544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=292.84 Aligned_cols=197 Identities=23% Similarity=0.329 Sum_probs=162.8
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.|+.++..+ +|++|+++++++...+.+++||||+++++|.+++...+ .+++..+..++.|++.||+|||+.||+||||
T Consensus 49 ~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDl 127 (323)
T cd05616 49 VEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127 (323)
T ss_pred HHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEecCC
Confidence 567777777 58999999999999999999999999999999987644 5999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||
T Consensus 128 kp~Nill~~~~~~kL~DfG~~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 186 (323)
T cd05616 128 KLDNVMLDSEGHIKIADFGMCKENMWDGV---------------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWA 186 (323)
T ss_pred CHHHeEECCCCcEEEccCCCceecCCCCC---------------------ccccCCCChhhcCHHHhcCCCCCCccchhc
Confidence 99999999999999999999875322111 111456899999999999999999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCCh
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF 367 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~ 367 (433)
||+++|||++|.+||...........+ ......++..++.++.+++.+||+.+|++|++.
T Consensus 187 lGvil~elltg~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 187 FGVLLYEMLAGQAPFEGEDEDELFQSI--MEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred hhHHHHHHHhCCCCCCCCCHHHHHHHH--HhCCCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 999999999999988653321111111 111223456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=297.60 Aligned_cols=232 Identities=19% Similarity=0.274 Sum_probs=183.5
Q ss_pred cccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeee
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 174 (433)
...+++.+.+.+++|+||.||... +|+.+++.++||||+++++++.+++..|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 345667788889999999888411 6888999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCC
Q psy6593 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
+||||++|++|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 120 lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 99999999999999976 3589999999999999999999999999999999999999999999999999986532211
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCC----CCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ----EYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF 330 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~ 330 (433)
. ......||+.|+|||++.+. .++.++||||||+++|+|++|.+||..........
T Consensus 198 ~--------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~ 257 (370)
T cd05621 198 V--------------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS 257 (370)
T ss_pred e--------------------ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1 01145799999999998764 37889999999999999999999886543211111
Q ss_pred CCchhhhccccC--CCCcHHHHHHHHHhcccCCCC--CCChhHHHH--HHHh
Q psy6593 331 GLDQTDFRNKFC--ASCPEPFVRIAFLCCDLNPDQ--RPPFEVLEV--WLEG 376 (433)
Q Consensus 331 ~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~--RPs~~~i~~--~l~~ 376 (433)
.+........++ ..++..+.+++..||..++.+ |++++++++ |++.
T Consensus 258 ~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 258 KIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred HHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 111111111222 356889999999999865543 889999984 6654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=301.46 Aligned_cols=232 Identities=22% Similarity=0.370 Sum_probs=182.9
Q ss_pred cCCeeeeeccCCCcchhhhhcc---------------------chHHHHhhcCCcceeeEEEEEEeC--------CeeeE
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC---------------------GQVAVLRSLHHHNVIRFIGVLYKD--------RKLNL 175 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~---------------------~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~l 175 (433)
...+.+.+.+|+|+||.||++. +|+.+|++++|+||+++++++... ..+++
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 3457788889999999998632 599999999999999999987532 24779
Q ss_pred EEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCC-ceEEeccccchhccC
Q psy6593 176 VTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDK-TVVVADFGLARIIHQ 251 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~ 251 (433)
||||++ ++|.+++.. .+..+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||+|||+++....
T Consensus 145 vmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~ 223 (440)
T PTZ00036 145 VMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA 223 (440)
T ss_pred EEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence 999996 578776642 345699999999999999999999999999999999999998654 799999999986543
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCC-
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPD- 329 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~- 329 (433)
... .....||+.|+|||++.+ ..++.++||||||+++|||++|.+||.........
T Consensus 224 ~~~----------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 281 (440)
T PTZ00036 224 GQR----------------------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV 281 (440)
T ss_pred CCC----------------------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 221 114578999999999876 46899999999999999999999998654221100
Q ss_pred --------------------------CCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhcc
Q psy6593 330 --------------------------FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLSM 379 (433)
Q Consensus 330 --------------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~~ 379 (433)
.......+...++...|+++.+||.+||+.||.+||++.+++ .||+.+..
T Consensus 282 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 282 RIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 001111222234456788999999999999999999999998 68887653
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=284.74 Aligned_cols=209 Identities=28% Similarity=0.457 Sum_probs=170.7
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC---------CCCCChHHHHHHHHHHHHHHhhhhc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---------GQPLPWGQRVNFARDIAAGMTYLHS 217 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~---------~~~~~~~~~~~i~~qi~~~L~~lH~ 217 (433)
+|+.+|++++|+||+++++++......++||||+++++|.+++... ...+++..++.++.|++.||.|||+
T Consensus 58 ~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 137 (277)
T cd05032 58 NEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA 137 (277)
T ss_pred HHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 7899999999999999999999999999999999999999998642 1246788999999999999999999
Q ss_pred CCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCC
Q psy6593 218 MNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY 297 (433)
Q Consensus 218 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 297 (433)
.|++|+||||+||+++.++.++|+|||+++.......... .....++..|+|||.+.+..+
T Consensus 138 ~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~-------------------~~~~~~~~~y~aPE~~~~~~~ 198 (277)
T cd05032 138 KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK-------------------GGKGLLPVRWMAPESLKDGVF 198 (277)
T ss_pred CCccccccChheEEEcCCCCEEECCcccchhhccCccccc-------------------CCCCCccccccCHHHHhcCCC
Confidence 9999999999999999999999999999876543221100 012345778999999988889
Q ss_pred CcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHH
Q psy6593 298 DETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375 (433)
Q Consensus 298 ~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 375 (433)
+.++||||||+++|||++ |.+|+............. .......+..++..+.+++.+||+.+|++||++.+|++.|+
T Consensus 199 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 199 TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 999999999999999997 888875433222111111 12223345667899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=281.88 Aligned_cols=232 Identities=30% Similarity=0.514 Sum_probs=184.5
Q ss_pred cccCCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
+..+++.+.++++.|+||.||++. +|+.++++++|+||+++++++. .+..++||||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 344556666777777777776422 6999999999999999999874 5678999999
Q ss_pred cCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcc
Q psy6593 180 IAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTT 258 (433)
Q Consensus 180 ~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 258 (433)
+++++|.+++.. .+..+++..+..++.|++.||+|||+.|++|+||+|+||++++++.++|+|||++..........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~-- 159 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA-- 159 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc--
Confidence 999999998865 34568999999999999999999999999999999999999999999999999987654221110
Q ss_pred ccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhh
Q psy6593 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDF 337 (433)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~ 337 (433)
.....++..|+|||.+.+..++.++||||||+++|+|++ |.+|+...........+ ....
T Consensus 160 ------------------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~ 220 (260)
T cd05067 160 ------------------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-ERGY 220 (260)
T ss_pred ------------------ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-HcCC
Confidence 002235678999999998889999999999999999997 88888643321111111 1112
Q ss_pred ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHh
Q psy6593 338 RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376 (433)
Q Consensus 338 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 376 (433)
....+...|.++.+++.+||+.+|++||++++|+.+|+.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 223446678899999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=289.12 Aligned_cols=238 Identities=29% Similarity=0.455 Sum_probs=187.7
Q ss_pred cccccCCeeeeeccCCCcchhhhhc-------------------------------cchHHHHhhc-CCcceeeEEEEEE
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQN-------------------------------CGQVAVLRSL-HHHNVIRFIGVLY 168 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~-------------------------------~~E~~~l~~l-~h~~iv~~~~~~~ 168 (433)
+.+..+++.+.+.++.|+||.|+++ .+|+++++++ +|+||+++++++.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 4455566677777777777776521 1699999999 7999999999999
Q ss_pred eCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccch
Q psy6593 169 KDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLAR 247 (433)
Q Consensus 169 ~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 247 (433)
..+..++||||+.+++|.+++... ...+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++.
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999999999653 2348999999999999999999999999999999999999999999999999987
Q ss_pred hccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCC
Q psy6593 248 IIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPR 326 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~ 326 (433)
.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |.+|+......
T Consensus 190 ~~~~~~~~~~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~ 250 (302)
T cd05055 190 DIMNDSNYVV-------------------KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD 250 (302)
T ss_pred cccCCCceee-------------------cCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch
Confidence 6543221100 002345678999999998889999999999999999996 88877543221
Q ss_pred CCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 327 SPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
...............+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 251 SKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111111111112223456788999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=277.41 Aligned_cols=223 Identities=26% Similarity=0.459 Sum_probs=195.2
Q ss_pred eeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCC
Q psy6593 128 LLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGT 184 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~s 184 (433)
+-+..++|+|+||.|+|++ .|+.||++.+.++||++||.+..+..+|||||||..||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 4566799999999999955 79999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccch
Q psy6593 185 LKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVP 264 (433)
Q Consensus 185 L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 264 (433)
+.++++..++++++.++..+++..+.||+|||...-+|||||..|||++.+|+.||+|||.+-.+.....
T Consensus 115 iSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA---------- 184 (502)
T KOG0574|consen 115 ISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA---------- 184 (502)
T ss_pred HHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH----------
Confidence 9999998888999999999999999999999999999999999999999999999999999987654332
Q ss_pred hhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh-hccccCC
Q psy6593 265 RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD-FRNKFCA 343 (433)
Q Consensus 265 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 343 (433)
++.+.+|||.|||||++..-.|+.++||||||++..||.-|+||+.+..+....+.+.... ....-+.
T Consensus 185 -----------KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE 253 (502)
T KOG0574|consen 185 -----------KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPE 253 (502)
T ss_pred -----------hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChH
Confidence 3347899999999999999999999999999999999999999999877765444332221 1112236
Q ss_pred CCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 344 SCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 344 ~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
.++.++-++++.||-++|++|-++-++.
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~ 281 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLC 281 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHh
Confidence 6788999999999999999999987775
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=281.66 Aligned_cols=233 Identities=30% Similarity=0.508 Sum_probs=182.2
Q ss_pred cccCCeeeeeccCCCcchhhhhc-----------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQN-----------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~-----------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
+..+.+.+.+++++|+||+||++ .+|++++++++|+||+++++.+. ....++||||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 34444556666666666666541 26899999999999999999874 4568999999
Q ss_pred cCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcc
Q psy6593 180 IAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTT 258 (433)
Q Consensus 180 ~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 258 (433)
+++++|.+++.+. +..+++..++.++.|++.||++||+.+++|+||||+||++++++.++|+|||.+...........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~- 160 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR- 160 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccc-
Confidence 9999999999753 34589999999999999999999999999999999999999999999999999976543221100
Q ss_pred ccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhh
Q psy6593 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDF 337 (433)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~ 337 (433)
....++..|+|||...+..++.++||||||+++|+|++ |.+|+............ ....
T Consensus 161 -------------------~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~-~~~~ 220 (262)
T cd05071 161 -------------------QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGY 220 (262)
T ss_pred -------------------cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH-hcCC
Confidence 02335677999999988889999999999999999997 78777543221111100 0111
Q ss_pred ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 338 RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 338 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
.......++..+.+++.+|++.+|++||++++++++|++.
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1222456789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=303.42 Aligned_cols=234 Identities=29% Similarity=0.492 Sum_probs=197.8
Q ss_pred eeeeeccCCCcchhhhh-----------------------------ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEe
Q psy6593 128 LLFCKEDYNGKYGEACQ-----------------------------NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTE 178 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~-----------------------------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 178 (433)
+.+.+-+|.|.||+|++ .+.|+.||.+++||||++|.|+....+...||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 55556778999999996 1179999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCC-CCc
Q psy6593 179 YIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR-APT 257 (433)
Q Consensus 179 ~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 257 (433)
||++|+|+.+|+++.+.|+..++..+++.|+.|++||-++|+|||||...|||++.+-..|++|||+++.+...+. ..+
T Consensus 711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~yt 790 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 790 (996)
T ss_pred hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCcccc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999997755441 111
Q ss_pred cccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHh-cCCCCCCCCCCCCCCCCCchhh
Q psy6593 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDYLPRSPDFGLDQTD 336 (433)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~~~~~~~~~~~~~~~~~~~~~~ 336 (433)
....+ -..+|.|||++...+++.++||||+|++|||.+ -|..|+.+..+. .........
T Consensus 791 t~GGK-------------------IPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ-dVIkaIe~g 850 (996)
T KOG0196|consen 791 TLGGK-------------------IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVIKAIEQG 850 (996)
T ss_pred ccCCc-------------------cceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH-HHHHHHHhc
Confidence 11111 135799999999999999999999999999998 444444443322 223334456
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccc
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~ 381 (433)
++...|.++|..|.+||..||++|-.+||.+.+|+..|+++....
T Consensus 851 yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 851 YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 677778999999999999999999999999999999999987543
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=291.88 Aligned_cols=207 Identities=22% Similarity=0.408 Sum_probs=166.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC-CccccCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~dl 225 (433)
+|+++|++++|+||+++++++..++..++||||+++++|.+++...+ .+++..+..++.|++.||.|||+. +++|+||
T Consensus 52 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dl 130 (333)
T cd06650 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 130 (333)
T ss_pred HHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCC
Confidence 79999999999999999999999999999999999999999997644 589999999999999999999975 7999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||+++.++.+||+|||++........ ....||..|+|||.+.+..++.++||||
T Consensus 131 kp~Nili~~~~~~kL~Dfg~~~~~~~~~~-----------------------~~~~~~~~y~aPE~~~~~~~~~~~Dvws 187 (333)
T cd06650 131 KPSNILVNSRGEIKLCDFGVSGQLIDSMA-----------------------NSFVGTRSYMSPERLQGTHYSVQSDIWS 187 (333)
T ss_pred ChhhEEEcCCCCEEEeeCCcchhhhhhcc-----------------------ccCCCCccccCHHHhcCCCCCcHHHHHH
Confidence 99999999999999999999876532211 1346889999999999888999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCC-------------------C----------------Cc--------hhhhccccC
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDF-------------------G----------------LD--------QTDFRNKFC 342 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~-------------------~----------------~~--------~~~~~~~~~ 342 (433)
||+++|+|++|..|+.......... . +. ........+
T Consensus 188 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (333)
T cd06650 188 MGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLP 267 (333)
T ss_pred HHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCC
Confidence 9999999998887764321100000 0 00 000000011
Q ss_pred -CCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhh
Q psy6593 343 -ASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGL 377 (433)
Q Consensus 343 -~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~ 377 (433)
...+.++.+|+.+||+.||++||++++++ .||+..
T Consensus 268 ~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 268 SGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred CCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 23567899999999999999999999997 577653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=288.60 Aligned_cols=211 Identities=30% Similarity=0.410 Sum_probs=169.0
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC---------------CCCChHHHHHHHHHHHH
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQRVNFARDIAA 210 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~ 210 (433)
+|++++.++ +|+||+++++++..++..++||||+++++|.+++...+ ..+++..++.++.|++.
T Consensus 56 ~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 135 (303)
T cd05088 56 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 135 (303)
T ss_pred HHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHH
Confidence 589999999 89999999999999999999999999999999986422 25789999999999999
Q ss_pred HHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccc
Q psy6593 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPE 290 (433)
Q Consensus 211 ~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 290 (433)
||+|||+.|++||||||+||+++.++.++|+|||++......... ....++..|+|||
T Consensus 136 al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~----------------------~~~~~~~~y~aPE 193 (303)
T cd05088 136 GMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK----------------------TMGRLPVRWMAIE 193 (303)
T ss_pred HHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchhhhc----------------------ccCCCcccccCHH
Confidence 999999999999999999999999999999999998632111000 0112356799999
Q ss_pred eecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhH
Q psy6593 291 MMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEV 369 (433)
Q Consensus 291 ~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 369 (433)
.+.+..++.++||||||+++|+|++ |.+||.......... ..........+..++..+.+++.+||+.+|++||++++
T Consensus 194 ~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 272 (303)
T cd05088 194 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 272 (303)
T ss_pred HHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH-HHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9988889999999999999999996 887775432211110 01111122234557889999999999999999999999
Q ss_pred HHHHHHhhccc
Q psy6593 370 LEVWLEGLSMH 380 (433)
Q Consensus 370 i~~~l~~~~~~ 380 (433)
++..|..+...
T Consensus 273 il~~l~~~~~~ 283 (303)
T cd05088 273 ILVSLNRMLEE 283 (303)
T ss_pred HHHHHHHHHHh
Confidence 99988876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=284.74 Aligned_cols=210 Identities=26% Similarity=0.459 Sum_probs=169.7
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC----------------CCCCChHHHHHHHHHHHH
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP----------------GQPLPWGQRVNFARDIAA 210 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----------------~~~~~~~~~~~i~~qi~~ 210 (433)
+|++++++++|+||+++++++..++..++||||+++++|.+++... ...+++..++.++.|++.
T Consensus 56 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~ 135 (283)
T cd05090 56 QEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAA 135 (283)
T ss_pred HHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHH
Confidence 6999999999999999999999999999999999999999998421 124788899999999999
Q ss_pred HHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccc
Q psy6593 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPE 290 (433)
Q Consensus 211 ~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 290 (433)
||.|||+.|++|+||||+||++++++.++|+|||+++......... ......++..|+|||
T Consensus 136 al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~-------------------~~~~~~~~~~y~aPE 196 (283)
T cd05090 136 GMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR-------------------VQPKSLLPIRWMPPE 196 (283)
T ss_pred HHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCccee-------------------cccCCCccceecChH
Confidence 9999999999999999999999999999999999998754322110 011334567799999
Q ss_pred eecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhH
Q psy6593 291 MMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEV 369 (433)
Q Consensus 291 ~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 369 (433)
.+.+..++.++||||||+++|||++ |.+|+........ ............+..++..+.+++.+||+.+|.+||++.+
T Consensus 197 ~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 275 (283)
T cd05090 197 AIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV-IEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKD 275 (283)
T ss_pred HhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHH
Confidence 9988889999999999999999997 8877654321111 0111111122344678899999999999999999999999
Q ss_pred HHHHHHh
Q psy6593 370 LEVWLEG 376 (433)
Q Consensus 370 i~~~l~~ 376 (433)
|.+.|+.
T Consensus 276 i~~~l~~ 282 (283)
T cd05090 276 IHTRLRS 282 (283)
T ss_pred HHHHhhc
Confidence 9988864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=291.39 Aligned_cols=227 Identities=25% Similarity=0.422 Sum_probs=194.5
Q ss_pred CeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcC-CcceeeEEEEEEeCCeeeEEE
Q psy6593 127 GLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVT 177 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 177 (433)
.+.+...+|+|.||.|+... +|+++|+++. ||||+.++++|.+...+++||
T Consensus 36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm 115 (382)
T KOG0032|consen 36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM 115 (382)
T ss_pred cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence 36666889999999888611 7999999998 999999999999999999999
Q ss_pred eccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc----CCceEEeccccchhccCCC
Q psy6593 178 EYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE----DKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 178 e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~----~~~~kl~Dfg~~~~~~~~~ 253 (433)
|++.||.|.+.+.+. .+++..+..++.|++.+++|||+.|++||||||+|+|+.. ++.++++|||++......
T Consensus 116 EL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~- 192 (382)
T KOG0032|consen 116 ELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG- 192 (382)
T ss_pred EecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC-
Confidence 999999999999775 3999999999999999999999999999999999999963 357999999999987541
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~ 333 (433)
......+||+.|+|||++....|+..+||||+|+++|.|++|.+||...........+.
T Consensus 193 ---------------------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~ 251 (382)
T KOG0032|consen 193 ---------------------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL 251 (382)
T ss_pred ---------------------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH
Confidence 12337899999999999999999999999999999999999999997765444333222
Q ss_pred hh--hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 334 QT--DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 334 ~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
.. .+....+..++..+.++++.++..||..|+++.++++ |+...
T Consensus 252 ~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 252 RGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred cCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 22 3344556888999999999999999999999999985 66654
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=286.71 Aligned_cols=231 Identities=22% Similarity=0.374 Sum_probs=181.2
Q ss_pred CCeeeeeccCCCcchhhhhc--------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 126 DGLLFCKEDYNGKYGEACQN--------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~--------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
+++...+++++|+||+||+. .+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 44666667777777777641 1699999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccc
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
++ ++|.+++...+..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.........
T Consensus 86 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---- 160 (309)
T cd07872 86 LD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT---- 160 (309)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc----
Confidence 96 4898888776666899999999999999999999999999999999999999999999999998754322111
Q ss_pred cccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC------
Q psy6593 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL------ 332 (433)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~------ 332 (433)
.....+|+.|+|||.+.+ ..++.++||||||+++|+|++|.++|...........+
T Consensus 161 -----------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 223 (309)
T cd07872 161 -----------------YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGT 223 (309)
T ss_pred -----------------cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 113457889999998865 46789999999999999999999988653221100000
Q ss_pred ---------------chhhhcc-------ccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 333 ---------------DQTDFRN-------KFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 333 ---------------~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
....... .....+++++.+++.+||+.||.+||++++++. |++.+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 224 PTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred CCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 0000000 111356789999999999999999999999984 887653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=295.17 Aligned_cols=244 Identities=27% Similarity=0.492 Sum_probs=207.6
Q ss_pred cccccccccCCeeeeeccCCCcchhhhhc------------------------cchHHHHhhcCCcceeeEEEEEEeCCe
Q psy6593 117 MLDNWYFEKDGLLFCKEDYNGKYGEACQN------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 117 ~l~~~~~~~~~~~~~~~~~~g~fg~v~~~------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~ 172 (433)
..++|.+++.++.+..++|.|.||+||.. +.|+++|+.++|||+|+++|+|..+..
T Consensus 258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred CcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 34889999999999999999999999852 279999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
+|||.|||..|+|.+++++.+ .-++....+.++.||.+|++||..+++|||||...|.|+.++..||++|||+++....
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 999999999999999998854 3477778889999999999999999999999999999999999999999999998766
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHh-cCCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDYLPRSPDF 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~~~~~~~~~~~~~~~~ 330 (433)
.++.... ..--.+.|.|||.+....++.++|||+||++|||+. -|..|++... .....
T Consensus 418 DTYTAHA--------------------GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-lSqVY 476 (1157)
T KOG4278|consen 418 DTYTAHA--------------------GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVY 476 (1157)
T ss_pred Cceeccc--------------------CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-HHHHH
Confidence 5443111 111234599999999999999999999999999999 5777776532 22233
Q ss_pred CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccc
Q psy6593 331 GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381 (433)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~ 381 (433)
.+-...++..-+.++|+.+.+||+.||+.+|.+||++.+|.+.|+.+..+.
T Consensus 477 ~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 477 GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 344556777778999999999999999999999999999998888765443
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=291.18 Aligned_cols=211 Identities=18% Similarity=0.242 Sum_probs=165.1
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++..++|+||+++++++..++++|+||||++|++|.+++.+.+..+++..+..++.||+.||+|||++||+|||||
T Consensus 50 ~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 129 (331)
T cd05597 50 EERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIK 129 (331)
T ss_pred HHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCC
Confidence 58889999999999999999999999999999999999999997655679999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-----CCCCccc
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-----QEYDETV 301 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~ 301 (433)
|+||+++.++.++|+|||++.......... .....||+.|+|||++.. ..++.++
T Consensus 130 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 189 (331)
T cd05597 130 PDNVLLDKNGHIRLADFGSCLRLLADGTVQ--------------------SNVAVGTPDYISPEILQAMEDGKGRYGPEC 189 (331)
T ss_pred HHHEEECCCCCEEEEECCceeecCCCCCcc--------------------ccceeccccccCHHHHhhccccccCCCCcc
Confidence 999999999999999999987654322111 113468999999999863 4578899
Q ss_pred CeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhh---ccccCCCCcHHHHHHHHHhcccCCCC--CCChhHHHH--HH
Q psy6593 302 DVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDF---RNKFCASCPEPFVRIAFLCCDLNPDQ--RPPFEVLEV--WL 374 (433)
Q Consensus 302 DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~--RPs~~~i~~--~l 374 (433)
||||||+++|+|++|..||...........+..... .......++..+.+++.+||..++++ |++++++++ ||
T Consensus 190 DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~ 269 (331)
T cd05597 190 DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF 269 (331)
T ss_pred eeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence 999999999999999988754322111000000000 01112347899999999998664443 788888874 66
Q ss_pred Hhh
Q psy6593 375 EGL 377 (433)
Q Consensus 375 ~~~ 377 (433)
...
T Consensus 270 ~~~ 272 (331)
T cd05597 270 EGI 272 (331)
T ss_pred CCC
Confidence 543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=284.12 Aligned_cols=212 Identities=33% Similarity=0.517 Sum_probs=170.8
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcC---------------CCCCCChHHHHHHHHHHHH
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---------------PGQPLPWGQRVNFARDIAA 210 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~---------------~~~~~~~~~~~~i~~qi~~ 210 (433)
+|+++++++ +|+||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.
T Consensus 64 ~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 143 (293)
T cd05053 64 SEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVAR 143 (293)
T ss_pred HHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHH
Confidence 689999999 899999999999999999999999999999999853 2346899999999999999
Q ss_pred HHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccc
Q psy6593 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPE 290 (433)
Q Consensus 211 ~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 290 (433)
||.|||+.||+||||||+||+++.++.++|+|||+++........... ....++..|+|||
T Consensus 144 al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~-------------------~~~~~~~~y~aPE 204 (293)
T cd05053 144 GMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT-------------------TNGRLPVKWMAPE 204 (293)
T ss_pred HHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceecc-------------------CCCCCCccccCHH
Confidence 999999999999999999999999999999999999875432211100 0122456799999
Q ss_pred eecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhH
Q psy6593 291 MMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEV 369 (433)
Q Consensus 291 ~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 369 (433)
.+.+..++.++||||||+++|+|++ |..|+........ ............+...+..+.+|+.+||+.+|++|||+++
T Consensus 205 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 283 (293)
T cd05053 205 ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQ 283 (293)
T ss_pred HhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH-HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHH
Confidence 9988889999999999999999995 7776654321111 1111111122334567889999999999999999999999
Q ss_pred HHHHHHhhc
Q psy6593 370 LEVWLEGLS 378 (433)
Q Consensus 370 i~~~l~~~~ 378 (433)
+++.|+++.
T Consensus 284 il~~l~~~~ 292 (293)
T cd05053 284 LVEDLDRML 292 (293)
T ss_pred HHHHHHHhh
Confidence 999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=285.87 Aligned_cols=209 Identities=27% Similarity=0.425 Sum_probs=170.7
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC-------------CCCChHHHHHHHHHHHHHHh
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-------------QPLPWGQRVNFARDIAAGMT 213 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-------------~~~~~~~~~~i~~qi~~~L~ 213 (433)
+|+++|++++|+||+++++++..+...++||||+++++|.+++...+ ..+++..+..++.|++.||.
T Consensus 57 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~ 136 (280)
T cd05049 57 REAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMV 136 (280)
T ss_pred HHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHH
Confidence 79999999999999999999999999999999999999999986532 34788999999999999999
Q ss_pred hhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec
Q psy6593 214 YLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT 293 (433)
Q Consensus 214 ~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 293 (433)
+||+.|++|+||||+||+++.++.++|+|||++........... .....+++.|+|||++.
T Consensus 137 ~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~-------------------~~~~~~~~~y~aPE~~~ 197 (280)
T cd05049 137 YLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRV-------------------GGHTMLPIRWMPPESIM 197 (280)
T ss_pred HHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceec-------------------CCCCcccceecChhhhc
Confidence 99999999999999999999999999999999875432211100 01234567899999999
Q ss_pred CCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 294 GQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 294 ~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
+..++.++||||||+++|+|++ |..|+............. .......+..++..+.+++.+||+.+|++||++++|++
T Consensus 198 ~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 198 YRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred cCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999997 888765432221111111 11122334668899999999999999999999999999
Q ss_pred HHH
Q psy6593 373 WLE 375 (433)
Q Consensus 373 ~l~ 375 (433)
.|+
T Consensus 277 ~l~ 279 (280)
T cd05049 277 RLQ 279 (280)
T ss_pred Hhh
Confidence 886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=283.21 Aligned_cols=208 Identities=31% Similarity=0.498 Sum_probs=172.9
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.|+.+++.++|+||+++++++...+..++||||+++++|.+++.+ .+..+++..++.++.|++.||.|||+.|++|+||
T Consensus 51 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl 130 (261)
T cd05148 51 KEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDL 130 (261)
T ss_pred HHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccc
Confidence 789999999999999999999999999999999999999999976 3456899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
+|+||+++.++.++|+|||++.......... ....++..|+|||.+.+..++.++||||
T Consensus 131 ~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~---------------------~~~~~~~~~~~PE~~~~~~~~~~~Diws 189 (261)
T cd05148 131 AARNILVGEDLVCKVADFGLARLIKEDVYLS---------------------SDKKIPYKWTAPEAASHGTFSTKSDVWS 189 (261)
T ss_pred CcceEEEcCCceEEEccccchhhcCCccccc---------------------cCCCCceEecCHHHHccCCCCchhhHHH
Confidence 9999999999999999999997654321110 0223566799999998888999999999
Q ss_pred hhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHh
Q psy6593 306 YGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376 (433)
Q Consensus 306 lG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 376 (433)
||+++|+|++ |.+|+.......... ..........+..+++.+.+++.+||+.+|.+||++++|++.|+.
T Consensus 190 lG~~l~~l~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 190 FGILLYEMFTYGQVPYPGMNNHEVYD-QITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHHHHHHHcCCCCCCCcCCHHHHHH-HHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 9999999997 788775433221111 111222333456788999999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=281.87 Aligned_cols=208 Identities=28% Similarity=0.457 Sum_probs=170.1
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.+|++++++++|+||+++++++...+..++||||++|++|.+++......+++..++.++.|++.||++||+.|++|+||
T Consensus 47 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl 126 (256)
T cd05059 47 IEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126 (256)
T ss_pred HHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence 36999999999999999999999999999999999999999999765557899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||+++.++.++|+|||+++.......... ....++..|+|||.+.+..++.++||||
T Consensus 127 ~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~--------------------~~~~~~~~y~~Pe~~~~~~~~~~~Di~s 186 (256)
T cd05059 127 AARNCLVGEDNVVKVSDFGLARYVLDDQYTSS--------------------QGTKFPVKWAPPEVFDYSRFSSKSDVWS 186 (256)
T ss_pred cHhhEEECCCCcEEECCcccceeccccccccc--------------------CCCCCCccccCHHHhccCCCCchhhHHH
Confidence 99999999999999999999876533211100 0112345799999999889999999999
Q ss_pred hhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHH
Q psy6593 306 YGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWL 374 (433)
Q Consensus 306 lG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 374 (433)
||+++|+|++ |.+|+.......... ..........+..+|..+.+++.+||+.+|++||++.++++.|
T Consensus 187 lG~il~~l~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 187 FGVLMWEVFSEGKMPYERFSNSEVVE-SVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH-HHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 9999999997 777775432221111 1111222233456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=293.29 Aligned_cols=234 Identities=19% Similarity=0.256 Sum_probs=183.5
Q ss_pred cccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCe
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~ 172 (433)
.....+++.+.+.+++|+||.||... +|+.+++.++||||+++++.+..++.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34456778888999999999988411 57889999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
.++||||++|++|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 9999999999999999976 35899999999999999999999999999999999999999999999999998865432
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCC----CCCcccCeEehhHHHHHHhcCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ----EYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~ 328 (433)
... ......||+.|+|||++.+. .++.++||||||+++|||++|.+||........
T Consensus 196 ~~~--------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 255 (371)
T cd05622 196 GMV--------------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 255 (371)
T ss_pred Ccc--------------------cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH
Confidence 111 01145799999999998753 378899999999999999999998865332111
Q ss_pred CCCCchhh--hccccCCCCcHHHHHHHHHhcccCCCC--CCChhHHHH--HHHh
Q psy6593 329 DFGLDQTD--FRNKFCASCPEPFVRIAFLCCDLNPDQ--RPPFEVLEV--WLEG 376 (433)
Q Consensus 329 ~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~--RPs~~~i~~--~l~~ 376 (433)
...+.... ........++..+.++|..||..++.+ |+++++|++ |++.
T Consensus 256 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 256 YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred HHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 11111100 111112467899999999999844433 678888875 4443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=279.97 Aligned_cols=211 Identities=29% Similarity=0.489 Sum_probs=170.0
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..+|++++++++|+||+++++++...+..++||||+++++|.+++...+..+++..++.++.|++.||.|||+.|++|+|
T Consensus 40 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~d 119 (252)
T cd05084 40 FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRD 119 (252)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Confidence 34899999999999999999999999999999999999999999976555689999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|||+||+++.++.++|+|||++............ .....+..|+|||.+.+..++.++|||
T Consensus 120 l~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~-------------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 180 (252)
T cd05084 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTG-------------------GMKQIPVKWTAPEALNYGRYSSESDVW 180 (252)
T ss_pred cchheEEEcCCCcEEECccccCcccccccccccC-------------------CCCCCceeecCchhhcCCCCChHHHHH
Confidence 9999999999999999999998754321110000 011224569999999988899999999
Q ss_pred ehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHH
Q psy6593 305 SYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375 (433)
Q Consensus 305 slG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 375 (433)
|||+++|+|++ |.+|+.......... ..........+..++..+.+++.+||+.+|++||++.++.+.|+
T Consensus 181 slG~il~e~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 181 SFGILLWEAFSLGAVPYANLSNQQTRE-AIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHHHhCCCCCccccCHHHHHH-HHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 99999999996 777765432211100 01111222344667899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=280.97 Aligned_cols=208 Identities=31% Similarity=0.556 Sum_probs=168.4
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+.++++++|+||+++++++. ....++||||+++++|.+++.+. ...+++..++.++.|++.||+|||+.|++|+||
T Consensus 50 ~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di 128 (260)
T cd05070 50 EEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDL 128 (260)
T ss_pred HHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 7999999999999999999875 55689999999999999998753 345899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
+|+||++++++.++|+|||++.......... .....++..|+|||.+.+..++.++||||
T Consensus 129 ~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~--------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 188 (260)
T cd05070 129 RSANILVGDGLVCKIADFGLARLIEDNEYTA--------------------RQGAKFPIKWTAPEAALYGRFTIKSDVWS 188 (260)
T ss_pred ccceEEEeCCceEEeCCceeeeeccCccccc--------------------ccCCCCCccccChHHHhcCCCcchhhhHH
Confidence 9999999999999999999997654321110 00223456799999998888999999999
Q ss_pred hhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHh
Q psy6593 306 YGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376 (433)
Q Consensus 306 lG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 376 (433)
||+++|+|++ |.+|+...........+ ........+...+..+.+++.+||+.+|.+||++.++.++|+.
T Consensus 189 lG~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 189 FGILLTELVTKGRVPYPGMNNREVLEQV-ERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 9999999997 88887553221111111 1112223346678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=284.20 Aligned_cols=216 Identities=23% Similarity=0.372 Sum_probs=185.6
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
.|+|+..|+.++|||||++|++......+|||+|+-++|+|.++|-++...++++.+.+++.||+.|+.|+|+..+||||
T Consensus 64 lfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRD 143 (864)
T KOG4717|consen 64 LFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRD 143 (864)
T ss_pred HHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhccc
Confidence 45899999999999999999999999999999999999999999988777899999999999999999999999999999
Q ss_pred CCCcceEEc-cCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCC-cccC
Q psy6593 225 LNSQNCLVR-EDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYD-ETVD 302 (433)
Q Consensus 225 lkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~D 302 (433)
|||+|+.+. .-|-|||.|||++-.+..+ ++..+.+|+..|.|||++.+..|+ +++|
T Consensus 144 LKPENVVFFEKlGlVKLTDFGFSNkf~PG----------------------~kL~TsCGSLAYSAPEILLGDsYDAPAVD 201 (864)
T KOG4717|consen 144 LKPENVVFFEKLGLVKLTDFGFSNKFQPG----------------------KKLTTSCGSLAYSAPEILLGDSYDAPAVD 201 (864)
T ss_pred CCcceeEEeeecCceEeeeccccccCCCc----------------------chhhcccchhhccCchhhhcCccCCcchh
Confidence 999998775 6699999999998766443 233478999999999999999886 6899
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhccc
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLSMH 380 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~~~ 380 (433)
|||||+|||.|+.|.+||..-........+....+ ..|..++.+.++||..||..||.+|.+.++|. .||+.....
T Consensus 202 iWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 202 IWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred hhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 99999999999999999976544433333332222 35678899999999999999999999999998 599877655
Q ss_pred ccCC
Q psy6593 381 LSVD 384 (433)
Q Consensus 381 ~~~~ 384 (433)
....
T Consensus 280 ~sT~ 283 (864)
T KOG4717|consen 280 LSTA 283 (864)
T ss_pred cccc
Confidence 5443
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=289.25 Aligned_cols=212 Identities=24% Similarity=0.374 Sum_probs=170.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.+++.++|+||+++++++..+ ..++|+||+++|+|.+++.+....+++..++.++.|++.||+|||+.||+|||||
T Consensus 58 ~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlk 136 (316)
T cd05108 58 DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLA 136 (316)
T ss_pred HHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccc
Confidence 688999999999999999998764 5789999999999999998766678999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.+||+|||+++.......... .....++..|+|||.+.+..++.++|||||
T Consensus 137 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~-------------------~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 197 (316)
T cd05108 137 ARNVLVKTPQHVKITDFGLAKLLGADEKEYH-------------------AEGGKVPIKWMALESILHRIYTHQSDVWSY 197 (316)
T ss_pred hhheEecCCCcEEEccccccccccCCCccee-------------------ccCCccceeecChHHhccCCCCchhhhHHH
Confidence 9999999999999999999987643221100 001223567999999999899999999999
Q ss_pred hHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 307 GIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 307 G~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
|+++|||++ |.+|+........ ............+..++..+.+++.+||+.+|++||++.+++..|..+..
T Consensus 198 Gv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 198 GVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 999999996 8877754321110 11111111222345677899999999999999999999999998887754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=290.65 Aligned_cols=208 Identities=21% Similarity=0.292 Sum_probs=168.3
Q ss_pred ccchHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 145 NCGQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 145 ~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
...|..++..+ +||||+++++++..++..|+||||+.|++|.+++... ..+++..+..++.|++.||+|||+.||+||
T Consensus 42 ~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHr 120 (316)
T cd05620 42 TMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120 (316)
T ss_pred HHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence 34677788765 8999999999999999999999999999999998764 358999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
||||+||+++.++.++|+|||+++....... ......||+.|+|||++.+..++.++||
T Consensus 121 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di 179 (316)
T cd05620 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDN---------------------RASTFCGTPDYIAPEILQGLKYTFSVDW 179 (316)
T ss_pred CCCHHHeEECCCCCEEeCccCCCeecccCCC---------------------ceeccCCCcCccCHHHHcCCCCCcccch
Confidence 9999999999999999999999864321111 1125678999999999999999999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChh-HHH--HHHHh
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFE-VLE--VWLEG 376 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~-~i~--~~l~~ 376 (433)
||||+++|+|++|.+||........... .......++..++.++.+++.+||+.||++||++. +++ .|++.
T Consensus 180 wslGvil~el~~g~~Pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 180 WSFGVLLYEMLIGQSPFHGDDEDELFES--IRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred hhhHHHHHHHHhCCCCCCCCCHHHHHHH--HHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence 9999999999999988864322111000 01112234456788999999999999999999974 665 35554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=290.89 Aligned_cols=197 Identities=24% Similarity=0.349 Sum_probs=162.6
Q ss_pred chHHHHhhcCC-cceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLHH-HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.|+.++..++| ++|+++++++...+.+|+||||++|++|.+++...+ .+++..+..++.||+.||+|||+.||+||||
T Consensus 49 ~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~dl 127 (324)
T cd05587 49 VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127 (324)
T ss_pred HHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCC
Confidence 68888888865 568899999999999999999999999999987644 5899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+|||++.++.++|+|||++........ ......||+.|+|||++.+..++.++||||
T Consensus 128 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 186 (324)
T cd05587 128 KLDNVMLDAEGHIKIADFGMCKENIFGGK---------------------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWA 186 (324)
T ss_pred CHHHeEEcCCCCEEEeecCcceecCCCCC---------------------ceeeecCCccccChhhhcCCCCCcccchhh
Confidence 99999999999999999999864322111 112567999999999999989999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCCh
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF 367 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~ 367 (433)
||+++|+|++|.+||........... .......++..++..+.+++.+||+.+|.+|++.
T Consensus 187 lGvil~elltG~~pf~~~~~~~~~~~--i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 187 FGVLLYEMLAGQPPFDGEDEDELFQS--IMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred hHHHHHHHHhCCCCCCCCCHHHHHHH--HHcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 99999999999998864322111111 1112233456788999999999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=279.84 Aligned_cols=227 Identities=28% Similarity=0.458 Sum_probs=178.5
Q ss_pred cCCeeeeeccCCCcchhhhh---------------------ccchHHHHhhcCCcceeeEEEEEE-eCCeeeEEEeccCC
Q psy6593 125 KDGLLFCKEDYNGKYGEACQ---------------------NCGQVAVLRSLHHHNVIRFIGVLY-KDRKLNLVTEYIAG 182 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~---------------------~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~g 182 (433)
.+++.+.+.+++|+||.||+ ..+|+.++++++|+||+++++++. .++..++||||+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 34455556666666666653 127999999999999999999865 44678999999999
Q ss_pred CCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccc
Q psy6593 183 GTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA 261 (433)
Q Consensus 183 ~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 261 (433)
++|.+++.+.+ ..+++..++.++.|++.||++||+.|++||||||+||+++.++.++|+|||++........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~------- 157 (256)
T cd05082 85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD------- 157 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccCC-------
Confidence 99999987643 3488999999999999999999999999999999999999999999999999875432211
Q ss_pred cchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccc
Q psy6593 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNK 340 (433)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (433)
...++..|+|||++.+..++.++||||||+++|+|++ |.+|+.......... .........
T Consensus 158 -----------------~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~-~~~~~~~~~ 219 (256)
T cd05082 158 -----------------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-RVEKGYKMD 219 (256)
T ss_pred -----------------CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHhcCCCCC
Confidence 2223457999999998889999999999999999995 777765321111000 001112223
Q ss_pred cCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHh
Q psy6593 341 FCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376 (433)
Q Consensus 341 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 376 (433)
.+..+|..+.+++.+||+.+|++||++.++++.|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 220 APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 446788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=282.80 Aligned_cols=212 Identities=24% Similarity=0.372 Sum_probs=168.9
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
.|+.++++++||||+++++++. +...++++||+++++|.+++......+++..++.|+.|++.||.|||+.|++|+|||
T Consensus 58 ~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlk 136 (279)
T cd05111 58 DHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLA 136 (279)
T ss_pred HHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccC
Confidence 4666788899999999999875 456789999999999999998766679999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.+||+|||+++.......... .....++..|+|||.+.+..++.++|||||
T Consensus 137 p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~-------------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl 197 (279)
T cd05111 137 ARNILLKSDSIVQIADFGVADLLYPDDKKYF-------------------YSEHKTPIKWMALESILFGRYTHQSDVWSY 197 (279)
T ss_pred cceEEEcCCCcEEEcCCccceeccCCCcccc-------------------cCCCCCcccccCHHHhccCCcCchhhHHHH
Confidence 9999999999999999999976533211100 012346678999999998889999999999
Q ss_pred hHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 307 GIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 307 G~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
|+++|||++ |.+|+....+..... ..........+..++..+.+++.+||..+|++||++.++.+.|..+..
T Consensus 198 G~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 198 GVTVWEMMSYGAEPYAGMRPHEVPD-LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 999999997 888775432211100 001111112234567889999999999999999999999998888653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=278.90 Aligned_cols=211 Identities=24% Similarity=0.384 Sum_probs=170.5
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++++++|+||+++++++. ....++||||+++++|.+++......+++..++.++.|++.||.|||+.|++|+|||
T Consensus 44 ~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk 122 (257)
T cd05115 44 REAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLA 122 (257)
T ss_pred HHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccc
Confidence 8999999999999999999875 457899999999999999997655679999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.++|+|||++............ .....++..|+|||.+....++.++|||||
T Consensus 123 p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 184 (257)
T cd05115 123 ARNVLLVNQHYAKISDFGLSKALGADDSYYKA------------------RSAGKWPLKWYAPECINFRKFSSRSDVWSY 184 (257)
T ss_pred hheEEEcCCCcEEeccCCccccccCCccceec------------------cCCCCCCcccCCHHHHccCCCCchhhHHHH
Confidence 99999999999999999998765432211000 001223567999999988889999999999
Q ss_pred hHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 307 GIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 307 G~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
|+++|+|++ |.+|+.......... ..........+...++++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 185 G~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 185 GITMWEAFSYGQKPYKKMKGPEVMS-FIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHhcCCCCCcCcCCHHHHHH-HHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 999999995 888775432211110 1111122334567789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=295.92 Aligned_cols=240 Identities=27% Similarity=0.441 Sum_probs=190.3
Q ss_pred ccccccCCeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhcC-CcceeeEEEEE
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSLH-HHNVIRFIGVL 167 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l~-h~~iv~~~~~~ 167 (433)
.|.+..+++.+.+.+|+|+||.||+.. +|+++|.++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 456677778888899999999987420 5899999997 99999999999
Q ss_pred EeCCeeeEEEeccCCCCHHHHhcCCC------------------------------------------------------
Q psy6593 168 YKDRKLNLVTEYIAGGTLKELLQDPG------------------------------------------------------ 193 (433)
Q Consensus 168 ~~~~~~~lv~e~~~g~sL~~~l~~~~------------------------------------------------------ 193 (433)
...+..++||||+++|+|.+++...+
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 99999999999999999999985421
Q ss_pred -------------------------------------------CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcce
Q psy6593 194 -------------------------------------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 230 (433)
Q Consensus 194 -------------------------------------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Ni 230 (433)
..+++..++.++.|++.||.|||+.+++||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 1356778899999999999999999999999999999
Q ss_pred EEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHH
Q psy6593 231 LVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310 (433)
Q Consensus 231 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 310 (433)
+++.++.++|+|||+++.......... .....+++.|+|||.+.+..++.++||||||+++
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil 331 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYIS-------------------KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILL 331 (401)
T ss_pred EEeCCCEEEEEecCcceeccccccccc-------------------CCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHH
Confidence 999999999999999976533211100 0133567889999999988899999999999999
Q ss_pred HHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 311 CEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 311 ~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
|||++ |.+|+.....................+..++..+.+++.+||+.+|.+||++++|+..|+.+.
T Consensus 332 ~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 332 WEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 99996 666664432111111111112222345567899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=289.34 Aligned_cols=199 Identities=20% Similarity=0.283 Sum_probs=163.9
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+.++.++ +|+||+++++++...+.+++||||++|++|.+++...+ .+++..++.++.||+.||+|||+.||+||||
T Consensus 44 ~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDl 122 (327)
T cd05617 44 TEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHERGIIYRDL 122 (327)
T ss_pred HHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 788888888 69999999999999999999999999999999886543 5999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||+++.++.++|+|||+++....... ......||+.|+|||.+.+..++.++||||
T Consensus 123 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 181 (327)
T cd05617 123 KLDNVLLDADGHIKLTDYGMCKEGLGPGD---------------------TTSTFCGTPNYIAPEILRGEEYGFSVDWWA 181 (327)
T ss_pred CHHHEEEeCCCCEEEeccccceeccCCCC---------------------ceecccCCcccCCHHHHCCCCCCchheeeh
Confidence 99999999999999999999874322111 112467999999999999999999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCC-----chhhhccccCCCCcHHHHHHHHHhcccCCCCCCCh
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGL-----DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF 367 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~ 367 (433)
||+++|+|++|.+||............ ........++..++..+.+++.+||+.||.+|+++
T Consensus 182 lGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 182 LGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred hHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 999999999999988543221111100 00111223456778999999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=283.36 Aligned_cols=209 Identities=26% Similarity=0.449 Sum_probs=167.9
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC---------CCCChHHHHHHHHHHHHHHhhhhc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------QPLPWGQRVNFARDIAAGMTYLHS 217 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~~lH~ 217 (433)
+|+.+++.++|+||+++++++..+...++||||+++++|.+++.+.. ..+++..++.++.|++.||.|||+
T Consensus 58 ~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 137 (277)
T cd05062 58 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA 137 (277)
T ss_pred HHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999999999999999999999999986521 235778899999999999999999
Q ss_pred CCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCC
Q psy6593 218 MNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY 297 (433)
Q Consensus 218 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 297 (433)
.|++|+||||+||++++++.++|+|||++........... .....+++.|+|||.+.+..+
T Consensus 138 ~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~-------------------~~~~~~~~~y~aPE~~~~~~~ 198 (277)
T cd05062 138 NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK-------------------GGKGLLPVRWMSPESLKDGVF 198 (277)
T ss_pred CCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeec-------------------CCCCccCHhhcChhHhhcCCc
Confidence 9999999999999999999999999999876543221100 002245678999999998889
Q ss_pred CcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHH
Q psy6593 298 DETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375 (433)
Q Consensus 298 ~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 375 (433)
+.++||||||+++|||++ +.+|+......... ...........+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 199 ~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 199 TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL-RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 999999999999999997 67776543221110 001111122345677899999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=280.47 Aligned_cols=209 Identities=26% Similarity=0.465 Sum_probs=171.7
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..+|++++++++||||+++++++..++..++|+||+++++|.+++...+ .+++..+..++.|++.||.+||+.|++|+|
T Consensus 51 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~d 129 (263)
T cd06625 51 LECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSNMIVHRD 129 (263)
T ss_pred HHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 3479999999999999999999999999999999999999999987643 589999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|+|+||+++.++.++|+|||+++.......... ......++..|+|||.+.+..++.++|||
T Consensus 130 l~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 191 (263)
T cd06625 130 IKGANILRDSAGNVKLGDFGASKRLQTICSSGT------------------GMKSVTGTPYWMSPEVISGEGYGRKADVW 191 (263)
T ss_pred CCHHHEEEcCCCCEEEeecccceeccccccccc------------------cccCCCcCccccCcceeccCCCCchhhhH
Confidence 999999999999999999999876532211100 00134577889999999998899999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
|||+++|+|++|.+|+....................++..++..+.+++.+||+.+|.+||+++++++
T Consensus 192 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 192 SVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred HHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 99999999999998876532221111111222233455678899999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=285.10 Aligned_cols=215 Identities=31% Similarity=0.530 Sum_probs=174.0
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-----------------------CCCCChHHH
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-----------------------GQPLPWGQR 201 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-----------------------~~~~~~~~~ 201 (433)
..+|+.+++.++||||+++++.+..++..++|+||+.+++|.+++... ...+++..+
T Consensus 50 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 129 (290)
T cd05045 50 LLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDL 129 (290)
T ss_pred HHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHH
Confidence 337999999999999999999999999999999999999999987531 134788999
Q ss_pred HHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeec
Q psy6593 202 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVV 281 (433)
Q Consensus 202 ~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (433)
+.++.|++.||.|||+.|++||||||+||++++++.++|+|||+++.......... .....
T Consensus 130 ~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~-------------------~~~~~ 190 (290)
T cd05045 130 ISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK-------------------RSKGR 190 (290)
T ss_pred HHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhc-------------------ccCCC
Confidence 99999999999999999999999999999999999999999999876533221100 00223
Q ss_pred cCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccC
Q psy6593 282 GNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLN 360 (433)
Q Consensus 282 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 360 (433)
++..|+|||.+.+..++.++||||||+++|+|++ |.+|+....+... ............+..++.++.+++.+||+.+
T Consensus 191 ~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~ 269 (290)
T cd05045 191 IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL-FNLLKTGYRMERPENCSEEMYNLMLTCWKQE 269 (290)
T ss_pred CCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHhCCCCCCCCCCCCHHHHHHHHHHccCC
Confidence 4667999999988889999999999999999997 8887754332211 1111111222335667899999999999999
Q ss_pred CCCCCChhHHHHHHHhhcc
Q psy6593 361 PDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 361 p~~RPs~~~i~~~l~~~~~ 379 (433)
|++||+++++++.|+++..
T Consensus 270 P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 270 PDKRPTFADISKELEKMMV 288 (290)
T ss_pred cccCCCHHHHHHHHHHHHh
Confidence 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=282.91 Aligned_cols=203 Identities=30% Similarity=0.405 Sum_probs=160.7
Q ss_pred chHHHHhhc---CCcceeeEEEEEEe-----CCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhc
Q psy6593 147 GQVAVLRSL---HHHNVIRFIGVLYK-----DRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHS 217 (433)
Q Consensus 147 ~E~~~l~~l---~h~~iv~~~~~~~~-----~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~ 217 (433)
+|+++++++ +||||+++++++.. ...+++||||++ ++|.+++... ...+++..++.++.|++.||.|||+
T Consensus 50 ~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~ 128 (290)
T cd07862 50 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128 (290)
T ss_pred HHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 577777766 69999999999862 356899999995 6999988653 3458999999999999999999999
Q ss_pred CCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCC
Q psy6593 218 MNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY 297 (433)
Q Consensus 218 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 297 (433)
.||+||||||+||+++.++.++|+|||++........ .....||+.|+|||.+.+..+
T Consensus 129 ~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----------------------~~~~~~~~~y~aPE~~~~~~~ 186 (290)
T cd07862 129 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA----------------------LTSVVVTLWYRAPEVLLQSSY 186 (290)
T ss_pred CCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCcc----------------------cccccccccccChHHHhCCCC
Confidence 9999999999999999999999999999876533211 114568999999999988889
Q ss_pred CcccCeEehhHHHHHHhcCCCCCCCCCCCCCC--------------C----CCchh-------hhccccCCCCcHHHHHH
Q psy6593 298 DETVDVFSYGIVLCEIIGRVPADPDYLPRSPD--------------F----GLDQT-------DFRNKFCASCPEPFVRI 352 (433)
Q Consensus 298 ~~~~DiwslG~il~ell~~~~~~~~~~~~~~~--------------~----~~~~~-------~~~~~~~~~~~~~l~~l 352 (433)
+.++||||||+++|||++|.++|......... . ..... .........++..+.++
T Consensus 187 ~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 266 (290)
T cd07862 187 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL 266 (290)
T ss_pred CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHH
Confidence 99999999999999999999988643221000 0 00000 00111224578889999
Q ss_pred HHHhcccCCCCCCChhHHHH
Q psy6593 353 AFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 353 i~~~l~~~p~~RPs~~~i~~ 372 (433)
+.+||+.||++||++.++++
T Consensus 267 i~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 267 LLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHhccCchhcCCHHHHhc
Confidence 99999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=290.43 Aligned_cols=214 Identities=21% Similarity=0.374 Sum_probs=166.3
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeC-----CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCc
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKD-----RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNL 220 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i 220 (433)
.+|+++|++++||||+++++++... ..+|+||||+ +++|.+++...+ .+++..+..++.||+.||.|||+.||
T Consensus 47 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~i 124 (338)
T cd07859 47 LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANV 124 (338)
T ss_pred HHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3799999999999999999998643 2589999999 569999887644 59999999999999999999999999
Q ss_pred cccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC--CCCC
Q psy6593 221 IHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG--QEYD 298 (433)
Q Consensus 221 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~ 298 (433)
+||||||+||+++.++.+||+|||+++.......... ......||+.|+|||++.+ ..++
T Consensus 125 vH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~------------------~~~~~~~t~~y~aPE~~~~~~~~~~ 186 (338)
T cd07859 125 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI------------------FWTDYVATRWYRAPELCGSFFSKYT 186 (338)
T ss_pred ecCCCCHHHeEECCCCcEEEccCccccccccccCccc------------------cccCCCCCCCcCCHHHHhccccccC
Confidence 9999999999999999999999999976432211100 0114578999999999876 6789
Q ss_pred cccCeEehhHHHHHHhcCCCCCCCCCCCCCC---------------CCCc-------hhhhcc-------ccCCCCcHHH
Q psy6593 299 ETVDVFSYGIVLCEIIGRVPADPDYLPRSPD---------------FGLD-------QTDFRN-------KFCASCPEPF 349 (433)
Q Consensus 299 ~~~DiwslG~il~ell~~~~~~~~~~~~~~~---------------~~~~-------~~~~~~-------~~~~~~~~~l 349 (433)
.++||||||+++|+|++|.++|......... ..+. ...... .....+++.+
T Consensus 187 ~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (338)
T cd07859 187 PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLA 266 (338)
T ss_pred chhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHH
Confidence 9999999999999999999988643211000 0000 000000 0113567889
Q ss_pred HHHHHHhcccCCCCCCChhHHH--HHHHhhcc
Q psy6593 350 VRIAFLCCDLNPDQRPPFEVLE--VWLEGLSM 379 (433)
Q Consensus 350 ~~li~~~l~~~p~~RPs~~~i~--~~l~~~~~ 379 (433)
.+++.+||+.+|++||++++++ .||+.+..
T Consensus 267 ~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 267 LRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 9999999999999999999998 47776543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=283.32 Aligned_cols=234 Identities=25% Similarity=0.419 Sum_probs=184.1
Q ss_pred ccccccccCCeeeeeccCCCcchhhhhc-------------------------cchHHHHhhcCCcceeeEEEEEEeCCe
Q psy6593 118 LDNWYFEKDGLLFCKEDYNGKYGEACQN-------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 118 l~~~~~~~~~~~~~~~~~~g~fg~v~~~-------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~ 172 (433)
+.++....+.+.+.++++.|+||.||+. .+|+.++++++|+||+++++.+..++.
T Consensus 4 ~~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (292)
T cd06644 4 VRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGK 83 (292)
T ss_pred hhcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCe
Confidence 3445555566667777777777777741 168899999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
.++||||+++++|..++.+....+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 99999999999999988765567999999999999999999999999999999999999999999999999988654321
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceec-----CCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT-----GQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~ 327 (433)
.. ......+++.|+|||.+. ...++.++||||||+++|+|++|.+|+.......
T Consensus 164 ~~---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 222 (292)
T cd06644 164 LQ---------------------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 222 (292)
T ss_pred cc---------------------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH
Confidence 11 111456888999999985 3456789999999999999999998876543211
Q ss_pred CCCCCchh-hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 328 PDFGLDQT-DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 328 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
........ ......+..++.++.+++.+||+.+|++||+++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 223 VLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11111000 0011223567789999999999999999999999974
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=285.04 Aligned_cols=212 Identities=29% Similarity=0.410 Sum_probs=170.0
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC---------------CCCChHHHHHHHHHHHH
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQRVNFARDIAA 210 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~ 210 (433)
+|++++.++ +||||+++++++......++||||+++++|.+++.+.. ..+++..++.++.|++.
T Consensus 51 ~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 130 (297)
T cd05089 51 GELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVAT 130 (297)
T ss_pred HHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHH
Confidence 699999999 79999999999999999999999999999999986421 34888999999999999
Q ss_pred HHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccc
Q psy6593 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPE 290 (433)
Q Consensus 211 ~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 290 (433)
||++||+.|++||||||+||+++.++.+||+|||++......... .....+..|+|||
T Consensus 131 al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~----------------------~~~~~~~~y~aPE 188 (297)
T cd05089 131 GMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK----------------------TMGRLPVRWMAIE 188 (297)
T ss_pred HHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccceecc----------------------CCCCcCccccCch
Confidence 999999999999999999999999999999999998642211000 0112245699999
Q ss_pred eecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhH
Q psy6593 291 MMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEV 369 (433)
Q Consensus 291 ~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 369 (433)
.+.+..++.++||||||+++|||++ |.+||.......... ..........+..++..+.+|+.+||+.+|.+||++++
T Consensus 189 ~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 267 (297)
T cd05089 189 SLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE-KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQ 267 (297)
T ss_pred hhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9998889999999999999999996 877775432211111 11111222344568899999999999999999999999
Q ss_pred HHHHHHhhcccc
Q psy6593 370 LEVWLEGLSMHL 381 (433)
Q Consensus 370 i~~~l~~~~~~~ 381 (433)
|++.|+.+....
T Consensus 268 i~~~l~~~~~~~ 279 (297)
T cd05089 268 ISVQLSRMLEAR 279 (297)
T ss_pred HHHHHHHHHHhh
Confidence 998888776544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=288.26 Aligned_cols=171 Identities=27% Similarity=0.504 Sum_probs=151.8
Q ss_pred CeeeeeccCCCcchhhhhcc------------------------chHHHHhhcC-C-----cceeeEEEEEEeCCeeeEE
Q psy6593 127 GLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSLH-H-----HNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l~-h-----~~iv~~~~~~~~~~~~~lv 176 (433)
.+.+.+-+|+|.||+|.++. .|+.+|..|+ | -|||+++++|...+++|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 35567789999999999733 7999999996 3 4899999999999999999
Q ss_pred EeccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc--CCceEEeccccchhccCCC
Q psy6593 177 TEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE--DKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~ 253 (433)
+|.+ ..+|+++++.++ ..|+...++.|+.||+.||..||+.||||.||||+||||.. ...|||+|||.+.....
T Consensus 267 fELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q-- 343 (586)
T KOG0667|consen 267 FELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ-- 343 (586)
T ss_pred ehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC--
Confidence 9999 679999998743 46999999999999999999999999999999999999973 35799999999987643
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCC
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPD 322 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~ 322 (433)
..++++.++.|+|||++.|.+|+.+.||||||||++||++|.|.|+.
T Consensus 344 ----------------------~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 344 ----------------------RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred ----------------------cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 33477889999999999999999999999999999999999988854
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=284.36 Aligned_cols=203 Identities=21% Similarity=0.282 Sum_probs=167.2
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+.++++++|+||+++++.+..++..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||
T Consensus 49 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dl 128 (285)
T cd05605 49 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDL 128 (285)
T ss_pred HHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Confidence 6999999999999999999999999999999999999999887543 346999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||++++++.++|+|||++........ .....|++.|+|||.+.+..++.++||||
T Consensus 129 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~~----------------------~~~~~~~~~y~aPE~~~~~~~~~~~Diws 186 (285)
T cd05605 129 KPENILLDDYGHIRISDLGLAVEIPEGET----------------------IRGRVGTVGYMAPEVVKNERYTFSPDWWG 186 (285)
T ss_pred CHHHEEECCCCCEEEeeCCCceecCCCCc----------------------cccccCCCCccCcHHhcCCCCCccccchh
Confidence 99999999999999999999876432111 01346899999999999888999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCc--hhhhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHH
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLD--QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLE 371 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~ 371 (433)
+|+++|+|++|.+||...........+. ........+..++..+.+|+.+||+.||.+|| ++++++
T Consensus 187 ~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~ 259 (285)
T cd05605 187 LGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVK 259 (285)
T ss_pred HHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHh
Confidence 9999999999999886532211100000 11112234456889999999999999999999 677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=289.11 Aligned_cols=207 Identities=23% Similarity=0.327 Sum_probs=168.2
Q ss_pred cchHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 146 CGQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 146 ~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..|..++..+ +||||+++++++.+++.+++||||++|++|.+++.+. ..+++..+..++.|++.||+|||+.||+|||
T Consensus 43 ~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrd 121 (316)
T cd05619 43 MVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRD 121 (316)
T ss_pred HHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCC
Confidence 3677888765 8999999999999999999999999999999999764 3589999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|||+||+++.++.++|+|||++........ ......||+.|+|||++.+..++.++|||
T Consensus 122 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 180 (316)
T cd05619 122 LKLDNILLDTDGHIKIADFGMCKENMLGDA---------------------KTCTFCGTPDYIAPEILLGQKYNTSVDWW 180 (316)
T ss_pred CCHHHEEECCCCCEEEccCCcceECCCCCC---------------------ceeeecCCccccCHHHHcCCCCCchhhhh
Confidence 999999999999999999999875322111 11256789999999999998999999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChh-HHHH--HHHh
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFE-VLEV--WLEG 376 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~-~i~~--~l~~ 376 (433)
|||+++|+|++|.+||...........+ ......++..++.++.+++.+||+.+|.+||++. ++.. |++.
T Consensus 181 slG~il~el~~G~~pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 181 SFGVLLYEMLIGQSPFHGHDEEELFQSI--RMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFRE 253 (316)
T ss_pred hHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence 9999999999999888643221111111 1111223456788999999999999999999996 6653 5554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=297.38 Aligned_cols=230 Identities=23% Similarity=0.315 Sum_probs=180.5
Q ss_pred cccCCeeeeeccCCCcchhhhhcc-------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCC
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC-------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGG 183 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~-------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 183 (433)
....++.+...+++|+||.||++. +|+++|++|+|+||+++++++..++..++|||++. +
T Consensus 166 ~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~ 244 (461)
T PHA03211 166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-S 244 (461)
T ss_pred cccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-C
Confidence 345578889999999999999733 69999999999999999999999999999999994 6
Q ss_pred CHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccc
Q psy6593 184 TLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263 (433)
Q Consensus 184 sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 263 (433)
+|.+++......+++..++.|+.|++.||.|||+.||+||||||+|||++.++.++|+|||+++.........
T Consensus 245 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~------- 317 (461)
T PHA03211 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP------- 317 (461)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc-------
Confidence 9999887655579999999999999999999999999999999999999999999999999997653321110
Q ss_pred hhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCC-CCCCCCCCC--CCCC-----Cch-
Q psy6593 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVP-ADPDYLPRS--PDFG-----LDQ- 334 (433)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~-~~~~~~~~~--~~~~-----~~~- 334 (433)
......||+.|+|||++.+..++.++||||||+++|||+++.. .+....... .... +..
T Consensus 318 ------------~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~ 385 (461)
T PHA03211 318 ------------FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA 385 (461)
T ss_pred ------------cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh
Confidence 1124579999999999999999999999999999999986543 332110000 0000 000
Q ss_pred ----hhh--------------------cccc-------CCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 335 ----TDF--------------------RNKF-------CASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 335 ----~~~--------------------~~~~-------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
..+ .... ...++..+.+||.+||+.||.+||++.|+++
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 386 QVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred ccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 000 0000 0134567899999999999999999999985
|
|
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=300.07 Aligned_cols=240 Identities=18% Similarity=0.284 Sum_probs=186.3
Q ss_pred CCeeeeeccCCCcchhhhhcc-------------------------chHHHHhhcC-CcceeeEEEEEE-eC------Ce
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLH-HHNVIRFIGVLY-KD------RK 172 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~-h~~iv~~~~~~~-~~------~~ 172 (433)
..+.+.+-+.+|||+.||-+. +||++|++|+ |+|||.+++... .. -.
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 335666677789999888521 8999999996 999999999432 11 25
Q ss_pred eeEEEeccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCC--ccccCCCCcceEEccCCceEEeccccchhc
Q psy6593 173 LNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMN--LIHRDLNSQNCLVREDKTVVVADFGLARII 249 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 249 (433)
++|+||||.||+|-+++.+ -...|++.++++|+.++++|+.+||... |||||||-+||||+.+|..||+|||.+...
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 7899999999999999864 2234999999999999999999999997 999999999999999999999999999865
Q ss_pred cCCCCCCccccccchhhhhhhcccccceeeeccCcccccccee---cCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCC
Q psy6593 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMM---TGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~ 326 (433)
......... ....+..-....|+.|+|||++ .+..++.|+|||+|||+||-|+-...||...-
T Consensus 197 ~~~~~~~~e------------~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-- 262 (738)
T KOG1989|consen 197 ILSPTSAQE------------VNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-- 262 (738)
T ss_pred cCCCccHHH------------HHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--
Confidence 544321110 0000111134579999999986 46789999999999999999997777775431
Q ss_pred CCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccc
Q psy6593 327 SPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381 (433)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~ 381 (433)
...+....+.......++..+.+||+.||+.||++||++-+++..+-+++...
T Consensus 263 --~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 263 --KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred --ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 12333344444344678899999999999999999999999998877766433
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=279.92 Aligned_cols=205 Identities=28% Similarity=0.496 Sum_probs=166.9
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++++++|+||+++++++..++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+|+||+
T Consensus 55 ~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~ 133 (267)
T cd06646 55 QEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIK 133 (267)
T ss_pred HHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 6999999999999999999999999999999999999999998754 358999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec---CCCCCcccCe
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT---GQEYDETVDV 303 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di 303 (433)
|+||+++.++.++|+|||++......... .....+++.|+|||.+. ...++.++||
T Consensus 134 p~nill~~~~~~~l~dfg~~~~~~~~~~~---------------------~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dv 192 (267)
T cd06646 134 GANILLTDNGDVKLADFGVAAKITATIAK---------------------RKSFIGTPYWMAPEVAAVEKNGGYNQLCDI 192 (267)
T ss_pred HHHEEECCCCCEEECcCccceeecccccc---------------------cCccccCccccCHhHcccccCCCCcchhhH
Confidence 99999999999999999999865322110 11346788999999874 3457889999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccc---cCCCCcHHHHHHHHHhcccCCCCCCChhHHHHH
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNK---FCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVW 373 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~ 373 (433)
||||+++|||++|.+|+....+......+....+... ....++..+.+++.+||+.+|++||++++|++.
T Consensus 193 ws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 193 WAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred HHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 9999999999998887754433222222222211111 124567899999999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=293.67 Aligned_cols=228 Identities=20% Similarity=0.356 Sum_probs=168.6
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++.+++|+||+++++.+.+++.+++||||++|++|.+++.+.+ .+++..+..++.|++.||+|||+.||+|||||
T Consensus 50 ~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~givHrDLk 128 (360)
T cd05627 50 AERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQLGFIHRDIK 128 (360)
T ss_pred HHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCC
Confidence 58899999999999999999999999999999999999999997644 59999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCcccc-----------ccch---hhhhhhcccccceeeeccCcccccccee
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM-----------AKVP---RKAAQRRGARKKRYTVVGNPYWMAPEMM 292 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~-----------~~~~---~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 292 (433)
|+||+++.++.++|+|||++.............. .... .................||+.|+|||++
T Consensus 129 p~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 208 (360)
T cd05627 129 PDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF 208 (360)
T ss_pred HHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHH
Confidence 9999999999999999999876533211000000 0000 0000000111122356799999999999
Q ss_pred cCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccC--CCCcHHHHHHHHHhcccCCCCCCC---h
Q psy6593 293 TGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFC--ASCPEPFVRIAFLCCDLNPDQRPP---F 367 (433)
Q Consensus 293 ~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~RPs---~ 367 (433)
.+..++.++||||||+++|||++|.+||....+......+........++ ..+++++.++|.+++. +|.+|++ +
T Consensus 209 ~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~ 287 (360)
T cd05627 209 MQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGV 287 (360)
T ss_pred cCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCH
Confidence 99999999999999999999999999986543322111111000111122 2467899999999874 9999985 5
Q ss_pred hHHH--HHHHh
Q psy6593 368 EVLE--VWLEG 376 (433)
Q Consensus 368 ~~i~--~~l~~ 376 (433)
++++ .|++.
T Consensus 288 ~ei~~hp~f~~ 298 (360)
T cd05627 288 EEIKSHPFFEG 298 (360)
T ss_pred HHHhcCCCCCC
Confidence 5665 35554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=278.96 Aligned_cols=211 Identities=23% Similarity=0.392 Sum_probs=170.9
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.+|+.++++++|+||+++++++. .+..++||||+++++|.+++.... .+++..+..++.|++.||++||+.|++|+||
T Consensus 44 ~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl 121 (257)
T cd05116 44 LREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEETNFVHRDL 121 (257)
T ss_pred HHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence 47899999999999999999875 557799999999999999997643 5899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||.||+++.++.++|+|||++........... ......++..|+|||.+....++.++||||
T Consensus 122 kp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 183 (257)
T cd05116 122 AARNVLLVTQHYAKISDFGLSKALGADENYYK------------------AKTHGKWPVKWYAPECMNYYKFSSKSDVWS 183 (257)
T ss_pred chhhEEEcCCCeEEECCCccccccCCCCCeee------------------ecCCCCCCccccCHhHhccCCcCchhHHHH
Confidence 99999999999999999999987643321100 001223457899999998888999999999
Q ss_pred hhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 306 YGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 306 lG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
||+++|||++ |.+||.......... ..........+..++.++.++|.+||+.||++||++.+|...|++.
T Consensus 184 lG~~l~el~t~g~~p~~~~~~~~~~~-~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 184 FGVLMWEAFSYGQKPYKGMKGNEVTQ-MIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 9999999996 888876543221111 1111222334567899999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=286.04 Aligned_cols=240 Identities=30% Similarity=0.469 Sum_probs=189.1
Q ss_pred cccccCCeeeeeccCCCcchhhhhc---------------------------------cchHHHHhhc-CCcceeeEEEE
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQN---------------------------------CGQVAVLRSL-HHHNVIRFIGV 166 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~---------------------------------~~E~~~l~~l-~h~~iv~~~~~ 166 (433)
+....+++++.+++++|+||.||.+ .+|+++++++ +|+||++++++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 3444566778888888888888731 1588899999 79999999999
Q ss_pred EEeCCeeeEEEeccCCCCHHHHhcCCC---------------CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceE
Q psy6593 167 LYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 231 (433)
Q Consensus 167 ~~~~~~~~lv~e~~~g~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil 231 (433)
+..++..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++||||||+||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 999999999999999999999996521 24888999999999999999999999999999999999
Q ss_pred EccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHH
Q psy6593 232 VREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLC 311 (433)
Q Consensus 232 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 311 (433)
++.++.++|+|||++........... .....+++.|+|||.+.+..++.++||||||+++|
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 233 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKK-------------------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 233 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhc-------------------cccCCCccceeChHHhccCCCCcHHHHHHHHHHHH
Confidence 99999999999999876532211000 00122456799999999888999999999999999
Q ss_pred HHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccc
Q psy6593 312 EIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMH 380 (433)
Q Consensus 312 ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~ 380 (433)
+|++ |.+|+....... .............+..++.++.+++.+||+.+|++||++.+|++.|+++...
T Consensus 234 el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 234 EIFTLGGSPYPGVPVEE-LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHcCCCCCCCcCCHHH-HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 9996 777765422111 1111111222234466789999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=290.54 Aligned_cols=231 Identities=22% Similarity=0.318 Sum_probs=181.8
Q ss_pred cccCCeeeeeccCCCcchhhhhcc-------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCC
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC-------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGG 183 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~-------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 183 (433)
....++.+.+.+++|+||.||++. .|+.+|++++|+||+++++++......++|||++. +
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 141 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-S 141 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-C
Confidence 445568888999999999998732 69999999999999999999999999999999994 6
Q ss_pred CHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccc
Q psy6593 184 TLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263 (433)
Q Consensus 184 sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 263 (433)
+|.+++......+++..++.|+.||+.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 142 ~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~--------- 212 (357)
T PHA03209 142 DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA--------- 212 (357)
T ss_pred cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcc---------
Confidence 89998877666799999999999999999999999999999999999999999999999999875322111
Q ss_pred hhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCC------------
Q psy6593 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDF------------ 330 (433)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~------------ 330 (433)
.....||+.|+|||++.+..++.++||||||+++|||++ +.+++..........
T Consensus 213 -------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~ 279 (357)
T PHA03209 213 -------------FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279 (357)
T ss_pred -------------cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHH
Confidence 114568999999999999899999999999999999995 444433211100000
Q ss_pred ---CCchhhhc--------------------------cccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 331 ---GLDQTDFR--------------------------NKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 331 ---~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
......+. ......++..+.++|.+||+.||.+|||++++++ ||+.
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 280 STLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 00000000 0001245677888999999999999999999984 5543
|
|
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=261.32 Aligned_cols=245 Identities=16% Similarity=0.202 Sum_probs=190.1
Q ss_pred ccccCCeeeeeccCCCcchhhhh-------------------------ccchHHHHhhcCCcceeeEEEEEEeC-----C
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQ-------------------------NCGQVAVLRSLHHHNVIRFIGVLYKD-----R 171 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~-------------------------~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 171 (433)
.++.+.+.+.+.++.|||.-|+- +.+|++.-++++||||++++++...+ .
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 45666688888999999987763 22899999999999999999886544 3
Q ss_pred eeeEEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCC--ccccCCCCcceEEccCCceEEeccccc
Q psy6593 172 KLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMN--LIHRDLNSQNCLVREDKTVVVADFGLA 246 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 246 (433)
..||+++|...|||.+.++. .+..+++.+++.|+.++.+||++||+.. ++||||||.||++++.+.++|.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 59999999999999998864 4557999999999999999999999998 999999999999999999999999998
Q ss_pred hhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC---CCCCcccCeEehhHHHHHHhcCCCCCCCC
Q psy6593 247 RIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG---QEYDETVDVFSYGIVLCEIIGRVPADPDY 323 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~~~~~~~~~ 323 (433)
......-.. .......+.......|..|+|||.+.- ...+.++|||||||++|+|+-|..||...
T Consensus 177 ~~a~i~i~~------------~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~ 244 (302)
T KOG2345|consen 177 TQAPIQIEG------------SRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI 244 (302)
T ss_pred cccceEeec------------hHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence 865432111 111111222334567889999999864 45789999999999999999777666443
Q ss_pred CCCCCCC--CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 324 LPRSPDF--GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 324 ~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
....... .+....+.......+++.+.+++++||+.||.+||++.+++..++++.
T Consensus 245 ~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 245 YQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred hhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 3222221 222222222222458899999999999999999999999999888764
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=278.77 Aligned_cols=232 Identities=31% Similarity=0.528 Sum_probs=184.6
Q ss_pred ccCCeeeeeccCCCcchhhhhc-----------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEecc
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQN-----------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYI 180 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~-----------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 180 (433)
..+++.+.+.++.|+||+||++ .+|+.++++++|+||+++++++..+...++||||+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 4455666666677777766642 16899999999999999999999889999999999
Q ss_pred CCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccc
Q psy6593 181 AGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 181 ~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
++++|.+++.+.. ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++..........
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--- 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA--- 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhh---
Confidence 9999999997633 468999999999999999999999999999999999999999999999999987654311100
Q ss_pred cccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhc
Q psy6593 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFR 338 (433)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~ 338 (433)
......+..|+|||.+.+..++.++||||||+++|+|++ |.+|+...........+ .....
T Consensus 161 -----------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~-~~~~~ 222 (261)
T cd05034 161 -----------------REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV-ERGYR 222 (261)
T ss_pred -----------------hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCC
Confidence 002234567999999998889999999999999999997 88887543221111111 11122
Q ss_pred cccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHh
Q psy6593 339 NKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376 (433)
Q Consensus 339 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 376 (433)
...+...|..+.+++.+||+.+|++||+++++.+.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 23345678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=279.85 Aligned_cols=210 Identities=23% Similarity=0.421 Sum_probs=170.5
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
+|++++++++||||+++++++...+..++|+||+++++|.+++.. ....+++..+..++.|++.||.|||+.|++|+
T Consensus 51 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~ 130 (267)
T cd08228 51 KEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHR 130 (267)
T ss_pred HHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCC
Confidence 699999999999999999999999999999999999999988753 23458999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
||+|+||+++.++.++|+|||++......... .....+++.|+|||.+.+..++.++||
T Consensus 131 dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~---------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di 189 (267)
T cd08228 131 DIKPANVFITATGVVKLGDLGLGRFFSSKTTA---------------------AHSLVGTPYYMSPERIHENGYNFKSDI 189 (267)
T ss_pred CCCHHHEEEcCCCCEEECccccceeccchhHH---------------------HhcCCCCccccChhhhccCCCCchhhH
Confidence 99999999999999999999998765332110 013457888999999988889999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCC--CCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPD--FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
||||+++|+|++|..|+......... ..+............++..+.+++.+||+.+|++||+++++++.++.+
T Consensus 190 ~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 190 WSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 99999999999888776432211100 000011111122245678899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=279.60 Aligned_cols=212 Identities=30% Similarity=0.507 Sum_probs=171.7
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|++++++++|+||+++++++...+..++||||+++++|.+++.+....+++..+..++.|++.||+|||+.|++|+|||
T Consensus 55 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlk 134 (268)
T cd05063 55 SEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLA 134 (268)
T ss_pred HHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 68999999999999999999999999999999999999999997765679999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.++|+|||++............ ......+..|+|||.+.+..++.++|||||
T Consensus 135 p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl 196 (268)
T cd05063 135 ARNILVNSNLECKVSDFGLSRVLEDDPEGTYT------------------TSGGKIPIRWTAPEAIAYRKFTSASDVWSF 196 (268)
T ss_pred hhhEEEcCCCcEEECCCccceeccccccccee------------------ccCCCcCceecCHHHhhcCCcChHhHHHHH
Confidence 99999999999999999998765432211100 001123457999999988889999999999
Q ss_pred hHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 307 GIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 307 G~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
|+++|||++ |..|+...........+. ..........++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 197 G~il~ell~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 197 GIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHHhCCCCCCCcCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999986 887765432211111111 1112222356789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=279.41 Aligned_cols=212 Identities=29% Similarity=0.506 Sum_probs=172.5
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++++++||||+++++++..++..++||||+++++|.+++......+++..++.++.|++.||++||+.|++|+|||
T Consensus 54 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlk 133 (267)
T cd05066 54 SEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLA 133 (267)
T ss_pred HHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhc
Confidence 79999999999999999999999999999999999999999998766678999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.++|+|||++............ .....++..|+|||.+.+..++.++|+|||
T Consensus 134 p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl 195 (267)
T cd05066 134 ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT------------------TRGGKIPIRWTAPEAIAYRKFTSASDVWSY 195 (267)
T ss_pred hhcEEECCCCeEEeCCCCcccccccccceeee------------------cCCCccceeecCHhHhccCccCchhhhHHH
Confidence 99999999999999999999876432211000 001223567999999998889999999999
Q ss_pred hHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 307 GIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 307 G~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
|+++|++++ |..|+...........+ ........+..+|..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 196 G~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 196 GIVMWEVMSYGERPYWEMSNQDVIKAI-EEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHhcCCCCCcccCCHHHHHHHH-hCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 999999885 88776543221111111 11112233456788999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=278.07 Aligned_cols=208 Identities=31% Similarity=0.543 Sum_probs=168.4
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|++++++++|+||+++++++. .+..++||||+.+++|.+++.+. +..+++..+..++.|++.||.|||+.|++|+||
T Consensus 50 ~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl 128 (260)
T cd05069 50 QEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDL 128 (260)
T ss_pred HHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeeccc
Confidence 6999999999999999999875 55789999999999999999653 345889999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
+|+||++++++.++|+|||++........... ....++..|+|||...+..++.++||||
T Consensus 129 ~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~--------------------~~~~~~~~y~~Pe~~~~~~~~~~~Di~s 188 (260)
T cd05069 129 RAANILVGDNLVCKIADFGLARLIEDNEYTAR--------------------QGAKFPIKWTAPEAALYGRFTIKSDVWS 188 (260)
T ss_pred CcceEEEcCCCeEEECCCccceEccCCccccc--------------------CCCccchhhCCHHHhccCCcChHHHHHH
Confidence 99999999999999999999976543221100 0223566799999998888999999999
Q ss_pred hhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHh
Q psy6593 306 YGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376 (433)
Q Consensus 306 lG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 376 (433)
||+++|+|++ |.+|+.......... ..........+...+..+.+++.+||+.+|++||++++|+++|++
T Consensus 189 lG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 189 FGILLTELVTKGRVPYPGMVNREVLE-QVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 9999999997 888876532211111 111112223345678999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=280.27 Aligned_cols=212 Identities=24% Similarity=0.366 Sum_probs=170.0
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.+++.++|+||+++++++.. ...++++||+++|+|.+++.+....+++..++.++.|++.||+|||+.|++|||||
T Consensus 58 ~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlk 136 (279)
T cd05109 58 DEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLA 136 (279)
T ss_pred HHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 68889999999999999999875 45789999999999999998755679999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||++++++.+||+|||+++........... ....+++.|+|||...+..++.++|||||
T Consensus 137 p~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~-------------------~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 197 (279)
T cd05109 137 ARNVLVKSPNHVKITDFGLARLLDIDETEYHA-------------------DGGKVPIKWMALESILHRRFTHQSDVWSY 197 (279)
T ss_pred cceEEEcCCCcEEECCCCceeecccccceeec-------------------CCCccchhhCCHHHhccCCCCchhHHHHH
Confidence 99999999999999999999876432211000 01234567999999998889999999999
Q ss_pred hHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 307 GIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 307 G~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
|+++|||++ |.+|+.......... ..........+..++..+.+++.+||+.||++||++.+++..|+.+..
T Consensus 198 G~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 198 GVTVWELMTFGAKPYDGIPAREIPD-LLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 999999997 777765432211100 001111122345678899999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=282.08 Aligned_cols=206 Identities=26% Similarity=0.437 Sum_probs=167.3
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.+|+++++.++|+||+++++++..++..++||||+++++|..++.+...++++..+..++.|++.||.|||+.|++|+||
T Consensus 50 ~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dl 129 (282)
T cd06643 50 MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129 (282)
T ss_pred HHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCC
Confidence 37999999999999999999999999999999999999999988665557999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec-----CCCCCcc
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT-----GQEYDET 300 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~ 300 (433)
||+||+++.++.++|+|||++......... .....+++.|+|||++. +..++.+
T Consensus 130 kp~nili~~~~~~kl~dfg~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 188 (282)
T cd06643 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQR---------------------RDSFIGTPYWMAPEVVMCETSKDRPYDYK 188 (282)
T ss_pred CcccEEEccCCCEEEccccccccccccccc---------------------cccccccccccCHhhccccCCCCCCCCcc
Confidence 999999999999999999998764322111 11446888999999974 3457789
Q ss_pred cCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh-hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 301 VDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT-DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 301 ~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
+||||||+++|+|++|.+|+............... ......+..++.++.+++.+||+.+|.+||+++++++
T Consensus 189 ~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 189 ADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred chhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999999999887654322111111111 1111223567889999999999999999999998873
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=282.35 Aligned_cols=210 Identities=27% Similarity=0.475 Sum_probs=167.2
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC----------CCCChHHHHHHHHHHHHHHhhhh
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG----------QPLPWGQRVNFARDIAAGMTYLH 216 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~----------~~~~~~~~~~i~~qi~~~L~~lH 216 (433)
+|+++|++++|+||+++++++..+...++|||++++++|.+++.+.. ..+++..++.++.|++.||+|||
T Consensus 68 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH 147 (296)
T cd05051 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE 147 (296)
T ss_pred HHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 68999999999999999999999999999999999999999986533 25899999999999999999999
Q ss_pred cCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC
Q psy6593 217 SMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE 296 (433)
Q Consensus 217 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 296 (433)
+.|++|+||||+||+++.++.++|+|||++........... .....+++.|+|||.+.+..
T Consensus 148 ~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~-------------------~~~~~~~~~y~aPE~~~~~~ 208 (296)
T cd05051 148 SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV-------------------QGRAPLPIRWMAWESVLLGK 208 (296)
T ss_pred HcCccccccchhceeecCCCceEEccccceeecccCcceee-------------------cCcCCCCceecCHHHhhcCC
Confidence 99999999999999999999999999999876533221110 01334567899999998888
Q ss_pred CCcccCeEehhHHHHHHhc--CCCCCCCCCCCCCCCCCc------hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChh
Q psy6593 297 YDETVDVFSYGIVLCEIIG--RVPADPDYLPRSPDFGLD------QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFE 368 (433)
Q Consensus 297 ~~~~~DiwslG~il~ell~--~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~ 368 (433)
++.++||||||+++|+|++ +.+|+............. ........+..+|.++.+++.+||+.+|.+||++.
T Consensus 209 ~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 288 (296)
T cd05051 209 FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFR 288 (296)
T ss_pred CCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHH
Confidence 9999999999999999985 555553321111000000 00111122345678999999999999999999999
Q ss_pred HHHHHHH
Q psy6593 369 VLEVWLE 375 (433)
Q Consensus 369 ~i~~~l~ 375 (433)
+|+++|+
T Consensus 289 el~~~L~ 295 (296)
T cd05051 289 EIHLFLQ 295 (296)
T ss_pred HHHHHhc
Confidence 9999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=292.24 Aligned_cols=224 Identities=22% Similarity=0.291 Sum_probs=173.3
Q ss_pred CeeeeeccCCCcchhhhhc--------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEecc
Q psy6593 127 GLLFCKEDYNGKYGEACQN--------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYI 180 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~--------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 180 (433)
++...++++.|+||+||+. .+|+++|++++|+||+++++++..++.+++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3445566777777777641 17999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcccc
Q psy6593 181 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260 (433)
Q Consensus 181 ~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 260 (433)
++++|.+.. ..++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 155 ~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~----- 224 (353)
T PLN00034 155 DGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP----- 224 (353)
T ss_pred CCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc-----
Confidence 999986532 3567888899999999999999999999999999999999999999999998865432111
Q ss_pred ccchhhhhhhcccccceeeeccCccccccceecC-----CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC--c
Q psy6593 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-----QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL--D 333 (433)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~--~ 333 (433)
.....||..|+|||.+.. ...+.++||||||+++|||++|..+|............ .
T Consensus 225 ----------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~ 288 (353)
T PLN00034 225 ----------------CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI 288 (353)
T ss_pred ----------------ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH
Confidence 114568999999998743 23456899999999999999998887632111100000 0
Q ss_pred hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 334 QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 334 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
........+..++.++.+||.+||+.||++||++++|++ ||..
T Consensus 289 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 289 CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence 011122234667899999999999999999999999984 5554
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=276.48 Aligned_cols=206 Identities=27% Similarity=0.413 Sum_probs=170.6
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
..+|++++++++||||+++++++..++..++||||++|++|.+++... +..+++..++.++.|++.||.|||+.|++|+
T Consensus 46 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~ 125 (256)
T cd08529 46 AIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHR 125 (256)
T ss_pred HHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 447999999999999999999999999999999999999999998763 4568999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
||+|+||+++.++.++|+|||++......... .....|++.|+|||++.+..++.++||
T Consensus 126 dl~~~nili~~~~~~~l~df~~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di 184 (256)
T cd08529 126 DIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF---------------------ANTIVGTPYYLSPELCEDKPYNEKSDV 184 (256)
T ss_pred CCCcceEEEeCCCCEEEcccccceeccCccch---------------------hhccccCccccCHHHhcCCCCCCccch
Confidence 99999999999999999999998765432211 113467889999999999889999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
||||+++|+|++|.+|+........... .........+..++..+.+++.+||+.+|++||++.++++
T Consensus 185 ~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 185 WALGVVLYECCTGKHPFDANNQGALILK-IIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 9999999999999988754331111000 0111122233467889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=292.32 Aligned_cols=218 Identities=32% Similarity=0.474 Sum_probs=180.9
Q ss_pred eeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 128 LLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
+.-..++|+|+||.||.+. .||..|++++|||++.+.|+|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 4445688899999988622 799999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccc
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
|- ||-.|++.-..+++.+.++..|..+.+.||+|||+.+.||||||..|||+++.|.|||+|||.+......
T Consensus 108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA------- 179 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA------- 179 (948)
T ss_pred Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch-------
Confidence 95 5888888766678999999999999999999999999999999999999999999999999999875432
Q ss_pred cccchhhhhhhcccccceeeeccCccccccceecC---CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh
Q psy6593 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG---QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD 336 (433)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~ 336 (433)
.+++|||+|||||++.. +.|+-++||||||++-.||.-.+||.-.-........+....
T Consensus 180 ------------------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe 241 (948)
T KOG0577|consen 180 ------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 241 (948)
T ss_pred ------------------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC
Confidence 17899999999998864 679999999999999999998888754321111111111111
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
..-.....+++.|..++..||++-|.+|||.++++
T Consensus 242 sPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 242 SPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred CCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 11112367889999999999999999999998875
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=283.95 Aligned_cols=214 Identities=31% Similarity=0.484 Sum_probs=171.0
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC---------------CCCCChHHHHHHHHHHHH
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---------------GQPLPWGQRVNFARDIAA 210 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~---------------~~~~~~~~~~~i~~qi~~ 210 (433)
+|+++++++ +|+||+++++++..++..++||||+++++|.+++... ...+++..+..++.|++.
T Consensus 66 ~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 145 (314)
T cd05099 66 SEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVAR 145 (314)
T ss_pred HHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHH
Confidence 689999999 6999999999999989999999999999999998642 134888999999999999
Q ss_pred HHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccc
Q psy6593 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPE 290 (433)
Q Consensus 211 ~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 290 (433)
||.|||+.|++|+||||+||+++.++.++|+|||+++.......... .....++..|+|||
T Consensus 146 aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~-------------------~~~~~~~~~y~aPE 206 (314)
T cd05099 146 GMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK-------------------TSNGRLPVKWMAPE 206 (314)
T ss_pred HHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccc-------------------cccCCCCccccCHH
Confidence 99999999999999999999999999999999999986543221100 00122345799999
Q ss_pred eecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhH
Q psy6593 291 MMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEV 369 (433)
Q Consensus 291 ~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 369 (433)
.+.+..++.++||||||+++|+|++ |..|+........ ............+..++.++.+++.+||+.+|++||++.+
T Consensus 207 ~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 285 (314)
T cd05099 207 ALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL-FKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQ 285 (314)
T ss_pred HHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 9988889999999999999999996 7776644321111 1111111122334667889999999999999999999999
Q ss_pred HHHHHHhhccc
Q psy6593 370 LEVWLEGLSMH 380 (433)
Q Consensus 370 i~~~l~~~~~~ 380 (433)
+++.|+++...
T Consensus 286 ll~~l~~~~~~ 296 (314)
T cd05099 286 LVEALDKVLAA 296 (314)
T ss_pred HHHHHHHHHHH
Confidence 99999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=284.41 Aligned_cols=210 Identities=30% Similarity=0.508 Sum_probs=164.8
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
..+|+++|++++||||++++|++...+..++|+||+++++|.+++... ...+++..+..|+.|++.||.|||+.+++|+
T Consensus 48 ~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~ 127 (259)
T PF07714_consen 48 FLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHG 127 (259)
T ss_dssp HHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred eeeccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 448999999999999999999999888899999999999999999875 5579999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
+|+++||+++.++.+||+|||++.......... ..........|+|||.+.+..++.++||
T Consensus 128 ~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~-------------------~~~~~~~~~~~~aPE~~~~~~~~~ksDV 188 (259)
T PF07714_consen 128 NLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK-------------------NDSSQQLPLRYLAPEVLKDGEYTKKSDV 188 (259)
T ss_dssp T-SGGGEEEETTTEEEEESTTTGEETTTSSSEE-------------------ESTTSESGGGGS-HHHHHHSEESHHHHH
T ss_pred ccccccccccccccccccccccccccccccccc-------------------cccccccccccccccccccccccccccc
Confidence 999999999999999999999998762221110 0012345677999999999889999999
Q ss_pred EehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHH
Q psy6593 304 FSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWL 374 (433)
Q Consensus 304 wslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 374 (433)
||||+++|||++ +..|+...........+ ........+..+|..+.+++..||+.+|++||++.+|++.|
T Consensus 189 ysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 189 YSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccccccccccccccccccccccccccc-cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 999999999998 66776544221111111 22233344577899999999999999999999999998865
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=276.61 Aligned_cols=206 Identities=21% Similarity=0.360 Sum_probs=169.9
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
..+|+.++++++|+||+++++.+..++..++||||+++++|.+++.. .+..+++..++.++.|++.||.+||+.|++|+
T Consensus 45 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~ 124 (255)
T cd08219 45 SRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHR 124 (255)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccC
Confidence 33799999999999999999999999999999999999999998864 34568999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
||||+||++++++.++|+|||++......... .....+++.|+|||++.+..++.++|+
T Consensus 125 dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~---------------------~~~~~~~~~~~aPE~~~~~~~~~~~Dv 183 (255)
T cd08219 125 DIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY---------------------ACTYVGTPYYVPPEIWENMPYNNKSDI 183 (255)
T ss_pred CCCcceEEECCCCcEEEcccCcceeecccccc---------------------cccccCCccccCHHHHccCCcCchhhh
Confidence 99999999999999999999998765332111 114568889999999998889999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
||||+++|+|++|.+||............ ........+..++..+.+++.+||+.+|++||++++|+.
T Consensus 184 ~slG~i~~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 184 WSLGCILYELCTLKHPFQANSWKNLILKV-CQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred hhhchhheehhhccCCCCCCCHHHHHHHH-hcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 99999999999998887543211111111 111122344667889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=278.57 Aligned_cols=204 Identities=27% Similarity=0.515 Sum_probs=166.0
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.+++.++||||+++++.+..++..++||||+++++|.+++...+ .+++..++.++.|++.||.|||+.|++|+|||
T Consensus 55 ~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk 133 (267)
T cd06645 55 QEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKGKMHRDIK 133 (267)
T ss_pred HHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 68999999999999999999999999999999999999999987644 59999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec---CCCCCcccCe
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT---GQEYDETVDV 303 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di 303 (433)
|+||+++.++.++|+|||++......... .....|+..|+|||.+. ...++.++||
T Consensus 134 p~nili~~~~~~~l~dfg~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv 192 (267)
T cd06645 134 GANILLTDNGHVKLADFGVSAQITATIAK---------------------RKSFIGTPYWMAPEVAAVERKGGYNQLCDI 192 (267)
T ss_pred HHHEEECCCCCEEECcceeeeEccCcccc---------------------cccccCcccccChhhhccccCCCCCchhhh
Confidence 99999999999999999998765332111 11456889999999874 4568889999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccc---cCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNK---FCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
||||+++|+|+++.+|+....+............... ....++..+.+++.+||+.+|++||++++|++
T Consensus 193 wSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 193 WAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 9999999999999888754433222111111111111 11346788999999999999999999998874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=284.72 Aligned_cols=230 Identities=18% Similarity=0.252 Sum_probs=182.9
Q ss_pred ccccCC--eeeeeccCCCcchhhhhcc--------------------------chHHHHhhc-CCcceeeEEEEEEeCCe
Q psy6593 122 YFEKDG--LLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSL-HHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 122 ~~~~~~--~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~ 172 (433)
++...+ +.+.+++|.||...||+.. +|+++|.+| .|.+|+++++|-..++.
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 344444 5566799999999999832 899999999 59999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
+|+|||+- .-+|.++|++.....+.-.++.+..||+.|+.++|+.||||.||||.|+|+- .|.+||+|||+|..+...
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred EEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 99999987 4699999988665555558899999999999999999999999999999985 478999999999988766
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC-----------CCcccCeEehhHHHHHHhcCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE-----------YDETVDVFSYGIVLCEIIGRVPADP 321 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~il~ell~~~~~~~ 321 (433)
++.... ...+||+.||+||++.... .++++||||||||||+|+-|++||.
T Consensus 513 TTsI~k-------------------dsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~ 573 (677)
T KOG0596|consen 513 TTSIVK-------------------DSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG 573 (677)
T ss_pred ccceee-------------------ccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH
Confidence 554332 2789999999999986533 4578999999999999999999987
Q ss_pred CCCCCC-CCCCCchhhhccccCCCC-cHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 322 DYLPRS-PDFGLDQTDFRNKFCASC-PEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 322 ~~~~~~-~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
...... ....+.......+++..- +.++.++++.||+.||.+||+..++++
T Consensus 574 ~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 574 QIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 643211 111222222222333222 234999999999999999999999874
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=291.11 Aligned_cols=230 Identities=20% Similarity=0.280 Sum_probs=182.4
Q ss_pred CCeeeeeccCCCcchhhhhcc----------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCC
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC----------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGG 183 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~----------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 183 (433)
..+.+.+.++.|+||.||... +|+++|++++|+||+++++++......++|||++. +
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 170 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-C 170 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-C
Confidence 457777888999999888521 69999999999999999999999999999999994 6
Q ss_pred CHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccc
Q psy6593 184 TLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263 (433)
Q Consensus 184 sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 263 (433)
+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..........
T Consensus 171 ~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~------- 242 (392)
T PHA03207 171 DLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP------- 242 (392)
T ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccc-------
Confidence 89988854 3469999999999999999999999999999999999999999999999999997654432211
Q ss_pred hhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCC--------------
Q psy6593 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPD-------------- 329 (433)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~-------------- 329 (433)
......||+.|+|||++.+..++.++||||||+++|||++|..|+.........
T Consensus 243 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~ 310 (392)
T PHA03207 243 ------------QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP 310 (392)
T ss_pred ------------cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCc
Confidence 112567999999999999989999999999999999999887776543221100
Q ss_pred ---CCCchh-----------hhcccc-------CCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 330 ---FGLDQT-----------DFRNKF-------CASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 330 ---~~~~~~-----------~~~~~~-------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
...... ..+... ....+.++.++|.+||..+|++||++.+++. ||.+
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 311 LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred cccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 000000 000000 0245678899999999999999999999984 6654
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=281.16 Aligned_cols=232 Identities=22% Similarity=0.363 Sum_probs=181.5
Q ss_pred cCCeeeeeccCCCcchhhhhc--------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEe
Q psy6593 125 KDGLLFCKEDYNGKYGEACQN--------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTE 178 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~--------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 178 (433)
.+++.+.++++.|+||.||+. .+|+.++++++|+||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 445666666677777766641 269999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcc
Q psy6593 179 YIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTT 258 (433)
Q Consensus 179 ~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 258 (433)
|++ ++|.+++.+.+..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--- 160 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--- 160 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc---
Confidence 996 5999988776667999999999999999999999999999999999999999999999999998754322111
Q ss_pred ccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCC----------
Q psy6593 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS---------- 327 (433)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~---------- 327 (433)
.....+++.|+|||.+.+ ..++.++||||||+++|+|++|.++|.......
T Consensus 161 ------------------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~ 222 (301)
T cd07873 161 ------------------YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG 222 (301)
T ss_pred ------------------ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 113456888999998865 457889999999999999999999886432110
Q ss_pred ----CCCC--Cch--------h----hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 328 ----PDFG--LDQ--------T----DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 328 ----~~~~--~~~--------~----~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
..+. ... . .........+++.+.+||.+||+.||.+||+++++++ |++.+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 223 TPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred CCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0000 000 0 0001122457889999999999999999999999985 776654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=282.93 Aligned_cols=210 Identities=24% Similarity=0.373 Sum_probs=169.6
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC---------------CCCCChHHHHHHHHHHHHH
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---------------GQPLPWGQRVNFARDIAAG 211 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~ 211 (433)
+|+.++++++||||+++++++...+..++++||+.+++|.+++... ...+++..+..++.|++.|
T Consensus 57 ~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~a 136 (283)
T cd05091 57 HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAG 136 (283)
T ss_pred HHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHH
Confidence 6899999999999999999999999999999999999999998421 2347888999999999999
Q ss_pred HhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccce
Q psy6593 212 MTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM 291 (433)
Q Consensus 212 L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 291 (433)
|.|||+.|++||||||+||++++++.+||+|||+++......... ......+++.|+|||.
T Consensus 137 L~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-------------------~~~~~~~~~~y~aPE~ 197 (283)
T cd05091 137 MEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK-------------------LMGNSLLPIRWMSPEA 197 (283)
T ss_pred HHHHHHcCccccccchhheEecCCCceEecccccccccccchhee-------------------eccCccCCccccCHHH
Confidence 999999999999999999999999999999999988653322110 0012345678999999
Q ss_pred ecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHH
Q psy6593 292 MTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370 (433)
Q Consensus 292 ~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i 370 (433)
+.+..++.++||||||+++|||++ |.+++........... .........+.++|..+.+++.+||+.+|.+||++++|
T Consensus 198 ~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i 276 (283)
T cd05091 198 IMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM-IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276 (283)
T ss_pred HhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence 988889999999999999999996 7777654322111111 11111223356789999999999999999999999999
Q ss_pred HHHHHh
Q psy6593 371 EVWLEG 376 (433)
Q Consensus 371 ~~~l~~ 376 (433)
+..|+.
T Consensus 277 ~~~l~~ 282 (283)
T cd05091 277 HSRLRT 282 (283)
T ss_pred HHHhhC
Confidence 998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=276.95 Aligned_cols=212 Identities=27% Similarity=0.516 Sum_probs=168.1
Q ss_pred chHHHHhhcCCcceeeEEEEEEeC--CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
+|+++|++++||||+++++++... ...++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.|++|+|
T Consensus 55 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~d 132 (283)
T cd05080 55 KEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRD 132 (283)
T ss_pred HHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 799999999999999999988754 468999999999999999976 3599999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|||+||++++++.++|+|||++........... ......++..|+|||.+.+..++.++|||
T Consensus 133 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~ 194 (283)
T cd05080 133 LAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR------------------VREDGDSPVFWYAVECLKENKFSYASDVW 194 (283)
T ss_pred cChheEEEcCCCcEEEeecccccccCCcchhhc------------------cCCCCCCCceeeCHhHhcccCCCcccccH
Confidence 999999999999999999999886543211000 00022345679999999888899999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCC-C-----CCc--------hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPD-F-----GLD--------QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~-~-----~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i 370 (433)
|||+++|+|++|..|+......... . ... ........+..+|..+.+++.+||+.+|++||++++|
T Consensus 195 slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i 274 (283)
T cd05080 195 SFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSL 274 (283)
T ss_pred HHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHH
Confidence 9999999999887765432211000 0 000 0011112245678999999999999999999999999
Q ss_pred HHHHHhhc
Q psy6593 371 EVWLEGLS 378 (433)
Q Consensus 371 ~~~l~~~~ 378 (433)
+.+|+.+.
T Consensus 275 ~~~l~~~~ 282 (283)
T cd05080 275 IPILKEMH 282 (283)
T ss_pred HHHHHHhh
Confidence 99998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=287.01 Aligned_cols=204 Identities=20% Similarity=0.286 Sum_probs=161.6
Q ss_pred ccchHHHHhhc---CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCcc
Q psy6593 145 NCGQVAVLRSL---HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLI 221 (433)
Q Consensus 145 ~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~ 221 (433)
...|..++..+ +||||+++++.+..++..|+||||+++++|.+++.+.+ .+++..++.++.||+.||+|||+.||+
T Consensus 40 ~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH~~~iv 118 (330)
T cd05586 40 TIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKYDIV 118 (330)
T ss_pred HHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 33567777666 69999999999999999999999999999999887644 599999999999999999999999999
Q ss_pred ccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcc
Q psy6593 222 HRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDET 300 (433)
Q Consensus 222 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~ 300 (433)
||||||+||+++.++.++|+|||++......... .....||+.|+|||++.+. .++.+
T Consensus 119 HrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~---------------------~~~~~gt~~y~aPE~~~~~~~~~~~ 177 (330)
T cd05586 119 YRDLKPENILLDATGHIALCDFGLSKANLTDNKT---------------------TNTFCGTTEYLAPEVLLDEKGYTKH 177 (330)
T ss_pred eccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC---------------------ccCccCCccccCHHHHcCCCCCCCc
Confidence 9999999999999999999999998753221111 1145789999999998764 47899
Q ss_pred cCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccC-CCCcHHHHHHHHHhcccCCCCCC----ChhHHHH
Q psy6593 301 VDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFC-ASCPEPFVRIAFLCCDLNPDQRP----PFEVLEV 372 (433)
Q Consensus 301 ~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~RP----s~~~i~~ 372 (433)
+||||||+++|+|++|..||...........+... ...++ ..+++.+.+++.+||+.||.+|| +++++++
T Consensus 178 ~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG--KVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC--CCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 99999999999999998887543211110000000 11122 34688999999999999999998 4666653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=276.80 Aligned_cols=214 Identities=29% Similarity=0.495 Sum_probs=171.0
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
.|+.++++++||||+++++++..+...++||||+++++|.+++...+..+++..++.++.|++.||+|||+.|++|+|||
T Consensus 54 ~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~ 133 (269)
T cd05065 54 SEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLA 133 (269)
T ss_pred HHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccC
Confidence 69999999999999999999999999999999999999999998765679999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.++|+|||++............. .......+..|+|||.+.+..++.++|||||
T Consensus 134 p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~----------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dvwsl 197 (269)
T cd05065 134 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT----------------SSLGGKIPIRWTAPEAIAYRKFTSASDVWSY 197 (269)
T ss_pred hheEEEcCCCcEEECCCccccccccCccccccc----------------cccCCCcceeecCHhHhccCcccchhhhhhh
Confidence 999999999999999999987654322111000 0001112457999999998899999999999
Q ss_pred hHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 307 GIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 307 G~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
|+++|||++ |.+|+...........+ ........+..+|..+.+++.+||+.+|++||++++|+..|+++
T Consensus 198 G~~l~e~l~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 198 GIVMWEVMSYGERPYWDMSNQDVINAI-EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 999999885 77776543221111111 11112223456788999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=280.05 Aligned_cols=210 Identities=26% Similarity=0.469 Sum_probs=166.2
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC----------CCCChHHHHHHHHHHHHHHhhhh
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG----------QPLPWGQRVNFARDIAAGMTYLH 216 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~----------~~~~~~~~~~i~~qi~~~L~~lH 216 (433)
+|+++|++++|+||+++++++..++..++||||+++++|.+++.+.. ..+++..++.++.|++.||+|||
T Consensus 68 ~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH 147 (296)
T cd05095 68 KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS 147 (296)
T ss_pred HHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 68999999999999999999999999999999999999999986522 24677899999999999999999
Q ss_pred cCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC
Q psy6593 217 SMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE 296 (433)
Q Consensus 217 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 296 (433)
+.|++|+||||+||+++.++.++|+|||++............ ....+++.|++||...+..
T Consensus 148 ~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~-------------------~~~~~~~~~~~pe~~~~~~ 208 (296)
T cd05095 148 SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ-------------------GRAVLPIRWMSWESILLGK 208 (296)
T ss_pred HCCeecccCChheEEEcCCCCEEeccCcccccccCCcceecc-------------------CcCcCccccCCHHHHhcCC
Confidence 999999999999999999999999999998865332211000 0223456799999988888
Q ss_pred CCcccCeEehhHHHHHHhc--CCCCCCCCCCCCCCCCCc------hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChh
Q psy6593 297 YDETVDVFSYGIVLCEIIG--RVPADPDYLPRSPDFGLD------QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFE 368 (433)
Q Consensus 297 ~~~~~DiwslG~il~ell~--~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~ 368 (433)
++.++||||||+++|||++ +..|+............. ........+..++..+.+++.+||+.||++||++.
T Consensus 209 ~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 288 (296)
T cd05095 209 FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQ 288 (296)
T ss_pred ccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence 9999999999999999996 556654332211110000 00011122356789999999999999999999999
Q ss_pred HHHHHHH
Q psy6593 369 VLEVWLE 375 (433)
Q Consensus 369 ~i~~~l~ 375 (433)
+|.+.|+
T Consensus 289 ~i~~~l~ 295 (296)
T cd05095 289 EIHATLL 295 (296)
T ss_pred HHHHHHh
Confidence 9998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=277.46 Aligned_cols=211 Identities=23% Similarity=0.404 Sum_probs=171.4
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++++++|+||+++++++.. ...++||||+++++|.+++......+++..++.++.|++.||+|||+.|++|+|||
T Consensus 56 ~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~ 134 (270)
T cd05056 56 QEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIA 134 (270)
T ss_pred HHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccC
Confidence 79999999999999999999864 56789999999999999998755568999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.++|+|||++........... ....++..|+|||.+....++.++|||||
T Consensus 135 p~nili~~~~~~~l~d~g~~~~~~~~~~~~~--------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 194 (270)
T cd05056 135 ARNVLVSSPDCVKLGDFGLSRYLEDESYYKA--------------------SKGKLPIKWMAPESINFRRFTSASDVWMF 194 (270)
T ss_pred hheEEEecCCCeEEccCceeeecccccceec--------------------CCCCccccccChhhhccCCCCchhhhHHH
Confidence 9999999999999999999876543211100 01223467999999988889999999999
Q ss_pred hHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 307 GIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 307 G~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
|+++|+|++ |.+||............ ........+..+|..+.+++.+|+..+|++||++.+++..|+++..
T Consensus 195 G~il~el~~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 195 GVCMWEILMLGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHHHHHHcCCCCCCCCCHHHHHHHH-HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 999999984 88877544322111111 1111223456788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=301.34 Aligned_cols=228 Identities=19% Similarity=0.268 Sum_probs=182.9
Q ss_pred cCCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCC------
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDR------ 171 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~------ 171 (433)
.+++.+...+|+|+||+||++. +|+.+|..++|+||+++++.+...+
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 3457777888999999887521 5888899999999999998876432
Q ss_pred --eeeEEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccc
Q psy6593 172 --KLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLA 246 (433)
Q Consensus 172 --~~~lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 246 (433)
.+++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 37899999999999998864 2346999999999999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCC
Q psy6593 247 RIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~ 326 (433)
+......... ......||+.|+|||++.+..++.++||||||+++|||++|.+||......
T Consensus 191 ~~~~~~~~~~-------------------~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~ 251 (496)
T PTZ00283 191 KMYAATVSDD-------------------VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME 251 (496)
T ss_pred eecccccccc-------------------ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 8654321111 112467999999999999999999999999999999999999887543211
Q ss_pred CCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 327 SPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
..... ........++..+++++.+++.+||+.+|.+||++.++++
T Consensus 252 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 252 EVMHK-TLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred HHHHH-HhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 11000 0111122345778899999999999999999999999974
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=276.09 Aligned_cols=201 Identities=20% Similarity=0.329 Sum_probs=163.9
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++++++||||+++++++..+...++||||+++++|.+++...+..+++..++.++.||+.||+|||+.||+|||||
T Consensus 48 ~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlk 127 (258)
T cd05078 48 EAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVC 127 (258)
T ss_pred HHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence 68899999999999999999999999999999999999999998766678999999999999999999999999999999
Q ss_pred CcceEEccCCc--------eEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCC
Q psy6593 227 SQNCLVREDKT--------VVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEY 297 (433)
Q Consensus 227 p~Nil~~~~~~--------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~ 297 (433)
|+||+++.++. ++++|||++....... ...+++.|+|||.+.+ ..+
T Consensus 128 p~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~~-------------------------~~~~~~~y~aPE~~~~~~~~ 182 (258)
T cd05078 128 AKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE-------------------------ILLERIPWVPPECIENPQNL 182 (258)
T ss_pred cceEEEecccccccCCCceEEecccccccccCCch-------------------------hccccCCccCchhccCCCCC
Confidence 99999987664 6899999876442211 3457788999999987 457
Q ss_pred CcccCeEehhHHHHHHhcC-CCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHH
Q psy6593 298 DETVDVFSYGIVLCEIIGR-VPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375 (433)
Q Consensus 298 ~~~~DiwslG~il~ell~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 375 (433)
+.++||||||+++|+|++| .+|+........ .........++...+.++.+++.+||+.+|++||++++|++.|+
T Consensus 183 ~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 183 SLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---LQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CchhhHHHHHHHHHHHHcCCCCChhhccHHHH---HHHHHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 8999999999999999987 455443221110 00111122344556688999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=274.08 Aligned_cols=208 Identities=29% Similarity=0.529 Sum_probs=169.0
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|++++++++|+||+++++.+.. ...++||||+++++|.+++.+ .+..+++..++.++.|++.||.+||+.|++|+||
T Consensus 50 ~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl 128 (260)
T cd05073 50 AEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128 (260)
T ss_pred HHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCcccccc
Confidence 79999999999999999999887 788999999999999999975 3445888999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
+|+||+++.++.++|+|||.+........... ....++..|+|||.+....++.++||||
T Consensus 129 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~--------------------~~~~~~~~y~~PE~~~~~~~~~~~Di~s 188 (260)
T cd05073 129 RAANILVSASLVCKIADFGLARVIEDNEYTAR--------------------EGAKFPIKWTAPEAINFGSFTIKSDVWS 188 (260)
T ss_pred CcceEEEcCCCcEEECCCcceeeccCCCcccc--------------------cCCcccccccCHhHhccCCcCccccchH
Confidence 99999999999999999999876533211100 0223456799999999888999999999
Q ss_pred hhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHh
Q psy6593 306 YGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376 (433)
Q Consensus 306 lG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 376 (433)
||+++|++++ |.+|+............ ........+...+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 189 lG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 189 FGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHHH-hCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 9999999997 88887653221111100 1111222346678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=273.99 Aligned_cols=210 Identities=31% Similarity=0.528 Sum_probs=170.8
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..+|++++++++|+||+++++++...+..++||||+++++|.+++......+++..++.++.|++.||.+||+.|++|+|
T Consensus 39 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~d 118 (250)
T cd05085 39 FLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRD 118 (250)
T ss_pred HHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 33799999999999999999999999999999999999999999876555689999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|+|+||+++.++.++|+|||++........... ....++..|+|||.+.+..++.++|||
T Consensus 119 l~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~--------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~ 178 (250)
T cd05085 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSS--------------------GLKQIPIKWTAPEALNYGRYSSESDVW 178 (250)
T ss_pred cChheEEEcCCCeEEECCCccceeccccccccC--------------------CCCCCcccccCHHHhccCCCCchhHHH
Confidence 999999999999999999999875432211100 012335679999999888899999999
Q ss_pred ehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHH
Q psy6593 305 SYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375 (433)
Q Consensus 305 slG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 375 (433)
|||+++|++++ |.+|+........... .........+..++..+.+++.+||+.+|++||++.++.+.|.
T Consensus 179 slG~ll~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 179 SYGILLWETFSLGVCPYPGMTNQQAREQ-VEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHhcCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 99999999997 8877754322111110 1111222345668899999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=279.02 Aligned_cols=209 Identities=28% Similarity=0.470 Sum_probs=167.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC------CCCChHHHHHHHHHHHHHHhhhhcCCc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG------QPLPWGQRVNFARDIAAGMTYLHSMNL 220 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~lH~~~i 220 (433)
+|+.++++++|+||+++++++.+.+..++||||++|++|.+++...+ ..+++..++.++.||+.||+|||+.++
T Consensus 58 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i 137 (277)
T cd05036 58 MEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHF 137 (277)
T ss_pred HHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 68899999999999999999999999999999999999999986532 258899999999999999999999999
Q ss_pred cccCCCCcceEEccCC---ceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCC
Q psy6593 221 IHRDLNSQNCLVREDK---TVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY 297 (433)
Q Consensus 221 ~H~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 297 (433)
+|+||||+||+++.++ .++|+|||+++........... .....+..|+|||.+.+..+
T Consensus 138 vH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~-------------------~~~~~~~~y~aPE~~~~~~~ 198 (277)
T cd05036 138 IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG-------------------GRAMLPIKWMPPEAFLDGIF 198 (277)
T ss_pred eecccchheEEEeccCCCcceEeccCccccccCCccceecC-------------------CCCCccHhhCCHHHHhcCCc
Confidence 9999999999998654 6999999999876322111000 01223467999999998899
Q ss_pred CcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHH
Q psy6593 298 DETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375 (433)
Q Consensus 298 ~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 375 (433)
+.++||||||+++|+|++ |..||......... ...........+..+|..+.+++.+||+.+|++||++.+|++.|+
T Consensus 199 ~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 199 TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM-EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 999999999999999995 88877543221111 111111223345678899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=279.06 Aligned_cols=213 Identities=26% Similarity=0.499 Sum_probs=168.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeC--CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
+|++++++++|+||+++++++... ...++||||++|++|.+++.+....+++..+..++.|++.||+|||+.|++|||
T Consensus 55 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~d 134 (284)
T cd05079 55 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRD 134 (284)
T ss_pred HHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 799999999999999999998875 568999999999999999976555689999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|||+||+++.++.++|+|||++..+........ ......++..|+|||.+.+..++.++|||
T Consensus 135 lkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 196 (284)
T cd05079 135 LAARNVLVESEHQVKIGDFGLTKAIETDKEYYT------------------VKDDLDSPVFWYAPECLIQSKFYIASDVW 196 (284)
T ss_pred cchheEEEcCCCCEEECCCccccccccCcccee------------------ecCCCCCCccccCHHHhccCCCCccccch
Confidence 999999999999999999999886543221100 00133466779999999888899999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCC------CCCCch--------hhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSP------DFGLDQ--------TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~------~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i 370 (433)
|||+++|+|+++..+......... ...... .......+..++..+.+|+.+||+.+|++||+++++
T Consensus 197 slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 276 (284)
T cd05079 197 SFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNL 276 (284)
T ss_pred hhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence 999999999986654321110000 000000 011122345678999999999999999999999999
Q ss_pred HHHHHhh
Q psy6593 371 EVWLEGL 377 (433)
Q Consensus 371 ~~~l~~~ 377 (433)
++.|+++
T Consensus 277 l~~l~~~ 283 (284)
T cd05079 277 IEGFEAI 283 (284)
T ss_pred HHHHHhh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=278.64 Aligned_cols=209 Identities=25% Similarity=0.443 Sum_probs=168.6
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC--------CCCChHHHHHHHHHHHHHHhhhhcC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG--------QPLPWGQRVNFARDIAAGMTYLHSM 218 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--------~~~~~~~~~~i~~qi~~~L~~lH~~ 218 (433)
+|++++++++|+||+++++++......++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.
T Consensus 57 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~ 136 (275)
T cd05046 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA 136 (275)
T ss_pred HHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc
Confidence 68999999999999999999998899999999999999999987533 1589999999999999999999999
Q ss_pred CccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCC
Q psy6593 219 NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYD 298 (433)
Q Consensus 219 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 298 (433)
||+|+||||+||+++.++.++|+|||++.......... .....++..|+|||.+.+...+
T Consensus 137 ~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~--------------------~~~~~~~~~y~~PE~~~~~~~~ 196 (275)
T cd05046 137 RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYK--------------------LRNALIPLRWLAPEAVQEDDFS 196 (275)
T ss_pred CcccCcCccceEEEeCCCcEEEcccccccccCcccccc--------------------cCCceeEEeecChhhhccCCCC
Confidence 99999999999999999999999999987543221110 1123456779999999888889
Q ss_pred cccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHH
Q psy6593 299 ETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375 (433)
Q Consensus 299 ~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 375 (433)
.++||||||+++|+|++ |.+++........................+|..+.+++.+||+.+|++||++.+++..|.
T Consensus 197 ~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 197 TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred chhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 99999999999999996 666664432211111111111112234567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=276.64 Aligned_cols=205 Identities=30% Similarity=0.517 Sum_probs=168.4
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|++++++++||||+++++++..++.++++|||+++++|.+++......+++..+..++.|++.||.|||+.|++|+||+
T Consensus 49 ~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~ 128 (262)
T cd06613 49 QEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIK 128 (262)
T ss_pred HHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Confidence 78999999999999999999999999999999999999999998765579999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC---CCCcccCe
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ---EYDETVDV 303 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di 303 (433)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+. .++.++||
T Consensus 129 p~ni~i~~~~~~~l~d~g~~~~~~~~~~---------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di 187 (262)
T cd06613 129 GANILLTEDGDVKLADFGVSAQLTATIA---------------------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDI 187 (262)
T ss_pred hhhEEECCCCCEEECccccchhhhhhhh---------------------ccccccCCccccCchhhcccccCCcCchhhh
Confidence 9999999999999999999876543211 11144678889999999876 78899999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhc---cccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFR---NKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
||||+++|+|++|.+|+....+...........+. ......++.++.+++.+||+.+|.+||++++|+.
T Consensus 188 ~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 188 WALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999999999999887654322211111111011 1112345678999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=279.63 Aligned_cols=207 Identities=28% Similarity=0.475 Sum_probs=170.3
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.+++.++|+||+++++.+..+...++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.||+|+|||
T Consensus 66 ~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLk 143 (296)
T cd06654 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143 (296)
T ss_pred HHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 689999999999999999999999999999999999999999875 358999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.++|+|||++......... .....+++.|+|||.+.+..++.++|||||
T Consensus 144 p~Nill~~~~~~kl~dfg~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~ 202 (296)
T cd06654 144 SDNILLGMDGSVKLTDFGFCAQITPEQSK---------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202 (296)
T ss_pred HHHEEEcCCCCEEECccccchhccccccc---------------------cCcccCCccccCHHHHcCCCCCccchHHHH
Confidence 99999999999999999998764322111 113468889999999998888999999999
Q ss_pred hHHHHHHhcCCCCCCCCCCCCCCCCCc-hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 307 GIVLCEIIGRVPADPDYLPRSPDFGLD-QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 307 G~il~ell~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
|+++|+|++|.+||....+........ ........+..++..+.+++.+||..+|++||++++|++ |+..
T Consensus 203 Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 203 GIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred HHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 999999999999886543321111111 011111223567889999999999999999999999984 5654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=274.76 Aligned_cols=203 Identities=19% Similarity=0.340 Sum_probs=163.1
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..+|+.++++++||||+++++++..+...++||||+++++|..++......+++..++.++.||+.||+|||+.||+|||
T Consensus 51 ~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 130 (262)
T cd05077 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGN 130 (262)
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCC
Confidence 34788999999999999999999999999999999999999999876556799999999999999999999999999999
Q ss_pred CCCcceEEccCCc-------eEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec-CCC
Q psy6593 225 LNSQNCLVREDKT-------VVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT-GQE 296 (433)
Q Consensus 225 lkp~Nil~~~~~~-------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~ 296 (433)
|||+||+++.++. ++++|||++....... ...++..|+|||.+. +..
T Consensus 131 lkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~~-------------------------~~~~~~~y~aPE~~~~~~~ 185 (262)
T cd05077 131 VCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ-------------------------ECVERIPWIAPECVEDSKN 185 (262)
T ss_pred CCcccEEEecCCccCCCCceeEeCCCCCCccccCcc-------------------------cccccccccChhhhcCCCC
Confidence 9999999986654 8999999886542211 345678899999886 467
Q ss_pred CCcccCeEehhHHHHHHh-cCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHH
Q psy6593 297 YDETVDVFSYGIVLCEII-GRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375 (433)
Q Consensus 297 ~~~~~DiwslG~il~ell-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 375 (433)
++.++||||||+++|+|+ +|.+|+......... .............+.++.+|+.+||+.||++||++.+|++.|+
T Consensus 186 ~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 186 LSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE---RFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH---HHHhcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 889999999999999998 677776542211100 0000011122334678999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=275.68 Aligned_cols=202 Identities=20% Similarity=0.330 Sum_probs=163.3
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..+|+.++++++|+||+++++++..+...++||||+++++|..++.+....+++..+..++.|++.||+|||++||+|||
T Consensus 63 ~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~d 142 (274)
T cd05076 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGN 142 (274)
T ss_pred HHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCC
Confidence 34788999999999999999999999999999999999999999977566799999999999999999999999999999
Q ss_pred CCCcceEEccCC-------ceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CC
Q psy6593 225 LNSQNCLVREDK-------TVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QE 296 (433)
Q Consensus 225 lkp~Nil~~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~ 296 (433)
|||+||+++..+ .++++|||++....... ...++..|+|||.+.+ ..
T Consensus 143 lkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~-------------------------~~~~~~~~~aPe~~~~~~~ 197 (274)
T cd05076 143 VCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE-------------------------ERVERIPWIAPECVPGGNS 197 (274)
T ss_pred CCcccEEEeccCcccCccceeeecCCcccccccccc-------------------------ccccCCcccCchhhcCCCC
Confidence 999999997543 48999999875432111 2346777999998865 56
Q ss_pred CCcccCeEehhHHHHHHh-cCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHH
Q psy6593 297 YDETVDVFSYGIVLCEII-GRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWL 374 (433)
Q Consensus 297 ~~~~~DiwslG~il~ell-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 374 (433)
++.++||||||+++|||+ +|.+|+....+..... ........+...++.+.+++.+||+.+|++||++++|++.|
T Consensus 198 ~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 198 LSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER---FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH---HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 899999999999999995 7888775433221100 00111123344567899999999999999999999998766
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=287.95 Aligned_cols=240 Identities=28% Similarity=0.417 Sum_probs=184.8
Q ss_pred cccccCCeeeeeccCCCcchhhhhc-------------------------------cchHHHHhhc-CCcceeeEEEEEE
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQN-------------------------------CGQVAVLRSL-HHHNVIRFIGVLY 168 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~-------------------------------~~E~~~l~~l-~h~~iv~~~~~~~ 168 (433)
|.+..+++.+.+.+|.|+||+||++ .+|+.+|.++ +|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 4566677777888888888888642 1699999999 6899999999876
Q ss_pred eC-CeeeEEEeccCCCCHHHHhcCCC------------------------------------------------------
Q psy6593 169 KD-RKLNLVTEYIAGGTLKELLQDPG------------------------------------------------------ 193 (433)
Q Consensus 169 ~~-~~~~lv~e~~~g~sL~~~l~~~~------------------------------------------------------ 193 (433)
.. ...++||||+++++|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 56889999999999999885421
Q ss_pred ------------CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccc
Q psy6593 194 ------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA 261 (433)
Q Consensus 194 ------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 261 (433)
..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++...........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~---- 237 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR---- 237 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhh----
Confidence 2367788899999999999999999999999999999999999999999999876533211100
Q ss_pred cchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccc
Q psy6593 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNK 340 (433)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (433)
.....++..|+|||.+.+..++.++||||||+++|+|++ |.+|+....................
T Consensus 238 ---------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 302 (343)
T cd05103 238 ---------------KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 302 (343)
T ss_pred ---------------cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC
Confidence 002234567999999988889999999999999999994 7777654321111111111111222
Q ss_pred cCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 341 FCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 341 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
.+...++.+.+++.+||+.+|.+||++.+|++.|+.+..
T Consensus 303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 334567889999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=275.10 Aligned_cols=206 Identities=32% Similarity=0.558 Sum_probs=170.2
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
.+|+.++++++|+||+++++++......++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+|
T Consensus 48 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~d 127 (256)
T cd05039 48 LAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRD 127 (256)
T ss_pred HHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchh
Confidence 379999999999999999999998899999999999999999997643 3689999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|||+||+++.++.++|+|||.+........ ....+..|+|||.+....++.++|||
T Consensus 128 i~p~Nili~~~~~~~l~d~g~~~~~~~~~~------------------------~~~~~~~~~ape~~~~~~~~~~~Di~ 183 (256)
T cd05039 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQD------------------------SGKLPVKWTAPEALREKKFSTKSDVW 183 (256)
T ss_pred cccceEEEeCCCCEEEcccccccccccccc------------------------cCCCcccccCchhhcCCcCCcHHHHH
Confidence 999999999999999999999986532211 11234569999999888899999999
Q ss_pred ehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHh
Q psy6593 305 SYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376 (433)
Q Consensus 305 slG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 376 (433)
|||+++|+|++ |.+|+......... ...........+..+|+.+.+++.+||+.+|++||+++++++.|+.
T Consensus 184 slG~il~~l~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 184 SFGILLWEIYSFGRVPYPRIPLKDVV-PHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHH-HHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 99999999995 87776543221110 0011112223446678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=284.72 Aligned_cols=213 Identities=31% Similarity=0.483 Sum_probs=170.7
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC---------------CCCCChHHHHHHHHHHHH
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---------------GQPLPWGQRVNFARDIAA 210 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~---------------~~~~~~~~~~~i~~qi~~ 210 (433)
+|+++++++ +|+||+++++++..++..++||||+++++|.+++.+. ...++...++.++.|++.
T Consensus 66 ~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 145 (334)
T cd05100 66 SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVAR 145 (334)
T ss_pred HHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHH
Confidence 689999999 7999999999999999999999999999999998642 124788899999999999
Q ss_pred HHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccc
Q psy6593 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPE 290 (433)
Q Consensus 211 ~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 290 (433)
||.|||+.|++||||||+||+++.++.++|+|||+++.......... .....++..|+|||
T Consensus 146 al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~-------------------~~~~~~~~~y~aPE 206 (334)
T cd05100 146 GMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK-------------------TTNGRLPVKWMAPE 206 (334)
T ss_pred HHHHHHHCCeeccccccceEEEcCCCcEEECCcccceeccccccccc-------------------ccCCCcCceEcCHH
Confidence 99999999999999999999999999999999999876543211100 00223356799999
Q ss_pred eecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhH
Q psy6593 291 MMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEV 369 (433)
Q Consensus 291 ~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 369 (433)
++.+..++.++||||||+++|||++ |.+|+........ ............+...+..+.+++.+||+.+|++||++.+
T Consensus 207 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 285 (334)
T cd05100 207 ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQ 285 (334)
T ss_pred HhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence 9999899999999999999999996 7776644321111 1111111222334567889999999999999999999999
Q ss_pred HHHHHHhhcc
Q psy6593 370 LEVWLEGLSM 379 (433)
Q Consensus 370 i~~~l~~~~~ 379 (433)
|++.|+.+..
T Consensus 286 ll~~l~~~~~ 295 (334)
T cd05100 286 LVEDLDRVLT 295 (334)
T ss_pred HHHHHHHHhh
Confidence 9999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=274.77 Aligned_cols=204 Identities=32% Similarity=0.551 Sum_probs=166.6
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+.++++++|+||+++++++..+ ..++||||+++++|.+++.... ..+++..++.++.|++.||.+||+.|++||||
T Consensus 48 ~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl 126 (254)
T cd05083 48 EETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126 (254)
T ss_pred HHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 799999999999999999998654 5799999999999999997533 35899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||+++.++.++|+|||++........ ....+..|+|||.+.+..++.++|+||
T Consensus 127 ~p~nili~~~~~~kl~Dfg~~~~~~~~~~------------------------~~~~~~~y~~pe~~~~~~~~~~~Dv~s 182 (254)
T cd05083 127 AARNILVSEDGVAKVSDFGLARVGSMGVD------------------------NSKLPVKWTAPEALKHKKFSSKSDVWS 182 (254)
T ss_pred CcceEEEcCCCcEEECCCccceeccccCC------------------------CCCCCceecCHHHhccCCcCchhhHHH
Confidence 99999999999999999999875432111 122345699999998888999999999
Q ss_pred hhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHh
Q psy6593 306 YGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376 (433)
Q Consensus 306 lG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 376 (433)
||+++|+|++ |.+|+.......... ..........+..+|..+.+++.+||+.+|++||++++|+..|++
T Consensus 183 lG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 183 YGVLLWEVFSYGRAPYPKMSLKEVKE-CVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHHHHhCCCCCCccCCHHHHHH-HHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 9999999995 888876543221111 111122223346778999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=276.27 Aligned_cols=211 Identities=22% Similarity=0.424 Sum_probs=171.9
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
+|+.++++++|+||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.|++|+
T Consensus 51 ~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~ 130 (267)
T cd08229 51 KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHR 130 (267)
T ss_pred HHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 799999999999999999999999999999999999999998863 23468999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++||
T Consensus 131 dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~---------------------~~~~~~~~~~~ape~~~~~~~~~~~Dv 189 (267)
T cd08229 131 DIKPANVFITATGVVKLGDLGLGRFFSSKTTA---------------------AHSLVGTPYYMSPERIHENGYNFKSDI 189 (267)
T ss_pred CCCHHHEEEcCCCCEEECcchhhhccccCCcc---------------------cccccCCcCccCHHHhcCCCccchhhH
Confidence 99999999999999999999998765432211 013468889999999988889999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCC--CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDF--GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
||||+++|+|++|.+|+.......... ...............+..+.+++.+||+.+|++|||+.+|.+.++++.
T Consensus 190 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 190 WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 999999999998888775322111000 000011111122457789999999999999999999999999888753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=281.70 Aligned_cols=213 Identities=28% Similarity=0.442 Sum_probs=170.8
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC---------------CCCCChHHHHHHHHHHHH
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---------------GQPLPWGQRVNFARDIAA 210 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~---------------~~~~~~~~~~~i~~qi~~ 210 (433)
+|+.+++.+ +|+||+++++++......++||||+++++|.+++.+. ...+++..++.++.||+.
T Consensus 69 ~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~ 148 (304)
T cd05101 69 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVAR 148 (304)
T ss_pred HHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHH
Confidence 689999999 8999999999999999999999999999999998652 134788889999999999
Q ss_pred HHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccc
Q psy6593 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPE 290 (433)
Q Consensus 211 ~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 290 (433)
||.|||+.|++||||||+||+++.++.++|+|||+++.......... .....+++.|+|||
T Consensus 149 al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~-------------------~~~~~~~~~y~aPE 209 (304)
T cd05101 149 GMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK-------------------TTNGRLPVKWMAPE 209 (304)
T ss_pred HHHHHHHCCeeecccccceEEEcCCCcEEECCCccceeccccccccc-------------------ccCCCCCceeeCch
Confidence 99999999999999999999999999999999999986643221110 01234567799999
Q ss_pred eecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhH
Q psy6593 291 MMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEV 369 (433)
Q Consensus 291 ~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 369 (433)
.+.+..++.++||||||+++|+|++ |.+|+.......... ..........+..++..+.+++.+||+.+|.+||++.+
T Consensus 210 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e 288 (304)
T cd05101 210 ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQ 288 (304)
T ss_pred hhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH-HHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHH
Confidence 9988889999999999999999996 666654321111100 01111122234567899999999999999999999999
Q ss_pred HHHHHHhhcc
Q psy6593 370 LEVWLEGLSM 379 (433)
Q Consensus 370 i~~~l~~~~~ 379 (433)
|++.|+++..
T Consensus 289 ~l~~l~~~~~ 298 (304)
T cd05101 289 LVEDLDRILT 298 (304)
T ss_pred HHHHHHHHHH
Confidence 9999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=273.72 Aligned_cols=211 Identities=26% Similarity=0.419 Sum_probs=170.4
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.+|++++++++|+||+++++++. .+..++||||+++++|.+++.... .+++..+..++.|++.||++||+.+++|+||
T Consensus 44 ~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di 121 (257)
T cd05060 44 LREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDL 121 (257)
T ss_pred HHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCc
Confidence 37999999999999999999875 557899999999999999997754 5899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||+++.++.++|+|||+++.......... ......++..|+|||.+.+..++.++||||
T Consensus 122 ~p~nili~~~~~~kl~df~~~~~~~~~~~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 183 (257)
T cd05060 122 AARNVLLVNRHQAKISDFGMSRALGAGSDYYR------------------ATTAGRWPLKWYAPECINYGKFSSKSDVWS 183 (257)
T ss_pred ccceEEEcCCCcEEeccccccceeecCCcccc------------------cccCccccccccCHHHhcCCCCCccchHHH
Confidence 99999999999999999999886643221100 001222456799999999888999999999
Q ss_pred hhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 306 YGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 306 lG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
||+++|+|++ |.+|+......... ...........+..++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 184 lG~~l~~~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 184 YGVTLWEAFSYGAKPYGEMKGAEVI-AMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHHHHHHHcCCCCCcccCCHHHHH-HHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 9999999996 88887543221110 01111112234467789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=280.79 Aligned_cols=210 Identities=27% Similarity=0.482 Sum_probs=165.5
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC-----------CCCChHHHHHHHHHHHHHHhhh
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-----------QPLPWGQRVNFARDIAAGMTYL 215 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-----------~~~~~~~~~~i~~qi~~~L~~l 215 (433)
+|+++|++++|+||+++++++...+..++||||+++++|.+++.... ..+++..++.++.|++.||.||
T Consensus 66 ~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 145 (295)
T cd05097 66 KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL 145 (295)
T ss_pred HHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHH
Confidence 69999999999999999999999999999999999999999985421 1367889999999999999999
Q ss_pred hcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC
Q psy6593 216 HSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ 295 (433)
Q Consensus 216 H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 295 (433)
|+.|++|+||||+||+++.++.+||+|||++........... .....++..|+|||.+.+.
T Consensus 146 H~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~-------------------~~~~~~~~~y~aPE~~~~~ 206 (295)
T cd05097 146 ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI-------------------QGRAVLPIRWMAWESILLG 206 (295)
T ss_pred HhcCeeccccChhhEEEcCCCcEEecccccccccccCcceec-------------------cCcCcCceeecChhhhccC
Confidence 999999999999999999999999999999876533211100 0022346789999999888
Q ss_pred CCCcccCeEehhHHHHHHhc--CCCCCCCCCCCCCCCCC------chhhhccccCCCCcHHHHHHHHHhcccCCCCCCCh
Q psy6593 296 EYDETVDVFSYGIVLCEIIG--RVPADPDYLPRSPDFGL------DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF 367 (433)
Q Consensus 296 ~~~~~~DiwslG~il~ell~--~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~ 367 (433)
.++.++||||||+++|+|++ +.+|+............ .........+...|+.+.+|+.+||+.+|++||++
T Consensus 207 ~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~ 286 (295)
T cd05097 207 KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTF 286 (295)
T ss_pred CcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence 89999999999999999986 45555432211100000 00001112234578999999999999999999999
Q ss_pred hHHHHHHH
Q psy6593 368 EVLEVWLE 375 (433)
Q Consensus 368 ~~i~~~l~ 375 (433)
++|++.|+
T Consensus 287 ~~i~~~l~ 294 (295)
T cd05097 287 NKIHHFLR 294 (295)
T ss_pred HHHHHHHh
Confidence 99999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=274.10 Aligned_cols=207 Identities=25% Similarity=0.439 Sum_probs=168.3
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|++++++++||||+++++++......++||||+++++|.+++......++++.++.++.|++.+|++||+.+++|+|||
T Consensus 48 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~ 127 (256)
T cd05112 48 EEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLA 127 (256)
T ss_pred HHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 69999999999999999999999999999999999999999998765668999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.++|+|||++.......... .....++..|+|||.+.+..++.++|||||
T Consensus 128 p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~--------------------~~~~~~~~~~~aPe~~~~~~~~~~~Dv~sl 187 (256)
T cd05112 128 ARNCLVGENQVVKVSDFGMTRFVLDDQYTS--------------------STGTKFPVKWSSPEVFSFSKYSSKSDVWSF 187 (256)
T ss_pred cceEEEcCCCeEEECCCcceeecccCcccc--------------------cCCCccchhhcCHhHhccCCcChHHHHHHH
Confidence 999999999999999999987653321110 002234567999999988889999999999
Q ss_pred hHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHH
Q psy6593 307 GIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWL 374 (433)
Q Consensus 307 G~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 374 (433)
|+++|||++ |.+|+............ ........+...+..+.+++.+||+.+|++||+++++++.|
T Consensus 188 G~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 188 GVLMWEVFSEGKTPYENRSNSEVVETI-NAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHHHHcCCCCCCCcCCHHHHHHHH-hCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 999999996 88877543211111000 00111122345688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=274.43 Aligned_cols=217 Identities=27% Similarity=0.456 Sum_probs=169.3
Q ss_pred hccchHHHHhhcCCcceeeEEEEEE-eCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccc
Q psy6593 144 QNCGQVAVLRSLHHHNVIRFIGVLY-KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 222 (433)
Q Consensus 144 ~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H 222 (433)
...+|+.+++.++||||+++++++. .++..++||||+.+++|.+++.+....+++..++.++.|++.||+|||+.+++|
T Consensus 42 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 121 (262)
T cd05058 42 QFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVH 121 (262)
T ss_pred HHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 3447999999999999999999775 455689999999999999999765555788888999999999999999999999
Q ss_pred cCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccC
Q psy6593 223 RDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVD 302 (433)
Q Consensus 223 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 302 (433)
|||||+||++++++.+||+|||+++........... ......++..|+|||.+.+..++.++|
T Consensus 122 ~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~D 184 (262)
T cd05058 122 RDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH-----------------NHTGAKLPVKWMALESLQTQKFTTKSD 184 (262)
T ss_pred cccCcceEEEcCCCcEEECCccccccccCCcceeec-----------------ccccCcCCccccChhHhccCccchHHH
Confidence 999999999999999999999998765332111000 001234567899999998888999999
Q ss_pred eEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 303 VFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 303 iwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
|||||+++|||++ |.+++.......... ..........+...|..+.+++.+||+.+|++||++.+|+..|+++.
T Consensus 185 i~slG~~l~el~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 185 VWSFGVLLWELMTRGAPPYPDVDSFDITV-YLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 9999999999997 566664322111000 00011111223456889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=274.45 Aligned_cols=211 Identities=33% Similarity=0.531 Sum_probs=175.1
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC--------CCCCChHHHHHHHHHHHHHHhhhh
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP--------GQPLPWGQRVNFARDIAAGMTYLH 216 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--------~~~~~~~~~~~i~~qi~~~L~~lH 216 (433)
..+|+++++.++|+||+++++++..+...++||||+++++|.+++... ...+++..++.++.|++.||++||
T Consensus 43 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH 122 (262)
T cd00192 43 FLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122 (262)
T ss_pred HHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 347999999999999999999999999999999999999999999875 467999999999999999999999
Q ss_pred cCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC
Q psy6593 217 SMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE 296 (433)
Q Consensus 217 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 296 (433)
+.|++|+||+|+||+++.++.++|+|||.+.......... ......++..|+|||.+....
T Consensus 123 ~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~ 183 (262)
T cd00192 123 SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYR-------------------KKTGGKLPIRWMAPESLKDGI 183 (262)
T ss_pred cCCcccCccCcceEEECCCCcEEEcccccccccccccccc-------------------cccCCCcCccccCHHHhccCC
Confidence 9999999999999999999999999999998765432111 111445788899999998888
Q ss_pred CCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHH
Q psy6593 297 YDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375 (433)
Q Consensus 297 ~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 375 (433)
++.++||||||+++|+|++ |.+|+........... .........+..+|.++.+++.+||+.+|.+||+++++++.|+
T Consensus 184 ~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 184 FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY-LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred cchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 9999999999999999996 5887765422111111 1112223345677899999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=281.25 Aligned_cols=208 Identities=27% Similarity=0.404 Sum_probs=157.8
Q ss_pred cchHHHHhhcCCcceeeEEEEEEe--CCeeeEEEeccCCCCHHHHhcCC--------CCCCChHHHHHHHHHHHHHHhhh
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQDP--------GQPLPWGQRVNFARDIAAGMTYL 215 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~~--------~~~~~~~~~~~i~~qi~~~L~~l 215 (433)
.+|+++|++++||||+++++++.. +...++||||+. ++|.+++... ...+++..+..++.||+.||+||
T Consensus 46 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L 124 (317)
T cd07868 46 CREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124 (317)
T ss_pred HHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHH
Confidence 379999999999999999999864 457899999994 6898887531 23589999999999999999999
Q ss_pred hcCCccccCCCCcceEE----ccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccce
Q psy6593 216 HSMNLIHRDLNSQNCLV----REDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM 291 (433)
Q Consensus 216 H~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 291 (433)
|+.||+||||||+|||+ +.++.+||+|||+++......... .......||+.|+|||+
T Consensus 125 H~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~------------------~~~~~~~~t~~y~aPE~ 186 (317)
T cd07868 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL------------------ADLDPVVVTFWYRAPEL 186 (317)
T ss_pred HhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccc------------------cccCCccccccccCCHH
Confidence 99999999999999999 456789999999998654322110 01114578999999999
Q ss_pred ecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC-------------------ch-------------hhhc
Q psy6593 292 MTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL-------------------DQ-------------TDFR 338 (433)
Q Consensus 292 ~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~-------------------~~-------------~~~~ 338 (433)
+.+ ..++.++||||+|+++|+|++|.++|............ .. ..+.
T Consensus 187 ~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (317)
T cd07868 187 LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFR 266 (317)
T ss_pred HcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhh
Confidence 877 45899999999999999999999988543221110000 00 0000
Q ss_pred -------------cccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 339 -------------NKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 339 -------------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
.......+..+.+||.+||+.||.+|||++++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 267 RNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred ccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0001123456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=284.55 Aligned_cols=197 Identities=24% Similarity=0.349 Sum_probs=162.2
Q ss_pred chHHHHhhcC-CcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.|+.++..+. |++|+++++++...+.+|+||||++|++|.+++...+ .+++..++.++.|++.||+|||+.||+||||
T Consensus 49 ~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivHrDi 127 (323)
T cd05615 49 VEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127 (323)
T ss_pred HHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 6788888885 6788899999999999999999999999999987644 5999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||+++.++.++|+|||+++....... ......||+.|+|||++.+..++.++||||
T Consensus 128 kp~Nill~~~~~ikL~Dfg~~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 186 (323)
T cd05615 128 KLDNVMLDSEGHIKIADFGMCKEHMVDGV---------------------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWA 186 (323)
T ss_pred CHHHeEECCCCCEEEeccccccccCCCCc---------------------cccCccCCccccCHHHHcCCCCCCccchhh
Confidence 99999999999999999999875322111 111456899999999999989999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCCh
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF 367 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~ 367 (433)
||+++|+|++|.+||...........+ .......+..++.++.+++.+||+.+|.+|++.
T Consensus 187 lGvil~elltG~~pf~~~~~~~~~~~i--~~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 187 YGVLLYEMLAGQPPFDGEDEDELFQSI--MEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred hHHHHHHHHhCCCCCCCCCHHHHHHHH--HhCCCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 999999999999988654321111111 111223456778999999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=307.74 Aligned_cols=232 Identities=22% Similarity=0.331 Sum_probs=181.2
Q ss_pred ccCCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeC--Ceee
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKD--RKLN 174 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 174 (433)
..+++.+...++.|+||+||... .|+.+|++|+||||++++++|... ..+|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 44568888899999999998521 699999999999999999998654 5699
Q ss_pred EEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcC-------CccccCCCCcceEEcc----------
Q psy6593 175 LVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSM-------NLIHRDLNSQNCLVRE---------- 234 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~-------~i~H~dlkp~Nil~~~---------- 234 (433)
|||||+++++|.+++.. ....+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 99999999999999864 234699999999999999999999985 4999999999999964
Q ss_pred -------CCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC--CCCCcccCeEe
Q psy6593 235 -------DKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG--QEYDETVDVFS 305 (433)
Q Consensus 235 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Diws 305 (433)
.+.+||+|||++......... ....||+.|+|||++.+ ..++.++||||
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~~----------------------~s~vGTp~YmAPEvL~ge~~~~s~KSDVWS 228 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESMA----------------------HSCVGTPYYWSPELLLHETKSYDDKSDMWA 228 (1021)
T ss_pred cccccCCCCceEEccCCccccccccccc----------------------cccCCCccccCHHHHhccCCCCCchhHHHH
Confidence 235899999999765332111 14578999999999864 45889999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhc
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
||||||+|++|.+||............ ............+.++.+||..||+.+|.+||++.+++ .|+..+.
T Consensus 229 LG~ILYELLTGk~PF~~~~~~~qli~~-lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 229 LGCIIYELCSGKTPFHKANNFSQLISE-LKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HHHHHHHHHHCCCCCCcCCcHHHHHHH-HhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 999999999999888543211110000 00001111245688999999999999999999999998 5776543
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=276.04 Aligned_cols=213 Identities=31% Similarity=0.456 Sum_probs=167.9
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeC------CeeeEEEeccCCCCHHHHhcC-----CCCCCChHHHHHHHHHHHHHHh
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKD------RKLNLVTEYIAGGTLKELLQD-----PGQPLPWGQRVNFARDIAAGMT 213 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~g~sL~~~l~~-----~~~~~~~~~~~~i~~qi~~~L~ 213 (433)
..+|++++++++|+||+++++++... ...++||||+++++|.+++.. ....+++..+..++.|++.||+
T Consensus 47 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 126 (272)
T cd05075 47 FLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126 (272)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHH
Confidence 34799999999999999999987532 247899999999999988732 2345899999999999999999
Q ss_pred hhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec
Q psy6593 214 YLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT 293 (433)
Q Consensus 214 ~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 293 (433)
|||+.||+||||||+||+++.++.++|+|||++........... .....+++.|++||.+.
T Consensus 127 ~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-------------------~~~~~~~~~~~~pe~~~ 187 (272)
T cd05075 127 YLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ-------------------GRIAKMPVKWIAIESLA 187 (272)
T ss_pred HHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceec-------------------CCcccCCcccCCHHHcc
Confidence 99999999999999999999999999999999987643221100 01223567799999999
Q ss_pred CCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 294 GQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 294 ~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
+..++.++||||||+++|+|++ |.+|+............ ........+..++..+.+++.+||+.+|++||++.+|++
T Consensus 188 ~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 188 DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL-RQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred CCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9899999999999999999997 77777543221111101 111112234567899999999999999999999999999
Q ss_pred HHHhh
Q psy6593 373 WLEGL 377 (433)
Q Consensus 373 ~l~~~ 377 (433)
.|+++
T Consensus 267 ~l~~~ 271 (272)
T cd05075 267 ELEKA 271 (272)
T ss_pred HHHhh
Confidence 98874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=275.20 Aligned_cols=213 Identities=31% Similarity=0.531 Sum_probs=165.9
Q ss_pred chHHHHhhcCCcceeeEEEEEEeC--CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
+|+++|++++|+||+++++++... ..+++||||+++++|.+++.+....+++..++.++.|++.||+|||+.|++|+|
T Consensus 54 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~d 133 (284)
T cd05081 54 REIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRD 133 (284)
T ss_pred HHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Confidence 799999999999999999987543 468999999999999999976555689999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|||+||+++.++.++|+|||++............ .....++..|+|||.+.+..++.++|||
T Consensus 134 lkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 195 (284)
T cd05081 134 LATRNILVESENRVKIGDFGLTKVLPQDKEYYKV------------------REPGESPIFWYAPESLTESKFSVASDVW 195 (284)
T ss_pred CCHhhEEECCCCeEEECCCcccccccCCCcceee------------------cCCCCCceEeeCHHHhccCCcChHHHHH
Confidence 9999999999999999999999876432211000 0011234459999999988899999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCC-----CCC---C-------chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSP-----DFG---L-------DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEV 369 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~-----~~~---~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 369 (433)
|||+++|||+++..++........ ... . .........+..++..+.+++.+||+.+|++|||+.+
T Consensus 196 slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e 275 (284)
T cd05081 196 SFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSE 275 (284)
T ss_pred HHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 999999999986544322110000 000 0 0001111223567889999999999999999999999
Q ss_pred HHHHHHhh
Q psy6593 370 LEVWLEGL 377 (433)
Q Consensus 370 i~~~l~~~ 377 (433)
|++.|+.+
T Consensus 276 i~~~l~~~ 283 (284)
T cd05081 276 LALQVEAI 283 (284)
T ss_pred HHHHHHhc
Confidence 99999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=273.85 Aligned_cols=212 Identities=28% Similarity=0.446 Sum_probs=171.5
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
..+|+.++++++|+||+++++++.. ...++||||+++++|.+++.+.. ..+++..++.++.|++.||++||+.|++|+
T Consensus 43 ~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~ 121 (257)
T cd05040 43 FLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHR 121 (257)
T ss_pred HHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 3389999999999999999999988 88999999999999999997744 568999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
||+|+||+++.++.++|+|||++............ .....++..|+|||.+.+..++.++||
T Consensus 122 di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~------------------~~~~~~~~~y~~pE~~~~~~~~~~~Di 183 (257)
T cd05040 122 DLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM------------------EEHLKVPFAWCAPESLRTRTFSHASDV 183 (257)
T ss_pred ccCcccEEEecCCEEEeccccccccccccccceec------------------ccCCCCCceecCHHHhcccCcCchhhh
Confidence 99999999999999999999999876442211000 002346678999999998889999999
Q ss_pred EehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHH
Q psy6593 304 FSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375 (433)
Q Consensus 304 wslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 375 (433)
||||+++|+|++ |.+|+.....................+...|..+.+++.+||+.+|++||++.+|++.|.
T Consensus 184 ~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 184 WMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 999999999997 888774332211111111111122233567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=283.89 Aligned_cols=225 Identities=22% Similarity=0.311 Sum_probs=173.5
Q ss_pred CCeeeeeccCCCcchhhhhc---------------------------cchHHHHhhcCCcceeeEEEEEEeCC------e
Q psy6593 126 DGLLFCKEDYNGKYGEACQN---------------------------CGQVAVLRSLHHHNVIRFIGVLYKDR------K 172 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~---------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~------~ 172 (433)
+++.+.+.+++|+||.||.. .+|+.+++.++||||+++++++...+ .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 44666677778888877652 16899999999999999999987543 5
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
.|+||||++ ++|.+.+.. .+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 101 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 101 VYLVMELMD-ANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred eEEEEeCCC-cCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 799999996 467776643 4889999999999999999999999999999999999999999999999998754321
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCC---
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPD--- 329 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~--- 329 (433)
.. .....||+.|+|||.+.+..++.++||||||+++|+|++|.+||.........
T Consensus 177 ~~----------------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~ 234 (359)
T cd07876 177 FM----------------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV 234 (359)
T ss_pred cc----------------------CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 11 11456899999999999999999999999999999999999888643210000
Q ss_pred -----------------------------CCCchhhhc--------cccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 330 -----------------------------FGLDQTDFR--------NKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 330 -----------------------------~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
......... .......++.+.+|+.+||+.||++||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 235 IEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 0011224577899999999999999999999984
Q ss_pred --HHHh
Q psy6593 373 --WLEG 376 (433)
Q Consensus 373 --~l~~ 376 (433)
|+..
T Consensus 315 hp~~~~ 320 (359)
T cd07876 315 HPYITV 320 (359)
T ss_pred Cchhhh
Confidence 6654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=272.16 Aligned_cols=211 Identities=20% Similarity=0.366 Sum_probs=172.0
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
+|++++++++|+||+++++++..++..++||||+++++|.+++.. .+..+++..++.++.|++.||.+||+.|++|+
T Consensus 51 ~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~ 130 (267)
T cd08224 51 KEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHR 130 (267)
T ss_pred HHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 799999999999999999999999999999999999999998853 34568999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
||+|+||+++.++.++|+|||++......... .....+++.|+|||.+.+..++.++||
T Consensus 131 dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~---------------------~~~~~~~~~y~apE~~~~~~~~~~~Di 189 (267)
T cd08224 131 DIKPANVFITATGVVKLGDLGLGRFFSSKTTA---------------------AHSLVGTPYYMSPERIHENGYNFKSDI 189 (267)
T ss_pred CcChhhEEECCCCcEEEeccceeeeccCCCcc---------------------cceecCCccccCHHHhccCCCCchhcH
Confidence 99999999999999999999998765332211 114567888999999988889999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCC-CCCCchhhhccccC-CCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSP-DFGLDQTDFRNKFC-ASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
||||+++|+|++|..|+........ .............+ ...+..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 190 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 190 WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 9999999999998887643221100 00000001111122 267789999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=278.82 Aligned_cols=212 Identities=28% Similarity=0.447 Sum_probs=167.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC---------CCCChHHHHHHHHHHHHHHhhhhc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------QPLPWGQRVNFARDIAAGMTYLHS 217 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~~lH~ 217 (433)
+|+.++++++|+||+++++++...+..++||||+++++|.+++.+.. ..++...+..++.|++.||.|||+
T Consensus 58 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 137 (288)
T cd05061 58 NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA 137 (288)
T ss_pred HHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 68889999999999999999999999999999999999999996421 234667889999999999999999
Q ss_pred CCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCC
Q psy6593 218 MNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY 297 (433)
Q Consensus 218 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 297 (433)
.|++||||||+||+++.++.++|+|||+++.......... .....++..|+|||.+.+..+
T Consensus 138 ~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~-------------------~~~~~~~~~y~~pE~~~~~~~ 198 (288)
T cd05061 138 KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK-------------------GGKGLLPVRWMAPESLKDGVF 198 (288)
T ss_pred CCCcCCCCChheEEEcCCCcEEECcCCccccccccccccc-------------------cCCCcccccccCHHHhccCCC
Confidence 9999999999999999999999999999876533221100 002234667999999998889
Q ss_pred CcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHh
Q psy6593 298 DETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376 (433)
Q Consensus 298 ~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 376 (433)
+.++||||||+++|||++ +.+|+.......... ..........+...++.+.+++.+||+.+|++||++.++++.|++
T Consensus 199 ~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 277 (288)
T cd05061 199 TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK-FVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277 (288)
T ss_pred ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 999999999999999996 666664322111000 000011122345668899999999999999999999999999987
Q ss_pred hc
Q psy6593 377 LS 378 (433)
Q Consensus 377 ~~ 378 (433)
..
T Consensus 278 ~~ 279 (288)
T cd05061 278 DL 279 (288)
T ss_pred hc
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=278.74 Aligned_cols=210 Identities=27% Similarity=0.451 Sum_probs=170.7
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|++++++++|+||+++++++..+...++||||+++++|.+++.+.+..+++..++.++.|++.||.|||+.||+|+||+
T Consensus 51 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~ 130 (280)
T cd06611 51 VEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLK 130 (280)
T ss_pred HHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 79999999999999999999999999999999999999999998766679999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec-----CCCCCccc
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT-----GQEYDETV 301 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~ 301 (433)
|+||+++.++.++|+|||++........ ......+++.|+|||.+. ...++.++
T Consensus 131 p~nili~~~~~~~l~d~g~~~~~~~~~~---------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~s 189 (280)
T cd06611 131 AGNILLTLDGDVKLADFGVSAKNKSTLQ---------------------KRDTFIGTPYWMAPEVVACETFKDNPYDYKA 189 (280)
T ss_pred hhhEEECCCCCEEEccCccchhhccccc---------------------ccceeecchhhcCHHHHhhcccCCCCCCccc
Confidence 9999999999999999998776432211 112456899999999875 34567899
Q ss_pred CeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh-hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhh
Q psy6593 302 DVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD-FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGL 377 (433)
Q Consensus 302 DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~ 377 (433)
||||||+++|+|++|.+|+................ .....+..++.++.+++.+||+.+|.+||++++++ .|+...
T Consensus 190 Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 190 DIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred cHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 99999999999999999886543221111110000 01112356788999999999999999999999998 466543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=275.47 Aligned_cols=209 Identities=30% Similarity=0.423 Sum_probs=167.7
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC---------------CCCChHHHHHHHHHHHH
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQRVNFARDIAA 210 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~ 210 (433)
+|+++++++ +||||+++++++...+..++||||+++++|.+++.+.. ..+++..++.++.|++.
T Consensus 44 ~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 123 (270)
T cd05047 44 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 123 (270)
T ss_pred HHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHH
Confidence 799999999 89999999999999999999999999999999986422 24789999999999999
Q ss_pred HHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccc
Q psy6593 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPE 290 (433)
Q Consensus 211 ~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 290 (433)
||+|||+.|++|+||||+||+++.++.++|+|||++........ ......+..|+|||
T Consensus 124 al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~----------------------~~~~~~~~~y~apE 181 (270)
T cd05047 124 GMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK----------------------KTMGRLPVRWMAIE 181 (270)
T ss_pred HHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchhhh----------------------ccCCCCccccCChH
Confidence 99999999999999999999999999999999999753211100 00122356799999
Q ss_pred eecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhH
Q psy6593 291 MMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEV 369 (433)
Q Consensus 291 ~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 369 (433)
.+....++.++||||||+++|||++ |.+||........... .........+..++.++.+++.+||+.+|.+||++.+
T Consensus 182 ~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 260 (270)
T cd05047 182 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 260 (270)
T ss_pred HHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH-HhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHH
Confidence 9988889999999999999999995 8777744221111100 1111122234567789999999999999999999999
Q ss_pred HHHHHHhhc
Q psy6593 370 LEVWLEGLS 378 (433)
Q Consensus 370 i~~~l~~~~ 378 (433)
++..|+.+.
T Consensus 261 il~~l~~~~ 269 (270)
T cd05047 261 ILVSLNRML 269 (270)
T ss_pred HHHHHHHhh
Confidence 999998754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=272.07 Aligned_cols=211 Identities=29% Similarity=0.509 Sum_probs=171.7
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..+|++++++++|+||+++++++......++||||+++++|.+++.+....++...++.++.+++.||.+||+.+++|||
T Consensus 39 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~d 118 (251)
T cd05041 39 FLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRD 118 (251)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhh
Confidence 44899999999999999999999999999999999999999999977555689999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|+|+||+++.++.++|+|||++............ .....+..|+|||.+.+..++.++|||
T Consensus 119 i~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~-------------------~~~~~~~~y~~PE~~~~~~~~~~~Di~ 179 (251)
T cd05041 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSD-------------------GLKQIPIKWTAPEALNYGRYTSESDVW 179 (251)
T ss_pred cCcceEEEcCCCcEEEeeccccccccCCcceecc-------------------ccCcceeccCChHhhccCCCCcchhHH
Confidence 9999999999999999999998765422111100 012235569999999888899999999
Q ss_pred ehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHH
Q psy6593 305 SYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375 (433)
Q Consensus 305 slG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 375 (433)
|||+++|+|++ +.+|+............ ........+...|..+.+++.+||+.+|.+||++++|++.|+
T Consensus 180 slG~i~~~l~t~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 180 SYGILLWETFSLGDTPYPGMSNQQTRERI-ESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccCCCCccCCHHHHHHHH-hcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 99999999997 77777554322111111 111122334667899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=274.99 Aligned_cols=213 Identities=30% Similarity=0.488 Sum_probs=170.3
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCe------eeEEEeccCCCCHHHHhcC-----CCCCCChHHHHHHHHHHHHHHh
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRK------LNLVTEYIAGGTLKELLQD-----PGQPLPWGQRVNFARDIAAGMT 213 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~g~sL~~~l~~-----~~~~~~~~~~~~i~~qi~~~L~ 213 (433)
..+|+++++.++|+||+++++++..... .++||||+++++|..++.. ....+++..+..++.|++.||.
T Consensus 48 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~ 127 (273)
T cd05035 48 FLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGME 127 (273)
T ss_pred HHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHH
Confidence 4479999999999999999998876544 7999999999999988743 2235899999999999999999
Q ss_pred hhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec
Q psy6593 214 YLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT 293 (433)
Q Consensus 214 ~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 293 (433)
|||+.|++|+||||+||++++++.+||+|||+++........... ....++..|+|||.+.
T Consensus 128 ~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~-------------------~~~~~~~~~~~pe~~~ 188 (273)
T cd05035 128 YLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG-------------------RIAKMPVKWIAIESLA 188 (273)
T ss_pred HHHhCCeeccccchheEEECCCCeEEECCccceeecccccccccc-------------------ccccCCccccCHhhcc
Confidence 999999999999999999999999999999998866433221100 0122456799999998
Q ss_pred CCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 294 GQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 294 ~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
+..++.++||||||+++|||++ |.+|+............ ........+..++..+.+++.+||+.||++||++.++++
T Consensus 189 ~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 189 DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL-RHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267 (273)
T ss_pred cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8889999999999999999997 88877553321111111 111222345678899999999999999999999999999
Q ss_pred HHHhh
Q psy6593 373 WLEGL 377 (433)
Q Consensus 373 ~l~~~ 377 (433)
.|+++
T Consensus 268 ~l~~~ 272 (273)
T cd05035 268 VLENI 272 (273)
T ss_pred HHHhh
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=278.25 Aligned_cols=229 Identities=26% Similarity=0.423 Sum_probs=184.2
Q ss_pred CeeeeeccCCCcchhhhhc-------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccC
Q psy6593 127 GLLFCKEDYNGKYGEACQN-------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIA 181 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~-------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 181 (433)
++.+.+.++.|+||.||+. .+|+.+++.++|+||+++++++..++..++||||++
T Consensus 20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (297)
T cd06656 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 99 (297)
T ss_pred hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccC
Confidence 3555566677777766642 168899999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccc
Q psy6593 182 GGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA 261 (433)
Q Consensus 182 g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 261 (433)
+++|.+++.+ ..+++..+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 100 ~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~------ 171 (297)
T cd06656 100 GGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK------ 171 (297)
T ss_pred CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC------
Confidence 9999999876 45899999999999999999999999999999999999999999999999998754322111
Q ss_pred cchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCch-hhhccc
Q psy6593 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQ-TDFRNK 340 (433)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~-~~~~~~ 340 (433)
.....+++.|+|||.+.+..++.++||||||+++|+|++|.+||....+......... ......
T Consensus 172 ---------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (297)
T cd06656 172 ---------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ 236 (297)
T ss_pred ---------------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCC
Confidence 1134678899999999988899999999999999999999998865433222111111 111112
Q ss_pred cCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 341 FCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 341 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
.+..++..+.+++.+||+.+|++||++++|++ |++...
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 34567888999999999999999999999985 777644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=279.29 Aligned_cols=207 Identities=22% Similarity=0.409 Sum_probs=167.0
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhc-CCccccC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRD 224 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~d 224 (433)
.+|++++++++||||+++++++..++..++||||++|++|.+++.+. ..+++..+..++.|++.||.|||+ .+++|+|
T Consensus 47 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~d 125 (308)
T cd06615 47 IRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRD 125 (308)
T ss_pred HHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECC
Confidence 37999999999999999999999999999999999999999999765 458999999999999999999997 5999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|+|+||+++.++.++|+|||++........ ....+++.|+|||.+.+..++.++|||
T Consensus 126 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~-----------------------~~~~~~~~~~aPE~~~~~~~~~~~Diw 182 (308)
T cd06615 126 VKPSNILVNSRGEIKLCDFGVSGQLIDSMA-----------------------NSFVGTRSYMSPERLQGTHYTVQSDIW 182 (308)
T ss_pred CChHHEEEecCCcEEEccCCCccccccccc-----------------------ccCCCCcCccChhHhcCCCCCccchHH
Confidence 999999999999999999999865432111 144688899999999888899999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCch-----------------------------------hhhccccC-CCCcHH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLDQ-----------------------------------TDFRNKFC-ASCPEP 348 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~~-----------------------------------~~~~~~~~-~~~~~~ 348 (433)
|||+++|+|++|.+|+.............. .......+ ..++.+
T Consensus 183 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (308)
T cd06615 183 SLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDE 262 (308)
T ss_pred HHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHH
Confidence 999999999999887643211110000000 00000111 235778
Q ss_pred HHHHHHHhcccCCCCCCChhHHH--HHHHh
Q psy6593 349 FVRIAFLCCDLNPDQRPPFEVLE--VWLEG 376 (433)
Q Consensus 349 l~~li~~~l~~~p~~RPs~~~i~--~~l~~ 376 (433)
+.+++.+||+.+|++||++++|+ .|+..
T Consensus 263 ~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 263 FQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 99999999999999999999998 46765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=277.14 Aligned_cols=208 Identities=19% Similarity=0.283 Sum_probs=170.2
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+.++++++|++|+++++.+..++..++||||++|++|.+++... ...+++..+..++.|++.||.|||+.||+|+||
T Consensus 49 ~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~di 128 (285)
T cd05630 49 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDL 128 (285)
T ss_pred HHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCC
Confidence 6999999999999999999999999999999999999999988542 335899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||+++.++.++|+|||++........ .....|++.|+|||++.+..++.++||||
T Consensus 129 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~~----------------------~~~~~g~~~y~aPE~~~~~~~~~~~Diws 186 (285)
T cd05630 129 KPENILLDDHGHIRISDLGLAVHVPEGQT----------------------IKGRVGTVGYMAPEVVKNERYTFSPDWWA 186 (285)
T ss_pred CHHHEEECCCCCEEEeeccceeecCCCcc----------------------ccCCCCCccccChHHHcCCCCCCccccHH
Confidence 99999999999999999999865432111 01346899999999999989999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCC--CCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCC-----hhHHHH--HHHh
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPD--FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP-----FEVLEV--WLEG 376 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~i~~--~l~~ 376 (433)
+|+++|+|++|.+||......... ............+..+++++.+|+.+||+.||++||+ ++++++ |++.
T Consensus 187 lG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 187 LGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 999999999999988653221100 0000111122345678899999999999999999999 778874 6654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=275.68 Aligned_cols=203 Identities=27% Similarity=0.367 Sum_probs=159.3
Q ss_pred chHHHHhhc---CCcceeeEEEEEEeC-----CeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhc
Q psy6593 147 GQVAVLRSL---HHHNVIRFIGVLYKD-----RKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHS 217 (433)
Q Consensus 147 ~E~~~l~~l---~h~~iv~~~~~~~~~-----~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~ 217 (433)
+|+++++++ +||||+++++++... ...++|||++. ++|.+++... ...+++..+..++.|++.||.|||+
T Consensus 48 ~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~ 126 (288)
T cd07863 48 REVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126 (288)
T ss_pred HHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 577777666 699999999998642 45899999996 5898888653 3458999999999999999999999
Q ss_pred CCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCC
Q psy6593 218 MNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY 297 (433)
Q Consensus 218 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 297 (433)
.|++||||||+||+++.++.++|+|||++......... ....+|+.|+|||.+.+..+
T Consensus 127 ~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~----------------------~~~~~~~~y~aPE~~~~~~~ 184 (288)
T cd07863 127 NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL----------------------TPVVVTLWYRAPEVLLQSTY 184 (288)
T ss_pred CCeecCCCCHHHEEECCCCCEEECccCccccccCcccC----------------------CCccccccccCchHhhCCCC
Confidence 99999999999999999999999999998765432111 13467889999999998889
Q ss_pred CcccCeEehhHHHHHHhcCCCCCCCCCCCCCC--------------C----CCchh-------hhccccCCCCcHHHHHH
Q psy6593 298 DETVDVFSYGIVLCEIIGRVPADPDYLPRSPD--------------F----GLDQT-------DFRNKFCASCPEPFVRI 352 (433)
Q Consensus 298 ~~~~DiwslG~il~ell~~~~~~~~~~~~~~~--------------~----~~~~~-------~~~~~~~~~~~~~l~~l 352 (433)
+.++||||||+++|+|++|.++|......... . ..... .........++..+.++
T Consensus 185 ~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 264 (288)
T cd07863 185 ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQL 264 (288)
T ss_pred CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHH
Confidence 99999999999999999999987543211000 0 00000 00011224577889999
Q ss_pred HHHhcccCCCCCCChhHHHH
Q psy6593 353 AFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 353 i~~~l~~~p~~RPs~~~i~~ 372 (433)
+.+||+.||++||++++++.
T Consensus 265 i~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 265 LLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHHHhccCcccCCCHHHHhc
Confidence 99999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=276.34 Aligned_cols=205 Identities=29% Similarity=0.499 Sum_probs=164.1
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeC------CeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcC
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKD------RKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSM 218 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~------~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~ 218 (433)
+|+.+++++ +|+||+++++++... ...++||||+++++|.+++... ...+++..+..++.|++.||+|||+.
T Consensus 51 ~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 130 (272)
T cd06637 51 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130 (272)
T ss_pred HHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 788999999 799999999998753 4689999999999999998763 34689999999999999999999999
Q ss_pred CccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec-----
Q psy6593 219 NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT----- 293 (433)
Q Consensus 219 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----- 293 (433)
+|+|+||+|+||+++.++.++|+|||++......... .....|++.|+|||++.
T Consensus 131 ~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~---------------------~~~~~g~~~y~aPE~~~~~~~~ 189 (272)
T cd06637 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR---------------------RNTFIGTPYWMAPEVIACDENP 189 (272)
T ss_pred CCccCCCCHHHEEECCCCCEEEccCCCceeccccccc---------------------CCcccccccccCHhHhccccCc
Confidence 9999999999999999999999999998764322111 11456889999999986
Q ss_pred CCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 294 GQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 294 ~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
+..++.++||||||+++|||++|.+|+....+...................++..+.+++.+||+.+|.+||++.++++
T Consensus 190 ~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 190 DATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 3457889999999999999999988875433222111111111112223467889999999999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=273.01 Aligned_cols=211 Identities=23% Similarity=0.312 Sum_probs=163.0
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC----CCCCChHHHHHHHHHHHHHHhhhhcCCc
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP----GQPLPWGQRVNFARDIAAGMTYLHSMNL 220 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~i 220 (433)
..+|+.++++++||||+++++++.+....++||||+++++|.+++... ....++..++.++.|++.||+|||+.|+
T Consensus 42 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i 121 (269)
T cd05087 42 FLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNF 121 (269)
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCE
Confidence 347999999999999999999999989999999999999999998642 2245677888999999999999999999
Q ss_pred cccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-----
Q psy6593 221 IHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ----- 295 (433)
Q Consensus 221 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----- 295 (433)
+|+||||+||+++.++.++|+|||++.......... ......++..|+|||++.+.
T Consensus 122 ~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~ 182 (269)
T cd05087 122 IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV-------------------TPDQLWVPLRWIAPELVDEVHGNLL 182 (269)
T ss_pred eccccCcceEEEcCCCcEEECCccccccccCcceee-------------------cCCCcCCcccccCHhHhcccccccc
Confidence 999999999999999999999999986533221110 00133567889999998642
Q ss_pred --CCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCC-C---chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChh
Q psy6593 296 --EYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFG-L---DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFE 368 (433)
Q Consensus 296 --~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~ 368 (433)
.++.++||||||+++|||++ |.+||........... . .............++.+.+++.+|+ .+|++||+++
T Consensus 183 ~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~ 261 (269)
T cd05087 183 VVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAE 261 (269)
T ss_pred ccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHH
Confidence 35789999999999999995 8888754332211100 0 0011111222456788999999998 6899999999
Q ss_pred HHHHHHH
Q psy6593 369 VLEVWLE 375 (433)
Q Consensus 369 ~i~~~l~ 375 (433)
+|+..|+
T Consensus 262 ~l~~~l~ 268 (269)
T cd05087 262 EVHLLLS 268 (269)
T ss_pred HHHHHhc
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=282.70 Aligned_cols=237 Identities=28% Similarity=0.497 Sum_probs=196.9
Q ss_pred ccccCCeeeeeccCCCcchhhhh------------------------cc-chHHHHhhcCCcceeeEEEEEEeCCeeeEE
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQ------------------------NC-GQVAVLRSLHHHNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~------------------------~~-~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 176 (433)
.+.++.+++.+++|+|.||+|-. .| .|+++|.+|+||||++++|+|..++.+++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 46778899999999999998763 11 799999999999999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCC-CChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCC
Q psy6593 177 TEYIAGGTLKELLQDPGQP-LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~-~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
+||+++|+|.+++.++..+ +......+|+.||++|++||.+.++|||||.+.|+|++.++++||+|||+++.+...++.
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999999999875333 355667789999999999999999999999999999999999999999999988776665
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHh--cCCCCCCCCCCCCCC----
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYLPRSPD---- 329 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell--~~~~~~~~~~~~~~~---- 329 (433)
...+ ..+-..+|||+|.+..++++.++|+|+||+++||++ ....|+.........
T Consensus 694 ~vqg-------------------r~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~ 754 (807)
T KOG1094|consen 694 RVQG-------------------RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG 754 (807)
T ss_pred eeec-------------------ceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh
Confidence 4432 344567899999999999999999999999999998 556666554332211
Q ss_pred --CCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 330 --FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 330 --~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
............|.-+|..+.++|.+||..+-.+||++++|...|++.
T Consensus 755 ~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 755 EFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111111222234577899999999999999999999999999998864
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=274.64 Aligned_cols=210 Identities=24% Similarity=0.354 Sum_probs=162.4
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC----CCCChHHHHHHHHHHHHHHhhhhcCCcc
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG----QPLPWGQRVNFARDIAAGMTYLHSMNLI 221 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~i~ 221 (433)
.+|+.+++.++|+||+++++.+.+....++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.||+
T Consensus 43 ~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 122 (269)
T cd05042 43 LQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI 122 (269)
T ss_pred HHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEe
Confidence 379999999999999999999999999999999999999999986632 2346788899999999999999999999
Q ss_pred ccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-------
Q psy6593 222 HRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG------- 294 (433)
Q Consensus 222 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------- 294 (433)
||||||+||+++.++.++|+|||++........... .....+++.|+|||++..
T Consensus 123 H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~ 183 (269)
T cd05042 123 HSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT-------------------KDCHAVPLRWLAPELVEIRGQDLLP 183 (269)
T ss_pred cccccHhheEecCCCcEEEeccccccccccchheec-------------------cCCCCCcccccCHHHHhhccccccc
Confidence 999999999999999999999999865332211100 012345677999998643
Q ss_pred CCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCC----CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhH
Q psy6593 295 QEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDF----GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEV 369 (433)
Q Consensus 295 ~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 369 (433)
..++.++||||||+++|||++ |.+|+....+..... ...........+..++..+.+++..|+ .||++||++++
T Consensus 184 ~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~ 262 (269)
T cd05042 184 KDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEE 262 (269)
T ss_pred cccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHH
Confidence 356789999999999999996 777765432211100 000111112234567888999999998 59999999999
Q ss_pred HHHHHH
Q psy6593 370 LEVWLE 375 (433)
Q Consensus 370 i~~~l~ 375 (433)
|++.|.
T Consensus 263 v~~~l~ 268 (269)
T cd05042 263 VHELLT 268 (269)
T ss_pred HHHHhc
Confidence 998863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=302.38 Aligned_cols=230 Identities=21% Similarity=0.273 Sum_probs=170.9
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC----------CCCCChHHHHHHHHHHHHHHhhhh
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP----------GQPLPWGQRVNFARDIAAGMTYLH 216 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----------~~~~~~~~~~~i~~qi~~~L~~lH 216 (433)
+|++++++++||||+++++++.+++..++||||++|++|.+++... ...++...++.++.||+.||+|||
T Consensus 51 rEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH 130 (932)
T PRK13184 51 REAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH 130 (932)
T ss_pred HHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH
Confidence 6899999999999999999999999999999999999999988531 123566788999999999999999
Q ss_pred cCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC
Q psy6593 217 SMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE 296 (433)
Q Consensus 217 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 296 (433)
+.||+||||||+||+++.++.++|+|||+++................ ... ............||+.|+|||.+.+..
T Consensus 131 s~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~--~~s-~~s~~t~~g~~vGT~~YmAPE~l~g~~ 207 (932)
T PRK13184 131 SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE--RNI-CYSSMTIPGKIVGTPDYMAPERLLGVP 207 (932)
T ss_pred HCCccccCCchheEEEcCCCCEEEEecCcceeccccccccccccccc--ccc-cccccccCCCCCCCCCCCCHHHhcCCC
Confidence 99999999999999999999999999999987632211100000000 000 000001112357999999999999999
Q ss_pred CCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh-hccccCCCCcHHHHHHHHHhcccCCCCCC-ChhHHHHHH
Q psy6593 297 YDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD-FRNKFCASCPEPFVRIAFLCCDLNPDQRP-PFEVLEVWL 374 (433)
Q Consensus 297 ~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~RP-s~~~i~~~l 374 (433)
++.++||||||+++|||++|.+|+................ ........+|+.+.+++.+||+.||++|| +++++.+.|
T Consensus 208 ~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L 287 (932)
T PRK13184 208 ASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL 287 (932)
T ss_pred CCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 9999999999999999999998886533221111100000 00011246789999999999999999997 566777777
Q ss_pred Hhhcc
Q psy6593 375 EGLSM 379 (433)
Q Consensus 375 ~~~~~ 379 (433)
+....
T Consensus 288 e~~lq 292 (932)
T PRK13184 288 EPHLQ 292 (932)
T ss_pred HHHHh
Confidence 76543
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=287.92 Aligned_cols=211 Identities=25% Similarity=0.383 Sum_probs=166.9
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCC-----eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDR-----KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN 219 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ 219 (433)
..+|+++|+.++|+||+++++++...+ ..|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.|
T Consensus 46 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ 123 (372)
T cd07853 46 VFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAG 123 (372)
T ss_pred HHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 448999999999999999999998776 7999999995 6888888654 35999999999999999999999999
Q ss_pred ccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCC
Q psy6593 220 LIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYD 298 (433)
Q Consensus 220 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~ 298 (433)
++||||||+||+++.++.+||+|||++.......... .....+|+.|+|||.+.+. .++
T Consensus 124 ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~--------------------~~~~~~~~~y~aPE~~~~~~~~~ 183 (372)
T cd07853 124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH--------------------MTQEVVTQYYRAPEILMGSRHYT 183 (372)
T ss_pred eeCCCCChHHEEECCCCCEEeccccceeecccCcccc--------------------CCCCCcCCCcCCHHHHcCCCCCC
Confidence 9999999999999999999999999987653322111 1134678899999998874 478
Q ss_pred cccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC------------------------------chhhhccccCCCCcHH
Q psy6593 299 ETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL------------------------------DQTDFRNKFCASCPEP 348 (433)
Q Consensus 299 ~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~ 348 (433)
.++||||||+++|||++|.++|....+......+ .............+++
T Consensus 184 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (372)
T cd07853 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHE 263 (372)
T ss_pred cHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHH
Confidence 9999999999999999999988643221100000 0000000122456788
Q ss_pred HHHHHHHhcccCCCCCCChhHHH--HHHHhh
Q psy6593 349 FVRIAFLCCDLNPDQRPPFEVLE--VWLEGL 377 (433)
Q Consensus 349 l~~li~~~l~~~p~~RPs~~~i~--~~l~~~ 377 (433)
+.+|+.+||+.||++||++++++ .||+..
T Consensus 264 ~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 264 AVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 99999999999999999999998 477664
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=276.95 Aligned_cols=209 Identities=26% Similarity=0.467 Sum_probs=172.3
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.+++.++|+||+++++++..++..++|+||+++++|.+++.+ ..+++..+..++.|++.||++||+.|++|+||+
T Consensus 65 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~ 142 (296)
T cd06655 65 NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIK 142 (296)
T ss_pred HHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 689999999999999999999999999999999999999999876 358999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.++|+|||++......... .....+++.|+|||.+.+..++.++|||||
T Consensus 143 p~Nili~~~~~~kl~dfg~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 201 (296)
T cd06655 143 SDNVLLGMDGSVKLTDFGFCAQITPEQSK---------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201 (296)
T ss_pred HHHEEECCCCCEEEccCccchhccccccc---------------------CCCcCCCccccCcchhcCCCCCchhhHHHH
Confidence 99999999999999999998765432211 113467889999999998889999999999
Q ss_pred hHHHHHHhcCCCCCCCCCCCCCCCCCch-hhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhc
Q psy6593 307 GIVLCEIIGRVPADPDYLPRSPDFGLDQ-TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 307 G~il~ell~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
|+++|+|++|.+||....+......... .......+..+++.+.++|.+||..+|.+||++.+|+ .|++...
T Consensus 202 Gvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 202 GIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 9999999999988755332111111100 0011123456788999999999999999999999998 5887544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=274.38 Aligned_cols=212 Identities=24% Similarity=0.377 Sum_probs=172.0
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++++++|+||+++++++.. ...++||||+++++|.+++.+....+++..++.++.|++.||+|||+.|++|+||+
T Consensus 58 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~ 136 (279)
T cd05057 58 DEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLA 136 (279)
T ss_pred HHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccC
Confidence 79999999999999999999887 78999999999999999998766679999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.++|+|||+++.......... .....++..|+|||.+....++.++|||||
T Consensus 137 p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~-------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 197 (279)
T cd05057 137 ARNVLVKTPQHVKITDFGLAKLLDVDEKEYH-------------------AEGGKVPIKWMALESILHRIYTHKSDVWSY 197 (279)
T ss_pred cceEEEcCCCeEEECCCcccccccCccccee-------------------cCCCcccccccCHHHhhcCCcCchhhHHHH
Confidence 9999999999999999999987643221100 001223567999999988889999999999
Q ss_pred hHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 307 GIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 307 G~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
|+++||+++ |.+|+...........+ ........+...+..+.+++.+||..+|.+||++.++++.|+.+..
T Consensus 198 G~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 198 GVTVWELMTFGAKPYEGIPAVEIPDLL-EKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHHHHHhcCCCCCCCCCCHHHHHHHH-hCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 999999997 88887553221111111 1111122334567889999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=276.49 Aligned_cols=209 Identities=22% Similarity=0.304 Sum_probs=170.0
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+++|++++|+||+++.+.+..++..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.||+||||
T Consensus 49 ~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~di 128 (285)
T cd05632 49 NEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDL 128 (285)
T ss_pred HHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCC
Confidence 6999999999999999999999999999999999999999888543 346999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||++++++.++|+|||++........ .....|+..|+|||.+.+..++.++||||
T Consensus 129 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~----------------------~~~~~g~~~~~aPE~~~~~~~~~~~Di~s 186 (285)
T cd05632 129 KPENILLDDYGHIRISDLGLAVKIPEGES----------------------IRGRVGTVGYMAPEVLNNQRYTLSPDYWG 186 (285)
T ss_pred CHHHEEECCCCCEEEecCCcceecCCCCc----------------------ccCCCCCcCccChHHhcCCCCCcccchHH
Confidence 99999999999999999998865432111 11446899999999999889999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCch--hhhccccCCCCcHHHHHHHHHhcccCCCCCCC-----hhHHH--HHHHh
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLDQ--TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP-----FEVLE--VWLEG 376 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~i~--~~l~~ 376 (433)
||+++|+|++|.+||...........+.. ......++..++..+.+|+..||+.+|++||+ +++++ .||..
T Consensus 187 lG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05632 187 LGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266 (285)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence 99999999999988865322111001110 11122344667889999999999999999999 66776 36655
Q ss_pred h
Q psy6593 377 L 377 (433)
Q Consensus 377 ~ 377 (433)
.
T Consensus 267 ~ 267 (285)
T cd05632 267 M 267 (285)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=275.72 Aligned_cols=213 Identities=27% Similarity=0.436 Sum_probs=170.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEe-CCeeeEEEeccCCCCHHHHhcCCC-------CCCChHHHHHHHHHHHHHHhhhhcC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYK-DRKLNLVTEYIAGGTLKELLQDPG-------QPLPWGQRVNFARDIAAGMTYLHSM 218 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~g~sL~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~lH~~ 218 (433)
+|+.++++++|+||+++++++.. +...++++||+++++|.+++.... ..+++..++.++.|++.||+|||+.
T Consensus 57 ~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~ 136 (280)
T cd05043 57 QESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR 136 (280)
T ss_pred HHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 79999999999999999998766 467899999999999999986521 4589999999999999999999999
Q ss_pred CccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCC
Q psy6593 219 NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYD 298 (433)
Q Consensus 219 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 298 (433)
+++|+||||+||+++.++.+||+|||+++.+......... ....++..|+|||.+.+..++
T Consensus 137 ~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~-------------------~~~~~~~~y~apE~~~~~~~~ 197 (280)
T cd05043 137 GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG-------------------DNENRPVKWMALESLVNKEYS 197 (280)
T ss_pred CEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeC-------------------CCCCcchhccCHHHHhcCCCC
Confidence 9999999999999999999999999999765332211000 022346679999999988899
Q ss_pred cccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 299 ETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 299 ~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
.++||||||+++||+++ |.+|+....+.... ..............+|+++.+++.+||+.+|++||++.+++..|+++
T Consensus 198 ~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 198 SASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-AYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred chhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH-HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 99999999999999997 88887543221111 00111122223356789999999999999999999999999999987
Q ss_pred cc
Q psy6593 378 SM 379 (433)
Q Consensus 378 ~~ 379 (433)
..
T Consensus 277 ~~ 278 (280)
T cd05043 277 HA 278 (280)
T ss_pred Hh
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=270.37 Aligned_cols=205 Identities=25% Similarity=0.453 Sum_probs=170.7
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|++++++++|+||+++++++..+...|+++||+++++|.+++...+..+++..+..++.|++.||.|||+.+++|+||+
T Consensus 47 ~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~ 126 (256)
T cd06612 47 KEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIK 126 (256)
T ss_pred HHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 79999999999999999999999999999999999999999997766679999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|||||
T Consensus 127 ~~ni~~~~~~~~~l~dfg~~~~~~~~~~~---------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~ 185 (256)
T cd06612 127 AGNILLNEEGQAKLADFGVSGQLTDTMAK---------------------RNTVIGTPFWMAPEVIQEIGYNNKADIWSL 185 (256)
T ss_pred cceEEECCCCcEEEcccccchhcccCccc---------------------cccccCCccccCHHHHhcCCCCchhhHHHH
Confidence 99999999999999999998876432211 113457888999999998889999999999
Q ss_pred hHHHHHHhcCCCCCCCCCCCCCCCCCchh-hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 307 GIVLCEIIGRVPADPDYLPRSPDFGLDQT-DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 307 G~il~ell~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
|+++|+|++|.+|+....+.......... ......+..++..+.+++.+||+.+|++||++++|+.
T Consensus 186 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 186 GITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 99999999999887654332221111110 1111123456789999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=272.42 Aligned_cols=210 Identities=24% Similarity=0.467 Sum_probs=171.2
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+++|++++|+||+++++++.+.+..++|+||++|++|.+++.+.+ .+++..+..++.|++.||++||+.|++|+||+
T Consensus 51 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~ 129 (265)
T cd06631 51 EEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIK 129 (265)
T ss_pred HHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcC
Confidence 79999999999999999999999999999999999999999997644 58999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||++++++.++|+|||++............ ........++..|+|||.+.+..++.++|||||
T Consensus 130 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~sl 194 (265)
T cd06631 130 GNNVMLMPNGIIKLIDFGCARRLAWVGLHGTH---------------SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSI 194 (265)
T ss_pred HHhEEECCCCeEEeccchhhHhhhhccccccc---------------cccccccCCCccccChhhhcCCCCcchhhHHHH
Confidence 99999999999999999998865322111000 001124568899999999999889999999999
Q ss_pred hHHHHHHhcCCCCCCCCCCCCCCCCC-chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 307 GIVLCEIIGRVPADPDYLPRSPDFGL-DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 307 G~il~ell~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
|+++|+|++|.+|+............ .........+..++.++.+++++||+.+|++||++.+++.
T Consensus 195 G~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 195 GCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 99999999999888643221111111 1112223455678899999999999999999999998874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=273.45 Aligned_cols=207 Identities=29% Similarity=0.502 Sum_probs=172.4
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.+|+++++.++|+||+++++++..+...++|+||+++++|.+++... ++++..+..++.|++.||.+||+.+++|+||
T Consensus 47 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl 124 (274)
T cd06609 47 QQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDI 124 (274)
T ss_pred HHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 37999999999999999999999999999999999999999999863 6899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
+|+||++++++.++|+|||++......... .....+++.|+|||.+.+..++.++||||
T Consensus 125 ~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~---------------------~~~~~~~~~y~~PE~~~~~~~~~~sDv~s 183 (274)
T cd06609 125 KAANILLSEEGDVKLADFGVSGQLTSTMSK---------------------RNTFVGTPFWMAPEVIKQSGYDEKADIWS 183 (274)
T ss_pred CHHHEEECCCCCEEEcccccceeecccccc---------------------cccccCCccccChhhhccCCCCchhhHHH
Confidence 999999999999999999999876543211 11446788999999999888999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCC-CcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCAS-CPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
||+++|+|++|.+|+....+......+. .......... ++..+.+++.+||..+|++||++++++. |+.+
T Consensus 184 lG~il~~l~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 184 LGITAIELAKGEPPLSDLHPMRVLFLIP-KNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred HHHHHHHHHhCCCCcccCchHHHHHHhh-hcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence 9999999999999886543221111111 1112222233 7889999999999999999999999974 6654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=272.68 Aligned_cols=202 Identities=25% Similarity=0.415 Sum_probs=164.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|++++++++||||+++++++..++..++||||+++++|..+. .+++..+..++.|++.||.|||+.|++|+|||
T Consensus 48 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 122 (279)
T cd06619 48 SELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVK 122 (279)
T ss_pred HHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCC
Confidence 7999999999999999999999999999999999999997652 47889999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.++|+|||++........ ....+|..|+|||.+.+..++.++|||||
T Consensus 123 p~Nill~~~~~~~l~dfg~~~~~~~~~~-----------------------~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 179 (279)
T cd06619 123 PSNMLVNTRGQVKLCDFGVSTQLVNSIA-----------------------KTYVGTNAYMAPERISGEQYGIHSDVWSL 179 (279)
T ss_pred HHHEEECCCCCEEEeeCCcceecccccc-----------------------cCCCCChhhcCceeecCCCCCCcchHHHH
Confidence 9999999999999999999876533211 14568899999999999899999999999
Q ss_pred hHHHHHHhcCCCCCCCCCCCCCCCCC-ch-h----hhccc-cCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 307 GIVLCEIIGRVPADPDYLPRSPDFGL-DQ-T----DFRNK-FCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 307 G~il~ell~~~~~~~~~~~~~~~~~~-~~-~----~~~~~-~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
|+++|+|++|.+|+............ .. . ..... .....+.++.+++.+||+.+|++||+++++++ |+..
T Consensus 180 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 180 GISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred HHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence 99999999998887543222111000 00 0 00011 12346788999999999999999999999974 5543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=277.07 Aligned_cols=210 Identities=29% Similarity=0.495 Sum_probs=166.2
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC---------------------CCCCChHHHHHHH
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---------------------GQPLPWGQRVNFA 205 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~---------------------~~~~~~~~~~~i~ 205 (433)
+|+.++++++||||+++++++..+...++||||+++++|.+++... ...+++..++.++
T Consensus 57 ~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 136 (288)
T cd05050 57 REAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIA 136 (288)
T ss_pred HHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHH
Confidence 6999999999999999999999999999999999999999998632 1247888899999
Q ss_pred HHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCcc
Q psy6593 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPY 285 (433)
Q Consensus 206 ~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 285 (433)
.|++.||.+||+.|++||||||+||+++.++.++|+|||++............ .....+..
T Consensus 137 ~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-------------------~~~~~~~~ 197 (288)
T cd05050 137 KQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS-------------------ENDAIPIR 197 (288)
T ss_pred HHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCcccccc-------------------CCCccChh
Confidence 99999999999999999999999999999999999999998765332211000 01234567
Q ss_pred ccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCC
Q psy6593 286 WMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQR 364 (433)
Q Consensus 286 y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 364 (433)
|+|||.+.+..++.++||||||+++|+|++ |..|+.............. ......+..++.++.+++.+||+.+|.+|
T Consensus 198 y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~R 276 (288)
T cd05050 198 WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRD-GNVLSCPDNCPLELYNLMRLCWSKLPSDR 276 (288)
T ss_pred hcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 999999988889999999999999999996 6655533221111000000 11112245678999999999999999999
Q ss_pred CChhHHHHHHHh
Q psy6593 365 PPFEVLEVWLEG 376 (433)
Q Consensus 365 Ps~~~i~~~l~~ 376 (433)
|++++|++.|++
T Consensus 277 pt~~el~~~l~~ 288 (288)
T cd05050 277 PSFASINRILQR 288 (288)
T ss_pred CCHHHHHHHhhC
Confidence 999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=283.42 Aligned_cols=226 Identities=23% Similarity=0.313 Sum_probs=174.8
Q ss_pred cCCeeeeeccCCCcchhhhhc---------------------------cchHHHHhhcCCcceeeEEEEEEeC------C
Q psy6593 125 KDGLLFCKEDYNGKYGEACQN---------------------------CGQVAVLRSLHHHNVIRFIGVLYKD------R 171 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~---------------------------~~E~~~l~~l~h~~iv~~~~~~~~~------~ 171 (433)
.+++...+.+++|+||.||+. .+|+.+++.++|+||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 345666777888888887642 1689999999999999999998644 3
Q ss_pred eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
..++||||++ ++|.+.+.. .+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 96 ~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 96 DVYLVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred eeEEEhhhhc-ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 5799999996 477777754 488999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCC--
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPD-- 329 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~-- 329 (433)
.... ....||+.|+|||++.+..++.++||||||+++|+|++|.++|.........
T Consensus 172 ~~~~----------------------~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 229 (355)
T cd07874 172 SFMM----------------------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229 (355)
T ss_pred cccc----------------------CCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 2111 1456899999999999989999999999999999999999887543210000
Q ss_pred ------------------------------CCCchhh--------hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 330 ------------------------------FGLDQTD--------FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 330 ------------------------------~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
....... .........+..+.++|.+||+.||++|||+.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell 309 (355)
T cd07874 230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309 (355)
T ss_pred HHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHh
Confidence 0000000 00001123456789999999999999999999998
Q ss_pred H--HHHh
Q psy6593 372 V--WLEG 376 (433)
Q Consensus 372 ~--~l~~ 376 (433)
+ ||..
T Consensus 310 ~hp~~~~ 316 (355)
T cd07874 310 QHPYINV 316 (355)
T ss_pred cCcchhc
Confidence 5 6653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=272.18 Aligned_cols=210 Identities=27% Similarity=0.484 Sum_probs=169.5
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcC------CCCCCChHHHHHHHHHHHHHHhhhhcCCc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD------PGQPLPWGQRVNFARDIAAGMTYLHSMNL 220 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~------~~~~~~~~~~~~i~~qi~~~L~~lH~~~i 220 (433)
+|++++++++||||+++++++...+..++||||+++++|.+++.+ ....+++..++.++.|++.||+|||+.++
T Consensus 48 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i 127 (269)
T cd05044 48 KEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHF 127 (269)
T ss_pred HHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCc
Confidence 799999999999999999999999999999999999999999864 12347889999999999999999999999
Q ss_pred cccCCCCcceEEccCC-----ceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC
Q psy6593 221 IHRDLNSQNCLVREDK-----TVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ 295 (433)
Q Consensus 221 ~H~dlkp~Nil~~~~~-----~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 295 (433)
+|+||+|+||+++.++ .++|+|||++........... .....++..|+|||.+.+.
T Consensus 128 ~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~-------------------~~~~~~~~~y~aPE~~~~~ 188 (269)
T cd05044 128 IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK-------------------EGEGLLPVRWMAPESLLDG 188 (269)
T ss_pred ccCCCChheEEEecCCCCCCcceEECCccccccccccccccc-------------------CcccCCCccccCHHHHccC
Confidence 9999999999999877 899999999976543221110 0123456789999999998
Q ss_pred CCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHH
Q psy6593 296 EYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWL 374 (433)
Q Consensus 296 ~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 374 (433)
.++.++||||||+++|+|++ |.+|+...........+ ........+..+|..+.+++.+||+.+|.+||++++|.+.|
T Consensus 189 ~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 267 (269)
T cd05044 189 KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV-TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267 (269)
T ss_pred CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH-hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 99999999999999999996 88777543221111110 11112233466789999999999999999999999999888
Q ss_pred Hh
Q psy6593 375 EG 376 (433)
Q Consensus 375 ~~ 376 (433)
++
T Consensus 268 ~~ 269 (269)
T cd05044 268 QN 269 (269)
T ss_pred hC
Confidence 63
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=276.76 Aligned_cols=208 Identities=26% Similarity=0.397 Sum_probs=157.6
Q ss_pred cchHHHHhhcCCcceeeEEEEEEe--CCeeeEEEeccCCCCHHHHhcC--------CCCCCChHHHHHHHHHHHHHHhhh
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQD--------PGQPLPWGQRVNFARDIAAGMTYL 215 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~--------~~~~~~~~~~~~i~~qi~~~L~~l 215 (433)
.+|+++|++++||||+++++++.. +...++||||+. ++|.+++.. ....+++..++.++.|++.||.||
T Consensus 46 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~l 124 (317)
T cd07867 46 CREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124 (317)
T ss_pred HHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHH
Confidence 379999999999999999999864 467899999995 588887642 123588999999999999999999
Q ss_pred hcCCccccCCCCcceEE----ccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccce
Q psy6593 216 HSMNLIHRDLNSQNCLV----REDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM 291 (433)
Q Consensus 216 H~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 291 (433)
|+.||+||||||+||++ +.++.+||+|||+++.......... ......+|+.|+|||.
T Consensus 125 H~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~------------------~~~~~~~t~~y~aPE~ 186 (317)
T cd07867 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA------------------DLDPVVVTFWYRAPEL 186 (317)
T ss_pred HhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCccccc------------------ccCcceecccccCcHH
Confidence 99999999999999999 4567899999999987643321110 1114568999999999
Q ss_pred ecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC-------------------Cc-------------hhh--
Q psy6593 292 MTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG-------------------LD-------------QTD-- 336 (433)
Q Consensus 292 ~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~-------------------~~-------------~~~-- 336 (433)
+.+ ..++.++||||||+++|||++|.++|........... .. ...
T Consensus 187 ~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (317)
T cd07867 187 LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFR 266 (317)
T ss_pred hcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhc
Confidence 876 4578999999999999999999998854321110000 00 000
Q ss_pred -----------hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 337 -----------FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 337 -----------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
.........+..+.+|+.+||+.||.+|||++++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 267 RTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred ccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 000011223467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=282.36 Aligned_cols=224 Identities=22% Similarity=0.312 Sum_probs=173.3
Q ss_pred CCeeeeeccCCCcchhhhhc---------------------------cchHHHHhhcCCcceeeEEEEEEeC------Ce
Q psy6593 126 DGLLFCKEDYNGKYGEACQN---------------------------CGQVAVLRSLHHHNVIRFIGVLYKD------RK 172 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~---------------------------~~E~~~l~~l~h~~iv~~~~~~~~~------~~ 172 (433)
+++.+.+.+++|+||.||+. .+|+.+++.++|+||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 44666677788888877641 1689999999999999999987643 35
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
.|+||||++ ++|.+.+.. .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 104 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 104 VYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred EEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 799999996 578887754 4889999999999999999999999999999999999999999999999999765332
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC--
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF-- 330 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~-- 330 (433)
... ....+|+.|+|||++.+..++.++||||||+++|+|++|.+||..........
T Consensus 180 ~~~----------------------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 237 (364)
T cd07875 180 FMM----------------------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237 (364)
T ss_pred Ccc----------------------cCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 111 14568999999999999999999999999999999999998885432100000
Q ss_pred ------------------------------CCchhhh--------ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 331 ------------------------------GLDQTDF--------RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 331 ------------------------------~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
....... ........+..+.++|.+||+.||.+|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 238 IEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000 00001123467899999999999999999999984
Q ss_pred --HHH
Q psy6593 373 --WLE 375 (433)
Q Consensus 373 --~l~ 375 (433)
|++
T Consensus 318 hp~~~ 322 (364)
T cd07875 318 HPYIN 322 (364)
T ss_pred Ccccc
Confidence 664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=273.49 Aligned_cols=205 Identities=29% Similarity=0.491 Sum_probs=164.3
Q ss_pred chHHHHhhc-CCcceeeEEEEEEe------CCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcC
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYK------DRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSM 218 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~------~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~ 218 (433)
.|+.+++++ +|+||+++++++.. .+..++||||+++++|.+++... +..+++..+..++.|++.||.|||+.
T Consensus 61 ~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~ 140 (282)
T cd06636 61 LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140 (282)
T ss_pred HHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 688888888 79999999999863 45789999999999999998653 34588889999999999999999999
Q ss_pred CccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec-----
Q psy6593 219 NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT----- 293 (433)
Q Consensus 219 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----- 293 (433)
|++|+||+|+||+++.++.++|+|||++......... .....|++.|+|||.+.
T Consensus 141 ~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~l~~~~~~ 199 (282)
T cd06636 141 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR---------------------RNTFIGTPYWMAPEVIACDENP 199 (282)
T ss_pred CcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccC---------------------CCcccccccccCHhhcCcccCc
Confidence 9999999999999999999999999998765322111 11456889999999875
Q ss_pred CCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 294 GQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 294 ~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
...++.++||||||+++|+|++|.+|+....+...................++..+.++|.+||+.||.+||++.+|++
T Consensus 200 ~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 200 DATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 3467889999999999999999998886543322222221111122223467899999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=269.57 Aligned_cols=206 Identities=23% Similarity=0.399 Sum_probs=166.4
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCC--ChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPL--PWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~--~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
.+|+.++++++|+||+++++++..++..++|+||+++++|.+++......+ ++..+..++.|++.||+|||+.||+||
T Consensus 53 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~ 132 (268)
T cd06624 53 HEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132 (268)
T ss_pred HHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence 379999999999999999999999999999999999999999997644445 888899999999999999999999999
Q ss_pred CCCCcceEEcc-CCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC--CCCcc
Q psy6593 224 DLNSQNCLVRE-DKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ--EYDET 300 (433)
Q Consensus 224 dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~ 300 (433)
||||+||+++. ++.++|+|||++......... .....+++.|+|||.+... .++.+
T Consensus 133 dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~---------------------~~~~~~~~~~~aPE~~~~~~~~~~~~ 191 (268)
T cd06624 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---------------------TETFTGTLQYMAPEVIDKGPRGYGAP 191 (268)
T ss_pred CCCHHHEEEcCCCCeEEEecchhheecccCCCc---------------------cccCCCCccccChhhhccccccCCch
Confidence 99999999976 679999999998765322111 0134578899999998664 37889
Q ss_pred cCeEehhHHHHHHhcCCCCCCCCCCCC-CCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 301 VDVFSYGIVLCEIIGRVPADPDYLPRS-PDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 301 ~DiwslG~il~ell~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
+||||||+++|+|++|.+|+....... .............++..+++++.+++.+||+.+|.+||++++++.
T Consensus 192 ~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 192 ADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 999999999999999988875432211 111111112223345677889999999999999999999999874
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=267.99 Aligned_cols=208 Identities=23% Similarity=0.414 Sum_probs=171.0
Q ss_pred hccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccc
Q psy6593 144 QNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIH 222 (433)
Q Consensus 144 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H 222 (433)
...+|+++|++++|+||+++++++.+.+..++||||+++++|.+++.+. +..+++..+..++.|++.+|.+||+.|++|
T Consensus 45 ~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h 124 (256)
T cd08221 45 DALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILH 124 (256)
T ss_pred HHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 3448999999999999999999999999999999999999999999764 456899999999999999999999999999
Q ss_pred cCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccC
Q psy6593 223 RDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVD 302 (433)
Q Consensus 223 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 302 (433)
+||+|+||+++.++.+||+|||++......... .....+++.|+|||.+.+..++.++|
T Consensus 125 ~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~---------------------~~~~~~~~~y~ape~~~~~~~~~~~D 183 (256)
T cd08221 125 RDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM---------------------AETVVGTPYYMSPELCQGVKYNFKSD 183 (256)
T ss_pred cCCChHhEEEeCCCCEEECcCcceEEccccccc---------------------ccccCCCccccCHhhcCCCCCCCcch
Confidence 999999999999999999999998765432211 01446889999999998888899999
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHH
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVW 373 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~ 373 (433)
|||||+++|+|++|.+++................ .......++..+.+++.+||+.+|++||+++++++.
T Consensus 184 v~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 184 IWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred hHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 9999999999999888775432211111111111 112235678899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=292.34 Aligned_cols=230 Identities=19% Similarity=0.274 Sum_probs=176.6
Q ss_pred CCeeeeeccCCCcchhhhhc-------------------------------------------cchHHHHhhcCCcceee
Q psy6593 126 DGLLFCKEDYNGKYGEACQN-------------------------------------------CGQVAVLRSLHHHNVIR 162 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~-------------------------------------------~~E~~~l~~l~h~~iv~ 162 (433)
+++.+..++|+|+||+||.. .+|+.+|++++|+||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 45888899999999998831 16999999999999999
Q ss_pred EEEEEEeCCeeeEEEeccCCCCHHHHhcCC----CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCce
Q psy6593 163 FIGVLYKDRKLNLVTEYIAGGTLKELLQDP----GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTV 238 (433)
Q Consensus 163 ~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~ 238 (433)
+++++...+..|+|+|++. ++|.+++... ........++.|+.||+.||.|||+.||+||||||+|||++.++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~v 306 (501)
T PHA03210 228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKI 306 (501)
T ss_pred EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence 9999999999999999994 5787776442 1224466788999999999999999999999999999999999999
Q ss_pred EEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCC-
Q psy6593 239 VVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRV- 317 (433)
Q Consensus 239 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~- 317 (433)
||+|||+++.+...... ......||+.|+|||++.+..++.++||||||+++|||+++.
T Consensus 307 kL~DFGla~~~~~~~~~--------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~ 366 (501)
T PHA03210 307 VLGDFGTAMPFEKEREA--------------------FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366 (501)
T ss_pred EEEeCCCceecCccccc--------------------ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999866432211 112467999999999999999999999999999999999665
Q ss_pred CCCCCCCCCCCC--------CCCchhh-----------------------hccc-cCCCCcHHHHHHHHHhcccCCCCCC
Q psy6593 318 PADPDYLPRSPD--------FGLDQTD-----------------------FRNK-FCASCPEPFVRIAFLCCDLNPDQRP 365 (433)
Q Consensus 318 ~~~~~~~~~~~~--------~~~~~~~-----------------------~~~~-~~~~~~~~l~~li~~~l~~~p~~RP 365 (433)
+|+......... ....... .... ....++..+.++|.+||+.||.+||
T Consensus 367 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rp 446 (501)
T PHA03210 367 CPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRP 446 (501)
T ss_pred CCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCc
Confidence 343321110000 0000000 0000 0124567888999999999999999
Q ss_pred ChhHHHH--HHHh
Q psy6593 366 PFEVLEV--WLEG 376 (433)
Q Consensus 366 s~~~i~~--~l~~ 376 (433)
++.+++. ||..
T Consensus 447 sa~elL~hp~f~~ 459 (501)
T PHA03210 447 GAAELLALPLFSA 459 (501)
T ss_pred CHHHHhhChhhhc
Confidence 9999984 6654
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=270.74 Aligned_cols=228 Identities=26% Similarity=0.425 Sum_probs=177.3
Q ss_pred ccCCeeeeeccCCCcchhhhhcc------------------------chHHHHhhc-CCcceeeEEEEEE-----eCCee
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSL-HHHNVIRFIGVLY-----KDRKL 173 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l-~h~~iv~~~~~~~-----~~~~~ 173 (433)
..+++.+...+++|+||+||+.. +|+.+++++ +|+||+++++++. .++..
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 45556667777888888877521 588899999 7999999999884 34578
Q ss_pred eEEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhcc
Q psy6593 174 NLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIH 250 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 250 (433)
++||||++|++|.+++.. .+..+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++....
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 999999999999998752 33468899999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-----CCCCcccCeEehhHHHHHHhcCCCCCCCCCC
Q psy6593 251 QGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-----QEYDETVDVFSYGIVLCEIIGRVPADPDYLP 325 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~~~~~~~~~~~ 325 (433)
..... .....|++.|+|||.+.. ..++.++||||||+++|+|++|.+|+.....
T Consensus 176 ~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 176 STRLR---------------------RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred cCCCc---------------------cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 32111 114468899999998753 4578899999999999999999888765433
Q ss_pred CCCCCCCchh-hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 326 RSPDFGLDQT-DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 326 ~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
.......... ......+..++..+.+++.+||+.+|++||++.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 235 MRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred hHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 2211111111 0111123446788999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=271.79 Aligned_cols=207 Identities=30% Similarity=0.522 Sum_probs=171.9
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.+|+.++++++|+||+++++++.++...++||||++|++|.+++.. .++++..+..++.|++.||++||+.+++|+||
T Consensus 50 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl 127 (277)
T cd06640 50 QQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDI 127 (277)
T ss_pred HHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCC
Confidence 3799999999999999999999999999999999999999999876 45899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
+|+||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+||
T Consensus 128 ~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~---------------------~~~~~~~~~y~apE~~~~~~~~~~~Dv~s 186 (277)
T cd06640 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIK---------------------RNTFVGTPFWMAPEVIQQSAYDSKADIWS 186 (277)
T ss_pred ChhhEEEcCCCCEEEcccccceeccCCccc---------------------cccccCcccccCHhHhccCCCccHHHHHH
Confidence 999999999999999999998765432111 11345788899999998888999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
||+++|||++|.+|+....+....... .......+...++..+.+++.+||+.+|++||++++++. |+..
T Consensus 187 lG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06640 187 LGITAIELAKGEPPNSDMHPMRVLFLI-PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVK 258 (277)
T ss_pred HHHHHHHHHHCCCCCCCcChHhHhhhh-hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhh
Confidence 999999999999887654332221111 111122334567889999999999999999999999974 5544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=270.59 Aligned_cols=209 Identities=24% Similarity=0.482 Sum_probs=170.9
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++++++||||+++++++...+..++||||+++++|.+++... ..+++..+..++.|++.||++||+.|++|+||+
T Consensus 55 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~ 133 (267)
T cd06628 55 REIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIK 133 (267)
T ss_pred HHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCC
Confidence 7999999999999999999999999999999999999999999764 358999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||++++++.++|+|||+++.......... .........|+..|+|||.+.+..++.++|||||
T Consensus 134 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~---------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl 198 (267)
T cd06628 134 GANILVDNKGGIKISDFGISKKLEANSLSTK---------------TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSL 198 (267)
T ss_pred HHHEEEcCCCCEEecccCCCcccccccccCC---------------ccccccccCCCcCccChhHhccCCCCchhhhHHH
Confidence 9999999999999999999987653211100 0011123458889999999998889999999999
Q ss_pred hHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 307 GIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 307 G~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
|+++|+|++|..|+............ .......++..++..+.+++.+||+.+|.+||++.+|++
T Consensus 199 G~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 199 GCLVVEMLTGKHPFPDCTQLQAIFKI-GENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHHHhhCCCCCCCccHHHHHHHH-hccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 99999999998887653221111100 112233445678899999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=270.92 Aligned_cols=211 Identities=24% Similarity=0.337 Sum_probs=162.0
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC---CCCCChHHHHHHHHHHHHHHhhhhcCCcc
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---GQPLPWGQRVNFARDIAAGMTYLHSMNLI 221 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~i~ 221 (433)
..+|+.+++.++||||+++++.+......++||||+++++|.+++.+. ...++...+..++.|++.||+|||+.+++
T Consensus 42 ~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~ 121 (268)
T cd05086 42 FLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL 121 (268)
T ss_pred HHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCee
Confidence 448899999999999999999999999999999999999999998753 23466778889999999999999999999
Q ss_pred ccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-------
Q psy6593 222 HRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG------- 294 (433)
Q Consensus 222 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------- 294 (433)
|+||||+||+++.++.++|+|||++.......... ......++..|+|||++..
T Consensus 122 H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~ 182 (268)
T cd05086 122 HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE-------------------TEDDKCVPLRWLAPELVGEFHGGLIT 182 (268)
T ss_pred ccCCccceEEEcCCccEEecccccccccCcchhhh-------------------cccCCcCcccccCchhcccccCcccc
Confidence 99999999999999999999999875432211100 0113457888999998753
Q ss_pred CCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCC----chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhH
Q psy6593 295 QEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGL----DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEV 369 (433)
Q Consensus 295 ~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 369 (433)
..++.++||||||+++|||++ +.+|+............ ........+...+++.+.+++..|| .+|++||++++
T Consensus 183 ~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~ 261 (268)
T cd05086 183 AEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEE 261 (268)
T ss_pred CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHH
Confidence 245789999999999999994 56666433221110000 0011122334557788999999999 68999999999
Q ss_pred HHHHHH
Q psy6593 370 LEVWLE 375 (433)
Q Consensus 370 i~~~l~ 375 (433)
|++.|.
T Consensus 262 i~~~l~ 267 (268)
T cd05086 262 VHRLLT 267 (268)
T ss_pred HHHHhc
Confidence 988774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=268.95 Aligned_cols=205 Identities=23% Similarity=0.385 Sum_probs=166.6
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeC-CeeeEEEeccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKD-RKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
.+|++++++++|+||+++++.+... ..+++||||+++++|.+++.. .+..+++.++..++.|++.||++||+.|++|+
T Consensus 47 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~ 126 (257)
T cd08223 47 EQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHR 126 (257)
T ss_pred HHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 3799999999999999999988644 468999999999999999875 34468999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
||+|+||+++.++.++|+|||++......... .....+++.|+|||.+.+..++.++||
T Consensus 127 di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv 185 (257)
T cd08223 127 DLKTQNVFLTRTNIIKVGDLGIARVLENQCDM---------------------ASTLIGTPYYMSPELFSNKPYNYKSDV 185 (257)
T ss_pred CCCchhEEEecCCcEEEecccceEEecccCCc---------------------cccccCCcCccChhHhcCCCCCchhhh
Confidence 99999999999999999999998765332111 114467889999999999899999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
||||+++|+|++|.+++........... .........+..+++.+.+++.+|++.+|++||++.++++
T Consensus 186 ~slG~il~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 186 WALGCCVYEMATLKHAFNAKDMNSLVYR-IIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 9999999999998887653221111000 0111122344667899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=272.76 Aligned_cols=205 Identities=23% Similarity=0.333 Sum_probs=162.6
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC--CCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP--GQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
.+|+.++++++|+||+++++++..++..++||||++ ++|.+++... +..+++..++.++.|++.||.|||+.|++|+
T Consensus 47 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~ 125 (285)
T cd07861 47 IREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHR 125 (285)
T ss_pred HHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 379999999999999999999999999999999996 5898888652 2568999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccC
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVD 302 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D 302 (433)
||+|+||+++.++.++|+|||++......... .....+++.|+|||.+.+ ..++.++|
T Consensus 126 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~D 184 (285)
T cd07861 126 DLKPQNLLIDNKGVIKLADFGLARAFGIPVRV---------------------YTHEVVTLWYRAPEVLLGSPRYSTPVD 184 (285)
T ss_pred CCCHHHEEEcCCCcEEECcccceeecCCCccc---------------------ccCCcccccccChHHhcCCCCcCcHHH
Confidence 99999999999999999999998754322110 013356888999998865 35688999
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCCCC--------------CC--Cchh-----------hhccccCCCCcHHHHHHHHH
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRSPD--------------FG--LDQT-----------DFRNKFCASCPEPFVRIAFL 355 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~~~--------------~~--~~~~-----------~~~~~~~~~~~~~l~~li~~ 355 (433)
|||||+++|+|++|.+++......... +. .... .........+++++.++|.+
T Consensus 185 v~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 264 (285)
T cd07861 185 IWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEK 264 (285)
T ss_pred HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHH
Confidence 999999999999999888643211000 00 0000 00011124578899999999
Q ss_pred hcccCCCCCCChhHHHH
Q psy6593 356 CCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 356 ~l~~~p~~RPs~~~i~~ 372 (433)
||+.||++||++++|+.
T Consensus 265 ~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 265 MLIYDPAKRISAKKALN 281 (285)
T ss_pred HhcCChhhCCCHHHHhc
Confidence 99999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=274.02 Aligned_cols=209 Identities=30% Similarity=0.520 Sum_probs=173.2
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.+|++++++++|+||+++++.+..++..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||
T Consensus 50 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl 127 (277)
T cd06642 50 QQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDI 127 (277)
T ss_pred HHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCC
Confidence 3799999999999999999999999999999999999999999865 45899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
+|+||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++||||
T Consensus 128 ~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 186 (277)
T cd06642 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIK---------------------RNTFVGTPFWMAPEVIKQSAYDFKADIWS 186 (277)
T ss_pred ChheEEEeCCCCEEEccccccccccCcchh---------------------hhcccCcccccCHHHhCcCCCchhhhHHH
Confidence 999999999999999999998765432110 11345788899999999988999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
||+++|+|++|.+|+....+........ ......+...++.++.+++.+||+.+|++||++.+++. |+....
T Consensus 187 lG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 187 LGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred HHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 9999999999998876543322211111 11122233567889999999999999999999999985 666543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=282.97 Aligned_cols=223 Identities=25% Similarity=0.406 Sum_probs=183.4
Q ss_pred eeeeeccCCCcchhhhhcc-----------------------------chHHHHhhcCCcceeeEEEEEEeCCe--eeEE
Q psy6593 128 LLFCKEDYNGKYGEACQNC-----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRK--LNLV 176 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~~-----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~--~~lv 176 (433)
..+...+|+|.|-+|||++ .|+.+|+.|+|+||+++|+++.+... +.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 4455578999999999966 79999999999999999999987654 8899
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC--CccccCCCCcceEEc-cCCceEEeccccchhccCCC
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM--NLIHRDLNSQNCLVR-EDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~--~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~ 253 (433)
+|.+..|+|..++++.++ .+...+..|++||+.||.|||++ -|+|||||.+||+|+ ..|.|||+|+|+|.....+.
T Consensus 122 TEL~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred eecccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 999999999999988664 99999999999999999999998 599999999999998 45999999999999876543
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCC-CCCCC
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS-PDFGL 332 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~-~~~~~ 332 (433)
.. ..+|||.|||||++. ..|+..+||||||++|+||+|+.-|+..-.... .+..+
T Consensus 201 ak-----------------------svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV 256 (632)
T KOG0584|consen 201 AK-----------------------SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV 256 (632)
T ss_pred cc-----------------------eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH
Confidence 32 579999999999999 589999999999999999999988876532221 11111
Q ss_pred chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 333 DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 333 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
........+..--.++++++|.+||.. .++|||+.+++. +|..
T Consensus 257 ~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 257 TSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred HcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 111111122222357899999999999 999999999984 6665
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=276.24 Aligned_cols=212 Identities=25% Similarity=0.403 Sum_probs=168.3
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++++++|+||+++++++... ..++|+||+++|+|.+++......+++..++.++.|++.||.|||+.||+|+|||
T Consensus 58 ~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dik 136 (303)
T cd05110 58 DEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLA 136 (303)
T ss_pred HHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccc
Confidence 688999999999999999998654 5779999999999999998766678999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.+||+|||+++.......... .....++..|+|||.+.+..++.++|||||
T Consensus 137 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~-------------------~~~~~~~~~y~~PE~~~~~~~~~~~Diwsl 197 (303)
T cd05110 137 ARNVLVKSPNHVKITDFGLARLLEGDEKEYN-------------------ADGGKMPIKWMALECIHYRKFTHQSDVWSY 197 (303)
T ss_pred cceeeecCCCceEEccccccccccCcccccc-------------------cCCCccccccCCHHHhccCCCChHHHHHHH
Confidence 9999999999999999999986543221100 002235678999999998889999999999
Q ss_pred hHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 307 GIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 307 G~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
|+++|||++ |..|+........ ............+...+..+.+++..||..+|++||++++++..|+.+..
T Consensus 198 G~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 198 GVTIWELMTFGGKPYDGIPTREI-PDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred HHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 999999985 6666643211110 00011111122234567899999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=280.14 Aligned_cols=233 Identities=21% Similarity=0.334 Sum_probs=203.3
Q ss_pred ccCCeeeeeccCCCcchhhhh----------------------------ccchHHHHhhcCCcceeeEEEEEEeCCeeeE
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQ----------------------------NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~----------------------------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 175 (433)
+..++..+..+|-|+||.|-- .+.|-.||...+.+.||++|.-|.++++.|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 344566677899999997652 1278899999999999999999999999999
Q ss_pred EEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCC
Q psy6593 176 VTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
+||-|-||.|+..+++.+ .|.+..++-++..+++|++|||++|||+|||||+|++++.+|-+||+|||+|+.+..+
T Consensus 498 LmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--- 573 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--- 573 (732)
T ss_pred hHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC---
Confidence 999999999999999865 5999999999999999999999999999999999999999999999999999987653
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~ 335 (433)
++.++++|||.|.|||++.....+.++|.||||+++|||++|.|||....+...+..+-..
T Consensus 574 -------------------~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG 634 (732)
T KOG0614|consen 574 -------------------RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG 634 (732)
T ss_pred -------------------CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh
Confidence 3567999999999999999999999999999999999999999999887766655555444
Q ss_pred hhccccCCCCcHHHHHHHHHhcccCCCCCCC-----hhHHH--HHHHhhcc
Q psy6593 336 DFRNKFCASCPEPFVRIAFLCCDLNPDQRPP-----FEVLE--VWLEGLSM 379 (433)
Q Consensus 336 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~i~--~~l~~~~~ 379 (433)
.-...+|..++....+||+++...+|.+|.- ..+|. .||+...+
T Consensus 635 id~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 635 IDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred hhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 4455677888999999999999999999975 45665 58887654
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=280.58 Aligned_cols=204 Identities=24% Similarity=0.366 Sum_probs=161.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeC------CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKD------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNL 220 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i 220 (433)
+|+.+|++++|+||+++++++... ...+++++++ +++|.+++.. ..+++..+..++.||+.||.|||+.||
T Consensus 63 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i 139 (343)
T cd07878 63 RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGI 139 (343)
T ss_pred HHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 699999999999999999988643 3578999988 7899998865 459999999999999999999999999
Q ss_pred cccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCc
Q psy6593 221 IHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDE 299 (433)
Q Consensus 221 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ 299 (433)
+||||||+||+++.++.+||+|||++....... ....||+.|+|||++.+ ..++.
T Consensus 140 vHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~------------------------~~~~~t~~y~aPE~~~~~~~~~~ 195 (343)
T cd07878 140 IHRDLKPSNVAVNEDCELRILDFGLARQADDEM------------------------TGYVATRWYRAPEIMLNWMHYNQ 195 (343)
T ss_pred ecccCChhhEEECCCCCEEEcCCccceecCCCc------------------------CCccccccccCchHhcCCccCCc
Confidence 999999999999999999999999987653211 14568999999999877 56889
Q ss_pred ccCeEehhHHHHHHhcCCCCCCCCCCCCCCC---------------CCch---hhhc-----------cccCCCCcHHHH
Q psy6593 300 TVDVFSYGIVLCEIIGRVPADPDYLPRSPDF---------------GLDQ---TDFR-----------NKFCASCPEPFV 350 (433)
Q Consensus 300 ~~DiwslG~il~ell~~~~~~~~~~~~~~~~---------------~~~~---~~~~-----------~~~~~~~~~~l~ 350 (433)
++||||||+++|+|++|.++|.......... .+.. .... .......++.+.
T Consensus 196 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (343)
T cd07878 196 TVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAI 275 (343)
T ss_pred hhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHH
Confidence 9999999999999999988875422100000 0000 0000 001134566789
Q ss_pred HHHHHhcccCCCCCCChhHHH--HHHHhh
Q psy6593 351 RIAFLCCDLNPDQRPPFEVLE--VWLEGL 377 (433)
Q Consensus 351 ~li~~~l~~~p~~RPs~~~i~--~~l~~~ 377 (433)
+|+.+||+.||.+|||+.+++ .||...
T Consensus 276 ~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 276 DLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 999999999999999999998 466653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=270.27 Aligned_cols=203 Identities=23% Similarity=0.374 Sum_probs=160.6
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|++++++++|+||+++++++..++..++||||+. ++|.+++.+....+++..+..++.|++.||.|||+.|++|+||+
T Consensus 52 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~ 130 (291)
T cd07844 52 REASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLK 130 (291)
T ss_pred HHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCC
Confidence 69999999999999999999999999999999997 49999987765678999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEe
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFS 305 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws 305 (433)
|+||+++.++.++|+|||+++........ .....++..|+|||.+.+ ..++.++||||
T Consensus 131 p~nil~~~~~~~kl~dfg~~~~~~~~~~~---------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~s 189 (291)
T cd07844 131 PQNLLISERGELKLADFGLARAKSVPSKT---------------------YSNEVVTLWYRPPDVLLGSTEYSTSLDMWG 189 (291)
T ss_pred HHHEEEcCCCCEEECccccccccCCCCcc---------------------ccccccccccCCcHHhhcCcccCcHHHHHH
Confidence 99999999999999999998754321110 012346788999999875 45788999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCC---------------CC----------C-----CchhhhccccCCCCc--HHHHHHH
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSP---------------DF----------G-----LDQTDFRNKFCASCP--EPFVRIA 353 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~---------------~~----------~-----~~~~~~~~~~~~~~~--~~l~~li 353 (433)
+|+++|+|++|.++|........ .. . ....... .....++ ..+.+++
T Consensus 190 lG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li 268 (291)
T cd07844 190 VGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLI-NHAPRLDRIPHGEELA 268 (291)
T ss_pred HHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHH-HhCcCCCCchhHHHHH
Confidence 99999999999888754321000 00 0 0000000 0112233 7889999
Q ss_pred HHhcccCCCCCCChhHHHH
Q psy6593 354 FLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 354 ~~~l~~~p~~RPs~~~i~~ 372 (433)
.+||+.+|++||++.+++.
T Consensus 269 ~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 269 LKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHHhccCcccccCHHHHhc
Confidence 9999999999999998874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=266.68 Aligned_cols=203 Identities=19% Similarity=0.316 Sum_probs=163.5
Q ss_pred hccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 144 QNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 144 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
...+|+.+|++++|+||+++++++.. ...++||||+++++|.+++......+++..+..++.||+.||+|||+.||+|+
T Consensus 47 ~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~ 125 (259)
T cd05037 47 AFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHG 125 (259)
T ss_pred HHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecc
Confidence 34478999999999999999999988 77899999999999999998755569999999999999999999999999999
Q ss_pred CCCCcceEEccCC-------ceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-
Q psy6593 224 DLNSQNCLVREDK-------TVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ- 295 (433)
Q Consensus 224 dlkp~Nil~~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~- 295 (433)
||||+||+++.++ .++|+|||++....... ...++..|+|||.+.+.
T Consensus 126 dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------------------------~~~~~~~y~aPE~~~~~~ 180 (259)
T cd05037 126 NVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE-------------------------ERVERIPWIAPECIRNGQ 180 (259)
T ss_pred cCccceEEEecCccccCCceeEEeCCCCccccccccc-------------------------ccccCCCccChhhhcCCC
Confidence 9999999999887 79999999987653311 23456679999998876
Q ss_pred -CCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHH
Q psy6593 296 -EYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVW 373 (433)
Q Consensus 296 -~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~ 373 (433)
.++.++||||||+++|+|++ +.+++............ ......+......+.+++.+||+.+|.+||++.+|++.
T Consensus 181 ~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 257 (259)
T cd05037 181 ASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY---QDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRD 257 (259)
T ss_pred CCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH---hcCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 78999999999999999996 56655443211110000 01111222233789999999999999999999999877
Q ss_pred HH
Q psy6593 374 LE 375 (433)
Q Consensus 374 l~ 375 (433)
|+
T Consensus 258 l~ 259 (259)
T cd05037 258 LN 259 (259)
T ss_pred cC
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=268.80 Aligned_cols=206 Identities=24% Similarity=0.400 Sum_probs=166.2
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.+|+.++++++|+||+++++++..++..++||||+ +++|.+++......+++..++.++.|++.||+|||+.|++|+||
T Consensus 47 ~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 125 (286)
T cd07832 47 LREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDL 125 (286)
T ss_pred HHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCc
Confidence 37999999999999999999999999999999999 99999999765567999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeE
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVF 304 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diw 304 (433)
+|+||+++.++.++|+|||++......... ......++..|+|||.+.+. .++.++|||
T Consensus 126 ~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~--------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 185 (286)
T cd07832 126 KPANLLISADGVLKIADFGLARLFSEEEPR--------------------LYSHQVATRWYRAPELLYGARKYDPGVDLW 185 (286)
T ss_pred CHHHEEEcCCCcEEEeeeeecccccCCCCC--------------------ccccccCcccccCceeeeccccCCchhHHH
Confidence 999999999999999999998866443211 01144688899999998654 468999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCC----------------------------CCCchhhhccccCCCCcHHHHHHHHHh
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPD----------------------------FGLDQTDFRNKFCASCPEPFVRIAFLC 356 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~~~l~~li~~~ 356 (433)
|||+++|+|++|.+++......... ................+..+.+++.+|
T Consensus 186 slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 265 (286)
T cd07832 186 AVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGL 265 (286)
T ss_pred HHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHH
Confidence 9999999999998877543210000 000000000112245678999999999
Q ss_pred cccCCCCCCChhHHHH
Q psy6593 357 CDLNPDQRPPFEVLEV 372 (433)
Q Consensus 357 l~~~p~~RPs~~~i~~ 372 (433)
|+.+|++||++++++.
T Consensus 266 l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 266 LVYDPSKRLSAAEALR 281 (286)
T ss_pred hccChhhCCCHHHHhh
Confidence 9999999999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=270.87 Aligned_cols=235 Identities=22% Similarity=0.312 Sum_probs=195.1
Q ss_pred cccccCCeeeeeccCCCcchhhhh----------------------------ccchHHHHhhcCCcceeeEEEEEEeCCe
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQ----------------------------NCGQVAVLRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~----------------------------~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 172 (433)
.-+..+.+..-+.+|+|+||+|+. +++|..+|.+++.+.||.+--+|.+.+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 344555677778899999999994 3389999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
+++|+..|.||+|.=+|.+.+ ..|++..++-++.+|+.||++||+.+||+|||||+|||+|++|++.|+|+|+|..+..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999988877644 3599999999999999999999999999999999999999999999999999988765
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG 331 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~ 331 (433)
.... ...+||.+|||||++.+..|+...|+|||||++|||+.|..||...........
T Consensus 340 g~~~----------------------~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE 397 (591)
T KOG0986|consen 340 GKPI----------------------RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE 397 (591)
T ss_pred CCcc----------------------ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH
Confidence 4332 255899999999999999999999999999999999999988866433322222
Q ss_pred Cchh--hhccccCCCCcHHHHHHHHHhcccCCCCCCC-----hhHHHH--HHHhh
Q psy6593 332 LDQT--DFRNKFCASCPEPFVRIAFLCCDLNPDQRPP-----FEVLEV--WLEGL 377 (433)
Q Consensus 332 ~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~i~~--~l~~~ 377 (433)
++.. ....+++...+++.++|.+.+|+.||.+|.- +.++.+ +++++
T Consensus 398 vdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 398 VDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred HHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 2222 2233456888999999999999999999964 445542 44443
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=274.70 Aligned_cols=231 Identities=19% Similarity=0.289 Sum_probs=173.0
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
.+|+++|++++|+||+++++.+..+...++||||+.|++|.+++... +..+++..+..++.|++.||+|||+.|++|+|
T Consensus 49 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~d 128 (316)
T cd05574 49 LTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRD 128 (316)
T ss_pred HHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 37999999999999999999999999999999999999999998753 35699999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccch--------hhhhhhcccccceeeeccCccccccceecCCC
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVP--------RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE 296 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 296 (433)
|||+||+++.++.++|+|||++.................. .................||..|+|||++.+..
T Consensus 129 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 208 (316)
T cd05574 129 LKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG 208 (316)
T ss_pred CChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC
Confidence 9999999999999999999998865433221110000000 00000001111222457899999999999988
Q ss_pred CCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCC----hhHHHH
Q psy6593 297 YDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP----FEVLEV 372 (433)
Q Consensus 297 ~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs----~~~i~~ 372 (433)
++.++||||||+++|+|++|..|+...........+.............+..+.+++.+||+.+|++||+ +++++.
T Consensus 209 ~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 209 HGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 9999999999999999999998875433221111111111111112336899999999999999999999 777764
Q ss_pred --HHHh
Q psy6593 373 --WLEG 376 (433)
Q Consensus 373 --~l~~ 376 (433)
||+.
T Consensus 289 ~~~~~~ 294 (316)
T cd05574 289 HPFFRG 294 (316)
T ss_pred Cchhhc
Confidence 5543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=271.34 Aligned_cols=234 Identities=14% Similarity=0.160 Sum_probs=175.6
Q ss_pred CCeeeeeccCCCcchhhhhcc------------------------chH---------------HHHhhcCCcceeeEEEE
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC------------------------GQV---------------AVLRSLHHHNVIRFIGV 166 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~------------------------~E~---------------~~l~~l~h~~iv~~~~~ 166 (433)
+++.+.+.+|+|+||.||++. .|. ..+..++|+||+++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 456777788999999988632 111 22345589999999998
Q ss_pred EEeCC----eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEec
Q psy6593 167 LYKDR----KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVAD 242 (433)
Q Consensus 167 ~~~~~----~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D 242 (433)
+.... ..++++|++ ..++.+++... ..+++..+..++.|++.||+|||+.+|+||||||+|||++.++.++|+|
T Consensus 92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKL-VENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeEecCCceEEEEEEehh-ccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 76543 457888987 45787777653 2367888999999999999999999999999999999999999999999
Q ss_pred cccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCC
Q psy6593 243 FGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPD 322 (433)
Q Consensus 243 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~ 322 (433)
||+++.+......... .........||+.|+|||++.+..++.++||||||+++|||++|.+||..
T Consensus 170 FGla~~~~~~~~~~~~--------------~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~ 235 (294)
T PHA02882 170 YGIASHFIIHGKHIEY--------------SKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG 235 (294)
T ss_pred cCCceeeccCCccccc--------------ccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence 9999876432211100 00111235699999999999999999999999999999999999999876
Q ss_pred CCCCCCCCCCchhhhc------cccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHH
Q psy6593 323 YLPRSPDFGLDQTDFR------NKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375 (433)
Q Consensus 323 ~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 375 (433)
..............+. .......|+.+.+++..|++.+|++||++.+|++.|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 236 FGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred cccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 5322211111111111 1123566899999999999999999999999998763
|
|
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=306.91 Aligned_cols=225 Identities=22% Similarity=0.332 Sum_probs=186.9
Q ss_pred eeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCC
Q psy6593 130 FCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAG 182 (433)
Q Consensus 130 ~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 182 (433)
+..+++.|.||.||.+. +|..+|..|+|||+|+++|+=.+.+..+|.||||+|
T Consensus 1239 rg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~ 1318 (1509)
T KOG4645|consen 1239 RGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEG 1318 (1509)
T ss_pred cccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhcc
Confidence 34478899999999632 799999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcccccc
Q psy6593 183 GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAK 262 (433)
Q Consensus 183 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 262 (433)
|+|.++++. ++..++.....+..|++.||.|||+.|||||||||+||+++.+|.+|++|||.|..+.......
T Consensus 1319 GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~------ 1391 (1509)
T KOG4645|consen 1319 GSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM------ 1391 (1509)
T ss_pred CcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC------
Confidence 999999976 3346777778889999999999999999999999999999999999999999999886652111
Q ss_pred chhhhhhhcccccceeeeccCccccccceecC---CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhcc
Q psy6593 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG---QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRN 339 (433)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (433)
........||+.|||||++.+ .....++|||||||++.||+||+.||......-.......-.-.+
T Consensus 1392 -----------~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P 1460 (1509)
T KOG4645|consen 1392 -----------PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP 1460 (1509)
T ss_pred -----------CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC
Confidence 112237789999999999987 346779999999999999999999887764433222222333445
Q ss_pred ccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 340 KFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 340 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
.+|..++++-+++|.+||..||..|.++.||++
T Consensus 1461 q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1461 QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 567778999999999999999999988877764
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=268.41 Aligned_cols=204 Identities=25% Similarity=0.423 Sum_probs=163.9
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++++++|+||+++++++..++..++||||+++++|..++.... .+++..++.++.|++.||.|||+.|++|+|||
T Consensus 49 ~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~ 127 (286)
T cd07847 49 REIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVK 127 (286)
T ss_pred HHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 79999999999999999999999999999999999988888776543 59999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEe
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFS 305 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws 305 (433)
|+||+++.++.++|+|||++......... .....++..|+|||.+.+ ..++.++||||
T Consensus 128 p~nil~~~~~~~~l~dfg~~~~~~~~~~~---------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s 186 (286)
T cd07847 128 PENILITKQGQIKLCDFGFARILTGPGDD---------------------YTDYVATRWYRAPELLVGDTQYGPPVDVWA 186 (286)
T ss_pred hhhEEEcCCCcEEECccccceecCCCccc---------------------ccCcccccccCCHHHHhCCCCcCchhhhHH
Confidence 99999999999999999999876432211 113457788999999876 45788999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCC------------------------chhh-----hccccCCCCcHHHHHHHHHh
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGL------------------------DQTD-----FRNKFCASCPEPFVRIAFLC 356 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~------------------------~~~~-----~~~~~~~~~~~~l~~li~~~ 356 (433)
||+++|+|++|.+||...........+ .... ........++..+.+++.+|
T Consensus 187 lG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 266 (286)
T cd07847 187 IGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGC 266 (286)
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHH
Confidence 999999999999888643321100000 0000 00011245678899999999
Q ss_pred cccCCCCCCChhHHHH
Q psy6593 357 CDLNPDQRPPFEVLEV 372 (433)
Q Consensus 357 l~~~p~~RPs~~~i~~ 372 (433)
|+.+|++||++.+++.
T Consensus 267 l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 267 LQMDPTERLSCEELLE 282 (286)
T ss_pred hcCCccccCCHHHHhc
Confidence 9999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=271.44 Aligned_cols=205 Identities=25% Similarity=0.343 Sum_probs=160.7
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.+|++++++++|+||+++++++.+....++|+||++ ++|.+++...+..+++..++.++.||+.||.|||+.|++|+||
T Consensus 47 ~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl 125 (284)
T cd07839 47 LREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDL 125 (284)
T ss_pred hHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCC
Confidence 369999999999999999999999999999999996 5888888765567999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeE
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVF 304 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diw 304 (433)
||+||+++.++.++|+|||+++........ .....+++.|+|||.+.+. .++.++|||
T Consensus 126 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Diw 184 (284)
T cd07839 126 KPQNLLINKNGELKLADFGLARAFGIPVRC---------------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMW 184 (284)
T ss_pred CHHHEEEcCCCcEEECccchhhccCCCCCC---------------------cCCCccccCCcChHHHhCCcccCcHHHHH
Confidence 999999999999999999998765332111 0134568889999998764 468999999
Q ss_pred ehhHHHHHHhcCCCC-CCCCCCCCC-----------------------CC----CCchhhhccccCCCCcHHHHHHHHHh
Q psy6593 305 SYGIVLCEIIGRVPA-DPDYLPRSP-----------------------DF----GLDQTDFRNKFCASCPEPFVRIAFLC 356 (433)
Q Consensus 305 slG~il~ell~~~~~-~~~~~~~~~-----------------------~~----~~~~~~~~~~~~~~~~~~l~~li~~~ 356 (433)
|||+++|+|++|..| +........ .. ..............+++++.+++.+|
T Consensus 185 slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 264 (284)
T cd07839 185 SAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNL 264 (284)
T ss_pred HHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHH
Confidence 999999999965544 432211000 00 00000000111245678999999999
Q ss_pred cccCCCCCCChhHHHH
Q psy6593 357 CDLNPDQRPPFEVLEV 372 (433)
Q Consensus 357 l~~~p~~RPs~~~i~~ 372 (433)
|+.||.+|||+++++.
T Consensus 265 l~~~P~~R~t~~~il~ 280 (284)
T cd07839 265 LVCNPVQRISAEEALQ 280 (284)
T ss_pred hcCChhhcCCHHHHhc
Confidence 9999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=272.01 Aligned_cols=198 Identities=24% Similarity=0.417 Sum_probs=166.4
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+++|++++||||+++++++..++..++||||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+
T Consensus 50 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~ 128 (290)
T cd05580 50 NEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLK 128 (290)
T ss_pred HHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC
Confidence 6899999999999999999999999999999999999999999765 459999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|.||+++.++.++|+|||++....... ....+++.|+|||.+.+...+.++|||||
T Consensus 129 p~nili~~~~~~kl~dfg~~~~~~~~~------------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 184 (290)
T cd05580 129 PENLLLDSDGYIKITDFGFAKRVKGRT------------------------YTLCGTPEYLAPEIILSKGYGKAVDWWAL 184 (290)
T ss_pred HHHEEECCCCCEEEeeCCCccccCCCC------------------------CCCCCCccccChhhhcCCCCCccccHHHH
Confidence 999999999999999999987654321 14468889999999988888999999999
Q ss_pred hHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHH
Q psy6593 307 GIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLE 371 (433)
Q Consensus 307 G~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~ 371 (433)
|+++|+|++|.+|+........... .......++..++..+.+++.+||+.+|.+|+ ++++++
T Consensus 185 G~il~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 185 GILIYEMLAGYPPFFDDNPIQIYEK--ILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHH--HhcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 9999999999988754331111000 11112234566789999999999999999998 555555
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=269.89 Aligned_cols=209 Identities=27% Similarity=0.470 Sum_probs=171.3
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++++++||||+++++++..++..|+|+||+++++|.+++.+ ..+++..+..++.|++.||.+||+.|++|+||+
T Consensus 65 ~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~ 142 (293)
T cd06647 65 NEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 142 (293)
T ss_pred HHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCC
Confidence 689999999999999999999999999999999999999999976 358899999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.++|+|||++......... .....+++.|++||.+.+..++.++|||||
T Consensus 143 p~Nili~~~~~~kL~dfg~~~~~~~~~~~---------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl 201 (293)
T cd06647 143 SDNILLGMDGSVKLTDFGFCAQITPEQSK---------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201 (293)
T ss_pred HHHEEEcCCCCEEEccCcceecccccccc---------------------cccccCChhhcCchhhccCCCCchhhHHHH
Confidence 99999999999999999988755332211 113468889999999988889999999999
Q ss_pred hHHHHHHhcCCCCCCCCCCCCCCCCCch-hhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhc
Q psy6593 307 GIVLCEIIGRVPADPDYLPRSPDFGLDQ-TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 307 G~il~ell~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
|+++|++++|.+||.............. .......+..++..+.+++.+||+.+|++||++++++ .|++...
T Consensus 202 G~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 202 GIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 9999999999998865433222111111 1111112345678899999999999999999999998 4776544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=254.06 Aligned_cols=210 Identities=24% Similarity=0.394 Sum_probs=174.6
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeC----CeeeEEEeccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCc
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKD----RKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNL 220 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~----~~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i 220 (433)
+|+++--.. .|+|||.+++++... +.+.+|||.++||.|.+.+++.+ +.|++.++..|++||..|+.|||+.+|
T Consensus 103 rEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nI 182 (400)
T KOG0604|consen 103 REVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNI 182 (400)
T ss_pred hHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcch
Confidence 888876666 599999999998643 45889999999999999998754 469999999999999999999999999
Q ss_pred cccCCCCcceEEc---cCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCC
Q psy6593 221 IHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY 297 (433)
Q Consensus 221 ~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 297 (433)
.||||||+|+|.+ .+-.+||+|||+|+........ .+-+-||+|.|||++....|
T Consensus 183 AHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L----------------------~TPc~TPyYvaPevlg~eKy 240 (400)
T KOG0604|consen 183 AHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDL----------------------MTPCFTPYYVAPEVLGPEKY 240 (400)
T ss_pred hhccCChhheeeecCCCCcceEecccccccccCCCccc----------------------cCCcccccccCHHHhCchhc
Confidence 9999999999997 4567999999999976532221 14567999999999999999
Q ss_pred CcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh------hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 298 DETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD------FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 298 ~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
+...|+||+|+++|-|+.|.|||...........+..+. +....+..+++..+++|+.+|..+|.+|.+++++.
T Consensus 241 dkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m 320 (400)
T KOG0604|consen 241 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVM 320 (400)
T ss_pred CCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhh
Confidence 999999999999999999999997766544444444332 22233467788999999999999999999999998
Q ss_pred --HHHHhhc
Q psy6593 372 --VWLEGLS 378 (433)
Q Consensus 372 --~~l~~~~ 378 (433)
.|+....
T Consensus 321 ~hpwi~~~~ 329 (400)
T KOG0604|consen 321 DHPWINQYE 329 (400)
T ss_pred cCchhcccc
Confidence 4777644
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=259.49 Aligned_cols=226 Identities=26% Similarity=0.387 Sum_probs=177.6
Q ss_pred eeeeeccCCCcchhhhh-------------------------------ccchHHHHhhcCCcceeeEEEEEEe-CCeeeE
Q psy6593 128 LLFCKEDYNGKYGEACQ-------------------------------NCGQVAVLRSLHHHNVIRFIGVLYK-DRKLNL 175 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~-------------------------------~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l 175 (433)
+..+.++++|.||.||+ +|+|+.+++.|+||||+.+..+|.. +..+++
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 55666778888888886 3489999999999999999999987 788999
Q ss_pred EEeccCCCCHHHHhcC----CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccC----CceEEeccccch
Q psy6593 176 VTEYIAGGTLKELLQD----PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRED----KTVVVADFGLAR 247 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~----~~~kl~Dfg~~~ 247 (433)
++||.+. +|+++++- ..+.++...+..|+.||++|+.|||+.-|+||||||.|||+..+ |.|||+|||+++
T Consensus 106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR 184 (438)
T KOG0666|consen 106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLAR 184 (438)
T ss_pred Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHH
Confidence 9999976 99999853 23469999999999999999999999999999999999999866 999999999999
Q ss_pred hccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCC
Q psy6593 248 IIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~ 326 (433)
.+...-.... .....+-|.+|+|||.+.+ ..|+++.|||++|||+.||+|-.|.|......
T Consensus 185 ~~~~plkpl~------------------s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k 246 (438)
T KOG0666|consen 185 LFNNPLKPLA------------------SLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEK 246 (438)
T ss_pred Hhhccccccc------------------cCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhh
Confidence 8876432211 1115678999999999988 57999999999999999999998877543211
Q ss_pred CCCC---C-----------------------------CchhhhccccC------------CCCcHHHHHHHHHhcccCCC
Q psy6593 327 SPDF---G-----------------------------LDQTDFRNKFC------------ASCPEPFVRIAFLCCDLNPD 362 (433)
Q Consensus 327 ~~~~---~-----------------------------~~~~~~~~~~~------------~~~~~~l~~li~~~l~~~p~ 362 (433)
.... . .....++.... ..-++...+|+.++|++||-
T Consensus 247 ~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~ 326 (438)
T KOG0666|consen 247 IKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPI 326 (438)
T ss_pred cccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCch
Confidence 1110 0 00001111111 11234478999999999999
Q ss_pred CCCChhHHHH
Q psy6593 363 QRPPFEVLEV 372 (433)
Q Consensus 363 ~RPs~~~i~~ 372 (433)
+|.++++.++
T Consensus 327 kRIta~qAle 336 (438)
T KOG0666|consen 327 KRITAEQALE 336 (438)
T ss_pred hhccHHHHhc
Confidence 9999999875
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=269.70 Aligned_cols=213 Identities=28% Similarity=0.512 Sum_probs=169.7
Q ss_pred chHHHHhhcCCcceeeEEEEEEe--CCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
+|++++++++|+||+++++++.. ....++||||+++++|.+++......+++..+..++.|++.||++||+.|++|+|
T Consensus 55 ~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~d 134 (284)
T cd05038 55 REIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRD 134 (284)
T ss_pred HHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 79999999999999999999887 5579999999999999999987655699999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|||+||+++.++.++|+|||++............ .....++..|++||.+.+..++.++|||
T Consensus 135 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~------------------~~~~~~~~~~~~Pe~~~~~~~~~~~Di~ 196 (284)
T cd05038 135 LAARNILVESEDLVKISDFGLAKVLPEDKDYYYV------------------KEPGESPIFWYAPECLRTSKFSSASDVW 196 (284)
T ss_pred CCHHhEEEcCCCCEEEcccccccccccCCcceec------------------cCCCCCcccccCcHHHccCCCCcccchH
Confidence 9999999999999999999999876532211000 0012345569999999888899999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCC-------C-C------chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDF-------G-L------DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~-------~-~------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i 370 (433)
|||+++|||++|..++.......... . . .........+..++.++.+++.+||+.+|.+||++.+|
T Consensus 197 slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei 276 (284)
T cd05038 197 SFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276 (284)
T ss_pred HHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHH
Confidence 99999999998877654321111000 0 0 00011112235667899999999999999999999999
Q ss_pred HHHHHhh
Q psy6593 371 EVWLEGL 377 (433)
Q Consensus 371 ~~~l~~~ 377 (433)
+++|+++
T Consensus 277 ~~~l~~i 283 (284)
T cd05038 277 ILIVDRL 283 (284)
T ss_pred HHHHhhc
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=271.53 Aligned_cols=211 Identities=21% Similarity=0.333 Sum_probs=169.5
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC--CCCCChHHHHHHHHHHHHHHhhhhc-CCcc
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP--GQPLPWGQRVNFARDIAAGMTYLHS-MNLI 221 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~ 221 (433)
..+|+.++++++|+||+++++.+..++..++||||+++++|.+++... ...+++..+..++.|++.||.|||+ .|++
T Consensus 46 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~ 125 (286)
T cd06622 46 IIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNII 125 (286)
T ss_pred HHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEe
Confidence 347999999999999999999999999999999999999999988763 2369999999999999999999996 5999
Q ss_pred ccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC------
Q psy6593 222 HRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ------ 295 (433)
Q Consensus 222 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------ 295 (433)
|+||+|+||+++.++.++|+|||++........ ....+++.|+|||.+.+.
T Consensus 126 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-----------------------~~~~~~~~y~aPE~~~~~~~~~~~ 182 (286)
T cd06622 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA-----------------------KTNIGCQSYMAPERIKSGGPNQNP 182 (286)
T ss_pred eCCCCHHHEEECCCCCEEEeecCCcccccCCcc-----------------------ccCCCccCccCcchhcCCCCCccC
Confidence 999999999999999999999999876532211 134578889999998653
Q ss_pred CCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC--chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH-
Q psy6593 296 EYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL--DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV- 372 (433)
Q Consensus 296 ~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~- 372 (433)
.++.++||||||+++|+|++|..||............ .........+..++.++.+++.+||+.+|++||++++++.
T Consensus 183 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 183 TYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 3478999999999999999998887543221111000 0011122344567899999999999999999999999984
Q ss_pred -HHHhhc
Q psy6593 373 -WLEGLS 378 (433)
Q Consensus 373 -~l~~~~ 378 (433)
|+....
T Consensus 263 ~~~~~~~ 269 (286)
T cd06622 263 PWLVKYK 269 (286)
T ss_pred hhhhhcc
Confidence 666543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=275.45 Aligned_cols=217 Identities=19% Similarity=0.332 Sum_probs=165.5
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+++++.++||||+++++++..++..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.||+||||
T Consensus 48 ~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dl 127 (327)
T cd08227 48 GELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSV 127 (327)
T ss_pred HHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCC
Confidence 6999999999999999999999999999999999999999998653 345899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC--CCCCcccCe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG--QEYDETVDV 303 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di 303 (433)
||+||+++.++.+++.||+.............. .........++..|+|||++.+ ..++.++||
T Consensus 128 kp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di 193 (327)
T cd08227 128 KASHILISVDGKVYLSGLRSNLSMINHGQRLRV--------------VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI 193 (327)
T ss_pred ChhhEEEecCCcEEEcccchhhccccccccccc--------------cccccccccceecccChHHhhcccCCCCchhhH
Confidence 999999999999999999876543221110000 0000012346778999999876 458899999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCC---------------------Cch-----------------------hhhcc
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFG---------------------LDQ-----------------------TDFRN 339 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~---------------------~~~-----------------------~~~~~ 339 (433)
||||+++|||++|.+||........... +.. .....
T Consensus 194 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (327)
T cd08227 194 YSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSH 273 (327)
T ss_pred HHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCccc
Confidence 9999999999999988754211000000 000 00000
Q ss_pred ccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 340 KFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 340 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
.....+++.+.+++.+||+.||++|||++++++ ||+.+
T Consensus 274 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 274 PYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred ccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 111345678999999999999999999999985 77654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=274.31 Aligned_cols=222 Identities=27% Similarity=0.450 Sum_probs=176.0
Q ss_pred eeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccC
Q psy6593 129 LFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIA 181 (433)
Q Consensus 129 ~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 181 (433)
.+.+.+++|+||+|++.. +|+.++++++|+||+++++++...+..++|||+++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 455677788888887622 48999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccc
Q psy6593 182 GGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA 261 (433)
Q Consensus 182 g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 261 (433)
+++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~------- 153 (260)
T PF00069_consen 82 GGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE------- 153 (260)
T ss_dssp TEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS-------
T ss_pred cccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------
Confidence 8899999983 24699999999999999999999999999999999999999999999999999875411111
Q ss_pred cchhhhhhhcccccceeeeccCccccccceec-CCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh---hh
Q psy6593 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT-GQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT---DF 337 (433)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~---~~ 337 (433)
......++..|+|||.+. +...+.++||||||+++|+|++|..|+............... ..
T Consensus 154 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~ 219 (260)
T PF00069_consen 154 --------------NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL 219 (260)
T ss_dssp --------------EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH
T ss_pred --------------ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc
Confidence 111456889999999998 788999999999999999999888776543000000000000 00
Q ss_pred ccccC--CCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 338 RNKFC--ASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 338 ~~~~~--~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
..... ...+..+.+++.+||+.||++||+++++++
T Consensus 220 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 220 PSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111 223489999999999999999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=271.68 Aligned_cols=223 Identities=22% Similarity=0.263 Sum_probs=168.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+++++.++|+||+++++.+..++..++||||++|++|.+++...+ .+++..+..++.|++.||.|||+.|++|+|||
T Consensus 50 ~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 128 (305)
T cd05609 50 VERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNYGIVHRDLK 128 (305)
T ss_pred HHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCc
Confidence 78999999999999999999999999999999999999999997654 58999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.++|+|||+++............ ..... ...........++..|+|||.+.+..++.++|||||
T Consensus 129 p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 202 (305)
T cd05609 129 PDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE-GHIEK-----DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAM 202 (305)
T ss_pred hHHEEECCCCCEEEeeCCCccccCcCccccccc-ccccc-----chhhccccCCccCccccCchhccCCCCCchhhHHHH
Confidence 999999999999999999987422111110000 00000 000001113457889999999988889999999999
Q ss_pred hHHHHHHhcCCCCCCCCCCCCCCCCCchhhh-ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHh
Q psy6593 307 GIVLCEIIGRVPADPDYLPRSPDFGLDQTDF-RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376 (433)
Q Consensus 307 G~il~ell~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 376 (433)
|+++|+|++|..|+................. .......+|.++.+++.+||+.+|++||+..++.+.|+.
T Consensus 203 G~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 203 GIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 9999999999888754322111111000000 011113578899999999999999999998777776665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=267.12 Aligned_cols=208 Identities=27% Similarity=0.496 Sum_probs=165.4
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeC--CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccc
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 222 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H 222 (433)
..+|+.++++++|+||+++++++... ...++++||+++++|.+++.+.+ .+++..++.++.|++.||++||+.+++|
T Consensus 51 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~i~H 129 (266)
T cd06651 51 LECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNMIVH 129 (266)
T ss_pred HHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 44799999999999999999998753 57889999999999999987643 4899999999999999999999999999
Q ss_pred cCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccC
Q psy6593 223 RDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVD 302 (433)
Q Consensus 223 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 302 (433)
+||+|+||+++.++.++|+|||++........... ......++..|+|||.+.+..++.++|
T Consensus 130 ~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~D 191 (266)
T cd06651 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGT------------------GIRSVTGTPYWMSPEVISGEGYGRKAD 191 (266)
T ss_pred CCCCHHHEEECCCCCEEEccCCCccccccccccCC------------------ccccCCccccccCHHHhCCCCCCchhh
Confidence 99999999999999999999999876532111100 011345788999999999888999999
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
|||||+++|+|++|.+|+....................++..+++.+.+++ +||..+|++||++++|++
T Consensus 192 v~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 192 VWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred hHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 999999999999999988654322211111111122333455678888888 677789999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=273.63 Aligned_cols=205 Identities=26% Similarity=0.431 Sum_probs=167.8
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..+|+.+++.++||||+++++++..++..++||||+++++|.+++.. ..+++..++.++.|++.||.+||+.|++|+|
T Consensus 65 ~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~d 142 (297)
T cd06659 65 LFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRD 142 (297)
T ss_pred HHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 34799999999999999999999999999999999999999998865 4589999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|||
T Consensus 143 l~p~Nill~~~~~~kL~dfg~~~~~~~~~~---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 201 (297)
T cd06659 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVP---------------------KRKSLVGTPYWMAPEVISRTPYGTEVDIW 201 (297)
T ss_pred CCHHHeEEccCCcEEEeechhHhhcccccc---------------------cccceecCccccCHHHHccCCCCchhhHH
Confidence 999999999999999999999875432211 11145688999999999988899999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCchh-hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLDQT-DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
|||+++|+|++|.+|+....+......+... .........++..+.+++.+||+.+|.+||++++|++
T Consensus 202 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 202 SLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 9999999999998887543221111000000 0011122456789999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=265.71 Aligned_cols=209 Identities=31% Similarity=0.519 Sum_probs=169.8
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCC-CChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP-LPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~-~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
..+|+.++++++|+||+++++++.+.+..+++|||+++++|.+++...... +++..+..++.|++.||++||+.|++|+
T Consensus 48 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~ 127 (258)
T smart00219 48 FLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHR 127 (258)
T ss_pred HHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeec
Confidence 337999999999999999999999999999999999999999999764433 8999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
||+|+||++++++.++|+|||++............ ...+++.|+|||.+.+..++.++||
T Consensus 128 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~--------------------~~~~~~~y~~Pe~~~~~~~~~~~Di 187 (258)
T smart00219 128 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK--------------------GGKLPIRWMAPESLKDGKFTSKSDV 187 (258)
T ss_pred ccccceEEEccCCeEEEcccCCceecccccccccc--------------------cCCCcccccChHHhccCCCCcchhH
Confidence 99999999999999999999999876543221100 1226778999999988889999999
Q ss_pred EehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHH
Q psy6593 304 FSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWL 374 (433)
Q Consensus 304 wslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 374 (433)
||||+++|+|++ |.+|+........... .........+...+.++.+++.+||+.+|++||++.+++++|
T Consensus 188 ~slG~i~~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 188 WSFGVLLWEIFTLGESPYPGMSNEEVLEY-LKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 999999999996 7777654221111000 111112233455789999999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=265.40 Aligned_cols=206 Identities=23% Similarity=0.411 Sum_probs=169.0
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
..+|+.++++++|+||+++++++...+..++||||+++++|.+++... ...+++..++.++.|++.||.+||+.|++|+
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~ 125 (256)
T cd08218 46 SRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHR 125 (256)
T ss_pred HHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 447999999999999999999999999999999999999999998653 3358999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
||+|+||+++.++.++|+|||++......... .....|++.|+|||.+.+..++.++|+
T Consensus 126 ~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---------------------~~~~~~~~~~~~pe~~~~~~~~~~~Dv 184 (256)
T cd08218 126 DIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL---------------------ARTCIGTPYYLSPEICENRPYNNKSDI 184 (256)
T ss_pred CCCHHHEEEcCCCCEEEeeccceeecCcchhh---------------------hhhccCCccccCHHHhCCCCCCCccch
Confidence 99999999999999999999998765332110 113457888999999998889999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
||||+++++|++|.+++............ ........+..++.++.+++.+||+.+|++||++.+|++
T Consensus 185 ~slG~i~~~l~~g~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 185 WALGCVLYEMCTLKHAFEAGNMKNLVLKI-IRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred hHHHHHHHHHHcCCCCccCCCHHHHHHHH-hcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 99999999999998887543211110000 011112234667889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=265.77 Aligned_cols=204 Identities=27% Similarity=0.472 Sum_probs=170.2
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.+|++++++++|+||+++++++..+...++|+||+++++|.+++.+.+ .+++..+..++.|++.||++||+.|++|+||
T Consensus 50 ~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 128 (258)
T cd06632 50 EQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTVHRDI 128 (258)
T ss_pred HHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 379999999999999999999999999999999999999999997654 5899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC-CCcccCeE
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE-YDETVDVF 304 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Diw 304 (433)
+|+||+++.++.++|+|||++........ .....++..|++||.+.... ++.++|+|
T Consensus 129 ~~~ni~~~~~~~~kl~d~~~~~~~~~~~~----------------------~~~~~~~~~y~~pe~~~~~~~~~~~~D~~ 186 (258)
T cd06632 129 KGANILVDTNGVVKLADFGMAKQVVEFSF----------------------AKSFKGSPYWMAPEVIAQQGGYGLAADIW 186 (258)
T ss_pred CHHHEEECCCCCEEEccCccceecccccc----------------------ccccCCCcceeCHHHhcCCCCCCchhhhH
Confidence 99999999999999999999876543221 01456788899999987766 89999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
|||+++|+|++|.+|+....................++..++..+.+++.+||+.+|++||++++++.
T Consensus 187 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 187 SLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 99999999999999886543222111111112223345677899999999999999999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=265.84 Aligned_cols=206 Identities=28% Similarity=0.532 Sum_probs=168.6
Q ss_pred chHHHHhhcC---CcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 147 GQVAVLRSLH---HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 147 ~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
+|++++++++ |+||+++++++..+...++||||++|++|.++++. ..+++..++.++.|++.||.+||+.|++|+
T Consensus 48 ~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~ 125 (277)
T cd06917 48 REVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHR 125 (277)
T ss_pred HHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 6889999996 99999999999999999999999999999999876 368999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccC
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVD 302 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D 302 (433)
||+|+||+++.++.++|+|||++......... .....|+..|+|||.+.+ ..++.++|
T Consensus 126 dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~D 184 (277)
T cd06917 126 DIKAANILVTNTGNVKLCDFGVAALLNQNSSK---------------------RSTFVGTPYWMAPEVITEGKYYDTKAD 184 (277)
T ss_pred CcCHHHEEEcCCCCEEEccCCceeecCCCccc---------------------cccccCCcceeCHHHhccCCccccchh
Confidence 99999999999999999999998766443211 114468889999998865 45688999
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccC-CCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFC-ASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
+||||+++|+|++|.+|+............... ....+. ...+.++.+++.+||+.+|++||++.+++. |+++
T Consensus 185 v~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 185 IWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred HHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence 999999999999999988654332221111111 111222 237889999999999999999999999984 6654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=268.12 Aligned_cols=205 Identities=31% Similarity=0.484 Sum_probs=162.5
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeCC------eeeEEEeccCCCCHHHHhcCC---CCCCChHHHHHHHHHHHHHHhhhh
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKDR------KLNLVTEYIAGGTLKELLQDP---GQPLPWGQRVNFARDIAAGMTYLH 216 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~~------~~~lv~e~~~g~sL~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH 216 (433)
+|+.+++++ +|+||+++++++.... .+++||||+++++|.+++... +..+++..+..++.|++.||.|||
T Consensus 51 ~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH 130 (275)
T cd06608 51 EEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130 (275)
T ss_pred HHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 799999999 7999999999997644 489999999999999988642 357999999999999999999999
Q ss_pred cCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC--
Q psy6593 217 SMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-- 294 (433)
Q Consensus 217 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 294 (433)
+.|++|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+..
T Consensus 131 ~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~ 189 (275)
T cd06608 131 ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR---------------------RNTFIGTPYWMAPEVIACDE 189 (275)
T ss_pred cCCcccCCCCHHHEEEccCCeEEECCCccceecccchhh---------------------hcCccccccccCHhHhcccc
Confidence 999999999999999999999999999998765332111 114468889999998754
Q ss_pred ---CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhh-ccccCCCCcHHHHHHHHHhcccCCCCCCChhHH
Q psy6593 295 ---QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDF-RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370 (433)
Q Consensus 295 ---~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i 370 (433)
..++.++||||||+++|+|++|.+|+...........+..... .......++..+.+++.+||+.||++||++++|
T Consensus 190 ~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~l 269 (275)
T cd06608 190 QPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEEL 269 (275)
T ss_pred cccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 3467889999999999999999998864322211111111100 011123467899999999999999999999998
Q ss_pred HH
Q psy6593 371 EV 372 (433)
Q Consensus 371 ~~ 372 (433)
++
T Consensus 270 l~ 271 (275)
T cd06608 270 LE 271 (275)
T ss_pred hc
Confidence 74
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=271.20 Aligned_cols=203 Identities=22% Similarity=0.354 Sum_probs=166.1
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhc-CCccccCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~dl 225 (433)
+|+++++.++|+||+++++++...+.+++||||+++++|.+++.+. +.+++..+..++.+++.||.|||+ .+++|+||
T Consensus 52 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl 130 (284)
T cd06620 52 RELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDI 130 (284)
T ss_pred HHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCC
Confidence 7999999999999999999999999999999999999999998764 358999999999999999999997 58999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
+|+||+++.++.++|+|||++........ ....|+..|+|||++.+..++.++||||
T Consensus 131 ~p~nil~~~~~~~~l~d~gl~~~~~~~~~-----------------------~~~~~~~~~~aPE~~~~~~~~~~~Di~s 187 (284)
T cd06620 131 KPSNILVNSRGQIKLCDFGVSGELINSIA-----------------------DTFVGTSTYMSPERIQGGKYTVKSDVWS 187 (284)
T ss_pred CHHHEEECCCCcEEEccCCcccchhhhcc-----------------------CccccCcccCCHHHHccCCCCccchHHH
Confidence 99999999999999999998765422111 1346888999999998888999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCC-------CCchhh---hccccC-CCCcHHHHHHHHHhcccCCCCCCChhHHHHH
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDF-------GLDQTD---FRNKFC-ASCPEPFVRIAFLCCDLNPDQRPPFEVLEVW 373 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~-------~~~~~~---~~~~~~-~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~ 373 (433)
||+++|+|++|.+||.......... ...... ....++ ..++..+.+++.+||+.||++||+++++++.
T Consensus 188 lG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 188 LGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred HHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 9999999999988886533211000 000000 011122 2377889999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=263.28 Aligned_cols=210 Identities=30% Similarity=0.492 Sum_probs=170.1
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC--CCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP--GQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
.+|+++|+.++|+||+++++.+..++..++|||++++++|.++++.. ...+++..+..++.|++.||++||+.|++|+
T Consensus 47 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~ 126 (267)
T cd06610 47 RKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHR 126 (267)
T ss_pred HHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 37999999999999999999999999999999999999999999753 2468999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccC
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVD 302 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~D 302 (433)
||+|+||++++++.++|+|||++........... .......|+..|+|||.+... .++.++|
T Consensus 127 ~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~-----------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~D 189 (267)
T cd06610 127 DIKAGNILLGEDGSVKIADFGVSASLADGGDRTR-----------------KVRKTFVGTPCWMAPEVMEQVHGYDFKAD 189 (267)
T ss_pred CCCHHhEEEcCCCCEEEcccchHHHhccCccccc-----------------cccccccCChhhcChHHHccccCcCcccc
Confidence 9999999999999999999999987654322110 111245688999999998776 7889999
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh---hccc-cCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD---FRNK-FCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
+||||+++|+|++|.+|+................ .... ....++..+.+++.+||+.||++||++++|++
T Consensus 190 v~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 190 IWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred hHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 9999999999999999886543322111111110 0000 01366789999999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=269.49 Aligned_cols=209 Identities=25% Similarity=0.377 Sum_probs=167.0
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.+|++++++++|+||+++++++.+++..++||||+ +++|.+++......+++..++.++.||+.||.|||+.|++|+||
T Consensus 50 ~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl 128 (298)
T cd07841 50 LREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDL 128 (298)
T ss_pred HHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCC
Confidence 36999999999999999999999999999999999 88999999875546999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeE
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVF 304 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw 304 (433)
+|+||+++.++.++|+|||++......... .....+++.|+|||.+.+ ..++.++|||
T Consensus 129 ~p~nill~~~~~~~l~dfg~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~ 187 (298)
T cd07841 129 KPNNLLIASDGVLKLADFGLARSFGSPNRK---------------------MTHQVVTRWYRAPELLFGARHYGVGVDMW 187 (298)
T ss_pred ChhhEEEcCCCCEEEccceeeeeccCCCcc---------------------ccccccceeeeCHHHHhCCCCCCcHHHHH
Confidence 999999999999999999999876442211 113356788999998865 4578899999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCC------------------C---c-----hhhhccccCCCCcHHHHHHHHHhcc
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFG------------------L---D-----QTDFRNKFCASCPEPFVRIAFLCCD 358 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~------------------~---~-----~~~~~~~~~~~~~~~l~~li~~~l~ 358 (433)
|||+++|+|++|.+++........... . . ............+..+.+++.+||+
T Consensus 188 slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 267 (298)
T cd07841 188 SVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLT 267 (298)
T ss_pred HHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhc
Confidence 999999999999887754322100000 0 0 0000011124457889999999999
Q ss_pred cCCCCCCChhHHHH--HHHh
Q psy6593 359 LNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 359 ~~p~~RPs~~~i~~--~l~~ 376 (433)
.+|++||++++++. ||++
T Consensus 268 ~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 268 LNPNKRITARQALEHPYFSN 287 (298)
T ss_pred CCcccCcCHHHHhhCccccC
Confidence 99999999999984 5665
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=265.18 Aligned_cols=209 Identities=22% Similarity=0.393 Sum_probs=172.4
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.+|+.++++++|+||+++++.+.+++..++||||+++++|.+++.+.. .+++..+..++.|++.||++||+.|++|+||
T Consensus 41 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl 119 (262)
T cd05572 41 FSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG-LFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119 (262)
T ss_pred HHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCC
Confidence 379999999999999999999999999999999999999999997643 4899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
+|+||+++.++.++|+|||++........ .....+++.|++||.+.+..++.++|+||
T Consensus 120 ~~~nilv~~~~~~~l~df~~~~~~~~~~~----------------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s 177 (262)
T cd05572 120 KPENLLLDSNGYVKLVDFGFAKKLKSGQK----------------------TWTFCGTPEYVAPEIILNKGYDFSVDYWS 177 (262)
T ss_pred CHHHEEEcCCCCEEEeeCCcccccCcccc----------------------cccccCCcCccChhHhcCCCCCChhhhhh
Confidence 99999999999999999999887643210 11446788999999998888999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCC--CCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCC-----hhHHHH--HHHh
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRS--PDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP-----FEVLEV--WLEG 376 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~i~~--~l~~ 376 (433)
||+++|+|++|.+|+....... ....+.........+...++.+.+++.+||+.+|++||+ ++++++ |+++
T Consensus 178 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 178 LGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 9999999999998886543211 001111111223344556889999999999999999999 788874 7665
Q ss_pred h
Q psy6593 377 L 377 (433)
Q Consensus 377 ~ 377 (433)
.
T Consensus 258 ~ 258 (262)
T cd05572 258 F 258 (262)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=269.62 Aligned_cols=209 Identities=25% Similarity=0.456 Sum_probs=170.4
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhc-CCcccc
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHR 223 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~ 223 (433)
..+|++++++++|+||+++++.+..++..++|+||+++++|.+++......+++..+..++.|++.||++||+ .|++|+
T Consensus 46 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~ 125 (265)
T cd06605 46 ILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHR 125 (265)
T ss_pred HHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecC
Confidence 3489999999999999999999999999999999999999999998754679999999999999999999999 999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
||+|+||+++.++.++|+|||.+......... ...++..|+|||.+.+..++.++||
T Consensus 126 dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-----------------------~~~~~~~y~~PE~~~~~~~~~~~Dv 182 (265)
T cd06605 126 DVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-----------------------TFVGTSSYMAPERIQGNDYSVKSDI 182 (265)
T ss_pred CCCHHHEEECCCCCEEEeecccchhhHHHHhh-----------------------cccCChhccCHHHHcCCCCCchhhH
Confidence 99999999999999999999998765321110 2567888999999999899999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCC-CCCchh---hhccccCCC-CcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPD-FGLDQT---DFRNKFCAS-CPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~-~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
||||+++|+|++|.+|+......... ...... ......+.. ++.++.++|.+||..+|++||++.+++. ||+.
T Consensus 183 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 183 WSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 99999999999988877543211110 000000 111122222 7888999999999999999999999983 6654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=263.75 Aligned_cols=203 Identities=27% Similarity=0.461 Sum_probs=167.2
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+++|++++|+||+++++.+..++..++||||+++++|.+++.+. +..+++..+..++.|++.+|++||+.|++|+||
T Consensus 48 ~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl 127 (256)
T cd08220 48 NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDL 127 (256)
T ss_pred HHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 7999999999999999999999999999999999999999999763 345899999999999999999999999999999
Q ss_pred CCcceEEccC-CceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 226 NSQNCLVRED-KTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 226 kp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
+|+||+++.+ +.++|+|||++......... ....++..|+|||.+.+..++.++|||
T Consensus 128 ~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~----------------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 185 (256)
T cd08220 128 KTQNILLDKHKMVVKIGDFGISKILSSKSKA----------------------YTVVGTPCYISPELCEGKPYNQKSDIW 185 (256)
T ss_pred CHHHEEEcCCCCEEEEccCCCceecCCCccc----------------------cccccCCcccCchhccCCCCCcccchH
Confidence 9999999854 56899999999876432211 134678899999999988899999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
|||+++|+|++|..++.......... .........++..++..+.+++.+||+.+|++||++++++.
T Consensus 186 slG~~l~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 186 ALGCVLYELASLKRAFEAANLPALVL-KIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHHHHHHHHHhCCCCcccCchHHHHH-HHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 99999999998887775432211110 11111122344667899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=286.35 Aligned_cols=229 Identities=12% Similarity=0.206 Sum_probs=175.3
Q ss_pred cCCeeeeeccCCCcchhhhhcc------------------------chHHHHhhcCCc------ceeeEEEEEEeC-Cee
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSLHHH------NVIRFIGVLYKD-RKL 173 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l~h~------~iv~~~~~~~~~-~~~ 173 (433)
.+++.+.+.+|+|+||+||++. .|+++++.++|. +|+++++++..+ .++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 4567888899999999998732 477788777554 589999998765 579
Q ss_pred eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhc-CCccccCCCCcceEEccCC----------------
Q psy6593 174 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCLVREDK---------------- 236 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~~~---------------- 236 (433)
++|||++ |++|.+++.+. +.+++..+..|+.||+.||+|||+ .||+||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred EEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 9999998 78999988764 359999999999999999999997 5999999999999998665
Q ss_pred ceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcC
Q psy6593 237 TVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGR 316 (433)
Q Consensus 237 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~ 316 (433)
.+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 286 ~vkl~DfG~~~~~~~~------------------------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG 341 (467)
T PTZ00284 286 RVRICDLGGCCDERHS------------------------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341 (467)
T ss_pred eEEECCCCccccCccc------------------------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhC
Confidence 4999999987532211 1156799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCC----------------------------------chhhhcc-----ccC-CCCcHHHHHHHHHh
Q psy6593 317 VPADPDYLPRSPDFGL----------------------------------DQTDFRN-----KFC-ASCPEPFVRIAFLC 356 (433)
Q Consensus 317 ~~~~~~~~~~~~~~~~----------------------------------~~~~~~~-----~~~-~~~~~~l~~li~~~ 356 (433)
.+||...........+ ....+.. ... ....+.+.+||.+|
T Consensus 342 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 421 (467)
T PTZ00284 342 KLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGL 421 (467)
T ss_pred CCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHh
Confidence 9998643221000000 0000000 000 01135678999999
Q ss_pred cccCCCCCCChhHHHH--HHHhhcc
Q psy6593 357 CDLNPDQRPPFEVLEV--WLEGLSM 379 (433)
Q Consensus 357 l~~~p~~RPs~~~i~~--~l~~~~~ 379 (433)
|+.||++||+++++++ ||.....
T Consensus 422 L~~dP~~R~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 422 LHYDRQKRLNARQMTTHPYVLKYYP 446 (467)
T ss_pred CCcChhhCCCHHHHhcCccccccCC
Confidence 9999999999999985 8876543
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=273.08 Aligned_cols=208 Identities=25% Similarity=0.446 Sum_probs=169.0
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..+|+.++++++|+||+++++.+..++..++||||+++++|.+++.. ..+++..+..++.||+.||.|||+.|++|||
T Consensus 66 ~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~d 143 (292)
T cd06658 66 LFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143 (292)
T ss_pred HHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecC
Confidence 34899999999999999999999999999999999999999998865 3589999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|||+||+++.++.++|+|||++......... .....|+..|+|||.+.+..++.++|||
T Consensus 144 lkp~Nill~~~~~~kL~dfg~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 202 (292)
T cd06658 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---------------------RKSLVGTPYWMAPEVISRLPYGTEVDIW 202 (292)
T ss_pred CCHHHEEEcCCCCEEEccCcchhhccccccc---------------------CceeecCccccCHHHHccCCCCchhhHH
Confidence 9999999999999999999998754322111 1145688999999999888899999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccc--cCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNK--FCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
|||+++|||++|..|+...........+ ....... .....+..+.+++.+||..+|.+||+++++++ |++.
T Consensus 203 slGvil~el~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 203 SLGIMVIEMIDGEPPYFNEPPLQAMRRI-RDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence 9999999999998887543221110000 0011111 12356788999999999999999999999984 5554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=265.80 Aligned_cols=204 Identities=25% Similarity=0.405 Sum_probs=167.5
Q ss_pred chHHHHhhcCCcceeeEEEEEEe--CCeeeEEEeccCCCCHHHHhcCC---CCCCChHHHHHHHHHHHHHHhhhh-----
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQDP---GQPLPWGQRVNFARDIAAGMTYLH----- 216 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH----- 216 (433)
+|++++++++|+||+++++++.. +...+++|||+++++|.+++... +.++++..++.++.|++.||.+||
T Consensus 48 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~ 127 (265)
T cd08217 48 SEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127 (265)
T ss_pred HHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccc
Confidence 68999999999999999998764 35689999999999999998652 456999999999999999999999
Q ss_pred cCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC
Q psy6593 217 SMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE 296 (433)
Q Consensus 217 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 296 (433)
+.+++|+||+|+||+++.++.++|+|||++......... .....+++.|+|||.+.+..
T Consensus 128 ~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~---------------------~~~~~~~~~~~~pE~~~~~~ 186 (265)
T cd08217 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF---------------------AKTYVGTPYYMSPEQLNHMS 186 (265)
T ss_pred cCcceecCCCHHHEEEecCCCEEEecccccccccCCccc---------------------ccccccCCCccChhhhcCCC
Confidence 889999999999999999999999999998876443211 11446888999999999888
Q ss_pred CCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 297 YDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 297 ~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
++.++|+||||+++|+|++|.+|+........ ...........++...+..+.+++.+||+.+|++||++++|++
T Consensus 187 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 187 YDEKSDIWSLGCLIYELCALSPPFTARNQLQL-ASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CCchhHHHHHHHHHHHHHHCCCcccCcCHHHH-HHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 99999999999999999999888765321111 0111111122344667899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=258.02 Aligned_cols=233 Identities=20% Similarity=0.257 Sum_probs=193.1
Q ss_pred ccccCCeeeeeccCCCcchhhhh----------------------------ccchHHHHhhcCCcceeeEEEEEEeCCee
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQ----------------------------NCGQVAVLRSLHHHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~----------------------------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 173 (433)
-+..+++-+.+-+|+|.||.|.. -+.|-.+|+..+||.+..+.-.|+..+++
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 34556678888999999997763 11677899999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 174 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
++||||..||.|.-.+.... .|++..++-+...|++||.|||+++||+||||.+|+|++.+|++||.|||+++.-....
T Consensus 244 CFVMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence 99999999999998887654 59999999999999999999999999999999999999999999999999998654332
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~ 333 (433)
. ...+++|||.|+|||++....|++++|+|.+|++||||+.|+.||...........+.
T Consensus 323 ~---------------------t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl 381 (516)
T KOG0690|consen 323 D---------------------TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL 381 (516)
T ss_pred c---------------------eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH
Confidence 2 2238999999999999999999999999999999999998888876543333222222
Q ss_pred hhhhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHH--HHHHhhc
Q psy6593 334 QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLE--VWLEGLS 378 (433)
Q Consensus 334 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~--~~l~~~~ 378 (433)
.. ...+|..++++...|+..+|.+||.+|. ++.||. .++..+.
T Consensus 382 ~e--d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 382 ME--DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred hh--hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence 22 2346788999999999999999999995 466775 3454433
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=265.80 Aligned_cols=209 Identities=22% Similarity=0.350 Sum_probs=168.7
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
.+|+++|++++||||+++++++...+..|+||||+++++|.+++.+.. ..+++..+..++.|++.||.|||+.|++|+|
T Consensus 41 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~d 120 (277)
T cd05577 41 LNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120 (277)
T ss_pred HHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 379999999999999999999999999999999999999999986633 3599999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|+|+||++++++.++|+|||++........ .....++..|+|||.+.+..++.++|||
T Consensus 121 i~p~Nil~~~~~~~~l~dfg~~~~~~~~~~----------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~ 178 (277)
T cd05577 121 LKPENVLLDDHGNVRISDLGLAVELKGGKK----------------------IKGRAGTPGYMAPEVLQGEVYDFSVDWF 178 (277)
T ss_pred CCHHHEEECCCCCEEEccCcchhhhccCCc----------------------cccccCCCCcCCHHHhcCCCCCchhhhH
Confidence 999999999999999999999876533111 1134577889999999888899999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCc--hhhhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHH--HHHH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLD--QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLE--VWLE 375 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~--~~l~ 375 (433)
|||+++|+|++|.+||...........+. ........+..+++.+.+++.+||+.+|.+|| ++.+++ .||.
T Consensus 179 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~ 258 (277)
T cd05577 179 ALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258 (277)
T ss_pred HHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhh
Confidence 99999999999988875433211111000 11112234456789999999999999999999 555565 3554
Q ss_pred h
Q psy6593 376 G 376 (433)
Q Consensus 376 ~ 376 (433)
.
T Consensus 259 ~ 259 (277)
T cd05577 259 D 259 (277)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=267.68 Aligned_cols=205 Identities=24% Similarity=0.360 Sum_probs=164.2
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeC--CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
.+|+.++++++||||+++++++... +..++||||++ ++|.+++......+++..++.++.|++.||+|||+.|++|+
T Consensus 52 ~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~ 130 (293)
T cd07843 52 LREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHR 130 (293)
T ss_pred HHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 4799999999999999999999877 89999999996 59999987655569999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccC
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVD 302 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~D 302 (433)
||+|+||+++.++.++|+|||++......... .....+++.|+|||.+.+. .++.++|
T Consensus 131 dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~---------------------~~~~~~~~~~~aPE~~~~~~~~~~~~D 189 (293)
T cd07843 131 DLKTSNLLLNNRGILKICDFGLAREYGSPLKP---------------------YTQLVVTLWYRAPELLLGAKEYSTAID 189 (293)
T ss_pred cCCHHHEEECCCCcEEEeecCceeeccCCccc---------------------cccccccccccCchhhcCCccccchhh
Confidence 99999999999999999999998866443111 0134568889999998764 4688999
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCCC-----------------------------CCCCchhhhccccCCC-CcHHHHHH
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRSP-----------------------------DFGLDQTDFRNKFCAS-CPEPFVRI 352 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~-~~~~l~~l 352 (433)
|||||+++|+|++|.+++........ ............++.. +++.+.++
T Consensus 190 i~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (293)
T cd07843 190 MWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDL 269 (293)
T ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHH
Confidence 99999999999999888754321100 0000011111222233 58889999
Q ss_pred HHHhcccCCCCCCChhHHHH
Q psy6593 353 AFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 353 i~~~l~~~p~~RPs~~~i~~ 372 (433)
|.+||+.+|++||++++++.
T Consensus 270 i~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 270 LNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHhccCccccCCHHHHhc
Confidence 99999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=265.41 Aligned_cols=208 Identities=24% Similarity=0.436 Sum_probs=164.9
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeC--CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccc
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 222 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H 222 (433)
..+|+.++++++|+||+++++++.+. ..+++||||+++++|.+++.+.. .+++..++.++.|++.||++||+.+++|
T Consensus 51 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H 129 (265)
T cd06652 51 LECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSNMIVH 129 (265)
T ss_pred HHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 34799999999999999999998764 46889999999999999987643 4899999999999999999999999999
Q ss_pred cCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccC
Q psy6593 223 RDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVD 302 (433)
Q Consensus 223 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 302 (433)
+||+|+||+++.++.++|+|||++........... ......++..|+|||.+.+..++.++|
T Consensus 130 ~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~D 191 (265)
T cd06652 130 RDIKGANILRDSVGNVKLGDFGASKRLQTICLSGT------------------GMKSVTGTPYWMSPEVISGEGYGRKAD 191 (265)
T ss_pred CCCCHHHEEecCCCCEEECcCcccccccccccccc------------------ccccCCCCccccChhhhcCCCCCcchh
Confidence 99999999999999999999999876532211100 011345888999999998888999999
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
|||||+++|+|++|.+|+.....................+..++..+.+++.+|+. +|.+||++++|+.
T Consensus 192 v~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 192 IWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 99999999999999988764322111111111111222345567789999999994 9999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=267.12 Aligned_cols=227 Identities=28% Similarity=0.419 Sum_probs=175.7
Q ss_pred cCCeeeeeccCCCcchhhhhcc------------------------chHHHHhhc-CCcceeeEEEEEEeC-----Ceee
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSL-HHHNVIRFIGVLYKD-----RKLN 174 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l-~h~~iv~~~~~~~~~-----~~~~ 174 (433)
.+++.+...++.|+||.||+.. +|+.+++++ +|+||+++++++... +..+
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 4456666677777777776411 588899999 899999999998754 3589
Q ss_pred EEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 175 LVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
+||||+++++|.++++. .+..+++..++.++.|++.||++||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 99999999999998753 345689999999999999999999999999999999999999999999999999886543
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-----CCCcccCeEehhHHHHHHhcCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-----EYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~~~~~~~~~~~~ 326 (433)
..... ....|+..|+|||.+... .++.++||||||+++|+|++|.+|+....+.
T Consensus 181 ~~~~~---------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~ 239 (291)
T cd06639 181 TRLRR---------------------NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV 239 (291)
T ss_pred ccccc---------------------cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence 22110 134578889999987643 3688999999999999999999887654321
Q ss_pred CCCCCCchh-hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 327 SPDFGLDQT-DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 327 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
.....+... ......+..++..+.+++.+||+.+|++||++.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 240 KTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111101 0011123456678999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=296.22 Aligned_cols=238 Identities=20% Similarity=0.302 Sum_probs=195.0
Q ss_pred cccccCCeeeeeccCCCcchhhhh--------------------------cc--chHHHHhhcCCcceeeEEEEEEeCCe
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQ--------------------------NC--GQVAVLRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~--------------------------~~--~E~~~l~~l~h~~iv~~~~~~~~~~~ 172 (433)
-....+++.+.+-+|+|+||+|.- +| .|-.||..-+.+.|+.++-+|+++++
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 456778899999999999999873 11 68888888899999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
+|+||||++||+|..++.+.+ ++++..++-++..|+.||..||+.|+|||||||+|||++..|++||+|||.+-.+...
T Consensus 150 LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 999999999999999999877 7999999999999999999999999999999999999999999999999999887744
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecC-----CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-----QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~ 327 (433)
....+. ..+|||.|.|||++.. +.|++..|+||+||++|||+-|..||....-..
T Consensus 229 G~V~s~--------------------~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve 288 (1317)
T KOG0612|consen 229 GTVRSS--------------------VAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE 288 (1317)
T ss_pred CcEEec--------------------cccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH
Confidence 332221 6789999999999853 568999999999999999997777765432222
Q ss_pred CCCCCchhhhccccC--CCCcHHHHHHHHHhcccCCCCCCC---hhHHH--HHHHhhccc
Q psy6593 328 PDFGLDQTDFRNKFC--ASCPEPFVRIAFLCCDLNPDQRPP---FEVLE--VWLEGLSMH 380 (433)
Q Consensus 328 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~RPs---~~~i~--~~l~~~~~~ 380 (433)
.+..+..-.-...+| ..+|.+..+||.+.+. +|+.|.. +++|. .||.++.+.
T Consensus 289 TY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 289 TYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWD 347 (1317)
T ss_pred HHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChh
Confidence 222222222222334 5689999999999884 7777876 88887 477776663
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=265.51 Aligned_cols=206 Identities=31% Similarity=0.531 Sum_probs=170.5
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++++++|+||+++++++..+...++||||+++++|.+++.. ..+++..+..++.|++.+|.+||+.|++|+||+
T Consensus 51 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~ 128 (277)
T cd06641 51 QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIK 128 (277)
T ss_pred HHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCC
Confidence 799999999999999999999999999999999999999999875 458999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+|||
T Consensus 129 p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~---------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl 187 (277)
T cd06641 129 AANVLLSEHGEVKLADFGVAGQLTDTQIK---------------------RNTFVGTPFWMAPEVIKQSAYDSKADIWSL 187 (277)
T ss_pred HHhEEECCCCCEEEeecccceecccchhh---------------------hccccCCccccChhhhccCCCCchhhHHHH
Confidence 99999999999999999998755322110 113457888999999988888999999999
Q ss_pred hHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 307 GIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 307 G~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
|+++|+|++|.+|+...........+ .......+...++.++.+++.+||+.+|.+||+++++++ |+..
T Consensus 188 G~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 188 GITAIELAKGEPPHSELHPMKVLFLI-PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred HHHHHHHHcCCCCCCccchHHHHHHH-hcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence 99999999999887643322111111 111122334567889999999999999999999999986 5554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=264.93 Aligned_cols=209 Identities=22% Similarity=0.393 Sum_probs=168.8
Q ss_pred ccchHHHHhh-cCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhc-CC
Q psy6593 145 NCGQVAVLRS-LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHS-MN 219 (433)
Q Consensus 145 ~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ 219 (433)
..+|+.++.+ ++|+||+++++++..++..++||||++|++|.+++.. .+..+++..++.++.|++.+|.+||+ .+
T Consensus 55 ~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~ 134 (269)
T cd08528 55 IVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR 134 (269)
T ss_pred HHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc
Confidence 4478888875 6999999999999999999999999999999988742 34569999999999999999999996 68
Q ss_pred ccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCc
Q psy6593 220 LIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDE 299 (433)
Q Consensus 220 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 299 (433)
++|+||+|+||+++.++.++|+|||++........ .....++..|++||.+.+..++.
T Consensus 135 i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~----------------------~~~~~~~~~~~~Pe~~~~~~~~~ 192 (269)
T cd08528 135 IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK----------------------LTSVVGTILYSCPEIVKNEPYGE 192 (269)
T ss_pred eeecCCCHHHEEECCCCcEEEecccceeecccccc----------------------cccccCcccCcChhhhcCCCCch
Confidence 99999999999999999999999999976543221 11446788899999999888999
Q ss_pred ccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHH
Q psy6593 300 TVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375 (433)
Q Consensus 300 ~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 375 (433)
++||||||+++|+|++|.+|+........................++..+.+++.+||+.||++||++.++.+.+.
T Consensus 193 ~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 193 KADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 9999999999999999988875432211111111111111112356789999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=264.55 Aligned_cols=205 Identities=26% Similarity=0.472 Sum_probs=164.6
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|++++++++|+||+++++++..++..++||||++++.|..+..+. ..+++..+..++.|++.||.|||+.|++|+||+
T Consensus 49 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~ 127 (288)
T cd07833 49 REVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIK 127 (288)
T ss_pred HHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 7999999999999999999999999999999999886666655543 458999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeEe
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFS 305 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diws 305 (433)
|+||+++.++.++|+|||++.......... .....++..|+|||++.+. .++.++||||
T Consensus 128 ~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~--------------------~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~s 187 (288)
T cd07833 128 PENILVSESGVLKLCDFGFARALRARPASP--------------------LTDYVATRWYRAPELLVGDTNYGKPVDVWA 187 (288)
T ss_pred HHHeEECCCCCEEEEeeecccccCCCcccc--------------------ccCcccccCCcCCchhcCCCCcCchhhHHH
Confidence 999999999999999999988765432211 1145678889999999887 7899999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCC------------------------C------CCCchhhhccccCCCCcHHHHHHHHH
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSP------------------------D------FGLDQTDFRNKFCASCPEPFVRIAFL 355 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~------------------------~------~~~~~~~~~~~~~~~~~~~l~~li~~ 355 (433)
||+++|+|++|.+++........ . ............+..++.++.+++++
T Consensus 188 lG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 267 (288)
T cd07833 188 IGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKA 267 (288)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHH
Confidence 99999999999988754211000 0 00000011112234458899999999
Q ss_pred hcccCCCCCCChhHHHH
Q psy6593 356 CCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 356 ~l~~~p~~RPs~~~i~~ 372 (433)
||+.+|++||++++++.
T Consensus 268 ~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 268 CLRMDPKERLTCDELLQ 284 (288)
T ss_pred HhccCchhcccHHHHhc
Confidence 99999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=263.27 Aligned_cols=212 Identities=20% Similarity=0.303 Sum_probs=169.8
Q ss_pred cCCCcchhhhhcc--------------------chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC
Q psy6593 134 DYNGKYGEACQNC--------------------GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP 192 (433)
Q Consensus 134 ~~~g~fg~v~~~~--------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~ 192 (433)
+++|+||.|++.. .|+.+...+ +|+||+++++.+..++..++||||+++++|.+++...
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~ 103 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE 103 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc
Confidence 5888888876511 244444434 7999999999999999999999999999999999775
Q ss_pred CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCC-ceEEeccccchhccCCCCCCccccccchhhhhhhc
Q psy6593 193 GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDK-TVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRR 271 (433)
Q Consensus 193 ~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (433)
. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 104 ~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~------------------ 164 (267)
T PHA03390 104 G-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS------------------ 164 (267)
T ss_pred C-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc------------------
Confidence 4 699999999999999999999999999999999999999888 99999999987543211
Q ss_pred ccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh--hhccccCCCCcHHH
Q psy6593 272 GARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT--DFRNKFCASCPEPF 349 (433)
Q Consensus 272 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l 349 (433)
...++..|+|||++.+..++.++||||||+++|+|++|..|+............... .........+++.+
T Consensus 165 -------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T PHA03390 165 -------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNA 237 (267)
T ss_pred -------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHH
Confidence 335788899999999988999999999999999999998887643222110000000 11112335688999
Q ss_pred HHHHHHhcccCCCCCCC-hhHHH
Q psy6593 350 VRIAFLCCDLNPDQRPP-FEVLE 371 (433)
Q Consensus 350 ~~li~~~l~~~p~~RPs-~~~i~ 371 (433)
.++|.+||+.+|.+||+ +++++
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHh
Confidence 99999999999999995 68887
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=263.81 Aligned_cols=206 Identities=25% Similarity=0.468 Sum_probs=165.9
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++++++|+||+++++++...+..++||||+++++|.+++++.+ .+++..+..++.|++.||.+||+.|++|+||+
T Consensus 57 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~ 135 (272)
T cd06629 57 SEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLK 135 (272)
T ss_pred HHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCC
Confidence 68999999999999999999999999999999999999999998754 58999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC--CCcccCeE
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE--YDETVDVF 304 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Diw 304 (433)
|+||+++.++.++|+|||++.......... ......++..|+|||.+.... ++.++|+|
T Consensus 136 ~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~ 196 (272)
T cd06629 136 ADNLLVDADGICKISDFGISKKSDDIYDND-------------------QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIW 196 (272)
T ss_pred hhhEEEcCCCeEEEeecccccccccccccc-------------------ccccccCCccccCHHHhccccCCCCccchhH
Confidence 999999999999999999987543211100 011345788999999987654 78999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCc----hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLD----QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
|||+++|+|++|.+|+............. ...........++..+.+++.+||+.+|++||++++|++
T Consensus 197 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 197 SLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred HHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 99999999999988875322211111000 111111222456889999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=266.79 Aligned_cols=209 Identities=23% Similarity=0.409 Sum_probs=169.0
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..+|+.++++++|+||+++++++...+..++|+||++|++|.+++.. .++++..+..++.|++.||++||+.|++|||
T Consensus 63 ~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~d 140 (285)
T cd06648 63 LFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRD 140 (285)
T ss_pred HHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 34799999999999999999999999999999999999999999987 4589999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|+|+||+++.++.++|+|||.+......... .....|++.|+|||.+.+..++.++|||
T Consensus 141 l~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 199 (285)
T cd06648 141 IKSDSILLTSDGRVKLSDFGFCAQVSKEVPR---------------------RKSLVGTPYWMAPEVISRLPYGTEVDIW 199 (285)
T ss_pred CChhhEEEcCCCcEEEcccccchhhccCCcc---------------------cccccCCccccCHHHhcCCCCCCcccHH
Confidence 9999999999999999999987754332111 1134688899999999888899999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCchh-hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLDQT-DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
|||+++|+|++|.+|+....+.......... .........++..+.+++.+||+.+|++||+++++++ |++.
T Consensus 200 slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 274 (285)
T cd06648 200 SLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK 274 (285)
T ss_pred HHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCccccc
Confidence 9999999999998887543221110000000 0000112336789999999999999999999999984 5544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=263.16 Aligned_cols=204 Identities=22% Similarity=0.326 Sum_probs=159.0
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|++++++++|+||+++++++..++..++||||+. ++|.+.+......+++..+..++.|++.||.|||+.||+|+|||
T Consensus 52 ~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlk 130 (291)
T cd07870 52 REASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLK 130 (291)
T ss_pred HHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 69999999999999999999999999999999995 68877776544568889999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEe
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFS 305 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws 305 (433)
|+||+++.++.++|+|||+++........ .....+++.|+|||.+.+ ..++.++||||
T Consensus 131 p~Nil~~~~~~~~l~Dfg~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 189 (291)
T cd07870 131 PQNLLISYLGELKLADFGLARAKSIPSQT---------------------YSSEVVTLWYRPPDVLLGATDYSSALDIWG 189 (291)
T ss_pred hHHEEEcCCCcEEEeccccccccCCCCCC---------------------CCCccccccccCCceeecCCCCCcHHHHHH
Confidence 99999999999999999998754322111 113456889999999876 35788999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCC----------------------CCchhhhcc-------ccC--CCCcHHHHHHHH
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDF----------------------GLDQTDFRN-------KFC--ASCPEPFVRIAF 354 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~----------------------~~~~~~~~~-------~~~--~~~~~~l~~li~ 354 (433)
||+++|+|++|.++|.......... ......... ... ...+..+.+++.
T Consensus 190 lG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 269 (291)
T cd07870 190 AGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLAS 269 (291)
T ss_pred HHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHH
Confidence 9999999999998875432110000 000000000 000 123578899999
Q ss_pred HhcccCCCCCCChhHHHH
Q psy6593 355 LCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 355 ~~l~~~p~~RPs~~~i~~ 372 (433)
+|+..||.+|||+++++.
T Consensus 270 ~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 270 QMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHhCcCcccCcCHHHHhc
Confidence 999999999999998863
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=269.77 Aligned_cols=200 Identities=32% Similarity=0.499 Sum_probs=161.5
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+++++.++||||+++++++..++..++||||+. ++|.+++......+++..+..++.|++.||.|||+.|++|+||+
T Consensus 64 ~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~ 142 (307)
T cd06607 64 KEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIK 142 (307)
T ss_pred HHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 79999999999999999999999999999999996 58888776545579999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec---CCCCCcccCe
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT---GQEYDETVDV 303 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di 303 (433)
|+||+++.++.++|+|||++....... ...+++.|+|||.+. ...++.++||
T Consensus 143 p~nIl~~~~~~~kL~dfg~~~~~~~~~-------------------------~~~~~~~y~aPE~~~~~~~~~~~~~sDv 197 (307)
T cd06607 143 AGNILLTEPGTVKLADFGSASLVSPAN-------------------------SFVGTPYWMAPEVILAMDEGQYDGKVDV 197 (307)
T ss_pred cccEEECCCCCEEEeecCcceecCCCC-------------------------CccCCccccCceeeeccCCCCCCcccch
Confidence 999999999999999999886542211 345778899999874 3567889999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
||||+++|+|++|.+|+........................++..+.+++.+||+.+|++||++.+|+.
T Consensus 198 ~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred HHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 999999999999998875432111000000000111112346788999999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=267.15 Aligned_cols=204 Identities=25% Similarity=0.442 Sum_probs=163.4
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|++++++++|+||+++++++..++..++||||+++++|..+..... .+++..++.++.|++.||+|||+.|++|+||+
T Consensus 49 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~ 127 (286)
T cd07846 49 REIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHNIIHRDIK 127 (286)
T ss_pred HHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 79999999999999999999999999999999999988888776543 48999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEe
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFS 305 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws 305 (433)
|+||++++++.++|+|||++......... .....++..|+|||.+.+ ..++.++||||
T Consensus 128 p~ni~~~~~~~~~l~dfg~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 186 (286)
T cd07846 128 PENILVSQSGVVKLCDFGFARTLAAPGEV---------------------YTDYVATRWYRAPELLVGDTKYGRAVDIWA 186 (286)
T ss_pred HHHEEECCCCcEEEEeeeeeeeccCCccc---------------------cCcccceeeccCcHHhccccccCchHhHHH
Confidence 99999999999999999998765432211 113457888999999875 44678999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCC-----------------------------CCCCchhhhccccCCCCcHHHHHHHHHh
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSP-----------------------------DFGLDQTDFRNKFCASCPEPFVRIAFLC 356 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~ 356 (433)
||+++|+|++|.+++........ ................++..+.+++.+|
T Consensus 187 lG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 266 (286)
T cd07846 187 VGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQC 266 (286)
T ss_pred HHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHH
Confidence 99999999999888753321000 0000000000111346788999999999
Q ss_pred cccCCCCCCChhHHHH
Q psy6593 357 CDLNPDQRPPFEVLEV 372 (433)
Q Consensus 357 l~~~p~~RPs~~~i~~ 372 (433)
|+.+|++||++++|+.
T Consensus 267 l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 267 LRIDPDDRPSSSQLLH 282 (286)
T ss_pred hcCCcccchhHHHHhc
Confidence 9999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=264.55 Aligned_cols=203 Identities=22% Similarity=0.299 Sum_probs=168.8
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.+|++++++++||||+++++.+..++..++|+||+.|++|.+++... .++++..+..++.|++.||.|||+.|++|+||
T Consensus 48 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl 126 (258)
T cd05578 48 LNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDI 126 (258)
T ss_pred HHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 37999999999999999999999999999999999999999999775 46999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
+|+||++++++.++|+|||++......... ....|+..|+|||.+.+..++.++|+||
T Consensus 127 ~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----------------------~~~~~~~~y~~PE~~~~~~~~~~~Di~s 184 (258)
T cd05578 127 KPDNILLDEQGHVHITDFNIATKVTPDTLT----------------------TSTSGTPGYMAPEVLCRQGYSVAVDWWS 184 (258)
T ss_pred CHHHeEEcCCCCEEEeecccccccCCCccc----------------------cccCCChhhcCHHHHcccCCCCcccchh
Confidence 999999999999999999998765432211 1345788899999999888999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCc-hhhhccccCCCCcHHHHHHHHHhcccCCCCCCCh--hHHH
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLD-QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF--EVLE 371 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~--~~i~ 371 (433)
||+++|+|++|..|+............. ........+..+|..+.++|.+||+.+|.+||++ ++++
T Consensus 185 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 185 LGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred hHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 9999999999988876543211111011 1113344556788999999999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=261.71 Aligned_cols=210 Identities=26% Similarity=0.411 Sum_probs=172.7
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhc-CCcccc
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHR 223 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~ 223 (433)
..+|+.++++++|+||+++++++..++..++||||+++++|.+++... ..+++..++.++.|++.||.+||+ .|++|+
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~ 124 (264)
T cd06623 46 LLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHR 124 (264)
T ss_pred HHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccC
Confidence 348999999999999999999999999999999999999999999764 459999999999999999999999 999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
||+|+||+++.++.++|+|||++.......... ....++..|+|||.+.+..++.++||
T Consensus 125 ~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~---------------------~~~~~~~~y~~pE~~~~~~~~~~~Dv 183 (264)
T cd06623 125 DIKPSNLLINSKGEVKIADFGISKVLENTLDQC---------------------NTFVGTVTYMSPERIQGESYSYAADI 183 (264)
T ss_pred CCCHHHEEECCCCCEEEccCccceecccCCCcc---------------------cceeecccccCHhhhCCCCCCchhhH
Confidence 999999999999999999999988664322211 14467888999999998889999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCC--CCCCCchhhhccccCCC-CcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRS--PDFGLDQTDFRNKFCAS-CPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
||||+++|+|++|.+|+....... ..............+.. ++..+.+++.+||+.+|++||++.++++ |++.
T Consensus 184 ~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 184 WSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 999999999999998876543200 00000011111223344 7889999999999999999999999984 6654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=266.69 Aligned_cols=210 Identities=30% Similarity=0.512 Sum_probs=171.4
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.+|++++++++|+||+++++++...+..++|+||++|++|.+++......+++..+..++.|++.||.+||+.|++|+||
T Consensus 63 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl 142 (286)
T cd06614 63 INEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDI 142 (286)
T ss_pred HHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCC
Confidence 37999999999999999999999999999999999999999999875546999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
+|+||+++.++.++|+|||++........ ......++..|++||.+.+..++.++|+||
T Consensus 143 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~s 201 (286)
T cd06614 143 KSDNILLSKDGSVKLADFGFAAQLTKEKS---------------------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWS 201 (286)
T ss_pred ChhhEEEcCCCCEEECccchhhhhccchh---------------------hhccccCCcccCCHhHhcCCCCCCccccHH
Confidence 99999999999999999999875533211 011345788899999998888999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhc-cccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHh
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFR-NKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEG 376 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~ 376 (433)
||+++|+|++|.+|+....+............. ......++..+.+++.+||+.+|.+||++.+|+ .++..
T Consensus 202 lGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 202 LGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 999999999999887543221111100000000 011234788999999999999999999999998 47765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=264.77 Aligned_cols=199 Identities=20% Similarity=0.266 Sum_probs=160.8
Q ss_pred hcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEc
Q psy6593 154 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 233 (433)
Q Consensus 154 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~ 233 (433)
..+|+||+.+++++..++..++||||+++++|.+++...+ .+++..+..++.|++.||+|||+.|++|+||||+||+++
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~ 131 (279)
T cd05633 53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD 131 (279)
T ss_pred hCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC
Confidence 3479999999999999999999999999999999887644 599999999999999999999999999999999999999
Q ss_pred cCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec-CCCCCcccCeEehhHHHHH
Q psy6593 234 EDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT-GQEYDETVDVFSYGIVLCE 312 (433)
Q Consensus 234 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~e 312 (433)
+++.++|+|||++........ ....|++.|+|||.+. +..++.++||||+|+++|+
T Consensus 132 ~~~~~~l~dfg~~~~~~~~~~-----------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~ 188 (279)
T cd05633 132 EHGHVRISDLGLACDFSKKKP-----------------------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFK 188 (279)
T ss_pred CCCCEEEccCCcceeccccCc-----------------------cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHH
Confidence 999999999999865432111 1346899999999986 4568899999999999999
Q ss_pred HhcCCCCCCCCCCCCCC-CCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHHH--HHHh
Q psy6593 313 IIGRVPADPDYLPRSPD-FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLEV--WLEG 376 (433)
Q Consensus 313 ll~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~~--~l~~ 376 (433)
|++|..||......... ...........++..++.++.+++.+||+.||.+|| +++++++ |+++
T Consensus 189 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 189 LLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred HHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 99998887643221111 000111122334567889999999999999999999 5888875 5655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=272.62 Aligned_cols=224 Identities=25% Similarity=0.394 Sum_probs=188.6
Q ss_pred ccCCeeeeeccCCCcchhhhh---------------------------ccchHHHHhhcCCcceeeEEEEEEeCCeeeEE
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQ---------------------------NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~---------------------------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 176 (433)
....+.+.+++++|.|+.|.- ..+|+++|..|+|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 455578888999999998774 22899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCC
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
|||..+|.+++++.+.+. ..+..+..++.|+++|++|+|+++|+|||||++||+++.+..+||+|||++..+......
T Consensus 134 ~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l- 211 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML- 211 (596)
T ss_pred EEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccc-
Confidence 999999999999998775 677999999999999999999999999999999999999999999999999987644322
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCC-CcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY-DETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~ 335 (433)
.+++|++.|.|||++.+..| ++.+|+||+|+++|.|+.|..||....-..........
T Consensus 212 ---------------------qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g 270 (596)
T KOG0586|consen 212 ---------------------QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG 270 (596)
T ss_pred ---------------------cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee
Confidence 27899999999999999766 57899999999999999888877543222222222222
Q ss_pred hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 336 DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 336 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
.+ .++..++.+..++|+++|-++|.+|++.++|.+
T Consensus 271 k~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 271 KY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ee--cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 22 234556788999999999999999999999973
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=263.83 Aligned_cols=208 Identities=22% Similarity=0.350 Sum_probs=161.2
Q ss_pred chHHH-HhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcC-Ccc
Q psy6593 147 GQVAV-LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSM-NLI 221 (433)
Q Consensus 147 ~E~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~ 221 (433)
.|+.+ ++.++|+||+++++++..++..++||||++ ++|.+++.. .+..+++..++.++.|++.||+|||+. +++
T Consensus 48 ~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~ 126 (283)
T cd06617 48 MDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVI 126 (283)
T ss_pred HHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCee
Confidence 45554 555689999999999999999999999996 688877753 334699999999999999999999997 999
Q ss_pred ccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC----CCC
Q psy6593 222 HRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG----QEY 297 (433)
Q Consensus 222 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~ 297 (433)
||||||+||+++.++.+||+|||++......... ....++..|+|||.+.+ ..+
T Consensus 127 h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~----------------------~~~~~~~~y~aPE~~~~~~~~~~~ 184 (283)
T cd06617 127 HRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK----------------------TIDAGCKPYMAPERINPELNQKGY 184 (283)
T ss_pred cCCCCHHHEEECCCCCEEEeeccccccccccccc----------------------ccccCCccccChhhcCCccccccc
Confidence 9999999999999999999999998765322110 13457888999998865 446
Q ss_pred CcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccC-CCCcHHHHHHHHHhcccCCCCCCChhHHHH--HH
Q psy6593 298 DETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFC-ASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WL 374 (433)
Q Consensus 298 ~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l 374 (433)
+.++|+||||+++|+|++|..|+....................++ ..+|.++.+++.+||+.+|.+||++++|+. |+
T Consensus 185 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 264 (283)
T cd06617 185 DVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264 (283)
T ss_pred CccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchh
Confidence 889999999999999999988875422111100000111111122 357889999999999999999999999984 66
Q ss_pred Hhh
Q psy6593 375 EGL 377 (433)
Q Consensus 375 ~~~ 377 (433)
+..
T Consensus 265 ~~~ 267 (283)
T cd06617 265 ELH 267 (283)
T ss_pred hhc
Confidence 653
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=262.81 Aligned_cols=203 Identities=18% Similarity=0.230 Sum_probs=163.3
Q ss_pred HHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcc
Q psy6593 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 229 (433)
Q Consensus 150 ~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~N 229 (433)
.+++..+|++|+++++++..++..++||||+.|++|.+++... ..+++..++.++.|++.||+|||+.+++|+||||+|
T Consensus 49 ~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~n 127 (278)
T cd05606 49 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPAN 127 (278)
T ss_pred HHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHH
Confidence 3444557999999999999999999999999999999988764 359999999999999999999999999999999999
Q ss_pred eEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeEehhH
Q psy6593 230 CLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGI 308 (433)
Q Consensus 230 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ 308 (433)
|+++.++.++|+|||++........ ....|+..|+|||.+.+. .++.++||||+|+
T Consensus 128 ili~~~~~~kl~dfg~~~~~~~~~~-----------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~ 184 (278)
T cd05606 128 ILLDEHGHVRISDLGLACDFSKKKP-----------------------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 184 (278)
T ss_pred EEECCCCCEEEccCcCccccCccCC-----------------------cCcCCCcCCcCcHHhcCCCCCCcccchHhHHH
Confidence 9999999999999999875432111 134688999999998754 6889999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCCCC-CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHHH--HHHh
Q psy6593 309 VLCEIIGRVPADPDYLPRSPDF-GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLEV--WLEG 376 (433)
Q Consensus 309 il~ell~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~~--~l~~ 376 (433)
++|+|++|.+||.......... ..........++..++..+.+++.+||..+|.+|| ++.++++ |+.+
T Consensus 185 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 185 MLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred HHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence 9999999988876542211111 11111112334556789999999999999999999 8888873 5544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=262.40 Aligned_cols=210 Identities=25% Similarity=0.438 Sum_probs=169.1
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..+|++++++++|+||+++++++.+.+..++||||++|++|.+++.+.+ ++++..++.++.|++.||.+||+.|++|+|
T Consensus 50 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~~i~H~~ 128 (268)
T cd06630 50 LRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHENQIIHRD 128 (268)
T ss_pred HHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 3479999999999999999999999999999999999999999997643 589999999999999999999999999999
Q ss_pred CCCcceEEccCC-ceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 225 LNSQNCLVREDK-TVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 225 lkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
|+|+||+++.++ .++|+|||++........... .......++..|+|||.+.+..++.++||
T Consensus 129 i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv 191 (268)
T cd06630 129 VKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG-----------------EFQGQLLGTIAFMAPEVLRGEQYGRSCDV 191 (268)
T ss_pred CCHHHEEEcCCCCEEEEcccccccccccccccCC-----------------ccccccccccceeCHhHhccCCCCcccch
Confidence 999999998765 699999999877644311100 00113467889999999988889999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCc---hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLD---QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
||||+++|+|++|.+|+............. ........+..+++++.+++.+||+.+|.+||++.++++
T Consensus 192 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 192 WSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 999999999999988875432211111000 011123344567889999999999999999999999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=266.00 Aligned_cols=208 Identities=21% Similarity=0.321 Sum_probs=163.3
Q ss_pred chHHHHhhcC-CcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhc----CCCCCCChHHHHHHHHHHHHHHhhhhcC-Cc
Q psy6593 147 GQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ----DPGQPLPWGQRVNFARDIAAGMTYLHSM-NL 220 (433)
Q Consensus 147 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~----~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i 220 (433)
+|+.++.++. |+||+++++++..++..+++|||+. ++|.++.. .....+++..+..++.|++.||+|||+. ++
T Consensus 51 ~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i 129 (288)
T cd06616 51 MDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKI 129 (288)
T ss_pred HHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Confidence 7899999995 9999999999999999999999985 57665432 1235699999999999999999999975 99
Q ss_pred cccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC---CC
Q psy6593 221 IHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ---EY 297 (433)
Q Consensus 221 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~ 297 (433)
+||||||+||+++.++.++|+|||++......... ....|++.|+|||.+.+. .+
T Consensus 130 ~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~----------------------~~~~~~~~y~aPE~~~~~~~~~~ 187 (288)
T cd06616 130 IHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK----------------------TRDAGCRPYMAPERIDPSARDGY 187 (288)
T ss_pred eccCCCHHHEEEccCCcEEEeecchhHHhccCCcc----------------------ccccCccCccCHHHhccccccCC
Confidence 99999999999999999999999999765432111 134578889999998775 68
Q ss_pred CcccCeEehhHHHHHHhcCCCCCCCCCCCCCC-CCC---chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--
Q psy6593 298 DETVDVFSYGIVLCEIIGRVPADPDYLPRSPD-FGL---DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE-- 371 (433)
Q Consensus 298 ~~~~DiwslG~il~ell~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~-- 371 (433)
+.++||||||+++|+|++|.+||......... ... ............++.++.+|+.+||+.+|++||++++|+
T Consensus 188 ~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 188 DVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999887654211000 000 000111111235788999999999999999999999998
Q ss_pred HHHHhh
Q psy6593 372 VWLEGL 377 (433)
Q Consensus 372 ~~l~~~ 377 (433)
.|++..
T Consensus 268 ~~~~~~ 273 (288)
T cd06616 268 PFIKDY 273 (288)
T ss_pred hhhhch
Confidence 477653
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=263.06 Aligned_cols=210 Identities=23% Similarity=0.404 Sum_probs=165.4
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeC--CeeeEEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCCc
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNL 220 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i 220 (433)
.+|++++++++|+||+++++++... ..+++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.|+
T Consensus 47 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i 126 (287)
T cd06621 47 LRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKI 126 (287)
T ss_pred HHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 4899999999999999999998654 468999999999999887642 34568999999999999999999999999
Q ss_pred cccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcc
Q psy6593 221 IHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDET 300 (433)
Q Consensus 221 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 300 (433)
+|+||+|+||+++.++.++|+|||++........ ....++..|+|||.+.+..++.+
T Consensus 127 ~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-----------------------~~~~~~~~y~~pE~~~~~~~~~~ 183 (287)
T cd06621 127 IHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA-----------------------GTFTGTSFYMAPERIQGKPYSIT 183 (287)
T ss_pred ccCCCCHHHEEEecCCeEEEeecccccccccccc-----------------------ccccCCccccCHHHhcCCCCCch
Confidence 9999999999999999999999999865432211 03356788999999998899999
Q ss_pred cCeEehhHHHHHHhcCCCCCCCCCCCCCC-CCCchh--h-hccccC------CCCcHHHHHHHHHhcccCCCCCCChhHH
Q psy6593 301 VDVFSYGIVLCEIIGRVPADPDYLPRSPD-FGLDQT--D-FRNKFC------ASCPEPFVRIAFLCCDLNPDQRPPFEVL 370 (433)
Q Consensus 301 ~DiwslG~il~ell~~~~~~~~~~~~~~~-~~~~~~--~-~~~~~~------~~~~~~l~~li~~~l~~~p~~RPs~~~i 370 (433)
+||||||+++|+|++|..|+......... ...... . ....+. ..+++.+.+++.+||+.+|++||++.+|
T Consensus 184 ~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ei 263 (287)
T cd06621 184 SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDM 263 (287)
T ss_pred hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHH
Confidence 99999999999999998877543221000 000000 0 000111 2345789999999999999999999999
Q ss_pred HH--HHHhhc
Q psy6593 371 EV--WLEGLS 378 (433)
Q Consensus 371 ~~--~l~~~~ 378 (433)
+. |+....
T Consensus 264 l~~~~~~~~~ 273 (287)
T cd06621 264 LEHPWIKAQM 273 (287)
T ss_pred HhCccccccc
Confidence 85 775543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=264.84 Aligned_cols=208 Identities=24% Similarity=0.356 Sum_probs=163.2
Q ss_pred chHHHHhhcCCcceeeEEEEEEeC--CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
+|+.++++++|+||+++++++... +..++||||+. ++|.+++......+++..++.++.|++.||+|||+.|++|+|
T Consensus 55 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~d 133 (309)
T cd07845 55 REITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRD 133 (309)
T ss_pred HHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 699999999999999999998765 46899999996 589988876556799999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCe
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDV 303 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 303 (433)
|+|+||+++.++.++|+|||++.......... ....+++.|+|||.+.+ ..++.++||
T Consensus 134 l~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~---------------------~~~~~~~~y~aPE~~~~~~~~~~~~Dv 192 (309)
T cd07845 134 LKVSNLLLTDKGCLKIADFGLARTYGLPAKPM---------------------TPKVVTLWYRAPELLLGCTTYTTAIDM 192 (309)
T ss_pred CCHHHEEECCCCCEEECccceeeecCCccCCC---------------------CcccccccccChhhhcCCCCcCchHHH
Confidence 99999999999999999999998764321110 12345778999999865 567899999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCC--------------------------CCchhh--hccccCCCCcHHHHHHHHH
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDF--------------------------GLDQTD--FRNKFCASCPEPFVRIAFL 355 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~--------------------------~~~~~~--~~~~~~~~~~~~l~~li~~ 355 (433)
||||+++|+|++|.+++.......... ...... .........++.+.++|.+
T Consensus 193 wslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 272 (309)
T cd07845 193 WAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNF 272 (309)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHH
Confidence 999999999999998875432111000 000000 0000012357889999999
Q ss_pred hcccCCCCCCChhHHH--HHHHh
Q psy6593 356 CCDLNPDQRPPFEVLE--VWLEG 376 (433)
Q Consensus 356 ~l~~~p~~RPs~~~i~--~~l~~ 376 (433)
||+.||++||++++++ .|+++
T Consensus 273 ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 273 LLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred HhcCChhhCcCHHHHhcChhhcc
Confidence 9999999999999998 46654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=258.92 Aligned_cols=211 Identities=23% Similarity=0.359 Sum_probs=168.7
Q ss_pred hccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 144 QNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 144 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
...+|+.++++++|+||+++++.+...+..++|+||+++++|.+++.... .+++..+..++.|++.||.+||+.|++|+
T Consensus 45 ~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~ 123 (264)
T cd06626 45 EIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHSHGIVHR 123 (264)
T ss_pred HHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 34489999999999999999999999999999999999999999997743 48999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC---CCcc
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE---YDET 300 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~ 300 (433)
||+|+||++++++.++|+|||++............ ......+++.|+|||++.+.. ++.+
T Consensus 124 dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~PE~~~~~~~~~~~~~ 186 (264)
T cd06626 124 DIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE-----------------EVQSLAGTPAYMAPEVITGGKGKGHGRA 186 (264)
T ss_pred CCCHHHEEECCCCCEEEcccccccccCCCCCcccc-----------------cccCCcCCcCccChhhccCCCCCCCCcc
Confidence 99999999999999999999998876543321110 011345788899999998766 8899
Q ss_pred cCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccC--CCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 301 VDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFC--ASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 301 ~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
+||||||+++|+|++|.+||....................++ ..++..+.+++.+||+.+|.+||++++++.
T Consensus 187 ~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 187 ADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred cchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 999999999999999998875432111100000011111222 234889999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=259.99 Aligned_cols=204 Identities=24% Similarity=0.379 Sum_probs=161.3
Q ss_pred ccchHHHHhhcC-CcceeeEEEEEEeC--CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCcc
Q psy6593 145 NCGQVAVLRSLH-HHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLI 221 (433)
Q Consensus 145 ~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~ 221 (433)
.++|+.+++++. |+||+++++++.++ +.+++||||++ ++|.+.+.+....+++..++.++.|++.||+|||+.|++
T Consensus 44 ~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~ 122 (282)
T cd07831 44 NLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIF 122 (282)
T ss_pred HHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 447899999995 99999999999987 88999999996 588888876555699999999999999999999999999
Q ss_pred ccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec-CCCCCcc
Q psy6593 222 HRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT-GQEYDET 300 (433)
Q Consensus 222 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~ 300 (433)
|+||+|+||+++. +.++|+|||++......... ....++..|+|||.+. +..++.+
T Consensus 123 H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~----------------------~~~~~~~~y~aPE~~~~~~~~~~~ 179 (282)
T cd07831 123 HRDIKPENILIKD-DILKLADFGSCRGIYSKPPY----------------------TEYISTRWYRAPECLLTDGYYGPK 179 (282)
T ss_pred ecccCHHHEEEcC-CCeEEEecccccccccCCCc----------------------CCCCCCcccCChhHhhcCCCCCcc
Confidence 9999999999999 99999999999865432211 1345788899999764 4557889
Q ss_pred cCeEehhHHHHHHhcCCCCCCCCCCCCCC-----------C---------CCchhhh-------ccccCCCCcHHHHHHH
Q psy6593 301 VDVFSYGIVLCEIIGRVPADPDYLPRSPD-----------F---------GLDQTDF-------RNKFCASCPEPFVRIA 353 (433)
Q Consensus 301 ~DiwslG~il~ell~~~~~~~~~~~~~~~-----------~---------~~~~~~~-------~~~~~~~~~~~l~~li 353 (433)
+||||||+++|||++|.+|+......... . ......+ .......++..+.+++
T Consensus 180 ~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (282)
T cd07831 180 MDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLL 259 (282)
T ss_pred hhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHH
Confidence 99999999999999999888643211000 0 0000000 0011235688999999
Q ss_pred HHhcccCCCCCCChhHHHH
Q psy6593 354 FLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 354 ~~~l~~~p~~RPs~~~i~~ 372 (433)
.+||+.+|++||++++++.
T Consensus 260 ~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 260 KKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHhccCcccccCHHHHhh
Confidence 9999999999999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=267.40 Aligned_cols=203 Identities=32% Similarity=0.487 Sum_probs=163.9
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|++++++++|+|++++++++..++..++||||+. ++|.+++.....++++..+..++.|++.||.+||+.|++|+||+
T Consensus 74 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~ 152 (317)
T cd06635 74 KEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 152 (317)
T ss_pred HHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 78999999999999999999999999999999996 58888876655679999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec---CCCCCcccCe
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT---GQEYDETVDV 303 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di 303 (433)
|+||+++.++.++|+|||++....... ...+++.|+|||.+. ...++.++||
T Consensus 153 p~Nil~~~~~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv 207 (317)
T cd06635 153 AGNILLTEPGQVKLADFGSASIASPAN-------------------------SFVGTPYWMAPEVILAMDEGQYDGKVDV 207 (317)
T ss_pred cccEEECCCCCEEEecCCCccccCCcc-------------------------cccCCccccChhhhhcCCCCCCCccccH
Confidence 999999999999999999876432211 345788899999974 3568889999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHH
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 375 (433)
||||+++|+|++|.+|+........................+++.+.+++.+||+.+|.+||++.+|++.+-
T Consensus 208 ~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 208 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred HHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 999999999999988765432111111111111111222456788999999999999999999999986433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=268.14 Aligned_cols=206 Identities=23% Similarity=0.325 Sum_probs=162.1
Q ss_pred chHHHHhhcCCcceeeEEEEEEeC------CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKD------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNL 220 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i 220 (433)
+|+.++++++|+||+++++++... ...|+||||+. ++|.+.+.. .+++..+..++.|++.||+|||+.|+
T Consensus 64 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi 139 (353)
T cd07850 64 RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGI 139 (353)
T ss_pred HHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 699999999999999999998644 35799999995 589888865 28999999999999999999999999
Q ss_pred cccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcc
Q psy6593 221 IHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDET 300 (433)
Q Consensus 221 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 300 (433)
+||||||+||+++.++.++|+|||++........ .....+++.|+|||.+.+..++.+
T Consensus 140 ~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~----------------------~~~~~~~~~y~aPE~~~~~~~~~~ 197 (353)
T cd07850 140 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM----------------------MTPYVVTRYYRAPEVILGMGYKEN 197 (353)
T ss_pred eeCCCCHHHEEECCCCCEEEccCccceeCCCCCC----------------------CCCCcccccccCHHHHhCCCCCCc
Confidence 9999999999999999999999999976533211 013457889999999999999999
Q ss_pred cCeEehhHHHHHHhcCCCCCCCCCCCCCCC-----------------------------CCchhhhcc------------
Q psy6593 301 VDVFSYGIVLCEIIGRVPADPDYLPRSPDF-----------------------------GLDQTDFRN------------ 339 (433)
Q Consensus 301 ~DiwslG~il~ell~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~------------ 339 (433)
+||||||+++|+|++|..+|.......... ......+..
T Consensus 198 ~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
T cd07850 198 VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSE 277 (353)
T ss_pred hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccc
Confidence 999999999999999988775432100000 000000000
Q ss_pred ccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhc
Q psy6593 340 KFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 340 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
......++.+.+++.+||+.||++||++.+++ .||+...
T Consensus 278 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~ 318 (353)
T cd07850 278 SHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY 318 (353)
T ss_pred cccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence 00123467789999999999999999999998 5777543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=272.20 Aligned_cols=221 Identities=19% Similarity=0.296 Sum_probs=181.1
Q ss_pred cCCeeeeeccCCCcchhhhhcc---------------------chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCC
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC---------------------GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAG 182 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~---------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g 182 (433)
.+++.+..+++.|+|+.|.... +|+.++... +|+||+++.+.+.++.+.|+|||.+.|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g 400 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG 400 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence 3445555668888888776411 677777777 799999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEE-ccCCceEEeccccchhccCCCCCCccccc
Q psy6593 183 GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV-REDKTVVVADFGLARIIHQGPRAPTTVMA 261 (433)
Q Consensus 183 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~-~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 261 (433)
+-|.+.+.... .....+..|+.+|+.|+.|||++|++||||||+|||+ ++.++++|+|||.++.......
T Consensus 401 ~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~------- 471 (612)
T KOG0603|consen 401 GELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCD------- 471 (612)
T ss_pred cHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhc-------
Confidence 98888877633 3337888899999999999999999999999999999 5899999999999987654411
Q ss_pred cchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhcccc
Q psy6593 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKF 341 (433)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (433)
+-+-|..|.|||++....|+.++||||||++||+|++|..++...... ..+........+
T Consensus 472 -----------------tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~ 531 (612)
T KOG0603|consen 472 -----------------TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKF 531 (612)
T ss_pred -----------------ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCcc
Confidence 234578899999999999999999999999999999999988654332 122222223334
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHH
Q psy6593 342 CASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWL 374 (433)
Q Consensus 342 ~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l 374 (433)
...+++..++|+.+||+.||.+||++.++. .|+
T Consensus 532 s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 532 SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 478899999999999999999999999997 577
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=260.32 Aligned_cols=201 Identities=23% Similarity=0.329 Sum_probs=161.0
Q ss_pred chHHHH-hhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVL-RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l-~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.|..++ ...+|+||+++++++..++..++|+||+++++|.+++...+ .+++..+..++.|++.||.|||+.|++|+||
T Consensus 45 ~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl 123 (260)
T cd05611 45 AERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123 (260)
T ss_pred HHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 444444 44589999999999999999999999999999999997643 5899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
+|+||+++.++.++|+|||++...... ....++..|+|||.+.+..++.++||||
T Consensus 124 ~p~nil~~~~~~~~l~dfg~~~~~~~~-------------------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~s 178 (260)
T cd05611 124 KPENLLIDQTGHLKLTDFGLSRNGLEN-------------------------KKFVGTPDYLAPETILGVGDDKMSDWWS 178 (260)
T ss_pred CHHHeEECCCCcEEEeecccceecccc-------------------------ccCCCCcCccChhhhcCCCCcchhhhHH
Confidence 999999999999999999988754321 1345788899999998888899999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCchh--hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHH
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLDQT--DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVW 373 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~ 373 (433)
||+++|+|++|.+|+............... .........+++.+.+++.+||+.+|++||++.++.+.
T Consensus 179 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 179 LGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 999999999999988543221111111100 11112234678999999999999999999977655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=266.77 Aligned_cols=258 Identities=21% Similarity=0.362 Sum_probs=195.0
Q ss_pred cccccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeC
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKD 170 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~ 170 (433)
.+--..+.-++.++.+|-|.||+|+... .|-.||...+++.||+||-.|+++
T Consensus 622 kRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk 701 (1034)
T KOG0608|consen 622 KRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK 701 (1034)
T ss_pred HHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC
Confidence 3334455669999999999999998522 588899999999999999999999
Q ss_pred CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhcc
Q psy6593 171 RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIH 250 (433)
Q Consensus 171 ~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 250 (433)
+.+|+||+|++||++..+|-+.+ -|.++.++-++..+..|+++.|.+|+|||||||+|||||.+|++||.||||+.-+.
T Consensus 702 dnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 702 DNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred CceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccce
Confidence 99999999999999999987755 49999999999999999999999999999999999999999999999999987443
Q ss_pred CC---------CCCCccccccchhhhh------------hhcccccceeeeccCccccccceecCCCCCcccCeEehhHH
Q psy6593 251 QG---------PRAPTTVMAKVPRKAA------------QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIV 309 (433)
Q Consensus 251 ~~---------~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 309 (433)
-. .....+.+...+.+.. .+...+-.....+||+.|+|||++....++...|+||.|+|
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 11 1111111111111100 01111112234589999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCCCC-chhhhc-cccCCCCcHHHHHHHHHhcccCCCCCC---ChhHHH--HHHHhhc
Q psy6593 310 LCEIIGRVPADPDYLPRSPDFGL-DQTDFR-NKFCASCPEPFVRIAFLCCDLNPDQRP---PFEVLE--VWLEGLS 378 (433)
Q Consensus 310 l~ell~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~RP---s~~~i~--~~l~~~~ 378 (433)
||||+-|.+||....+......+ .+..+. .....+++.+..++|.++.. +++.|. -+++|. .||+.+.
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccc
Confidence 99999999999887776654443 333332 23347889999999988663 556664 234454 3555443
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=245.97 Aligned_cols=227 Identities=19% Similarity=0.345 Sum_probs=176.6
Q ss_pred eeeeeccCCCcchhhhh---------------------------ccchHHHHhhcCCcceeeEEEEEEeC--------Ce
Q psy6593 128 LLFCKEDYNGKYGEACQ---------------------------NCGQVAVLRSLHHHNVIRFIGVLYKD--------RK 172 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~---------------------------~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~ 172 (433)
+....++++|.||+|++ +++|+.+|..|+|+|++.+++.+... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 34445788999999997 22899999999999999999887632 35
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
+|+||.+|+. +|.-++.+...+++..++.+++++++.||.|+|+..|+|||+||+|+||+.+|.++|+|||+++.+...
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~ 177 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTS 177 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence 9999999975 999999887778999999999999999999999999999999999999999999999999999877654
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCC------
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLP------ 325 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~------ 325 (433)
...... .....+-|.+|++||.+.+ ..++++.|||..|||+.||+++.|.+.....
T Consensus 178 ~n~~kp-----------------rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~ 240 (376)
T KOG0669|consen 178 KNVVKP-----------------RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHL 240 (376)
T ss_pred cccCCC-----------------CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHH
Confidence 322111 1224566999999999887 5799999999999999999999987743211
Q ss_pred --------------CCCCCC----Cchhhhccc--------c-CCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 326 --------------RSPDFG----LDQTDFRNK--------F-CASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 326 --------------~~~~~~----~~~~~~~~~--------~-~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
...... +....+... . +-.-.++..+|+..++..||.+|+++.++++
T Consensus 241 Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 241 ISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred HHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 110000 000000000 0 1112356789999999999999999999874
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=265.79 Aligned_cols=201 Identities=32% Similarity=0.491 Sum_probs=162.9
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.+|++++++++|+|++++++++.+++..|+||||+. ++|.+++.....++++..++.++.|++.||.|||+.|++|+||
T Consensus 69 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl 147 (313)
T cd06633 69 IKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147 (313)
T ss_pred HHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 378999999999999999999999999999999995 5888888665567999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec---CCCCCcccC
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT---GQEYDETVD 302 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~D 302 (433)
+|+||+++.++.++|+|||++...... ....|+..|+|||.+. ...++.++|
T Consensus 148 ~p~nili~~~~~~kL~dfg~~~~~~~~-------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~sD 202 (313)
T cd06633 148 KAGNILLTEPGQVKLADFGSASKSSPA-------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVD 202 (313)
T ss_pred ChhhEEECCCCCEEEeecCCCcccCCC-------------------------CCccccccccChhhccccCCCCCCchhh
Confidence 999999999999999999987542111 1346788899999984 356788999
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
|||||+++|+|++|.+|+........................++..+.+++.+||+.+|.+||++.+++.
T Consensus 203 v~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 203 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999988875432211111111111111122456788999999999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=255.78 Aligned_cols=206 Identities=31% Similarity=0.572 Sum_probs=169.7
Q ss_pred hccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 144 QNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 144 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
...+|++++++++|+||+++++.+..++..++++||+++++|.+++......+++..+..++.|++.||.+||+.|++|+
T Consensus 43 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~ 122 (253)
T cd05122 43 KIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHR 122 (253)
T ss_pred HHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecC
Confidence 34489999999999999999999999999999999999999999998764579999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+...+.++||
T Consensus 123 dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----------------------~~~~~~~~~~~~PE~~~~~~~~~~~Dv 180 (253)
T cd05122 123 DIKAANILLTSDGEVKLIDFGLSAQLSDTKA----------------------RNTMVGTPYWMAPEVINGKPYDYKADI 180 (253)
T ss_pred CCCHHHEEEccCCeEEEeecccccccccccc----------------------ccceecCCcccCHHHHcCCCCCccccH
Confidence 9999999999999999999999876644321 114567888999999988888999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccC--CCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFC--ASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
||||+++|+|++|.+|+.............. ....... ..++..+.+++.+||+.||++||++.+++.
T Consensus 181 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 181 WSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 9999999999999888754321111111111 1111122 223789999999999999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=263.65 Aligned_cols=209 Identities=24% Similarity=0.409 Sum_probs=169.5
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..+|+.++++++|+||+++++.+..++..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.|++|+|
T Consensus 64 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~d 141 (292)
T cd06657 64 LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141 (292)
T ss_pred HHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 33799999999999999999999999999999999999999998865 3589999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|+|+||+++.++.++|+|||++......... .....+++.|+|||.+.+..++.++|+|
T Consensus 142 l~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~---------------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~ 200 (292)
T cd06657 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---------------------RKSLVGTPYWMAPELISRLPYGPEVDIW 200 (292)
T ss_pred CCHHHEEECCCCCEEEcccccceeccccccc---------------------ccccccCccccCHHHhcCCCCCchhhHH
Confidence 9999999999999999999987654321110 1134678899999999888889999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccc--cCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNK--FCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
|+|+++|+|++|.+|+.......... ......... ....++..+.+++.+||+.+|.+||++++++. ||...
T Consensus 201 slGvil~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 201 SLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276 (292)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence 99999999999988875432111000 000011111 12456889999999999999999999999984 77654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=259.62 Aligned_cols=211 Identities=31% Similarity=0.455 Sum_probs=164.9
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCC------eeeEEEeccCCCCHHHHhcC-----CCCCCChHHHHHHHHHHHHHHhhh
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDR------KLNLVTEYIAGGTLKELLQD-----PGQPLPWGQRVNFARDIAAGMTYL 215 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~g~sL~~~l~~-----~~~~~~~~~~~~i~~qi~~~L~~l 215 (433)
+|+++|++++||||+++++++...+ ..++++||+.+++|.+++.. ....++...++.++.|++.||+||
T Consensus 50 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l 129 (273)
T cd05074 50 REAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL 129 (273)
T ss_pred HHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 7999999999999999999986542 24789999999999887642 122478899999999999999999
Q ss_pred hcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC
Q psy6593 216 HSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ 295 (433)
Q Consensus 216 H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 295 (433)
|+.||+|+||||+||+++.++.++|+|||+++.......... .....+++.|++||.+...
T Consensus 130 H~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~-------------------~~~~~~~~~~~~pe~~~~~ 190 (273)
T cd05074 130 SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ-------------------GCASKLPVKWLALESLADN 190 (273)
T ss_pred HhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceec-------------------CCCccCchhhcCHhHHhcC
Confidence 999999999999999999999999999999886543221110 0022345679999999988
Q ss_pred CCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHH
Q psy6593 296 EYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWL 374 (433)
Q Consensus 296 ~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 374 (433)
.++.++||||||+++|+|++ |.+|+............. ...........+..+.+++.+||+.+|++||++.+++..|
T Consensus 191 ~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l 269 (273)
T cd05074 191 VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269 (273)
T ss_pred ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 89999999999999999997 778775432211100000 0011122345778999999999999999999999999999
Q ss_pred Hhh
Q psy6593 375 EGL 377 (433)
Q Consensus 375 ~~~ 377 (433)
+++
T Consensus 270 ~~~ 272 (273)
T cd05074 270 ELI 272 (273)
T ss_pred Hhh
Confidence 865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=260.05 Aligned_cols=206 Identities=23% Similarity=0.388 Sum_probs=162.9
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC--CCCChHHHHHHHHHHHHHHhhhhcCCccc
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG--QPLPWGQRVNFARDIAAGMTYLHSMNLIH 222 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H 222 (433)
..+|+.++++++|+||+++++++...+..++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+.|++|
T Consensus 45 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h 123 (284)
T cd07836 45 AIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123 (284)
T ss_pred HHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 34799999999999999999999999999999999975 8988886533 46899999999999999999999999999
Q ss_pred cCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCccc
Q psy6593 223 RDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETV 301 (433)
Q Consensus 223 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~ 301 (433)
+||+|+||++++++.++|+|||++......... .....++..|++||.+.+ ..++.++
T Consensus 124 ~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~---------------------~~~~~~~~~y~~PE~~~~~~~~~~~~ 182 (284)
T cd07836 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNT---------------------FSNEVVTLWYRAPDVLLGSRTYSTSI 182 (284)
T ss_pred CCCCHHHEEECCCCcEEEeecchhhhhcCCccc---------------------cccccccccccChHHhcCCCCCCcHH
Confidence 999999999999999999999998765332110 113456888999998866 4568899
Q ss_pred CeEehhHHHHHHhcCCCCCCCCCCCCCCCCC----------------chhh-----------hccccCCCCcHHHHHHHH
Q psy6593 302 DVFSYGIVLCEIIGRVPADPDYLPRSPDFGL----------------DQTD-----------FRNKFCASCPEPFVRIAF 354 (433)
Q Consensus 302 DiwslG~il~ell~~~~~~~~~~~~~~~~~~----------------~~~~-----------~~~~~~~~~~~~l~~li~ 354 (433)
||||||+++|+|++|.+++...........+ .... ....+....+..+.+++.
T Consensus 183 Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 262 (284)
T cd07836 183 DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLH 262 (284)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHH
Confidence 9999999999999999887643211000000 0000 001112345788999999
Q ss_pred HhcccCCCCCCChhHHHH
Q psy6593 355 LCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 355 ~~l~~~p~~RPs~~~i~~ 372 (433)
+||+.+|.+||+++++++
T Consensus 263 ~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 263 RLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHhcCCcccCCCHHHHhc
Confidence 999999999999998874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=263.61 Aligned_cols=205 Identities=24% Similarity=0.408 Sum_probs=161.9
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
.+|++++++++||||+++++++.+++..++||||+. ++|.+++.. .+..+++..+..++.|++.||+|||+.|++|+|
T Consensus 47 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~ 125 (284)
T cd07860 47 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 125 (284)
T ss_pred HHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 379999999999999999999999999999999995 689888854 335689999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC-CCcccCe
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE-YDETVDV 303 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di 303 (433)
|+|+||+++.++.++|+|||++......... .....+++.|+|||.+.+.. ++.++||
T Consensus 126 l~p~nill~~~~~~~l~dfg~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 184 (284)
T cd07860 126 LKPQNLLINTEGAIKLADFGLARAFGVPVRT---------------------YTHEVVTLWYRAPEILLGCKYYSTAVDI 184 (284)
T ss_pred CCHHHEEECCCCCEEEeeccchhhcccCccc---------------------cccccccccccCCeEEecCCCCCcHHHH
Confidence 9999999999999999999998765332111 11335678899999887644 5888999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCC----------------ch-----------hhhccccCCCCcHHHHHHHHHh
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGL----------------DQ-----------TDFRNKFCASCPEPFVRIAFLC 356 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~----------------~~-----------~~~~~~~~~~~~~~l~~li~~~ 356 (433)
||||+++|+|++|.+++............ .. ..........++..+.++|.+|
T Consensus 185 ~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 264 (284)
T cd07860 185 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQM 264 (284)
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHh
Confidence 99999999999998887543211000000 00 0000111235678899999999
Q ss_pred cccCCCCCCChhHHHH
Q psy6593 357 CDLNPDQRPPFEVLEV 372 (433)
Q Consensus 357 l~~~p~~RPs~~~i~~ 372 (433)
|+.||.+||++++++.
T Consensus 265 l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 265 LHYDPNKRISAKAALA 280 (284)
T ss_pred cCCCcccCCCHHHHhc
Confidence 9999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=258.25 Aligned_cols=205 Identities=22% Similarity=0.416 Sum_probs=166.6
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
.+|+.++++++|+||+++++.+..+...++|+||+++++|.+++... +..+++..+..++.|++.||.|||+.+++|+|
T Consensus 47 ~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~d 126 (257)
T cd08225 47 KKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRD 126 (257)
T ss_pred HHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 37999999999999999999999999999999999999999998653 33589999999999999999999999999999
Q ss_pred CCCcceEEccCC-ceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 225 LNSQNCLVREDK-TVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 225 lkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
|+|+||++++++ .++|+|||.+......... .....|++.|+|||.+.+..++.++|+
T Consensus 127 l~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~---------------------~~~~~~~~~~~ape~~~~~~~~~~~Dv 185 (257)
T cd08225 127 IKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL---------------------AYTCVGTPYYLSPEICQNRPYNNKTDI 185 (257)
T ss_pred CCHHHEEEcCCCCeEEecccccchhccCCccc---------------------ccccCCCccccCHHHHcCCCCCchhhH
Confidence 999999999875 5699999998765432211 113457889999999988889999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
||||+++|+|++|.+|+........... .............+.++.+++.+||+.+|++||++.+|++
T Consensus 186 ~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 186 WSLGCVLYELCTLKHPFEGNNLHQLVLK-ICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred HHHHHHHHHHHhCCCCCCCccHHHHHHH-HhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 9999999999999888754321111100 0111112233567889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=257.46 Aligned_cols=207 Identities=26% Similarity=0.480 Sum_probs=167.1
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeC--CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
.+|++++++++|+||+++++++.+. ..+++|+||+++++|.+++...+ .+++..++.++.|++.||.+||+.|++|+
T Consensus 52 ~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~i~H~ 130 (264)
T cd06653 52 ECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNMIVHR 130 (264)
T ss_pred HHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 3799999999999999999998764 46889999999999999987644 48999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
||+|+||+++.++.++|+|||++........... ......++..|+|||.+.+..++.++||
T Consensus 131 dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di 192 (264)
T cd06653 131 DIKGANILRDSAGNVKLGDFGASKRIQTICMSGT------------------GIKSVTGTPYWMSPEVISGEGYGRKADV 192 (264)
T ss_pred CCCHHHEEEcCCCCEEECccccccccccccccCc------------------cccccCCcccccCHhhhcCCCCCccccH
Confidence 9999999999999999999999986532111000 0113468889999999998888999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
||||+++|+|++|.+||....................++..+++.+.+++.+||+ +|..||++.+++.
T Consensus 193 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 193 WSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 9999999999999998865322211111111222344567788999999999999 5799999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=256.35 Aligned_cols=206 Identities=24% Similarity=0.446 Sum_probs=171.0
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC---CCCCChHHHHHHHHHHHHHHhhhhcCCcc
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---GQPLPWGQRVNFARDIAAGMTYLHSMNLI 221 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~i~ 221 (433)
..+|++++++++|+|++++++.+..+...++|+|++++++|.+++.+. +..+++..+..++.+++.||.+||+.|++
T Consensus 46 ~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 125 (258)
T cd08215 46 ALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKIL 125 (258)
T ss_pred HHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 347999999999999999999999999999999999999999998764 36799999999999999999999999999
Q ss_pred ccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCccc
Q psy6593 222 HRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETV 301 (433)
Q Consensus 222 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 301 (433)
|+||+|+||+++.++.++|+|||.+........ ......|++.|+|||.+.+..++.++
T Consensus 126 H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---------------------~~~~~~~~~~y~~pe~~~~~~~~~~~ 184 (258)
T cd08215 126 HRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD---------------------LAKTVVGTPYYLSPELCQNKPYNYKS 184 (258)
T ss_pred cccCChHHeEEcCCCcEEECCccceeecccCcc---------------------eecceeeeecccChhHhccCCCCccc
Confidence 999999999999999999999999876543321 01134678899999999888899999
Q ss_pred CeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 302 DVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 302 DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
|+||+|+++++|++|.+|+............ .......++..++..+.+++.+||+.+|++||+++++++
T Consensus 185 Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 185 DIWSLGCVLYELCTLKHPFEGENLLELALKI-LKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred cHHHHHHHHHHHHcCCCCCCCCcHHHHHHHH-hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 9999999999999998887543211111111 111123344577899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=273.62 Aligned_cols=230 Identities=24% Similarity=0.345 Sum_probs=192.4
Q ss_pred ccccCCeeeeeccCCCcchhhhh-----------------------------ccchHHHHhhcCCcceeeEEEEEEeCCe
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQ-----------------------------NCGQVAVLRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~-----------------------------~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 172 (433)
.+..+.+..++.+|+|.||.|++ .++|+.+|.+|+|+|++++||+..+ ..
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 45666678888999999999886 1289999999999999999999887 78
Q ss_pred eeEEEeccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 173 LNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
+.+|||+++.|||.+.|++ ....|.......++.||+.|+.||..+++|||||...|+++.....|||+|||+.+.+..
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 8999999999999999977 556789999999999999999999999999999999999999999999999999998876
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHh-cCCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDYLPRSPDF 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~~~~~~~~~~~~~~~~ 330 (433)
....-.-. . ..--...|.|||.+....++.++|||++||++|||+ .|..||..........
T Consensus 265 ned~Yvm~------------p------~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~ 326 (1039)
T KOG0199|consen 265 NEDMYVMA------------P------QRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILK 326 (1039)
T ss_pred CCcceEec------------C------CCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHH
Confidence 54321100 0 001123599999999999999999999999999999 5666776655555555
Q ss_pred CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 331 GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
.++ ..-+..-+..+|+++.++++.||..+|.+||+|..|.
T Consensus 327 ~iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 327 NID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred hcc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 555 3334445688999999999999999999999999997
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=261.59 Aligned_cols=210 Identities=24% Similarity=0.379 Sum_probs=162.4
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
.+|++++++++|+||+++++++..+...++||||++ ++|.+++... ...+++..+..++.||+.||+|||+.|++|+|
T Consensus 49 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~d 127 (294)
T PLN00009 49 IREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRD 127 (294)
T ss_pred HHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 379999999999999999999999999999999995 5888877543 33468888999999999999999999999999
Q ss_pred CCCcceEEcc-CCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccC
Q psy6593 225 LNSQNCLVRE-DKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVD 302 (433)
Q Consensus 225 lkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D 302 (433)
|+|+||+++. ++.+||+|||++......... .....+++.|+|||.+.+ ..++.++|
T Consensus 128 l~p~nill~~~~~~~kl~dfg~~~~~~~~~~~---------------------~~~~~~~~~y~~PE~~~~~~~~~~~~D 186 (294)
T PLN00009 128 LKPQNLLIDRRTNALKLADFGLARAFGIPVRT---------------------FTHEVVTLWYRAPEILLGSRHYSTPVD 186 (294)
T ss_pred CCcceEEEECCCCEEEEcccccccccCCCccc---------------------cccCceeecccCHHHHhCCCCCCcHHH
Confidence 9999999985 567999999999765332111 013456788999998866 45788999
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCCCCCCC-----------------------ch----hhhccccCCCCcHHHHHHHHH
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRSPDFGL-----------------------DQ----TDFRNKFCASCPEPFVRIAFL 355 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~~~~~~-----------------------~~----~~~~~~~~~~~~~~l~~li~~ 355 (433)
|||||+++|+|++|.+++............ .. ..........+++.+.+++.+
T Consensus 187 v~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 266 (294)
T PLN00009 187 IWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSK 266 (294)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHH
Confidence 999999999999999888543211000000 00 000001124567889999999
Q ss_pred hcccCCCCCCChhHHHH--HHHhh
Q psy6593 356 CCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 356 ~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
||+.+|++||+++++++ ||++.
T Consensus 267 ~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 267 MLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred HccCChhhCcCHHHHhcCchHhHH
Confidence 99999999999999984 66653
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=254.89 Aligned_cols=205 Identities=26% Similarity=0.512 Sum_probs=170.9
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..+|++++++++|+||+++++++..++..++||||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+|
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~d 124 (254)
T cd06627 46 IMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRD 124 (254)
T ss_pred HHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCC
Confidence 348999999999999999999999999999999999999999999765 4599999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|+|+||+++.++.++|+|||++......... .....++..|+|||...+..++.++|||
T Consensus 125 l~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~---------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~ 183 (254)
T cd06627 125 IKAANILTTKDGVVKLADFGVATKLNDVSKD---------------------DASVVGTPYWMAPEVIEMSGASTASDIW 183 (254)
T ss_pred CCHHHEEECCCCCEEEeccccceecCCCccc---------------------ccccccchhhcCHhhhcCCCCCcchhHH
Confidence 9999999999999999999999876543221 1144678889999999888889999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
|+|+++|+|++|.+|+............. ......++..++..+.+++.+||+.+|++||++.+++.
T Consensus 184 ~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 184 SLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 99999999999988875432211111111 11222345677899999999999999999999998873
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=263.48 Aligned_cols=201 Identities=33% Similarity=0.495 Sum_probs=163.0
Q ss_pred cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.+|++++++++|+|++++++++..+...++||||+. ++|.+++......+++..+..++.|++.||.|||+.+++|+||
T Consensus 63 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl 141 (308)
T cd06634 63 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDV 141 (308)
T ss_pred HHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 379999999999999999999999999999999996 5888877654566899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec---CCCCCcccC
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT---GQEYDETVD 302 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~D 302 (433)
+|+||+++.++.++|+|||++...... ....+++.|+|||.+. ...++.++|
T Consensus 142 ~p~nil~~~~~~~kl~dfg~~~~~~~~-------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~D 196 (308)
T cd06634 142 KAGNILLSEPGLVKLGDFGSASIMAPA-------------------------NXFVGTPYWMAPEVILAMDEGQYDGKVD 196 (308)
T ss_pred CHHhEEECCCCcEEECCcccceeecCc-------------------------ccccCCccccCHHHHhhcccCCCCcccc
Confidence 999999999999999999998754321 1345788899999874 345788999
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
|||||+++|+|++|.+|+........................++..+.++|.+||+.+|++||++++++.
T Consensus 197 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 197 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred hHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 9999999999999988765432211111111111111123467788999999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=260.84 Aligned_cols=208 Identities=21% Similarity=0.362 Sum_probs=158.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCC--------eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDR--------KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM 218 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~ 218 (433)
+|++++++++||||+++++++.... ..++||||+. ++|.+++...+..+++..++.++.|++.||+|||+.
T Consensus 60 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 138 (310)
T cd07865 60 REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN 138 (310)
T ss_pred HHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 5899999999999999999987654 4599999995 589988877655799999999999999999999999
Q ss_pred CccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CC
Q psy6593 219 NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EY 297 (433)
Q Consensus 219 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~ 297 (433)
|++|+||+|+||+++.++.++|+|||++........... .......++..|+|||.+.+. .+
T Consensus 139 ~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~ 201 (310)
T cd07865 139 KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP-----------------NRYTNRVVTLWYRPPELLLGERDY 201 (310)
T ss_pred CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCC-----------------CCccCcccCccccCcHHhcCCccc
Confidence 999999999999999999999999999987644322110 001134578889999988664 46
Q ss_pred CcccCeEehhHHHHHHhcCCCCCCCCCCCCC---------------CCCC---c--------h---hhhcccc-CCCCcH
Q psy6593 298 DETVDVFSYGIVLCEIIGRVPADPDYLPRSP---------------DFGL---D--------Q---TDFRNKF-CASCPE 347 (433)
Q Consensus 298 ~~~~DiwslG~il~ell~~~~~~~~~~~~~~---------------~~~~---~--------~---~~~~~~~-~~~~~~ 347 (433)
+.++||||||+++|+|++|.+++........ .... . . ......+ ....+.
T Consensus 202 ~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 281 (310)
T cd07865 202 GPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDP 281 (310)
T ss_pred CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCH
Confidence 8899999999999999999888754321100 0000 0 0 0000000 112346
Q ss_pred HHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 348 PFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 348 ~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
.+.++|.+||+.||.+||+++++++
T Consensus 282 ~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 282 HALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHHHHHHhcCChhhccCHHHHhc
Confidence 7789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=260.51 Aligned_cols=215 Identities=24% Similarity=0.367 Sum_probs=169.2
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..+|++++++++|+||+++++.+..++..++|+||+++++|.+++.+.+ .+++..+..++.|++.||.+||+.|++|+|
T Consensus 40 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 118 (265)
T cd05579 40 VLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRD 118 (265)
T ss_pred HHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCC
Confidence 3478999999999999999999999999999999999999999997754 589999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|+|+||+++.++.++|+|||++........... ...........++..|++||.......+.++|||
T Consensus 119 i~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~ 185 (265)
T cd05579 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL-------------NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWW 185 (265)
T ss_pred CCHHHeEEcCCCCEEEEecccchhcccCccccc-------------ccccccccCcccCccccCHHHhcCCCCCcchhhH
Confidence 999999999999999999999876543221100 0000011245678889999999888889999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCC--CcHHHHHHHHHhcccCCCCCCChhHHHHHHH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCAS--CPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 375 (433)
|||+++|+|++|.+++............... ....+.. ++..+.+++.+||+.+|.+||++.++.+.|+
T Consensus 186 slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 186 SLGCILYEFLVGIPPFHGETPEEIFQNILNG--KIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 9999999999998887543322111111110 1112222 4899999999999999999999966655444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=244.43 Aligned_cols=226 Identities=19% Similarity=0.254 Sum_probs=181.2
Q ss_pred ccCCeeeeeccCCCcchhhhhcc--------------------------chHHHHhhc-CCcceeeEEEEEEeCCeeeEE
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 176 (433)
..+++.....+|+|.-|+|++.. ..+.++..- +.|+||+.+|+|..+...+|.
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 44556677788899999888722 344444444 489999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC-CccccCCCCcceEEccCCceEEeccccchhccCCCCC
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
||.| +.-++.+++.-.+++++..+-++...++.||.||-.+ ||+|||+||+|||+++.|.+||+|||++-++..+...
T Consensus 170 MelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 170 MELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred HHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 9998 5677888877667899999999999999999999977 8999999999999999999999999999887665433
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecC---CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG---QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL 332 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~ 332 (433)
. ...|-+.|||||.+.- ..|+.++||||||++++||.||.-|+..-.........
T Consensus 249 t----------------------rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltk 306 (391)
T KOG0983|consen 249 T----------------------RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTK 306 (391)
T ss_pred c----------------------cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHH
Confidence 2 4578999999999864 46889999999999999999999988764332222222
Q ss_pred chhhhccccC--CCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 333 DQTDFRNKFC--ASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 333 ~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
......+.++ .+.++.|.+++..||.+|+.+||.+.++++
T Consensus 307 vln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 307 VLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 2222222222 457899999999999999999999998874
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=260.13 Aligned_cols=209 Identities=20% Similarity=0.303 Sum_probs=168.3
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+++++++ +|+||+++++.+..+...++||||+++++|.+++... ..+++..+..++.|++.+|.+||+.|++|+||
T Consensus 53 ~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl 131 (288)
T cd05583 53 TERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDI 131 (288)
T ss_pred HHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 689999999 6999999999999999999999999999999998764 35899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC--CCcccCe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE--YDETVDV 303 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di 303 (433)
+|.||+++.++.++|+|||++......... ......|+..|+|||.+.+.. .+.++||
T Consensus 132 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv 191 (288)
T cd05583 132 KLENILLDSEGHVVLTDFGLSKEFLAEEEE--------------------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDW 191 (288)
T ss_pred CHHHeEECCCCCEEEEECcccccccccccc--------------------ccccccCCccccCHHHhcCCCCCCcchhhh
Confidence 999999999999999999998765432111 111346788999999987754 7889999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCchh--hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHh
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT--DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 376 (433)
||||+++|+|++|.+|+............... ......+..++..+.+++.+||+.+|++||++.++...|+.
T Consensus 192 ~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 192 WSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 99999999999998887532211111111111 11123345678899999999999999999999888776665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=253.28 Aligned_cols=208 Identities=30% Similarity=0.509 Sum_probs=172.0
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeC--CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccc
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 222 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H 222 (433)
..+|++++++++|+||+++++.+... +..++|+||+++++|.+++.+.. .+++..+..++.|++.||++||+.|++|
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h 124 (260)
T cd06606 46 LEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVH 124 (260)
T ss_pred HHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 33799999999999999999999988 89999999999999999998754 6999999999999999999999999999
Q ss_pred cCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccC
Q psy6593 223 RDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVD 302 (433)
Q Consensus 223 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 302 (433)
+||+|+||+++.++.++|+|||.+.......... ......++..|+|||.+.+...+.++|
T Consensus 125 ~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~-------------------~~~~~~~~~~y~~pE~~~~~~~~~~~D 185 (260)
T cd06606 125 RDIKGANILVDSDGVVKLADFGCAKRLGDIETGE-------------------GTGSVRGTPYWMAPEVIRGEEYGRAAD 185 (260)
T ss_pred cCCCHHHEEEcCCCCEEEcccccEEecccccccc-------------------cccCCCCCccccCHhhhcCCCCCchhh
Confidence 9999999999999999999999988765543210 011346788899999999888999999
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCC-CCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRS-PDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
|||||+++|+|++|..|+....... .............++...+..+.+++.+|++.+|++||++.+++.
T Consensus 186 v~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 186 IWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 9999999999999888875543110 111111112233445667899999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=256.68 Aligned_cols=205 Identities=22% Similarity=0.375 Sum_probs=169.6
Q ss_pred hccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCCc
Q psy6593 144 QNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNL 220 (433)
Q Consensus 144 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i 220 (433)
...+|++++++++|+||+++++++..+...++||||+++++|.+++.+ .+..+++..+..++.|++.||++||+.|+
T Consensus 45 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i 124 (256)
T cd08530 45 DAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKI 124 (256)
T ss_pred HHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence 344899999999999999999999999999999999999999998855 23468999999999999999999999999
Q ss_pred cccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcc
Q psy6593 221 IHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDET 300 (433)
Q Consensus 221 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 300 (433)
+|+||+|+||+++.++.++|+|||++........ ....+++.|++||.+.+..++.+
T Consensus 125 ~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-----------------------~~~~~~~~~~~Pe~~~~~~~~~~ 181 (256)
T cd08530 125 LHRDLKSANILLVANDLVKIGDLGISKVLKKNMA-----------------------KTQIGTPHYMAPEVWKGRPYSYK 181 (256)
T ss_pred ccCCCCcceEEEecCCcEEEeeccchhhhccCCc-----------------------ccccCCccccCHHHHCCCCCCch
Confidence 9999999999999999999999999987654311 13457888999999999889999
Q ss_pred cCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 301 VDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 301 ~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
+|+||||+++|+|++|.+|+........... .........+...+.++.+++.+||+.+|++||++.++++
T Consensus 182 ~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 182 SDIWSLGCLLYEMATFAPPFEARSMQDLRYK-VQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 9999999999999999988754322111011 1111122334567889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=264.56 Aligned_cols=214 Identities=23% Similarity=0.410 Sum_probs=166.1
Q ss_pred cchHHHHhhcCCcceeeEEEEEEe----CCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCcc
Q psy6593 146 CGQVAVLRSLHHHNVIRFIGVLYK----DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLI 221 (433)
Q Consensus 146 ~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~ 221 (433)
.+|+.+|++++|+||+++++++.. ....++||||+. ++|.+++...+ .+++..+..++.|++.||.|||+.|++
T Consensus 52 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iv 129 (334)
T cd07855 52 LRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSANVI 129 (334)
T ss_pred HHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 379999999999999999998763 346899999995 69999987644 499999999999999999999999999
Q ss_pred ccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcc
Q psy6593 222 HRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDET 300 (433)
Q Consensus 222 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~ 300 (433)
||||||+||+++.++.++|+|||++............ ......++..|+|||.+.+ ..++.+
T Consensus 130 H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~-----------------~~~~~~~~~~y~~PE~~~~~~~~~~~ 192 (334)
T cd07855 130 HRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY-----------------FMTEYVATRWYRAPELLLSLPEYTTA 192 (334)
T ss_pred cCCCCHHHEEEcCCCcEEecccccceeecccCcCCCc-----------------ccccccccccccChHHhcCCcccccc
Confidence 9999999999999999999999998765433221100 0113468889999999866 458899
Q ss_pred cCeEehhHHHHHHhcCCCCCCCCCCCCC--------------CC-CCchh-------hhc-------cccCCCCcHHHHH
Q psy6593 301 VDVFSYGIVLCEIIGRVPADPDYLPRSP--------------DF-GLDQT-------DFR-------NKFCASCPEPFVR 351 (433)
Q Consensus 301 ~DiwslG~il~ell~~~~~~~~~~~~~~--------------~~-~~~~~-------~~~-------~~~~~~~~~~l~~ 351 (433)
+||||||+++|+|++|.++|........ .. ..... ... .......+.++.+
T Consensus 193 ~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (334)
T cd07855 193 IDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALD 272 (334)
T ss_pred cchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHH
Confidence 9999999999999999998854321100 00 00000 000 1112456889999
Q ss_pred HHHHhcccCCCCCCChhHHH--HHHHhhc
Q psy6593 352 IAFLCCDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 352 li~~~l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
++.+||+.+|++||++++++ .|++...
T Consensus 273 li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 273 LLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred HHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 99999999999999999998 4777644
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=258.30 Aligned_cols=206 Identities=25% Similarity=0.385 Sum_probs=163.2
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
..+|++++++++|+||+++++++.+++..++||||++ ++|.+++.... ..+++..++.++.|++.||+|||+.+++|+
T Consensus 45 ~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~ 123 (283)
T cd07835 45 AIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHR 123 (283)
T ss_pred HHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCC
Confidence 3479999999999999999999999999999999995 69999886633 358999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccC
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVD 302 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~D 302 (433)
||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+. .++.++|
T Consensus 124 dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---------------------~~~~~~~~~~~aPE~~~~~~~~~~~~D 182 (283)
T cd07835 124 DLKPQNLLIDREGALKLADFGLARAFGVPVRT---------------------YTHEVVTLWYRAPEILLGSRQYSTPVD 182 (283)
T ss_pred CCCHHHEEEcCCCcEEEeecccccccCCCccc---------------------cCccccccCCCCCceeecCcccCcHHH
Confidence 99999999999999999999998754322111 0123467889999988764 5688999
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCCCCCC----------------Cch-----------hhhccccCCCCcHHHHHHHHH
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRSPDFG----------------LDQ-----------TDFRNKFCASCPEPFVRIAFL 355 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~~~~~----------------~~~-----------~~~~~~~~~~~~~~l~~li~~ 355 (433)
|||||+++|+|++|.++|........... ... ..........++..+.+++.+
T Consensus 183 i~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 262 (283)
T cd07835 183 IWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSK 262 (283)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHH
Confidence 99999999999999988754321000000 000 000111235677899999999
Q ss_pred hcccCCCCCCChhHHHH
Q psy6593 356 CCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 356 ~l~~~p~~RPs~~~i~~ 372 (433)
||+.+|.+||++++++.
T Consensus 263 ~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 263 MLVYDPAKRISAKAALQ 279 (283)
T ss_pred HhcCChhhCcCHHHHhc
Confidence 99999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=258.85 Aligned_cols=205 Identities=23% Similarity=0.375 Sum_probs=159.1
Q ss_pred cchHHHHhhcC-CcceeeEEEEEEeCCe-----eeEEEeccCCCCHHHHhcCC----CCCCChHHHHHHHHHHHHHHhhh
Q psy6593 146 CGQVAVLRSLH-HHNVIRFIGVLYKDRK-----LNLVTEYIAGGTLKELLQDP----GQPLPWGQRVNFARDIAAGMTYL 215 (433)
Q Consensus 146 ~~E~~~l~~l~-h~~iv~~~~~~~~~~~-----~~lv~e~~~g~sL~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~l 215 (433)
.+|+.+++++. |+||+++++++...+. .|+||||+++ +|.+++... +..+++..++.++.||+.||.||
T Consensus 48 ~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L 126 (295)
T cd07837 48 LREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126 (295)
T ss_pred HHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 37999999994 6999999999987665 8999999975 898887542 34589999999999999999999
Q ss_pred hcCCccccCCCCcceEEcc-CCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC
Q psy6593 216 HSMNLIHRDLNSQNCLVRE-DKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG 294 (433)
Q Consensus 216 H~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 294 (433)
|+.|++||||+|+||+++. ++.++|+|||++......... .....+++.|+|||.+.+
T Consensus 127 H~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~---------------------~~~~~~~~~~~aPE~~~~ 185 (295)
T cd07837 127 HKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS---------------------YTHEIVTLWYRAPEVLLG 185 (295)
T ss_pred HHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCccc---------------------cCCcccccCCCChHHhhC
Confidence 9999999999999999998 899999999998765332111 112356788999998865
Q ss_pred -CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCC--------------C-CC---c--------hhhhccccCCCCcH
Q psy6593 295 -QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPD--------------F-GL---D--------QTDFRNKFCASCPE 347 (433)
Q Consensus 295 -~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~--------------~-~~---~--------~~~~~~~~~~~~~~ 347 (433)
..++.++||||||+++|+|++|.+++......... . .. . ...........++.
T Consensus 186 ~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (295)
T cd07837 186 STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSP 265 (295)
T ss_pred CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCH
Confidence 45789999999999999999999887543211000 0 00 0 00000111245788
Q ss_pred HHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 348 PFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 348 ~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
.+.++|.+||+.+|.+||++++++.
T Consensus 266 ~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 266 EGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHHHHHHHccCChhhcCCHHHHhc
Confidence 9999999999999999999999873
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=261.09 Aligned_cols=231 Identities=20% Similarity=0.283 Sum_probs=173.6
Q ss_pred cccCCeeeeeccCCCcchhhhh--------------------------ccchHHHHhhc-CCcceeeEEEEEEeCCeeeE
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQ--------------------------NCGQVAVLRSL-HHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~--------------------------~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 175 (433)
++.+++.+...++.|+||+||+ ...|+.++.++ .|+||+++++++..+...++
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 3445555566666666666654 12466666666 59999999999999999999
Q ss_pred EEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhc-CCccccCCCCcceEEccCCceEEeccccchhccCCCC
Q psy6593 176 VTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
||||+ +++|.+++......+++..+..++.|++.||+|||+ .||+||||+|+||++++++.++|+|||++........
T Consensus 92 v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 92 CMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred Eeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 99998 458888876655579999999999999999999997 5999999999999999999999999999876533211
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCCC----CCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE----YDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF 330 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~ 330 (433)
. ....++..|+|||.+.+.. ++.++||||||+++|+|++|.+|+..........
T Consensus 171 ~----------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 228 (296)
T cd06618 171 K----------------------TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL 228 (296)
T ss_pred c----------------------cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHH
Confidence 1 1234678899999987653 7889999999999999999998875421110000
Q ss_pred CCchhhhcccc--CCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 331 GLDQTDFRNKF--CASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 331 ~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
........... ...++.++.+++.+||+.+|++||++++++. |++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 229 TKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 00000001111 1246889999999999999999999999973 5554
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=226.83 Aligned_cols=220 Identities=25% Similarity=0.341 Sum_probs=175.4
Q ss_pred eeccCCCcchhhhh---------------------------ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCC
Q psy6593 131 CKEDYNGKYGEACQ---------------------------NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGG 183 (433)
Q Consensus 131 ~~~~~~g~fg~v~~---------------------------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 183 (433)
..++|+|.||+|+| +.+|+.+|+.++|.|||++++....++.+.+|+||| ..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dq 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQ 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hH
Confidence 45788888998887 338999999999999999999999999999999999 57
Q ss_pred CHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccc
Q psy6593 184 TLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263 (433)
Q Consensus 184 sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 263 (433)
+|..++..-++.+..+.++.++.|++.||.++|+.+++|||+||+|++|+.+|.+||+|||+++.++.....
T Consensus 86 dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc-------- 157 (292)
T KOG0662|consen 86 DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC-------- 157 (292)
T ss_pred HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe--------
Confidence 999999887778999999999999999999999999999999999999999999999999999987653211
Q ss_pred hhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeEehhHHHHHHh-cCCCCCCCCCCCCCCCC----------
Q psy6593 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEII-GRVPADPDYLPRSPDFG---------- 331 (433)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell-~~~~~~~~~~~~~~~~~---------- 331 (433)
....+-|.+|.+|.++.+. -|+...|+||.|||+.|+. .|.|.|+..........
T Consensus 158 -------------ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~e 224 (292)
T KOG0662|consen 158 -------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224 (292)
T ss_pred -------------eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcc
Confidence 1134668999999999884 5889999999999999999 78887764321111000
Q ss_pred -----C---chhhhccccC---------CCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 332 -----L---DQTDFRNKFC---------ASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 332 -----~---~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
+ ..-...+.++ ..+...-+++++++|.-+|..|.++++.++
T Consensus 225 d~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 225 DQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 0 0000000011 223334588999999999999999987763
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=255.47 Aligned_cols=207 Identities=24% Similarity=0.387 Sum_probs=163.6
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeC--CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccc
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 222 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H 222 (433)
..+|++++++++|+||+++++++... +..++||||++ ++|.+++......+++..++.++.|++.||++||+.|++|
T Consensus 45 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h 123 (287)
T cd07840 45 AIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILH 123 (287)
T ss_pred HHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence 33799999999999999999999988 89999999996 5999998776557999999999999999999999999999
Q ss_pred cCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCccc
Q psy6593 223 RDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETV 301 (433)
Q Consensus 223 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~ 301 (433)
+||+|+||++++++.++|+|||++.......... .....++..|+|||.+.+ ..++.++
T Consensus 124 ~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~--------------------~~~~~~~~~y~~PE~~~~~~~~~~~~ 183 (287)
T cd07840 124 RDIKGSNILINNDGVLKLADFGLARPYTKRNSAD--------------------YTNRVITLWYRPPELLLGATRYGPEV 183 (287)
T ss_pred ccCcHHHeEEcCCCCEEEccccceeeccCCCccc--------------------ccccccccccCCceeeEccccCChHH
Confidence 9999999999999999999999998765432110 113356788999998765 4578999
Q ss_pred CeEehhHHHHHHhcCCCCCCCCCCCCC--------------CC----CC-----------chhhhccccCCCCcHHHHHH
Q psy6593 302 DVFSYGIVLCEIIGRVPADPDYLPRSP--------------DF----GL-----------DQTDFRNKFCASCPEPFVRI 352 (433)
Q Consensus 302 DiwslG~il~ell~~~~~~~~~~~~~~--------------~~----~~-----------~~~~~~~~~~~~~~~~l~~l 352 (433)
||||||+++|+|++|.+++........ .. .+ ........+...++..+.++
T Consensus 184 Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (287)
T cd07840 184 DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDL 263 (287)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHH
Confidence 999999999999999888754321100 00 00 00000011112248899999
Q ss_pred HHHhcccCCCCCCChhHHHH
Q psy6593 353 AFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 353 i~~~l~~~p~~RPs~~~i~~ 372 (433)
+.+||+.+|.+||++++++.
T Consensus 264 i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 264 LDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred HHHHcCCChhhCcCHHHHhh
Confidence 99999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-33 Score=257.73 Aligned_cols=205 Identities=22% Similarity=0.390 Sum_probs=165.1
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCCcc
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLI 221 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~ 221 (433)
...|+.++++++||||+++++++.+.+..++||||+++++|.+++.+ .+..+++..++.++.|++.||.+||+.|++
T Consensus 49 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~ 128 (260)
T cd08222 49 ANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRIL 128 (260)
T ss_pred HHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCcc
Confidence 33688999999999999999999999999999999999999988853 345699999999999999999999999999
Q ss_pred ccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCccc
Q psy6593 222 HRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETV 301 (433)
Q Consensus 222 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 301 (433)
|+||+|+||+++. +.++|+|||++.......... ....|++.|+|||.+.+..++.++
T Consensus 129 h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~---------------------~~~~~~~~~~~pe~~~~~~~~~~~ 186 (260)
T cd08222 129 HRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLA---------------------TTFTGTPYYMSPEALKHQGYDSKS 186 (260)
T ss_pred ccCCChhheEeec-CCEeecccCceeecCCCcccc---------------------cCCCCCcCccCHHHHccCCCCchh
Confidence 9999999999975 569999999987654322111 134578889999999888889999
Q ss_pred CeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 302 DVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 302 DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
|+||||+++|+|+++..++............ ........+..++.++.+++.+||+.+|++||+++++++
T Consensus 187 Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 187 DIWSLGCILYEMCCLAHAFEGQNFLSVVLRI-VEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred hHHHHHHHHHHHHhCCCCCCCccHHHHHHHH-HcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 9999999999999988877532211100000 011122234567889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=257.37 Aligned_cols=205 Identities=23% Similarity=0.375 Sum_probs=160.7
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCC----------eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhh
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDR----------KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLH 216 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~----------~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH 216 (433)
+|++++++++||||+++++++.... .+++|+||+++ +|.+.+......+++..++.++.|++.||+|||
T Consensus 55 ~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH 133 (302)
T cd07864 55 REIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH 133 (302)
T ss_pred HHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 6999999999999999999987654 79999999975 788887765556999999999999999999999
Q ss_pred cCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-C
Q psy6593 217 SMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-Q 295 (433)
Q Consensus 217 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~ 295 (433)
+.||+|+||+|+||++++++.+||+|||++........... ....++..|+|||.+.+ .
T Consensus 134 ~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~--------------------~~~~~~~~y~~PE~~~~~~ 193 (302)
T cd07864 134 KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY--------------------TNKVITLWYRPPELLLGEE 193 (302)
T ss_pred hCCeecCCCCHHHEEECCCCcEEeCcccccccccCCccccc--------------------ccceeccCccChHHhcCCC
Confidence 99999999999999999999999999999986644321110 12345778999998865 3
Q ss_pred CCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCC---------------CCCc-------------hhhhccccCCCCcH
Q psy6593 296 EYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPD---------------FGLD-------------QTDFRNKFCASCPE 347 (433)
Q Consensus 296 ~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~---------------~~~~-------------~~~~~~~~~~~~~~ 347 (433)
.++.++||||||+++|+|++|.+++......... .... ...........+|.
T Consensus 194 ~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (302)
T cd07864 194 RYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPT 273 (302)
T ss_pred CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCH
Confidence 5688999999999999999999887542110000 0000 00000112245689
Q ss_pred HHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 348 PFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 348 ~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
.+.+++.+||+.+|.+||++++++.
T Consensus 274 ~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 274 PALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhc
Confidence 9999999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=262.55 Aligned_cols=209 Identities=23% Similarity=0.368 Sum_probs=164.5
Q ss_pred chHHHHhhcCCcceeeEEEEEEeC-----CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCcc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKD-----RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLI 221 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~ 221 (433)
+|+.+++.++|+||+++++++... ...++|+||+. ++|.+++...+ .+++..+..++.|++.||.|||+.+++
T Consensus 53 ~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~ 130 (337)
T cd07858 53 REIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHSANVL 130 (337)
T ss_pred HHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 699999999999999999988654 35899999995 79999887644 599999999999999999999999999
Q ss_pred ccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcc
Q psy6593 222 HRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDET 300 (433)
Q Consensus 222 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~ 300 (433)
|+||||+||+++.++.++|+|||++......... .....++..|+|||.+.+ ..++.+
T Consensus 131 H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~ 189 (337)
T cd07858 131 HRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF---------------------MTEYVVTRWYRAPELLLNCSEYTTA 189 (337)
T ss_pred cCCCCHHHEEEcCCCCEEECcCccccccCCCccc---------------------ccccccccCccChHHHhcCCCCCCc
Confidence 9999999999999999999999998765432111 013457888999998765 468899
Q ss_pred cCeEehhHHHHHHhcCCCCCCCCCCC---------------CCCCCCch---h-----------hhccccCCCCcHHHHH
Q psy6593 301 VDVFSYGIVLCEIIGRVPADPDYLPR---------------SPDFGLDQ---T-----------DFRNKFCASCPEPFVR 351 (433)
Q Consensus 301 ~DiwslG~il~ell~~~~~~~~~~~~---------------~~~~~~~~---~-----------~~~~~~~~~~~~~l~~ 351 (433)
+||||||+++|+|++|.++|...... .....+.. . .........+++++.+
T Consensus 190 ~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (337)
T cd07858 190 IDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAID 269 (337)
T ss_pred ccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHH
Confidence 99999999999999999888542110 00000000 0 0001112467889999
Q ss_pred HHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 352 IAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 352 li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
++.+||+.+|++||+++++++ ||..+.
T Consensus 270 li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 270 LLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred HHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 999999999999999999984 777643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=263.27 Aligned_cols=211 Identities=25% Similarity=0.419 Sum_probs=162.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeC-----CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCcc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKD-----RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLI 221 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~ 221 (433)
+|+.++++++|+||+++++++... ...++|+||+. ++|.+++.. ..+++..+..++.|++.||++||+.||+
T Consensus 52 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~iv 128 (336)
T cd07849 52 REIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVL 128 (336)
T ss_pred HHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 699999999999999999987644 35899999995 589888865 4699999999999999999999999999
Q ss_pred ccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcc
Q psy6593 222 HRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDET 300 (433)
Q Consensus 222 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~ 300 (433)
||||||+||+++.++.++|+|||++........... ......||+.|+|||.+.+ ..++.+
T Consensus 129 H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~ 190 (336)
T cd07849 129 HRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTG------------------FLTEYVATRWYRAPEIMLNSKGYTKA 190 (336)
T ss_pred ccCCCHHHEEECCCCCEEECcccceeeccccccccC------------------CcCCcCcCCCccChHHhhCCCCCCcH
Confidence 999999999999999999999999876543221110 1113568899999998654 568899
Q ss_pred cCeEehhHHHHHHhcCCCCCCCCCCCC--------------CC-CCC---chhhhc-----------cccCCCCcHHHHH
Q psy6593 301 VDVFSYGIVLCEIIGRVPADPDYLPRS--------------PD-FGL---DQTDFR-----------NKFCASCPEPFVR 351 (433)
Q Consensus 301 ~DiwslG~il~ell~~~~~~~~~~~~~--------------~~-~~~---~~~~~~-----------~~~~~~~~~~l~~ 351 (433)
+||||||+++|+|++|.+++....... .. ..+ ...... .......+.++.+
T Consensus 191 ~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (336)
T cd07849 191 IDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALD 270 (336)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHH
Confidence 999999999999999998885421100 00 000 000000 0011345788999
Q ss_pred HHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 352 IAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 352 li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
++.+||+.+|++||++.++++ ||+...
T Consensus 271 li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 271 LLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 999999999999999999984 677554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=255.67 Aligned_cols=204 Identities=21% Similarity=0.337 Sum_probs=162.7
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+++|+++ +|+||+++++.+..+...++||||+++++|.+++.... .+++..+..++.|++.||.+||+.|++||||
T Consensus 53 ~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl 131 (290)
T cd05613 53 TERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKLGIIYRDI 131 (290)
T ss_pred HHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 699999999 69999999999999999999999999999999987643 5899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC--CCCcccCe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ--EYDETVDV 303 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di 303 (433)
+|+||+++.++.++|+|||++......... ......|+..|+|||.+.+. .++.++||
T Consensus 132 ~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv 191 (290)
T cd05613 132 KLENILLDSNGHVVLTDFGLSKEFHEDEVE--------------------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDW 191 (290)
T ss_pred CHHHeEECCCCCEEEeeCccceeccccccc--------------------ccccccCCcccCChhhccCCCCCCCccccH
Confidence 999999999999999999998765332111 11145688899999998753 46789999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCchh--hhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHH
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT--DFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLE 371 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~ 371 (433)
||||+++|+|++|.+|+...........+... ......+..++..+.+++.+||+.+|++|| ++++++
T Consensus 192 ~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~ 266 (290)
T cd05613 192 WSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266 (290)
T ss_pred HHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 99999999999998877532111111111111 111223456788999999999999999997 556665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=258.58 Aligned_cols=209 Identities=22% Similarity=0.362 Sum_probs=161.8
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeC--CeeeEEEeccCCCCHHHHhcC----CCCCCChHHHHHHHHHHHHHHhhhhcC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQD----PGQPLPWGQRVNFARDIAAGMTYLHSM 218 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~~ 218 (433)
..+|+.++++++||||+++++++... ..+++||||++ ++|.+++.. ....+++..++.++.|++.||.|||+.
T Consensus 49 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 127 (316)
T cd07842 49 ACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN 127 (316)
T ss_pred HHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC
Confidence 34799999999999999999999988 78999999996 578777643 223689999999999999999999999
Q ss_pred CccccCCCCcceEEcc----CCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC
Q psy6593 219 NLIHRDLNSQNCLVRE----DKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG 294 (433)
Q Consensus 219 ~i~H~dlkp~Nil~~~----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 294 (433)
+|+||||||+||+++. ++.+||+|||++........... ......+++.|+|||.+.+
T Consensus 128 ~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~------------------~~~~~~~~~~y~aPE~~~~ 189 (316)
T cd07842 128 WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA------------------DLDPVVVTIWYRAPELLLG 189 (316)
T ss_pred CEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCccccc------------------ccCCccccccccCHHHHhC
Confidence 9999999999999998 89999999999986543221100 1114467889999998776
Q ss_pred -CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC------------------------------Cch---hhhccc
Q psy6593 295 -QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG------------------------------LDQ---TDFRNK 340 (433)
Q Consensus 295 -~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~------------------------------~~~---~~~~~~ 340 (433)
..++.++||||||+++|+|++|.+++........... ... ......
T Consensus 190 ~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (316)
T cd07842 190 ARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKT 269 (316)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCC
Confidence 4578999999999999999999988864432210000 000 000000
Q ss_pred c---------C--CCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 341 F---------C--ASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 341 ~---------~--~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
. . ...+..+.+++.+||+.||++||++.+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 270 YPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred CCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 0 156678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=259.24 Aligned_cols=219 Identities=18% Similarity=0.307 Sum_probs=165.7
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+.+++.++||||+++++++..++..++||||+.+++|.+++.+. ...+++..+..++.|++.||+|||+.|++||||
T Consensus 48 ~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDl 127 (328)
T cd08226 48 NEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNI 127 (328)
T ss_pred HHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 7889999999999999999999999999999999999999998763 235899999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC--CCCcccCe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ--EYDETVDV 303 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di 303 (433)
||+||+++.++.+++.||+.+............ .........++..|+|||++.+. .++.++||
T Consensus 128 kp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di 193 (328)
T cd08226 128 KASHILISGDGLVSLSGLSHLYSLVRNGQKAKV--------------VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDI 193 (328)
T ss_pred CHHHEEEeCCCcEEEechHHHhhhhccCccccc--------------cccccccccCccCccChhhhcCCCCCCCchhhH
Confidence 999999999999999999866443221110000 00000012345679999998763 47899999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCC---------------------------------------------CCchhhhc
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDF---------------------------------------------GLDQTDFR 338 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~ 338 (433)
||||+++|+|++|.+|+.......... .+......
T Consensus 194 wslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (328)
T cd08226 194 YSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR 273 (328)
T ss_pred HHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhcccccccccccccc
Confidence 999999999999988875432100000 00000001
Q ss_pred cccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhcc
Q psy6593 339 NKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLSM 379 (433)
Q Consensus 339 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~~ 379 (433)
......+++.+.+|+++||+.||++||++++++ .||+.+..
T Consensus 274 ~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 274 TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 111234567899999999999999999999997 58887654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-33 Score=259.13 Aligned_cols=222 Identities=21% Similarity=0.336 Sum_probs=171.8
Q ss_pred chHHHHhhcC-CcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|++++++++ |+||+++++.+..++..++|||++++++|.+++.+.+ .+++..++.++.|++.||.+||+.|++|+||
T Consensus 50 ~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl 128 (280)
T cd05581 50 IEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDL 128 (280)
T ss_pred HHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCC
Confidence 6889999998 9999999999999999999999999999999998754 5999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
+|+||+++.++.++|+|||++................. .................++..|+|||......++.++||||
T Consensus 129 ~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~s 207 (280)
T cd05581 129 KPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT-NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWA 207 (280)
T ss_pred CHHHeEECCCCCEEecCCccccccCCccccccCCCCCc-cccccccccccccccccCCccccCHHHhCCCCCChhhhHHH
Confidence 99999999999999999999987654332110000000 00000001112223556889999999998888999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCCh----hHHHH
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF----EVLEV 372 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~----~~i~~ 372 (433)
||++++++++|.+|+.......... ........++..+++.+.+++.+||+.+|.+||++ +++++
T Consensus 208 lG~~l~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 208 LGCIIYQMLTGKPPFRGSNEYLTFQ--KILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHHHHhCCCCCCCccHHHHHH--HHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 9999999999998876543111100 01122233456778999999999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=263.44 Aligned_cols=206 Identities=23% Similarity=0.357 Sum_probs=164.5
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCC------eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDR------KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNL 220 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i 220 (433)
+|+++|++++|+||+++++++..+. .+++||||+ |++|.+++.. ..+++..++.++.|++.||+|||+.||
T Consensus 63 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi 139 (343)
T cd07880 63 RELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGI 139 (343)
T ss_pred HHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 6999999999999999999987654 468999999 7899998875 459999999999999999999999999
Q ss_pred cccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCc
Q psy6593 221 IHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDE 299 (433)
Q Consensus 221 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ 299 (433)
+||||||+||+++.++.++|+|||++....... ....+++.|+|||.+.+ ..++.
T Consensus 140 ~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~------------------------~~~~~~~~y~aPE~~~~~~~~~~ 195 (343)
T cd07880 140 IHRDLKPGNLAVNEDCELKILDFGLARQTDSEM------------------------TGYVVTRWYRAPEVILNWMHYTQ 195 (343)
T ss_pred ecCCCCHHHEEEcCCCCEEEeecccccccccCc------------------------cccccCCcccCHHHHhCCCCCCc
Confidence 999999999999999999999999987543211 13456888999999876 45788
Q ss_pred ccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC------------------Cchhhh-----------ccccCCCCcHHHH
Q psy6593 300 TVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG------------------LDQTDF-----------RNKFCASCPEPFV 350 (433)
Q Consensus 300 ~~DiwslG~il~ell~~~~~~~~~~~~~~~~~------------------~~~~~~-----------~~~~~~~~~~~l~ 350 (433)
++|+||||+++|+|++|.+|+........... ...... .......++..+.
T Consensus 196 ~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (343)
T cd07880 196 TVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAV 275 (343)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHH
Confidence 99999999999999999988754321100000 000000 0112246778899
Q ss_pred HHHHHhcccCCCCCCChhHHH--HHHHhhcc
Q psy6593 351 RIAFLCCDLNPDQRPPFEVLE--VWLEGLSM 379 (433)
Q Consensus 351 ~li~~~l~~~p~~RPs~~~i~--~~l~~~~~ 379 (433)
+++.+||+.||.+||++.+++ .||+....
T Consensus 276 ~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 276 NVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 999999999999999999998 68887654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=258.89 Aligned_cols=215 Identities=23% Similarity=0.365 Sum_probs=160.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCC--------eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDR--------KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM 218 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~ 218 (433)
+|++++++++|+||+++++++.... .+++||||+. ++|.+.+......+++..+..++.|++.||.|||+.
T Consensus 56 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~ 134 (311)
T cd07866 56 REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN 134 (311)
T ss_pred HHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 6999999999999999999876433 4699999995 578888776556799999999999999999999999
Q ss_pred CccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCC
Q psy6593 219 NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEY 297 (433)
Q Consensus 219 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~ 297 (433)
|++|+||||+||++++++.++|+|||++............. ............+++.|+|||.+.+ ..+
T Consensus 135 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 204 (311)
T cd07866 135 HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG----------GGGGTRKYTNLVVTRWYRPPELLLGERRY 204 (311)
T ss_pred CeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccC----------CcccccccccceeccCcCChHHhhCCCcc
Confidence 99999999999999999999999999998665432211100 0001111224567889999998765 357
Q ss_pred CcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC--------------------------CC--chhhhccccCCCCcHHH
Q psy6593 298 DETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF--------------------------GL--DQTDFRNKFCASCPEPF 349 (433)
Q Consensus 298 ~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~--------------------------~~--~~~~~~~~~~~~~~~~l 349 (433)
+.++||||||+++|+|++|.+++.......... .. .............+..+
T Consensus 205 ~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (311)
T cd07866 205 TTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEG 284 (311)
T ss_pred CchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhH
Confidence 899999999999999999998875422110000 00 00000000113445788
Q ss_pred HHHHHHhcccCCCCCCChhHHHH
Q psy6593 350 VRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 350 ~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
.+++.+||+.+|.+||++.+++.
T Consensus 285 ~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 285 LDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHcccCcccCcCHHHHhc
Confidence 99999999999999999988874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=279.05 Aligned_cols=239 Identities=28% Similarity=0.469 Sum_probs=200.1
Q ss_pred ccccccCCeeeeeccCCCcchhhhhcc---------------------------------chHHHHhhc-CCcceeeEEE
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQNC---------------------------------GQVAVLRSL-HHHNVIRFIG 165 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~~---------------------------------~E~~~l~~l-~h~~iv~~~~ 165 (433)
.|.+..+++.+.+.++.|.||.|+++. .|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 566777777788899999999998732 799999999 7999999999
Q ss_pred EEEeCCeeeEEEeccCCCCHHHHhcCCC---------------CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcce
Q psy6593 166 VLYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 230 (433)
Q Consensus 166 ~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Ni 230 (433)
++.+++.+++|+||+..|+|.++++..+ ..++..+.+.++.||+.|++||++.+++||||...||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 9999999999999999999999998755 3489999999999999999999999999999999999
Q ss_pred EEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeec--cCccccccceecCCCCCcccCeEehhH
Q psy6593 231 LVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVV--GNPYWMAPEMMTGQEYDETVDVFSYGI 308 (433)
Q Consensus 231 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DiwslG~ 308 (433)
|++.+..+||+|||+++........... .-. -...|||||.+....++.++||||+|+
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~--------------------~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI 509 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTK--------------------SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGI 509 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEec--------------------CCCCccceeecCHHHhccCcccccchhhHHHH
Confidence 9999999999999999976554433211 111 123499999999999999999999999
Q ss_pred HHHHHh-cCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 309 VLCEII-GRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 309 il~ell-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
+|||++ -|.+|++................+...|..+++++.++|+.||+.+|++||++.++.+.|+...
T Consensus 510 ~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 510 LLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 999999 4566665532222223334455566778889999999999999999999999999999999854
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=259.03 Aligned_cols=205 Identities=26% Similarity=0.399 Sum_probs=162.2
Q ss_pred chHHHHhhcCCcceeeEEEEEEe-CCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYK-DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|++++++++||||+++++++.. .+..++|+||+ +++|.+++.. ..+++..+..++.|++.||.+||+.|++|+||
T Consensus 58 ~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl 134 (328)
T cd07856 58 RELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDL 134 (328)
T ss_pred HHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 69999999999999999999875 46789999999 6799998875 35889999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeE
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVF 304 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw 304 (433)
+|+||++++++.++|+|||++....... ....++..|+|||.+.+ ..++.++|||
T Consensus 135 ~p~Nili~~~~~~~l~dfg~~~~~~~~~------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~ 190 (328)
T cd07856 135 KPSNILINENCDLKICDFGLARIQDPQM------------------------TGYVSTRYYRAPEIMLTWQKYDVEVDIW 190 (328)
T ss_pred CHHHEeECCCCCEEeCccccccccCCCc------------------------CCCcccccccCceeeeccCCcCcHHHHH
Confidence 9999999999999999999987542211 13456788999998766 5689999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCC---------------CC---Cchhhh-----------ccccCCCCcHHHHHHHHH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPD---------------FG---LDQTDF-----------RNKFCASCPEPFVRIAFL 355 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~---------------~~---~~~~~~-----------~~~~~~~~~~~l~~li~~ 355 (433)
|||+++|+|++|.+++......... .. .....+ .......++..+.++|.+
T Consensus 191 slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 270 (328)
T cd07856 191 SAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEK 270 (328)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHH
Confidence 9999999999999888543210000 00 000000 001124567899999999
Q ss_pred hcccCCCCCCChhHHHH--HHHhhc
Q psy6593 356 CCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 356 ~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
||+.+|++||++++++. |++...
T Consensus 271 ~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 271 MLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred HcCCChhhCCCHHHHhcCCcccccc
Confidence 99999999999999984 666544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=248.52 Aligned_cols=191 Identities=17% Similarity=0.147 Sum_probs=156.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|...+....||||+++++++...+..++||||++|++|.+++.+.. .+++..+..++.|++.||.|||+.|++|+|||
T Consensus 34 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlk 112 (237)
T cd05576 34 RERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHREGIVCRDLN 112 (237)
T ss_pred hHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence 45555666679999999999999999999999999999999987643 58999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.++|+|||.+........ ...++..|+|||.+.+..++.++||||+
T Consensus 113 p~Nil~~~~~~~~l~df~~~~~~~~~~~------------------------~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 168 (237)
T cd05576 113 PNNILLDDRGHIQLTYFSRWSEVEDSCD------------------------GEAVENMYCAPEVGGISEETEACDWWSL 168 (237)
T ss_pred HHHEEEcCCCCEEEecccchhccccccc------------------------cCCcCccccCCcccCCCCCCchhhHHHH
Confidence 9999999999999999998765433211 2345667999999988889999999999
Q ss_pred hHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChh
Q psy6593 307 GIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFE 368 (433)
Q Consensus 307 G~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~ 368 (433)
|+++|+|++|.+++....... .......++..+++.+.+++.+||+.||++||++.
T Consensus 169 G~il~el~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 169 GAILFELLTGKTLVECHPSGI------NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHHCcchhhcCchhc------ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 999999999887654321110 00111234466788999999999999999999873
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=259.57 Aligned_cols=214 Identities=24% Similarity=0.375 Sum_probs=165.7
Q ss_pred ccchHHHHhhc-CCcceeeEEEEEEeC--CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCcc
Q psy6593 145 NCGQVAVLRSL-HHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLI 221 (433)
Q Consensus 145 ~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~ 221 (433)
.++|+.+++++ +|+||+++++++... ...++||||++ ++|.+++.+. .+++..+..++.|++.||.|||+.||+
T Consensus 53 ~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~ 129 (337)
T cd07852 53 TFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVI 129 (337)
T ss_pred hhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 34799999999 999999999998654 36899999996 5999998763 688999999999999999999999999
Q ss_pred ccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcc
Q psy6593 222 HRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDET 300 (433)
Q Consensus 222 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~ 300 (433)
|+||+|+||+++.++.++|+|||++........... ........|+..|+|||.+.+ ..++.+
T Consensus 130 H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 193 (337)
T cd07852 130 HRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE----------------NPVLTDYVATRWYRAPEILLGSTRYTKG 193 (337)
T ss_pred cCCCCHHHEEEcCCCcEEEeeccchhcccccccccc----------------CcchhcccccccccCceeeecccccccc
Confidence 999999999999999999999999987644322100 001124568999999998765 457889
Q ss_pred cCeEehhHHHHHHhcCCCCCCCCCCCCCCCC---------------------------C--chhhhccccCCCCcHHHHH
Q psy6593 301 VDVFSYGIVLCEIIGRVPADPDYLPRSPDFG---------------------------L--DQTDFRNKFCASCPEPFVR 351 (433)
Q Consensus 301 ~DiwslG~il~ell~~~~~~~~~~~~~~~~~---------------------------~--~~~~~~~~~~~~~~~~l~~ 351 (433)
+||||||+++|+|++|.+++........... . ............++.++.+
T Consensus 194 sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 273 (337)
T cd07852 194 VDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALD 273 (337)
T ss_pred chHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHH
Confidence 9999999999999999988754321110000 0 0000001112347889999
Q ss_pred HHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 352 IAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 352 li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
++.+||+.+|++||++.++++ |++..
T Consensus 274 li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 274 LLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHhccCCcccccCHHHHhhChhhhhh
Confidence 999999999999999999984 66654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-33 Score=260.42 Aligned_cols=225 Identities=21% Similarity=0.350 Sum_probs=184.5
Q ss_pred eccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCC
Q psy6593 132 KEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGT 184 (433)
Q Consensus 132 ~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~s 184 (433)
+.+|.|.||+||-.. +|++||+++.||.||.+.-.|++.+..++|||-+.|.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 367899999999521 89999999999999999999999999999999996544
Q ss_pred HHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccC---CceEEeccccchhccCCCCCCccccc
Q psy6593 185 LKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRED---KTVVVADFGLARIIHQGPRAPTTVMA 261 (433)
Q Consensus 185 L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~ 261 (433)
|+-++....+++++....-++.||+.||.|||.+||+|.||||+|||+.+. ..+||+|||+++.+....
T Consensus 650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-------- 721 (888)
T KOG4236|consen 650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-------- 721 (888)
T ss_pred HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh--------
Confidence 455555566779999999999999999999999999999999999999744 579999999999876532
Q ss_pred cchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhcccc
Q psy6593 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKF 341 (433)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (433)
.++..+|||.|+|||++....|++.-|+||.|+|+|--+.|.-||.....-........--+....
T Consensus 722 --------------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~P 787 (888)
T KOG4236|consen 722 --------------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNP 787 (888)
T ss_pred --------------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCc
Confidence 234789999999999999999999999999999999999998888654322211111111233344
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhc
Q psy6593 342 CASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 342 ~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
+..++....+||..+|+..-++|.|.++-+ .||++.+
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 578899999999999999999999988776 4666543
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=255.91 Aligned_cols=207 Identities=24% Similarity=0.406 Sum_probs=166.2
Q ss_pred hccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 144 QNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 144 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
+..+|+++|++++|+||+++++++..++..++|+||+++ +|.+++......+++..+..++.|++.||.+||+.|++|+
T Consensus 44 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~ 122 (283)
T cd05118 44 TALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHR 122 (283)
T ss_pred HHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 344799999999999999999999999999999999965 8988887755679999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccC
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVD 302 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~D 302 (433)
||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+. .++.++|
T Consensus 123 dl~p~nili~~~~~~~l~df~~~~~~~~~~~~---------------------~~~~~~~~~~~~PE~~~~~~~~~~~~D 181 (283)
T cd05118 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRP---------------------YTHYVVTRWYRAPELLLGDKGYSTPVD 181 (283)
T ss_pred CcCHHHEEECCCCcEEEeeeeeeEecCCCccc---------------------ccCccCcccccCcHHHhcCCCCCchhH
Confidence 99999999999999999999998766443210 1134577889999998876 7889999
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCCCC--------------C-CCch-------------hhhccccCCCCcHHHHHHHH
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRSPD--------------F-GLDQ-------------TDFRNKFCASCPEPFVRIAF 354 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~~~--------------~-~~~~-------------~~~~~~~~~~~~~~l~~li~ 354 (433)
|||||+++|+|++|.++|......... . .... ..........++.++.++|.
T Consensus 182 i~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 261 (283)
T cd05118 182 IWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLS 261 (283)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHH
Confidence 999999999999999887543210000 0 0000 00001122456789999999
Q ss_pred HhcccCCCCCCChhHHHH
Q psy6593 355 LCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 355 ~~l~~~p~~RPs~~~i~~ 372 (433)
+||+.||.+||++++++.
T Consensus 262 ~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 262 QMLHYDPHKRITAEQALA 279 (283)
T ss_pred HHhccCcccCcCHHHHhh
Confidence 999999999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=261.84 Aligned_cols=215 Identities=25% Similarity=0.398 Sum_probs=170.6
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCC-----eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDR-----KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN 219 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ 219 (433)
..+|+.++++++|+||+++++++.... ..|+||||+. ++|.+++.+.. .+++..++.++.|++.||++||+.|
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~g 123 (330)
T cd07834 46 ILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSAN 123 (330)
T ss_pred HHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 337999999999999999999998775 7899999996 58999987644 6999999999999999999999999
Q ss_pred ccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCC
Q psy6593 220 LIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYD 298 (433)
Q Consensus 220 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~ 298 (433)
++|+||||+||+++.++.++|+|||++.......... .......+++.|+|||.+.+. .++
T Consensus 124 i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~ 185 (330)
T cd07834 124 VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK------------------GFLTEYVVTRWYRAPELLLSSSRYT 185 (330)
T ss_pred eecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc------------------ccccccccccCcCCceeeecccCCC
Confidence 9999999999999999999999999998765432100 011134678899999999887 789
Q ss_pred cccCeEehhHHHHHHhcCCCCCCCCCCCC--------------CCCC----Cch-----------hhhccccCCCCcHHH
Q psy6593 299 ETVDVFSYGIVLCEIIGRVPADPDYLPRS--------------PDFG----LDQ-----------TDFRNKFCASCPEPF 349 (433)
Q Consensus 299 ~~~DiwslG~il~ell~~~~~~~~~~~~~--------------~~~~----~~~-----------~~~~~~~~~~~~~~l 349 (433)
.++||||||+++|+|++|.++|....... .... ... ..........++..+
T Consensus 186 ~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T cd07834 186 KAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEA 265 (330)
T ss_pred cchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHH
Confidence 99999999999999999999885432100 0000 000 000011124468899
Q ss_pred HHHHHHhcccCCCCCCChhHHHH--HHHhhcc
Q psy6593 350 VRIAFLCCDLNPDQRPPFEVLEV--WLEGLSM 379 (433)
Q Consensus 350 ~~li~~~l~~~p~~RPs~~~i~~--~l~~~~~ 379 (433)
.+++.+||+.+|++||++++++. ||+....
T Consensus 266 ~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 266 IDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 99999999999999999999985 8887553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=263.97 Aligned_cols=205 Identities=25% Similarity=0.382 Sum_probs=163.3
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCe------eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRK------LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNL 220 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i 220 (433)
+|+.++++++|+||+++++++...+. .++|+||+ +++|.+++.. ..+++..+..++.|++.||.+||+.|+
T Consensus 63 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi 139 (343)
T cd07851 63 RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGI 139 (343)
T ss_pred HHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 69999999999999999998876554 89999999 6799999876 469999999999999999999999999
Q ss_pred cccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCc
Q psy6593 221 IHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDE 299 (433)
Q Consensus 221 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ 299 (433)
+|+||+|+||+++.++.++|+|||++....... ....++..|+|||.+.+ ..++.
T Consensus 140 ~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~------------------------~~~~~~~~y~aPE~~~~~~~~~~ 195 (343)
T cd07851 140 IHRDLKPSNIAVNEDCELKILDFGLARHTDDEM------------------------TGYVATRWYRAPEIMLNWMHYNQ 195 (343)
T ss_pred ecCCCCHHHeEECCCCCEEEccccccccccccc------------------------cCCcccccccCHHHHhCCCCCCc
Confidence 999999999999999999999999987653221 13457888999998865 46788
Q ss_pred ccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC---------------Cch---hhh-----------ccccCCCCcHHHH
Q psy6593 300 TVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG---------------LDQ---TDF-----------RNKFCASCPEPFV 350 (433)
Q Consensus 300 ~~DiwslG~il~ell~~~~~~~~~~~~~~~~~---------------~~~---~~~-----------~~~~~~~~~~~l~ 350 (433)
++||||||+++|+|++|.++|........... ... ..+ ........++.+.
T Consensus 196 ~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~ 275 (343)
T cd07851 196 TVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAI 275 (343)
T ss_pred hHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHH
Confidence 99999999999999999988864322110000 000 000 0011134588999
Q ss_pred HHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 351 RIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 351 ~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
+++.+||+.+|.+||++.+|+. ||+...
T Consensus 276 dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 276 DLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred HHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 9999999999999999999984 776543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=252.62 Aligned_cols=204 Identities=25% Similarity=0.412 Sum_probs=162.3
Q ss_pred cchHHHHhhcC-CcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 146 CGQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 146 ~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
.+|+..+++++ |+||+++++++..++..++||||+ +++|.+++.... ..+++..+..++.|++.+|.|||+.|++|+
T Consensus 45 ~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~ 123 (283)
T cd07830 45 LREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHR 123 (283)
T ss_pred HHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 36899999998 999999999999999999999999 789999887643 468999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccC
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVD 302 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D 302 (433)
||+|+||+++.++.++|+|||++......... ....++..|+|||.+.+ ..++.++|
T Consensus 124 dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~----------------------~~~~~~~~~~aPE~~~~~~~~~~~~D 181 (283)
T cd07830 124 DLKPENLLVSGPEVVKIADFGLAREIRSRPPY----------------------TDYVSTRWYRAPEILLRSTSYSSPVD 181 (283)
T ss_pred CCChhhEEEcCCCCEEEeecccceeccCCCCc----------------------CCCCCcccccCceeeecCcCcCCccc
Confidence 99999999999999999999998765432211 13457888999998754 45789999
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCCCCC----------------------CCc------hhhhccccCCCCcHHHHHHHH
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRSPDF----------------------GLD------QTDFRNKFCASCPEPFVRIAF 354 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~~~~----------------------~~~------~~~~~~~~~~~~~~~l~~li~ 354 (433)
+||||+++++|++|.++++......... ... ............+..+.+++.
T Consensus 182 i~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 261 (283)
T cd07830 182 IWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIK 261 (283)
T ss_pred hhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHH
Confidence 9999999999999988875432110000 000 000001111233688999999
Q ss_pred HhcccCCCCCCChhHHHH
Q psy6593 355 LCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 355 ~~l~~~p~~RPs~~~i~~ 372 (433)
+||+.+|++||++++++.
T Consensus 262 ~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 262 DMLRWDPKKRPTASQALQ 279 (283)
T ss_pred HhcccCcccCCCHHHHhh
Confidence 999999999999998874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-33 Score=243.52 Aligned_cols=222 Identities=22% Similarity=0.319 Sum_probs=174.7
Q ss_pred ccchHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 145 NCGQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 145 ~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
.|+|++++.+. .|+||+.++++|+++..+|||||-+.||+|...|++. ..|++.++.++.+.|+.||.+||.+||.||
T Consensus 122 vfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHR 200 (463)
T KOG0607|consen 122 VFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHR 200 (463)
T ss_pred HHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccc
Confidence 34999999999 5999999999999999999999999999999999774 469999999999999999999999999999
Q ss_pred CCCCcceEEccCC---ceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-----C
Q psy6593 224 DLNSQNCLVREDK---TVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-----Q 295 (433)
Q Consensus 224 dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~ 295 (433)
||||+|||-...+ -|||+||.+............. ......+-+|+..|||||+..- .
T Consensus 201 DlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa--------------stP~L~tPvGSAEfMAPEVVd~fv~qA~ 266 (463)
T KOG0607|consen 201 DLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA--------------STPELLTPVGSAEFMAPEVVDVFVDQAT 266 (463)
T ss_pred cCCccceeecCCCCcCceeeeccccccccccCCCCCCC--------------CCccccCcccchhhcchhHHhhhccccc
Confidence 9999999997543 4899999998765443322111 1112235689999999998642 4
Q ss_pred CCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC---------------c--hhhhccccCCCCcHHHHHHHHHhcc
Q psy6593 296 EYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL---------------D--QTDFRNKFCASCPEPFVRIAFLCCD 358 (433)
Q Consensus 296 ~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~---------------~--~~~~~~~~~~~~~~~l~~li~~~l~ 358 (433)
.|+.+.|.||||+|+|-|+.|.|||...-...--+.. . .-.+..+-+..++.+..+++..+|.
T Consensus 267 ~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlv 346 (463)
T KOG0607|consen 267 FYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLV 346 (463)
T ss_pred cccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHh
Confidence 5889999999999999999999999654321111110 0 0112222346778899999999999
Q ss_pred cCCCCCCChhHHHH--HHHhhcccc
Q psy6593 359 LNPDQRPPFEVLEV--WLEGLSMHL 381 (433)
Q Consensus 359 ~~p~~RPs~~~i~~--~l~~~~~~~ 381 (433)
.++.+|.++.++++ |++....+-
T Consensus 347 rda~~rlsa~~vlnhPw~~~~~~ek 371 (463)
T KOG0607|consen 347 RDAKQRLSAAQVLNHPWVQRCAPEK 371 (463)
T ss_pred ccHHhhhhhhhccCCccccccchhc
Confidence 99999999999985 777665443
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=259.89 Aligned_cols=204 Identities=25% Similarity=0.362 Sum_probs=160.3
Q ss_pred chHHHHhhcCCcceeeEEEEEEeC------CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKD------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNL 220 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i 220 (433)
+|+.++++++|+||+++++++... ...+++++++ |++|.+++.. ..+++..+..++.|++.||+|||+.|+
T Consensus 65 ~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i 141 (345)
T cd07877 65 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADI 141 (345)
T ss_pred HHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 699999999999999999988643 3478899987 7899998875 359999999999999999999999999
Q ss_pred cccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCc
Q psy6593 221 IHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDE 299 (433)
Q Consensus 221 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ 299 (433)
+||||||+||+++.++.++|+|||++....... ....++..|+|||.+.+ ..++.
T Consensus 142 vH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~------------------------~~~~~~~~y~aPE~~~~~~~~~~ 197 (345)
T cd07877 142 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM------------------------TGYVATRWYRAPEIMLNWMHYNQ 197 (345)
T ss_pred eecCCChHHEEEcCCCCEEEecccccccccccc------------------------cccccCCCccCHHHHhCccCCCc
Confidence 999999999999999999999999987542211 13467888999998866 56888
Q ss_pred ccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC---------------Cc---hhhhc-----------cccCCCCcHHHH
Q psy6593 300 TVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG---------------LD---QTDFR-----------NKFCASCPEPFV 350 (433)
Q Consensus 300 ~~DiwslG~il~ell~~~~~~~~~~~~~~~~~---------------~~---~~~~~-----------~~~~~~~~~~l~ 350 (433)
++||||||+++|+|++|.+++........... .. ...+. .......++.+.
T Consensus 198 ~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (345)
T cd07877 198 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAV 277 (345)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHH
Confidence 99999999999999999988754321110000 00 00000 001124577899
Q ss_pred HHHHHhcccCCCCCCChhHHH--HHHHhh
Q psy6593 351 RIAFLCCDLNPDQRPPFEVLE--VWLEGL 377 (433)
Q Consensus 351 ~li~~~l~~~p~~RPs~~~i~--~~l~~~ 377 (433)
++|.+||+.+|.+||++.+++ .|+.+.
T Consensus 278 ~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 278 DLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 999999999999999999998 466653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=257.16 Aligned_cols=221 Identities=21% Similarity=0.321 Sum_probs=166.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|++++++++|+||+++++++..++..++||||+. ++|.+++.... .+++..+..++.|++.||++||+.|++|+||+
T Consensus 69 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~ 146 (335)
T PTZ00024 69 RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHKWYFMHRDLS 146 (335)
T ss_pred HHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 68999999999999999999999999999999996 69999987643 59999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeEe
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFS 305 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diws 305 (433)
|+||+++.++.++|+|||++............... .............+++.|+|||.+.+. .++.++||||
T Consensus 147 ~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 219 (335)
T PTZ00024 147 PANIFINSKGICKIADFGLARRYGYPPYSDTLSKD-------ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWS 219 (335)
T ss_pred HHHeEECCCCCEEECCccceeeccccccccccccc-------ccccccccccccccccCCCCChhcccCCCCCcHHHHHH
Confidence 99999999999999999999876532211100000 000001111234568889999998764 4688999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCC--------------CCC------------chhhhccccCCCCcHHHHHHHHHhccc
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPD--------------FGL------------DQTDFRNKFCASCPEPFVRIAFLCCDL 359 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~--------------~~~------------~~~~~~~~~~~~~~~~l~~li~~~l~~ 359 (433)
||+++|+|++|.+++......... +.. .............++.+.+++.+||+.
T Consensus 220 lG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 299 (335)
T PTZ00024 220 VGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299 (335)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCC
Confidence 999999999999888643221000 000 000000011245578899999999999
Q ss_pred CCCCCCChhHHH--HHHHh
Q psy6593 360 NPDQRPPFEVLE--VWLEG 376 (433)
Q Consensus 360 ~p~~RPs~~~i~--~~l~~ 376 (433)
+|++||++++++ .|++.
T Consensus 300 ~P~~R~s~~~~l~~~~~~~ 318 (335)
T PTZ00024 300 NPLERISAKEALKHEYFKS 318 (335)
T ss_pred CchhccCHHHHhcCcccCC
Confidence 999999999998 46654
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=251.43 Aligned_cols=204 Identities=27% Similarity=0.389 Sum_probs=163.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++++++|+||+++++++...+..++||||++ ++|.+++.+....+++..+..++.|++.||++||+.|++|+||+
T Consensus 47 ~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~ 125 (282)
T cd07829 47 REISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLK 125 (282)
T ss_pred HHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 69999999999999999999999999999999996 59999998754569999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeEe
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFS 305 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diws 305 (433)
|+||++++++.++|+|||++......... .....++..|+|||.+.+. .++.++||||
T Consensus 126 ~~ni~~~~~~~~~l~d~g~~~~~~~~~~~---------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~s 184 (282)
T cd07829 126 PQNILINRDGVLKLADFGLARAFGIPLRT---------------------YTHEVVTLWYRAPEILLGSKHYSTAVDIWS 184 (282)
T ss_pred hheEEEcCCCCEEEecCCcccccCCCccc---------------------cCccccCcCcCChHHhcCCcCCCccccHHH
Confidence 99999999999999999998765432211 0133456789999998776 7899999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCC-----------------------CCCchhh----hccccCCCCcHHHHHHHHHhcc
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPD-----------------------FGLDQTD----FRNKFCASCPEPFVRIAFLCCD 358 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~-----------------------~~~~~~~----~~~~~~~~~~~~l~~li~~~l~ 358 (433)
||+++|||++|.+++......... ....... .........+..+.+++.+||+
T Consensus 185 lG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 264 (282)
T cd07829 185 VGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQ 264 (282)
T ss_pred HHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhc
Confidence 999999999998887543210000 0000000 0001123457889999999999
Q ss_pred cCCCCCCChhHHHH
Q psy6593 359 LNPDQRPPFEVLEV 372 (433)
Q Consensus 359 ~~p~~RPs~~~i~~ 372 (433)
.+|++||++++++.
T Consensus 265 ~~P~~Rp~~~~~l~ 278 (282)
T cd07829 265 YNPAKRISAKEALK 278 (282)
T ss_pred cCcccCCCHHHHhh
Confidence 99999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=250.26 Aligned_cols=205 Identities=28% Similarity=0.393 Sum_probs=160.9
Q ss_pred ccchHHHHhhc---CCcceeeEEEEEEeCCe-----eeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhh
Q psy6593 145 NCGQVAVLRSL---HHHNVIRFIGVLYKDRK-----LNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYL 215 (433)
Q Consensus 145 ~~~E~~~l~~l---~h~~iv~~~~~~~~~~~-----~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~l 215 (433)
..+|+.+++++ +|+||+++++++...+. .+++|||+. ++|.+++... ...+++..++.++.|++.||.+|
T Consensus 45 ~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~L 123 (287)
T cd07838 45 TLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFL 123 (287)
T ss_pred HHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34688877766 59999999999998776 999999996 5899888653 23589999999999999999999
Q ss_pred hcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC
Q psy6593 216 HSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ 295 (433)
Q Consensus 216 H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 295 (433)
|+.+++|+||+|+||+++.++.++|+|||++......... ....++..|+|||.+.+.
T Consensus 124 H~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~----------------------~~~~~~~~~~~PE~~~~~ 181 (287)
T cd07838 124 HSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL----------------------TSVVVTLWYRAPEVLLQS 181 (287)
T ss_pred HHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCccc----------------------ccccccccccChHHhccC
Confidence 9999999999999999999999999999998765432111 133468889999999998
Q ss_pred CCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC--------------c----hhhhc-------cccCCCCcHHHH
Q psy6593 296 EYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL--------------D----QTDFR-------NKFCASCPEPFV 350 (433)
Q Consensus 296 ~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~--------------~----~~~~~-------~~~~~~~~~~l~ 350 (433)
.++.++||||||+++|+|++|.+++...........+ . ...+. ......++..+.
T Consensus 182 ~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (287)
T cd07838 182 SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGL 261 (287)
T ss_pred CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHH
Confidence 8999999999999999999998887643221100000 0 00000 011134567889
Q ss_pred HHHHHhcccCCCCCCChhHHHH
Q psy6593 351 RIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 351 ~li~~~l~~~p~~RPs~~~i~~ 372 (433)
+++.+||+.||.+||++++++.
T Consensus 262 ~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 262 DLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHHHHHhccCCccCCCHHHHhc
Confidence 9999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=262.42 Aligned_cols=175 Identities=26% Similarity=0.488 Sum_probs=149.1
Q ss_pred eeeccCCCcchhhhh--------------------------ccchHHHHhhcCCcceeeEEEEEEeC------CeeeEEE
Q psy6593 130 FCKEDYNGKYGEACQ--------------------------NCGQVAVLRSLHHHNVIRFIGVLYKD------RKLNLVT 177 (433)
Q Consensus 130 ~~~~~~~g~fg~v~~--------------------------~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~ 177 (433)
....+|+|+||.||+ -++|+++|++|+|+|||+++++=.+. +...+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 345678999999886 11899999999999999999985543 3567999
Q ss_pred eccCCCCHHHHhcCC--CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEc--cC--CceEEeccccchhccC
Q psy6593 178 EYIAGGTLKELLQDP--GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR--ED--KTVVVADFGLARIIHQ 251 (433)
Q Consensus 178 e~~~g~sL~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~--~~--~~~kl~Dfg~~~~~~~ 251 (433)
|||.||||+..+.++ ...+++.+.+.++..+..||.|||+.||+||||||.||++- .+ ...||+|||.|+.+..
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d 176 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDD 176 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCC
Confidence 999999999999873 34699999999999999999999999999999999999985 22 3579999999998876
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~ 326 (433)
.... .+.+||+.|.+||++.. ..|+..+|.||||+++|+.+||..||......
T Consensus 177 ~s~~----------------------~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 177 NSLF----------------------TSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCee----------------------eeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 5422 27899999999999994 88999999999999999999999888655443
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=255.31 Aligned_cols=213 Identities=25% Similarity=0.367 Sum_probs=163.0
Q ss_pred cchHHHHhhc-CCcceeeEEEEEEeC----CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCc
Q psy6593 146 CGQVAVLRSL-HHHNVIRFIGVLYKD----RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNL 220 (433)
Q Consensus 146 ~~E~~~l~~l-~h~~iv~~~~~~~~~----~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i 220 (433)
.+|+++++++ +|+||+++++.+... ...++++|++. ++|.+++... ..+++..++.++.||+.||+|||+.|+
T Consensus 49 ~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gi 126 (332)
T cd07857 49 LRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANV 126 (332)
T ss_pred HHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 4799999999 599999999975432 45889999985 6999988654 459999999999999999999999999
Q ss_pred cccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCc
Q psy6593 221 IHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDE 299 (433)
Q Consensus 221 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ 299 (433)
+||||||+||+++.++.++|+|||++........... .......||+.|+|||.+.+ ..++.
T Consensus 127 vH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~-----------------~~~~~~~g~~~y~aPE~~~~~~~~~~ 189 (332)
T cd07857 127 LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA-----------------GFMTEYVATRWYRAPEIMLSFQSYTK 189 (332)
T ss_pred ccCCCCHHHeEEcCCCCEEeCcCCCceeccccccccc-----------------ccccCcccCccccCcHHHhCCCCCCc
Confidence 9999999999999999999999999986543221100 01114578999999998765 46889
Q ss_pred ccCeEehhHHHHHHhcCCCCCCCCCCCC------------CC---CCCch--------------hhhccccCCCCcHHHH
Q psy6593 300 TVDVFSYGIVLCEIIGRVPADPDYLPRS------------PD---FGLDQ--------------TDFRNKFCASCPEPFV 350 (433)
Q Consensus 300 ~~DiwslG~il~ell~~~~~~~~~~~~~------------~~---~~~~~--------------~~~~~~~~~~~~~~l~ 350 (433)
++||||||+++|+|++|.+++....... .. ..... ...........+..+.
T Consensus 190 ~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (332)
T cd07857 190 AIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLAL 269 (332)
T ss_pred HHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHH
Confidence 9999999999999999998875432100 00 00000 0000111234578899
Q ss_pred HHHHHhcccCCCCCCChhHHH--HHHHhh
Q psy6593 351 RIAFLCCDLNPDQRPPFEVLE--VWLEGL 377 (433)
Q Consensus 351 ~li~~~l~~~p~~RPs~~~i~--~~l~~~ 377 (433)
+++.+||+.+|.+||++++++ .||+..
T Consensus 270 ~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 270 DLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred HHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 999999999999999999998 477654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=249.19 Aligned_cols=201 Identities=24% Similarity=0.348 Sum_probs=167.0
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..+|+.++++++|+||+++++.+..++..++||||+++++|.+++.... .+++..+..++.|++.||.+||+.+++|+|
T Consensus 40 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~ 118 (250)
T cd05123 40 TLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRD 118 (250)
T ss_pred HHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecC
Confidence 3478999999999999999999999999999999999999999997654 589999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|+|+||+++.++.++|+|||++......... .....++..|+|||.+.+...+.++|+|
T Consensus 119 l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~---------------------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~ 177 (250)
T cd05123 119 LKPENILLDADGHIKLTDFGLAKELSSEGSR---------------------TNTFCGTPEYLAPEVLLGKGYGKAVDWW 177 (250)
T ss_pred CCcceEEEcCCCcEEEeecCcceecccCCCc---------------------ccCCcCCccccChHHhCCCCCCchhhHH
Confidence 9999999999999999999998776443211 1144678889999999888889999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEV 369 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 369 (433)
|||+++|+|++|..|+............. .....++...+..+.+++++||..||++||++.+
T Consensus 178 slG~~~~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKIL--KDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHHCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 99999999999988875432211101111 1223345667899999999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-32 Score=255.08 Aligned_cols=221 Identities=21% Similarity=0.376 Sum_probs=169.7
Q ss_pred hccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccc
Q psy6593 144 QNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIH 222 (433)
Q Consensus 144 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H 222 (433)
...+|++++++++|+||+++++++..++..+++|||+++++|.+++.+. ...+++..+..++.|++.||+|||+.+|+|
T Consensus 45 ~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH 124 (314)
T cd08216 45 LLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIH 124 (314)
T ss_pred HHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 3448999999999999999999999999999999999999999998753 345899999999999999999999999999
Q ss_pred cCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC--CCCCcc
Q psy6593 223 RDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG--QEYDET 300 (433)
Q Consensus 223 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~ 300 (433)
+||||+||+++.++.++|+|||.+............ .........++..|+|||.+.+ ..++.+
T Consensus 125 ~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 190 (314)
T cd08216 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV--------------VHDFPKSSVKNLPWLSPEVLQQNLQGYNEK 190 (314)
T ss_pred CCCCcceEEEecCCceEEecCccceeeccccccccc--------------cccccccccccccccCHHHhcCCCCCCCcc
Confidence 999999999999999999999988765432211000 0011124457788999999876 357899
Q ss_pred cCeEehhHHHHHHhcCCCCCCCCCCCCCCCC---------------------Cc-----------hhhhccccCCCCcHH
Q psy6593 301 VDVFSYGIVLCEIIGRVPADPDYLPRSPDFG---------------------LD-----------QTDFRNKFCASCPEP 348 (433)
Q Consensus 301 ~DiwslG~il~ell~~~~~~~~~~~~~~~~~---------------------~~-----------~~~~~~~~~~~~~~~ 348 (433)
+||||||+++|+|++|.+||........... +. ...........++..
T Consensus 191 ~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (314)
T cd08216 191 SDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEH 270 (314)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHH
Confidence 9999999999999999988864321110000 00 000000111233567
Q ss_pred HHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 349 FVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 349 l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
+.+++.+||+.||++||+++++++ |+....
T Consensus 271 ~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 271 FHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred HHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 899999999999999999999984 776543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-33 Score=251.11 Aligned_cols=220 Identities=23% Similarity=0.319 Sum_probs=184.1
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhc-CCcceeeEEEEEEeCCe
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSL-HHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~ 172 (433)
.+...++-+..-+|+|+||.|..+- .|-.+|... +-|.++.++..|++-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 3444556777789999999887421 566666666 56889999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
+|+||||+.||+|.-.+++-++ |.+..+.-++..|+.||-+||++||++||||.+||+++.+|++||+|||+++.-...
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence 9999999999999888887664 999999999999999999999999999999999999999999999999999864332
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL 332 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~ 332 (433)
....++++|||.|+|||++...+|+.++|+||+|++||||+.|.|||...........+
T Consensus 504 ---------------------~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI 562 (683)
T KOG0696|consen 504 ---------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI 562 (683)
T ss_pred ---------------------CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 22344899999999999999999999999999999999999999999765443332222
Q ss_pred chhhhccccCCCCcHHHHHHHHHhcccCCCCCC
Q psy6593 333 DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365 (433)
Q Consensus 333 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP 365 (433)
.. -...++..++.+..++.+..|.+.|.+|.
T Consensus 563 ~e--hnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 563 ME--HNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HH--ccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 21 22345688899999999999999999995
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=260.12 Aligned_cols=205 Identities=22% Similarity=0.352 Sum_probs=160.9
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCC------eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDR------KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNL 220 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i 220 (433)
+|++++++++|+||+++++++.... .+++|+||+. .+|.+++. ..+++..+..++.|++.||+|||+.|+
T Consensus 63 ~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i 138 (342)
T cd07879 63 RELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAGI 138 (342)
T ss_pred HHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 7999999999999999999987543 4699999995 58887763 358999999999999999999999999
Q ss_pred cccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCc
Q psy6593 221 IHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDE 299 (433)
Q Consensus 221 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ 299 (433)
+||||||+||+++.++.++|+|||+++...... ....+++.|+|||.+.+ ..++.
T Consensus 139 ~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~------------------------~~~~~~~~y~aPE~~~~~~~~~~ 194 (342)
T cd07879 139 IHRDLKPGNLAVNEDCELKILDFGLARHADAEM------------------------TGYVVTRWYRAPEVILNWMHYNQ 194 (342)
T ss_pred ccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCC------------------------CCceeeecccChhhhcCccccCc
Confidence 999999999999999999999999987542211 13457888999999876 46889
Q ss_pred ccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC------------------Cchhhh-----------ccccCCCCcHHHH
Q psy6593 300 TVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG------------------LDQTDF-----------RNKFCASCPEPFV 350 (433)
Q Consensus 300 ~~DiwslG~il~ell~~~~~~~~~~~~~~~~~------------------~~~~~~-----------~~~~~~~~~~~l~ 350 (433)
++||||||+++|||++|..+|........... ...... ........+..+.
T Consensus 195 ~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (342)
T cd07879 195 TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAV 274 (342)
T ss_pred hHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHH
Confidence 99999999999999999988864321000000 000000 0001134677899
Q ss_pred HHHHHhcccCCCCCCChhHHH--HHHHhhcc
Q psy6593 351 RIAFLCCDLNPDQRPPFEVLE--VWLEGLSM 379 (433)
Q Consensus 351 ~li~~~l~~~p~~RPs~~~i~--~~l~~~~~ 379 (433)
+++.+||+.||.+||++++++ .||+....
T Consensus 275 ~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 275 DLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 999999999999999999998 67887643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=279.42 Aligned_cols=191 Identities=23% Similarity=0.374 Sum_probs=133.0
Q ss_pred eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
.+||-||||+..+|.+++.++.-.-....+++++++|+.||.|+|++|||||||||.||++++++.|||+|||++.....
T Consensus 670 ~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~ 749 (1351)
T KOG1035|consen 670 ILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKE 749 (1351)
T ss_pred EEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhh
Confidence 37899999998777777776332114788999999999999999999999999999999999999999999999997321
Q ss_pred ---CCCCCccccccchhhhhhhcc-cccceeeeccCccccccceecCC---CCCcccCeEehhHHHHHHhcCCCCCCCCC
Q psy6593 252 ---GPRAPTTVMAKVPRKAAQRRG-ARKKRYTVVGNPYWMAPEMMTGQ---EYDETVDVFSYGIVLCEIIGRVPADPDYL 324 (433)
Q Consensus 252 ---~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~~~~~~~~~~ 324 (433)
......... ..... ........+||.-|+|||++.+. .|+.|+|+||||+|++||+.- |....
T Consensus 750 ~~~~~d~~~~~~-------~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsM 819 (1351)
T KOG1035|consen 750 NLESIDQDLSFS-------TNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTSM 819 (1351)
T ss_pred hhhhHhhccCcc-------ccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCchH
Confidence 100000000 00111 11134578999999999999874 499999999999999999832 22211
Q ss_pred CCC-CCCCCchhhhc--cccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 325 PRS-PDFGLDQTDFR--NKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 325 ~~~-~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
.+. .........+. ..+..+--+.-..+|++|++.||++||||.++++
T Consensus 820 ERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 820 ERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 110 00011111111 1112222345688999999999999999999873
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=264.73 Aligned_cols=227 Identities=30% Similarity=0.459 Sum_probs=192.6
Q ss_pred ccCCeeeeeccCCCcchhhhhcc------------------------chHHHHhhc-CCcceeeEEEEEEe-----CCee
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSL-HHHNVIRFIGVLYK-----DRKL 173 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l-~h~~iv~~~~~~~~-----~~~~ 173 (433)
..+...+...+++|.+|.||+.- .|.++|+.+ +|||++.++++|.. ++.+
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 34457777888999999999722 466778877 79999999999974 3689
Q ss_pred eEEEeccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 174 NLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
|||||||.|||..|+++. .+..+.++.+.-|+..++.||.+||+..++|||||-.|||++.++.|||+|||++..+...
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 999999999999999976 3567999999999999999999999999999999999999999999999999999887653
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecC-----CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-----QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~ 327 (433)
.. ++.+.+|||.|||||++.- ..|+.++|+||||++..||-.|.||+.+..+..
T Consensus 177 ~g---------------------rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr 235 (953)
T KOG0587|consen 177 VG---------------------RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR 235 (953)
T ss_pred cc---------------------cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh
Confidence 32 3347899999999999865 357789999999999999999999998877776
Q ss_pred CCCCCchhhhccc-cCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 328 PDFGLDQTDFRNK-FCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 328 ~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
..+.+........ -+..++++|.++|..||.+|.++||+..+++
T Consensus 236 aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll 280 (953)
T KOG0587|consen 236 ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELL 280 (953)
T ss_pred hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhc
Confidence 6666554433332 2578899999999999999999999998876
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=242.10 Aligned_cols=229 Identities=17% Similarity=0.243 Sum_probs=179.2
Q ss_pred eeeeeccCCCcchhhhhcc--------------------------------chHHHHhhcCCcceeeEEEEEEe-CCeee
Q psy6593 128 LLFCKEDYNGKYGEACQNC--------------------------------GQVAVLRSLHHHNVIRFIGVLYK-DRKLN 174 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~~--------------------------------~E~~~l~~l~h~~iv~~~~~~~~-~~~~~ 174 (433)
+.+..-+|+|+|.+|||+| +|..|-+.|+||.||++|++|.- .+.++
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC 544 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC 544 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence 4445567899999999955 89999999999999999999974 46799
Q ss_pred EEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC--CccccCCCCcceEEcc---CCceEEeccccchhc
Q psy6593 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM--NLIHRDLNSQNCLVRE---DKTVVVADFGLARII 249 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~--~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~~ 249 (433)
-|+|||+|.+|.-+++.+. .+++.+++.|+.||+.||.||... .|+|-||||.|||+.+ -|.+||.|||+++..
T Consensus 545 TVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIM 623 (775)
T KOG1151|consen 545 TVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIM 623 (775)
T ss_pred eeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhc
Confidence 9999999999999998754 599999999999999999999977 6999999999999964 478999999999998
Q ss_pred cCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC----CCCcccCeEehhHHHHHHhcCCCCCCCCCC
Q psy6593 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ----EYDETVDVFSYGIVLCEIIGRVPADPDYLP 325 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~~~~~~~~~~~ 325 (433)
....+...++.. -.....||.+|++||.+.-+ ..+.++||||+|+|+|..+-|+.||.....
T Consensus 624 dddSy~~vdGme--------------LTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 624 DDDSYNSVDGME--------------LTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred cCCccCccccee--------------eecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 776554433221 12256899999999987543 578899999999999999977777654322
Q ss_pred CCCCCCC--chhhhccccC--CCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 326 RSPDFGL--DQTDFRNKFC--ASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 326 ~~~~~~~--~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
....... ......-.++ .-++.+..++|++||++.-++|.+..++.
T Consensus 690 QQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 690 QQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred HHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1111100 0111111222 56788999999999999999998766554
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=274.55 Aligned_cols=123 Identities=25% Similarity=0.457 Sum_probs=108.2
Q ss_pred CCeeeeeccCCCcchhhhhc----------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeEEE
Q psy6593 126 DGLLFCKEDYNGKYGEACQN----------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVT 177 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~----------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 177 (433)
+++.+..++++|+||+||.. ..|+.++..++|+||+++++.+.....+||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 44566667777777777641 16788899999999999999999999999999
Q ss_pred eccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhc
Q psy6593 178 EYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARII 249 (433)
Q Consensus 178 e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 249 (433)
||+.|++|.+++...+ .+++..++.|+.||+.||.|||+.||+||||||+|||++.++.++|+|||+++..
T Consensus 84 Ey~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 84 EYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 9999999999997643 5899999999999999999999999999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=255.89 Aligned_cols=209 Identities=21% Similarity=0.342 Sum_probs=158.7
Q ss_pred chHHHHhhcCCcceeeEEEEEEeC--------------CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHH
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKD--------------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGM 212 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~--------------~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L 212 (433)
+|++++++++|+||+++++.+... ...++||||++ ++|.+++.. ..+++..++.++.||+.||
T Consensus 51 ~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL 127 (342)
T cd07854 51 REIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGL 127 (342)
T ss_pred HHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHH
Confidence 699999999999999999876543 35789999996 599988865 3589999999999999999
Q ss_pred hhhhcCCccccCCCCcceEEc-cCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccce
Q psy6593 213 TYLHSMNLIHRDLNSQNCLVR-EDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM 291 (433)
Q Consensus 213 ~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 291 (433)
.|||+.|++||||||+||+++ .++.++|+|||++........... ......++..|+|||.
T Consensus 128 ~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~------------------~~~~~~~~~~y~aPE~ 189 (342)
T cd07854 128 KYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKG------------------YLSEGLVTKWYRSPRL 189 (342)
T ss_pred HHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCcccccc------------------ccccccccccccCHHH
Confidence 999999999999999999997 456789999999876532211100 0012357888999998
Q ss_pred ecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC----------------------------CchhhhccccC
Q psy6593 292 MTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG----------------------------LDQTDFRNKFC 342 (433)
Q Consensus 292 ~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~ 342 (433)
+.+ ..++.++||||||+++|+|++|.+||....+...... ...........
T Consensus 190 ~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (342)
T cd07854 190 LLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLL 269 (342)
T ss_pred HhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHc
Confidence 654 5678899999999999999999988754321000000 00000001112
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHh
Q psy6593 343 ASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEG 376 (433)
Q Consensus 343 ~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~ 376 (433)
..++.++.+++.+||+.||.+||++++++ .||+.
T Consensus 270 ~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 270 PGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred cCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 45778899999999999999999999998 57764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=243.49 Aligned_cols=227 Identities=18% Similarity=0.271 Sum_probs=176.2
Q ss_pred CCeeeeeccCCCcchhhhh------------------------ccchHHHHhhcCC--c----ceeeEEEEEEeCCeeeE
Q psy6593 126 DGLLFCKEDYNGKYGEACQ------------------------NCGQVAVLRSLHH--H----NVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~------------------------~~~E~~~l~~l~h--~----~iv~~~~~~~~~~~~~l 175 (433)
..+.+...+|+|.||.|.+ +.-|+++|+++++ | -++.+.++|.-.++.+|
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCi 168 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICI 168 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEE
Confidence 3366677899999998875 2268999999942 2 38889999999999999
Q ss_pred EEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc--------------------
Q psy6593 176 VTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE-------------------- 234 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~-------------------- 234 (433)
|+|.+ |.|+.+++.++ -.+|+...++.|+.|++.++++||+.+++|.||||+|||+.+
T Consensus 169 vfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~k 247 (415)
T KOG0671|consen 169 VFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLK 247 (415)
T ss_pred EEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCC
Confidence 99998 78999999874 457999999999999999999999999999999999999831
Q ss_pred CCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHh
Q psy6593 235 DKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII 314 (433)
Q Consensus 235 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 314 (433)
+-.|+|+|||.|....... ...+.|..|+|||++.+-.++.+.||||+||||+||.
T Consensus 248 s~~I~vIDFGsAtf~~e~h------------------------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 248 STAIKVIDFGSATFDHEHH------------------------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY 303 (415)
T ss_pred CcceEEEecCCcceeccCc------------------------ceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence 2358999999998755432 2678899999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCCCC-----------CCCchhh-----------------------hccccC----------CCCcHHHH
Q psy6593 315 GRVPADPDYLPRSPD-----------FGLDQTD-----------------------FRNKFC----------ASCPEPFV 350 (433)
Q Consensus 315 ~~~~~~~~~~~~~~~-----------~~~~~~~-----------------------~~~~~~----------~~~~~~l~ 350 (433)
+|...|..-...... ..+.... ...+.+ +..-.+|.
T Consensus 304 tG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 304 TGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred ccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 988766432211100 0000000 000000 11224689
Q ss_pred HHHHHhcccCCCCCCChhHHH--HHHHhh
Q psy6593 351 RIAFLCCDLNPDQRPPFEVLE--VWLEGL 377 (433)
Q Consensus 351 ~li~~~l~~~p~~RPs~~~i~--~~l~~~ 377 (433)
+|+++||..||.+|+|+.|++ .+|+.+
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred HHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 999999999999999999998 466654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=287.66 Aligned_cols=218 Identities=20% Similarity=0.358 Sum_probs=170.8
Q ss_pred eccCCCcchhhhhcc---------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhc
Q psy6593 132 KEDYNGKYGEACQNC---------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ 190 (433)
Q Consensus 132 ~~~~~g~fg~v~~~~---------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~ 190 (433)
..+++|+||+||++. .|++++++++||||+++++++.+++..++||||+++++|.++++
T Consensus 696 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~ 775 (968)
T PLN00113 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR 775 (968)
T ss_pred cEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh
Confidence 457899999999732 47899999999999999999999999999999999999999996
Q ss_pred CCCCCCChHHHHHHHHHHHHHHhhhh---cCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhh
Q psy6593 191 DPGQPLPWGQRVNFARDIAAGMTYLH---SMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267 (433)
Q Consensus 191 ~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 267 (433)
. +++..+..|+.|++.||+||| +.+|+||||||+||+++.++..++. |+........
T Consensus 776 ~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--------------- 835 (968)
T PLN00113 776 N----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--------------- 835 (968)
T ss_pred c----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---------------
Confidence 4 899999999999999999999 6799999999999999988887765 5544322110
Q ss_pred hhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC---------Cchhhh-
Q psy6593 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG---------LDQTDF- 337 (433)
Q Consensus 268 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~---------~~~~~~- 337 (433)
....+|+.|+|||++.+..++.++||||||+++|||++|.+|+........... ......
T Consensus 836 ----------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 905 (968)
T PLN00113 836 ----------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWI 905 (968)
T ss_pred ----------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhee
Confidence 023578899999999999999999999999999999999888743211110000 000000
Q ss_pred cccc------CCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 338 RNKF------CASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 338 ~~~~------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
.... ......++.+++.+||+.+|++||+++++++.|+++..
T Consensus 906 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 0000 01112357789999999999999999999999998754
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-33 Score=243.18 Aligned_cols=229 Identities=21% Similarity=0.292 Sum_probs=179.2
Q ss_pred cccccCCeeeeeccCCCcchhhhhcc--------------------------chHHHHhh-cCCcceeeEEEEEEeCCee
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRS-LHHHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~-l~h~~iv~~~~~~~~~~~~ 173 (433)
+-++.+++.-...+|+|.||+|.|.. .|.++..+ -+.||||++||+...++..
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc 138 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC 138 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence 45677777778899999999999822 34443333 3689999999999999999
Q ss_pred eEEEeccCCCCHHHHhcC----CCCCCChHHHHHHHHHHHHHHhhhhcC-CccccCCCCcceEEccCCceEEeccccchh
Q psy6593 174 NLVTEYIAGGTLKELLQD----PGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNSQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
||-||+| ..||..+.+. ....+++..+-.|..-.+.||.||-.. +|+||||||+|||++..|.+||+|||++-.
T Consensus 139 WiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 139 WICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred eeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence 9999999 4688776532 234699999999999999999999865 899999999999999999999999999987
Q ss_pred ccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC--CCCCcccCeEehhHHHHHHhcCCCCCCCCCCC
Q psy6593 249 IHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG--QEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~~~~~~~~~~~~ 326 (433)
+..+-... ..+|-..|||||.+.. ..|+.+||+||||++|||+.||.-|+..+...
T Consensus 218 Lv~SiAkT----------------------~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv 275 (361)
T KOG1006|consen 218 LVDSIAKT----------------------VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV 275 (361)
T ss_pred HHHHHHhh----------------------hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH
Confidence 65543322 4468888999999865 35899999999999999999999988765432
Q ss_pred CCCCCCchhhhcc-----ccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 327 SPDFGLDQTDFRN-----KFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 327 ~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
.+...+....-.+ .-....+..+..+|.-||.+|-++||++.++++
T Consensus 276 feql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 276 FEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 2111111111111 111447789999999999999999999999984
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=260.32 Aligned_cols=230 Identities=27% Similarity=0.409 Sum_probs=188.0
Q ss_pred eeeeeccCCCcchhhhhcc------------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEE
Q psy6593 128 LLFCKEDYNGKYGEACQNC------------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVT 177 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~~------------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 177 (433)
....+.+|.|.||+||+.. +|+-+|.+|+|||++|+++++.... +-||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 4555688999999999822 7899999999999999999998665 88999
Q ss_pred eccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCc
Q psy6593 178 EYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPT 257 (433)
Q Consensus 178 e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 257 (433)
+|+++|+|.++++.++..+.....+.|..||++|+.|||.++++||||...|+|+.+-..+|+.|||+++.+........
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999998765433222
Q ss_pred cccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHh--cCCCCCCCCCCCCCCCCCchh
Q psy6593 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell--~~~~~~~~~~~~~~~~~~~~~ 335 (433)
... ..-.+-|+|-|.+....++.++|||||||++||++ +.+|.+.. +..+....-..
T Consensus 857 ~~~-------------------gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi--~~~eI~dlle~ 915 (1177)
T KOG1025|consen 857 APG-------------------GKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI--PAEEIPDLLEK 915 (1177)
T ss_pred ccc-------------------cccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC--CHHHhhHHHhc
Confidence 111 11234599999999999999999999999999999 34443322 11111122222
Q ss_pred hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 336 DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 336 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
..+...+..++-++..++.+||..|+..||.++++...|.+..+
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 33345568889999999999999999999999999987776554
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=238.21 Aligned_cols=233 Identities=27% Similarity=0.412 Sum_probs=182.9
Q ss_pred CeeeeeccCCCcchhhhhcc--------------------chHHHHhhc--CCcceeeEEEEEEeCC----eeeEEEecc
Q psy6593 127 GLLFCKEDYNGKYGEACQNC--------------------GQVAVLRSL--HHHNVIRFIGVLYKDR----KLNLVTEYI 180 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~~--------------------~E~~~l~~l--~h~~iv~~~~~~~~~~----~~~lv~e~~ 180 (433)
++++.+.+|+|.||+||+.. +|.+|.+.. +|+||+.++++=..++ .+|||.+|.
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH 291 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH 291 (513)
T ss_pred eeEEEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence 37888899999999999722 788888766 9999999998865443 699999999
Q ss_pred CCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC--------CccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 181 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM--------NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 181 ~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~--------~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
+.|||+|+|.. ..++.+..++++..++.||++||.. .|.|||||..|||+..++..-|+|+|+|......
T Consensus 292 e~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~ 369 (513)
T KOG2052|consen 292 EHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSD 369 (513)
T ss_pred cCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEeccc
Confidence 99999999988 5699999999999999999999964 5999999999999999999999999999887665
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC------CCcccCeEehhHHHHHHh-----cC-----
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE------YDETVDVFSYGIVLCEII-----GR----- 316 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~ell-----~~----- 316 (433)
...... .....+||-+|||||++...- .-..+||||||.++||+. +|
T Consensus 370 t~~idi-----------------~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 370 TDTIDI-----------------PPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred CCcccC-----------------CCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 432211 122668999999999987621 124689999999999998 33
Q ss_pred CCCCCCCCCCCCCCCCc-----hhhhccccC---CCCc--HHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 317 VPADPDYLPRSPDFGLD-----QTDFRNKFC---ASCP--EPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 317 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~---~~~~--~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
++||.+..+..+..... .+.+++.++ ...| ..+.++|+.||..+|..|.++--|.+.|.++.
T Consensus 433 ~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 433 QLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred cCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 45666655554433221 122333333 2222 35788999999999999999999998888865
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=229.26 Aligned_cols=223 Identities=19% Similarity=0.284 Sum_probs=179.0
Q ss_pred cccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhc-CCcceeeEEEEEEeCC
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSL-HHHNVIRFIGVLYKDR 171 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l-~h~~iv~~~~~~~~~~ 171 (433)
+-+.-.++-...-+++|+|..|...- .|..+..+. +||.+|.++..|+++.
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 34445557777788999999877511 566777777 7999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
.+++|.||++||+|.-.+++.+ +++++.++-+...|..||.|||+.||++||||.+|+|++..|++||.|+|+.+.-..
T Consensus 325 rlffvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred eEEEEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 9999999999999987777644 599999999999999999999999999999999999999999999999999986443
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG 331 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~ 331 (433)
.... ..+++|||.|.|||++.+..|+..+|+|+||++|+||+.|..||.-.-.......
T Consensus 404 ~gd~---------------------tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~n 462 (593)
T KOG0695|consen 404 PGDT---------------------TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMN 462 (593)
T ss_pred CCcc---------------------cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccc
Confidence 3222 2388999999999999999999999999999999999988877742211111100
Q ss_pred C------chhhhccccCCCCcHHHHHHHHHhcccCCCCCC
Q psy6593 332 L------DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365 (433)
Q Consensus 332 ~------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP 365 (433)
. ....-...++..++-....+++..|++||.+|.
T Consensus 463 tedylfqvilekqiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 463 TEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhc
Confidence 0 011112234567777788999999999999995
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=234.71 Aligned_cols=231 Identities=28% Similarity=0.453 Sum_probs=174.4
Q ss_pred eeeeeccCCCcchhhhhcc--------------------chHHHHhh--cCCcceeeEEEEEEeCC----eeeEEEeccC
Q psy6593 128 LLFCKEDYNGKYGEACQNC--------------------GQVAVLRS--LHHHNVIRFIGVLYKDR----KLNLVTEYIA 181 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~~--------------------~E~~~l~~--l~h~~iv~~~~~~~~~~----~~~lv~e~~~ 181 (433)
+....-+++|+||.|||+. +|-+|.+. ++|+||++++++-.... .++||++|.+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred hhhHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 4444466799999999843 55555554 48999999999976554 7999999999
Q ss_pred CCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC---------CccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 182 GGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM---------NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 182 g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---------~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
.|||.+++.. ..+++....+|+..|++||+|||+. .|+|||||..|||+.+|++..|+|||+|..+...
T Consensus 292 kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~ 369 (534)
T KOG3653|consen 292 KGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPG 369 (534)
T ss_pred CCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCC
Confidence 9999999988 4599999999999999999999963 6999999999999999999999999999988643
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCC-----cccCeEehhHHHHHHhcCCCCCCC----
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYD-----ETVDVFSYGIVLCEIIGRVPADPD---- 322 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~DiwslG~il~ell~~~~~~~~---- 322 (433)
.... .....+||.+|||||++.+. .+. .+.||||+|.++|||+++-.....
T Consensus 370 ~~~~-------------------d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp 430 (534)
T KOG3653|consen 370 KPQG-------------------DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP 430 (534)
T ss_pred CCCc-------------------chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC
Confidence 3221 11257899999999999873 222 368999999999999954332210
Q ss_pred -C-CCCC------C-CCC----CchhhhccccCC-----CCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 323 -Y-LPRS------P-DFG----LDQTDFRNKFCA-----SCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 323 -~-~~~~------~-~~~----~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
+ .+.. + ... +.....++.++. .-...+.+.+..||+.|++.|.|+.=+.+.+..+..
T Consensus 431 ~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 431 EYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred cccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 0 0000 0 000 112222333331 223568999999999999999999988888887664
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=213.19 Aligned_cols=269 Identities=16% Similarity=0.165 Sum_probs=223.2
Q ss_pred ccccccCCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcC-CcceeeEEEEEEeCCeeeE
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLH-HHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 175 (433)
+..+-...+.+++++|.|+||..|.+. -|..+.+.|+ ...|+.+..++.+.++-.+
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 345566678899999999999999743 6888888886 5789999999999999999
Q ss_pred EEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEc---cCCceEEeccccchhccCC
Q psy6593 176 VTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~ 252 (433)
||+.+ |.||++++.-..+.|+..+++.++.|++.-++|+|..+++||||||+|+|+. ....+.|+|||+++.+...
T Consensus 89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 99998 9999999977667899999999999999999999999999999999999996 3467999999999987654
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC--
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF-- 330 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~-- 330 (433)
.+.. +-+-++.+...||.+|.+-.++.+...+++.|+-|+|+++.++.-|..||..........
T Consensus 168 ~t~~--------------HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy 233 (341)
T KOG1163|consen 168 RTRQ--------------HIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY 233 (341)
T ss_pred cccc--------------cCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH
Confidence 3321 122234457789999999999999999999999999999999987777776654433221
Q ss_pred ----CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccccCCCCCCCchhhhhhhhhhccC
Q psy6593 331 ----GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPLPSDLEADIYQFATRKS 403 (433)
Q Consensus 331 ----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (433)
..........++.+.|.++.-.+..|-..-.++-|++.-|.+.+.-+...++......++|.....+..+..+
T Consensus 234 EkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk~~q~~~ 310 (341)
T KOG1163|consen 234 EKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQKSQQSGR 310 (341)
T ss_pred HHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHHhhcccC
Confidence 1223334445679999999999999999999999999999999999999999999999999988766554443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=227.87 Aligned_cols=205 Identities=33% Similarity=0.455 Sum_probs=166.7
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..+|++++++++|+||+++++.+......++++|++++++|.+++..... ++...++.++.+++.+|.+||+.+++|+|
T Consensus 34 ~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~~ 112 (244)
T smart00220 34 ILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR-LSEDEARFYARQILSALEYLHSNGIIHRD 112 (244)
T ss_pred HHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHHHcCeecCC
Confidence 34899999999999999999999999999999999999999999976443 89999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|+|.||+++.++.++|+|||.+........ .....++..|++||.+.+..++.++|||
T Consensus 113 i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~----------------------~~~~~~~~~~~~pE~~~~~~~~~~~Di~ 170 (244)
T smart00220 113 LKPENILLDEDGHVKLADFGLARQLDPGGL----------------------LTTFVGTPEYMAPEVLLGKGYGKAVDVW 170 (244)
T ss_pred cCHHHeEECCCCcEEEccccceeeeccccc----------------------cccccCCcCCCCHHHHccCCCCchhhHH
Confidence 999999999999999999999987654321 1144578889999999888889999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccC--CCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFC--ASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
|||+++++|+++.+++...................... ..++.++.+++.+|+..+|++||++.++++
T Consensus 171 slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 171 SLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 99999999999888775421111000000000000011 117889999999999999999999999875
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=213.15 Aligned_cols=228 Identities=20% Similarity=0.333 Sum_probs=178.2
Q ss_pred ccCCeeeeeccCCCcchhhhhcc----------------------chHHHHhhcC-CcceeeEEEEEEeC--CeeeEEEe
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC----------------------GQVAVLRSLH-HHNVIRFIGVLYKD--RKLNLVTE 178 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~----------------------~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e 178 (433)
..+++.+..+.|+|.|.+|+..+ +|+.||+.|. ||||+++++...+. ....||+|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 56678888899999999999733 8999999996 99999999998765 46789999
Q ss_pred ccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc-CCceEEeccccchhccCCCCCCc
Q psy6593 179 YIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE-DKTVVVADFGLARIIHQGPRAPT 257 (433)
Q Consensus 179 ~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~ 257 (433)
++.+.+...+... ++.-.++-.+.+++.||.|+|++||+|||+||.|++|+. ...++|+|+|+|.+.......
T Consensus 116 ~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY-- 189 (338)
T KOG0668|consen 116 YVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-- 189 (338)
T ss_pred hhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCcee--
Confidence 9999888888754 889999999999999999999999999999999999994 567999999999987654432
Q ss_pred cccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHh-cCCCCCCCCCCCCCCC-----
Q psy6593 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEII-GRVPADPDYLPRSPDF----- 330 (433)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell-~~~~~~~~~~~~~~~~----- 330 (433)
...+.+..|.-||.+-. ..|+.+-|+|||||++..|+ ...|+|..........
T Consensus 190 --------------------nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV 249 (338)
T KOG0668|consen 190 --------------------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV 249 (338)
T ss_pred --------------------eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence 24456778999998876 56888999999999999998 4555554322111000
Q ss_pred -----------------------------CCchhhhccc-cCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhh
Q psy6593 331 -----------------------------GLDQTDFRNK-FCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGL 377 (433)
Q Consensus 331 -----------------------------~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~ 377 (433)
...+..+... ...-++++..+++.++|..|-.+|++++|.. .+|...
T Consensus 250 LGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 250 LGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred hChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 0011111111 1123458899999999999999999999886 355543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=256.14 Aligned_cols=238 Identities=18% Similarity=0.197 Sum_probs=158.9
Q ss_pred ccccccCCeeeeeccCCCcchhhhhcc----------------------chHHHHhhcC---CcceeeEEEE------EE
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQNC----------------------GQVAVLRSLH---HHNVIRFIGV------LY 168 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~~----------------------~E~~~l~~l~---h~~iv~~~~~------~~ 168 (433)
...+..+++.+.+.+|+|+||.||+.. .|+.+..++. +.+++.++.. ..
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccc
Confidence 445677889999999999999999743 1222333332 2233332222 13
Q ss_pred eCCeeeEEEeccCCCCHHHHhcCCCCCC-------------------ChHHHHHHHHHHHHHHhhhhcCCccccCCCCcc
Q psy6593 169 KDRKLNLVTEYIAGGTLKELLQDPGQPL-------------------PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 229 (433)
Q Consensus 169 ~~~~~~lv~e~~~g~sL~~~l~~~~~~~-------------------~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~N 229 (433)
.+...++|+||+.+++|.+++......+ ....+..++.||+.||+|||+.||+||||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 4567999999999999999987532111 234466899999999999999999999999999
Q ss_pred eEEcc-CCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-------------
Q psy6593 230 CLVRE-DKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ------------- 295 (433)
Q Consensus 230 il~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------------- 295 (433)
||++. ++.+||+|||+++.+....... .....+|+.|+|||.+...
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~--------------------~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~ 345 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYI--------------------PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 345 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccC--------------------CcccccCCCccChHHhhccCCCCCCccccccc
Confidence 99985 5899999999998654322211 1156789999999966432
Q ss_pred ---------CCCcccCeEehhHHHHHHhcCCCCCCCCCCC----CCCCCCchhhhcccc--------------CCCCcHH
Q psy6593 296 ---------EYDETVDVFSYGIVLCEIIGRVPADPDYLPR----SPDFGLDQTDFRNKF--------------CASCPEP 348 (433)
Q Consensus 296 ---------~~~~~~DiwslG~il~ell~~~~~~~~~~~~----~~~~~~~~~~~~~~~--------------~~~~~~~ 348 (433)
.++.++|||||||++|||+++..+....... ..........+.... .+.....
T Consensus 346 ~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 425 (566)
T PLN03225 346 ALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGA 425 (566)
T ss_pred cccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchH
Confidence 2344569999999999999654332110000 000000000110000 1112334
Q ss_pred HHHHHHHhcccCCCCCCChhHHH--HHHHhh
Q psy6593 349 FVRIAFLCCDLNPDQRPPFEVLE--VWLEGL 377 (433)
Q Consensus 349 l~~li~~~l~~~p~~RPs~~~i~--~~l~~~ 377 (433)
..+|+.+||+.||++||++++++ .||...
T Consensus 426 ~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 426 GWELLKSMMRFKGRQRISAKAALAHPYFDRE 456 (566)
T ss_pred HHHHHHHHccCCcccCCCHHHHhCCcCcCCC
Confidence 56899999999999999999998 477653
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=214.14 Aligned_cols=180 Identities=22% Similarity=0.361 Sum_probs=149.5
Q ss_pred cccccCCeeeeeccCCCcchhhhhc--------------------------cchHHHHhhc-CCcceeeEEEEEEeCCee
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQN--------------------------CGQVAVLRSL-HHHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~--------------------------~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 173 (433)
..+..+.+....++|+|+||.|-+- ++|+++..+- ..|.+|.+||........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 3456667888889999999988761 1555554444 689999999999999999
Q ss_pred eEEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcC-CccccCCCCcceEEccCCceEEeccccchhc
Q psy6593 174 NLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNSQNCLVREDKTVVVADFGLARII 249 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 249 (433)
||.||.|+ .||..+.++ .++.+++..+-+|+..++.||.+||++ .++|||+||+|||++.+|++|++|||++-.+
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 99999994 688877643 567899999999999999999999987 9999999999999999999999999998876
Q ss_pred cCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC----CCCCcccCeEehhHHHHHHhcCCCCCCCC
Q psy6593 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG----QEYDETVDVFSYGIVLCEIIGRVPADPDY 323 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~~~~~~~~~ 323 (433)
..+-... ...|.-.|+|||.+.. ..|+-++||||||+++.||.++.-|+..+
T Consensus 200 ~dSiAkt----------------------~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 200 VDSIAKT----------------------MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hhhhHHH----------------------HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 5543321 2457777999999864 46889999999999999999888777554
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=245.40 Aligned_cols=205 Identities=24% Similarity=0.345 Sum_probs=161.3
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCC---CCChHHHHHHHHHHHHHHhhhhcCCccc
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ---PLPWGQRVNFARDIAAGMTYLHSMNLIH 222 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~i~H 222 (433)
+||..|+.- +|||||++++.=.+....||..|.|. .+|.+++...+. .......+.++.|+++||++||+.+|||
T Consensus 551 rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVH 629 (903)
T KOG1027|consen 551 REIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVH 629 (903)
T ss_pred HHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhccccc
Confidence 899999999 69999999999888999999999995 699999987411 1222556888999999999999999999
Q ss_pred cCCCCcceEEcc---C--CceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCC
Q psy6593 223 RDLNSQNCLVRE---D--KTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY 297 (433)
Q Consensus 223 ~dlkp~Nil~~~---~--~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 297 (433)
|||||+||||+. + ..++|+|||+++.+........ ...+..||-+|+|||++.....
T Consensus 630 RDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~------------------r~s~~sGt~GW~APE~L~~~~~ 691 (903)
T KOG1027|consen 630 RDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFS------------------RLSGGSGTSGWQAPEQLREDRK 691 (903)
T ss_pred ccCCCceEEEEccCCCcceeEEecccccccccCCCcchhh------------------cccCCCCcccccCHHHHhcccc
Confidence 999999999975 2 4789999999999876543221 1336789999999999999888
Q ss_pred CcccCeEehhHHHHHHh-cCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 298 DETVDVFSYGIVLCEII-GRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 298 ~~~~DiwslG~il~ell-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
+.++|||||||++|+.+ +|..||.+...+..........+. .+......+..+||.+|++.+|..||++.+|+
T Consensus 692 ~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~-~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 692 TQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLV-HLEPLPDCEAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred CcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCcccee-eeccCchHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 89999999999999999 568888765443221111111111 11111112789999999999999999999996
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=241.29 Aligned_cols=231 Identities=16% Similarity=0.191 Sum_probs=164.0
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc-------------------------------------------------------
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC------------------------------------------------------- 146 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~------------------------------------------------------- 146 (433)
.+..+++...+++|+|+||.||+..
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 3578889999999999999998531
Q ss_pred chHHHHhhcCCcc-----eeeEEEEEEe--------CCeeeEEEeccCCCCHHHHhcCCC--------------------
Q psy6593 147 GQVAVLRSLHHHN-----VIRFIGVLYK--------DRKLNLVTEYIAGGTLKELLQDPG-------------------- 193 (433)
Q Consensus 147 ~E~~~l~~l~h~~-----iv~~~~~~~~--------~~~~~lv~e~~~g~sL~~~l~~~~-------------------- 193 (433)
.|+..+.+++|.+ ++++++++.. ++..++||||+++++|.+++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 1444555665554 3677777653 356899999999999999886421
Q ss_pred ---CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhh
Q psy6593 194 ---QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQR 270 (433)
Q Consensus 194 ---~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (433)
..+++..++.++.|++.+|.|||+.+|+||||||+||+++.++.++|+|||++..........
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-------------- 366 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-------------- 366 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--------------
Confidence 124567788999999999999999999999999999999999999999999987543221110
Q ss_pred cccccceeeeccCccccccceecCCCC----------------------CcccCeEehhHHHHHHhcCCC-CCCCCCCCC
Q psy6593 271 RGARKKRYTVVGNPYWMAPEMMTGQEY----------------------DETVDVFSYGIVLCEIIGRVP-ADPDYLPRS 327 (433)
Q Consensus 271 ~~~~~~~~~~~gt~~y~aPE~~~~~~~----------------------~~~~DiwslG~il~ell~~~~-~~~~~~~~~ 327 (433)
.....+|+.|+|||.+..... ..+.||||+|+++|+|+++.. ++.......
T Consensus 367 ------~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~ 440 (507)
T PLN03224 367 ------PLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFN 440 (507)
T ss_pred ------ccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhh
Confidence 012235789999998764321 124699999999999997653 443211100
Q ss_pred CCC---CCch--------hhhccccCCCCcHHHHHHHHHhcccCC---CCCCChhHHHH
Q psy6593 328 PDF---GLDQ--------TDFRNKFCASCPEPFVRIAFLCCDLNP---DQRPPFEVLEV 372 (433)
Q Consensus 328 ~~~---~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~~p---~~RPs~~~i~~ 372 (433)
... .... ...........++..++|+.++|..+| .+|+|++++++
T Consensus 441 ~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 441 TELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred hHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 000 0000 011111235567889999999999866 68999999984
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-29 Score=235.59 Aligned_cols=173 Identities=24% Similarity=0.412 Sum_probs=150.8
Q ss_pred ccCCeeeeeccCCCcchhhhhcc---------------------------------chHHHHhhcC---CcceeeEEEEE
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC---------------------------------GQVAVLRSLH---HHNVIRFIGVL 167 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~---------------------------------~E~~~l~~l~---h~~iv~~~~~~ 167 (433)
...++...+++|.|+||.|+-+. .||+||..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 44457788899999999988522 7999999997 99999999999
Q ss_pred EeCCeeeEEEecc-CCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccc
Q psy6593 168 YKDRKLNLVTEYI-AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLA 246 (433)
Q Consensus 168 ~~~~~~~lv~e~~-~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 246 (433)
++++++||+||-- +|.+|.+++.-+. .+++.++..|++|++.|+++||++||||||||-+|+.++.+|.+||+|||.+
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence 9999999999963 5568999997755 4999999999999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCC-CcccCeEehhHHHHHHhcCCCCC
Q psy6593 247 RIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY-DETVDVFSYGIVLCEIIGRVPAD 320 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~~~~~~ 320 (433)
.....++-. .++||..|.|||++.+.+| +..-|||+||++||.++-..-|+
T Consensus 718 a~~ksgpfd-----------------------~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 718 AYTKSGPFD-----------------------VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred hhhcCCCcc-----------------------eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 876554322 7899999999999999776 56789999999999988554443
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-30 Score=220.78 Aligned_cols=219 Identities=26% Similarity=0.397 Sum_probs=166.5
Q ss_pred eccCCCcchhhhh---------------------------ccchHHHHhhcCCcceeeEEEEEEeCC-----eeeEEEec
Q psy6593 132 KEDYNGKYGEACQ---------------------------NCGQVAVLRSLHHHNVIRFIGVLYKDR-----KLNLVTEY 179 (433)
Q Consensus 132 ~~~~~g~fg~v~~---------------------------~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~ 179 (433)
+.+|-|.||.||. .|+|++.|..++|.||+..+++.+-.. .+|+|.|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 4567888888883 238999999999999999999987543 58899999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccc
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
+. .+|..++-.+. .++.+.+.-++.||+.||+|||+.||+||||||.|+|++++-.+||+|||+++..........+
T Consensus 139 mQ-SDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMT- 215 (449)
T KOG0664|consen 139 MQ-SDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMT- 215 (449)
T ss_pred HH-hhhhheeccCC-CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhH-
Confidence 94 68998887754 6999999999999999999999999999999999999999999999999999987654332221
Q ss_pred cccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC------
Q psy6593 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL------ 332 (433)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~------ 332 (433)
..+-|-+|+|||.+.+ ..|+.+.||||.|||+.||++.+-.|....+-.....+
T Consensus 216 -------------------qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGT 276 (449)
T KOG0664|consen 216 -------------------HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGT 276 (449)
T ss_pred -------------------HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCC
Confidence 2345778999999988 57899999999999999999877655332111100000
Q ss_pred -------------chhhhcc-----------cc--CCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 333 -------------DQTDFRN-----------KF--CASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 333 -------------~~~~~~~-----------~~--~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
..-.++. .+ +..-..+...++..++..||+.|.+.++.+.
T Consensus 277 Ps~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 277 PSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred CcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 0000000 00 1122345677888999999999998887764
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-29 Score=240.23 Aligned_cols=226 Identities=29% Similarity=0.493 Sum_probs=194.3
Q ss_pred ccCCeeeeeccCCCcchhhhhcc-------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEe
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTE 178 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 178 (433)
..+++....+.+.|.||+|||+- +|+-+++..+|+|||.+++.+.....+||.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 45667777889999999999833 78889999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcc
Q psy6593 179 YIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTT 258 (433)
Q Consensus 179 ~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 258 (433)
|+.||+|.+...-.+ ++++.++....+..+.+|+|||++|-+|||||-.||++++.|.+||.|||.+..+...-
T Consensus 93 ycgggslQdiy~~Tg-plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati----- 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI----- 166 (829)
T ss_pred ecCCCcccceeeecc-cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh-----
Confidence 999999999887655 69999999999999999999999999999999999999999999999999988765432
Q ss_pred ccccchhhhhhhcccccceeeeccCccccccceec---CCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh
Q psy6593 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT---GQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~ 335 (433)
.++..+.||++|||||+.. .+.|...+|||++|++..|+---.||..+..+....+.+...
T Consensus 167 ----------------~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS 230 (829)
T KOG0576|consen 167 ----------------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS 230 (829)
T ss_pred ----------------hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc
Confidence 2445889999999999874 367999999999999999998778887777766665555555
Q ss_pred hhccc---cCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 336 DFRNK---FCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 336 ~~~~~---~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
.+... -...+.+.|.++++.+|.++|.+||+++.++
T Consensus 231 ~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 231 GFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 44332 2366788999999999999999999998765
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=216.68 Aligned_cols=202 Identities=23% Similarity=0.313 Sum_probs=159.7
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCC------eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDR------KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM 218 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~ 218 (433)
+.+|..++..++|+||++++.+|.-.+ ..|+|||++ ..+|.+.+.. .+..+.+..|+.|++.|+++||+.
T Consensus 62 a~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~ 137 (369)
T KOG0665|consen 62 AYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLHSA 137 (369)
T ss_pred hhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhc
Confidence 559999999999999999999997543 589999999 5699998873 478899999999999999999999
Q ss_pred CccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCC
Q psy6593 219 NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYD 298 (433)
Q Consensus 219 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 298 (433)
||+||||||+||++..+..+||.|||+++.....- .. ..++.|..|.|||++.+..+.
T Consensus 138 ~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~--~m--------------------tpyVvtRyyrapevil~~~~k 195 (369)
T KOG0665|consen 138 GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDF--MM--------------------TPYVVTRYYRAPEVILGMGYK 195 (369)
T ss_pred ceeecccCcccceecchhheeeccchhhcccCccc--cc--------------------CchhheeeccCchheeccCCc
Confidence 99999999999999999999999999998765431 11 167889999999999998899
Q ss_pred cccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC-----------------------------CchhhhccccC-------
Q psy6593 299 ETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG-----------------------------LDQTDFRNKFC------- 342 (433)
Q Consensus 299 ~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~------- 342 (433)
..+||||+||++.||++|.-.|+....-..... .....+...++
T Consensus 196 e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~ 275 (369)
T KOG0665|consen 196 ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVV 275 (369)
T ss_pred ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCccccccc
Confidence 999999999999999977665542211000000 00001111111
Q ss_pred ----CCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 343 ----ASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 343 ----~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
..-....++++.+||..+|++|.|++++++
T Consensus 276 ~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 276 LEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred ccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 122356799999999999999999999884
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=218.64 Aligned_cols=226 Identities=24% Similarity=0.369 Sum_probs=185.4
Q ss_pred ccCCCcchhhhhcc-------------------------------chHHHHhhcCCcceeeEEEEEEeC-CeeeEEEecc
Q psy6593 133 EDYNGKYGEACQNC-------------------------------GQVAVLRSLHHHNVIRFIGVLYKD-RKLNLVTEYI 180 (433)
Q Consensus 133 ~~~~g~fg~v~~~~-------------------------------~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~ 180 (433)
-+-+|.||.++..+ +|.-.|..+.|||+..+.++..++ ...++++.+.
T Consensus 291 llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~ 370 (563)
T KOG1024|consen 291 LLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPAT 370 (563)
T ss_pred hhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEecc
Confidence 44589999998753 566777788899999999998765 5678889999
Q ss_pred CCCCHHHHhc-----C--CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 181 AGGTLKELLQ-----D--PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 181 ~g~sL~~~l~-----~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
.-|+|..+++ + ..+.++..+...++.|++.|++|||+.|++|.||...|.+|++.-.+||+|=.+++.+-...
T Consensus 371 ~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~D 450 (563)
T KOG1024|consen 371 GVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGD 450 (563)
T ss_pred CcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCccc
Confidence 8899999997 2 23457888899999999999999999999999999999999999999999999998776554
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHh-cCCCCCCCCCCCCCCCCC
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDYLPRSPDFGL 332 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~~~~~~~~~~~~~~~~~~ 332 (433)
+.-... +......||+||.+....|+.++|+||||++||||+ -|+.|+.+..+.. ...+
T Consensus 451 YhcLGD-------------------nEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-m~~y 510 (563)
T KOG1024|consen 451 YHCLGD-------------------NENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-MEHY 510 (563)
T ss_pred ccccCC-------------------CCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-HHHH
Confidence 432211 223345699999999999999999999999999999 4556665544433 2334
Q ss_pred chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 333 DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 333 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
-.+.++...|.++|+++..+|.-||...|++||+++++..-|.+.-
T Consensus 511 lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 511 LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 4566777788999999999999999999999999999998877653
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=211.89 Aligned_cols=253 Identities=15% Similarity=0.194 Sum_probs=210.8
Q ss_pred eeeeeccCCCcchhhhhcc-----------------------chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCC
Q psy6593 128 LLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGG 183 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 183 (433)
+.+.+++|.|+||+.+..- .|....+.| ..++|+.++-+..++.+..||||++ |.
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GP 108 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GP 108 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-Cc
Confidence 6677899999999888511 688888888 5799999999999999999999999 99
Q ss_pred CHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc-----CCceEEeccccchhccCCCCCCcc
Q psy6593 184 TLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE-----DKTVVVADFGLARIIHQGPRAPTT 258 (433)
Q Consensus 184 sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~-----~~~~kl~Dfg~~~~~~~~~~~~~~ 258 (433)
||+|++.-.++.|+..++..++.|++.-++++|++.+|+|||||+|+||.. .+.+.|+|||+|+......+...
T Consensus 109 SLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqH- 187 (449)
T KOG1165|consen 109 SLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQH- 187 (449)
T ss_pred CHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccccc-
Confidence 999999888889999999999999999999999999999999999999973 35699999999998876544321
Q ss_pred ccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC------C
Q psy6593 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG------L 332 (433)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~------~ 332 (433)
-+=++...-.||.+||+-..+.+.+.+++.|+.|||-+++++|.|..||........-.. .
T Consensus 188 -------------IPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 188 -------------IPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred -------------CccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 122234467899999999999999999999999999999999977777765433222111 1
Q ss_pred chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccccCCCCCCCchhhhh
Q psy6593 333 DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPLPSDLEADI 395 (433)
Q Consensus 333 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~~~~~~~~~~~~~~ 395 (433)
........++.++|.++...+...-.++..+-|+++-+...|.++...........++|....
T Consensus 255 Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 255 KRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred cccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 122233456688999999999999999999999999999999999998888888888888654
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=220.76 Aligned_cols=115 Identities=19% Similarity=0.334 Sum_probs=99.7
Q ss_pred cccccccccCCeeeeeccCCCcchhhhh------------------------ccchHHHHhhcC-----C---cceeeEE
Q psy6593 117 MLDNWYFEKDGLLFCKEDYNGKYGEACQ------------------------NCGQVAVLRSLH-----H---HNVIRFI 164 (433)
Q Consensus 117 ~l~~~~~~~~~~~~~~~~~~g~fg~v~~------------------------~~~E~~~l~~l~-----h---~~iv~~~ 164 (433)
+--++.|....+++.+++|.|-|.+||- ++.||.+|++++ | .+||+|+
T Consensus 69 V~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 69 VRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred eeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 3345677778899999999999999995 238999999993 2 4699999
Q ss_pred EEEEeC----CeeeEEEeccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcC-CccccCCCCcceEE
Q psy6593 165 GVLYKD----RKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNSQNCLV 232 (433)
Q Consensus 165 ~~~~~~----~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~dlkp~Nil~ 232 (433)
+.|... .++++|+|++ |.+|..+|.. ..+.++...+.+|++||+.||.|||.. ||+|-||||+|||+
T Consensus 149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 999854 5899999999 8899999876 345699999999999999999999987 99999999999998
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=222.00 Aligned_cols=257 Identities=19% Similarity=0.212 Sum_probs=197.8
Q ss_pred CeeeeeccCCCcchhhhhcc--------------------------chHHHHhhcCC----cceeeEEEEE-EeCCeeeE
Q psy6593 127 GLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSLHH----HNVIRFIGVL-YKDRKLNL 175 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l~h----~~iv~~~~~~-~~~~~~~l 175 (433)
.+.+.+++++|+||+||... .|+.++..+.. .+++.+++.+ ..+...|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 68889999999999999522 47888988863 6999999999 47789999
Q ss_pred EEeccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccC-----CceEEeccccchhc
Q psy6593 176 VTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRED-----KTVVVADFGLARII 249 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~-----~~~kl~Dfg~~~~~ 249 (433)
||+.+ |.||.++..... +.|+..++++|+.|++.+|++||+.|++||||||+|+++... ..++|+|||+++..
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99988 899999986543 679999999999999999999999999999999999999854 46999999999943
Q ss_pred cCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCC
Q psy6593 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPD 329 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~ 329 (433)
......... ....+.....+.||..|.+++++.+...+++.|+|||++++.+++.|..||.........
T Consensus 178 ~~~~~~~~~-----------~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~ 246 (322)
T KOG1164|consen 178 KYVGDSGGN-----------LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK 246 (322)
T ss_pred cccCCCCcc-----------cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence 221111000 001111123567999999999999999999999999999999999885555443322221
Q ss_pred CCCchhhhccc---cCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccccCCCCCCCchhhhh
Q psy6593 330 FGLDQTDFRNK---FCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPLPSDLEADI 395 (433)
Q Consensus 330 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~~~~~~~~~~~~~~ 395 (433)
........... .....|.++.++...+-+.+..++|++..+...|+............|.+|+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~~ 315 (322)
T KOG1164|consen 247 SKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVKL 315 (322)
T ss_pred HHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcccccc
Confidence 11111111111 2344678899999999999999999999999999988877767777788877543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=257.80 Aligned_cols=224 Identities=15% Similarity=0.168 Sum_probs=151.2
Q ss_pred HHHHhhcCC-cceeeEEEEE-------EeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCc
Q psy6593 149 VAVLRSLHH-HNVIRFIGVL-------YKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNL 220 (433)
Q Consensus 149 ~~~l~~l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i 220 (433)
++-.+.++| +||++++++| .+.+.++++||++ +++|.+++......+++..++.++.||+.||+|||++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gI 101 (793)
T PLN00181 23 TDGSKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGI 101 (793)
T ss_pred CCccchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 344566777 7999999988 3345678889988 679999998766679999999999999999999999999
Q ss_pred cccCCCCcceEEccCCceEEeccccchhccCCCCCCcccc-ccchh-------------hhhhhcccccceeeeccCccc
Q psy6593 221 IHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM-AKVPR-------------KAAQRRGARKKRYTVVGNPYW 286 (433)
Q Consensus 221 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~-~~~~~-------------~~~~~~~~~~~~~~~~gt~~y 286 (433)
+||||||+||||+..+.+|++|||++.............. ..... ......+.........||++|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 9999999999998766677666666544321110000000 00000 000000000111235689999
Q ss_pred cccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCC
Q psy6593 287 MAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP 366 (433)
Q Consensus 287 ~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs 366 (433)
+|||++.+..++.++|||||||+||||+++.+++...... ............. ........+++.+||+.+|.+||+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps 258 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT--MSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPS 258 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH--HHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcC
Confidence 9999999999999999999999999999987765421100 0000000001111 112345678999999999999999
Q ss_pred hhHHHH--HHHh
Q psy6593 367 FEVLEV--WLEG 376 (433)
Q Consensus 367 ~~~i~~--~l~~ 376 (433)
+.+|++ |+..
T Consensus 259 ~~eil~h~~~~~ 270 (793)
T PLN00181 259 MSELLQSEFINE 270 (793)
T ss_pred hHHHhhchhhhh
Confidence 999974 5543
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-28 Score=226.45 Aligned_cols=172 Identities=22% Similarity=0.346 Sum_probs=147.4
Q ss_pred eeeeeccCCCcchhhhhcc------------------------chHHHHhhcC------CcceeeEEEEEEeCCeeeEEE
Q psy6593 128 LLFCKEDYNGKYGEACQNC------------------------GQVAVLRSLH------HHNVIRFIGVLYKDRKLNLVT 177 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~ 177 (433)
+.+....|+|-|++|..+. .|++||++|+ .-|+++++..|...+++||||
T Consensus 434 Y~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVF 513 (752)
T KOG0670|consen 434 YEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVF 513 (752)
T ss_pred eEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEe
Confidence 4555677899999888622 7999999995 358999999999999999999
Q ss_pred eccCCCCHHHHhcCCC--CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc-CCceEEeccccchhccCCCC
Q psy6593 178 EYIAGGTLKELLQDPG--QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE-DKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 178 e~~~g~sL~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~ 254 (433)
|.+ ..+|.+++++-+ -.|....++.++.|++.||..|-..||+|.||||+|||+++ ...+||+|||.|........
T Consensus 514 E~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei 592 (752)
T KOG0670|consen 514 EPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENEI 592 (752)
T ss_pred hhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccccccc
Confidence 988 679999998744 35888999999999999999999999999999999999985 46789999999988765433
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCC
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDY 323 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~ 323 (433)
. .+.-+..|.|||++.|.+|+...|+||.||+||||.||+-.|+..
T Consensus 593 t-----------------------PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 593 T-----------------------PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred c-----------------------HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 2 334456699999999999999999999999999999998777543
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=215.36 Aligned_cols=245 Identities=18% Similarity=0.316 Sum_probs=181.2
Q ss_pred CeeeeeccCCCcchhhhhcc--------------------------chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEec
Q psy6593 127 GLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
.+..+.+++.|.|+.|+++. +|++.|..+ -+.||+++.+++..++...+||||
T Consensus 37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~ 116 (418)
T KOG1167|consen 37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY 116 (418)
T ss_pred hhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence 36677789999999999843 799999999 599999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEc-cCCceEEeccccchhccCCCCCCcc
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR-EDKTVVVADFGLARIIHQGPRAPTT 258 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 258 (433)
++..+..++... ++..++..++..++.||.++|.+|||||||||.|++.+ ..+.-.|+|||++............
T Consensus 117 ~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s 192 (418)
T KOG1167|consen 117 FEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS 192 (418)
T ss_pred cCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence 999999999876 88999999999999999999999999999999999998 4578899999999843221100000
Q ss_pred cc------------c---------cchhhhhh--hcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHh
Q psy6593 259 VM------------A---------KVPRKAAQ--RRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEII 314 (433)
Q Consensus 259 ~~------------~---------~~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell 314 (433)
.. . ..+..... .......+....||++|+|||++.. ...++++||||.|+|+..++
T Consensus 193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsll 272 (418)
T KOG1167|consen 193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLL 272 (418)
T ss_pred hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhh
Confidence 00 0 00000011 2333445667899999999999876 56789999999999999999
Q ss_pred cCCCCCCC-CC-----------------------CCC-CCCC-----------Cchhh-------------hccc-cCCC
Q psy6593 315 GRVPADPD-YL-----------------------PRS-PDFG-----------LDQTD-------------FRNK-FCAS 344 (433)
Q Consensus 315 ~~~~~~~~-~~-----------------------~~~-~~~~-----------~~~~~-------------~~~~-~~~~ 344 (433)
++..||-. .. ... ..+. ..... .... ....
T Consensus 273 s~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~ 352 (418)
T KOG1167|consen 273 SRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDV 352 (418)
T ss_pred ccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccccc
Confidence 77665521 00 000 0000 00000 0111 1133
Q ss_pred CcHHHHHHHHHhcccCCCCCCChhHHHH--HHH
Q psy6593 345 CPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLE 375 (433)
Q Consensus 345 ~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~ 375 (433)
.|..+.+++.+||..||.+|.++++.+. ++.
T Consensus 353 ~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 353 FPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred ccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 4568999999999999999999999873 444
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=203.05 Aligned_cols=161 Identities=22% Similarity=0.274 Sum_probs=125.3
Q ss_pred CCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcccccc
Q psy6593 183 GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAK 262 (433)
Q Consensus 183 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 262 (433)
|||.+++.+.+.++++..++.|+.|++.||.|||+.+ ||+||+++.++.+++ ||++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~---------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE---------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----------
Confidence 6899999876667999999999999999999999998 999999999999999 9998764321
Q ss_pred chhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccc--
Q psy6593 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNK-- 340 (433)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-- 340 (433)
...||+.|+|||++.+..++.++||||||+++|||++|.+|+....................
T Consensus 63 ----------------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 126 (176)
T smart00750 63 ----------------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP 126 (176)
T ss_pred ----------------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc
Confidence 22578999999999999999999999999999999999988754322111000000000110
Q ss_pred ----cCCCCcH--HHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 341 ----FCASCPE--PFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 341 ----~~~~~~~--~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
....++. .+.+++.+||+.+|.+||++.++++.+...
T Consensus 127 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 127 RDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred cccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0112223 699999999999999999999999876654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=202.95 Aligned_cols=175 Identities=32% Similarity=0.594 Sum_probs=155.2
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..+|+++++.++|++|+++++++......++++|++.|++|.+++......++...+..++.+++.+|.+||+.|++|+|
T Consensus 38 ~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~d 117 (215)
T cd00180 38 LLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117 (215)
T ss_pred HHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccC
Confidence 44899999999999999999999999999999999998999999987534689999999999999999999999999999
Q ss_pred CCCcceEEcc-CCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccC
Q psy6593 225 LNSQNCLVRE-DKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVD 302 (433)
Q Consensus 225 lkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~D 302 (433)
|+|.||+++. ++.++|+|||.+........ ......+...|++||..... ..+.++|
T Consensus 118 l~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D 176 (215)
T cd00180 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKS---------------------LLKTIVGTPAYMAPEVLLGKGYYSEKSD 176 (215)
T ss_pred CCHhhEEEeCCCCcEEEecCCceEEccCCcc---------------------hhhcccCCCCccChhHhcccCCCCchhh
Confidence 9999999999 89999999999986644321 01134567789999999887 7889999
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHH
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVW 373 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~ 373 (433)
+|++|+++++| ..+.+++..|++.+|++||++.++++.
T Consensus 177 ~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 177 IWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred hHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 99999999999 678999999999999999999988754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.4e-26 Score=195.31 Aligned_cols=190 Identities=18% Similarity=0.231 Sum_probs=142.3
Q ss_pred CCcceeeEEEE-EEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEc-
Q psy6593 156 HHHNVIRFIGV-LYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR- 233 (433)
Q Consensus 156 ~h~~iv~~~~~-~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~- 233 (433)
.|.||+.-|+. |+..+.+.+++||++.|+|..-+... .+.+....+++.|+++||.|+|++++||||||.+||||-
T Consensus 79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~ 156 (378)
T KOG1345|consen 79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFD 156 (378)
T ss_pred cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEec
Confidence 38899988765 67778889999999999999988773 489999999999999999999999999999999999995
Q ss_pred -cCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-----CCCcccCeEehh
Q psy6593 234 -EDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-----EYDETVDVFSYG 307 (433)
Q Consensus 234 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG 307 (433)
+..+|||+|||+.+..+..... ...+..|.+||..... ...+.+|||.||
T Consensus 157 ~df~rvKlcDFG~t~k~g~tV~~------------------------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfG 212 (378)
T KOG1345|consen 157 ADFYRVKLCDFGLTRKVGTTVKY------------------------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFG 212 (378)
T ss_pred CCccEEEeeecccccccCceehh------------------------hhhhcccCCcHHHhhccccceEecccccchhee
Confidence 4458999999998876543221 1234458899876432 346789999999
Q ss_pred HHHHHHhcCCCCCCCCCCCC-CCCCC-----chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 308 IVLCEIIGRVPADPDYLPRS-PDFGL-----DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 308 ~il~ell~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
+++|..++|.+||....... ..... ......+.....+++.+..+.++-|..+|++|-...+..
T Consensus 213 Ii~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 213 IIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred eeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 99999999998886322111 11110 000111222356678889999999999999995444443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.9e-24 Score=189.90 Aligned_cols=158 Identities=36% Similarity=0.628 Sum_probs=137.6
Q ss_pred ccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 145 NCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
..+|++.+++++|+|++++++++......++++|++++++|.+++......+++..+..++.+++.+|.+||+.+++|+|
T Consensus 44 ~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~d 123 (225)
T smart00221 44 FLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRD 123 (225)
T ss_pred HHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 33799999999999999999999998999999999999999999976443388999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCcccccccee-cCCCCCcccCe
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMM-TGQEYDETVDV 303 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di 303 (433)
|+|.||+++.++.++|+|||.+......... ......++..|++||.+ ....++.++|+
T Consensus 124 i~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~--------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv 183 (225)
T smart00221 124 LKPENILLGMDGLVKLADFGLARFIHRDLAA--------------------LLKTVKGTPFYLAPEVLLGGKGYGEAVDI 183 (225)
T ss_pred CCHHHEEEcCCCCEEEeeCceeeEecCcccc--------------------cccceeccCCcCCHhHhcCCCCCCchhhH
Confidence 9999999999999999999998876543200 11245678889999998 66778889999
Q ss_pred EehhHHHHHHhcCCCCCCC
Q psy6593 304 FSYGIVLCEIIGRVPADPD 322 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~ 322 (433)
|+||+++++|++|.+||..
T Consensus 184 ~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 184 WSLGVILYELLWGPEPFSG 202 (225)
T ss_pred HHHHHHHHHHHHCCCCccc
Confidence 9999999999999988854
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.6e-23 Score=207.82 Aligned_cols=214 Identities=27% Similarity=0.371 Sum_probs=167.6
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
.|..+-..|.|+|++..+....+....+-+|||+++ +|..++...+ .++..++..+++|++.||+|+|..||.|||+|
T Consensus 370 sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK 447 (601)
T KOG0590|consen 370 SEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLK 447 (601)
T ss_pred hheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHHhcCceeccCc
Confidence 455566678999998888777766666666999998 9999998743 59999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCc-ccCeEe
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDE-TVDVFS 305 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Diws 305 (433)
|+|++++.+|.+||+|||.+..+....... .......+|+..|+|||.+.+..|.+ ..||||
T Consensus 448 ~enll~~~~g~lki~Dfg~~~vf~~~~e~~-----------------~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS 510 (601)
T KOG0590|consen 448 LENLLVTENGILKIIDFGAASVFRYPWEKN-----------------IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWS 510 (601)
T ss_pred cccEEEecCCceEEeecCcceeeccCcchh-----------------hhhhcCcccCCcCcCcccccccccCcchhhhhh
Confidence 999999999999999999998765432211 01223778999999999999998876 589999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCC-CC------chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHh
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDF-GL------DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEG 376 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~-~~------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~ 376 (433)
.|++++.|+++..+|..-....... .. ....-...+...+|...+.+|.+||+.+|.+|.++++|+ .|++.
T Consensus 511 ~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~ 590 (601)
T KOG0590|consen 511 CGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS 590 (601)
T ss_pred ccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence 9999999997776664332222210 00 111111223367788999999999999999999999999 59987
Q ss_pred hcc
Q psy6593 377 LSM 379 (433)
Q Consensus 377 ~~~ 379 (433)
+..
T Consensus 591 i~~ 593 (601)
T KOG0590|consen 591 IEC 593 (601)
T ss_pred cce
Confidence 653
|
|
| >KOG1701|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.9e-23 Score=186.48 Aligned_cols=113 Identities=23% Similarity=0.537 Sum_probs=101.9
Q ss_pred cCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEe-eCCeeeeccccccccccccccccccccCC-------
Q psy6593 3 FGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFE-KDGLLFCKEDYNGKYGEACQNCGQMMSGP------- 73 (433)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~-~~~~~~C~~~~~~~~~~~C~~C~~~i~~~------- 73 (433)
|..|++. |.+..|+|+|+.||+.||+|..|++.|++. |.. .++++||-.||+++|+|+|..|+++|...
T Consensus 337 C~~Cg~~--I~d~iLrA~GkayHp~CF~Cv~C~r~ldgipFtvd~~n~v~Cv~dfh~kfAPrCs~C~~PI~P~~G~~etv 414 (468)
T KOG1701|consen 337 CNKCGEP--IMDRILRALGKAYHPGCFTCVVCARCLDGIPFTVDSQNNVYCVPDFHKKFAPRCSVCGNPILPRDGKDETV 414 (468)
T ss_pred HhhhhhH--HHHHHHHhcccccCCCceEEEEeccccCCccccccCCCceeeehhhhhhcCcchhhccCCccCCCCCcceE
Confidence 7788886 567899999999999999999999999998 755 57799999999999999999999999433
Q ss_pred eEEecCcccCCCCccccCCccccC---CCCcccccCCcccccccccc
Q psy6593 74 VMVVGDHKFHPECFKCTSCSCCIG---DGESYALVERSILCSACDVM 117 (433)
Q Consensus 74 ~~~~~~~~~h~~cf~C~~C~~~l~---~g~~~~~~~~~~~C~~c~~~ 117 (433)
.|+++++.||.+||+|..|+.+|. +|...+..++..+|+.|+..
T Consensus 415 Rvvamdr~fHv~CY~CEDCg~~LS~e~e~qgCyPld~HllCk~Ch~~ 461 (468)
T KOG1701|consen 415 RVVAMDRDFHVNCYKCEDCGLLLSSEEEGQGCYPLDGHLLCKTCHLK 461 (468)
T ss_pred EEEEccccccccceehhhcCccccccCCCCcceeccCceeechhhhh
Confidence 677999999999999999999997 57778999999999999864
|
|
| >KOG1044|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.7e-23 Score=192.05 Aligned_cols=124 Identities=28% Similarity=0.609 Sum_probs=115.0
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCceEeeCCeeeeccccccccccccccccccccCCeEEecCcc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHK 81 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~~~~~~~~~~C~~~~~~~~~~~C~~C~~~i~~~~~~~~~~~ 81 (433)
.|++|++..- +++.+.|+++.||..||+|+.|...|.++|+.+||.+||..||++.||-||..|.+.|.+.++++++++
T Consensus 135 ~cagc~~~lk-~gq~llald~qwhv~cfkc~~c~~vL~gey~skdg~pyce~dy~~~fgvkc~~c~~fisgkvLqag~kh 213 (670)
T KOG1044|consen 135 TCAGCGEELK-NGQALLALDKQWHVSCFKCKSCSAVLNGEYMSKDGVPYCEKDYQAKFGVKCEECEKFISGKVLQAGDKH 213 (670)
T ss_pred cccchhhhhh-ccceeeeeccceeeeeeehhhhcccccceeeccCCCcchhhhhhhhcCeehHHhhhhhhhhhhhccCcc
Confidence 6999998765 899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCccccCCccccCCCCcccccCCccccccccccccccccccC
Q psy6593 82 FHPECFKCTSCSCCIGDGESYALVERSILCSACDVMLDNWYFEKD 126 (433)
Q Consensus 82 ~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~l~~~~~~~~ 126 (433)
||+.|-.|+.|++.+++|+.-++.....|-+.|...-..+.+...
T Consensus 214 ~HPtCARCsRCgqmF~eGEEMYlQGs~iWHP~C~qa~~tE~i~~~ 258 (670)
T KOG1044|consen 214 FHPTCARCSRCGQMFGEGEEMYLQGSEIWHPDCKQATKTEEILKP 258 (670)
T ss_pred cCcchhhhhhhccccccchheeeccccccCCccccccchhhcccC
Confidence 999999999999999999999999999998888876544444333
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.1e-22 Score=171.45 Aligned_cols=204 Identities=25% Similarity=0.419 Sum_probs=170.5
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCC--cccc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMN--LIHR 223 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~ 223 (433)
.|.-.|+-+.||||+.+++.+....++.++..|++.|||++++.+. +--.+..++.+++..++.|++|||+.. |.--
T Consensus 236 eefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~ 315 (448)
T KOG0195|consen 236 EEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRF 315 (448)
T ss_pred hhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhh
Confidence 5667788889999999999999999999999999999999999763 334677899999999999999999873 3344
Q ss_pred CCCCcceEEccCCceEE--eccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCC---C
Q psy6593 224 DLNSQNCLVREDKTVVV--ADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY---D 298 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl--~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~ 298 (433)
-|....++++++-+.+| +|--++.... ...-.|.|++||.+...+- -
T Consensus 316 ~lns~hvmidedltarismad~kfsfqe~----------------------------gr~y~pawmspealqrkped~n~ 367 (448)
T KOG0195|consen 316 YLNSKHVMIDEDLTARISMADTKFSFQEV----------------------------GRAYSPAWMSPEALQRKPEDLNI 367 (448)
T ss_pred hcccceEEecchhhhheecccceeeeecc----------------------------ccccCcccCCHHHHhcCchhcch
Confidence 67888899998866555 3322221110 2334678999999987543 3
Q ss_pred cccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 299 ETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 299 ~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
+++|+|||++++|||.|...||.+..+..-...+....++..++.+++..+.+|+.-|++.||.+||.+..|+.+|++..
T Consensus 368 raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 368 RAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 57999999999999999999999998888888888899999999999999999999999999999999999999998753
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.7e-21 Score=172.91 Aligned_cols=204 Identities=24% Similarity=0.249 Sum_probs=151.8
Q ss_pred cCCcceeeEEEEEEe---------------------------CCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHH
Q psy6593 155 LHHHNVIRFIGVLYK---------------------------DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207 (433)
Q Consensus 155 l~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~q 207 (433)
-+|||||++.++|.+ +..+|+||..++ .+|.+++-. +..+.....-|+.|
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~--~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT--RHRSYRTGRVILAQ 349 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc--CCCchHHHHHHHHH
Confidence 379999999998863 346899999995 599999866 34678888899999
Q ss_pred HHHHHhhhhcCCccccCCCCcceEEc--cC--CceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccC
Q psy6593 208 IAAGMTYLHSMNLIHRDLNSQNCLVR--ED--KTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGN 283 (433)
Q Consensus 208 i~~~L~~lH~~~i~H~dlkp~Nil~~--~~--~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 283 (433)
+++|+.|||+.|+.|||+|.+|||+. +| ..+.|+|||.+-.-....-........+ ..-|.
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~V---------------d~GGN 414 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEV---------------DLGGN 414 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccc---------------cCCCc
Confidence 99999999999999999999999995 33 3578999998754332111111111111 23467
Q ss_pred ccccccceecCCC------CCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhc
Q psy6593 284 PYWMAPEMMTGQE------YDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCC 357 (433)
Q Consensus 284 ~~y~aPE~~~~~~------~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 357 (433)
...||||+....+ --.++|.|+.|.+.||++|..-||...-.........+....+.++..+|+.+++++..+|
T Consensus 415 a~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL 494 (598)
T KOG4158|consen 415 AKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLL 494 (598)
T ss_pred ceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHh
Confidence 7789999987532 1247899999999999998887776533323333334445556677999999999999999
Q ss_pred ccCCCCCCChhHHHHHHHh
Q psy6593 358 DLNPDQRPPFEVLEVWLEG 376 (433)
Q Consensus 358 ~~~p~~RPs~~~i~~~l~~ 376 (433)
+.||++|++..-..+.|+-
T Consensus 495 ~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 495 KRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred cCCccccCCccHHHhHHHH
Confidence 9999999997655554443
|
|
| >KOG4577|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-23 Score=179.12 Aligned_cols=114 Identities=24% Similarity=0.531 Sum_probs=102.1
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCceEeeCCeeeeccccccccccccccccccccCC-eE-EecC
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQNCGQMMSGP-VM-VVGD 79 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~~~~~~~~~~C~~~~~~~~~~~C~~C~~~i~~~-~~-~~~~ 79 (433)
.|+||-+-+. |...+.++++.||..|.+|+.|+.+|..+||.++|..||+++|.++||.||..|.++|.+. ++ .+.+
T Consensus 35 ~CagC~q~Il-DrFilKvl~R~wHs~CLkCs~C~~qL~drCFsR~~s~yCkedFfKrfGTKCsaC~~GIpPtqVVRkAqd 113 (383)
T KOG4577|consen 35 ICAGCDQHIL-DRFILKVLDRHWHSSCLKCSDCHDQLADRCFSREGSVYCKEDFFKRFGTKCSACQEGIPPTQVVRKAQD 113 (383)
T ss_pred cccchHHHHH-HHHHHHHHhhhhhhhhcchhhhhhHHHHHHhhcCCceeehHHHHHHhCCcchhhcCCCChHHHHHHhhc
Confidence 4888887765 7888899999999999999999999999999999999999999999999999999999776 33 4889
Q ss_pred cccCCCCccccCCccccCCCCcccccCCc-cccccccc
Q psy6593 80 HKFHPECFKCTSCSCCIGDGESYALVERS-ILCSACDV 116 (433)
Q Consensus 80 ~~~h~~cf~C~~C~~~l~~g~~~~~~~~~-~~C~~c~~ 116 (433)
.+||.+||.|..|+++|.+|+.|++-... ..|+..+.
T Consensus 114 ~VYHl~CF~C~iC~R~L~TGdEFYLmeD~rLvCK~DYE 151 (383)
T KOG4577|consen 114 FVYHLHCFACFICKRQLATGDEFYLMEDARLVCKDDYE 151 (383)
T ss_pred ceeehhhhhhHhhhcccccCCeeEEeccceeehhhhHH
Confidence 99999999999999999999999866544 44888775
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-21 Score=184.47 Aligned_cols=190 Identities=17% Similarity=0.201 Sum_probs=158.9
Q ss_pred hccchHHHHhhcC-CcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccc
Q psy6593 144 QNCGQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 222 (433)
Q Consensus 144 ~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H 222 (433)
....|..++...+ ||.++++.-.++.+...++++++..|+.|...+.+.. .+.+.........++.+++++|+.+|+|
T Consensus 42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~iiy 120 (612)
T KOG0603|consen 42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLGIAY 120 (612)
T ss_pred ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhHHHH
Confidence 3447889999996 9999999999999999999999999999998887754 4888889999999999999999999999
Q ss_pred cCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccC
Q psy6593 223 RDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVD 302 (433)
Q Consensus 223 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 302 (433)
||+|++||+++.+|++++.|||+++...... ..+||..|||||++. ....++|
T Consensus 121 rd~k~enilld~~Ghi~~tdfglske~v~~~-------------------------~~cgt~eymApEI~~--gh~~a~D 173 (612)
T KOG0603|consen 121 RDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-------------------------IACGTYEYRAPEIIN--GHLSAAD 173 (612)
T ss_pred hcccccceeecccCccccCCchhhhHhHhhh-------------------------hcccchhhhhhHhhh--ccCCccc
Confidence 9999999999999999999999998764422 227899999999998 4678899
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCCh
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF 367 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~ 367 (433)
.||+|+++++|++|..+|... ............+.......++++.+++..+|.+|.-.
T Consensus 174 ~ws~gvl~felltg~~pf~~~------~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 174 WWSFGVLAFELLTGTLPFGGD------TMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhhhHHHHhhCCCCCchH------HHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 999999999999998887651 00111111223456677888999999999999999744
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-22 Score=201.08 Aligned_cols=206 Identities=17% Similarity=0.198 Sum_probs=159.0
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
.|++ ...+++||++++..+...++..|||-+|.. -+|+|.+... ..+...+...|+.|++.||..+|..||.|||||
T Consensus 71 ~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvk-hnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIK 147 (1431)
T KOG1240|consen 71 EEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVK-HNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIK 147 (1431)
T ss_pred HHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHh-hhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 5566 566699999999999888999999999995 5999999763 357888999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC----------C
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ----------E 296 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~ 296 (433)
.+||||++-+.+.|+||...+........+.+..+.++..+ .-..|.|||.+-.. .
T Consensus 148 sENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSr--------------RRtCYiAPERFv~~~~~~~~~q~~~ 213 (1431)
T KOG1240|consen 148 SENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSR--------------RRTCYIAPERFVSALGKTSVGQDAP 213 (1431)
T ss_pred cceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCC--------------ceeeecChHhhhccccccccCCccc
Confidence 99999999999999999999887777666666555553221 12349999987541 2
Q ss_pred -CCcccCeEehhHHHHHHh-cCCCCCCCCCCCCCCC---CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 297 -YDETVDVFSYGIVLCEII-GRVPADPDYLPRSPDF---GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 297 -~~~~~DiwslG~il~ell-~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
.+++.||||+||+++||+ -|.|+|.-. +-..+. ..........+. ...+++++..|++.||++|.++++.+
T Consensus 214 ~L~paMDIFS~GCViaELf~Eg~PlF~LS-QL~aYr~~~~~~~e~~Le~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL 289 (1431)
T KOG1240|consen 214 LLTPAMDIFSAGCVIAELFLEGRPLFTLS-QLLAYRSGNADDPEQLLEKIE---DVSLRNLILSMIQRDPSKRLSAEDYL 289 (1431)
T ss_pred ccChhhhhhhhhHHHHHHHhcCCCcccHH-HHHhHhccCccCHHHHHHhCc---CccHHHHHHHHHccCchhccCHHHHH
Confidence 678999999999999999 568877421 100001 111122222222 24789999999999999999999987
Q ss_pred HH
Q psy6593 372 VW 373 (433)
Q Consensus 372 ~~ 373 (433)
+-
T Consensus 290 ~~ 291 (1431)
T KOG1240|consen 290 QK 291 (1431)
T ss_pred Hh
Confidence 53
|
|
| >KOG1701|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-22 Score=183.19 Aligned_cols=102 Identities=21% Similarity=0.548 Sum_probs=96.4
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeeccccccccccccccccccccCCeEEecCc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDH 80 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~C~~~i~~~~~~~~~~ 80 (433)
-|++|++-++-++..++||++.||..||+|..|++.|.+. ||..|+++||+.||.... .||..|++.|.+.++++.++
T Consensus 276 iC~~C~K~V~g~~~ac~Am~~~fHv~CFtC~~C~r~L~Gq~FY~v~~k~~CE~cyq~tl-ekC~~Cg~~I~d~iLrA~Gk 354 (468)
T KOG1701|consen 276 ICAFCHKTVSGQGLAVEAMDQLFHVQCFTCRTCRRQLAGQSFYQVDGKPYCEGCYQDTL-EKCNKCGEPIMDRILRALGK 354 (468)
T ss_pred hhhhcCCcccCcchHHHHhhhhhcccceehHhhhhhhccccccccCCcccchHHHHHHH-HHHhhhhhHHHHHHHHhccc
Confidence 3899999999999999999999999999999999999998 999999999999998766 89999999999999999999
Q ss_pred ccCCCCccccCCccccCCCCccccc
Q psy6593 81 KFHPECFKCTSCSCCIGDGESYALV 105 (433)
Q Consensus 81 ~~h~~cf~C~~C~~~l~~g~~~~~~ 105 (433)
.||+.||+|.+|++.| +|..|.+.
T Consensus 355 ayHp~CF~Cv~C~r~l-dgipFtvd 378 (468)
T KOG1701|consen 355 AYHPGCFTCVVCARCL-DGIPFTVD 378 (468)
T ss_pred ccCCCceEEEEecccc-CCcccccc
Confidence 9999999999999999 78777664
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.4e-20 Score=175.69 Aligned_cols=123 Identities=21% Similarity=0.301 Sum_probs=93.7
Q ss_pred chHHHHhhcCCcceee-EEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLHHHNVIR-FIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+++|++++|+||+. ++++ +..|+||||++|++|... .. .. ...++.|++.+|.|||+.||+||||
T Consensus 70 ~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL 137 (365)
T PRK09188 70 REIRALKTVRGIGVVPQLLAT----GKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLHRAGITHNDL 137 (365)
T ss_pred HHHHHHHhccCCCCCcEEEEc----CCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHHHCCCeeCCC
Confidence 8999999999999985 4432 468999999999999732 21 11 1468899999999999999999999
Q ss_pred -CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC
Q psy6593 226 -NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG 294 (433)
Q Consensus 226 -kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 294 (433)
||+|||++.++.++|+|||+++.+....... .+ .......+..+++.|++||.+..
T Consensus 138 ~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~-----~~--------~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 138 AKPQNWLMGPDGEAAVIDFQLASVFRRRGALY-----RI--------AAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CCcceEEEcCCCCEEEEECccceecccCcchh-----hh--------hhhhhhhhhhccCccCCcccCCh
Confidence 9999999999999999999999765421100 00 00011126678889999999865
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=171.37 Aligned_cols=213 Identities=26% Similarity=0.406 Sum_probs=161.8
Q ss_pred ccchHHHHhhcCCc-ceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC--CCCChHHHHHHHHHHHHHHhhhhcCCcc
Q psy6593 145 NCGQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG--QPLPWGQRVNFARDIAAGMTYLHSMNLI 221 (433)
Q Consensus 145 ~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~ 221 (433)
..+|+.+++.+.|+ +|+++++.+......+++++++.+++|.+++.... ..++...+..++.|++.++.++|+.+++
T Consensus 44 ~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~ 123 (384)
T COG0515 44 FLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGII 123 (384)
T ss_pred HHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 34789999999888 79999999987777899999999999998877644 2699999999999999999999999999
Q ss_pred ccCCCCcceEEccCC-ceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC---CCC
Q psy6593 222 HRDLNSQNCLVREDK-TVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG---QEY 297 (433)
Q Consensus 222 H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~ 297 (433)
|||+||+||+++..+ .+++.|||.+............. .......||..|++||.+.+ ...
T Consensus 124 hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~---------------~~~~~~~~t~~~~~pe~~~~~~~~~~ 188 (384)
T COG0515 124 HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIP---------------ALPSTSVGTPGYMAPEVLLGLSLAYA 188 (384)
T ss_pred ccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccccc---------------ccccccccccccCCHHHhcCCCCCCC
Confidence 999999999999888 79999999998544332211000 01226789999999999988 578
Q ss_pred CcccCeEehhHHHHHHhcCCCCCCCCCCC---CCCCCCchhhh----ccccCCCC----cHHHHHHHHHhcccCCCCCCC
Q psy6593 298 DETVDVFSYGIVLCEIIGRVPADPDYLPR---SPDFGLDQTDF----RNKFCASC----PEPFVRIAFLCCDLNPDQRPP 366 (433)
Q Consensus 298 ~~~~DiwslG~il~ell~~~~~~~~~~~~---~~~~~~~~~~~----~~~~~~~~----~~~l~~li~~~l~~~p~~RPs 366 (433)
+...|+||+|+++++++.+..|+...... ........... ........ ...+.+++..++..+|..|.+
T Consensus 189 ~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~ 268 (384)
T COG0515 189 SSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS 268 (384)
T ss_pred CchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCC
Confidence 89999999999999999888775443221 00000000000 00111111 147899999999999999998
Q ss_pred hhHHHH
Q psy6593 367 FEVLEV 372 (433)
Q Consensus 367 ~~~i~~ 372 (433)
..+...
T Consensus 269 ~~~~~~ 274 (384)
T COG0515 269 SSSDLS 274 (384)
T ss_pred HHHHhh
Confidence 877664
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.2e-19 Score=172.18 Aligned_cols=211 Identities=26% Similarity=0.447 Sum_probs=163.6
Q ss_pred HhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCc-cccCCCCcce
Q psy6593 152 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNL-IHRDLNSQNC 230 (433)
Q Consensus 152 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i-~H~dlkp~Ni 230 (433)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+......++.--...+++.++.||+|||+..| .|+.++..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 567899999999999999999999999999999999998877778888999999999999999999866 9999999999
Q ss_pred EEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-------CCCcccCe
Q psy6593 231 LVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-------EYDETVDV 303 (433)
Q Consensus 231 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Di 303 (433)
+++....+||.|||+............ .....-..-|.|||.+... ..+.+.||
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~-------------------~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdi 141 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEA-------------------HHPIRKALLWTAPELLRGALSQSLESALTQKGDI 141 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccc-------------------cchhHHHHhccCHHHhcccccccccccccccCCe
Confidence 999999999999999877643100000 0011123458999998763 14677999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCC-------chhhhccccC--CCCcHHHHHHHHHhcccCCCCCCChhHHHHHH
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGL-------DQTDFRNKFC--ASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWL 374 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 374 (433)
||+|++++|+++...+|...........+ ....+++.+. ...++.+..+++.||..+|++||++++|...+
T Consensus 142 Ys~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~ 221 (484)
T KOG1023|consen 142 YSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKL 221 (484)
T ss_pred ehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhh
Confidence 99999999999887777653322221111 1111222222 24566899999999999999999999999888
Q ss_pred Hhhcccc
Q psy6593 375 EGLSMHL 381 (433)
Q Consensus 375 ~~~~~~~ 381 (433)
+.+....
T Consensus 222 ~~~~~~~ 228 (484)
T KOG1023|consen 222 LTINKGG 228 (484)
T ss_pred hhhcccc
Confidence 8776544
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=5e-20 Score=174.47 Aligned_cols=174 Identities=24% Similarity=0.398 Sum_probs=132.3
Q ss_pred eeeEEEeccCCCCHHHHhcC--CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhc
Q psy6593 172 KLNLVTEYIAGGTLKELLQD--PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARII 249 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 249 (433)
++||.|+++.-.+|.+++.. .....+....+.++.|++.|++| +|.+|+|+||.||++..+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 58999999999999999954 44567888999999999999999 99999999999999999999999999998876
Q ss_pred cCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc--CCCCCCCCCCCC
Q psy6593 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG--RVPADPDYLPRS 327 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--~~~~~~~~~~~~ 327 (433)
...... ....+......||.+||+||.+.+..|+.++||||||+|++||+. ...... ..
T Consensus 407 ~~~~~~---------------~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~ 467 (516)
T KOG1033|consen 407 DKDETV---------------APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IA 467 (516)
T ss_pred ccCCcc---------------cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HH
Confidence 554311 112234447889999999999999999999999999999999985 111110 00
Q ss_pred CCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChh
Q psy6593 328 PDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFE 368 (433)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~ 368 (433)
....+....+.+.+..+.|. -..|+.+++...|.+||++.
T Consensus 468 t~~d~r~g~ip~~~~~d~p~-e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 468 TLTDIRDGIIPPEFLQDYPE-EYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred hhhhhhcCCCChHHhhcCcH-HHHHHHHhcCCCcccCchHH
Confidence 01112222222233344443 36899999999999999443
|
|
| >KOG2272|consensus | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-20 Score=159.60 Aligned_cols=113 Identities=19% Similarity=0.508 Sum_probs=105.5
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeeccccccccccccccccccccCCeEEecCc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDH 80 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~C~~~i~~~~~~~~~~ 80 (433)
+||.|.. +|+++.|.||||.||.++|+|+.|.+|+-|- .|+++|..||+.+|+++||..|..|++.|.|.++++.++
T Consensus 197 iCgaC~r--pIeervi~amgKhWHveHFvCa~CekPFlGHrHYEkkGlaYCe~h~~qLfG~~CF~C~~~i~G~vv~al~K 274 (332)
T KOG2272|consen 197 ICGACRR--PIEERVIFAMGKHWHVEHFVCAKCEKPFLGHRHYEKKGLAYCETHYHQLFGNLCFICNRVIGGDVVSALNK 274 (332)
T ss_pred ccccccC--chHHHHHHHhccccchhheeehhcCCcccchhhhhhcCchhHHHHHHHHhhhhheecCCccCccHHHHhhh
Confidence 3666654 5789999999999999999999999999775 999999999999999999999999999999999999999
Q ss_pred ccCCCCccccCCccccCCCCcccccCCccccccccc
Q psy6593 81 KFHPECFKCTSCSCCIGDGESYALVERSILCSACDV 116 (433)
Q Consensus 81 ~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~ 116 (433)
.|-++||.|+.|.+.|.....|+..+..+.|+.|+.
T Consensus 275 awCv~cf~Cs~Cdkkl~~K~Kf~E~DmkP~CKkCy~ 310 (332)
T KOG2272|consen 275 AWCVECFSCSTCDKKLTQKNKFYEFDMKPVCKKCYD 310 (332)
T ss_pred hhccccccccccccccccccceeeeccchHHHHHHh
Confidence 999999999999999998889999999999999986
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1e-18 Score=150.80 Aligned_cols=154 Identities=21% Similarity=0.172 Sum_probs=109.4
Q ss_pred chHHHHhhcC-CcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+++|++|+ +++|++++++ +..+++|||+.|.+|.+.+.. ....++.|++.+|.++|+.||+||||
T Consensus 50 rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL 117 (218)
T PRK12274 50 REALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDL 117 (218)
T ss_pred HHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCC
Confidence 7999999995 5889999986 356999999999999765422 12357889999999999999999999
Q ss_pred -CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhh-hhhcccccceeeeccCccccccceecCC-CCC-ccc
Q psy6593 226 -NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA-AQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYD-ETV 301 (433)
Q Consensus 226 -kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~~ 301 (433)
||+||+++.++.++|+|||++.......... .... ....... +. -...++.|++|+...-. ..+ .+.
T Consensus 118 ~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~-------r~L~~rDl~~ll-k~-~~~y~~~~l~~~~~~~l~~~~~~~~ 188 (218)
T PRK12274 118 AKEANWLVQEDGSPAVIDFQLAVRGNPRARWM-------RLLAREDLRHLL-KH-KRMYCPAALTPVERRVLKRTSWIRE 188 (218)
T ss_pred CCcceEEEcCCCCEEEEECCCceecCCcchHH-------HHHHHHHHHHHH-HH-HHhcCCCCCCHHHHhhhccchhHHH
Confidence 7999999999999999999998544321100 0000 0000000 01 11257778888765432 223 567
Q ss_pred CeEehhHHHHHHhcCCCCCC
Q psy6593 302 DVFSYGIVLCEIIGRVPADP 321 (433)
Q Consensus 302 DiwslG~il~ell~~~~~~~ 321 (433)
++++.|+.+|.++|+..+..
T Consensus 189 ~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 189 LWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHhcchHHHHHhccCCcc
Confidence 88899999999997766543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-18 Score=154.14 Aligned_cols=125 Identities=14% Similarity=0.212 Sum_probs=98.1
Q ss_pred chHHHHhhcCCcceeeEEEEEEeC--------CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKD--------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM 218 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~ 218 (433)
+|+..+.+++|++|+.+.+++... ...+|||||++|.+|.++.. +++ ..+.+++.+|..+|+.
T Consensus 84 ~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~ 154 (232)
T PRK10359 84 NLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQH 154 (232)
T ss_pred HHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHc
Confidence 677799999999999999987643 35889999999999988732 333 2466999999999999
Q ss_pred CccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCC
Q psy6593 219 NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYD 298 (433)
Q Consensus 219 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 298 (433)
|++|||++|+||+++++| ++|+|||........... ........++
T Consensus 155 gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~---------------------------------d~~vler~y~ 200 (232)
T PRK10359 155 GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK---------------------------------DRIDLERHYG 200 (232)
T ss_pred CCccCCCChHHEEEeCCC-EEEEECCCcccccchhhH---------------------------------HHHHHHhHhc
Confidence 999999999999999988 999999988754221110 0122334566
Q ss_pred cccCeEehhHHHHHHh
Q psy6593 299 ETVDVFSYGIVLCEII 314 (433)
Q Consensus 299 ~~~DiwslG~il~ell 314 (433)
.++||||||+++..+.
T Consensus 201 ~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 201 IKNEIKDLGYYLLIYK 216 (232)
T ss_pred ccccccceeEeehHHH
Confidence 7899999999987664
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.8e-18 Score=146.44 Aligned_cols=99 Identities=19% Similarity=0.197 Sum_probs=80.6
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhh-hcCCccccCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYL-HSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~l-H~~~i~H~dl 225 (433)
+|+++|.++.++++.....+.. ...+|||||++|++|...+.+. ..++...+..++.|++.+|.++ |+.||+||||
T Consensus 68 ~E~~~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDl 144 (190)
T cd05147 68 KEMRNLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDCRLVHADL 144 (190)
T ss_pred HHHHHHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 5999999998887754443322 2348999999887776543322 4689999999999999999999 7999999999
Q ss_pred CCcceEEccCCceEEeccccchhc
Q psy6593 226 NSQNCLVREDKTVVVADFGLARII 249 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~ 249 (433)
||+||+++ ++.++|+|||++...
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CHHHEEEE-CCcEEEEEccccccC
Confidence 99999998 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG2272|consensus | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.5e-19 Score=153.07 Aligned_cols=115 Identities=20% Similarity=0.488 Sum_probs=100.3
Q ss_pred CCcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeeccccccccccccccccccccCCeEEecC
Q psy6593 1 MVFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGD 79 (433)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~C~~~i~~~~~~~~~ 79 (433)
|+|--|.+.-...+..++..|..||..||.|+.|-+|+.+. ||+-+|+.||+.||+.+|+|-|..|++.|.|++|.+++
T Consensus 13 ~~C~RC~~gF~~~e~~vns~ge~wH~~CFvCAQCf~pf~~g~~~efEgRkYCEhDF~~LfaPcC~kC~EFiiGrVikamn 92 (332)
T KOG2272|consen 13 MVCERCRDGFEPAEKIVNSNGELWHEQCFVCAQCFRPFPDGIFYEFEGRKYCEHDFHVLFAPCCGKCGEFIIGRVIKAMN 92 (332)
T ss_pred HHHHHHhccCCchhhhhccCchhhHHHHHHHHHhcCcCCCceeEEecCcccccccchhhhchhhcccccchhhHHHHhhc
Confidence 56777888777788889999999999999999999999666 99999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCccccCCCCcccccCCccccccccc
Q psy6593 80 HKFHPECFKCTSCSCCIGDGESYALVERSILCSACDV 116 (433)
Q Consensus 80 ~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~ 116 (433)
..||+.||.|..|+..|.+ ..|+--.+..+|..|+.
T Consensus 93 nSwHp~CF~Cd~Cn~~Lad-~gf~rnqgr~LC~~Cn~ 128 (332)
T KOG2272|consen 93 NSWHPACFRCDLCNKHLAD-QGFYRNQGRALCRECNQ 128 (332)
T ss_pred cccCcccchhHHHHHHHhh-hhhHhhcchHHhhhhhh
Confidence 9999999999999999964 33444445555666654
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.7e-18 Score=171.12 Aligned_cols=216 Identities=25% Similarity=0.318 Sum_probs=139.8
Q ss_pred CCeeeeeccCCCcchhhhhcc----chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHH
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC----GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQR 201 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~----~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~ 201 (433)
+++-.++-+.+|.||.||..- +.--++ +++..|+|-= ++...-+..+.| |+-..+++..+ +++...
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~lilR-nilt~a~npfvv------gDc~tllk~~g-~lPvdm- 152 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLILR-NILTFAGNPFVV------GDCATLLKNIG-PLPVDM- 152 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhh-cccccchhhh-ccccccCCccee------chhhhhcccCC-CCcchh-
Confidence 446667778899999998642 222233 5555444321 122222333344 45555555533 344333
Q ss_pred HHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeec
Q psy6593 202 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVV 281 (433)
Q Consensus 202 ~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (433)
+.+++|||+.||+|||+||+|.+|+.-|++|+.|||+++...-....... -..+.. .. ..-.....+
T Consensus 153 -------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~-eg~I~k-~t----~Ef~dKqvc 219 (1205)
T KOG0606|consen 153 -------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK-EGHIEK-DT----HEFQDKQVC 219 (1205)
T ss_pred -------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh-hcchHH-HH----HHhhhcccc
Confidence 78999999999999999999999999999999999999865433222110 001100 01 011122568
Q ss_pred cCccccccceecCCCCCcccCeEehhHHHHHHh-cCCCCCCCCCCCCCCCC-CchhhhccccCCCCcHHHHHHHHHhccc
Q psy6593 282 GNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDYLPRSPDFG-LDQTDFRNKFCASCPEPFVRIAFLCCDL 359 (433)
Q Consensus 282 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~ 359 (433)
|||.|.|||++....|+..+|+|++|+|+||.+ +..|+|.+ .+...... +.......+-...++++.++++.++|..
T Consensus 220 gTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd-tpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~q 298 (1205)
T KOG0606|consen 220 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-TPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQ 298 (1205)
T ss_pred CCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC-CHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHh
Confidence 999999999999999999999999999999998 55555544 22221111 1111111222466789999999999999
Q ss_pred CCCCCC
Q psy6593 360 NPDQRP 365 (433)
Q Consensus 360 ~p~~RP 365 (433)
+|..|-
T Consensus 299 np~~Rl 304 (1205)
T KOG0606|consen 299 NPLCRL 304 (1205)
T ss_pred ChHhhc
Confidence 999995
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.3e-17 Score=142.88 Aligned_cols=100 Identities=18% Similarity=0.223 Sum_probs=81.1
Q ss_pred ccchHHHHhhc-----CCcceeeEEEEEEeCC---e-eeEEEec--cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHH-
Q psy6593 145 NCGQVAVLRSL-----HHHNVIRFIGVLYKDR---K-LNLVTEY--IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGM- 212 (433)
Q Consensus 145 ~~~E~~~l~~l-----~h~~iv~~~~~~~~~~---~-~~lv~e~--~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L- 212 (433)
..+|+.+++++ +||||+++++++.++. . +.+|+|| ..+++|.+++++. .+++. ..++.|++.++
T Consensus 43 ~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~ 118 (210)
T PRK10345 43 IRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLK 118 (210)
T ss_pred HHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHH
Confidence 45899999999 5799999999999874 4 3478999 5578999999762 36655 35678888887
Q ss_pred hhhhcCCccccCCCCcceEEcc----CCceEEeccccchh
Q psy6593 213 TYLHSMNLIHRDLNSQNCLVRE----DKTVVVADFGLARI 248 (433)
Q Consensus 213 ~~lH~~~i~H~dlkp~Nil~~~----~~~~kl~Dfg~~~~ 248 (433)
+|||+.+|+||||||+||+++. ++.++|+||+.+..
T Consensus 119 ~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~ 158 (210)
T PRK10345 119 RYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGEST 158 (210)
T ss_pred HHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCcc
Confidence 9999999999999999999974 34799999554443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.6e-18 Score=154.50 Aligned_cols=161 Identities=22% Similarity=0.304 Sum_probs=105.9
Q ss_pred eeEEEeccCCCCHHHHhcC---CC---CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccc
Q psy6593 173 LNLVTEYIAGGTLKELLQD---PG---QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLA 246 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~---~~---~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 246 (433)
.+++|+-+ -+||.+++.. .. ..+.....+.+..|++..+++||..|++|+||+|+|++++.+|.++|+||+..
T Consensus 114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~ 192 (288)
T PF14531_consen 114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSL 192 (288)
T ss_dssp EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGE
T ss_pred hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHH
Confidence 46788888 4699888642 11 12334445667799999999999999999999999999999999999999887
Q ss_pred hhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC--------CCCCcccCeEehhHHHHHHhcCCC
Q psy6593 247 RIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG--------QEYDETVDVFSYGIVLCEIIGRVP 318 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~~~~ 318 (433)
...+.... ....+..|.+||.... -.++.+.|.|+||+++|.|+.+..
T Consensus 193 ~r~g~~~~------------------------~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 193 VRAGTRYR------------------------CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp EETTEEEE------------------------GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eecCceee------------------------ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 75433111 1234567899997644 247888999999999999998877
Q ss_pred CCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCC
Q psy6593 319 ADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQR 364 (433)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 364 (433)
|+....+.... ...-..+.++|+.++.||..+|+.||++|
T Consensus 249 Pf~~~~~~~~~------~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADP------EWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTS------GGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccc------cccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 76543221111 10222346889999999999999999987
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.6e-17 Score=167.94 Aligned_cols=229 Identities=19% Similarity=0.244 Sum_probs=166.4
Q ss_pred cccCCeeeeeccCCCcchhhhhcc-----------------ch----HHHHhhcC---CcceeeEEEEEEeCCeeeEEEe
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC-----------------GQ----VAVLRSLH---HHNVIRFIGVLYKDRKLNLVTE 178 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~-----------------~E----~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e 178 (433)
+..+.+-+.+.+|+|+||.||.+- -| .+++.+|+ -+.|..+..+..-.+.-+||+|
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e 774 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE 774 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence 344446666789999999999732 23 34555555 3556666666667778889999
Q ss_pred ccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc-------CCceEEeccccchhccC
Q psy6593 179 YIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE-------DKTVVVADFGLARIIHQ 251 (433)
Q Consensus 179 ~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~-------~~~~kl~Dfg~~~~~~~ 251 (433)
|.+.|+|.+++.. .+..++..+..+..||+..++.||..+|||+||||+|+||.. .-.++|+|||.+-.+..
T Consensus 775 y~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l 853 (974)
T KOG1166|consen 775 YSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL 853 (974)
T ss_pred ccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeE
Confidence 9999999999984 456999999999999999999999999999999999999952 34599999999876654
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG 331 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~ 331 (433)
.+.. .+-....+|-.+-.+|+..|.+++...|.|.|+.+++-||-|.-.. . .....+.
T Consensus 854 fp~~-------------------~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~-~~g~~~~ 911 (974)
T KOG1166|consen 854 FPDG-------------------TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--V-KNGSSWM 911 (974)
T ss_pred cCCC-------------------cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--h-cCCccee
Confidence 3332 2233677899999999999999999999999999999999554321 0 0000011
Q ss_pred CchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 332 LDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
... .+...+. -+.+.+++..+|+.|-..=|...+|...|++..
T Consensus 912 ~~~-~~~Ry~~---~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 912 VKT-NFPRYWK---RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred ccc-cchhhhh---HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 111 1111110 134677888888855555677778877776644
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.1e-15 Score=133.67 Aligned_cols=100 Identities=25% Similarity=0.257 Sum_probs=82.6
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHH-hcCCCCCCChHHHHHHHHHHHHHHhhhhc-CCccccC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKEL-LQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRD 224 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~-l~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~d 224 (433)
.|.+.+.++.+++|.....+... ..+|||||++|+++... +.+ ..++...+..++.|++.+|.++|+ .||+|||
T Consensus 68 ~E~~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrD 143 (190)
T cd05145 68 KEFRNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGD 143 (190)
T ss_pred HHHHHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence 68999999999987554444333 24899999988755433 433 357889999999999999999999 9999999
Q ss_pred CCCcceEEccCCceEEeccccchhccC
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
|||+||+++ ++.++|+|||++.....
T Consensus 144 lkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 144 LSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CChhhEEEE-CCCEEEEEcccceecCC
Confidence 999999998 88999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1703|consensus | Back alignment and domain information |
|---|
Probab=99.61 E-value=1e-16 Score=158.44 Aligned_cols=111 Identities=21% Similarity=0.401 Sum_probs=101.3
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeecccccccccccccccccccc--CCeEEec
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQNCGQMMS--GPVMVVG 78 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~C~~~i~--~~~~~~~ 78 (433)
.|.+|+.- |.++.|.|+++.||+.||.|..|+++|... |+.++|.+||+.||+++|.++|..|++++. +..+++.
T Consensus 365 ~C~~C~~~--i~~~~v~a~~~~wH~~cf~C~~C~~~~~~~~~~~~~~~pyce~~~~~~~~~~~~~~~~p~~~~~~~ie~~ 442 (479)
T KOG1703|consen 365 NCKRCLLP--ILEEGVCALGRLWHPECFVCADCGKPLKNSSFFESDGEPYCEDHYKKLFTTKCDYCKKPVEFGSRQIEAD 442 (479)
T ss_pred cccccCCc--hHHhHhhhccCeechhceeeecccCCCCCCcccccCCccchhhhHhhhccccchhccchhHhhhhHhhcc
Confidence 47888764 568899999999999999999999999776 999999999999999999999999999985 7799999
Q ss_pred CcccCCCCccccCCccccCCCCcccccCCcccccccc
Q psy6593 79 DHKFHPECFKCTSCSCCIGDGESYALVERSILCSACD 115 (433)
Q Consensus 79 ~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~ 115 (433)
+..||..||+|..|...+ .++.|.......+|..|.
T Consensus 443 ~~~~h~~~F~c~~c~~~l-~~~~~~~~~~~p~c~~~~ 478 (479)
T KOG1703|consen 443 GSPFHGDCFRCANCMKKL-TKKTFFETLDKPLCQKHF 478 (479)
T ss_pred Cccccccceehhhhhccc-cCCceeecCCccccccCC
Confidence 999999999999999999 678899999999988764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.4e-15 Score=133.99 Aligned_cols=96 Identities=25% Similarity=0.420 Sum_probs=86.4
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|++++..+.|++|+....++...+..++||||++|++|.+++... .. ....++.+++.+|.++|+.|++|+|++
T Consensus 48 ~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~ 122 (211)
T PRK14879 48 REARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSN----GM-EELELSREIGRLVGKLHSAGIIHGDLT 122 (211)
T ss_pred HHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 7999999999999888777777788899999999999999998652 22 888999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchh
Q psy6593 227 SQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
|.||+++ ++.++|+|||.+..
T Consensus 123 p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 123 TSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred cccEEEE-CCCEEEEECCcccC
Confidence 9999999 78899999999865
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.2e-16 Score=156.91 Aligned_cols=212 Identities=24% Similarity=0.341 Sum_probs=166.2
Q ss_pred chHHHHhhcC-CcceeeEEEEEEeCCeeeEEEeccCCCCHHHHh-cCCCCCCChHHHHHHHHHHHHHHhhhh-cCCcccc
Q psy6593 147 GQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL-QDPGQPLPWGQRVNFARDIAAGMTYLH-SMNLIHR 223 (433)
Q Consensus 147 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l-~~~~~~~~~~~~~~i~~qi~~~L~~lH-~~~i~H~ 223 (433)
.|..+=..+. |.|++++++...+.+..++++++..|+++.+.+ .......+...+-..+.|+..+|.|+| ..++.|+
T Consensus 69 ~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~ 148 (601)
T KOG0590|consen 69 TETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHR 148 (601)
T ss_pred ccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccC
Confidence 5677777775 999999999999999999999999999999988 443325788889999999999999999 9999999
Q ss_pred CCCCcceEEccCC-ceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeecc-CccccccceecCC-CCCcc
Q psy6593 224 DLNSQNCLVREDK-TVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVG-NPYWMAPEMMTGQ-EYDET 300 (433)
Q Consensus 224 dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~ 300 (433)
|+||+|.+++..+ .+++.|||++..+..... .........| ++.|+|||...+. ...+.
T Consensus 149 ~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g------------------~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~ 210 (601)
T KOG0590|consen 149 DIKPSNSLLDESGSALKIADFGLATAYRNKNG------------------AERSLKDRCGSSPPYGAPEHLSGKAYRGPS 210 (601)
T ss_pred CCCCccchhccCCCcccCCCchhhccccccCC------------------cceeeecccCCCCCCCCcccccchhhcCCC
Confidence 9999999999998 999999999987765211 1122235567 9999999999984 55778
Q ss_pred cCeEehhHHHHHHhcCCCCCCCCCCCC-CCCCCch--hhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHH
Q psy6593 301 VDVFSYGIVLCEIIGRVPADPDYLPRS-PDFGLDQ--TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLE 375 (433)
Q Consensus 301 ~DiwslG~il~ell~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~ 375 (433)
.|+||.|+++.-+++|..++....... ....... ..+....+..++....+++.+++..+|..|.+.+++. .|+.
T Consensus 211 ~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~ 290 (601)
T KOG0590|consen 211 VDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLS 290 (601)
T ss_pred cccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhcccccccccccccc
Confidence 999999999999997766654322222 1111111 1223444577888999999999999999999988876 3555
Q ss_pred h
Q psy6593 376 G 376 (433)
Q Consensus 376 ~ 376 (433)
.
T Consensus 291 ~ 291 (601)
T KOG0590|consen 291 S 291 (601)
T ss_pred c
Confidence 4
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.6e-15 Score=151.15 Aligned_cols=108 Identities=22% Similarity=0.336 Sum_probs=95.5
Q ss_pred eeccCCCcchhhhhc-------------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 131 CKEDYNGKYGEACQN-------------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 131 ~~~~~~g~fg~v~~~-------------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
.+.+++|+||+||+. .+|++++++++|++|+....+.......++||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 457789999999861 1588999999999999888888777788999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchh
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
++|++|.+++. ....++.+++.+|.+||+.|++||||||+||++ .++.++|+|||+++.
T Consensus 418 ~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 418 IGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred cCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999875 356789999999999999999999999999999 678899999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.2e-15 Score=130.62 Aligned_cols=93 Identities=26% Similarity=0.448 Sum_probs=80.3
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+++++.++|+++....-++...+..++||||++|++|.+++..... .++.+++.+|.+||+.|++|+|++
T Consensus 46 ~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~ 117 (199)
T TIGR03724 46 NEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLT 117 (199)
T ss_pred HHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCC
Confidence 799999999888765555555667778999999999999998755211 789999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchh
Q psy6593 227 SQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
|.||+++ ++.++++|||++..
T Consensus 118 ~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 118 TSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred cceEEEE-CCcEEEEECCCCcC
Confidence 9999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1703|consensus | Back alignment and domain information |
|---|
Probab=99.54 E-value=7.5e-16 Score=152.35 Aligned_cols=115 Identities=17% Similarity=0.316 Sum_probs=102.4
Q ss_pred cCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeeccccccccccccccccccccCCeEEecCcc
Q psy6593 3 FGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHK 81 (433)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~C~~~i~~~~~~~~~~~ 81 (433)
|+.|.-+++ +.+.+.++++.||+.||.|..|+..+... |...+|++||..||.+.+.++|.+|+++|.++.|.+.+..
T Consensus 306 c~~c~~~i~-~~~~i~~~~~~~h~~~~~c~~~~~~~~~~~~~~~~g~~~c~~~~~~~~~p~C~~C~~~i~~~~v~a~~~~ 384 (479)
T KOG1703|consen 306 CLSCNQKIR-SVKVIVALGKEWHPEHFSCEVCAIVILDGGPRELDGKILCHECFHAPFRPNCKRCLLPILEEGVCALGRL 384 (479)
T ss_pred ccccccCcc-cceeEeeccccccccceeeccccccccCCCccccCCCccHHHHHHHhhCccccccCCchHHhHhhhccCe
Confidence 566655444 33899999999999999999999999555 8899999999999999999999999999999999999999
Q ss_pred cCCCCccccCCccccCCCCcccccCCcccccccccccc
Q psy6593 82 FHPECFKCTSCSCCIGDGESYALVERSILCSACDVMLD 119 (433)
Q Consensus 82 ~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~l~ 119 (433)
||++||.|..|...+ .+..|+..++..||..|+..+.
T Consensus 385 wH~~cf~C~~C~~~~-~~~~~~~~~~~pyce~~~~~~~ 421 (479)
T KOG1703|consen 385 WHPECFVCADCGKPL-KNSSFFESDGEPYCEDHYKKLF 421 (479)
T ss_pred echhceeeecccCCC-CCCcccccCCccchhhhHhhhc
Confidence 999999999998888 5677999999999999987654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.3e-14 Score=130.85 Aligned_cols=98 Identities=27% Similarity=0.266 Sum_probs=79.9
Q ss_pred chHHHHhhcCC--cceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCC-cccc
Q psy6593 147 GQVAVLRSLHH--HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN-LIHR 223 (433)
Q Consensus 147 ~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~-i~H~ 223 (433)
.|+.++.++.+ ..+++++++ ...++||||++|.+|....... ..+....+..++.|++.+|.+||+.| ++|+
T Consensus 99 ~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~ 173 (237)
T smart00090 99 KEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHG 173 (237)
T ss_pred HHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeC
Confidence 69999999975 345555543 2358999999998887665332 34667778899999999999999999 9999
Q ss_pred CCCCcceEEccCCceEEeccccchhcc
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIH 250 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 250 (433)
||||+||+++ ++.++|+|||.+....
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999999 8899999999987643
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=9.9e-14 Score=125.39 Aligned_cols=99 Identities=24% Similarity=0.324 Sum_probs=80.9
Q ss_pred ccchHHHHhhcCCcce--eeEEEEEEeCC----eeeEEEeccCC-CCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhc
Q psy6593 145 NCGQVAVLRSLHHHNV--IRFIGVLYKDR----KLNLVTEYIAG-GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS 217 (433)
Q Consensus 145 ~~~E~~~l~~l~h~~i--v~~~~~~~~~~----~~~lv~e~~~g-~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~ 217 (433)
..+|++++.+|+|++| ++.+++...+. ..++|||+++| .+|.+++.+ ..+++. .+.+++.+|.+||+
T Consensus 87 ~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~ 160 (239)
T PRK01723 87 AFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHD 160 (239)
T ss_pred HHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHH
Confidence 3479999999988774 77877754432 23599999997 699998865 335544 35789999999999
Q ss_pred CCccccCCCCcceEEccCCceEEeccccchhc
Q psy6593 218 MNLIHRDLNSQNCLVREDKTVVVADFGLARII 249 (433)
Q Consensus 218 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 249 (433)
.||+|+||||+|||++.++.++|+|||.+...
T Consensus 161 ~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 161 AGVYHADLNAHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred CCCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence 99999999999999999899999999998763
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.5e-13 Score=133.18 Aligned_cols=229 Identities=23% Similarity=0.251 Sum_probs=172.9
Q ss_pred cCCeeeeeccCC--Ccchhhhh-----------------------------ccchHHHHhhc-CCcceeeEEEEEEeCCe
Q psy6593 125 KDGLLFCKEDYN--GKYGEACQ-----------------------------NCGQVAVLRSL-HHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 125 ~~~~~~~~~~~~--g~fg~v~~-----------------------------~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 172 (433)
..........+. |.+|++|+ ..+|+.....+ .|+|.++.+..+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 333555566667 88888876 11677777777 49999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHH----HHhhhhcCCccccCCCCcceEEccC-CceEEeccccch
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA----GMTYLHSMNLIHRDLNSQNCLVRED-KTVVVADFGLAR 247 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~----~L~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~ 247 (433)
.++-+|++ +.+|.++.......++...++..+.+... ||.++|..+++|.|++|+||++..+ ...+++|||+..
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 99999999 68999999887777899999999999999 9999999999999999999999988 889999999999
Q ss_pred hccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCC
Q psy6593 248 IIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~ 327 (433)
.+......... .....-.|...|++||...+ .++..+||+++|.++.+...+......... .
T Consensus 272 ~i~~~~~~~~~----------------~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-~ 333 (524)
T KOG0601|consen 272 KISDGNFSSVF----------------KVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN-S 333 (524)
T ss_pred EccCCccccce----------------eeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC-C
Confidence 88765532221 01112256777999999887 678899999999999998755433221100 0
Q ss_pred CCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 328 PDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
............++..+.+.++...+..|++.+|..|+++..+.+
T Consensus 334 ~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 334 SWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred CccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 011111112334455666777888999999999999998877753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.7e-13 Score=120.74 Aligned_cols=93 Identities=23% Similarity=0.267 Sum_probs=77.4
Q ss_pred chHHHHhhcCCc--ceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 147 GQVAVLRSLHHH--NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 147 ~E~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
.|..++..+.+. .+++.++. ...++||||++|++|.++... .....++.+++.++.++|+.|++|+|
T Consensus 82 ~E~~~l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~D 150 (198)
T cd05144 82 KEFAALKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGD 150 (198)
T ss_pred HHHHHHHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCC
Confidence 688899999777 45555542 456899999999999776431 34567889999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhcc
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIH 250 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~ 250 (433)
|+|+||+++.++.++|+|||++....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1044|consensus | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.7e-14 Score=132.27 Aligned_cols=161 Identities=25% Similarity=0.544 Sum_probs=119.8
Q ss_pred cCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeeccccccccccccccccccccCCeEEecCcc
Q psy6593 3 FGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHK 81 (433)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~C~~~i~~~~~~~~~~~ 81 (433)
|-.|+.-+ .++.+++.++.||..||.|..|++.|... ||.+++. +++++ ..|.+.+.+.++.+.++.
T Consensus 19 c~~c~~kc--~gevlrv~d~~fhi~cf~c~~cg~~la~~gff~k~~~--------~~ygt--~~c~~~~~gevvsa~gkt 86 (670)
T KOG1044|consen 19 CDKCRKKC--SGEVLRVNDNHFHINCFQCKKCGRNLAEGGFFTKPEN--------RLYGT--DDCRAFVEGEVVSTLGKT 86 (670)
T ss_pred hhhhCCcc--ccceeEeeccccceeeeeccccCCCcccccceecccc--------eeecc--cchhhhccceeEecccce
Confidence 44555544 36799999999999999999999999666 9998875 44556 889999999999999999
Q ss_pred cCCCCccccCCccccCCCCcccc----------------------------------cCC--------c-----cccccc
Q psy6593 82 FHPECFKCTSCSCCIGDGESYAL----------------------------------VER--------S-----ILCSAC 114 (433)
Q Consensus 82 ~h~~cf~C~~C~~~l~~g~~~~~----------------------------------~~~--------~-----~~C~~c 114 (433)
||+.||.|++|..+...|+.... +++ + ..|..|
T Consensus 87 yh~~cf~cs~ck~pf~~g~~vt~~gk~~~c~~c~~~~~~~p~~~~~ps~cagc~~~lk~gq~llald~qwhv~cfkc~~c 166 (670)
T KOG1044|consen 87 YHPKCFSCSTCKSPFKSGDKVTFSGKECLCQTCSQPMPVSPAESYGPSTCAGCGEELKNGQALLALDKQWHVSCFKCKSC 166 (670)
T ss_pred eccccceecccCCCCCCCCeeeecchhhhhhhhcCcccCCcccccCCccccchhhhhhccceeeeeccceeeeeeehhhh
Confidence 99999999999988876554311 111 1 125666
Q ss_pred cccccccccccCCeeeeeccCCCcchhhhhccc---hHHHHhhc---CCcceee---EEEEEEeCCeeeE
Q psy6593 115 DVMLDNWYFEKDGLLFCKEDYNGKYGEACQNCG---QVAVLRSL---HHHNVIR---FIGVLYKDRKLNL 175 (433)
Q Consensus 115 ~~~l~~~~~~~~~~~~~~~~~~g~fg~v~~~~~---E~~~l~~l---~h~~iv~---~~~~~~~~~~~~l 175 (433)
..+|.++|+.+++..+|.++++++||.++..+. --.+|..= -||-..+ .-..|.+++.+||
T Consensus 167 ~~vL~gey~skdg~pyce~dy~~~fgvkc~~c~~fisgkvLqag~kh~HPtCARCsRCgqmF~eGEEMYl 236 (670)
T KOG1044|consen 167 SAVLNGEYMSKDGVPYCEKDYQAKFGVKCEECEKFISGKVLQAGDKHFHPTCARCSRCGQMFGEGEEMYL 236 (670)
T ss_pred cccccceeeccCCCcchhhhhhhhcCeehHHhhhhhhhhhhhccCcccCcchhhhhhhccccccchheee
Confidence 678888999999999999999999999887552 12223222 2665544 4445556666554
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.5e-13 Score=123.29 Aligned_cols=199 Identities=18% Similarity=0.276 Sum_probs=136.8
Q ss_pred HHhhcCCcceeeEEEEEEeCC-----eeeEEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcC--Cc
Q psy6593 151 VLRSLHHHNVIRFIGVLYKDR-----KLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSM--NL 220 (433)
Q Consensus 151 ~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~--~i 220 (433)
-|.++.|.||++++.|+.+.+ ...++.||+..|+|.++|++ .+..+......+|+.||++||.|||+. -|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 455667999999999987554 47789999999999999975 445688999999999999999999987 69
Q ss_pred cccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcc
Q psy6593 221 IHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDET 300 (433)
Q Consensus 221 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 300 (433)
+|+++..+.|++..+|-+|+.--.-.. .... .+...........+-++|.+||.=.....+.+
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s-~h~s----------------~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a 262 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDS-THPS----------------VNSTREAEKSVNTSLPGFSAPESGTTTNTTGA 262 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccc-cchh----------------hhhhhHhhhhccccCCccccCCcCcccccccc
Confidence 999999999999999988874311111 0000 00011111223456788999998777777889
Q ss_pred cCeEehhHHHHHHhcCC-CCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 301 VDVFSYGIVLCEIIGRV-PADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 301 ~DiwslG~il~ell~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
+|||++|....+|.-+. .+-...... .........+.......-+.++..|++-.|..||++.+++
T Consensus 263 ~dIy~fgmcAlemailEiq~tnseS~~-----~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 263 SDIYKFGMCALEMAILEIQSTNSESKV-----EVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred hhhhhhhHHHHHHHHheeccCCCccee-----ehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhh
Confidence 99999999999997332 211111111 1111111111111112235788999999999999998774
|
|
| >PF00412 LIM: LIM domain; InterPro: IPR001781 Zinc finger (Znf) domains are relatively small protein motifs which contain multiple finger-like protrusions that make tandem contacts with their target molecule | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.4e-13 Score=95.30 Aligned_cols=57 Identities=19% Similarity=0.343 Sum_probs=50.1
Q ss_pred cCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeecccccccc
Q psy6593 3 FGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKY 59 (433)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~ 59 (433)
|.+|++.+.-.+..+.+.|+.||++||+|..|+++|.+. |+..+|++||+.||.++|
T Consensus 1 C~~C~~~I~~~~~~~~~~~~~~H~~Cf~C~~C~~~l~~~~~~~~~~~~~C~~c~~~~f 58 (58)
T PF00412_consen 1 CARCGKPIYGTEIVIKAMGKFWHPECFKCSKCGKPLNDGDFYEKDGKPYCKDCYQKRF 58 (58)
T ss_dssp BTTTSSBESSSSEEEEETTEEEETTTSBETTTTCBTTTSSEEEETTEEEEHHHHHHHT
T ss_pred CCCCCCCccCcEEEEEeCCcEEEccccccCCCCCccCCCeeEeECCEEECHHHHhhhC
Confidence 778988877444444799999999999999999999877 999999999999999876
|
Some of these domains bind zinc, but many do not; instead binding other metals such as iron, or no metal at all. For example, some family members form salt bridges to stabilise the finger-like folds. They were first identified as a DNA-binding motif in transcription factor TFIIIA from Xenopus laevis (African clawed frog), however they are now recognised to bind DNA, RNA, protein and/or lipid substrates [, , , , ]. Their binding properties depend on the amino acid sequence of the finger domains and of the linker between fingers, as well as on the higher-order structures and the number of fingers. Znf domains are often found in clusters, where fingers can have different binding specificities. There are many superfamilies of Znf motifs, varying in both sequence and structure. They display considerable versatility in binding modes, even between members of the same class (e.g. some bind DNA, others protein), suggesting that Znf motifs are stable scaffolds that have evolved specialised functions. For example, Znf-containing proteins function in gene transcription, translation, mRNA trafficking, cytoskeleton organisation, epithelial development, cell adhesion, protein folding, chromatin remodelling and zinc sensing, to name but a few []. Zinc-binding motifs are stable structures, and they rarely undergo conformational changes upon binding their target. This entry represents LIM-type zinc finger (Znf) domains. LIM domains coordinate one or more zinc atoms, and are named after the three proteins (LIN-11, Isl1 and MEC-3) in which they were first found. They consist of two zinc-binding motifs that resemble GATA-like Znf's, however the residues holding the zinc atom(s) are variable, involving Cys, His, Asp or Glu residues. LIM domains are involved in proteins with differing functions, including gene expression, and cytoskeleton organisation and development [, ]. Protein containing LIM Znf domains include: Caenorhabditis elegans mec-3; a protein required for the differentiation of the set of six touch receptor neurons in this nematode. C. elegans. lin-11; a protein required for the asymmetric division of vulval blast cells. Vertebrate insulin gene enhancer binding protein isl-1. Isl-1 binds to one of the two cis-acting protein-binding domains of the insulin gene. Vertebrate homeobox proteins lim-1, lim-2 (lim-5) and lim3. Vertebrate lmx-1, which acts as a transcriptional activator by binding to the FLAT element; a beta-cell-specific transcriptional enhancer found in the insulin gene. Mammalian LH-2, a transcriptional regulatory protein involved in the control of cell differentiation in developing lymphoid and neural cell types. Drosophila melanogaster (Fruit fly) protein apterous, required for the normal development of the wing and halter imaginal discs. Vertebrate protein kinases LIMK-1 and LIMK-2. Mammalian rhombotins. Rhombotin 1 (RBTN1 or TTG-1) and rhombotin-2 (RBTN2 or TTG-2) are proteins of about 160 amino acids whose genes are disrupted by chromosomal translocations in T-cell leukemia. Mammalian and avian cysteine-rich protein (CRP), a 192 amino-acid protein of unknown function. Seems to interact with zyxin. Mammalian cysteine-rich intestinal protein (CRIP), a small protein which seems to have a role in zinc absorption and may function as an intracellular zinc transport protein. Vertebrate paxillin, a cytoskeletal focal adhesion protein. Mus musculus (Mouse) testin which should not be confused with rat testin which is a thiol protease homologue (see IPR000169 from INTERPRO). Helianthus annuus (Common sunflower) pollen specific protein SF3. Chicken zyxin. Zyxin is a low-abundance adhesion plaque protein which has been shown to interact with CRP. Yeast protein LRG1 which is involved in sporulation []. Saccharomyces cerevisiae (Baker's yeast) rho-type GTPase activating protein RGA1/DBM1. C. elegans homeobox protein ceh-14. C. elegans homeobox protein unc-97. S. cerevisiae hypothetical protein YKR090w. C. elegans hypothetical proteins C28H8.6. These proteins generally contain two tandem copies of the LIM domain in their N-terminal section. Zyxin and paxillin are exceptions in that they contain respectively three and four LIM domains at their C-terminal extremity. In apterous, isl-1, LH-2, lin-11, lim-1 to lim-3, lmx-1 and ceh-14 and mec-3 there is a homeobox domain some 50 to 95 amino acids after the LIM domains. LIM domains contain seven conserved cysteine residues and a histidine. The arrangement followed by these conserved residues is: C-x(2)-C-x(16,23)-H-x(2)-[CH]-x(2)-C-x(2)-C-x(16,21)-C-x(2,3)-[CHD] LIM domains bind two zinc ions []. LIM does not bind DNA, rather it seems to act as an interface for protein-protein interaction. More information about these proteins can be found at Protein of the Month: Zinc Fingers [].; GO: 0008270 zinc ion binding; PDB: 2CO8_A 2EGQ_A 2CUR_A 3IXE_B 1CTL_A 1B8T_A 1X62_A 2DFY_C 1IML_A 2CUQ_A .... |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.7e-12 Score=107.48 Aligned_cols=96 Identities=28% Similarity=0.352 Sum_probs=83.7
Q ss_pred ccchHHHHhhcCC--cceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC---C
Q psy6593 145 NCGQVAVLRSLHH--HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM---N 219 (433)
Q Consensus 145 ~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ 219 (433)
..+|+.+++.+++ .++++++.+....+..+++|||++|.++..+ +......++.+++.+|+.+|.. +
T Consensus 38 ~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~ 109 (155)
T cd05120 38 REREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLV 109 (155)
T ss_pred HHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceE
Confidence 3479999999976 5999999998888889999999988777644 5566778899999999999985 7
Q ss_pred ccccCCCCcceEEccCCceEEeccccchh
Q psy6593 220 LIHRDLNSQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 220 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
++|+|++|+||++++.+.++++|||.+..
T Consensus 110 i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEecCCCcceEEEECCcEEEEEecccccC
Confidence 99999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.30 E-value=2e-12 Score=132.05 Aligned_cols=211 Identities=21% Similarity=0.259 Sum_probs=153.2
Q ss_pred CcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCC
Q psy6593 157 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDK 236 (433)
Q Consensus 157 h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~ 236 (433)
+|.+++..--+......+||++|+.|++|...++..+ ..+.+-++.....+..++++||...+.|+|++|.|+++..++
T Consensus 863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g 941 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG 941 (1205)
T ss_pred CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccC
Confidence 3445544444445678999999999999999998865 477777888888999999999999999999999999999999
Q ss_pred ceEEeccccchhccCCCCCCcc-------ccccchhhhhh---hcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 237 TVVVADFGLARIIHQGPRAPTT-------VMAKVPRKAAQ---RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 237 ~~kl~Dfg~~~~~~~~~~~~~~-------~~~~~~~~~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
+.++.|||.......-...... ........... ............||+.|.+||...+......+|+|++
T Consensus 942 h~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~ 1021 (1205)
T KOG0606|consen 942 HRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSS 1021 (1205)
T ss_pred CcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhh
Confidence 9999999955544322111100 00011111100 1111123446789999999999999999999999999
Q ss_pred hHHHHHHhcCCCCCCCCCCCCCCCCCchhhhc-cccCCCCcHHHHHHHHHhcccCCCCCCChh
Q psy6593 307 GIVLCEIIGRVPADPDYLPRSPDFGLDQTDFR-NKFCASCPEPFVRIAFLCCDLNPDQRPPFE 368 (433)
Q Consensus 307 G~il~ell~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~RPs~~ 368 (433)
|++++|.++|.|++....+......+...... ..-+...+...++++...+..+|.+|..+.
T Consensus 1022 g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1022 GVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99999999999999876665554333222211 122355678899999999999999998765
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.4e-11 Score=119.27 Aligned_cols=144 Identities=19% Similarity=0.274 Sum_probs=113.4
Q ss_pred hccchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhh-cCCccc
Q psy6593 144 QNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLH-SMNLIH 222 (433)
Q Consensus 144 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH-~~~i~H 222 (433)
...+-++-|+.++||||+++++.+..+...|||+|.+ ..|..++++ ++...+...+.||+.||.+|| +.+++|
T Consensus 55 ~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvH 128 (690)
T KOG1243|consen 55 LAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVH 128 (690)
T ss_pred HHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeee
Confidence 3446688899999999999999999999999999988 478888876 557788888999999999997 568999
Q ss_pred cCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccC
Q psy6593 223 RDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVD 302 (433)
Q Consensus 223 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 302 (433)
++|.-..++++..|..||++|.++......... .. ....--.|..|+.+.... ...|
T Consensus 129 gNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~-~~--------------------~~~~~~s~~~P~~~~~s~--~s~D 185 (690)
T KOG1243|consen 129 GNVCKDSVFVNESGEWKLGGLELVSKASGFNAP-AK--------------------SLYLIESFDDPEEIDPSE--WSID 185 (690)
T ss_pred ccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc-cc--------------------cchhhhcccChhhcCccc--cchh
Confidence 999999999999999999999998765432210 00 111112255566544322 4569
Q ss_pred eEehhHHHHHHhcC
Q psy6593 303 VFSYGIVLCEIIGR 316 (433)
Q Consensus 303 iwslG~il~ell~~ 316 (433)
.|.||+++++++.|
T Consensus 186 ~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 186 SWGLGCLIEELFNG 199 (690)
T ss_pred hhhHHHHHHHHhCc
Confidence 99999999999988
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.22 E-value=1e-11 Score=120.58 Aligned_cols=196 Identities=17% Similarity=0.155 Sum_probs=148.3
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.|+-+...+ .|.++++.+..+...+..|+-.||++++++...+.- ...+.+...+++..|++.++.++|++.++|+|+
T Consensus 314 ~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~ 392 (524)
T KOG0601|consen 314 GEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDV 392 (524)
T ss_pred hhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccccchhhhcccc
Confidence 788888888 599999999999888999999999999988766522 235888899999999999999999999999999
Q ss_pred CCcceEEccC-CceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCcccc--ccceecCCCCCcccC
Q psy6593 226 NSQNCLVRED-KTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWM--APEMMTGQEYDETVD 302 (433)
Q Consensus 226 kp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~D 302 (433)
+|+||++..+ +.-++.|||....+..... .....-++. ++.......+..+.|
T Consensus 393 ~psni~i~~~~~~~~~~~~~~~t~~~~~~~------------------------~~~~~~r~~p~~~~~~e~~~~~~~~~ 448 (524)
T KOG0601|consen 393 KPSNILISNDGFFSKLGDFGCWTRLAFSSG------------------------VFHHIDRLYPIAEILLEDYPHLSKAD 448 (524)
T ss_pred cccceeeccchhhhhccccccccccceecc------------------------cccccccccccchhhccccccccccc
Confidence 9999999876 7889999999875332211 222333333 566666678889999
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
++|||..+.+.+++.+.-.... .+........... ......+..+.+.++..++..||.+.++..
T Consensus 449 ~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 449 IFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNL-PGLKLQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred cccccccccccccCcccCcccc----cceeeecccccCC-CchHHhhhhhhhhhcCCccccchhhhhhcc
Confidence 9999999999998876543321 1111112212222 333478899999999999999999887764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=7.4e-11 Score=98.57 Aligned_cols=93 Identities=25% Similarity=0.388 Sum_probs=77.4
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.+|.+++--.|.-.+=+..+.....|+|||++|..|.+.+... ...++..+-.-+.-||..||+|+||+
T Consensus 48 ~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLT 119 (204)
T COG3642 48 REARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLT 119 (204)
T ss_pred HHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCc
Confidence 8999999997556555555556777888999999999999888763 24567777778888999999999999
Q ss_pred CcceEEccCCceEEeccccchh
Q psy6593 227 SQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
++||+++.++ +.++|||++..
T Consensus 120 tsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 120 TSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred cceEEEeCCc-EEEEECCcccc
Confidence 9999998765 99999999975
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=7.7e-11 Score=102.80 Aligned_cols=97 Identities=28% Similarity=0.308 Sum_probs=73.2
Q ss_pred chHHHHhhcCCc--ceeeEEEEEEeCCeeeEEEeccCCCCHHH-HhcCCCCCCChHHHHHHHHHHHHHHhhhhc-CCccc
Q psy6593 147 GQVAVLRSLHHH--NVIRFIGVLYKDRKLNLVTEYIAGGTLKE-LLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIH 222 (433)
Q Consensus 147 ~E~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~g~sL~~-~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H 222 (433)
.|...+.++.+. .+++.++. ...++||||++|+++.. .+.... . ...+..++.+++.++.++|. .||+|
T Consensus 66 ~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~ivH 138 (187)
T cd05119 66 KEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAGLVH 138 (187)
T ss_pred HHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccCcCc
Confidence 567777777543 35666554 24689999999854321 122111 1 16788999999999999999 99999
Q ss_pred cCCCCcceEEccCCceEEeccccchhccC
Q psy6593 223 RDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 223 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
+||+|+||+++ ++.++|+|||.+.....
T Consensus 139 ~Dl~p~Nili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 139 GDLSEYNILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCCChhhEEEE-CCcEEEEECcccccccC
Confidence 99999999999 89999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.5e-10 Score=100.08 Aligned_cols=97 Identities=22% Similarity=0.213 Sum_probs=77.0
Q ss_pred chHHHHhhcC--CcceeeEEEEEEeCCeeeEEEeccCCCCHH-HHhcCCCCCCChHHHHHHHHHHHHHHhhh-hcCCccc
Q psy6593 147 GQVAVLRSLH--HHNVIRFIGVLYKDRKLNLVTEYIAGGTLK-ELLQDPGQPLPWGQRVNFARDIAAGMTYL-HSMNLIH 222 (433)
Q Consensus 147 ~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~-~~l~~~~~~~~~~~~~~i~~qi~~~L~~l-H~~~i~H 222 (433)
.|...|+++. .-++++.+++ ...+|||||+.+..+. ..+++ ..++...+..+..+++.+|..| |+.|++|
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVH 148 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVH 148 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 8999999995 4678888875 4678999999664342 22333 2355667788899999999998 8999999
Q ss_pred cCCCCcceEEccCCceEEeccccchhcc
Q psy6593 223 RDLNSQNCLVREDKTVVVADFGLARIIH 250 (433)
Q Consensus 223 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 250 (433)
+||++.||++. ++.++|+|||.+....
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999999997 4679999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.5e-09 Score=99.21 Aligned_cols=104 Identities=19% Similarity=0.195 Sum_probs=82.9
Q ss_pred ccchHHHHhhcC--CcceeeEEEEEEe-----CCeeeEEEeccCCC-CHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhh
Q psy6593 145 NCGQVAVLRSLH--HHNVIRFIGVLYK-----DRKLNLVTEYIAGG-TLKELLQDP-GQPLPWGQRVNFARDIAAGMTYL 215 (433)
Q Consensus 145 ~~~E~~~l~~l~--h~~iv~~~~~~~~-----~~~~~lv~e~~~g~-sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~l 215 (433)
+.+|...+.+|. .-.++..+.++.. ....+||+|++++. +|.+++.+. ....+......++.+++..+..|
T Consensus 75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L 154 (268)
T PRK15123 75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM 154 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 348999999884 4445556666653 23578999999876 899998542 23456778889999999999999
Q ss_pred hcCCccccCCCCcceEEcc-------CCceEEeccccchh
Q psy6593 216 HSMNLIHRDLNSQNCLVRE-------DKTVVVADFGLARI 248 (433)
Q Consensus 216 H~~~i~H~dlkp~Nil~~~-------~~~~kl~Dfg~~~~ 248 (433)
|+.||+|+|+++.|||++. +..+.|+||+.+..
T Consensus 155 H~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 155 HAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 9999999999999999975 46899999998864
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.04 E-value=7.4e-10 Score=92.21 Aligned_cols=105 Identities=23% Similarity=0.312 Sum_probs=83.5
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCC-CCHHHHhcCCCCC-CChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAG-GTLKELLQDPGQP-LPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~sL~~~l~~~~~~-~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
+|+.+|.++.--.|.-..=++.+...-.|+|||++| .++.+++...... ........++.+|-..|.-||..+|+|+|
T Consensus 59 ~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGD 138 (229)
T KOG3087|consen 59 QEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGD 138 (229)
T ss_pred HHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeeccc
Confidence 899999999766766666677788888999999977 4778887653322 33334478999999999999999999999
Q ss_pred CCCcceEEccCC---ceEEeccccchhccC
Q psy6593 225 LNSQNCLVREDK---TVVVADFGLARIIHQ 251 (433)
Q Consensus 225 lkp~Nil~~~~~---~~kl~Dfg~~~~~~~ 251 (433)
|..+||++.+++ .+.|+|||++.....
T Consensus 139 LTTSNill~~~~~~~~~~lIdfgls~~s~~ 168 (229)
T KOG3087|consen 139 LTTSNILLRSDGNQITPILIDFGLSSVSRL 168 (229)
T ss_pred ccccceEEecCCCcCceEEEeecchhcccC
Confidence 999999997554 358999999876543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.01 E-value=8.1e-10 Score=94.63 Aligned_cols=91 Identities=23% Similarity=0.212 Sum_probs=70.1
Q ss_pred cchHHHHhhcCCcc-eeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCc----
Q psy6593 146 CGQVAVLRSLHHHN-VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNL---- 220 (433)
Q Consensus 146 ~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i---- 220 (433)
..|+.+++.+.+.+ +++++... ....++||||++|.++.+. . . ....++.+++.+|+.||+.++
T Consensus 40 ~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~--~----~---~~~~~~~~l~~~l~~LH~~~~~~~~ 108 (170)
T cd05151 40 ENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTE--D----F---SDPENLEKIAKLLKKLHSSPLPDLV 108 (170)
T ss_pred HHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccccc--c----c---cCHHHHHHHHHHHHHHhCCCCCCce
Confidence 37899999996544 45566553 3345899999999887643 0 1 113457899999999999985
Q ss_pred -cccCCCCcceEEccCCceEEeccccchh
Q psy6593 221 -IHRDLNSQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 221 -~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
+|+|++|.||+++ ++.++++||+.+..
T Consensus 109 ~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 109 PCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred eecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9999999999999 67899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.9e-09 Score=101.78 Aligned_cols=203 Identities=18% Similarity=0.269 Sum_probs=143.8
Q ss_pred ccCCeeeeeccCCCcchhhh-hccchHHHHhhcCCcceeeEEEEEEe----CCeeeEEEeccCC-CCHHHHhcC------
Q psy6593 124 EKDGLLFCKEDYNGKYGEAC-QNCGQVAVLRSLHHHNVIRFIGVLYK----DRKLNLVTEYIAG-GTLKELLQD------ 191 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~-~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~g-~sL~~~l~~------ 191 (433)
..+|..|+++..+|.-..-- |.-.=++.++++.|.|||++.++|.. +..+.+|++|.++ ++|.++...
T Consensus 298 ~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~ 377 (655)
T KOG3741|consen 298 NVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTK 377 (655)
T ss_pred ccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCcccc
Confidence 44555555554444332211 22245889999999999999999983 3568999999876 477776532
Q ss_pred --------CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccc
Q psy6593 192 --------PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263 (433)
Q Consensus 192 --------~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 263 (433)
.+...++..+|.++.|+..||.++|+.|+.-+-|.|.+|+++.+.+++|..-|....+...+.
T Consensus 378 ~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~--------- 448 (655)
T KOG3741|consen 378 RTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT--------- 448 (655)
T ss_pred ccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCCC---------
Confidence 234578899999999999999999999999999999999999988999998888776544321
Q ss_pred hhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCC
Q psy6593 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCA 343 (433)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (433)
+.+. --.+.|.=.||.+++.|.+|..- ..........-...+..
T Consensus 449 --------------------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n-------s~~~d~~~~s~~~~I~~ 492 (655)
T KOG3741|consen 449 --------------------------EPLE---SQQQNDLRDLGLLLLALATGTEN-------SNRTDSTQSSHLTRITT 492 (655)
T ss_pred --------------------------cchh---HHhhhhHHHHHHHHHHHhhcccc-------cccccchHHHHHHHhhh
Confidence 1111 12346888999999999987432 11111222222333446
Q ss_pred CCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 344 SCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 344 ~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
.++.++++++..+...++++ -+..+++.
T Consensus 493 ~yS~D~rn~v~yl~s~~~~~-ksI~~llp 520 (655)
T KOG3741|consen 493 TYSTDLRNVVEYLESLNFRE-KSIQDLLP 520 (655)
T ss_pred hhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence 67889999999999999997 36766664
|
|
| >KOG1700|consensus | Back alignment and domain information |
|---|
Probab=98.98 E-value=6.4e-11 Score=102.60 Aligned_cols=111 Identities=20% Similarity=0.410 Sum_probs=89.4
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeeccccccccccc------------------
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEA------------------ 62 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~------------------ 62 (433)
-|..|+..+.+.+. +...|..||+.||+|..|++.|+.. +..+++.+||+.||...|+++
T Consensus 9 kc~~c~k~vy~~e~-~~~~g~~~hk~c~~c~~~~k~l~~~~~~~~e~~~yc~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (200)
T KOG1700|consen 9 KCNACGKTVYFVEK-VQKDGVDFHKECFKCEKCKKTLTLSGYSEHEGVPYCKNCHVAQFGPKGGGFGKGFQKAGGLGKDG 87 (200)
T ss_pred hhhhccCcchHHHH-HhccCcchhhhHHhccccccccccccccccccccccccchHhhhCcccccccccccccCCCCccc
Confidence 37889988886544 5589999999999999999999887 999999999999887766653
Q ss_pred -----------------------cccccccccCC-eEEecCcccCCCCccccCCccccCCCCcccccCCccccccc
Q psy6593 63 -----------------------CQNCGQMMSGP-VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSAC 114 (433)
Q Consensus 63 -----------------------C~~C~~~i~~~-~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c 114 (433)
|..|++.+.+. .+...+..||..||.|+.|+..|.. ..|....+..+|..-
T Consensus 88 ~~~~~~~~~~~~~~~~~~g~~~~c~~c~k~vy~~Ek~~~~~~~~hk~cfrc~~~~~~ls~-~~~~~~~g~l~~~~~ 162 (200)
T KOG1700|consen 88 KSLNESKPNQSAKFQVFAGEKEKCARCQKTVYPLEKVTGNGLEFHKSCFRCTHCGKKLSP-KNYAALEGVLYCKHH 162 (200)
T ss_pred ccccccccccchhHHhhhccccccccccceeeehHHHhhhhhhhhhhheeecccccccCC-cchhhcCCccccchh
Confidence 88888877544 5556788999999999999999965 457776666665433
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.95 E-value=7.5e-09 Score=96.62 Aligned_cols=188 Identities=19% Similarity=0.247 Sum_probs=129.8
Q ss_pred eeeEEEeccCCCCH-HHHhc-----CCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEecccc
Q psy6593 172 KLNLVTEYIAGGTL-KELLQ-----DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGL 245 (433)
Q Consensus 172 ~~~lv~e~~~g~sL-~~~l~-----~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 245 (433)
..-++|+.+.|..= ..++. +.-..+.+.-+++.++.++.+.+.||+.|.+-+|++++|+|+++++.|.|+|=..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 37788888877522 22221 1112477899999999999999999999999999999999999999999998543
Q ss_pred chhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec-----CCCCCcccCeEehhHHHHHHh-cCCCC
Q psy6593 246 ARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT-----GQEYDETVDVFSYGIVLCEII-GRVPA 319 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell-~~~~~ 319 (433)
....... .-...-+|.+.|.+||... +-..+...|.|.||+++++++ +|..|
T Consensus 164 fqi~~ng----------------------~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHP 221 (637)
T COG4248 164 FQINANG----------------------TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHP 221 (637)
T ss_pred eeeccCC----------------------ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCC
Confidence 3322111 1222557889999999765 345567899999999999998 76887
Q ss_pred CCCCCCCCCCC-----CC---------chhhhcc----cc-CCCCcHHHHHHHHHhccc--CCCCCCChhHHHHHHHhhc
Q psy6593 320 DPDYLPRSPDF-----GL---------DQTDFRN----KF-CASCPEPFVRIAFLCCDL--NPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 320 ~~~~~~~~~~~-----~~---------~~~~~~~----~~-~~~~~~~l~~li~~~l~~--~p~~RPs~~~i~~~l~~~~ 378 (433)
+.........- .+ +...-.. .+ ..-+|+.++.+..+|+.. ++.-||+++..+..|..+.
T Consensus 222 ysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 222 YSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred CCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 75432211100 00 0000011 11 155678999999999976 3668999998887776655
Q ss_pred ccc
Q psy6593 379 MHL 381 (433)
Q Consensus 379 ~~~ 381 (433)
..+
T Consensus 302 ~~L 304 (637)
T COG4248 302 QQL 304 (637)
T ss_pred Hhh
Confidence 433
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.93 E-value=1e-09 Score=108.38 Aligned_cols=162 Identities=15% Similarity=0.229 Sum_probs=112.9
Q ss_pred CChHHHHHHHHHHHHHHhhhhcC-CccccCCCCcceEEccCCceEEeccccchhccCCCCCCcccc-ccchhhhhhhccc
Q psy6593 196 LPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM-AKVPRKAAQRRGA 273 (433)
Q Consensus 196 ~~~~~~~~i~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 273 (433)
...+....=+.++++||.++|+. ++||++|.|++|.++..+.+||..|+.+.........+.... ...+.
T Consensus 96 ~aTe~~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~-------- 167 (700)
T KOG2137|consen 96 KATEDGFANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPL-------- 167 (700)
T ss_pred hcccHhhhhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCCh--------
Confidence 33444455566677999999976 999999999999999999999999998876655332211100 00111
Q ss_pred ccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHh-cCCCCCCCCCCCCCCCCC---chhhhccccCCCCcHHH
Q psy6593 274 RKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDYLPRSPDFGL---DQTDFRNKFCASCPEPF 349 (433)
Q Consensus 274 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l 349 (433)
-..-...|.|||.+.+..-+.++|++|+|+++|.+. +|++.+..... ...... ............+|.++
T Consensus 168 -----~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~~~~~~~~~~~~~~s~~~p~el 241 (700)
T KOG2137|consen 168 -----LLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSYSFSRNLLNAGAFGYSNNLPSEL 241 (700)
T ss_pred -----hhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCC-cchhhhhhcccccccccccccCcHHH
Confidence 122345699999999988899999999999999998 66665432211 111111 11111222347899999
Q ss_pred HHHHHHhcccCCCCCCChhHHH
Q psy6593 350 VRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 350 ~~li~~~l~~~p~~RPs~~~i~ 371 (433)
.+=+.+++..+..-||++.++.
T Consensus 242 ~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 242 RESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHHHHHHhcCCcccCcchhhhh
Confidence 9999999999999999877665
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.5e-09 Score=105.22 Aligned_cols=99 Identities=21% Similarity=0.254 Sum_probs=72.1
Q ss_pred chHHHHhhcC-----Ccc--eeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHH-HHhhhhcC
Q psy6593 147 GQVAVLRSLH-----HHN--VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA-GMTYLHSM 218 (433)
Q Consensus 147 ~E~~~l~~l~-----h~~--iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~-~L~~lH~~ 218 (433)
+|+..+.++. +++ |++++..+ ....+|||||++|++|.++.......+ ....++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~--~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR--TSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh--cCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC
Confidence 5777777663 233 33443322 345789999999999988764321112 23456666666 47889999
Q ss_pred CccccCCCCcceEEccCCceEEeccccchhcc
Q psy6593 219 NLIHRDLNSQNCLVREDKTVVVADFGLARIIH 250 (433)
Q Consensus 219 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 250 (433)
|++|+|++|.||+++.++.++|+|||++..+.
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999997664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.6e-09 Score=92.14 Aligned_cols=96 Identities=26% Similarity=0.304 Sum_probs=67.9
Q ss_pred chHHHHhhcCCc--ceeeEEEEEEeCCeeeEEEeccC--CCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhh-hhcCCcc
Q psy6593 147 GQVAVLRSLHHH--NVIRFIGVLYKDRKLNLVTEYIA--GGTLKELLQDPGQPLPWGQRVNFARDIAAGMTY-LHSMNLI 221 (433)
Q Consensus 147 ~E~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~--g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~-lH~~~i~ 221 (433)
+|.+.|.++... ++++++++. ...|||||++ |..+..+... .++......++.+++..+.. +|..||+
T Consensus 57 ~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~---~~~~~~~~~~~~~il~~~~~~~~~~giv 129 (188)
T PF01163_consen 57 KEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDV---DLSPEEPKELLEEILEEIIKMLHKAGIV 129 (188)
T ss_dssp HHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHC---GGGGSTHHHHHHHHHHHHHHHHHCTTEE
T ss_pred HHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhc---cccchhHHHHHHHHHHHHHHHHHhcCce
Confidence 899999999755 678887652 4569999998 6555554433 13356677788888885555 6899999
Q ss_pred ccCCCCcceEEccCCceEEeccccchhcc
Q psy6593 222 HRDLNSQNCLVREDKTVVVADFGLARIIH 250 (433)
Q Consensus 222 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 250 (433)
|+||.+.||+++++ .+.++|||.+....
T Consensus 130 HGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 130 HGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp ESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred ecCCChhhEEeecc-eEEEEecCcceecC
Confidence 99999999999987 89999999887653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.4e-08 Score=89.82 Aligned_cols=104 Identities=27% Similarity=0.302 Sum_probs=85.2
Q ss_pred ccchHHHHhhcC--CcceeeEEEEEEeCC----eeeEEEeccCCC-CHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhc
Q psy6593 145 NCGQVAVLRSLH--HHNVIRFIGVLYKDR----KLNLVTEYIAGG-TLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS 217 (433)
Q Consensus 145 ~~~E~~~l~~l~--h~~iv~~~~~~~~~~----~~~lv~e~~~g~-sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~ 217 (433)
..+|...+.+|. .-.+++.+.+..... ..++|+|++++. +|.+++.+... .+......++.+++..+.-||+
T Consensus 58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~lH~ 136 (206)
T PF06293_consen 58 AKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKLHD 136 (206)
T ss_pred HHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHHHH
Confidence 347888888884 445677777776532 468999999874 89999876333 6777888999999999999999
Q ss_pred CCccccCCCCcceEEccCC---ceEEeccccchhc
Q psy6593 218 MNLIHRDLNSQNCLVREDK---TVVVADFGLARII 249 (433)
Q Consensus 218 ~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~~~~ 249 (433)
.||+|+|+++.|||++.++ .+.|+||+.++..
T Consensus 137 ~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 137 AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999999999999877 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF00412 LIM: LIM domain; InterPro: IPR001781 Zinc finger (Znf) domains are relatively small protein motifs which contain multiple finger-like protrusions that make tandem contacts with their target molecule | Back alignment and domain information |
|---|
Probab=98.81 E-value=2e-09 Score=74.23 Aligned_cols=53 Identities=32% Similarity=0.812 Sum_probs=46.4
Q ss_pred cccccccccCC--eEEecCcccCCCCccccCCccccCCCCcccccCCccccccccc
Q psy6593 63 CQNCGQMMSGP--VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDV 116 (433)
Q Consensus 63 C~~C~~~i~~~--~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~ 116 (433)
|.+|+++|.+. .+++.++.||++||+|..|++.|..+. |+..++..+|..|+.
T Consensus 1 C~~C~~~I~~~~~~~~~~~~~~H~~Cf~C~~C~~~l~~~~-~~~~~~~~~C~~c~~ 55 (58)
T PF00412_consen 1 CARCGKPIYGTEIVIKAMGKFWHPECFKCSKCGKPLNDGD-FYEKDGKPYCKDCYQ 55 (58)
T ss_dssp BTTTSSBESSSSEEEEETTEEEETTTSBETTTTCBTTTSS-EEEETTEEEEHHHHH
T ss_pred CCCCCCCccCcEEEEEeCCcEEEccccccCCCCCccCCCe-eEeECCEEECHHHHh
Confidence 88999999766 446999999999999999999996655 889999999998874
|
Some of these domains bind zinc, but many do not; instead binding other metals such as iron, or no metal at all. For example, some family members form salt bridges to stabilise the finger-like folds. They were first identified as a DNA-binding motif in transcription factor TFIIIA from Xenopus laevis (African clawed frog), however they are now recognised to bind DNA, RNA, protein and/or lipid substrates [, , , , ]. Their binding properties depend on the amino acid sequence of the finger domains and of the linker between fingers, as well as on the higher-order structures and the number of fingers. Znf domains are often found in clusters, where fingers can have different binding specificities. There are many superfamilies of Znf motifs, varying in both sequence and structure. They display considerable versatility in binding modes, even between members of the same class (e.g. some bind DNA, others protein), suggesting that Znf motifs are stable scaffolds that have evolved specialised functions. For example, Znf-containing proteins function in gene transcription, translation, mRNA trafficking, cytoskeleton organisation, epithelial development, cell adhesion, protein folding, chromatin remodelling and zinc sensing, to name but a few []. Zinc-binding motifs are stable structures, and they rarely undergo conformational changes upon binding their target. This entry represents LIM-type zinc finger (Znf) domains. LIM domains coordinate one or more zinc atoms, and are named after the three proteins (LIN-11, Isl1 and MEC-3) in which they were first found. They consist of two zinc-binding motifs that resemble GATA-like Znf's, however the residues holding the zinc atom(s) are variable, involving Cys, His, Asp or Glu residues. LIM domains are involved in proteins with differing functions, including gene expression, and cytoskeleton organisation and development [, ]. Protein containing LIM Znf domains include: Caenorhabditis elegans mec-3; a protein required for the differentiation of the set of six touch receptor neurons in this nematode. C. elegans. lin-11; a protein required for the asymmetric division of vulval blast cells. Vertebrate insulin gene enhancer binding protein isl-1. Isl-1 binds to one of the two cis-acting protein-binding domains of the insulin gene. Vertebrate homeobox proteins lim-1, lim-2 (lim-5) and lim3. Vertebrate lmx-1, which acts as a transcriptional activator by binding to the FLAT element; a beta-cell-specific transcriptional enhancer found in the insulin gene. Mammalian LH-2, a transcriptional regulatory protein involved in the control of cell differentiation in developing lymphoid and neural cell types. Drosophila melanogaster (Fruit fly) protein apterous, required for the normal development of the wing and halter imaginal discs. Vertebrate protein kinases LIMK-1 and LIMK-2. Mammalian rhombotins. Rhombotin 1 (RBTN1 or TTG-1) and rhombotin-2 (RBTN2 or TTG-2) are proteins of about 160 amino acids whose genes are disrupted by chromosomal translocations in T-cell leukemia. Mammalian and avian cysteine-rich protein (CRP), a 192 amino-acid protein of unknown function. Seems to interact with zyxin. Mammalian cysteine-rich intestinal protein (CRIP), a small protein which seems to have a role in zinc absorption and may function as an intracellular zinc transport protein. Vertebrate paxillin, a cytoskeletal focal adhesion protein. Mus musculus (Mouse) testin which should not be confused with rat testin which is a thiol protease homologue (see IPR000169 from INTERPRO). Helianthus annuus (Common sunflower) pollen specific protein SF3. Chicken zyxin. Zyxin is a low-abundance adhesion plaque protein which has been shown to interact with CRP. Yeast protein LRG1 which is involved in sporulation []. Saccharomyces cerevisiae (Baker's yeast) rho-type GTPase activating protein RGA1/DBM1. C. elegans homeobox protein ceh-14. C. elegans homeobox protein unc-97. S. cerevisiae hypothetical protein YKR090w. C. elegans hypothetical proteins C28H8.6. These proteins generally contain two tandem copies of the LIM domain in their N-terminal section. Zyxin and paxillin are exceptions in that they contain respectively three and four LIM domains at their C-terminal extremity. In apterous, isl-1, LH-2, lin-11, lim-1 to lim-3, lmx-1 and ceh-14 and mec-3 there is a homeobox domain some 50 to 95 amino acids after the LIM domains. LIM domains contain seven conserved cysteine residues and a histidine. The arrangement followed by these conserved residues is: C-x(2)-C-x(16,23)-H-x(2)-[CH]-x(2)-C-x(2)-C-x(16,21)-C-x(2,3)-[CHD] LIM domains bind two zinc ions []. LIM does not bind DNA, rather it seems to act as an interface for protein-protein interaction. More information about these proteins can be found at Protein of the Month: Zinc Fingers [].; GO: 0008270 zinc ion binding; PDB: 2CO8_A 2EGQ_A 2CUR_A 3IXE_B 1CTL_A 1B8T_A 1X62_A 2DFY_C 1IML_A 2CUQ_A .... |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.5e-08 Score=101.01 Aligned_cols=98 Identities=17% Similarity=0.264 Sum_probs=64.7
Q ss_pred chHHHHhhcC----CcceeeEEEEEEe-CCeeeEEEeccCCCCHHHHh--cCCCC---CCChHHHHHHHHHHHHHHhhhh
Q psy6593 147 GQVAVLRSLH----HHNVIRFIGVLYK-DRKLNLVTEYIAGGTLKELL--QDPGQ---PLPWGQRVNFARDIAAGMTYLH 216 (433)
Q Consensus 147 ~E~~~l~~l~----h~~iv~~~~~~~~-~~~~~lv~e~~~g~sL~~~l--~~~~~---~~~~~~~~~i~~qi~~~L~~lH 216 (433)
+|+..+.++. +.+.+.+-.++.+ ....+|||||++|++|.++- ...+. .+....+..++.|+ .
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 4555555552 3333333333322 34678999999999998752 22221 23333444444444 4
Q ss_pred cCCccccCCCCcceEEccCC----ceEEeccccchhccC
Q psy6593 217 SMNLIHRDLNSQNCLVREDK----TVVVADFGLARIIHQ 251 (433)
Q Consensus 217 ~~~i~H~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~ 251 (433)
..|++|+|++|.||+++.++ .++++|||++..+..
T Consensus 278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 58999999999999999887 999999999887643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.8e-07 Score=83.68 Aligned_cols=102 Identities=27% Similarity=0.337 Sum_probs=78.5
Q ss_pred ccchHHHHhhcCC--cceeeEEEEEEeCC---eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhc--
Q psy6593 145 NCGQVAVLRSLHH--HNVIRFIGVLYKDR---KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-- 217 (433)
Q Consensus 145 ~~~E~~~l~~l~h--~~iv~~~~~~~~~~---~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~-- 217 (433)
..+|+++++.+.+ .++++++.+..... ..++||||++|.+|.+.+.. ..++......++.+++.+|..||+
T Consensus 42 ~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ 119 (223)
T cd05154 42 VAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVD 119 (223)
T ss_pred HHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCC
Confidence 3479999999965 45688888876542 67899999999988776532 246667777777777777777773
Q ss_pred ------------------------------------------------------CCccccCCCCcceEEcc--CCceEEe
Q psy6593 218 ------------------------------------------------------MNLIHRDLNSQNCLVRE--DKTVVVA 241 (433)
Q Consensus 218 ------------------------------------------------------~~i~H~dlkp~Nil~~~--~~~~kl~ 241 (433)
..++|+|+.|.||+++. ++.+.|+
T Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iI 199 (223)
T cd05154 120 PAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVL 199 (223)
T ss_pred hhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEE
Confidence 24689999999999998 6778999
Q ss_pred ccccchh
Q psy6593 242 DFGLARI 248 (433)
Q Consensus 242 Dfg~~~~ 248 (433)
||+.+..
T Consensus 200 D~e~~~~ 206 (223)
T cd05154 200 DWELATL 206 (223)
T ss_pred ecccccc
Confidence 9998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.3e-06 Score=75.93 Aligned_cols=103 Identities=20% Similarity=0.190 Sum_probs=78.9
Q ss_pred chHHHHhhcC--CcceeeEEEEEEeC----CeeeEEEeccCC-CCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcC
Q psy6593 147 GQVAVLRSLH--HHNVIRFIGVLYKD----RKLNLVTEYIAG-GTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSM 218 (433)
Q Consensus 147 ~E~~~l~~l~--h~~iv~~~~~~~~~----~~~~lv~e~~~g-~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~ 218 (433)
+|...|.+|. .-.+++........ ...+||+|-++| .||.+++.+.. .+.+......++.+++..|+-||+.
T Consensus 68 rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~ 147 (216)
T PRK09902 68 REVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV 147 (216)
T ss_pred HHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC
Confidence 6888888884 33366666222221 247899997743 58999886632 2467788889999999999999999
Q ss_pred CccccCCCCcceEEccCCc--eEEeccccchhc
Q psy6593 219 NLIHRDLNSQNCLVREDKT--VVVADFGLARII 249 (433)
Q Consensus 219 ~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~ 249 (433)
|+.|+|+.+.||+++.++. +.++||.-++..
T Consensus 148 Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 148 NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred CCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 9999999999999986666 999999987653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=6.3e-07 Score=79.84 Aligned_cols=95 Identities=27% Similarity=0.282 Sum_probs=75.3
Q ss_pred ccchHHHHhhcCCc--ceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccc
Q psy6593 145 NCGQVAVLRSLHHH--NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 222 (433)
Q Consensus 145 ~~~E~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H 222 (433)
+-+|.++|.+|... .|++.+++ +...+|||+++|-.|...- +..+..-.++..|+.-+..+-..|+||
T Consensus 156 A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVH 225 (304)
T COG0478 156 AEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVH 225 (304)
T ss_pred HHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccc
Confidence 44899999999654 88888776 4567999999987766542 234555566666777666666899999
Q ss_pred cCCCCcceEEccCCceEEeccccchhc
Q psy6593 223 RDLNSQNCLVREDKTVVVADFGLARII 249 (433)
Q Consensus 223 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 249 (433)
+|+.+-||+++++|.+.++||-.+...
T Consensus 226 GDlSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 226 GDLSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred cCCchheEEEecCCCEEEEeCcccccC
Confidence 999999999999999999999877654
|
|
| >smart00132 LIM Zinc-binding domain present in Lin-11, Isl-1, Mec-3 | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.2e-07 Score=57.39 Aligned_cols=38 Identities=18% Similarity=0.039 Sum_probs=32.4
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccC
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLD 39 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~ 39 (433)
.|.+|++.+.-....+.+.++.||+.||+|..|+++|.
T Consensus 1 ~C~~C~~~i~~~~~~~~~~~~~~H~~Cf~C~~C~~~L~ 38 (39)
T smart00132 1 KCAGCGKPIRGGELVLRALGKVWHPECFKCSKCGKPLG 38 (39)
T ss_pred CccccCCcccCCcEEEEeCCccccccCCCCcccCCcCc
Confidence 37889887664447889999999999999999999985
|
Zinc-binding domain family. Some LIM domains bind protein partners via tyrosine-containing motifs. LIM domains are found in many key regulators of developmental pathways. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.4e-06 Score=76.01 Aligned_cols=68 Identities=25% Similarity=0.387 Sum_probs=54.3
Q ss_pred CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchh
Q psy6593 171 RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 171 ~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
...++||||++|..|.++.. +++ .++..+.+++..||+.|++|+|..|.|++++.++ ++++||+..+.
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred eEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECccccc
Confidence 35678999999988876532 222 2456677889999999999999999999998655 99999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >smart00132 LIM Zinc-binding domain present in Lin-11, Isl-1, Mec-3 | Back alignment and domain information |
|---|
Probab=98.29 E-value=4.6e-07 Score=56.62 Aligned_cols=36 Identities=39% Similarity=0.971 Sum_probs=32.3
Q ss_pred ccccccccccC--CeEEecCcccCCCCccccCCccccC
Q psy6593 62 ACQNCGQMMSG--PVMVVGDHKFHPECFKCTSCSCCIG 97 (433)
Q Consensus 62 ~C~~C~~~i~~--~~~~~~~~~~h~~cf~C~~C~~~l~ 97 (433)
+|.+|+++|.+ ..+.+.+..||+.||.|..|+..|.
T Consensus 1 ~C~~C~~~i~~~~~~~~~~~~~~H~~Cf~C~~C~~~L~ 38 (39)
T smart00132 1 KCAGCGKPIRGGELVLRALGKVWHPECFKCSKCGKPLG 38 (39)
T ss_pred CccccCCcccCCcEEEEeCCccccccCCCCcccCCcCc
Confidence 59999999977 5778899999999999999999884
|
Zinc-binding domain family. Some LIM domains bind protein partners via tyrosine-containing motifs. LIM domains are found in many key regulators of developmental pathways. |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.5e-06 Score=84.15 Aligned_cols=147 Identities=22% Similarity=0.241 Sum_probs=110.3
Q ss_pred chHHHHhhcCCcc-eeeEEEEEEeCCeeeEEEeccCCC-CHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 147 GQVAVLRSLHHHN-VIRFIGVLYKDRKLNLVTEYIAGG-TLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 147 ~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~g~-sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
-++++|.+++||| .++.++-...+...+++++++.++ +....+......+.+-+...+.+.-..+|+++|+.-=+|+|
T Consensus 282 l~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d 361 (829)
T KOG0576|consen 282 LAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD 361 (829)
T ss_pred HHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc
Confidence 5889999999999 777777777778999999999776 22222211112244445556667778889999998778888
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
||+.++ +..++.||+....+.... +.....+|+.++|||+.....+....|.|
T Consensus 362 ----~~l~s~-~~~~~~~~~v~~~L~~~~----------------------~~~t~~~~~~~~~pev~~~~~~~~~p~~~ 414 (829)
T KOG0576|consen 362 ----NILGSE-EEVKLLDFAVPPQLTRTM----------------------KPRTAIGTPEPLAPEVIQENTIDGCPDSG 414 (829)
T ss_pred ----cccccc-cccccccccCCcccCccc----------------------ccccCCCCCCCCCchhhcccccccCCCcc
Confidence 776654 678999999887665432 22367899999999999999999999999
Q ss_pred ehhHHHHHHhcCCCCC
Q psy6593 305 SYGIVLCEIIGRVPAD 320 (433)
Q Consensus 305 slG~il~ell~~~~~~ 320 (433)
++|.-..++--+.||.
T Consensus 415 ~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 415 SLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCcchhhcCCCCCCC
Confidence 9998777777666554
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.6e-05 Score=68.95 Aligned_cols=100 Identities=19% Similarity=0.241 Sum_probs=79.0
Q ss_pred chHHHHhhcCC-cceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcC--CCCCCChHHHHHHHHHHHHHHhhhhc---CCc
Q psy6593 147 GQVAVLRSLHH-HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD--PGQPLPWGQRVNFARDIAAGMTYLHS---MNL 220 (433)
Q Consensus 147 ~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i 220 (433)
+|.-+|+.+.+ +++++++|+|- .++|.|+...+++...... .-...++..+.+|+.++++.+.+|+. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58888999965 69999999982 3578899976665422100 00136899999999999999999998 357
Q ss_pred cccCCCCcceEEccCCceEEeccccchhcc
Q psy6593 221 IHRDLNSQNCLVREDKTVVVADFGLARIIH 250 (433)
Q Consensus 221 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 250 (433)
.-.|++|+|+.+++++++|++|...+....
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 778999999999999999999998876553
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG4577|consensus | Back alignment and domain information |
|---|
Probab=97.98 E-value=2.7e-07 Score=80.68 Aligned_cols=80 Identities=28% Similarity=0.728 Sum_probs=64.1
Q ss_pred ccccccccccccccccccCCe-EEecCcccCCCCccccCCccccCCCCcccccCCccccccccccccccccccCCeeeee
Q psy6593 54 DYNGKYGEACQNCGQMMSGPV-MVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVMLDNWYFEKDGLLFCK 132 (433)
Q Consensus 54 ~~~~~~~~~C~~C~~~i~~~~-~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~l~~~~~~~~~~~~~~ 132 (433)
++...--|+|++|.+.|.+++ +.+.+++||..|..|+.|.-+|+ ...+.+++.+||+
T Consensus 27 df~~~eip~CagC~q~IlDrFilKvl~R~wHs~CLkCs~C~~qL~----------------------drCFsR~~s~yCk 84 (383)
T KOG4577|consen 27 DFSNVEIPICAGCDQHILDRFILKVLDRHWHSSCLKCSDCHDQLA----------------------DRCFSREGSVYCK 84 (383)
T ss_pred cccccccccccchHHHHHHHHHHHHHhhhhhhhhcchhhhhhHHH----------------------HHHhhcCCceeeh
Confidence 333334489999999999994 46999999999999999998884 2356777888889
Q ss_pred ccCCCcchhhhhccch----HHHHhhc
Q psy6593 133 EDYNGKYGEACQNCGQ----VAVLRSL 155 (433)
Q Consensus 133 ~~~~g~fg~v~~~~~E----~~~l~~l 155 (433)
+++-..||+.+.+++| .+++++.
T Consensus 85 edFfKrfGTKCsaC~~GIpPtqVVRkA 111 (383)
T KOG4577|consen 85 EDFFKRFGTKCSACQEGIPPTQVVRKA 111 (383)
T ss_pred HHHHHHhCCcchhhcCCCChHHHHHHh
Confidence 8889999999998853 4566666
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.97 E-value=3.8e-05 Score=68.87 Aligned_cols=99 Identities=13% Similarity=0.171 Sum_probs=61.4
Q ss_pred cchHHHHhhcCCc--ceeeEEEEEEeCCeeeEEEeccCCCC-HHHHh---------------------cCCC-CCCChH-
Q psy6593 146 CGQVAVLRSLHHH--NVIRFIGVLYKDRKLNLVTEYIAGGT-LKELL---------------------QDPG-QPLPWG- 199 (433)
Q Consensus 146 ~~E~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~g~s-L~~~l---------------------~~~~-~~~~~~- 199 (433)
.+|.++++.+..- .+++.+++....+...+|||+++|.+ +...+ .... ...+..
T Consensus 40 ~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~ 119 (226)
T TIGR02172 40 KREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQS 119 (226)
T ss_pred HHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHH
Confidence 4799999999643 35888888888888899999999863 21111 1100 001111
Q ss_pred -----------------HHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccch
Q psy6593 200 -----------------QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLAR 247 (433)
Q Consensus 200 -----------------~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 247 (433)
..+..+...+..+. -...++|+|+.|.||++++++ +.++||+.+.
T Consensus 120 ~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~--~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 120 YKEKIRKFIEEKDFVPKDYKEKARAFIKEVP--DTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred HHHHHHHHHHhccCCCHHHHHHHHHHHHhCC--CCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 11111111111110 012578999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.93 E-value=6.5e-05 Score=68.37 Aligned_cols=104 Identities=21% Similarity=0.193 Sum_probs=66.1
Q ss_pred hccchHHHHhhcC-CcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhc-------------------C-C--CCCCChH-
Q psy6593 144 QNCGQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-------------------D-P--GQPLPWG- 199 (433)
Q Consensus 144 ~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~-------------------~-~--~~~~~~~- 199 (433)
....|+++++.+. +--+++++++...++..++|||+++|.+|.+... . . +.++...
T Consensus 37 ~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~ 116 (244)
T cd05150 37 ELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRL 116 (244)
T ss_pred chHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhH
Confidence 3447999999983 4567888888877777899999999987764321 1 0 0011100
Q ss_pred -HHHHH-----------------------HHHHHHHHhhh----hcCCccccCCCCcceEEccCCceEEeccccch
Q psy6593 200 -QRVNF-----------------------ARDIAAGMTYL----HSMNLIHRDLNSQNCLVREDKTVVVADFGLAR 247 (433)
Q Consensus 200 -~~~~i-----------------------~~qi~~~L~~l----H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 247 (433)
..... ..++...|... ....++|+|+.|.||++++++.+.|+||+.+.
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 117 DRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred HHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 00000 11111111111 22358999999999999998888999999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0490|consensus | Back alignment and domain information |
|---|
Probab=97.85 E-value=1.1e-06 Score=79.50 Aligned_cols=102 Identities=25% Similarity=0.477 Sum_probs=83.8
Q ss_pred eccceeecCCCcCcCCccccccccccC--CceEeeCCeeeecccccc--cccccccccccccc--CCeEEecCcccCCCC
Q psy6593 13 ENENLRFLCRSSLIFTSGCSACDVMLD--NWYFEKDGLLFCKEDYNG--KYGEACQNCGQMMS--GPVMVVGDHKFHPEC 86 (433)
Q Consensus 13 ~~~~~~~~~~~~h~~cf~C~~C~~~l~--~~~~~~~~~~~C~~~~~~--~~~~~C~~C~~~i~--~~~~~~~~~~~h~~c 86 (433)
+...+.+.+..||..|..|..|...+. ..++.++|.+||+.+|.. .+..+|.+|.+.+. +.++.+.... |.-|
T Consensus 8 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~d~~~~~~~~~rr~rt~~~~~ql~~ler~f~~~-h~Pd 86 (235)
T KOG0490|consen 8 DRYLLRVLDRYWHASCLKCAECDNPLGVGDTCFSKDGSIYCKRDYQREFKFSKRCARCKFTISQLDELERAFEKV-HLPC 86 (235)
T ss_pred chHHhhcccHHHHHHHHhhhhhcchhccCCCcccCCCcccccccchhhhhccccccCCCCCcCHHHHHHHhhcCC-CcCc
Confidence 455666779999999999999999997 446667999999999999 88899999999983 3466677777 9999
Q ss_pred ccccCCccccCCCCcccccCC-cccccccc
Q psy6593 87 FKCTSCSCCIGDGESYALVER-SILCSACD 115 (433)
Q Consensus 87 f~C~~C~~~l~~g~~~~~~~~-~~~C~~c~ 115 (433)
|.|..|...+..+..+.+... ...|...+
T Consensus 87 ~~~r~~la~~~~~~e~rVqvwFqnrrak~r 116 (235)
T KOG0490|consen 87 FACRECLALLLTGDEFRVQVWFQNRRAKDR 116 (235)
T ss_pred cchHHHHhhcCCCCeeeeehhhhhhcHhhh
Confidence 999999999988888877766 44454443
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=97.81 E-value=4.4e-05 Score=80.49 Aligned_cols=192 Identities=17% Similarity=0.225 Sum_probs=133.3
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCe----eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRK----LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 222 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H 222 (433)
.|...+.++.|+|++.++.|..+... ..+..+++..-++...++..+ ..+.+.++.+..+++.||.++|+....|
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-~i~~~~~r~~~~~~~~GL~~~h~~~l~~ 309 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-SIPLETLRILHQKLLEGLAYLHSLSLEH 309 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-ccCHHHHHHHHHHHhhhHHHHHHhccce
Confidence 56777888899999999999876543 335567788888888887754 4899999999999999999999996666
Q ss_pred cCCCCc---ceEEccCCceEEe--ccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCC
Q psy6593 223 RDLNSQ---NCLVREDKTVVVA--DFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY 297 (433)
Q Consensus 223 ~dlkp~---Nil~~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 297 (433)
.-+... +...+..+.+.+. ||+.+.......... ....+..+.++|.......
T Consensus 310 v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~----------------------~~~~~~~~~~~e~~~~~~~ 367 (1351)
T KOG1035|consen 310 VVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF----------------------SDLLAEIRNADEDLKENTA 367 (1351)
T ss_pred eEEecccccccccCccceeecchhhhcccccCCCcccch----------------------hhcCccccccccccccccc
Confidence 655554 3344455666666 888877665433221 2234455778887776554
Q ss_pred Cc--ccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 298 DE--TVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 298 ~~--~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
.. ..|+|.+|.....+..+....... .....+ ++........+...+|+.-+.++|+++.+++.
T Consensus 368 ~~~r~~dL~~lgll~~~~~~~~~i~~~~--------~~~~~~---l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 368 KKSRLTDLWCLGLLLLQLSQGEDISEKS--------AVPVSL---LDVLSTSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred hhhhhhHHHHHHHHHhhhhhcCcccccc--------cchhhh---hccccchhhhhhhhhhcchhhhhccchhhhhh
Confidence 44 479999999999888554432110 011111 11222236788899999999999999988875
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00015 Score=64.28 Aligned_cols=98 Identities=27% Similarity=0.280 Sum_probs=74.0
Q ss_pred chHHHHhhcC--CcceeeEEEEEEeCCeeeEEEeccCCCCH-HHHhcCCCCCCChHHHHHHHHHHHHHHhhhhc-CCccc
Q psy6593 147 GQVAVLRSLH--HHNVIRFIGVLYKDRKLNLVTEYIAGGTL-KELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIH 222 (433)
Q Consensus 147 ~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~g~sL-~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H 222 (433)
.|..-|+++. +-.+++-+.+. ...|||||+....+ .-.|++ -++..+++..+..++++.+.-|-. .++||
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~LVH 190 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGLVH 190 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCccc
Confidence 7888899984 56677777775 45699999943211 111222 234445788889999999988877 89999
Q ss_pred cCCCCcceEEccCCceEEeccccchhccC
Q psy6593 223 RDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 223 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
+||..=|||+. ++.+.++|||.+.....
T Consensus 191 gDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 191 GDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred ccchhhheEEE-CCeEEEEECccccccCC
Confidence 99999999999 88999999999887653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00033 Score=69.86 Aligned_cols=100 Identities=18% Similarity=0.239 Sum_probs=67.1
Q ss_pred chHHHHhhcC-----Ccc--eeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHH-HhhhhcC
Q psy6593 147 GQVAVLRSLH-----HHN--VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAG-MTYLHSM 218 (433)
Q Consensus 147 ~E~~~l~~l~-----h~~--iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~-L~~lH~~ 218 (433)
+|+.-+.+++ .++ |++++.- -.....|+|||++|..+.+...-....++...+. ..++.+ +..+-..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we--~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia---~~~~~~f~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWE--YTTRRVLTMEWIDGIKISDIAALKSAGIDRKELA---ELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehh--ccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHH---HHHHHHHHHHHHhc
Confidence 6777777763 233 3333322 2356779999999999988843222335533332 222222 3444458
Q ss_pred CccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 219 NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 219 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
|++|.|..|.||+++.+|.+.+.|||+...+..
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999876653
|
|
| >KOG1700|consensus | Back alignment and domain information |
|---|
Probab=97.38 E-value=3.7e-05 Score=66.86 Aligned_cols=56 Identities=16% Similarity=0.239 Sum_probs=46.7
Q ss_pred cCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeecccccccc
Q psy6593 3 FGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKY 59 (433)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~ 59 (433)
|+.|+..+- .-+.+.+.+..||+.||+|+.|+..|+.. +...+|.+||+..+..+|
T Consensus 111 c~~c~k~vy-~~Ek~~~~~~~~hk~cfrc~~~~~~ls~~~~~~~~g~l~~~~~~~~~~ 167 (200)
T KOG1700|consen 111 CARCQKTVY-PLEKVTGNGLEFHKSCFRCTHCGKKLSPKNYAALEGVLYCKHHFAQLF 167 (200)
T ss_pred cccccceee-ehHHHhhhhhhhhhhheeecccccccCCcchhhcCCccccchhhheee
Confidence 677776554 67789999999999999999999999887 999899998877665544
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.00062 Score=61.51 Aligned_cols=31 Identities=32% Similarity=0.467 Sum_probs=26.4
Q ss_pred CCccccCCCCcceEEccCCceEEeccccchh
Q psy6593 218 MNLIHRDLNSQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 218 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
.+++|+|+.|.||+++.++..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3589999999999998776667999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0021 Score=56.04 Aligned_cols=95 Identities=25% Similarity=0.390 Sum_probs=67.8
Q ss_pred chHHHHhhcC------CcceeeEEEEEEeCCeeeEEEeccCC------CCHHHHhcCCCCCCChHHHHHHHHHHHHHHhh
Q psy6593 147 GQVAVLRSLH------HHNVIRFIGVLYKDRKLNLVTEYIAG------GTLKELLQDPGQPLPWGQRVNFARDIAAGMTY 214 (433)
Q Consensus 147 ~E~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e~~~g------~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~ 214 (433)
+|+....++. +.+|.+++|+.+++.-.-+|+|.+.. .+|.+++++ ..++. ...+ .+-.-..+
T Consensus 60 ~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~~---~L~~f~~~ 133 (199)
T PF10707_consen 60 RELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELRQ---ALDEFKRY 133 (199)
T ss_pred HHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHHH---HHHHHHHH
Confidence 4554444443 88999999999999989999998643 378888866 33555 3333 33444567
Q ss_pred hhcCCccccCCCCcceEEccC---C-ceEEec-cccch
Q psy6593 215 LHSMNLIHRDLNSQNCLVRED---K-TVVVAD-FGLAR 247 (433)
Q Consensus 215 lH~~~i~H~dlkp~Nil~~~~---~-~~kl~D-fg~~~ 247 (433)
|-+.+|+.+|++|.||++... . .+.|+| ||...
T Consensus 134 l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 134 LLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred HHHcCCeecCCCcccEEEEecCCCceEEEEEeCCCCcc
Confidence 788899999999999999632 2 578888 55433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0018 Score=58.08 Aligned_cols=104 Identities=29% Similarity=0.307 Sum_probs=55.9
Q ss_pred ccchHHHHhhcCCc--ceeeEEEEEEeC---CeeeEEEeccCCCCHHH----------------Hhc---CC---CCCCC
Q psy6593 145 NCGQVAVLRSLHHH--NVIRFIGVLYKD---RKLNLVTEYIAGGTLKE----------------LLQ---DP---GQPLP 197 (433)
Q Consensus 145 ~~~E~~~l~~l~h~--~iv~~~~~~~~~---~~~~lv~e~~~g~sL~~----------------~l~---~~---~~~~~ 197 (433)
..+|+.+++.+... .+++++...... ...+++|++++|.++.. .+. +. ...+.
T Consensus 37 ~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~ 116 (239)
T PF01636_consen 37 LRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFA 116 (239)
T ss_dssp HHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHT
T ss_pred HHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccccccccccchhhhhhcccccccccccc
Confidence 33788999998533 467777754333 35789999999988877 111 11 01111
Q ss_pred hHH---------HHHH------------HHHHHH-HHhhhh-------cCCccccCCCCcceEEc-cCCceEEeccccch
Q psy6593 198 WGQ---------RVNF------------ARDIAA-GMTYLH-------SMNLIHRDLNSQNCLVR-EDKTVVVADFGLAR 247 (433)
Q Consensus 198 ~~~---------~~~i------------~~qi~~-~L~~lH-------~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~ 247 (433)
... .... ...+.. .+..++ ...++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 117 DWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 100 0000 011111 222222 34699999999999999 66767899999875
Q ss_pred h
Q psy6593 248 I 248 (433)
Q Consensus 248 ~ 248 (433)
.
T Consensus 197 ~ 197 (239)
T PF01636_consen 197 W 197 (239)
T ss_dssp E
T ss_pred E
Confidence 3
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.001 Score=71.36 Aligned_cols=40 Identities=23% Similarity=0.319 Sum_probs=31.0
Q ss_pred cchHHHHhhcC-Ccce--eeEEEEEEeC---CeeeEEEeccCCCCH
Q psy6593 146 CGQVAVLRSLH-HHNV--IRFIGVLYKD---RKLNLVTEYIAGGTL 185 (433)
Q Consensus 146 ~~E~~~l~~l~-h~~i--v~~~~~~~~~---~~~~lv~e~~~g~sL 185 (433)
.+|+++|+.+. |.+| ++++.++.+. +..|+||||++|..+
T Consensus 86 ~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 86 EREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred HHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence 38999999995 6665 8888887654 467899999988653
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.001 Score=66.37 Aligned_cols=86 Identities=24% Similarity=0.326 Sum_probs=60.1
Q ss_pred eeeEEEEEEeCCeeeEEEeccCCCCHHHH--hcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc---
Q psy6593 160 VIRFIGVLYKDRKLNLVTEYIAGGTLKEL--LQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE--- 234 (433)
Q Consensus 160 iv~~~~~~~~~~~~~lv~e~~~g~sL~~~--l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~--- 234 (433)
|++++..+. ....|+|||++|..+.++ +.+ ..++...+..-+.+... +.+-..|++|.|-.|.||+++.
T Consensus 266 VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~ 339 (538)
T KOG1235|consen 266 VPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDK--RGISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPE 339 (538)
T ss_pred CCeehhhcC--cceEEEEEecCCccCCCHHHHHH--cCCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCC
Confidence 666655543 457799999999877655 333 33666654444333332 3344568999999999999983
Q ss_pred -CCceEEeccccchhccC
Q psy6593 235 -DKTVVVADFGLARIIHQ 251 (433)
Q Consensus 235 -~~~~kl~Dfg~~~~~~~ 251 (433)
++.+.+.|||+...+..
T Consensus 340 ~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 340 GDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccEEEEcccccccccH
Confidence 67899999999886643
|
|
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=96.98 E-value=2.1e-05 Score=84.71 Aligned_cols=153 Identities=10% Similarity=0.011 Sum_probs=114.6
Q ss_pred chHHHHhhcCCcceeeEEEEEEe--CCeeeEEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcC---
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSM--- 218 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~--- 218 (433)
.|...++...|+++.....-... +...|.+++++.+|.+.+.+-+ ...++...-+....++.+.+..-+|+.
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 56666777889998877666543 3468899999999999998854 223344444555555557777776654
Q ss_pred --CccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC
Q psy6593 219 --NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE 296 (433)
Q Consensus 219 --~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 296 (433)
--+|+++|+.|.+|..+..+++.++|+.+....... ..-...+++.|++|+......
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s---------------------f~Gl~l~sp~~v~qli~N~ik 1416 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS---------------------FFGLELCSPIYVLQLIKNEIK 1416 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCchHh---------------------hhhhhhCCHHHHHHHHHHHHh
Confidence 268999999999999999999999999983222111 111557788899999999889
Q ss_pred CCcccCeEehhHHHHHHhcCCCCC
Q psy6593 297 YDETVDVFSYGIVLCEIIGRVPAD 320 (433)
Q Consensus 297 ~~~~~DiwslG~il~ell~~~~~~ 320 (433)
++.++|+|..++-+|+.-.+.+++
T Consensus 1417 ~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1417 FTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hhhHHHHHHHHHHHHHHhcccHHH
Confidence 999999999999999988776655
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0029 Score=58.00 Aligned_cols=29 Identities=21% Similarity=0.291 Sum_probs=25.7
Q ss_pred CccccCCCCcceEEccCCceEEeccccchh
Q psy6593 219 NLIHRDLNSQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 219 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
.++|+|+.|.||++++++ +.|+||+.+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 589999999999999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1702|consensus | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0001 Score=61.74 Aligned_cols=56 Identities=16% Similarity=0.209 Sum_probs=44.5
Q ss_pred cCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeecccccccc
Q psy6593 3 FGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKY 59 (433)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~ 59 (433)
|..||..+--. |.+.-+++.||+.||+|..|+.+|.-. |-..|.++||..+|-+..
T Consensus 7 ~~~cgk~vYPv-E~v~cldk~whk~cfkce~c~mtlnmKnyKgy~kkpycn~hYpkq~ 63 (264)
T KOG1702|consen 7 REDCGKTVYPV-EEVKCLDKVWHKQCFKCEVCGMTLNMKNYKGYDKKPYCNPHYPKQV 63 (264)
T ss_pred hhhhccccccH-HHHhhHHHHHHHHhheeeeccCChhhhhccccccCCCcCcccccce
Confidence 34455544422 468889999999999999999999887 777899999999996644
|
|
| >PRK14559 putative protein serine/threonine phosphatase; Provisional | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.017 Score=59.24 Aligned_cols=82 Identities=20% Similarity=0.143 Sum_probs=63.7
Q ss_pred CcceeeEEEEEEeCCeeeEEEeccCC-CCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccC
Q psy6593 157 HHNVIRFIGVLYKDRKLNLVTEYIAG-GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRED 235 (433)
Q Consensus 157 h~~iv~~~~~~~~~~~~~lv~e~~~g-~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~ 235 (433)
+.||+++|+++..++.-.+++|+... .+|.+...+ ...+.-+.+.|+.||+.--.-|...|+.--=|.++|+-++++
T Consensus 179 ~~~iP~v~~~~~~~~~~i~Lle~~~~~~~l~~~w~~--~~~~~l~~l~Wl~q~~~LW~~l~~~~~~~sll~~~nlrv~~~ 256 (645)
T PRK14559 179 PTEIPKIHDAWQDGDLQVILLEDRSHWQPLLDLWQD--QTLPTLQILYWLNQMTQLWKALEPWGCCQSLLELENLRVDED 256 (645)
T ss_pred cccCcchheeecCCCCcEEEeCCCCCCchHHHHhhh--cCCcHHHHHHHHHHHHHHHHHHHhcCeehhccchhheeeCCC
Confidence 45699999999988878888887632 234444443 236678889999999999999999999999999999999865
Q ss_pred CceEE
Q psy6593 236 KTVVV 240 (433)
Q Consensus 236 ~~~kl 240 (433)
..+.|
T Consensus 257 ~~~~l 261 (645)
T PRK14559 257 QTLGL 261 (645)
T ss_pred ceehH
Confidence 54444
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.0073 Score=56.78 Aligned_cols=29 Identities=34% Similarity=0.492 Sum_probs=26.3
Q ss_pred CccccCCCCcceEEccC----CceEEeccccch
Q psy6593 219 NLIHRDLNSQNCLVRED----KTVVVADFGLAR 247 (433)
Q Consensus 219 ~i~H~dlkp~Nil~~~~----~~~kl~Dfg~~~ 247 (433)
.++|+|+.|.||+++.+ +.+.|+||+.+.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 68999999999999974 889999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.0081 Score=56.36 Aligned_cols=73 Identities=21% Similarity=0.271 Sum_probs=59.5
Q ss_pred eCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC-CccccCCCCcceEEccCCceEEeccccch
Q psy6593 169 KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNSQNCLVREDKTVVVADFGLAR 247 (433)
Q Consensus 169 ~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 247 (433)
+..+.|++|++- |++|.-. . .-..+++..|+.+.+..|.-+..+ .+-|||+.-.||+|+ +|.|.|+||-+++
T Consensus 297 e~~y~yl~~kdh-gt~is~i-k----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISII-K----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred CceEEEEEEecC-Cceeeee-e----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeee
Confidence 445788889976 6666433 2 245788899999999988888765 799999999999999 9999999999998
Q ss_pred h
Q psy6593 248 I 248 (433)
Q Consensus 248 ~ 248 (433)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 4
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.0037 Score=57.72 Aligned_cols=95 Identities=23% Similarity=0.306 Sum_probs=70.2
Q ss_pred ccchHHHHhhcC-C-cceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccc
Q psy6593 145 NCGQVAVLRSLH-H-HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 222 (433)
Q Consensus 145 ~~~E~~~l~~l~-h-~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H 222 (433)
+..|.+.|+.|. | =-|++.+++ +..++|||++.|-.|.+.-.- . .+-.+...++.-+--|-..|+||
T Consensus 157 a~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v----~---d~~~ly~~lm~~Iv~la~~GlIH 225 (465)
T KOG2268|consen 157 ATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV----E---DPPTLYDDLMGLIVRLANHGLIH 225 (465)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec----C---ChHHHHHHHHHHHHHHHHcCcee
Confidence 338999999994 3 335555554 467899999999888765422 1 22334455555666778899999
Q ss_pred cCCCCcceEEccCCceEEeccccchhcc
Q psy6593 223 RDLNSQNCLVREDKTVVVADFGLARIIH 250 (433)
Q Consensus 223 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 250 (433)
+|.+--||++++++.++++||.......
T Consensus 226 gDFNEFNimv~dd~~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 226 GDFNEFNIMVKDDDKIVVIDFPQMVSTS 253 (465)
T ss_pred cccchheeEEecCCCEEEeechHhhccC
Confidence 9999999999999999999998765443
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.01 Score=49.96 Aligned_cols=109 Identities=19% Similarity=0.127 Sum_probs=75.5
Q ss_pred eeeeeccCCCcchhhhhc---------------------cchHHHHhhcCCcce-eeEEEEEEeCCeeeEEEeccCCCCH
Q psy6593 128 LLFCKEDYNGKYGEACQN---------------------CGQVAVLRSLHHHNV-IRFIGVLYKDRKLNLVTEYIAGGTL 185 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~---------------------~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~g~sL 185 (433)
.-.++.+++|.++.||.. ..|+++|..++..++ ++++.|.. .++.|||+.|.+|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L 99 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcch
Confidence 334456677777777751 179999999987665 55666643 3456999999898
Q ss_pred HHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC-CcceEEccCCceEEeccccchh
Q psy6593 186 KELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN-SQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 186 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk-p~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
.++... .... -+..++.+---|-..||-|+.|. |..+++.+++.+.|+||..|+.
T Consensus 100 ~~~~~~----~~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIG----GDRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhc----ccHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 877643 1222 23445555555667899999986 6666676777999999999874
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.036 Score=51.85 Aligned_cols=31 Identities=35% Similarity=0.380 Sum_probs=27.5
Q ss_pred CCccccCCCCcceEEccCCceEEeccccchh
Q psy6593 218 MNLIHRDLNSQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 218 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
.+++|+|+.|.||++++++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999988789999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.016 Score=54.33 Aligned_cols=31 Identities=26% Similarity=0.383 Sum_probs=28.0
Q ss_pred CccccCCCCcceEEccCCceEEeccccchhc
Q psy6593 219 NLIHRDLNSQNCLVREDKTVVVADFGLARII 249 (433)
Q Consensus 219 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 249 (433)
.++|+|+++.|+++++++.+-++||+++..-
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 4899999999999999888999999998753
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.047 Score=51.71 Aligned_cols=31 Identities=32% Similarity=0.344 Sum_probs=26.7
Q ss_pred CCccccCCCCcceEEccCCceEEeccccchh
Q psy6593 218 MNLIHRDLNSQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 218 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
.+++|+|+.|.||+++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4899999999999999776668999998753
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.031 Score=53.55 Aligned_cols=31 Identities=23% Similarity=0.514 Sum_probs=26.7
Q ss_pred CCccccCCCCcceEEcc-CCceEEeccccchh
Q psy6593 218 MNLIHRDLNSQNCLVRE-DKTVVVADFGLARI 248 (433)
Q Consensus 218 ~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 248 (433)
..+.|+|+++.||++++ ++.+.|+||..+..
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 36899999999999986 47899999998753
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.029 Score=53.43 Aligned_cols=29 Identities=28% Similarity=0.431 Sum_probs=25.4
Q ss_pred ccccCCCCcceEEcc-CCceEEeccccchh
Q psy6593 220 LIHRDLNSQNCLVRE-DKTVVVADFGLARI 248 (433)
Q Consensus 220 i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 248 (433)
+.|+|+.+.||++++ ++.++++||+.+-.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 789999999999974 57899999998753
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.12 Score=45.68 Aligned_cols=62 Identities=19% Similarity=0.145 Sum_probs=40.9
Q ss_pred cccCCeeeeeccCCCcchhhhhccchHHHHhhc---CCcceeeEEEEEEeCCeeeEEEeccCCCCHH
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNCGQVAVLRSL---HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLK 186 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~ 186 (433)
+......+-.+...+.+-..+. .|+.-|+.| +.-.|++++.+.....+.|+||||++-+.+.
T Consensus 35 v~dg~~~~FvK~n~~~~~~~f~--AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 35 LRDGTDPFFVKCNQREQLSMFT--AEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred eecCCcceEEEecchhhHHHHH--HHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 3333334444444444433333 366666666 4567999999999999999999999876554
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.11 Score=50.47 Aligned_cols=40 Identities=20% Similarity=0.192 Sum_probs=29.3
Q ss_pred hhccchHHHHhhcC-CcceeeEEEEEEeCCeeeEEEeccCCCCHH
Q psy6593 143 CQNCGQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLK 186 (433)
Q Consensus 143 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~ 186 (433)
..+-+|+++++.+. +..-+++++.+. -++|.||++|.+|.
T Consensus 97 IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~efIeGr~l~ 137 (383)
T PTZ00384 97 IDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEWVEGNTMG 137 (383)
T ss_pred eccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEEeccccCC
Confidence 34458999999995 445566777764 25999999987764
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.029 Score=55.10 Aligned_cols=42 Identities=21% Similarity=0.393 Sum_probs=34.5
Q ss_pred HHHHhhcCCcceeeEEEEEEeC-CeeeEEEeccCCCCHHHHhcC
Q psy6593 149 VAVLRSLHHHNVIRFIGVLYKD-RKLNLVTEYIAGGTLKELLQD 191 (433)
Q Consensus 149 ~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~g~sL~~~l~~ 191 (433)
...++.+.|+|....+++-... ....+|||++ +.||++++..
T Consensus 33 ~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 33 FQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred hHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 5677888999999999887644 3578899999 7899999876
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 433 | ||||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-78 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-23 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-23 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-23 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-23 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-23 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-23 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-23 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-23 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-23 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-23 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-22 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-22 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-22 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-22 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-22 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-22 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-22 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-22 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-22 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-22 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-22 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-22 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-22 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-22 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-22 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-22 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-21 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-21 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-21 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-21 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-21 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-21 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-21 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-21 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-21 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-21 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-21 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-21 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-21 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-21 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-21 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-21 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-21 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-21 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-21 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-20 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-20 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-20 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-20 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-20 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-20 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-20 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-20 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-20 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-20 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-20 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-20 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-19 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-18 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-18 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-18 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-18 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-18 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-18 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-18 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-18 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-18 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-18 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-18 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-18 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-15 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-15 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-15 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-13 | ||
| 1x6a_A | 81 | Solution Structures Of The Second Lim Domain Of Hum | 7e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-13 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-12 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-12 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-12 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-11 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-08 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 9e-08 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-06 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 3mmk_A | 169 | The Structural Basis For Partial Redundancy In A Cl | 1e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 9e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-05 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 6e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-04 | ||
| 2rgt_A | 169 | Crystal Structure Of Lhx3 Lim Domains 1 And 2 With | 1e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-04 | ||
| 2jtn_A | 182 | Nmr Solution Structure Of A Ldb1-Lid:lhx3-Lim Compl | 1e-04 |
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1X6A|A Chain A, Solution Structures Of The Second Lim Domain Of Human Lim- Kinase 2 (limk2) Length = 81 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MMK|A Chain A, The Structural Basis For Partial Redundancy In A Class Of Transcription Factors, The Lim-Homeodomain Proteins, In Neural Cell Type Specification Length = 169 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2RGT|A Chain A, Crystal Structure Of Lhx3 Lim Domains 1 And 2 With The Binding Domain Of Isl1 Length = 169 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2JTN|A Chain A, Nmr Solution Structure Of A Ldb1-Lid:lhx3-Lim Complex Length = 182 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 324 bits (832), Expect = e-109
Identities = 146/259 (56%), Positives = 179/259 (69%), Gaps = 8/259 (3%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V V+R L H NV++FIGVLYKD++LN +TEYI GGTL+ +++ PW QRV+FA+DI
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDI 117
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
A+GM YLHSMN+IHRDLNS NCLVRE+K VVVADFGLAR++ P +
Sbjct: 118 ASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG-------LRS 170
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328
++ RKKRYTVVGNPYWMAPEM+ G+ YDE VDVFS+GIVLCEIIGRV ADPDYLPR+
Sbjct: 171 LKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230
Query: 329 DFGLDQTDFRNKFC-ASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPL 387
DFGL+ F +++C +CP F I CCDL+P++RP F LE WLE L MHL+ PL
Sbjct: 231 DFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPL 290
Query: 388 PSDLEADIYQFATRKSASP 406
LE F
Sbjct: 291 GPQLEQLDRGFWETYRRGE 309
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 2e-66
Identities = 72/248 (29%), Positives = 116/248 (46%), Gaps = 28/248 (11%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL--QDPGQPLPWGQRVNFAR 206
VA+++ L H N++ F+G + + L++VTEY++ G+L LL + L +R++ A
Sbjct: 85 VAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAY 144
Query: 207 DIAAGMTYLHSMN--LIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVP 264
D+A GM YLH+ N ++HR+L S N LV + TV V DFGL+R+ + +
Sbjct: 145 DVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA----- 199
Query: 265 RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDY 323
G P WMAPE++ + +E DV+S+G++L E+ + P +
Sbjct: 200 ----------------AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW-GNL 242
Query: 324 LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSV 383
P + R + + I C P +RP F + L L +V
Sbjct: 243 NPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS-AV 301
Query: 384 DKPLPSDL 391
P SDL
Sbjct: 302 PPPNRSDL 309
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 8e-64
Identities = 67/238 (28%), Positives = 108/238 (45%), Gaps = 29/238 (12%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V VLR H N++ F+G + L +VT++ G +L L + ++ AR
Sbjct: 71 VGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQT 129
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
A GM YLH+ ++IHRDL S N + ED TV + DFGLA + +
Sbjct: 130 ARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE--------- 180
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQE---YDETVDVFSYGIVLCEII-GRVPADPDYL 324
+ G+ WMAPE++ Q+ Y DV+++GIVL E++ G++P +
Sbjct: 181 ----------QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY-SNIN 229
Query: 325 PRSPDFGLDQTDFR----NKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378
R + +K ++CP+ R+ C D+RP F + +E L+
Sbjct: 230 NRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 3e-63
Identities = 60/240 (25%), Positives = 102/240 (42%), Gaps = 37/240 (15%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V ++ +L+H N+++ G+++ +V E++ G L L D P+ W ++ DI
Sbjct: 74 VFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDI 131
Query: 209 AAGMTYLHSMN--LIHRDLNSQNCLVRE-----DKTVVVADFGLARIIHQGPRAPTTVMA 261
A G+ Y+ + N ++HRDL S N ++ VADFGL++ +V
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH------SVSG 185
Query: 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE--YDETVDVFSYGIVLCEII-GRVP 318
++GN WMAPE + +E Y E D +S+ ++L I+ G P
Sbjct: 186 ------------------LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
Query: 319 -ADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377
+ Y + + R CP + LC +P +RP F + L L
Sbjct: 228 FDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 5e-62
Identities = 53/242 (21%), Positives = 88/242 (36%), Gaps = 34/242 (14%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V R H NV+ F+G L ++T G TL +++D L + A++I
Sbjct: 80 VMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEI 139
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
GM YLH+ ++H+DL S+N ++ VV+ DFGL I ++
Sbjct: 140 VKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQ---- 194
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQE---------YDETVDVFSYGIVLCEII-GRVP 318
G +APE++ + + DVF+ G + E+ P
Sbjct: 195 ------------NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
Query: 319 ---ADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375
+ + G+ + + I C ++RP F L LE
Sbjct: 243 FKTQPAEAIIWQMGTGMKPNLSQI----GMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298
Query: 376 GL 377
L
Sbjct: 299 KL 300
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-61
Identities = 74/241 (30%), Positives = 110/241 (45%), Gaps = 38/241 (15%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ L H N+I GV K+ L LV E+ GG L +L G+ +P VN+A I
Sbjct: 57 AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQI 114
Query: 209 AAGMTYLHSMN---LIHRDLNSQNCLVRE--------DKTVVVADFGLARIIHQGPRAPT 257
A GM YLH +IHRDL S N L+ + +K + + DFGLAR H+ T
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-----T 169
Query: 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GR 316
T M + G WMAPE++ + + DV+SYG++L E++ G
Sbjct: 170 TKM------------------SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
Query: 317 VPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376
VP + +G+ ++CPEPF ++ C + +P RP F + L
Sbjct: 212 VPF-RGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
Query: 377 L 377
+
Sbjct: 271 I 271
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 4e-60
Identities = 71/249 (28%), Positives = 102/249 (40%), Gaps = 34/249 (13%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL--QDPGQPLPWGQRVNFAR 206
+ L ++H N+++ G + LV EY GG+L +L +P +++
Sbjct: 52 LRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 109
Query: 207 DIAAGMTYLHSMN---LIHRDLNSQNCLVREDKTVV-VADFGLARIIHQGPRAPTTVMAK 262
+ G+ YLHSM LIHRDL N L+ TV+ + DFG A I T M
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ-------THMT- 161
Query: 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADP 321
G+ WMAPE+ G Y E DVFS+GI+L E+I R P D
Sbjct: 162 ----------------NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205
Query: 322 DYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381
P R + P+P + C +P QRP E + + L +
Sbjct: 206 IGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
Query: 382 S-VDKPLPS 389
D+PL
Sbjct: 266 PGADEPLQY 274
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-58
Identities = 47/239 (19%), Positives = 92/239 (38%), Gaps = 36/239 (15%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNL--VTEYIAGGTLKELLQD-PGQPLPWGQRVNFA 205
LR H NV+ +G + +T ++ G+L +L + + Q V FA
Sbjct: 58 CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117
Query: 206 RDIAAGMTYLHSMN--LIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263
D+A GM +LH++ + LNS++ ++ ED T ++ +
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP----------- 166
Query: 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYD---ETVDVFSYGIVLCEII-GRVPA 319
+ P W+APE + + D + D++S+ ++L E++ VP
Sbjct: 167 ---------------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211
Query: 320 DPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378
D + R ++ +C + +P +RP F+++ LE +
Sbjct: 212 A-DLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-51
Identities = 70/236 (29%), Positives = 101/236 (42%), Gaps = 35/236 (14%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIA 209
+L+ H N++R IGV + + + +V E + GG L+ G L + D A
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAA 223
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
AGM YL S IHRDL ++NCLV E + ++DFG++R G A + + +VP K
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK--- 280
Query: 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYLPRS 327
W APE + Y DV+S+GI+L E G P Y
Sbjct: 281 ----------------WTAPEALNYGRYSSESDVWSFGILLWETFSLGASP----Y---- 316
Query: 328 PDFGLDQT------DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377
P+ QT R CP+ R+ C P QRP F + L+ +
Sbjct: 317 PNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-51
Identities = 53/273 (19%), Positives = 92/273 (33%), Gaps = 57/273 (20%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLN----LVTEYIAGGTLKELLQDPGQPLPWGQRVNF 204
+ + H N++ FI K L+T+Y G+L + L+ L +
Sbjct: 82 IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKL 139
Query: 205 ARDIAAGMTYLHSMNL--------IHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256
A +G+ +LH+ HRDL S+N LV+++ T +AD GLA
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
Query: 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG------QEYDETVDVFSYGIVL 310
T VG +M PE++ + D++S+G++L
Sbjct: 200 DIPP-----------------NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLIL 242
Query: 311 CEIIGRVPADP----------DYLPRSPDFGLDQT-----DFR-----NKFCASCPEPFV 350
E+ R + D +P P + + R C
Sbjct: 243 WEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG 302
Query: 351 RIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSV 383
++ C NP R ++ L +S +
Sbjct: 303 KLMTECWAHNPASRLTALRVKKTLAKMSESQDI 335
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-51
Identities = 59/267 (22%), Positives = 99/267 (37%), Gaps = 57/267 (21%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLN----LVTEYIAGGTLKELLQDPGQPLPWGQRVNF 204
+ L H N++ FI R + L+T Y G+L + LQ L +
Sbjct: 53 LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRI 110
Query: 205 ARDIAAGMTYLHS--------MNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256
IA+G+ +LH + HRDL S+N LV+++ +AD GLA + Q
Sbjct: 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ----- 165
Query: 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ------EYDETVDVFSYGIVL 310
+T V VG +MAPE++ + + VD++++G+VL
Sbjct: 166 STNQLDVGNNPR------------VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 213
Query: 311 CEIIGRVPADP----------DYLPRSPDFGLDQT-----DFR-----NKFCASCPEPFV 350
E+ R+ ++ D +P P F + R F
Sbjct: 214 WEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLA 273
Query: 351 RIAFLCCDLNPDQRPPFEVLEVWLEGL 377
++ C NP R ++ L +
Sbjct: 274 KLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-49
Identities = 57/273 (20%), Positives = 88/273 (32%), Gaps = 57/273 (20%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLN----LVTEYIAGGTLKELLQDPGQPLPWGQRVNF 204
+ L H N++ FI KD LV++Y G+L + L + +
Sbjct: 87 IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKL 144
Query: 205 ARDIAAGMTYLHS--------MNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256
A A+G+ +LH + HRDL S+N LV+++ T +AD GLA
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204
Query: 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG------QEYDETVDVFSYGIVL 310
VG +MAPE++ E + D+++ G+V
Sbjct: 205 DIAP-----------------NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 247
Query: 311 CEIIGRVPAD---PDY-LPRSPDFGLDQTDF----------------RNKFCASCPEPFV 350
EI R DY LP D +
Sbjct: 248 WEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA 307
Query: 351 RIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSV 383
+I C N R ++ L LS +
Sbjct: 308 KIMRECWYANGAARLTALRIKKTLSQLSQQEGI 340
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 7e-46
Identities = 59/287 (20%), Positives = 98/287 (34%), Gaps = 60/287 (20%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKD-----RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 203
+ + + H N+ RFI + + LV EY G+L + L W
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCR 115
Query: 204 FARDIAAGMTYLHSMNL---------IHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254
A + G+ YLH+ HRDLNS+N LV+ D T V++DFGL+ +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-------QEYDETVDVFSYG 307
+ VG +MAPE++ G + + VD+++ G
Sbjct: 176 VRPGEEDNAAI-------------SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG 222
Query: 308 IVLCEIIGRVPAD------PDY-LPRSPDFGLDQT--DFRNKFC---------------A 343
++ EI R P+Y + + G T D + +
Sbjct: 223 LIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENS 282
Query: 344 SCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPLPSD 390
C D + + R + E + L M +K +
Sbjct: 283 LAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPT 329
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-45
Identities = 55/275 (20%), Positives = 101/275 (36%), Gaps = 61/275 (22%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLN----LVTEYIAGGTLKELLQDPGQPLPWGQRVNF 204
V L + H N+++FIG + ++ L+T + G+L + L+ + W + +
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCHI 126
Query: 205 ARDIAAGMTYLHSMNL----------IHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254
A +A G+ YLH HRD+ S+N L++ + T +ADFGLA G
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-----QEYDETVDVFSYGIV 309
A T VG +MAPE++ G ++ +D+++ G+V
Sbjct: 187 AGDTH-------------------GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV 227
Query: 310 LCEII-GRVPAD---PDY-------LPRSPDFG-----LDQTDFRNKFCASCPE-----P 348
L E+ AD +Y + + P + R +
Sbjct: 228 LWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAM 287
Query: 349 FVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSV 383
C D + + R + + + ++
Sbjct: 288 LCETIEECWDHDAEARLSAGCVGERITQMQRLTNI 322
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-45
Identities = 75/292 (25%), Positives = 120/292 (41%), Gaps = 61/292 (20%)
Query: 119 DNWYFEKDGLLFCKEDYNGKYGEACQ-----NCGQVAV-------------------LRS 154
D W E+ + + G+YGE + VAV ++
Sbjct: 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 272
Query: 155 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMT 213
+ H N+++ +GV ++ ++TE++ G L + L++ Q + + A I++ M
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 332
Query: 214 YLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGA 273
YL N IHR+L ++NCLV E+ V VADFGL+R++ AK P K
Sbjct: 333 YLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIK------- 384
Query: 274 RKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYLPRSPDFG 331
W APE + ++ DV+++G++L EI G P Y P
Sbjct: 385 ------------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----Y----PGID 424
Query: 332 LDQT------DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377
L Q D+R + CPE + C NP RP F + E +
Sbjct: 425 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-44
Identities = 81/289 (28%), Positives = 121/289 (41%), Gaps = 61/289 (21%)
Query: 119 DNWYFEKDGLLFCKEDYNGKYGEACQ----NCGQVAV-------------------LRSL 155
D W ++ L + G +GE +VA+ ++ L
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL 236
Query: 156 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTY 214
H +++ V+ ++ +VTEY++ G+L + L+ G+ L Q V+ A IA+GM Y
Sbjct: 237 RHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 215 LHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGAR 274
+ MN +HRDL + N LV E+ VADFGLAR+I AK P K
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIK-------- 346
Query: 275 KKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYLPRSPDFGL 332
W APE + DV+S+GI+L E+ GRVP Y P
Sbjct: 347 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----Y----PGMVN 387
Query: 333 DQT------DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375
+ +R CPE + C P++RP FE L+ +LE
Sbjct: 388 REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-44
Identities = 67/254 (26%), Positives = 109/254 (42%), Gaps = 41/254 (16%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDI 208
AV++ + H N+++ +GV ++ ++TE++ G L + L++ Q + + A I
Sbjct: 61 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 120
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
++ M YL N IHRDL ++NCLV E+ V VADFGL+R++ AK P K
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIK-- 177
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYLPR 326
W APE + ++ DV+++G++L EI G P Y
Sbjct: 178 -----------------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----Y--- 213
Query: 327 SPDFGLDQTDFRNKFCA--------SCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378
G+D + CPE + C NP RP F + E +
Sbjct: 214 ---PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270
Query: 379 MHLSVDKPLPSDLE 392
S+ + +L
Sbjct: 271 QESSISDEVEKELG 284
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 8e-44
Identities = 77/290 (26%), Positives = 118/290 (40%), Gaps = 57/290 (19%)
Query: 119 DNWYFEKDGLLFCKEDYNGKYGEACQ---NCGQVAV------------------LRSLHH 157
W L + G++G+ +VAV + L H
Sbjct: 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRH 245
Query: 158 HNVIRFIGVLYKDR-KLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYL 215
N+++ +GV+ +++ L +VTEY+A G+L + L+ L + F+ D+ M YL
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 216 HSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARK 275
N +HRDL ++N LV ED V+DFGL + T K+P K
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVK--------- 351
Query: 276 KRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYLPRSPD---F 330
W APE + +++ DV+S+GI+L EI GRVP Y PR P
Sbjct: 352 ----------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP----Y-PRIPLKDVV 396
Query: 331 GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMH 380
+ ++ CP + C L+ RP F L LE + H
Sbjct: 397 PRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 9e-44
Identities = 64/244 (26%), Positives = 101/244 (41%), Gaps = 50/244 (20%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIA 209
+++ H N+IR GV+ + R +VTEY+ G+L L+ Q V R +
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVG 161
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM-AKVPRKAA 268
AGM YL + +HRDL ++N LV + V+DFGL+R++ P A T K+P +
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR-- 219
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVP-------- 318
W APE + + + DV+S+G+V+ E++ G P
Sbjct: 220 -----------------WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262
Query: 319 ----ADPDY-LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVW 373
+ Y LP CP ++ C + QRP F +
Sbjct: 263 VISSVEEGYRLPAPMG---------------CPHALHQLMLDCWHKDRAQRPRFSQIVSV 307
Query: 374 LEGL 377
L+ L
Sbjct: 308 LDAL 311
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-43
Identities = 58/247 (23%), Positives = 101/247 (40%), Gaps = 37/247 (14%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRK--LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
+ +L+SL H N++++ GV Y + L L+ EY+ G+L++ LQ + + + + +
Sbjct: 62 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA-PTTVMAKVPR 265
I GM YL + IHRDL ++N LV + V + DFGL +++ Q + P
Sbjct: 122 QICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI 181
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-------GRVP 318
W APE +T ++ DV+S+G+VL E+
Sbjct: 182 F-------------------WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 222
Query: 319 ADPDYLPRSPDFGLDQTDFRNKF-------C-ASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
+ + CP+ I C + N +QRP F L
Sbjct: 223 EFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 282
Query: 371 EVWLEGL 377
+ ++ +
Sbjct: 283 ALRVDQI 289
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-43
Identities = 70/244 (28%), Positives = 106/244 (43%), Gaps = 50/244 (20%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIA 209
+++ H N+IR GV+ K + + +VTEY+ G+L L+ Q V R IA
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP-TTVMAKVPRKAA 268
+GM YL M +HRDL ++N L+ + V+DFGL R++ P A TT K+P +
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR-- 215
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVP-------- 318
W +PE + +++ DV+SYGIVL E++ G P
Sbjct: 216 -----------------WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 319 ----ADPDY-LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVW 373
D Y LP D CP ++ C + + RP FE +
Sbjct: 259 VIKAVDEGYRLPPPMD---------------CPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 374 LEGL 377
L+ L
Sbjct: 304 LDKL 307
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 82/310 (26%), Positives = 125/310 (40%), Gaps = 61/310 (19%)
Query: 114 CDVMLDNWYFEKDGLLFCKEDYNGKYGEACQ----NCGQVAV------------------ 151
+ D W ++ L + G +GE +VA+
Sbjct: 255 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQ 314
Query: 152 -LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIA 209
++ L H +++ V+ ++ + +VTEY++ G+L + L+ G+ L Q V+ A IA
Sbjct: 315 VMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 373
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
+GM Y+ MN +HRDL + N LV E+ VADFGLAR+I AK P K
Sbjct: 374 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIK--- 429
Query: 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYLPRS 327
W APE + DV+S+GI+L E+ GRVP Y
Sbjct: 430 ----------------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----Y---- 465
Query: 328 PDFGLDQT------DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381
P + +R CPE + C P++RP FE L+ +LE
Sbjct: 466 PGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525
Query: 382 SVDKPLPSDL 391
+L
Sbjct: 526 EPQYQPGENL 535
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 2e-43
Identities = 64/243 (26%), Positives = 101/243 (41%), Gaps = 50/243 (20%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIA 209
+ L H +++F GV K+ + +VTEYI+ G L L+ G+ L Q + D+
Sbjct: 55 QTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVC 114
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
GM +L S IHRDL ++NCLV D V V+DFG+ R + + K P K
Sbjct: 115 EGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG-TKFPVK--- 170
Query: 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVP--------- 318
W APE+ +Y DV+++GI++ E+ G++P
Sbjct: 171 ----------------WSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV 214
Query: 319 ---ADPDY-LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWL 374
+ L R + +I + C P++RP F+ L +
Sbjct: 215 VLKVSQGHRLYRPHL---------------ASDTIYQIMYSCWHELPEKRPTFQQLLSSI 259
Query: 375 EGL 377
E L
Sbjct: 260 EPL 262
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-43
Identities = 69/248 (27%), Positives = 107/248 (43%), Gaps = 58/248 (23%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIA 209
++ HHN+IR GV+ K + + ++TEY+ G L + L++ Q V R IA
Sbjct: 98 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 157
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM-AKVPRKAA 268
AGM YL +MN +HRDL ++N LV + V+DFGL+R++ P A T K+P +
Sbjct: 158 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR-- 215
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDY--- 323
W APE ++ +++ DV+S+GIV+ E++ G P Y
Sbjct: 216 -----------------WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP----YWEL 254
Query: 324 --------------LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEV 369
LP D CP ++ C +RP F
Sbjct: 255 SNHEVMKAINDGFRLPTPMD---------------CPSAIYQLMMQCWQQERARRPKFAD 299
Query: 370 LEVWLEGL 377
+ L+ L
Sbjct: 300 IVSILDKL 307
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-43
Identities = 60/252 (23%), Positives = 100/252 (39%), Gaps = 48/252 (19%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRK--LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
+ +L++LH ++++ GV Y + L LV EY+ G L++ LQ L + + ++
Sbjct: 75 IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS 134
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP---RAPTTVMAKV 263
I GM YL S +HRDL ++N LV + V +ADFGLA+++ +
Sbjct: 135 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE--PGQS 192
Query: 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADP 321
P W APE ++ + DV+S+G+VL E+
Sbjct: 193 PIF-------------------WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS--- 230
Query: 322 DYLPRSPDFGLDQTDFRNKFCA----------------SCPEPFVRIAFLCCDLNPDQRP 365
P + + + + +CP + LC +P RP
Sbjct: 231 -CSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRP 289
Query: 366 PFEVLEVWLEGL 377
F L L+ L
Sbjct: 290 SFSALGPQLDML 301
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 3e-43
Identities = 73/297 (24%), Positives = 113/297 (38%), Gaps = 77/297 (25%)
Query: 119 DNWYFEKDGLLFCKEDYNGKYGEACQ---NCGQVAV------------------LRSLHH 157
W L + G++G+ +VAV + L H
Sbjct: 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRH 73
Query: 158 HNVIRFIGVLYKDR-KLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYL 215
N+++ +GV+ +++ L +VTEY+A G+L + L+ L + F+ D+ M YL
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 216 HSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARK 275
N +HRDL ++N LV ED V+DFGL + T K+P K
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVK--------- 179
Query: 276 KRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVP------------ADP 321
W APE + +++ DV+S+GI+L EI GRVP +
Sbjct: 180 ----------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 229
Query: 322 DY-LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377
Y + CP + C L+ RP F L LE +
Sbjct: 230 GYKMDAPDG---------------CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-43
Identities = 58/247 (23%), Positives = 101/247 (40%), Gaps = 37/247 (14%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRK--LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
+ +L+SL H N++++ GV Y + L L+ EY+ G+L++ LQ + + + + +
Sbjct: 93 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 152
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA-PTTVMAKVPR 265
I GM YL + IHRDL ++N LV + V + DFGL +++ Q + P
Sbjct: 153 QICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI 212
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-------GRVP 318
W APE +T ++ DV+S+G+VL E+
Sbjct: 213 F-------------------WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 253
Query: 319 ADPDYLPRSPDFGLDQTDFRNKF-------C-ASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
+ + CP+ I C + N +QRP F L
Sbjct: 254 EFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 313
Query: 371 EVWLEGL 377
+ ++ +
Sbjct: 314 ALRVDQI 320
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-43
Identities = 60/244 (24%), Positives = 100/244 (40%), Gaps = 36/244 (14%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRK--LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+LR+L+H N++++ G+ +D + L+ E++ G+LKE L + Q++ +A I
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA-PTTVMAKVPRKA 267
GM YL S +HRDL ++N LV + V + DFGL + I P
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF- 194
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYLP 325
W APE + ++ DV+S+G+ L E++ + P L
Sbjct: 195 ------------------WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF 236
Query: 326 R----SPDFGLDQTDFRNKF-------C-ASCPEPFVRIAFLCCDLNPDQRPPFEVLEVW 373
+ T N C +CP+ ++ C + P R F+ L
Sbjct: 237 LKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296
Query: 374 LEGL 377
E L
Sbjct: 297 FEAL 300
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 5e-43
Identities = 78/298 (26%), Positives = 126/298 (42%), Gaps = 75/298 (25%)
Query: 119 DNWYFEKDGLLFCKEDYNGKYGEACQ----NCGQVAV-------------------LRSL 155
D W ++ L K+ G++GE +VAV +++L
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL 240
Query: 156 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTY 214
H +++ V+ K+ + ++TE++A G+L + L+ G P + ++F+ IA GM +
Sbjct: 241 QHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 215 LHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGAR 274
+ N IHRDL + N LV +ADFGLAR+I AK P K
Sbjct: 300 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG-AKFPIK-------- 350
Query: 275 KKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVP----ADPD------ 322
W APE + + DV+S+GI+L EI+ GR+P ++P+
Sbjct: 351 -----------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
Query: 323 --Y-LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377
Y +PR + CPE I C P++RP FE ++ L+
Sbjct: 400 RGYRMPRPEN---------------CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 7e-43
Identities = 60/241 (24%), Positives = 99/241 (41%), Gaps = 42/241 (17%)
Query: 150 AVLRSLHHHNVIRFIGV-LYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+++ H NV+ +G+ L + +V Y+ G L+ +++ + F +
Sbjct: 78 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP--RAPTTVMAKVPRK 266
A GM YL S +HRDL ++NC++ E TV VADFGLAR ++ AK+P K
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYL 324
WMA E + Q++ DV+S+G++L E++ G P Y
Sbjct: 198 -------------------WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP----Y- 233
Query: 325 PRSPDFGLDQTDFRNKFC--------ASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376
++ D CP+P + C + RP F L +
Sbjct: 234 -----PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288
Query: 377 L 377
+
Sbjct: 289 I 289
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-42
Identities = 63/235 (26%), Positives = 102/235 (43%), Gaps = 30/235 (12%)
Query: 150 AVLRSLHHHNVIRFIGV-LYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
++R L+H NV+ IG+ L + +++ Y+ G L + ++ P + ++F +
Sbjct: 74 LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQV 133
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP--RAPTTVMAKVPRK 266
A GM YL +HRDL ++NC++ E TV VADFGLAR I A++P K
Sbjct: 134 ARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK 193
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYL 324
W A E + + DV+S+G++L E++ G P Y
Sbjct: 194 -------------------WTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP----YR 230
Query: 325 PRSPD--FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377
P R CP+ ++ C + +P RP F VL +E +
Sbjct: 231 HIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-42
Identities = 59/247 (23%), Positives = 98/247 (39%), Gaps = 58/247 (23%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIA 209
V+ S+ + +V R +G+ + L+T+ + G L + +++ + +N+ IA
Sbjct: 69 YVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
GM YL L+HRDL ++N LV+ + V + DFGLA+++ + KVP K
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK--- 184
Query: 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDY---- 323
WMA E + + Y DV+SYG+ + E++ G P Y
Sbjct: 185 ----------------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----YDGIP 224
Query: 324 -------------LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
LP+ P C I C ++ D RP F L
Sbjct: 225 ASEISSILEKGERLPQPPI---------------CTIDVYMIMRKCWMIDADSRPKFREL 269
Query: 371 EVWLEGL 377
+ +
Sbjct: 270 IIEFSKM 276
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-42
Identities = 65/297 (21%), Positives = 114/297 (38%), Gaps = 73/297 (24%)
Query: 119 DNWYFEKDGLLFCKEDYNGKYGEACQ----NCGQVAV-------------------LRSL 155
+W + L F KE G++G VA+ + +L
Sbjct: 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL 76
Query: 156 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYL 215
H +++ GV K R + ++TEY+A G L L++ Q + +D+ M YL
Sbjct: 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 216 HSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARK 275
S +HRDL ++NCLV + V V+DFGL+R + ++V +K P +
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVR--------- 186
Query: 276 KRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVP------------ADP 321
W PE++ ++ D++++G+++ EI G++P
Sbjct: 187 ----------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236
Query: 322 DY-LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377
L R E I + C D+RP F++L + +
Sbjct: 237 GLRLYRPHL---------------ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-41
Identities = 59/235 (25%), Positives = 98/235 (41%), Gaps = 30/235 (12%)
Query: 150 AVLRSLHHHNVIRFIGV-LYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+++ H NV+ +G+ L + +V Y+ G L+ +++ + F +
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG--PRAPTTVMAKVPRK 266
A GM +L S +HRDL ++NC++ E TV VADFGLAR ++ AK+P K
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYL 324
WMA E + Q++ DV+S+G++L E++ G P Y
Sbjct: 262 -------------------WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP----YP 298
Query: 325 PRSPD--FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377
+ R CP+P + C + RP F L + +
Sbjct: 299 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-41
Identities = 77/298 (25%), Positives = 120/298 (40%), Gaps = 75/298 (25%)
Query: 119 DNWYFEKDGLLFCKEDYNGKYGEACQ----NCGQVAV-------------------LRSL 155
D W ++ L + G++GE +VAV ++ L
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 65
Query: 156 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTY 214
H ++R V+ ++ ++TEY+ G+L + L+ P G L + ++ A IA GM +
Sbjct: 66 QHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 215 LHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGAR 274
+ N IHRDL + N LV + + +ADFGLAR+I AK P K
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIK-------- 175
Query: 275 KKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVP------------AD 320
W APE + + DV+S+GI+L EI+ GR+P +
Sbjct: 176 -----------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
Query: 321 PDY-LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377
Y + R + CPE ++ LC P+ RP F+ L LE
Sbjct: 225 RGYRMVRPDN---------------CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-41
Identities = 56/243 (23%), Positives = 94/243 (38%), Gaps = 50/243 (20%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIA 209
V+ L H +++ GV + + LVTE++ G L + L+ + D+
Sbjct: 55 EVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 114
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
GM YL +IHRDL ++NCLV E++ + V+DFG+ R + +T K P K
Sbjct: 115 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVK--- 170
Query: 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVP--------- 318
W +PE+ + Y DV+S+G+++ E+ G++P
Sbjct: 171 ----------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 214
Query: 319 ---ADPDY-LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWL 374
+ L + +I C P+ RP F L L
Sbjct: 215 VEDISTGFRLYKPRL---------------ASTHVYQIMNHCWRERPEDRPAFSRLLRQL 259
Query: 375 EGL 377
+
Sbjct: 260 AEI 262
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-41
Identities = 66/280 (23%), Positives = 111/280 (39%), Gaps = 29/280 (10%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIA 209
V+ S+ + +V R +G+ + L+T+ + G L + +++ + +N+ IA
Sbjct: 69 YVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
GM YL L+HRDL ++N LV+ + V + DFGLA+++ + KVP K
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK--- 184
Query: 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDY--LP 325
WMA E + + Y DV+SYG+ + E++ G P Y +P
Sbjct: 185 ----------------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----YDGIP 224
Query: 326 RSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDK 385
S + + R C I C ++ D RP F L + ++
Sbjct: 225 ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 284
Query: 386 PLPSDLEADIYQFATRKSASPL-TEPECTAPTPADGALRP 424
+ D + L E + AD L P
Sbjct: 285 VIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIP 324
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-41
Identities = 64/260 (24%), Positives = 103/260 (39%), Gaps = 44/260 (16%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRK--LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
+ +LR+L+H ++I++ G L LV EY+ G+L++ L + Q + FA+
Sbjct: 84 IDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQ 141
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP---RAPTTVMAKV 263
I GM YLH+ + IHRDL ++N L+ D+ V + DFGLA+ + +G R
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED--GDS 199
Query: 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADP 321
P W APE + ++ DV+S+G+ L E++ P
Sbjct: 200 PVF-------------------WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240
Query: 322 DY----LPRSPDFGLDQTDFRNKFCA--------SCPEPFVRIAFLCCDLNPDQRPPFEV 369
L + CP + C + RP FE
Sbjct: 241 PTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFEN 300
Query: 370 LEVWLEGLSMHLSVDKPLPS 389
L L+ ++H PS
Sbjct: 301 LIPILK--TVHEKYQGQAPS 318
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 7e-41
Identities = 53/250 (21%), Positives = 90/250 (36%), Gaps = 51/250 (20%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
++ L + ++R IGV + L LV E GG L + L + +P +
Sbjct: 61 AQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA-PTTVMAKVPRKA 267
+ GM YL N +HRDL ++N L+ ++DFGL++ + K P K
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK- 178
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVP------- 318
W APE + +++ DV+SYG+ + E + G+ P
Sbjct: 179 ------------------WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 220
Query: 319 -----ADPDY-LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372
+ + P+ CP + C + RP F +E
Sbjct: 221 EVMAFIEQGKRMECPPE---------------CPPELYALMSDCWIYKWEDRPDFLTVEQ 265
Query: 373 WLEGLSMHLS 382
+ L+
Sbjct: 266 RMRACYYSLA 275
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-40
Identities = 75/271 (27%), Positives = 113/271 (41%), Gaps = 50/271 (18%)
Query: 150 AVLRSLHHHNVIRFIGV------LYKDRKLNLVTEYIAGGTLKELLQ-----DPGQPLPW 198
A ++ H +V + +GV + ++ ++ G L L + LP
Sbjct: 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 199 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTT 258
V F DIA GM YL S N IHRDL ++NC++ ED TV VADFGL+R I+ G
Sbjct: 137 QTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG 196
Query: 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GR 316
+K+P K W+A E + Y DV+++G+ + EI+ G+
Sbjct: 197 CASKLPVK-------------------WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ 237
Query: 317 VPADPDYLPRSPDFGLDQTDFRNKFCA--------SCPEPFVRIAFLCCDLNPDQRPPFE 368
P Y G++ + N C E + + C +P QRP F
Sbjct: 238 TP----Y------AGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFT 287
Query: 369 VLEVWLEGLSMHLSVDKPLPSDLEADIYQFA 399
L + LE + HLSV L +I +
Sbjct: 288 CLRMELENILGHLSVLSTSQDPLYINIERAH 318
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-40
Identities = 65/266 (24%), Positives = 110/266 (41%), Gaps = 44/266 (16%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ---------DPGQPLPWGQ 200
+V++ + H+V+R +GV+ + + ++ E + G LK L+ P +
Sbjct: 80 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 201 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260
+ A +IA GM YL++ +HRDL ++NC+V ED TV + DFG+ R I++
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVP 318
+P + WM+PE + + DV+S+G+VL EI P
Sbjct: 200 GLLPVR-------------------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
Query: 319 ADPDYLPRSPD--FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376
Y S + +CP+ + +C NP RP F + ++
Sbjct: 241 ----YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 296
Query: 377 L--------SMHLSVDKPLPSDLEAD 394
S + S + LP E D
Sbjct: 297 EMEPGFREVSFYYSEENKLPEPEELD 322
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-40
Identities = 57/247 (23%), Positives = 96/247 (38%), Gaps = 58/247 (23%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIA 209
+ SL H +++R +G+ L LVT+Y+ G+L + ++ L +N+ IA
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
GM YL ++HR+L ++N L++ V VADFG+A ++ + AK P K
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK--- 182
Query: 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDY---- 323
WMA E + +Y DV+SYG+ + E++ G P Y
Sbjct: 183 ----------------WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP----YAGLR 222
Query: 324 -------------LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
L + C + C ++ + RP F+ L
Sbjct: 223 LAEVPDLLEKGERLAQPQI---------------CTIDVYMVMVKCWMIDENIRPTFKEL 267
Query: 371 EVWLEGL 377
+
Sbjct: 268 ANEFTRM 274
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 66/267 (24%), Positives = 97/267 (36%), Gaps = 69/267 (25%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V + SL H N+IR GV+ + +VTE G+L + L+ G +A +
Sbjct: 72 VNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 130
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA-PTTVMAKVPRKA 267
A GM YL S IHRDL ++N L+ V + DFGL R + Q KVP
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA- 189
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDY-- 323
W APE + + + D + +G+ L E+ G+ P +
Sbjct: 190 ------------------WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP----WIG 227
Query: 324 ----------------LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF 367
LPR D CP+ + C P+ RP F
Sbjct: 228 LNGSQILHKIDKEGERLPRPED---------------CPQDIYNVMVQCWAHKPEDRPTF 272
Query: 368 EVLEVWLEGLSMHLSVDKPLPSDLEAD 394
L +L P+D+ A+
Sbjct: 273 VALRDFLLEAQ---------PTDMRAE 290
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-40
Identities = 51/246 (20%), Positives = 88/246 (35%), Gaps = 60/246 (24%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIA 209
V++ L + ++R IG+ + LV E G L + LQ + + + ++
Sbjct: 70 NVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVS 127
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA-PTTVMAKVPRKAA 268
GM YL N +HRDL ++N L+ ++DFGL++ + K P K
Sbjct: 128 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK-- 185
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDY--- 323
W APE + ++ DV+S+G+++ E G+ P Y
Sbjct: 186 -----------------WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP----YRGM 224
Query: 324 --------------LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEV 369
+ CP + LC + + RP F
Sbjct: 225 KGSEVTAMLEKGERMGCPAG---------------CPREMYDLMNLCWTYDVENRPGFAA 269
Query: 370 LEVWLE 375
+E+ L
Sbjct: 270 VELRLR 275
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-40
Identities = 69/248 (27%), Positives = 107/248 (43%), Gaps = 49/248 (19%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDR-----KLNLVTEYIAGGTLKELLQ-----DPGQPLPWG 199
A ++ H NVIR +GV + K ++ ++ G L L + +P
Sbjct: 88 ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147
Query: 200 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259
+ F DIA GM YL + N +HRDL ++NC++R+D TV VADFGL++ I+ G
Sbjct: 148 TLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR 207
Query: 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRV 317
+AK+P K W+A E + + Y DV+++G+ + EI G
Sbjct: 208 IAKMPVK-------------------WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMT 248
Query: 318 PADPDYLPRSPDFGLDQTDFRNKFCA--------SCPEPFVRIAFLCCDLNPDQRPPFEV 369
P Y G+ + + C + I + C +P RP F V
Sbjct: 249 P----Y------PGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSV 298
Query: 370 LEVWLEGL 377
L + LE L
Sbjct: 299 LRLQLEKL 306
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-40
Identities = 54/247 (21%), Positives = 95/247 (38%), Gaps = 59/247 (23%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIA 209
+R H ++++ IGV+ ++ ++ E G L+ LQ L + +A ++
Sbjct: 68 LTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 126
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
+ YL S +HRD+ ++N LV + V + DFGL+R + + K+P K
Sbjct: 127 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK-GKLPIK--- 182
Query: 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDY---- 323
WMAPE + + + DV+ +G+ + EI+ G P +
Sbjct: 183 ----------------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVK 222
Query: 324 -------------LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
LP P+ CP + C +P +RP F L
Sbjct: 223 NNDVIGRIENGERLPMPPN---------------CPPTLYSLMTKCWAYDPSRRPRFTEL 267
Query: 371 EVWLEGL 377
+ L +
Sbjct: 268 KAQLSTI 274
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-39
Identities = 60/259 (23%), Positives = 101/259 (38%), Gaps = 64/259 (24%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ---------------DPG 193
+L +L H ++++F GV L +V EY+ G L + L+
Sbjct: 68 AELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127
Query: 194 QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253
L Q ++ A IA+GM YL S + +HRDL ++NCLV + V + DFG++R ++
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
Query: 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI 313
+P + WM PE + +++ DV+S+G++L EI
Sbjct: 188 YYRVGGHTMLPIR-------------------WMPPESIMYRKFTTESDVWSFGVILWEI 228
Query: 314 I--GRVP----ADPD---------YLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCD 358
G+ P ++ + L R CP+ + C
Sbjct: 229 FTYGKQPWFQLSNTEVIECITQGRVLERPRV---------------CPKEVYDVMLGCWQ 273
Query: 359 LNPDQRPPFEVLEVWLEGL 377
P QR + + L L
Sbjct: 274 REPQQRLNIKEIYKILHAL 292
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-39
Identities = 78/275 (28%), Positives = 110/275 (40%), Gaps = 49/275 (17%)
Query: 156 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ---------------DPGQPLPWGQ 200
H N+I +G +D L ++ EY + G L+E LQ +P + L
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 201 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260
V+ A +A GM YL S IHRDL ++N LV ED + +ADFGLAR IH T
Sbjct: 193 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVP 318
++P K WMAPE + + Y DV+S+G++L EI G P
Sbjct: 253 GRLPVK-------------------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
Query: 319 ADPDYLPRSPD--FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376
Y + F L + R ++C + C P QRP F+ L L+
Sbjct: 294 ----YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349
Query: 377 LSMHLSVDKPLPSDLEADIYQFATRKSASPLTEPE 411
+ L S+ E Y T
Sbjct: 350 I-------VALTSNQEMGYYHHHHHHDYDIPTTEN 377
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 68/241 (28%), Positives = 103/241 (42%), Gaps = 42/241 (17%)
Query: 156 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ---------------DPGQPLPWGQ 200
H N+I +G +D L ++ EY + G L+E L+ P + + +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 201 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260
V+ +A GM YL S IHRDL ++N LV E+ + +ADFGLAR I+ T
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVP 318
++P K WMAPE + + Y DV+S+G+++ EI G P
Sbjct: 219 GRLPVK-------------------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 319 ADPDYLPRSPD--FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376
Y + F L + R A+C + C P QRP F+ L L+
Sbjct: 260 ----YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 315
Query: 377 L 377
+
Sbjct: 316 I 316
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 2e-39
Identities = 62/261 (23%), Positives = 98/261 (37%), Gaps = 72/261 (27%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ---------------DPG 193
+ L H NV+ +GV+ KD+ L+++ Y + G L E L
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 194 QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253
L V+ IAAGM YL S +++H+DL ++N LV + V ++D GL R ++
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
Query: 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI 313
+ +P + WMAPE + ++ D++SYG+VL E+
Sbjct: 183 YYKLLGNSLLPIR-------------------WMAPEAIMYGKFSIDSDIWSYGVVLWEV 223
Query: 314 I--GRVPADPDY-----------------LPRSPDFGLDQTDFRNKFCASCPEPFVRIAF 354
G P Y LP D CP +
Sbjct: 224 FSYGLQP----YCGYSNQDVVEMIRNRQVLPCPDD---------------CPAWVYALMI 264
Query: 355 LCCDLNPDQRPPFEVLEVWLE 375
C + P +RP F+ + L
Sbjct: 265 ECWNEFPSRRPRFKDIHSRLR 285
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-39
Identities = 53/247 (21%), Positives = 96/247 (38%), Gaps = 59/247 (23%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIA 209
++++L H ++++ IG++ ++ ++ E G L L+ L V ++ I
Sbjct: 65 VIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 123
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
M YL S+N +HRD+ +N LV + V + DFGL+R I + + ++P K
Sbjct: 124 KAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIK--- 179
Query: 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDY---- 323
WM+PE + + + DV+ + + + EI+ G+ P +
Sbjct: 180 ----------------WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP----FFWLE 219
Query: 324 -------------LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
LP+ CP + C D +P RP F L
Sbjct: 220 NKDVIGVLEKGDRLPKPDL---------------CPPVLYTLMTRCWDYDPSDRPRFTEL 264
Query: 371 EVWLEGL 377
L +
Sbjct: 265 VCSLSDV 271
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-39
Identities = 54/243 (22%), Positives = 96/243 (39%), Gaps = 51/243 (20%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIA 209
+R H ++++ IGV+ ++ ++ E G L+ LQ L + +A ++
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLS 501
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
+ YL S +HRD+ ++N LV + V + DFGL+R + + K+P K
Sbjct: 502 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK-GKLPIK--- 557
Query: 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVP--------- 318
WMAPE + + + DV+ +G+ + EI+ G P
Sbjct: 558 ----------------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 601
Query: 319 ----ADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWL 374
+ + LP P+ CP + C +P +RP F L+ L
Sbjct: 602 IGRIENGERLPMPPN---------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQL 646
Query: 375 EGL 377
+
Sbjct: 647 STI 649
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-39
Identities = 65/264 (24%), Positives = 105/264 (39%), Gaps = 49/264 (18%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD------PGQPLPWGQRV 202
++ +H N++R IGV + ++ E +AGG LK L++ L +
Sbjct: 84 ALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 143
Query: 203 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAPTTV 259
+ ARDIA G YL + IHRD+ ++NCL+ + + DFG+AR I++
Sbjct: 144 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 203
Query: 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRV 317
A +P K WM PE + D +S+G++L EI G +
Sbjct: 204 CAMLPVK-------------------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 244
Query: 318 PADPDYLPRSPDFGLDQTDFRNKFCA--------SCPEPFVRIAFLCCDLNPDQRPPFEV 369
P Y + + +CP P RI C P+ RP F +
Sbjct: 245 P----Y------PSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAI 294
Query: 370 LEVWLEGLSMHLSV-DKPLPSDLE 392
+ +E + V + LP +
Sbjct: 295 ILERIEYCTQDPDVINTALPIEYG 318
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-39
Identities = 56/243 (23%), Positives = 92/243 (37%), Gaps = 59/243 (24%)
Query: 149 VAVLRSLHHHNVIRFIG----VLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF 204
+L+ L H N++RF + + + LVTE + GTLK L+ + ++
Sbjct: 76 AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSW 134
Query: 205 ARDIAAGMTYLHSMN--LIHRDLNSQNCLV-REDKTVVVADFGLARIIHQGPRAPTTVMA 261
R I G+ +LH+ +IHRDL N + +V + D GLA +
Sbjct: 135 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---------- 184
Query: 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVP-- 318
V+G P +MAPEM ++YDE+VDV+++G+ + E+ P
Sbjct: 185 -------------SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYS 230
Query: 319 -----------ADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF 367
P S D + + + C N D+R
Sbjct: 231 ECQNAAQIYRRVTSGVKPASFDKVAIP-EVKE---------IIE---GCIRQNKDERYSI 277
Query: 368 EVL 370
+ L
Sbjct: 278 KDL 280
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-39
Identities = 68/241 (28%), Positives = 103/241 (42%), Gaps = 42/241 (17%)
Query: 156 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ---------------DPGQPLPWGQ 200
H N+I +G +D L ++ EY + G L+E L+ P + + +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 201 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260
V+ +A GM YL S IHRDL ++N LV E+ + +ADFGLAR I+ T
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVP 318
++P K WMAPE + + Y DV+S+G+++ EI G P
Sbjct: 265 GRLPVK-------------------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
Query: 319 ADPDYLPRSPD--FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376
Y + F L + R A+C + C P QRP F+ L L+
Sbjct: 306 ----YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361
Query: 377 L 377
+
Sbjct: 362 I 362
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 65/263 (24%), Positives = 104/263 (39%), Gaps = 49/263 (18%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ------DPGQPLPWGQRV 202
++ +H N++R IGV + ++ E +AGG LK L+ L +
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184
Query: 203 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAPTTV 259
+ ARDIA G YL + IHRD+ ++NCL+ + + DFG+AR I++
Sbjct: 185 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG 244
Query: 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRV 317
A +P K WM PE + D +S+G++L EI G +
Sbjct: 245 CAMLPVK-------------------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 285
Query: 318 PADPDYLPRSPDFGLDQTDFRNKFCA--------SCPEPFVRIAFLCCDLNPDQRPPFEV 369
P Y + + +CP P RI C P+ RP F +
Sbjct: 286 P----Y------PSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAI 335
Query: 370 LEVWLEGLSMHLSV-DKPLPSDL 391
+ +E + V + LP +
Sbjct: 336 ILERIEYCTQDPDVINTALPIEY 358
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 64/244 (26%), Positives = 94/244 (38%), Gaps = 45/244 (18%)
Query: 156 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-----------------DPGQPLPW 198
+H N++ +G ++TEY G L L+ D L
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 199 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTT 258
++F+ +A GM +L S N IHRDL ++N L+ + + DFGLAR I
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GR 316
A++P K WMAPE + Y DV+SYGI L E+ G
Sbjct: 205 GNARLPVK-------------------WMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245
Query: 317 VPADPDYLPRSPD---FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVW 373
P Y D + + + FR P I C D +P +RP F+ +
Sbjct: 246 SP----YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 374 LEGL 377
+E
Sbjct: 302 IEKQ 305
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-38
Identities = 51/244 (20%), Positives = 88/244 (36%), Gaps = 51/244 (20%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIA 209
++ L + ++R IGV + L LV E GG L + L + +P ++
Sbjct: 388 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 446
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA-PTTVMAKVPRKAA 268
GM YL N +HR+L ++N L+ ++DFGL++ + K P K
Sbjct: 447 MGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK-- 504
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVP-------- 318
W APE + +++ DV+SYG+ + E + G+ P
Sbjct: 505 -----------------WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547
Query: 319 ----ADPDY-LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVW 373
+ + P+ CP + C + RP F +E
Sbjct: 548 VMAFIEQGKRMECPPE---------------CPPELYALMSDCWIYKWEDRPDFLTVEQR 592
Query: 374 LEGL 377
+
Sbjct: 593 MRAC 596
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-38
Identities = 45/239 (18%), Positives = 87/239 (36%), Gaps = 40/239 (16%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIA 209
+++ L H +++ GV + LV E++ G+L L+ + ++ A+ +A
Sbjct: 64 SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVV--------VADFGLARIIHQGPRAPTTVMA 261
A M +L LIH ++ ++N L+ ++ ++D G++ + +
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP------KDIL 177
Query: 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEII--GRVP 318
+ W+ PE + + + D +S+G L EI G P
Sbjct: 178 QERIP-------------------WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
Query: 319 ADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377
L + R++ A + C D PD RP F + L L
Sbjct: 219 ----LSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 6e-38
Identities = 71/255 (27%), Positives = 112/255 (43%), Gaps = 50/255 (19%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ------------------- 190
VL+ ++H +VI+ G +D L L+ EY G+L+ L+
Sbjct: 78 NVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 191 ----DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLA 246
+ L G ++FA I+ GM YL M L+HRDL ++N LV E + + ++DFGL+
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 247 RIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306
R +++ ++P K WMA E + Y DV+S+
Sbjct: 198 RDVYEEDSYVKRSQGRIPVK-------------------WMAIESLFDHIYTTQSDVWSF 238
Query: 307 GIVLCEII--GRVPADPDYLPRSPD--FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPD 362
G++L EI+ G P Y P+ F L +T R + +C E R+ C PD
Sbjct: 239 GVLLWEIVTLGGNP----YPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPD 294
Query: 363 QRPPFEVLEVWLEGL 377
+RP F + LE +
Sbjct: 295 KRPVFADISKDLEKM 309
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 7e-38
Identities = 67/248 (27%), Positives = 97/248 (39%), Gaps = 46/248 (18%)
Query: 150 AVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ---------------DPG 193
VL L HH N+I +G L L EY G L + L+
Sbjct: 77 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 194 QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253
L Q ++FA D+A GM YL IHRDL ++N LV E+ +ADFGL+R
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-- 194
Query: 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI 313
M ++P + WMA E + Y DV+SYG++L EI
Sbjct: 195 -YVKKTMGRLPVR-------------------WMAIESLNYSVYTTNSDVWSYGVLLWEI 234
Query: 314 I--GRVPADPDYLPRSPD--FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEV 369
+ G P Y + + +R + +C + + C P +RP F
Sbjct: 235 VSLGGTP----YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 290
Query: 370 LEVWLEGL 377
+ V L +
Sbjct: 291 ILVSLNRM 298
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-37
Identities = 63/237 (26%), Positives = 94/237 (39%), Gaps = 35/237 (14%)
Query: 156 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-------------PGQPLPWGQRV 202
H N++ +G + ++TEY G L L+ +
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 203 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAK 262
+F+ +A GM +L S N IHRD+ ++N L+ + DFGLAR I A+
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPAD 320
+P K WMAPE + Y DV+SYGI+L EI G P
Sbjct: 228 LPVK-------------------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY- 267
Query: 321 PDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377
P L S + L + ++ A P+ I C L P RP F+ + +L+
Sbjct: 268 PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 67/272 (24%), Positives = 102/272 (37%), Gaps = 75/272 (27%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ--------------DPGQ 194
+L L H +++RF GV + R L +V EY+ G L L+
Sbjct: 94 AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153
Query: 195 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254
PL GQ + A +AAGM YL ++ +HRDL ++NCLV + V + DFG++R I+
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 213
Query: 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII 314
+P + WM PE + +++ DV+S+G+VL EI
Sbjct: 214 YRVGGRTMLPIR-------------------WMPPESILYRKFTTESDVWSFGVVLWEIF 254
Query: 315 --GRVPADPDY-----------------LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFL 355
G+ P + L R CP I
Sbjct: 255 TYGKQP----WYQLSNTEAIDCITQGRELERPRA---------------CPPEVYAIMRG 295
Query: 356 CCDLNPDQRPPF----EVLEVWLEGLSMHLSV 383
C P QR L+ + ++L V
Sbjct: 296 CWQREPQQRHSIKDVHARLQALAQAPPVYLDV 327
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 66/262 (25%), Positives = 103/262 (39%), Gaps = 62/262 (23%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ------------------ 190
A++ + N+++ +GV + + L+ EY+A G L E L+
Sbjct: 101 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 160
Query: 191 -----DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGL 245
PL +++ AR +AAGM YL +HRDL ++NCLV E+ V +ADFGL
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 220
Query: 246 ARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305
+R I+ +P + WM PE + Y DV++
Sbjct: 221 SRNIYSADYYKADGNDAIPIR-------------------WMPPESIFYNRYTTESDVWA 261
Query: 306 YGIVLCEII--GRVPADPDYLPRSPDFGLDQTDFRNKFCA--------SCPEPFVRIAFL 355
YG+VL EI G P Y +G+ + +CP + L
Sbjct: 262 YGVVLWEIFSYGLQP----Y------YGMAHEEVIYYVRDGNILACPENCPLELYNLMRL 311
Query: 356 CCDLNPDQRPPFEVLEVWLEGL 377
C P RP F + L+ +
Sbjct: 312 CWSKLPADRPSFCSIHRILQRM 333
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 62/243 (25%), Positives = 92/243 (37%), Gaps = 44/243 (18%)
Query: 156 HHHNVIRFIGV-LYKDRKLNLVTEYIAGGTLKELLQ---------------DPGQPLPWG 199
HH NV+ +G L ++ E+ G L L+ L
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 200 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259
+ ++ +A GM +L S IHRDL ++N L+ E V + DFGLAR I++ P
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRV 317
A++P K WMAPE + + Y DV+S+G++L EI G
Sbjct: 209 DARLPLK-------------------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 318 PADPDY--LPRSPD-FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWL 374
P Y + + + R + + C P QRP F L L
Sbjct: 250 P----YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305
Query: 375 EGL 377
L
Sbjct: 306 GNL 308
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-37
Identities = 65/251 (25%), Positives = 91/251 (36%), Gaps = 54/251 (21%)
Query: 156 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL----------------------QDPG 193
H N++ +G + L+ EY G L L ++
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 194 QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253
L + + FA +A GM +L + +HRDL ++N LV K V + DFGLAR I
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 254 --RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLC 311
A++P K WMAPE + Y DV+SYGI+L
Sbjct: 227 NYVVRGN--ARLPVK-------------------WMAPESLFEGIYTIKSDVWSYGILLW 265
Query: 312 EII--GRVPADPDYLPRSPD---FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP 366
EI G P Y D + L Q F+ E I C + +RP
Sbjct: 266 EIFSLGVNP----YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS 321
Query: 367 FEVLEVWLEGL 377
F L +L
Sbjct: 322 FPNLTSFLGCQ 332
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 46/224 (20%), Positives = 75/224 (33%), Gaps = 38/224 (16%)
Query: 148 QVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
+V + H +R + L L TE G +L++ + G LP Q + R
Sbjct: 106 EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLR 164
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
D + +LHS L+H D+ N + + DFGL +
Sbjct: 165 DTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-------------- 210
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326
G+P +MAPE++ G Y DVFS G+ + E+ +
Sbjct: 211 --------GAGEVQEGDPRYMAPELLQGS-YGTAADVFSLGLTILEVACNMEL------- 254
Query: 327 SPDFGLDQTDFRNKFC-----ASCPEPFVRIAFLCCDLNPDQRP 365
P G R + A + + + +P R
Sbjct: 255 -PHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRA 297
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 54/230 (23%), Positives = 98/230 (42%), Gaps = 46/230 (20%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+++++ +V+++ G +K+ L +V EY G++ ++++ + L + +
Sbjct: 75 ISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQST 134
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G+ YLH M IHRD+ + N L+ + +ADFG+A
Sbjct: 135 LKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVA---------------------G 173
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDY----- 323
Q KR TV+G P+WMAPE++ Y+ D++S GI E+ P D
Sbjct: 174 QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA 233
Query: 324 ---LPRSPDFGLDQ-----TDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
+P +P + +F + FV+ C +P+QR
Sbjct: 234 IFMIPTNPPPTFRKPELWSDNFTD---------FVK---QCLVKSPEQRA 271
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 57/236 (24%), Positives = 97/236 (41%), Gaps = 31/236 (13%)
Query: 149 VAVLRSLHHHNVIRFIGV-------------LYKDRKLNLVTEYIAGGTLKELLQDPGQP 195
V +L SL+H V+R+ + K L + EY GTL +L+
Sbjct: 53 VMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN 112
Query: 196 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255
+ R I ++Y+HS +IHRDL N + E + V + DFGLA+ +H+
Sbjct: 113 QQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS--- 169
Query: 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEII 314
+ + + G+ + +G ++A E++ G Y+E +D++S GI+ E+I
Sbjct: 170 ----LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
Query: 315 -GRVPADPDYLP----RSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
RS NK + +I L D +P++RP
Sbjct: 226 YPFSTGMERVNILKKLRSVSIEFPPDFDDNKM-----KVEKKIIRLLIDHDPNKRP 276
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-36
Identities = 51/238 (21%), Positives = 82/238 (34%), Gaps = 27/238 (11%)
Query: 149 VAVLRSLHHHNVIRFIGV------------LYKDRKLNLVTEYIAGGTLKELL--QDPGQ 194
V L L H ++R+ L + + LK+ + + +
Sbjct: 54 VKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE 113
Query: 195 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254
++ IA + +LHS L+HRDL N D V V DFGL + Q
Sbjct: 114 ERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173
Query: 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII 314
T + A + VG +M+PE + G Y VD+FS G++L E++
Sbjct: 174 EQTVL---------TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
Query: 315 GRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-PFEVLE 371
P + F F P + +P +RP ++E
Sbjct: 225 --YPFSTQMERVRTLTDVRNLKFPPLFTQKYPC-EYVMVQDMLSPSPMERPEAINIIE 279
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-36
Identities = 40/167 (23%), Positives = 74/167 (44%), Gaps = 24/167 (14%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFA 205
+ +L+ L+H NVI++ +D +LN+V E G L +++ + +P +
Sbjct: 83 IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF 142
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
+ + + ++HS ++HRD+ N + V + D GL R T A
Sbjct: 143 VQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-----KTTAAH--- 194
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE 312
++VG PY+M+PE + Y+ D++S G +L E
Sbjct: 195 -------------SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 228
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-36
Identities = 44/172 (25%), Positives = 85/172 (49%), Gaps = 22/172 (12%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARD 207
VAVL ++ H N++++ ++ L +V +Y GG L + + G Q +++
Sbjct: 74 VAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ 133
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
I + ++H ++HRD+ SQN + +D TV + DFG+AR+++ T +A+
Sbjct: 134 ICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-----TVELAR----- 183
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPA 319
+G PY+++PE+ + Y+ D+++ G VL E+ A
Sbjct: 184 -----------ACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-36
Identities = 47/236 (19%), Positives = 85/236 (36%), Gaps = 49/236 (20%)
Query: 149 VAVLRSLHHHNVIRFIG----------------VLYKDRKLNLVTEYIAGGTLKELLQD- 191
V L L H N++ + G K + L + E+ GTL++ ++
Sbjct: 55 VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114
Query: 192 PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251
G+ L + I G+ Y+HS LI+RDL N + + K V + DFGL +
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174
Query: 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLC 311
KR G +M+PE ++ Q+Y + VD+++ G++L
Sbjct: 175 D----------------------GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILA 212
Query: 312 EIIGRVPADPDYLPRSP--DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
E++ ++ + + + P+ RP
Sbjct: 213 ELL--------HVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRP 260
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 46/228 (20%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ VL V ++ G KD KL ++ EY+ GG+ +LL+ PL Q R+I
Sbjct: 71 ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREI 128
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G+ YLHS IHRD+ + N L+ E V +ADFG+A
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA---------------------G 167
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDY----- 323
Q + KR T VG P+WMAPE++ YD D++S GI E+ P +
Sbjct: 168 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV 227
Query: 324 ---LPRSPDFGLDQ---TDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
+P++ L+ + FV C + P RP
Sbjct: 228 LFLIPKNNPPTLEGNYSKPLKE---------FVE---ACLNKEPSFRP 263
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 23/170 (13%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ V+R + N++ ++ +L +V EY+AGG+L +++ + + GQ R+
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCREC 125
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
+ +LHS +IHRD+ S N L+ D +V + DFG A
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC---------------------A 164
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVP 318
Q + KR T+VG PYWMAPE++T + Y VD++S GI+ E+I P
Sbjct: 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 51/235 (21%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ +L + H +++ +G Y D KL ++ E+ GG + ++ + + L Q R +
Sbjct: 67 IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQM 126
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
+ +LHS +IHRDL + N L+ + + +ADFG+ +A
Sbjct: 127 LEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGV---------------------SA 165
Query: 269 QRRGARKKRYTVVGNPYWMAPE-----MMTGQEYDETVDVFSYGIVLCEIIGRVPADPDY 323
+ +KR + +G PYWMAPE M YD D++S GI L E+ P +
Sbjct: 166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225
Query: 324 --------LPRSPDFGLDQ-----TDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
+ +S L +FR+ F++ + D NP+ RP
Sbjct: 226 NPMRVLLKIAKSDPPTLLTPSKWSVEFRD---------FLK---IALDKNPETRP 268
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 40/234 (17%), Positives = 77/234 (32%), Gaps = 49/234 (20%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ L ++ G + + +N+ E + GG+L +L++ G LP + + +
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQA 159
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVV-VADFGLARIIHQGPRAPTTVMAKVPRKA 267
G+ YLH+ ++H D+ + N L+ D + + DFG A +
Sbjct: 160 LEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD--------------- 204
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVP-------- 318
+ + G MAPE++ G+ D VD++S ++ ++ G P
Sbjct: 205 -GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263
Query: 319 -------ADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
P P + P R
Sbjct: 264 LCLKIASEPPPIREIPPSCAPLTAQAIQE---------------GLRKEPVHRA 302
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-34
Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 23/166 (13%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V ++R H NV+ +L ++ E++ GG L +++ L Q +
Sbjct: 93 VVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAV 150
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
+ YLH+ +IHRD+ S + L+ D V ++DFG A
Sbjct: 151 LQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFC---------------------A 189
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII 314
Q KR ++VG PYWMAPE+++ Y VD++S GI++ E++
Sbjct: 190 QISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMV 235
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 52/233 (22%), Positives = 86/233 (36%), Gaps = 40/233 (17%)
Query: 149 VAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
V +LR H NVIR+ + + E TL+E ++ + + +
Sbjct: 68 VQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL-CAATLQEYVEQKDFAHLGLEPITLLQQ 126
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKT-----VVVADFGLARIIHQGPRAPTTVMAK 262
+G+ +LHS+N++HRDL N L+ +++DFGL + + G
Sbjct: 127 TTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG---------- 176
Query: 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG---QEYDETVDVFSYGIVLCEIIGRVPA 319
R + +R V G W+APEM++ + TVD+FS G V +I
Sbjct: 177 --------RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEG-- 226
Query: 320 DPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDL-------NPDQRP 365
P C P + +L +P +RP
Sbjct: 227 ---SHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP 276
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-33
Identities = 36/174 (20%), Positives = 71/174 (40%), Gaps = 18/174 (10%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARD 207
+ V + +H N++ + D +L +VT ++A G+ K+L+ + +
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQG 136
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ + Y+H M +HR + + + L+ D V ++ +
Sbjct: 137 VLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLR--------------SNLSMISHG 182
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMT--GQEYDETVDVFSYGIVLCEII-GRVP 318
++R V W++PE++ Q YD D++S GI CE+ G VP
Sbjct: 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 56/237 (23%), Positives = 99/237 (41%), Gaps = 40/237 (16%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-------DPGQPLPWGQR 201
+ + HH N++ + +L LV + ++GG++ ++++ L
Sbjct: 64 IQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 202 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA 261
R++ G+ YLH IHRD+ + N L+ ED +V +ADFG++ + G
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN--- 180
Query: 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT-GQEYDETVDVFSYGIVLCEIIGRVPAD 320
K R T VG P WMAPE+M + YD D++S+GI E+
Sbjct: 181 -------------KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227
Query: 321 PDY--------LPRSP----DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
Y ++ + G+ + K+ S + + LC +P++RP
Sbjct: 228 HKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRK-MIS---LCLQKDPEKRP 280
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-31
Identities = 64/252 (25%), Positives = 105/252 (41%), Gaps = 47/252 (18%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG--QPLPWGQRVNFAR 206
+ V+ H N++ +G L LV Y+ G+L + L PL W R A+
Sbjct: 81 IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQ 140
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
A G+ +LH + IHRD+ S N L+ E T ++DFGLAR + TVM
Sbjct: 141 GAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA---SEKFAQTVMT----- 192
Query: 267 AAQRRGARKKRYT-VVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDYL 324
+ +VG +MAPE + G+ ++ D++S+G+VL EII G D
Sbjct: 193 ------------SRIVGTTAYMAPEALRGEITPKS-DIYSFGVVLLEIITGLPAVDE--- 236
Query: 325 PRSPDFGL---------DQTDFR-------NKFCASCPEPFVRIAFLCCDLNPDQRPPF- 367
L ++ N ++ E +A C ++RP
Sbjct: 237 -HREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 368 EVLEVWLEGLSM 379
+V ++ L+ ++
Sbjct: 296 KVQQL-LQEMTA 306
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 49/238 (20%), Positives = 93/238 (39%), Gaps = 57/238 (23%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV--NFAR 206
+A+ + L H N+++++G ++ + + E + GG+L LL+ PL ++ + +
Sbjct: 70 IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK 129
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVV-VADFGLARIIHQGPRAPTTVMAKVPR 265
I G+ YLH ++HRD+ N L+ V+ ++DFG ++ +
Sbjct: 130 QILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA--------------- 174
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEM--MTGQEYDETVDVFSYGIVLCEII-GRVP---- 318
G T G +MAPE+ + Y + D++S G + E+ G+ P
Sbjct: 175 ------GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228
Query: 319 ----------ADPDYLPRSPD-FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
P P+ + F K C + +PD+R
Sbjct: 229 GEPQAAMFKVGMFKVHPEIPESMSAEAKAFILK---------------CFEPDPDKRA 271
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 57/208 (27%), Positives = 85/208 (40%), Gaps = 34/208 (16%)
Query: 125 KDGLLFC-KE-DYNGKYGEACQNCGQ-VAVLRSLHHHNVIRFIG--VLYKDRKLNLVTEY 179
DG + KE DY Q V +LR L H N++R+ + + L +V EY
Sbjct: 29 SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88
Query: 180 IAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNL-----IHRDLNSQNCL 231
GG L ++ Q L + + + H + +HRDL N
Sbjct: 89 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVF 148
Query: 232 VREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM 291
+ + V + DFGLARI++ T AK T VG PY+M+PE
Sbjct: 149 LDGKQNVKLGDFGLARILNH-----DTSFAK----------------TFVGTPYYMSPEQ 187
Query: 292 MTGQEYDETVDVFSYGIVLCEIIGRVPA 319
M Y+E D++S G +L E+ +P
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 63/228 (27%), Positives = 88/228 (38%), Gaps = 45/228 (19%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V L+ L H N I++ G ++ LV EY G +LL+ +PL +
Sbjct: 105 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHGA 163
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G+ YLHS N+IHRD+ + N L+ E V + DFG A+
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS---------------------AS 202
Query: 269 QRRGARKKRYTVVGNPYWMAPE---MMTGQEYDETVDVFSYGIVLCEIIGRVPADPDY-- 323
+ VG PYWMAPE M +YD VDV+S GI E+ R P +
Sbjct: 203 I----MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258
Query: 324 ------LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
+ ++ L + F FV C P RP
Sbjct: 259 MSALYHIAQNESPALQSGHWSEYFRN-----FVD---SCLQKIPQDRP 298
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 66/238 (27%), Positives = 102/238 (42%), Gaps = 50/238 (21%)
Query: 149 VAVLRSL-HHHNVIRFIGVLYK------DRKLNLVTEYIAGGTLKELLQD-PGQPLPWGQ 200
+ +L+ HH N+ + G K D +L LV E+ G++ +L+++ G L
Sbjct: 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW 130
Query: 201 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260
R+I G+++LH +IHRD+ QN L+ E+ V + DFG+
Sbjct: 131 IAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV--------------- 175
Query: 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE-----YDETVDVFSYGIVLCEIIG 315
+AQ +R T +G PYWMAPE++ E YD D++S GI E+
Sbjct: 176 ------SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229
Query: 316 RVPADPDY--------LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
P D +PR+P L + KF + F+ C N QRP
Sbjct: 230 GAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQS-----FIE---SCLVKNHSQRP 279
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 47/232 (20%), Positives = 81/232 (34%), Gaps = 15/232 (6%)
Query: 143 CQNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL--QDPGQPLPWGQ 200
++ + N + + L + + LK+ + + + G
Sbjct: 106 DAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165
Query: 201 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260
++ IA + +LHS L+HRDL N D V V DFGL + Q T +
Sbjct: 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL- 224
Query: 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPAD 320
A VG +M+PE + G Y VD+FS G++L E++
Sbjct: 225 --------TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL--YSFS 274
Query: 321 PDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-PFEVLE 371
+ F F P+ + +P +RP +++E
Sbjct: 275 TQMERVRIITDVRNLKFPLLFTQKYPQ-EHMMVQDMLSPSPTERPEATDIIE 325
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-30
Identities = 38/229 (16%), Positives = 78/229 (34%), Gaps = 27/229 (11%)
Query: 148 QVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVN 203
+V L H +V+R+ +D + + EY GG+L + + + + +
Sbjct: 60 EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 204 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263
+ G+ Y+HSM+L+H D+ N + + + KV
Sbjct: 120 LLLQVGRGLRYIHSMSLVHMDIKPSNIFISRT--------SIPNAASEEGDEDDWASNKV 171
Query: 264 PRKAAQRRGARK--KRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPAD 320
K + G+ ++A E++ + D+F+ + + G P
Sbjct: 172 MFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL- 230
Query: 321 PDYLPRSPDFGLDQTDFRNKFCASCPE----PFVRIAFLCCDLNPDQRP 365
P G + R P+ F + + +P++RP
Sbjct: 231 -------PRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRP 272
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-30
Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 34/189 (17%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLN------LVTEYIAGGTLKELLQDPGQP--LPWGQ 200
+ +++ L+H NV+ V +KL L EY GG L++ L L G
Sbjct: 63 IQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP 122
Query: 201 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV---REDKTVVVADFGLARIIHQGPRAPT 257
DI++ + YLH +IHRDL +N ++ + + D G A+ + QG
Sbjct: 123 IRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG----- 177
Query: 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GR 316
+ VG ++APE++ ++Y TVD +S+G + E I G
Sbjct: 178 -----------------ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
Query: 317 VPADPDYLP 325
P P++ P
Sbjct: 221 RPFLPNWQP 229
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 47/235 (20%), Positives = 86/235 (36%), Gaps = 24/235 (10%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDR----KLNLVTEYIAGGTLKELLQ---DPGQPLPWGQR 201
+ R +H N++R + ++R + L+ + GTL ++ D G L Q
Sbjct: 77 ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136
Query: 202 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA 261
+ I G+ +H+ HRDL N L+ ++ V+ D G A
Sbjct: 137 LWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ------------A 184
Query: 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY---DETVDVFSYGIVLCEII-GRV 317
+ + +++ + + APE+ + Q + DE DV+S G VL ++ G
Sbjct: 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
Query: 318 PADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP-FEVLE 371
P D + Q ++ ++P QRP +L
Sbjct: 245 PYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS 299
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 38/196 (19%), Positives = 75/196 (38%), Gaps = 39/196 (19%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLN--LVTEYIAGGTLKELLQDPGQPLPWGQRV--NF 204
VL+ L+H N+++ + + + L+ E+ G+L +L++P +
Sbjct: 58 FEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117
Query: 205 ARDIAAGMTYLHSMNLIHRDLNSQNCLVR----EDKTVVVADFGLARIIHQGPRAPTTVM 260
RD+ GM +L ++HR++ N + + DFG AR +
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-------- 169
Query: 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG--------QEYDETVDVFSYGIVLCE 312
++ ++ G ++ P+M ++Y TVD++S G+
Sbjct: 170 --------------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYH 215
Query: 313 II-GRVPADPDYLPRS 327
G +P P PR
Sbjct: 216 AATGSLPFRPFEGPRR 231
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 55/253 (21%), Positives = 93/253 (36%), Gaps = 59/253 (23%)
Query: 149 VAVLR-SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV----- 202
+ +L S H NVIR+ DR L + E L++L++ +
Sbjct: 59 IKLLTESDDHPNVIRYYCSETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 203 -NFARDIAAGMTYLHSMNLIHRDLNSQNCLV-------------REDKTVVVADFGLARI 248
+ R IA+G+ +LHS+ +IHRDL QN LV E+ ++++DFGL +
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 249 IHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-------QEYDETV 301
+ G + T + G W APE++ + ++
Sbjct: 178 LDSGQSSFRTNLN-----------------NPSGTSGWRAPELLEESNNLQTKRRLTRSI 220
Query: 302 DVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPE--PFVRIAFLCCDL 359
D+FS G V I+ + P + + R F + + DL
Sbjct: 221 DIFSMGCVFYYILSKG-----KHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDL 275
Query: 360 -------NPDQRP 365
+P +RP
Sbjct: 276 ISQMIDHDPLKRP 288
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 43/258 (16%), Positives = 85/258 (32%), Gaps = 47/258 (18%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLN--LVTEYIAGGTLKELLQDPGQPLPWGQRV--NF 204
VL+ L+H N+++ + + + L+ E+ G+L +L++P +
Sbjct: 58 FEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117
Query: 205 ARDIAAGMTYLHSMNLIHRDLNSQNCLVR----EDKTVVVADFGLARIIHQGPRAPTTVM 260
RD+ GM +L ++HR++ N + + DFG AR +
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-------- 169
Query: 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG--------QEYDETVDVFSYGIVLCE 312
++ ++ G ++ P+M ++Y TVD++S G+
Sbjct: 170 --------------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYH 215
Query: 313 II-GRVPADPDYLPRSPDFGLDQT---DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF- 367
G +P P PR + + I +
Sbjct: 216 AATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGL 275
Query: 368 -EVLEVWLEGLSMHLSVD 384
+L L + L D
Sbjct: 276 QVLLTPVLANI---LEAD 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 53/193 (27%), Positives = 77/193 (39%), Gaps = 28/193 (14%)
Query: 190 QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARII 249
L + ++ +A GM +L S IHRDL ++N L+ E V + DFGLAR I
Sbjct: 184 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIV 309
++ P A++P K WMAPE + + Y DV+S+G++
Sbjct: 244 YKDPDYVRKGDARLPLK-------------------WMAPETIFDRVYTIQSDVWSFGVL 284
Query: 310 LCEII--GRVPADPDY--LPRSPDF-GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQR 364
L EI G P Y + +F + R + + C P QR
Sbjct: 285 LWEIFSLGASP----YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 340
Query: 365 PPFEVLEVWLEGL 377
P F L L L
Sbjct: 341 PTFSELVEHLGNL 353
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-29
Identities = 53/166 (31%), Positives = 80/166 (48%), Gaps = 22/166 (13%)
Query: 154 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMT 213
L H N++ I V +D LV EYI G TL E ++ G PL +NF I G+
Sbjct: 67 QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIK 125
Query: 214 YLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGA 273
+ H M ++HRD+ QN L+ +KT+ + DFG+A+ + + T
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN--------------- 170
Query: 274 RKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVP 318
V+G + +PE G+ DE D++S GIVL E++ G P
Sbjct: 171 -----HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 46/171 (26%), Positives = 74/171 (43%), Gaps = 22/171 (12%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V + L H +++ + LV E G + L++ +P + +F I
Sbjct: 62 VKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI 121
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
GM YLHS ++HRDL N L+ + + +ADFGL A
Sbjct: 122 ITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGL---------------------AT 160
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
Q + +K YT+ G P +++PE+ T + DV+S G + +IGR P
Sbjct: 161 QLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 56/241 (23%), Positives = 95/241 (39%), Gaps = 49/241 (20%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL---QDPGQPLPWGQRVNFA 205
+ L H +++ IG + ++ L+ +Y+ G LK L P + W QR+
Sbjct: 86 IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP----TTVMA 261
A G+ YLH+ +IHRD+ S N L+ E+ + DFG+++ G +TV
Sbjct: 146 IGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK---GTELDQTHLSTV-- 200
Query: 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEII-GRVPA 319
V G ++ PE + G+ +++ DV+S+G+VL E++ R
Sbjct: 201 ------------------VKGTLGYIDPEYFIKGRLTEKS-DVYSFGVVLFEVLCARSAI 241
Query: 320 DPDYLPRSPD-------FGLDQTDF--------RNKFCASCPEPFVRIAFLCCDLNPDQR 364
LPR + +K F A C L+ + R
Sbjct: 242 VQS-LPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDR 300
Query: 365 P 365
P
Sbjct: 301 P 301
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 72/254 (28%), Positives = 108/254 (42%), Gaps = 49/254 (19%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ---PLPWGQRVNFA 205
V ++ H N++R G + LV Y+A G++ L++ + PL W +R A
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 206 RDIAAGMTYLH---SMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAK 262
A G+ YLH +IHRD+ + N L+ E+ VV DFGLA+++ TT
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT---- 193
Query: 263 VPRKAAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEII-GRVPAD 320
V G +APE + TG+ E DVF YG++L E+I G+ D
Sbjct: 194 ----------------AVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFD 236
Query: 321 PDYLPRSPDFGL-----------------DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQ 363
L D L D D + + E +++A LC +P +
Sbjct: 237 LARLANDDDVMLLDWVKGLLKEKKLEALVDV-DLQGNYKDEEVEQLIQVALLCTQSSPME 295
Query: 364 RPPF-EVLEVWLEG 376
RP EV+ LEG
Sbjct: 296 RPKMSEVVR-MLEG 308
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 50/223 (22%), Positives = 88/223 (39%), Gaps = 26/223 (11%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
VL + ++ F G Y D ++++ E++ GG+L ++L+ G +P + +
Sbjct: 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIK 142
Query: 211 GMTYLHS-MNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
G+TYL ++HRD+ N LV + + DFG++ + MA
Sbjct: 143 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-------IDSMAN------- 188
Query: 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI-IGRVPADPDYLPRSP 328
+ VG +M+PE + G Y D++S G+ L E+ +GR P P
Sbjct: 189 ---------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 239
Query: 329 DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371
Q + P R + FE+L+
Sbjct: 240 LMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLD 282
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 39/145 (26%), Positives = 63/145 (43%), Gaps = 20/145 (13%)
Query: 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 234
+V EY+ G TL++++ G P+ + + D + + H +IHRD+ N ++
Sbjct: 93 IVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 235 DKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG 294
V V DFG+AR I + T V+G +++PE G
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTA------------------AVIGTAQYLSPEQARG 193
Query: 295 QEYDETVDVFSYGIVLCEII-GRVP 318
D DV+S G VL E++ G P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 43/171 (25%), Positives = 78/171 (45%), Gaps = 25/171 (14%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V + L H N++R G + ++ L+ EY GT+ LQ + + ++
Sbjct: 60 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITEL 118
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
A ++Y HS +IHRD+ +N L+ + +ADFG + P
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--------------VHAP---- 160
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
+R + G ++ PEM+ G+ +DE VD++S G++ E ++G+ P
Sbjct: 161 -----SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 35/184 (19%), Positives = 67/184 (36%), Gaps = 36/184 (19%)
Query: 149 VAVLRSLHHHN--VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
+A L L H+ +IR D+ + +V E L L+ + +R ++ +
Sbjct: 58 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWK 115
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
++ + +H ++H DL N L+ D + + DFG+A +
Sbjct: 116 NMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPD-------------- 160
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQ-----------EYDETVDVFSYGIVLCEII- 314
+ + VG +M PE + + DV+S G +L +
Sbjct: 161 -----TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 215
Query: 315 GRVP 318
G+ P
Sbjct: 216 GKTP 219
|
| >2rgt_A Fusion of LIM/homeobox protein LHX3, linker, INSU enhancer protein ISL-1; protein-protein complex, LIM domain, Zn finger, activator, D binding; 2.05A {Mus musculus} PDB: 3mmk_A Length = 169 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 28/120 (23%), Positives = 42/120 (35%), Gaps = 21/120 (17%)
Query: 31 CSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQNCGQMM--SGPVMVVGDHKFHPECFK 88
CS C V L F + ++CK+D+ ++G C C + + V D +H CF
Sbjct: 36 CSDCHVPLAERCFSRGESVYCKDDFFKRFGTKCAACQLGIPPTQVVRRAQDFVYHLHCFA 95
Query: 89 CTSCSCCIGDGESYALVERSILCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQNCGQ 148
C C + G+ + Y +D L CK DY G
Sbjct: 96 CVVCKRQLATGDEF-------------------YLMEDSRLVCKADYETAKQGGSGGSGG 136
|
| >2rgt_A Fusion of LIM/homeobox protein LHX3, linker, INSU enhancer protein ISL-1; protein-protein complex, LIM domain, Zn finger, activator, D binding; 2.05A {Mus musculus} PDB: 3mmk_A Length = 169 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 2e-12
Identities = 17/88 (19%), Positives = 30/88 (34%), Gaps = 23/88 (26%)
Query: 63 CQNCGQMMSGP-VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVMLDNW 121
C C Q + ++ D +H +C KC+ C L
Sbjct: 9 CAGCDQHILDRFILKALDRHWHSKCLKCSDCHV----------------------PLAER 46
Query: 122 YFEKDGLLFCKEDYNGKYGEACQNCGQV 149
F + ++CK+D+ ++G C C
Sbjct: 47 CFSRGESVYCKDDFFKRFGTKCAACQLG 74
|
| >2rgt_A Fusion of LIM/homeobox protein LHX3, linker, INSU enhancer protein ISL-1; protein-protein complex, LIM domain, Zn finger, activator, D binding; 2.05A {Mus musculus} PDB: 3mmk_A Length = 169 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 2e-12
Identities = 16/66 (24%), Positives = 20/66 (30%), Gaps = 3/66 (4%)
Query: 31 CSACDVML---DNWYFEKDGLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECF 87
C C L D +Y +D L CK DY G G MV + H
Sbjct: 96 CVVCKRQLATGDEFYLMEDSRLVCKADYETAKQGGSGGSGGSGGGTPMVAASPERHDGGL 155
Query: 88 KCTSCS 93
+
Sbjct: 156 QANPVE 161
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 35/184 (19%), Positives = 67/184 (36%), Gaps = 36/184 (19%)
Query: 149 VAVLRSLHHHN--VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
+A L L H+ +IR D+ + +V E L L+ + +R ++ +
Sbjct: 105 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWK 162
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
++ + +H ++H DL N L+ D + + DFG+A +
Sbjct: 163 NMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPD-------------- 207
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQ-----------EYDETVDVFSYGIVLCEII- 314
+ + VG +M PE + + DV+S G +L +
Sbjct: 208 -----TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 262
Query: 315 GRVP 318
G+ P
Sbjct: 263 GKTP 266
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 35/184 (19%), Positives = 67/184 (36%), Gaps = 36/184 (19%)
Query: 149 VAVLRSLHHHN--VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
+A L L H+ +IR D+ + +V E L L+ + +R ++ +
Sbjct: 77 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWK 134
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
++ + +H ++H DL N L+ D + + DFG+A +
Sbjct: 135 NMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPD-------------- 179
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQ-----------EYDETVDVFSYGIVLCEII- 314
+ + VG +M PE + + DV+S G +L +
Sbjct: 180 -----TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234
Query: 315 GRVP 318
G+ P
Sbjct: 235 GKTP 238
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 40/172 (23%), Positives = 59/172 (34%), Gaps = 34/172 (19%)
Query: 154 SLHHHNVI------RFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
L +V+ G LY + I G L +L+ G PL + V R
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLY------VDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQ 142
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
I + + H+ HRD+ +N LV D + DFG+A
Sbjct: 143 IGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLG--------- 193
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVP 318
VG Y+MAPE + D+++ VL E + G P
Sbjct: 194 -----------NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 26/175 (14%), Positives = 55/175 (31%), Gaps = 34/175 (19%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD----PGQPLPWGQRVNFAR 206
L+ H ++F LV E + GTL + P + +P G ++FA
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVR-----------EDKTVVVADFGLARIIHQGPRA 255
+ + +H +IH D+ N ++ + + D G + + P+
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310
+ EM++ + ++ +D F +
Sbjct: 240 TIF-------------------TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATV 275
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 29/169 (17%), Positives = 70/169 (41%), Gaps = 28/169 (16%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
++++ LHH +I ++ L+ E+++GG L + + + + +N+ R
Sbjct: 99 ISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQA 158
Query: 209 AAGMTYLHSMNLIHRDLNSQN--CLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
G+ ++H +++H D+ +N C ++ +V + DFGLA ++
Sbjct: 159 CEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-------------- 204
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYG----IVLC 311
+ + APE++ + D+++ G ++L
Sbjct: 205 --------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 245
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 29/186 (15%), Positives = 67/186 (36%), Gaps = 34/186 (18%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-------QPLPWGQR 201
+ ++ + + + G++ ++ ++ EY+ ++ + + +P
Sbjct: 94 LQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 202 VNFARDIAAGMTYLHS-MNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260
+ + +Y+H+ N+ HRD+ N L+ ++ V ++DFG + +
Sbjct: 154 KCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-------- 205
Query: 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE--YDETVDVFSYGIVLCEII-GRV 317
K G +M PE + + VD++S GI L + V
Sbjct: 206 ---------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
Query: 318 PADPDY 323
P
Sbjct: 251 PFSLKI 256
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 38/174 (21%), Positives = 75/174 (43%), Gaps = 43/174 (24%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF---- 204
+AVL+ + H N++ + LV + ++GG L + + +R +
Sbjct: 57 IAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL---------ERGVYTEKD 107
Query: 205 ----ARDIAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAPT 257
+ + + + YLH ++HRDL +N L E+ +++ DFGL+++ G
Sbjct: 108 ASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----- 162
Query: 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLC 311
+M T G P ++APE++ + Y + VD +S G++
Sbjct: 163 -IM-----------------STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITY 198
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 51/289 (17%), Positives = 100/289 (34%), Gaps = 63/289 (21%)
Query: 154 SLHHHNVIR-----------FIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV 202
+ H ++++ V Y +V EY+ G +LK GQ LP + +
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGY------IVMEYVGGQSLKRSK---GQKLPVAEAI 185
Query: 203 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAK 262
+ +I ++YLHS+ L++ DL +N ++ E+ + + D G I+
Sbjct: 186 AYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS----------- 233
Query: 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADP 321
G + G P + APE++ T D+++ G L + +
Sbjct: 234 --------FGY------LYGTPGFQAPEIVRTGPTVAT-DIYTVGRTLAALTLDLPTRNG 278
Query: 322 DYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP------FEVLEVWLE 375
Y+ P+ D + + + R+ D +P QR ++ V E
Sbjct: 279 RYVDGLPE---DDPVLKT------YDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329
Query: 376 GLSMHLSVDKPLPSDLEADIYQFATRKSASPLTEPECTAPTPADGALRP 424
++ V +P S + + T+ A+
Sbjct: 330 VVAQDTGVPRPGLSTIFSPSRSTFGVDLLVAHTDVYLDGQVHAEKLTAN 378
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 8e-26
Identities = 40/171 (23%), Positives = 74/171 (43%), Gaps = 25/171 (14%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ + L H N++R + +++ L+ E+ G L + LQ G + F ++
Sbjct: 65 IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEEL 123
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
A + Y H +IHRD+ +N L+ + +ADFG +
Sbjct: 124 ADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---------------- 167
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVP 318
+R T+ G ++ PEM+ G+ +DE VD++ G++ E + G P
Sbjct: 168 -------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 32/169 (18%), Positives = 64/169 (37%), Gaps = 28/169 (16%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+++L H N++ +L ++ E+I+G + E + L + V++ +
Sbjct: 52 ISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQV 111
Query: 209 AAGMTYLHSMNLIHRDLNSQN--CLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
+ +LHS N+ H D+ +N R T+ + +FG AR + G
Sbjct: 112 CEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-------------- 157
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYG----IVLC 311
+ P + APE+ D++S G ++L
Sbjct: 158 --------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-25
Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 23/178 (12%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+++ RSL H +V+ F G + + +V E +L EL + L + + R I
Sbjct: 66 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQI 124
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G YLH +IHRDL N + ED V + DFGLA +
Sbjct: 125 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---------------- 168
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE-IIGRVPADPDYLP 325
+++ + G P ++APE+++ + + VDV+S G ++ ++G+ P + L
Sbjct: 169 -----GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 221
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 47/182 (25%), Positives = 72/182 (39%), Gaps = 54/182 (29%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQR------- 201
+ VL L H N+I+ + +++LV E + GG EL R
Sbjct: 99 IGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG---ELF----------DRIVEKGYY 145
Query: 202 -----VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGP 253
+ + I + YLH ++HRDL +N L D + +ADFGL++I+
Sbjct: 146 SERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ- 204
Query: 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYG----IV 309
TV G P + APE++ G Y VD++S G I+
Sbjct: 205 ---------------------VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYIL 243
Query: 310 LC 311
LC
Sbjct: 244 LC 245
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 46/178 (25%), Positives = 79/178 (44%), Gaps = 23/178 (12%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+++ RSL H +V+ F G + + +V E +L EL + R + R I
Sbjct: 92 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQI 150
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G YLH +IHRDL N + ED V + DFGLA +
Sbjct: 151 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---------------- 194
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE-IIGRVPADPDYLP 325
+++ + G P ++APE+++ + + VDV+S G ++ ++G+ P + L
Sbjct: 195 -----GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 247
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 27/165 (16%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+++L+SL H N+I+ V + LVTE+ GG L E + + + N + I
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK-FDECDAANIMKQI 155
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
+G+ YLH N++HRD+ +N L+ + + DFGL+ +
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD------------- 202
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310
K +G Y++APE++ + Y+E DV+S G+++
Sbjct: 203 ---------YKLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIM 237
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 42/169 (24%), Positives = 72/169 (42%), Gaps = 28/169 (16%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
++V+ L H N+I+ + LV EY+ GG L + + D L + F + I
Sbjct: 137 ISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI 196
Query: 209 AAGMTYLHSMNLIHRDLNSQN--CLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
G+ ++H M ++H DL +N C+ R+ K + + DFGLAR
Sbjct: 197 CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-------------- 242
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYG----IVLC 311
+K G P ++APE++ D++S G ++L
Sbjct: 243 --------EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS 283
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 29/183 (15%)
Query: 149 VAVLRSLHHHNVIRFIGVLY--KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
+A+L+ L H NV++ + VL + L +V E + G + E+ +PL Q + +
Sbjct: 87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQ 144
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
D+ G+ YLH +IHRD+ N LV ED + +ADFG++
Sbjct: 145 DLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD------------- 191
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTG--QEYD-ETVDVFSYGIVL-CEIIGRVPADPD 322
VG P +MAPE ++ + + + +DV++ G+ L C + G+ P +
Sbjct: 192 --------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243
Query: 323 YLP 325
+
Sbjct: 244 RIM 246
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 43/205 (20%), Positives = 73/205 (35%), Gaps = 60/205 (29%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV------ 202
V +++ LHH N+ R V ++ + LV E GG L + L +
Sbjct: 79 VRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138
Query: 203 ---------------------------------NFARDIAAGMTYLHSMNLIHRDLNSQN 229
N R I + + YLH+ + HRD+ +N
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPEN 198
Query: 230 CLV--REDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWM 287
L + + + DFGL++ ++ M T G PY++
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT-----------------TKAGTPYFV 241
Query: 288 APEMM--TGQEYDETVDVFSYGIVL 310
APE++ T + Y D +S G++L
Sbjct: 242 APEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 29/166 (17%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRK-LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
V +L+ L H N+++ ++D+ LV E GG L + + + R
Sbjct: 77 VQLLKQLDHPNIMKLYEF-FEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQ 134
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAPTTVMAKVP 264
+ +G+TY+H ++HRDL +N L+ +D + + DFGL+
Sbjct: 135 VLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS------------ 182
Query: 265 RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310
KK +G Y++APE++ G YDE DV+S G++L
Sbjct: 183 ----------KKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVIL 217
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 29/166 (17%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRK-LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
VAVL+ L H N+++ ++D++ LV E GG L + + + +
Sbjct: 87 VAVLKLLDHPNIMKLYDF-FEDKRNYYLVMECYKGGELFDEIIHRMK-FNEVDAAVIIKQ 144
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAPTTVMAKVP 264
+ +G+TYLH N++HRDL +N L+ +D + + DFGL+ +
Sbjct: 145 VLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ------------ 192
Query: 265 RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310
KK +G Y++APE++ + YDE DV+S G++L
Sbjct: 193 ----------KKMKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVIL 227
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 53/290 (18%), Positives = 103/290 (35%), Gaps = 60/290 (20%)
Query: 149 VAVLRSL-HHHNVIRFIGVLYKDRKLN--------LVTEYIAGGTLKELLQ-DPGQPLPW 198
V ++ L H N+++F ++ + L+TE G ++ L + + PL
Sbjct: 76 VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135
Query: 199 GQRVNFARDIAAGMTYLHSMN--LIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256
+ + ++H +IHRDL +N L+ T+ + DFG A I P
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195
Query: 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEM---MTGQEYDETVDVFSYGIVLCEI 313
+ AQRR ++ T P + PE+ + E D+++ G +L +
Sbjct: 196 WS---------AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246
Query: 314 I-GRVPAD--------------PDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCD 358
+ P + P + + F +R
Sbjct: 247 CFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVF----------------HSLIRA---MLQ 287
Query: 359 LNPDQRPP-FEVLE-VWLEGLSMHLSVDKPLPSDLEADIYQFATRKSASP 406
+NP++R EV+ + + +++ P+ LE + + S P
Sbjct: 288 VNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRGP 337
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 39/172 (22%), Positives = 69/172 (40%), Gaps = 37/172 (21%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRK-LNLVTEYIAGGTLKELLQDPGQPLPWGQR------ 201
+ VL+SL H N+I+ V ++D + +V E GG ELL+ G+
Sbjct: 71 IEVLKSLDHPNIIKIFEV-FEDYHNMYIVMETCEGG---ELLERIVSAQARGKALSEGYV 126
Query: 202 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAPTT 258
+ + + Y HS +++H+DL +N L + + + DFGLA +
Sbjct: 127 AELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD------ 180
Query: 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310
+ G +MAPE+ + D++S G+V+
Sbjct: 181 ----------------EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVM 215
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 43/166 (25%), Positives = 75/166 (45%), Gaps = 29/166 (17%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRK-LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
V +L+ L H N+++ + +D +V E GG L + + + +
Sbjct: 72 VELLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQ 129
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAPTTVMAKVP 264
+ +G+TY+H N++HRDL +N L+ +D + + DFGL+ Q
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN------------ 177
Query: 265 RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310
K +G Y++APE++ G YDE DV+S G++L
Sbjct: 178 ----------TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVIL 212
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 39/168 (23%), Positives = 74/168 (44%), Gaps = 30/168 (17%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ +L+ L+H +I+ + +V E + GG L + + + L + +
Sbjct: 191 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQM 248
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
+ YLH +IHRDL +N L+ ED + + DFG ++I+ + ++M
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-----SLM----- 298
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQE---YDETVDVFSYGIVL 310
T+ G P ++APE++ Y+ VD +S G++L
Sbjct: 299 ------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 38/166 (22%), Positives = 70/166 (42%), Gaps = 27/166 (16%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V +LR + H N+I + + L+ E ++GG L + L + L + F + I
Sbjct: 59 VNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES-LTEDEATQFLKQI 117
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLV----REDKTVVVADFGLARIIHQGPRAPTTVMAKVP 264
G+ YLHS + H DL +N ++ + + + DFG+A I G
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG------------ 165
Query: 265 RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310
+ + G P ++APE++ + D++S G++
Sbjct: 166 ----------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 32/169 (18%), Positives = 64/169 (37%), Gaps = 28/169 (16%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ + L H ++ D ++ ++ E+++GG L E + D + + V + R +
Sbjct: 205 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 264
Query: 209 AAGMTYLHSMNLIHRDLNSQN--CLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
G+ ++H N +H DL +N + + + DFGL +
Sbjct: 265 CKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-------------- 310
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYG----IVLC 311
+ G + APE+ G+ D++S G I+L
Sbjct: 311 --------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 351
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 40/180 (22%), Positives = 73/180 (40%), Gaps = 54/180 (30%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV------ 202
+ +L+ L+H +I+ + +V E + GG EL +V
Sbjct: 66 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG---ELFD----------KVVGNKRL 111
Query: 203 ------NFARDIAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGP 253
+ + + YLH +IHRDL +N L+ ED + + DFG ++I+ +
Sbjct: 112 KEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET- 170
Query: 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE---YDETVDVFSYGIVL 310
++M T+ G P ++APE++ Y+ VD +S G++L
Sbjct: 171 ----SLM-----------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 40/227 (17%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ + + L+H NV++F G + L EY +GG L + ++ +P F +
Sbjct: 56 ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQL 114
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
AG+ YLH + + HRD+ +N L+ E + ++DFGLA + R
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------------- 160
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYD-ETVDVFSYGIVLCEII-GRVPADPDYLPR 326
+ + G ++APE++ +E+ E VDV+S GIVL ++ G +P D
Sbjct: 161 -----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD------ 209
Query: 327 SPDFGLDQTDFRNKFCA--SCPEPFVRIAFLCCDL-------NPDQR 364
++ + P+ +I L NP R
Sbjct: 210 --QPSDSCQEYSDWKEKKTYLN-PWKKIDSAPLALLHKILVENPSAR 253
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 38/173 (21%), Positives = 72/173 (41%), Gaps = 42/173 (24%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF---- 204
+ R L H N++R + ++ LV + + GG EL +D R +
Sbjct: 56 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG---ELFED------IVAREFYSEAD 106
Query: 205 ----ARDIAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAPT 257
+ I + Y HS ++HR+L +N L+ + V +ADFGLA ++
Sbjct: 107 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS----- 161
Query: 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310
+ + G P +++PE++ Y + VD+++ G++L
Sbjct: 162 -----------------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 40/227 (17%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ + + L+H NV++F G + L EY +GG L + ++ +P F +
Sbjct: 56 ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQL 114
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
AG+ YLH + + HRD+ +N L+ E + ++DFGLA + R
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------------- 160
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYD-ETVDVFSYGIVLCEII-GRVPADPDYLPR 326
+ + G ++APE++ +E+ E VDV+S GIVL ++ G +P D
Sbjct: 161 -----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD------ 209
Query: 327 SPDFGLDQTDFRNKFCA--SCPEPFVRIAFLCCDL-------NPDQR 364
++ + P+ +I L NP R
Sbjct: 210 --QPSDSCQEYSDWKEKKTYLN-PWKKIDSAPLALLHKILVENPSAR 253
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 45/171 (26%), Positives = 72/171 (42%), Gaps = 33/171 (19%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRK-LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+ +++SL H N+IR ++D + LV E GG L E + +D
Sbjct: 57 IEIMKSLDHPNIIRLYET-FEDNTDIYLVMELCTGGELFERVVHKRV-FRESDAARIMKD 114
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAPTTVMAKVP 264
+ + + Y H +N+ HRDL +N L D + + DFGLA G
Sbjct: 115 VLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG------------ 162
Query: 265 RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYG----IVLC 311
K T VG PY+++P+++ G Y D +S G ++LC
Sbjct: 163 ----------KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLC 202
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 52/236 (22%), Positives = 88/236 (37%), Gaps = 46/236 (19%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLK--ELLQDPGQPLPWGQRVNFARDI 208
+R++ + F G L+++ + + E + K + + D GQ +P A I
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 209 AAGMTYLHS-MNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ +LHS +++IHRD+ N L+ V + DFG++ + +AK
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-------VDDVAK----- 166
Query: 268 AQRRGARKKRYTVVGNPYWMAPE----MMTGQEYDETVDVFSYGIVLCEI-IGRVPADPD 322
G +MAPE + + Y D++S GI + E+ I R P D
Sbjct: 167 ----------DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216
Query: 323 --------YLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370
+ P L F +F F C N +RP + L
Sbjct: 217 GTPFQQLKQVVEEPSPQLPADKFSAEFVD-----FTS---QCLKKNSKERPTYPEL 264
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 41/166 (24%), Positives = 71/166 (42%), Gaps = 27/166 (16%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V++L+ + H NVI V + L+ E +AGG L + L + L + F + I
Sbjct: 65 VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQI 123
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVR----EDKTVVVADFGLARIIHQGPRAPTTVMAKVP 264
G+ YLHS+ + H DL +N ++ + + DFGLA I G
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG------------ 171
Query: 265 RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310
+ + G P ++APE++ + D++S G++
Sbjct: 172 ----------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 38/178 (21%), Positives = 71/178 (39%), Gaps = 46/178 (25%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF---- 204
+ R L H N++R + ++ LV + + GG L E + R +
Sbjct: 79 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---------AREFYSEAD 129
Query: 205 ----ARDIAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAPT 257
+ I + Y HS ++HR+L +N L+ + V +ADFGLA ++
Sbjct: 130 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS----- 184
Query: 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYG----IVLC 311
+ + G P +++PE++ Y + VD+++ G I+L
Sbjct: 185 -----------------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 41/166 (24%), Positives = 71/166 (42%), Gaps = 27/166 (16%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V++LR + HHNVI V + L+ E ++GG L + L L + +F + I
Sbjct: 66 VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQI 124
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVR----EDKTVVVADFGLARIIHQGPRAPTTVMAKVP 264
G+ YLH+ + H DL +N ++ + + DFGLA I G
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG------------ 172
Query: 265 RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310
+ + G P ++APE++ + D++S G++
Sbjct: 173 ----------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 5e-24
Identities = 46/178 (25%), Positives = 76/178 (42%), Gaps = 47/178 (26%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF---- 204
V +L+ L H N+++ +L +V E GG L + + +R F
Sbjct: 72 VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII---------KRKRFSEHD 122
Query: 205 ----ARDIAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAPT 257
+ + +G+TY+H N++HRDL +N L+ +D + + DFGL+ Q
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN----- 177
Query: 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYG----IVLC 311
K +G Y++APE++ G YDE DV+S G I+L
Sbjct: 178 -----------------TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLS 217
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 39/166 (23%), Positives = 70/166 (42%), Gaps = 27/166 (16%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V++LR + H N+I V + L+ E ++GG L + L L + +F + I
Sbjct: 66 VSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQI 124
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVR----EDKTVVVADFGLARIIHQGPRAPTTVMAKVP 264
G+ YLH+ + H DL +N ++ + + DFGLA I G
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG------------ 172
Query: 265 RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310
+ + G P ++APE++ + D++S G++
Sbjct: 173 ----------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 37/178 (20%), Positives = 70/178 (39%), Gaps = 45/178 (25%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF---- 204
+ R L H N++R + ++ L+ + + GG EL +D R +
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG---ELFED------IVAREYYSEAD 111
Query: 205 ----ARDIAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAPT 257
+ I + + H M ++HR+L +N L+ + V +ADFGLA +
Sbjct: 112 ASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV----EGEQ 167
Query: 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYG----IVLC 311
+ G P +++PE++ Y + VD+++ G I+L
Sbjct: 168 QAW-----------------FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV 208
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 38/167 (22%), Positives = 67/167 (40%), Gaps = 27/167 (16%)
Query: 149 VAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKE-LLQDPGQPLPWGQRVNFAR 206
+AVL VI V ++ L+ EY AGG + L + + + + +
Sbjct: 79 IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK 138
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLV---REDKTVVVADFGLARIIHQGPRAPTTVMAKV 263
I G+ YLH N++H DL QN L+ + + DFG++R I
Sbjct: 139 QILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA----------- 187
Query: 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310
+ ++G P ++APE++ D+++ GI+
Sbjct: 188 -----------CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 38/168 (22%), Positives = 71/168 (42%), Gaps = 27/168 (16%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTL-KELLQDPGQPLPWGQRV--NFA 205
++ L H +++ + D L +V E++ G L E+++ + + V ++
Sbjct: 77 ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM 136
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAPTTVMAK 262
R I + Y H N+IHRD+ L+ V + FG+A + + V
Sbjct: 137 RQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE----SGLVA-- 190
Query: 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310
VG P++MAPE++ + Y + VDV+ G++L
Sbjct: 191 ---------------GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-23
Identities = 40/202 (19%), Positives = 79/202 (39%), Gaps = 51/202 (25%)
Query: 149 VAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF--- 204
+ L+ H N+++ V + LV E + GG EL + ++ +F
Sbjct: 56 ITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG---ELFER------IKKKKHFSET 106
Query: 205 -----ARDIAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAP 256
R + + ++++H + ++HRDL +N L ++ + + DFG AR+
Sbjct: 107 EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK----PPD 162
Query: 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYG----IVLCE 312
+ T ++ APE++ YDE+ D++S G +L
Sbjct: 163 NQPL-----------------KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLS- 204
Query: 313 IIGRVP--ADPDYLPRSPDFGL 332
G+VP + L + +
Sbjct: 205 --GQVPFQSHDRSLTCTSAVEI 224
|
| >2jtn_A LIM domain-binding protein 1, LIM/homeobox protein LHX3; intramolecular (fusion) protein-protein complex, protein binding/transcription complex; NMR {Mus musculus} Length = 182 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 4e-23
Identities = 27/107 (25%), Positives = 40/107 (37%), Gaps = 21/107 (19%)
Query: 31 CSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQNCGQ--MMSGPVMVVGDHKFHPECFK 88
CS C V L F + ++CK+D+ ++G C C + V D +H CF
Sbjct: 90 CSDCHVPLAERCFSRGESVYCKDDFFKRFGTKCAACQLGIPPTQVVRRAQDFVYHLHCFA 149
Query: 89 CTSCSCCIGDGESYALVERSILCSACDVMLDNWYFEKDGLLFCKEDY 135
C C + G+ + Y +D L CK DY
Sbjct: 150 CVVCKRQLATGDEF-------------------YLMEDSRLVCKADY 177
|
| >2jtn_A LIM domain-binding protein 1, LIM/homeobox protein LHX3; intramolecular (fusion) protein-protein complex, protein binding/transcription complex; NMR {Mus musculus} Length = 182 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 8e-16
Identities = 19/119 (15%), Positives = 34/119 (28%), Gaps = 23/119 (19%)
Query: 31 CSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQNCGQMMSG-PVMVVGDHKFHPECFKC 89
N ++ G C C Q + ++ D +H +C KC
Sbjct: 31 LENTQFDAANGIDDEGGSGGHMGSGGTPEIPMCAGCDQHILDRFILKALDRHWHSKCLKC 90
Query: 90 TSCSCCIGDGESYALVERSILCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQNCGQ 148
+ C L F + ++CK+D+ ++G C C
Sbjct: 91 SDCHV----------------------PLAERCFSRGESVYCKDDFFKRFGTKCAACQL 127
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 4e-23
Identities = 43/303 (14%), Positives = 86/303 (28%), Gaps = 50/303 (16%)
Query: 141 EACQNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYI----AGGTLKELLQ------ 190
+A + + + + I V +R + +++ + L+ +
Sbjct: 143 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202
Query: 191 DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIH 250
+ L R+ + + LH L+H L + ++ + V + F
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 251 QGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE-----YDETVDVFS 305
+P P A M+ + D ++
Sbjct: 263 ASAVSPIG--------------------RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302
Query: 306 YGIVLCEII-GRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQR 364
G+ + I +P G + FR+ C + P+P + + R
Sbjct: 303 LGLAIYWIWCADLP-----NTDDAALGGSEWIFRS--CKNIPQPVRALLEGFLRYPKEDR 355
Query: 365 P-PFEVLEV-WLEGLSMHLSVDKPLPSDLEADIYQFATRKSASPLTEPECTAPTPADGAL 422
P + +E E L LS PL TR+ +P + A A+
Sbjct: 356 LLPLQAMETPEYEQLRTELSAALPLYQTDGE-----PTREGGAPPSGTSQPDEAGAAEAV 410
Query: 423 RPI 425
I
Sbjct: 411 TAI 413
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-23
Identities = 48/179 (26%), Positives = 84/179 (46%), Gaps = 25/179 (13%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V +++ L+H N+++ V+ ++ L L+ EY +GG + + L G + + + R I
Sbjct: 65 VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQI 123
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
+ + Y H ++HRDL ++N L+ D + +ADFG + G
Sbjct: 124 VSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---------------- 167
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYD-ETVDVFSYGIVL-CEIIGRVPADPDYLP 325
K G P + APE+ G++YD VDV+S G++L + G +P D L
Sbjct: 168 ------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 220
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 6e-23
Identities = 42/173 (24%), Positives = 73/173 (42%), Gaps = 27/173 (15%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ +L+ L H N++ + V + R+L+LV EY T+ L + +P +
Sbjct: 53 IRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQT 111
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
+ + H N IHRD+ +N L+ + + + DFG AR++
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL------------------- 152
Query: 269 QRRGARKKRYT--VVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVP 318
Y V Y +PE++ G +Y VDV++ G V E++ VP
Sbjct: 153 ---TGPSDYYDDEVATRWYR-SPELLVGDTQYGPPVDVWAIGCVFAELLSGVP 201
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 45/173 (26%), Positives = 78/173 (45%), Gaps = 27/173 (15%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ +L+ L H N++ + V K ++ LV E++ T+ + L+ L + + I
Sbjct: 75 IKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQI 133
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G+ + HS N+IHRD+ +N LV + V + DFG AR +
Sbjct: 134 INGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL------------------- 174
Query: 269 QRRGARKKRYT--VVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVP 318
A + Y V Y APE++ G +Y + VDV++ G ++ E+ P
Sbjct: 175 ---AAPGEVYDDEVATRWYR-APELLVGDVKYGKAVDVWAIGCLVTEMFMGEP 223
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 1e-22
Identities = 28/257 (10%), Positives = 57/257 (22%), Gaps = 46/257 (17%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLN--LVTEYIAG--GTLKELLQDP---GQPLPWGQRVN 203
+ + N L+ + L L
Sbjct: 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHI 198
Query: 204 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263
+ L S L+H N + D +++ D
Sbjct: 199 LTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW---------------- 242
Query: 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE--YDETVDVFSYGIVLCEII-GRVP-- 318
+ G R + E + + ++ + G+ + + +P
Sbjct: 243 ------KVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294
Query: 319 ------ADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-PFEVLE 371
P G D F + C P+ + + + +R P E +E
Sbjct: 295 LVTPGIKGSWKRPSLRVPGTDSLAFGS--CTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
Query: 372 -VWLEGLSMHLSVDKPL 387
L +S
Sbjct: 353 TPEFLQLQNEISSSLST 369
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 39/177 (22%), Positives = 72/177 (40%), Gaps = 46/177 (25%)
Query: 149 VAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF--- 204
V +LR + H N+I+ + LV + + G L + L ++V
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---------EKVTLSEK 124
Query: 205 -----ARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259
R + + LH +N++HRDL +N L+ +D + + DFG + + G
Sbjct: 125 ETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG------- 177
Query: 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE------YDETVDVFSYGIVL 310
+K V G P ++APE++ Y + VD++S G+++
Sbjct: 178 ---------------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 50/235 (21%), Positives = 80/235 (34%), Gaps = 55/235 (23%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
VL+S +++ G + + + E + K + G P+P I
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG-PIPERILGKMTVAIVK 135
Query: 211 GMTYLHS-MNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
+ YL +IHRD+ N L+ E + + DFG + ++ A+
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG--------------ISGRLVDDKAK 181
Query: 270 RRGARKKRYTVVGNPYWMAPE-----MMTGQEYDETVDVFSYGIVLCEI-IGRVPADPDY 323
G +MAPE T +YD DV+S GI L E+ G+ P Y
Sbjct: 182 D--------RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP----Y 229
Query: 324 LPRSPDFGL-------------DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
DF + F F + FV+ C + +RP
Sbjct: 230 KNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQS-----FVK---DCLTKDHRKRP 276
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 36/177 (20%), Positives = 74/177 (41%), Gaps = 46/177 (25%)
Query: 149 VAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF--- 204
+LR + H ++I I + LV + + G L + L ++V
Sbjct: 150 THILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT---------EKVALSEK 200
Query: 205 -----ARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259
R + +++LH+ N++HRDL +N L+ ++ + ++DFG + + G
Sbjct: 201 ETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG------- 253
Query: 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE------YDETVDVFSYGIVL 310
+K + G P ++APE++ Y + VD+++ G++L
Sbjct: 254 ---------------EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 48/235 (20%), Positives = 83/235 (35%), Gaps = 50/235 (21%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGG---TLKELLQDPGQPLPWGQRVNFARD 207
V+RS +++F G L+++ + E ++ K + +P
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 208 IAAGMTYLHS-MNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
+ +L + +IHRD+ N L+ + + DFG+
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI--------------------- 172
Query: 267 AAQRRGARKKRYTVVGNPYWMAPE----MMTGQEYDETVDVFSYGIVLCEI-IGRVP-AD 320
+ Q + K G +MAPE + Q YD DV+S GI L E+ GR P
Sbjct: 173 SGQLVDSIAKTRD-AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231
Query: 321 PD-------YLPRSPDFGL---DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
+ + + L ++ +F F FV LC + +RP
Sbjct: 232 WNSVFDQLTQVVKGDPPQLSNSEEREFSPSFIN-----FVN---LCLTKDESKRP 278
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 40/178 (22%), Positives = 72/178 (40%), Gaps = 46/178 (25%)
Query: 149 VAVLRSLHHH-NVIRFIGV----LYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 203
V +++ + V + R L ++ E + GG L +Q+ G
Sbjct: 72 VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD-------QA 124
Query: 204 F--------ARDIAAGMTYLHSMNLIHRDLNSQNCLV---REDKTVVVADFGLARIIHQG 252
F RDI + +LHS N+ HRD+ +N L +D + + DFG A+ Q
Sbjct: 125 FTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184
Query: 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310
T PY++APE++ ++YD++ D++S G+++
Sbjct: 185 AL-----------------------QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2xjy_A Rhombotin-2; oncoprotein, T-cell leukemia, proto-oncogene, transcription, developmental protein; 2.40A {Homo sapiens} PDB: 2xjz_A Length = 131 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 6e-22
Identities = 26/91 (28%), Positives = 37/91 (40%), Gaps = 7/91 (7%)
Query: 31 CSACDVMLDN---WYFEKDGLLFCKEDYNGKYG--EACQNCGQMMSGP--VMVVGDHKFH 83
C C L + K G C+ DY +G C +C + + M V D +H
Sbjct: 32 CDLCGCRLGEVGRRLYYKLGRKLCRRDYLRLFGQDGLCASCDKRIRAYEMTMRVKDKVYH 91
Query: 84 PECFKCTSCSCCIGDGESYALVERSILCSAC 114
ECFKC +C G+ Y L+ I+C
Sbjct: 92 LECFKCAACQKHFCVGDRYLLINSDIVCEQD 122
|
| >2xjy_A Rhombotin-2; oncoprotein, T-cell leukemia, proto-oncogene, transcription, developmental protein; 2.40A {Homo sapiens} PDB: 2xjz_A Length = 131 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-11
Identities = 18/90 (20%), Positives = 29/90 (32%), Gaps = 22/90 (24%)
Query: 63 CQNCGQMMSG-PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVMLDNW 121
C C Q + + D +H +C C C C +G+
Sbjct: 5 CGGCQQNIGDRYFLKAIDQYWHEDCLSCDLCGCRLGEVGR-------------------R 45
Query: 122 YFEKDGLLFCKEDYNGKYG--EACQNCGQV 149
+ K G C+ DY +G C +C +
Sbjct: 46 LYYKLGRKLCRRDYLRLFGQDGLCASCDKR 75
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 7e-22
Identities = 45/176 (25%), Positives = 74/176 (42%), Gaps = 45/176 (25%)
Query: 149 VAVL-RSLHHHNVIRFIGVLYKDRK-LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF-- 204
+ +L R H N+I V Y D K + +VTE + GG ELL ++ F
Sbjct: 66 IEILLRYGQHPNIITLKDV-YDDGKYVYVVTELMKGG---ELLDK------ILRQKFFSE 115
Query: 205 ------ARDIAAGMTYLHSMNLIHRDLNSQNCLVREDK----TVVVADFGLARIIHQGPR 254
I + YLH+ ++HRDL N L ++ ++ + DFG A+ + R
Sbjct: 116 REASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL----R 171
Query: 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310
A ++ T ++APE++ Q YD D++S G++L
Sbjct: 172 AENGLL-----------------MTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 46/173 (26%), Positives = 75/173 (43%), Gaps = 27/173 (15%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V++L+ L H N++ +++ ++ L LV EY+ LK+ L D G + F +
Sbjct: 51 VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G+ Y H ++HRDL QN L+ E + +ADFGLAR
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAK------------------- 150
Query: 269 QRRGARKKRYT--VVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVP 318
K Y VV Y P+++ G +Y +D++ G + E+ P
Sbjct: 151 ---SIPTKTYDNEVVTLWYR-PPDILLGSTDYSTQIDMWGVGCIFYEMATGRP 199
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 43/180 (23%), Positives = 84/180 (46%), Gaps = 25/180 (13%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ L+ H ++I+ V+ +V EY++GG L + + G + + + I
Sbjct: 62 IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQI 120
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
+ + Y H ++HRDL +N L+ +ADFGL+ ++ G
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---------------- 164
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYD-ETVDVFSYGIVLCEII-GRVPADPDYLPR 326
+ T G+P + APE+++G+ Y VD++S G++L ++ G +P D +++P
Sbjct: 165 ------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 43/191 (22%), Positives = 74/191 (38%), Gaps = 47/191 (24%)
Query: 149 VAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF--- 204
V +L H NV+ I ++ + LV E + GG++ + +R +F
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH---------KRRHFNEL 111
Query: 205 -----ARDIAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAP 256
+D+A+ + +LH+ + HRDL +N L + V + DF L I
Sbjct: 112 EASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171
Query: 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE-----YDETVDVFSYG---- 307
+ + T G+ +MAPE++ YD+ D++S G
Sbjct: 172 PI--------------STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217
Query: 308 IVLCEIIGRVP 318
I+L G P
Sbjct: 218 ILLS---GYPP 225
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 38/260 (14%), Positives = 72/260 (27%), Gaps = 57/260 (21%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEY-IAGGTLKELLQD------PGQPLPWGQRVN 203
+++ +IR L+ Y L+ + + L R+
Sbjct: 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQ 210
Query: 204 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263
+ + LH L+H L + ++ + V + F
Sbjct: 211 LTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV---------------- 254
Query: 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE-----------YDETVDVFSYGIVLCE 312
R G R + + PE+ + + D ++ G+V+
Sbjct: 255 ------RDG---ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 313 II-GRVP--ADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-PFE 368
I +P D F + C + P+P + + R P +
Sbjct: 306 IWCADLPITKDAALGGSEWIF---------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQ 356
Query: 369 VLE-VWLEGLSMHLSVDKPL 387
+E E L LS PL
Sbjct: 357 AMETPEYEQLRTELSAALPL 376
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 2e-21
Identities = 47/173 (27%), Positives = 84/173 (48%), Gaps = 27/173 (15%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+++L+ L H N+++ V++ ++L LV E++ LK+LL L +F +
Sbjct: 51 ISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQL 109
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G+ Y H ++HRDL QN L+ + + +ADFGLAR
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF------------------- 150
Query: 269 QRRGARKKRYT--VVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVP 318
G ++YT +V Y AP+++ G ++Y T+D++S G + E++ P
Sbjct: 151 ---GIPVRKYTHEIVTLWYR-APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 4e-21
Identities = 51/173 (29%), Positives = 85/173 (49%), Gaps = 27/173 (15%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+++L+ LHH N++ I V++ +R L LV E++ LK++L + L Q + +
Sbjct: 70 ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQL 128
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G+ + H ++HRDL QN L+ D + +ADFGLAR
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF------------------- 169
Query: 269 QRRGARKKRYT--VVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVP 318
G + YT VV Y AP+++ G ++Y +VD++S G + E+I P
Sbjct: 170 ---GIPVRSYTHEVVTLWYR-APDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 8e-21
Identities = 38/164 (23%), Positives = 70/164 (42%), Gaps = 25/164 (15%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTE-YIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+A+L + H N+I+ + + LV E + +G L + + L R
Sbjct: 80 IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFRQ 138
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ + + YL ++IHRD+ +N ++ ED T+ + DFG A + +G
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-------------- 184
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYD-ETVDVFSYGIVL 310
YT G + APE++ G Y ++++S G+ L
Sbjct: 185 --------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 8e-21
Identities = 45/190 (23%), Positives = 75/190 (39%), Gaps = 52/190 (27%)
Query: 149 VAVLRSLHHH-NVIRFIGV----LYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 203
V + +++R + V + L +V E + GG L +QD G
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-------QA 157
Query: 204 F--------ARDIAAGMTYLHSMNLIHRDLNSQNCLV---REDKTVVVADFGLARIIHQG 252
F + I + YLHS+N+ HRD+ +N L R + + + DFG A+
Sbjct: 158 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217
Query: 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYG----I 308
T PY++APE++ ++YD++ D++S G I
Sbjct: 218 ----------------------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 255
Query: 309 VLCEIIGRVP 318
+LC G P
Sbjct: 256 LLC---GYPP 262
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 27/173 (15%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ +L+ L H N+I + ++LV +++ L+ +++D L +
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G+ YLH ++HRDL N L+ E+ + +ADFGLA+ P +A
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG------------SPNRA- 168
Query: 269 QRRGARKKRYT--VVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVP 318
YT VV Y APE++ G + Y VD+++ G +L E++ RVP
Sbjct: 169 ---------YTHQVVTRWYR-APELLFGARMYGVGVDMWAVGCILAELLLRVP 211
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-20
Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 27/169 (15%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ +L+ L H N++R VL+ D+KL LV E+ LK+ L +F +
Sbjct: 52 ICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G+ + HS N++HRDL QN L+ + + +A+FGLAR
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF------------------- 151
Query: 269 QRRGARKKRYT--VVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEII 314
G + Y+ VV Y P+++ G + Y ++D++S G + E+
Sbjct: 152 ---GIPVRCYSAEVVTLWYR-PPDVLFGAKLYSTSIDMWSAGCIFAELA 196
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 51/182 (28%), Positives = 86/182 (47%), Gaps = 27/182 (14%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ RSL H N++RF V+ L ++ EY +GG L E + + G+ + F + +
Sbjct: 67 IINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR-FSEDEARFFFQQL 125
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKT--VVVADFGLARIIHQGPRAPTTVMAKVPRK 266
+G++Y HSM + HRDL +N L+ + + DFG ++ + +T
Sbjct: 126 LSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-------- 177
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYD-ETVDVFSYGIVL-CEIIGRVPADPDYL 324
VG P ++APE++ QEYD + DV+S G+ L ++G P +
Sbjct: 178 --------------VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223
Query: 325 PR 326
PR
Sbjct: 224 PR 225
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 5e-20
Identities = 48/184 (26%), Positives = 84/184 (45%), Gaps = 26/184 (14%)
Query: 149 VAVLRSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFA 205
+ +LR L H NVI+ + VLY +K+ +V EY G ++E+L P + P Q +
Sbjct: 57 IQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYF 115
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
+ G+ YLHS ++H+D+ N L+ T+ ++ G+A +H
Sbjct: 116 CQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF------------- 162
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQE-YD-ETVDVFSYGIVLCEII-GRVPADPD 322
+ T G+P + PE+ G + + VD++S G+ L I G P + D
Sbjct: 163 ----AADDTCR--TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216
Query: 323 YLPR 326
+ +
Sbjct: 217 NIYK 220
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-20
Identities = 51/179 (28%), Positives = 88/179 (49%), Gaps = 26/179 (14%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
++ L+ L H ++I+ V+ + +V EY AGG L + + + + + F + I
Sbjct: 60 ISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKK-RMTEDEGRRFFQQI 117
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
+ Y H ++HRDL +N L+ ++ V +ADFGL+ I+ G
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---------------- 161
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYD-ETVDVFSYGIVLCEII-GRVPADPDYLP 325
T G+P + APE++ G+ Y VDV+S GIVL ++ GR+P D +++P
Sbjct: 162 ------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP 214
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 9e-20
Identities = 47/193 (24%), Positives = 84/193 (43%), Gaps = 17/193 (8%)
Query: 152 LRSLHHHNVIRFIGVLY-----KDRKLNLVTEYIAGGT-LKELLQDPGQPLPWGQRVNFA 205
L L+H +V++ + ++ K +L +V E + K+L + P L
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTP-VYLTELHIKTLL 162
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
++ G+ Y+HS ++HRDL NCLV +D +V V DFGLAR + + +
Sbjct: 163 YNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 266 KAAQRRGARKKRYTV------VGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEIIGRVP 318
+ V ++ APE ++ + Y E +DV+S G + E++ +
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282
Query: 319 AD-PDYLPRSPDF 330
+ + R P F
Sbjct: 283 ENVAYHADRGPLF 295
|
| >1rut_X Flinc4, fusion protein of LMO4 protein and LIM domain- binding protein 1; B-tandem zipper, protein binding; 1.30A {Mus musculus} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 g.39.1.3 PDB: 2dfy_X 2xjz_I 2xjy_B Length = 188 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 9e-20
Identities = 29/125 (23%), Positives = 48/125 (38%), Gaps = 27/125 (21%)
Query: 31 CSACDVMLDNW---YFEKDGLLFCKEDYNGKYGEA--CQNCGQMMSG--PVMVVGDHKFH 83
CS+C L + + K G++ C+ DY +G + C CGQ + VM + +H
Sbjct: 35 CSSCQAQLGDIGTSSYTKSGMILCRNDYIRLFGNSGACSACGQSIPASELVMRAQGNVYH 94
Query: 84 PECFKCTSCSCCIGDGESYALVERSILCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEAC 143
+CF C++C + G+ + +G LFC+ D
Sbjct: 95 LKCFTCSTCRNRLVPGDR--------------------FHYINGSLFCEHDRPTALINGH 134
Query: 144 QNCGQ 148
N G
Sbjct: 135 LNSGG 139
|
| >1rut_X Flinc4, fusion protein of LMO4 protein and LIM domain- binding protein 1; B-tandem zipper, protein binding; 1.30A {Mus musculus} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 g.39.1.3 PDB: 2dfy_X 2xjz_I 2xjy_B Length = 188 | Back alignment and structure |
|---|
Score = 57.7 bits (139), Expect = 5e-10
Identities = 22/93 (23%), Positives = 37/93 (39%), Gaps = 22/93 (23%)
Query: 60 GEACQNCGQMMSG-PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVML 118
+ C CG ++ ++ D +H C KC+SC +GD +
Sbjct: 5 WKRCAGCGGKIADRFLLYAMDSYWHSRCLKCSSCQAQLGDIGT----------------- 47
Query: 119 DNWYFEKDGLLFCKEDYNGKYGEA--CQNCGQV 149
+ K G++ C+ DY +G + C CGQ
Sbjct: 48 --SSYTKSGMILCRNDYIRLFGNSGACSACGQS 78
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 51/189 (26%), Positives = 81/189 (42%), Gaps = 14/189 (7%)
Query: 152 LRSLHHHNVIRFIGVLYKDRKLN-----LVTEYIAGGT-LKELLQDPGQPLPWGQRVNFA 205
L L +IR ++ D L +V E + LK+L + P L
Sbjct: 79 LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTP-IFLTEEHIKTIL 135
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
++ G ++H +IHRDL NCL+ +D +V V DFGLAR I+ +
Sbjct: 136 YNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 266 KAAQRRGARKKRYT--VVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEII-GRVPADP 321
+ KK+ T VV Y APE ++ + Y +++D++S G + E++
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWY-RAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254
Query: 322 DYLPRSPDF 330
D R P F
Sbjct: 255 DPTNRFPLF 263
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 2e-19
Identities = 47/182 (25%), Positives = 85/182 (46%), Gaps = 31/182 (17%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ L+ H ++I+ V+ + +V EY++GG L + + G L + + I
Sbjct: 67 IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQI 125
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
+G+ Y H ++HRDL +N L+ +ADFGL+ ++ G
Sbjct: 126 LSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---------------- 169
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYD-ETVDVFSYGIVL----CEIIGRVPADPDY 323
+ T G+P + APE+++G+ Y VD++S G++L C G +P D D+
Sbjct: 170 ------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC---GTLPFDDDH 220
Query: 324 LP 325
+P
Sbjct: 221 VP 222
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 47/178 (26%), Positives = 77/178 (43%), Gaps = 34/178 (19%)
Query: 152 LRSLHHHNVIRFIGVLY------KDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRV 202
+R L H N++R Y + LNLV +Y+ T+ + + Q LP
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVK 159
Query: 203 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVV-VADFGLARIIHQGPRAPTTVMA 261
+ + + Y+HS + HRD+ QN L+ D V+ + DFG A+ + +G P
Sbjct: 160 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNV--- 214
Query: 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVP 318
Y Y+ APE++ G +Y ++DV+S G VL E++ P
Sbjct: 215 ---------------SYICSR--YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 50/214 (23%), Positives = 82/214 (38%), Gaps = 54/214 (25%)
Query: 136 NGKYGEACQ----NCGQVAV----------------LRSLHHHNVIRFIGVLY------K 169
NG +G Q +VA+ +R + H NV+ Y
Sbjct: 50 NGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109
Query: 170 DRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226
+ LNLV EY+ T+ + Q +P + + + Y+HS+ + HRD+
Sbjct: 110 EVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIK 168
Query: 227 SQNCLVREDKTVV-VADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPY 285
QN L+ V+ + DFG A+I+ G P Y Y
Sbjct: 169 PQNLLLDPPSGVLKLIDFGSAKILIAGE--PNV------------------SYICSR--Y 206
Query: 286 WMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVP 318
+ APE++ G Y +D++S G V+ E++ P
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 54/232 (23%), Positives = 90/232 (38%), Gaps = 63/232 (27%)
Query: 121 WYFEKDGLLF-CKEDY-------NGKYGEAC-----QNCGQVAV---------------- 151
W +E + + ++DY GKY E N +V V
Sbjct: 23 WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK 82
Query: 152 -LRSLHHH-NVIRFIGVLY--KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
L +L N+I ++ R LV E++ K+L Q L + +
Sbjct: 83 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYE 138
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLV-REDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
I + Y HSM ++HRD+ N ++ E + + + D+GLA H G
Sbjct: 139 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-------------- 184
Query: 267 AAQRRGARKKRYTV-VGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEIIGR 316
+ Y V V + Y+ PE ++ Q YD ++D++S G +L +I R
Sbjct: 185 ---------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 227
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 44/174 (25%), Positives = 72/174 (41%), Gaps = 32/174 (18%)
Query: 151 VLRSLHHHNVIRFIGVLY----KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF-A 205
+L ++ RF+ L L LV + GG LK + GQ R F A
Sbjct: 237 ILEKVNS----RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
+I G+ LH +++RDL +N L+ + + ++D GLA + +G
Sbjct: 293 AEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI---------- 342
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
VG +MAPE++ + Y + D ++ G +L E I G+ P
Sbjct: 343 ------------KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 42/182 (23%), Positives = 73/182 (40%), Gaps = 33/182 (18%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDR--------KLNLVTEYIAGGTLKELLQDPGQPLPWGQ 200
+ +L+ L H NV+ I + + LV ++ L LL + +
Sbjct: 67 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSE 125
Query: 201 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260
+ + G+ Y+H ++HRD+ + N L+ D + +ADFGLAR +
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ---- 181
Query: 261 AKVPRKAAQRRGARKKRYT--VVGNPYWM-APEMMTGQE-YDETVDVFSYGIVLCEIIGR 316
RYT VV W PE++ G+ Y +D++ G ++ E+ R
Sbjct: 182 --------------PNRYTNRVV--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225
Query: 317 VP 318
P
Sbjct: 226 SP 227
|
| >1x6a_A LIMK-2, LIM domain kinase 2; LIM-kinase 2, zinc finger domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 81 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-18
Identities = 32/67 (47%), Positives = 43/67 (64%), Gaps = 1/67 (1%)
Query: 49 LFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERS 108
+DY GK+GE C C +M+GP MV G+ K+HPECF C SC I DG++YALV+ +
Sbjct: 4 GSSGKDYWGKFGEFCHGCSLLMTGPFMVAGEFKYHPECFACMSCKVIIEDGDAYALVQHA 63
Query: 109 -ILCSAC 114
+ C C
Sbjct: 64 TLYCGKC 70
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 44/178 (24%), Positives = 80/178 (44%), Gaps = 32/178 (17%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-----GQPLPWGQRVN 203
+++++ L H N++R V++ + KL LV E++ LK+ + + L
Sbjct: 54 ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 204 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263
F + G+ + H ++HRDL QN L+ + + + DFGLAR
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF-------------- 158
Query: 264 PRKAAQRRGARKKRYT--VVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVP 318
G ++ VV Y AP+++ G + Y ++D++S G +L E+I P
Sbjct: 159 --------GIPVNTFSSEVVTLWYR-APDVLMGSRTYSTSIDIWSCGCILAEMITGKP 207
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 54/214 (25%), Positives = 89/214 (41%), Gaps = 39/214 (18%)
Query: 140 GEACQNCGQVAVLRSLHHHNVIRFIGVL--YKDRKLNLVTEYIAGGTLKELL-------- 189
G + C ++A+LR L H NVI V + DRK+ L+ +Y A L ++
Sbjct: 60 GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKA 118
Query: 190 QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDK----TVVVADFGL 245
LP G + I G+ YLH+ ++HRDL N LV + V +AD G
Sbjct: 119 NKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
Query: 246 ARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWM-APEMMTG-QEYDETVDV 303
AR+ + + + V T W APE++ G + Y + +D+
Sbjct: 179 ARLFNSPLKPLADLDPVV--------------VTF-----WYRAPELLLGARHYTKAIDI 219
Query: 304 FSYGIVLCEIIGRVP---ADPDYLPRSPDFGLDQ 334
++ G + E++ P + + S + DQ
Sbjct: 220 WAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 6e-18
Identities = 37/171 (21%), Positives = 71/171 (41%), Gaps = 25/171 (14%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNF-ARDI 208
V+ L H ++ D KL Y G L + ++ G F +I
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---CTRFYTAEI 139
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
+ + YLH +IHRDL +N L+ ED + + DFG A+++ +
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA---------- 189
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
+ VG +++PE++T + ++ D+++ G ++ + + G P
Sbjct: 190 ---------NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2dar_A PDZ and LIM domain protein 5; enigma homolog protein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 90 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-17
Identities = 22/104 (21%), Positives = 36/104 (34%), Gaps = 22/104 (21%)
Query: 41 WYFEKDGLLFCKEDY-NGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDG 99
++D L+ E GK C +C Q++ GP +V +HPE F C C +
Sbjct: 5 SSGDQDTLVQRAEHIPAGKRTPMCAHCNQVIRGPFLVALGKSWHPEEFNCAHCKNTMAYI 64
Query: 100 ESYALVERSILCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEAC 143
+ E+ G L+C+ Y +
Sbjct: 65 G---------------------FVEEKGALYCELCYEKFFASGP 87
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 44/178 (24%), Positives = 80/178 (44%), Gaps = 33/178 (18%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V++L+ L H N+I V++ + +L+L+ EY LK+ + D + +F +
Sbjct: 84 VSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYM-DKNPDVSMRVIKSFLYQL 141
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLV-----REDKTVVVADFGLARIIHQGPRAPTTVMAKV 263
G+ + HS +HRDL QN L+ E + + DFGLAR
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-------------- 187
Query: 264 PRKAAQRRGARKKRYT--VVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVP 318
G +++T ++ Y PE++ G + Y +VD++S + E++ + P
Sbjct: 188 --------GIPIRQFTHEIITLWYR-PPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 45/172 (26%), Positives = 76/172 (44%), Gaps = 9/172 (5%)
Query: 152 LRSLHHH-NVIRFIGVLY--KDRKLNLVTEYIAGGT-LKELLQDPGQPLPWGQRVNFARD 207
L L H N++ + VL DR + LV +Y+ T L +++ L +
Sbjct: 62 LTELSGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIR--ANILEPVHKQYVVYQ 117
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ + YLHS L+HRD+ N L+ + V VADFGL+R R + +
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 268 AQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEIIGRVP 318
+ V ++ APE ++ +Y + +D++S G +L EI+ P
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 44/173 (25%), Positives = 73/173 (42%), Gaps = 32/173 (18%)
Query: 152 LRSLHHHNVIRFIGVLYKDRKLN------LVTEYIAGGTLKELLQDPGQPLPWGQRVNFA 205
++ ++H N+I + V + L +V E + L +++Q L +
Sbjct: 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQ---MELDHERMSYLL 133
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
+ G+ +LHS +IHRDL N +V+ D T+ + DFGLAR V
Sbjct: 134 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV------ 187
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVP 318
R Y+ APE++ G Y E VD++S G ++ E+I
Sbjct: 188 --VTR--------------YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >1v6g_A Actin binding LIM protein 2; LIM domain, zinc binding domain, ablim2, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 81 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 5e-17
Identities = 18/62 (29%), Positives = 26/62 (41%)
Query: 54 DYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSA 113
DY YG C +C Q + G V+ +HP+CF C C G+ + +C
Sbjct: 9 DYQRLYGTRCFSCDQFIEGEVVSALGKTYHPDCFVCAVCRLPFPPGDRVTFNGKECMCQK 68
Query: 114 CD 115
C
Sbjct: 69 CS 70
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 27/152 (17%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQPLPW--GQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQ 228
L LV + GG ++ + + + P R F I +G+ +LH N+I+RDL +
Sbjct: 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPE 318
Query: 229 NCLVREDKTVVVADFGLA-RIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWM 287
N L+ +D V ++D GLA + + G P +M
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTKT----------------------KGYAGTPGFM 356
Query: 288 APEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
APE++ G+EYD +VD F+ G+ L E I R P
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2xqn_T Testin, TESS; metal-binding protein, cytoskeleton, focal adhesion, acrosom; 2.62A {Homo sapiens} Length = 126 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 8e-17
Identities = 24/110 (21%), Positives = 38/110 (34%), Gaps = 26/110 (23%)
Query: 31 CSACDVML-DNWYFEKDGLLFCKEDYNGKYGEACQNCGQMMSGPVMVV--GDHKFHP--E 85
C CD +L Y + CK Y + CQ C + V V + +H E
Sbjct: 33 CFDCDSILAGEIYVMVNDKPVCKPCYVKNHAVVCQGCHNAIDPEVQRVTYNNFSWHASTE 92
Query: 86 CFKCTSCSCCIGDGESYALVERSILCSACDVMLDNWYFEKDGLLFCKEDY 135
CF C+ CS C+ + + +G++FC +
Sbjct: 93 CFLCSCCSKCLIGQK---------------------FMPVEGMVFCSVEC 121
|
| >2xqn_T Testin, TESS; metal-binding protein, cytoskeleton, focal adhesion, acrosom; 2.62A {Homo sapiens} Length = 126 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-11
Identities = 14/87 (16%), Positives = 22/87 (25%), Gaps = 22/87 (25%)
Query: 63 CQNCGQM-MSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVMLDNW 121
C C ++ S + +H + F C C +
Sbjct: 6 CAGCDELIFSNEYTQAENQNWHLKHFCCFDCDSILAG---------------------EI 44
Query: 122 YFEKDGLLFCKEDYNGKYGEACQNCGQ 148
Y + CK Y + CQ C
Sbjct: 45 YVMVNDKPVCKPCYVKNHAVVCQGCHN 71
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 47/183 (25%), Positives = 71/183 (38%), Gaps = 41/183 (22%)
Query: 152 LRSLHHHNVIRFIGVLY-------KDRKLNLVTEYIAGGTLKELL---QDPGQPLPWGQR 201
L LHH N+++ Y +D LN+V EY+ TL P
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILI 131
Query: 202 VNFARDIAAGMTYLH--SMNLIHRDLNSQNCLV-REDKTVVVADFGLARIIHQGPRAPTT 258
F + + LH S+N+ HRD+ N LV D T+ + DFG A+ + P
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE--PNV 189
Query: 259 --VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIG 315
+ R Y+ APE++ G Q Y VD++S G + E++
Sbjct: 190 AYI--------CSR--------------YYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227
Query: 316 RVP 318
P
Sbjct: 228 GEP 230
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 39/173 (22%), Positives = 67/173 (38%), Gaps = 29/173 (16%)
Query: 152 LRSLHHHNVIRFIGVLYKDRKLN-----LVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
L HH N++ + + LVTE + L +++ D + F
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
I G+ LH ++HRDL+ N L+ ++ + + DF LAR V R
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV---THR- 197
Query: 267 AAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEIIGRVP 318
++ APE +M + + + VD++S G V+ E+ R
Sbjct: 198 ------------------WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 47/177 (26%), Positives = 71/177 (40%), Gaps = 28/177 (15%)
Query: 152 LRSLHHHNVIRFIGVLYKDRKLN-----LVTEYIAGGT-LKELLQDPGQPLPWGQRVNFA 205
L+ H N+I + D N ++ E + T L ++ Q L F
Sbjct: 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVIS--TQMLSDDHIQYFI 118
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
+ LH N+IHRDL N L+ + + V DFGLARII + + +
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 266 K---AAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEIIGRVP 318
A R ++ APE M+T +Y +DV+S G +L E+ R P
Sbjct: 179 MVEFVATR--------------WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 56/181 (30%), Positives = 77/181 (42%), Gaps = 36/181 (19%)
Query: 149 VAVLRSLH---HHNVIRFIGVLYKDR-----KLNLVTEYIAGGTLKELLQD-PGQPLPWG 199
VA+LR L H NV+R + V R K+ LV E++ L+ L P LP
Sbjct: 62 VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAE 120
Query: 200 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259
+ R G+ +LH+ ++HRDL +N LV TV +ADFGLARI
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS--------- 171
Query: 260 MAKVPRKAAQRRGARKKRYT--VVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRV 317
T VV Y APE++ Y VD++S G + E+ R
Sbjct: 172 ---YQM-----------ALTPVVVTLWYR-APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
Query: 318 P 318
P
Sbjct: 217 P 217
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 44/173 (25%), Positives = 72/173 (41%), Gaps = 32/173 (18%)
Query: 152 LRSLHHHNVIRFIGVLYKDRKLN------LVTEYIAGGTLKELLQDPGQPLPWGQRVNFA 205
++ ++H N+I + V + L LV E L +++Q L +
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIQ---MELDHERMSYLL 170
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
+ G+ +LHS +IHRDL N +V+ D T+ + DFGLAR V
Sbjct: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV------ 224
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVP 318
R Y+ APE++ G Y E VD++S G ++ E++
Sbjct: 225 --VTR--------------YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 43/173 (24%), Positives = 72/173 (41%), Gaps = 27/173 (15%)
Query: 152 LRSLHHHNVIRFIGVLYKDRKLN-----LVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
L H N+I ++ +V + + L +LL+ Q L F
Sbjct: 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLK--TQHLSNDHICYFLY 135
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
I G+ Y+HS N++HRDL N L+ + + DFGLAR+ + V
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--- 192
Query: 267 AAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEIIGRVP 318
A R ++ APE M+ + Y +++D++S G +L E++ P
Sbjct: 193 -ATR--------------WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 50/175 (28%), Positives = 72/175 (41%), Gaps = 33/175 (18%)
Query: 152 LRSLHHHNVIRFIGVLY-----KDRKLNLVTEYIAGGTLKELLQDPGQP-LPWGQRVNFA 205
L + H NV+R V ++ KL LV E++ L L +P +P +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
+ G+ +LHS ++HRDL QN LV + +ADFGLARI
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS------------FQM 174
Query: 266 KAAQRRGARKKRYT--VVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVP 318
T VV Y APE++ Y VD++S G + E+ R P
Sbjct: 175 -----------ALTSVVVTLWYR-APEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 46/174 (26%), Positives = 74/174 (42%), Gaps = 34/174 (19%)
Query: 152 LRSLHHHNVIRFIGVLYKDRKLN------LVTEYIAGGTLKELLQDPGQPLPWGQRVNFA 205
L+ + H NVI + V D L+ LV ++ G L +L++ + L +
Sbjct: 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLV 134
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
+ G+ Y+H+ +IHRDL N V ED + + DFGLAR V V R
Sbjct: 135 YQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMTGYV---VTR 189
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEIIGRVP 318
++ APE ++ Y +TVD++S G ++ E+I
Sbjct: 190 -------------------WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 8e-16
Identities = 49/174 (28%), Positives = 73/174 (41%), Gaps = 34/174 (19%)
Query: 152 LRSLHHHNVIRFIGVLYKDRKLN------LVTEYIAGGTLKELLQDPGQPLPWGQRVNFA 205
L+ + H NVI + V R L LVT + G L +++ Q L
Sbjct: 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK--CQKLTDDHVQFLI 138
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
I G+ Y+HS ++IHRDL N V ED + + DFGLAR H V R
Sbjct: 139 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYV---ATR 193
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEIIGRVP 318
++ APE M+ Y++TVD++S G ++ E++
Sbjct: 194 -------------------WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 40/150 (26%), Positives = 65/150 (43%), Gaps = 28/150 (18%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNC 230
KL+ + + + GG L L G + F A +I G+ ++H+ +++RDL N
Sbjct: 266 KLSFILDLMNGGDLHYHLSQHGVFSE--ADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 323
Query: 231 LVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPE 290
L+ E V ++D GLA + K + VG +MAPE
Sbjct: 324 LLDEHGHVRISDLGLACDFSKK-----------------------KPHASVGTHGYMAPE 360
Query: 291 MMT-GQEYDETVDVFSYGIVLCE-IIGRVP 318
++ G YD + D FS G +L + + G P
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 41/174 (23%), Positives = 71/174 (40%), Gaps = 35/174 (20%)
Query: 152 LRSLHHHNVIRFIGVLYKDRKLN------LVTEYIAGGTLKELLQDPGQPLPWGQRVNFA 205
L+ + H NVI + V L LV ++ L++++ +
Sbjct: 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMG---LKFSEEKIQYLV 132
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
+ G+ Y+HS ++HRDL N V ED + + DFGLAR M
Sbjct: 133 YQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA-------DAEMTG--- 182
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEIIGRVP 318
Y V ++ APE +++ Y++TVD++S G ++ E++
Sbjct: 183 ------------Y--VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >1x3h_A Leupaxin; paxillin family, protein-protein interaction, LIM domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 80 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-15
Identities = 20/97 (20%), Positives = 31/97 (31%), Gaps = 21/97 (21%)
Query: 47 GLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVE 106
+D+ + C C + + + D +HPECF C C G
Sbjct: 2 SSGSSGKDFLAMFSPKCGGCNRPVLENYLSAMDTVWHPECFVCGDCFTSFSTGS------ 55
Query: 107 RSILCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEAC 143
+FE DG FC+ Y+ + G
Sbjct: 56 ---------------FFELDGRPFCELHYHHRRGSGP 77
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 29/162 (17%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQN 229
+L V EY+ GG L +Q + P F + +I+ + YLH +I+RDL N
Sbjct: 84 RLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLALNYLHERGIIYRDLKLDN 140
Query: 230 CLVREDKTVVVADFGLARI-IHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMA 288
L+ + + + D+G+ + + G T G P ++A
Sbjct: 141 VLLDSEGHIKLTDYGMCKEGLRPGDTT----------------------STFCGTPNYIA 178
Query: 289 PEMMTGQEYDETVDVFSYGIVLCE-IIGRVPADPDYLPRSPD 329
PE++ G++Y +VD ++ G+++ E + GR P D +PD
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 4e-15
Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 29/151 (19%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQN 229
KL L+ +++ GG L L V F ++A + +LHS+ +I+RDL +N
Sbjct: 100 KLYLILDFLRGGDLFTRLSKEVMFTEE---DVKFYLAELALALDHLHSLGIIYRDLKPEN 156
Query: 230 CLVREDKTVVVADFGLARI-IHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMA 288
L+ E+ + + DFGL++ I +A Y+ G +MA
Sbjct: 157 ILLDEEGHIKLTDFGLSKESIDHEKKA----------------------YSFCGTVEYMA 194
Query: 289 PEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
PE++ + + ++ D +S+G+++ E + G +P
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 36/159 (22%), Positives = 61/159 (38%), Gaps = 32/159 (20%)
Query: 170 DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQ 228
+ L LV EY GG L LL G+ +P + F +I + +H + +HRD+
Sbjct: 133 ENYLYLVMEYYVGGDLLTLLSKFGERIP-AEMARFYLAEIVMAIDSVHRLGYVHRDIKPD 191
Query: 229 NCLVREDKTVVVADFGLA-RIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWM 287
N L+ + +ADFG ++ G + VG P ++
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRADGT---------------------VRSLVAVGTPDYL 230
Query: 288 APEMMTGQE-------YDETVDVFSYGIVLCE-IIGRVP 318
+PE++ Y D ++ G+ E G+ P
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2dlo_A Thyroid receptor-interacting protein 6; LIM domain, OPA-interacting protein 1, zyxin related protein 1 (ZRP-1), structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 81 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 7e-15
Identities = 15/93 (16%), Positives = 26/93 (27%), Gaps = 20/93 (21%)
Query: 51 CKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSIL 110
E E C C Q + ++ +HP CF C C +
Sbjct: 6 SGEGCYVATLEKCATCSQPILDRILRAMGKAYHPGCFTCVVCHRGLDG------------ 53
Query: 111 CSACDVMLDNWYFEKDGLLFCKEDYNGKYGEAC 143
+ + + C ED++ K+
Sbjct: 54 --------IPFTVDATSQIHCIEDFHRKFASGP 78
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 7e-15
Identities = 39/151 (25%), Positives = 64/151 (42%), Gaps = 29/151 (19%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQN 229
+L V E++ GG L +Q + R F A +I + + +LH +I+RDL N
Sbjct: 98 RLFFVMEFVNGGDLMFHIQKSRRFDEA---RARFYAAEIISALMFLHDKGIIYRDLKLDN 154
Query: 230 CLVREDKTVVVADFGLARI-IHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMA 288
L+ + +ADFG+ + I G T G P ++A
Sbjct: 155 VLLDHEGHCKLADFGMCKEGICNGVTT----------------------ATFCGTPDYIA 192
Query: 289 PEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
PE++ Y VD ++ G++L E + G P
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 36/155 (23%), Positives = 63/155 (40%), Gaps = 31/155 (20%)
Query: 170 DRKLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNS 227
+ + +V + + GG L+ LQ V ++ + YL + +IHRD+
Sbjct: 87 EEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVKLFICELVMALDYLQNQRIIHRDMKP 143
Query: 228 QNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWM 287
N L+ E V + DF +A ++ + + T+ G +M
Sbjct: 144 DNILLDEHGHVHITDFNIAAMLPRETQI----------------------TTMAGTKPYM 181
Query: 288 APEMMTGQE---YDETVDVFSYGIVLCE-IIGRVP 318
APEM + ++ Y VD +S G+ E + GR P
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 1e-14
Identities = 39/151 (25%), Positives = 65/151 (43%), Gaps = 29/151 (19%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQN 229
KL L+ EY++GG L L+ G F +I+ + +LH +I+RDL +N
Sbjct: 95 KLYLILEYLSGGELFMQLEREGIFMED---TACFYLAEISMALGHLHQKGIIYRDLKPEN 151
Query: 230 CLVREDKTVVVADFGLARI-IHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMA 288
++ V + DFGL + IH G +T G +MA
Sbjct: 152 IMLNHQGHVKLTDFGLCKESIHDGTVT----------------------HTFCGTIEYMA 189
Query: 289 PEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
PE++ ++ VD +S G ++ + + G P
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 29/162 (17%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQN 229
+L V EY+ GG L +Q + P F + +I+ + YLH +I+RDL N
Sbjct: 127 RLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLALNYLHERGIIYRDLKLDN 183
Query: 230 CLVREDKTVVVADFGLARI-IHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMA 288
L+ + + + D+G+ + + G T G P ++A
Sbjct: 184 VLLDSEGHIKLTDYGMCKEGLRPGDTT----------------------STFCGTPNYIA 221
Query: 289 PEMMTGQEYDETVDVFSYGIVLCE-IIGRVPADPDYLPRSPD 329
PE++ G++Y +VD ++ G+++ E + GR P D +PD
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 40/151 (26%), Positives = 66/151 (43%), Gaps = 29/151 (19%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQN 229
+L V EY GG L L R F +I + + YLHS ++++RD+ +N
Sbjct: 79 RLCFVMEYANGGELFFHLSRERVFTEE---RARFYGAEIVSALEYLHSRDVVYRDIKLEN 135
Query: 230 CLVREDKTVVVADFGLARI-IHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMA 288
++ +D + + DFGL + I G T G P ++A
Sbjct: 136 LMLDKDGHIKITDFGLCKEGISDGATM----------------------KTFCGTPEYLA 173
Query: 289 PEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
PE++ +Y VD + G+V+ E + GR+P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 50/151 (33%), Positives = 68/151 (45%), Gaps = 29/151 (19%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQN 229
KL V +YI GG L LQ P R F A +IA+ + YLHS+N+++RDL +N
Sbjct: 113 KLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIASALGYLHSLNIVYRDLKPEN 169
Query: 230 CLVREDKTVVVADFGLA-RIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMA 288
L+ +V+ DFGL I T G P ++A
Sbjct: 170 ILLDSQGHIVLTDFGLCKENIEHNSTT----------------------STFCGTPEYLA 207
Query: 289 PEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
PE++ Q YD TVD + G VL E + G P
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 29/151 (19%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQN 229
L V EY+ GG L +Q + L R F A +I G+ +LHS +++RDL N
Sbjct: 92 NLFFVMEYLNGGDLMYHIQSCHKFDLS---RATFYAAEIILGLQFLHSKGIVYRDLKLDN 148
Query: 230 CLVREDKTVVVADFGLARI-IHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMA 288
L+ +D + +ADFG+ + + + T G P ++A
Sbjct: 149 ILLDKDGHIKIADFGMCKENMLGDAKT----------------------NTFCGTPDYIA 186
Query: 289 PEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
PE++ GQ+Y+ +VD +S+G++L E +IG+ P
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 44/171 (25%), Positives = 80/171 (46%), Gaps = 30/171 (17%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNF-ARDI 208
+L++++ +++ + L +V EY+AGG + L+ G+ P F A I
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARFYAAQI 150
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
YLHS++LI+RDL +N L+ + + V DFG A+ + T
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT---------- 195
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
+T+ G P +APE++ + Y++ VD ++ G+++ E G P
Sbjct: 196 ---------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 37/157 (23%), Positives = 64/157 (40%), Gaps = 30/157 (19%)
Query: 170 DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQ 228
D L LV +Y GG L LL LP + F ++ + +H ++ +HRD+
Sbjct: 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLP-EEMARFYLAEMVIAIDSVHQLHYVHRDIKPD 204
Query: 229 NCLVREDKTVVVADFGLA-RIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWM 287
N L+ + + +ADFG +++ G + VG P ++
Sbjct: 205 NILMDMNGHIRLADFGSCLKLMEDG---------------------TVQSSVAVGTPDYI 243
Query: 288 APEMMTGQE-----YDETVDVFSYGIVLCE-IIGRVP 318
+PE++ E Y D +S G+ + E + G P
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1wig_A KIAA1808 protein; LIM domain, zinc finger, metal-binding protein, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 73 | Back alignment and structure |
|---|
Score = 67.1 bits (163), Expect = 2e-14
Identities = 17/57 (29%), Positives = 25/57 (43%)
Query: 58 KYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSAC 114
C +C + ++G V+ G+ +HP C C C +GE L SI AC
Sbjct: 3 SGSSGCDSCEKYITGRVLEAGEKHYHPSCALCVRCGQMFAEGEEMYLQGSSIWHPAC 59
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 45/212 (21%), Positives = 84/212 (39%), Gaps = 70/212 (33%)
Query: 152 LRSLHHHNVIRFIGVLY--------------------------------------KDRKL 173
++ L H N+I+ + Y +++ L
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 174 NLVTEYIAGGTLKELLQ---DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 230
N++ EY+ TL ++L+ G+ +P + + + ++HS+ + HRD+ QN
Sbjct: 114 NVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNL 172
Query: 231 LV-REDKTVVVADFGLARIIHQGPRAPTT--VMAKVPRKAAQRRGARKKRYTVVGNPYWM 287
LV +D T+ + DFG A+ + P+ + R ++
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSE--PSVAYI--------CSR--------------FYR 208
Query: 288 APEMMTG-QEYDETVDVFSYGIVLCEIIGRVP 318
APE+M G EY ++D++S G V E+I P
Sbjct: 209 APELMLGATEYTPSIDLWSIGCVFGELILGKP 240
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 31/178 (17%), Positives = 66/178 (37%), Gaps = 34/178 (19%)
Query: 149 VAVLRSLHHH--NVIRFIGVLYKDRKLNLVTEYIAGGTLKEL---LQDPGQPLPWGQRVN 203
V +L+ + VIR + + L+ E ++L + + G L +
Sbjct: 97 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV--QDLFDFITERG-ALQEELARS 153
Query: 204 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVV-VADFGLARIIHQGPRAPTTVMAK 262
F + + + H+ ++HRD+ +N L+ ++ + + DFG ++
Sbjct: 154 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--------- 204
Query: 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYD-ETVDVFSYGIVLCEII-GRVP 318
G + PE + Y + V+S GI+L +++ G +P
Sbjct: 205 --------------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 5e-14
Identities = 43/151 (28%), Positives = 72/151 (47%), Gaps = 29/151 (19%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQN 229
+L V EY+ GG L +Q G+ P F A +IA G+ +L S +I+RDL N
Sbjct: 95 RLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAAEIAIGLFFLQSKGIIYRDLKLDN 151
Query: 230 CLVREDKTVVVADFGLARI-IHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMA 288
++ + + +ADFG+ + I G T G P ++A
Sbjct: 152 VMLDSEGHIKIADFGMCKENIWDGVTT----------------------KTFCGTPDYIA 189
Query: 289 PEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
PE++ Q Y ++VD +++G++L E + G+ P
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 42/178 (23%), Positives = 74/178 (41%), Gaps = 37/178 (20%)
Query: 151 VLRSLHHHNVIRFIGVLY----KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF-A 205
++ + ++ L+ DR L +V EY+ GG L L+ + P W + F
Sbjct: 122 IMAFANS----PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAR---FYT 174
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
++ + +HSM IHRD+ N L+ + + +ADFG +++
Sbjct: 175 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC-------- 226
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQ----EYDETVDVFSYGIVLCE-IIGRVP 318
T VG P +++PE++ Q Y D +S G+ L E ++G P
Sbjct: 227 ------------DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-14
Identities = 19/94 (20%), Positives = 35/94 (37%), Gaps = 3/94 (3%)
Query: 154 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMT 213
+ V R + V++ +V E+I GG+L+E+ P+ + + +AA
Sbjct: 87 RIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPV---GAIRAMQSLAAAAD 143
Query: 214 YLHSMNLIHRDLNSQNCLVREDKTVVVADFGLAR 247
H + + V D VV+A
Sbjct: 144 AAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 8e-14
Identities = 36/190 (18%), Positives = 75/190 (39%), Gaps = 51/190 (26%)
Query: 152 LRSLHHHNVIRFIGVLYKDRKLN--------------LVTEYIAGGT-LKELLQDPGQPL 196
+R L H N+++ +L +V EY+ T L +L+ PL
Sbjct: 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLE--QGPL 117
Query: 197 PWGQRVNFARDIAAGMTYLHSMNLIHRDL-------NSQNCLVREDKTVVVADFGLARII 249
F + G+ Y+HS N++HRDL N+++ +++ + DFGLARI+
Sbjct: 118 LEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK------IGDFGLARIM 171
Query: 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGI 308
+ + + ++ +P +++ Y + +D+++ G
Sbjct: 172 DPHYSHKGHLSEGL----VTK--------------WYRSPRLLLSPNNYTKAIDMWAAGC 213
Query: 309 VLCEIIGRVP 318
+ E++
Sbjct: 214 IFAEMLTGKT 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 44/151 (29%), Positives = 68/151 (45%), Gaps = 28/151 (18%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNF-ARDIAAGMTYLHS-MNLIHRDLNSQ 228
+L V EY GG L L R F +I + + YLHS N+++RDL +
Sbjct: 222 RLCFVMEYANGGELFFHLSRERVFSED---RARFYGAEIVSALDYLHSEKNVVYRDLKLE 278
Query: 229 NCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMA 288
N ++ +D + + DFGL K + GA K T G P ++A
Sbjct: 279 NLMLDKDGHIKITDFGLC-------------------KEGIKDGATMK--TFCGTPEYLA 317
Query: 289 PEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
PE++ +Y VD + G+V+ E + GR+P
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2cup_A Skeletal muscle LIM-protein 1; four and half LIM domains protein 1, LIM domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 Length = 101 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-13
Identities = 12/65 (18%), Positives = 24/65 (36%), Gaps = 3/65 (4%)
Query: 31 CSACDVML-DNWYFEKDGLLFCKEDYNGKYGEACQNCGQMMSGP--VMVVGDHKFHPECF 87
C+ C L + + KD + C + + C+ C + + + +H +CF
Sbjct: 36 CAKCLHPLANETFVAKDNKILCNKCTTREDSPKCKGCFKAIVAGDQNVEYKGTVWHKDCF 95
Query: 88 KCTSC 92
S
Sbjct: 96 SGPSS 100
|
| >2cup_A Skeletal muscle LIM-protein 1; four and half LIM domains protein 1, LIM domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 Length = 101 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 4e-11
Identities = 12/93 (12%), Positives = 26/93 (27%), Gaps = 23/93 (24%)
Query: 58 KYGEACQNCGQMMSG--PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACD 115
C C + + + + +H CF+C C + +
Sbjct: 3 SGSSGCVECRKPIGADSKEVHYKNRFWHDTCFRCAKCLHPLANE---------------- 46
Query: 116 VMLDNWYFEKDGLLFCKEDYNGKYGEACQNCGQ 148
+ KD + C + + C+ C +
Sbjct: 47 -----TFVAKDNKILCNKCTTREDSPKCKGCFK 74
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 51/235 (21%), Positives = 83/235 (35%), Gaps = 55/235 (23%)
Query: 149 VAVLRSLH----HHNVIRFIGVLYKDRKLNLVTEY-IAGGTLKELLQDPGQPLPWGQRVN 203
VA+L + H VIR + LV E + L + + + G PL G
Sbjct: 85 VALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRC 143
Query: 204 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVV-VADFGLARIIHQGPRAPTTVMAK 262
F + A + + HS ++HRD+ +N L+ + + DFG ++H P
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--------- 194
Query: 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYD-ETVDVFSYGIVLCEII-GRVPAD 320
G + PE ++ +Y V+S GI+L +++ G +P
Sbjct: 195 --------------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP-- 238
Query: 321 PDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDL-------NPDQRPPFE 368
F DQ + P ++ CC L P RP E
Sbjct: 239 ---------FERDQEILEAEL--HFPA---HVSPDCCALIRRCLAPKPSSRPSLE 279
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 32/154 (20%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQN 229
KL+L+ +YI GG L L + V +I + +LH + +I+RD+ +N
Sbjct: 133 KLHLILDYINGGELFTHLSQRERFTEH---EVQIYVGEIVLALEHLHKLGIIYRDIKLEN 189
Query: 230 CLVREDKTVVVADFGLAR--IIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWM 287
L+ + VV+ DFGL++ + + RA Y G +M
Sbjct: 190 ILLDSNGHVVLTDFGLSKEFVADETERA----------------------YDFCGTIEYM 227
Query: 288 APEMMTGQE--YDETVDVFSYGIVLCE-IIGRVP 318
AP+++ G + +D+ VD +S G+++ E + G P
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 3e-13
Identities = 46/171 (26%), Positives = 87/171 (50%), Gaps = 30/171 (17%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNF-ARDI 208
+L + H +IR G +++ ++ +YI GG L LL+ + P P F A ++
Sbjct: 59 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---VAKFYAAEV 115
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
+ YLHS ++I+RDL +N L+ ++ + + DFG A+ + T
Sbjct: 116 CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VT---------- 160
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
YT+ G P ++APE+++ + Y++++D +S+GI++ E + G P
Sbjct: 161 ---------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 27/150 (18%)
Query: 172 KLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQN 229
+L V EY+ GG L +Q G+ P F A +IA G+ +L S +I+RDL N
Sbjct: 416 RLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAAEIAIGLFFLQSKGIIYRDLKLDN 472
Query: 230 CLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAP 289
++ + + +ADFG+ K G K T G P ++AP
Sbjct: 473 VMLDSEGHIKIADFGMC-------------------KENIWDGVTTK--TFCGTPDYIAP 511
Query: 290 EMMTGQEYDETVDVFSYGIVLCE-IIGRVP 318
E++ Q Y ++VD +++G++L E + G+ P
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1b8t_A Protein (CRP1); LIM domain, muscle differentiation, contractIle; NMR {Gallus gallus} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 g.39.1.3 PDB: 1ibi_A 1qli_A 1cxx_A 1ctl_A 2o13_A Length = 192 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 4e-13
Identities = 22/131 (16%), Positives = 37/131 (28%), Gaps = 22/131 (16%)
Query: 21 CRSSLIFTSGCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQNCGQ-MMSGPVMVVGD 79
+L G S + + + C CGQ + + ++
Sbjct: 76 GAGTLSTDKGESLGIKYEEGQSHRPTNPNASRMAQKVGGSDGCPRCGQAVYAAEKVIGAG 135
Query: 80 HKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVMLDNWYFEKDGLLFCKEDYNGKY 139
+H CF+C C + +KDG ++CK Y +
Sbjct: 136 KSWHKSCFRCAKCGKSLESTT---------------------LADKDGEIYCKGCYAKNF 174
Query: 140 GEACQNCGQVA 150
G GQ A
Sbjct: 175 GPKGFGFGQGA 185
|
| >1b8t_A Protein (CRP1); LIM domain, muscle differentiation, contractIle; NMR {Gallus gallus} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 g.39.1.3 PDB: 1ibi_A 1qli_A 1cxx_A 1ctl_A 2o13_A Length = 192 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 9e-06
Identities = 16/90 (17%), Positives = 23/90 (25%), Gaps = 22/90 (24%)
Query: 60 GEACQNCGQM-MSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVML 118
G+ C C + + FH CF C C +
Sbjct: 7 GKKCGVCQKAVYFAEEVQCEGSSFHKSCFLCMVCKKNLDSTT------------------ 48
Query: 119 DNWYFEKDGLLFCKEDYNGKYGEACQNCGQ 148
++CK Y KYG + G
Sbjct: 49 ---VAVHGDEIYCKSCYGKKYGPKGKGKGM 75
|
| >2cuq_A Four and A half LIM domains 3; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 80 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-13
Identities = 13/95 (13%), Positives = 26/95 (27%), Gaps = 21/95 (22%)
Query: 49 LFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERS 108
Y K+ C C + ++ + D +H EC CT C + +
Sbjct: 4 GSSGPCYENKFAPRCARCSKTLTQGGVTYRDQPWHRECLVCTGCQTPLAGQQ-------- 55
Query: 109 ILCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEAC 143
+ +D +C + +
Sbjct: 56 -------------FTSRDEDPYCVACFGELFASGP 77
|
| >1x62_A C-terminal LIM domain protein 1; PDZ and LIM domain protein 1, LIM domain protein CLP-36, contractIle protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 79 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 7e-13
Identities = 15/90 (16%), Positives = 28/90 (31%), Gaps = 21/90 (23%)
Query: 54 DYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSA 113
N + C CG + G + + D HPEC+ CT C +
Sbjct: 9 IGNAQKLPMCDKCGTGIVGVFVKLRDRHRHPECYVCTDCGTNLKQK-------------- 54
Query: 114 CDVMLDNWYFEKDGLLFCKEDYNGKYGEAC 143
+F + ++C++ +
Sbjct: 55 -------GHFFVEDQIYCEKHARERVSGPS 77
|
| >1x62_A C-terminal LIM domain protein 1; PDZ and LIM domain protein 1, LIM domain protein CLP-36, contractIle protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 79 | Back alignment and structure |
|---|
Score = 38.6 bits (90), Expect = 3e-04
Identities = 5/34 (14%), Positives = 13/34 (38%), Gaps = 1/34 (2%)
Query: 31 CSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEAC 63
C+ C L +F + ++C++ +
Sbjct: 44 CTDCGTNLKQKGHFFVEDQIYCEKHARERVSGPS 77
|
| >1x64_A Alpha-actinin-2 associated LIM protein; LIM domain, PDZ and LIM domain 3, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 Length = 89 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-12
Identities = 18/89 (20%), Positives = 28/89 (31%), Gaps = 21/89 (23%)
Query: 55 YNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSAC 114
+ + C CG + G V+ D HPECF C C+ +
Sbjct: 20 GSAQRMPLCDKCGSGIVGAVVKARDKYRHPECFVCADCNLNLKQK--------------- 64
Query: 115 DVMLDNWYFEKDGLLFCKEDYNGKYGEAC 143
YF +G L+C+ +
Sbjct: 65 ------GYFFVEGELYCETHARARTSGPS 87
|
| >1x64_A Alpha-actinin-2 associated LIM protein; LIM domain, PDZ and LIM domain 3, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 Length = 89 | Back alignment and structure |
|---|
Score = 37.5 bits (87), Expect = 8e-04
Identities = 8/34 (23%), Positives = 15/34 (44%), Gaps = 1/34 (2%)
Query: 31 CSACDVML-DNWYFEKDGLLFCKEDYNGKYGEAC 63
C+ C++ L YF +G L+C+ +
Sbjct: 54 CADCNLNLKQKGYFFVEGELYCETHARARTSGPS 87
|
| >2dj7_A Actin-binding LIM protein 3; LIM domain, Zn binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 80 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 2e-12
Identities = 20/91 (21%), Positives = 34/91 (37%), Gaps = 23/91 (25%)
Query: 54 DYNGKYGEACQNCGQM-MSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCS 112
+ C C + G ++ D ++H CFKC +CS
Sbjct: 9 PIKIRGPSHCAGCKEEIKHGQSLLALDKQWHVSCFKCQTCSV------------------ 50
Query: 113 ACDVMLDNWYFEKDGLLFCKEDYNGKYGEAC 143
+L Y KDG+ +C+ DY+ ++G
Sbjct: 51 ----ILTGEYISKDGVPYCESDYHAQFGSGP 77
|
| >2dj7_A Actin-binding LIM protein 3; LIM domain, Zn binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 80 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 4e-08
Identities = 12/33 (36%), Positives = 19/33 (57%)
Query: 31 CSACDVMLDNWYFEKDGLLFCKEDYNGKYGEAC 63
C C V+L Y KDG+ +C+ DY+ ++G
Sbjct: 45 CQTCSVILTGEYISKDGVPYCESDYHAQFGSGP 77
|
| >2d8x_A Protein pinch; LIM domain, pinch protein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 70 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-12
Identities = 17/85 (20%), Positives = 31/85 (36%), Gaps = 22/85 (25%)
Query: 63 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVMLDNWY 122
C CG+ + G V+ ++ +HPECF+C C + D +
Sbjct: 8 CHQCGEFIIGRVIKAMNNSWHPECFRCDLCQEVLADIG---------------------F 46
Query: 123 FEKDGLLFCKEDYNGKYGEACQNCG 147
+ G C+ +N + + G
Sbjct: 47 VKNAGRHLCRPCHNREKASGP-SSG 70
|
| >2ehe_A Four and A half LIM domains 3; FHL-3, skeletal muscle LIM- protein 2, SLIM 2, FHL3, SLIM2, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 82 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 3e-12
Identities = 16/96 (16%), Positives = 25/96 (26%), Gaps = 23/96 (23%)
Query: 50 FCKEDYNGKYGEACQNCGQ--MMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVER 107
Y+ + C C Q + D FH CF+C C + D
Sbjct: 5 SSGPCYDNTFANTCAECQQLIGHDSRELFYEDRHFHEGCFRCCRCQRSLADEP------- 57
Query: 108 SILCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEAC 143
+ +D L C + Y +
Sbjct: 58 --------------FTCQDSELLCNDCYCSAFSSGP 79
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 6e-12
Identities = 28/111 (25%), Positives = 49/111 (44%), Gaps = 11/111 (9%)
Query: 149 VAVLRSLHHH-NVIRFIGV----LYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQR-- 201
V + +++R + V + L +V E + GG L +QD G + +R
Sbjct: 61 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREA 119
Query: 202 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARII 249
+ I + YLHS+N+ HRD+ +N L + + + DFG A+
Sbjct: 120 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170
|
| >1x63_A Skeletal muscle LIM-protein 1; LIM domain, four and A half LIM domains protein 1, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 82 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 7e-12
Identities = 14/99 (14%), Positives = 28/99 (28%), Gaps = 23/99 (23%)
Query: 47 GLLFCKEDYNGKYGEACQNCGQ--MMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYAL 104
+ + C+ C + + + +H +CF C++C IG G
Sbjct: 2 SSGSSGKCTTREDSPKCKGCFKAIVAGDQNVEYKGTVWHKDCFTCSNCKQVIGTGS---- 57
Query: 105 VERSILCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEAC 143
+F K +C + K+
Sbjct: 58 -----------------FFPKGEDFYCVTCHETKFASGP 79
|
| >2d8z_A Four and A half LIM domains 2; skeletal muscle LIM-protein 3, LIM-domain protein DRAL, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 70 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-11
Identities = 12/86 (13%), Positives = 24/86 (27%), Gaps = 21/86 (24%)
Query: 58 KYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117
C C + ++ + + +H ECF CT+C +
Sbjct: 3 SGSSGCVQCKKPITTGGVTYREQPWHKECFVCTACRKQLSGQR----------------- 45
Query: 118 LDNWYFEKDGLLFCKEDYNGKYGEAC 143
+ +D +C + Y
Sbjct: 46 ----FTARDDFAYCLNCFCDLYASGP 67
|
| >2l4z_A DNA endonuclease RBBP8, LIM domain transcription LMO4; protein-protein interaction, LIM-interaction DOM LMO4, RBBP8/CTIP, LIM-only protein; HET: DNA; NMR {Homo sapiens} Length = 123 | Back alignment and structure |
|---|
Score = 60.1 bits (145), Expect = 2e-11
Identities = 21/115 (18%), Positives = 37/115 (32%), Gaps = 20/115 (17%)
Query: 27 FTSGCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQNCGQ-MMSGPVMVVGDHKFHPE 85
+ + D + G G + C CG + ++ D +H
Sbjct: 28 YKMDVTVIDTKDGSQSKLGGGGSGGHMGSGGLSWKRCAGCGGKIADRFLLYAMDSYWHSR 87
Query: 86 CFKCTSCSCCIGDGESYALVERSILCSACDVMLDNWYFEKDGLLFCKEDYNGKYG 140
C KC+SC +GD + + K G++ C+ DY +G
Sbjct: 88 CLKCSSCQAQLGDIGT-------------------SSYTKSGMILCRNDYIRLFG 123
|
| >1nyp_A Pinch protein; LIM domain, protein recognition, cell adhesion; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 PDB: 1u5s_B Length = 66 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-11
Identities = 16/79 (20%), Positives = 28/79 (35%), Gaps = 21/79 (26%)
Query: 63 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVMLDNWY 122
C C + + G V+ ++H E F C C +
Sbjct: 8 CGACRRPIEGRVVNAMGKQWHVEHFVCAKCEKPFLGH---------------------RH 46
Query: 123 FEKDGLLFCKEDYNGKYGE 141
+E+ GL +C+ YN +G+
Sbjct: 47 YERKGLAYCETHYNQLFGD 65
|
| >1nyp_A Pinch protein; LIM domain, protein recognition, cell adhesion; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 PDB: 1u5s_B Length = 66 | Back alignment and structure |
|---|
Score = 38.0 bits (89), Expect = 3e-04
Identities = 9/32 (28%), Positives = 18/32 (56%), Gaps = 1/32 (3%)
Query: 31 CSACDVMLDN-WYFEKDGLLFCKEDYNGKYGE 61
C+ C+ ++E+ GL +C+ YN +G+
Sbjct: 34 CAKCEKPFLGHRHYERKGLAYCETHYNQLFGD 65
|
| >2egq_A FHL1 protein; LIM domain, four and A half LIM domains protein 1, skeletal muscle LIM- protein 1, SLIM 1, structural genomics NPPSFA; NMR {Homo sapiens} Length = 77 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 4e-11
Identities = 13/73 (17%), Positives = 24/73 (32%), Gaps = 6/73 (8%)
Query: 47 GLLFCKEDYNGKYGEACQNCGQMMSGP-----VMVVGDHKFHPECFKCTSCSCCIGDGES 101
+ Y + C C ++G V+ +H CF C CS + +
Sbjct: 2 SSGSSGDCYKNFVAKKCAGCKNPITGFGKGSSVVAYEGQSWHDYCFHCKKCSVNLA-NKR 60
Query: 102 YALVERSILCSAC 114
+ + + C C
Sbjct: 61 FVFHQEQVYCPDC 73
|
| >2cur_A Skeletal muscle LIM-protein 1; four and A half LIM domains protein 1, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 69 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 9e-11
Identities = 11/82 (13%), Positives = 23/82 (28%), Gaps = 21/82 (25%)
Query: 63 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVMLDNWY 122
C C + ++ + D +H +CF C +CS + +
Sbjct: 8 CVKCNKAITSGGITYQDQPWHADCFVCVTCSKKLAGQR---------------------F 46
Query: 123 FEKDGLLFCKEDYNGKYGEACQ 144
+ +C + Y
Sbjct: 47 TAVEDQYYCVDCYKNFVSGPSS 68
|
| >1a7i_A QCRP2 (LIM1); LIM domain containing proteins, metal-binding protein, zinc finger; NMR {Coturnix japonica} SCOP: g.39.1.3 g.39.1.3 PDB: 2o10_A Length = 81 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-10
Identities = 19/90 (21%), Positives = 24/90 (26%), Gaps = 22/90 (24%)
Query: 60 GEACQNCGQM-MSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVML 118
G C CG+ + FH CF C C +
Sbjct: 7 GNKCGACGRTVYHAEEVQCDGRSFHRCCFLCMVCRKNLDSTT------------------ 48
Query: 119 DNWYFEKDGLLFCKEDYNGKYGEACQNCGQ 148
D ++CK Y KYG GQ
Sbjct: 49 ---VAIHDAEVYCKSCYGKKYGPKGYGYGQ 75
|
| >1a7i_A QCRP2 (LIM1); LIM domain containing proteins, metal-binding protein, zinc finger; NMR {Coturnix japonica} SCOP: g.39.1.3 g.39.1.3 PDB: 2o10_A Length = 81 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 7e-05
Identities = 13/39 (33%), Positives = 16/39 (41%), Gaps = 1/39 (2%)
Query: 31 CSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQNCGQ 68
C C LD+ D ++CK Y KYG GQ
Sbjct: 37 CMVCRKNLDSTTVAIHDAEVYCKSCYGKKYGPKGYGYGQ 75
|
| >1wyh_A SLIM 2, skeletal muscle LIM-protein 2; structural genomics, riken structural genomics/proteomics initiative, RSGI, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 72 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-10
Identities = 15/88 (17%), Positives = 23/88 (26%), Gaps = 23/88 (26%)
Query: 58 KYGEACQNCGQ--MMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACD 115
C CG+ M + G +H CF C+ C +G
Sbjct: 3 SGSSGCSACGETVMPGSRKLEYGGQTWHEHCFLCSGCEQPLGSRS--------------- 47
Query: 116 VMLDNWYFEKDGLLFCKEDYNGKYGEAC 143
+ G +C Y K+
Sbjct: 48 ------FVPDKGAHYCVPCYENKFASGP 69
|
| >1wyh_A SLIM 2, skeletal muscle LIM-protein 2; structural genomics, riken structural genomics/proteomics initiative, RSGI, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 72 | Back alignment and structure |
|---|
Score = 37.4 bits (87), Expect = 5e-04
Identities = 8/34 (23%), Positives = 13/34 (38%), Gaps = 1/34 (2%)
Query: 31 CSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEAC 63
CS C+ L + + G +C Y K+
Sbjct: 36 CSGCEQPLGSRSFVPDKGAHYCVPCYENKFASGP 69
|
| >1m3v_A FLIN4, fusion of the LIM interacting domain of LDB1 and the N-terminal LIM domain of LMO4...; fusion protein, LMO proteins, metal binding protein; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 Length = 122 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 5e-10
Identities = 18/100 (18%), Positives = 33/100 (33%), Gaps = 20/100 (20%)
Query: 60 GEACQNCGQ-MMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVML 118
+ C CG + ++ D +H C KC+SC +GD +
Sbjct: 5 WKRCAGCGGKIADRFLLYAMDSYWHSRCLKCSSCQAQLGDIGT----------------- 47
Query: 119 DNWYFEKDGLLFCKEDYNGKYGEACQNCGQVAVLRSLHHH 158
+ K G++ C+ DY +G + +
Sbjct: 48 --SSYTKSGMILCRNDYIRLFGNSGAGGSGGHMGSGGDVM 85
|
| >1m3v_A FLIN4, fusion of the LIM interacting domain of LDB1 and the N-terminal LIM domain of LMO4...; fusion protein, LMO proteins, metal binding protein; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 Length = 122 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 1e-06
Identities = 12/92 (13%), Positives = 25/92 (27%), Gaps = 15/92 (16%)
Query: 31 CSACDVMLDNW---YFEKDGLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECF 87
CS+C L + + K G++ C+ DY +G +
Sbjct: 35 CSSCQAQLGDIGTSSYTKSGMILCRNDYIRLFGNSGAGGSG------------GHMGSGG 82
Query: 88 KCTSCSCCIGDGESYALVERSILCSACDVMLD 119
G + + ++ + D
Sbjct: 83 DVMVVGEPTLMGGEFGDEDERLITRLENTQFD 114
|
| >3f6q_B LIM and senescent cell antigen-like-containing domain protein 1; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 2kbx_B 3ixe_B Length = 72 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-10
Identities = 13/89 (14%), Positives = 28/89 (31%), Gaps = 23/89 (25%)
Query: 54 DYNGKYGEACQNCGQ--MMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILC 111
+ G C+ C + ++ +H +CF C C +G
Sbjct: 5 YFQGSASATCERCKGGFAPAEKIVNSNGELYHEQCFVCAQCFQQFPEGL----------- 53
Query: 112 SACDVMLDNWYFEKDGLLFCKEDYNGKYG 140
++E +G +C+ D+ +
Sbjct: 54 ----------FYEFEGRKYCEHDFQMLFA 72
|
| >1g47_A Pinch protein; LIM domain, Zn finger, cell adhesion; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 77 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-10
Identities = 13/92 (14%), Positives = 28/92 (30%), Gaps = 23/92 (25%)
Query: 51 CKEDYNGKYGEACQNCGQ--MMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERS 108
+ N C+ C + ++ +H +CF C C +G
Sbjct: 2 SEFMANALASATCERCKGGFAPAEKIVNSNGELYHEQCFVCAQCFQQFPEGL-------- 53
Query: 109 ILCSACDVMLDNWYFEKDGLLFCKEDYNGKYG 140
++E +G +C+ D+ +
Sbjct: 54 -------------FYEFEGRKYCEHDFQMLFA 72
|
| >1x4k_A Skeletal muscle LIM-protein 3; LIM domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 72 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 8e-10
Identities = 17/88 (19%), Positives = 22/88 (25%), Gaps = 23/88 (26%)
Query: 58 KYGEACQNCGQ--MMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACD 115
CQ C + M M +H CF C C IG
Sbjct: 3 SGSSGCQECKKTIMPGTRKMEYKGSSWHETCFICHRCQQPIGTKS--------------- 47
Query: 116 VMLDNWYFEKDGLLFCKEDYNGKYGEAC 143
+ KD FC Y ++
Sbjct: 48 ------FIPKDNQNFCVPCYEKQHASGP 69
|
| >1j2o_A FLIN2, fusion of rhombotin-2 and LIM domain-binding protein 1; LIM-interaction-domain (LID), metal binding protein; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 Length = 114 | Back alignment and structure |
|---|
Score = 54.3 bits (130), Expect = 2e-09
Identities = 17/91 (18%), Positives = 26/91 (28%), Gaps = 20/91 (21%)
Query: 63 CQNCGQ-MMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVMLDNW 121
C C Q + + D +H +C C C C +G+
Sbjct: 6 CGGCQQNIGDRYFLKAIDQYWHEDCLSCDLCGCRLGEVGR-------------------R 46
Query: 122 YFEKDGLLFCKEDYNGKYGEACQNCGQVAVL 152
+ K G C+ DY G V+
Sbjct: 47 LYYKLGRKLCRRDYLRLGGSGGHMGSGGDVM 77
|
| >1j2o_A FLIN2, fusion of rhombotin-2 and LIM domain-binding protein 1; LIM-interaction-domain (LID), metal binding protein; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 Length = 114 | Back alignment and structure |
|---|
Score = 51.6 bits (123), Expect = 1e-08
Identities = 12/71 (16%), Positives = 18/71 (25%), Gaps = 7/71 (9%)
Query: 31 CSACDVMLDN---WYFEKDGLLFCKEDYNGKYGEACQNCGQMM----SGPVMVVGDHKFH 83
C C L + K G C+ DY G P ++ G+
Sbjct: 33 CDLCGCRLGEVGRRLYYKLGRKLCRRDYLRLGGSGGHMGSGGDVMVVGEPTLMGGEFGDE 92
Query: 84 PECFKCTSCSC 94
E +
Sbjct: 93 DERLITRLENT 103
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 39/174 (22%), Positives = 71/174 (40%), Gaps = 34/174 (19%)
Query: 149 VAVLRSL------HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL-QDPGQPLPWGQR 201
+ +L L + NVI + + + E + L EL+ ++ Q
Sbjct: 144 IRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLV 202
Query: 202 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE-DKTVV-VADFGLARIIHQGPRAPTTV 259
FA I + LH +IH DL +N L+++ ++ + V DFG + HQ
Sbjct: 203 RKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-------- 254
Query: 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI 313
+ YT + + ++ APE++ G Y +D++S G +L E+
Sbjct: 255 ----------------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >1x61_A Thyroid receptor interacting protein 6; LIM domain, OPA-interacting protein 1, zyxin related protein 1 (ZRP-1), structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 72 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-08
Identities = 16/87 (18%), Positives = 28/87 (32%), Gaps = 24/87 (27%)
Query: 63 CQNCGQMMSGPVMVVG--DHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVMLDN 120
C CG+ + G V D FH CF C++C +
Sbjct: 8 CGGCGEDVVGDGAGVVALDRVFHVGCFVCSTCRAQLRGQH-------------------- 47
Query: 121 WYFEKDGLLFCKEDYNGKYGEACQNCG 147
++ + +C+ Y E+ + G
Sbjct: 48 -FYAVERRAYCEGCYVATL-ESGPSSG 72
|
| >1x4l_A Skeletal muscle LIM-protein 3; LIM domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 72 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-08
Identities = 12/90 (13%), Positives = 24/90 (26%), Gaps = 25/90 (27%)
Query: 58 KYGEACQNCGQMMSGP----VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSA 113
C C +SG + + ++H +CF C CS +
Sbjct: 3 SGSSGCAGCTNPISGLGGTKYISFEERQWHNDCFNCKKCSLSLVGRG------------- 49
Query: 114 CDVMLDNWYFEKDGLLFCKEDYNGKYGEAC 143
+ + + C + G +
Sbjct: 50 --------FLTERDDILCPDCGKDISGPSS 71
|
| >2cor_A Pinch protein; LIM domain, particularly interesting NEW Cys- His protein, LIM and senescent cell antigen-like domains 1, structural genomics; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 79 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 4e-08
Identities = 13/74 (17%), Positives = 24/74 (32%), Gaps = 22/74 (29%)
Query: 63 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVMLDNWY 122
CQ C ++ ++ + +HP+ F C +C L
Sbjct: 18 CQKCHAIIDEQPLIFKNDPYHPDHFNCANCGK----------------------ELTADA 55
Query: 123 FEKDGLLFCKEDYN 136
E G L+C ++
Sbjct: 56 RELKGELYCLPCHD 69
|
| >1x68_A FHL5 protein; four-and-A-half LIM protein 5, zinc finger domain, AN actin- interacting protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 76 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 5e-08
Identities = 16/61 (26%), Positives = 25/61 (40%), Gaps = 5/61 (8%)
Query: 58 KYGEACQNCGQMMSGP----VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSA 113
C C + +SG + D ++H ECF C CS + G+ + + I C
Sbjct: 3 SGSSGCVACSKPISGLTGAKFICFQDSQWHSECFNCGKCSVSLV-GKGFLTQNKEIFCQK 61
Query: 114 C 114
C
Sbjct: 62 C 62
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 25/148 (16%), Positives = 54/148 (36%), Gaps = 33/148 (22%)
Query: 175 LVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNSQNCLV 232
+V E + G L L++ + +P ++ + G+ Y+H +IH D+ +N L+
Sbjct: 107 MVFE-VLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM 165
Query: 233 RE------DKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYW 286
+ +AD G A + + +
Sbjct: 166 EIVDSPENLIQIKIADLGNACWYDE------------------------HYTNSIQTREY 201
Query: 287 MAPEMMTGQEYDETVDVFSYGIVLCEII 314
+PE++ G + D++S ++ E+I
Sbjct: 202 RSPEVLLGAPWGCGADIWSTACLIFELI 229
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 34/175 (19%), Positives = 71/175 (40%), Gaps = 36/175 (20%)
Query: 149 VAVLRSL------HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQR 201
V +L + + ++ L LV E + L +LL++ + +
Sbjct: 101 VRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLT 159
Query: 202 VNFARDIAAGMTYLHS--MNLIHRDLNSQNCLVREDK--TVVVADFGLARIIHQGPRAPT 257
FA+ + + +L + +++IH DL +N L+ K + + DFG + + Q
Sbjct: 160 RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ------ 213
Query: 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE 312
+ Y + + ++ +PE++ G YD +D++S G +L E
Sbjct: 214 ------------------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >1iml_A CRIP, cysteine rich intestinal protein; metal-binding protein, LIM domain protein; NMR {Rattus rattus} SCOP: g.39.1.3 g.39.1.3 Length = 76 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-07
Identities = 14/87 (16%), Positives = 23/87 (26%), Gaps = 23/87 (26%)
Query: 63 CQNCGQM-MSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVMLDNW 121
C C + + +H C KC C + G
Sbjct: 3 CPKCDKEVYFAERVTSLGKDWHRPCLKCEKCGKTLTSG---------------------G 41
Query: 122 YFEKDGLLFCKED-YNGKYGEACQNCG 147
+ E +G +C Y+ +G G
Sbjct: 42 HAEHEGKPYCNHPCYSAMFGPKGFGRG 68
|
| >2d8y_A Eplin protein; LIM domain, epithelial protein LOST in neoplasm, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 91 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 2e-06
Identities = 16/94 (17%), Positives = 27/94 (28%), Gaps = 30/94 (31%)
Query: 60 GEACQNCGQMMSGPV-----MVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSAC 114
E C C + V ++ FH CF+C+ C+ + G
Sbjct: 15 RETCVECQK----TVYPMERLLANQQVFHISCFRCSYCNNKLSLGT-------------- 56
Query: 115 DVMLDNWYFEKDGLLFCKEDYNGKYGEACQNCGQ 148
Y G ++CK +N +
Sbjct: 57 -------YASLHGRIYCKPHFNQLFKSKGNYDEG 83
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 5e-06
Identities = 17/81 (20%), Positives = 32/81 (39%), Gaps = 3/81 (3%)
Query: 168 YKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLH-SMNLIHRDLN 226
+KD +L +V E+ GG L Q + + + A + S+ HRDL+
Sbjct: 132 FKDDQLFIVLEFEFGGID--LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLH 189
Query: 227 SQNCLVREDKTVVVADFGLAR 247
N L+++ + +
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGK 210
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 26/169 (15%), Positives = 55/169 (32%), Gaps = 30/169 (17%)
Query: 175 LVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCLV 232
+V E + G L + + Q LP + + G+ YLH+ +IH D+ +N L+
Sbjct: 122 MVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILL 180
Query: 233 REDKTVVVADFGLARIIHQGPRAPTT--------------------------VMAKVPRK 266
++ + A + P + + K+
Sbjct: 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADL 240
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG 315
+ + Y + E++ G Y+ D++S + E+
Sbjct: 241 GNACWVHKHFTEDIQTRQY-RSLEVLIGSGYNTPADIWSTACMAFELAT 288
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 31/178 (17%), Positives = 60/178 (33%), Gaps = 27/178 (15%)
Query: 149 VAVLRSLHH------HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQR 201
+ VL+ + + + + E + G E L++ QP P
Sbjct: 67 INVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHV 125
Query: 202 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA 261
+ A + + +LH L H DL +N L + + +
Sbjct: 126 RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL------------YNEHKSCEE 173
Query: 262 KVPRKAAQRR---G----ARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE 312
K + + R G + T+V ++ PE++ + + DV+S G +L E
Sbjct: 174 KSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 31/177 (17%), Positives = 69/177 (38%), Gaps = 20/177 (11%)
Query: 149 VAVLRSL-----HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRV 202
+L+ + +++N++++ G + L+ E G +L E++
Sbjct: 82 ADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIK 140
Query: 203 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAK 262
+ +I + YL M+L H DL +N L+ + F + I + +
Sbjct: 141 LYCIEILKALNYLRKMSLTHTDLKPENILLDDP------YFEKSLITVRRVTDGKKIQIY 194
Query: 263 VPRKAAQRR---G----ARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE 312
+ + G +++ + APE++ +D + D++S+G VL E
Sbjct: 195 RTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >2cu8_A Cysteine-rich protein 2; CRP2, CRIP2, ESP1 protein, zinc-binding, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 76 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-05
Identities = 14/77 (18%), Positives = 20/77 (25%), Gaps = 22/77 (28%)
Query: 60 GEACQNCGQM-MSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVML 118
C C + + +H C KC CS + G
Sbjct: 9 ASKCPKCDKTVYFAEKVSSLGKDWHKFCLKCERCSKTLTPGG------------------ 50
Query: 119 DNWYFEKDGLLFCKEDY 135
+ E DG FC +
Sbjct: 51 ---HAEHDGKPFCHKPC 64
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 9e-05
Identities = 34/190 (17%), Positives = 60/190 (31%), Gaps = 51/190 (26%)
Query: 149 VAVLRSL------HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQR 201
+ VL L ++ + + +V E + G + + +++ G P
Sbjct: 62 IQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHI 120
Query: 202 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVA-------------------D 242
A I + +LHS L H DL +N L + D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 243 FGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVD 302
FG A + T+V ++ APE++ + + D
Sbjct: 181 FGSATYDDE------------------------HHSTLVSTRHYRAPEVILALGWSQPCD 216
Query: 303 VFSYGIVLCE 312
V+S G +L E
Sbjct: 217 VWSIGCILIE 226
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 20/74 (27%), Positives = 37/74 (50%), Gaps = 11/74 (14%)
Query: 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 234
++ YI G K++++D ++ A I + LH ++IH DL + N + +
Sbjct: 416 IMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK 466
Query: 235 DKTVVVADFGLARI 248
D + + DFGL +I
Sbjct: 467 D--LYIIDFGLGKI 478
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 10/39 (25%), Positives = 20/39 (51%), Gaps = 5/39 (12%)
Query: 214 YLHSMNLIHRDLNSQNCLV-----REDKTVVVADFGLAR 247
+H +L++RD+ N L+ + + V DFG+ +
Sbjct: 121 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 21/76 (27%), Positives = 38/76 (50%), Gaps = 4/76 (5%)
Query: 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV-- 232
LV + + G +L++L + L + A + + ++HS + +HRD+ N L+
Sbjct: 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 138
Query: 233 -REDKTVVVADFGLAR 247
R V + DFGLA+
Sbjct: 139 GRRANQVYIIDFGLAK 154
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 11/36 (30%), Positives = 19/36 (52%), Gaps = 2/36 (5%)
Query: 214 YLHSMNLIHRDLNSQNCLV--REDKTVVVADFGLAR 247
Y+H +H D+ + N L+ + V + D+GLA
Sbjct: 167 YIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 11/36 (30%), Positives = 20/36 (55%), Gaps = 2/36 (5%)
Query: 214 YLHSMNLIHRDLNSQNCLV--REDKTVVVADFGLAR 247
Y+H +H D+ + N L+ + V +AD+GL+
Sbjct: 166 YIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 14/39 (35%), Positives = 24/39 (61%), Gaps = 5/39 (12%)
Query: 214 YLHSMNLIHRDLNSQNCLV-----REDKTVVVADFGLAR 247
Y+HS NLI+RD+ +N L+ + + + + DF LA+
Sbjct: 120 YVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 11/36 (30%), Positives = 21/36 (58%), Gaps = 2/36 (5%)
Query: 214 YLHSMNLIHRDLNSQNCLV-REDKTVV-VADFGLAR 247
+LH +H ++ ++N V ED++ V +A +G A
Sbjct: 174 FLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 16/37 (43%), Positives = 23/37 (62%), Gaps = 3/37 (8%)
Query: 214 YLHSMNLIHRDLNSQNCLV---REDKTVVVADFGLAR 247
Y+HS N IHRD+ N L+ ++ V + DFGLA+
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 433 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 2xqn_T | 126 | Testin, TESS; metal-binding protein, cytoskeleton, | 99.92 | |
| 2xjy_A | 131 | Rhombotin-2; oncoprotein, T-cell leukemia, proto-o | 99.91 | |
| 2rgt_A | 169 | Fusion of LIM/homeobox protein LHX3, linker, INSU | 99.91 | |
| 2jtn_A | 182 | LIM domain-binding protein 1, LIM/homeobox protein | 99.91 | |
| 1rut_X | 188 | Flinc4, fusion protein of LMO4 protein and LIM dom | 99.9 | |
| 2cup_A | 101 | Skeletal muscle LIM-protein 1; four and half LIM d | 99.9 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1b8t_A | 192 | Protein (CRP1); LIM domain, muscle differentiation | 99.88 | |
| 1m3v_A | 122 | FLIN4, fusion of the LIM interacting domain of LDB | 99.78 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.75 | |
| 1j2o_A | 114 | FLIN2, fusion of rhombotin-2 and LIM domain-bindin | 99.74 | |
| 1iml_A | 76 | CRIP, cysteine rich intestinal protein; metal-bind | 99.64 | |
| 1x68_A | 76 | FHL5 protein; four-and-A-half LIM protein 5, zinc | 99.64 | |
| 2dj7_A | 80 | Actin-binding LIM protein 3; LIM domain, Zn bindin | 99.63 | |
| 1a7i_A | 81 | QCRP2 (LIM1); LIM domain containing proteins, meta | 99.63 | |
| 2egq_A | 77 | FHL1 protein; LIM domain, four and A half LIM doma | 99.62 | |
| 2ehe_A | 82 | Four and A half LIM domains 3; FHL-3, skeletal mus | 99.61 | |
| 1x6a_A | 81 | LIMK-2, LIM domain kinase 2; LIM-kinase 2, zinc fi | 99.61 | |
| 1wyh_A | 72 | SLIM 2, skeletal muscle LIM-protein 2; structural | 99.59 | |
| 1v6g_A | 81 | Actin binding LIM protein 2; LIM domain, zinc bind | 99.59 | |
| 2cuq_A | 80 | Four and A half LIM domains 3; structural genomics | 99.58 | |
| 2cur_A | 69 | Skeletal muscle LIM-protein 1; four and A half LIM | 99.58 | |
| 2dar_A | 90 | PDZ and LIM domain protein 5; enigma homolog prote | 99.58 | |
| 1x4k_A | 72 | Skeletal muscle LIM-protein 3; LIM domain, structu | 99.58 | |
| 1x4l_A | 72 | Skeletal muscle LIM-protein 3; LIM domain, structu | 99.57 | |
| 1x3h_A | 80 | Leupaxin; paxillin family, protein-protein interac | 99.57 | |
| 1g47_A | 77 | Pinch protein; LIM domain, Zn finger, cell adhesio | 99.57 | |
| 2cu8_A | 76 | Cysteine-rich protein 2; CRP2, CRIP2, ESP1 protein | 99.57 | |
| 2ehe_A | 82 | Four and A half LIM domains 3; FHL-3, skeletal mus | 99.56 | |
| 2d8z_A | 70 | Four and A half LIM domains 2; skeletal muscle LIM | 99.55 | |
| 1nyp_A | 66 | Pinch protein; LIM domain, protein recognition, ce | 99.55 | |
| 2cor_A | 79 | Pinch protein; LIM domain, particularly interestin | 99.54 | |
| 1x63_A | 82 | Skeletal muscle LIM-protein 1; LIM domain, four an | 99.53 | |
| 2dlo_A | 81 | Thyroid receptor-interacting protein 6; LIM domain | 99.52 | |
| 1x64_A | 89 | Alpha-actinin-2 associated LIM protein; LIM domain | 99.51 | |
| 2dlo_A | 81 | Thyroid receptor-interacting protein 6; LIM domain | 99.51 | |
| 1x63_A | 82 | Skeletal muscle LIM-protein 1; LIM domain, four an | 99.51 | |
| 2d8x_A | 70 | Protein pinch; LIM domain, pinch protein, structur | 99.51 | |
| 1x3h_A | 80 | Leupaxin; paxillin family, protein-protein interac | 99.5 | |
| 1x62_A | 79 | C-terminal LIM domain protein 1; PDZ and LIM domai | 99.5 | |
| 1x61_A | 72 | Thyroid receptor interacting protein 6; LIM domain | 99.5 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.49 | |
| 2cuq_A | 80 | Four and A half LIM domains 3; structural genomics | 99.49 | |
| 2d8y_A | 91 | Eplin protein; LIM domain, epithelial protein LOST | 99.49 | |
| 2l3k_A | 123 | Rhombotin-2, linker, LIM domain-binding protein 1; | 99.47 | |
| 1wig_A | 73 | KIAA1808 protein; LIM domain, zinc finger, metal-b | 99.45 | |
| 2co8_A | 82 | NEDD9 interacting protein with calponin homology a | 99.45 | |
| 1b8t_A | 192 | Protein (CRP1); LIM domain, muscle differentiation | 99.44 | |
| 3f6q_B | 72 | LIM and senescent cell antigen-like-containing dom | 99.42 | |
| 2iyb_E | 65 | Testin, TESS, TES; LIM domain, SH3-binding, tumour | 99.4 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.39 | |
| 2l4z_A | 123 | DNA endonuclease RBBP8, LIM domain transcription L | 99.39 | |
| 1x6a_A | 81 | LIMK-2, LIM domain kinase 2; LIM-kinase 2, zinc fi | 99.39 | |
| 1wig_A | 73 | KIAA1808 protein; LIM domain, zinc finger, metal-b | 99.33 | |
| 2egq_A | 77 | FHL1 protein; LIM domain, four and A half LIM doma | 99.33 | |
| 1rut_X | 188 | Flinc4, fusion protein of LMO4 protein and LIM dom | 99.21 | |
| 1x68_A | 76 | FHL5 protein; four-and-A-half LIM protein 5, zinc | 99.19 | |
| 2dar_A | 90 | PDZ and LIM domain protein 5; enigma homolog prote | 99.17 | |
| 1nyp_A | 66 | Pinch protein; LIM domain, protein recognition, ce | 99.17 | |
| 2iyb_E | 65 | Testin, TESS, TES; LIM domain, SH3-binding, tumour | 99.16 | |
| 1x4l_A | 72 | Skeletal muscle LIM-protein 3; LIM domain, structu | 99.15 | |
| 1v6g_A | 81 | Actin binding LIM protein 2; LIM domain, zinc bind | 99.14 | |
| 2l3k_A | 123 | Rhombotin-2, linker, LIM domain-binding protein 1; | 99.13 | |
| 2cur_A | 69 | Skeletal muscle LIM-protein 1; four and A half LIM | 99.12 | |
| 2d8z_A | 70 | Four and A half LIM domains 2; skeletal muscle LIM | 99.12 | |
| 1x4k_A | 72 | Skeletal muscle LIM-protein 3; LIM domain, structu | 99.09 | |
| 2xjy_A | 131 | Rhombotin-2; oncoprotein, T-cell leukemia, proto-o | 99.08 | |
| 2d8x_A | 70 | Protein pinch; LIM domain, pinch protein, structur | 99.07 | |
| 1wyh_A | 72 | SLIM 2, skeletal muscle LIM-protein 2; structural | 99.06 | |
| 3f6q_B | 72 | LIM and senescent cell antigen-like-containing dom | 99.04 | |
| 1x61_A | 72 | Thyroid receptor interacting protein 6; LIM domain | 99.04 | |
| 2cu8_A | 76 | Cysteine-rich protein 2; CRP2, CRIP2, ESP1 protein | 99.02 | |
| 2cor_A | 79 | Pinch protein; LIM domain, particularly interestin | 99.0 | |
| 2l4z_A | 123 | DNA endonuclease RBBP8, LIM domain transcription L | 99.0 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 2xqn_T | 126 | Testin, TESS; metal-binding protein, cytoskeleton, | 98.97 | |
| 1x62_A | 79 | C-terminal LIM domain protein 1; PDZ and LIM domai | 98.95 | |
| 1g47_A | 77 | Pinch protein; LIM domain, Zn finger, cell adhesio | 98.95 | |
| 1x64_A | 89 | Alpha-actinin-2 associated LIM protein; LIM domain | 98.94 | |
| 2dj7_A | 80 | Actin-binding LIM protein 3; LIM domain, Zn bindin | 98.88 | |
| 1iml_A | 76 | CRIP, cysteine rich intestinal protein; metal-bind | 98.87 | |
| 1j2o_A | 114 | FLIN2, fusion of rhombotin-2 and LIM domain-bindin | 98.86 | |
| 2co8_A | 82 | NEDD9 interacting protein with calponin homology a | 98.85 | |
| 2cup_A | 101 | Skeletal muscle LIM-protein 1; four and half LIM d | 98.85 | |
| 1a7i_A | 81 | QCRP2 (LIM1); LIM domain containing proteins, meta | 98.84 | |
| 2d8y_A | 91 | Eplin protein; LIM domain, epithelial protein LOST | 98.82 | |
| 2rgt_A | 169 | Fusion of LIM/homeobox protein LHX3, linker, INSU | 98.82 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.77 | |
| 1m3v_A | 122 | FLIN4, fusion of the LIM interacting domain of LDB | 98.75 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.74 | |
| 2jtn_A | 182 | LIM domain-binding protein 1, LIM/homeobox protein | 98.67 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.48 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.29 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.17 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.1 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.07 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.76 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.76 | |
| 1zfo_A | 31 | LAsp-1; LIM domain, zinc-finger, metal-binding pro | 96.88 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.85 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.82 | |
| 1zfo_A | 31 | LAsp-1; LIM domain, zinc-finger, metal-binding pro | 96.78 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.67 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.42 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.35 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.3 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.09 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.05 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.75 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.5 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.03 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 91.74 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 91.6 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.54 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 90.53 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.87 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.49 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 88.93 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 87.26 | |
| 1t1h_A | 78 | Gspef-atpub14, armadillo repeat containing protein | 82.62 | |
| 1jm7_B | 117 | BARD1, BRCA1-associated ring domain protein 1; rin | 80.88 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=391.00 Aligned_cols=241 Identities=29% Similarity=0.459 Sum_probs=196.5
Q ss_pred cccccccCCeeeeeccCCCcchhhhhcc------------------------chHHHHhhcCCcceeeEEEEEEeCCeee
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 174 (433)
..|.+..+++.+.+++|+|+||+||++. +|+++|++++|||||++++++. ++.++
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~ 107 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLA 107 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEE
Confidence 4566778889999999999999999722 7999999999999999999875 46789
Q ss_pred EEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCC
Q psy6593 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
|||||++||+|.+++.....++++..++.|+.||+.||+|||+++|+||||||+|||+++++.+||+|||+|+.......
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 99999999999999987666799999999999999999999999999999999999999999999999999986543221
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecC---CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG---QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG 331 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~ 331 (433)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||...........
T Consensus 188 ~~-------------------~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~ 248 (307)
T 3omv_A 188 SQ-------------------QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF 248 (307)
T ss_dssp -------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH
T ss_pred ce-------------------eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH
Confidence 11 1125689999999999864 3589999999999999999999999865432211111
Q ss_pred Cchhh----hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 332 LDQTD----FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 332 ~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
..... .....+..+|+.+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 249 ~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 249 MVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp HHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred HHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11111 1123456789999999999999999999999999999987653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=400.99 Aligned_cols=230 Identities=21% Similarity=0.362 Sum_probs=188.4
Q ss_pred cCCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEE
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVT 177 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 177 (433)
.+++.+.+++|+|+||+||++. +|+++|++|+|||||++++++.+++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 4678999999999999999722 7999999999999999999999999999999
Q ss_pred eccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCC
Q psy6593 178 EYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 178 e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
||++||+|.+++.. .+..+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--- 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--- 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH---
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc---
Confidence 99999999999964 34468999999999999999999999999999999999999999999999999998653210
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD 336 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~ 336 (433)
......+||+.|+|||++.+..|+.++|||||||++|||++|.+||...........+.. .
T Consensus 180 ------------------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-~ 240 (350)
T 4b9d_A 180 ------------------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS-G 240 (350)
T ss_dssp ------------------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-T
T ss_pred ------------------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-C
Confidence 011256899999999999999999999999999999999999999865422111111111 1
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHh
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEG 376 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~ 376 (433)
.....+..+|+++.+||.+||+.||++|||+++++ .||.+
T Consensus 241 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 241 SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 11234567899999999999999999999999998 47765
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-53 Score=392.04 Aligned_cols=238 Identities=25% Similarity=0.397 Sum_probs=199.0
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc------------------------------chHHHHhhcCCcceeeEEEEEEeCC
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC------------------------------GQVAVLRSLHHHNVIRFIGVLYKDR 171 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~------------------------------~E~~~l~~l~h~~iv~~~~~~~~~~ 171 (433)
.+.++++++.+++|+|+||+||++. +|+++|++|+|||||++++++.+++
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 3566789999999999999998631 7999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhcCC------------CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceE
Q psy6593 172 KLNLVTEYIAGGTLKELLQDP------------GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVV 239 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~------------~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~k 239 (433)
.++|||||++||+|.+++++. ...+++..++.|+.||+.||+|||+++|+||||||+|||++.++.+|
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence 999999999999999999642 24699999999999999999999999999999999999999999999
Q ss_pred EeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCC
Q psy6593 240 VADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVP 318 (433)
Q Consensus 240 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~ 318 (433)
|+|||+++......... ......||+.|+|||++.+..++.++||||||+++|||+| |.+
T Consensus 169 i~DFGla~~~~~~~~~~-------------------~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~ 229 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYR-------------------VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 229 (299)
T ss_dssp ECCCSCHHHHTGGGCEE-------------------ETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ECCcccceecCCCCcee-------------------ecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 99999998764322111 0113568999999999999999999999999999999997 888
Q ss_pred CCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 319 ADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
||........... .........+..+|+++.+|+.+||+.||++|||+++|+++|+++.+
T Consensus 230 Pf~~~~~~~~~~~-i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 230 PWYQLSNNEVIEC-ITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp TTTTSCHHHHHHH-HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHH-HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 8865432211111 11222345568899999999999999999999999999999998764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-52 Score=391.94 Aligned_cols=239 Identities=18% Similarity=0.272 Sum_probs=197.6
Q ss_pred cCCeeeeeccCCCcchhhhhcc--------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCC
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC--------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGT 184 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~--------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~s 184 (433)
.+.+...+++|+|+||+||++. +|+.+|++++|||||++++++.+++.+||||||++||+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 3457778899999999999732 79999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCC-ceEEeccccchhccCCCCCCccccccc
Q psy6593 185 LKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDK-TVVVADFGLARIIHQGPRAPTTVMAKV 263 (433)
Q Consensus 185 L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 263 (433)
|.+++++.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+++.+.........
T Consensus 137 L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~----- 210 (336)
T 4g3f_A 137 LGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL----- 210 (336)
T ss_dssp HHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------------
T ss_pred HHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce-----
Confidence 999997644 599999999999999999999999999999999999999887 6999999999876543211100
Q ss_pred hhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh-hccccC
Q psy6593 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD-FRNKFC 342 (433)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 342 (433)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||...........+.... ....++
T Consensus 211 -----------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 279 (336)
T 4g3f_A 211 -----------LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP 279 (336)
T ss_dssp --------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSC
T ss_pred -----------ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcC
Confidence 01124679999999999999999999999999999999999999997654433322222211 122456
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccc
Q psy6593 343 ASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMH 380 (433)
Q Consensus 343 ~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~ 380 (433)
..+++.+.++|.+||+.||.+|||+.||++.|......
T Consensus 280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 78999999999999999999999999999888776543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=390.60 Aligned_cols=226 Identities=19% Similarity=0.311 Sum_probs=193.0
Q ss_pred ccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeE
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 175 (433)
..+++.+.+.+|+|+||+||++. +|+++|++|+|||||+++++|.+++.+||
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34668899999999999999622 79999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCC
Q psy6593 176 VTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
||||++||+|.+++++.+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 110 vmEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 999999999999997644 5999999999999999999999999999999999999999999999999999876533221
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~ 335 (433)
. ...+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...........+ .
T Consensus 189 ~-------------------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i--~ 247 (311)
T 4aw0_A 189 A-------------------RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI--I 247 (311)
T ss_dssp C-------------------CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--H
T ss_pred c-------------------cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H
Confidence 1 122678999999999999999999999999999999999999998653221111111 1
Q ss_pred hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 336 DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 336 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
.....++..+++++.+||.+||+.||++||+++|+.
T Consensus 248 ~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 248 KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred cCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 122345678899999999999999999999999874
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-52 Score=390.32 Aligned_cols=238 Identities=27% Similarity=0.415 Sum_probs=194.4
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc------------------------------chHHHHhhcCCcceeeEEEEEEeCC
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC------------------------------GQVAVLRSLHHHNVIRFIGVLYKDR 171 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~------------------------------~E~~~l~~l~h~~iv~~~~~~~~~~ 171 (433)
.+..+++++.+++|+|+||+||++. +|+++|++|+|||||++++++.+++
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4566788999999999999998630 7999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhcCC--------------CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCc
Q psy6593 172 KLNLVTEYIAGGTLKELLQDP--------------GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKT 237 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~--------------~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~ 237 (433)
.++|||||+++|+|.+++++. ..++++.+++.|+.|++.||+|||+.+|+||||||+|||++.++.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc
Confidence 999999999999999998653 235999999999999999999999999999999999999999999
Q ss_pred eEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-C
Q psy6593 238 VVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-R 316 (433)
Q Consensus 238 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~ 316 (433)
+||+|||+++.......... .....||+.|+|||++.+..++.++||||||+++|||+| |
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~-------------------~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G 257 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRV-------------------GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 257 (329)
T ss_dssp EEECCCC-----------------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred EEEcccccceeccCCCccee-------------------cCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCC
Confidence 99999999987644322111 114579999999999999999999999999999999997 8
Q ss_pred CCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 317 VPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
.+||.......... ......+...+..+|+++.+|+.+||+.||++|||+++|+++|+.+..
T Consensus 258 ~~Pf~~~~~~~~~~-~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 258 KQPWYQLSNTEAID-CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp CCTTCSSCHHHHHH-HHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHH-HHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 88886543221111 111223445668899999999999999999999999999999998764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=390.64 Aligned_cols=227 Identities=24% Similarity=0.393 Sum_probs=192.3
Q ss_pred CCeeeeeccCCCcchhhhhcc-------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEecc
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYI 180 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 180 (433)
+.+...+++|+|+||+||++. +|+++|++++|||||++++++.+++.+||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 447778899999999999722 7999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcccc
Q psy6593 181 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260 (433)
Q Consensus 181 ~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 260 (433)
+||+|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+......
T Consensus 154 ~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~----- 226 (346)
T 4fih_A 154 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR----- 226 (346)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-----
T ss_pred CCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc-----
Confidence 99999999976 45999999999999999999999999999999999999999999999999999876543221
Q ss_pred ccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhh--c
Q psy6593 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDF--R 338 (433)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~--~ 338 (433)
..+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||...........+ .... .
T Consensus 227 ----------------~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-~~~~~~~ 289 (346)
T 4fih_A 227 ----------------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-RDNLPPR 289 (346)
T ss_dssp ----------------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-HHSSCCC
T ss_pred ----------------ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-HcCCCCC
Confidence 12678999999999999999999999999999999999999998653221111111 1111 1
Q ss_pred cccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 339 NKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 339 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
...+..+++++.+||.+||+.||++|||++|+++ ||.+
T Consensus 290 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 290 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence 1123567899999999999999999999999984 7765
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=383.35 Aligned_cols=235 Identities=25% Similarity=0.389 Sum_probs=197.6
Q ss_pred cccCCeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhcCCcceeeEEEEEEeCC
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSLHHHNVIRFIGVLYKDR 171 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l~h~~iv~~~~~~~~~~ 171 (433)
+..+++.+.+++|+|+||+||++. +|+.+|++++|||||+++|++.+++
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 455667888999999999998621 6999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhcCC---------------CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCC
Q psy6593 172 KLNLVTEYIAGGTLKELLQDP---------------GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDK 236 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~ 236 (433)
.++|||||+++|||.+++... ...+++..++.|+.||+.||+|||+.+|+||||||+|||+++++
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC
Confidence 999999999999999999542 13589999999999999999999999999999999999999999
Q ss_pred ceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-
Q psy6593 237 TVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG- 315 (433)
Q Consensus 237 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~- 315 (433)
.+||+|||+++.......... .....||+.|+|||++.+..++.++||||||+++|||+|
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~-------------------~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~ 243 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKL-------------------LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY 243 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCS-------------------SSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CEEECCcccceeccCCCceeE-------------------ecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhC
Confidence 999999999987643322111 114579999999999999999999999999999999997
Q ss_pred CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 316 RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
|.+||.......... ......+...+..+|+++.+|+.+||+.||++|||+++|++.|+..
T Consensus 244 g~~Pf~~~~~~~~~~-~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 244 GLQPYCGYSNQDVVE-MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp TCCTTTTCCHHHHHH-HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCCCHHHHHH-HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 888886543222111 1122233445688999999999999999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=381.90 Aligned_cols=229 Identities=18% Similarity=0.271 Sum_probs=188.1
Q ss_pred ccCCeeeeeccCCCcchhhhhcc------------------------------chHHHHhhcCCcceeeEEEEEEeCCee
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC------------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~------------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~ 173 (433)
..+++.+.+.+|+|+||+||++. +|+++|++++|||||++++++.+++.+
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 34568899999999999998420 699999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 174 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
||||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 99999999999999997644 59999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~ 333 (433)
.. ..+.+||+.|+|||++.+..++.++|||||||++|||++|.+||...........+
T Consensus 181 ~~---------------------~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i- 238 (304)
T 3ubd_A 181 KK---------------------AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI- 238 (304)
T ss_dssp CC---------------------CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-
T ss_pred cc---------------------ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH-
Confidence 11 12568999999999999999999999999999999999999998653221111111
Q ss_pred hhhhccccCCCCcHHHHHHHHHhcccCCCCCCCh-----hHHH--HHHHh
Q psy6593 334 QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF-----EVLE--VWLEG 376 (433)
Q Consensus 334 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~-----~~i~--~~l~~ 376 (433)
......++..+|+++.+||.+||+.||++||++ ++++ .||+.
T Consensus 239 -~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 239 -LKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp -HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred -HcCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 112234567889999999999999999999985 5665 35554
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=392.16 Aligned_cols=228 Identities=24% Similarity=0.378 Sum_probs=193.4
Q ss_pred CCeeeeeccCCCcchhhhhcc-------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEecc
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYI 180 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 180 (433)
+.+...+++|+|+||+||++. +|+.+|++++|||||+++++|.+++.+||||||+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 457888999999999999722 7999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcccc
Q psy6593 181 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260 (433)
Q Consensus 181 ~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 260 (433)
+||+|.++++. ..+++..+..|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.+......
T Consensus 231 ~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~----- 303 (423)
T 4fie_A 231 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR----- 303 (423)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC-----
T ss_pred CCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc-----
Confidence 99999999976 45999999999999999999999999999999999999999999999999999876543221
Q ss_pred ccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh-hhcc
Q psy6593 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT-DFRN 339 (433)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~-~~~~ 339 (433)
..+.+||+.|||||++.+..|+.++|||||||++|||++|.+||...........+... ....
T Consensus 304 ----------------~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~ 367 (423)
T 4fie_A 304 ----------------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL 367 (423)
T ss_dssp ----------------BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred ----------------ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC
Confidence 12678999999999999999999999999999999999999998653221111111000 0111
Q ss_pred ccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 340 KFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 340 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
..+..+++++.+||.+||+.||++||+++|+++ ||.+
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence 233678999999999999999999999999985 7765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-51 Score=387.46 Aligned_cols=242 Identities=27% Similarity=0.399 Sum_probs=204.0
Q ss_pred cccccccCCeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhcCC-cceeeEEEE
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSLHH-HNVIRFIGV 166 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l~h-~~iv~~~~~ 166 (433)
++|.+..+++.+.+.+|+|+||+||++. +|+++|++++| ||||+++++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 4577888999999999999999998621 69999999965 899999999
Q ss_pred EEeC-CeeeEEEeccCCCCHHHHhcCC---------------CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcce
Q psy6593 167 LYKD-RKLNLVTEYIAGGTLKELLQDP---------------GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 230 (433)
Q Consensus 167 ~~~~-~~~~lv~e~~~g~sL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Ni 230 (433)
+.+. +.++|||||+++|+|.+++++. ...+++..++.|+.||+.||+|||+++|+||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 9764 5789999999999999999642 23589999999999999999999999999999999999
Q ss_pred EEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHH
Q psy6593 231 LVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310 (433)
Q Consensus 231 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 310 (433)
|++.++.+||+|||+|+......... ......||+.|+|||++.+..++.++|||||||++
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~-------------------~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l 277 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYV-------------------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 277 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSE-------------------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred eeCCCCCEEECcchhhhhcccCCCce-------------------eeccccccccccCHHHHhcCCCCCcccEeehHHHH
Confidence 99999999999999998765433221 11146789999999999999999999999999999
Q ss_pred HHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 311 CEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 311 ~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
|||+| |.+||.................+...+..+|+++.++|.+||+.||++|||+.+|++.|+.+..
T Consensus 278 ~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 278 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 99997 8988876433322222233344556678899999999999999999999999999999988764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=370.89 Aligned_cols=225 Identities=24% Similarity=0.355 Sum_probs=178.9
Q ss_pred CCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEE
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVT 177 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 177 (433)
+++.+.+.+|+|+||+||++. +|+++|++++|||||++++++.+++.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 457788899999999998622 7999999999999999999999999999999
Q ss_pred eccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCc
Q psy6593 178 EYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPT 257 (433)
Q Consensus 178 e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 257 (433)
||+ +|+|.+++.+.+ ++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~--- 167 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF--- 167 (275)
T ss_dssp ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc---
Confidence 999 679999987654 599999999999999999999999999999999999999999999999999986543211
Q ss_pred cccccchhhhhhhcccccceeeeccCccccccceecCCCC-CcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh
Q psy6593 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY-DETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD 336 (433)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~ 336 (433)
..+.+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.......... ....
T Consensus 168 -------------------~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~--~i~~ 226 (275)
T 3hyh_A 168 -------------------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFK--NISN 226 (275)
T ss_dssp --------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHH
T ss_pred -------------------cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHHc
Confidence 125689999999999998876 579999999999999999999986532111100 1112
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
....++..+++++.+||.+||+.||++|||++++++ ||+.
T Consensus 227 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 227 GVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 223456788999999999999999999999999985 8864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=374.08 Aligned_cols=222 Identities=26% Similarity=0.408 Sum_probs=181.7
Q ss_pred eeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEe----CCeeeEEE
Q psy6593 129 LFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYK----DRKLNLVT 177 (433)
Q Consensus 129 ~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~ 177 (433)
.+.+++|+|+||+||++. +|+++|++|+|||||++++++.+ ++.+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 455679999999999722 79999999999999999999975 34689999
Q ss_pred eccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCC--ccccCCCCcceEEc-cCCceEEeccccchhccCCCC
Q psy6593 178 EYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN--LIHRDLNSQNCLVR-EDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 178 e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
||++||+|.+++.+. ..+++..++.|+.||+.||+|||++| |+||||||+|||++ .++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~-- 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-- 185 (290)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC--
Confidence 999999999999764 35999999999999999999999998 99999999999998 4799999999999753221
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC-Cc
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG-LD 333 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~-~~ 333 (433)
...+.+||+.|+|||++.+ .++.++|||||||++|||++|.+||........... +.
T Consensus 186 ---------------------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~ 243 (290)
T 3fpq_A 186 ---------------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 243 (290)
T ss_dssp ---------------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred ---------------------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHH
Confidence 1126789999999999876 699999999999999999999999865322111100 11
Q ss_pred hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHH
Q psy6593 334 QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLE 375 (433)
Q Consensus 334 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~ 375 (433)
.......++...++++.+||.+||+.||++|||++++++ ||+
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~ 287 (290)
T 3fpq_A 244 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287 (290)
T ss_dssp TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred cCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence 111122334567889999999999999999999999984 654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=362.14 Aligned_cols=235 Identities=25% Similarity=0.337 Sum_probs=181.5
Q ss_pred CeeeeeccCCCcchhhhhcc----------------------chHHHHhhcCCcceeeEEEEEEeCC----eeeEEEecc
Q psy6593 127 GLLFCKEDYNGKYGEACQNC----------------------GQVAVLRSLHHHNVIRFIGVLYKDR----KLNLVTEYI 180 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~~----------------------~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~ 180 (433)
++++.+++|+|+||+||++. .|+..+.+++|||||++++++.+++ .+||||||+
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~ 83 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence 47778899999999999732 3556667889999999999998764 589999999
Q ss_pred CCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC--------CccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 181 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM--------NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 181 ~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~--------~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
+||+|.++++. .+++++.+.+++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 161 (303)
T 3hmm_A 84 EHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp TTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred CCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence 99999999976 4599999999999999999999987 9999999999999999999999999999876543
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCC------CCCcccCeEehhHHHHHHhcCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ------EYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~~~~~~~~~~~~ 326 (433)
..... .......||+.|+|||++.+. .++.++||||||+++|||+||.+++......
T Consensus 162 ~~~~~-----------------~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~ 224 (303)
T 3hmm_A 162 TDTID-----------------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp TTEES-----------------CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred CCcee-----------------eecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccc
Confidence 32111 111256799999999998764 4678999999999999999998776432221
Q ss_pred CC-CCCC-----c---------hhhhccccCC-----CCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccc
Q psy6593 327 SP-DFGL-----D---------QTDFRNKFCA-----SCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMH 380 (433)
Q Consensus 327 ~~-~~~~-----~---------~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~ 380 (433)
.. .... . ....++.++. ..+..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 225 ~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 11 1000 0 0111112221 1235789999999999999999999999999987653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=362.95 Aligned_cols=235 Identities=22% Similarity=0.288 Sum_probs=166.9
Q ss_pred CeeeeeccCCCcchhhhhcc--------------------------chHHHHhhcCCcceeeEEEEEEeCC---------
Q psy6593 127 GLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSLHHHNVIRFIGVLYKDR--------- 171 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l~h~~iv~~~~~~~~~~--------- 171 (433)
++.+.+.+|+|+||+||++. +|+++|++|+|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 36677888999999988622 7999999999999999999997654
Q ss_pred ---eeeEEEeccCCCCHHHHhcCCCC--CCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccc
Q psy6593 172 ---KLNLVTEYIAGGTLKELLQDPGQ--PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLA 246 (433)
Q Consensus 172 ---~~~lv~e~~~g~sL~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 246 (433)
.+||||||++||+|.+++.+... ..+...++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla 165 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 165 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccc
Confidence 37999999999999999976432 2445668899999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCC
Q psy6593 247 RIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~ 326 (433)
+............ ..........+.+||+.|+|||++.+..|+.++|||||||++|||++ | |.....
T Consensus 166 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~--P-f~~~~~- 232 (299)
T 4g31_A 166 TAMDQDEEEQTVL---------TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--P-FSTQME- 232 (299)
T ss_dssp -----------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS--C-CSSHHH-
T ss_pred eecCCCccccccc---------cccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc--C-CCCccH-
Confidence 8875533221100 00011112335789999999999999999999999999999999996 3 321100
Q ss_pred CCCCCCchhhhccccC---CCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 327 SPDFGLDQTDFRNKFC---ASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 327 ~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
............++ ...++.+.+||.+||+.||++|||+.++++ ||++
T Consensus 233 --~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 233 --RVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp --HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred --HHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 00000000001111 223456789999999999999999999985 6654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=353.63 Aligned_cols=248 Identities=16% Similarity=0.231 Sum_probs=183.9
Q ss_pred CCeeeeeccCCCcchhhhhcc--------------------------chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEe
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTE 178 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 178 (433)
+.+.+.+++|+|+||+||++. +|+++|+++ +||||+++++++.+++++|||||
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 447788899999999998631 799999999 69999999999999999999999
Q ss_pred ccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccC-CceEEeccccchhccCCCCCCc
Q psy6593 179 YIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRED-KTVVVADFGLARIIHQGPRAPT 257 (433)
Q Consensus 179 ~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~ 257 (433)
|++|++|.+++. .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..........
T Consensus 101 ~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~ 176 (361)
T 4f9c_A 101 YLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELL 176 (361)
T ss_dssp CCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGG
T ss_pred CCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccc
Confidence 999999999994 39999999999999999999999999999999999999876 8999999999986654322111
Q ss_pred cccccchh-------hhhhhcccccceeeeccCccccccceecCC-CCCcccCeEehhHHHHHHhcCCCCCCCCCCCCC-
Q psy6593 258 TVMAKVPR-------KAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP- 328 (433)
Q Consensus 258 ~~~~~~~~-------~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~- 328 (433)
........ .............+.+||+.|+|||++.+. .++.++||||+||++|||++|.+||........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~ 256 (361)
T 4f9c_A 177 KFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTA 256 (361)
T ss_dssp GGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHH
Confidence 10000000 000000111223456899999999999875 589999999999999999999887743221000
Q ss_pred -----------------------------CCCCc-----------------------hhhhccccCCCCcHHHHHHHHHh
Q psy6593 329 -----------------------------DFGLD-----------------------QTDFRNKFCASCPEPFVRIAFLC 356 (433)
Q Consensus 329 -----------------------------~~~~~-----------------------~~~~~~~~~~~~~~~l~~li~~~ 356 (433)
..... ...........+++++.+||.+|
T Consensus 257 l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~l 336 (361)
T 4f9c_A 257 LAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKL 336 (361)
T ss_dssp HHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHH
T ss_pred HHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHH
Confidence 00000 00001112356789999999999
Q ss_pred cccCCCCCCChhHHHH--HHHhh
Q psy6593 357 CDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 357 l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
|+.||++|||++|+++ ||+++
T Consensus 337 L~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 337 LDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp TCSCTTTSCCHHHHHTSGGGTTC
T ss_pred CcCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999984 77654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=359.13 Aligned_cols=234 Identities=21% Similarity=0.356 Sum_probs=185.4
Q ss_pred CCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeC------Ce
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKD------RK 172 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~------~~ 172 (433)
+.+.+.+.+|+|+||+||++. +|+++|++|+|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 458888999999999999722 699999999999999999998643 57
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
+||||||++ |+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 899999995 68999997754 6999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC-
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF- 330 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~- 330 (433)
.... .....+.+||+.|+|||++.+. .++.++||||+||++|||++|.+||..........
T Consensus 212 ~~~~-----------------~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~ 274 (398)
T 4b99_A 212 PAEH-----------------QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQL 274 (398)
T ss_dssp ---------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH
T ss_pred cccc-----------------ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 2111 1112267899999999998875 56999999999999999999999986532110000
Q ss_pred --------------CC---chhhhc-----------cccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 331 --------------GL---DQTDFR-----------NKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 331 --------------~~---~~~~~~-----------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
.. ...... ......+++++.+||.+||..||++|||++++++ ||++..
T Consensus 275 I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 275 IMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp HHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 00 000000 1122457889999999999999999999999984 887643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=375.50 Aligned_cols=233 Identities=18% Similarity=0.242 Sum_probs=194.8
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhcCCcceeeEEEEEEeC
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSLHHHNVIRFIGVLYKD 170 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l~h~~iv~~~~~~~~~ 170 (433)
.+..+++.+.+.+|+|+||+|+.+. +++.+++.++|||||+++++|.++
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 4567789999999999999999622 235667777999999999999999
Q ss_pred CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhcc
Q psy6593 171 RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIH 250 (433)
Q Consensus 171 ~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 250 (433)
+.+||||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.+.
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999999997654 59999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCC
Q psy6593 251 QGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPD 329 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~ 329 (433)
.... .+.+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.........
T Consensus 344 ~~~~-----------------------~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~ 400 (689)
T 3v5w_A 344 KKKP-----------------------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400 (689)
T ss_dssp SCCC-----------------------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH
T ss_pred CCCC-----------------------CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 3221 26789999999999964 57999999999999999999999999653222111
Q ss_pred CCCc--hhhhccccCCCCcHHHHHHHHHhcccCCCCCCC-----hhHHH--HHHHhhcc
Q psy6593 330 FGLD--QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP-----FEVLE--VWLEGLSM 379 (433)
Q Consensus 330 ~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~i~--~~l~~~~~ 379 (433)
.+. .......++..+++++.+||.+||+.||.+|++ +++|+ .||+.+.+
T Consensus 401 -~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 401 -EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp -HHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred -HHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 111 112233456789999999999999999999998 68887 47776543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=373.27 Aligned_cols=230 Identities=17% Similarity=0.276 Sum_probs=194.3
Q ss_pred CCeeeeeccCCCcchhhhhcc-------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEecc
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYI 180 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 180 (433)
+++.+.+.+|+|+||+|+++. +|+++|++|+|||||+++++|.+++.+||||||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 457888999999999999622 7999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccC--CceEEeccccchhccCCCCCCcc
Q psy6593 181 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRED--KTVVVADFGLARIIHQGPRAPTT 258 (433)
Q Consensus 181 ~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~--~~~kl~Dfg~~~~~~~~~~~~~~ 258 (433)
+||+|.+++.+....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~----- 311 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----- 311 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-----
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-----
Confidence 9999999997766679999999999999999999999999999999999999854 899999999998764321
Q ss_pred ccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh--h
Q psy6593 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT--D 336 (433)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~--~ 336 (433)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||...........+... .
T Consensus 312 -----------------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~ 374 (573)
T 3uto_A 312 -----------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN 374 (573)
T ss_dssp -----------------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC
T ss_pred -----------------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC
Confidence 223678999999999999999999999999999999999999998654322111111111 1
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
+....+..+++++.+||.+||+.||.+||+++++++ ||+..
T Consensus 375 ~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 375 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence 122233678999999999999999999999999986 77643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=338.49 Aligned_cols=268 Identities=55% Similarity=0.987 Sum_probs=214.4
Q ss_pred ccccccCCeeeeeccCCCcchhhhhcc-------------------------chHHHHhhcCCcceeeEEEEEEeCCeee
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 174 (433)
...+..+++.+.+.+++|+||+||+.. +|+++|++++||||+++++++.+++..+
T Consensus 4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp CEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 345677788888999999999988622 7999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCC
Q psy6593 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
+||||+++++|.+++......+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999999987666799999999999999999999999999999999999999999999999999987654332
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCch
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQ 334 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~ 334 (433)
..... ...............||+.|+|||.+.+..++.++||||||+++|+|++|.+++..............
T Consensus 164 ~~~~~-------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~ 236 (310)
T 3s95_A 164 QPEGL-------RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV 236 (310)
T ss_dssp -----------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH
T ss_pred ccccc-------ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh
Confidence 21100 00001112223356899999999999999999999999999999999999988876655444443333
Q ss_pred hh-hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccccCCCCCCCchhhh
Q psy6593 335 TD-FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPLPSDLEAD 394 (433)
Q Consensus 335 ~~-~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~~~~~~~~~~~~~ 394 (433)
.. .....+..+|+.+.+++.+||+.||++||++++|+++|+.+........+.+...+..
T Consensus 237 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~~~~~~~~~~ 297 (310)
T 3s95_A 237 RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQL 297 (310)
T ss_dssp HHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred hccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCcccCCcchhhc
Confidence 33 3334468889999999999999999999999999999999887766555554444433
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=331.86 Aligned_cols=241 Identities=29% Similarity=0.442 Sum_probs=191.7
Q ss_pred ccccccCCeeeeeccCCCcchhhhhcc-------------------------chHHHHhhcCCcceeeEEEEEEeCCeee
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 174 (433)
.+.+..+++.+.+.+++|+||+||++. +|+++|++++||||+++++++...+..+
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 344566778888999999999998621 6999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhcCCCC--CCChHHHHHHHHHHHHHHhhhhcCC--ccccCCCCcceEEccCCceEEeccccchhcc
Q psy6593 175 LVTEYIAGGTLKELLQDPGQ--PLPWGQRVNFARDIAAGMTYLHSMN--LIHRDLNSQNCLVREDKTVVVADFGLARIIH 250 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 250 (433)
+||||+++++|.+++...+. .+++..++.++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++...
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999999987432 3899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC
Q psy6593 251 QGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF 330 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~ 330 (433)
.... ......||+.|+|||.+.+..++.++||||||+++|+|++|.+||..........
T Consensus 191 ~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~ 249 (309)
T 3p86_A 191 STFL---------------------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA 249 (309)
T ss_dssp --------------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH
T ss_pred cccc---------------------ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 3211 1125679999999999999999999999999999999999998886543221111
Q ss_pred CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccc
Q psy6593 331 GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381 (433)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~ 381 (433)
.+.........+..+++.+.++|.+||+.||.+||++++|++.|+.+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 250 AVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 111122233456788999999999999999999999999999999987543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=327.47 Aligned_cols=253 Identities=16% Similarity=0.167 Sum_probs=205.8
Q ss_pred ccCCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEec
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
-.+++.+.+.++.|+||+||+.. +|+.+++++ +|+||+++++++..++..++||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 34567888899999999998622 799999999 999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCc-----eEEeccccchhccCCCC
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKT-----VVVADFGLARIIHQGPR 254 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~-----~kl~Dfg~~~~~~~~~~ 254 (433)
+ +++|.+++...+..+++..++.++.|++.||+|||+.||+||||||+||+++.++. +||+|||+++.......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~ 165 (330)
T 2izr_A 87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165 (330)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence 9 89999999865567999999999999999999999999999999999999998877 99999999987654322
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCch
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQ 334 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~ 334 (433)
.... .........||+.|+|||++.+..++.++||||||+++|||++|.+||..............
T Consensus 166 ~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~ 231 (330)
T 2izr_A 166 KKHI--------------PYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK 231 (330)
T ss_dssp CCBC--------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH
T ss_pred Cccc--------------cccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH
Confidence 1100 00112356899999999999999999999999999999999999998876432221110000
Q ss_pred ---h---hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccccCCCCCCCchh
Q psy6593 335 ---T---DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPLPSDLE 392 (433)
Q Consensus 335 ---~---~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~~~~~~~~~~~ 392 (433)
. .........+| ++.+++.+||+.+|.+||++++|.+.|+++............+|+
T Consensus 232 i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 232 IGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp HHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred HHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 0 01111234566 999999999999999999999999999999888877777788887
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=334.07 Aligned_cols=256 Identities=15% Similarity=0.152 Sum_probs=200.7
Q ss_pred cCCeeeeeccCCCcchhhhhcc--------------------------chH---------------HHHhhcCCcceeeE
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC--------------------------GQV---------------AVLRSLHHHNVIRF 163 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~--------------------------~E~---------------~~l~~l~h~~iv~~ 163 (433)
.+++.+.+.+|+|+||+||++. +|+ ..++.++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4468888899999999998641 233 34555679999999
Q ss_pred EEEEEeC----CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEc--cCCc
Q psy6593 164 IGVLYKD----RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR--EDKT 237 (433)
Q Consensus 164 ~~~~~~~----~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~--~~~~ 237 (433)
++++... ...+|||||+ |++|.+++...+..+++..++.|+.||+.||+|||+.||+||||||+|||++ .++.
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 9999865 4589999999 9999999987666799999999999999999999999999999999999999 8899
Q ss_pred eEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCC
Q psy6593 238 VVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRV 317 (433)
Q Consensus 238 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~ 317 (433)
+||+|||+++.+......... .........||+.|+|||++.+..++.++||||||+++|||++|.
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 258 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAY--------------AADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCS--------------SCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred EEEEECCcceecccCCccccc--------------ccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999876432211110 011122556999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCchhhhccc--------c-CCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccccCCCCCC
Q psy6593 318 PADPDYLPRSPDFGLDQTDFRNK--------F-CASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPLP 388 (433)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~--------~-~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~~~~~~~ 388 (433)
+||.................... + ...+|+++.+++..||+.+|.+||++++|++.|+.+..........+
T Consensus 259 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~ 338 (364)
T 3op5_A 259 LPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGK 338 (364)
T ss_dssp CTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCC
T ss_pred CCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCc
Confidence 98864322211111111111111 1 16779999999999999999999999999999999999888888889
Q ss_pred Cchhhhh
Q psy6593 389 SDLEADI 395 (433)
Q Consensus 389 ~~~~~~~ 395 (433)
.+|....
T Consensus 339 ~dw~~~~ 345 (364)
T 3op5_A 339 LDLSVVE 345 (364)
T ss_dssp CCC----
T ss_pred cceEecc
Confidence 9998654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=320.74 Aligned_cols=239 Identities=24% Similarity=0.407 Sum_probs=198.9
Q ss_pred ccccccCCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEE
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 176 (433)
.|.+..+++.+.+.+++|+||+||+.. +|++++++++||||+++++++.+++..++|
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 456777888999999999999998622 799999999999999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCC
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
|||+++++|.+++......+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 162 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 162 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccc-
Confidence 9999999999999876677999999999999999999999999999999999999999999999999999865332110
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchh
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~ 335 (433)
......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+|+......... .....
T Consensus 163 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~-~~~~~ 222 (269)
T 4hcu_A 163 -------------------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-EDIST 222 (269)
T ss_dssp -------------------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HHHHT
T ss_pred -------------------cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH-HHHhc
Confidence 0113456788999999998899999999999999999998 88887643221110 00111
Q ss_pred hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 336 DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 336 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
......+...++.+.+++.+||+.||++||+++++++.|+++..
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 223 GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 12333456678999999999999999999999999999998764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=317.63 Aligned_cols=255 Identities=16% Similarity=0.220 Sum_probs=208.4
Q ss_pred ccCCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEec
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
-.+++.+.+.+++|+||+||+.. +|+.+++++ +|+||+++++++..+...++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 34457777888888888888622 699999999 799999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCc-----eEEeccccchhccCCCC
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKT-----VVVADFGLARIIHQGPR 254 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~-----~kl~Dfg~~~~~~~~~~ 254 (433)
+ +++|.+++...+..+++..++.++.|++.||+|||+.||+||||||+||+++.++. +||+|||++........
T Consensus 88 ~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~ 166 (298)
T 1csn_A 88 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166 (298)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred c-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence 9 99999999876667999999999999999999999999999999999999987765 99999999987654332
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc-
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD- 333 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~- 333 (433)
.... .........||+.|+|||.+.+..++.++||||||+++|+|++|.+||.............
T Consensus 167 ~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (298)
T 1csn_A 167 KQHI--------------PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 232 (298)
T ss_dssp CCBC--------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred cccc--------------cccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH
Confidence 1110 0011225679999999999999999999999999999999999999886643222111000
Q ss_pred --h---hhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccccCCCCCCCchhh
Q psy6593 334 --Q---TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPLPSDLEA 393 (433)
Q Consensus 334 --~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~~~~~~~~~~~~ 393 (433)
. ..........+|+.+.+++.+||+.||++||++++|++.|+++..........+.+|+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 233 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred HHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence 0 01112233578999999999999999999999999999999999888888888899864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=327.98 Aligned_cols=240 Identities=27% Similarity=0.440 Sum_probs=195.8
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc-----------------------------chHHHHhhcCCcceeeEEEEEEeCCe
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC-----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~-----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~ 172 (433)
.+..+.+.+.+.+|+|+||+||++. +|+.+|++++||||+++++++.+++.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 3456668888899999999987521 69999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
.++||||++|++|.+++......+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++.....
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999999999876667999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFG 331 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~ 331 (433)
..... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||..........
T Consensus 205 ~~~~~------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~- 265 (325)
T 3kul_A 205 PDAAY------------------TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS- 265 (325)
T ss_dssp --CCE------------------ECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH-
T ss_pred cccee------------------eccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHH-
Confidence 22111 1113346788999999998899999999999999999997 888875432211110
Q ss_pred CchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccc
Q psy6593 332 LDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMH 380 (433)
Q Consensus 332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~ 380 (433)
..........+..+++.+.+|+.+||+.||++||++++|++.|+.+...
T Consensus 266 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 266 SVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 1111223334577899999999999999999999999999999998753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=329.73 Aligned_cols=239 Identities=29% Similarity=0.469 Sum_probs=197.8
Q ss_pred cccccCCeeeeeccCCCcchhhhhc---------------------------------cchHHHHhhc-CCcceeeEEEE
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQN---------------------------------CGQVAVLRSL-HHHNVIRFIGV 166 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~---------------------------------~~E~~~l~~l-~h~~iv~~~~~ 166 (433)
+.+..+++.+.+.+|+|+||+||++ .+|+++|+++ +||||++++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 4556778889999999999999842 1699999999 89999999999
Q ss_pred EEeCCeeeEEEeccCCCCHHHHhcCCC---------------CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceE
Q psy6593 167 LYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 231 (433)
Q Consensus 167 ~~~~~~~~lv~e~~~g~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil 231 (433)
+.+++.+|+||||+++++|.+++...+ ..+++..++.++.||+.||+|||+.||+||||||+||+
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 999999999999999999999986532 34899999999999999999999999999999999999
Q ss_pred EccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHH
Q psy6593 232 VREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLC 311 (433)
Q Consensus 232 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 311 (433)
++.++.+||+|||+++.......... .....+|+.|+|||++.+..++.++||||||+++|
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~-------------------~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ 296 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKK-------------------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 296 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCT-------------------TTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred ECCCCCEEEccccCCcccCcccceec-------------------ccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHH
Confidence 99999999999999986644322111 01345688999999999999999999999999999
Q ss_pred HHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 312 EIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 312 ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
||++ |.+||........ ............+..+++++.++|.+||+.||++||++.+|++.|+.+..
T Consensus 297 ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 297 EIFTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp HHHTTSCCSSTTCCGGGH-HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCCCCHHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 9997 8888765322111 11111222334557788999999999999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=322.07 Aligned_cols=229 Identities=26% Similarity=0.430 Sum_probs=188.7
Q ss_pred cCCeeeeeccCCCcchhhhhcc-------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
.+++...+.+++|+||+||++. +|+.++++++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 3456777788899999888631 799999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccc
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
++|++|.+++.+ ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---- 172 (297)
T 3fxz_A 99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---- 172 (297)
T ss_dssp CTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC----
T ss_pred CCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc----
Confidence 999999999976 35999999999999999999999999999999999999999999999999998765433221
Q ss_pred cccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh-hhc
Q psy6593 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT-DFR 338 (433)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~-~~~ 338 (433)
.....||+.|+|||++.+..++.++||||||+++|+|++|.+||...........+... ...
T Consensus 173 -----------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (297)
T 3fxz_A 173 -----------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE 235 (297)
T ss_dssp -----------------BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC
T ss_pred -----------------cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 12567999999999999999999999999999999999999988543221110000000 011
Q ss_pred cccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 339 NKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 339 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
...+..+++.+.+++.+||+.||++||+++++++ |++.
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 1223567889999999999999999999999984 6654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=326.12 Aligned_cols=233 Identities=23% Similarity=0.369 Sum_probs=187.7
Q ss_pred CCeeeeeccCCCcchhhhhcc--------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
+++.+.+.+++|+||+||++. +|+.++++++||||+++++++.+++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 457777888888888888621 799999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccc
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
++|++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 87 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~---- 161 (323)
T 3tki_A 87 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE---- 161 (323)
T ss_dssp CTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE----
T ss_pred CCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc----
Confidence 99999999997644 5999999999999999999999999999999999999999999999999999865432111
Q ss_pred cccchhhhhhhcccccceeeeccCccccccceecCCCC-CcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC-chhhh
Q psy6593 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY-DETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL-DQTDF 337 (433)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~-~~~~~ 337 (433)
.......||+.|+|||++.+..+ +.++||||||+++|+|++|.+||............ .....
T Consensus 162 ---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 226 (323)
T 3tki_A 162 ---------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226 (323)
T ss_dssp ---------------CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT
T ss_pred ---------------cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc
Confidence 01124579999999999988765 77899999999999999999988653322111000 00011
Q ss_pred ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 338 RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 338 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
.......+++.+.+|+.+||+.||++||+++++++ |++...
T Consensus 227 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 11112567899999999999999999999999984 776543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=335.51 Aligned_cols=241 Identities=28% Similarity=0.497 Sum_probs=199.3
Q ss_pred cccccccCCeeeeeccCCCcchhhhhcc--------------------------chHHHHhhcCCcceeeEEEEEEeCCe
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~ 172 (433)
+.|.+..+++.+.+.+|+|+||+||++. +|+++|++++||||+++++++..++.
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 4567788889999999999999999621 69999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
.++||||+++++|.++++..+..+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999999999875556999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFG 331 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~ 331 (433)
..... .....+++.|+|||.+.+..++.++||||||+++|||++ |.+|+........ ..
T Consensus 267 ~~~~~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~-~~ 326 (377)
T 3cbl_A 267 VYAAS-------------------GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-RE 326 (377)
T ss_dssp EEECC-------------------SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH-HH
T ss_pred ceeec-------------------CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HH
Confidence 11000 001234678999999998889999999999999999997 8888765322111 01
Q ss_pred CchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 332 LDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
..........+..+|+.+.+||.+||+.||++|||+++|++.|+.+..
T Consensus 327 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 327 FVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 111122334457789999999999999999999999999999998754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=321.27 Aligned_cols=232 Identities=16% Similarity=0.246 Sum_probs=191.2
Q ss_pred CCeeeeeccCCCcchhhhhcc------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccC
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIA 181 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 181 (433)
+++.+.+.+|+|+||+||+.. +|+.+|++++||||+++++++.+.+..++||||++
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 346777788888888888621 79999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc--CCceEEeccccchhccCCCCCCccc
Q psy6593 182 GGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE--DKTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 182 g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
|++|.+++...+..+++..++.++.|++.||.|||+.||+||||||+||+++. ++.+||+|||++.......
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~------ 158 (321)
T 1tki_A 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD------ 158 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC------
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC------
Confidence 99999999876667999999999999999999999999999999999999986 7899999999998654321
Q ss_pred cccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh--h
Q psy6593 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD--F 337 (433)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~--~ 337 (433)
......||+.|+|||++.+..++.++||||||+++|+|++|.+||...........+.... +
T Consensus 159 ----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 222 (321)
T 1tki_A 159 ----------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF 222 (321)
T ss_dssp ----------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC
T ss_pred ----------------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC
Confidence 1225679999999999999889999999999999999999999886532211000000000 1
Q ss_pred ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhcc
Q psy6593 338 RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLSM 379 (433)
Q Consensus 338 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~~ 379 (433)
.......++.++.+++.+||+.||.+|||+.++++ ||.....
T Consensus 223 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 11122577899999999999999999999999984 8876543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=324.71 Aligned_cols=242 Identities=29% Similarity=0.432 Sum_probs=199.8
Q ss_pred ccccccCCeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhc-CCcceeeEEEEE
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSL-HHHNVIRFIGVL 167 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l-~h~~iv~~~~~~ 167 (433)
.+.+..+++.+.+.+|+|+||+||++. +|+.+|+++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 456677788899999999999987411 799999999 899999999999
Q ss_pred EeCCeeeEEEeccCCCCHHHHhcCCCC----------------------CCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 168 YKDRKLNLVTEYIAGGTLKELLQDPGQ----------------------PLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 168 ~~~~~~~lv~e~~~g~sL~~~l~~~~~----------------------~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
..++..++||||+++++|.+++..... .+++..++.++.||+.||.|||+.||+||||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 999999999999999999999976432 3789999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||+++.++.++|+|||++.......... ......+|+.|+|||.+.+..++.++||||
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~s 259 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYV-------------------VRGNARLPVKWMAPESLFEGIYTIKSDVWS 259 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSE-------------------EETTEEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccce-------------------eccCccCccCccCHHHhccCCCChhHhHHH
Confidence 9999999999999999999998765432211 111445788999999999889999999999
Q ss_pred hhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccc
Q psy6593 306 YGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMH 380 (433)
Q Consensus 306 lG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~ 380 (433)
||+++|+|++ |.+||.....................+..+++.+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus 260 lG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 260 YGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp HHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 9999999997 98888654322211112222233344567899999999999999999999999999999987654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=324.66 Aligned_cols=228 Identities=22% Similarity=0.380 Sum_probs=189.0
Q ss_pred ccCCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEE
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 176 (433)
..+++.+.+.+++|+||.||++. +|+++|++++||||+++++++...+..|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 44567888888899999888521 799999999999999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCC
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
|||++|++|.+++...+ .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 93 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-- 169 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-- 169 (328)
T ss_dssp ECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG--
T ss_pred EECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc--
Confidence 99999999999986643 599999999999999999999999999999999999999999999999999976543211
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCCC-cccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYD-ETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~ 335 (433)
.....||+.|+|||++.+..++ .++||||||+++|+|++|.+||.......... ...
T Consensus 170 --------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~i~ 227 (328)
T 3fe3_A 170 --------------------LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE--RVL 227 (328)
T ss_dssp --------------------GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHH
T ss_pred --------------------cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHH--HHH
Confidence 1145799999999999987765 78999999999999999999886532111000 001
Q ss_pred hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 336 DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 336 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
.....++..+++++.+|+.+||+.||.+|||++++++ |++.
T Consensus 228 ~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 270 (328)
T 3fe3_A 228 RGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270 (328)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred hCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence 1122345678899999999999999999999999984 6654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=321.25 Aligned_cols=238 Identities=24% Similarity=0.353 Sum_probs=195.9
Q ss_pred cccccCCeeeeeccCCCcchhhhhcc------------------------------chHHHHhhcCCcceeeEEEEEEeC
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQNC------------------------------GQVAVLRSLHHHNVIRFIGVLYKD 170 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~~------------------------------~E~~~l~~l~h~~iv~~~~~~~~~ 170 (433)
..+..+++...+.+|+|+||+||++. +|+.++++++||||+++++++. +
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 45677778889999999999998621 6889999999999999999985 5
Q ss_pred CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhcc
Q psy6593 171 RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIH 250 (433)
Q Consensus 171 ~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 250 (433)
+..++||||+++++|.+++...+..+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 67899999999999999998766679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCC
Q psy6593 251 QGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPD 329 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~ 329 (433)
....... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||........
T Consensus 167 ~~~~~~~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~- 226 (325)
T 3kex_A 167 PDDKQLL-------------------YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV- 226 (325)
T ss_dssp CCTTCCC------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-
T ss_pred ccccccc-------------------ccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-
Confidence 4332211 114567889999999998899999999999999999998 9988865332211
Q ss_pred CCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 330 FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
............+..++..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 227 PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp HHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11111122333456678899999999999999999999999999998764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=322.72 Aligned_cols=230 Identities=19% Similarity=0.238 Sum_probs=189.5
Q ss_pred ccCCeeeeeccCCCcchhhhhc----------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeE
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQN----------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~----------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 175 (433)
..+++.+.+.+|+|+||.|+.. .+|+.+|++++||||+++++++...+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 3456777888888888888751 168899999999999999999999999999
Q ss_pred EEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCC
Q psy6593 176 VTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
||||++|++|.+++.+.+ .+++..++.++.||+.||+|||+.||+||||||+||+++.+|.+||+|||+++.......
T Consensus 83 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 160 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp EEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-
Confidence 999999999999987643 599999999999999999999999999999999999999999999999999975432211
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~ 335 (433)
......||+.|+|||++.+..++.++||||||+++|||++|.+||........... ..
T Consensus 161 --------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~--i~ 218 (337)
T 1o6l_A 161 --------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL--IL 218 (337)
T ss_dssp --------------------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HH
T ss_pred --------------------cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHH--HH
Confidence 11256799999999999999999999999999999999999988854321110000 01
Q ss_pred hhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHHH--HHHhh
Q psy6593 336 DFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLEV--WLEGL 377 (433)
Q Consensus 336 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~~--~l~~~ 377 (433)
.....++..+++++.++|.+||+.||++|| ++++|++ |+..+
T Consensus 219 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 219 MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred cCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 112234577899999999999999999999 8999973 66543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=335.78 Aligned_cols=238 Identities=18% Similarity=0.250 Sum_probs=195.4
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCee
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~ 173 (433)
.+..+++.+.+.+|+|+||+||+.. +|+.+|.+++||||+++++++.+++.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 3456778899999999999998621 688999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 174 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
|+||||++||+|.+++.+....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 99999999999999998765679999999999999999999999999999999999999999999999999997654322
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceec-----CCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCC
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT-----GQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~ 328 (433)
.. ......||+.|+|||++. ...++.++||||||+++|||++|.+||........
T Consensus 230 ~~--------------------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~ 289 (437)
T 4aw2_A 230 TV--------------------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 289 (437)
T ss_dssp CE--------------------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred Cc--------------------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH
Confidence 11 111457999999999987 45789999999999999999999999865322111
Q ss_pred CCCCchhhhccccC---CCCcHHHHHHHHHhcccCCCC--CCChhHHH--HHHHhhcc
Q psy6593 329 DFGLDQTDFRNKFC---ASCPEPFVRIAFLCCDLNPDQ--RPPFEVLE--VWLEGLSM 379 (433)
Q Consensus 329 ~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~--RPs~~~i~--~~l~~~~~ 379 (433)
...+........++ ..+++++.+||++||..+|++ ||++++|+ .||+.+.+
T Consensus 290 ~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w 347 (437)
T 4aw2_A 290 YGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW 347 (437)
T ss_dssp HHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred HHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence 11111111112222 458999999999999888888 99999998 48876554
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=316.41 Aligned_cols=239 Identities=26% Similarity=0.424 Sum_probs=196.3
Q ss_pred cccccCCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEE
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVT 177 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 177 (433)
+.+..+++.+.+.+++|+||+||+.. +|++++++++||||+++++++.+++..++||
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 44567778888889999999888521 7999999999999999999999999999999
Q ss_pred eccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCc
Q psy6593 178 EYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPT 257 (433)
Q Consensus 178 e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 257 (433)
||+++++|.+++...+..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-- 160 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-- 160 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE--
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh--
Confidence 999999999999776556999999999999999999999999999999999999999999999999999865432211
Q ss_pred cccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhh
Q psy6593 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTD 336 (433)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~ 336 (433)
......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.......... .....
T Consensus 161 ------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~~~~~ 221 (268)
T 3sxs_A 161 ------------------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL-KVSQG 221 (268)
T ss_dssp ------------------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTT
T ss_pred ------------------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH-HHHcC
Confidence 1113456778999999999889999999999999999997 888875432211100 01111
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccc
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMH 380 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~ 380 (433)
.....+...++.+.+++.+||+.+|++|||++++++.|+.+...
T Consensus 222 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 222 HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 12233466789999999999999999999999999999987643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=315.96 Aligned_cols=236 Identities=22% Similarity=0.388 Sum_probs=183.2
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc-----------------------------chHHHHhhcCCcceeeEEEEEEeCCe
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC-----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~-----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~ 172 (433)
.+..+++.+.+.+++|+||+||++. +|+.++++++||||+++++++ .++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCc
Confidence 4455667777888888888887521 689999999999999999998 4567
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
.++||||+++++|.+++...+..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 89999999999999999876667999999999999999999999999999999999999999999999999999876443
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFG 331 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~ 331 (433)
.... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...........
T Consensus 170 ~~~~--------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~ 229 (281)
T 1mp8_A 170 TYYK--------------------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 229 (281)
T ss_dssp -----------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred cccc--------------------cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH
Confidence 2111 113456788999999998899999999999999999995 8888765322211100
Q ss_pred CchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 332 LDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
.........+..+|+.+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 230 -i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 230 -IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp -HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 01111233457889999999999999999999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=316.13 Aligned_cols=235 Identities=24% Similarity=0.375 Sum_probs=188.6
Q ss_pred CCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEE
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVT 177 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 177 (433)
+.+.+.+.+++|+||+||++. +|+.++++++||||+++++++..++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 457777888888888888521 6999999999999999999999999999999
Q ss_pred eccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCc
Q psy6593 178 EYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPT 257 (433)
Q Consensus 178 e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 257 (433)
||++|++|.+++...+ ++++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 91 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 167 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-- 167 (294)
T ss_dssp ECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc--
Confidence 9999999999997643 5999999999999999999999999999999999999999999999999999875432211
Q ss_pred cccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC---CCch
Q psy6593 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF---GLDQ 334 (433)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~---~~~~ 334 (433)
......||+.|+|||.+.+..++.++||||||+++|+|++|.+||.......... ....
T Consensus 168 ------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 229 (294)
T 4eqm_A 168 ------------------QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV 229 (294)
T ss_dssp -------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC
T ss_pred ------------------ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC
Confidence 1114579999999999999999999999999999999999999886532211000 0001
Q ss_pred hhhccccCCCCcHHHHHHHHHhcccCCCCCC-ChhHHHHHHHhhcccc
Q psy6593 335 TDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-PFEVLEVWLEGLSMHL 381 (433)
Q Consensus 335 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-s~~~i~~~l~~~~~~~ 381 (433)
..........+|+.+.+++.+||+.||.+|| +++++.+.|+.+....
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 230 PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 1122234577899999999999999999999 8889999998876543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=327.10 Aligned_cols=242 Identities=27% Similarity=0.409 Sum_probs=198.9
Q ss_pred cccccccCCeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhc-CCcceeeEEEE
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSL-HHHNVIRFIGV 166 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l-~h~~iv~~~~~ 166 (433)
..|.+..+++.+.+.+|+|+||.||+.. +|+++|+++ +||||++++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 4566777889999999999999998631 699999999 79999999999
Q ss_pred EEeCC-eeeEEEeccCCCCHHHHhcCCCC---------------------------------------------------
Q psy6593 167 LYKDR-KLNLVTEYIAGGTLKELLQDPGQ--------------------------------------------------- 194 (433)
Q Consensus 167 ~~~~~-~~~lv~e~~~g~sL~~~l~~~~~--------------------------------------------------- 194 (433)
+...+ ..++||||++|++|.+++.....
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 98765 49999999999999999976432
Q ss_pred --------------CCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcccc
Q psy6593 195 --------------PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260 (433)
Q Consensus 195 --------------~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 260 (433)
.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..........
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~---- 250 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV---- 250 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE----
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch----
Confidence 28999999999999999999999999999999999999999999999999998654332211
Q ss_pred ccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhcc
Q psy6593 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRN 339 (433)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~ 339 (433)
......||+.|+|||++.+..++.++||||||+++|+|++ |.+||...................
T Consensus 251 ---------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 315 (359)
T 3vhe_A 251 ---------------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 315 (359)
T ss_dssp ---------------EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC
T ss_pred ---------------hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC
Confidence 1124568899999999999999999999999999999997 988886543222211222222334
Q ss_pred ccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 340 KFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 340 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
..+..+++++.+++.+||+.||.+||++++|++.|+.+..
T Consensus 316 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 316 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 4557788999999999999999999999999999998764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=315.98 Aligned_cols=240 Identities=24% Similarity=0.424 Sum_probs=196.7
Q ss_pred cccccccCCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCCcceeeEEEEEEeCCeeeE
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 175 (433)
..|.+..+++.+.+.+++|+||+||+.. +|++++++++|+||+++++++.+++..++
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 4566778889999999999999998521 79999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCC
Q psy6593 176 VTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
||||+++++|.+++......+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.........
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 99999999999999875567999999999999999999999999999999999999999999999999999865332110
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCch
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQ 334 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~ 334 (433)
......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.......... ...
T Consensus 177 --------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~-~~~ 235 (283)
T 3gen_A 177 --------------------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-HIA 235 (283)
T ss_dssp --------------------STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHH
T ss_pred --------------------cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH-HHh
Confidence 0113456788999999998899999999999999999997 888876532211110 111
Q ss_pred hhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 335 TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 335 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
.......+...++.+.+++.+||+.+|.+||+++++++.|+++..
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 236 QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 112233446678999999999999999999999999999988764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=319.61 Aligned_cols=228 Identities=22% Similarity=0.383 Sum_probs=190.3
Q ss_pred ccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeE
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 175 (433)
..+++.+.+.+++|+||.||... +|+.+|+.++||||+++++++.+.+.+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 44567788888899999888511 58899999999999999999999999999
Q ss_pred EEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCC
Q psy6593 176 VTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
||||++|++|.+++.+.+ .+++..++.++.||+.||.|||+.||+||||||+||+++.+|.+||+|||+++.....
T Consensus 84 v~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp EECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred EEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 999999999999997644 5999999999999999999999999999999999999999999999999999864321
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~ 335 (433)
.....||+.|+|||++.+..++.++||||||+++|||++|.+||........... ..
T Consensus 160 ---------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--i~ 216 (318)
T 1fot_A 160 ---------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK--IL 216 (318)
T ss_dssp ---------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--HH
T ss_pred ---------------------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH--HH
Confidence 1156799999999999999999999999999999999999998864321111000 01
Q ss_pred hhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHH--HHHHhhc
Q psy6593 336 DFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLE--VWLEGLS 378 (433)
Q Consensus 336 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~--~~l~~~~ 378 (433)
.....++..+++++.+++.+||+.||.+|| ++++|+ .|++.+.
T Consensus 217 ~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 217 NAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred hCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 112234577889999999999999999999 888998 4666543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=319.12 Aligned_cols=243 Identities=28% Similarity=0.438 Sum_probs=199.6
Q ss_pred cccccccCCeeeeeccCCCcchhhhhc-------------------------------cchHHHHhhc-CCcceeeEEEE
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQN-------------------------------CGQVAVLRSL-HHHNVIRFIGV 166 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~-------------------------------~~E~~~l~~l-~h~~iv~~~~~ 166 (433)
..+.+..+++.+.+.+++|+||+||++ .+|+.+|+++ +||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 345566677888899999999998742 1799999999 99999999999
Q ss_pred EEeCCeeeEEEeccCCCCHHHHhcCCCC-----------------CCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcc
Q psy6593 167 LYKDRKLNLVTEYIAGGTLKELLQDPGQ-----------------PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 229 (433)
Q Consensus 167 ~~~~~~~~lv~e~~~g~sL~~~l~~~~~-----------------~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~N 229 (433)
+..++..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.||+||||||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 9999999999999999999999865332 48999999999999999999999999999999999
Q ss_pred eEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHH
Q psy6593 230 CLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIV 309 (433)
Q Consensus 230 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 309 (433)
|+++.++.+||+|||++........... .....+|+.|+|||.+.+..++.++||||||++
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 236 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVV-------------------KGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEE-------------------CSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred EEEcCCCCEEEcccccccccccccccee-------------------ccCCCCcceeeChHHhcCCCCChHHHHHHHHHH
Confidence 9999999999999999987654322110 113456888999999999899999999999999
Q ss_pred HHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccc
Q psy6593 310 LCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMH 380 (433)
Q Consensus 310 l~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~ 380 (433)
+|+|++ |.+|+.....................+..+++.+.+++.+||+.||.+||+++++++.|+++..+
T Consensus 237 l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 237 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp HHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 999997 88887654322211111222223334567899999999999999999999999999999987653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=322.62 Aligned_cols=234 Identities=18% Similarity=0.275 Sum_probs=190.9
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhc-CCcceeeEEEEEEeCCe
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSL-HHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~ 172 (433)
.+..+++.+.+.+|+|+||.||+.. +|+.+|.++ +||||+++++++.+++.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 3456678899999999999999521 688888888 89999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
+|+||||++|++|.+++.+.+ .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 999999999999999987643 5999999999999999999999999999999999999999999999999999753222
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL 332 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~ 332 (433)
.. ......||+.|+|||++.+..++.++||||||+++|||++|.+||............
T Consensus 207 ~~---------------------~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~ 265 (396)
T 4dc2_A 207 GD---------------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265 (396)
T ss_dssp TC---------------------CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C
T ss_pred CC---------------------ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh
Confidence 11 122668999999999999999999999999999999999999998543221111111
Q ss_pred c-------hhhhccccCCCCcHHHHHHHHHhcccCCCCCCCh------hHHHH--HHHhh
Q psy6593 333 D-------QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF------EVLEV--WLEGL 377 (433)
Q Consensus 333 ~-------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~------~~i~~--~l~~~ 377 (433)
. .......++..++.++.+||.+||+.||.+||++ ++|++ ||+.+
T Consensus 266 ~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 266 TEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred hHHHHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 0 1112234567889999999999999999999986 56663 66544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=319.35 Aligned_cols=238 Identities=22% Similarity=0.345 Sum_probs=194.8
Q ss_pred cccccCCeeeeeccCCCcchhhhhcc------------------------------chHHHHhhcCCcceeeEEEEEEeC
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQNC------------------------------GQVAVLRSLHHHNVIRFIGVLYKD 170 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~~------------------------------~E~~~l~~l~h~~iv~~~~~~~~~ 170 (433)
..+..+++...+.+++|+||+||++. +|+.+|++++||||+++++++..+
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp EECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred hhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 34566778888899999999988621 699999999999999999999865
Q ss_pred CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhcc
Q psy6593 171 RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIH 250 (433)
Q Consensus 171 ~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 250 (433)
..++|+|++.+++|.+++......+++..++.|+.|++.||.|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 90 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp -SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred -CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 4789999999999999998766679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCC
Q psy6593 251 QGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPD 329 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~ 329 (433)
....... .....+|+.|+|||.+.+..++.++||||||+++|||++ |.+||........
T Consensus 169 ~~~~~~~-------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 228 (327)
T 3poz_A 169 AEEKEYH-------------------AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI- 228 (327)
T ss_dssp TTCC--------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-
T ss_pred CCccccc-------------------ccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH-
Confidence 4332111 113456889999999999999999999999999999998 8888865322111
Q ss_pred CCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 330 FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
............+..++..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 229 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11111122233456788999999999999999999999999999988764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=331.94 Aligned_cols=228 Identities=19% Similarity=0.302 Sum_probs=185.2
Q ss_pred CeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 127 GLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
++.+.+.+|+|+||+||+.. +|+.+|++++||||+++++++.+++..++||||
T Consensus 12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 91 (444)
T 3soa_A 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL 91 (444)
T ss_dssp HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEe
Confidence 46677888899999888521 799999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEc---cCCceEEeccccchhccCCCCCC
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
++|++|.+.+...+ .+++..+..++.||+.||.|||+.||+||||||+||+++ .++.+||+|||++.........
T Consensus 92 ~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~- 169 (444)
T 3soa_A 92 VTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA- 169 (444)
T ss_dssp CBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB-
T ss_pred CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce-
Confidence 99999999887644 599999999999999999999999999999999999998 4678999999999765432211
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD 336 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~ 336 (433)
.....||+.|+|||++.+..++.++||||||+++|+|++|.+||...........+....
T Consensus 170 --------------------~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 229 (444)
T 3soa_A 170 --------------------WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA 229 (444)
T ss_dssp --------------------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred --------------------eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC
Confidence 124679999999999999899999999999999999999999886532211111111111
Q ss_pred --hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 337 --FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 337 --~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
+.......+++++.+||.+||+.||.+||++.++++ |+..
T Consensus 230 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 230 YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred CCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 111122577899999999999999999999999985 5554
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=320.40 Aligned_cols=241 Identities=25% Similarity=0.399 Sum_probs=193.0
Q ss_pred cccccccCCeeeeeccCCCcchhhhhcc----------------------chHHHHhhcCCcceeeEEEEEEeCC----e
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQNC----------------------GQVAVLRSLHHHNVIRFIGVLYKDR----K 172 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~~----------------------~E~~~l~~l~h~~iv~~~~~~~~~~----~ 172 (433)
.++++..+++.+.+.+++|+||+||++. .|+.+|++++||||+++++++.... .
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 5678888899999999999999999732 5888899999999999999998754 4
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC----------CccccCCCCcceEEccCCceEEec
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM----------NLIHRDLNSQNCLVREDKTVVVAD 242 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~----------~i~H~dlkp~Nil~~~~~~~kl~D 242 (433)
+++||||+++++|.++++. ..+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|
T Consensus 97 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 7999999999999999976 3599999999999999999999999 999999999999999999999999
Q ss_pred cccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-----CCCCcccCeEehhHHHHHHhcCC
Q psy6593 243 FGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-----QEYDETVDVFSYGIVLCEIIGRV 317 (433)
Q Consensus 243 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~~~ 317 (433)
||+++.......... .....||+.|+|||++.+ ..++.++||||||+++|||++|.
T Consensus 175 Fg~a~~~~~~~~~~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~ 235 (322)
T 3soc_A 175 FGLALKFEAGKSAGD-------------------THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235 (322)
T ss_dssp CTTCEEECTTSCCCC-------------------CTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred CCcccccccccCccc-------------------cccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCC
Confidence 999987654322111 114578999999999987 34567889999999999999998
Q ss_pred CCCCCCCCCCCCCCC-------chhh---------hccccC-----CCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHh
Q psy6593 318 PADPDYLPRSPDFGL-------DQTD---------FRNKFC-----ASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376 (433)
Q Consensus 318 ~~~~~~~~~~~~~~~-------~~~~---------~~~~~~-----~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 376 (433)
+||............ .... ....+. ...++.+.+||.+||+.||++|||+++|++.|+.
T Consensus 236 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp TTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 888653322111100 0000 000000 1223459999999999999999999999999998
Q ss_pred hccc
Q psy6593 377 LSMH 380 (433)
Q Consensus 377 ~~~~ 380 (433)
+...
T Consensus 316 l~~~ 319 (322)
T 3soc_A 316 MQRL 319 (322)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=316.70 Aligned_cols=228 Identities=23% Similarity=0.349 Sum_probs=190.8
Q ss_pred cCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEE
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 176 (433)
.+++.+.+.+|+|+||+||++. +|+.+|+.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4557888889999999888521 699999999999999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCC
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
|||+ +|+|.+++.+.+ .+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~-- 163 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-- 163 (336)
T ss_dssp ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT--
T ss_pred EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc--
Confidence 9999 689999886543 599999999999999999999999999999999999999999999999999976543221
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCC-CcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY-DETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~ 335 (433)
.....||+.|+|||++.+..+ +.++||||||+++|+|++|.+||...........+.
T Consensus 164 --------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~-- 221 (336)
T 3h4j_B 164 --------------------LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN-- 221 (336)
T ss_dssp --------------------TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC--
T ss_pred --------------------cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH--
Confidence 115579999999999988776 789999999999999999999886543333222222
Q ss_pred hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhc
Q psy6593 336 DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 336 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
.....++..+++.+.+||.+||+.||.+|||+++++ .||+...
T Consensus 222 ~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 222 SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCC
Confidence 122334577899999999999999999999999998 5887543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=328.48 Aligned_cols=233 Identities=19% Similarity=0.244 Sum_probs=187.6
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhc-CCcceeeEEEEEEeCCe
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSL-HHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~ 172 (433)
.+..+++.+.+.+|+|+||.||+.. +|+.+|+.+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 4566778999999999999999521 688899988 79999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
+|+||||++|++|.+++.+.+ .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 999999999999999997643 5999999999999999999999999999999999999999999999999999753322
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL 332 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~ 332 (433)
.. ......||+.|+|||++.+..++.++||||||+++|||++|.+||...........
T Consensus 178 ~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~- 235 (353)
T 3txo_A 178 GV---------------------TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA- 235 (353)
T ss_dssp -----------------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-
T ss_pred Cc---------------------cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH-
Confidence 11 12256899999999999998899999999999999999999999865322111110
Q ss_pred chhhhccccCCCCcHHHHHHHHHhcccCCCCCCCh------hHHHH--HHHhhc
Q psy6593 333 DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF------EVLEV--WLEGLS 378 (433)
Q Consensus 333 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~------~~i~~--~l~~~~ 378 (433)
.......++..+++.+.++|.+||+.||.+||++ ++|++ ||+.+.
T Consensus 236 -i~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 236 -ILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp -HHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred -HHcCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 1111223456788999999999999999999998 77773 776543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=327.24 Aligned_cols=239 Identities=26% Similarity=0.443 Sum_probs=194.4
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhcCCcceeeEEEEEEeC
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSLHHHNVIRFIGVLYKD 170 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l~h~~iv~~~~~~~~~ 170 (433)
.+..+++.+.+.+|+|+||+||++. +|+.+|++++||||+++++++.++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 3455678888999999999998521 699999999999999999999999
Q ss_pred CeeeEEEeccCCCCHHHHhcCCC------CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCC---ceEEe
Q psy6593 171 RKLNLVTEYIAGGTLKELLQDPG------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDK---TVVVA 241 (433)
Q Consensus 171 ~~~~lv~e~~~g~sL~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~---~~kl~ 241 (433)
...++||||++|++|.+++...+ ..+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999999996522 4589999999999999999999999999999999999999554 59999
Q ss_pred ccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCC
Q psy6593 242 DFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPAD 320 (433)
Q Consensus 242 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~ 320 (433)
|||+++......... ......||+.|+|||++.+..++.++||||||+++|||++ |.+||
T Consensus 227 DFG~a~~~~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf 287 (367)
T 3l9p_A 227 DFGMARDIYRAGYYR-------------------KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287 (367)
T ss_dssp CCHHHHHHHHHSSCT-------------------TCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCccccccccccccc-------------------cCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999998654322111 1114567899999999999899999999999999999997 88887
Q ss_pred CCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccc
Q psy6593 321 PDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMH 380 (433)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~ 380 (433)
........ ............+..+++.+.+|+.+||+.+|++||++++|++.|+.+...
T Consensus 288 ~~~~~~~~-~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 288 PSKSNQEV-LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp TTCCHHHH-HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCHHHH-HHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 65322111 011111122334577899999999999999999999999999999887643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=312.62 Aligned_cols=229 Identities=31% Similarity=0.529 Sum_probs=182.6
Q ss_pred ccCCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEE
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 176 (433)
..+++.+.+.+++|+||+||+.. +|++++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred chhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 44567777788888888888621 689999999999999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCC---ccccCCCCcceEEcc--------CCceEEecccc
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN---LIHRDLNSQNCLVRE--------DKTVVVADFGL 245 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~--------~~~~kl~Dfg~ 245 (433)
|||+++++|.+++.. ..+++..++.++.|++.||.|||+.| |+||||||+||+++. ++.++|+|||+
T Consensus 85 ~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 999999999999975 46999999999999999999999999 899999999999985 77899999999
Q ss_pred chhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCC
Q psy6593 246 ARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLP 325 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~ 325 (433)
+........ ....||+.|+|||.+.+..++.++||||||+++|+|++|.+||.....
T Consensus 163 ~~~~~~~~~-----------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 219 (271)
T 3dtc_A 163 AREWHRTTK-----------------------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG 219 (271)
T ss_dssp ------------------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred ccccccccc-----------------------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 976543221 145689999999999998999999999999999999999988865322
Q ss_pred CCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 326 RSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
................+..+++.+.+++.+||+.||.+||++.++++.|+.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 220 LAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111111122223344577899999999999999999999999999999753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=314.20 Aligned_cols=230 Identities=23% Similarity=0.360 Sum_probs=185.7
Q ss_pred CCeeeeeccCCCcchhhhhcc--------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
+++.+.+.+++|+||+||++. +|+++|++++||||+++++++.+++..++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 346677778888888887521 799999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccc
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
++ ++|.+++......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 101 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~---- 175 (311)
T 3niz_A 101 ME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS---- 175 (311)
T ss_dssp CS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----
T ss_pred CC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc----
Confidence 97 5898888776667999999999999999999999999999999999999999999999999999876432211
Q ss_pred cccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc-----
Q psy6593 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD----- 333 (433)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~----- 333 (433)
.....||+.|+|||++.+ ..++.++||||||+++|+|++|.+||...........+.
T Consensus 176 -----------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 238 (311)
T 3niz_A 176 -----------------YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGT 238 (311)
T ss_dssp -------------------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCC
T ss_pred -----------------ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCC
Confidence 114568999999999876 568999999999999999999999886543322110000
Q ss_pred -----------------------hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 334 -----------------------QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 334 -----------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
...........+++++.+||.+||+.||++|||++++++ ||+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp CCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred CChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 000001122457789999999999999999999999985 77764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=309.72 Aligned_cols=253 Identities=17% Similarity=0.240 Sum_probs=202.8
Q ss_pred CCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCCcceeeEEEEE-EeCCeeeEEEeccC
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHHHNVIRFIGVL-YKDRKLNLVTEYIA 181 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~ 181 (433)
+++.+.+.+++|+||+||+.. +|+.++++++|++++..+..+ ..++..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence 446777788888888888622 799999999877766655554 6778899999999
Q ss_pred CCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEE---ccCCceEEeccccchhccCCCCCCcc
Q psy6593 182 GGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV---REDKTVVVADFGLARIIHQGPRAPTT 258 (433)
Q Consensus 182 g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~ 258 (433)
+++|.+++......+++..++.++.|++.||.|||+.||+||||||+||++ +.++.+||+|||++............
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~ 167 (296)
T 4hgt_A 88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167 (296)
T ss_dssp CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccC
Confidence 899999998655679999999999999999999999999999999999999 78899999999999876543321100
Q ss_pred ccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCch---h
Q psy6593 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQ---T 335 (433)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~---~ 335 (433)
.........||+.|+|||.+.+..++.++||||||+++|+|++|.+||.............. .
T Consensus 168 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 4hgt_A 168 --------------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp --------------CCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred --------------CCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc
Confidence 00112256799999999999999999999999999999999999998876433322211111 0
Q ss_pred h---hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccccCCCCCCCchhh
Q psy6593 336 D---FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPLPSDLEA 393 (433)
Q Consensus 336 ~---~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~~~~~~~~~~~~ 393 (433)
. ........+|+.+.+++.+||+.||++||++++|++.|+++....+.+...+.+|+.
T Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 4hgt_A 234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGG
T ss_pred cccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhh
Confidence 1 111223678999999999999999999999999999999999988888888889875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=330.58 Aligned_cols=258 Identities=18% Similarity=0.255 Sum_probs=207.3
Q ss_pred CCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCC-cceeeEEEEEEeCCeeeEEEeccC
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHH-HNVIRFIGVLYKDRKLNLVTEYIA 181 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~ 181 (433)
+++.+.+.+++|+||+||+.. +|+++++.|+| ++|+.+..++...+..+|||||+
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~- 85 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence 457777788888888888632 79999999975 67777777788888999999999
Q ss_pred CCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEE---ccCCceEEeccccchhccCCCCCCcc
Q psy6593 182 GGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV---REDKTVVVADFGLARIIHQGPRAPTT 258 (433)
Q Consensus 182 g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~ 258 (433)
+++|.+++......+++..++.|+.||+.||.|||+.||+||||||+|||| +.++.+||+|||+++...........
T Consensus 86 g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (483)
T 3sv0_A 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (483)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccccc
Confidence 899999998655679999999999999999999999999999999999999 58899999999999876543321110
Q ss_pred ccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc---h-
Q psy6593 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD---Q- 334 (433)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~---~- 334 (433)
.........||+.|+|||.+.+..++.++||||||+++|||++|.+||............. .
T Consensus 166 --------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (483)
T 3sv0_A 166 --------------PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (483)
T ss_dssp --------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH
T ss_pred --------------ccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc
Confidence 0011225679999999999999999999999999999999999999886543322111110 0
Q ss_pred --hhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccccCCCCCCCchhhhhhhh
Q psy6593 335 --TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPLPSDLEADIYQF 398 (433)
Q Consensus 335 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 398 (433)
......++..+|.++.+|+.+||+.+|++||++++|++.|+.+............+|+......
T Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~ 297 (483)
T 3sv0_A 232 KVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQ 297 (483)
T ss_dssp HHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC--
T ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhcccc
Confidence 0111223377899999999999999999999999999999999988888888889998765443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=323.48 Aligned_cols=226 Identities=21% Similarity=0.334 Sum_probs=185.5
Q ss_pred CeeeeeccCCCcchhhhhc-------------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeE
Q psy6593 127 GLLFCKEDYNGKYGEACQN-------------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~-------------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 175 (433)
.+.+.+.+|+|+||.||+. .+|+.+|++++||||+++++++.+.+.+++
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 4666777888888887751 169999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCC----ceEEeccccchhccC
Q psy6593 176 VTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDK----TVVVADFGLARIIHQ 251 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~ 251 (433)
||||++|++|.+++.+.+ .+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++.....
T Consensus 93 v~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~ 171 (361)
T 2yab_A 93 ILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (361)
T ss_dssp EEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred EEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence 999999999999997644 599999999999999999999999999999999999998776 799999999987644
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG 331 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~ 331 (433)
... .....||+.|+|||++.+..++.++||||||+++|+|++|.+||...........
T Consensus 172 ~~~----------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~ 229 (361)
T 2yab_A 172 GVE----------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 229 (361)
T ss_dssp TCC----------------------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH
T ss_pred CCc----------------------cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 221 1155799999999999998999999999999999999999998865322111000
Q ss_pred Cchh--hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHH
Q psy6593 332 LDQT--DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLE 375 (433)
Q Consensus 332 ~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~ 375 (433)
+... .+....+..+++.+.+||.+||+.||.+||+++++++ ||.
T Consensus 230 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 277 (361)
T 2yab_A 230 ITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (361)
T ss_dssp HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred HHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence 0000 1111223677899999999999999999999999984 665
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=325.20 Aligned_cols=244 Identities=30% Similarity=0.460 Sum_probs=200.6
Q ss_pred cccccccCCeeeeeccCCCcchhhhhc---------------------------------cchHHHHhhc-CCcceeeEE
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQN---------------------------------CGQVAVLRSL-HHHNVIRFI 164 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~---------------------------------~~E~~~l~~l-~h~~iv~~~ 164 (433)
..+.+..+++.+.+.+|+|+||+||++ .+|+++++++ +||||++++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 345566778899999999999999842 1799999999 999999999
Q ss_pred EEEEeCCeeeEEEeccCCCCHHHHhcCCC---------------CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcc
Q psy6593 165 GVLYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 229 (433)
Q Consensus 165 ~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~N 229 (433)
+++..++..++||||+++++|.+++.... ..+++..++.|+.||+.||.|||+.||+||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 99999999999999999999999996532 359999999999999999999999999999999999
Q ss_pred eEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHH
Q psy6593 230 CLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIV 309 (433)
Q Consensus 230 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 309 (433)
|+++.++.+||+|||+++.......... .....+|+.|+|||++.+..++.++||||||++
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~-------------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~i 282 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKK-------------------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 282 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCC-------------------CTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHH
T ss_pred EEEcCCCcEEEcccCccccccccccccc-------------------ccCCCCCcceeCHHHhcCCCCCchhHHHHHHHH
Confidence 9999999999999999986654322111 113457889999999999999999999999999
Q ss_pred HHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccccc
Q psy6593 310 LCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLS 382 (433)
Q Consensus 310 l~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~ 382 (433)
+|+|++ |.+|+....... .............+..+++++.+++.+||+.||++||++++|++.|+.+.....
T Consensus 283 l~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 283 LWEIFTLGGSPYPGVPVEE-LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp HHHHHTTSCCSSTTCCHHH-HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 999998 888876432111 111111122333457789999999999999999999999999999998875443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=336.51 Aligned_cols=241 Identities=27% Similarity=0.511 Sum_probs=201.5
Q ss_pred ccccccccCCeeeeeccCCCcchhhhhcc------------------------chHHHHhhcCCcceeeEEEEEEeCCee
Q psy6593 118 LDNWYFEKDGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 118 l~~~~~~~~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~ 173 (433)
.+.|.+..+++.+.+.+++|+||+||+.. +|+.+|++++||||+++++++...+.+
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 35567788889999999999999999622 799999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 174 NLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
+|||||+++++|.+++++ ....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 999999999999999975 3346999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFG 331 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~ 331 (433)
.... .....+++.|+|||.+.+..++.++||||||+++|||++ |.+|+........ ..
T Consensus 372 ~~~~--------------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~-~~ 430 (495)
T 1opk_A 372 TYTA--------------------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YE 430 (495)
T ss_dssp CEEC--------------------CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-HH
T ss_pred ceee--------------------cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH-HH
Confidence 1110 013345778999999998899999999999999999997 8888765332111 11
Q ss_pred CchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 332 LDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
..........+..+|+.+.+||.+||+.||++||++.+|++.|+.+..
T Consensus 431 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 431 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 112223344567889999999999999999999999999999998753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=313.20 Aligned_cols=242 Identities=28% Similarity=0.512 Sum_probs=202.3
Q ss_pred ccccccccCCeeeeeccCCCcchhhhhcc------------------------chHHHHhhcCCcceeeEEEEEEeCCee
Q psy6593 118 LDNWYFEKDGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 118 l~~~~~~~~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~ 173 (433)
++.+.+..+++.+.+.+++|+||+||+.. +|++++++++||||+++++++.+++..
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 35677788889999999999999999622 799999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 174 NLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
++||||++|++|.+++.. ....+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999999999975 3356999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFG 331 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~ 331 (433)
... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+|+........ ..
T Consensus 165 ~~~--------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~-~~ 223 (288)
T 3kfa_A 165 TYT--------------------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YE 223 (288)
T ss_dssp SSE--------------------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-HH
T ss_pred ccc--------------------cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HH
Confidence 211 1114456888999999998899999999999999999998 8888765322111 11
Q ss_pred CchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccc
Q psy6593 332 LDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMH 380 (433)
Q Consensus 332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~ 380 (433)
..........+..+|+.+.+++.+||+.||.+||+++++++.|+.+...
T Consensus 224 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 224 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 1112223344577899999999999999999999999999999987643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=313.15 Aligned_cols=239 Identities=28% Similarity=0.476 Sum_probs=183.6
Q ss_pred cccccCCeeeeeccCCCcchhhhhcc------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEE
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 176 (433)
.-+..+.+.+.+.+++|+||+||+.. +|+.+|++++|+||++++++. .....++|
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 34556668888899999999998621 699999999999999999965 56678999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCC
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
|||+++++|.+++......+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..........
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 99999999999998766779999999999999999999999999999999999999999999999999997654321110
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceec---CCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT---GQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~ 333 (433)
......||+.|+|||.+. +..++.++||||||+++|+|++|.+||.............
T Consensus 178 -------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 238 (289)
T 3og7_A 178 -------------------QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238 (289)
T ss_dssp -------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHH
T ss_pred -------------------cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHh
Confidence 112457899999999986 5678889999999999999999998886532211111000
Q ss_pred hh----hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 334 QT----DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 334 ~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
.. .........+|+.+.+++.+||+.+|++||++++|++.|+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 239 GRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 00 01112335788999999999999999999999999999998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=330.44 Aligned_cols=236 Identities=28% Similarity=0.477 Sum_probs=198.0
Q ss_pred cccccccCCeeeeeccCCCcchhhhhcc---------------------chHHHHhhcCCcceeeEEEEEEeCC-eeeEE
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQNC---------------------GQVAVLRSLHHHNVIRFIGVLYKDR-KLNLV 176 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~~---------------------~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv 176 (433)
..|.+..+++.+.+.+++|+||+||+.. +|+.+|++++||||+++++++...+ ..++|
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 4566778889999999999999999621 7999999999999999999987765 79999
Q ss_pred EeccCCCCHHHHhcCCCC-CCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCC
Q psy6593 177 TEYIAGGTLKELLQDPGQ-PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
|||+++++|.+++.+.+. .+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 343 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 343 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence 999999999999976433 47999999999999999999999999999999999999999999999999987532211
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCch
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQ 334 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~ 334 (433)
....+++.|+|||.+.+..++.++||||||+++|||++ |.+|+......... ....
T Consensus 344 ----------------------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-~~i~ 400 (450)
T 1k9a_A 344 ----------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PRVE 400 (450)
T ss_dssp -------------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH-HHHH
T ss_pred ----------------------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHH
Confidence 02356788999999999999999999999999999997 88888654332211 1112
Q ss_pred hhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 335 TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 335 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
...+...+..+|+.+.+||.+||+.||++||++.+|++.|+.+..
T Consensus 401 ~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 401 KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 233445567899999999999999999999999999999998753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=328.96 Aligned_cols=236 Identities=19% Similarity=0.267 Sum_probs=193.9
Q ss_pred cccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCe
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~ 172 (433)
.....+++.+.+.+|+|+||+||+.. +|+.+|+.++||||+++++++.+++.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 34566778999999999999999521 68999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
+|+||||++||+|.+++.+ ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 144 ~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 9999999999999999976 35999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC----CCcccCeEehhHHHHHHhcCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE----YDETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~~~~~~~~~~~~~~ 328 (433)
... ......||+.|+|||++.+.. ++.++||||||+++|||++|.+||........
T Consensus 222 ~~~--------------------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 281 (410)
T 3v8s_A 222 GMV--------------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 281 (410)
T ss_dssp SEE--------------------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred Ccc--------------------cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH
Confidence 110 112567999999999998755 78999999999999999999999865322111
Q ss_pred CCCCchhhhccccC--CCCcHHHHHHHHHhcccCCCC--CCChhHHH--HHHHhhc
Q psy6593 329 DFGLDQTDFRNKFC--ASCPEPFVRIAFLCCDLNPDQ--RPPFEVLE--VWLEGLS 378 (433)
Q Consensus 329 ~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~--RPs~~~i~--~~l~~~~ 378 (433)
...+........++ ..+++++.+||.+||+.+|.+ ||++++|+ .|++.+.
T Consensus 282 ~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 282 YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp HHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred HHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 11111111111222 468999999999999999988 99999998 4887654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=321.94 Aligned_cols=241 Identities=27% Similarity=0.472 Sum_probs=198.5
Q ss_pred ccccccCCeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhc-CCcceeeEEEEE
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSL-HHHNVIRFIGVL 167 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l-~h~~iv~~~~~~ 167 (433)
.+.+..+++.+.+.+++|+||+||+.. +|+.+|+++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 456677788889999999999998521 799999999 899999999999
Q ss_pred EeCCeeeEEEeccCCCCHHHHhcCC-------------CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc
Q psy6593 168 YKDRKLNLVTEYIAGGTLKELLQDP-------------GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 234 (433)
Q Consensus 168 ~~~~~~~lv~e~~~g~sL~~~l~~~-------------~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~ 234 (433)
.+++..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.||+||||||+||+++.
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence 9999999999999999999998642 245899999999999999999999999999999999999999
Q ss_pred CCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHh
Q psy6593 235 DKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII 314 (433)
Q Consensus 235 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 314 (433)
++.+||+|||++........... .....+|+.|+|||.+.+..++.++||||||+++|+|+
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 260 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIV-------------------KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEE-------------------CSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred CCeEEECccccccccccccceee-------------------cCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHH
Confidence 99999999999986644322110 11345688999999999889999999999999999999
Q ss_pred c-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 315 G-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 315 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
+ |.+|+.....................+...|+.+.+++.+||+.||.+||++++|+++|+.+..
T Consensus 261 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 261 SLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp TTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 7 8888765432222112222223334456778999999999999999999999999999998654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=319.38 Aligned_cols=238 Identities=22% Similarity=0.344 Sum_probs=190.3
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc------------------------------chHHHHhhcCCcceeeEEEEEEeCC
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC------------------------------GQVAVLRSLHHHNVIRFIGVLYKDR 171 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~------------------------------~E~~~l~~l~h~~iv~~~~~~~~~~ 171 (433)
.+..+++.+.+.+++|+||+||+.. +|+.+|++++||||+++++++..+.
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 4566778888999999999988621 6999999999999999999998654
Q ss_pred eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
.++|+|++.+++|.+++......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 8899999999999999987666799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDF 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~ 330 (433)
..... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||........ .
T Consensus 170 ~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-~ 229 (327)
T 3lzb_A 170 EEKEY-------------------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-S 229 (327)
T ss_dssp -----------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-H
T ss_pred ccccc-------------------cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-H
Confidence 32211 1113456888999999999999999999999999999998 9888865322211 1
Q ss_pred CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccc
Q psy6593 331 GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMH 380 (433)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~ 380 (433)
...........+..++..+.+++.+||+.||.+||++.+|++.|+.+...
T Consensus 230 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 230 SILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11111222334567889999999999999999999999999999987753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=320.66 Aligned_cols=234 Identities=20% Similarity=0.309 Sum_probs=192.8
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCee
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~ 173 (433)
-+..+++.+.+.+|+|+||.||... +|+.+|++++||||+++++++.+.+..
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4556778889999999999998521 699999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 174 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
|+||||+.|++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 99999999999999998744 59999999999999999999999999999999999999999999999999998654321
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecC---CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG---QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF 330 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~ 330 (433)
. .....||+.|+|||++.+ ..++.++||||||+++|+|++|.+||..........
T Consensus 170 ~----------------------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~ 227 (384)
T 4fr4_A 170 Q----------------------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE 227 (384)
T ss_dssp C----------------------BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH
T ss_pred c----------------------eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH
Confidence 1 125679999999999874 458999999999999999999999886432221110
Q ss_pred C-CchhhhccccCCCCcHHHHHHHHHhcccCCCCCCC-hhHHHH--HHHhhc
Q psy6593 331 G-LDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP-FEVLEV--WLEGLS 378 (433)
Q Consensus 331 ~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-~~~i~~--~l~~~~ 378 (433)
. .........++..+++.+.+||.+||+.||.+||+ +++|.+ |++.+.
T Consensus 228 ~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 228 IVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp HHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred HHHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 0 01112223455778999999999999999999998 777763 665543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=324.46 Aligned_cols=238 Identities=28% Similarity=0.489 Sum_probs=182.1
Q ss_pred ccCCeeeeeccCCCcchhhhhc-----------------------------cchHHHHhhcCCcceeeEEEEEEeCCeee
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQN-----------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~-----------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 174 (433)
..+++.+.+.+++|+||+||+. .+|+.+|++++||||+++++++.+++..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3345666667777777777641 17999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCC
Q psy6593 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
+||||+++++|.+++.+.+..+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 99999999999999988766799999999999999999999999999999999999999999999999999987644321
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCc
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~ 333 (433)
... ......+++.|+|||.+.+..++.++||||||+++|||++ |.+|+......... ...
T Consensus 203 ~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~-~~i 263 (373)
T 2qol_A 203 AAY------------------TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-KAV 263 (373)
T ss_dssp -----------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH-HHH
T ss_pred cce------------------eccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHH
Confidence 110 0112345778999999999999999999999999999996 88887543221110 011
Q ss_pred hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccc
Q psy6593 334 QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMH 380 (433)
Q Consensus 334 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~ 380 (433)
........+..++..+.+++.+||+.||++||++++|++.|+.+...
T Consensus 264 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 11222334567899999999999999999999999999999988653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=309.90 Aligned_cols=232 Identities=22% Similarity=0.367 Sum_probs=191.4
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc-------------------------chHHHHhhcCCcceeeEEEEEEeC--Ceee
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLHHHNVIRFIGVLYKD--RKLN 174 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 174 (433)
.+..+++.+.+.+++|+||+||+.. +|+.+|++++||||+++++++.+. +..+
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 4456667788888888888888621 799999999999999999999877 7889
Q ss_pred EEEeccCCCCHHHHhcCCCC-CCChHHHHHHHHHHHHHHhhhhcCC--ccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 175 LVTEYIAGGTLKELLQDPGQ-PLPWGQRVNFARDIAAGMTYLHSMN--LIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
+||||+++++|.+++..... .+++..++.++.|++.||+|||+.| ++||||||+||+++.++.++|.|||++.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999999987443 5899999999999999999999999 99999999999999999999999888654221
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCc---ccCeEehhHHHHHHhcCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDE---TVDVFSYGIVLCEIIGRVPADPDYLPRSP 328 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~ell~~~~~~~~~~~~~~ 328 (433)
. ...||+.|+|||.+.+..++. ++||||||+++|+|++|.+||........
T Consensus 166 ~--------------------------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 219 (271)
T 3kmu_A 166 P--------------------------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI 219 (271)
T ss_dssp T--------------------------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH
T ss_pred c--------------------------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH
Confidence 1 346889999999998765544 79999999999999999988865322211
Q ss_pred CCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 329 DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
.............+..+++.+.+++.+||+.||++||+++++++.|+.+..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 220 GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111122233344567889999999999999999999999999999998753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=340.52 Aligned_cols=250 Identities=23% Similarity=0.378 Sum_probs=198.4
Q ss_pred cccccCCeeeee-ccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCC
Q psy6593 121 WYFEKDGLLFCK-EDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDR 171 (433)
Q Consensus 121 ~~~~~~~~~~~~-~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~ 171 (433)
+.+..+++.+.. ++|+|+||+||+.. +|+++|++++||||+++++++.. +
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 344555555555 79999999998521 79999999999999999999975 5
Q ss_pred eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
..++||||+++++|.+++...+..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 79999999999999999987667799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDF 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~ 330 (433)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |.+||.........
T Consensus 489 ~~~~~~------------------~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~- 549 (613)
T 2ozo_A 489 DDSYYT------------------ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM- 549 (613)
T ss_dssp -------------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH-
T ss_pred CCceee------------------eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-
Confidence 221110 0113345788999999998899999999999999999997 99888654322111
Q ss_pred CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccccCCCCCCCc
Q psy6593 331 GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPLPSD 390 (433)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~~~~~~~~~ 390 (433)
.......+...+..+|+++.+||.+||+.+|++||++++|++.|+.+........+.+..
T Consensus 550 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~s~ 609 (613)
T 2ozo_A 550 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSA 609 (613)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCSSS
T ss_pred HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCccc
Confidence 111122233456789999999999999999999999999999999987666555554443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=311.54 Aligned_cols=239 Identities=24% Similarity=0.409 Sum_probs=195.4
Q ss_pred ccccccCCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEE
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 176 (433)
+|.+..+++.+.+.+++|+||.||+.. +|++++++++||||+++++++.+++..++|
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence 345566778888888888888887521 799999999999999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCC
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
|||+++++|.+++......+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 160 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 160 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc-
Confidence 9999999999999876667999999999999999999999999999999999999999999999999999865321100
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchh
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~ 335 (433)
......+++.|+|||.+.+..++.++||||||+++|+|++ |.+|+.......... ....
T Consensus 161 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~i~~ 220 (267)
T 3t9t_A 161 -------------------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE-DIST 220 (267)
T ss_dssp -------------------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-HHHT
T ss_pred -------------------ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHH-HHhc
Confidence 0113356788999999998899999999999999999998 888876432111000 0111
Q ss_pred hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 336 DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 336 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
......+...+..+.+++.+||+.||++||+++++++.|+++..
T Consensus 221 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 221 GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 12233446678999999999999999999999999999998753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=312.40 Aligned_cols=236 Identities=25% Similarity=0.424 Sum_probs=190.7
Q ss_pred eeeeeccCCCcchhhhhcc-----------------------------chHHHHhhcCCcceeeEEEEEE-eCCeeeEEE
Q psy6593 128 LLFCKEDYNGKYGEACQNC-----------------------------GQVAVLRSLHHHNVIRFIGVLY-KDRKLNLVT 177 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~~-----------------------------~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~ 177 (433)
+.+.+.+++|+||+||++. +|+.++++++||||+++++++. .++..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 5666788889999888511 7999999999999999999864 456889999
Q ss_pred eccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCc
Q psy6593 178 EYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPT 257 (433)
Q Consensus 178 e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 257 (433)
||+++++|.+++......+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++..........
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~- 185 (298)
T 3f66_A 107 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS- 185 (298)
T ss_dssp ECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCB-
T ss_pred eCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhc-
Confidence 9999999999998867779999999999999999999999999999999999999999999999999998654322111
Q ss_pred cccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhh
Q psy6593 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTD 336 (433)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~ 336 (433)
........+|+.|+|||.+.+..++.++||||||+++|+|++ +.+|+........ .......
T Consensus 186 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~-~~~~~~~ 248 (298)
T 3f66_A 186 ----------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-TVYLLQG 248 (298)
T ss_dssp ----------------C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH-HHHHHTT
T ss_pred ----------------cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH-HHHHhcC
Confidence 111224567889999999999999999999999999999997 7777654332221 1111112
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccc
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~ 381 (433)
.....+..+|+.+.+++.+||+.||++||+++++++.|+++....
T Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 249 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 223335678999999999999999999999999999999887544
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=334.41 Aligned_cols=241 Identities=27% Similarity=0.490 Sum_probs=199.0
Q ss_pred cccccccCCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCCcceeeEEEEEEeCCeeeE
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 175 (433)
+.|.+..+++.+.+.+++|+||+||+.. +|+.+|++++||||+++++++. ++..++
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 4567777889999999999999999622 7999999999999999999986 678999
Q ss_pred EEeccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCC
Q psy6593 176 VTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
||||+++++|.++++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 999999999999997632 3589999999999999999999999999999999999999999999999999987532110
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCc
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~ 333 (433)
. ......+|+.|+|||++....++.++||||||+++|||++ |.+||......... ...
T Consensus 340 ~--------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~-~~i 398 (454)
T 1qcf_A 340 T--------------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RAL 398 (454)
T ss_dssp H--------------------TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-HHH
T ss_pred e--------------------ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH-HHH
Confidence 0 0013346788999999998899999999999999999998 88888653221111 111
Q ss_pred hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccc
Q psy6593 334 QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381 (433)
Q Consensus 334 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~ 381 (433)
........+..+|+.+.+||.+||+.||++||++++|++.|+.+....
T Consensus 399 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 399 ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 122233445788999999999999999999999999999999876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=332.72 Aligned_cols=242 Identities=30% Similarity=0.510 Sum_probs=195.1
Q ss_pred cccccccCCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCCcceeeEEEEEEeCCeeeE
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 175 (433)
+.|.+..+++.+.+++++|+||+||+.. +|+++|++++||||+++++++.+ +..++
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 4566777889999999999999999622 79999999999999999999865 77999
Q ss_pred EEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCC
Q psy6593 176 VTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
||||+++++|.+++... +..+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 99999999999999752 34599999999999999999999999999999999999999999999999999986543221
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCc
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~ 333 (433)
.. .....+++.|+|||.+.+..++.++||||||+++|||++ |.+|+......... ...
T Consensus 336 ~~--------------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-~~i 394 (452)
T 1fmk_A 336 TA--------------------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-DQV 394 (452)
T ss_dssp ---------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHH
T ss_pred ec--------------------ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH-HHH
Confidence 11 113456788999999998899999999999999999998 88887653221111 111
Q ss_pred hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccccc
Q psy6593 334 QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLS 382 (433)
Q Consensus 334 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~ 382 (433)
....+...+..+|+.+.++|.+||+.||++||++++|++.|+.+.....
T Consensus 395 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 395 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 1222334457889999999999999999999999999999998775443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=310.54 Aligned_cols=243 Identities=23% Similarity=0.403 Sum_probs=195.1
Q ss_pred cccccCCeeeee-ccCCCcchhhhhc----------------------------cchHHHHhhcCCcceeeEEEEEEeCC
Q psy6593 121 WYFEKDGLLFCK-EDYNGKYGEACQN----------------------------CGQVAVLRSLHHHNVIRFIGVLYKDR 171 (433)
Q Consensus 121 ~~~~~~~~~~~~-~~~~g~fg~v~~~----------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~ 171 (433)
+++..+++.+.. .+++|+||+||+. .+|+++|++++||||+++++++ ..+
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 344555555554 7778888877752 1699999999999999999999 566
Q ss_pred eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
..++||||+++++|.+++.+....+++..++.++.|++.||.+||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 79999999999999999987667799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDF 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~ 330 (433)
...... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.........
T Consensus 163 ~~~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~- 223 (287)
T 1u59_A 163 DDSYYT------------------ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM- 223 (287)
T ss_dssp CSCEEC------------------CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-
T ss_pred Ccceee------------------ccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH-
Confidence 221100 1113356889999999998889999999999999999997 98888653321111
Q ss_pred CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccccC
Q psy6593 331 GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSV 383 (433)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~~ 383 (433)
...........+..+|+.+.+++.+||+.+|++||++.++++.|+.+..+...
T Consensus 224 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 224 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred HHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 01111122345578899999999999999999999999999999998765544
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.99 Aligned_cols=235 Identities=26% Similarity=0.424 Sum_probs=190.0
Q ss_pred eeccCCCcchhhhhc-----------------------------cchHHHHhhcCCcceeeEEEEEEeCCee-eEEEecc
Q psy6593 131 CKEDYNGKYGEACQN-----------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKL-NLVTEYI 180 (433)
Q Consensus 131 ~~~~~~g~fg~v~~~-----------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~lv~e~~ 180 (433)
.+.+++|+||+||++ .+|+.++++++||||+++++++.+.+.. ++||||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 367888888888852 1789999999999999999999876655 9999999
Q ss_pred CCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcccc
Q psy6593 181 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260 (433)
Q Consensus 181 ~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 260 (433)
.+++|.+++...+..+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++..........
T Consensus 106 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~---- 181 (298)
T 3pls_A 106 CHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS---- 181 (298)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC----
T ss_pred cCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc----
Confidence 9999999998877779999999999999999999999999999999999999999999999999997654321110
Q ss_pred ccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhcc
Q psy6593 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRN 339 (433)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~ 339 (433)
........+|+.|+|||.+.+..++.++||||||+++|+|++ +.|++....... ...........
T Consensus 182 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~ 247 (298)
T 3pls_A 182 -------------VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLAQGRRL 247 (298)
T ss_dssp -------------SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-HHHHHHTTCCC
T ss_pred -------------cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-HHHHhhcCCCC
Confidence 011124567889999999999999999999999999999997 666654432211 11111111223
Q ss_pred ccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccccC
Q psy6593 340 KFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSV 383 (433)
Q Consensus 340 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~~ 383 (433)
..+..+++.+.+++.+||+.||.+|||++++++.|+.+...+..
T Consensus 248 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 248 PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 34567889999999999999999999999999999998765543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=315.41 Aligned_cols=240 Identities=31% Similarity=0.541 Sum_probs=197.0
Q ss_pred ccccccCCeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhcCCcceeeEEEEEE
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSLHHHNVIRFIGVLY 168 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l~h~~iv~~~~~~~ 168 (433)
.+.+..+++.+.+.+++|+||.||++. +|+++|++++||||+++++++.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 445666778888888999999887531 6999999999999999999999
Q ss_pred eCCeeeEEEeccCCCCHHHHhcCCC-----------------------CCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 169 KDRKLNLVTEYIAGGTLKELLQDPG-----------------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 169 ~~~~~~lv~e~~~g~sL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+++..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.||+||||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 176 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence 9999999999999999999996532 24889999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||+++.++.+||+|||++.......... ......+|+.|+|||.+.+..++.++||||
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 237 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYV-------------------KRSQGRIPVKWMAIESLFDHIYTTQSDVWS 237 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEE-------------------CSSCCCSCGGGCCHHHHHHCEECHHHHHHH
T ss_pred chheEEEcCCCCEEEccccccccccccccce-------------------eccCCCCcccccChhhhcCCCcCchhhHHH
Confidence 9999999999999999999998654322110 111345788899999999988999999999
Q ss_pred hhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 306 YGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 306 lG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
||+++|+|++ |.+|+........ ............+..+++.+.+++.+||+.||++||++.+|++.|+++..
T Consensus 238 lG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 238 FGVLLWEIVTLGGNPYPGIPPERL-FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp HHHHHHHHHTTSCCSSTTCCGGGH-HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHH-HHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999998 8888765432111 11111122234457789999999999999999999999999999998764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=317.79 Aligned_cols=230 Identities=20% Similarity=0.340 Sum_probs=187.5
Q ss_pred CCeeeeeccCCCcchhhhhcc---------------------chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCC
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC---------------------GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGG 183 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~---------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 183 (433)
+++.+.+.+|+|+||.||+.. +|+++|.++ +||||+++++++.+++..|+||||++|+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg 101 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG 101 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCC
Confidence 447778889999999998622 799999998 7999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccC----CceEEeccccchhccCCCCCCccc
Q psy6593 184 TLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRED----KTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 184 sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~----~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
+|.+++.+.+ .+++..+..++.||+.||+|||+.||+||||||+||++..+ +.+||+|||+++........
T Consensus 102 ~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~---- 176 (342)
T 2qr7_A 102 ELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL---- 176 (342)
T ss_dssp BHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC----
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc----
Confidence 9999997754 59999999999999999999999999999999999998533 35999999999876443221
Q ss_pred cccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh----
Q psy6593 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT---- 335 (433)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~---- 335 (433)
.....||+.|+|||++.+..++.++||||||+++|+|++|.+||......... .+...
T Consensus 177 -----------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~~~~i~~~ 238 (342)
T 2qr7_A 177 -----------------LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE-EILARIGSG 238 (342)
T ss_dssp -----------------BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH-HHHHHHHHC
T ss_pred -----------------eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH-HHHHHHccC
Confidence 11457899999999999888999999999999999999999988643211110 00000
Q ss_pred --hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhc
Q psy6593 336 --DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 336 --~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
.+....+..+++++.+||.+||+.||++||++++++ .||....
T Consensus 239 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 239 KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence 011122356899999999999999999999999998 5886643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=320.13 Aligned_cols=241 Identities=27% Similarity=0.460 Sum_probs=195.2
Q ss_pred cccccCCeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhcCCcceeeEEEEEEe
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSLHHHNVIRFIGVLYK 169 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l~h~~iv~~~~~~~~ 169 (433)
..+..+++.+.+.+++|+||+||+.. +|+.+|++++||||+++++++..
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 34556677888888899999888521 69999999999999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhcCCC-----------------------CCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 170 DRKLNLVTEYIAGGTLKELLQDPG-----------------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 170 ~~~~~lv~e~~~g~sL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
++..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.||+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 999999999999999999986531 469999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+||+++.++.+||+|||++.......... ......+|+.|+|||.+.+..++.++|||||
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 262 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYK-------------------ADGNDAIPIRWMPPESIFYNRYTTESDVWAY 262 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC-----------------------CCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cceEEECCCCeEEEeecCCCcccccCcccc-------------------ccCCCcccceecChhhhccCCcCcccccHHH
Confidence 999999999999999999998764322110 1114567899999999998899999999999
Q ss_pred hHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccc
Q psy6593 307 GIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381 (433)
Q Consensus 307 G~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~ 381 (433)
|+++|+|++ |.+||.......... ..........+..+|+.+.+++.+||+.||++||++.+|++.|+++....
T Consensus 263 G~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 263 GVVLWEIFSYGLQPYYGMAHEEVIY-YVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp HHHHHHHHTTTCCTTTTSCHHHHHH-HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred HHHHHHHHhcCCCcCCCCChHHHHH-HHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 999999998 888775432111100 00111122345778999999999999999999999999999999987544
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=308.90 Aligned_cols=229 Identities=26% Similarity=0.498 Sum_probs=187.5
Q ss_pred cccCCeeeeeccCCCcchhhhhcc--------------------------------chHHHHhhcCCcceeeEEEEEEeC
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC--------------------------------GQVAVLRSLHHHNVIRFIGVLYKD 170 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~--------------------------------~E~~~l~~l~h~~iv~~~~~~~~~ 170 (433)
+..+++.+.+.+++|+||+||+.. +|+.++++++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 445667778888888888888521 589999999999999999998654
Q ss_pred CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCC--ccccCCCCcceEEccCCc-----eEEecc
Q psy6593 171 RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN--LIHRDLNSQNCLVREDKT-----VVVADF 243 (433)
Q Consensus 171 ~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~-----~kl~Df 243 (433)
. ++||||+++++|.+.+.+....+++..++.++.|++.||+|||+.| |+||||||+||+++.++. +||+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 4 7999999999999998776778999999999999999999999999 999999999999987776 999999
Q ss_pred ccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec--CCCCCcccCeEehhHHHHHHhcCCCCCC
Q psy6593 244 GLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT--GQEYDETVDVFSYGIVLCEIIGRVPADP 321 (433)
Q Consensus 244 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~~~~~~~ 321 (433)
|+++..... .....||+.|+|||.+. ...++.++||||||+++|+|++|.+||.
T Consensus 174 g~~~~~~~~------------------------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 229 (287)
T 4f0f_A 174 GLSQQSVHS------------------------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229 (287)
T ss_dssp TTCBCCSSC------------------------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred Ccccccccc------------------------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCc
Confidence 998743221 12457899999999984 4567899999999999999999999886
Q ss_pred CCCCCCCC--CCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 322 DYLPRSPD--FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 322 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
........ ............+..+|+.+.+++.+||+.||++||++++|++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 230 EYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp TCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred cccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 54322110 011122233445678899999999999999999999999999999863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=328.67 Aligned_cols=239 Identities=18% Similarity=0.236 Sum_probs=193.3
Q ss_pred cccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCe
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~ 172 (433)
..+..+++.+.+.+|+|+||+||... +|+.+|.+++||||+++++++.+++.
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 34566778999999999999998621 68899999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
+|+||||++|++|.+++.+.+..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 99999999999999999775557999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceec-------CCCCCcccCeEehhHHHHHHhcCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT-------GQEYDETVDVFSYGIVLCEIIGRVPADPDYLP 325 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~~~~~~~~~~~ 325 (433)
... ......||+.|+|||++. ...++.++||||||+++|||++|.+||.....
T Consensus 216 ~~~--------------------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 275 (412)
T 2vd5_A 216 GTV--------------------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST 275 (412)
T ss_dssp SCE--------------------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred Ccc--------------------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH
Confidence 211 111457999999999987 35689999999999999999999999865322
Q ss_pred CCCCCCCchhhhc---cccCCCCcHHHHHHHHHhcccCCCCC---CChhHHH--HHHHhhccc
Q psy6593 326 RSPDFGLDQTDFR---NKFCASCPEPFVRIAFLCCDLNPDQR---PPFEVLE--VWLEGLSMH 380 (433)
Q Consensus 326 ~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~R---Ps~~~i~--~~l~~~~~~ 380 (433)
......+...... ......+++++.+||.+||. +|.+| |++++|+ .||+.+.+.
T Consensus 276 ~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~ 337 (412)
T 2vd5_A 276 AETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD 337 (412)
T ss_dssp HHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred HHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 1111111111111 11235789999999999999 99998 5899998 488776543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=314.71 Aligned_cols=235 Identities=24% Similarity=0.361 Sum_probs=187.4
Q ss_pred CCeeeeeccCCCcchhhhhc------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccC
Q psy6593 126 DGLLFCKEDYNGKYGEACQN------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIA 181 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 181 (433)
+++.....+++|+||+||+. .+|+.+|++++||||+++++++..++..++||||++
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 118 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCT
T ss_pred hccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCC
Confidence 34555556667777766652 279999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCC---CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcc
Q psy6593 182 GGTLKELLQDPG---QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTT 258 (433)
Q Consensus 182 g~sL~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 258 (433)
+++|.+++.... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..........
T Consensus 119 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-- 196 (321)
T 2qkw_B 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH-- 196 (321)
T ss_dssp TCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC--
T ss_pred CCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccc--
Confidence 999999997633 358999999999999999999999999999999999999999999999999998654322111
Q ss_pred ccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC-------
Q psy6593 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG------- 331 (433)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~------- 331 (433)
......||+.|+|||.+.+..++.++||||||+++|+|++|.+|+....+......
T Consensus 197 -----------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 259 (321)
T 2qkw_B 197 -----------------LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259 (321)
T ss_dssp -----------------CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH
T ss_pred -----------------cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc
Confidence 11145689999999999988999999999999999999999988765433221110
Q ss_pred --------CchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 332 --------LDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 332 --------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
..............+..+.+++.+||+.||++||++.++++.|+.+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 000111112223446789999999999999999999999999998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=306.17 Aligned_cols=253 Identities=17% Similarity=0.244 Sum_probs=202.2
Q ss_pred CCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCCcceeeEEEE-EEeCCeeeEEEeccC
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHHHNVIRFIGV-LYKDRKLNLVTEYIA 181 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h~~iv~~~~~-~~~~~~~~lv~e~~~ 181 (433)
+++.+.+.+++|+||+||+.. +|+.++++++|++++..+.+ ...++..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence 456777778888888888622 79999999988775555554 46677899999999
Q ss_pred CCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEE---ccCCceEEeccccchhccCCCCCCcc
Q psy6593 182 GGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV---REDKTVVVADFGLARIIHQGPRAPTT 258 (433)
Q Consensus 182 g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~ 258 (433)
+++|.+++......+++..++.++.|++.||+|||+.||+||||||+||++ +.++.+||+|||++............
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (296)
T 3uzp_A 88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167 (296)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccc
Confidence 899999998555679999999999999999999999999999999999999 48899999999999876554321110
Q ss_pred ccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc---hh
Q psy6593 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD---QT 335 (433)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~---~~ 335 (433)
.........||+.|+|||.+.+..++.++||||||+++|+|++|.+||............. ..
T Consensus 168 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 3uzp_A 168 --------------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp --------------CCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred --------------ccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc
Confidence 0011225679999999999999999999999999999999999999887543322211111 11
Q ss_pred hh---ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccccCCCCCCCchhh
Q psy6593 336 DF---RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPLPSDLEA 393 (433)
Q Consensus 336 ~~---~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~~~~~~~~~~~~ 393 (433)
.. .......+|+.+.+++.+||+.||++||++++|++.|+.+..........+.+|+.
T Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 3uzp_A 234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGG
T ss_pred ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence 11 11233778999999999999999999999999999999999888888888888875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=319.58 Aligned_cols=227 Identities=21% Similarity=0.333 Sum_probs=191.2
Q ss_pred cccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeee
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 174 (433)
...+++.+.+.+++|+||.||... +|+.+|++++||||+++++++.+++.+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 455678888999999999998621 5899999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCC
Q psy6593 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
+||||++|++|.+++.+.+ .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 118 lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~- 195 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp EEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred EEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCCc-
Confidence 9999999999999997643 59999999999999999999999999999999999999999999999999998653321
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCch
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQ 334 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~ 334 (433)
....||+.|+|||++.+..++.++||||||+++|+|++|.+||........... .
T Consensus 196 -----------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~--i 250 (350)
T 1rdq_E 196 -----------------------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK--I 250 (350)
T ss_dssp -----------------------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--H
T ss_pred -----------------------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHH--H
Confidence 155799999999999999999999999999999999999998864321111000 1
Q ss_pred hhhccccCCCCcHHHHHHHHHhcccCCCCCCC-----hhHHHH--HHHh
Q psy6593 335 TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP-----FEVLEV--WLEG 376 (433)
Q Consensus 335 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~i~~--~l~~ 376 (433)
......++..++..+.++|.+||+.||.+||+ +++|++ |++.
T Consensus 251 ~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 251 VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HcCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 11123355778999999999999999999998 888873 6554
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=320.22 Aligned_cols=233 Identities=21% Similarity=0.309 Sum_probs=190.9
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhc-CCcceeeEEEEEEeCCe
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSL-HHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~ 172 (433)
.+..+++.+.+.+|+|+||.||++. .|..+|.++ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 3456778888999999999998621 578888887 89999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
+|+||||++|++|.+++.+.+ .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 999999999999999997643 5999999999999999999999999999999999999999999999999999754322
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL 332 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~ 332 (433)
.. ......||+.|+|||++.+..++.++||||||+++|||++|.+||...........
T Consensus 172 ~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~- 229 (345)
T 1xjd_A 172 DA---------------------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS- 229 (345)
T ss_dssp TC---------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-
T ss_pred CC---------------------cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHH-
Confidence 11 11256899999999999999999999999999999999999998865322111000
Q ss_pred chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChh-HHH--HHHHhhc
Q psy6593 333 DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFE-VLE--VWLEGLS 378 (433)
Q Consensus 333 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~-~i~--~~l~~~~ 378 (433)
.......++..+++++.++|.+||+.||++||++. +|+ .||+.+.
T Consensus 230 -i~~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 230 -IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp -HHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred -HHhCCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 11112334567889999999999999999999997 776 4666543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=320.85 Aligned_cols=228 Identities=20% Similarity=0.301 Sum_probs=185.8
Q ss_pred CCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEe
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTE 178 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 178 (433)
+++.+.+.+++|+||.||+.. +|+.+|++++||||+++++++.+++..|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 346777888899999888621 69999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccC---CceEEeccccchhccCCCCC
Q psy6593 179 YIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRED---KTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 179 ~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~ 255 (433)
|++|++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+||+++.+ +.+||+|||++........
T Consensus 109 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~- 186 (362)
T 2bdw_A 109 LVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA- 186 (362)
T ss_dssp CCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS-
T ss_pred cCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc-
Confidence 999999999987643 59999999999999999999999999999999999999854 4599999999976543221
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~ 335 (433)
.....||+.|+|||++.+..++.++||||||+++|+|++|.+||...........+...
T Consensus 187 ---------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~ 245 (362)
T 2bdw_A 187 ---------------------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 245 (362)
T ss_dssp ---------------------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred ---------------------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 11457999999999999989999999999999999999999988653211110000000
Q ss_pred hh--ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHh
Q psy6593 336 DF--RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEG 376 (433)
Q Consensus 336 ~~--~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~ 376 (433)
.. .......+++++.+||.+||+.||++||++.+++ .|+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 246 AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 00 1111245789999999999999999999999998 47764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=305.40 Aligned_cols=207 Identities=24% Similarity=0.410 Sum_probs=166.3
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+++|++++||||+++++++..++..++||||+++ +|.+++......+++..++.++.|++.||+|||+.||+|||||
T Consensus 49 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 127 (288)
T 1ob3_A 49 REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127 (288)
T ss_dssp HHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 799999999999999999999999999999999975 9999998766679999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEe
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFS 305 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws 305 (433)
|+||+++.++.+||+|||++......... .....||+.|+|||++.+ ..++.++||||
T Consensus 128 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 186 (288)
T 1ob3_A 128 PQNLLINREGELKIADFGLARAFGIPVRK---------------------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWS 186 (288)
T ss_dssp GGGEEECTTSCEEECCTTHHHHHCC------------------------------CCCTTCCHHHHTTCCSCCTHHHHHH
T ss_pred HHHEEEcCCCCEEEeECccccccCccccc---------------------cccccccccccCchheeCCCCCCcHHHHHH
Confidence 99999999999999999999876432111 114578999999999876 45899999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCC--------------CCC-------------CchhhhccccCCCCcHHHHHHHHHhcc
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSP--------------DFG-------------LDQTDFRNKFCASCPEPFVRIAFLCCD 358 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~--------------~~~-------------~~~~~~~~~~~~~~~~~l~~li~~~l~ 358 (433)
||+++|+|++|.+||........ ... .............+++++.+|+.+||+
T Consensus 187 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 266 (288)
T 1ob3_A 187 VGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLK 266 (288)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTC
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcC
Confidence 99999999999988854321000 000 000000112235688999999999999
Q ss_pred cCCCCCCChhHHHH--HHH
Q psy6593 359 LNPDQRPPFEVLEV--WLE 375 (433)
Q Consensus 359 ~~p~~RPs~~~i~~--~l~ 375 (433)
.||++||+++++++ ||+
T Consensus 267 ~dP~~Rpt~~e~l~hp~f~ 285 (288)
T 1ob3_A 267 LDPNQRITAKQALEHAYFK 285 (288)
T ss_dssp SSTTTSCCHHHHHTSGGGG
T ss_pred CCcccCCCHHHHhcCcchh
Confidence 99999999999974 544
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=312.15 Aligned_cols=206 Identities=25% Similarity=0.390 Sum_probs=166.0
Q ss_pred chHHHHhhcCCcceeeEEEEEEe--CCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
+|+++|++++||||+++++++.+ ++..++||||+++++|.+++.. ..+++..++.++.|++.||+|||+.||+|||
T Consensus 85 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~D 162 (298)
T 2zv2_A 85 QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHRD 162 (298)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 48999999999999999999986 5689999999999999887654 4699999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC---CCccc
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE---YDETV 301 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~ 301 (433)
|||+||+++.++.+||+|||++......... .....||+.|+|||.+.+.. ++.++
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 221 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDAL---------------------LSNTVGTPAFMAPESLSETRKIFSGKAL 221 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSCE---------------------ECCCCSCGGGCCGGGCCTTCCCEESHHH
T ss_pred CCHHHEEECCCCCEEEecCCCcccccccccc---------------------ccCCcCCccccChhhhccCCCCCCCchh
Confidence 9999999999999999999999865432211 11457999999999998755 37789
Q ss_pred CeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHH
Q psy6593 302 DVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLE 375 (433)
Q Consensus 302 DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~ 375 (433)
||||||+++|+|++|.+||...........+............+++.+.++|.+||+.||++||++++++ .||+
T Consensus 222 Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 222 DVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred hhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 9999999999999999887543111000000001111112256889999999999999999999999997 3554
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=316.35 Aligned_cols=244 Identities=28% Similarity=0.449 Sum_probs=185.8
Q ss_pred ccccccccCCeeeeeccCCCcchhhhhcc------------------------------chHHHHhhcCCcceeeEEEEE
Q psy6593 118 LDNWYFEKDGLLFCKEDYNGKYGEACQNC------------------------------GQVAVLRSLHHHNVIRFIGVL 167 (433)
Q Consensus 118 l~~~~~~~~~~~~~~~~~~g~fg~v~~~~------------------------------~E~~~l~~l~h~~iv~~~~~~ 167 (433)
+....+..+++.+.+.+++|+||+||+.. +|++++++++||||+++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 34455667778888889999999888521 799999999999999999999
Q ss_pred EeCCee------eEEEeccCCCCHHHHhcC-----CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCC
Q psy6593 168 YKDRKL------NLVTEYIAGGTLKELLQD-----PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDK 236 (433)
Q Consensus 168 ~~~~~~------~lv~e~~~g~sL~~~l~~-----~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~ 236 (433)
...+.. ++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.||+||||||+||+++.++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence 877655 999999999999999853 122599999999999999999999999999999999999999999
Q ss_pred ceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-
Q psy6593 237 TVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG- 315 (433)
Q Consensus 237 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~- 315 (433)
.+||+|||++.......... ......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~ 235 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYR-------------------QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235 (323)
T ss_dssp CEEECCCCC------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CEEEeecccccccccccccc-------------------ccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhC
Confidence 99999999998764432211 1113456888999999999999999999999999999998
Q ss_pred CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccc
Q psy6593 316 RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381 (433)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~ 381 (433)
|.+||......... ...........+..+++.+.+++.+||+.||++||++.++++.|+++....
T Consensus 236 g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 236 GQTPYAGIENAEIY-NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp SCCTTTTCCGGGHH-HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CCCCccccChHHHH-HHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 88887653321111 011111223345778899999999999999999999999999999987644
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=313.04 Aligned_cols=233 Identities=18% Similarity=0.281 Sum_probs=188.3
Q ss_pred cccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhc-CCcceeeEEEEEEeCCee
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSL-HHHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 173 (433)
+..+++.+.+.+++|+||.||+.. +|+.+|+++ +||||+++++++.+++.+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 345667888888899999888521 588899888 899999999999999999
Q ss_pred eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 174 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
|+||||++|++|.+++.+.+ .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 99999999999999987643 59999999999999999999999999999999999999999999999999997543221
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~ 333 (433)
. ......||+.|+|||++.+..++.++||||||+++|||++|.+||.............
T Consensus 165 ~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 223 (345)
T 3a8x_A 165 D---------------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 223 (345)
T ss_dssp C---------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------C
T ss_pred C---------------------cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccccc
Confidence 1 1125689999999999999999999999999999999999999885422111100000
Q ss_pred -------hhhhccccCCCCcHHHHHHHHHhcccCCCCCCCh------hHHH--HHHHhh
Q psy6593 334 -------QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF------EVLE--VWLEGL 377 (433)
Q Consensus 334 -------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~------~~i~--~~l~~~ 377 (433)
.......++..++..+.++|.+||+.||.+||++ ++|+ .||+.+
T Consensus 224 ~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 224 EDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 0111223557789999999999999999999996 5665 366543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=322.92 Aligned_cols=230 Identities=17% Similarity=0.289 Sum_probs=190.4
Q ss_pred CCeeeeeccCCCcchhhhhcc-------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEecc
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYI 180 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 180 (433)
+.+.+.+.+++|+||+||+.. +|+++|++++||||+++++++.+++..++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 457888899999999998622 6999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc--CCceEEeccccchhccCCCCCCcc
Q psy6593 181 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE--DKTVVVADFGLARIIHQGPRAPTT 258 (433)
Q Consensus 181 ~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~ 258 (433)
+|++|.+++...+..+++..++.++.||+.||+|||+.||+||||||+||+++. ++.+||+|||++.......
T Consensus 131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~----- 205 (387)
T 1kob_A 131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----- 205 (387)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-----
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-----
Confidence 999999999876667999999999999999999999999999999999999974 5789999999998654321
Q ss_pred ccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh--h
Q psy6593 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT--D 336 (433)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~--~ 336 (433)
......||+.|+|||++.+..++.++||||||+++|+|++|.+||...........+... .
T Consensus 206 -----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~ 268 (387)
T 1kob_A 206 -----------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE 268 (387)
T ss_dssp -----------------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC
T ss_pred -----------------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 112557999999999999999999999999999999999999988653211100000000 1
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
+.......+++++.++|.+||+.||++||+++++++ ||+..
T Consensus 269 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 112233578999999999999999999999999985 66543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=315.82 Aligned_cols=258 Identities=23% Similarity=0.316 Sum_probs=192.4
Q ss_pred cccccccccCCeeeeeccCCCcchhhhhcc------------------------chHHHHhhcCCcceeeEEEEEEeCCe
Q psy6593 117 MLDNWYFEKDGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 117 ~l~~~~~~~~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~ 172 (433)
.+..+.+..+++.+.+.+++|+||.||+.. +|+.++++++|+||+++++++...+.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 345666777888999999999999998621 79999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
.++||||++|++|.+++...+..+++..++.++.|++.||+|||+.|++||||||+||+++ ++.++|+|||++......
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 9999999999999999988666799999999999999999999999999999999999998 679999999998765322
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecC---------CCCCcccCeEehhHHHHHHhcCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG---------QEYDETVDVFSYGIVLCEIIGRVPADPDY 323 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~ell~~~~~~~~~ 323 (433)
.... .........||+.|+|||.+.+ ..++.++||||||+++|+|++|..||...
T Consensus 183 ~~~~----------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 246 (319)
T 2y4i_B 183 QAGR----------------REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246 (319)
T ss_dssp ---------------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred cccc----------------cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1110 0111224568999999999875 35788999999999999999998887543
Q ss_pred CCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccccCCCCCCCch
Q psy6593 324 LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPLPSDL 391 (433)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~~~~~~~~~~ 391 (433)
........+............++.++.+++.+||+.||++||++.++++.|+.+.............|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~ 314 (319)
T 2y4i_B 247 PAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW 314 (319)
T ss_dssp CHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------------
T ss_pred CHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccc
Confidence 21111100001111111124678899999999999999999999999999999876554433333333
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=315.88 Aligned_cols=232 Identities=25% Similarity=0.369 Sum_probs=180.0
Q ss_pred cccCCeeeeeccCCCcchhhhhcc------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEe
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTE 178 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 178 (433)
...+++.+.+.+|+|+||+||+.. +|+.++++++||||+++++++.+.+..++|||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 345668888999999999998622 79999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCc--eEEeccccchhccCCCCCC
Q psy6593 179 YIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKT--VVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 179 ~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 256 (433)
|++|++|.+++...+ .+++..++.++.|++.||+|||+.||+||||||+||+++.++. +||+|||+++.......
T Consensus 97 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~-- 173 (361)
T 3uc3_A 97 YASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 173 (361)
T ss_dssp CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC--
Confidence 999999999986643 5999999999999999999999999999999999999987665 99999999874322111
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcc-cCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDET-VDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~ 335 (433)
.....||+.|+|||++.+..++.+ +||||||+++|+|++|.+||...............
T Consensus 174 --------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 233 (361)
T 3uc3_A 174 --------------------PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR 233 (361)
T ss_dssp ---------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHH
T ss_pred --------------------CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHH
Confidence 124579999999999988877655 89999999999999999988654332221111111
Q ss_pred hh--cccc--CCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhh
Q psy6593 336 DF--RNKF--CASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGL 377 (433)
Q Consensus 336 ~~--~~~~--~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~ 377 (433)
.. ...+ ...+++.+.+||.+||+.||++|||+++++ .||...
T Consensus 234 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 234 ILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 11 1111 235789999999999999999999999998 577653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=315.55 Aligned_cols=234 Identities=28% Similarity=0.440 Sum_probs=187.7
Q ss_pred ccCCeeeeeccCCCcchhhhhc-------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEe
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQN-------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTE 178 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~-------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 178 (433)
..+++...+.+++|+||.||+. .+|++++++++||||+++++++...+..++|||
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 107 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 107 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEE
T ss_pred HhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEE
Confidence 4445666667777777777752 169999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCC---CCCCChHHHHHHHHHHHHHHhhhhcC---CccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 179 YIAGGTLKELLQDP---GQPLPWGQRVNFARDIAAGMTYLHSM---NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 179 ~~~g~sL~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
|+++++|.+++... ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++......
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 187 (326)
T 3uim_A 108 YMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187 (326)
T ss_dssp CCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSS
T ss_pred eccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcc
Confidence 99999999999763 23599999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCC---------
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDY--------- 323 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~--------- 323 (433)
.... .....||+.|+|||.+.+..++.++||||||+++|+|++|.+||...
T Consensus 188 ~~~~--------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (326)
T 3uim_A 188 DTHV--------------------TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247 (326)
T ss_dssp SSCE--------------------ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred cccc--------------------cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence 2211 12456999999999999888999999999999999999999887411
Q ss_pred --------CCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 324 --------LPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 324 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
......................+..+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 001111111111122222334457899999999999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=319.95 Aligned_cols=237 Identities=24% Similarity=0.431 Sum_probs=183.1
Q ss_pred eeeeeccCCCcchhhhhcc-----------------------------chHHHHhhcCCcceeeEEEEEEe-CCeeeEEE
Q psy6593 128 LLFCKEDYNGKYGEACQNC-----------------------------GQVAVLRSLHHHNVIRFIGVLYK-DRKLNLVT 177 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~~-----------------------------~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 177 (433)
+.+.+.+++|+||+||+.. +|+.+|++++||||+++++++.. ++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 3455678899999988411 68999999999999999998754 46789999
Q ss_pred eccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCc
Q psy6593 178 EYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPT 257 (433)
Q Consensus 178 e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 257 (433)
||+++++|.+++.+.+..+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++..........
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~ 250 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 250 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccccc
Confidence 99999999999988777799999999999999999999999999999999999999999999999999986543221110
Q ss_pred cccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhh
Q psy6593 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTD 336 (433)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~ 336 (433)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |.+|+.......... .....
T Consensus 251 -----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~-~~~~~ 312 (373)
T 3c1x_A 251 -----------------HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-YLLQG 312 (373)
T ss_dssp ------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH-HHHTT
T ss_pred -----------------cccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH-HHHcC
Confidence 01124567889999999999999999999999999999997 788776543222111 11111
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccccc
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLS 382 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~ 382 (433)
.....+..+|+.+.+++.+||+.||++||++++|++.|+.+.....
T Consensus 313 ~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 313 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 2223456789999999999999999999999999999998876543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=315.16 Aligned_cols=242 Identities=27% Similarity=0.491 Sum_probs=188.9
Q ss_pred ccccCCeeeeeccCCCcchhhhhc-----------------------------cchHHHHhhcCCcceeeEEEEEEeC--
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQN-----------------------------CGQVAVLRSLHHHNVIRFIGVLYKD-- 170 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~-----------------------------~~E~~~l~~l~h~~iv~~~~~~~~~-- 170 (433)
.+..+.+.+.+.+++|+||+||+. .+|+++|++++||||+++++++...
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 345566777888888888888642 1799999999999999999998643
Q ss_pred CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhcc
Q psy6593 171 RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIH 250 (433)
Q Consensus 171 ~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 250 (433)
...++||||+++++|.+++...+..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 56899999999999999998766669999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCC-----
Q psy6593 251 QGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLP----- 325 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~----- 325 (433)
....... ......+++.|+|||.+.+..++.++||||||+++|+|++|..++.....
T Consensus 166 ~~~~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~ 227 (295)
T 3ugc_A 166 QDKEFFK------------------VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 227 (295)
T ss_dssp ----------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHH
T ss_pred CCcceee------------------eccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhh
Confidence 4321110 11133567789999999999999999999999999999998776643110
Q ss_pred --CCCCCC--------CchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccc
Q psy6593 326 --RSPDFG--------LDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381 (433)
Q Consensus 326 --~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~ 381 (433)
...... ..........+..+|+++.+++.+||+.||++|||+++|++.|+.+....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 228 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 000000 00111122345778999999999999999999999999999999876543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=303.48 Aligned_cols=228 Identities=20% Similarity=0.310 Sum_probs=167.4
Q ss_pred CCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEE
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVT 177 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 177 (433)
+++.+.+.+++|+||.||+.. +|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 446667777788888777521 6899999999999999999999999999999
Q ss_pred eccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCc
Q psy6593 178 EYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPT 257 (433)
Q Consensus 178 e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 257 (433)
||+++++|.+++......+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--- 167 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE--- 167 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC---
Confidence 99999999999988666799999999999999999999999999999999999999999999999999876543211
Q ss_pred cccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhh
Q psy6593 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDF 337 (433)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~ 337 (433)
......||+.|+|||.+.+..++.++||||||+++|+|++|.+|+...............
T Consensus 168 ------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-- 227 (278)
T 3cok_A 168 ------------------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-- 227 (278)
T ss_dssp ------------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS--
T ss_pred ------------------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc--
Confidence 112456899999999999988999999999999999999999888654332222111111
Q ss_pred ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 338 RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 338 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
....+..++.++.+++.+||+.||++||+++++++ ||..
T Consensus 228 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 228 DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence 12345668899999999999999999999999984 5543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=317.58 Aligned_cols=232 Identities=21% Similarity=0.281 Sum_probs=189.3
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhc-CCcceeeEEEEEEeCCe
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSL-HHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~ 172 (433)
.+..+++.+.+.+|+|+||.||+.. .|..+|..+ +||||+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 3566778899999999999998621 578888888 79999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
+|+||||++|++|.+++.+.+ .+++..++.++.||+.||+|||+.||+||||||+||+++.+|.+||+|||+++.....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 999999999999999997643 5999999999999999999999999999999999999999999999999999854322
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL 332 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~ 332 (433)
.. ......||+.|+|||++.+..++.++||||||+++|||++|.+||...........
T Consensus 175 ~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~- 232 (353)
T 2i0e_A 175 GV---------------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS- 232 (353)
T ss_dssp TC---------------------CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-
T ss_pred Cc---------------------ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHH-
Confidence 11 11256799999999999999999999999999999999999998865322111000
Q ss_pred chhhhccccCCCCcHHHHHHHHHhcccCCCCCCC-----hhHHH--HHHHhh
Q psy6593 333 DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP-----FEVLE--VWLEGL 377 (433)
Q Consensus 333 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~i~--~~l~~~ 377 (433)
.......++..+++++.+||.+||+.||.+||+ +++|+ .|++.+
T Consensus 233 -i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 233 -IMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp -HHHCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred -HHhCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 111122355778999999999999999999995 47776 355543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=314.69 Aligned_cols=238 Identities=28% Similarity=0.465 Sum_probs=186.9
Q ss_pred ccCCeeeeeccCCCcchhhhhc------------------------------cchHHHHhhcCCcceeeEEEEEEeCCee
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQN------------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~------------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 173 (433)
..+.+...+.+++|+||+||++ .+|+.++++++||||+++++++...+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 4445666677778888877752 1689999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 174 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
++||||+++++|.+++......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 99999999999999998766679999999999999999999999999999999999999999999999999998764432
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCC
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGL 332 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~ 332 (433)
.... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||......... ..
T Consensus 202 ~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~-~~ 262 (333)
T 1mqb_A 202 EATY------------------TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-KA 262 (333)
T ss_dssp ---------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HH
T ss_pred cccc------------------ccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHH-HH
Confidence 1110 0113346788999999999899999999999999999997 88887543221110 00
Q ss_pred chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccc
Q psy6593 333 DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMH 380 (433)
Q Consensus 333 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~ 380 (433)
.........+..++..+.+++.+||+.+|++||++.+|++.|+.+...
T Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 263 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 111122234567899999999999999999999999999999987643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=314.46 Aligned_cols=225 Identities=21% Similarity=0.356 Sum_probs=183.1
Q ss_pred eeeeeccCCCcchhhhhc-------------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeEE
Q psy6593 128 LLFCKEDYNGKYGEACQN-------------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~-------------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 176 (433)
+.+.+.+++|+||.||+. .+|+.+|++++||||+++++++.+++..++|
T Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 92 (326)
T 2y0a_A 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 92 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 556667777777777651 1699999999999999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCC----ceEEeccccchhccCC
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDK----TVVVADFGLARIIHQG 252 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~ 252 (433)
|||++|++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~ 171 (326)
T 2y0a_A 93 LELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171 (326)
T ss_dssp EECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTT
T ss_pred EEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCC
Confidence 9999999999999764 4599999999999999999999999999999999999999877 8999999999876432
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL 332 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~ 332 (433)
... ....||+.|+|||++.+..++.++||||||+++|+|++|.+||...........+
T Consensus 172 ~~~----------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 229 (326)
T 2y0a_A 172 NEF----------------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 229 (326)
T ss_dssp SCC----------------------CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred Ccc----------------------ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence 211 1457999999999999989999999999999999999999888543211100000
Q ss_pred ch--hhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHH
Q psy6593 333 DQ--TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLE 375 (433)
Q Consensus 333 ~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~ 375 (433)
.. ..+.......++..+.++|.+||+.||++||+++++++ ||.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 276 (326)
T 2y0a_A 230 SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276 (326)
T ss_dssp HHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTS
T ss_pred HhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCcc
Confidence 00 01111223567899999999999999999999999985 554
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=317.38 Aligned_cols=230 Identities=19% Similarity=0.257 Sum_probs=183.4
Q ss_pred cccCCeeeeeccCCCcchhhhhc--------------------------------cchHHHHhhcCCcceeeEEEEEEeC
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQN--------------------------------CGQVAVLRSLHHHNVIRFIGVLYKD 170 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~--------------------------------~~E~~~l~~l~h~~iv~~~~~~~~~ 170 (433)
+..+++.+.+.+++|+||.||+. .+|+.+|++++||||+++++++..+
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 44566777788888888887731 1599999999999999999999999
Q ss_pred CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhcc
Q psy6593 171 RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIH 250 (433)
Q Consensus 171 ~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 250 (433)
+..|+||||++|++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 99999999999999999997643 58999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC
Q psy6593 251 QGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF 330 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~ 330 (433)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|.+||..........
T Consensus 173 ~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 231 (327)
T 3a62_A 173 HDGT---------------------VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 231 (327)
T ss_dssp ---------------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cCCc---------------------cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 2211 1114578999999999999899999999999999999999999886432111000
Q ss_pred CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHHH--HHHh
Q psy6593 331 GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLEV--WLEG 376 (433)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~~--~l~~ 376 (433)
........++..+++.+.++|.+||+.||.+|| +++++++ ||+.
T Consensus 232 --~i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 232 --KILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp --HHHHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred --HHHhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 011112234567899999999999999999999 6677764 5554
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=317.25 Aligned_cols=239 Identities=15% Similarity=0.173 Sum_probs=184.3
Q ss_pred cCCeeeeeccCCCcchhhhhcc---------------------------------------chHHHHhhcCCcceeeEEE
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC---------------------------------------GQVAVLRSLHHHNVIRFIG 165 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~---------------------------------------~E~~~l~~l~h~~iv~~~~ 165 (433)
.+++.+.+.+++|+||+||++. +|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4567888889999999888621 3455677779999999999
Q ss_pred EEEe----CCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCC--ceE
Q psy6593 166 VLYK----DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDK--TVV 239 (433)
Q Consensus 166 ~~~~----~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~--~~k 239 (433)
++.. +...++||||+ |++|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+||+++.++ .+|
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 9988 67899999999 999999998754 699999999999999999999999999999999999999877 999
Q ss_pred EeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCC
Q psy6593 240 VADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPA 319 (433)
Q Consensus 240 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~ 319 (433)
|+|||+++........... .........||+.|+|||++.+..++.++||||||+++|||++|.+|
T Consensus 194 L~Dfg~a~~~~~~~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p 259 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQY--------------QENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259 (345)
T ss_dssp ECCCTTCEESSGGGCCCCC--------------CCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred EEeCCCceecccccccccc--------------hhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999876432211100 01111256799999999999999999999999999999999999988
Q ss_pred CCCCCCCCCCCCCchhhhccccC---------CCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 320 DPDYLPRSPDFGLDQTDFRNKFC---------ASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
|....................++ ..+|+++.+++.+||+.||++||++++|++.|+.+..
T Consensus 260 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 260 WEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp TGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred ccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 85422221111111111111222 2788999999999999999999999999999998653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=306.02 Aligned_cols=234 Identities=22% Similarity=0.371 Sum_probs=187.3
Q ss_pred cccCCeeeeeccCCCcchhhhhc-----------------------------cchHHHHhhcCCcceeeEEEEEEeCCee
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQN-----------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~-----------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 173 (433)
+..+++.+.+.+++|+||+||+. .+|+.++++++||||+++++++. ++..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 87 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE-EEPT 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC-SSSC
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCC
Confidence 34555667777777888777752 15999999999999999999976 4567
Q ss_pred eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 174 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
++||||+++++|.+++...+..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 89999999999999997765679999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCC
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGL 332 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~ 332 (433)
... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||......... ..
T Consensus 168 ~~~--------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~-~~ 226 (281)
T 3cc6_A 168 YYK--------------------ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI-GV 226 (281)
T ss_dssp -------------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH-HH
T ss_pred ccc--------------------cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH-HH
Confidence 111 113456888999999998899999999999999999997 88887543221111 01
Q ss_pred chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 333 DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 333 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
.........+..+++.+.+++.+||+.||++||++.++++.|+.+.
T Consensus 227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 227 LEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 1111222345678899999999999999999999999999998865
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=304.27 Aligned_cols=228 Identities=24% Similarity=0.334 Sum_probs=177.8
Q ss_pred CeeeeeccCCCcchhhhhc---------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 127 GLLFCKEDYNGKYGEACQN---------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~---------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
++.+.+.+++|+||+||++ .+|+.+|++++||||+++++++.+++..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 4556667777777777652 2699999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccc
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
+++ +|.+.+...+..+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---- 157 (292)
T 3o0g_A 83 CDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC---- 157 (292)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC----
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc----
Confidence 965 677666554567999999999999999999999999999999999999999999999999999876432221
Q ss_pred cccchhhhhhhcccccceeeeccCccccccceecCCC-CCcccCeEehhHHHHHHhcC-CCCCCCCCCC-----------
Q psy6593 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE-YDETVDVFSYGIVLCEIIGR-VPADPDYLPR----------- 326 (433)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~~-~~~~~~~~~~----------- 326 (433)
.....||+.|+|||++.+.. ++.++||||||+++|+|++| .|++......
T Consensus 158 -----------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~ 220 (292)
T 3o0g_A 158 -----------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220 (292)
T ss_dssp -----------------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHC
T ss_pred -----------------ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC
Confidence 11457899999999998765 79999999999999999954 5544322100
Q ss_pred ---CCCCC-------------CchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 327 ---SPDFG-------------LDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 327 ---~~~~~-------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
...+. .............+++.+.+|+.+||+.||++|||++++++ ||++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred CCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 00000 00001111223467899999999999999999999999984 6654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=311.44 Aligned_cols=227 Identities=20% Similarity=0.323 Sum_probs=186.8
Q ss_pred ccCCeeeeeccCCCcchhhhhc--------------------------------cchHHHHhhcCCcceeeEEEEEEeCC
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQN--------------------------------CGQVAVLRSLHHHNVIRFIGVLYKDR 171 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~--------------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~ 171 (433)
..+++.+.+.+++|+||+||+. .+|+.+|++++||||+++++++..++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 4455777777788888877752 16899999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCc--------eEEecc
Q psy6593 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKT--------VVVADF 243 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--------~kl~Df 243 (433)
..++||||++|++|.+++.+.+..+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+||
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 999999999999999999876656999999999999999999999999999999999999998876 999999
Q ss_pred ccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhc-CCCCCC
Q psy6593 244 GLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIG-RVPADP 321 (433)
Q Consensus 244 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~-~~~~~~ 321 (433)
|++...... ....||+.|+|||.+.+ ..++.++||||||+++|+|++ +.+|+.
T Consensus 166 g~~~~~~~~-------------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~ 220 (289)
T 4fvq_A 166 GISITVLPK-------------------------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS 220 (289)
T ss_dssp CSCTTTSCH-------------------------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cccccccCc-------------------------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc
Confidence 998654221 13457889999999987 678999999999999999997 555543
Q ss_pred CCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 322 DYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
..... ............+...++++.+++.+||+.||++|||++++++.|+.+.
T Consensus 221 ~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 221 ALDSQ---RKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp TSCHH---HHHHHHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred ccchH---HHHHHhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 32110 0111112233345667889999999999999999999999999999876
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=312.89 Aligned_cols=234 Identities=21% Similarity=0.343 Sum_probs=183.2
Q ss_pred CCeeeeeccCCCcchhhhhc--------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 126 DGLLFCKEDYNGKYGEACQN--------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~--------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
+++.+.+.+|+|+||+||++ .+|+++|++++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 34666777788888877752 2799999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccc
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
++ ++|.+++...+..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~---- 156 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT---- 156 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc----
Confidence 96 5999998876677999999999999999999999999999999999999999999999999999764432111
Q ss_pred cccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCC-----------
Q psy6593 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS----------- 327 (433)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~----------- 327 (433)
.....||+.|+|||.+.+ ..++.++||||||+++|+|++|.+||.......
T Consensus 157 -----------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 219 (324)
T 3mtl_A 157 -----------------YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGT 219 (324)
T ss_dssp -----------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred -----------------cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 114578999999999876 568999999999999999999998886532110
Q ss_pred ---CCCC-C-chh------------hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhcccc
Q psy6593 328 ---PDFG-L-DQT------------DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLSMHL 381 (433)
Q Consensus 328 ---~~~~-~-~~~------------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~~~~ 381 (433)
.... . ... .........+++++.+||.+||+.||.+|||++++++ ||..+....
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 292 (324)
T 3mtl_A 220 PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI 292 (324)
T ss_dssp CCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred CChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence 0000 0 000 0001122467889999999999999999999999984 888765443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=312.97 Aligned_cols=242 Identities=27% Similarity=0.409 Sum_probs=196.8
Q ss_pred cccccccCCeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhc-CCcceeeEEEE
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSL-HHHNVIRFIGV 166 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l-~h~~iv~~~~~ 166 (433)
..+.+..+++.+.+.+++|+||+||++. +|+.+|+++ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 3455667778888899999999987531 689999999 79999999999
Q ss_pred EEeCC-eeeEEEeccCCCCHHHHhcCCCC---------------CCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcce
Q psy6593 167 LYKDR-KLNLVTEYIAGGTLKELLQDPGQ---------------PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 230 (433)
Q Consensus 167 ~~~~~-~~~lv~e~~~g~sL~~~l~~~~~---------------~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Ni 230 (433)
+...+ ..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.||+||||||+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 88754 59999999999999999976432 288999999999999999999999999999999999
Q ss_pred EEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHH
Q psy6593 231 LVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310 (433)
Q Consensus 231 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 310 (433)
+++.++.+||+|||++.......... ......+|+.|+|||.+.+..++.++||||||+++
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 240 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPDYV-------------------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSE-------------------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred EECCCCCEEECCCccccccccCccce-------------------eccCCCcceeecCchhhccccccchhHHHHHHHHH
Confidence 99999999999999998654332211 11145678899999999998999999999999999
Q ss_pred HHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 311 CEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 311 ~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
|+|++ |.+|+.....................+..+++.+.+++.+||+.||.+||++++|++.|+.+..
T Consensus 241 ~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 241 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp HHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 99997 8888765332211111111122233456788999999999999999999999999999998764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=304.19 Aligned_cols=231 Identities=23% Similarity=0.355 Sum_probs=190.8
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCee
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~ 173 (433)
.+..+++.+.+.++.|+||+||+.. +|+.++++++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 4566778888999999999998631 589999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 174 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
++||||+++++|.+++.+.. .+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 99999999999999987643 59999999999999999999999999999999999999999999999999986543221
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~ 333 (433)
.....||+.|+|||.+.+..++.++||||||+++|+|++|.+||......... ..
T Consensus 164 -----------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~ 218 (279)
T 3fdn_A 164 -----------------------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY--KR 218 (279)
T ss_dssp ---------------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HH
T ss_pred -----------------------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH--HH
Confidence 11457899999999999999999999999999999999999887542211100 01
Q ss_pred hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhc
Q psy6593 334 QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 334 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
.......++..+++.+.+|+.+||+.||.+||++++++ .||+...
T Consensus 219 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 219 ISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 11222345577889999999999999999999999999 4887643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=312.37 Aligned_cols=235 Identities=28% Similarity=0.393 Sum_probs=191.3
Q ss_pred ccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhc-CCcceeeEEEEEEeCCeee
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSL-HHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 174 (433)
..+++.+.+.+++|+||.||++. +|+++|+++ +||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 44557777888888888888521 599999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHHhcCCC---------------CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceE
Q psy6593 175 LVTEYIAGGTLKELLQDPG---------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVV 239 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~k 239 (433)
+||||+++++|.+++.+.+ ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+|
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEE
Confidence 9999999999999997643 4699999999999999999999999999999999999999999999
Q ss_pred EeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCC
Q psy6593 240 VADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVP 318 (433)
Q Consensus 240 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~ 318 (433)
|+|||+++....... .....+++.|+|||.+.+..++.++||||||+++|+|++ |.+
T Consensus 183 L~Dfg~~~~~~~~~~----------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 240 (327)
T 1fvr_A 183 IADFGLSRGQEVYVK----------------------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 240 (327)
T ss_dssp ECCTTCEESSCEECC----------------------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred EcccCcCcccccccc----------------------ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCC
Confidence 999999874322111 113456888999999998889999999999999999997 888
Q ss_pred CCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccc
Q psy6593 319 ADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381 (433)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~ 381 (433)
||.......... ..........+..+++.+.+++.+||+.+|.+||+++++++.|+.+....
T Consensus 241 pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 241 PYCGMTCAELYE-KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp TTTTCCHHHHHH-HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CCCCCcHHHHHH-HhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 875432211110 11111223345678899999999999999999999999999999877544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=308.82 Aligned_cols=240 Identities=28% Similarity=0.494 Sum_probs=194.6
Q ss_pred ccccccCCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEE
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 176 (433)
.|.+..+++.+.+.+++|+||+||+.. +|+++|++++||||+++++++. ++..++|
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 85 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII 85 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence 455666778888888999999888621 7999999999999999999986 5568999
Q ss_pred EeccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCC
Q psy6593 177 TEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 99999999999997632 25999999999999999999999999999999999999999999999999999876432211
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCch
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQ 334 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~ 334 (433)
. .....+++.|+|||.+.+..++.++||||||+++|+|++ |.+|+......... ....
T Consensus 166 ~--------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-~~~~ 224 (279)
T 1qpc_A 166 A--------------------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLE 224 (279)
T ss_dssp C--------------------CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHH
T ss_pred c--------------------ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH-HHHh
Confidence 1 013356788999999998889999999999999999998 88887543221100 0011
Q ss_pred hhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccc
Q psy6593 335 TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381 (433)
Q Consensus 335 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~ 381 (433)
.......+..+++.+.+++.+||+.||++||++++|++.|+++....
T Consensus 225 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 11223345678999999999999999999999999999999876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=311.09 Aligned_cols=225 Identities=25% Similarity=0.393 Sum_probs=183.1
Q ss_pred eeeeeccCCCcchhhhhcc-------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCC
Q psy6593 128 LLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAG 182 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 182 (433)
+.....+++|+||+||++. +|+.+|++++||||+++++++...+..++||||++|
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 3444577888888887521 799999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcccccc
Q psy6593 183 GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAK 262 (433)
Q Consensus 183 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 262 (433)
++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 127 ~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~------- 197 (321)
T 2c30_A 127 GALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK------- 197 (321)
T ss_dssp CBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-------
T ss_pred CCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc-------
Confidence 999999976 45999999999999999999999999999999999999999999999999998865432211
Q ss_pred chhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhcc--c
Q psy6593 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRN--K 340 (433)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~--~ 340 (433)
.....||+.|+|||.+.+..++.++||||||+++|+|++|.+||...........+. ..... .
T Consensus 198 --------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~ 262 (321)
T 2c30_A 198 --------------RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR-DSPPPKLK 262 (321)
T ss_dssp --------------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSSCCCCT
T ss_pred --------------cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCcC
Confidence 125579999999999999999999999999999999999998875432111000000 00000 1
Q ss_pred cCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 341 FCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 341 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
....+++.+.+++.+||+.||++||+++++++ |+..
T Consensus 263 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 263 NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence 12356889999999999999999999999985 5543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=316.61 Aligned_cols=242 Identities=27% Similarity=0.451 Sum_probs=194.8
Q ss_pred ccccccCCeeeeeccCCCcchhhhhc-----------------------------cchHHHHhhcCCcceeeEEEEEE--
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQN-----------------------------CGQVAVLRSLHHHNVIRFIGVLY-- 168 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~-----------------------------~~E~~~l~~l~h~~iv~~~~~~~-- 168 (433)
+..++.+++.+.+.+++|+||.||+. .+|+++|++++|+||+++++++.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 34677888888999999999998742 17999999999999999999987
Q ss_pred eCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchh
Q psy6593 169 KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 169 ~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
..+..++||||+++++|.+++......+++..++.++.|++.||+|||+.||+|+||||+||+++.++.+||+|||++..
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 44679999999999999999976555699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCC--
Q psy6593 249 IHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPR-- 326 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~-- 326 (433)
......... ......||+.|+|||.+.+..++.++||||||+++|+|++|.+|+......
T Consensus 177 ~~~~~~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~ 238 (327)
T 3lxl_A 177 LPLDKDYYV------------------VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL 238 (327)
T ss_dssp CCTTCSEEE------------------CSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH
T ss_pred cccCCccce------------------eeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhh
Confidence 643321100 111346788899999999988999999999999999999988776432110
Q ss_pred ------CCC------CCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 327 ------SPD------FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 327 ------~~~------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
... ............+..+++.+.+++.+||+.||++||++++|++.|+.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 239 RMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred hhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 000 00001112223456789999999999999999999999999999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=316.59 Aligned_cols=232 Identities=20% Similarity=0.307 Sum_probs=186.9
Q ss_pred cCCeeeeeccCCCcchhhhhcc------------------------------chHHHHhhcCCcceeeEEEEEEeCCeee
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC------------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~------------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 174 (433)
.+.+.+.+.+++|+||+||+.. +|+.+|++++||||+++++++.+++..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3457778889999999988621 6999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCc---eEEeccccchh
Q psy6593 175 LVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKT---VVVADFGLARI 248 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~~ 248 (433)
+||||++|++|.+.+.+ .+..+++..++.++.||+.||+|||+.||+||||||+||+++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 99999999999887753 2345899999999999999999999999999999999999986554 99999999987
Q ss_pred ccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCC
Q psy6593 249 IHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~ 328 (433)
....... .....||+.|+|||++.+..++.++||||||+++|+|++|.+||...... .
T Consensus 183 ~~~~~~~---------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~ 240 (351)
T 3c0i_A 183 LGESGLV---------------------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-L 240 (351)
T ss_dssp CCTTSCB---------------------CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-H
T ss_pred ecCCCee---------------------ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-H
Confidence 6442211 11457999999999999989999999999999999999999888642110 0
Q ss_pred CCCCchhh--hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhc
Q psy6593 329 DFGLDQTD--FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 329 ~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
...+.... ........+++.+.+||.+||+.||++||++.+++ .||+...
T Consensus 241 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 241 FEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp HHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred HHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 00000000 01111256789999999999999999999999998 4887643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=322.09 Aligned_cols=232 Identities=21% Similarity=0.333 Sum_probs=192.5
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCee
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~ 173 (433)
.+..+++.+.+.+|+|+||.|+.+. +|+.+|+.++||||+++++++...+..
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3455668888899999999988521 699999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 174 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
++||||++|++|.+++.+.+ .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 99999999999999997644 59999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCC-CcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY-DETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL 332 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~ 332 (433)
. .....||+.|+|||++.+..+ +.++||||||+++|+|++|.+||...........
T Consensus 171 ~----------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~- 227 (476)
T 2y94_A 171 F----------------------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK- 227 (476)
T ss_dssp C----------------------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH-
T ss_pred c----------------------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH-
Confidence 1 115579999999999998765 6899999999999999999988864321111000
Q ss_pred chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 333 DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 333 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
........+..+++++.+||.+||+.||++||++++|++ ||....
T Consensus 228 -i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 274 (476)
T 2y94_A 228 -ICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL 274 (476)
T ss_dssp -HHTTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred -HhcCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence 011112334668899999999999999999999999984 887643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=318.20 Aligned_cols=254 Identities=17% Similarity=0.218 Sum_probs=203.1
Q ss_pred cCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceee--------------
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIR-------------- 162 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~-------------- 162 (433)
.+++.+.+.+++|+||+||+.. +|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 3568888899999999988641 6999999999999987
Q ss_pred -EEEEEEe-CCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCC--c
Q psy6593 163 -FIGVLYK-DRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDK--T 237 (433)
Q Consensus 163 -~~~~~~~-~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~--~ 237 (433)
+++++.. ++..++||||+ +++|.+++... +..+++..++.++.||+.||.|||+.||+||||||+||+++.++ .
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~ 199 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQ 199 (352)
T ss_dssp CCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEE
T ss_pred chhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCce
Confidence 6788876 67899999999 99999999764 35699999999999999999999999999999999999999988 9
Q ss_pred eEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCC
Q psy6593 238 VVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRV 317 (433)
Q Consensus 238 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~ 317 (433)
+||+|||+++........... .........||+.|+|||.+.+..++.++||||||+++|+|++|.
T Consensus 200 ~kl~Dfg~a~~~~~~~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 265 (352)
T 2jii_A 200 VTLAGYGFAFRYCPSGKHVAY--------------VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265 (352)
T ss_dssp EEECCGGGCBCSSGGGCCCCC--------------CTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred EEEecCcceeeccCCCccccc--------------cccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999876532211100 001112457999999999999989999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCchhhhcc---ccC------CCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccccCCCCCC
Q psy6593 318 PADPDYLPRSPDFGLDQTDFRN---KFC------ASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPLP 388 (433)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~---~~~------~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~~~~~~~ 388 (433)
+||................+.. .+. ..+++.+.+++.+||+.||++||++++|++.|+.+..........+
T Consensus 266 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~ 345 (352)
T 2jii_A 266 LPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDP 345 (352)
T ss_dssp CTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSC
T ss_pred CCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCcc
Confidence 8876543211110000110111 111 2568999999999999999999999999999999998888888888
Q ss_pred Cchhh
Q psy6593 389 SDLEA 393 (433)
Q Consensus 389 ~~~~~ 393 (433)
.+|+.
T Consensus 346 ~dw~~ 350 (352)
T 2jii_A 346 IGLPM 350 (352)
T ss_dssp CCCCC
T ss_pred ccCcC
Confidence 88864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=329.86 Aligned_cols=232 Identities=20% Similarity=0.246 Sum_probs=188.3
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCee
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~ 173 (433)
.+..+++.+.+.+|+|+||.||+.. +|+.+|++++||||+++++++...+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 3455678889999999999999511 688899999999999999999999999
Q ss_pred eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhc-CCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 174 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
++||||++|++|.+++...+ .+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++.....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEEEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999999999987643 59999999999999999999998 99999999999999999999999999999754322
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL 332 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~ 332 (433)
.. ......||+.|+|||++.+..++.++||||||+++|||++|.+||...........
T Consensus 303 ~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~- 360 (446)
T 4ejn_A 303 GA---------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL- 360 (446)
T ss_dssp -------------------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-
T ss_pred Cc---------------------ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH-
Confidence 11 11256799999999999999999999999999999999999988854321111000
Q ss_pred chhhhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHHH--HHHhh
Q psy6593 333 DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLEV--WLEGL 377 (433)
Q Consensus 333 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~~--~l~~~ 377 (433)
.......++..+++.+.+||.+||+.||.+|| +++++++ ||+.+
T Consensus 361 -i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 361 -ILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp -HHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -HHhCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 01112234577899999999999999999999 9999874 66653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=311.32 Aligned_cols=242 Identities=26% Similarity=0.474 Sum_probs=193.4
Q ss_pred cccccccCCeeeeeccCCCcchhhhhc------------------------------cchHHHHhhcCCcceeeEEEEEE
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQN------------------------------CGQVAVLRSLHHHNVIRFIGVLY 168 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~------------------------------~~E~~~l~~l~h~~iv~~~~~~~ 168 (433)
....+..+.+...+.+++|+||.||.. .+|+++|++++||||+++++++.
T Consensus 14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 344556666788888889999988642 16999999999999999999998
Q ss_pred eC--CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccc
Q psy6593 169 KD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLA 246 (433)
Q Consensus 169 ~~--~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 246 (433)
.. +..++||||+++++|.+++......+++..++.++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 76 6789999999999999999665567999999999999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCC--
Q psy6593 247 RIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYL-- 324 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~-- 324 (433)
.......... .......||+.|+|||.+.+..++.++||||||+++|+|++|.+++....
T Consensus 174 ~~~~~~~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 235 (302)
T 4e5w_A 174 KAIETDKEYY------------------TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL 235 (302)
T ss_dssp EECCTTCCEE------------------ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH
T ss_pred ccccCCCcce------------------eccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH
Confidence 8765432110 01114467888999999999899999999999999999999877642210
Q ss_pred ------CCCCCC------CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 325 ------PRSPDF------GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 325 ------~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
+..... ...........+..+++.+.+++.+||+.||.+|||++++++.|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 236 FLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 000000 000111122345678999999999999999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=316.38 Aligned_cols=225 Identities=22% Similarity=0.329 Sum_probs=177.7
Q ss_pred eeccCCCcchhhhhcc--------------------chHHHHhhc-CCcceeeEEEEEEe----CCeeeEEEeccCCCCH
Q psy6593 131 CKEDYNGKYGEACQNC--------------------GQVAVLRSL-HHHNVIRFIGVLYK----DRKLNLVTEYIAGGTL 185 (433)
Q Consensus 131 ~~~~~~g~fg~v~~~~--------------------~E~~~l~~l-~h~~iv~~~~~~~~----~~~~~lv~e~~~g~sL 185 (433)
.+.+|.|+||+||+.. +|++++.++ +||||+++++++.. ...+||||||++|++|
T Consensus 67 ~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L 146 (400)
T 1nxk_A 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL 146 (400)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEH
T ss_pred cceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcH
Confidence 3678999999999732 688887555 89999999999876 5679999999999999
Q ss_pred HHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc---CCceEEeccccchhccCCCCCCccccc
Q psy6593 186 KELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE---DKTVVVADFGLARIIHQGPRAPTTVMA 261 (433)
Q Consensus 186 ~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 261 (433)
.+++.+.+ ..+++..++.|+.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++.......
T Consensus 147 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~------- 219 (400)
T 1nxk_A 147 FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS------- 219 (400)
T ss_dssp HHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCc-------
Confidence 99998743 46999999999999999999999999999999999999997 78999999999986532211
Q ss_pred cchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhh----
Q psy6593 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDF---- 337 (433)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~---- 337 (433)
.....||+.|+|||++.+..++.++||||||+++|+|++|.+||...........+.....
T Consensus 220 ---------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~ 284 (400)
T 1nxk_A 220 ---------------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284 (400)
T ss_dssp ----------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC
T ss_pred ---------------cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc
Confidence 1256789999999999999999999999999999999999998865433322111111111
Q ss_pred --ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 338 --RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 338 --~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
.......+++++.+||.+||+.||++||++++|++ ||...
T Consensus 285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 11112568899999999999999999999999985 77653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=317.77 Aligned_cols=223 Identities=24% Similarity=0.304 Sum_probs=181.9
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc----------------------------chHHH-HhhcCCcceeeEEEEEEeCCe
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAV-LRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~-l~~l~h~~iv~~~~~~~~~~~ 172 (433)
....+++.+.+.+|+|+||.||+.. .|..+ ++.++||||+++++++.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 3456778899999999999998621 34444 466799999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
+|+||||++|++|.+++.+.+ .+++..++.++.||+.||+|||+.||+||||||+|||++.+|.+||+|||+++.....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 999999999999999987643 5999999999999999999999999999999999999999999999999999864332
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL 332 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~ 332 (433)
... .....||+.|+|||++.+..++.++||||||+++|||++|.+||...........+
T Consensus 193 ~~~---------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i 251 (373)
T 2r5t_A 193 NST---------------------TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 251 (373)
T ss_dssp CCC---------------------CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH
T ss_pred CCc---------------------cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 211 12568999999999999999999999999999999999999988643211110000
Q ss_pred chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChh
Q psy6593 333 DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFE 368 (433)
Q Consensus 333 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~ 368 (433)
......++..++..+.+||.+||+.||.+||++.
T Consensus 252 --~~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 252 --LNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp --HHSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred --HhcccCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 1112234577899999999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=307.56 Aligned_cols=220 Identities=20% Similarity=0.323 Sum_probs=185.6
Q ss_pred CCeeeeeccCCCcchhhhhcc---------------------------------chHHHHhhcCCcceeeEEEEEEeCCe
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC---------------------------------GQVAVLRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~---------------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~ 172 (433)
+++.+.+.+++|+||+||++. +|+.+|++++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 346777888889999888631 39999999999999999999999999
Q ss_pred eeEEEeccCCC-CHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 173 LNLVTEYIAGG-TLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 173 ~~lv~e~~~g~-sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
.++||||+.++ +|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 99999998666 9999998754 599999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCC-CcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY-DETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~ 330 (433)
... .....||+.|+|||++.+..+ +.++||||||+++|+|++|.+||......
T Consensus 183 ~~~----------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---- 236 (335)
T 3dls_A 183 GKL----------------------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---- 236 (335)
T ss_dssp TCC----------------------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----
T ss_pred CCc----------------------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----
Confidence 221 125679999999999988776 78999999999999999999888542111
Q ss_pred CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 331 GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
.......+..+++++.+||.+||+.||++||+++++++ |++.
T Consensus 237 ----~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 237 ----VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp ----TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred ----HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 11112234567899999999999999999999999985 5543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=306.86 Aligned_cols=232 Identities=27% Similarity=0.439 Sum_probs=183.4
Q ss_pred ccCCeeeeeccCCCcchhhhhcc---------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCC
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC---------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAG 182 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~---------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 182 (433)
..+++.+.+.+++|+||+||+.. +|+.+|++++||||+++++++. +..++||||++|
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~ 83 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG 83 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred CHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence 44567777788888888887622 7999999999999999999876 458999999999
Q ss_pred CCHHHHhcCCCC--CCChHHHHHHHHHHHHHHhhhhc---CCccccCCCCcceEEccCCc-eEEeccccchhccCCCCCC
Q psy6593 183 GTLKELLQDPGQ--PLPWGQRVNFARDIAAGMTYLHS---MNLIHRDLNSQNCLVREDKT-VVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 183 ~sL~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~ 256 (433)
++|.+++..... .++...++.++.|++.||+|||+ .||+||||||+||+++.++. +||+|||++.......
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~--- 160 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--- 160 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc---
Confidence 999999976432 47899999999999999999999 89999999999999998876 7999999987543211
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC-CCchh
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF-GLDQT 335 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~-~~~~~ 335 (433)
....||+.|+|||.+.+..++.++||||||+++|+|++|.+||.......... .....
T Consensus 161 ---------------------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 219 (307)
T 2eva_A 161 ---------------------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN 219 (307)
T ss_dssp -------------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT
T ss_pred ---------------------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc
Confidence 13468999999999999999999999999999999999998876432111000 00011
Q ss_pred hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccc
Q psy6593 336 DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381 (433)
Q Consensus 336 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~ 381 (433)
.........+|..+.+++.+||+.||++||+++++++.|+.+....
T Consensus 220 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 220 GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 1223344678999999999999999999999999999999887544
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=312.71 Aligned_cols=241 Identities=29% Similarity=0.471 Sum_probs=197.1
Q ss_pred ccccccCCeeeeeccCCCcchhhhhc---------------------------------cchHHHHhhc-CCcceeeEEE
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQN---------------------------------CGQVAVLRSL-HHHNVIRFIG 165 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~---------------------------------~~E~~~l~~l-~h~~iv~~~~ 165 (433)
.+.+..+++.+.+.+++|+||+||++ .+|+++|+++ +||||+++++
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 34566778888899999999998842 1689999999 8999999999
Q ss_pred EEEeCCeeeEEEeccCCCCHHHHhcCCC---------------CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcce
Q psy6593 166 VLYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 230 (433)
Q Consensus 166 ~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Ni 230 (433)
++..++..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 9999999999999999999999997643 2489999999999999999999999999999999999
Q ss_pred EEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHH
Q psy6593 231 LVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310 (433)
Q Consensus 231 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 310 (433)
+++.++.+||+|||++.......... ......+|+.|+|||.+.+..++.++||||||+++
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 249 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYK-------------------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEE-------------------CCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred EEcCCCCEEEcccccccccccccccc-------------------ccCCCCcccceeChHHhcCCCcChHHHHHHHHHHH
Confidence 99999999999999998654322110 11134568889999999988899999999999999
Q ss_pred HHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccc
Q psy6593 311 CEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMH 380 (433)
Q Consensus 311 ~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~ 380 (433)
|+|++ |.+|+........ ............+..++..+.+++.+||+.+|.+||++++|++.|+.+...
T Consensus 250 ~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 250 WEIFTLGGSPYPGIPVEEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp HHHHTTSCCSSTTCCHHHH-HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCcCcCCHHHH-HHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99998 8888754321110 001111122344577899999999999999999999999999999987653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=316.65 Aligned_cols=241 Identities=18% Similarity=0.270 Sum_probs=186.3
Q ss_pred ccCCeeeeeccCCC--cchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCeee
Q psy6593 124 EKDGLLFCKEDYNG--KYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 124 ~~~~~~~~~~~~~g--~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 174 (433)
+.+++.+.+.+++| +||+||++. +|+.+|++++||||+++++++.+++..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 44557777778888 888777521 5999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 175 LVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
+||||+++++|.+++... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||.+.......
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 999999999999998653 3469999999999999999999999999999999999999999999999999987553321
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecC--CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG--QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG 331 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~ 331 (433)
..... .........||+.|+|||++.+ ..++.++||||||+++|+|++|.+||...........
T Consensus 183 ~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 248 (389)
T 3gni_B 183 QRQRV--------------VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 248 (389)
T ss_dssp EECSC--------------BCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH
T ss_pred ccccc--------------cccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 11000 0001113478999999999987 6789999999999999999999999865332221110
Q ss_pred Cchh--------------------------------------------hhccccCCCCcHHHHHHHHHhcccCCCCCCCh
Q psy6593 332 LDQT--------------------------------------------DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF 367 (433)
Q Consensus 332 ~~~~--------------------------------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~ 367 (433)
.... ......+..+++.+.+||.+||+.||++||++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta 328 (389)
T 3gni_B 249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA 328 (389)
T ss_dssp C--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH
T ss_pred HhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH
Confidence 0000 00011335678899999999999999999999
Q ss_pred hHHH--HHHHhhc
Q psy6593 368 EVLE--VWLEGLS 378 (433)
Q Consensus 368 ~~i~--~~l~~~~ 378 (433)
++++ .||+.+.
T Consensus 329 ~ell~hp~f~~~~ 341 (389)
T 3gni_B 329 STLLNHSFFKQIK 341 (389)
T ss_dssp HHHTTSGGGGGC-
T ss_pred HHHhcCHHHHHHh
Confidence 9998 4777654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=312.41 Aligned_cols=228 Identities=24% Similarity=0.340 Sum_probs=177.7
Q ss_pred CCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCC
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAG 182 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 182 (433)
+.+.+.+.+++|+||.||+.. +|+++|++++||||+++++++...+..++||||+++
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 132 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence 447778889999999998622 699999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc---CCceEEeccccchhccCCCCCCccc
Q psy6593 183 GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE---DKTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 183 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
++|.+++...+ .+++..++.++.|++.||.|||+.||+||||||+||+++. ++.+||+|||+++.......
T Consensus 133 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~----- 206 (349)
T 2w4o_A 133 GELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL----- 206 (349)
T ss_dssp CBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------------
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc-----
Confidence 99999997754 5999999999999999999999999999999999999975 88999999999986543211
Q ss_pred cccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC-Cch--hh
Q psy6593 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG-LDQ--TD 336 (433)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~-~~~--~~ 336 (433)
.....||+.|+|||++.+..++.++||||||+++|+|++|.+||........... +.. ..
T Consensus 207 -----------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~ 269 (349)
T 2w4o_A 207 -----------------MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY 269 (349)
T ss_dssp -----------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC
T ss_pred -----------------cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc
Confidence 1145789999999999998999999999999999999999888754322110000 000 00
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
........++..+.+||.+||+.||++||++.++++ ||..
T Consensus 270 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 311 (349)
T 2w4o_A 270 FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311 (349)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 111223568899999999999999999999999985 6654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=317.78 Aligned_cols=225 Identities=21% Similarity=0.306 Sum_probs=180.4
Q ss_pred eeccCCCcchhhhhcc-------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCH
Q psy6593 131 CKEDYNGKYGEACQNC-------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTL 185 (433)
Q Consensus 131 ~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL 185 (433)
.+.+++|+||+||+.. +|+++|++++||||+++++++...+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 4568899999888621 799999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEE--ccCCceEEeccccchhccCCCCCCccccccc
Q psy6593 186 KELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV--REDKTVVVADFGLARIIHQGPRAPTTVMAKV 263 (433)
Q Consensus 186 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 263 (433)
.+++......+++..++.++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+++........
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~-------- 245 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL-------- 245 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC--------
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc--------
Confidence 99887655569999999999999999999999999999999999999 46689999999999876432211
Q ss_pred hhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh--hhcccc
Q psy6593 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT--DFRNKF 341 (433)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 341 (433)
....||+.|+|||++.+..++.++||||||+++|+|++|.+||...........+... ......
T Consensus 246 --------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 311 (373)
T 2x4f_A 246 --------------KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE 311 (373)
T ss_dssp --------------CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGG
T ss_pred --------------ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhh
Confidence 1446999999999999989999999999999999999999888643221110000000 011122
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 342 CASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 342 ~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
...+++++.+||.+||+.||.+||+++++++ ||.+.
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 3567899999999999999999999999985 88764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.52 Aligned_cols=234 Identities=26% Similarity=0.396 Sum_probs=182.2
Q ss_pred cCCeeeeeccCCCcchhhhhcc--------------------chHHHHhh--cCCcceeeEEEEEEeC----CeeeEEEe
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC--------------------GQVAVLRS--LHHHNVIRFIGVLYKD----RKLNLVTE 178 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~--------------------~E~~~l~~--l~h~~iv~~~~~~~~~----~~~~lv~e 178 (433)
.+++.+.+.+++|+||+||++. .|.+++.. ++||||+++++++... ...++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e 86 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence 3457778888999999988632 46677766 7999999999997653 46899999
Q ss_pred ccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhh--------cCCccccCCCCcceEEccCCceEEeccccchhcc
Q psy6593 179 YIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLH--------SMNLIHRDLNSQNCLVREDKTVVVADFGLARIIH 250 (433)
Q Consensus 179 ~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH--------~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 250 (433)
|+++++|.++++. ..+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++...
T Consensus 87 ~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 164 (301)
T 3q4u_A 87 YHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 164 (301)
T ss_dssp CCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred hccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecc
Confidence 9999999999966 46999999999999999999999 9999999999999999999999999999997655
Q ss_pred CCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC------CCCcccCeEehhHHHHHHhcC--------
Q psy6593 251 QGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ------EYDETVDVFSYGIVLCEIIGR-------- 316 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~~-------- 316 (433)
....... .......||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 165 ~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~ 227 (301)
T 3q4u_A 165 QSTNQLD-----------------VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227 (301)
T ss_dssp TTTTEEE-----------------CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred ccccccc-----------------ccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccc
Confidence 4322110 011144799999999999876 455789999999999999998
Q ss_pred --CCCCCCCCCCCCCCCCchhh-----hcccc-----CCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 317 --VPADPDYLPRSPDFGLDQTD-----FRNKF-----CASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 317 --~~~~~~~~~~~~~~~~~~~~-----~~~~~-----~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
.+||................ ..... ....++.+.+++.+||+.||++|||+++|++.|+++
T Consensus 228 ~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 228 DYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 66665433322211111000 01111 123457899999999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=306.73 Aligned_cols=210 Identities=23% Similarity=0.396 Sum_probs=169.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC-----CCCCChHHHHHHHHHHHHHHhhhhcCCcc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-----GQPLPWGQRVNFARDIAAGMTYLHSMNLI 221 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-----~~~~~~~~~~~i~~qi~~~L~~lH~~~i~ 221 (433)
+|+++|++++||||+++++++..++..++||||++ ++|.+++... ...+++..+..++.||+.||.|||+.||+
T Consensus 52 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~iv 130 (317)
T 2pmi_A 52 REISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKIL 130 (317)
T ss_dssp HHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 79999999999999999999999999999999997 5999988542 24589999999999999999999999999
Q ss_pred ccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcc
Q psy6593 222 HRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDET 300 (433)
Q Consensus 222 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~ 300 (433)
||||||+||+++.++.+||+|||++......... .....||+.|+|||++.+ ..++.+
T Consensus 131 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~---------------------~~~~~~t~~y~aPE~~~~~~~~~~~ 189 (317)
T 2pmi_A 131 HRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT---------------------FSSEVVTLWYRAPDVLMGSRTYSTS 189 (317)
T ss_dssp CCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC---------------------CCCCCSCCTTCCHHHHTTCCCCCTH
T ss_pred eCCCChHHeEEcCCCCEEECcCccceecCCCccc---------------------CCCCcccccccCchHhhCCCCCCcH
Confidence 9999999999999999999999999876432211 114578999999999976 468999
Q ss_pred cCeEehhHHHHHHhcCCCCCCCCCCCC--------------CCCC------------------CchhhhccccCCCCcHH
Q psy6593 301 VDVFSYGIVLCEIIGRVPADPDYLPRS--------------PDFG------------------LDQTDFRNKFCASCPEP 348 (433)
Q Consensus 301 ~DiwslG~il~ell~~~~~~~~~~~~~--------------~~~~------------------~~~~~~~~~~~~~~~~~ 348 (433)
+||||||+++|+|++|.+||....... ..+. .............++..
T Consensus 190 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (317)
T 2pmi_A 190 IDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGN 269 (317)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHH
Confidence 999999999999999998885432100 0000 00001112223467889
Q ss_pred HHHHHHHhcccCCCCCCChhHHH--HHHHhhc
Q psy6593 349 FVRIAFLCCDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 349 l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
+.+||.+||+.||++||++++++ .||.+..
T Consensus 270 l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 270 LMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred HHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 99999999999999999999998 4777644
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=312.16 Aligned_cols=241 Identities=25% Similarity=0.435 Sum_probs=195.3
Q ss_pred cccccccCCeeeeeccCCCcchhhhhc-------------------------------cchHHHHhhcCCcceeeEEEEE
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQN-------------------------------CGQVAVLRSLHHHNVIRFIGVL 167 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~-------------------------------~~E~~~l~~l~h~~iv~~~~~~ 167 (433)
+.+.+..+++.+.+.+++|+||.||++ .+|+.+|++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 455566677888889999999999852 1699999999999999999999
Q ss_pred EeCCeeeEEEeccCCCCHHHHhcCC---------CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCce
Q psy6593 168 YKDRKLNLVTEYIAGGTLKELLQDP---------GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTV 238 (433)
Q Consensus 168 ~~~~~~~lv~e~~~g~sL~~~l~~~---------~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~ 238 (433)
.+++..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 9999999999999999999998642 1357999999999999999999999999999999999999999999
Q ss_pred EEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CC
Q psy6593 239 VVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RV 317 (433)
Q Consensus 239 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~ 317 (433)
||+|||++.......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 178 kl~Dfg~~~~~~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~ 238 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYR-------------------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 238 (322)
T ss_dssp EECCTTCCCGGGGGGCEE-------------------GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSC
T ss_pred EECcCccccccccccccc-------------------cccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCC
Confidence 999999997654321110 1113456889999999999899999999999999999997 78
Q ss_pred CCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 318 PADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
+|+.......... ..........+..+++.+.+++.+||+.||.+||++.++++.|++...
T Consensus 239 ~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 239 QPYQGLSNEQVLR-FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp CTTTTSCHHHHHH-HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CccccCCHHHHHH-HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 8775432111000 000111223457789999999999999999999999999999998654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=334.76 Aligned_cols=242 Identities=30% Similarity=0.509 Sum_probs=198.5
Q ss_pred cccccccCCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCCcceeeEEEEEEeCCeeeE
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 175 (433)
+.|.+..+++.+.+.+++|+||+||+.. +|+++|++++|+||+++++++.+ +..+|
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 4566777889999999999999999622 79999999999999999999865 77999
Q ss_pred EEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCC
Q psy6593 176 VTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
||||+++++|.+++... +..+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999999999752 34599999999999999999999999999999999999999999999999999986532110
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCc
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~ 333 (433)
. ......++..|+|||.+.+..++.++||||||+++|||++ |.+||......... ...
T Consensus 419 ~--------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~-~~i 477 (535)
T 2h8h_A 419 T--------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-DQV 477 (535)
T ss_dssp H--------------------TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH-HHH
T ss_pred e--------------------cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHH
Confidence 0 0113346788999999998899999999999999999998 88887653221111 111
Q ss_pred hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccccc
Q psy6593 334 QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLS 382 (433)
Q Consensus 334 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~ 382 (433)
....+...+..+++.+.+||.+||+.||++||++++|++.|+.+.....
T Consensus 478 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 478 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 1222334457889999999999999999999999999999998765443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=310.32 Aligned_cols=224 Identities=19% Similarity=0.297 Sum_probs=162.4
Q ss_pred eccCCCcchhhhhcc----------------------chHHHHhhcC-CcceeeEEEEEEeCCeeeEEEeccCCCCHHHH
Q psy6593 132 KEDYNGKYGEACQNC----------------------GQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKEL 188 (433)
Q Consensus 132 ~~~~~g~fg~v~~~~----------------------~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~ 188 (433)
+.+|+|+||+||+.. +|+.+|+++. ||||+++++++.++...++||||++|++|.++
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 96 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFER 96 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHH
Confidence 457778888777522 7999999996 99999999999999999999999999999999
Q ss_pred hcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCC---ceEEeccccchhccCCCCCCccccccchh
Q psy6593 189 LQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDK---TVVVADFGLARIIHQGPRAPTTVMAKVPR 265 (433)
Q Consensus 189 l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 265 (433)
+... ..+++..++.++.|++.||+|||+.||+||||||+||+++.++ .+||+|||+++........
T Consensus 97 l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~---------- 165 (325)
T 3kn6_A 97 IKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP---------- 165 (325)
T ss_dssp HHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------------
T ss_pred HHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc----------
Confidence 9764 4599999999999999999999999999999999999998665 8999999999765432211
Q ss_pred hhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc---hhhh-----
Q psy6593 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD---QTDF----- 337 (433)
Q Consensus 266 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~---~~~~----- 337 (433)
.....||+.|+|||.+.+..++.++||||||+++|+|++|.+||............. ....
T Consensus 166 -----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~ 234 (325)
T 3kn6_A 166 -----------LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234 (325)
T ss_dssp -----------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC
T ss_pred -----------ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC
Confidence 124568999999999999999999999999999999999999886543221111000 0000
Q ss_pred -ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhh
Q psy6593 338 -RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGL 377 (433)
Q Consensus 338 -~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~ 377 (433)
.......+++++.+||.+||+.||.+||++++++ .||+..
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 0111135789999999999999999999999998 477653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=308.33 Aligned_cols=232 Identities=16% Similarity=0.265 Sum_probs=183.5
Q ss_pred cCCeeeeeccCCCcchhhhhc--------------------------cchHHHHhhcCCcceeeEEEEEEeCC--eeeEE
Q psy6593 125 KDGLLFCKEDYNGKYGEACQN--------------------------CGQVAVLRSLHHHNVIRFIGVLYKDR--KLNLV 176 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~--------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 176 (433)
.+.+.+.+.+++|+||+||++ .+|+++|++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 344667777788888887752 17999999999999999999998765 78999
Q ss_pred EeccCCCCHHHHhcCCC--CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEE----ccCCceEEeccccchhcc
Q psy6593 177 TEYIAGGTLKELLQDPG--QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV----REDKTVVVADFGLARIIH 250 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg~~~~~~ 250 (433)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+.||+||||||+||++ +.++.+||+|||+++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 99999999999997633 239999999999999999999999999999999999999 777889999999998764
Q ss_pred CCCCCCccccccchhhhhhhcccccceeeeccCccccccceec--------CCCCCcccCeEehhHHHHHHhcCCCCCCC
Q psy6593 251 QGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT--------GQEYDETVDVFSYGIVLCEIIGRVPADPD 322 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~~~~~~~~ 322 (433)
..... ....||+.|+|||++. +..++.++||||||+++|||++|.+||..
T Consensus 168 ~~~~~----------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 225 (319)
T 4euu_A 168 DDEQF----------------------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (319)
T ss_dssp TTCCB----------------------CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred CCCce----------------------eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 43211 1456899999999986 56789999999999999999999988854
Q ss_pred CCCCCCCCCCchhh---------------------h------ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHH
Q psy6593 323 YLPRSPDFGLDQTD---------------------F------RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375 (433)
Q Consensus 323 ~~~~~~~~~~~~~~---------------------~------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 375 (433)
.............. + ...+...+++.+.+++.+||+.||++||+++++++...
T Consensus 226 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 226 FEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp TTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 32211110000000 0 00112344568899999999999999999999998887
Q ss_pred hhc
Q psy6593 376 GLS 378 (433)
Q Consensus 376 ~~~ 378 (433)
+..
T Consensus 306 d~~ 308 (319)
T 4euu_A 306 DIL 308 (319)
T ss_dssp HHT
T ss_pred HHh
Confidence 654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=305.65 Aligned_cols=243 Identities=28% Similarity=0.473 Sum_probs=188.4
Q ss_pred ccccccccCCeeeeeccCCCcchhhhhcc------------------------------chHHHHhhcCCcceeeEEEEE
Q psy6593 118 LDNWYFEKDGLLFCKEDYNGKYGEACQNC------------------------------GQVAVLRSLHHHNVIRFIGVL 167 (433)
Q Consensus 118 l~~~~~~~~~~~~~~~~~~g~fg~v~~~~------------------------------~E~~~l~~l~h~~iv~~~~~~ 167 (433)
+....+..+.+.+.+.+++|+||.||++. +|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 34455667778888889999999988421 689999999999999999999
Q ss_pred EeCC-----eeeEEEeccCCCCHHHHhc-----CCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCc
Q psy6593 168 YKDR-----KLNLVTEYIAGGTLKELLQ-----DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKT 237 (433)
Q Consensus 168 ~~~~-----~~~lv~e~~~g~sL~~~l~-----~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~ 237 (433)
...+ ..++||||+++++|.+++. .....+++..++.++.|++.||.|||+.||+||||||+||+++.++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence 8654 3599999999999999983 23356999999999999999999999999999999999999999999
Q ss_pred eEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-C
Q psy6593 238 VVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-R 316 (433)
Q Consensus 238 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~ 316 (433)
+||+|||++.......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 246 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYR-------------------QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRG 246 (313)
T ss_dssp EEECSCSCC-----------------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTS
T ss_pred EEEeecCcceecccccccC-------------------cccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcC
Confidence 9999999998764332111 1113457889999999999999999999999999999998 8
Q ss_pred CCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccc
Q psy6593 317 VPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMH 380 (433)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~ 380 (433)
.+|+......... ...........+..+++.+.+++.+||+.||.+||++++|++.|+++...
T Consensus 247 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 247 MTPYPGVQNHEMY-DYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp CCSSTTCCGGGHH-HHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCccCCHHHHH-HHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 8887553221110 01111222344577889999999999999999999999999999987653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=302.60 Aligned_cols=232 Identities=22% Similarity=0.356 Sum_probs=192.5
Q ss_pred cccccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCe
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~ 172 (433)
..+..+++.+.+.+++|+||.||+.. +|++++++++||||+++++++.+++.
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 34566778888889999999888621 68999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
.++||||+++++|.+++...+ .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 999999999999999987643 5999999999999999999999999999999999999999999999999998654321
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL 332 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~ 332 (433)
.. ....||+.|+|||.+.+..++.++||||||+++|+|++|.+||......... .
T Consensus 168 ~~-----------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~ 222 (284)
T 2vgo_A 168 RR-----------------------RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH--R 222 (284)
T ss_dssp CB-----------------------CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--H
T ss_pred cc-----------------------ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH--H
Confidence 11 1456899999999999989999999999999999999999887543211100 0
Q ss_pred chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhc
Q psy6593 333 DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 333 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
........++..++..+.++|.+||+.||.+||++++++ .||+...
T Consensus 223 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 223 RIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHTTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHhccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 011112234567889999999999999999999999998 4887644
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=305.75 Aligned_cols=238 Identities=21% Similarity=0.385 Sum_probs=181.0
Q ss_pred ccCCeeeeeccCCCcchhhhhc----------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeE
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQN----------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~----------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 175 (433)
..+++.+.+.+++|+||.||+. .+|+.++++++||||+++++++..++..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3445777778888888888752 169999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 176 VTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999999864 3456999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC--
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF-- 330 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~-- 330 (433)
... .....||+.|+|||.+.+..++.++||||||+++|+|++|.+||..........
T Consensus 190 ~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 248 (310)
T 2wqm_A 190 TTA---------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 248 (310)
T ss_dssp ------------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHH
T ss_pred Ccc---------------------ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHH
Confidence 211 114568999999999999899999999999999999999888775422110000
Q ss_pred CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccccc
Q psy6593 331 GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLS 382 (433)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~ 382 (433)
.+............+++++.+++.+||+.||++||++++|++.|+.+.....
T Consensus 249 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 249 KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp HHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 0000111111225678999999999999999999999999999999875443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=314.01 Aligned_cols=223 Identities=31% Similarity=0.467 Sum_probs=181.6
Q ss_pred eeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 128 LLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
+...+.+++|+||+||++. +|+++|++++||||+++++++..++..++||||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence 5666778888888888521 799999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccc
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
+. |+|.+++......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 136 ~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------- 207 (348)
T 1u5q_A 136 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------- 207 (348)
T ss_dssp CS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-------
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-------
Confidence 96 6888888654567999999999999999999999999999999999999999999999999998764321
Q ss_pred cccchhhhhhhcccccceeeeccCccccccceec---CCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh
Q psy6593 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT---GQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD 336 (433)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~ 336 (433)
....||+.|+|||++. ...++.++||||||+++|||++|.+|+...........+....
T Consensus 208 ------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 269 (348)
T 1u5q_A 208 ------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 269 (348)
T ss_dssp ------------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred ------------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Confidence 1457899999999985 4678999999999999999999998875432111100011111
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
........+++.+.++|.+||+.||++||+++++++ |+..
T Consensus 270 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 270 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 111223567899999999999999999999999984 6643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=301.72 Aligned_cols=230 Identities=20% Similarity=0.295 Sum_probs=185.3
Q ss_pred CCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEe
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTE 178 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 178 (433)
+++.+.+.+++|+||.||++. +|+.++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 446667777788888777521 69999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCc---eEEeccccchhccCCCCC
Q psy6593 179 YIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKT---VVVADFGLARIIHQGPRA 255 (433)
Q Consensus 179 ~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~ 255 (433)
|+++++|.+.+... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++. +||+|||++.........
T Consensus 86 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (284)
T 3kk8_A 86 LVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164 (284)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBC
T ss_pred cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccc
Confidence 99999998888654 35999999999999999999999999999999999999986654 999999999765432211
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~ 335 (433)
....||+.|+|||.+.+..++.++||||||+++|+|++|.+||...........+...
T Consensus 165 ----------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 222 (284)
T 3kk8_A 165 ----------------------HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 222 (284)
T ss_dssp ----------------------CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred ----------------------cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc
Confidence 1456899999999999999999999999999999999999887543221111111111
Q ss_pred h--hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhc
Q psy6593 336 D--FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 336 ~--~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
. ........+++.+.+++.+||+.||++||++++++ .||....
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 223 AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 1 11112256789999999999999999999999998 4887643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=304.28 Aligned_cols=235 Identities=28% Similarity=0.475 Sum_probs=188.1
Q ss_pred ccccccCCeeeeeccCCCcchhhhhcc---------------------chHHHHhhcCCcceeeEEEEEEeC-CeeeEEE
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQNC---------------------GQVAVLRSLHHHNVIRFIGVLYKD-RKLNLVT 177 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~~---------------------~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 177 (433)
++.+..+++.+.+.+++|+||+||+.. +|+.++++++||||+++++++.+. +..++||
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 445667778888999999999988621 699999999999999999997654 4799999
Q ss_pred eccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCC
Q psy6593 178 EYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 178 e~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
||+++++|.+++.+.+ ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 172 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-- 172 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccccc--
Confidence 9999999999997532 2388999999999999999999999999999999999999999999999999875432211
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchh
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~ 335 (433)
...+++.|+|||.+.+..++.++||||||+++|+|++ |.+|+......... .....
T Consensus 173 ----------------------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-~~~~~ 229 (278)
T 1byg_A 173 ----------------------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PRVEK 229 (278)
T ss_dssp -------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-HHHTT
T ss_pred ----------------------CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHhc
Confidence 3357888999999998899999999999999999997 88887653221111 00111
Q ss_pred hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 336 DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 336 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
......+..+|+.+.+++.+||+.||++||++.++++.|+.+..
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 230 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 22334457789999999999999999999999999999998754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=304.41 Aligned_cols=237 Identities=22% Similarity=0.392 Sum_probs=189.3
Q ss_pred ccccCCeeeee-ccCCCcchhhhhc-----------------------------cchHHHHhhcCCcceeeEEEEEEeCC
Q psy6593 122 YFEKDGLLFCK-EDYNGKYGEACQN-----------------------------CGQVAVLRSLHHHNVIRFIGVLYKDR 171 (433)
Q Consensus 122 ~~~~~~~~~~~-~~~~g~fg~v~~~-----------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~ 171 (433)
.+..+.+.+.. .+++|+||+||+. .+|++++++++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 34444555555 7888888888753 1699999999999999999999 667
Q ss_pred eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
..++||||+++++|.+++...+ .+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CcEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 8899999999999999997643 599999999999999999999999999999999999999999999999999986643
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDF 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~ 330 (433)
..... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.........
T Consensus 170 ~~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~- 230 (291)
T 1xbb_A 170 DENYY------------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT- 230 (291)
T ss_dssp TCSEE------------------EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-
T ss_pred CCCcc------------------cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-
Confidence 32110 01113346788999999998889999999999999999998 88887653221110
Q ss_pred CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 331 GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
...........+..+|+.+.+++.+||+.||.+||++.+|++.|+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 231 AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0111112233457789999999999999999999999999999998764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=323.21 Aligned_cols=234 Identities=23% Similarity=0.343 Sum_probs=193.0
Q ss_pred cccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeee
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 174 (433)
+..+++...+.+|+|+||+||+.. +|+.+|++++||||+++++++.+.+.+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 455678888999999999999621 5899999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhcCC---CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 175 LVTEYIAGGTLKELLQDP---GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
+||||++|++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+||+++.+|.+||+|||+++....
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999998653 34699999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG 331 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~ 331 (433)
.... .....||+.|+|||++.+..++.++||||||+++|||++|.+||...........
T Consensus 342 ~~~~---------------------~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~ 400 (543)
T 3c4z_A 342 GQTK---------------------TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE 400 (543)
T ss_dssp TCCC---------------------BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHH
T ss_pred CCcc---------------------cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHH
Confidence 2211 1145899999999999999999999999999999999999999865432211111
Q ss_pred Cchh--hhccccCCCCcHHHHHHHHHhcccCCCCCCCh-----hHHH--HHHHhh
Q psy6593 332 LDQT--DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF-----EVLE--VWLEGL 377 (433)
Q Consensus 332 ~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~-----~~i~--~~l~~~ 377 (433)
+... .....++..+++.+.+||.+||+.||.+||++ ++|+ .||+.+
T Consensus 401 ~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 401 LKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp HHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred HHHHHhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 1111 11233557889999999999999999999975 5665 355543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=306.57 Aligned_cols=238 Identities=25% Similarity=0.384 Sum_probs=185.1
Q ss_pred cccCCeeeeeccCCCcchhhhhc-------------------------------cchHHHHhhcCCcceeeEEEEEEeCC
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQN-------------------------------CGQVAVLRSLHHHNVIRFIGVLYKDR 171 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~-------------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~ 171 (433)
+..+++.+.+.+++|+||+||+. .+|++++++++||||+++++++..+.
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 34555677777777777777641 16899999999999999999997654
Q ss_pred eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
.++||||+++++|.+++......+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 8999999999999999976555699999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDF 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~ 330 (433)
..... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||..........
T Consensus 174 ~~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~ 235 (291)
T 1u46_A 174 NDDHY------------------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 235 (291)
T ss_dssp -CCEE------------------EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred cccch------------------hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH
Confidence 32110 01113457888999999998889999999999999999998 888886532211111
Q ss_pred CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 331 GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
.+.........+..+|..+.+++.+||+.||.+||++.+++++|+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 236 KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 1111111223346789999999999999999999999999999998753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=326.85 Aligned_cols=233 Identities=20% Similarity=0.307 Sum_probs=194.5
Q ss_pred cccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeee
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 174 (433)
+..+++.+.+.+|+|+||.||+.. +|+.+|++++||||+++++++.+++.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 556778889999999999998621 6999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 175 LVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
+||||++||+|.+++...+ ..+++..++.++.||+.||+|||+.||+||||||+|||++.+|.+||+|||+++......
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 9999999999999987643 359999999999999999999999999999999999999999999999999998654321
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~ 333 (433)
......||+.|+|||++.+..++.++||||||+++|||++|.+||...........+.
T Consensus 341 ----------------------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~ 398 (576)
T 2acx_A 341 ----------------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398 (576)
T ss_dssp ----------------------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH
T ss_pred ----------------------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH
Confidence 1124589999999999999899999999999999999999999986543221111111
Q ss_pred --hhhhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHH--HHHHhh
Q psy6593 334 --QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLE--VWLEGL 377 (433)
Q Consensus 334 --~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~--~~l~~~ 377 (433)
.......++..+++++.+||.+||+.||.+|| ++++|+ .||+.+
T Consensus 399 ~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 399 RLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp HHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred HHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 11122345577899999999999999999999 678887 466653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=304.74 Aligned_cols=233 Identities=24% Similarity=0.382 Sum_probs=184.3
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCeee
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 174 (433)
+...+++.+...+++|+||+||+.. +|+.++++++||||+++++++...+..+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 3355668888899999999888521 6999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCC
Q psy6593 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
+||||+++++|.+++...+ .+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 101 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EEEECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 9999999988888876544 599999999999999999999999999999999999999999999999999976543221
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCC----
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPD---- 329 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~---- 329 (433)
. .....||+.|+|||.+.+. .++.++||||||+++|+|++|.+||.........
T Consensus 180 ~---------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 238 (331)
T 4aaa_A 180 V---------------------YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238 (331)
T ss_dssp -------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred c---------------------cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 1 1145689999999999875 7899999999999999999999888653211000
Q ss_pred -------------------------CCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHh
Q psy6593 330 -------------------------FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEG 376 (433)
Q Consensus 330 -------------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~ 376 (433)
...............+++.+.+|+.+||+.||++||++++++ .||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 239 MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred HHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 000000011112246789999999999999999999999998 47765
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=301.75 Aligned_cols=228 Identities=23% Similarity=0.360 Sum_probs=183.8
Q ss_pred CeeeeeccCCCcchhhhhcc-------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccC
Q psy6593 127 GLLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIA 181 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 181 (433)
.+.+.+.+++|+||+||++. +|+++|++++||||+++++++.+++..++||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT 89 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccC
Confidence 36666777888888887521 69999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEE---ccCCceEEeccccchhccCCCCCCcc
Q psy6593 182 GGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV---REDKTVVVADFGLARIIHQGPRAPTT 258 (433)
Q Consensus 182 g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~ 258 (433)
+++|.+++... ..+++..++.++.|++.||.|||+.||+|+||||+||++ +.++.++|+|||++........
T Consensus 90 ~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~---- 164 (277)
T 3f3z_A 90 GGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---- 164 (277)
T ss_dssp SCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC----
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc----
Confidence 99999988664 359999999999999999999999999999999999999 7889999999999976543221
Q ss_pred ccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh--
Q psy6593 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD-- 336 (433)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~-- 336 (433)
.....||+.|+|||.+.+. ++.++||||||+++|+|++|.+||...........+....
T Consensus 165 ------------------~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (277)
T 3f3z_A 165 ------------------MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT 225 (277)
T ss_dssp ------------------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred ------------------hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 1145689999999998764 8999999999999999999998885432111000000000
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhc
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
........+++.+.+++.+||+.||++||++.+++ .||++..
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 226 FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 00011136789999999999999999999999998 5887654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=302.40 Aligned_cols=210 Identities=23% Similarity=0.409 Sum_probs=166.1
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|++++++++||||+++++++..++..++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.||+|||||
T Consensus 51 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlk 129 (311)
T 4agu_A 51 REIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVK 129 (311)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence 69999999999999999999999999999999999999999887643 59999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEe
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFS 305 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws 305 (433)
|+||+++.++.++|+|||++......... .....||+.|+|||.+.+ ..++.++||||
T Consensus 130 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 188 (311)
T 4agu_A 130 PENILITKHSVIKLCDFGFARLLTGPSDY---------------------YDDEVATRWYRSPELLVGDTQYGPPVDVWA 188 (311)
T ss_dssp GGGEEECTTSCEEECCCTTCEECC---------------------------------GGGCCHHHHHTCSCCCTHHHHHH
T ss_pred hhhEEEcCCCCEEEeeCCCchhccCcccc---------------------cCCCcCCccccChHHHhcCCCCCcchhhHH
Confidence 99999999999999999999865432211 114578999999999876 66899999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCCc-----------------------------hhhhccccCCCCcHHHHHHHHHh
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGLD-----------------------------QTDFRNKFCASCPEPFVRIAFLC 356 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~l~~li~~~ 356 (433)
||+++|+|++|.+||...........+. ...........++..+.+++.+|
T Consensus 189 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 268 (311)
T 4agu_A 189 IGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGC 268 (311)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHH
Confidence 9999999999999886532111000000 00000011246788999999999
Q ss_pred cccCCCCCCChhHHH--HHHHhhc
Q psy6593 357 CDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 357 l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
|+.||++|||+++++ .||+++.
T Consensus 269 L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 269 LHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp CCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccCChhhcCCHHHHhcChHHHhcc
Confidence 999999999999998 4777643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=305.51 Aligned_cols=235 Identities=20% Similarity=0.228 Sum_probs=180.1
Q ss_pred cCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEE
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 176 (433)
.+++.+.+.+++|+||+||+.. +|+.++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 3456777777788888777521 689999999999999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCC
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
|||++|++|.+++...+ .+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.........
T Consensus 113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~- 190 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT- 190 (309)
T ss_dssp EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc-
Confidence 99999999999997643 5999999999999999999999999999999999999999999999999998765432211
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc-hh
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD-QT 335 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~-~~ 335 (433)
......||+.|+|||.+.+..++.++||||||+++|+|++|.+||...........+. ..
T Consensus 191 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (309)
T 2h34_A 191 -------------------QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAI 251 (309)
T ss_dssp -------------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCC
T ss_pred -------------------cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCC
Confidence 1114568999999999999899999999999999999999998876432110000000 00
Q ss_pred hhccccCCCCcHHHHHHHHHhcccCCCCCC-ChhHHHHHHHhhccc
Q psy6593 336 DFRNKFCASCPEPFVRIAFLCCDLNPDQRP-PFEVLEVWLEGLSMH 380 (433)
Q Consensus 336 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-s~~~i~~~l~~~~~~ 380 (433)
......+..+|+.+.+++.+||+.||++|| +++++++.|+.+...
T Consensus 252 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 252 PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 011233467899999999999999999999 999999999986643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=310.12 Aligned_cols=240 Identities=27% Similarity=0.447 Sum_probs=191.3
Q ss_pred ccccCCeeeeeccCCCcchhhhhc------------------------------cchHHHHhhcCCcceeeEEEEEEeC-
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQN------------------------------CGQVAVLRSLHHHNVIRFIGVLYKD- 170 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~------------------------------~~E~~~l~~l~h~~iv~~~~~~~~~- 170 (433)
.+....+.+.+.+++|+||+||.. .+|+++|++++||||+++++++.+.
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 344444577788889999988421 1799999999999999999999884
Q ss_pred -CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhc
Q psy6593 171 -RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARII 249 (433)
Q Consensus 171 -~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 249 (433)
..+++||||+++++|.+++... .+++..++.++.|++.||.+||+.||+|+||||+||+++.++.++|+|||++...
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 6789999999999999999773 4999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCC--
Q psy6593 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS-- 327 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~-- 327 (433)
....... .......+|+.|+|||.+.+..++.++||||||+++|+|++|..|+.......
T Consensus 185 ~~~~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~ 246 (318)
T 3lxp_A 185 PEGHEYY------------------RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE 246 (318)
T ss_dssp CTTCSEE------------------EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH
T ss_pred ccccccc------------------ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh
Confidence 4432110 01124467888999999999889999999999999999999887764321000
Q ss_pred ----C--------CCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccc
Q psy6593 328 ----P--------DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381 (433)
Q Consensus 328 ----~--------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~ 381 (433)
. .............+..+++.+.+||.+||+.||++||++++++++|+.+....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 247 LIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 0 00000111122345778999999999999999999999999999999876544
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=307.31 Aligned_cols=220 Identities=24% Similarity=0.318 Sum_probs=177.6
Q ss_pred CCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhc-CCcceeeEEEEEEeCCeeeEEE
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVT 177 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 177 (433)
+++...+++|+|+||+||++. .|+..+.++ +|+||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 457888899999999999622 455555555 8999999999999999999999
Q ss_pred eccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCc
Q psy6593 178 EYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPT 257 (433)
Q Consensus 178 e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 257 (433)
||+ +++|.+++...+..+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~--- 212 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--- 212 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-------
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC---
Confidence 999 6799999877666799999999999999999999999999999999999999999999999999876543221
Q ss_pred cccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhh
Q psy6593 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDF 337 (433)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~ 337 (433)
.....||+.|+|||++.+ .++.++||||||+++|||++|.+++..... ...+.....
T Consensus 213 -------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~ 269 (311)
T 3p1a_A 213 -------------------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYL 269 (311)
T ss_dssp ---------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCC
T ss_pred -------------------CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCC
Confidence 114468999999999886 789999999999999999988554432110 001111111
Q ss_pred ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 338 RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 338 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
...++..+++.+.+++.+||+.||++||+++++++
T Consensus 270 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 22334678899999999999999999999999984
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=302.76 Aligned_cols=228 Identities=28% Similarity=0.377 Sum_probs=179.3
Q ss_pred CCeeeeeccCCCcchhhhhcc------------------------------chHHHHhhcC---CcceeeEEEEEEeCC-
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC------------------------------GQVAVLRSLH---HHNVIRFIGVLYKDR- 171 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~------------------------------~E~~~l~~l~---h~~iv~~~~~~~~~~- 171 (433)
+++.+.+.+++|+||+||++. +|++++++++ ||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 346677778888888887521 5777777774 999999999998765
Q ss_pred ----eeeEEEeccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccc
Q psy6593 172 ----KLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLA 246 (433)
Q Consensus 172 ----~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 246 (433)
..++||||+. ++|.+++.... ..+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 5899999996 59999987643 34999999999999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCC
Q psy6593 247 RIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~ 326 (433)
......... ....||+.|+|||++.+..++.++||||||+++|+|++|.+||......
T Consensus 168 ~~~~~~~~~----------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 225 (308)
T 3g33_A 168 RIYSYQMAL----------------------TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 225 (308)
T ss_dssp TTSTTCCCS----------------------GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH
T ss_pred cccCCCccc----------------------CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 865432211 1457899999999999999999999999999999999999988543211
Q ss_pred CCC------------------CCCchhhh-------ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 327 SPD------------------FGLDQTDF-------RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 327 ~~~------------------~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
... .......+ .......+++.+.+||.+||+.||++|||++++++ ||+.
T Consensus 226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 226 DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp HHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred HHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 000 00000000 01123567899999999999999999999999984 5543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=335.75 Aligned_cols=232 Identities=21% Similarity=0.288 Sum_probs=191.8
Q ss_pred cccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhc-CCcceeeEEEEEEeCCee
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSL-HHHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 173 (433)
+..+++.+.+.+|+|+||.||+.. .|..+|..+ +|++|+++++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 345668889999999999999621 578888888 799999999999999999
Q ss_pred eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 174 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
||||||++|++|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 99999999999999997644 59999999999999999999999999999999999999999999999999998543221
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~ 333 (433)
. ......||+.|+|||++.+..++.++||||||+++|||++|.+||...........
T Consensus 497 ~---------------------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~-- 553 (674)
T 3pfq_A 497 V---------------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS-- 553 (674)
T ss_dssp C---------------------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--
T ss_pred c---------------------ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHH--
Confidence 1 12266899999999999999999999999999999999999999865322111111
Q ss_pred hhhhccccCCCCcHHHHHHHHHhcccCCCCCCCh-----hHHH--HHHHhhc
Q psy6593 334 QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF-----EVLE--VWLEGLS 378 (433)
Q Consensus 334 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~-----~~i~--~~l~~~~ 378 (433)
.......++..+++++.+||.+||+.||++||++ ++|+ .||+.+.
T Consensus 554 i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 554 IMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp HHSSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred HHhCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 1111234567889999999999999999999997 7776 3666543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=302.47 Aligned_cols=227 Identities=22% Similarity=0.383 Sum_probs=177.7
Q ss_pred CCeeeeeccCCCcchhhhhcc--------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
+.+.+.+.+++|+||+||+.. +|+++|++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 447778888899999888511 699999999999999999999999999999999
Q ss_pred cCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEE---ccCCceEEeccccchhccCCC
Q psy6593 180 IAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV---REDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 180 ~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
+++++|.+++.. .+..+++..++.++.|++.||+|||+.||+||||||+||++ +.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 999999998853 23569999999999999999999999999999999999999 456889999999997654322
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~ 333 (433)
. .....||+.|+|||.+.+ .++.++||||||+++|+|++|.+||.............
T Consensus 182 ~----------------------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~ 238 (285)
T 3is5_A 182 H----------------------STNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT 238 (285)
T ss_dssp ---------------------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred c----------------------CcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc
Confidence 1 114578999999999864 68999999999999999999988886432111000000
Q ss_pred hhh-hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHH
Q psy6593 334 QTD-FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLE 375 (433)
Q Consensus 334 ~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~ 375 (433)
... ........+++.+.+++.+||+.||++||+++++++ ||+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~ 283 (285)
T 3is5_A 239 YKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283 (285)
T ss_dssp HCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGG
T ss_pred cCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhh
Confidence 000 000112447899999999999999999999999984 554
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=304.14 Aligned_cols=212 Identities=29% Similarity=0.496 Sum_probs=172.3
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCC--CCCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP--GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
+|+.++++++||||+++++++.+++..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++|+|
T Consensus 79 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~d 158 (307)
T 2nru_A 79 QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRD 158 (307)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCC
Confidence 7999999999999999999999999999999999999999998642 34699999999999999999999999999999
Q ss_pred CCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeE
Q psy6593 225 LNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVF 304 (433)
Q Consensus 225 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 304 (433)
|||+||+++.++.++|+|||++.......... ......||+.|+|||.+.+ .++.++|||
T Consensus 159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~-------------------~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~ 218 (307)
T 2nru_A 159 IKSANILLDEAFTAKISDFGLARASEKFAQTV-------------------MTSRIVGTTAYMAPEALRG-EITPKSDIY 218 (307)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECCSCSSCE-------------------ECSSCCSCGGGCCHHHHTT-EECTHHHHH
T ss_pred CCHHHEEEcCCCcEEEeecccccccccccccc-------------------cccccCCCcCcCChHHhcC-CCCccchhH
Confidence 99999999999999999999988654322111 0114568999999998876 588999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCCCch---------hhhc----cccCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFGLDQ---------TDFR----NKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~~~~---------~~~~----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
|||+++|+|++|.+|+...........+.. .... ...+...+..+.+++.+||+.+|.+||++++|+
T Consensus 219 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~ 298 (307)
T 2nru_A 219 SFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298 (307)
T ss_dssp HHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 999999999999998865433221111100 0000 111223456799999999999999999999999
Q ss_pred HHHHhhc
Q psy6593 372 VWLEGLS 378 (433)
Q Consensus 372 ~~l~~~~ 378 (433)
+.|+++.
T Consensus 299 ~~L~~l~ 305 (307)
T 2nru_A 299 QLLQEMT 305 (307)
T ss_dssp HHHHHHC
T ss_pred HHHHHHh
Confidence 9999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=309.59 Aligned_cols=227 Identities=21% Similarity=0.305 Sum_probs=172.6
Q ss_pred CCeeeeeccCCCcchhhhhc----------------------------cchHHHHhhcCCcceeeEEEEEEeCCe----e
Q psy6593 126 DGLLFCKEDYNGKYGEACQN----------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRK----L 173 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~----------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~----~ 173 (433)
+.+.+.+.+++|+||+||++ .+|+.++++++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 44667777888888887741 168889999999999999999886653 4
Q ss_pred eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 174 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
|+||||++|++|.+++...+ .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 170 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence 99999999999999997643 59999999999999999999999999999999999999999999999999998764432
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~ 333 (433)
... .......||+.|+|||.+.+..++.++||||||+++|+|++|.+||.............
T Consensus 171 ~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~ 232 (311)
T 3ork_A 171 NSV------------------TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232 (311)
T ss_dssp -----------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccc------------------ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh
Confidence 111 11124578999999999999999999999999999999999998886532211100000
Q ss_pred hh--hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 334 QT--DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 334 ~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
.. .........+++++.+++.+||+.||++||+..+++
T Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l 272 (311)
T 3ork_A 233 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272 (311)
T ss_dssp HCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred cCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHH
Confidence 00 001112356889999999999999999999766655
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=312.85 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=176.0
Q ss_pred CCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcC-CcceeeEEEEEEeCC--eeeE
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLH-HHNVIRFIGVLYKDR--KLNL 175 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~-h~~iv~~~~~~~~~~--~~~l 175 (433)
+++.+.+.+|+|+||.||++. +|+.+|+++. ||||+++++++..++ .+|+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 346777788888888888621 7999999997 999999999998654 7899
Q ss_pred EEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCC
Q psy6593 176 VTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 89 v~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 999996 599999976 46999999999999999999999999999999999999999999999999999876442221
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc-
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD- 333 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~- 333 (433)
..........................||+.|+|||++.+ ..++.++||||||+++|||++|.+||...........+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 110000000000000011112335689999999999986 678999999999999999999999986532110000000
Q ss_pred --------------------------------hh------------hhccccCCCCcHHHHHHHHHhcccCCCCCCChhH
Q psy6593 334 --------------------------------QT------------DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEV 369 (433)
Q Consensus 334 --------------------------------~~------------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 369 (433)
.. .........+++++.+|+.+||+.||++|||+++
T Consensus 246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence 00 0000112367889999999999999999999999
Q ss_pred HHH--HHHhh
Q psy6593 370 LEV--WLEGL 377 (433)
Q Consensus 370 i~~--~l~~~ 377 (433)
+++ ||+..
T Consensus 326 ~l~Hp~~~~~ 335 (388)
T 3oz6_A 326 ALKHPFVSIF 335 (388)
T ss_dssp HTTSTTTTTT
T ss_pred HhCCHHHHHh
Confidence 984 56543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=307.49 Aligned_cols=228 Identities=22% Similarity=0.316 Sum_probs=189.0
Q ss_pred cCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEE
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 176 (433)
.+++.+.+.+++|+||.||+.. +|+.++++++|+||+++++++.+++..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4457777888899999888521 689999999999999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCC
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
|||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.........
T Consensus 120 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~- 197 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER- 197 (335)
T ss_dssp ECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred EecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc-
Confidence 9999999999998763 35999999999999999999999999999999999999999999999999999875432211
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD 336 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~ 336 (433)
.....||+.|+|||.+.+..++.++||||||+++|+|++|.+||......... .....
T Consensus 198 --------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~ 255 (335)
T 2owb_A 198 --------------------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY--LRIKK 255 (335)
T ss_dssp --------------------BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHHH
T ss_pred --------------------ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH--HHHhc
Confidence 11457899999999999989999999999999999999999887542211100 00111
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
....++..++..+.++|.+||+.||++||+++++++ ||..
T Consensus 256 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 256 NEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 122345678899999999999999999999999984 7765
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=332.21 Aligned_cols=227 Identities=22% Similarity=0.386 Sum_probs=184.5
Q ss_pred eccCCCcchhhhhcc-----------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCC
Q psy6593 132 KEDYNGKYGEACQNC-----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAG 182 (433)
Q Consensus 132 ~~~~~g~fg~v~~~~-----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 182 (433)
+++|+|+||+||+.. +|+++|++++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 479999999998631 6999999999999999999986 4568999999999
Q ss_pred CCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcccccc
Q psy6593 183 GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAK 262 (433)
Q Consensus 183 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 262 (433)
++|.+++... ..+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++..........
T Consensus 454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~----- 527 (635)
T 4fl3_A 454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK----- 527 (635)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc-----
Confidence 9999999764 4599999999999999999999999999999999999999999999999999987654322110
Q ss_pred chhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhcccc
Q psy6593 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKF 341 (433)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (433)
......+|+.|+|||++.+..++.++||||||+++|||++ |.+||........ ............
T Consensus 528 -------------~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-~~~i~~~~~~~~ 593 (635)
T 4fl3_A 528 -------------AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TAMLEKGERMGC 593 (635)
T ss_dssp --------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HHHHHTTCCCCC
T ss_pred -------------cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHcCCCCCC
Confidence 1113456788999999999999999999999999999997 9888865332111 111112223345
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 342 CASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 342 ~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
+..+|+++.+||.+||+.||++||++++|++.|+++..
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 67889999999999999999999999999999988654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=305.63 Aligned_cols=231 Identities=22% Similarity=0.353 Sum_probs=179.5
Q ss_pred ccCCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEE
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 176 (433)
..+++.+.+.+++|+||+||++. +|+.+|++++||||+++++++.+++..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 44568888889999999988631 699999999999999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEc-----cCCceEEeccccchhccC
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR-----EDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~-----~~~~~kl~Dfg~~~~~~~ 251 (433)
|||++ ++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+|||++.....
T Consensus 112 ~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp EECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred EecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 99997 59999997654 499999999999999999999999999999999999994 455699999999987643
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~ 330 (433)
.... .....||+.|+|||++.+. .++.++||||||+++|+|++|.+||..........
T Consensus 190 ~~~~---------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 248 (329)
T 3gbz_A 190 PIRQ---------------------FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF 248 (329)
T ss_dssp -------------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred cccc---------------------cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH
Confidence 2211 1145689999999999874 48999999999999999999998885432100000
Q ss_pred ----------------------------CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 331 ----------------------------GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 331 ----------------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
..........+...+++++.+||.+||+.||++|||++++++ ||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 249 KIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred HHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 000000111112236789999999999999999999999985 66653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=309.75 Aligned_cols=233 Identities=24% Similarity=0.418 Sum_probs=186.4
Q ss_pred ccCCeeeeeccCCCcchhhhhcc---------------------chHHHHhhcCCcceeeEEEEEEe-------------
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC---------------------GQVAVLRSLHHHNVIRFIGVLYK------------- 169 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~---------------------~E~~~l~~l~h~~iv~~~~~~~~------------- 169 (433)
..+++.+.+.+|+|+||+||++. +|+++|++++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence 34568888899999999999732 79999999999999999999854
Q ss_pred -------------------------CCeeeEEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCCcc
Q psy6593 170 -------------------------DRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLI 221 (433)
Q Consensus 170 -------------------------~~~~~lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~ 221 (433)
+..+++||||++ ++|.+.+.. .+..+++..++.++.||+.||+|||+.||+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~ 163 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGIC 163 (383)
T ss_dssp -------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCc
Confidence 334899999997 588777642 345799999999999999999999999999
Q ss_pred ccCCCCcceEEc-cCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCc
Q psy6593 222 HRDLNSQNCLVR-EDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDE 299 (433)
Q Consensus 222 H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ 299 (433)
||||||+||+++ .++.+||+|||+++........ ....||+.|+|||.+.+. .++.
T Consensus 164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~----------------------~~~~~t~~y~aPE~~~~~~~~~~ 221 (383)
T 3eb0_A 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS----------------------VAYICSRFYRAPELMLGATEYTP 221 (383)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC----------------------CCCCCCSSCCCHHHHTTCSSCCT
T ss_pred cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC----------------------cCcccCCCccCHHHhcCCCCCCc
Confidence 999999999998 6899999999999866433221 145789999999998774 5899
Q ss_pred ccCeEehhHHHHHHhcCCCCCCCCCCCC---------------------------CCCCCchhhhccccCCCCcHHHHHH
Q psy6593 300 TVDVFSYGIVLCEIIGRVPADPDYLPRS---------------------------PDFGLDQTDFRNKFCASCPEPFVRI 352 (433)
Q Consensus 300 ~~DiwslG~il~ell~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~~~l~~l 352 (433)
++||||||+++|+|++|.+||....... .........+...++..+++.+.+|
T Consensus 222 ~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 301 (383)
T 3eb0_A 222 SIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDL 301 (383)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHH
T ss_pred chhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHH
Confidence 9999999999999999999886532110 0011112223334556789999999
Q ss_pred HHHhcccCCCCCCChhHHH--HHHHhhcc
Q psy6593 353 AFLCCDLNPDQRPPFEVLE--VWLEGLSM 379 (433)
Q Consensus 353 i~~~l~~~p~~RPs~~~i~--~~l~~~~~ 379 (433)
+.+||+.||++|||+.+++ .||+.+..
T Consensus 302 i~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 302 LEQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred HHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 9999999999999999998 47776543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=307.28 Aligned_cols=237 Identities=26% Similarity=0.456 Sum_probs=188.1
Q ss_pred cccCCeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhcCCcceeeEEEEEEeCC
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSLHHHNVIRFIGVLYKDR 171 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l~h~~iv~~~~~~~~~~ 171 (433)
+..+++.+.+.+++|+||.||+.. +|+.++++++||||+++++++....
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 345567777888888888887521 6899999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhcCCC------CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc---CCceEEec
Q psy6593 172 KLNLVTEYIAGGTLKELLQDPG------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE---DKTVVVAD 242 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~D 242 (433)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.||+||||||+||+++. +..++|+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECc
Confidence 9999999999999999997532 34899999999999999999999999999999999999984 45699999
Q ss_pred cccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCC
Q psy6593 243 FGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADP 321 (433)
Q Consensus 243 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~ 321 (433)
||++........... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |.+|+.
T Consensus 187 fg~~~~~~~~~~~~~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 247 (327)
T 2yfx_A 187 FGMARDIYRASYYRK-------------------GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 247 (327)
T ss_dssp CHHHHHHHC-------------------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccccccccccccccc-------------------CCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 999986543322111 113467889999999998899999999999999999997 888875
Q ss_pred CCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 322 DYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
....... ............+..++..+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 248 ~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 248 SKSNQEV-LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp TCCHHHH-HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCHHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 4321110 00011111233456789999999999999999999999999999987664
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=310.41 Aligned_cols=237 Identities=22% Similarity=0.282 Sum_probs=183.0
Q ss_pred CCeeeeeccCCCcchhhhhcc------------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeE
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC------------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~------------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 175 (433)
+++.+.+.+++|+||+||++. +|+++|++++||||+++++++.+.+..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 347777888899999888521 59999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhcCC---------------------------------------CCCCChHHHHHHHHHHHHHHhhhh
Q psy6593 176 VTEYIAGGTLKELLQDP---------------------------------------GQPLPWGQRVNFARDIAAGMTYLH 216 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~---------------------------------------~~~~~~~~~~~i~~qi~~~L~~lH 216 (433)
||||++|++|.+++... ...+++..++.++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999998520 112467788999999999999999
Q ss_pred cCCccccCCCCcceEEccCC--ceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC
Q psy6593 217 SMNLIHRDLNSQNCLVREDK--TVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG 294 (433)
Q Consensus 217 ~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 294 (433)
+.||+||||||+||+++.++ .+||+|||++........... .......||+.|+|||.+.+
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY-----------------YGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-------------------------CCCGGGCCHHHHTC
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCcccc-----------------ccccccCCCccccCchhhcc
Confidence 99999999999999998766 899999999986643222110 01125679999999999875
Q ss_pred --CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh--hccccCCCCcHHHHHHHHHhcccCCCCCCChhHH
Q psy6593 295 --QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD--FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVL 370 (433)
Q Consensus 295 --~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i 370 (433)
..++.++||||||+++|+|++|.+||...........+.... +.......+++.+.+||.+||+.||.+||++.++
T Consensus 249 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 678999999999999999999998885432211100000000 0111113478899999999999999999999999
Q ss_pred HH--HHHhhcc
Q psy6593 371 EV--WLEGLSM 379 (433)
Q Consensus 371 ~~--~l~~~~~ 379 (433)
++ ||+....
T Consensus 329 l~hp~~~~~~~ 339 (345)
T 3hko_A 329 LQHPWISQFSD 339 (345)
T ss_dssp HHSHHHHTTSS
T ss_pred hcChhhccChH
Confidence 84 8887654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=307.44 Aligned_cols=230 Identities=18% Similarity=0.254 Sum_probs=178.6
Q ss_pred cCCeeeeeccCCCcchhhhhcc--------------------------chHHHHhhcCC--cceeeEEEEEEeCCeeeEE
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSLHH--HNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv 176 (433)
.+.+.+.+.+|+|+||.||+.. +|+.+|++++| +||+++++++..++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3446777788888888888521 69999999976 9999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCC
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
||+. +++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++.........
T Consensus 88 ~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 164 (343)
T 3dbq_A 88 MECG-NIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 164 (343)
T ss_dssp ECCC-SEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred EeCC-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence 9954 789999997743 599999999999999999999999999999999999997 6789999999998764332111
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecC-----------CCCCcccCeEehhHHHHHHhcCCCCCCCCCC
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-----------QEYDETVDVFSYGIVLCEIIGRVPADPDYLP 325 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~~~~~~~~~~~ 325 (433)
......||+.|+|||++.+ ..++.++||||||+++|+|++|.+||.....
T Consensus 165 -------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 225 (343)
T 3dbq_A 165 -------------------VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225 (343)
T ss_dssp ------------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred -------------------cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh
Confidence 1114579999999999865 6788999999999999999999988854321
Q ss_pred CCCC-CCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHh
Q psy6593 326 RSPD-FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEG 376 (433)
Q Consensus 326 ~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~ 376 (433)
.... ...........++...+..+.+|+.+||+.||.+||++.+++ .|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 226 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred HHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 1000 000011122334566678999999999999999999999998 47764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=322.38 Aligned_cols=228 Identities=22% Similarity=0.383 Sum_probs=185.5
Q ss_pred CeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 127 GLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
.+.+.+.+|+|+||+||+.. +|+++|++++||||+++++++.+.+.+++||||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 102 (486)
T 3mwu_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102 (486)
T ss_dssp HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEc
Confidence 36778889999999998621 699999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEc---cCCceEEeccccchhccCCCCCC
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
+.|++|.+.+...+ .+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+|||++........
T Consensus 103 ~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~-- 179 (486)
T 3mwu_A 103 YTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-- 179 (486)
T ss_dssp CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----
T ss_pred CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc--
Confidence 99999999886543 599999999999999999999999999999999999995 456799999999986543221
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD 336 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~ 336 (433)
.....||+.|+|||++.+ .++.++||||||+++|+|++|.+||...........+....
T Consensus 180 --------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 238 (486)
T 3mwu_A 180 --------------------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238 (486)
T ss_dssp ----------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred --------------------cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 114579999999999986 58999999999999999999999886532211111111111
Q ss_pred h--ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 337 F--RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 337 ~--~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
. .......+++.+.+||.+||+.||.+|||+.++++ |++...
T Consensus 239 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 239 YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 1 11122567899999999999999999999999984 888754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=305.62 Aligned_cols=226 Identities=22% Similarity=0.344 Sum_probs=183.1
Q ss_pred CeeeeeccCCCcchhhhhc-------------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeE
Q psy6593 127 GLLFCKEDYNGKYGEACQN-------------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~-------------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 175 (433)
.+.+.+.+++|+||.||++ .+|+.+|++++||||+++++++.+.+..++
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (321)
T 2a2a_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92 (321)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3556667777777777651 168999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCC----ceEEeccccchhccC
Q psy6593 176 VTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDK----TVVVADFGLARIIHQ 251 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~ 251 (433)
||||++|++|.+++...+ .+++..++.++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~ 171 (321)
T 2a2a_A 93 ILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (321)
T ss_dssp EECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence 999999999999998743 599999999999999999999999999999999999999887 799999999986644
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG 331 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~ 331 (433)
.... ....||+.|+|||.+.+..++.++||||||+++|+|++|.+||...........
T Consensus 172 ~~~~----------------------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 229 (321)
T 2a2a_A 172 GVEF----------------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 229 (321)
T ss_dssp TCCC----------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH
T ss_pred cccc----------------------cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 2211 145689999999999998999999999999999999999888754321110000
Q ss_pred Cch--hhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHH
Q psy6593 332 LDQ--TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLE 375 (433)
Q Consensus 332 ~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~ 375 (433)
+.. ..........++..+.+++.+||+.||++||+++++++ ||.
T Consensus 230 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~ 277 (321)
T 2a2a_A 230 ITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (321)
T ss_dssp HHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTS
T ss_pred HHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence 000 01111223567899999999999999999999999985 554
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=313.94 Aligned_cols=228 Identities=22% Similarity=0.360 Sum_probs=178.1
Q ss_pred cCCeeeeeccCCCcchhhhhcc---------------------------------chHHHHhhcCCcceeeEEEEEEeCC
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC---------------------------------GQVAVLRSLHHHNVIRFIGVLYKDR 171 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~---------------------------------~E~~~l~~l~h~~iv~~~~~~~~~~ 171 (433)
.+++.+.+.+|+|+||+||++. +|+.+|++++||||+++++++. .+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 3558888999999999998621 5999999999999999999975 55
Q ss_pred eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccC---CceEEeccccchh
Q psy6593 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRED---KTVVVADFGLARI 248 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~ 248 (433)
..++||||+++++|.+++...+ .+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred ceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 6899999999999999987644 59999999999999999999999999999999999999754 4599999999987
Q ss_pred ccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC---CCCCcccCeEehhHHHHHHhcCCCCCCCCCC
Q psy6593 249 IHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG---QEYDETVDVFSYGIVLCEIIGRVPADPDYLP 325 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~~~~~~~~~~~ 325 (433)
...... .....||+.|+|||++.+ ..++.++||||||+++|+|++|.+||.....
T Consensus 292 ~~~~~~----------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 292 LGETSL----------------------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp CC---------------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred cCCCcc----------------------ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 543211 125679999999999864 5678899999999999999999999865332
Q ss_pred CCCCCCCchh---hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 326 RSPDFGLDQT---DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 326 ~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
.......... .........+++.+.+++.+||+.||++||+++++++ ||++
T Consensus 350 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 350 QVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp SCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred hHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 2111110000 1111223567899999999999999999999999985 5543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=312.59 Aligned_cols=230 Identities=24% Similarity=0.373 Sum_probs=181.6
Q ss_pred CeeeeeccCCCcchhhhhcc---------------------chHHHHhhcCCcceeeEEEEEEeC------CeeeEEEec
Q psy6593 127 GLLFCKEDYNGKYGEACQNC---------------------GQVAVLRSLHHHNVIRFIGVLYKD------RKLNLVTEY 179 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~~---------------------~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~ 179 (433)
.+...+.+|+|+||.||++. +|+++|++++|+||+++++++... ..+++||||
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 46777889999999999732 699999999999999999998642 247799999
Q ss_pred cCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccC-CceEEeccccchhccCCCCC
Q psy6593 180 IAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRED-KTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 180 ~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 255 (433)
+++ +|.+++.. ....+++..++.++.||+.||+|||+.||+||||||+|||++.+ +.+||+|||+++........
T Consensus 135 ~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~ 213 (420)
T 1j1b_A 135 VPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213 (420)
T ss_dssp CCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred ccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCc
Confidence 965 77666542 34569999999999999999999999999999999999999955 67899999999865432211
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeEehhHHHHHHhcCCCCCCCCCCCCC------
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP------ 328 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~------ 328 (433)
....||+.|+|||++.+. .++.++||||||+++|||++|.+||........
T Consensus 214 ----------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~ 271 (420)
T 1j1b_A 214 ----------------------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271 (420)
T ss_dssp ----------------------CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ----------------------eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 145789999999998764 789999999999999999999998865321100
Q ss_pred ---------------------CCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhcc
Q psy6593 329 ---------------------DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLSM 379 (433)
Q Consensus 329 ---------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~~ 379 (433)
........+...+...+++++.+||.+||+.||.+||++.+++ .||+.+..
T Consensus 272 ~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 272 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp HHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred HhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 0000111112223456789999999999999999999999998 48877653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=323.44 Aligned_cols=229 Identities=24% Similarity=0.389 Sum_probs=184.2
Q ss_pred CeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 127 GLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
.+.+.+.+|+|+||+||+.. +|+.+|++++||||+++++++.+.+..++||||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 117 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 47788899999999999521 699999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc---CCceEEeccccchhccCCCCCC
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE---DKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
++|++|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++........
T Consensus 118 ~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~-- 194 (494)
T 3lij_A 118 YKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-- 194 (494)
T ss_dssp CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC--
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc--
Confidence 9999999988654 35999999999999999999999999999999999999975 45699999999986543221
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD 336 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~ 336 (433)
.....||+.|+|||++.+ .++.++||||||+++|+|++|.+||...........+....
T Consensus 195 --------------------~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 253 (494)
T 3lij_A 195 --------------------MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK 253 (494)
T ss_dssp --------------------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred --------------------ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 124579999999999874 68999999999999999999999986532211111111111
Q ss_pred --hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhcc
Q psy6593 337 --FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLSM 379 (433)
Q Consensus 337 --~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~~ 379 (433)
+.......+++.+.+||.+||+.||.+|||+++++ .||.....
T Consensus 254 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 300 (494)
T 3lij_A 254 YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCS 300 (494)
T ss_dssp CCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHH
T ss_pred CCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcc
Confidence 11112256889999999999999999999999998 58877543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=298.58 Aligned_cols=226 Identities=21% Similarity=0.317 Sum_probs=185.1
Q ss_pred eeeeeccCCCcchhhhhcc---------------------chHHHHhhcCCcceeeEEEEEEe----------------C
Q psy6593 128 LLFCKEDYNGKYGEACQNC---------------------GQVAVLRSLHHHNVIRFIGVLYK----------------D 170 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~~---------------------~E~~~l~~l~h~~iv~~~~~~~~----------------~ 170 (433)
+...+.+++|+||.||+.. +|++++++++||||+++++++.. .
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (284)
T 2a19_B 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKT 92 (284)
T ss_dssp EEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEE
T ss_pred cceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCc
Confidence 5666777788888777522 79999999999999999999864 4
Q ss_pred CeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhc
Q psy6593 171 RKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARII 249 (433)
Q Consensus 171 ~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 249 (433)
...++||||+++++|.+++... +..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 172 (284)
T 2a19_B 93 KCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172 (284)
T ss_dssp EEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEES
T ss_pred ceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheec
Confidence 4589999999999999999642 346999999999999999999999999999999999999999999999999998876
Q ss_pred cCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCC
Q psy6593 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPD 329 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~ 329 (433)
...... ....||+.|+|||.+.+..++.++||||||+++|+|++|..++....
T Consensus 173 ~~~~~~----------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 225 (284)
T 2a19_B 173 KNDGKR----------------------TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----- 225 (284)
T ss_dssp SCCSCC----------------------CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----
T ss_pred cccccc----------------------cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----
Confidence 443211 14468999999999999899999999999999999998876653210
Q ss_pred CCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccc
Q psy6593 330 FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381 (433)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~ 381 (433)
..........++..++..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 226 -KFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp -HHHHHHHTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred -HHHHHhhcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 001111122344668899999999999999999999999999999876543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=307.67 Aligned_cols=225 Identities=24% Similarity=0.366 Sum_probs=180.3
Q ss_pred eeccCCCcchhhhhcc---------------------------chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCC
Q psy6593 131 CKEDYNGKYGEACQNC---------------------------GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAG 182 (433)
Q Consensus 131 ~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g 182 (433)
.+.+++|+||+||+.. +|+.+++++ +||||+++++++...+..++||||+++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (327)
T 3lm5_A 34 SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG 113 (327)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred cceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCC
Confidence 3778899999888621 689999999 579999999999999999999999999
Q ss_pred CCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc---CCceEEeccccchhccCCCCCCcc
Q psy6593 183 GTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE---DKTVVVADFGLARIIHQGPRAPTT 258 (433)
Q Consensus 183 ~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~ 258 (433)
++|.+++... ...+++..++.++.|++.||+|||+.||+||||||+||+++. ++.+||+|||++........
T Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---- 189 (327)
T 3lm5_A 114 GEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---- 189 (327)
T ss_dssp EEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------
T ss_pred CcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc----
Confidence 9999998653 456999999999999999999999999999999999999987 78999999999986543221
Q ss_pred ccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCch--hh
Q psy6593 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQ--TD 336 (433)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~--~~ 336 (433)
.....||+.|+|||++.+..++.++||||||+++|+|++|.+||...........+.. ..
T Consensus 190 ------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 251 (327)
T 3lm5_A 190 ------------------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD 251 (327)
T ss_dssp ----------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred ------------------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc
Confidence 1145799999999999999999999999999999999999988754321111000000 11
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
........+++.+.++|.+||+.||++||+++++++ ||+..
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 252 YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 112233568899999999999999999999999984 66554
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=307.81 Aligned_cols=230 Identities=19% Similarity=0.290 Sum_probs=186.0
Q ss_pred ccccCCeeeeeccCCCcchhhhhc--------------------------------cchHHHHhhc-CCcceeeEEEEEE
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQN--------------------------------CGQVAVLRSL-HHHNVIRFIGVLY 168 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~--------------------------------~~E~~~l~~l-~h~~iv~~~~~~~ 168 (433)
.+..+++.+.+.+++|+||+||+. .+|+++|+++ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 345567888899999999999831 1699999999 6999999999999
Q ss_pred eCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchh
Q psy6593 169 KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 169 ~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
.++..++||||+++++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++.
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eCceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 9999999999999999999997643 599999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC--CCCCcccCeEehhHHHHHHhcCCCCCCCCCCC
Q psy6593 249 IHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG--QEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~~~~~~~~~~~~ 326 (433)
...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|.+||......
T Consensus 209 ~~~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 268 (355)
T 1vzo_A 209 FVADET--------------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 268 (355)
T ss_dssp CCGGGG--------------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred cccCCC--------------------CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc
Confidence 532111 01124579999999999986 34788999999999999999999888643322
Q ss_pred CCCCCCchh--hhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHHH
Q psy6593 327 SPDFGLDQT--DFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLEV 372 (433)
Q Consensus 327 ~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~~ 372 (433)
.....+... .....++..++..+.+||.+||+.||.+|| +++++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 269 NSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred chHHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 211111111 122345577889999999999999999999 8888874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=316.09 Aligned_cols=227 Identities=23% Similarity=0.313 Sum_probs=175.3
Q ss_pred cCCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeC------C
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKD------R 171 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~------~ 171 (433)
.+++.+.+.+|+|+||+||++. +|+.+|++++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4567888899999999998621 799999999999999999999755 3
Q ss_pred eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
..|+||||+++ +|.+.+.. .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 57999999965 67777754 499999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC-
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF- 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~- 330 (433)
... .....||+.|+|||++.+..++.++||||||+++|||++|.+||..........
T Consensus 217 ~~~----------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~ 274 (464)
T 3ttj_A 217 SFM----------------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 274 (464)
T ss_dssp CCC----------------------C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred Ccc----------------------cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 221 125689999999999999999999999999999999999999986532100000
Q ss_pred --------------CCc--------------hhhhccccCC-----------CCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 331 --------------GLD--------------QTDFRNKFCA-----------SCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 331 --------------~~~--------------~~~~~~~~~~-----------~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
... ...+...++. ..++++.+||.+||+.||++|||+++++
T Consensus 275 i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 354 (464)
T 3ttj_A 275 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354 (464)
T ss_dssp HHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 000 0000000000 0156789999999999999999999998
Q ss_pred H--HHHhh
Q psy6593 372 V--WLEGL 377 (433)
Q Consensus 372 ~--~l~~~ 377 (433)
+ ||+..
T Consensus 355 ~Hp~~~~~ 362 (464)
T 3ttj_A 355 QHPYINVW 362 (464)
T ss_dssp TSTTTGGG
T ss_pred cChhhhhc
Confidence 4 77653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=303.97 Aligned_cols=238 Identities=25% Similarity=0.415 Sum_probs=183.3
Q ss_pred CCeeeeeccCCCcchhhhhcc--------------------chHHHHhhc--CCcceeeEEEEEEeC----CeeeEEEec
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC--------------------GQVAVLRSL--HHHNVIRFIGVLYKD----RKLNLVTEY 179 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~--------------------~E~~~l~~l--~h~~iv~~~~~~~~~----~~~~lv~e~ 179 (433)
+++.+.+.+++|+||+||++. .|.+++..+ +||||+++++++... ...++||||
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 116 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECC
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEec
Confidence 457788899999999999622 455666555 899999999999987 789999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC--------CccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM--------NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~--------~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
+++++|.++++. ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++.....
T Consensus 117 ~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 194 (337)
T 3mdy_A 117 HENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS 194 (337)
T ss_dssp CTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred cCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeecc
Confidence 999999999976 3599999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcc------cCeEehhHHHHHHhcC---------
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDET------VDVFSYGIVLCEIIGR--------- 316 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~il~ell~~--------- 316 (433)
...... .......||+.|+|||++.+...+.. +||||||+++|||++|
T Consensus 195 ~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 195 DTNEVD-----------------IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp -------------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred cccccc-----------------CCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 322110 01114579999999999988766665 9999999999999998
Q ss_pred -CCCCCCCCCCCCCCCCch-----hhhccccC-----CCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccccc
Q psy6593 317 -VPADPDYLPRSPDFGLDQ-----TDFRNKFC-----ASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLS 382 (433)
Q Consensus 317 -~~~~~~~~~~~~~~~~~~-----~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~ 382 (433)
..|+.............. ......++ ..+++.+.+++.+||+.||.+||++++|++.|+.+.....
T Consensus 258 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 258 YQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred ccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 444433222221110000 01111111 2456779999999999999999999999999999876443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=310.17 Aligned_cols=232 Identities=21% Similarity=0.353 Sum_probs=188.4
Q ss_pred cccCCeeeeeccCCCcchhhhhcc--------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEE
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 176 (433)
+..+++.+.+.+++|+||+||+.. +|+.+|++++||||+++++++..++..++|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 445668888899999999998621 799999999999999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC-CccccCCCCcceEEccCCceEEeccccchhccCCCCC
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
|||++|++|.+++...+ .+++..+..++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++.......
T Consensus 110 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 186 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 186 (360)
T ss_dssp ECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred EECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc--
Confidence 99999999999997643 599999999999999999999996 99999999999999999999999999987653221
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCC------
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPD------ 329 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~------ 329 (433)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 187 ---------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 245 (360)
T 3eqc_A 187 ---------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 245 (360)
T ss_dssp -------------------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--
T ss_pred ---------------------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccc
Confidence 11457899999999999999999999999999999999998887542210000
Q ss_pred ---------------------------CCCc---------hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--
Q psy6593 330 ---------------------------FGLD---------QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE-- 371 (433)
Q Consensus 330 ---------------------------~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~-- 371 (433)
.... ...........++..+.+||.+||+.||++|||+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 246 VEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ----------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000 00000011134688999999999999999999999998
Q ss_pred HHHHhhc
Q psy6593 372 VWLEGLS 378 (433)
Q Consensus 372 ~~l~~~~ 378 (433)
.||+...
T Consensus 326 p~~~~~~ 332 (360)
T 3eqc_A 326 AFIKRSD 332 (360)
T ss_dssp HHHHHHH
T ss_pred hHhhcch
Confidence 5888754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=307.02 Aligned_cols=233 Identities=13% Similarity=0.178 Sum_probs=188.2
Q ss_pred ccccCCeeeeeccCCCcchhhhhc-----c----------------------chHHHHhhcC---CcceeeEEEEEEeCC
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQN-----C----------------------GQVAVLRSLH---HHNVIRFIGVLYKDR 171 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~-----~----------------------~E~~~l~~l~---h~~iv~~~~~~~~~~ 171 (433)
.+..+.+.+.+.+|+|+||+||++ . .|++++++++ |+||+++++++..++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 345566888889999999999986 1 5778888886 999999999999999
Q ss_pred eeeEEEeccCCCCHHHHhcC----CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc-----------CC
Q psy6593 172 KLNLVTEYIAGGTLKELLQD----PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE-----------DK 236 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~-----------~~ 236 (433)
..++||||++|++|.+++.. ....+++..++.|+.||+.||+|||+.||+||||||+|||++. ++
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence 99999999999999999963 3456999999999999999999999999999999999999998 89
Q ss_pred ceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcC
Q psy6593 237 TVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGR 316 (433)
Q Consensus 237 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~ 316 (433)
.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++|
T Consensus 221 ~~kl~DFG~a~~~~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 281 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKG-------------------TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281 (365)
T ss_dssp TEEECCCTTCEEGGGSCTT-------------------EEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred CEEEeeCchhhhhhccCCC-------------------ceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence 9999999999765422111 112256799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCC-CChhHHHHHHHhhcc
Q psy6593 317 VPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQR-PPFEVLEVWLEGLSM 379 (433)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R-Ps~~~i~~~l~~~~~ 379 (433)
.+|+......... ....... ...++.+.+++..||+.+|.+| |++.++.+.|++...
T Consensus 282 ~~pf~~~~~~~~~----~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 282 TYMKVKNEGGECK----PEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp SCCCEEEETTEEE----ECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCccccCCCCcee----echhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 8877432221100 0000001 1346789999999999999998 577788877777654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=298.57 Aligned_cols=228 Identities=22% Similarity=0.312 Sum_probs=187.2
Q ss_pred cCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEE
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 176 (433)
.+++.+.+.+++|+||+||+.. +|+.++++++|+||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 3446667778888888877511 699999999999999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCC
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
|||+++++|.+++...+ .+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~- 171 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER- 171 (294)
T ss_dssp EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc-
Confidence 99999999999987643 5999999999999999999999999999999999999999999999999999865432211
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD 336 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~ 336 (433)
.....||+.|+|||.+.+..++.++||||||+++|+|++|.+|+......... .....
T Consensus 172 --------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~ 229 (294)
T 2rku_A 172 --------------------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY--LRIKK 229 (294)
T ss_dssp --------------------BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHHT
T ss_pred --------------------cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHhh
Confidence 11456899999999999988999999999999999999999887543211100 00011
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
....++..+++.+.+++.+||+.||++||+++++++ |+..
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 230 NEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred ccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence 122345678899999999999999999999999984 7764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=314.44 Aligned_cols=253 Identities=22% Similarity=0.369 Sum_probs=174.4
Q ss_pred cCCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeC-----Ce
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKD-----RK 172 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 172 (433)
.+++.+.+.+|+|+||+||++. +|+.+|++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 3557888899999999998631 699999999999999999999543 56
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
+|+||||+ +++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred EEEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 99999998 57999999774 35999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCccccccchh------hhhhhcccccceeeeccCcccccccee-cCCCCCcccCeEehhHHHHHHhc----------
Q psy6593 253 PRAPTTVMAKVPR------KAAQRRGARKKRYTVVGNPYWMAPEMM-TGQEYDETVDVFSYGIVLCEIIG---------- 315 (433)
Q Consensus 253 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~---------- 315 (433)
............. ...............+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 2211100000000 000000011223467899999999976 45679999999999999999998
Q ss_pred -CCCCCCCCCCCCCCCCC-------------------------------------------------chhhhccccCCCC
Q psy6593 316 -RVPADPDYLPRSPDFGL-------------------------------------------------DQTDFRNKFCASC 345 (433)
Q Consensus 316 -~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~~ 345 (433)
+.|+|+........... .............
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 55655432210000000 0000001122456
Q ss_pred cHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhcc
Q psy6593 346 PEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLSM 379 (433)
Q Consensus 346 ~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~~ 379 (433)
++++.+||.+||+.||++||+++++++ ||+.+..
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 889999999999999999999999995 8887643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=323.34 Aligned_cols=229 Identities=21% Similarity=0.350 Sum_probs=187.5
Q ss_pred CeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEe
Q psy6593 127 GLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTE 178 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 178 (433)
.+.+.+.+++|+||+||+.. +|+.+|++++||||+++++++.+.+..++|||
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 106 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 36667788888888888511 79999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEE---ccCCceEEeccccchhccCCCCC
Q psy6593 179 YIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV---REDKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 179 ~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
|+.|++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++........
T Consensus 107 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~- 184 (484)
T 3nyv_A 107 VYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK- 184 (484)
T ss_dssp CCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS-
T ss_pred cCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc-
Confidence 999999999987654 59999999999999999999999999999999999999 4678999999999987643221
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~ 335 (433)
.....||+.|+|||++.+ .++.++||||||+++|+|++|.+||...........+...
T Consensus 185 ---------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 242 (484)
T 3nyv_A 185 ---------------------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG 242 (484)
T ss_dssp ---------------------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred ---------------------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence 114579999999999877 6899999999999999999999998653221111111111
Q ss_pred hh--ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhcc
Q psy6593 336 DF--RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLSM 379 (433)
Q Consensus 336 ~~--~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~~ 379 (433)
.. ....+..+++.+.+||.+||+.+|.+|||+++++ .|++....
T Consensus 243 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 243 KYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp CCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred CCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 11 1112256789999999999999999999999998 58887653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=307.17 Aligned_cols=208 Identities=23% Similarity=0.360 Sum_probs=169.7
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|++++++++||||+++++++.+.+..++||||+++ +|.+++......+++..++.++.|++.||+|||+.||+|||||
T Consensus 61 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 139 (346)
T 1ua2_A 61 REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLK 139 (346)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCC
Confidence 699999999999999999999999999999999975 9999998866679999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeEe
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFS 305 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diws 305 (433)
|+||+++.++.+||+|||+++........ .....||+.|+|||.+.+. .++.++||||
T Consensus 140 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~---------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 198 (346)
T 1ua2_A 140 PNNLLLDENGVLKLADFGLAKSFGSPNRA---------------------YTHQVVTRWYRAPELLFGARMYGVGVDMWA 198 (346)
T ss_dssp GGGEEECTTCCEEECCCGGGSTTTSCCCC---------------------CCCSCCCCTTCCHHHHTTCSCCCHHHHHHH
T ss_pred HHHEEEcCCCCEEEEecccceeccCCccc---------------------CCcccccccccCchHhhCCCCCCchhhhHh
Confidence 99999999999999999999876432211 1145789999999998764 5889999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCC--------------CCC----Cch--------hhhccccCCCCcHHHHHHHHHhccc
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSP--------------DFG----LDQ--------TDFRNKFCASCPEPFVRIAFLCCDL 359 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~--------------~~~----~~~--------~~~~~~~~~~~~~~l~~li~~~l~~ 359 (433)
||+++|+|++|.+++........ .+. ... ..........+++.+.+||.+||+.
T Consensus 199 lG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 278 (346)
T 1ua2_A 199 VGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLF 278 (346)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhcc
Confidence 99999999999988754321000 000 000 0000112256778999999999999
Q ss_pred CCCCCCChhHHHH--HHHh
Q psy6593 360 NPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 360 ~p~~RPs~~~i~~--~l~~ 376 (433)
||++|||++++++ ||..
T Consensus 279 dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 279 NPCARITATQALKMKYFSN 297 (346)
T ss_dssp STTTSCCHHHHHTSGGGTS
T ss_pred ChhhCCCHHHHhcChhhhc
Confidence 9999999999984 6654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=301.22 Aligned_cols=232 Identities=23% Similarity=0.426 Sum_probs=184.2
Q ss_pred cCCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccC
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIA 181 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 181 (433)
.+.+.+.+.++.|+||.||+.. +|+.++++++||||+++++++..++..++||||++
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG 107 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence 3446777788888898888622 69999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccc
Q psy6593 182 GGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA 261 (433)
Q Consensus 182 g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 261 (433)
+++|.+++......+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 108 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~------ 181 (314)
T 3com_A 108 AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK------ 181 (314)
T ss_dssp TEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC------
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc------
Confidence 99999999754567999999999999999999999999999999999999999999999999999765432211
Q ss_pred cchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh-hhccc
Q psy6593 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT-DFRNK 340 (433)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~-~~~~~ 340 (433)
.....||+.|+|||.+.+..++.++||||||+++|+|++|.+||............... .....
T Consensus 182 ---------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (314)
T 3com_A 182 ---------------RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFR 246 (314)
T ss_dssp ---------------BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS
T ss_pred ---------------cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccC
Confidence 12457899999999999989999999999999999999999887643211100000000 00011
Q ss_pred cCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhh
Q psy6593 341 FCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGL 377 (433)
Q Consensus 341 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~ 377 (433)
.+..++..+.+++.+||+.||.+||++++++ .|++..
T Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 247 KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 1245688999999999999999999999998 477753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=298.21 Aligned_cols=228 Identities=29% Similarity=0.495 Sum_probs=188.5
Q ss_pred CCeeeeeccCCCcchhhhhcc--------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
+.+...+.+++|+||+||+.. +|+.++++++||||+++++++..+...++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 446677788888888888621 689999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccc
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
+++++|.+++.. ..+++..++.++.|++.||.+||+.||+|+||||+||+++.++.++|+|||++.........
T Consensus 102 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---- 175 (303)
T 3a7i_A 102 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---- 175 (303)
T ss_dssp CTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC----
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccc----
Confidence 999999999976 46999999999999999999999999999999999999999999999999999765432211
Q ss_pred cccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhcc
Q psy6593 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRN 339 (433)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (433)
.....||+.|+|||.+.+..++.++||||||+++|+|++|.+|+.......... ........
T Consensus 176 -----------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~ 237 (303)
T 3a7i_A 176 -----------------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-LIPKNNPP 237 (303)
T ss_dssp -----------------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHSCCC
T ss_pred -----------------cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH-HhhcCCCC
Confidence 114578999999999999999999999999999999999998875432111000 00111122
Q ss_pred ccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 340 KFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 340 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
.+...++..+.+++.+||+.||++||+++++++ |+...
T Consensus 238 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 344678899999999999999999999999984 66553
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=298.24 Aligned_cols=223 Identities=26% Similarity=0.411 Sum_probs=179.2
Q ss_pred eeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEe----CCeeeEE
Q psy6593 128 LLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYK----DRKLNLV 176 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 176 (433)
+.+.+.+++|+||+||++. +|+.+|++++||||+++++++.. +..+++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 5666678889999888622 69999999999999999999875 3568999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCC--ccccCCCCcceEEc-cCCceEEeccccchhccCCC
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN--LIHRDLNSQNCLVR-EDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~ 253 (433)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.| |+|+||||+||+++ .++.++|+|||++.......
T Consensus 108 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 186 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 186 (290)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred EEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc
Confidence 9999999999999764 35999999999999999999999999 99999999999998 78999999999997543221
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC-C
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG-L 332 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~-~ 332 (433)
.....||+.|+|||.+.+ .++.++||||||+++|+|++|.+||........... .
T Consensus 187 -----------------------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 242 (290)
T 1t4h_A 187 -----------------------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 242 (290)
T ss_dssp -----------------------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH
T ss_pred -----------------------cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHH
Confidence 125578999999998875 589999999999999999999888754322111000 0
Q ss_pred chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHH
Q psy6593 333 DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLE 375 (433)
Q Consensus 333 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~ 375 (433)
........++...++.+.+++.+||+.||.+||+++++++ ||+
T Consensus 243 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~ 287 (290)
T 1t4h_A 243 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287 (290)
T ss_dssp TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred hccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccc
Confidence 0111112233556789999999999999999999999984 554
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=300.48 Aligned_cols=216 Identities=21% Similarity=0.327 Sum_probs=164.0
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+++|.++ +||||+++++++.+++..++||||++|++|.+++... ..+++..++.++.||+.||+|||+.||+||||
T Consensus 59 ~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 137 (316)
T 2ac3_A 59 REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDL 137 (316)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC
Confidence 799999995 7999999999999999999999999999999999764 35999999999999999999999999999999
Q ss_pred CCcceEEccCCc---eEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-----CCC
Q psy6593 226 NSQNCLVREDKT---VVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-----QEY 297 (433)
Q Consensus 226 kp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~ 297 (433)
||+||+++.++. +||+|||++............ .........||+.|+|||++.+ ..+
T Consensus 138 kp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 203 (316)
T 2ac3_A 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI--------------STPELLTPCGSAEYMAPEVVEAFSEEASIY 203 (316)
T ss_dssp CGGGEEESCSSSSCSEEECCTTCCC---------------------------------CCSGGGCCHHHHHHTSHHHHHH
T ss_pred CHHHEEEccCCCcCceEEEEccCccccccCCccccc--------------cccccccccCCcCccChHHhhcccccccCC
Confidence 999999987765 999999998765432111000 0011124569999999999875 468
Q ss_pred CcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCch----------hh---hccccC----CCCcHHHHHHHHHhcccC
Q psy6593 298 DETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQ----------TD---FRNKFC----ASCPEPFVRIAFLCCDLN 360 (433)
Q Consensus 298 ~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~----------~~---~~~~~~----~~~~~~l~~li~~~l~~~ 360 (433)
+.++||||||+++|+|++|.+||.........+.... .. ....++ ..++..+.+|+.+||+.|
T Consensus 204 ~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 283 (316)
T 2ac3_A 204 DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRD 283 (316)
T ss_dssp TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSS
T ss_pred CcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCC
Confidence 8999999999999999999998865433221111000 00 000111 457889999999999999
Q ss_pred CCCCCChhHHHH--HHHhh
Q psy6593 361 PDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 361 p~~RPs~~~i~~--~l~~~ 377 (433)
|++||+++++++ ||+..
T Consensus 284 P~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 284 AKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp TTTSCCHHHHHHSTTCC--
T ss_pred hhhCCCHHHHhcChhhcCC
Confidence 999999999985 66543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=298.09 Aligned_cols=241 Identities=25% Similarity=0.457 Sum_probs=177.1
Q ss_pred cccccCCeeeeeccCCCcchhhhhcc--------------------------chHHHHhhcCCcceeeEEEEEEeCCeee
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 174 (433)
+.+..+++.+.+.+++|+||.||+.. +|+.++++++||||+++++++..++..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 34556667778888888888887621 7889999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhcC-------CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccch
Q psy6593 175 LVTEYIAGGTLKELLQD-------PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLAR 247 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~-------~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 247 (433)
+||||++|++|.+++.. ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999999863 23569999999999999999999999999999999999999999999999999998
Q ss_pred hccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCC
Q psy6593 248 IIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~ 326 (433)
.......... ........||+.|+|||.+.+ ..++.++||||||+++|+|++|.+||......
T Consensus 170 ~~~~~~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 233 (303)
T 2vwi_A 170 FLATGGDITR----------------NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM 233 (303)
T ss_dssp HCC-------------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG
T ss_pred eeccCCCccc----------------hhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh
Confidence 7643221100 011124578999999999876 56899999999999999999999888653221
Q ss_pred CCCC--------CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 327 SPDF--------GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 327 ~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
.... ..............++..+.+++.+||+.||.+||+++++++ ||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 234 KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp GHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred hHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 1000 000001112233567899999999999999999999999985 66543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=328.92 Aligned_cols=236 Identities=22% Similarity=0.382 Sum_probs=191.6
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc-----------------------------chHHHHhhcCCcceeeEEEEEEeCCe
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC-----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~-----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~ 172 (433)
.+..+.+.+.+.+|+|+||+||++. +|+.+|++++||||+++++++. ++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3445668888899999999998521 6899999999999999999984 567
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
.++||||+++++|.+++...+..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 89999999999999999876567999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFG 331 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~ 331 (433)
.... .....+|+.|+|||.+.+..++.++||||||+++|||++ |.+||..........
T Consensus 545 ~~~~--------------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~- 603 (656)
T 2j0j_A 545 TYYK--------------------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG- 603 (656)
T ss_dssp -----------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-
T ss_pred ccee--------------------ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH-
Confidence 2111 113456789999999998899999999999999999995 888876532211100
Q ss_pred CchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 332 LDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 332 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
..........+..+|+.+.++|.+||+.||++||++.+|++.|+.+..
T Consensus 604 ~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 604 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 011112233567889999999999999999999999999999998753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=295.81 Aligned_cols=210 Identities=23% Similarity=0.397 Sum_probs=169.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.++++++||||+++++++.+++..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+|||
T Consensus 54 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 132 (276)
T 2yex_A 54 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132 (276)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence 6999999999999999999999999999999999999999999764 359999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCC-CcccCeEe
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY-DETVDVFS 305 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Diws 305 (433)
|+||+++.++.++|+|||++......... .......||+.|+|||.+.+..+ +.++||||
T Consensus 133 p~Nil~~~~~~~kl~dfg~~~~~~~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 193 (276)
T 2yex_A 133 PENLLLDERDNLKISDFGLATVFRYNNRE-------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193 (276)
T ss_dssp GGGEEECTTCCEEECCCTTCEECEETTEE-------------------CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHH
T ss_pred hHHEEEccCCCEEEeeCCCccccCCCcch-------------------hcccCCccccCccChHHHhcCCCCCCcchHHH
Confidence 99999999999999999999765432110 01114578999999999988665 77899999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCCCC-chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 306 YGIVLCEIIGRVPADPDYLPRSPDFGL-DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
||+++|+|++|.+||............ ............+++.+.+++.+||+.||++||+++++++ |+++
T Consensus 194 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (276)
T 2yex_A 194 CGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (276)
T ss_dssp HHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccC
Confidence 999999999999888653322111000 0000011112457899999999999999999999999974 5544
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=308.48 Aligned_cols=231 Identities=23% Similarity=0.386 Sum_probs=183.6
Q ss_pred CCeeeeeccCCCcchhhhhcc--------------------chHHHHhhcCCcceeeEEEEEEeCCe------eeEEEec
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC--------------------GQVAVLRSLHHHNVIRFIGVLYKDRK------LNLVTEY 179 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~--------------------~E~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~ 179 (433)
..+...+.+|+|+||+||++. +|+++|++++||||+++++++..... +++||||
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~ 119 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence 347788899999999999632 69999999999999999999975543 8899999
Q ss_pred cCCCCHHHHhc---CCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEc-cCCceEEeccccchhccCCCCC
Q psy6593 180 IAGGTLKELLQ---DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR-EDKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 180 ~~g~sL~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
+++ +|.+.+. .....+++..++.++.||+.||+|||+.||+||||||+||+++ .++.+||+|||+++........
T Consensus 120 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~ 198 (394)
T 4e7w_A 120 VPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198 (394)
T ss_dssp CSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred cCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCC
Confidence 976 4444332 2235699999999999999999999999999999999999999 7999999999999876433221
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeEehhHHHHHHhcCCCCCCCCCCCCC------
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP------ 328 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~------ 328 (433)
....||+.|+|||++.+. .++.++||||||+++|||++|.+||........
T Consensus 199 ----------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~ 256 (394)
T 4e7w_A 199 ----------------------VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK 256 (394)
T ss_dssp ----------------------CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ----------------------cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 145789999999998764 589999999999999999999999865321100
Q ss_pred ---------------------CCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhcc
Q psy6593 329 ---------------------DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLSM 379 (433)
Q Consensus 329 ---------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~~ 379 (433)
........+...+...+++++.+||.+||+.||.+||++.++++ ||+++..
T Consensus 257 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 257 VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred HhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 00011111222234568899999999999999999999999984 7887654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=310.78 Aligned_cols=229 Identities=18% Similarity=0.254 Sum_probs=179.3
Q ss_pred CCeeeeeccCCCcchhhhhcc--------------------------chHHHHhhcC--CcceeeEEEEEEeCCeeeEEE
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSLH--HHNVIRFIGVLYKDRKLNLVT 177 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~ 177 (433)
+.+.+.+.+|+|+||.||+.. +|+++|++++ |+||+++++++..++.+++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 347777888999999888621 7999999996 599999999999999999999
Q ss_pred eccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCc
Q psy6593 178 EYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPT 257 (433)
Q Consensus 178 e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 257 (433)
|+ .+++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++.........
T Consensus 136 E~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~- 211 (390)
T 2zmd_A 136 EC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV- 211 (390)
T ss_dssp EC-CSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--------
T ss_pred ec-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc-
Confidence 95 5889999997654 589999999999999999999999999999999999995 5889999999998764322110
Q ss_pred cccccchhhhhhhcccccceeeeccCccccccceecC-----------CCCCcccCeEehhHHHHHHhcCCCCCCCCCCC
Q psy6593 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-----------QEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326 (433)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~~~~~~~~~~~~ 326 (433)
......||+.|+|||++.+ ..++.++||||||+++|+|++|.+||......
T Consensus 212 ------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 273 (390)
T 2zmd_A 212 ------------------VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273 (390)
T ss_dssp --------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred ------------------cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH
Confidence 0114579999999999865 36888999999999999999999988643211
Q ss_pred CC-CCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHh
Q psy6593 327 SP-DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEG 376 (433)
Q Consensus 327 ~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~ 376 (433)
.. ...+........++...+..+.+||.+||+.||.+||++.+++ .|++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 274 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred HHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence 00 0000011122233455678999999999999999999999998 47764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=303.19 Aligned_cols=235 Identities=25% Similarity=0.422 Sum_probs=184.8
Q ss_pred cccccCCeeeeeccCCCcchhhhhcc-------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeE
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 175 (433)
..-..+.+.+.+.++.|+||+||+.. +|+.++++++||||+++++++..++..++
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 34455667888889999999988622 69999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCC
Q psy6593 176 VTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
||||+++++|.+++......+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 171 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-- 171 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--
Confidence 999999999999987655679999999999999999999999999999999999999999999999999876432110
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceec-----CCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT-----GQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF 330 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~ 330 (433)
.......||+.|+|||.+. +..++.++||||||+++|+|++|.+|+..........
T Consensus 172 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 232 (302)
T 2j7t_A 172 -------------------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL 232 (302)
T ss_dssp -------------------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred -------------------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH
Confidence 0112457899999999983 5678899999999999999999998876532211000
Q ss_pred CCchhhh-ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 331 GLDQTDF-RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 331 ~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
....... ....+..++..+.+++.+||+.||++||+++++++ |++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 281 (302)
T 2j7t_A 233 KIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281 (302)
T ss_dssp HHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred HHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence 0000000 01123557889999999999999999999999974 5554
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=301.23 Aligned_cols=227 Identities=22% Similarity=0.408 Sum_probs=183.4
Q ss_pred CeeeeeccCCCcchhhhhc-------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccC
Q psy6593 127 GLLFCKEDYNGKYGEACQN-------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIA 181 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~-------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 181 (433)
++.+.+.+++|+||+||+. .+|+.++++++||||+++++++.+++..++||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS 89 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence 3556666777777777641 179999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEE---ccCCceEEeccccchhccCCCCCCcc
Q psy6593 182 GGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV---REDKTVVVADFGLARIIHQGPRAPTT 258 (433)
Q Consensus 182 g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~ 258 (433)
+++|.+++...+ .+++..++.++.|++.||.|||+.||+|+||||+||++ +.++.++|+|||++.......
T Consensus 90 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~----- 163 (304)
T 2jam_A 90 GGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----- 163 (304)
T ss_dssp SCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT-----
T ss_pred CccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc-----
Confidence 999999986543 59999999999999999999999999999999999999 678899999999986532211
Q ss_pred ccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh--h
Q psy6593 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT--D 336 (433)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~--~ 336 (433)
.....||+.|+|||.+.+..++.++||||||+++|+|++|.+||...........+... .
T Consensus 164 ------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 225 (304)
T 2jam_A 164 ------------------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE 225 (304)
T ss_dssp ------------------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC
T ss_pred ------------------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC
Confidence 01346899999999999999999999999999999999999887543211100000000 1
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhh
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGL 377 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~ 377 (433)
+.......+++.+.+++.+||+.||++||++++++ .||+..
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 11223367889999999999999999999999998 488753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=320.16 Aligned_cols=230 Identities=22% Similarity=0.410 Sum_probs=186.0
Q ss_pred CCeeeeeccCCCcchhhhhcc--------------------------------------chHHHHhhcCCcceeeEEEEE
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC--------------------------------------GQVAVLRSLHHHNVIRFIGVL 167 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~--------------------------------------~E~~~l~~l~h~~iv~~~~~~ 167 (433)
+.+.+.+.+|+|+||+||+.. +|+.+|++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 447778899999999998511 489999999999999999999
Q ss_pred EeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCC---ceEEeccc
Q psy6593 168 YKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDK---TVVVADFG 244 (433)
Q Consensus 168 ~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg 244 (433)
.+++.+++||||++|++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 194 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence 99999999999999999999886643 599999999999999999999999999999999999998765 69999999
Q ss_pred cchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCC
Q psy6593 245 LARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYL 324 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~ 324 (433)
++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|.+||....
T Consensus 195 ~a~~~~~~~~----------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 195 LSSFFSKDYK----------------------LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp TCEECCTTSC----------------------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCEEcCCCCc----------------------cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9986543221 114579999999999875 68999999999999999999999886532
Q ss_pred CCCCCCCCchhhh--ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhcc
Q psy6593 325 PRSPDFGLDQTDF--RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLSM 379 (433)
Q Consensus 325 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~~ 379 (433)
.......+..... .......+++++.+||.+||+.||.+|||+++++ .|++....
T Consensus 252 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 252 DQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred HHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 2111111111110 1111257889999999999999999999999998 58887543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=308.20 Aligned_cols=227 Identities=24% Similarity=0.340 Sum_probs=179.2
Q ss_pred cCCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCC------
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDR------ 171 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~------ 171 (433)
.+.+...+.+|+|+||.||++. +|+.+|++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 3457777888888888888621 7999999999999999999998653
Q ss_pred eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
.+|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 469999999 8899999976 4599999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~ 330 (433)
.. ....+|+.|+|||++.+ ..++.++||||||+++|+|++|.++|..........
T Consensus 181 ~~------------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~ 236 (367)
T 1cm8_A 181 EM------------------------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 236 (367)
T ss_dssp SC------------------------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred cc------------------------CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 21 14578999999999887 679999999999999999999999886432110000
Q ss_pred C---------------Cc--------------hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 331 G---------------LD--------------QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 331 ~---------------~~--------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
. +. ............++.+.+|+.+||+.||++|||++++++ ||+.+.
T Consensus 237 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 237 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 0 00 000011223567899999999999999999999999985 777654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=302.53 Aligned_cols=246 Identities=25% Similarity=0.381 Sum_probs=182.4
Q ss_pred cccccCCeeeeeccCCCcchhhhhcc--------------------chHHH--HhhcCCcceeeEEEEEEe-----CCee
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQNC--------------------GQVAV--LRSLHHHNVIRFIGVLYK-----DRKL 173 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~~--------------------~E~~~--l~~l~h~~iv~~~~~~~~-----~~~~ 173 (433)
..+..+++.+.+.+++|+||+||++. .|.++ +..++|+||+++++.+.. ...+
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 34567789999999999999999632 34444 445799999999987653 2357
Q ss_pred eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC---------CccccCCCCcceEEccCCceEEeccc
Q psy6593 174 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM---------NLIHRDLNSQNCLVREDKTVVVADFG 244 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---------~i~H~dlkp~Nil~~~~~~~kl~Dfg 244 (433)
++||||+++++|.+++... ..++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 8999999999999999763 468999999999999999999999 99999999999999999999999999
Q ss_pred cchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-------CCCCcccCeEehhHHHHHHhcCC
Q psy6593 245 LARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-------QEYDETVDVFSYGIVLCEIIGRV 317 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~~~ 317 (433)
+++........... ..........||+.|+|||++.+ ..++.++||||||+++|||++|.
T Consensus 166 ~a~~~~~~~~~~~~-------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 166 LSMRLTGNRLVRPG-------------EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp TCEECSSSSCC----------------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred ceeecccccccCcc-------------ccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 99876543221100 00011224579999999999987 45667899999999999999774
Q ss_pred -CCCCCCCCCCCCCCCc-----------------hhhhccccCCC------CcHHHHHHHHHhcccCCCCCCChhHHHHH
Q psy6593 318 -PADPDYLPRSPDFGLD-----------------QTDFRNKFCAS------CPEPFVRIAFLCCDLNPDQRPPFEVLEVW 373 (433)
Q Consensus 318 -~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~------~~~~l~~li~~~l~~~p~~RPs~~~i~~~ 373 (433)
|++............. .......++.. +++.+.+||.+||+.||++|||++++++.
T Consensus 233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~ 312 (336)
T 3g2f_A 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312 (336)
T ss_dssp GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence 4444322211111100 00111112222 34479999999999999999999999999
Q ss_pred HHhhcccc
Q psy6593 374 LEGLSMHL 381 (433)
Q Consensus 374 l~~~~~~~ 381 (433)
|+.+....
T Consensus 313 L~~ll~~~ 320 (336)
T 3g2f_A 313 MAELMMIW 320 (336)
T ss_dssp HHHHHHCC
T ss_pred HHHHHHHH
Confidence 99887543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=301.82 Aligned_cols=247 Identities=21% Similarity=0.282 Sum_probs=174.3
Q ss_pred cccCCeeeeeccCCCcchhhhhcc-------------------------chHHHHhhcC-CcceeeEEEEEEe-------
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLH-HHNVIRFIGVLYK------- 169 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~-h~~iv~~~~~~~~------- 169 (433)
+....+.+.+.+++|+||.||+.. +|+.+++++. ||||+++++++..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 344457788889999999988622 7899999995 9999999999953
Q ss_pred -CCeeeEEEeccCCCCHHHHhcC--CCCCCChHHHHHHHHHHHHHHhhhhcCC--ccccCCCCcceEEccCCceEEeccc
Q psy6593 170 -DRKLNLVTEYIAGGTLKELLQD--PGQPLPWGQRVNFARDIAAGMTYLHSMN--LIHRDLNSQNCLVREDKTVVVADFG 244 (433)
Q Consensus 170 -~~~~~lv~e~~~g~sL~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg 244 (433)
...+++||||+. |+|.+++.. ....+++..++.++.||+.||.|||+.| |+||||||+||+++.++.+||+|||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 345899999995 699988854 3456999999999999999999999999 9999999999999999999999999
Q ss_pred cchhccCCCCCCccccccchhhhhhhcccccceeeeccCcccccccee---cCCCCCcccCeEehhHHHHHHhcCCCCCC
Q psy6593 245 LARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMM---TGQEYDETVDVFSYGIVLCEIIGRVPADP 321 (433)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~ell~~~~~~~ 321 (433)
++............ ..............||+.|+|||++ .+..++.++||||||+++|+|++|.+||.
T Consensus 184 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 184 SATTISHYPDYSWS---------AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp TCBCCSSCC----------------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred cceeccccCccccc---------ccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 99876543321100 0000011122255689999999998 56678999999999999999999998886
Q ss_pred CCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccccC
Q psy6593 322 DYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSV 383 (433)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~~ 383 (433)
...... ..............+..+.+|+.+||+.||.+||+++++++.|+.+......
T Consensus 255 ~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 255 DGAKLR----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp ---------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred chhHHH----hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 432221 1122222233466678899999999999999999999999999988765433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=302.10 Aligned_cols=225 Identities=18% Similarity=0.307 Sum_probs=180.9
Q ss_pred cccCCeeeeeccCCCcchhhhhcc------------------------chHHHHhhcC-----CcceeeEEEEEEeCCee
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSLH-----HHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l~-----h~~iv~~~~~~~~~~~~ 173 (433)
.-.+++.+.+.+++|+||+||+.. .|+.+|+.+. ||||+++++++...+..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 345568888999999999999622 5899999996 99999999999999999
Q ss_pred eEEEeccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc------------------
Q psy6593 174 NLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE------------------ 234 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~------------------ 234 (433)
++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence 9999999 899999987533 45999999999999999999999999999999999999975
Q ss_pred -------CCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehh
Q psy6593 235 -------DKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYG 307 (433)
Q Consensus 235 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 307 (433)
++.+||+|||++....... ....||+.|+|||++.+..++.++||||||
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~~~------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 246 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSDYH------------------------GSIINTRQYRAPEVILNLGWDVSSDMWSFG 246 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTSCC------------------------CSCCSCGGGCCHHHHTTCCCCTTHHHHHHH
T ss_pred ccccccCCCCEEEEeccCceecCCCC------------------------cCccCcccccCcHHHcCCCCCCccchHHHH
Confidence 7899999999997643321 145789999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCCCCCCCCCC------------------------Cchhhhcccc--------------------CC
Q psy6593 308 IVLCEIIGRVPADPDYLPRSPDFG------------------------LDQTDFRNKF--------------------CA 343 (433)
Q Consensus 308 ~il~ell~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~--------------------~~ 343 (433)
+++|+|++|.+||........... .........+ ..
T Consensus 247 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 326 (360)
T 3llt_A 247 CVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326 (360)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHH
T ss_pred HHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccccc
Confidence 999999999988854321000000 0000000000 01
Q ss_pred CCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 344 SCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 344 ~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
..++.+.+||.+||+.||++|||++++++
T Consensus 327 ~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 327 IKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred chHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 22367889999999999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=297.60 Aligned_cols=210 Identities=21% Similarity=0.397 Sum_probs=170.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.+|++++||||+++++++.+.+..++||||+++++|.+++.+. ..+++..++.++.|++.||.|||+.|++|+|||
T Consensus 57 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 135 (283)
T 3bhy_A 57 REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLK 135 (283)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC
Confidence 6899999999999999999999999999999999999999999753 359999999999999999999999999999999
Q ss_pred CcceEEccCC----ceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccC
Q psy6593 227 SQNCLVREDK----TVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVD 302 (433)
Q Consensus 227 p~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 302 (433)
|+||+++.++ .++|+|||++........ .....||+.|+|||.+.+..++.++|
T Consensus 136 p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~----------------------~~~~~~~~~y~aPE~~~~~~~~~~~D 193 (283)
T 3bhy_A 136 PENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----------------------FKNIFGTPEFVAPEIVNYEPLGLEAD 193 (283)
T ss_dssp GGGEEESCSSSSSCCEEECCCTTCEECC------------------------------CCCGGGCCHHHHTTCCCCTHHH
T ss_pred hHHEEEecCCCCCCceEEEecccceeccCCCc----------------------ccccCCCcCccCcceecCCCCCcchh
Confidence 9999998776 899999999976543211 11456899999999999989999999
Q ss_pred eEehhHHHHHHhcCCCCCCCCCCCCCCCCCc--hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 303 VFSYGIVLCEIIGRVPADPDYLPRSPDFGLD--QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 303 iwslG~il~ell~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
|||||+++|+|++|.+|+...........+. ...........++..+.+++.+||+.||++||++.++++ |++.+.
T Consensus 194 i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 194 MWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred hhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 9999999999999988875432111000000 000111223567899999999999999999999999985 888765
Q ss_pred c
Q psy6593 379 M 379 (433)
Q Consensus 379 ~ 379 (433)
.
T Consensus 274 ~ 274 (283)
T 3bhy_A 274 R 274 (283)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=297.81 Aligned_cols=234 Identities=20% Similarity=0.302 Sum_probs=181.4
Q ss_pred cCCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEe--------
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYK-------- 169 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~-------- 169 (433)
.+++.+.+.+++|+||+||++. +|+.+|++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 3557788888888888888521 69999999999999999999987
Q ss_pred CCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhc
Q psy6593 170 DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARII 249 (433)
Q Consensus 170 ~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 249 (433)
.+..++||||+++ +|.+.+......+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 4568999999964 888888776667999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCC-
Q psy6593 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS- 327 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~- 327 (433)
........ .......||+.|+|||++.+ ..++.++||||||+++|+|++|.+||.......
T Consensus 175 ~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 237 (351)
T 3mi9_A 175 SLAKNSQP-----------------NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 237 (351)
T ss_dssp CCCSSSSC-----------------CCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccc-----------------cccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 53222111 11124578999999999876 457999999999999999999999886432110
Q ss_pred --------------CCCCCchhhhccccC---------------CCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 328 --------------PDFGLDQTDFRNKFC---------------ASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 328 --------------~~~~~~~~~~~~~~~---------------~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
............... ...++.+.+||.+||+.||++||+++++++ ||..
T Consensus 238 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 317 (351)
T 3mi9_A 238 LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317 (351)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred HHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence 000000000000000 012577999999999999999999999984 6654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=314.00 Aligned_cols=233 Identities=16% Similarity=0.261 Sum_probs=183.4
Q ss_pred cCCeeeeeccCCCcchhhhhc--------------------------cchHHHHhhcCCcceeeEEEEEEeCC--eeeEE
Q psy6593 125 KDGLLFCKEDYNGKYGEACQN--------------------------CGQVAVLRSLHHHNVIRFIGVLYKDR--KLNLV 176 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~--------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 176 (433)
.+.+.+.+.+++|+||+||++ .+|+++|++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 344666777788888877752 17999999999999999999998765 78999
Q ss_pred EeccCCCCHHHHhcCCC--CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEE----ccCCceEEeccccchhcc
Q psy6593 177 TEYIAGGTLKELLQDPG--QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV----REDKTVVVADFGLARIIH 250 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg~~~~~~ 250 (433)
|||++|++|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+||++ +.++.+||+|||+++...
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 99999999999997632 239999999999999999999999999999999999999 677889999999998654
Q ss_pred CCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC--------CCCCcccCeEehhHHHHHHhcCCCCCCC
Q psy6593 251 QGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG--------QEYDETVDVFSYGIVLCEIIGRVPADPD 322 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~~~~~~~~ 322 (433)
.... .....||+.|+|||++.+ ..++.++||||||+++|||++|.+||..
T Consensus 168 ~~~~----------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 168 DDEQ----------------------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp CGGG----------------------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred CCCc----------------------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 3211 114568999999999875 4678899999999999999999988854
Q ss_pred CCCCCCCCCCchhh---------------------hc------cccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHH
Q psy6593 323 YLPRSPDFGLDQTD---------------------FR------NKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375 (433)
Q Consensus 323 ~~~~~~~~~~~~~~---------------------~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 375 (433)
.............. +. ..+...++..+.+++.+||+.||++||+++++++.++
T Consensus 226 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~ 305 (396)
T 4eut_A 226 FEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (396)
T ss_dssp TTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHH
Confidence 32211111000000 00 0111335568899999999999999999999998888
Q ss_pred hhcc
Q psy6593 376 GLSM 379 (433)
Q Consensus 376 ~~~~ 379 (433)
+++.
T Consensus 306 ~il~ 309 (396)
T 4eut_A 306 DILH 309 (396)
T ss_dssp HHHT
T ss_pred HHhh
Confidence 7664
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=301.04 Aligned_cols=232 Identities=28% Similarity=0.481 Sum_probs=179.6
Q ss_pred ccCCeeeeeccCCCcchhhhhcc------------------------chHHHHhhc-CCcceeeEEEEEEe------CCe
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSL-HHHNVIRFIGVLYK------DRK 172 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l-~h~~iv~~~~~~~~------~~~ 172 (433)
..+.+.+.+.++.|+||.||++. +|+.+++++ +||||+++++++.. .+.
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 44557777888888888888621 789999999 89999999999987 468
Q ss_pred eeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 173 LNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
.++||||+++++|.+++... +..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence 99999999999999999753 34699999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceec-----CCCCCcccCeEehhHHHHHHhcCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT-----GQEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~ 326 (433)
... ......||+.|+|||.+. +..++.++||||||+++|+|++|.+|+......
T Consensus 182 ~~~---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 240 (326)
T 2x7f_A 182 TVG---------------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240 (326)
T ss_dssp ------------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred Ccc---------------------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence 211 112457899999999987 467889999999999999999999887543211
Q ss_pred CCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 327 SPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
..................++..+.++|.+||+.||.+||+++++++ ||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 241 RALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp HHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred HHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 1100001111111223567899999999999999999999999984 7775
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=296.20 Aligned_cols=217 Identities=17% Similarity=0.295 Sum_probs=175.6
Q ss_pred CeeeeeccCCCcchhhhh---------------------------ccchHHHHhhc-CCcceeeEEEEEEeCCeeeEEEe
Q psy6593 127 GLLFCKEDYNGKYGEACQ---------------------------NCGQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTE 178 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~---------------------------~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 178 (433)
++.+.+.+++|+||+||+ ..+|+.++.++ +||||+++++++.+++..++|||
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e 91 (289)
T 1x8b_A 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNE 91 (289)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEE
Confidence 355566667777777765 22688889998 99999999999999999999999
Q ss_pred ccCCCCHHHHhcCC---CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccC-------------------C
Q psy6593 179 YIAGGTLKELLQDP---GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRED-------------------K 236 (433)
Q Consensus 179 ~~~g~sL~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~-------------------~ 236 (433)
|++|++|.+++.+. ...+++..++.++.||+.||.|||+.||+||||||+||+++.+ .
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 171 (289)
T 1x8b_A 92 YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171 (289)
T ss_dssp CCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CC
T ss_pred ecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence 99999999999653 2469999999999999999999999999999999999999844 4
Q ss_pred ceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeEehhHHHHHHhc
Q psy6593 237 TVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIG 315 (433)
Q Consensus 237 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~ 315 (433)
.++|+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|+|++
T Consensus 172 ~~kl~Dfg~~~~~~~~~-------------------------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (289)
T 1x8b_A 172 MFKIGDLGHVTRISSPQ-------------------------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 226 (289)
T ss_dssp CEEECCCTTCEETTCSC-------------------------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTT
T ss_pred EEEEcccccccccCCcc-------------------------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhc
Confidence 79999999988654321 33589999999999875 56689999999999999999
Q ss_pred CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 316 RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
+.+++..... ...........++..+++.+.+++.+||+.||++||++.++++
T Consensus 227 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 227 AEPLPRNGDQ----WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CCCCCSSSHH----HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCcchhH----HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 9887533210 1111112223455778999999999999999999999999974
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=297.72 Aligned_cols=231 Identities=20% Similarity=0.283 Sum_probs=185.7
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc----------------------chHHHHhhcC-CcceeeEEEEEEe--CCeeeEE
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC----------------------GQVAVLRSLH-HHNVIRFIGVLYK--DRKLNLV 176 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~----------------------~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv 176 (433)
+...+++.+.+.+++|+||+||++. +|+.+|++++ ||||+++++++.. ....++|
T Consensus 32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 32 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp CEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred ccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 3456678899999999999999732 7999999997 9999999999987 5679999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCC-ceEEeccccchhccCCCCC
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDK-TVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~ 255 (433)
|||+++++|.+++.. +++..++.++.||+.||+|||+.||+||||||+||+++.++ .+||+|||+++........
T Consensus 112 ~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~ 187 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187 (330)
T ss_dssp EECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred EeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc
Confidence 999999999999864 89999999999999999999999999999999999999776 8999999999865433221
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC----
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF---- 330 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~---- 330 (433)
....||+.|+|||.+.+ ..++.++||||||+++|+|++|..|+..........
T Consensus 188 ----------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~ 245 (330)
T 3nsz_A 188 ----------------------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 245 (330)
T ss_dssp ----------------------CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHH
T ss_pred ----------------------ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHH
Confidence 14568999999999887 678999999999999999998887763321100000
Q ss_pred -------------------------------CCch-hhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 331 -------------------------------GLDQ-TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 331 -------------------------------~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
.... ..........+++.+.+||.+||+.||++|||++++++ ||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 325 (330)
T 3nsz_A 246 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325 (330)
T ss_dssp HHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence 0000 00001111337899999999999999999999999985 7776
Q ss_pred hc
Q psy6593 377 LS 378 (433)
Q Consensus 377 ~~ 378 (433)
+.
T Consensus 326 ~~ 327 (330)
T 3nsz_A 326 VV 327 (330)
T ss_dssp CC
T ss_pred hc
Confidence 54
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=301.68 Aligned_cols=202 Identities=21% Similarity=0.353 Sum_probs=163.2
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+++|++++||||+++++++..++ .++||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+|||||
T Consensus 64 ~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 141 (322)
T 2ycf_A 64 TEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 141 (322)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 6999999999999999999987654 899999999999999987643 59999999999999999999999999999999
Q ss_pred CcceEEccCCc---eEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec---CCCCCcc
Q psy6593 227 SQNCLVREDKT---VVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT---GQEYDET 300 (433)
Q Consensus 227 p~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~ 300 (433)
|+||+++.++. +||+|||++....... ......||+.|+|||++. ...++.+
T Consensus 142 p~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 199 (322)
T 2ycf_A 142 PENVLLSSQEEDCLIKITDFGHSKILGETS----------------------LMRTLCGTPTYLAPEVLVSVGTAGYNRA 199 (322)
T ss_dssp GGGEEESSSSSSCCEEECCCTTCEECCCCH----------------------HHHHHHSCCTTCCHHHHHHTTTTTCTTH
T ss_pred HHHEEEecCCCCCeEEEccCccceeccccc----------------------ccccccCCcCccCchhhccCCCCCCCch
Confidence 99999986654 9999999997653211 011346899999999974 4678899
Q ss_pred cCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh---hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 301 VDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT---DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 301 ~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
+||||||+++|+|++|.+||............... .........+++.+.+++.+||+.||++||+++++++
T Consensus 200 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 200 VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 99999999999999999888654322111110000 0111223567899999999999999999999999984
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=291.86 Aligned_cols=230 Identities=20% Similarity=0.331 Sum_probs=179.9
Q ss_pred cccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeee
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 174 (433)
+..+++.+.+.+++|+||.||+.. +|+.++++++||||+++++++...+..+
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence 345567777788888888877521 6899999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCC
Q psy6593 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
+||||+++++|.+++...+ .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 88 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp EEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 9999999999999997643 599999999999999999999999999999999999999999999999999976543211
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCCCC-CcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY-DETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~ 333 (433)
.....||+.|+|||.+.+..+ +.++||||||+++|+|++|.+|+......... ..
T Consensus 167 ----------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~~ 222 (276)
T 2h6d_A 167 ----------------------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF--KK 222 (276)
T ss_dssp --------------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HH
T ss_pred ----------------------eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH--HH
Confidence 114568999999999988765 68999999999999999998887542111000 00
Q ss_pred hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 334 QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 334 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
........+..++..+.+++.+||+.||++||+++++++ ||+..
T Consensus 223 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 223 IRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred hhcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 011112345677899999999999999999999999984 77653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=299.50 Aligned_cols=244 Identities=19% Similarity=0.231 Sum_probs=185.9
Q ss_pred cccCCeeeeeccCCCcchhhhhcc-------------------------chHHHHhhcCCcceeeEEEEEEe----CCee
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLHHHNVIRFIGVLYK----DRKL 173 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 173 (433)
+..+++.+.+.+++|+||.||+.. +|++++++++||||+++++++.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 345567888889999999887521 79999999999999999999873 3478
Q ss_pred eEEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhcc
Q psy6593 174 NLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIH 250 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 250 (433)
++||||+++++|.+++.. .+..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999999999998865 45679999999999999999999999999999999999999999999999999887543
Q ss_pred CCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC---CCcccCeEehhHHHHHHhcCCCCCCCCCCCC
Q psy6593 251 QGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE---YDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~~~~~~~~~~~~~ 327 (433)
....... ............||+.|+|||.+.+.. ++.++||||||+++|+|++|.+||.......
T Consensus 186 ~~~~~~~------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 253 (317)
T 2buj_A 186 IHVEGSR------------QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253 (317)
T ss_dssp EEEESHH------------HHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT
T ss_pred ccccccc------------ccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc
Confidence 2110000 000000111345799999999987644 6889999999999999999988874311111
Q ss_pred CC-CCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 328 PD-FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 328 ~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
.. ...............++..+.+++.+||+.||.+||+++++++.|+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 254 DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp SCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred chhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 00 0001111112223567899999999999999999999999999999865
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=296.82 Aligned_cols=232 Identities=21% Similarity=0.285 Sum_probs=174.0
Q ss_pred cccCCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeE
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 175 (433)
+..+++.+.+.+++|+||+||+.. ++...++.++||||+++++++.+++..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 345667888888999999888622 33344777899999999999999999999
Q ss_pred EEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcC-CccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 176 VTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
||||++ ++|.+++.. .+..+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++.....
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 999996 588777643 445799999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCcccccccee----cCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMM----TGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~ 327 (433)
.... ....||+.|+|||.+ .+..++.++||||||+++|+|++|.+|+.......
T Consensus 163 ~~~~----------------------~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 220 (290)
T 3fme_A 163 DVAK----------------------DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF 220 (290)
T ss_dssp -----------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH
T ss_pred cccc----------------------cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH
Confidence 2211 134689999999996 55678999999999999999999998875422111
Q ss_pred CCCCC-chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 328 PDFGL-DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 328 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
..... ............+++.+.+++.+||+.||++||+++++++ ||+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 221 QQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp HHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 00000 0011111122567899999999999999999999999985 88764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=305.88 Aligned_cols=233 Identities=21% Similarity=0.281 Sum_probs=170.6
Q ss_pred eeeeeccCCCcchhhhhc--------------------------cchHHHHhhcCCcceeeEEEEEEeCC----------
Q psy6593 128 LLFCKEDYNGKYGEACQN--------------------------CGQVAVLRSLHHHNVIRFIGVLYKDR---------- 171 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~--------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~---------- 171 (433)
+.+.+.+++|+||+||++ .+|+.+|++++||||+++++++.+..
T Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~ 87 (332)
T 3qd2_B 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE 87 (332)
T ss_dssp EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence 555666777777777642 17999999999999999999986643
Q ss_pred -----------------------------------------------eeeEEEeccCCCCHHHHhcCCCC--CCChHHHH
Q psy6593 172 -----------------------------------------------KLNLVTEYIAGGTLKELLQDPGQ--PLPWGQRV 202 (433)
Q Consensus 172 -----------------------------------------------~~~lv~e~~~g~sL~~~l~~~~~--~~~~~~~~ 202 (433)
..++||||++|++|.+++..... ..++..++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 167 (332)
T 3qd2_B 88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL 167 (332)
T ss_dssp --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHH
T ss_pred hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHH
Confidence 38999999999999999977432 34556789
Q ss_pred HHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeecc
Q psy6593 203 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVG 282 (433)
Q Consensus 203 ~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 282 (433)
.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++............. ............|
T Consensus 168 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~---------~~~~~~~~~~~~g 238 (332)
T 3qd2_B 168 HIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT---------PMPAYATHTGQVG 238 (332)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-----------------------CCCSCC-
T ss_pred HHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccc---------cccccccccccCC
Confidence 9999999999999999999999999999999999999999999987655422111000 0000011224579
Q ss_pred CccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCC
Q psy6593 283 NPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPD 362 (433)
Q Consensus 283 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 362 (433)
|+.|+|||.+.+..++.++||||||+++|+|++|.+++..... .................++.+.+++.+||+.||+
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 315 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR---IITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPT 315 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH---HHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGG
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH---HHHHhhccCCCcccccCChhHHHHHHHHccCCCC
Confidence 9999999999999999999999999999999987654321000 0000000000011133457789999999999999
Q ss_pred CCCChhHHHH
Q psy6593 363 QRPPFEVLEV 372 (433)
Q Consensus 363 ~RPs~~~i~~ 372 (433)
+||+++++++
T Consensus 316 ~Rps~~~~l~ 325 (332)
T 3qd2_B 316 ERPEATDIIE 325 (332)
T ss_dssp GSCCHHHHHH
T ss_pred cCCCHHHHhh
Confidence 9999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=305.27 Aligned_cols=227 Identities=24% Similarity=0.354 Sum_probs=167.2
Q ss_pred CCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeC------Ce
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKD------RK 172 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~------~~ 172 (433)
+++...+.+|+|+||.||++. +|+.+|++++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 457777888888888888631 699999999999999999999754 56
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
.++|+|++ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 109 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~ 185 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185 (367)
T ss_dssp CEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred EEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc
Confidence 89999999 7899999876 46999999999999999999999999999999999999999999999999999764321
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC-
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF- 330 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~- 330 (433)
.....||+.|+|||++.+ ..++.++||||||+++|+|++|.+||..........
T Consensus 186 ------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~ 241 (367)
T 2fst_X 186 ------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241 (367)
T ss_dssp -----------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ------------------------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 115678999999999887 678999999999999999999999886532110000
Q ss_pred --------------CCch---hhh-----------ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhcc
Q psy6593 331 --------------GLDQ---TDF-----------RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLSM 379 (433)
Q Consensus 331 --------------~~~~---~~~-----------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~~ 379 (433)
.+.. ..+ ........++.+.+||.+||+.||++||+++++++ ||+....
T Consensus 242 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 242 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp HHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 0000 000 01122456889999999999999999999999984 7776543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=297.58 Aligned_cols=207 Identities=25% Similarity=0.401 Sum_probs=167.2
Q ss_pred chHHHHhhcCCcceeeEEEEEEe--CCeeeEEEeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCC--
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMN-- 219 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~-- 219 (433)
+|+.++++++||||+++++++.. +...++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.|
T Consensus 54 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~ 133 (279)
T 2w5a_A 54 SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133 (279)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC--
T ss_pred HHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCC
Confidence 79999999999999999998864 5689999999999999999864 2345999999999999999999999999
Q ss_pred ---ccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC
Q psy6593 220 ---LIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE 296 (433)
Q Consensus 220 ---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 296 (433)
|+|+||||+||+++.++.+||+|||++........ ......||+.|+|||.+.+..
T Consensus 134 ~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~---------------------~~~~~~~~~~y~aPE~~~~~~ 192 (279)
T 2w5a_A 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS---------------------FAKTFVGTPYYMSPEQMNRMS 192 (279)
T ss_dssp ----CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH---------------------HHHHHHSCCTTCCHHHHHCC-
T ss_pred CCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc---------------------cccccCCCccccChHHhccCC
Confidence 99999999999999999999999999987543211 011346899999999999989
Q ss_pred CCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHH
Q psy6593 297 YDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375 (433)
Q Consensus 297 ~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 375 (433)
++.++||||||+++|+|++|.+|+.......... .........++..++.++.+++.+||+.||++||++++|++.+.
T Consensus 193 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG-KIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHH-HHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 9999999999999999999998876532111000 00111122345678999999999999999999999999986543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=307.68 Aligned_cols=227 Identities=9% Similarity=0.017 Sum_probs=168.6
Q ss_pred CeeeeeccCCCcchhhhhcc----------------------------chHHHHhhc--CCcceeeEE-------EEEEe
Q psy6593 127 GLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSL--HHHNVIRFI-------GVLYK 169 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l--~h~~iv~~~-------~~~~~ 169 (433)
.+.+.+.+++|+||+||+.. +|+.+++.| +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 36777888999999988622 464444444 699988765 55544
Q ss_pred C-----------------CeeeEEEeccCCCCHHHHhcCCCCCCChHHH------HHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 170 D-----------------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQR------VNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 170 ~-----------------~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~------~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
. ..++|||||++ ++|.+++...+..+++... +.++.||+.||+|||+.||+|||||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 3 33899999997 7999999764445666666 7888999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC--CCCCcccCeE
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG--QEYDETVDVF 304 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Diw 304 (433)
|+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~Diw 277 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTR------------------------GPASSVPVTYAPREFLNASTATFTHALNAW 277 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCE------------------------EEGGGSCGGGCCHHHHTCSEEECCHHHHHH
T ss_pred HHHEEECCCCCEEEEecceeeecCCC------------------------ccCccCCcCCcChhhccCCCCCcCccccHH
Confidence 99999999999999999999865321 113457799999999987 6799999999
Q ss_pred ehhHHHHHHhcCCCCCCCCCCCCCCCC-------CchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHH
Q psy6593 305 SYGIVLCEIIGRVPADPDYLPRSPDFG-------LDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLE 375 (433)
Q Consensus 305 slG~il~ell~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~ 375 (433)
|||+++|+|++|.+||....+...... .............+++.+.+||.+||+.||++||++++++ .||+
T Consensus 278 SlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 357 (371)
T 3q60_A 278 QLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357 (371)
T ss_dssp HHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred HHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence 999999999999998876533221111 0111122222357899999999999999999999999998 5887
Q ss_pred hhc
Q psy6593 376 GLS 378 (433)
Q Consensus 376 ~~~ 378 (433)
++.
T Consensus 358 ~~~ 360 (371)
T 3q60_A 358 QLQ 360 (371)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=301.82 Aligned_cols=241 Identities=27% Similarity=0.480 Sum_probs=190.8
Q ss_pred ccccCCeeeeeccCCCcchhhhhc-----------------------------cchHHHHhhcCCcceeeEEEEEEeCC-
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQN-----------------------------CGQVAVLRSLHHHNVIRFIGVLYKDR- 171 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~-----------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~- 171 (433)
.+..+.+.+.+.+++|+||.||+. .+|+++|++++||||+++++++...+
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 345566777888888888888642 17999999999999999999987543
Q ss_pred -eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhcc
Q psy6593 172 -KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIH 250 (433)
Q Consensus 172 -~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 250 (433)
..++||||+++++|.+++......+++..++.++.|++.||.+||+.||+|+||||+||+++.++.++|+|||++....
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 7899999999999999998766679999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCC------
Q psy6593 251 QGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYL------ 324 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~------ 324 (433)
....... ......++..|+|||.+.+..++.++||||||+++|+|++|.+++....
T Consensus 197 ~~~~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~ 258 (326)
T 2w1i_A 197 QDKEYYK------------------VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 258 (326)
T ss_dssp SSCSEEE------------------CSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHH
T ss_pred ccccccc------------------cccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHh
Confidence 4321100 0113456778999999998889999999999999999999877654210
Q ss_pred -CCCCCCC--------CchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccc
Q psy6593 325 -PRSPDFG--------LDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMH 380 (433)
Q Consensus 325 -~~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~ 380 (433)
....... ..........+..+|+++.++|.+||+.||++||++.+|++.|+.+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 259 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0000000 0001112234577899999999999999999999999999999987643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=308.51 Aligned_cols=253 Identities=21% Similarity=0.363 Sum_probs=180.6
Q ss_pred cCCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeC-----Ce
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKD-----RK 172 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 172 (433)
.+++.+.+.+|+|+||+||++. +|+.+|++++|+||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4557788888899999888621 799999999999999999999876 57
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
.|+||||++ ++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred EEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 999999995 6999999874 35999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccc-chhhhhhhcccccceeeeccCcccccccee-cCCCCCcccCeEehhHHHHHHhcCC-----------CC
Q psy6593 253 PRAPTTVMAK-VPRKAAQRRGARKKRYTVVGNPYWMAPEMM-TGQEYDETVDVFSYGIVLCEIIGRV-----------PA 319 (433)
Q Consensus 253 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~~~-----------~~ 319 (433)
.......... ..................+||++|+|||++ .+..++.++|||||||++|||++|. |+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~ 262 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence 2210000000 000000000011123467899999999986 5567999999999999999999744 44
Q ss_pred CCCCCCCCCCCC--------------------------------Cch---hhhc-----------cccCCCCcHHHHHHH
Q psy6593 320 DPDYLPRSPDFG--------------------------------LDQ---TDFR-----------NKFCASCPEPFVRIA 353 (433)
Q Consensus 320 ~~~~~~~~~~~~--------------------------------~~~---~~~~-----------~~~~~~~~~~l~~li 353 (433)
|........... +.. .... ......+++.+.+||
T Consensus 263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl 342 (432)
T 3n9x_A 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL 342 (432)
T ss_dssp CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence 332211000000 000 0000 001245789999999
Q ss_pred HHhcccCCCCCCChhHHHH--HHHhhcc
Q psy6593 354 FLCCDLNPDQRPPFEVLEV--WLEGLSM 379 (433)
Q Consensus 354 ~~~l~~~p~~RPs~~~i~~--~l~~~~~ 379 (433)
.+||+.||++|||++++++ ||+.+..
T Consensus 343 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 343 ESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 9999999999999999984 8887653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=306.23 Aligned_cols=226 Identities=23% Similarity=0.345 Sum_probs=182.1
Q ss_pred CCeeeeeccCCCcchhhhhcc------------------------chHHHHhhc------CCcceeeEEEEEEeCCeeeE
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSL------HHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l------~h~~iv~~~~~~~~~~~~~l 175 (433)
..+.+.+.+|+|+||+||++. +|+.+++.+ +|+||+++++++...+..++
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 347888899999999999732 588888888 56799999999999999999
Q ss_pred EEeccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCc--eEEeccccchhccCC
Q psy6593 176 VTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKT--VVVADFGLARIIHQG 252 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~ 252 (433)
||||+. ++|.+++.... ..+++..++.|+.||+.||+|||+.||+||||||+|||++.++. +||+|||++......
T Consensus 177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~ 255 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255 (429)
T ss_dssp EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC
T ss_pred EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCc
Confidence 999995 69999886533 45999999999999999999999999999999999999998887 999999998654322
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC-
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG- 331 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~- 331 (433)
. ....||+.|+|||++.+..++.++||||||+++|||++|.+||...........
T Consensus 256 ~------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i 311 (429)
T 3kvw_A 256 V------------------------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACM 311 (429)
T ss_dssp C------------------------CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred c------------------------cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 1 145789999999999999999999999999999999999998864321000000
Q ss_pred --------------------------------------------------------CchhhhccccCCCCcHHHHHHHHH
Q psy6593 332 --------------------------------------------------------LDQTDFRNKFCASCPEPFVRIAFL 355 (433)
Q Consensus 332 --------------------------------------------------------~~~~~~~~~~~~~~~~~l~~li~~ 355 (433)
.....+...+....++.+.+||.+
T Consensus 312 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~ 391 (429)
T 3kvw_A 312 IELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQ 391 (429)
T ss_dssp HHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHH
T ss_pred HHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHH
Confidence 000011111223457889999999
Q ss_pred hcccCCCCCCChhHHHH--HHHh
Q psy6593 356 CCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 356 ~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
||+.||++|||++++++ ||++
T Consensus 392 ~L~~dP~~Rpta~e~L~Hpw~~~ 414 (429)
T 3kvw_A 392 CLEWDPAVRMTPGQALRHPWLRR 414 (429)
T ss_dssp HTCSSTTTSCCHHHHHTSTTTC-
T ss_pred HCCCChhhCCCHHHHhCChhhcc
Confidence 99999999999999985 6665
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=297.40 Aligned_cols=209 Identities=22% Similarity=0.385 Sum_probs=168.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCC--CCCChHHHHHHHHHHHHHHhhhhcCCccccC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG--QPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 224 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~d 224 (433)
+|+.++++++||||+++++++...+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+|
T Consensus 68 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d 147 (295)
T 2clq_A 68 EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRD 147 (295)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccC
Confidence 69999999999999999999999999999999999999999997542 3467889999999999999999999999999
Q ss_pred CCCcceEEcc-CCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC--CCccc
Q psy6593 225 LNSQNCLVRE-DKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE--YDETV 301 (433)
Q Consensus 225 lkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~ 301 (433)
|||+||+++. ++.++|+|||++......... .....||+.|+|||.+.+.. ++.++
T Consensus 148 l~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~ 206 (295)
T 2clq_A 148 IKGDNVLINTYSGVLKISDFGTSKRLAGINPC---------------------TETFTGTLQYMAPEIIDKGPRGYGKAA 206 (295)
T ss_dssp CSGGGEEEETTTCCEEECCTTTCEESCC--------------------------CCCCCCGGGCCHHHHHHGGGGCSHHH
T ss_pred CChhhEEEECCCCCEEEeecccccccCCCCCc---------------------ccccCCCccccChhhhcCCCCCCCcHH
Confidence 9999999987 899999999999865432111 11456899999999987643 78999
Q ss_pred CeEehhHHHHHHhcCCCCCCCCCCCCC-CCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 302 DVFSYGIVLCEIIGRVPADPDYLPRSP-DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 302 DiwslG~il~ell~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
||||||+++|+|++|.+||........ ............++..+++++.+++.+||+.||++||+++++++ ||+.
T Consensus 207 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 284 (295)
T 2clq_A 207 DIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284 (295)
T ss_dssp HHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred HHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhh
Confidence 999999999999999888753211100 00000112223455778999999999999999999999999983 5543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=311.61 Aligned_cols=222 Identities=12% Similarity=0.066 Sum_probs=175.1
Q ss_pred cCCeeeeeccCCCcchhhhhcc----------------------------chH---HHHhhcCCcceeeEE-------EE
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC----------------------------GQV---AVLRSLHHHNVIRFI-------GV 166 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~---~~l~~l~h~~iv~~~-------~~ 166 (433)
.+.+.+.+.+++|+||+||++. +|+ ++|++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 3457778889999999988621 678 556666899999998 77
Q ss_pred EEeCC-----------------eeeEEEeccCCCCHHHHhcCCCC------CCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 167 LYKDR-----------------KLNLVTEYIAGGTLKELLQDPGQ------PLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 167 ~~~~~-----------------~~~lv~e~~~g~sL~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
+...+ ..|+||||+ +|+|.+++...+. .+++..++.|+.||+.||+|||+.||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 76553 288999999 6799999975321 23348888999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC--------
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-------- 295 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------- 295 (433)
||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+.
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~------------------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~ 285 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA------------------------RVVSSVS-RGFEPPELEARRATISYHRD 285 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC------------------------EEECCCC-TTCCCHHHHHHHTSTHHHHC
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC------------------------cccCCCC-cCccChhhhccccccccccc
Confidence 9999999999999999999999985322 1124567 999999999887
Q ss_pred ---CCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH-
Q psy6593 296 ---EYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE- 371 (433)
Q Consensus 296 ---~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~- 371 (433)
.++.++||||||+++|||++|.+||.......... ........+|+.+.+||.+||+.||++||++.+++
T Consensus 286 ~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 286 RRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp CEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG------GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred ccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh------hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 89999999999999999999999886543222111 11122367899999999999999999999999998
Q ss_pred -HHHHhhc
Q psy6593 372 -VWLEGLS 378 (433)
Q Consensus 372 -~~l~~~~ 378 (433)
.||+.+.
T Consensus 360 hp~f~~~~ 367 (377)
T 3byv_A 360 TPEYEQLR 367 (377)
T ss_dssp SHHHHHHH
T ss_pred ChHHHHHH
Confidence 4887654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=298.60 Aligned_cols=226 Identities=22% Similarity=0.301 Sum_probs=171.7
Q ss_pred cCCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCC------
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDR------ 171 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~------ 171 (433)
.+++.+.+.+|+|+||.||++. +|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 3557778888899999887521 6999999999999999999998665
Q ss_pred eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
..++||||++ ++|.+++.. .+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred ceEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 7899999996 589888864 489999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC-
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF- 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~- 330 (433)
... .....||+.|+|||++.+..++.++||||||+++|+|++|.+||..........
T Consensus 180 ~~~----------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 237 (371)
T 2xrw_A 180 SFM----------------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 237 (371)
T ss_dssp --------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ccc----------------------cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 211 114578999999999999999999999999999999999998886532100000
Q ss_pred -------------------------------CCchhhhccc--cC------CCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 331 -------------------------------GLDQTDFRNK--FC------ASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 331 -------------------------------~~~~~~~~~~--~~------~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
.......... ++ ...+..+.+||.+||+.||++|||+++++
T Consensus 238 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 317 (371)
T 2xrw_A 238 VIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 317 (371)
T ss_dssp HHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHh
Confidence 0000000000 00 01256799999999999999999999998
Q ss_pred --HHHHh
Q psy6593 372 --VWLEG 376 (433)
Q Consensus 372 --~~l~~ 376 (433)
.||+.
T Consensus 318 ~hp~~~~ 324 (371)
T 2xrw_A 318 QHPYINV 324 (371)
T ss_dssp HSHHHHT
T ss_pred CCcchhh
Confidence 48875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=302.62 Aligned_cols=203 Identities=19% Similarity=0.337 Sum_probs=165.9
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+.+++++ +||||+++++++......++||||++|++|.+++... ..+++..++.++.||+.||.|||+.||+|+||
T Consensus 148 ~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dl 226 (365)
T 2y7j_A 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDL 226 (365)
T ss_dssp HHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 688899999 7999999999999999999999999999999999753 35999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC------CCCCc
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG------QEYDE 299 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ 299 (433)
||+||+++.++.++|+|||++........ .....||+.|+|||++.+ ..++.
T Consensus 227 kp~NIl~~~~~~ikl~DfG~~~~~~~~~~----------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 284 (365)
T 2y7j_A 227 KPENILLDDNMQIRLSDFGFSCHLEPGEK----------------------LRELCGTPGYLAPEILKCSMDETHPGYGK 284 (365)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCTTCC----------------------BCCCCSCGGGCCHHHHHHTTCTTSCCBCT
T ss_pred CHHHEEECCCCCEEEEecCcccccCCCcc----------------------cccCCCCCCccChhhccccccccCcCCCc
Confidence 99999999999999999999876543221 114579999999999863 35888
Q ss_pred ccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhh--ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 300 TVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDF--RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 300 ~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
++||||||+++|+|++|.+||...........+..... .......++..+.+++.+||+.||++||+++++++
T Consensus 285 ~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 285 EVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 99999999999999999988754221100000000000 00112467888999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=293.65 Aligned_cols=209 Identities=24% Similarity=0.415 Sum_probs=165.1
Q ss_pred chHHHHhhcCCcceeeEEEEEE--eCCeeeEEEeccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCCcccc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLY--KDRKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 223 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 223 (433)
+|++++++++|+||+++++++. +.+..++||||++++ |.+++.. ....+++..++.++.||+.||.|||+.||+|+
T Consensus 55 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~ 133 (305)
T 2wtk_C 55 KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHK 133 (305)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 7999999999999999999985 445799999999765 7776643 34569999999999999999999999999999
Q ss_pred CCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC--CCccc
Q psy6593 224 DLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE--YDETV 301 (433)
Q Consensus 224 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~ 301 (433)
||||+||+++.++.++|+|||++.......... ......||+.|+|||.+.+.. .+.++
T Consensus 134 dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 194 (305)
T 2wtk_C 134 DIKPGNLLLTTGGTLKISALGVAEALHPFAADD-------------------TCRTSQGSPAFQPPEIANGLDTFSGFKV 194 (305)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCTTCSSC-------------------EECCCCSCGGGCCHHHHTCCSCEESHHH
T ss_pred CCCcccEEEcCCCcEEeeccccccccCcccccc-------------------ccccCCCCCCCcChhhccCcccCCcchh
Confidence 999999999999999999999998654322111 112456899999999988644 37799
Q ss_pred CeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhh
Q psy6593 302 DVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGL 377 (433)
Q Consensus 302 DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~ 377 (433)
||||||+++|+|++|.+|+......... .........++..+++.+.+++.+||+.||.+||++++++ .|++..
T Consensus 195 Di~slG~il~~l~~g~~p~~~~~~~~~~--~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 195 DIWSAGVTLYNITTGLYPFEGDNIYKLF--ENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred hHHHHHHHHHHHHhCCCCCCCchHHHHH--HHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 9999999999999998887542211000 0001112234567899999999999999999999999998 477753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=298.96 Aligned_cols=237 Identities=25% Similarity=0.367 Sum_probs=183.8
Q ss_pred CCeeeeeccCCCcchhhhhcc--------------------chHHHHhh--cCCcceeeEEEEEEeCC----eeeEEEec
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC--------------------GQVAVLRS--LHHHNVIRFIGVLYKDR----KLNLVTEY 179 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~--------------------~E~~~l~~--l~h~~iv~~~~~~~~~~----~~~lv~e~ 179 (433)
+++.+.+.+++|+||+||+.. +|++++.. ++||||+++++++.... ..++||||
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~ 121 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 121 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECC
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEee
Confidence 447777888899999888622 68888887 68999999999998776 79999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhh--------cCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLH--------SMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH--------~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
+++++|.+++.+ ..+++..++.++.|++.||.||| +.||+||||||+||+++.++.+||+|||++.....
T Consensus 122 ~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 199 (342)
T 1b6c_B 122 HEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 199 (342)
T ss_dssp CTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEET
T ss_pred cCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccc
Confidence 999999999976 35999999999999999999999 89999999999999999999999999999987654
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC------CCCcccCeEehhHHHHHHhcC---------
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ------EYDETVDVFSYGIVLCEIIGR--------- 316 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~~--------- 316 (433)
...... .......||+.|+|||.+.+. .++.++||||||+++|+|++|
T Consensus 200 ~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 200 ATDTID-----------------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TTTEEE-----------------ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred cccccc-----------------cccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 322100 011245789999999999875 234689999999999999988
Q ss_pred -CCCCCCCCCCCCCCCCch-----hhhccccC-----CCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccc
Q psy6593 317 -VPADPDYLPRSPDFGLDQ-----TDFRNKFC-----ASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381 (433)
Q Consensus 317 -~~~~~~~~~~~~~~~~~~-----~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~ 381 (433)
..||.............. ......++ ...++.+.+|+.+||+.||++||++++|++.|+.+....
T Consensus 263 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 263 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 444433222111100000 01111111 233467999999999999999999999999999987544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=303.13 Aligned_cols=212 Identities=25% Similarity=0.345 Sum_probs=157.5
Q ss_pred chHHHHhhcCCcceeeEEEEEEe--CCeeeEEEeccCCCCHHHHhcC--------CCCCCChHHHHHHHHHHHHHHhhhh
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQD--------PGQPLPWGQRVNFARDIAAGMTYLH 216 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~--------~~~~~~~~~~~~i~~qi~~~L~~lH 216 (433)
+|+.+|++++||||+++++++.. +...++||||+. ++|.+++.. ....+++..++.|+.||+.||+|||
T Consensus 67 ~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 145 (405)
T 3rgf_A 67 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145 (405)
T ss_dssp HHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 79999999999999999999965 578999999996 588887752 1234999999999999999999999
Q ss_pred cCCccccCCCCcceEE----ccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCcccccccee
Q psy6593 217 SMNLIHRDLNSQNCLV----REDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMM 292 (433)
Q Consensus 217 ~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 292 (433)
+.||+||||||+|||+ +.++.+||+|||+++......... .......||+.|+|||++
T Consensus 146 ~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~ 207 (405)
T 3rgf_A 146 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL------------------ADLDPVVVTFWYRAPELL 207 (405)
T ss_dssp HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------------------------CCCTTCCHHHH
T ss_pred hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCccc------------------ccCCCceecCcccCchhh
Confidence 9999999999999999 677899999999998764321110 112256799999999999
Q ss_pred cC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc-------------------hh-----------------
Q psy6593 293 TG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD-------------------QT----------------- 335 (433)
Q Consensus 293 ~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~-------------------~~----------------- 335 (433)
.+ ..++.++||||||+++|+|++|.+||............. ..
T Consensus 208 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 287 (405)
T 3rgf_A 208 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRR 287 (405)
T ss_dssp TTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCG
T ss_pred cCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccc
Confidence 87 458999999999999999999999986433211000000 00
Q ss_pred ---------hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 336 ---------DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 336 ---------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
..........++.+.+||.+||+.||.+|||++++++ ||.+.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~ 340 (405)
T 3rgf_A 288 NTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED 340 (405)
T ss_dssp GGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSS
T ss_pred cCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccC
Confidence 0000111233678999999999999999999999984 77653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=294.87 Aligned_cols=231 Identities=23% Similarity=0.377 Sum_probs=162.5
Q ss_pred cCCeeeee-ccCCCcchhhhhcc--------------------chHH-HHhhcCCcceeeEEEEEEe----CCeeeEEEe
Q psy6593 125 KDGLLFCK-EDYNGKYGEACQNC--------------------GQVA-VLRSLHHHNVIRFIGVLYK----DRKLNLVTE 178 (433)
Q Consensus 125 ~~~~~~~~-~~~~g~fg~v~~~~--------------------~E~~-~l~~l~h~~iv~~~~~~~~----~~~~~lv~e 178 (433)
.+++.+.+ .+|+|+||+||+.. +|+. .++.++|+||+++++++.. +...++|||
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 106 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIME 106 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEe
Confidence 33455544 48999999999732 3333 3555689999999999986 456899999
Q ss_pred ccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc---CCceEEeccccchhccCCCC
Q psy6593 179 YIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE---DKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 179 ~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~ 254 (433)
|++|++|.+++.+.+ ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++........
T Consensus 107 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~ 186 (336)
T 3fhr_A 107 CMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL 186 (336)
T ss_dssp CCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccccc
Confidence 999999999997743 46999999999999999999999999999999999999975 45699999999976532211
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCch
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQ 334 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~ 334 (433)
....||+.|+|||++.+..++.++||||||+++|+|++|.+||..............
T Consensus 187 -----------------------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 243 (336)
T 3fhr_A 187 -----------------------QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR 243 (336)
T ss_dssp ----------------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred -----------------------ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH
Confidence 145689999999999888899999999999999999999988865433222111111
Q ss_pred ----h--hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 335 ----T--DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 335 ----~--~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
. .........+++.+.+|+.+||+.||++||+++++++ ||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 244 RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp -------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 1 1111222578999999999999999999999999995 887643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=300.90 Aligned_cols=231 Identities=23% Similarity=0.364 Sum_probs=183.2
Q ss_pred CCeeeeeccCCCcchhhhhcc--------------------------chHHHHhhcCCcceeeEEEEEEeC-----Ceee
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSLHHHNVIRFIGVLYKD-----RKLN 174 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 174 (433)
+++.+.+.+|+|+||.||++. +|+++|++++||||+++++++... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 457788888899999888621 799999999999999999999755 3689
Q ss_pred EEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCC
Q psy6593 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
+||||+. ++|.+++.. ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 107 iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 183 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183 (364)
T ss_dssp EEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence 9999996 599999876 4599999999999999999999999999999999999999999999999999986543221
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~ 333 (433)
.. .......||+.|+|||++.+ ..++.++||||||+++|+|++|.+||...........+.
T Consensus 184 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 245 (364)
T 3qyz_A 184 HT------------------GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245 (364)
T ss_dssp BC------------------CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH
T ss_pred cc------------------ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 11 01124579999999998755 458999999999999999999999886532211100000
Q ss_pred ------------------hhh-----------hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 334 ------------------QTD-----------FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 334 ------------------~~~-----------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
... ........+++.+.+||.+||+.||++||+++++++ ||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 246 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 000 001122567889999999999999999999999984 77664
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=293.20 Aligned_cols=236 Identities=20% Similarity=0.325 Sum_probs=167.7
Q ss_pred ccccccCCeeeeeccCCCcchhhhhcc--------------------------chHH-HHhhcCCcceeeEEEEEEeCCe
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQNC--------------------------GQVA-VLRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~~--------------------------~E~~-~l~~l~h~~iv~~~~~~~~~~~ 172 (433)
.+.+..+++...+.+++|+||.||+.. .|+. +++.++||||+++++++..++.
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 345566778888888999999888622 3444 6677799999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcC----CCCCCChHHHHHHHHHHHHHHhhhhcC-CccccCCCCcceEEccCCceEEeccccch
Q psy6593 173 LNLVTEYIAGGTLKELLQD----PGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNSQNCLVREDKTVVVADFGLAR 247 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 247 (433)
.++||||+++ +|.+++.. ....+++..+..++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++.
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999999975 88887752 245699999999999999999999999 99999999999999999999999999997
Q ss_pred hccCCCCCCccccccchhhhhhhcccccceeeeccCcccccccee----cCCCCCcccCeEehhHHHHHHhcCCCCCCCC
Q psy6593 248 IIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMM----TGQEYDETVDVFSYGIVLCEIIGRVPADPDY 323 (433)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~ell~~~~~~~~~ 323 (433)
........ ....||+.|+|||.+ .+..++.++||||||+++|+|++|.+||...
T Consensus 175 ~~~~~~~~----------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 175 QLVDSIAK----------------------TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp C----------------------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred eccccccc----------------------ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 65432111 134689999999998 4567899999999999999999999888653
Q ss_pred CCCCCCCCCchh----hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhc
Q psy6593 324 LPRSPDFGLDQT----DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 324 ~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
............ .+.......+++.+.+|+.+||+.||++||++.+|+ .|+....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 233 NSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp -------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred chHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 322111111111 111122256889999999999999999999999998 4776643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=303.27 Aligned_cols=223 Identities=17% Similarity=0.239 Sum_probs=176.5
Q ss_pred cCCeeeeeccCCCcchhhhhcc------------------------chHHHHhhcC--------CcceeeEEEEEE----
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSLH--------HHNVIRFIGVLY---- 168 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l~--------h~~iv~~~~~~~---- 168 (433)
.+.+.+.+.+++|+||+||++. +|+.+|++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 3558888899999999999732 6999999995 788999999998
Q ss_pred eCCeeeEEEeccCCCCHHHHhc-CCCCCCChHHHHHHHHHHHHHHhhhhcC-CccccCCCCcceEEccCC----------
Q psy6593 169 KDRKLNLVTEYIAGGTLKELLQ-DPGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNSQNCLVREDK---------- 236 (433)
Q Consensus 169 ~~~~~~lv~e~~~g~sL~~~l~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~---------- 236 (433)
.....++||||+ +++|.+.+. .....+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 456899999999 556666554 4445699999999999999999999998 999999999999998765
Q ss_pred ---------------------------------------ceEEeccccchhccCCCCCCccccccchhhhhhhcccccce
Q psy6593 237 ---------------------------------------TVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKR 277 (433)
Q Consensus 237 ---------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (433)
.+||+|||++.......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~------------------------ 250 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF------------------------ 250 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS------------------------
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC------------------------
Confidence 79999999998654321
Q ss_pred eeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh----h-----------------
Q psy6593 278 YTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT----D----------------- 336 (433)
Q Consensus 278 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~----~----------------- 336 (433)
....||+.|+|||++.+..++.++||||||+++|+|++|.+||............... .
T Consensus 251 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 330 (397)
T 1wak_A 251 TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK 330 (397)
T ss_dssp CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGG
T ss_pred ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccc
Confidence 1446899999999999999999999999999999999999988654322211000000 0
Q ss_pred -------------------------hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 337 -------------------------FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 337 -------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
.....+...++.+.+||.+||+.||++||+++++++
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp GTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000111233467899999999999999999999984
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=291.07 Aligned_cols=208 Identities=22% Similarity=0.409 Sum_probs=168.5
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|++++++++||||+++++++...+..++||||+++++|.+++...+ .+++..++.++.||+.||.+||+.|++|+|||
T Consensus 70 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~ 148 (287)
T 2wei_A 70 REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148 (287)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 69999999999999999999999999999999999999999886533 59999999999999999999999999999999
Q ss_pred CcceEEccC---CceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCe
Q psy6593 227 SQNCLVRED---KTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDV 303 (433)
Q Consensus 227 p~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 303 (433)
|+||+++.+ +.+||+|||++......... ....||+.|+|||.+.+ .++.++||
T Consensus 149 p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~----------------------~~~~~~~~y~aPE~~~~-~~~~~~Di 205 (287)
T 2wei_A 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKM----------------------KDRIGTAYYIAPEVLRG-TYDEKCDV 205 (287)
T ss_dssp GGGEEESCSSTTCCEEECSTTGGGTBCCCSSC----------------------SCHHHHHTTCCHHHHTT-CCCTHHHH
T ss_pred hhhEEEecCCCcccEEEeccCcceeecCCCcc----------------------ccccCcccccChHHhcC-CCCCchhh
Confidence 999999754 47999999999876432211 13457889999999876 48999999
Q ss_pred EehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhh--ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 304 FSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDF--RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 304 wslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
||||+++|+|++|.+|+...........+..... .......+++.+.+++.+||+.||++||+++++++ ||++..
T Consensus 206 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 206 WSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 9999999999999888754321110000000000 01112567899999999999999999999999985 887654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=297.65 Aligned_cols=209 Identities=22% Similarity=0.317 Sum_probs=161.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeC-----CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCcc
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKD-----RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLI 221 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~ 221 (433)
+|+++|++++||||+++++++... ...++||||++ ++|.+++...+..+++..++.++.||+.||.|||+.||+
T Consensus 78 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 156 (362)
T 3pg1_A 78 REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVV 156 (362)
T ss_dssp HHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCE
Confidence 699999999999999999999643 36899999996 689998887666799999999999999999999999999
Q ss_pred ccCCCCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcc
Q psy6593 222 HRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDET 300 (433)
Q Consensus 222 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~ 300 (433)
||||||+||+++.++.+||+|||++........ .....||+.|+|||.+.+ ..++.+
T Consensus 157 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~----------------------~~~~~~t~~y~aPE~~~~~~~~~~~ 214 (362)
T 3pg1_A 157 HRDLHPGNILLADNNDITICDFNLAREDTADAN----------------------KTHYVTHRWYRAPELVMQFKGFTKL 214 (362)
T ss_dssp CCCCCGGGEEECTTCCEEECCTTC-------------------------------------CGGGCCHHHHTTCTTCCTH
T ss_pred ecCCChHHEEEcCCCCEEEEecCcccccccccc----------------------cceecccceecCcHHhcCCCCCCcH
Confidence 999999999999999999999999975433211 114578999999999887 678999
Q ss_pred cCeEehhHHHHHHhcCCCCCCCCCCCCCCC------------------------------CCchhhhccccCCCCcHHHH
Q psy6593 301 VDVFSYGIVLCEIIGRVPADPDYLPRSPDF------------------------------GLDQTDFRNKFCASCPEPFV 350 (433)
Q Consensus 301 ~DiwslG~il~ell~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~l~ 350 (433)
+||||||+++|+|++|.+||.......... ...............++.+.
T Consensus 215 ~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (362)
T 3pg1_A 215 VDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVAL 294 (362)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHH
T ss_pred hHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHH
Confidence 999999999999999998886432100000 00000001122356688999
Q ss_pred HHHHHhcccCCCCCCChhHHH--HHHHhhc
Q psy6593 351 RIAFLCCDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 351 ~li~~~l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
+||.+||+.||.+|||+++++ .||+.+.
T Consensus 295 ~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 295 DLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 999999999999999999998 4777654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=291.55 Aligned_cols=208 Identities=20% Similarity=0.346 Sum_probs=168.2
Q ss_pred chHHHHhhcC-CcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+++|+++. ||||+++++++..++..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||
T Consensus 72 ~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 150 (298)
T 1phk_A 72 KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDL 150 (298)
T ss_dssp HHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 6899999995 999999999999999999999999999999999763 35999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceec------CCCCCc
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT------GQEYDE 299 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ 299 (433)
+|+||+++.++.++|+|||++........ .....||+.|+|||.+. ...++.
T Consensus 151 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~~----------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 208 (298)
T 1phk_A 151 KPENILLDDDMNIKLTDFGFSCQLDPGEK----------------------LREVCGTPSYLAPEIIECSMNDNHPGYGK 208 (298)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCTTCC----------------------BCCCCSCGGGCCHHHHHHHHCTTSCCBCT
T ss_pred CcceEEEcCCCcEEEecccchhhcCCCcc----------------------cccccCCccccCHHHhccccccccccCCc
Confidence 99999999999999999999876543221 11456899999999985 456889
Q ss_pred ccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhc--cccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHH
Q psy6593 300 TVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFR--NKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLE 375 (433)
Q Consensus 300 ~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~ 375 (433)
++||||||+++|+|++|.+|+...........+...... ......++..+.+++.+||+.||++||+++++++ ||+
T Consensus 209 ~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (298)
T 1phk_A 209 EVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 288 (298)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred ccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhh
Confidence 999999999999999998887543211100000000000 0111457889999999999999999999999984 665
Q ss_pred hh
Q psy6593 376 GL 377 (433)
Q Consensus 376 ~~ 377 (433)
+.
T Consensus 289 ~~ 290 (298)
T 1phk_A 289 QY 290 (298)
T ss_dssp TT
T ss_pred hc
Confidence 43
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=291.76 Aligned_cols=234 Identities=22% Similarity=0.296 Sum_probs=172.1
Q ss_pred cccCCeeeeeccCCCcchhhhhcc------------------------chHHHHhhcCCcceeeEEEEEEeCCe------
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSLHHHNVIRFIGVLYKDRK------ 172 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~------ 172 (433)
...+++.+.+.+++|+||+||+.. +|+..++.++||||+++++++...+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 455668888899999999999622 56667788899999999999976443
Q ss_pred -eeEEEeccCCCCHHHHhc---CCCCCCChHHHHHHHHHHHHHHhhhh--cCCccccCCCCcceEEcc-CCceEEecccc
Q psy6593 173 -LNLVTEYIAGGTLKELLQ---DPGQPLPWGQRVNFARDIAAGMTYLH--SMNLIHRDLNSQNCLVRE-DKTVVVADFGL 245 (433)
Q Consensus 173 -~~lv~e~~~g~sL~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~ 245 (433)
.++||||+++ +|.+.+. .....+++..+..++.|++.||.||| +.||+||||||+||+++. ++.+||+|||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 8899999975 5554443 23456899999999999999999999 999999999999999996 89999999999
Q ss_pred chhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeEehhHHHHHHhcCCCCCCCCC
Q psy6593 246 ARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVPADPDYL 324 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~~~~~~~~~~ 324 (433)
+......... ....||+.|+|||++.+. .++.++||||||+++|+|++|.+||....
T Consensus 179 a~~~~~~~~~----------------------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 179 AKKLSPSEPN----------------------VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp CBCCCTTSCC----------------------CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecCCCCCc----------------------ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 9876433221 145689999999998764 48999999999999999999998886532
Q ss_pred CCCCC------------------------------CCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--H
Q psy6593 325 PRSPD------------------------------FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--V 372 (433)
Q Consensus 325 ~~~~~------------------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~ 372 (433)
..... ................++.+.+|+.+||+.||.+||++.+++ .
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 237 SAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316 (360)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred hHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence 11000 000111111222334678999999999999999999999998 4
Q ss_pred HHHhhcc
Q psy6593 373 WLEGLSM 379 (433)
Q Consensus 373 ~l~~~~~ 379 (433)
||++...
T Consensus 317 ~f~~~~~ 323 (360)
T 3e3p_A 317 YFDELHD 323 (360)
T ss_dssp GGGGGGC
T ss_pred cccccCC
Confidence 8887643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=289.43 Aligned_cols=230 Identities=28% Similarity=0.402 Sum_probs=180.9
Q ss_pred CCeeeeeccCCCcchhhhhc----------------------------cchHHHHhhc---CCcceeeEEEEEE-----e
Q psy6593 126 DGLLFCKEDYNGKYGEACQN----------------------------CGQVAVLRSL---HHHNVIRFIGVLY-----K 169 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~----------------------------~~E~~~l~~l---~h~~iv~~~~~~~-----~ 169 (433)
+++.+.+.+++|+||+||+. .+|+.+++++ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 44666666777777766641 1578888777 8999999999987 4
Q ss_pred CCeeeEEEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchh
Q psy6593 170 DRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 170 ~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
....++||||++ ++|.+++... ...+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 567999999997 5999998653 34599999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCC
Q psy6593 249 IHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~ 328 (433)
..... ......||+.|+|||.+.+..++.++||||||+++|+|++|.+||........
T Consensus 170 ~~~~~----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 227 (326)
T 1blx_A 170 YSFQM----------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 227 (326)
T ss_dssp CCGGG----------------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccCCC----------------------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 43211 11245789999999999998999999999999999999999988864321000
Q ss_pred --------------CC-----------CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhc
Q psy6593 329 --------------DF-----------GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 329 --------------~~-----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
.+ ..........+...++..+.+|+.+||+.||++||++.+++ .||+.+.
T Consensus 228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 228 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 00 00000111233467889999999999999999999999998 4776543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=296.04 Aligned_cols=229 Identities=18% Similarity=0.262 Sum_probs=181.0
Q ss_pred CCeeeeeccCCCcchhhhhcc-------------------------chHHHHhhcCCcc------eeeEEEEEEeCCeee
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLHHHN------VIRFIGVLYKDRKLN 174 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~------iv~~~~~~~~~~~~~ 174 (433)
+++.+.+.+++|+||+||+.. +|+.+++.++|++ |+++++++..++..+
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 457777788888888887521 6889999997665 999999999999999
Q ss_pred EEEeccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc-------------------
Q psy6593 175 LVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE------------------- 234 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~------------------- 234 (433)
+||||+ +++|.+++...+ ..+++..++.++.||+.||+|||+.||+||||||+||+++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~ 172 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172 (339)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence 999999 889999987643 36899999999999999999999999999999999999987
Q ss_pred CCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHh
Q psy6593 235 DKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII 314 (433)
Q Consensus 235 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 314 (433)
++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||+
T Consensus 173 ~~~~kl~Dfg~~~~~~~~~------------------------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 228 (339)
T 1z57_A 173 NPDIKVVDFGSATYDDEHH------------------------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY 228 (339)
T ss_dssp CCCEEECCCSSCEETTSCC------------------------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCceEeeCcccccCcccc------------------------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHH
Confidence 6689999999987643221 1456899999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCCCCCCCc-------hh-----------------------------------hhccccCCCCcHHHHHH
Q psy6593 315 GRVPADPDYLPRSPDFGLD-------QT-----------------------------------DFRNKFCASCPEPFVRI 352 (433)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~-------~~-----------------------------------~~~~~~~~~~~~~l~~l 352 (433)
+|.+||...........+. .. ..........++.+.+|
T Consensus 229 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 308 (339)
T 1z57_A 229 LGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDL 308 (339)
T ss_dssp HSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHH
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHH
Confidence 9998886432110000000 00 00000112335789999
Q ss_pred HHHhcccCCCCCCChhHHH--HHHHhhcc
Q psy6593 353 AFLCCDLNPDQRPPFEVLE--VWLEGLSM 379 (433)
Q Consensus 353 i~~~l~~~p~~RPs~~~i~--~~l~~~~~ 379 (433)
+.+||+.||.+||++++++ .||+.+..
T Consensus 309 i~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 309 IQKMLEYDPAKRITLREALKHPFFDLLKK 337 (339)
T ss_dssp HHHHTCSSTTTSCCHHHHTTSGGGGGGGC
T ss_pred HHHHhCcCcccccCHHHHhcCHHHHHHhc
Confidence 9999999999999999998 57776543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=299.94 Aligned_cols=225 Identities=21% Similarity=0.318 Sum_probs=179.2
Q ss_pred CCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCee-----
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKL----- 173 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~----- 173 (433)
+.+...+.+|+|+||+||++. +|+.++++++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 457888899999999998632 699999999999999999999877654
Q ss_pred -eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 174 -NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 174 -~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
++||||+. ++|.+++.. .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 122 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred EEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 99999996 689888854 4999999999999999999999999999999999999999999999999999765322
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG 331 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~ 331 (433)
. ....||+.|+|||++.+ ..++.++||||||+++|+|++|.+||...........
T Consensus 198 ~------------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 253 (371)
T 4exu_A 198 M------------------------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ 253 (371)
T ss_dssp --------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred c------------------------CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 1 14568999999999887 6889999999999999999999988864321000000
Q ss_pred C---------------c---h-----------hhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhc
Q psy6593 332 L---------------D---Q-----------TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 332 ~---------------~---~-----------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
+ . . ..........+++.+.+||.+||+.||++||++++++ .||+.+.
T Consensus 254 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 254 ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 0 0 0 0000112346789999999999999999999999998 4776543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=291.08 Aligned_cols=220 Identities=18% Similarity=0.300 Sum_probs=183.8
Q ss_pred cCCeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhcC--CcceeeEEEEEEeCC
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSLH--HHNVIRFIGVLYKDR 171 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l~--h~~iv~~~~~~~~~~ 171 (433)
.+++.+.+.+++|+||.||+.. +|+.++++++ |+||+++++++..++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 4457888889999999998631 4899999996 599999999999999
Q ss_pred eeeEEEeccCC-CCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEc-cCCceEEeccccchhc
Q psy6593 172 KLNLVTEYIAG-GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR-EDKTVVVADFGLARII 249 (433)
Q Consensus 172 ~~~lv~e~~~g-~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~ 249 (433)
..++|||++.+ ++|.+++... ..+++..++.++.|++.||+|||+.||+||||||+||+++ .++.+||+|||++...
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred cEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 99999999976 8999998764 3599999999999999999999999999999999999999 7899999999999865
Q ss_pred cCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCC-CcccCeEehhHHHHHHhcCCCCCCCCCCCCC
Q psy6593 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY-DETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~~~~~~~~~~~~~~ 328 (433)
..... ....||+.|+|||++.+..+ +.++||||||+++|+|++|.+||....
T Consensus 201 ~~~~~-----------------------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---- 253 (320)
T 3a99_A 201 KDTVY-----------------------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 253 (320)
T ss_dssp CSSCB-----------------------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred ccccc-----------------------cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----
Confidence 43211 14568999999999887665 678999999999999999988875321
Q ss_pred CCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 329 DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
........++..+++.+.++|.+||+.||++||++++|++ ||++
T Consensus 254 ----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 299 (320)
T 3a99_A 254 ----EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299 (320)
T ss_dssp ----HHHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred ----hhhcccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcC
Confidence 0111122344678999999999999999999999999985 6654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=293.02 Aligned_cols=236 Identities=25% Similarity=0.394 Sum_probs=168.9
Q ss_pred eeeeeccCCCcchhhhhc------------------------cchHHHHhhcCCcceeeEEEEEEe-------------C
Q psy6593 128 LLFCKEDYNGKYGEACQN------------------------CGQVAVLRSLHHHNVIRFIGVLYK-------------D 170 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~------------------------~~E~~~l~~l~h~~iv~~~~~~~~-------------~ 170 (433)
+.+.+.+++|+||.||++ .+|+.++++++||||+++++++.+ .
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (303)
T 1zy4_A 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKK 87 (303)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CE
T ss_pred chhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccC
Confidence 455566666777766652 279999999999999999999865 3
Q ss_pred CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhcc
Q psy6593 171 RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIH 250 (433)
Q Consensus 171 ~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 250 (433)
+..++||||+++++|.+++...+..+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 167 (303)
T 1zy4_A 88 STLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167 (303)
T ss_dssp EEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTT
T ss_pred CceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcc
Confidence 56899999999999999998655668899999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCC
Q psy6593 251 QGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPD 329 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~ 329 (433)
......... ...............||+.|+|||.+.+. .++.++||||||+++|+|++ |+..........
T Consensus 168 ~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~--p~~~~~~~~~~~ 238 (303)
T 1zy4_A 168 RSLDILKLD-------SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNIL 238 (303)
T ss_dssp C--------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS--CCSSHHHHHHHH
T ss_pred cccchhccc-------cccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh--ccCCchhHHHHH
Confidence 322110000 00000011122356789999999999864 68999999999999999997 222110000000
Q ss_pred CC--CchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 330 FG--LDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 330 ~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
.. .....+...+....+..+.+++.+||+.||.+||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 00 00011122334567788999999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=290.12 Aligned_cols=235 Identities=20% Similarity=0.275 Sum_probs=170.4
Q ss_pred cccccCCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCee
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~ 173 (433)
+..+.+++...+.+++|+||.||+.. ++..+++.++||||+++++++..++..
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 34466778888899999999988622 233467777999999999999999999
Q ss_pred eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC-CccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 174 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
++||||+ ++.+..+.......+++..++.++.|++.||.|||++ |++|+||||+||+++.++.+||+|||++......
T Consensus 100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 9999999 6677777655445799999999999999999999996 9999999999999999999999999998765432
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceec-----CCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT-----GQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~ 327 (433)
.. .....||+.|+|||.+. ...++.++||||||+++|+|++|.+||.......
T Consensus 179 ~~----------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 236 (318)
T 2dyl_A 179 KA----------------------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF 236 (318)
T ss_dssp ------------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred cc----------------------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH
Confidence 11 11446899999999984 4568889999999999999999988875422111
Q ss_pred CCCCCchhhhcccc--CCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhhc
Q psy6593 328 PDFGLDQTDFRNKF--CASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGLS 378 (433)
Q Consensus 328 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~~ 378 (433)
.............. ...+++.+.+++.+||+.||.+||++++|+ .||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 237 EVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp HHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 00000000111111 145789999999999999999999999998 4777643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=296.09 Aligned_cols=230 Identities=17% Similarity=0.279 Sum_probs=184.8
Q ss_pred ccCCeeeeeccCCCcchhhhhc----------------------------------------cchHHHHhhcCCcceeeE
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQN----------------------------------------CGQVAVLRSLHHHNVIRF 163 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~----------------------------------------~~E~~~l~~l~h~~iv~~ 163 (433)
..+++.+.+.+++|+||.||++ .+|+.++++++||||+++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 4456888888899999988752 158899999999999999
Q ss_pred EEEEEeCCeeeEEEeccCCCCHHHH------hcCC-CCCCChHHHHHHHHHHHHHHhhhhc-CCccccCCCCcceEEccC
Q psy6593 164 IGVLYKDRKLNLVTEYIAGGTLKEL------LQDP-GQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCLVRED 235 (433)
Q Consensus 164 ~~~~~~~~~~~lv~e~~~g~sL~~~------l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~~ 235 (433)
++++.+.+..++||||+++++|.++ +... ...+++..++.++.|++.||.|||+ .|++|+||||+||+++.+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN 188 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence 9999999999999999999999998 5542 4579999999999999999999999 999999999999999999
Q ss_pred CceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCc-ccCeEehhHHHHHH
Q psy6593 236 KTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDE-TVDVFSYGIVLCEI 313 (433)
Q Consensus 236 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~el 313 (433)
+.++|+|||++....... .....||+.|+|||.+.+. .++. ++||||||+++|+|
T Consensus 189 ~~~kl~dfg~~~~~~~~~-----------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l 245 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDKK-----------------------IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM 245 (348)
T ss_dssp SCEEECCCTTCEECBTTE-----------------------ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHH
T ss_pred CcEEEecccccccccccc-----------------------ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHH
Confidence 999999999998654321 1145689999999999887 5666 99999999999999
Q ss_pred hcCCCCCCCCCCCCCCC-CCchhhh-----------------ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--H
Q psy6593 314 IGRVPADPDYLPRSPDF-GLDQTDF-----------------RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--W 373 (433)
Q Consensus 314 l~~~~~~~~~~~~~~~~-~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~ 373 (433)
++|.+|+.......... .+..... .......++..+.+++.+||+.||.+||+++++++ |
T Consensus 246 ~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~ 325 (348)
T 2pml_X 246 FYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325 (348)
T ss_dssp HHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred HhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 99998886543210000 0000000 00011568899999999999999999999999985 6
Q ss_pred HHh
Q psy6593 374 LEG 376 (433)
Q Consensus 374 l~~ 376 (433)
|+.
T Consensus 326 f~~ 328 (348)
T 2pml_X 326 LAD 328 (348)
T ss_dssp GTT
T ss_pred ccC
Confidence 654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=295.49 Aligned_cols=239 Identities=23% Similarity=0.352 Sum_probs=180.5
Q ss_pred CCeeeeeccCCCcchhhhhc--------------------------cchHHHHhhcCCcceeeEEEEEEeC-----Ceee
Q psy6593 126 DGLLFCKEDYNGKYGEACQN--------------------------CGQVAVLRSLHHHNVIRFIGVLYKD-----RKLN 174 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~--------------------------~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 174 (433)
+++.+.+.+++|+||.||++ .+|+++|++++||||+++++++... ...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 44666677777777777752 1799999999999999999998754 6789
Q ss_pred EEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCC
Q psy6593 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
+||||+. ++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 91 lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp EEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 9999996 699999876 4699999999999999999999999999999999999999999999999999987654322
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCC-------
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPR------- 326 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~------- 326 (433)
..... ...........||+.|+|||++.+ ..++.++||||||+++|+|++|.+||......
T Consensus 168 ~~~~~-----------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 236 (353)
T 2b9h_A 168 DNSEP-----------TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236 (353)
T ss_dssp -----------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccCc-----------cccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 11100 000111224578999999998765 67899999999999999999999988653210
Q ss_pred ---------CCCCCCch---hh-----------hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 327 ---------SPDFGLDQ---TD-----------FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 327 ---------~~~~~~~~---~~-----------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
........ .. ........+++.+.+|+.+||+.||++||+++++++ ||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 00000000 00 011123578899999999999999999999999984 776643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=290.26 Aligned_cols=231 Identities=19% Similarity=0.289 Sum_probs=174.5
Q ss_pred CCeeeeeccCCCcchhhhhc-------------------------cchHHHHhhcCCcceeeEEEEEE------------
Q psy6593 126 DGLLFCKEDYNGKYGEACQN-------------------------CGQVAVLRSLHHHNVIRFIGVLY------------ 168 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~-------------------------~~E~~~l~~l~h~~iv~~~~~~~------------ 168 (433)
+++...+.++.|+||.||++ .+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 44667777888888887752 17999999999999999999873
Q ss_pred --eCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEc-cCCceEEecccc
Q psy6593 169 --KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR-EDKTVVVADFGL 245 (433)
Q Consensus 169 --~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~ 245 (433)
+....++||||++ ++|.+++.+ ..+++..++.++.|++.||+|||+.||+||||||+||+++ .++.+||+|||+
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 3467899999997 599999976 4699999999999999999999999999999999999997 567999999999
Q ss_pred chhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCC
Q psy6593 246 ARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYL 324 (433)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~ 324 (433)
+.......... .......+|+.|+|||.+.+ ..++.++||||||+++|+|++|.+||....
T Consensus 168 ~~~~~~~~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 168 ARIMDPHYSHK------------------GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp CBCC--------------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccCCCcccc------------------cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 98654321110 01113467899999998865 678999999999999999999998886532
Q ss_pred CCCCCCCCc----------h------------------hhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHH
Q psy6593 325 PRSPDFGLD----------Q------------------TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWL 374 (433)
Q Consensus 325 ~~~~~~~~~----------~------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l 374 (433)
.......+. . ..........++.++.+++.+||+.||++||++++++ .||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (320)
T 2i6l_A 230 ELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309 (320)
T ss_dssp HHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred HHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence 110000000 0 0000112356889999999999999999999999998 488
Q ss_pred Hhh
Q psy6593 375 EGL 377 (433)
Q Consensus 375 ~~~ 377 (433)
+..
T Consensus 310 ~~~ 312 (320)
T 2i6l_A 310 SIY 312 (320)
T ss_dssp HTT
T ss_pred ccc
Confidence 764
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=301.85 Aligned_cols=231 Identities=23% Similarity=0.297 Sum_probs=171.5
Q ss_pred cccCCeeeeeccCCCcchhhhh---------------------ccchHHHHhhc-CCcceeeEEEEEEeCCeeeEEEecc
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQ---------------------NCGQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYI 180 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~---------------------~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 180 (433)
+...++.....+|+|+||+|+. ..+|+++|+++ +||||+++++++.+.+..|+||||+
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 3444466677888999998543 11799999999 7999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc-----CCceEEeccccchhccCCCCC
Q psy6593 181 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE-----DKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 181 ~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~-----~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
. ++|.+++......+.+..++.++.||+.||.|||+.||+||||||+||+++. ...+||+|||+++........
T Consensus 101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~ 179 (432)
T 3p23_A 101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179 (432)
T ss_dssp S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence 5 6999999876666777788999999999999999999999999999999953 235889999999876433211
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceec---CCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCC
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT---GQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFG 331 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~ 331 (433)
. .......||+.|+|||++. ...++.++||||||+++|||++ |.+|+...........
T Consensus 180 ~------------------~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~ 241 (432)
T 3p23_A 180 F------------------SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL 241 (432)
T ss_dssp ------------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH
T ss_pred e------------------eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH
Confidence 0 0112567999999999997 4567889999999999999998 8888754221110000
Q ss_pred Cchhhhcc-ccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 332 LDQTDFRN-KFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 332 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
........ ......+..+.+||.+||+.||.+||+++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 242 LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00000000 001223456899999999999999999999983
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=288.29 Aligned_cols=233 Identities=18% Similarity=0.255 Sum_probs=178.5
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc--------------------------chHHHHhhcC--CcceeeEEEEEEeCCee
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSLH--HHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l~--h~~iv~~~~~~~~~~~~ 173 (433)
.+..+.+.+.+.+++|+||.||+.. +|+++|++++ |+||+++++++..++..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 3444557777788888888888521 6899999997 59999999999999999
Q ss_pred eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 174 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
++|||+ .+++|.+++...+ .+++..++.++.|++.||.|||+.||+||||||+||+++ ++.+||+|||++.......
T Consensus 104 ~lv~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 104 YMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEEECC-CSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-----
T ss_pred EEEEec-CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcc
Confidence 999995 4789999997644 599999999999999999999999999999999999996 4899999999998664322
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecC-----------CCCCcccCeEehhHHHHHHhcCCCCCCC
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-----------QEYDETVDVFSYGIVLCEIIGRVPADPD 322 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~~~~~~~~ 322 (433)
... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|.+||..
T Consensus 181 ~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 181 TSV-------------------VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp ----------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccc-------------------cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 111 1114568999999999875 4678899999999999999999988754
Q ss_pred CCCCCCC-CCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHh
Q psy6593 323 YLPRSPD-FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEG 376 (433)
Q Consensus 323 ~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~ 376 (433)
....... ...........++...+..+.+++.+||+.||.+||++++++ .|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 242 IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp CCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred HHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 3211000 000011112234456688999999999999999999999998 47764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=298.11 Aligned_cols=233 Identities=15% Similarity=0.257 Sum_probs=182.2
Q ss_pred ccccccCCeeeeeccCCCcchhhhhcc------------------------chHHHHhhcC-----------CcceeeEE
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSLH-----------HHNVIRFI 164 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l~-----------h~~iv~~~ 164 (433)
+..+..+++.+.+.+++|+||+||++. +|+.++++++ |+||++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 13 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 344566778888999999999998632 6889999886 78999999
Q ss_pred EEEEeCC----eeeEEEeccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcC-CccccCCCCcceEEcc----
Q psy6593 165 GVLYKDR----KLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNSQNCLVRE---- 234 (433)
Q Consensus 165 ~~~~~~~----~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~---- 234 (433)
+++...+ ..++|||++ +++|.+++.. ....+++..++.++.||+.||+|||+. ||+||||||+||+++.
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence 9998654 799999999 8899999865 334599999999999999999999998 9999999999999953
Q ss_pred --CCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHH
Q psy6593 235 --DKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE 312 (433)
Q Consensus 235 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 312 (433)
.+.+||+|||++........ ...||+.|+|||++.+..++.++||||||+++|+
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~~------------------------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e 227 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHYT------------------------NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFE 227 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCCC------------------------SCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHH
T ss_pred cCcceEEEcccccccccCCCCC------------------------CCCCCccccCcHHHhCCCCCchHhHHHHHHHHHH
Confidence 34899999999976543211 4468999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCCCCCCCC-------------------------------------Cch------h---hhccccCCCCc
Q psy6593 313 IIGRVPADPDYLPRSPDFG-------------------------------------LDQ------T---DFRNKFCASCP 346 (433)
Q Consensus 313 ll~~~~~~~~~~~~~~~~~-------------------------------------~~~------~---~~~~~~~~~~~ 346 (433)
|++|.+||........... +.. . .....++..++
T Consensus 228 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (373)
T 1q8y_A 228 LITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307 (373)
T ss_dssp HHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHH
T ss_pred HHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchH
Confidence 9999988864332110000 000 0 00011223456
Q ss_pred HHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 347 EPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 347 ~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
..+.+||.+||+.||++||+++++++ ||++.
T Consensus 308 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 308 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp HHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred HHHHHHHHHHhccCccccCCHHHHhhChhhhcc
Confidence 78999999999999999999999985 77653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=294.11 Aligned_cols=224 Identities=21% Similarity=0.319 Sum_probs=176.6
Q ss_pred CCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCe------
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRK------ 172 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~------ 172 (433)
+++.....++.|+||.||++. +|+.+|++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 457777788888888887621 69999999999999999999987654
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
.++||||+. ++|.+++.. .+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 104 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred EEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 499999996 689888754 4999999999999999999999999999999999999999999999999998764321
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC-
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF- 330 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~- 330 (433)
.....+|+.|+|||.+.+ ..++.++||||||+++|+|++|.+||..........
T Consensus 180 ------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 235 (353)
T 3coi_A 180 ------------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ 235 (353)
T ss_dssp ----------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHH
T ss_pred ------------------------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 114578999999999887 678999999999999999999998886432100000
Q ss_pred --------------CCch--------------hhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHHhh
Q psy6593 331 --------------GLDQ--------------TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLEGL 377 (433)
Q Consensus 331 --------------~~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~~~ 377 (433)
.... ..........+++.+.+||.+||+.||++||++++++ .||+..
T Consensus 236 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 236 ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0000 0000112356789999999999999999999999998 477654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.19 Aligned_cols=214 Identities=20% Similarity=0.307 Sum_probs=169.6
Q ss_pred CCeeeeeccCCCcchhhhhc---------------------------cchHHHHhhcCCcceeeEEEEEEeCCe-----e
Q psy6593 126 DGLLFCKEDYNGKYGEACQN---------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRK-----L 173 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~---------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~-----~ 173 (433)
+.+.+.+.+++|+||.||+. .+|+.+|++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 45667777788888877752 168999999999999999999987765 7
Q ss_pred eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 174 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
||||||++|++|.+++.. .+++..++.|+.||+.||.|||+.||+||||||+||+++.+ .+||+|||+++.....
T Consensus 160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF- 234 (681)
T ss_dssp EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-
T ss_pred EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC-
Confidence 999999999999988765 59999999999999999999999999999999999999875 8999999999865432
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~ 333 (433)
....||+.|+|||++.+. ++.++||||||+++|+|++|.+++.........
T Consensus 235 ------------------------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~---- 285 (681)
T 2pzi_A 235 ------------------------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP---- 285 (681)
T ss_dssp ------------------------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC----
T ss_pred ------------------------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc----
Confidence 145699999999998775 488999999999999999998876542211110
Q ss_pred hhhhccccCCCCcHHHHHHHHHhcccCCCCCCC-hhHHHHHHHhh
Q psy6593 334 QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP-FEVLEVWLEGL 377 (433)
Q Consensus 334 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-~~~i~~~l~~~ 377 (433)
... .....++.+.++|.+||+.||++||+ ++++...|..+
T Consensus 286 ~~~----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 EDD----PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp TTC----HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ccc----cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 000 00123578999999999999999995 55565555544
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=287.08 Aligned_cols=218 Identities=22% Similarity=0.364 Sum_probs=175.5
Q ss_pred CeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhc----CCcceeeEEEEEEeCC
Q psy6593 127 GLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSL----HHHNVIRFIGVLYKDR 171 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l----~h~~iv~~~~~~~~~~ 171 (433)
++.+.+.+++|+||.||+.. +|+.+++++ +|+||+++++++...+
T Consensus 32 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~ 111 (312)
T 2iwi_A 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQE 111 (312)
T ss_dssp -CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC----
T ss_pred ceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCC
Confidence 35666677777777777521 589999999 8999999999999999
Q ss_pred eeeEEEec-cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEc-cCCceEEeccccchhc
Q psy6593 172 KLNLVTEY-IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR-EDKTVVVADFGLARII 249 (433)
Q Consensus 172 ~~~lv~e~-~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~ 249 (433)
..++|||+ +.+++|.+++.+.+ .+++..++.++.||+.||.|||+.||+||||||+||+++ .++.++|+|||++...
T Consensus 112 ~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~ 190 (312)
T 2iwi_A 112 GFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190 (312)
T ss_dssp -CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEEC
T ss_pred eEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhc
Confidence 99999999 78999999997643 599999999999999999999999999999999999999 8899999999998876
Q ss_pred cCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCC-cccCeEehhHHHHHHhcCCCCCCCCCCCCC
Q psy6593 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYD-ETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~~~~~~~~~~~~~~ 328 (433)
..... ....||+.|+|||.+.+..+. .++||||||+++|+|++|..+|....
T Consensus 191 ~~~~~-----------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---- 243 (312)
T 2iwi_A 191 HDEPY-----------------------TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---- 243 (312)
T ss_dssp CSSCB-----------------------CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred ccCcc-----------------------cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----
Confidence 43221 145689999999998876664 48999999999999999988875321
Q ss_pred CCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 329 DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
........++..++..+.++|.+||+.||++||+++++++ |++.
T Consensus 244 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~ 289 (312)
T 2iwi_A 244 ----EILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289 (312)
T ss_dssp ----HHHHTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC
T ss_pred ----HHhhhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcC
Confidence 1111223345778999999999999999999999999985 5443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=291.43 Aligned_cols=228 Identities=19% Similarity=0.283 Sum_probs=178.7
Q ss_pred cCCeeeeeccCCCcchhhhhcc-------------------------chHHHHhhcCCcc------eeeEEEEEEeCCee
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLHHHN------VIRFIGVLYKDRKL 173 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~------iv~~~~~~~~~~~~ 173 (433)
.+++.+.+.+++|+||+||+.. +|+.++++++|++ ++.+++++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 3457778888889998888521 5899999997766 99999999999999
Q ss_pred eEEEeccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEE-------------------c
Q psy6593 174 NLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV-------------------R 233 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~-------------------~ 233 (433)
++||||+ +++|.+.+.. ....+++..++.++.||+.||+|||+.||+||||||+||++ +
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~ 176 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccccc
Confidence 9999999 5677766654 33569999999999999999999999999999999999999 5
Q ss_pred cCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHH
Q psy6593 234 EDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEI 313 (433)
Q Consensus 234 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 313 (433)
.++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||
T Consensus 177 ~~~~~kl~Dfg~~~~~~~~~------------------------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 232 (355)
T 2eu9_A 177 KNTSIRVADFGSATFDHEHH------------------------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 232 (355)
T ss_dssp SCCCEEECCCTTCEETTSCC------------------------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred CCCcEEEeecCccccccccc------------------------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHH
Confidence 67899999999997643221 145789999999999999999999999999999999
Q ss_pred hcCCCCCCCCCCCCCCCCCch--------------------------------hhh--------c--cccCCCCcHHHHH
Q psy6593 314 IGRVPADPDYLPRSPDFGLDQ--------------------------------TDF--------R--NKFCASCPEPFVR 351 (433)
Q Consensus 314 l~~~~~~~~~~~~~~~~~~~~--------------------------------~~~--------~--~~~~~~~~~~l~~ 351 (433)
++|.+||...........+.. ... . .......+..+.+
T Consensus 233 ~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 312 (355)
T 2eu9_A 233 YRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFD 312 (355)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHH
Confidence 999998864321100000000 000 0 0001122457899
Q ss_pred HHHHhcccCCCCCCChhHHH--HHHHhh
Q psy6593 352 IAFLCCDLNPDQRPPFEVLE--VWLEGL 377 (433)
Q Consensus 352 li~~~l~~~p~~RPs~~~i~--~~l~~~ 377 (433)
||.+||+.||++||++++++ .||+.+
T Consensus 313 li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 313 LMRRMLEFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred HHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence 99999999999999999998 477764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=304.56 Aligned_cols=223 Identities=22% Similarity=0.295 Sum_probs=171.7
Q ss_pred CeeeeeccCCCcchhhhhc--------------------------cchHHHHhhcCCcceeeEEEEEEe------CCeee
Q psy6593 127 GLLFCKEDYNGKYGEACQN--------------------------CGQVAVLRSLHHHNVIRFIGVLYK------DRKLN 174 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~--------------------------~~E~~~l~~l~h~~iv~~~~~~~~------~~~~~ 174 (433)
++.+...+|.|+||+||+. .+|+++|++++||||+++++++.. ++..+
T Consensus 15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~ 94 (676)
T 3qa8_A 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL 94 (676)
T ss_dssp --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence 3555566677777777641 169999999999999999999765 67789
Q ss_pred EEEeccCCCCHHHHhcCCC--CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCc---eEEeccccchhc
Q psy6593 175 LVTEYIAGGTLKELLQDPG--QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKT---VVVADFGLARII 249 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~~~ 249 (433)
+||||++|++|.+++.... ..+++..++.++.|++.||+|||+.||+||||||+||+++.++. ++|+|||++...
T Consensus 95 LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~ 174 (676)
T 3qa8_A 95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 174 (676)
T ss_dssp CEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBT
T ss_pred EEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccc
Confidence 9999999999999997633 36999999999999999999999999999999999999996654 999999999876
Q ss_pred cCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCC----
Q psy6593 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLP---- 325 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~---- 325 (433)
...... ....||+.|+|||.+.+..++.++||||||+++|+|++|.+||.....
T Consensus 175 ~~~~~~----------------------~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~ 232 (676)
T 3qa8_A 175 DQGELC----------------------TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW 232 (676)
T ss_dssp TSCCCC----------------------CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHS
T ss_pred cccccc----------------------ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhh
Confidence 443221 145789999999999999999999999999999999999888743200
Q ss_pred ----------CCCCCC-----Cchh---hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 326 ----------RSPDFG-----LDQT---DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 326 ----------~~~~~~-----~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
...... .... .....+...+++.+.+++.+||+.||++||++++++
T Consensus 233 ~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 233 HGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp STTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 000000 0000 001122344678999999999999999999998854
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=298.89 Aligned_cols=225 Identities=24% Similarity=0.316 Sum_probs=163.9
Q ss_pred eeeeeccCCCcchhhhh---------------------ccchHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCH
Q psy6593 128 LLFCKEDYNGKYGEACQ---------------------NCGQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTL 185 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~---------------------~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL 185 (433)
++..+.+|+|+||+|+. ..+|+.+|+++ +||||+++++++.+++..++||||+. ++|
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 34445678888888753 12799999987 89999999999999999999999995 699
Q ss_pred HHHhcCCCCC------CChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccC-------------CceEEeccccc
Q psy6593 186 KELLQDPGQP------LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRED-------------KTVVVADFGLA 246 (433)
Q Consensus 186 ~~~l~~~~~~------~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~-------------~~~kl~Dfg~~ 246 (433)
.+++...+.. .++..++.++.||+.||+|||+.||+||||||+||+++.+ +.+||+|||++
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a 175 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccc
Confidence 9999764321 1334567899999999999999999999999999999754 48999999999
Q ss_pred hhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-------CCCCcccCeEehhHHHHHHhc-CCC
Q psy6593 247 RIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-------QEYDETVDVFSYGIVLCEIIG-RVP 318 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-~~~ 318 (433)
+.......... .......||+.|+|||++.+ ..++.++||||||+++|||++ |.+
T Consensus 176 ~~~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 176 KKLDSGQSSFR-----------------TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp EECCC-------------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred eecCCCCccce-----------------eeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 87654321100 01124579999999999875 568999999999999999997 888
Q ss_pred CCCCCCCCCCCCCCchhh-----hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 319 ADPDYLPRSPDFGLDQTD-----FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
|+........ .+.... ........+++++.+++.+||+.||.+||++.+|++
T Consensus 239 Pf~~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 239 PFGDKYSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TTCSTTTHHH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCchhhHH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 8754321110 000000 000001234578999999999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=290.37 Aligned_cols=173 Identities=22% Similarity=0.399 Sum_probs=149.1
Q ss_pred cCCeeeeeccCCCcchhhhhcc------------------------chHHHHhhcC-Cc-----ceeeEEEEEEeCCeee
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSLH-HH-----NVIRFIGVLYKDRKLN 174 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l~-h~-----~iv~~~~~~~~~~~~~ 174 (433)
.+++.+.+.+++|+||+||++. .|+.+++.++ |+ +|+++++++...+..+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 3457788899999999999732 5788888884 44 4999999999999999
Q ss_pred EEEeccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhh--cCCccccCCCCcceEEc--cCCceEEeccccchhc
Q psy6593 175 LVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLH--SMNLIHRDLNSQNCLVR--EDKTVVVADFGLARII 249 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~dlkp~Nil~~--~~~~~kl~Dfg~~~~~ 249 (433)
+||||++ ++|.+++.... ..+++..++.++.|++.||.||| +.||+||||||+|||++ .++.+||+|||++...
T Consensus 133 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp EEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 9999995 59999987643 46999999999999999999999 57999999999999995 4788999999999865
Q ss_pred cCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCC
Q psy6593 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPD 322 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~ 322 (433)
.... ....||+.|+|||++.+..++.++||||||+++|||++|.+||..
T Consensus 212 ~~~~------------------------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 212 GQRI------------------------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp TCCC------------------------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccc------------------------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 4321 145789999999999999999999999999999999999998864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=273.86 Aligned_cols=202 Identities=15% Similarity=0.034 Sum_probs=164.7
Q ss_pred CCeeeeeccCCCcchhhhhc----------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeEEE
Q psy6593 126 DGLLFCKEDYNGKYGEACQN----------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVT 177 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~----------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 177 (433)
+.+.+.+.+++|+||+||+. .+|+.++++++||||+++++++.+++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 34666677777777777751 27889999999999999999999999999999
Q ss_pred eccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCc
Q psy6593 178 EYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPT 257 (433)
Q Consensus 178 e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 257 (433)
||++|++|.+++++ + ....++..|+.|++.||+|||+.||+||||||+||+++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred EecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence 99999999999965 2 4667789999999999999999999999999999999999999997543
Q ss_pred cccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC---CCch
Q psy6593 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF---GLDQ 334 (433)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~---~~~~ 334 (433)
|++ .++.++||||||+++|+|++|.+||.......... ....
T Consensus 175 ----------------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~ 219 (286)
T 3uqc_A 175 ----------------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA 219 (286)
T ss_dssp ----------------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTT
T ss_pred ----------------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhc
Confidence 333 36889999999999999999999887644332111 0001
Q ss_pred h--hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 335 T--DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 335 ~--~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
. .........+|+.+.+++.+||+.||++| |+.++++.|+.+..
T Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 1 11123346789999999999999999999 99999999998764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=271.37 Aligned_cols=204 Identities=22% Similarity=0.338 Sum_probs=163.0
Q ss_pred eccCCCcchhhhhcc--------------------chHHHHh-hcCCcceeeEEEEEEe----CCeeeEEEeccCCCCHH
Q psy6593 132 KEDYNGKYGEACQNC--------------------GQVAVLR-SLHHHNVIRFIGVLYK----DRKLNLVTEYIAGGTLK 186 (433)
Q Consensus 132 ~~~~~g~fg~v~~~~--------------------~E~~~l~-~l~h~~iv~~~~~~~~----~~~~~lv~e~~~g~sL~ 186 (433)
+.+++|+||.||+.. +|++++. .++||||+++++++.. +...++||||++|++|.
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF 103 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHH
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHH
Confidence 568999999998632 6888884 4589999999999987 67899999999999999
Q ss_pred HHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc---CCceEEeccccchhccCCCCCCcccccc
Q psy6593 187 ELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE---DKTVVVADFGLARIIHQGPRAPTTVMAK 262 (433)
Q Consensus 187 ~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 262 (433)
+++... +..+++..++.++.|++.||.|||+.||+||||||+||+++. ++.++|+|||++....
T Consensus 104 ~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------ 171 (299)
T 3m2w_A 104 SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------ 171 (299)
T ss_dssp HHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT------------
T ss_pred HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc------------
Confidence 999764 346999999999999999999999999999999999999997 7899999999886431
Q ss_pred chhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh------
Q psy6593 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD------ 336 (433)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~------ 336 (433)
+..++.++||||||+++|+|++|.+||................
T Consensus 172 -------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 220 (299)
T 3m2w_A 172 -------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 220 (299)
T ss_dssp -------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCS
T ss_pred -------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcccc
Confidence 1346788999999999999999999886543322111111110
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
........+++++.+++.+||+.||++||+++++++ ||....
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 111111568899999999999999999999999984 887654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=290.12 Aligned_cols=220 Identities=14% Similarity=0.092 Sum_probs=165.3
Q ss_pred CeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCC-cc------------------
Q psy6593 127 GLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHH-HN------------------ 159 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h-~~------------------ 159 (433)
.+...+.+|+|+||+||++. +|+.+++.++| .|
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 36667789999999999732 67888888876 21
Q ss_pred ---eeeEEEEEEe-----CCeeeEEEeccCCCCHHHHhc------CCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 160 ---VIRFIGVLYK-----DRKLNLVTEYIAGGTLKELLQ------DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 160 ---iv~~~~~~~~-----~~~~~lv~e~~~g~sL~~~l~------~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
...+..++.. ...++++|+++ +++|.++++ ..+..+++..++.++.||+.||+|||+.||+||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 1112222222 22467888877 689999984 33456888899999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCcccccccee----------cCC
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMM----------TGQ 295 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~ 295 (433)
||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+.
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~------------------------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~ 292 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS------------------------AVSPIG-RGFAPPETTAERMLPFGQHHPT 292 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE------------------------ECCCCC-TTTCCHHHHHHHTSTTGGGCCE
T ss_pred ccceEEEecCCeEEEEeccceeecCCc------------------------cccCCC-CceeCchhhhccccccccccCc
Confidence 999999999999999999998764322 114567 999999999 555
Q ss_pred CCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HH
Q psy6593 296 EYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VW 373 (433)
Q Consensus 296 ~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~ 373 (433)
.++.++||||||+++|||++|.+||........ .. ........+|+.+.+||.+||+.||++||++.+++ .|
T Consensus 293 ~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~----~~--~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~ 366 (413)
T 3dzo_A 293 LMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG----SE--WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 366 (413)
T ss_dssp EECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSC----SG--GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCCcchhhh----HH--HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 688899999999999999999988865332211 11 11112357889999999999999999999998887 35
Q ss_pred HHhhc
Q psy6593 374 LEGLS 378 (433)
Q Consensus 374 l~~~~ 378 (433)
++.+.
T Consensus 367 ~~~~~ 371 (413)
T 3dzo_A 367 YEQLR 371 (413)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 66544
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-35 Score=278.98 Aligned_cols=191 Identities=18% Similarity=0.189 Sum_probs=145.6
Q ss_pred chHHHHhhcC---------CcceeeEEEEEE------------------------------eCCeeeEEEeccCCCCHHH
Q psy6593 147 GQVAVLRSLH---------HHNVIRFIGVLY------------------------------KDRKLNLVTEYIAGGTLKE 187 (433)
Q Consensus 147 ~E~~~l~~l~---------h~~iv~~~~~~~------------------------------~~~~~~lv~e~~~g~sL~~ 187 (433)
+|+.+|+.++ |+||+++.+.+. .++..||||||+++|++.+
T Consensus 72 ~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~ 151 (336)
T 2vuw_A 72 PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLE 151 (336)
T ss_dssp HHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETG
T ss_pred HHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHH
Confidence 6888998886 788888777653 2678999999999997766
Q ss_pred HhcCCCCCCChHHHHHHHHHHHHHHhhhh-cCCccccCCCCcceEEccCC--------------------ceEEeccccc
Q psy6593 188 LLQDPGQPLPWGQRVNFARDIAAGMTYLH-SMNLIHRDLNSQNCLVREDK--------------------TVVVADFGLA 246 (433)
Q Consensus 188 ~l~~~~~~~~~~~~~~i~~qi~~~L~~lH-~~~i~H~dlkp~Nil~~~~~--------------------~~kl~Dfg~~ 246 (433)
.+.+ ..+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||++
T Consensus 152 ~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a 229 (336)
T 2vuw_A 152 QMRT--KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLS 229 (336)
T ss_dssp GGTT--TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTC
T ss_pred HHHh--cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeecccc
Confidence 6654 45899999999999999999999 99999999999999999887 8999999999
Q ss_pred hhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHH-HHHHhcCCCCCCCCCC
Q psy6593 247 RIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIV-LCEIIGRVPADPDYLP 325 (433)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i-l~ell~~~~~~~~~~~ 325 (433)
+..... ...||+.|+|||++.+.. +.++|||||+.+ .++++.|.+|+.....
T Consensus 230 ~~~~~~--------------------------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~ 282 (336)
T 2vuw_A 230 RLERDG--------------------------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW 282 (336)
T ss_dssp BEEETT--------------------------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH
T ss_pred EecCCC--------------------------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh
Confidence 865421 457999999999998766 889999998777 6667778777632100
Q ss_pred -----CCCC-CCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH
Q psy6593 326 -----RSPD-FGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371 (433)
Q Consensus 326 -----~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 371 (433)
.... ............+..+++++.+||.+||+.| |+++++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 283 LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 0000 0000000001112346788999999999976 888877
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-31 Score=270.73 Aligned_cols=144 Identities=13% Similarity=0.092 Sum_probs=110.5
Q ss_pred chHHHHhhc-CCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+++|+++ .|+||+++++++++++..||||||++|++|.+++++.+ +++.. +|+.||+.||+|+|++||+||||
T Consensus 290 ~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~GIIHRDI 365 (569)
T 4azs_A 290 NEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQGFWHDDV 365 (569)
T ss_dssp HHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHTTCEESCC
T ss_pred HHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHCCceeccC
Confidence 899999999 79999999999999999999999999999999998754 46654 58899999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+|||++.+|.+||+|||+++........ ..+.+||+.|+|||++.+ .+..++|+||
T Consensus 366 KPeNILL~~dg~vKL~DFGlAr~~~~~~~~---------------------~~t~vGTp~YmAPE~l~g-~~~~~~d~~s 423 (569)
T 4azs_A 366 RPWNVMVDARQHARLIDFGSIVTTPQDCSW---------------------PTNLVQSFFVFVNELFAE-NKSWNGFWRS 423 (569)
T ss_dssp CGGGEEECTTSCEEECCCTTEESCC---CC---------------------SHHHHHHHHHHHHHHC-------------
T ss_pred chHhEEECCCCCEEEeecccCeeCCCCCcc---------------------ccCceechhhccHHHhCC-CCCCcccccc
Confidence 999999999999999999999876443221 125689999999999987 4677899999
Q ss_pred hhHHHHHHhcC
Q psy6593 306 YGIVLCEIIGR 316 (433)
Q Consensus 306 lG~il~ell~~ 316 (433)
+|++++++.++
T Consensus 424 ~g~~~~~l~~~ 434 (569)
T 4azs_A 424 APVHPFNLPQP 434 (569)
T ss_dssp -----CCCCTT
T ss_pred cccchhhhccc
Confidence 99998877643
|
| >2xqn_T Testin, TESS; metal-binding protein, cytoskeleton, focal adhesion, acrosom; 2.62A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-26 Score=184.83 Aligned_cols=111 Identities=24% Similarity=0.448 Sum_probs=102.7
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeecccccccccccccccccccc--CCeEEec
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQNCGQMMS--GPVMVVG 78 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~C~~~i~--~~~~~~~ 78 (433)
.|++|++.+. +++.+.|+|+.||++||+|..|+++|++. |+.+||++||+.||.++|+++|.+|+++|. +.+|++.
T Consensus 5 ~C~~C~~~I~-~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~f~~~~g~~yC~~cy~~~~~~~C~~C~~~I~~~~~~~~a~ 83 (126)
T 2xqn_T 5 RCAGCDELIF-SNEYTQAENQNWHLKHFCCFDCDSILAGEIYVMVNDKPVCKPCYVKNHAVVCQGCHNAIDPEVQRVTYN 83 (126)
T ss_dssp BBTTTSSBCC-SSCEEEETTEEECGGGSBCTTTCCBCTTSEEEEETTEEEEHHHHHHHSCCBCTTTCSBCCTTSCEEEET
T ss_pred CCccCCCEeC-CceEEeeCCCCccCCCCCcCCCCCCCCcCEEEeECCEEechHHhCcCcCccCcccCCcCCcCceEEECC
Confidence 5899998776 57789999999999999999999999886 999999999999999999999999999998 4689999
Q ss_pred CcccC--CCCccccCCccccCCCCcccccCCccccccc
Q psy6593 79 DHKFH--PECFKCTSCSCCIGDGESYALVERSILCSAC 114 (433)
Q Consensus 79 ~~~~h--~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c 114 (433)
++.|| ++||+|..|+++|. |+.|++.++..+|..+
T Consensus 84 ~~~~H~~~~CF~C~~C~~~l~-~~~f~~~~~~~yC~~~ 120 (126)
T 2xqn_T 84 NFSWHASTECFLCSCCSKCLI-GQKFMPVEGMVFCSVE 120 (126)
T ss_dssp TEEEESSTTTSBCTTTCCBCT-TSEEEEETTEEESSHH
T ss_pred CCEeeCCCCCcCcCCCCCccC-CCeeEeECCEEcchHH
Confidence 99999 99999999999995 8889999999999843
|
| >2xjy_A Rhombotin-2; oncoprotein, T-cell leukemia, proto-oncogene, transcription, developmental protein; 2.40A {Homo sapiens} PDB: 2xjz_A | Back alignment and structure |
|---|
Probab=99.91 E-value=9e-26 Score=183.84 Aligned_cols=114 Identities=25% Similarity=0.490 Sum_probs=104.5
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccC--Cc-eEeeCCeeeecccccccccc--ccccccccccC--Ce
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLD--NW-YFEKDGLLFCKEDYNGKYGE--ACQNCGQMMSG--PV 74 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~--~~-~~~~~~~~~C~~~~~~~~~~--~C~~C~~~i~~--~~ 74 (433)
.|++|++.+. +++.|.|+|+.||++||+|+.|+++|+ +. |+.++|++||+.||.++|++ +|..|+++|.+ .+
T Consensus 4 ~C~~C~~~I~-~~~~~~a~~~~wH~~CF~C~~C~~~L~~~~~~~~~~~g~~yC~~~y~~~~~~~~~C~~C~~~I~~~e~~ 82 (131)
T 2xjy_A 4 TCGGCQQNIG-DRYFLKAIDQYWHEDCLSCDLCGCRLGEVGRRLYYKLGRKLCRRDYLRLFGQDGLCASCDKRIRAYEMT 82 (131)
T ss_dssp BBTTTCCBCC-SSEEEEETTEEEETTTCBCTTTCCBCSSTTCCEEEETTEEECHHHHHHHHCCCEECTTTCCEECTTSEE
T ss_pred cCcCCCCEeC-CcEEEEECCCcccHHHcccCcCCCccccCCCeEEEECCEEeecCchhhhCCCccChhhcCCccCcccee
Confidence 5899999876 555799999999999999999999996 34 99999999999999999999 99999999975 48
Q ss_pred EEecCcccCCCCccccCCccccCCCCcccccCCccccccccc
Q psy6593 75 MVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDV 116 (433)
Q Consensus 75 ~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~ 116 (433)
|++.++.||++||+|..|++.|..|+.|++.++..+|..|+.
T Consensus 83 ~~a~~~~~H~~CF~C~~C~~~L~~g~~f~~~~~~~~C~~c~~ 124 (131)
T 2xjy_A 83 MRVKDKVYHLECFKCAACQKHFCVGDRYLLINSDIVCEQDIY 124 (131)
T ss_dssp EEETTEEEEGGGCBCTTTCCBCCTTCEEEEETTEEEEGGGHH
T ss_pred EeeCCceECccCcccCCCCCCCCCCCEEEEECCEEEcHHHHH
Confidence 899999999999999999999987888999999999999875
|
| >2rgt_A Fusion of LIM/homeobox protein LHX3, linker, INSU enhancer protein ISL-1; protein-protein complex, LIM domain, Zn finger, activator, D binding; 2.05A {Mus musculus} PDB: 3mmk_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-25 Score=188.00 Aligned_cols=116 Identities=22% Similarity=0.459 Sum_probs=104.0
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCceEeeCCeeeeccccccccccccccccccccCC--eEEecC
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQNCGQMMSGP--VMVVGD 79 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~~~~~~~~~~C~~~~~~~~~~~C~~C~~~i~~~--~~~~~~ 79 (433)
.|++|++.+. +++.|.|+|+.||+.||+|..|+++|++.+|.+||++||+.||.++|+++|.+|+++|.+. ++++.+
T Consensus 8 ~C~~C~~~I~-~~~~~~a~~~~wH~~CF~C~~C~~~L~~~~f~~~g~~yC~~~y~~~f~~~C~~C~~~I~~~~~v~~a~~ 86 (169)
T 2rgt_A 8 MCAGCDQHIL-DRFILKALDRHWHSKCLKCSDCHVPLAERCFSRGESVYCKDDFFKRFGTKCAACQLGIPPTQVVRRAQD 86 (169)
T ss_dssp BBSSSSSBCC-SSSCEECSSCEECTTTSBCTTTCCBCCSCCEESSSCEECHHHHHHHHSCBCTTTCCBCCTTSEEEEETT
T ss_pred ccccCCCccC-CcEEEEECCcEEccccCccCCCCCcCCCCCcccCCeeeecccccccccccccccccccCCCcEEEEcCC
Confidence 6999999876 5667899999999999999999999988867899999999999999999999999999764 678999
Q ss_pred cccCCCCccccCCccccCCCCccc-ccCCccccccccccc
Q psy6593 80 HKFHPECFKCTSCSCCIGDGESYA-LVERSILCSACDVML 118 (433)
Q Consensus 80 ~~~h~~cf~C~~C~~~l~~g~~~~-~~~~~~~C~~c~~~l 118 (433)
..||++||+|..|++.|..|+.|+ ..++..+|..|+..+
T Consensus 87 ~~~H~~CF~C~~C~~~L~~g~~f~~~~~g~~~C~~c~~~~ 126 (169)
T 2rgt_A 87 FVYHLHCFACVVCKRQLATGDEFYLMEDSRLVCKADYETA 126 (169)
T ss_dssp EEEEGGGCBCTTTCCBCCTTCEEEECTTSCEEEHHHHHHH
T ss_pred ceEeeCCCcCCCCCCCCCCCCceEEccCCeEECHHHHHHH
Confidence 999999999999999998788775 457889999998643
|
| >2jtn_A LIM domain-binding protein 1, LIM/homeobox protein LHX3; intramolecular (fusion) protein-protein complex, protein binding/transcription complex; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.5e-25 Score=189.84 Aligned_cols=115 Identities=22% Similarity=0.466 Sum_probs=102.8
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCceEeeCCeeeeccccccccccccccccccccCC--eEEecC
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQNCGQMMSGP--VMVVGD 79 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~~~~~~~~~~C~~~~~~~~~~~C~~C~~~i~~~--~~~~~~ 79 (433)
.|++|++.+. +.+.+.|+|+.||+.||+|..|+++|.+.+|.++|++||+.||.++|+++|.+|+++|.+. ++.+.+
T Consensus 62 ~C~~C~~~I~-~~~~~~a~~~~wH~~CF~C~~C~~~L~~~~f~~~g~~yC~~~y~~~f~~kC~~C~~~I~~~~~v~~a~~ 140 (182)
T 2jtn_A 62 MCAGCDQHIL-DRFILKALDRHWHSKCLKCSDCHVPLAERCFSRGESVYCKDDFFKRFGTKCAACQLGIPPTQVVRRAQD 140 (182)
T ss_dssp BCBTSSSBCC-CSEEEEETTEEECSSTTSCTTTCCCCSSCCEEETTEEECHHHHHHTTSCCCTTTCCCCCSSCCCCEETT
T ss_pred cCccCCCCcc-CceeEEecCCeEccccCccCCCCCccCCCceeECCEeeecCccccccccccccCCCccCCCceEEecCC
Confidence 5899999776 4557899999999999999999999988866899999999999999999999999999754 678999
Q ss_pred cccCCCCccccCCccccCCCCccc-ccCCcccccccccc
Q psy6593 80 HKFHPECFKCTSCSCCIGDGESYA-LVERSILCSACDVM 117 (433)
Q Consensus 80 ~~~h~~cf~C~~C~~~l~~g~~~~-~~~~~~~C~~c~~~ 117 (433)
..||++||+|..|++.|..|+.|+ ..++..+|..|+..
T Consensus 141 ~~~H~~CF~C~~C~~~L~~g~~f~~~~~g~~yC~~cy~~ 179 (182)
T 2jtn_A 141 FVYHLHCFACVVCKRQLATGDEFYLMEDSRLVCKADYET 179 (182)
T ss_dssp EECCTTTCCCTTTCCCCCTTCEEEECTTSCEECHHHHHH
T ss_pred CCEEeCCCcCCCCCCCCCCCCceEEccCCEEECHHHHHH
Confidence 999999999999999998788776 45788999998754
|
| >1rut_X Flinc4, fusion protein of LMO4 protein and LIM domain- binding protein 1; B-tandem zipper, protein binding; 1.30A {Mus musculus} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 g.39.1.3 PDB: 2dfy_X 2xjz_I 2xjy_B | Back alignment and structure |
|---|
Probab=99.90 E-value=6.2e-25 Score=189.86 Aligned_cols=115 Identities=23% Similarity=0.503 Sum_probs=105.1
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCC---ceEeeCCeeeecccccccccc--ccccccccccC--Ce
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDN---WYFEKDGLLFCKEDYNGKYGE--ACQNCGQMMSG--PV 74 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~---~~~~~~~~~~C~~~~~~~~~~--~C~~C~~~i~~--~~ 74 (433)
.|++|++.+. +.+.|.|+|+.||++||+|..|+++|.. .|+.++|++||+.||.++|++ +|..|+++|.+ .+
T Consensus 7 ~C~~C~~~I~-~~~~~~a~~~~wH~~CF~C~~C~~~L~~~g~~~~~~~g~~yC~~cy~~~~~~~~~C~~C~~~I~~~e~~ 85 (188)
T 1rut_X 7 RCAGCGGKIA-DRFLLYAMDSYWHSRCLKCSSCQAQLGDIGTSSYTKSGMILCRNDYIRLFGNSGACSACGQSIPASELV 85 (188)
T ss_dssp BBTTTCCBCC-CSEEEEETTEEECGGGCBCTTTCCBHHHHCSEEEEETTEEECHHHHHHHHSCCEECTTTCCEECTTSEE
T ss_pred cCccCCCEeC-CceeEEecCcEecccCcccCCCCcccccCCceEEEeCCccccccccccccccCCccccCCCccccCcEE
Confidence 5999998776 5557999999999999999999999974 499999999999999999999 79999999975 47
Q ss_pred EEecCcccCCCCccccCCccccCCCCcccccCCcccccccccc
Q psy6593 75 MVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 75 ~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
|++.++.||++||+|..|++.|..|+.|++.++..+|..|+..
T Consensus 86 i~a~~~~~H~~CF~C~~C~~~L~~g~~f~~~~g~~yC~~c~~~ 128 (188)
T 1rut_X 86 MRAQGNVYHLKCFTCSTCRNRLVPGDRFHYINGSLFCEHDRPT 128 (188)
T ss_dssp EEETTEEECGGGCBCTTTCCBCCTTCEEEEETTEEEEGGGCCT
T ss_pred EEcCCCEEeCCCCeECCCCCCCCCCCeEEEECCeEECHHHHHH
Confidence 8999999999999999999999878889999999999999853
|
| >2cup_A Skeletal muscle LIM-protein 1; four and half LIM domains protein 1, LIM domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-24 Score=167.15 Aligned_cols=92 Identities=15% Similarity=0.260 Sum_probs=86.6
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeecccccccccccccccccccc--CCeEEec
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQNCGQMMS--GPVMVVG 78 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~C~~~i~--~~~~~~~ 78 (433)
.|.+|++.+..+++.|.|+|+.||+.||+|..|+++|.+. |+.++|++||+.||.++|+++|.+|+++|. +.+|+++
T Consensus 7 ~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~g~~yC~~cy~~~~~~~C~~C~~~I~~~~~~~~a~ 86 (101)
T 2cup_A 7 GCVECRKPIGADSKEVHYKNRFWHDTCFRCAKCLHPLANETFVAKDNKILCNKCTTREDSPKCKGCFKAIVAGDQNVEYK 86 (101)
T ss_dssp BCSSSCCBCCSSSCEEEETTEEEETTTCCCSSSCCCTTSSCCEEETTEEECHHHHTTCCCCBCSSSCCBCCSSSCEEESS
T ss_pred cCcccCCcccCCceEEEECccChhhcCCcccccCCCCCcCeeECcCCEEEChhHhhhhcCCccccCCCccccCCeEEEeC
Confidence 5899999887678999999999999999999999999776 999999999999999999999999999997 5689999
Q ss_pred CcccCCCCccccCCc
Q psy6593 79 DHKFHPECFKCTSCS 93 (433)
Q Consensus 79 ~~~~h~~cf~C~~C~ 93 (433)
++.||++||+|..|+
T Consensus 87 ~~~~H~~CF~C~~C~ 101 (101)
T 2cup_A 87 GTVWHKDCFSGPSSG 101 (101)
T ss_dssp SCEEETTTCCCTTCC
T ss_pred CcchHHhCCCCCCCC
Confidence 999999999999985
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.7e-25 Score=222.11 Aligned_cols=162 Identities=17% Similarity=0.200 Sum_probs=125.4
Q ss_pred eeccCCCcchhhhhc-------------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 131 CKEDYNGKYGEACQN-------------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 131 ~~~~~~g~fg~v~~~-------------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
.+.+++|+||+||+. .+|+++|++++||||+++..++...+..||||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~ 420 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY 420 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence 457899999999930 2799999999999999666666678888999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccc
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
++|++|.+++.+ ++.++.|++.||+|||+.||+||||||+|||++. .+||+|||+++..........
T Consensus 421 ~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~-- 487 (540)
T 3en9_A 421 INGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV-- 487 (540)
T ss_dssp CCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH--
T ss_pred CCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc--
Confidence 999999999875 5689999999999999999999999999999998 999999999987643211000
Q ss_pred cccchhhhhhhcccccceeeeccCccccccceecC--CCCCcccCeEehhHHHHHHhcCC
Q psy6593 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG--QEYDETVDVFSYGIVLCEIIGRV 317 (433)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~~~ 317 (433)
..........||+.|+|||++.. ..|+...|+||..+-..+.+...
T Consensus 488 ------------~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r 535 (540)
T 3en9_A 488 ------------DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERR 535 (540)
T ss_dssp ------------HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTC
T ss_pred ------------chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhc
Confidence 00001125679999999999987 66888899999888877776443
|
| >1b8t_A Protein (CRP1); LIM domain, muscle differentiation, contractIle; NMR {Gallus gallus} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 g.39.1.3 PDB: 1ibi_A 1qli_A 1cxx_A 1ctl_A 2o13_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-23 Score=180.31 Aligned_cols=114 Identities=23% Similarity=0.454 Sum_probs=101.6
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeeccccccccccc------------------
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEA------------------ 62 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~------------------ 62 (433)
.|.+|++.+. .++.|.|+|+.||+.||+|..|+++|.+. |+.++|++||+.||.++|+++
T Consensus 9 ~C~~C~~~I~-~~~~v~a~g~~wH~~CF~C~~C~~~L~~~~~~~~~g~~yC~~cy~~~f~~~c~~c~~~~g~~~~~~~~~ 87 (192)
T 1b8t_A 9 KCGVCQKAVY-FAEEVQCEGSSFHKSCFLCMVCKKNLDSTTVAVHGDEIYCKSCYGKKYGPKGKGKGMGAGTLSTDKGES 87 (192)
T ss_dssp ECTTTCCEEC-SSCCEEETTEEECTTTCBCTTTCCBCCSSSEEEETTEEEEHHHHHHHHSCCCCCCCCCCCCCCCCCCCC
T ss_pred cCccCCCeec-ceeEEEeCCceecCCCCcCcccCCcCCCCeeEecCCEeeChhhhHhhcCccccccccccccEecCCCcc
Confidence 4889999765 46678999999999999999999999887 999999999999999999886
Q ss_pred ------------------------------ccccccccc-CCeEEecCcccCCCCccccCCccccCCCCcccccCCcccc
Q psy6593 63 ------------------------------CQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILC 111 (433)
Q Consensus 63 ------------------------------C~~C~~~i~-~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C 111 (433)
|.+|+++|. +..+.+.++.||++||+|..|+.+|.. ..|+..++..+|
T Consensus 88 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~C~~C~~~I~~~~~v~a~~~~~H~~CF~C~~C~~~L~~-~~~~~~~g~~yC 166 (192)
T 1b8t_A 88 LGIKYEEGQSHRPTNPNASRMAQKVGGSDGCPRCGQAVYAAEKVIGAGKSWHKSCFRCAKCGKSLES-TTLADKDGEIYC 166 (192)
T ss_dssp CCCCCCCCCCCCCCCCCCCCCCCCCCCCEECTTTSCEECSSSCEEETTEEECTTTCBCTTTCCBCCS-SSEEEETTEEEE
T ss_pred cccccccccccCCCCcCccccccccCCCCcCCCCCCEecCcEEEecCCCccchhcCCccccCCCCCC-CcccccCCEEeC
Confidence 778999996 457789999999999999999999954 468899999999
Q ss_pred cccccc
Q psy6593 112 SACDVM 117 (433)
Q Consensus 112 ~~c~~~ 117 (433)
..|+..
T Consensus 167 ~~cy~~ 172 (192)
T 1b8t_A 167 KGCYAK 172 (192)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999864
|
| >1m3v_A FLIN4, fusion of the LIM interacting domain of LDB1 and the N-terminal LIM domain of LMO4...; fusion protein, LMO proteins, metal binding protein; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.78 E-value=3.4e-20 Score=148.23 Aligned_cols=102 Identities=18% Similarity=0.224 Sum_probs=87.9
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccC--Cc-eEeeCCeeeecccccccccc--ccccccccccCCeEE
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLD--NW-YFEKDGLLFCKEDYNGKYGE--ACQNCGQMMSGPVMV 76 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~--~~-~~~~~~~~~C~~~~~~~~~~--~C~~C~~~i~~~~~~ 76 (433)
.|.+|++.+. +.+.|.|+|+.||+.||+|+.|+++|. +. |+.++|++||+.||.++|++ +|.+|+++|.+..+.
T Consensus 7 ~C~~C~~~I~-~~~~~~a~~~~wH~~CF~C~~C~~~L~~~~~~~~~~~g~~yC~~cy~~~f~~~~~C~~C~~~I~~~~~~ 85 (122)
T 1m3v_A 7 RCAGCGGKIA-DRFLLYAMDSYWHSRCLKCSSCQAQLGDIGTSSYTKSGMILCRNDYIRLFGNSGAGGSGGHMGSGGDVM 85 (122)
T ss_dssp CBSSSSSCCC-SSCCEEETTEEECHHHHCCSSSCCCTTTSEECCEEETTEEECHHHHHHHHCCCCSSSCSSCCSCCEESS
T ss_pred CCcccCCEeC-CcEEEEECCceeHhhCCCcCCCCCcccccCCeEEEECCeeecHHHHHHHcCCCCccccCCCCcCchheE
Confidence 6999999776 555799999999999999999999996 34 99999999999999999999 999999999876554
Q ss_pred ecCcccCCCCccccCCccccCCCCcccccCCccccccccccc
Q psy6593 77 VGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVML 118 (433)
Q Consensus 77 ~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~l 118 (433)
+.+ +++..|+.|+++++.++|..++...
T Consensus 86 ~~g--------------~~~l~g~~f~~~~~~~yC~~~~~~~ 113 (122)
T 1m3v_A 86 VVG--------------EPTLMGGEFGDEDERLITRLENTQF 113 (122)
T ss_dssp SSS--------------SSSCCSCTTCCTTCCCCEECTTTTT
T ss_pred EcC--------------CcCCCCCccEecCCEeEccCcchhc
Confidence 443 2344799999999999999998754
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.3e-19 Score=167.50 Aligned_cols=89 Identities=17% Similarity=0.186 Sum_probs=75.6
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+++|++++| +++.+++.. +..++||||++|++|.+ +.. .....++.|++.||.+||+.||+|||||
T Consensus 153 ~E~~~l~~l~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlk 220 (282)
T 1zar_A 153 NEFRALQKLQG---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLS 220 (282)
T ss_dssp HHHHHHHHTTT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHHHHhccC---CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCC
Confidence 79999999984 555555433 56799999999999998 422 2355799999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchh
Q psy6593 227 SQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
|+|||++ ++.++|+|||+++.
T Consensus 221 p~NILl~-~~~vkl~DFG~a~~ 241 (282)
T 1zar_A 221 QYNVLVS-EEGIWIIDFPQSVE 241 (282)
T ss_dssp TTSEEEE-TTEEEECCCTTCEE
T ss_pred HHHEEEE-CCcEEEEECCCCeE
Confidence 9999999 99999999999864
|
| >1j2o_A FLIN2, fusion of rhombotin-2 and LIM domain-binding protein 1; LIM-interaction-domain (LID), metal binding protein; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.74 E-value=5.9e-19 Score=139.20 Aligned_cols=98 Identities=16% Similarity=0.181 Sum_probs=83.7
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCC---ceEeeCCeeeeccccccccccccccccccccCCeEEec
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDN---WYFEKDGLLFCKEDYNGKYGEACQNCGQMMSGPVMVVG 78 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~---~~~~~~~~~~C~~~~~~~~~~~C~~C~~~i~~~~~~~~ 78 (433)
.|.+|++.+. +.+.|.|+|+.||+.||+|+.|+++|.. .|+.++|++||+.||.++|+++|..|.. +.+|.
T Consensus 5 ~C~~C~~~I~-~~~~~~a~~~~wH~~CF~C~~C~~~L~~~g~~~~~~~g~~yC~~~y~~~f~~~c~~c~~---~~~~~-- 78 (114)
T 1j2o_A 5 TCGGCQQNIG-DRYFLKAIDQYWHEDCLSCDLCGCRLGEVGRRLYYKLGRKLCRRDYLRLGGSGGHMGSG---GDVMV-- 78 (114)
T ss_dssp CBSSSCSCBC-SSEEEECSSSEECTTTCCCSSSCSCCCCSSSCCCCBTTBCCCHHHHHHHHTSCCSSCBS---CSCCC--
T ss_pred CCcCCCCeeC-CcEEEEECchhHHHhcCcccccCCchhcCCCeeEEECCeeechHHHHHHhCcccCcCCC---CceeE--
Confidence 5899999776 5568999999999999999999999963 4999999999999999999999999872 33332
Q ss_pred CcccCCCCccccCCccccCCCCcccccCCccccccccccc
Q psy6593 79 DHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVML 118 (433)
Q Consensus 79 ~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~l 118 (433)
|..++..|+.|++.++.++|..|+...
T Consensus 79 -------------~~~~~~~g~~f~~~~~~~~C~~~~~~~ 105 (114)
T 1j2o_A 79 -------------VGEPTLMGGEFGDEDERLITRLENTQF 105 (114)
T ss_dssp -------------SSCSSTTSSBCCCSSSCCCEEEECTTC
T ss_pred -------------cCCccCCCCeeEEcCCEeecchhhhcc
Confidence 456766899999999999999998653
|
| >1iml_A CRIP, cysteine rich intestinal protein; metal-binding protein, LIM domain protein; NMR {Rattus rattus} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.64 E-value=9.1e-17 Score=116.95 Aligned_cols=69 Identities=17% Similarity=0.183 Sum_probs=62.3
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeec-ccccccccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCK-EDYNGKYGEACQNCGQMMS 71 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~-~~~~~~~~~~C~~C~~~i~ 71 (433)
.|.+|++.+. .++.|.|+|+.||+.||+|..|+++|.+. |+.++|++||+ .||.++|+++|.+|++.+.
T Consensus 2 ~C~~C~~~I~-~~~~v~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~g~~yC~~~cy~~~f~~~C~~C~~~~~ 72 (76)
T 1iml_A 2 KCPKCDKEVY-FAERVTSLGKDWHRPCLKCEKCGKTLTSGGHAEHEGKPYCNHPCYSAMFGPKGFGRGGAES 72 (76)
T ss_dssp BCTTTSSBCC-GGGEEEETTEEEETTTCBCTTTCCBCCTTTEEEETTEEEETTTHHHHHSSCCCSSCCCSSS
T ss_pred cCCCCCCEEE-CceEEEECCccccCCCCCccccCccCCCCceECcCCeEeeCHHHHHHHhCccCCCcCCcee
Confidence 5899999765 46789999999999999999999999876 99999999999 6999999999999997654
|
| >1x68_A FHL5 protein; four-and-A-half LIM protein 5, zinc finger domain, AN actin- interacting protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.64 E-value=9.4e-17 Score=116.83 Aligned_cols=66 Identities=15% Similarity=0.136 Sum_probs=60.6
Q ss_pred CcCCCCCeeEe--eccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeecccccccccccccccc
Q psy6593 2 VFGTRSEVTSM--ENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQNCG 67 (433)
Q Consensus 2 ~~~~~~~~~~~--~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~C~ 67 (433)
.|.+|++.+.. +.+.|.|+|+.||++||+|..|+++|.+. |+.+++++||+.||.++|+++|+.++
T Consensus 7 ~C~~C~~~I~~~g~~~~~~a~~~~wH~~CF~C~~C~~~L~~~~f~~~~g~~yC~~cy~~~f~~~C~~~s 75 (76)
T 1x68_A 7 GCVACSKPISGLTGAKFICFQDSQWHSECFNCGKCSVSLVGKGFLTQNKEIFCQKCGSGMDTDISGPSS 75 (76)
T ss_dssp CCTTTCCCCCTTTTCCEEEETTEEEEGGGCBCTTTCCBCSSSCEEEETTEEEETTTTCCCCCCSSSSSC
T ss_pred CCccCCCcccCCCCceeEEECCcccCcccCChhhCCCcCCCCceEeECCEEECHHHhhhhhCCcCCCCC
Confidence 58999997764 45899999999999999999999999876 99999999999999999999999875
|
| >2dj7_A Actin-binding LIM protein 3; LIM domain, Zn binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.63 E-value=9.8e-17 Score=117.57 Aligned_cols=63 Identities=24% Similarity=0.479 Sum_probs=58.0
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCceEeeCCeeeecccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQN 65 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~~~~~~~~~~C~~~~~~~~~~~C~~ 65 (433)
.|.+|++.+. +++.|.|+++.||++||+|..|+++|++.|+.+|+++||+.||.++|+++|.+
T Consensus 17 ~C~~C~~~I~-~~~~v~a~~~~wH~~CF~C~~C~~~L~~~~~~~~g~~yC~~~y~~~fg~~C~~ 79 (80)
T 2dj7_A 17 HCAGCKEEIK-HGQSLLALDKQWHVSCFKCQTCSVILTGEYISKDGVPYCESDYHAQFGSGPSS 79 (80)
T ss_dssp CCTTTCCCCS-SSCCEEETTEEECTTTCBCSSSCCBCSSCCEEETTEEECTTHHHHHTTCCSTT
T ss_pred CCcCcCCeeC-CCeEEEECCcccccccCCcCcCCCCcCCCeEEECCEEECHHHHHHHcCCCCCC
Confidence 5899998765 56789999999999999999999999878999999999999999999999974
|
| >1a7i_A QCRP2 (LIM1); LIM domain containing proteins, metal-binding protein, zinc finger; NMR {Coturnix japonica} SCOP: g.39.1.3 g.39.1.3 PDB: 2o10_A | Back alignment and structure |
|---|
Probab=99.63 E-value=6.3e-17 Score=119.39 Aligned_cols=68 Identities=25% Similarity=0.286 Sum_probs=53.4
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeeccccccccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQNCGQMM 70 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~C~~~i 70 (433)
.|.+|++.+. +++.|.|+|+.||+.||+|..|+++|.+. |+.+++++||+.||.++|+++|.+|++..
T Consensus 9 ~C~~C~~~I~-~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~~~~yC~~cy~~~f~~~c~gcg~g~ 77 (81)
T 1a7i_A 9 KCGACGRTVY-HAEEVQCDGRSFHRCCFLCMVCRKNLDSTTVAIHDAEVYCKSCYGKKYGPKGYGYGQGA 77 (81)
T ss_dssp BCSSSCCBCS-STTEEEETTEEEESSSEECSSSCCEECSSCCEEETTEEECSHHHHHHCC----------
T ss_pred cCcCcCcccc-CceeEEeCCcccccccCccCCCCCCCCCCCeEeeCCEEECHHHHHHHhCCcccccCCcc
Confidence 5889998764 56789999999999999999999999877 99999999999999999999999999875
|
| >2egq_A FHL1 protein; LIM domain, four and A half LIM domains protein 1, skeletal muscle LIM- protein 1, SLIM 1, structural genomics NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.4e-16 Score=116.38 Aligned_cols=70 Identities=19% Similarity=0.557 Sum_probs=64.7
Q ss_pred CCeeeeccccccccccccccccccccC-----CeEEecCcccCCCCccccCCccccCCCCcccccCCccccccccc
Q psy6593 46 DGLLFCKEDYNGKYGEACQNCGQMMSG-----PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDV 116 (433)
Q Consensus 46 ~~~~~C~~~~~~~~~~~C~~C~~~i~~-----~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~ 116 (433)
++++||+.||.++|+++|.+|+++|.+ ..|.+.++.||++||+|..|+++|. +..|+..++.++|..|+.
T Consensus 1 g~~~yC~~cy~~~~~~~C~~C~~~I~~~g~~~~~~~a~~~~~H~~CF~C~~C~~~L~-~~~f~~~~~~~yC~~cy~ 75 (77)
T 2egq_A 1 GSSGSSGDCYKNFVAKKCAGCKNPITGFGKGSSVVAYEGQSWHDYCFHCKKCSVNLA-NKRFVFHQEQVYCPDCAK 75 (77)
T ss_dssp CCSSCCTTCCCSCCCCCCSSSCCCCCCCSSCCCEEEETTEEEETTTCBCSSSCCBCT-TSCCCEETTEECCHHHHH
T ss_pred CCCeEchhHhchhhCccCcccCCcccCCCCCceeEEECcceeCcccCEehhcCCCCC-CCccEeECCEEEChHHhc
Confidence 478999999999999999999999986 6899999999999999999999995 678999999999998874
|
| >2ehe_A Four and A half LIM domains 3; FHL-3, skeletal muscle LIM- protein 2, SLIM 2, FHL3, SLIM2, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.8e-16 Score=116.20 Aligned_cols=71 Identities=21% Similarity=0.620 Sum_probs=65.1
Q ss_pred CCeeeecccccccccccccccccccc--CCeEEecCcccCCCCccccCCccccCCCCcccccCCcccccccccc
Q psy6593 46 DGLLFCKEDYNGKYGEACQNCGQMMS--GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 46 ~~~~~C~~~~~~~~~~~C~~C~~~i~--~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
+|++||+.||.++|+++|.+|+++|. +.+|.+.++.||++||+|..|+++|. +..|+..++.++|..|+..
T Consensus 1 ~g~~yC~~~y~~~~~~~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~-~~~f~~~~~~~~C~~c~~~ 73 (82)
T 2ehe_A 1 GSSGSSGPCYDNTFANTCAECQQLIGHDSRELFYEDRHFHEGCFRCCRCQRSLA-DEPFTCQDSELLCNDCYCS 73 (82)
T ss_dssp CCCCCCCCCCCCCCSCBCTTTCCBCCSSCCBCCCSSCCCBTTTSBCTTTCCBCS-SCCEEEETTEEEETTTSSC
T ss_pred CCceechhHhCcccCCcCccCCCccccCcEEEEeCCccccccCCeecCCCCccC-CCccEeeCCEEECHHHHhh
Confidence 68999999999999999999999998 66889999999999999999999995 6678899999999988754
|
| >1x6a_A LIMK-2, LIM domain kinase 2; LIM-kinase 2, zinc finger domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.61 E-value=2e-16 Score=116.66 Aligned_cols=71 Identities=44% Similarity=0.985 Sum_probs=65.9
Q ss_pred CCeeeeccccccccccccccccccccCCeEEecCcccCCCCccccCCccccCCCCcccc-cCCccccccccc
Q psy6593 46 DGLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYAL-VERSILCSACDV 116 (433)
Q Consensus 46 ~~~~~C~~~~~~~~~~~C~~C~~~i~~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~-~~~~~~C~~c~~ 116 (433)
++.+||+.||.++|+++|.+|+++|.+..|++.++.||++||+|..|++.|..|..|.+ .++.++|..|+.
T Consensus 1 g~~~yC~~~y~~~~~~~C~~C~~~I~~~~~~a~~~~~H~~CF~C~~C~~~L~~g~~f~~~~~~~~~C~~c~~ 72 (81)
T 1x6a_A 1 GSSGSSGKDYWGKFGEFCHGCSLLMTGPFMVAGEFKYHPECFACMSCKVIIEDGDAYALVQHATLYCGKCHN 72 (81)
T ss_dssp CCCCCCCCCSSCCSSCBCTTTCCBCCSCCBCCTTCCBCTTSCBCTTTCCBCCTTSCEEECSSSCEEEHHHHH
T ss_pred CCCccchhHHhhhcCCcCccCCCCcCceEEEECCceeccccCCccCCCCccCCCCcEEEeeCCEEECHHHHH
Confidence 46899999999999999999999999999999999999999999999999988888884 888999998875
|
| >1wyh_A SLIM 2, skeletal muscle LIM-protein 2; structural genomics, riken structural genomics/proteomics initiative, RSGI, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.59 E-value=3.7e-16 Score=112.52 Aligned_cols=64 Identities=16% Similarity=0.270 Sum_probs=59.0
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeecccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQN 65 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~ 65 (433)
.|.+|++.+...++.|.|+|+.||+.||+|..|+++|.+. |+.+++++||+.||.++|+++|+.
T Consensus 7 ~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~~~~yC~~cy~~~f~~~C~~ 71 (72)
T 1wyh_A 7 GCSACGETVMPGSRKLEYGGQTWHEHCFLCSGCEQPLGSRSFVPDKGAHYCVPCYENKFASGPSS 71 (72)
T ss_dssp BCSSSCCBCCSSSCEECSTTCCEETTTCBCTTTCCBTTTSCEEEETTEEEEHHHHHHHTSCCCCC
T ss_pred CCccCCCccccCccEEEECccccCcccCeECCCCCcCCCCccCCcCCeEECHHHHHHHccCcCCC
Confidence 5899999877557899999999999999999999999876 999999999999999999999964
|
| >1v6g_A Actin binding LIM protein 2; LIM domain, zinc binding domain, ablim2, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.59 E-value=5.7e-16 Score=114.21 Aligned_cols=72 Identities=25% Similarity=0.637 Sum_probs=64.7
Q ss_pred CeeeeccccccccccccccccccccCCeEEecCcccCCCCccccCCccccCCCCcccccCCccccccccccc
Q psy6593 47 GLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVML 118 (433)
Q Consensus 47 ~~~~C~~~~~~~~~~~C~~C~~~i~~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~l 118 (433)
+.+||+.||.++|+++|.+|+++|.+..|++.++.||++||+|..|+++|..+..|.......+|..|+..+
T Consensus 2 ~~~yC~~dy~~~~~~~C~~C~~~I~~~~v~a~~~~wH~~CF~C~~C~~~L~~~~~~~~~~~~~~C~~C~~~~ 73 (81)
T 1v6g_A 2 SSGSSGLDYQRLYGTRCFSCDQFIEGEVVSALGKTYHPDCFVCAVCRLPFPPGDRVTFNGKECMCQKCSLPV 73 (81)
T ss_dssp CCCCCCSCGGGSCCCBCTTTCCBCCSCCEEETTEEECTTTSSCSSSCCCCCSSSCEEEETTEEEEHHHHSCC
T ss_pred CCCcchHHHHhHhCCcCccccCEeccceEEECCceeCccCCccccCCCCCCCCCEEEeCCCCEEChhhhccc
Confidence 568999999999999999999999999999999999999999999999998777776666667899998654
|
| >2cuq_A Four and A half LIM domains 3; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.58 E-value=5.2e-16 Score=114.21 Aligned_cols=71 Identities=21% Similarity=0.497 Sum_probs=65.9
Q ss_pred CCeeeeccccccccccccccccccccCCeEEecCcccCCCCccccCCccccCCCCcccccCCcccccccccc
Q psy6593 46 DGLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 46 ~~~~~C~~~~~~~~~~~C~~C~~~i~~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
+|++||+.||.++|+++|.+|+++|.+..|++.++.||++||+|..|+++| .+..|+..++.++|..|+..
T Consensus 1 gg~~yC~~cy~~~~~~~C~~C~~~I~~~~v~a~~~~~H~~CF~C~~C~~~L-~~~~~~~~~~~~yC~~cy~~ 71 (80)
T 2cuq_A 1 GSSGSSGPCYENKFAPRCARCSKTLTQGGVTYRDQPWHRECLVCTGCQTPL-AGQQFTSRDEDPYCVACFGE 71 (80)
T ss_dssp CCCCSCCCCCCCCSSCCCTTTCCCCCSCCEESSSSEECTTTCBCSSSCCBC-TTCCEEECSSSEEEHHHHHH
T ss_pred CCcEEcHHHHccccCCcCCCCCCEecCcEEEECCchhhhhhCCcccCCCcC-CCCeeEeECCEEECHHHHHH
Confidence 589999999999999999999999998999999999999999999999999 56789999999999888753
|
| >2cur_A Skeletal muscle LIM-protein 1; four and A half LIM domains protein 1, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.58 E-value=4.8e-16 Score=110.81 Aligned_cols=62 Identities=8% Similarity=0.137 Sum_probs=57.0
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeecccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQN 65 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~ 65 (433)
.|.+|++.+. ++.|.|+|+.||+.||+|..|+++|.+. |+.+++++||+.||.++|+++|.+
T Consensus 7 ~C~~C~~~I~--~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~~~~yC~~cy~~~f~~~C~g 69 (69)
T 2cur_A 7 GCVKCNKAIT--SGGITYQDQPWHADCFVCVTCSKKLAGQRFTAVEDQYYCVDCYKNFVSGPSSG 69 (69)
T ss_dssp CCSSSCCCCC--TTCEEETTEEECTTTTBCTTTCCBCTTSCEEECSSCEEEHHHHHHHHTCSCCC
T ss_pred CCcccCCEeC--cceEEECccccccCcCEECCCCCCCCCCccEeECCEEECHHHhHHHhcCCCCC
Confidence 5899998764 6789999999999999999999999776 999999999999999999999974
|
| >2dar_A PDZ and LIM domain protein 5; enigma homolog protein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.58 E-value=5.1e-16 Score=116.87 Aligned_cols=62 Identities=18% Similarity=0.294 Sum_probs=57.4
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeecccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQN 65 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~ 65 (433)
.|.+|++.+ .++.|.|+|+.||++||+|..|+++|.+. |+.+++++||+.||.++|+++|..
T Consensus 27 ~C~~C~~~I--~~~~v~a~~~~~H~~CF~C~~C~~~L~~~~f~~~~g~~yC~~cy~~~f~~~c~s 89 (90)
T 2dar_A 27 MCAHCNQVI--RGPFLVALGKSWHPEEFNCAHCKNTMAYIGFVEEKGALYCELCYEKFFASGPSS 89 (90)
T ss_dssp BBSSSCCBC--CSCEEEETTEEECTTTCBCSSSCCBCSSSCBEESSSCEECHHHHHHHTSCCCCC
T ss_pred CCccCCCEe--cceEEEECCccccccCCccCCCCCCCCCCEeEeECCEEECHHHHHHHcCCCCCC
Confidence 599999976 57899999999999999999999999876 999999999999999999999963
|
| >1x4k_A Skeletal muscle LIM-protein 3; LIM domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.58 E-value=5.8e-16 Score=111.47 Aligned_cols=64 Identities=13% Similarity=0.139 Sum_probs=58.8
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeecccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQN 65 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~ 65 (433)
.|.+|++.+...+..|.|+|+.||+.||+|..|+++|.+. |+.+++++||+.||.++|+++|..
T Consensus 7 ~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~~~~yC~~cy~~~f~~~C~~ 71 (72)
T 1x4k_A 7 GCQECKKTIMPGTRKMEYKGSSWHETCFICHRCQQPIGTKSFIPKDNQNFCVPCYEKQHASGPSS 71 (72)
T ss_dssp CBSSSCCCCCSSSCEEEETTEEEETTTTCCSSSCCCCCSSSEEEETTEEEEHHHHHHHTSSCCCC
T ss_pred CCccCCCcccCCceEEEECcCeecccCCcccccCCccCCCccCccCCeEECHHHHhHHhCCCCCC
Confidence 5899999877556799999999999999999999999876 999999999999999999999963
|
| >1x4l_A Skeletal muscle LIM-protein 3; LIM domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.57 E-value=6.3e-16 Score=111.21 Aligned_cols=63 Identities=13% Similarity=0.142 Sum_probs=57.5
Q ss_pred CcCCCCCeeEe--eccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeeccccccccccccc
Q psy6593 2 VFGTRSEVTSM--ENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQ 64 (433)
Q Consensus 2 ~~~~~~~~~~~--~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~ 64 (433)
.|.+|++.+.. +++.|.|+|+.||++||+|..|+++|.+. |+.+++++||+.||.++|+|++.
T Consensus 7 ~C~~C~~~I~~~~~~~~~~a~~~~wH~~CF~C~~C~~~L~~~~f~~~~g~~yC~~c~~~~~~p~~g 72 (72)
T 1x4l_A 7 GCAGCTNPISGLGGTKYISFEERQWHNDCFNCKKCSLSLVGRGFLTERDDILCPDCGKDISGPSSG 72 (72)
T ss_dssp SBTTTTBCCCCSSSCSCEECSSCEECTTTCBCSSSCCBCTTSCCEECSSSEECHHHHHTCCCSSCC
T ss_pred CCcCCCccccCCCCcceEEECCcccCcccCEeccCCCcCCCCccEeECCEEEChhHcCcccCCCCC
Confidence 58999997775 56899999999999999999999999877 99999999999999999999873
|
| >1x3h_A Leupaxin; paxillin family, protein-protein interaction, LIM domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.57 E-value=1e-15 Score=112.58 Aligned_cols=70 Identities=20% Similarity=0.457 Sum_probs=64.4
Q ss_pred CCeeeeccccccccccccccccccccCCeEEecCcccCCCCccccCCccccCCCCcccccCCccccccccc
Q psy6593 46 DGLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDV 116 (433)
Q Consensus 46 ~~~~~C~~~~~~~~~~~C~~C~~~i~~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~ 116 (433)
+|++||+.||.++|+++|.+|+++|.+..|++.++.||++||+|..|+++|..+ .|+..++.++|..|+.
T Consensus 1 gg~~yC~~~y~~~~~~~C~~C~~~I~~~~v~a~~~~~H~~CF~C~~C~~~L~~~-~~~~~~~~~yC~~~y~ 70 (80)
T 1x3h_A 1 GSSGSSGKDFLAMFSPKCGGCNRPVLENYLSAMDTVWHPECFVCGDCFTSFSTG-SFFELDGRPFCELHYH 70 (80)
T ss_dssp CCCCCCCCCCCCCCSCBCTTTCCBCCSSCEEETTEEECTTTCBCSSSCCBSCSS-CCEESSSCEECHHHHH
T ss_pred CCCccchhHHhhhcCCccccCCCeecceeEEECCCeEecCcCChhhCCCCCCCC-cEEeECCEEECHHHHH
Confidence 578999999999999999999999999999999999999999999999999654 6888899999988875
|
| >1g47_A Pinch protein; LIM domain, Zn finger, cell adhesion; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.57 E-value=5.6e-16 Score=113.17 Aligned_cols=63 Identities=10% Similarity=0.114 Sum_probs=56.8
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeeccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQ 64 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~ 64 (433)
.|.+|++.+...+..+.|+|+.||+.||+|..|+++|.+. |+.++|++||+.||.++|+++|.
T Consensus 13 ~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~g~~yC~~~y~~~f~~~C~ 76 (77)
T 1g47_A 13 TCERCKGGFAPAEKIVNSNGELYHEQCFVCAQCFQQFPEGLFYEFEGRKYCEHDFQMLFAPCWI 76 (77)
T ss_dssp BCSSSCCBCCSTTTCEEETTEEECTTTCCCTTTCCCCGGGCSEEETTEEECHHHHHHHCCCC--
T ss_pred CchhcCCccCCCceEEEeCccEeccccCeECCCCCCCCCCCeEeECCeEeCHHHHHHHhhcccC
Confidence 5899999877667788999999999999999999999776 99999999999999999999995
|
| >2cu8_A Cysteine-rich protein 2; CRP2, CRIP2, ESP1 protein, zinc-binding, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.57 E-value=9e-16 Score=111.64 Aligned_cols=63 Identities=21% Similarity=0.268 Sum_probs=57.3
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeec-ccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCK-EDYNGKYGEACQN 65 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~-~~~~~~~~~~C~~ 65 (433)
.|.+|++.+. .++.|.|+|+.||+.||+|..|+++|.+. |+.+++++||+ .||.++|+++|.+
T Consensus 11 ~C~~C~~~I~-~~~~v~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~g~~yC~~~cy~~~f~~kc~g 75 (76)
T 2cu8_A 11 KCPKCDKTVY-FAEKVSSLGKDWHKFCLKCERCSKTLTPGGHAEHDGKPFCHKPCYATLFGSGPSS 75 (76)
T ss_dssp BCTTTCCBCC-TTTEEEETTEEEETTTCBCSSSCCBCCTTSCEEETTEEECTTTHHHHHSCSSCSC
T ss_pred CCcCCCCEeE-CCeEEEECCeEeeCCCCCCCCCCCccCCCceEeECCEEecchHHHHHhcccccCC
Confidence 5889998765 46789999999999999999999999876 99999999999 7999999999974
|
| >2ehe_A Four and A half LIM domains 3; FHL-3, skeletal muscle LIM- protein 2, SLIM 2, FHL3, SLIM2, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=2.1e-15 Score=111.47 Aligned_cols=64 Identities=14% Similarity=0.238 Sum_probs=58.9
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeecccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQN 65 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~ 65 (433)
.|.+|+..+.-++..|.|+|+.||+.||+|+.|+++|++. |+.+++++||+.||.++|+++|+.
T Consensus 17 ~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~f~~~~~~~~C~~c~~~~~~~~C~~ 81 (82)
T 2ehe_A 17 TCAECQQLIGHDSRELFYEDRHFHEGCFRCCRCQRSLADEPFTCQDSELLCNDCYCSAFSSGPSS 81 (82)
T ss_dssp BCTTTCCBCCSSCCBCCCSSCCCBTTTSBCTTTCCBCSSCCEEEETTEEEETTTSSCCGGGSSCC
T ss_pred cCccCCCccccCcEEEEeCCccccccCCeecCCCCccCCCccEeeCCEEECHHHHhhhcCCCCCC
Confidence 4889998776668899999999999999999999999876 999999999999999999999974
|
| >2d8z_A Four and A half LIM domains 2; skeletal muscle LIM-protein 3, LIM-domain protein DRAL, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.55 E-value=9e-16 Score=109.79 Aligned_cols=62 Identities=11% Similarity=0.186 Sum_probs=56.6
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeecccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQN 65 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~ 65 (433)
.|.+|++.+. ++.|.|+|+.||+.||+|..|+++|.+. |+.+++++||+.||.++|+++|.+
T Consensus 7 ~C~~C~~~I~--~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~~~~yC~~cy~~~f~~~c~~ 69 (70)
T 2d8z_A 7 GCVQCKKPIT--TGGVTYREQPWHKECFVCTACRKQLSGQRFTARDDFAYCLNCFCDLYASGPSS 69 (70)
T ss_dssp BCSSSCCBCC--SSEEESSSSEEETTTSBCSSSCCBCTTSCCEESSSSEECHHHHHHHTCCCCTT
T ss_pred CCcccCCeec--cceEEECccccCCCCCccCCCCCcCCcCceEeeCCeEECHHHHHHHhccccCC
Confidence 5899998764 5679999999999999999999999776 999999999999999999999964
|
| >1nyp_A Pinch protein; LIM domain, protein recognition, cell adhesion; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 PDB: 1u5s_B | Back alignment and structure |
|---|
Probab=99.55 E-value=1.1e-15 Score=107.85 Aligned_cols=59 Identities=17% Similarity=0.425 Sum_probs=54.6
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeeccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEA 62 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~ 62 (433)
.|.+|++.+. ++.|.|+|+.||+.||+|..|+++|.+. |+.++|++||+.||.++|++|
T Consensus 7 ~C~~C~~~I~--~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~g~~yC~~~y~~~f~~k 66 (66)
T 1nyp_A 7 ICGACRRPIE--GRVVNAMGKQWHVEHFVCAKCEKPFLGHRHYERKGLAYCETHYNQLFGDV 66 (66)
T ss_dssp EETTTTEECC--SCEECCTTSBEETTTCBCTTTCCBCSSSCCEEETTEEECHHHHHHHCSCC
T ss_pred CCcccCCEec--ceEEEECccccccCcCEECCCCCCCCCCceEeECCcEECHHHHHHHhCCC
Confidence 5889998776 7789999999999999999999999876 999999999999999999986
|
| >2cor_A Pinch protein; LIM domain, particularly interesting NEW Cys- His protein, LIM and senescent cell antigen-like domains 1, structural genomics; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.54 E-value=2.2e-15 Score=110.21 Aligned_cols=61 Identities=15% Similarity=0.094 Sum_probs=55.9
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCceEeeCCeeeeccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQ 64 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~~~~~~~~~~C~~~~~~~~~~~C~ 64 (433)
.|.+|++.+. ++.|.|+|+.||++||+|..|+++|.+.+|.++|++||+.||.++|+|++.
T Consensus 17 ~C~~C~~~I~--~~~v~a~~~~~H~~CF~C~~C~~~L~~~~f~~~g~~yC~~cy~~~f~p~~s 77 (79)
T 2cor_A 17 ICQKCHAIID--EQPLIFKNDPYHPDHFNCANCGKELTADARELKGELYCLPCHDKMGVSGPS 77 (79)
T ss_dssp BCTTTCCBCC--SCCCCCSSSCCCTTTSBCSSSCCBCCTTCEEETTEEECHHHHHTTSCCSSC
T ss_pred CCccCCCEec--ceEEEECcceeCCCCCEeCCCCCccCCCCEeECCEEeCHHHHHHhCCCCCC
Confidence 5899998766 788999999999999999999999988767999999999999999999764
|
| >1x63_A Skeletal muscle LIM-protein 1; LIM domain, four and A half LIM domains protein 1, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.53 E-value=2.4e-15 Score=111.21 Aligned_cols=71 Identities=17% Similarity=0.399 Sum_probs=64.3
Q ss_pred CCeeeecccccccccccccccccccc--CCeEEecCcccCCCCccccCCccccCCCCcccccCCcccccccccc
Q psy6593 46 DGLLFCKEDYNGKYGEACQNCGQMMS--GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 46 ~~~~~C~~~~~~~~~~~C~~C~~~i~--~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
++.+||+.||.++|+++|.+|+++|. +.+|.+.++.||++||+|..|+++|.. ..|+..++..+|..|+..
T Consensus 1 ~~~~yC~~cy~~~~~~~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~~-~~~~~~~~~~yC~~cy~~ 73 (82)
T 1x63_A 1 GSSGSSGKCTTREDSPKCKGCFKAIVAGDQNVEYKGTVWHKDCFTCSNCKQVIGT-GSFFPKGEDFYCVTCHET 73 (82)
T ss_dssp CCSCCCCCCCSCCCSCBCSSSCCBCCSSSCEEECSSCEEETTTCCCSSSCCCCTT-SCEEEETTEEEEHHHHHH
T ss_pred CCCcCchhHHccccCCcCccCCcccccCceEEEECccccccccCchhhCCCccCC-CccEeeCCEEECHHHHHH
Confidence 47899999999999999999999997 668999999999999999999999965 478889999999988753
|
| >2dlo_A Thyroid receptor-interacting protein 6; LIM domain, OPA-interacting protein 1, zyxin related protein 1 (ZRP-1), structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.52 E-value=4.4e-15 Score=109.39 Aligned_cols=69 Identities=20% Similarity=0.393 Sum_probs=62.8
Q ss_pred CCeeeeccccccccccccccccccccCCeEEecCcccCCCCccccCCccccCCCCccccc-CCccccccccc
Q psy6593 46 DGLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALV-ERSILCSACDV 116 (433)
Q Consensus 46 ~~~~~C~~~~~~~~~~~C~~C~~~i~~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~-~~~~~C~~c~~ 116 (433)
||++||+.||. .++++|.+|+++|.+..|++.++.||++||+|..|+++|. +..|... ++.++|..|+.
T Consensus 2 ~g~~yC~~~y~-~~~~~C~~C~~~I~~~~~~a~~~~~H~~CF~C~~C~~~L~-~~~f~~~~~g~~yC~~cy~ 71 (81)
T 2dlo_A 2 SSGSSGEGCYV-ATLEKCATCSQPILDRILRAMGKAYHPGCFTCVVCHRGLD-GIPFTVDATSQIHCIEDFH 71 (81)
T ss_dssp CCCCCCCCCCC-SSCCBCTTTCCBCCSCCEEETTEEECTTTCBCSSSCCBCT-TSCEECCTTCCCEEHHHHH
T ss_pred cCCEECHHHhh-cCCCccccCCCeecceeEEECCccccHHhcCcccCCCccC-CCeeEECCCCEEECHHHHH
Confidence 68999999999 7999999999999999999999999999999999999995 6778776 67888988875
|
| >1x64_A Alpha-actinin-2 associated LIM protein; LIM domain, PDZ and LIM domain 3, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.51 E-value=4.3e-15 Score=111.49 Aligned_cols=62 Identities=13% Similarity=0.219 Sum_probs=56.5
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeecccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQN 65 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~ 65 (433)
.|.+|++.+. ++.|.|+++.||++||+|..|+++|.+. |+.+++++||+.||.++|+++|.+
T Consensus 27 ~C~~C~~~I~--~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~g~~yC~~~y~~~f~p~~~g 89 (89)
T 1x64_A 27 LCDKCGSGIV--GAVVKARDKYRHPECFVCADCNLNLKQKGYFFVEGELYCETHARARTSGPSSG 89 (89)
T ss_dssp BCTTTCCBCC--SCCEESSSCEECTTTCCCSSSCCCTTTSCCEEETTEEECHHHHHHHSSSCCCC
T ss_pred CcccCCCEec--ccEEEECCceECccCCEecCCCCCCCCCCeEeECCEEECHHHHHHHhCCCCCC
Confidence 5899998765 5789999999999999999999999875 999999999999999999999863
|
| >2dlo_A Thyroid receptor-interacting protein 6; LIM domain, OPA-interacting protein 1, zyxin related protein 1 (ZRP-1), structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.51 E-value=3.7e-15 Score=109.80 Aligned_cols=62 Identities=19% Similarity=0.272 Sum_probs=55.8
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEee-CCeeeecccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEK-DGLLFCKEDYNGKYGEACQN 65 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~-~~~~~C~~~~~~~~~~~C~~ 65 (433)
.|.+|++.+. ++.|.|+|+.||+.||+|..|+++|.+. |+.+ +|++||+.||.++|+++|++
T Consensus 17 ~C~~C~~~I~--~~~~~a~~~~~H~~CF~C~~C~~~L~~~~f~~~~~g~~yC~~cy~~~f~~~C~~ 80 (81)
T 2dlo_A 17 KCATCSQPIL--DRILRAMGKAYHPGCFTCVVCHRGLDGIPFTVDATSQIHCIEDFHRKFASGPSS 80 (81)
T ss_dssp BCTTTCCBCC--SCCEEETTEEECTTTCBCSSSCCBCTTSCEECCTTCCCEEHHHHHHHTTSSSCC
T ss_pred ccccCCCeec--ceeEEECCccccHHhcCcccCCCccCCCeeEECCCCEEECHHHHHHHhcCcCCC
Confidence 5889998765 6799999999999999999999999877 7766 78999999999999999974
|
| >1x63_A Skeletal muscle LIM-protein 1; LIM domain, four and A half LIM domains protein 1, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.51 E-value=5.2e-15 Score=109.37 Aligned_cols=63 Identities=13% Similarity=0.186 Sum_probs=58.0
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeeccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQ 64 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~ 64 (433)
.|.+|++.+...+..|.|+|+.||+.||+|..|+++|.+. |+.+++++||+.||.++|+++|.
T Consensus 17 ~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~~~~yC~~cy~~~f~~~~~ 80 (82)
T 1x63_A 17 KCKGCFKAIVAGDQNVEYKGTVWHKDCFTCSNCKQVIGTGSFFPKGEDFYCVTCHETKFASGPS 80 (82)
T ss_dssp BCSSSCCBCCSSSCEEECSSCEEETTTCCCSSSCCCCTTSCEEEETTEEEEHHHHHHHTSCCCS
T ss_pred cCccCCcccccCceEEEECccccccccCchhhCCCccCCCccEeeCCEEECHHHHHHHhCCCCC
Confidence 5899999877557789999999999999999999999776 99999999999999999999985
|
| >2d8x_A Protein pinch; LIM domain, pinch protein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.51 E-value=5.7e-15 Score=105.55 Aligned_cols=61 Identities=13% Similarity=0.167 Sum_probs=55.6
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeeccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQ 64 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~ 64 (433)
.|.+|++.+. ++.|.|+|+.||++||+|..|+++|.+. |+.+++++||+.||.++|++++.
T Consensus 7 ~C~~C~~~I~--~~~~~a~~~~~H~~CF~C~~C~~~L~~~~f~~~~g~~yC~~c~~~~~~~~~~ 68 (70)
T 2d8x_A 7 GCHQCGEFII--GRVIKAMNNSWHPECFRCDLCQEVLADIGFVKNAGRHLCRPCHNREKASGPS 68 (70)
T ss_dssp BCSSSCCBCC--SCCEEETTEEECTTTSBCSSSCCBCSSSCCEEETTEEECHHHHHHHHCCCSC
T ss_pred cCccCCCEec--ceEEEECcccccccCCEeCCCCCcCCCCccEeECCeEECHHHhhhhcCCCCC
Confidence 5899998765 6789999999999999999999999876 99999999999999999998764
|
| >1x3h_A Leupaxin; paxillin family, protein-protein interaction, LIM domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.50 E-value=5.4e-15 Score=108.73 Aligned_cols=62 Identities=19% Similarity=0.259 Sum_probs=56.5
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeecccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQN 65 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~ 65 (433)
.|.+|++.+. ++.|.|+|+.||+.||+|..|+++|.+. |+.+++++||+.||.++|+++|++
T Consensus 17 ~C~~C~~~I~--~~~v~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~~~~yC~~~y~~~f~~~C~~ 79 (80)
T 1x3h_A 17 KCGGCNRPVL--ENYLSAMDTVWHPECFVCGDCFTSFSTGSFFELDGRPFCELHYHHRRGSGPSS 79 (80)
T ss_dssp BCTTTCCBCC--SSCEEETTEEECTTTCBCSSSCCBSCSSCCEESSSCEECHHHHHHHHSSSCCC
T ss_pred ccccCCCeec--ceeEEECCCeEecCcCChhhCCCCCCCCcEEeECCEEECHHHHHHHcCCCCCC
Confidence 5889998654 5789999999999999999999999775 999999999999999999999974
|
| >1x62_A C-terminal LIM domain protein 1; PDZ and LIM domain protein 1, LIM domain protein CLP-36, contractIle protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.50 E-value=3.1e-15 Score=109.59 Aligned_cols=62 Identities=10% Similarity=0.146 Sum_probs=56.3
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeecccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQN 65 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~ 65 (433)
.|.+|++.+. ++.|.|+++.||+.||+|..|+++|.+. |+.+++++||+.||.++|+|++.+
T Consensus 17 ~C~~C~~~I~--~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~g~~yC~~cy~~~~~p~g~g 79 (79)
T 1x62_A 17 MCDKCGTGIV--GVFVKLRDRHRHPECYVCTDCGTNLKQKGHFFVEDQIYCEKHARERVSGPSSG 79 (79)
T ss_dssp CCSSSCCCCC--SSCEECSSCEECTTTTSCSSSCCCHHHHCCEESSSCEECHHHHHHHHSSCCCC
T ss_pred ccccCCCCcc--CcEEEECcceeCcCcCeeCCCCCCCCCCCeEeECCEEECHHHHHHHhCCCCCC
Confidence 5899998765 5699999999999999999999999776 999999999999999999999753
|
| >1x61_A Thyroid receptor interacting protein 6; LIM domain, OPA-interacting protein 1, zyxin related protein 1 (ZRP-1), structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.50 E-value=6.2e-15 Score=106.03 Aligned_cols=65 Identities=18% Similarity=0.262 Sum_probs=57.6
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeecccccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQNCG 67 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~C~ 67 (433)
.|.+|++.+.-++..|.|+|+.||+.||+|..|+++|.+. |+.+++++||+.||.++| .+|..++
T Consensus 7 ~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~~~~yC~~cy~~~~-~~~~~~~ 72 (72)
T 1x61_A 7 GCGGCGEDVVGDGAGVVALDRVFHVGCFVCSTCRAQLRGQHFYAVERRAYCEGCYVATL-ESGPSSG 72 (72)
T ss_dssp CCSSSCSCCCSSSCCEECSSSEECTTTCBCSSSCCBCTTSCEEESSSCEEEHHHHHHHH-HTCSSCC
T ss_pred CCccCCCccCCCceEEEECCCeEcccCCcccccCCcCCcCcCEeeCCeEECHHHHHHHH-ccCCCCC
Confidence 5899998776567799999999999999999999999776 999999999999999998 5676553
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=1.4e-14 Score=132.01 Aligned_cols=94 Identities=23% Similarity=0.221 Sum_probs=77.5
Q ss_pred cchHHHHhhcCCcc--eeeEEEEEEeCCeeeEEEeccCC-C----CHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhh-c
Q psy6593 146 CGQVAVLRSLHHHN--VIRFIGVLYKDRKLNLVTEYIAG-G----TLKELLQDPGQPLPWGQRVNFARDIAAGMTYLH-S 217 (433)
Q Consensus 146 ~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~g-~----sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH-~ 217 (433)
.+|+.+|.+++|++ ++.+++. +..+|||||+.+ | +|.++... .++..+..++.|++.+|.+|| +
T Consensus 118 ~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~ 189 (258)
T 1zth_A 118 EKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQE 189 (258)
T ss_dssp HHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHH
Confidence 37999999998875 4555543 367899999942 3 77776543 346678899999999999999 9
Q ss_pred CCccccCCCCcceEEccCCceEEeccccchhc
Q psy6593 218 MNLIHRDLNSQNCLVREDKTVVVADFGLARII 249 (433)
Q Consensus 218 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 249 (433)
.||+||||||+|||++. .++|+|||++...
T Consensus 190 ~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 190 AELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999999999998 8999999999764
|
| >2cuq_A Four and A half LIM domains 3; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.49 E-value=8.9e-15 Score=107.55 Aligned_cols=62 Identities=10% Similarity=0.165 Sum_probs=56.3
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeecccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQN 65 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~ 65 (433)
.|.+|++.+ .++.|.|+|+.||+.||+|..|+++|.+. |+.+++++||+.||.++|+++|..
T Consensus 17 ~C~~C~~~I--~~~~v~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~~~~yC~~cy~~~f~~~c~s 79 (80)
T 2cuq_A 17 RCARCSKTL--TQGGVTYRDQPWHRECLVCTGCQTPLAGQQFTSRDEDPYCVACFGELFASGPSS 79 (80)
T ss_dssp CCTTTCCCC--CSCCEESSSSEECTTTCBCSSSCCBCTTCCEEECSSSEEEHHHHHHHTTCSTTC
T ss_pred cCCCCCCEe--cCcEEEECCchhhhhhCCcccCCCcCCCCeeEeECCEEECHHHHHHHcCCCCCC
Confidence 588999866 45689999999999999999999999876 999999999999999999999963
|
| >2d8y_A Eplin protein; LIM domain, epithelial protein LOST in neoplasm, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.49 E-value=4.3e-15 Score=112.00 Aligned_cols=64 Identities=19% Similarity=0.183 Sum_probs=58.0
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeeccccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQNC 66 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~C 66 (433)
.|.+|++.+. ..+.|.|+++.||+.||+|..|+++|... |+.+++++||+.||.++|+++|..+
T Consensus 17 ~C~~C~~~I~-~~~~v~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~g~~yC~~~y~~~f~~kc~~~ 81 (91)
T 2d8y_A 17 TCVECQKTVY-PMERLLANQQVFHISCFRCSYCNNKLSLGTYASLHGRIYCKPHFNQLFKSKGNYD 81 (91)
T ss_dssp BCTTTCCBCC-TTSEEECSSSEEETTTCBCTTTCCBCCTTTCCCSSSCCCCHHHHHHHSCCCSCCC
T ss_pred cCccCCCccC-CceeEEECCCEECCCCCeeCCCCCCCCCCCcEeECCEEECHHHHHHHhCCCcCcc
Confidence 5899998766 45689999999999999999999999876 9999999999999999999999843
|
| >1wig_A KIAA1808 protein; LIM domain, zinc finger, metal-binding protein, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.45 E-value=3.7e-14 Score=101.92 Aligned_cols=59 Identities=8% Similarity=0.017 Sum_probs=52.7
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccC-Cc-eEeeCCeeeeccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLD-NW-YFEKDGLLFCKEDYNGKYGEA 62 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~-~~-~~~~~~~~~C~~~~~~~~~~~ 62 (433)
.|++|++.+ .++.|.|+|+.||++||+|..|+++|. +. |+.+++++||+.||.+.++..
T Consensus 7 ~C~~C~~~I--~~~~v~a~~~~wH~~CF~C~~C~~~L~~~~~f~~~~~~~yC~~C~~~~~~~~ 67 (73)
T 1wig_A 7 GCDSCEKYI--TGRVLEAGEKHYHPSCALCVRCGQMFAEGEEMYLQGSSIWHPACRQAARTED 67 (73)
T ss_dssp SCSSSCCCC--SSCCBCCSSCCBCTTTSCCSSSCCCCCSSCCCEEETTEEECTTHHHHTSSSS
T ss_pred CcccCCCEe--cCeeEEeCCCCCCCCcCEeCCCCCCCCCCCeeEeeCCEEEChHHChHhhccc
Confidence 589999855 468999999999999999999999997 55 999999999999999988754
|
| >2co8_A NEDD9 interacting protein with calponin homology and LIM domains; zinc finger protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.45 E-value=3.7e-14 Score=104.41 Aligned_cols=62 Identities=16% Similarity=0.119 Sum_probs=54.1
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eE--eeCCeeeeccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YF--EKDGLLFCKEDYNGKYGEACQ 64 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~--~~~~~~~C~~~~~~~~~~~C~ 64 (433)
.|.+|++.+. +.+.|.|+|+.||+.||+|..|+++|... |+ ++||++||+.||.++|++-+.
T Consensus 17 ~C~~C~~~I~-~~e~v~a~~~~wH~~CF~C~~C~~~L~~~~~~~~~~~g~~yC~~~y~~~~~~~~~ 81 (82)
T 2co8_A 17 LCALCGEHLY-VLERLCVNGHFFHRSCFRCHTCEATLWPGGYEQHPGDGHFYCLQHLPQTDSGPSS 81 (82)
T ss_dssp BCSSSCCBCC-TTTBCCBTTBCCBTTTCBCSSSCCBCCTTSEECCTTTCCCEETTTCCCCCCCCCC
T ss_pred CCcccCCCcc-cceEEEECCCeeCCCcCEEcCCCCCcCCCceeEeCcCCEEEChHHHHhhhcCCCC
Confidence 5899998765 56788999999999999999999999887 66 479999999999999987553
|
| >1b8t_A Protein (CRP1); LIM domain, muscle differentiation, contractIle; NMR {Gallus gallus} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 g.39.1.3 PDB: 1ibi_A 1qli_A 1cxx_A 1ctl_A 2o13_A | Back alignment and structure |
|---|
Probab=99.44 E-value=3.4e-14 Score=122.90 Aligned_cols=68 Identities=21% Similarity=0.272 Sum_probs=62.1
Q ss_pred cCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeecccccccccccccccccccc
Q psy6593 3 FGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQNCGQMMS 71 (433)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~C~~~i~ 71 (433)
|.+|++.+. +++.|.|+|+.||+.||+|..|+++|.+. |+.++|++||+.||.++|+++|.+|++++.
T Consensus 118 C~~C~~~I~-~~~~v~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~g~~yC~~cy~~~f~~kc~~C~~~~g 186 (192)
T 1b8t_A 118 CPRCGQAVY-AAEKVIGAGKSWHKSCFRCAKCGKSLESTTLADKDGEIYCKGCYAKNFGPKGFGFGQGAG 186 (192)
T ss_dssp CTTTSCEEC-SSSCEEETTEEECTTTCBCTTTCCBCCSSSEEEETTEEEEHHHHHHHTCCCCCCCCCCCC
T ss_pred CCCCCCEec-CcEEEecCCCccchhcCCccccCCCCCCCcccccCCEEeCHHHHHHhcCCcCCCCCCccc
Confidence 889998665 46789999999999999999999999765 999999999999999999999999999863
|
| >3f6q_B LIM and senescent cell antigen-like-containing domain protein 1; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 2kbx_B 3ixe_B | Back alignment and structure |
|---|
Probab=99.42 E-value=3.1e-14 Score=102.44 Aligned_cols=59 Identities=10% Similarity=0.138 Sum_probs=53.3
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeeccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYG 60 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~ 60 (433)
.|++|++.+.-.+..+.|+|+.||+.||+|..|+++|.+. |+.++|++||+.||.++|+
T Consensus 13 ~C~~C~~~i~~~e~~~~~~~~~~H~~CF~C~~C~~~L~~~~~~~~~g~~yC~~~y~~lf~ 72 (72)
T 3f6q_B 13 TCERCKGGFAPAEKIVNSNGELYHEQCFVCAQCFQQFPEGLFYEFEGRKYCEHDFQMLFA 72 (72)
T ss_dssp BCTTTCCBCCTTCEEEEETTEEEETTTSSCTTTCCCCGGGCCEEETTEEECHHHHHHHTC
T ss_pred cchhcCccccCCceEEEeCcCeeCcCCCcccCCCCCCCCCCeEeECCeEeCHHHHHHhhC
Confidence 5899999877556678899999999999999999999776 9999999999999999885
|
| >2iyb_E Testin, TESS, TES; LIM domain, SH3-binding, tumour supressor LIM domain EVH1 DO cell motility, phosphorylation, cytoskeleton; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=8.8e-14 Score=97.54 Aligned_cols=57 Identities=19% Similarity=0.217 Sum_probs=50.9
Q ss_pred CcCCCCCeeEeeccceeecCCCcC--cCCccccccccccCCc-eEeeCCeeee-ccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSL--IFTSGCSACDVMLDNW-YFEKDGLLFC-KEDYNGK 58 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h--~~cf~C~~C~~~l~~~-~~~~~~~~~C-~~~~~~~ 58 (433)
.|.+|++.+..+++.|.|+|+.|| ++||+|+.|+++|.+. |+.++|++|| ++||.++
T Consensus 4 ~C~~C~~~I~~~~~~v~a~~~~wH~~~~CF~C~~C~~~L~~~~f~~~~g~~yC~~~C~~k~ 64 (65)
T 2iyb_E 4 VCQGCHNAIDPEVQRVTYNNFSWHASTECFLCSCCSKCLIGQKFMPVEGMVFCSVECKKRM 64 (65)
T ss_dssp ECTTTSSEECTTSCEEEETTEEEETTTTTSBCTTTCCBCTTSCCEEETTEEESSHHHHHTT
T ss_pred CCcCCCCeeccCceEEEECCCccCCCCCCEECCCCCCcCCCCceEEECCEEecCHHHhhhh
Confidence 489999976644789999999999 9999999999999887 9999999999 8898764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.39 E-value=1.2e-13 Score=131.24 Aligned_cols=91 Identities=21% Similarity=0.295 Sum_probs=68.2
Q ss_pred hHHHHhhcCCcce--eeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 148 QVAVLRSLHHHNV--IRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 148 E~~~l~~l~h~~i--v~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
|...|.++.+.++ +..++. ...+|||||++|++|.++.. ......++.|++.+|.+||+.|||||||
T Consensus 163 E~~nL~rL~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~gIVHrDL 231 (397)
T 4gyi_A 163 EFAFMKALYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHGLIHGDF 231 (397)
T ss_dssp HHHHHHHHHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHHHHHHhcCCCCCeeeec----cCceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence 4556666644433 233322 23479999999988876542 2345678999999999999999999999
Q ss_pred CCcceEEccCC----------ceEEeccccchhc
Q psy6593 226 NSQNCLVREDK----------TVVVADFGLARII 249 (433)
Q Consensus 226 kp~Nil~~~~~----------~~kl~Dfg~~~~~ 249 (433)
||.|||+++++ .+.|+||+.+...
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 99999998776 4899999987653
|
| >2l4z_A DNA endonuclease RBBP8, LIM domain transcription LMO4; protein-protein interaction, LIM-interaction DOM LMO4, RBBP8/CTIP, LIM-only protein; HET: DNA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=4.8e-14 Score=112.01 Aligned_cols=58 Identities=19% Similarity=0.313 Sum_probs=51.9
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccC--C-ceEeeCCeeeeccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLD--N-WYFEKDGLLFCKEDYNGKYG 60 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~--~-~~~~~~~~~~C~~~~~~~~~ 60 (433)
.|.+|++.+. +.+.|.|+|+.||+.||+|..|+++|. + .|+.++|++||+.||.++||
T Consensus 63 ~C~~C~~~I~-~~~~v~a~~~~wH~~CF~C~~C~~~L~~~g~~f~~~dg~~yC~~cy~~~Fg 123 (123)
T 2l4z_A 63 RCAGCGGKIA-DRFLLYAMDSYWHSRCLKCSSCQAQLGDIGTSSYTKSGMILCRNDYIRLFG 123 (123)
T ss_dssp BBSSSSSBCC-SSSEEEETTEEEETTTSBCTTTCCBGGGTTCCCBCSSSCCBCHHHHHHHCC
T ss_pred cCcCCCCCcC-CcEEEEeCCcEEcccccCcCcCCCcccccCCceEEECCEEeCHHHhhhhcC
Confidence 5999998765 555699999999999999999999996 3 49999999999999999986
|
| >1x6a_A LIMK-2, LIM domain kinase 2; LIM-kinase 2, zinc finger domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.39 E-value=1.1e-13 Score=101.96 Aligned_cols=62 Identities=13% Similarity=0.104 Sum_probs=54.9
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccC-Cc-eE-eeCCeeeecccccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLD-NW-YF-EKDGLLFCKEDYNGKYGEACQN 65 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~-~~-~~-~~~~~~~C~~~~~~~~~~~C~~ 65 (433)
.|.+|++.+. ++.|.|+|+.||++||+|..|+++|. +. |+ .+++++||+.||.++|++.|.+
T Consensus 17 ~C~~C~~~I~--~~~~~a~~~~~H~~CF~C~~C~~~L~~g~~f~~~~~~~~~C~~c~~~~~~~~~sg 81 (81)
T 1x6a_A 17 FCHGCSLLMT--GPFMVAGEFKYHPECFACMSCKVIIEDGDAYALVQHATLYCGKCHNEVVSGPSSG 81 (81)
T ss_dssp BCTTTCCBCC--SCCBCCTTCCBCTTSCBCTTTCCBCCTTSCEEECSSSCEEEHHHHHHHHCTTSCC
T ss_pred cCccCCCCcC--ceEEEECCceeccccCCccCCCCccCCCCcEEEeeCCEEECHHHHHHHhcCCCCC
Confidence 5889998766 78899999999999999999999995 45 66 5899999999999999998753
|
| >1wig_A KIAA1808 protein; LIM domain, zinc finger, metal-binding protein, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.33 E-value=3.5e-13 Score=96.76 Aligned_cols=62 Identities=27% Similarity=0.656 Sum_probs=57.6
Q ss_pred cccccccccccccccCCeEEecCcccCCCCccccCCccccCCCCcccccCCccccccccccc
Q psy6593 57 GKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVML 118 (433)
Q Consensus 57 ~~~~~~C~~C~~~i~~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~l 118 (433)
.+|+++|.+|+++|.+.+|.+.++.||++||+|..|+.+|..|..|++.++..+|..|+..+
T Consensus 2 s~~~~~C~~C~~~I~~~~v~a~~~~wH~~CF~C~~C~~~L~~~~~f~~~~~~~yC~~C~~~~ 63 (73)
T 1wig_A 2 SSGSSGCDSCEKYITGRVLEAGEKHYHPSCALCVRCGQMFAEGEEMYLQGSSIWHPACRQAA 63 (73)
T ss_dssp CCSCCSCSSSCCCCSSCCBCCSSCCBCTTTSCCSSSCCCCCSSCCCEEETTEEECTTHHHHT
T ss_pred CcCcCCcccCCCEecCeeEEeCCCCCCCCcCEeCCCCCCCCCCCeeEeeCCEEEChHHChHh
Confidence 46899999999999999999999999999999999999997789999999999999998654
|
| >2egq_A FHL1 protein; LIM domain, four and A half LIM domains protein 1, skeletal muscle LIM- protein 1, SLIM 1, structural genomics NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=3.3e-13 Score=98.28 Aligned_cols=56 Identities=13% Similarity=0.178 Sum_probs=50.5
Q ss_pred CcCCCCCeeEe---eccceeecCCCcCcCCccccccccccCCc-eEeeCCeeeecccccc
Q psy6593 2 VFGTRSEVTSM---ENENLRFLCRSSLIFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNG 57 (433)
Q Consensus 2 ~~~~~~~~~~~---~~~~~~~~~~~~h~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~ 57 (433)
.|++|++.+.- +.+.|.|+|+.||+.||+|..|+++|++. |+.++|++||+.||.+
T Consensus 17 ~C~~C~~~I~~~g~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~f~~~~~~~yC~~cy~~ 76 (77)
T 2egq_A 17 KCAGCKNPITGFGKGSSVVAYEGQSWHDYCFHCKKCSVNLANKRFVFHQEQVYCPDCAKK 76 (77)
T ss_dssp CCSSSCCCCCCCSSCCCEEEETTEEEETTTCBCSSSCCBCTTSCCCEETTEECCHHHHHH
T ss_pred cCcccCCcccCCCCCceeEEECcceeCcccCEehhcCCCCCCCccEeECCEEEChHHhcc
Confidence 48899987764 45899999999999999999999999877 9999999999999965
|
| >1rut_X Flinc4, fusion protein of LMO4 protein and LIM domain- binding protein 1; B-tandem zipper, protein binding; 1.30A {Mus musculus} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 g.39.1.3 PDB: 2dfy_X 2xjz_I 2xjy_B | Back alignment and structure |
|---|
Probab=99.21 E-value=7.5e-12 Score=107.69 Aligned_cols=88 Identities=19% Similarity=0.189 Sum_probs=61.5
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccC-Cc-eEeeCCeeeeccccccccccccccccccc-----cCCe
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLD-NW-YFEKDGLLFCKEDYNGKYGEACQNCGQMM-----SGPV 74 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~-~~-~~~~~~~~~C~~~~~~~~~~~C~~C~~~i-----~~~~ 74 (433)
.|..|++.+.-.+..|.|+++.||+.||+|..|+++|. +. |+.+++++||+.||.++|+++|...+..- ...+
T Consensus 71 ~C~~C~~~I~~~e~~i~a~~~~~H~~CF~C~~C~~~L~~g~~f~~~~g~~yC~~c~~~~~~~~~~~~g~~~~~~~~~~~v 150 (188)
T 1rut_X 71 ACSACGQSIPASELVMRAQGNVYHLKCFTCSTCRNRLVPGDRFHYINGSLFCEHDRPTALINGHLNSGGSGGSGGSGGDV 150 (188)
T ss_dssp ECTTTCCEECTTSEEEEETTEEECGGGCBCTTTCCBCCTTCEEEEETTEEEEGGGCCTTTC----------------CCC
T ss_pred ccccCCCccccCcEEEEcCCCEEeCCCCeECCCCCCCCCCCeEEEECCeEECHHHHHHHhcccccccCCCCcccccCCcc
Confidence 38899987664456789999999999999999999995 55 99999999999999999999998877632 1123
Q ss_pred E-----EecCcccCCCCccc
Q psy6593 75 M-----VVGDHKFHPECFKC 89 (433)
Q Consensus 75 ~-----~~~~~~~h~~cf~C 89 (433)
| ..++..+|++..+.
T Consensus 151 ~vvgep~l~g~~~~~~~~r~ 170 (188)
T 1rut_X 151 MVVGEPTLMGGEFGDEDERL 170 (188)
T ss_dssp EECCCCEETTCCCCCTTEEE
T ss_pred cccCCCcccCCCCCCCCCce
Confidence 3 34455666666553
|
| >1x68_A FHL5 protein; four-and-A-half LIM protein 5, zinc finger domain, AN actin- interacting protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.19 E-value=7.3e-12 Score=90.74 Aligned_cols=60 Identities=27% Similarity=0.727 Sum_probs=54.7
Q ss_pred cccccccccccccccC----CeEEecCcccCCCCccccCCccccCCCCcccccCCcccccccccc
Q psy6593 57 GKYGEACQNCGQMMSG----PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 57 ~~~~~~C~~C~~~i~~----~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
++|+++|.+|+++|.+ ..|.+.++.||++||+|..|+.+|. +..|+..++.++|..|+..
T Consensus 2 ~~~~~~C~~C~~~I~~~g~~~~~~a~~~~wH~~CF~C~~C~~~L~-~~~f~~~~g~~yC~~cy~~ 65 (76)
T 1x68_A 2 SSGSSGCVACSKPISGLTGAKFICFQDSQWHSECFNCGKCSVSLV-GKGFLTQNKEIFCQKCGSG 65 (76)
T ss_dssp TTCCCCCTTTCCCCCTTTTCCEEEETTEEEEGGGCBCTTTCCBCS-SSCEEEETTEEEETTTTCC
T ss_pred CccCCCCccCCCcccCCCCceeEEECCcccCcccCChhhCCCcCC-CCceEeECCEEECHHHhhh
Confidence 5789999999999987 7999999999999999999999994 7789999999999999864
|
| >2dar_A PDZ and LIM domain protein 5; enigma homolog protein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.17 E-value=1.4e-11 Score=92.40 Aligned_cols=69 Identities=23% Similarity=0.530 Sum_probs=60.4
Q ss_pred eeeeccccccccccccccccccccCCeEEecCcccCCCCccccCCccccCCCCcccccCCcccccccccc
Q psy6593 48 LLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 48 ~~~C~~~~~~~~~~~C~~C~~~i~~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
...+...+...++++|.+|+++|.+..|.+.++.||++||+|..|++.|. +..|+..++..+|..|+..
T Consensus 13 ~~~~~~~~~~~~~~~C~~C~~~I~~~~v~a~~~~~H~~CF~C~~C~~~L~-~~~f~~~~g~~yC~~cy~~ 81 (90)
T 2dar_A 13 VQRAEHIPAGKRTPMCAHCNQVIRGPFLVALGKSWHPEEFNCAHCKNTMA-YIGFVEEKGALYCELCYEK 81 (90)
T ss_dssp CBCCEEECTTTCCCBBSSSCCBCCSCEEEETTEEECTTTCBCSSSCCBCS-SSCBEESSSCEECHHHHHH
T ss_pred hhhcccCCCCCCCCCCccCCCEecceEEEECCccccccCCccCCCCCCCC-CCEeEeECCEEECHHHHHH
Confidence 34455557888999999999999999999999999999999999999995 5678899999999998853
|
| >1nyp_A Pinch protein; LIM domain, protein recognition, cell adhesion; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 PDB: 1u5s_B | Back alignment and structure |
|---|
Probab=99.17 E-value=7.1e-12 Score=88.12 Aligned_cols=60 Identities=18% Similarity=0.280 Sum_probs=54.2
Q ss_pred cccccccccccccccCCeEEecCcccCCCCccccCCccccCCCCcccccCCcccccccccc
Q psy6593 57 GKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 57 ~~~~~~C~~C~~~i~~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
++|+++|.+|+++|.+..|.+.++.||++||+|..|+++|. +..|+..++..+|..|+..
T Consensus 2 ~~~~~~C~~C~~~I~~~~~~a~~~~~H~~CF~C~~C~~~L~-~~~~~~~~g~~yC~~~y~~ 61 (66)
T 1nyp_A 2 SMGVPICGACRRPIEGRVVNAMGKQWHVEHFVCAKCEKPFL-GHRHYERKGLAYCETHYNQ 61 (66)
T ss_dssp CCCCCEETTTTEECCSCEECCTTSBEETTTCBCTTTCCBCS-SSCCEEETTEEECHHHHHH
T ss_pred CcCCCCCcccCCEecceEEEECccccccCcCEECCCCCCCC-CCceEeECCcEECHHHHHH
Confidence 46889999999999988999999999999999999999994 6778899999999988753
|
| >2iyb_E Testin, TESS, TES; LIM domain, SH3-binding, tumour supressor LIM domain EVH1 DO cell motility, phosphorylation, cytoskeleton; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.16 E-value=1e-11 Score=86.84 Aligned_cols=58 Identities=28% Similarity=0.720 Sum_probs=51.8
Q ss_pred ccccccccccccc--CCeEEecCcccC--CCCccccCCccccCCCCcccccCCcccc-cccccc
Q psy6593 59 YGEACQNCGQMMS--GPVMVVGDHKFH--PECFKCTSCSCCIGDGESYALVERSILC-SACDVM 117 (433)
Q Consensus 59 ~~~~C~~C~~~i~--~~~~~~~~~~~h--~~cf~C~~C~~~l~~g~~~~~~~~~~~C-~~c~~~ 117 (433)
|+++|.+|+++|. +..|.+.++.|| ++||+|..|+++| .|..|+..++.++| ..|+..
T Consensus 1 fa~~C~~C~~~I~~~~~~v~a~~~~wH~~~~CF~C~~C~~~L-~~~~f~~~~g~~yC~~~C~~k 63 (65)
T 2iyb_E 1 HAVVCQGCHNAIDPEVQRVTYNNFSWHASTECFLCSCCSKCL-IGQKFMPVEGMVFCSVECKKR 63 (65)
T ss_dssp -CEECTTTSSEECTTSCEEEETTEEEETTTTTSBCTTTCCBC-TTSCCEEETTEEESSHHHHHT
T ss_pred CcCCCcCCCCeeccCceEEEECCCccCCCCCCEECCCCCCcC-CCCceEEECCEEecCHHHhhh
Confidence 6789999999998 679999999999 9999999999999 57789999999999 777653
|
| >1x4l_A Skeletal muscle LIM-protein 3; LIM domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.15 E-value=1.6e-11 Score=87.89 Aligned_cols=60 Identities=25% Similarity=0.683 Sum_probs=54.0
Q ss_pred cccccccccccccccC----CeEEecCcccCCCCccccCCccccCCCCcccccCCcccccccccc
Q psy6593 57 GKYGEACQNCGQMMSG----PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 57 ~~~~~~C~~C~~~i~~----~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
..++++|.+|+++|.+ .+|.+.++.||++||+|..|+.+| .+..|...++..+|..|+..
T Consensus 2 s~~~~~C~~C~~~I~~~~~~~~~~a~~~~wH~~CF~C~~C~~~L-~~~~f~~~~g~~yC~~c~~~ 65 (72)
T 1x4l_A 2 SSGSSGCAGCTNPISGLGGTKYISFEERQWHNDCFNCKKCSLSL-VGRGFLTERDDILCPDCGKD 65 (72)
T ss_dssp CSCSCSBTTTTBCCCCSSSCSCEECSSCEECTTTCBCSSSCCBC-TTSCCEECSSSEECHHHHHT
T ss_pred CCCCCCCcCCCccccCCCCcceEEECCcccCcccCEeccCCCcC-CCCccEeECCEEEChhHcCc
Confidence 4578999999999986 688999999999999999999999 47789999999999999864
|
| >1v6g_A Actin binding LIM protein 2; LIM domain, zinc binding domain, ablim2, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.14 E-value=2.6e-11 Score=89.01 Aligned_cols=58 Identities=10% Similarity=0.004 Sum_probs=48.6
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccCC-ceEeeCC-eeeecccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLDN-WYFEKDG-LLFCKEDYNGKYGE 61 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~~-~~~~~~~-~~~C~~~~~~~~~~ 61 (433)
.|.+|++.+. ++.|.|+|+.||++||+|..|+++|.. .++..++ .+||+.||.+.++.
T Consensus 17 ~C~~C~~~I~--~~~v~a~~~~wH~~CF~C~~C~~~L~~~~~~~~~~~~~~C~~C~~~~~~~ 76 (81)
T 1v6g_A 17 RCFSCDQFIE--GEVVSALGKTYHPDCFVCAVCRLPFPPGDRVTFNGKECMCQKCSLPVSVS 76 (81)
T ss_dssp BCTTTCCBCC--SCCEEETTEEECTTTSSCSSSCCCCCSSSCEEEETTEEEEHHHHSCCSSC
T ss_pred cCccccCEec--cceEEECCceeCccCCccccCCCCCCCCCEEEeCCCCEEChhhhcccCCC
Confidence 5889998655 689999999999999999999999965 4666555 57999999887753
|
| >2cur_A Skeletal muscle LIM-protein 1; four and A half LIM domains protein 1, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.12 E-value=2.4e-11 Score=86.20 Aligned_cols=60 Identities=23% Similarity=0.633 Sum_probs=54.2
Q ss_pred cccccccccccccccCCeEEecCcccCCCCccccCCccccCCCCcccccCCcccccccccc
Q psy6593 57 GKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 57 ~~~~~~C~~C~~~i~~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
..++++|.+|+++|.+..|.+.++.||++||+|..|+++|. +..|+..++.++|..|+..
T Consensus 2 s~~~~~C~~C~~~I~~~~~~a~~~~~H~~CF~C~~C~~~L~-~~~~~~~~~~~yC~~cy~~ 61 (69)
T 2cur_A 2 SSGSSGCVKCNKAITSGGITYQDQPWHADCFVCVTCSKKLA-GQRFTAVEDQYYCVDCYKN 61 (69)
T ss_dssp CCCCCCCSSSCCCCCTTCEEETTEEECTTTTBCTTTCCBCT-TSCEEECSSCEEEHHHHHH
T ss_pred CCCcCCCcccCCEeCcceEEECccccccCcCEECCCCCCCC-CCccEeECCEEECHHHhHH
Confidence 45789999999999988999999999999999999999994 7789999999999988753
|
| >2d8z_A Four and A half LIM domains 2; skeletal muscle LIM-protein 3, LIM-domain protein DRAL, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.12 E-value=2.6e-11 Score=86.34 Aligned_cols=60 Identities=20% Similarity=0.528 Sum_probs=54.3
Q ss_pred cccccccccccccccCCeEEecCcccCCCCccccCCccccCCCCcccccCCcccccccccc
Q psy6593 57 GKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 57 ~~~~~~C~~C~~~i~~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
.+|+++|..|+++|.+..|.+.++.||++||+|..|+++| .+..|+..++..+|..|+..
T Consensus 2 ~~~~~~C~~C~~~I~~~~~~a~~~~~H~~CF~C~~C~~~L-~~~~~~~~~~~~yC~~cy~~ 61 (70)
T 2d8z_A 2 SSGSSGCVQCKKPITTGGVTYREQPWHKECFVCTACRKQL-SGQRFTARDDFAYCLNCFCD 61 (70)
T ss_dssp CCCCCBCSSSCCBCCSSEEESSSSEEETTTSBCSSSCCBC-TTSCCEESSSSEECHHHHHH
T ss_pred CCCCCCCcccCCeeccceEEECccccCCCCCccCCCCCcC-CcCceEeeCCeEECHHHHHH
Confidence 4688999999999998899999999999999999999999 56788899999999988753
|
| >1x4k_A Skeletal muscle LIM-protein 3; LIM domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.09 E-value=3.8e-11 Score=85.97 Aligned_cols=60 Identities=23% Similarity=0.537 Sum_probs=53.0
Q ss_pred cccccccccccccccC--CeEEecCcccCCCCccccCCccccCCCCcccccCCcccccccccc
Q psy6593 57 GKYGEACQNCGQMMSG--PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 57 ~~~~~~C~~C~~~i~~--~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
++|+++|.+|+++|.+ .+|.+.++.||++||+|..|+++|.. ..|+..++..+|..|+..
T Consensus 2 ~~~~~~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~~-~~~~~~~~~~yC~~cy~~ 63 (72)
T 1x4k_A 2 SSGSSGCQECKKTIMPGTRKMEYKGSSWHETCFICHRCQQPIGT-KSFIPKDNQNFCVPCYEK 63 (72)
T ss_dssp CSCCCCBSSSCCCCCSSSCEEEETTEEEETTTTCCSSSCCCCCS-SSEEEETTEEEEHHHHHH
T ss_pred CccCCCCccCCCcccCCceEEEECcCeecccCCcccccCCccCC-CccCccCCeEECHHHHhH
Confidence 5789999999999974 58999999999999999999999954 478889999999988753
|
| >2xjy_A Rhombotin-2; oncoprotein, T-cell leukemia, proto-oncogene, transcription, developmental protein; 2.40A {Homo sapiens} PDB: 2xjz_A | Back alignment and structure |
|---|
Probab=99.08 E-value=2.5e-11 Score=98.10 Aligned_cols=61 Identities=11% Similarity=0.123 Sum_probs=52.8
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCcccccccccc-CCc-eEeeCCeeeeccccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVML-DNW-YFEKDGLLFCKEDYNGKYGEA 62 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l-~~~-~~~~~~~~~C~~~~~~~~~~~ 62 (433)
.|.+|++.+.-.+..|.|+++.||+.||+|..|+++| .+. |+.+++++||+.||.++|+++
T Consensus 68 ~C~~C~~~I~~~e~~~~a~~~~~H~~CF~C~~C~~~L~~g~~f~~~~~~~~C~~c~~~~~~~~ 130 (131)
T 2xjy_A 68 LCASCDKRIRAYEMTMRVKDKVYHLECFKCAACQKHFCVGDRYLLINSDIVCEQDIYEWTKIN 130 (131)
T ss_dssp ECTTTCCEECTTSEEEEETTEEEEGGGCBCTTTCCBCCTTCEEEEETTEEEEGGGHHHHHHHH
T ss_pred ChhhcCCccCccceeEeeCCceECccCcccCCCCCCCCCCCEEEEECCEEEcHHHHHHHhhcc
Confidence 4888998765445688999999999999999999999 455 999999999999999988753
|
| >2d8x_A Protein pinch; LIM domain, pinch protein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.07 E-value=6.1e-11 Score=84.36 Aligned_cols=59 Identities=27% Similarity=0.722 Sum_probs=53.1
Q ss_pred ccccccccccccccCCeEEecCcccCCCCccccCCccccCCCCcccccCCcccccccccc
Q psy6593 58 KYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 58 ~~~~~C~~C~~~i~~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
.+.++|..|+++|.+..|.+.++.||++||+|..|+++|..+ .|+..++..+|..|+..
T Consensus 3 ~~~~~C~~C~~~I~~~~~~a~~~~~H~~CF~C~~C~~~L~~~-~f~~~~g~~yC~~c~~~ 61 (70)
T 2d8x_A 3 SGSSGCHQCGEFIIGRVIKAMNNSWHPECFRCDLCQEVLADI-GFVKNAGRHLCRPCHNR 61 (70)
T ss_dssp CCSSBCSSSCCBCCSCCEEETTEEECTTTSBCSSSCCBCSSS-CCEEETTEEECHHHHHH
T ss_pred CCCCcCccCCCEecceEEEECcccccccCCEeCCCCCcCCCC-ccEeECCeEECHHHhhh
Confidence 467899999999999999999999999999999999999655 68889999999999854
|
| >1wyh_A SLIM 2, skeletal muscle LIM-protein 2; structural genomics, riken structural genomics/proteomics initiative, RSGI, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.06 E-value=4.3e-11 Score=85.71 Aligned_cols=60 Identities=22% Similarity=0.592 Sum_probs=53.0
Q ss_pred ccccccccccccccc--CCeEEecCcccCCCCccccCCccccCCCCcccccCCcccccccccc
Q psy6593 57 GKYGEACQNCGQMMS--GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 57 ~~~~~~C~~C~~~i~--~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
++|+++|.+|+++|. +.+|.+.++.||++||+|..|+++|. +..|+..++.++|..|+..
T Consensus 2 ~~~~~~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~-~~~~~~~~~~~yC~~cy~~ 63 (72)
T 1wyh_A 2 SSGSSGCSACGETVMPGSRKLEYGGQTWHEHCFLCSGCEQPLG-SRSFVPDKGAHYCVPCYEN 63 (72)
T ss_dssp CCCCCBCSSSCCBCCSSSCEECSTTCCEETTTCBCTTTCCBTT-TSCEEEETTEEEEHHHHHH
T ss_pred CccCCCCccCCCccccCccEEEECccccCcccCeECCCCCcCC-CCccCCcCCeEECHHHHHH
Confidence 578899999999997 56889999999999999999999995 4568889999999888753
|
| >3f6q_B LIM and senescent cell antigen-like-containing domain protein 1; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 2kbx_B 3ixe_B | Back alignment and structure |
|---|
Probab=99.04 E-value=4.6e-11 Score=85.60 Aligned_cols=61 Identities=18% Similarity=0.474 Sum_probs=53.1
Q ss_pred cccccccccccccccccCC--eEEecCcccCCCCccccCCccccCCCCcccccCCccccccccc
Q psy6593 55 YNGKYGEACQNCGQMMSGP--VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDV 116 (433)
Q Consensus 55 ~~~~~~~~C~~C~~~i~~~--~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~ 116 (433)
|...++++|.+|+++|.+. ++.+.++.||++||+|..|+++|..+ .|+..++..+|..|+.
T Consensus 6 y~~~~~~~C~~C~~~i~~~e~~~~~~~~~~H~~CF~C~~C~~~L~~~-~~~~~~g~~yC~~~y~ 68 (72)
T 3f6q_B 6 FQGSASATCERCKGGFAPAEKIVNSNGELYHEQCFVCAQCFQQFPEG-LFYEFEGRKYCEHDFQ 68 (72)
T ss_dssp CCCCTTCBCTTTCCBCCTTCEEEEETTEEEETTTSSCTTTCCCCGGG-CCEEETTEEECHHHHH
T ss_pred ccCcCCccchhcCccccCCceEEEeCcCeeCcCCCcccCCCCCCCCC-CeEeECCeEeCHHHHH
Confidence 3557889999999999744 67899999999999999999999766 7888999999988875
|
| >1x61_A Thyroid receptor interacting protein 6; LIM domain, OPA-interacting protein 1, zyxin related protein 1 (ZRP-1), structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.04 E-value=8.6e-11 Score=84.09 Aligned_cols=59 Identities=32% Similarity=0.741 Sum_probs=53.2
Q ss_pred ccccccccccccccC--CeEEecCcccCCCCccccCCccccCCCCcccccCCcccccccccc
Q psy6593 58 KYGEACQNCGQMMSG--PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 58 ~~~~~C~~C~~~i~~--~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
.++++|.+|+++|.+ ..|.+.++.||++||+|..|+++| .+..|+..++..+|..|+..
T Consensus 3 ~~~~~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L-~~~~~~~~~~~~yC~~cy~~ 63 (72)
T 1x61_A 3 SGSSGCGGCGEDVVGDGAGVVALDRVFHVGCFVCSTCRAQL-RGQHFYAVERRAYCEGCYVA 63 (72)
T ss_dssp SCCCCCSSSCSCCCSSSCCEECSSSEECTTTCBCSSSCCBC-TTSCEEESSSCEEEHHHHHH
T ss_pred CCCCCCccCCCccCCCceEEEECCCeEcccCCcccccCCcC-CcCcCEeeCCeEECHHHHHH
Confidence 578999999999974 589999999999999999999999 67889999999999998853
|
| >2cu8_A Cysteine-rich protein 2; CRP2, CRIP2, ESP1 protein, zinc-binding, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.02 E-value=1.7e-10 Score=83.50 Aligned_cols=62 Identities=18% Similarity=0.403 Sum_probs=54.0
Q ss_pred ccccccccccccccccc-CCeEEecCcccCCCCccccCCccccCCCCcccccCCccccc-ccccc
Q psy6593 55 YNGKYGEACQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCS-ACDVM 117 (433)
Q Consensus 55 ~~~~~~~~C~~C~~~i~-~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~-~c~~~ 117 (433)
....++++|.+|+++|. +..+.+.++.||++||+|..|+++|. +..|+..++.++|. .|+..
T Consensus 4 ~~~~~~~~C~~C~~~I~~~~~v~a~~~~~H~~CF~C~~C~~~L~-~~~~~~~~g~~yC~~~cy~~ 67 (76)
T 2cu8_A 4 GSSGMASKCPKCDKTVYFAEKVSSLGKDWHKFCLKCERCSKTLT-PGGHAEHDGKPFCHKPCYAT 67 (76)
T ss_dssp SCCCCCCBCTTTCCBCCTTTEEEETTEEEETTTCBCSSSCCBCC-TTSCEEETTEEECTTTHHHH
T ss_pred ccCCCCCCCcCCCCEeECCeEEEECCeEeeCCCCCCCCCCCccC-CCceEeECCEEecchHHHHH
Confidence 34567899999999997 67889999999999999999999995 66788999999998 68753
|
| >2cor_A Pinch protein; LIM domain, particularly interesting NEW Cys- His protein, LIM and senescent cell antigen-like domains 1, structural genomics; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.00 E-value=1.1e-10 Score=85.01 Aligned_cols=59 Identities=19% Similarity=0.553 Sum_probs=51.6
Q ss_pred cccccccccccccccCCeEEecCcccCCCCccccCCccccCCCCcccccCCcccccccccc
Q psy6593 57 GKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 57 ~~~~~~C~~C~~~i~~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
..+.++|.+|+++|.+..|.+.++.||++||+|..|+.+|..+ .| ..++.++|..|+..
T Consensus 12 ~~~~~~C~~C~~~I~~~~v~a~~~~~H~~CF~C~~C~~~L~~~-~f-~~~g~~yC~~cy~~ 70 (79)
T 2cor_A 12 GLGKYICQKCHAIIDEQPLIFKNDPYHPDHFNCANCGKELTAD-AR-ELKGELYCLPCHDK 70 (79)
T ss_dssp CCCCCBCTTTCCBCCSCCCCCSSSCCCTTTSBCSSSCCBCCTT-CE-EETTEEECHHHHHT
T ss_pred ccCCCCCccCCCEecceEEEECcceeCCCCCEeCCCCCccCCC-CE-eECCEEeCHHHHHH
Confidence 3567899999999999999999999999999999999999644 45 88999999998754
|
| >2l4z_A DNA endonuclease RBBP8, LIM domain transcription LMO4; protein-protein interaction, LIM-interaction DOM LMO4, RBBP8/CTIP, LIM-only protein; HET: DNA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.00 E-value=1.7e-10 Score=91.41 Aligned_cols=60 Identities=28% Similarity=0.584 Sum_probs=53.7
Q ss_pred cccccccccccccccCC-eEEecCcccCCCCccccCCccccC-CCCcccccCCccccccccc
Q psy6593 57 GKYGEACQNCGQMMSGP-VMVVGDHKFHPECFKCTSCSCCIG-DGESYALVERSILCSACDV 116 (433)
Q Consensus 57 ~~~~~~C~~C~~~i~~~-~~~~~~~~~h~~cf~C~~C~~~l~-~g~~~~~~~~~~~C~~c~~ 116 (433)
..+.++|.+|+++|.+. ++.+.++.||++||+|..|+..|. .|..|+.+++..||..|+.
T Consensus 58 ~~~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~~g~~f~~~dg~~yC~~cy~ 119 (123)
T 2l4z_A 58 GLSWKRCAGCGGKIADRFLLYAMDSYWHSRCLKCSSCQAQLGDIGTSSYTKSGMILCRNDYI 119 (123)
T ss_dssp CSSCSBBSSSSSBCCSSSEEEETTEEEETTTSBCTTTCCBGGGTTCCCBCSSSCCBCHHHHH
T ss_pred CccCCcCcCCCCCcCCcEEEEeCCcEEcccccCcCcCCCcccccCCceEEECCEEeCHHHhh
Confidence 45678999999999887 689999999999999999999996 3678999999999999875
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.00 E-value=9.1e-10 Score=100.15 Aligned_cols=97 Identities=20% Similarity=0.165 Sum_probs=81.0
Q ss_pred ccchHHHHhhcC-CcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhc------
Q psy6593 145 NCGQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS------ 217 (433)
Q Consensus 145 ~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~------ 217 (433)
..+|+++|+.+. +..++++++++...+..|+|||+++|.+|.+.+.. ......++.+++.+|..||+
T Consensus 56 ~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~ 129 (263)
T 3tm0_A 56 VEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDC 129 (263)
T ss_dssp HHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTC
T ss_pred HHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccC
Confidence 347999999994 77899999999998999999999999999886422 23345788899999999998
Q ss_pred -----------------------------------------------------CCccccCCCCcceEEccCCceEEeccc
Q psy6593 218 -----------------------------------------------------MNLIHRDLNSQNCLVREDKTVVVADFG 244 (433)
Q Consensus 218 -----------------------------------------------------~~i~H~dlkp~Nil~~~~~~~kl~Dfg 244 (433)
..++|+|++|.||++++++.+.|+||+
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe 209 (263)
T 3tm0_A 130 PYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLG 209 (263)
T ss_dssp SCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCT
T ss_pred CCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEch
Confidence 458999999999999876666799999
Q ss_pred cch
Q psy6593 245 LAR 247 (433)
Q Consensus 245 ~~~ 247 (433)
.+.
T Consensus 210 ~a~ 212 (263)
T 3tm0_A 210 RSG 212 (263)
T ss_dssp TCE
T ss_pred hcc
Confidence 875
|
| >2xqn_T Testin, TESS; metal-binding protein, cytoskeleton, focal adhesion, acrosom; 2.62A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.8e-10 Score=92.31 Aligned_cols=59 Identities=17% Similarity=0.255 Sum_probs=52.2
Q ss_pred CcCCCCCeeEeeccceeecCCCcC--cCCccccccccccCCc-eEeeCCeeeeccccccccc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSL--IFTSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYG 60 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h--~~cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~ 60 (433)
.|.+|+..+..++..|.|+|+.|| +.||+|..|+++|.+. |+.++|++||+.+|.++|.
T Consensus 65 ~C~~C~~~I~~~~~~~~a~~~~~H~~~~CF~C~~C~~~l~~~~f~~~~~~~yC~~~~~~~f~ 126 (126)
T 2xqn_T 65 VCQGCHNAIDPEVQRVTYNNFSWHASTECFLCSCCSKCLIGQKFMPVEGMVFCSVECKKRMS 126 (126)
T ss_dssp BCTTTCSBCCTTSCEEEETTEEEESSTTTSBCTTTCCBCTTSEEEEETTEEESSHHHHHSCC
T ss_pred cCcccCCcCCcCceEEECCCCEeeCCCCCcCcCCCCCccCCCeeEeECCEEcchHHhhhhcC
Confidence 488899876655678999999999 9999999999999876 9999999999988888763
|
| >1x62_A C-terminal LIM domain protein 1; PDZ and LIM domain protein 1, LIM domain protein CLP-36, contractIle protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=98.95 E-value=1.1e-10 Score=85.11 Aligned_cols=57 Identities=28% Similarity=0.612 Sum_probs=51.4
Q ss_pred cccccccccccccCCeEEecCcccCCCCccccCCccccCCCCcccccCCccccccccc
Q psy6593 59 YGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDV 116 (433)
Q Consensus 59 ~~~~C~~C~~~i~~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~ 116 (433)
..++|.+|+++|.+.+|.+.++.||++||+|..|++.|. +..|+..++..+|..|+.
T Consensus 14 ~~~~C~~C~~~I~~~~~~a~~~~~H~~CF~C~~C~~~L~-~~~~~~~~g~~yC~~cy~ 70 (79)
T 1x62_A 14 KLPMCDKCGTGIVGVFVKLRDRHRHPECYVCTDCGTNLK-QKGHFFVEDQIYCEKHAR 70 (79)
T ss_dssp CCCCCSSSCCCCCSSCEECSSCEECTTTTSCSSSCCCHH-HHCCEESSSCEECHHHHH
T ss_pred CCCccccCCCCccCcEEEECcceeCcCcCeeCCCCCCCC-CCCeEeECCEEECHHHHH
Confidence 357999999999999999999999999999999999994 566888999999998875
|
| >1g47_A Pinch protein; LIM domain, Zn finger, cell adhesion; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=98.95 E-value=2.5e-10 Score=82.86 Aligned_cols=60 Identities=18% Similarity=0.427 Sum_probs=52.2
Q ss_pred ccccccccccccccc--CCeEEecCcccCCCCccccCCccccCCCCcccccCCcccccccccc
Q psy6593 57 GKYGEACQNCGQMMS--GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 57 ~~~~~~C~~C~~~i~--~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
..++++|.+|+++|. +.++.+.++.||++||+|..|+++|..+ .|+..++..+|..|+..
T Consensus 8 ~~~~~~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~-~~~~~~g~~yC~~~y~~ 69 (77)
T 1g47_A 8 ALASATCERCKGGFAPAEKIVNSNGELYHEQCFVCAQCFQQFPEG-LFYEFEGRKYCEHDFQM 69 (77)
T ss_dssp CCCCCBCSSSCCBCCSTTTCEEETTEEECTTTCCCTTTCCCCGGG-CSEEETTEEECHHHHHH
T ss_pred CCCCCCchhcCCccCCCceEEEeCccEeccccCeECCCCCCCCCC-CeEeECCeEeCHHHHHH
Confidence 467899999999995 5688999999999999999999999655 58889999999888753
|
| >1x64_A Alpha-actinin-2 associated LIM protein; LIM domain, PDZ and LIM domain 3, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=98.94 E-value=3.2e-10 Score=84.73 Aligned_cols=59 Identities=29% Similarity=0.665 Sum_probs=51.8
Q ss_pred ccccccccccccccCCeEEecCcccCCCCccccCCccccCCCCcccccCCcccccccccc
Q psy6593 58 KYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 58 ~~~~~C~~C~~~i~~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
...++|..|++.|.+.+|.+.++.||++||+|..|++.|.. ..|+..++..+|..|+..
T Consensus 23 ~~~~~C~~C~~~I~~~~~~a~~~~~H~~CF~C~~C~~~L~~-~~~~~~~g~~yC~~~y~~ 81 (89)
T 1x64_A 23 QRMPLCDKCGSGIVGAVVKARDKYRHPECFVCADCNLNLKQ-KGYFFVEGELYCETHARA 81 (89)
T ss_dssp CSCCBCTTTCCBCCSCCEESSSCEECTTTCCCSSSCCCTTT-SCCEEETTEEECHHHHHH
T ss_pred CcCCCcccCCCEecccEEEECCceECccCCEecCCCCCCCC-CCeEeECCEEECHHHHHH
Confidence 34579999999999999999999999999999999999954 468888999999988753
|
| >2dj7_A Actin-binding LIM protein 3; LIM domain, Zn binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=98.88 E-value=8.5e-10 Score=80.39 Aligned_cols=56 Identities=25% Similarity=0.619 Sum_probs=49.5
Q ss_pred cccccccccccc-CCeEEecCcccCCCCccccCCccccCCCCcccccCCcccccccccc
Q psy6593 60 GEACQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 60 ~~~C~~C~~~i~-~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
.++|.+|+++|. +..+.+.++.||++||+|..|+..|. + .|+..++.++|..|+..
T Consensus 15 ~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~-~-~~~~~~g~~yC~~~y~~ 71 (80)
T 2dj7_A 15 PSHCAGCKEEIKHGQSLLALDKQWHVSCFKCQTCSVILT-G-EYISKDGVPYCESDYHA 71 (80)
T ss_dssp CSCCTTTCCCCSSSCCEEETTEEECTTTCBCSSSCCBCS-S-CCEEETTEEECTTHHHH
T ss_pred CCCCcCcCCeeCCCeEEEECCcccccccCCcCcCCCCcC-C-CeEEECCEEECHHHHHH
Confidence 468999999996 67889999999999999999999995 5 58899999999988753
|
| >1iml_A CRIP, cysteine rich intestinal protein; metal-binding protein, LIM domain protein; NMR {Rattus rattus} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=98.87 E-value=8.7e-10 Score=79.66 Aligned_cols=56 Identities=21% Similarity=0.517 Sum_probs=49.3
Q ss_pred ccccccccccc-CCeEEecCcccCCCCccccCCccccCCCCcccccCCccccc-ccccc
Q psy6593 61 EACQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCS-ACDVM 117 (433)
Q Consensus 61 ~~C~~C~~~i~-~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~-~c~~~ 117 (433)
|+|.+|+++|. +..+.+.++.||++||+|..|+.+|..+ .|+..++..+|. .|+..
T Consensus 1 p~C~~C~~~I~~~~~v~a~~~~~H~~CF~C~~C~~~L~~~-~~~~~~g~~yC~~~cy~~ 58 (76)
T 1iml_A 1 PKCPKCDKEVYFAERVTSLGKDWHRPCLKCEKCGKTLTSG-GHAEHEGKPYCNHPCYSA 58 (76)
T ss_dssp CBCTTTSSBCCGGGEEEETTEEEETTTCBCTTTCCBCCTT-TEEEETTEEEETTTHHHH
T ss_pred CcCCCCCCEEECceEEEECCccccCCCCCccccCccCCCC-ceECcCCeEeeCHHHHHH
Confidence 68999999997 7788999999999999999999999654 788899999998 58753
|
| >1j2o_A FLIN2, fusion of rhombotin-2 and LIM domain-binding protein 1; LIM-interaction-domain (LID), metal binding protein; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=98.86 E-value=1.2e-09 Score=85.67 Aligned_cols=58 Identities=22% Similarity=0.528 Sum_probs=52.0
Q ss_pred ccccccccccccCC-eEEecCcccCCCCccccCCccccCC-CCcccccCCcccccccccc
Q psy6593 60 GEACQNCGQMMSGP-VMVVGDHKFHPECFKCTSCSCCIGD-GESYALVERSILCSACDVM 117 (433)
Q Consensus 60 ~~~C~~C~~~i~~~-~~~~~~~~~h~~cf~C~~C~~~l~~-g~~~~~~~~~~~C~~c~~~ 117 (433)
.++|.+|+++|.+. .+.+.++.||++||+|..|+.+|.. |..|+..++.++|..|+..
T Consensus 3 ~~~C~~C~~~I~~~~~~~a~~~~wH~~CF~C~~C~~~L~~~g~~~~~~~g~~yC~~~y~~ 62 (114)
T 1j2o_A 3 LLTCGGCQQNIGDRYFLKAIDQYWHEDCLSCDLCGCRLGEVGRRLYYKLGRKLCRRDYLR 62 (114)
T ss_dssp CBCBSSSCSCBCSSEEEECSSSEECTTTCCCSSSCSCCCCSSSCCCCBTTBCCCHHHHHH
T ss_pred CCCCcCCCCeeCCcEEEEECchhHHHhcCcccccCCchhcCCCeeEEECCeeechHHHHH
Confidence 37899999999888 8899999999999999999999974 6789999999999888753
|
| >2co8_A NEDD9 interacting protein with calponin homology and LIM domains; zinc finger protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=98.85 E-value=1.4e-09 Score=79.73 Aligned_cols=59 Identities=24% Similarity=0.520 Sum_probs=48.5
Q ss_pred cccccccccccc-CCeEEecCcccCCCCccccCCccccCCCCccc-ccCCccccccccccc
Q psy6593 60 GEACQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYA-LVERSILCSACDVML 118 (433)
Q Consensus 60 ~~~C~~C~~~i~-~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~-~~~~~~~C~~c~~~l 118 (433)
.++|.+|+++|. ...+.+.++.||.+||+|..|++.|..+..+. ..++..+|..|+..+
T Consensus 15 ~~~C~~C~~~I~~~e~v~a~~~~wH~~CF~C~~C~~~L~~~~~~~~~~~g~~yC~~~y~~~ 75 (82)
T 2co8_A 15 GDLCALCGEHLYVLERLCVNGHFFHRSCFRCHTCEATLWPGGYEQHPGDGHFYCLQHLPQT 75 (82)
T ss_dssp SCBCSSSCCBCCTTTBCCBTTBCCBTTTCBCSSSCCBCCTTSEECCTTTCCCEETTTCCCC
T ss_pred CCCCcccCCCcccceEEEECCCeeCCCcCEEcCCCCCcCCCceeEeCcCCEEEChHHHHhh
Confidence 468999999995 45777999999999999999999996554332 478899999988654
|
| >2cup_A Skeletal muscle LIM-protein 1; four and half LIM domains protein 1, LIM domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=98.85 E-value=1.2e-09 Score=83.77 Aligned_cols=61 Identities=20% Similarity=0.566 Sum_probs=53.7
Q ss_pred ccccccccccccccc--CCeEEecCcccCCCCccccCCccccCCCCcccccCCccccccccccc
Q psy6593 57 GKYGEACQNCGQMMS--GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVML 118 (433)
Q Consensus 57 ~~~~~~C~~C~~~i~--~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~l 118 (433)
..++++|.+|+++|. +.+|.+.++.||++||+|..|+++| .+..|+..++..+|..|+..+
T Consensus 2 s~~~~~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L-~~~~~~~~~g~~yC~~cy~~~ 64 (101)
T 2cup_A 2 SSGSSGCVECRKPIGADSKEVHYKNRFWHDTCFRCAKCLHPL-ANETFVAKDNKILCNKCTTRE 64 (101)
T ss_dssp CSCCCBCSSSCCBCCSSSCEEEETTEEEETTTCCCSSSCCCT-TSSCCEEETTEEECHHHHTTC
T ss_pred CCCCCcCcccCCcccCCceEEEECccChhhcCCcccccCCCC-CcCeeECcCCEEEChhHhhhh
Confidence 467899999999996 5689999999999999999999999 577889999999998887643
|
| >1a7i_A QCRP2 (LIM1); LIM domain containing proteins, metal-binding protein, zinc finger; NMR {Coturnix japonica} SCOP: g.39.1.3 g.39.1.3 PDB: 2o10_A | Back alignment and structure |
|---|
Probab=98.84 E-value=9.8e-10 Score=80.48 Aligned_cols=59 Identities=22% Similarity=0.571 Sum_probs=49.8
Q ss_pred cccccccccccccc-CCeEEecCcccCCCCccccCCccccCCCCcccccCCcccccccccc
Q psy6593 58 KYGEACQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 58 ~~~~~C~~C~~~i~-~~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
..+++|..|+++|. +..+.+.++.||++||+|..|+++|. +..|+..++..+|..|+..
T Consensus 5 ~~~~~C~~C~~~I~~~~~~~a~~~~~H~~CF~C~~C~~~L~-~~~~~~~~~~~yC~~cy~~ 64 (81)
T 1a7i_A 5 GGGNKCGACGRTVYHAEEVQCDGRSFHRCCFLCMVCRKNLD-STTVAIHDAEVYCKSCYGK 64 (81)
T ss_dssp ---CBCSSSCCBCSSTTEEEETTEEEESSSEECSSSCCEEC-SSCCEEETTEEECSHHHHH
T ss_pred CCCCcCcCcCccccCceeEEeCCcccccccCccCCCCCCCC-CCCeEeeCCEEECHHHHHH
Confidence 35689999999995 66889999999999999999999995 4568888999999988853
|
| >2d8y_A Eplin protein; LIM domain, epithelial protein LOST in neoplasm, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=98.82 E-value=1.7e-09 Score=81.11 Aligned_cols=60 Identities=23% Similarity=0.547 Sum_probs=52.1
Q ss_pred cccccccccccccccC-CeEEecCcccCCCCccccCCccccCCCCcccccCCcccccccccc
Q psy6593 57 GKYGEACQNCGQMMSG-PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 57 ~~~~~~C~~C~~~i~~-~~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
...+++|..|+++|.+ ..+.+.++.||++||+|..|+..|..+ .|+..++..+|..|+..
T Consensus 12 ~~~~~~C~~C~~~I~~~~~v~a~~~~~H~~CF~C~~C~~~L~~~-~~~~~~g~~yC~~~y~~ 72 (91)
T 2d8y_A 12 APARETCVECQKTVYPMERLLANQQVFHISCFRCSYCNNKLSLG-TYASLHGRIYCKPHFNQ 72 (91)
T ss_dssp SSSSCBCTTTCCBCCTTSEEECSSSEEETTTCBCTTTCCBCCTT-TCCCSSSCCCCHHHHHH
T ss_pred CCCCCcCccCCCccCCceeEEECCCEECCCCCeeCCCCCCCCCC-CcEeECCEEECHHHHHH
Confidence 3457899999999975 678899999999999999999999655 48899999999999854
|
| >2rgt_A Fusion of LIM/homeobox protein LHX3, linker, INSU enhancer protein ISL-1; protein-protein complex, LIM domain, Zn finger, activator, D binding; 2.05A {Mus musculus} PDB: 3mmk_A | Back alignment and structure |
|---|
Probab=98.82 E-value=7.7e-10 Score=93.33 Aligned_cols=85 Identities=15% Similarity=0.124 Sum_probs=58.1
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCccccccccccC-Cc-eE-eeCCeeeeccccccccccccc--cccccccCCeEE
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTSGCSACDVMLD-NW-YF-EKDGLLFCKEDYNGKYGEACQ--NCGQMMSGPVMV 76 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf~C~~C~~~l~-~~-~~-~~~~~~~C~~~~~~~~~~~C~--~C~~~i~~~~~~ 76 (433)
.|.+|++.+.-.+..+.|+++.||+.||+|..|+++|. +. |+ .++|++||+.||.+.+...+. +++++.+ .+.
T Consensus 67 ~C~~C~~~I~~~~~v~~a~~~~~H~~CF~C~~C~~~L~~g~~f~~~~~g~~~C~~c~~~~~~~~~~~~~~~rprt--~~~ 144 (169)
T 2rgt_A 67 KCAACQLGIPPTQVVRRAQDFVYHLHCFACVVCKRQLATGDEFYLMEDSRLVCKADYETAKQGGSGGSGGSGGGT--PMV 144 (169)
T ss_dssp BCTTTCCBCCTTSEEEEETTEEEEGGGCBCTTTCCBCCTTCEEEECTTSCEEEHHHHHHHHHCC----------E--EEE
T ss_pred cccccccccCCCcEEEEcCCceEeeCCCcCCCCCCCCCCCCceEEccCCeEECHHHHHHHhhccCCCCCCcCCCC--ccc
Confidence 47889886653344568999999999999999999996 44 65 468999999999998876553 2222221 444
Q ss_pred ecCcccCCCCcc
Q psy6593 77 VGDHKFHPECFK 88 (433)
Q Consensus 77 ~~~~~~h~~cf~ 88 (433)
+....+|...|.
T Consensus 145 ~~q~~~l~~~f~ 156 (169)
T 2rgt_A 145 AASPERHDGGLQ 156 (169)
T ss_dssp CCCCEECCSSCC
T ss_pred HHHHHHHHHHHh
Confidence 444555666554
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.77 E-value=7.4e-09 Score=93.75 Aligned_cols=93 Identities=19% Similarity=0.209 Sum_probs=72.4
Q ss_pred chHHHHhhcCCcc--eeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCC-----
Q psy6593 147 GQVAVLRSLHHHN--VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN----- 219 (433)
Q Consensus 147 ~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~----- 219 (433)
.|+++|+.+.+.+ +++++++...++..++||||++|.+|. ... .+ ...++.+++..|..||+..
T Consensus 62 ~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~ 132 (264)
T 1nd4_A 62 DEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCP 132 (264)
T ss_dssp HHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCC
T ss_pred HHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCC
Confidence 7999999995434 677999988888899999999998884 211 11 2356677777777777643
Q ss_pred -----------------------------------------------------ccccCCCCcceEEccCCceEEeccccc
Q psy6593 220 -----------------------------------------------------LIHRDLNSQNCLVREDKTVVVADFGLA 246 (433)
Q Consensus 220 -----------------------------------------------------i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 246 (433)
++|+|++|.||++++++.+.|+||+.+
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a 212 (264)
T 1nd4_A 133 FDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL 212 (264)
T ss_dssp CBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred CchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhc
Confidence 999999999999987766779999987
Q ss_pred hh
Q psy6593 247 RI 248 (433)
Q Consensus 247 ~~ 248 (433)
..
T Consensus 213 ~~ 214 (264)
T 1nd4_A 213 GV 214 (264)
T ss_dssp EE
T ss_pred cc
Confidence 53
|
| >1m3v_A FLIN4, fusion of the LIM interacting domain of LDB1 and the N-terminal LIM domain of LMO4...; fusion protein, LMO proteins, metal binding protein; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=98.75 E-value=1.1e-09 Score=86.91 Aligned_cols=61 Identities=28% Similarity=0.578 Sum_probs=53.0
Q ss_pred cccccccccccccccCC-eEEecCcccCCCCccccCCccccCC-CCcccccCCcccccccccc
Q psy6593 57 GKYGEACQNCGQMMSGP-VMVVGDHKFHPECFKCTSCSCCIGD-GESYALVERSILCSACDVM 117 (433)
Q Consensus 57 ~~~~~~C~~C~~~i~~~-~~~~~~~~~h~~cf~C~~C~~~l~~-g~~~~~~~~~~~C~~c~~~ 117 (433)
.++.++|.+|+++|.+. ++.+.++.||++||+|..|+.+|.. |..|+..++.++|..|+..
T Consensus 2 s~~~~~C~~C~~~I~~~~~~~a~~~~wH~~CF~C~~C~~~L~~~~~~~~~~~g~~yC~~cy~~ 64 (122)
T 1m3v_A 2 SLSWKRCAGCGGKIADRFLLYAMDSYWHSRCLKCSSCQAQLGDIGTSSYTKSGMILCRNDYIR 64 (122)
T ss_dssp CSCCCCBSSSSSCCCSSCCEEETTEEECHHHHCCSSSCCCTTTSEECCEEETTEEECHHHHHH
T ss_pred CCCCCCCcccCCEeCCcEEEEECCceeHhhCCCcCCCCCcccccCCeEEEECCeeecHHHHHH
Confidence 35678999999999887 5899999999999999999999963 6778899999888887753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.74 E-value=1.5e-08 Score=96.52 Aligned_cols=99 Identities=14% Similarity=0.288 Sum_probs=81.3
Q ss_pred chHHHHhhcC--CcceeeEEEEEEeC---CeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhc----
Q psy6593 147 GQVAVLRSLH--HHNVIRFIGVLYKD---RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS---- 217 (433)
Q Consensus 147 ~E~~~l~~l~--h~~iv~~~~~~~~~---~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~---- 217 (433)
+|+.+|+.|. +..+++++.++.+. +..|+||||++|.++.+... ..++......++.+++..|..||+
T Consensus 85 ~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~ 161 (359)
T 3dxp_A 85 REYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQ 161 (359)
T ss_dssp HHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTT
T ss_pred HHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCch
Confidence 7999999996 45689999988766 35899999999988754221 237788889999999999999996
Q ss_pred ------------------------------------------------------CCccccCCCCcceEEccCC--ceEEe
Q psy6593 218 ------------------------------------------------------MNLIHRDLNSQNCLVREDK--TVVVA 241 (433)
Q Consensus 218 ------------------------------------------------------~~i~H~dlkp~Nil~~~~~--~~kl~ 241 (433)
..++|+|++|.||+++.++ .+.|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~vi 241 (359)
T 3dxp_A 162 AIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVL 241 (359)
T ss_dssp TTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEEC
T ss_pred hccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEE
Confidence 4689999999999999765 36899
Q ss_pred ccccchh
Q psy6593 242 DFGLARI 248 (433)
Q Consensus 242 Dfg~~~~ 248 (433)
||+.+..
T Consensus 242 Dwe~a~~ 248 (359)
T 3dxp_A 242 DWELSTL 248 (359)
T ss_dssp CCTTCEE
T ss_pred Ccccccc
Confidence 9998763
|
| >2jtn_A LIM domain-binding protein 1, LIM/homeobox protein LHX3; intramolecular (fusion) protein-protein complex, protein binding/transcription complex; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=98.67 E-value=1.1e-08 Score=87.29 Aligned_cols=70 Identities=17% Similarity=0.361 Sum_probs=58.3
Q ss_pred CCeeeeccccc---cccccccccccccccCC-eEEecCcccCCCCccccCCccccCCCCcccccCCcccccccccc
Q psy6593 46 DGLLFCKEDYN---GKYGEACQNCGQMMSGP-VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 46 ~~~~~C~~~~~---~~~~~~C~~C~~~i~~~-~~~~~~~~~h~~cf~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
++..||..++. ....++|.+|+++|.+. ++.+.++.||++||+|..|+.+|.. ..| ..++..+|..|+..
T Consensus 43 ~~~~~~~~~~~~~~~~~~~~C~~C~~~I~~~~~~~a~~~~wH~~CF~C~~C~~~L~~-~~f-~~~g~~yC~~~y~~ 116 (182)
T 2jtn_A 43 DDEGGSGGHMGSGGTPEIPMCAGCDQHILDRFILKALDRHWHSKCLKCSDCHVPLAE-RCF-SRGESVYCKDDFFK 116 (182)
T ss_dssp SSSCSSSSSCCCCCCCSCCBCBTSSSBCCCSEEEEETTEEECSSTTSCTTTCCCCSS-CCE-EETTEEECHHHHHH
T ss_pred ccccccccccccCCCCCCCcCccCCCCccCceeEEecCCeEccccCccCCCCCccCC-Cce-eECCEeeecCcccc
Confidence 45689999987 55568999999999887 5789999999999999999999954 445 68888888888753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.48 E-value=2.7e-08 Score=92.44 Aligned_cols=102 Identities=25% Similarity=0.269 Sum_probs=75.5
Q ss_pred ccchHHHHhhc-CCcc--eeeEEEEEEeCC---eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhc-
Q psy6593 145 NCGQVAVLRSL-HHHN--VIRFIGVLYKDR---KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS- 217 (433)
Q Consensus 145 ~~~E~~~l~~l-~h~~--iv~~~~~~~~~~---~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~- 217 (433)
.-+|+++|+.+ .+.. +++++......+ ..|+||++++|.+|.+.... .++..+...++.+++..|..||+
T Consensus 57 ~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~ 133 (304)
T 3sg8_A 57 LFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSI 133 (304)
T ss_dssp HHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcC
Confidence 34799999988 3333 566666544333 35899999999888753321 36777778888888888888885
Q ss_pred ---------------------------------------------------------CCccccCCCCcceEEcc--CCce
Q psy6593 218 ---------------------------------------------------------MNLIHRDLNSQNCLVRE--DKTV 238 (433)
Q Consensus 218 ---------------------------------------------------------~~i~H~dlkp~Nil~~~--~~~~ 238 (433)
..++|+|++|.||++++ ++.+
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~ 213 (304)
T 3sg8_A 134 NISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTIC 213 (304)
T ss_dssp CCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEE
T ss_pred CCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEE
Confidence 24799999999999998 5668
Q ss_pred EEeccccchhc
Q psy6593 239 VVADFGLARII 249 (433)
Q Consensus 239 kl~Dfg~~~~~ 249 (433)
.|+||+.+..-
T Consensus 214 ~~iD~~~~~~~ 224 (304)
T 3sg8_A 214 GIIDFGDAAIS 224 (304)
T ss_dssp EECCCTTCEEE
T ss_pred EEEeCCCCccC
Confidence 89999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=5.4e-06 Score=75.27 Aligned_cols=96 Identities=21% Similarity=0.208 Sum_probs=73.3
Q ss_pred chHHHHhhcC-CcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC-------
Q psy6593 147 GQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM------- 218 (433)
Q Consensus 147 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~------- 218 (433)
.|+.+|+.|. +--|++++.++.+.+..++|||+++|.++.+.... .......+..++...|..||+.
T Consensus 68 ~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~-----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~ 142 (272)
T 4gkh_A 68 DEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEE-----YPDSGENIVDALAVFLRRLHSIPVCNCPF 142 (272)
T ss_dssp HHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHH-----CGGGHHHHHHHHHHHHHHHHTSCGGGCCB
T ss_pred HHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccC-----CHHHHHHHHHHHHHHHHHhcCCCcccCCc
Confidence 6999999884 44588999999999999999999999888776532 1223334555555666655531
Q ss_pred ---------------------------------------------------CccccCCCCcceEEccCCceEEeccccch
Q psy6593 219 ---------------------------------------------------NLIHRDLNSQNCLVREDKTVVVADFGLAR 247 (433)
Q Consensus 219 ---------------------------------------------------~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 247 (433)
.++|+|+.+.||++++++.+-|+||+.+.
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 143 NSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp BCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 27899999999999988777899999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=9.2e-06 Score=75.30 Aligned_cols=100 Identities=24% Similarity=0.241 Sum_probs=70.4
Q ss_pred cchHHHHhhcCCc---ceeeEEEEEE-eCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC---
Q psy6593 146 CGQVAVLRSLHHH---NVIRFIGVLY-KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM--- 218 (433)
Q Consensus 146 ~~E~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~--- 218 (433)
-.|+++|+.|.+. .|++++.+.. ..+..++|||+++|.+|.+..-. .++......++.++...|..||+.
T Consensus 57 ~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~ 133 (306)
T 3tdw_A 57 NKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVE 133 (306)
T ss_dssp HHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHH
T ss_pred HHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcc
Confidence 3899999999642 4778888775 34567899999999888763221 244455555555555555555532
Q ss_pred ---------------------------------------------------------CccccCCCCcceEEcc---CCc-
Q psy6593 219 ---------------------------------------------------------NLIHRDLNSQNCLVRE---DKT- 237 (433)
Q Consensus 219 ---------------------------------------------------------~i~H~dlkp~Nil~~~---~~~- 237 (433)
.++|+|++|.||+++. ++.
T Consensus 134 ~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~ 213 (306)
T 3tdw_A 134 TAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPL 213 (306)
T ss_dssp HHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCE
T ss_pred cccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCce
Confidence 4589999999999987 355
Q ss_pred eEEeccccchh
Q psy6593 238 VVVADFGLARI 248 (433)
Q Consensus 238 ~kl~Dfg~~~~ 248 (433)
+.|+||+.+..
T Consensus 214 ~~~iD~~~a~~ 224 (306)
T 3tdw_A 214 TGIIDFGDAAI 224 (306)
T ss_dssp EEECCCTTCEE
T ss_pred EEEEehhhcCC
Confidence 58999998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.07 E-value=1.4e-05 Score=68.58 Aligned_cols=139 Identities=15% Similarity=0.110 Sum_probs=95.1
Q ss_pred CCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhc-CCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccccc
Q psy6593 183 GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMA 261 (433)
Q Consensus 183 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 261 (433)
.||.++|+..+.+++++++|.++.|.+.+|.-+-. ..-..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 47999998878899999999999999999888721 1112344557889999999888764 1111
Q ss_pred cchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccc
Q psy6593 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNK 340 (433)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (433)
.....+.+||... ...+.+.=|||||+++|..+. |.+..
T Consensus 98 -------------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~-------------------- 137 (229)
T 2yle_A 98 -------------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN-------------------- 137 (229)
T ss_dssp ----------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT--------------------
T ss_pred -------------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc--------------------
Confidence 0112366888764 244567789999999999994 33321
Q ss_pred cCCCCcHHHHHHHHHhccc-------------------------CCCCCCChhHHHHHHHh
Q psy6593 341 FCASCPEPFVRIAFLCCDL-------------------------NPDQRPPFEVLEVWLEG 376 (433)
Q Consensus 341 ~~~~~~~~l~~li~~~l~~-------------------------~p~~RPs~~~i~~~l~~ 376 (433)
....++++|.+||..|.+. .+..|+++++|++.-..
T Consensus 138 eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~ 198 (229)
T 2yle_A 138 EERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA 198 (229)
T ss_dssp EEECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHT
T ss_pred cchhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHh
Confidence 1245689999999999866 24578888888877665
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=3.2e-05 Score=73.20 Aligned_cols=41 Identities=17% Similarity=0.094 Sum_probs=31.1
Q ss_pred cchHHHHhhcC-C--cceeeEEEEEEeC---CeeeEEEeccCCCCHH
Q psy6593 146 CGQVAVLRSLH-H--HNVIRFIGVLYKD---RKLNLVTEYIAGGTLK 186 (433)
Q Consensus 146 ~~E~~~l~~l~-h--~~iv~~~~~~~~~---~~~~lv~e~~~g~sL~ 186 (433)
.+|+.+|+.|. + -.+++++.+..+. +..++|||+++|.++.
T Consensus 75 ~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 75 DHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp HHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred HHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence 37899999984 3 4688888887654 3568999999987654
|
| >1zfo_A LAsp-1; LIM domain, zinc-finger, metal-binding protein; NMR {Sus scrofa} SCOP: g.39.1.4 | Back alignment and structure |
|---|
Probab=96.88 E-value=0.00021 Score=40.91 Aligned_cols=27 Identities=7% Similarity=-0.134 Sum_probs=23.4
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
.|..|+..+... |.+.+.|+.||+.||
T Consensus 5 ~C~~C~k~Vy~~-Ek~~~~g~~~Hk~CF 31 (31)
T 1zfo_A 5 NCARCGKIVYPT-EKVNCLDKFWHKACF 31 (31)
T ss_dssp BCSSSCSBCCGG-GCCCSSSSCCCGGGC
T ss_pred cCCccCCEEecc-eeEEECCeEecccCC
Confidence 489999988755 778899999999998
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0014 Score=60.21 Aligned_cols=29 Identities=17% Similarity=0.259 Sum_probs=24.7
Q ss_pred CccccCCCCcceEEccCCceEEeccccchh
Q psy6593 219 NLIHRDLNSQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 219 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
.++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 5899999999999 5667789999997753
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0015 Score=61.02 Aligned_cols=31 Identities=32% Similarity=0.465 Sum_probs=27.7
Q ss_pred cCCccccCCCCcceEEccCCceEEeccccch
Q psy6593 217 SMNLIHRDLNSQNCLVREDKTVVVADFGLAR 247 (433)
Q Consensus 217 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 247 (433)
...++|+|+++.||+++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 3689999999999999888889999999774
|
| >1zfo_A LAsp-1; LIM domain, zinc-finger, metal-binding protein; NMR {Sus scrofa} SCOP: g.39.1.4 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.00025 Score=40.57 Aligned_cols=28 Identities=25% Similarity=0.645 Sum_probs=23.9
Q ss_pred cccccccccccc-CCeEEecCcccCCCCc
Q psy6593 60 GEACQNCGQMMS-GPVMVVGDHKFHPECF 87 (433)
Q Consensus 60 ~~~C~~C~~~i~-~~~~~~~~~~~h~~cf 87 (433)
+++|..|++.+. ...+.+.++.||..||
T Consensus 3 ~~~C~~C~k~Vy~~Ek~~~~g~~~Hk~CF 31 (31)
T 1zfo_A 3 NPNCARCGKIVYPTEKVNCLDKFWHKACF 31 (31)
T ss_dssp CCBCSSSCSBCCGGGCCCSSSSCCCGGGC
T ss_pred CCcCCccCCEEecceeEEECCeEecccCC
Confidence 479999999994 4577789999999997
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0036 Score=58.32 Aligned_cols=32 Identities=38% Similarity=0.527 Sum_probs=27.6
Q ss_pred cCCccccCCCCcceEEccC----CceEEeccccchh
Q psy6593 217 SMNLIHRDLNSQNCLVRED----KTVVVADFGLARI 248 (433)
Q Consensus 217 ~~~i~H~dlkp~Nil~~~~----~~~kl~Dfg~~~~ 248 (433)
...++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4579999999999999874 6899999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0045 Score=59.23 Aligned_cols=30 Identities=30% Similarity=0.358 Sum_probs=25.7
Q ss_pred cCCccccCCCCcceEEccCCceEEeccccch
Q psy6593 217 SMNLIHRDLNSQNCLVREDKTVVVADFGLAR 247 (433)
Q Consensus 217 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 247 (433)
...++|+|+.|.||+++.++ ++|+||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~~-~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEHE-TKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCCC-eEEEeCcccc
Confidence 45799999999999998764 8999998765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.30 E-value=0.0043 Score=58.90 Aligned_cols=100 Identities=17% Similarity=0.269 Sum_probs=62.9
Q ss_pred ccchHHHHhhcC-CcceeeEEEEEEeCCeeeEEEeccCCCCHHH--------------Hh---cCC----CCCCC--hHH
Q psy6593 145 NCGQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKE--------------LL---QDP----GQPLP--WGQ 200 (433)
Q Consensus 145 ~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~--------------~l---~~~----~~~~~--~~~ 200 (433)
..+|..+++.|. +.-.+++++.+.+ .+||||++|.+|.. .+ ... ++... +..
T Consensus 100 ~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~ 175 (379)
T 3feg_A 100 LVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGT 175 (379)
T ss_dssp HHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHH
Confidence 348999999884 3334777776542 29999999865431 11 111 11122 345
Q ss_pred HHHHHHHHHHH-------------------Hhhh----h----cCCccccCCCCcceEEccC----CceEEeccccchh
Q psy6593 201 RVNFARDIAAG-------------------MTYL----H----SMNLIHRDLNSQNCLVRED----KTVVVADFGLARI 248 (433)
Q Consensus 201 ~~~i~~qi~~~-------------------L~~l----H----~~~i~H~dlkp~Nil~~~~----~~~kl~Dfg~~~~ 248 (433)
+.+++.++-.. +..| . ...++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 176 i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 176 MERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 55555544221 2222 1 1369999999999999876 7899999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.09 E-value=0.011 Score=54.57 Aligned_cols=39 Identities=18% Similarity=0.075 Sum_probs=33.2
Q ss_pred chHHHHhhcC---CcceeeEEEEEEeCCeeeEEEeccCCCCH
Q psy6593 147 GQVAVLRSLH---HHNVIRFIGVLYKDRKLNLVTEYIAGGTL 185 (433)
Q Consensus 147 ~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~g~sL 185 (433)
.|++.|+.|. ...+++++.+....+..++|||+++|.++
T Consensus 77 ~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 77 AEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp HHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred HHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 6889998883 36799999998888899999999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.75 E-value=0.017 Score=54.53 Aligned_cols=29 Identities=21% Similarity=0.361 Sum_probs=24.4
Q ss_pred CCccccCCCCcceEEccCCceEEeccccch
Q psy6593 218 MNLIHRDLNSQNCLVREDKTVVVADFGLAR 247 (433)
Q Consensus 218 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 247 (433)
..++|+|+.+.||+++.++ +.|+||..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 3699999999999998655 8999998775
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.50 E-value=0.033 Score=53.65 Aligned_cols=32 Identities=28% Similarity=0.393 Sum_probs=28.3
Q ss_pred hcCCccccCCCCcceEEccCCceEEeccccchh
Q psy6593 216 HSMNLIHRDLNSQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 216 H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
+...++|+|++|.||+++.++ +.|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 567899999999999998776 99999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.03 E-value=0.047 Score=52.51 Aligned_cols=29 Identities=24% Similarity=0.471 Sum_probs=25.9
Q ss_pred CccccCCCCcceEEccCCceEEeccccchh
Q psy6593 219 NLIHRDLNSQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 219 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
.++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 5899999999999 7788999999998763
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.74 E-value=0.076 Score=48.83 Aligned_cols=30 Identities=30% Similarity=0.354 Sum_probs=26.2
Q ss_pred CCccccCCCCcceEEccCCceEEeccccch
Q psy6593 218 MNLIHRDLNSQNCLVREDKTVVVADFGLAR 247 (433)
Q Consensus 218 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 247 (433)
.+++|+|+.+.||++++++.+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 479999999999999987666899999775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.60 E-value=0.17 Score=46.56 Aligned_cols=30 Identities=30% Similarity=0.331 Sum_probs=25.6
Q ss_pred cCCccccCCCCcceEEccCCceEEeccccchh
Q psy6593 217 SMNLIHRDLNSQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 217 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
...++|+|+++.||+++ + .+.|+||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 45689999999999998 4 899999987653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.54 E-value=0.06 Score=51.46 Aligned_cols=30 Identities=23% Similarity=0.419 Sum_probs=25.2
Q ss_pred CccccCCCCcceEE------ccCCceEEeccccchh
Q psy6593 219 NLIHRDLNSQNCLV------REDKTVVVADFGLARI 248 (433)
Q Consensus 219 ~i~H~dlkp~Nil~------~~~~~~kl~Dfg~~~~ 248 (433)
.++|+|+.+.||++ ++++.+.++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 3467899999998763
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=90.53 E-value=0.2 Score=46.52 Aligned_cols=31 Identities=23% Similarity=0.462 Sum_probs=27.3
Q ss_pred CCccccCCCCcceEEccCCceEEeccccchh
Q psy6593 218 MNLIHRDLNSQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 218 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.87 E-value=0.86 Score=38.95 Aligned_cols=85 Identities=8% Similarity=0.080 Sum_probs=61.7
Q ss_pred CCcceeeEEEEEEeCCeeeEEEeccC-CCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc
Q psy6593 156 HHHNVIRFIGVLYKDRKLNLVTEYIA-GGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 234 (433)
Q Consensus 156 ~h~~iv~~~~~~~~~~~~~lv~e~~~-g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~ 234 (433)
.||+++.. .+-.+++.+.+.++.-+ +-++.. ++ ..+....++++.+|+....+++ .-+|--|.|+||+++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik----~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK----SFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTR 114 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG----GSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH----hcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcC
Confidence 57888866 56666676666666543 223333 33 3788999999999998875543 3467789999999999
Q ss_pred CCceEEeccccchh
Q psy6593 235 DKTVVVADFGLARI 248 (433)
Q Consensus 235 ~~~~kl~Dfg~~~~ 248 (433)
++.+++.-.|+...
T Consensus 115 ~~~p~i~~RGik~~ 128 (215)
T 4ann_A 115 DGLPIAKTRGLQNV 128 (215)
T ss_dssp TSCEEESCCEETTT
T ss_pred CCCEEEEEccCccC
Confidence 99999988887543
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.49 E-value=1.6 Score=37.42 Aligned_cols=84 Identities=7% Similarity=0.026 Sum_probs=61.6
Q ss_pred CCcceeeEEEEEEeCCeeeEEEeccCCC-CHHHHhcCCCCCCChHHHHHHHHHHHHHHh-hhhcCCccccCCCCcceEEc
Q psy6593 156 HHHNVIRFIGVLYKDRKLNLVTEYIAGG-TLKELLQDPGQPLPWGQRVNFARDIAAGMT-YLHSMNLIHRDLNSQNCLVR 233 (433)
Q Consensus 156 ~h~~iv~~~~~~~~~~~~~lv~e~~~g~-sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~-~lH~~~i~H~dlkp~Nil~~ 233 (433)
.||++ -..+-.+++.+.+.++.-++. ++. .+++ ++....++++.+|+.... ++ ..-+|--|.|+||+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~~----~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIRK----TTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFN 118 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHHT----SCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEEC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHHh----cCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEe
Confidence 57888 344446777777777755333 444 4433 788999999999988766 44 4457788999999999
Q ss_pred cCCceEEeccccchh
Q psy6593 234 EDKTVVVADFGLARI 248 (433)
Q Consensus 234 ~~~~~kl~Dfg~~~~ 248 (433)
.++.+++.-.|+-..
T Consensus 119 ~~~~p~i~hRGi~~~ 133 (219)
T 4ano_A 119 RALEPFFLHVGVKES 133 (219)
T ss_dssp TTCCEEESCCEETTT
T ss_pred CCCcEEEEEcCCccc
Confidence 999999998887543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=88.93 E-value=0.41 Score=46.41 Aligned_cols=36 Identities=14% Similarity=0.164 Sum_probs=25.5
Q ss_pred cchHHHHhhcCCcc-eeeEEEEEEeCCeeeEEEeccCCCCH
Q psy6593 146 CGQVAVLRSLHHHN-VIRFIGVLYKDRKLNLVTEYIAGGTL 185 (433)
Q Consensus 146 ~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~g~sL 185 (433)
-+|..+|+.|...+ .+++++.+. + .+||||++|.+|
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred HHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 37999999996444 467887762 2 359999987544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=87.26 E-value=0.4 Score=46.12 Aligned_cols=35 Identities=20% Similarity=0.358 Sum_probs=24.2
Q ss_pred chHHHHhhcC-CcceeeEEEEEEeCCeeeEEEeccCCCCH
Q psy6593 147 GQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTL 185 (433)
Q Consensus 147 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g~sL 185 (433)
+|+.+++.|. +.-.+++++.+. + .+|+||++|.+|
T Consensus 124 ~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~l~G~~l 159 (429)
T 1nw1_A 124 AESVIFTLLSERHLGPKLYGIFS--G--GRLEEYIPSRPL 159 (429)
T ss_dssp HHHHHHHHHHHTTSSSCEEEEET--T--EEEECCCCEEEC
T ss_pred HHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEEeCCccc
Confidence 6999999884 333477777653 2 389999987443
|
| >1t1h_A Gspef-atpub14, armadillo repeat containing protein; ubiquitin ligase, E3 ligase, U-BOX,; NMR {Arabidopsis thaliana} SCOP: g.44.1.2 | Back alignment and structure |
|---|
Probab=82.62 E-value=0.61 Score=32.56 Aligned_cols=48 Identities=6% Similarity=0.092 Sum_probs=36.6
Q ss_pred cCCccccccccccCCceEeeCCeeeeccccccccc---cccccccccccCC
Q psy6593 26 IFTSGCSACDVMLDNWYFEKDGLLFCKEDYNGKYG---EACQNCGQMMSGP 73 (433)
Q Consensus 26 ~~cf~C~~C~~~l~~~~~~~~~~~~C~~~~~~~~~---~~C~~C~~~i~~~ 73 (433)
+.-|.|..|...+..-.....|..||+.|..+.+. ..|..|++.+...
T Consensus 6 ~~~~~C~IC~~~~~~Pv~~~CgH~fc~~Ci~~~~~~~~~~CP~C~~~~~~~ 56 (78)
T 1t1h_A 6 PEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHA 56 (78)
T ss_dssp SSSSSCTTTSCCCSSEEEETTTEEEEHHHHHHHHTTTCCBCTTTCCBCSSC
T ss_pred cccCCCCCccccccCCEEcCCCCeecHHHHHHHHHHCcCCCCCCcCCCChh
Confidence 45689999999886656667999999999877653 3577787777543
|
| >1jm7_B BARD1, BRCA1-associated ring domain protein 1; ring finger, zinc-binding protein, heterodimer, ubiquitin ligase, antitumor; NMR {Homo sapiens} SCOP: g.44.1.1 | Back alignment and structure |
|---|
Probab=80.88 E-value=0.84 Score=34.86 Aligned_cols=44 Identities=20% Similarity=0.313 Sum_probs=34.6
Q ss_pred CccccccccccCCceEe-eCCeeeecccccccccccccccccccc
Q psy6593 28 TSGCSACDVMLDNWYFE-KDGLLFCKEDYNGKYGEACQNCGQMMS 71 (433)
Q Consensus 28 cf~C~~C~~~l~~~~~~-~~~~~~C~~~~~~~~~~~C~~C~~~i~ 71 (433)
-+.|..|...+..-... .-|..||..|..+.+...|..|+..+.
T Consensus 22 ~~~C~IC~~~~~~pv~~~~CgH~fC~~Ci~~~~~~~CP~Cr~~~~ 66 (117)
T 1jm7_B 22 LLRCSRCTNILREPVCLGGCEHIFCSNCVSDCIGTGCPVCYTPAW 66 (117)
T ss_dssp TTSCSSSCSCCSSCBCCCSSSCCBCTTTGGGGTTTBCSSSCCBCS
T ss_pred CCCCCCCChHhhCccEeCCCCCHHHHHHHHHHhcCCCcCCCCcCc
Confidence 57899998888655555 789999999998877767777777763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 433 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-43 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-43 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-42 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-42 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-41 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-41 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-40 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-39 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-38 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-36 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-33 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-32 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-32 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-30 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-30 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-26 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-26 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-26 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-20 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-19 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-19 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-15 | |
| d1x6aa1 | 34 | g.39.1.3 (A:8-41) Lim domain kinase 2 {Human (Homo | 2e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-13 | |
| d1v6ga1 | 41 | g.39.1.3 (A:1-41) Actin-binding LIM protein 2, abL | 6e-12 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-12 | |
| d1x3ha1 | 35 | g.39.1.3 (A:8-42) Leupaxin {Human (Homo sapiens) [ | 1e-08 | |
| d1x6aa2 | 34 | g.39.1.3 (A:42-75) Lim domain kinase 2 {Human (Hom | 6e-06 | |
| d2dj7a1 | 31 | g.39.1.3 (A:44-74) Actin-binding LIM protein 3, ab | 4e-04 | |
| d2dj7a1 | 31 | g.39.1.3 (A:44-74) Actin-binding LIM protein 3, ab | 4e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 3e-50
Identities = 68/240 (28%), Positives = 110/240 (45%), Gaps = 27/240 (11%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V VLR H N++ F+G +L +VT++ G +L L + ++ AR
Sbjct: 55 VGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 113
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
A GM YLH+ ++IHRDL S N + ED TV + DFGLA + +
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW---------------- 157
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQE---YDETVDVFSYGIVLCEII-GRVPADPDYL 324
+ + G+ WMAPE++ Q+ Y DV+++GIVL E++ G++P
Sbjct: 158 ---SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214
Query: 325 PRSPDFGLDQTDFR---NKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381
F + + +K ++CP+ R+ C D+RP F + +E L+ L
Sbjct: 215 RDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-46
Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 26/234 (11%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDR-KLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFAR 206
+V+ L H N+++ +GV+ +++ L +VTEY+A G+L + L+ G L + F+
Sbjct: 51 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 110
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
D+ M YL N +HRDL ++N LV ED V+DFGL +
Sbjct: 111 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--------------- 155
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPR 326
+ T W APE + +++ DV+S+GI+L EI +P
Sbjct: 156 ---------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 206
Query: 327 SPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMH 380
+ ++ CP + C L+ RP F L LE + H
Sbjct: 207 KDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 6e-46
Identities = 54/230 (23%), Positives = 92/230 (40%), Gaps = 28/230 (12%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ +L S H N+++ + Y + L ++ E+ AGG + ++ + +PL Q +
Sbjct: 60 IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQT 119
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
+ YLH +IHRDL + N L D + +ADFG++ +
Sbjct: 120 LDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---------------- 163
Query: 269 QRRGARKKRYTVVGNPYWMAPEMM-----TGQEYDETVDVFSYGIVLCEII-GRVPADPD 322
++R + +G PYWMAPE++ + YD DV+S GI L E+ P
Sbjct: 164 -----IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218
Query: 323 YLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF-EVLE 371
R + F C + N D R ++L+
Sbjct: 219 NPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 8e-46
Identities = 53/236 (22%), Positives = 89/236 (37%), Gaps = 23/236 (9%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
++ L + ++R IGV + L LV E GG L + L + +P +
Sbjct: 60 AQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 118
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
+ GM YL N +HRDL ++N L+ ++DFGL++ + T
Sbjct: 119 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA---------- 168
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYLPR 326
R W APE + +++ DV+SYG+ + E + G+ P P
Sbjct: 169 --------RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 220
Query: 327 SPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLS 382
+ R + CP + C + RP F +E + L+
Sbjct: 221 --VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (391), Expect = 2e-44
Identities = 63/227 (27%), Positives = 89/227 (39%), Gaps = 30/227 (13%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V L+ L H N I++ G ++ LV EY G L +PL +
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGA 124
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G+ YLHS N+IHRD+ + N L+ E V + DFG A I+
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---------------- 168
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQ---EYDETVDVFSYGIVLCEIIGRVPADPDYLP 325
+ VG PYWMAPE++ +YD VDV+S GI E+ R P +
Sbjct: 169 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219
Query: 326 RSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF-EVLE 371
S + + Q + E F C P RP +L+
Sbjct: 220 MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 6e-44
Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 27/224 (12%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V + L H N++R G + ++ L+ EY GT+ LQ + + ++
Sbjct: 57 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITEL 115
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
A ++Y HS +IHRD+ +N L+ + +ADFG +
Sbjct: 116 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---------------- 159
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328
+R T+ G ++ PEM+ G+ +DE VD++S G++ E + P +
Sbjct: 160 -------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 212
Query: 329 DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF-EVLE 371
+ + +F F E + NP QRP EVLE
Sbjct: 213 YKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 154 bits (390), Expect = 9e-44
Identities = 50/281 (17%), Positives = 103/281 (36%), Gaps = 30/281 (10%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
++++ LHH +I ++ L+ E+++GG L + + + + +N+ R
Sbjct: 77 ISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQA 136
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVR--EDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
G+ ++H +++H D+ +N + + +V + DFGLA ++
Sbjct: 137 CEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-------------- 182
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVP-ADPDYL 324
+ + APE++ + D+++ G++ ++ G P A D L
Sbjct: 183 --------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 234
Query: 325 PRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF-EVLE-VWLEGLSMHLS 382
+ +F +S P +R + LE WL+G H +
Sbjct: 235 ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD--HSN 292
Query: 383 VDKPLPSDLEADIYQFATRKSASPLTEPECTAPTPADGALR 423
+ +PS I Q K A +LR
Sbjct: 293 LTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLR 333
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-43
Identities = 60/228 (26%), Positives = 96/228 (42%), Gaps = 22/228 (9%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARD 207
+++ L H ++R V + ++TEY+ G+L + L+ P G L + ++ A
Sbjct: 59 ANLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
IA GM ++ N IHRDL + N LV + + +ADFGLAR+I
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE--------- 168
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
W APE + + DV+S+GI+L EI+ +
Sbjct: 169 -----------GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217
Query: 328 PDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375
+ +R +CPE ++ LC P+ RP F+ L LE
Sbjct: 218 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-43
Identities = 50/226 (22%), Positives = 89/226 (39%), Gaps = 29/226 (12%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ VL + ++ F G Y D ++++ E++ GG+L ++L+ G +P + +
Sbjct: 55 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAV 113
Query: 209 AAGMTYLHSMN-LIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
G+TYL + ++HRD+ N LV + + DFG++ +
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--------------- 158
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDYLPR 326
+ VG +M+PE + G Y D++S G+ L E+ GR P P
Sbjct: 159 --------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP---D 207
Query: 327 SPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372
+ + L A P D RPP + E+
Sbjct: 208 AKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFEL 253
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (382), Expect = 4e-43
Identities = 63/245 (25%), Positives = 102/245 (41%), Gaps = 23/245 (9%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+++ H NVI GV+ K + ++TE++ G+L L+ Q V R I
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGI 137
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
AAGM YL MN +HRDL ++N LV + V+DFGL+R + PT
Sbjct: 138 AAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY---------- 187
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328
W APE + +++ DV+SYGIV+ E++ +
Sbjct: 188 ------TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
Query: 329 DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPLP 388
+ D+R CP ++ C + + RP F + L+ + + P
Sbjct: 242 VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN-------P 294
Query: 389 SDLEA 393
+ L+A
Sbjct: 295 NSLKA 299
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 5e-43
Identities = 52/224 (23%), Positives = 89/224 (39%), Gaps = 21/224 (9%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V+ +L H +++ GV K R + ++TEY+A G L L++ Q + +D+
Sbjct: 50 AKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 109
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
M YL S +HRDL ++NCLV + V V+DFGL+R + +
Sbjct: 110 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV---------- 159
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328
W PE++ ++ D++++G+++ EI + S
Sbjct: 160 ----------GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209
Query: 329 DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF-EVLE 371
R E I + C D+RP F +L
Sbjct: 210 TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLS 253
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-42
Identities = 48/227 (21%), Positives = 87/227 (38%), Gaps = 20/227 (8%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V++ L + ++R IG+ + + LV E G L + LQ + + +
Sbjct: 59 ANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQV 116
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
+ GM YL N +HRDL ++N L+ ++DFGL++ +
Sbjct: 117 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA---------- 166
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328
+ W APE + ++ DV+S+G+++ E + S
Sbjct: 167 --------QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
Query: 329 DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375
+ + R A CP + LC + + RP F +E+ L
Sbjct: 219 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 5e-42
Identities = 52/230 (22%), Positives = 88/230 (38%), Gaps = 20/230 (8%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V+ L H +++ GV + + LV E++ G L + L+ + D+
Sbjct: 51 AEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 110
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
GM YL +IHRDL ++NCLV E++ + V+DFG+ R + +
Sbjct: 111 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS----------- 159
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328
W +PE+ + Y DV+S+G+++ E+ + S
Sbjct: 160 ---------TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210
Query: 329 DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378
T FR +I C P+ RP F L L ++
Sbjct: 211 VVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 147 bits (373), Expect = 6e-42
Identities = 62/244 (25%), Positives = 108/244 (44%), Gaps = 21/244 (8%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARD 207
AV++ + H N+++ +GV ++ ++TE++ G L + L++ Q + + A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
I++ M YL N IHRDL ++NCLV E+ V VADFGL+R++
Sbjct: 124 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA--------- 174
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
W APE + ++ DV+++G++L EI + + S
Sbjct: 175 -----------GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 223
Query: 328 PDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPL 387
+ L + D+R + CPE + C NP RP F + E + S+ +
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 283
Query: 388 PSDL 391
+L
Sbjct: 284 EKEL 287
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 6e-42
Identities = 66/245 (26%), Positives = 108/245 (44%), Gaps = 35/245 (14%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ V+R + N++ ++ +L +V EY+AGG+L +++ + GQ R+
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCREC 125
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
+ +LHS +IHRD+ S N L+ D +V + DFG I
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---------------- 169
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDYLPRS 327
+ KR T+VG PYWMAPE++T + Y VD++S GI+ E+I G P + R+
Sbjct: 170 -----QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224
Query: 328 PDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF-EVLEVWLEGLSMH--LSVD 384
+ F C D++ ++R E+L+ H L +
Sbjct: 225 LYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--------HQFLKIA 276
Query: 385 KPLPS 389
KPL S
Sbjct: 277 KPLSS 281
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 4e-41
Identities = 54/234 (23%), Positives = 90/234 (38%), Gaps = 33/234 (14%)
Query: 149 VAVLRSLHHHNVIRFIGVLY--KDRKLNLVTEYIAGGTLKELLQDPG---QPLPWGQRVN 203
V +LR L H N++R+ + + L +V EY GG L ++ Q L +
Sbjct: 54 VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 113
Query: 204 FARDIAAGMTYLH-----SMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTT 258
+ + H ++HRDL N + + V + DFGLARI++
Sbjct: 114 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
Query: 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVP 318
+ G PY+M+PE M Y+E D++S G +L E+ +P
Sbjct: 174 FV---------------------GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 212
Query: 319 ADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF-EVLE 371
+ + + + FR + + I +L RP E+LE
Sbjct: 213 PFTAFSQKELAGKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 5e-41
Identities = 63/252 (25%), Positives = 91/252 (36%), Gaps = 45/252 (17%)
Query: 149 VAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ------------- 194
+ ++ L H N++ +G + L+ EY G L L+ +
Sbjct: 91 LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 195 ---------PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGL 245
L + + FA +A GM +L + +HRDL ++N LV K V + DFGL
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 246 ARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305
AR I R WMAPE + Y DV+S
Sbjct: 211 ARDIMSDSN-------------------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWS 251
Query: 306 YGIVLCEII--GRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQ 363
YGI+L EI G P P + + L Q F+ E I C + +
Sbjct: 252 YGILLWEIFSLGVNP-YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRK 310
Query: 364 RPPFEVLEVWLE 375
RP F L +L
Sbjct: 311 RPSFPNLTSFLG 322
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 146 bits (369), Expect = 8e-41
Identities = 37/228 (16%), Positives = 82/228 (35%), Gaps = 27/228 (11%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ + L H ++ D ++ ++ E+++GG L E + D + + V + R +
Sbjct: 74 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 133
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLV--REDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
G+ ++H N +H DL +N + + + + DFGL +
Sbjct: 134 CKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--------------- 178
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVP-ADPDYL 324
++ G + APE+ G+ D++S G++ ++ G P +
Sbjct: 179 -------KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 231
Query: 325 PRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF-EVLE 371
+ + + + E +P+ R + LE
Sbjct: 232 ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-40
Identities = 64/229 (27%), Positives = 100/229 (43%), Gaps = 18/229 (7%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
++ HHN+IR GV+ K + + ++TEY+ G L + L++ Q V R I
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 119
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
AAGM YL +MN +HRDL ++N LV + V+DFGL+R++ P A T
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG------- 172
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328
W APE ++ +++ DV+S+GIV+ E++ L
Sbjct: 173 -----------GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
Query: 329 DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377
FR CP ++ C +RP F + L+ L
Sbjct: 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-40
Identities = 54/243 (22%), Positives = 95/243 (39%), Gaps = 31/243 (12%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ + + L+H NV++F G + L EY +GG L + ++ +P F +
Sbjct: 54 ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQL 112
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
AG+ YLH + + HRD+ +N L+ E + ++DFGLA + R
Sbjct: 113 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------- 162
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYD-ETVDVFSYGIVLCEII-GRVPADPDYLPR 326
+ G ++APE++ +E+ E VDV+S GIVL ++ G +P D
Sbjct: 163 ---------NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 213
Query: 327 SPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF-EVLEVWLEGLSMHLSVDK 385
+ + + NP R ++ + +K
Sbjct: 214 QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK--------DRWYNK 265
Query: 386 PLP 388
PL
Sbjct: 266 PLK 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-40
Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 22/228 (9%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKEL-LQDPGQPLPWGQRVNFARD 207
V++ L H +++ V+ ++ + +VTEY++ G+L + + G+ L Q V+ A
Sbjct: 63 AQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
IA+GM Y+ MN +HRDL + N LV E+ VADFGLAR+I
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ--------- 172
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327
W APE + DV+S+GI+L E+ + +
Sbjct: 173 -----------GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 221
Query: 328 PDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLE 375
+ +R CPE + C P++RP FE L+ +LE
Sbjct: 222 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (361), Expect = 4e-40
Identities = 63/260 (24%), Positives = 98/260 (37%), Gaps = 58/260 (22%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG--------------- 193
A++ + N+++ +GV + + L+ EY+A G L E L+
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 194 --------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGL 245
PL +++ AR +AAGM YL +HRDL ++NCLV E+ V +ADFGL
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 246 ARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305
+R I+ WM PE + Y DV++
Sbjct: 187 SRNIYSADYYKAD-------------------GNDAIPIRWMPPESIFYNRYTTESDVWA 227
Query: 306 YGIVLCEIIGRVPADPDYLPRSPDFGLDQTDF--------RNKFCASCPEPFVRIAFLCC 357
YG+VL EI P +G+ + +CP + LC
Sbjct: 228 YGVVLWEIF--------SYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCW 279
Query: 358 DLNPDQRPPFEVLEVWLEGL 377
P RP F + L+ +
Sbjct: 280 SKLPADRPSFCSIHRILQRM 299
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-39
Identities = 47/283 (16%), Positives = 96/283 (33%), Gaps = 34/283 (12%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+++L H N++ +L ++ E+I+G + E + L + V++ +
Sbjct: 52 ISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQV 111
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLV--REDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
+ +LHS N+ H D+ +N + R T+ + +FG AR + G
Sbjct: 112 CEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-------------- 157
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDYLP 325
+ P + APE+ D++S G ++ ++ G P +
Sbjct: 158 --------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209
Query: 326 RSPDFGLDQT-DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF-EVLE-VWL-EGLSMHL 381
+ + ++ F + + R E L+ WL + +
Sbjct: 210 QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER-- 267
Query: 382 SVDKPLPSDLEADIYQFATRKSASPLTEPECTAPTPADGALRP 424
V + L+ Y K + A GA+R
Sbjct: 268 -VSTKVIRTLKHRRYYHTLIKKDLNMVVSA--ARISCGGAIRS 307
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-39
Identities = 63/245 (25%), Positives = 93/245 (37%), Gaps = 38/245 (15%)
Query: 149 VAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ---------------DP 192
+ VL L HH N+I +G L L EY G L + L+
Sbjct: 61 LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120
Query: 193 GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252
L Q ++FA D+A GM YL IHRDL ++N LV E+ +ADFGL+R
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180
Query: 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCE 312
K+ WMA E + Y DV+SYG++L E
Sbjct: 181 ----------------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 218
Query: 313 IIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372
I+ + + + +R + +C + + C P +RP F + V
Sbjct: 219 IVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 278
Query: 373 WLEGL 377
L +
Sbjct: 279 SLNRM 283
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 3e-39
Identities = 62/248 (25%), Positives = 91/248 (36%), Gaps = 38/248 (15%)
Query: 149 VAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ----------------- 190
+ VL L +H N++ +G ++TEY G L L+
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 191 DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIH 250
D L ++F+ +A GM +L S N IHRDL ++N L+ + + DFGLAR I
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 251 QGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310
WMAPE + Y DV+SYGI L
Sbjct: 197 NDSNYVVKGN-------------------ARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237
Query: 311 CEII-GRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEV 369
E+ P S + + + FR P I C D +P +RP F+
Sbjct: 238 WELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 297
Query: 370 LEVWLEGL 377
+ +E
Sbjct: 298 IVQLIEKQ 305
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-39
Identities = 58/230 (25%), Positives = 88/230 (38%), Gaps = 23/230 (10%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V + SL H N+IR GV + +VTE G+L + L+ G +A +
Sbjct: 62 VNAMHSLDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
A GM YL S IHRDL ++N L+ V + DFGL R + Q
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM---------- 170
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII--GRVPADPDYLPR 326
+ W APE + + + D + +G+ L E+ G+ P
Sbjct: 171 --------QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-WIGLNGS 221
Query: 327 SPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF-EVLEVWLE 375
+D+ R CP+ + C P+ RP F + + LE
Sbjct: 222 QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 4e-39
Identities = 55/232 (23%), Positives = 89/232 (38%), Gaps = 34/232 (14%)
Query: 149 VAVLRSLHHHNVIRFIGVLY----KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF 204
+L+ L H N++RF + + LVTE + GTLK L+ + + ++
Sbjct: 59 AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSW 117
Query: 205 ARDIAAGMTYLHSMN--LIHRDLNSQNCLVR-EDKTVVVADFGLARIIHQGPRAPTTVMA 261
R I G+ +LH+ +IHRDL N + +V + D GLA +
Sbjct: 118 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---------- 167
Query: 262 KVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPAD 320
V+G P +MAPEM + YDE+VDV+++G+ + E+ P
Sbjct: 168 -------------SFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYS 213
Query: 321 PDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF-EVLE 371
+ F I C N D+R ++L
Sbjct: 214 ECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 7e-39
Identities = 48/229 (20%), Positives = 89/229 (38%), Gaps = 21/229 (9%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+R H ++++ IGV + + ++ E G L+ LQ L + +A +
Sbjct: 59 ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
+ + YL S +HRD+ ++N LV + V + DFGL+R + +
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS---------- 167
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328
WMAPE + + + DV+ +G+ + EI+ + +
Sbjct: 168 ----------KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217
Query: 329 DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377
G + R +CP + C +P +RP F L+ L +
Sbjct: 218 VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (353), Expect = 8e-39
Identities = 50/261 (19%), Positives = 107/261 (40%), Gaps = 33/261 (12%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+AVL + H N++ + L L+ + ++GG L + + + G +
Sbjct: 58 IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQV 116
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
+ YLH + ++HRDL +N L ED ++++DFGL+++ G
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG------------- 163
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDYL 324
T G P ++APE++ + Y + VD +S G++ ++ G P +
Sbjct: 164 ---------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 214
Query: 325 PRSPDFGLDQT-DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF-EVLE-VWLEGLSMHL 381
+ + L +F + + + + +P++R + L+ W+ G +
Sbjct: 215 AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT--- 271
Query: 382 SVDKPLPSDLEADIYQFATRK 402
++DK + + I + +
Sbjct: 272 ALDKNIHQSVSEQIKKNFAKS 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 3e-38
Identities = 56/263 (21%), Positives = 101/263 (38%), Gaps = 20/263 (7%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V+ S+ + +V R +G+ + L+T+ + G L + +++ + +N+ I
Sbjct: 62 AYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
A GM YL L+HRDL ++N LV+ + V + DFGLA+++ +
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--------- 171
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328
WMA E + + Y DV+SYG+ + E++ D +P S
Sbjct: 172 ----------GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221
Query: 329 DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPLP 388
+ + R C I C ++ D RP F L + ++ +
Sbjct: 222 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 281
Query: 389 SDLEADIYQFATRKSASPLTEPE 411
D + L + E
Sbjct: 282 GDERMHLPSPTDSNFYRALMDEE 304
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 5e-38
Identities = 56/231 (24%), Positives = 94/231 (40%), Gaps = 20/231 (8%)
Query: 149 VAVLRSLHHHNVIRFIGVLYK-DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
+++ H NV+ +G+ + + +V Y+ G L+ +++ + F
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+A GM +L S +HRDL ++NC++ E TV VADFGLAR ++
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT------ 192
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDYLPR 326
WMA E + Q++ DV+S+G++L E++ P PD
Sbjct: 193 -----------GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 241
Query: 327 SPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377
L Q R CP+P + C + RP F L + +
Sbjct: 242 DITVYLLQ-GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 4e-37
Identities = 41/230 (17%), Positives = 86/230 (37%), Gaps = 26/230 (11%)
Query: 151 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 210
V+ L H ++ D KL Y G L + ++ G + +I +
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVS 119
Query: 211 GMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQR 270
+ YLH +IHRDL +N L+ ED + + DFG A+++ +
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA------------ 167
Query: 271 RGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDYLPRSPD 329
+ VG +++PE++T + ++ D+++ G ++ +++ G P + +
Sbjct: 168 -------NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEY 216
Query: 330 FGLDQ-TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378
+ F + L+ +R E +E + +
Sbjct: 217 LIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 135 bits (340), Expect = 4e-37
Identities = 41/254 (16%), Positives = 73/254 (28%), Gaps = 23/254 (9%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ + + I I + N++ + G +L++L + + A +
Sbjct: 53 SKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQM 112
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVRE---DKTVVVADFGLARIIHQGPRAPTTVMAKVPR 265
+ + Y+HS N IHRD+ N L+ V + DFGLA+
Sbjct: 113 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY----- 167
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLP 325
++ + G + + G E D+ S G VL
Sbjct: 168 ---------RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218
Query: 326 RSPDFGLDQTDFRN------KFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379
+ ++ + C P F C L D +P + L L
Sbjct: 219 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278
Query: 380 HLSVDKPLPSDLEA 393
D
Sbjct: 279 RQGFSYDYVFDWNM 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 134 bits (339), Expect = 5e-37
Identities = 37/240 (15%), Positives = 79/240 (32%), Gaps = 25/240 (10%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ L I + ++ N++ + G +L++LL G+ A+ +
Sbjct: 51 YRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQM 110
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVRE-----DKTVVVADFGLARIIHQGPRAPTTVMAKV 263
A + +H +L++RD+ N L+ + V DFG+ +
Sbjct: 111 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY--- 167
Query: 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDY 323
+++ + G +M+ G+E D+ + G V +
Sbjct: 168 -----------REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216
Query: 324 LPRSPDF------GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377
+ Q+ + CA PE F + +L D P ++ L+ +
Sbjct: 217 KAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 3e-36
Identities = 70/246 (28%), Positives = 108/246 (43%), Gaps = 35/246 (14%)
Query: 148 QVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ---------------D 191
++ +++ + H N+I +G +D L ++ EY + G L+E LQ +
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 192 PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251
P + L V+ A +A GM YL S IHRDL ++N LV ED + +ADFGLAR IH
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLC 311
T ++P WMAPE + + Y DV+S+G++L
Sbjct: 188 IDYYKKTTNGRLP-------------------VKWMAPEALFDRIYTHQSDVWSFGVLLW 228
Query: 312 EIIGRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE 371
EI + +P F L + R ++C + C P QRP F+ L
Sbjct: 229 EIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
Query: 372 VWLEGL 377
L+ +
Sbjct: 289 EDLDRI 294
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 9e-36
Identities = 54/269 (20%), Positives = 87/269 (32%), Gaps = 57/269 (21%)
Query: 148 QVAVLRSLHHHNVIRFIGVLYKDR----KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 203
++ L H N++ FI KD +L LV++Y G+L + L + +
Sbjct: 47 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIK 104
Query: 204 FARDIAAGMTYLHS--------MNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255
A A+G+ +LH + HRDL S+N LV+++ T +AD GLA
Sbjct: 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164
Query: 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ------EYDETVDVFSYGIV 309
VG +MAPE++ E + D+++ G+V
Sbjct: 165 IDI-----------------APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 207
Query: 310 LCEIIGRVPADPDYLPRSPDF--------------------GLDQTDFRNKFCASCPEPF 349
EI R + + L
Sbjct: 208 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM 267
Query: 350 VRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378
+I C N R ++ L LS
Sbjct: 268 AKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-35
Identities = 50/235 (21%), Positives = 91/235 (38%), Gaps = 37/235 (15%)
Query: 152 LRSLHHHNVIRFIGVLY----KDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFAR 206
R+ +++R + V + L +V E + GG L +QD G Q + +
Sbjct: 59 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLV---REDKTVVVADFGLARIIHQGPRAPTTVMAKV 263
I + YLHS+N+ HRD+ +N L R + + + DFG A+
Sbjct: 119 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH----------- 167
Query: 264 PRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDY 323
T PY++APE++ ++YD++ D++S G+++ ++ P
Sbjct: 168 -----------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216
Query: 324 LPRSPDFGL------DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF-EVLE 371
+ G+ Q +F N + E + P QR E +
Sbjct: 217 HGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 128 bits (323), Expect = 7e-35
Identities = 47/234 (20%), Positives = 84/234 (35%), Gaps = 27/234 (11%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLN----LVTEYIAGGTLKELLQDPGQPLPWGQRVNF 204
+L+H ++ + +V EY+ G TL++++ G P+ + +
Sbjct: 58 AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEV 116
Query: 205 ARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVP 264
D + + H +IHRD+ N ++ V V DFG+AR I + T
Sbjct: 117 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT------- 169
Query: 265 RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYL 324
+ V+G +++PE G D DV+S G VL E++ P
Sbjct: 170 -----------QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218
Query: 325 PRSPDFGLDQTD--FRNKFCASCPEPFVRIAFLCCDLNPDQRPPF--EVLEVWL 374
P S + + D + + NP+ R E+ +
Sbjct: 219 PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 7e-35
Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 28/238 (11%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------QPLPWG 199
+V++ + H+V+R +GV+ + + ++ E + G LK L+ P
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 200 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259
+ + A +IA GM YL++ +HRDL ++NC+V ED TV + DFG+ R I++
Sbjct: 134 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG- 192
Query: 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPA 319
+ WM+PE + + DV+S+G+VL EI
Sbjct: 193 ------------------GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234
Query: 320 DPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377
L +CP+ + +C NP RP F + ++
Sbjct: 235 PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 125 bits (314), Expect = 1e-33
Identities = 46/233 (19%), Positives = 87/233 (37%), Gaps = 33/233 (14%)
Query: 149 VAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
V +LR + H N+I+ + LV + + G L + L + L + R
Sbjct: 60 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRA 118
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
+ + LH +N++HRDL +N L+ +D + + DFG + + G
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--------------- 163
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQE------YDETVDVFSYGIVLCEII-GRVPAD 320
+K V G P ++APE++ Y + VD++S G+++ ++ G P
Sbjct: 164 -------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 216
Query: 321 PDYLPRSPDFGLDQT-DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF-EVLE 371
+ F + + + + P +R E L
Sbjct: 217 HRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 2e-32
Identities = 47/221 (21%), Positives = 88/221 (39%), Gaps = 28/221 (12%)
Query: 150 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIA 209
+ + H + L V EY+ GG L +Q + +A +I
Sbjct: 55 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEII 113
Query: 210 AGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQ 269
G+ +LHS +++RDL N L+ +D + +ADFG+ + G
Sbjct: 114 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----------------- 156
Query: 270 RRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDYLPRSP 328
K T G P ++APE++ GQ+Y+ +VD +S+G++L E++ G+ P + +
Sbjct: 157 ----DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP----FHGQDE 208
Query: 329 DFGLDQTDFRN-KFCASCPEPFVRIAFLCCDLNPDQRPPFE 368
+ N + + + P++R
Sbjct: 209 EELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVR 249
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 3e-32
Identities = 58/244 (23%), Positives = 88/244 (36%), Gaps = 36/244 (14%)
Query: 151 VLRSLHHHNVIRFIGVLYKD-RKLNLVTEYIAGGTLKELLQDPG---------------Q 194
++ HH NV+ +G K L ++ E+ G L L+
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 195 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254
L + ++ +A GM +L S IHRDL ++N L+ E V + DFGLAR I++ P
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP- 188
Query: 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII 314
++ WMAPE + + Y DV+S+G++L EI
Sbjct: 189 ------------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230
Query: 315 -GRVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVW 373
P + R + + C P QRP F L
Sbjct: 231 SLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
Query: 374 LEGL 377
L L
Sbjct: 291 LGNL 294
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 123 bits (309), Expect = 4e-32
Identities = 42/219 (19%), Positives = 82/219 (37%), Gaps = 26/219 (11%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
++++ + ++ + KL+ + + + GG L L G +A +I
Sbjct: 58 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEI 116
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G+ ++H+ +++RDL N L+ E V ++D GLA
Sbjct: 117 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF------------------- 157
Query: 269 QRRGARKKRYTVVGNPYWMAPEM-MTGQEYDETVDVFSYGIVLCEII-GRVPADPDYLPR 326
++KK + VG +MAPE+ G YD + D FS G +L +++ G P
Sbjct: 158 ----SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213
Query: 327 SPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
+ + S + + ++R
Sbjct: 214 KHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRL 252
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 4e-30
Identities = 48/230 (20%), Positives = 93/230 (40%), Gaps = 30/230 (13%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
V++L+ + H NVI V + L+ E +AGG L + L + L + F + I
Sbjct: 64 VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQI 122
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVRED----KTVVVADFGLARIIHQGPRAPTTVMAKVP 264
G+ YLHS+ + H DL +N ++ + + + DFGLA I G
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG------------ 170
Query: 265 RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADPDY 323
+ + G P ++APE++ + D++S G++ ++ G P D
Sbjct: 171 ----------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220
Query: 324 LPRS-PDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPF-EVLE 371
+ + +F +++ ++ +P +R + L+
Sbjct: 221 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (291), Expect = 5e-30
Identities = 47/218 (21%), Positives = 92/218 (42%), Gaps = 27/218 (12%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+L + H +IR G +++ ++ +YI GG L L Q P +A ++
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEV 113
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
+ YLHS ++I+RDL +N L+ ++ + + DFG A+ +
Sbjct: 114 CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----------------- 156
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328
YT+ G P ++APE+++ + Y++++D +S+GI++ E++ D
Sbjct: 157 -------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 209
Query: 329 DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP 366
+ + R F E + + QR
Sbjct: 210 YEKILNAELR--FPPFFNEDVKDLLSRLITRDLSQRLG 245
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 2e-29
Identities = 41/240 (17%), Positives = 80/240 (33%), Gaps = 43/240 (17%)
Query: 149 VAVLRSLH--HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
V +L+ + VIR + + L+ E L +F
Sbjct: 58 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDK-TVVVADFGLARIIHQGPRAPTTVMAKVPR 265
+ + + H+ ++HRD+ +N L+ ++ + + DFG ++
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------------ 165
Query: 266 KAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY-DETVDVFSYGIVLCEII-GRVPADPDY 323
G + PE + Y + V+S GI+L +++ G +P
Sbjct: 166 -----------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----- 209
Query: 324 LPRSPDFGLDQTDFRNK--FCASCPEPFVRIAFLCCDLNPDQRPPF-EVLE-VWLEGLSM 379
F D+ R + F + C L P RP F E+ W++ + +
Sbjct: 210 ------FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 263
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 3e-29
Identities = 49/304 (16%), Positives = 99/304 (32%), Gaps = 62/304 (20%)
Query: 149 VAVLRSLHHHNVIRFIGVLY------KDRKLNLVTEYIAGGTLKELLQ--DPGQPLPWGQ 200
+ ++R L H N++R Y + LNLV +Y+ + Q LP
Sbjct: 64 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 201 RVNFARDIAAGMTYLHSMNLIHRDLN-SQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259
+ + + Y+HS + HRD+ L + + + DFG A+ + +G + +
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVP 318
++ Y + +Y ++DV+S G VL E++ G+
Sbjct: 184 CSR---------------------YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
Query: 319 -----------------------ADPDYLPRSPDFGLDQT---DFRNKFCASCPEPFVRI 352
+ P +F Q + F P + +
Sbjct: 223 FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282
Query: 353 AFLCCDLNPDQRP-PFEVLE-VWLEGL---SMHLSVDKPLPSDLEADIYQFATRKSASPL 407
+ P R P E + + L ++ L + P+ + ++ + +
Sbjct: 283 CSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI 342
Query: 408 TEPE 411
P
Sbjct: 343 LIPP 346
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 6e-27
Identities = 62/258 (24%), Positives = 93/258 (36%), Gaps = 54/258 (20%)
Query: 152 LRSLHHHNVIRFIGVLYKDR-----KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFAR 206
L + H NV+R V R KL LV E++ L + P +P +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 207 DIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRK 266
+ G+ +LHS ++HRDL QN LV + +ADFGLARI
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--------------- 168
Query: 267 AAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPD---- 322
+ +VV ++ APE++ Y VD++S G + E+ R P
Sbjct: 169 -------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 221
Query: 323 ----------YLPRSPDFGLDQTDFRNKFCASCPEPFVRIA---------FL--CCDLNP 361
LP D+ D R F + +P + L C NP
Sbjct: 222 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNP 281
Query: 362 DQRPPF-EVLE-VWLEGL 377
+R L + + L
Sbjct: 282 AKRISAYSALSHPYFQDL 299
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 105 bits (263), Expect = 2e-26
Identities = 53/252 (21%), Positives = 98/252 (38%), Gaps = 51/252 (20%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+++L+ L H N+++ V++ ++L LV E++ K L G L +F +
Sbjct: 51 ISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQL 109
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G+ Y H ++HRDL QN L+ + + +ADFGLAR
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP---------------- 153
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQE-YDETVDVFSYGIVLCEII-GRVP-------- 318
+K + ++ AP+++ G + Y T+D++S G + E++ G
Sbjct: 154 -----VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208
Query: 319 -----------ADPDYLPR-------SPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLN 360
+ P P+F + + F E + + L+
Sbjct: 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLD 268
Query: 361 PDQRPPF-EVLE 371
P+QR + LE
Sbjct: 269 PNQRITAKQALE 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 106 bits (266), Expect = 3e-26
Identities = 44/218 (20%), Positives = 88/218 (40%), Gaps = 27/218 (12%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+L++++ +++ + L +V EY+AGG + L+ G +A I
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQI 150
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
YLHS++LI+RDL +N L+ + + V DFG A+ +
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----------------- 193
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328
+ +T+ G P +APE++ + Y++ VD ++ G+++ E+ P P
Sbjct: 194 -------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 329 DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP 366
+ R F + + ++ +R
Sbjct: 247 YEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKRFG 282
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 3e-26
Identities = 53/271 (19%), Positives = 98/271 (36%), Gaps = 59/271 (21%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ +L+ L H N+I + ++LV +++ +++D L +
Sbjct: 51 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMT 109
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G+ YLH ++HRDL N L+ E+ + +ADFGLA+ RA T
Sbjct: 110 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT----------- 158
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVP--------- 318
V ++ APE++ G + Y VD+++ G +L E++ RVP
Sbjct: 159 ----------HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 208
Query: 319 -----------------ADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNP 361
D LP F + ++ + + + NP
Sbjct: 209 QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNP 268
Query: 362 DQRP-PFEVLE-VWLEGLSMHLSVDKPLPSD 390
R + L+ + ++P P+
Sbjct: 269 CARITATQALKMKYFS--------NRPGPTP 291
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 5e-26
Identities = 48/258 (18%), Positives = 87/258 (33%), Gaps = 55/258 (21%)
Query: 149 VAVLRSLHHHNVIRFIGVL----YKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF 204
+ +L H N+I ++ + K + ++ G L +LL+ Q L F
Sbjct: 57 IKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYF 114
Query: 205 ARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVP 264
I G+ Y+HS N++HRDL N L+ + + DFGLAR+
Sbjct: 115 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF------ 168
Query: 265 RKAAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEII-GRVP---- 318
V ++ APE M+ + Y +++D++S G +L E++ R
Sbjct: 169 ------------LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216
Query: 319 ---------------ADPDYLPRSPDFGLDQTDFR---------NKFCASCPEPFVRIAF 354
+ L + N+ + + +
Sbjct: 217 HYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD 276
Query: 355 LCCDLNPDQRP-PFEVLE 371
NP +R + L
Sbjct: 277 KMLTFNPHKRIEVEQALA 294
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 7e-26
Identities = 49/283 (17%), Positives = 93/283 (32%), Gaps = 63/283 (22%)
Query: 149 VAVLRSLHHHNVIRFIGVLY--------KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 200
+ +L+ L H NV+ I + + LV ++ LL + +
Sbjct: 60 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-GLLSNVLVKFTLSE 118
Query: 201 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260
+ + G+ Y+H ++HRD+ + N L+ D + +ADFGLAR +
Sbjct: 119 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPA 319
V ++ PE++ G ++Y +D++ G ++ E+ R P
Sbjct: 179 -----------------TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
Query: 320 DPD---------------YLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFL--------- 355
+ +D + K + L
Sbjct: 222 MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYA 281
Query: 356 ------CCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPLPSDLE 392
L+P QR + + L+ P+PSDL+
Sbjct: 282 LDLIDKLLVLDPAQRIDSD------DALNHDFFWSDPMPSDLK 318
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 2e-25
Identities = 41/217 (18%), Positives = 79/217 (36%), Gaps = 24/217 (11%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
VL++ H + +L V EY GG L L + + + +I
Sbjct: 56 SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEI 114
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
+ + YLHS ++++RD+ +N ++ +D + + DFGL +
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---------------- 158
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328
T G P ++APE++ +Y VD + G+V+ E++ +
Sbjct: 159 -----GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 329 DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
+ + R F + + +P QR
Sbjct: 214 FELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRL 248
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 5e-25
Identities = 54/274 (19%), Positives = 104/274 (37%), Gaps = 63/274 (22%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+++L+ L+H N+++ + V++ + KL LV E++ K + +P ++ +
Sbjct: 52 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G+ + HS ++HRDL QN L+ + + +ADFGLAR
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---------------- 155
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEY-DETVDVFSYGIVLCEII-GRVP-------- 318
+ V ++ APE++ G +Y VD++S G + E++ R
Sbjct: 156 -----VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 210
Query: 319 ---------------------ADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCC 357
+ PDY P P + +K E +
Sbjct: 211 QLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW---ARQDFSKVVPPLDEDGRSLLSQML 267
Query: 358 DLNPDQRPPF-EVLE-VWLEGLSMHLSVDKPLPS 389
+P++R L + + ++ KP+P
Sbjct: 268 HYDPNKRISAKAALAHPFFQDVT------KPVPH 295
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 4e-24
Identities = 42/222 (18%), Positives = 83/222 (37%), Gaps = 26/222 (11%)
Query: 149 VAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 207
VL + ++ + KL+L+ +YI GG L L + + + +
Sbjct: 79 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGE 137
Query: 208 IAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKA 267
I + +LH + +I+RD+ +N L+ + VV+ DFGL++
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF------- 190
Query: 268 AQRRGARKKRYTVVGNPYWMAPEMMTGQE--YDETVDVFSYGIVLCEII-GRVPADPDYL 324
G +MAP+++ G + +D+ VD +S G+++ E++ G P D
Sbjct: 191 -------------CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237
Query: 325 PRSPDFGLDQT-DFRNKFCASCPEPFVRIAFLCCDLNPDQRP 365
S + + + +P +R
Sbjct: 238 KNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRL 279
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 93.8 bits (232), Expect = 7e-22
Identities = 40/176 (22%), Positives = 75/176 (42%), Gaps = 32/176 (18%)
Query: 149 VAVLRSLHHH-NVIRFIGVLY--KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFA 205
+ +L +L N+I ++ R LV E++ K+L Q L +
Sbjct: 80 IKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYM 135
Query: 206 RDIAAGMTYLHSMNLIHRDLNSQNCLV-REDKTVVVADFGLARIIHQGPRAPTTVMAKVP 264
+I + Y HSM ++HRD+ N ++ E + + + D+GLA H G
Sbjct: 136 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG------------ 183
Query: 265 RKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE-YDETVDVFSYGIVLCEII-GRVP 318
++ V + Y+ PE++ + YD ++D++S G +L +I + P
Sbjct: 184 ----------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 3e-20
Identities = 44/177 (24%), Positives = 76/177 (42%), Gaps = 33/177 (18%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYI-----AGGTLKELLQDPGQPLPWGQRVN 203
+ +L+ + H NVI + V D L+ T++ G L +L++ + L +
Sbjct: 68 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQF 125
Query: 204 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263
+ G+ Y+H+ +IHRDL N V ED + + DFGLAR
Sbjct: 126 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS------------ 173
Query: 264 PRKAAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVLCEII-GRVP 318
+ V ++ APE ++ Y +TVD++S G ++ E+I G+
Sbjct: 174 ------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.9 bits (214), Expect = 1e-19
Identities = 43/171 (25%), Positives = 71/171 (41%), Gaps = 22/171 (12%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 208
+ +L+ L H N++R VL+ D+KL LV E+ K G +F +
Sbjct: 52 ICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQL 110
Query: 209 AAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAA 268
G+ + HS N++HRDL QN L+ + + +A+FGLAR R +
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS----------- 159
Query: 269 QRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVP 318
VV Y + + Y ++D++S G + E+ P
Sbjct: 160 ---------AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.0 bits (209), Expect = 9e-19
Identities = 40/177 (22%), Positives = 75/177 (42%), Gaps = 33/177 (18%)
Query: 149 VAVLRSLHHHNVIRFIGV------LYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV 202
+ +++ ++H N+I + V L + + + LV E + + + + +
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMS 122
Query: 203 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAK 262
+ G+ +LHS +IHRDL N +V+ D T+ + DFGLAR
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---------- 172
Query: 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVP 318
V Y+ APE++ G Y E VD++S G ++ E++ ++
Sbjct: 173 ------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.7 bits (185), Expect = 1e-15
Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 33/177 (18%)
Query: 149 VAVLRSLHHHNVIRFIGVLYKDRKLN-----LVTEYIAGGTLKELLQDPGQPLPWGQRVN 203
+ +L+ + H NVI + V R L + ++ G L +++ Q L
Sbjct: 68 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQF 125
Query: 204 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKV 263
I G+ Y+HS ++IHRDL N V ED + + DFGLAR
Sbjct: 126 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD------------ 173
Query: 264 PRKAAQRRGARKKRYTVVGNPYWMAPE-MMTGQEYDETVDVFSYGIVL-CEIIGRVP 318
+ V ++ APE M+ Y++TVD++S G ++ + GR
Sbjct: 174 ------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1x6aa1 g.39.1.3 (A:8-41) Lim domain kinase 2 {Human (Homo sapiens) [TaxId: 9606]} Length = 34 | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Lim domain kinase 2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.4 bits (157), Expect = 2e-14
Identities = 19/34 (55%), Positives = 25/34 (73%)
Query: 53 EDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPEC 86
+DY GK+GE C C +M+GP MV G+ K+HPEC
Sbjct: 1 KDYWGKFGEFCHGCSLLMTGPFMVAGEFKYHPEC 34
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 67.4 bits (163), Expect = 6e-13
Identities = 34/260 (13%), Positives = 82/260 (31%), Gaps = 27/260 (10%)
Query: 149 VAVLRSLHHHNVIRFIGVLY----KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF 204
S+ +++++ + + +V E + L + + + +P
Sbjct: 71 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 205 ARDIAAGMTYLH-SMNLIHRDLNSQNCLVR-EDKTVVVADFGLARIIHQGPRAPTTVMAK 262
++ + G+ Y+H +IH D+ +N L+ D + +A +
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL-------------- 176
Query: 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEII-GRVPADP 321
+ + + +PE++ G + D++S ++ E+I G +P
Sbjct: 177 -----GNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231
Query: 322 DYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381
D S D + P +R + + ++ L L
Sbjct: 232 DE-GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL 290
Query: 382 SVDKPLPSDLEADIYQFATR 401
+ D +I F +
Sbjct: 291 TEKYKFSKDEAKEISDFLSP 310
|
| >d1v6ga1 g.39.1.3 (A:1-41) Actin-binding LIM protein 2, abLIM2 {Human (Homo sapiens) [TaxId: 9606]} Length = 41 | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 2, abLIM2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.9 bits (140), Expect = 6e-12
Identities = 12/33 (36%), Positives = 17/33 (51%)
Query: 54 DYNGKYGEACQNCGQMMSGPVMVVGDHKFHPEC 86
DY YG C +C Q + G V+ +HP+C
Sbjct: 9 DYQRLYGTRCFSCDQFIEGEVVSALGKTYHPDC 41
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 61.7 bits (149), Expect = 8e-12
Identities = 17/140 (12%), Positives = 39/140 (27%), Gaps = 14/140 (10%)
Query: 118 LDNWYFEKDGLLFCKEDYNGKYGEACQNCGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVT 177
+ + F+K D + + L+ L V + ++
Sbjct: 34 VGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW----EGNAVLM 89
Query: 178 EYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKT 237
E I + I + + ++H DL+ N LV ++
Sbjct: 90 ELID--------AKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV-SEEG 140
Query: 238 VVVADFGLARIIHQGPRAPT 257
+ + DF + + +
Sbjct: 141 IWIIDFPQSVEVGE-EGWRE 159
|
| >d1x3ha1 g.39.1.3 (A:8-42) Leupaxin {Human (Homo sapiens) [TaxId: 9606]} Length = 35 | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Leupaxin species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.5 bits (116), Expect = 1e-08
Identities = 9/35 (25%), Positives = 16/35 (45%)
Query: 53 EDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECF 87
+D+ + C C + + + D +HPECF
Sbjct: 1 KDFLAMFSPKCGGCNRPVLENYLSAMDTVWHPECF 35
|
| >d1x6aa2 g.39.1.3 (A:42-75) Lim domain kinase 2 {Human (Homo sapiens) [TaxId: 9606]} Length = 34 | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Lim domain kinase 2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (95), Expect = 6e-06
Identities = 14/29 (48%), Positives = 18/29 (62%), Gaps = 1/29 (3%)
Query: 87 FKCTSCSCCIGDGESYALVERSIL-CSAC 114
F C SC I DG++YALV+ + L C C
Sbjct: 1 FACMSCKVIIEDGDAYALVQHATLYCGKC 29
|
| >d2dj7a1 g.39.1.3 (A:44-74) Actin-binding LIM protein 3, abLIM-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 31 | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 3, abLIM-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.1 bits (81), Expect = 4e-04
Identities = 12/30 (40%), Positives = 19/30 (63%)
Query: 31 CSACDVMLDNWYFEKDGLLFCKEDYNGKYG 60
C C V+L Y KDG+ +C+ DY+ ++G
Sbjct: 2 CQTCSVILTGEYISKDGVPYCESDYHAQFG 31
|
| >d2dj7a1 g.39.1.3 (A:44-74) Actin-binding LIM protein 3, abLIM-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 31 | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 3, abLIM-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.1 bits (81), Expect = 4e-04
Identities = 12/30 (40%), Positives = 19/30 (63%)
Query: 111 CSACDVMLDNWYFEKDGLLFCKEDYNGKYG 140
C C V+L Y KDG+ +C+ DY+ ++G
Sbjct: 2 CQTCSVILTGEYISKDGVPYCESDYHAQFG 31
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 433 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.78 | |
| d1x3ha1 | 35 | Leupaxin {Human (Homo sapiens) [TaxId: 9606]} | 99.31 | |
| d1b8ta4 | 49 | Cysteine-rich (intestinal) protein, CRP, CRIP {Chi | 99.01 | |
| d1g47a2 | 35 | Pinch (particularly interesting new Cys-His) prote | 99.0 | |
| d2dj7a1 | 31 | Actin-binding LIM protein 3, abLIM-3 {Human (Homo | 98.92 | |
| d1v6ga1 | 41 | Actin-binding LIM protein 2, abLIM2 {Human (Homo s | 98.89 | |
| d2cuqa2 | 35 | Four and a half LIM domains 3, FHL3 {Human (Homo s | 98.88 | |
| d1x63a1 | 37 | Four and a half LIM domains protein 1, FHL-1 {Huma | 98.76 | |
| d1x6aa1 | 34 | Lim domain kinase 2 {Human (Homo sapiens) [TaxId: | 98.71 | |
| d1ibia2 | 31 | Cysteine-rich (intestinal) protein, CRP, CRIP {Jap | 98.69 | |
| d1imla2 | 48 | Cysteine-rich (intestinal) protein, CRP, CRIP {Rat | 98.65 | |
| d2dloa1 | 35 | Thyroid receptor interacting protein 6, TRIP6 {Hum | 98.56 | |
| d1x61a1 | 27 | Thyroid receptor interacting protein 6, TRIP6 {Hum | 98.54 | |
| d2dara2 | 45 | PDZ and LIM domain protein 5, Enigma {Human (Homo | 98.51 | |
| d2d8za2 | 32 | Four and a half LIM domains protein 2, FHL2 {Human | 98.51 | |
| d1b8ta2 | 65 | Cysteine-rich (intestinal) protein, CRP, CRIP {Chi | 98.48 | |
| d2d8xa2 | 26 | Pinch (particularly interesting new Cys-His) prote | 98.45 | |
| d1x3ha2 | 32 | Leupaxin {Human (Homo sapiens) [TaxId: 9606]} | 98.4 | |
| d1u5sb2 | 35 | Pinch (particularly interesting new Cys-His) prote | 98.38 | |
| d2cuqa1 | 32 | Four and a half LIM domains 3, FHL3 {Human (Homo s | 98.37 | |
| d2d8xa2 | 26 | Pinch (particularly interesting new Cys-His) prote | 98.35 | |
| d1u5sb1 | 31 | Pinch (particularly interesting new Cys-His) prote | 98.35 | |
| d1x4ka1 | 32 | Four and a half LIM domains protein 2, FHL2 {Human | 98.21 | |
| d2dj7a2 | 36 | Actin-binding LIM protein 3, abLIM-3 {Human (Homo | 98.2 | |
| d2d8ya2 | 42 | Eplin, LIMA1 {Human (Homo sapiens) [TaxId: 9606]} | 98.18 | |
| d1a7ia2 | 32 | Cysteine-rich (intestinal) protein, CRP, CRIP {Jap | 98.15 | |
| d1x3ha1 | 35 | Leupaxin {Human (Homo sapiens) [TaxId: 9606]} | 98.13 | |
| d2cu8a2 | 33 | Cysteine-rich (intestinal) protein, CRP, CRIP {Hum | 98.13 | |
| d1wyha1 | 32 | Four and a half LIM domains 3, FHL3 {Human (Homo s | 98.12 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.1 | |
| d1x62a2 | 35 | PDZ and LIM domain protein 1 Elfin {Human (Homo sa | 98.03 | |
| d2dara2 | 45 | PDZ and LIM domain protein 5, Enigma {Human (Homo | 97.98 | |
| d1x64a1 | 45 | PDZ and LIM domain protein 3, PDLIM3 {Mouse (Mus m | 97.87 | |
| d2d8za1 | 26 | Four and a half LIM domains protein 2, FHL2 {Human | 97.85 | |
| d2dara1 | 32 | PDZ and LIM domain protein 5, Enigma {Human (Homo | 97.84 | |
| d1x4la1 | 29 | Four and a half LIM domains protein 2, FHL2 {Human | 97.75 | |
| d1wiga1 | 32 | Actin-binding LIM protein 2, abLIM2 {Human (Homo s | 97.75 | |
| d2dloa2 | 33 | Thyroid receptor interacting protein 6, TRIP6 {Hum | 97.75 | |
| d1rutx3 | 31 | LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10 | 97.73 | |
| d1rutx1 | 30 | LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10 | 97.72 | |
| d2cura2 | 26 | Four and a half LIM domains protein 1, FHL-1 {Huma | 97.72 | |
| d2dj7a2 | 36 | Actin-binding LIM protein 3, abLIM-3 {Human (Homo | 97.66 | |
| d2cura1 | 31 | Four and a half LIM domains protein 1, FHL-1 {Huma | 97.66 | |
| d1j2oa1 | 30 | Rhombotin-2 (Lmo2) {Mouse (Mus musculus) [TaxId: 1 | 97.64 | |
| d1j2oa1 | 30 | Rhombotin-2 (Lmo2) {Mouse (Mus musculus) [TaxId: 1 | 97.6 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.6 | |
| d2dloa1 | 35 | Thyroid receptor interacting protein 6, TRIP6 {Hum | 97.6 | |
| d1x68a1 | 29 | Four and a half LIM domains protein 5, FHL-5 {Huma | 97.58 | |
| d1x61a2 | 32 | Thyroid receptor interacting protein 6, TRIP6 {Hum | 97.54 | |
| d1x63a2 | 32 | Four and a half LIM domains protein 1, FHL-1 {Huma | 97.51 | |
| d1rutx1 | 30 | LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10 | 97.34 | |
| d1u5sb1 | 31 | Pinch (particularly interesting new Cys-His) prote | 97.33 | |
| d1x63a1 | 37 | Four and a half LIM domains protein 1, FHL-1 {Huma | 97.33 | |
| d1x4ka2 | 27 | Four and a half LIM domains protein 2, FHL2 {Human | 97.31 | |
| d1rutx2 | 34 | LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10 | 97.15 | |
| d1wyha2 | 27 | Four and a half LIM domains 3, FHL3 {Human (Homo s | 97.01 | |
| d1zfoa_ | 30 | LASP-1 {Pig (Sus scrofa) [TaxId: 9823]} | 96.98 | |
| d2cuqa2 | 35 | Four and a half LIM domains 3, FHL3 {Human (Homo s | 96.97 | |
| d1wyha2 | 27 | Four and a half LIM domains 3, FHL3 {Human (Homo s | 96.84 | |
| d1b8ta3 | 43 | Cysteine-rich (intestinal) protein, CRP, CRIP {Chi | 96.82 | |
| d2cupa3 | 27 | Four and a half LIM domains protein 1, FHL-1 {Huma | 96.75 | |
| d1zfoa_ | 30 | LASP-1 {Pig (Sus scrofa) [TaxId: 9823]} | 96.67 | |
| d2cora1 | 31 | Pinch (particularly interesting new Cys-His) prote | 96.63 | |
| d1rutx3 | 31 | LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10 | 96.6 | |
| d1b8ta3 | 43 | Cysteine-rich (intestinal) protein, CRP, CRIP {Chi | 96.6 | |
| d2d8za1 | 26 | Four and a half LIM domains protein 2, FHL2 {Human | 96.5 | |
| d1x6aa2 | 34 | Lim domain kinase 2 {Human (Homo sapiens) [TaxId: | 96.5 | |
| d2cu8a1 | 30 | Cysteine-rich (intestinal) protein, CRP, CRIP {Hum | 96.47 | |
| d2cu8a1 | 30 | Cysteine-rich (intestinal) protein, CRP, CRIP {Hum | 96.47 | |
| d2d8ya1 | 35 | Eplin, LIMA1 {Human (Homo sapiens) [TaxId: 9606]} | 96.45 | |
| d2d8za2 | 32 | Four and a half LIM domains protein 2, FHL2 {Human | 96.44 | |
| d2d8ya1 | 35 | Eplin, LIMA1 {Human (Homo sapiens) [TaxId: 9606]} | 96.43 | |
| d2cura2 | 26 | Four and a half LIM domains protein 1, FHL-1 {Huma | 96.42 | |
| d1x4ka2 | 27 | Four and a half LIM domains protein 2, FHL2 {Human | 96.34 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.33 | |
| d2co8a2 | 36 | Nedd9 interacting protein with calponin homology, | 96.18 | |
| d2co8a2 | 36 | Nedd9 interacting protein with calponin homology, | 96.11 | |
| d1x4la1 | 29 | Four and a half LIM domains protein 2, FHL2 {Human | 96.09 | |
| d1b8ta1 | 35 | Cysteine-rich (intestinal) protein, CRP, CRIP {Chi | 96.07 | |
| d1x64a2 | 31 | PDZ and LIM domain protein 3, PDLIM3 {Mouse (Mus m | 95.98 | |
| d1v6ga1 | 41 | Actin-binding LIM protein 2, abLIM2 {Human (Homo s | 95.77 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.64 | |
| d1g47a2 | 35 | Pinch (particularly interesting new Cys-His) prote | 95.61 | |
| d1a7ia1 | 28 | Cysteine-rich (intestinal) protein, CRP, CRIP {Jap | 95.58 | |
| d2cuqa1 | 32 | Four and a half LIM domains 3, FHL3 {Human (Homo s | 95.56 | |
| d1b8ta1 | 35 | Cysteine-rich (intestinal) protein, CRP, CRIP {Chi | 95.49 | |
| d2cupa2 | 31 | Four and a half LIM domains protein 1, FHL-1 {Huma | 95.49 | |
| d1ibia1 | 28 | Cysteine-rich (intestinal) protein, CRP, CRIP {Jap | 95.41 | |
| d1x61a1 | 27 | Thyroid receptor interacting protein 6, TRIP6 {Hum | 95.38 | |
| d2dj7a1 | 31 | Actin-binding LIM protein 3, abLIM-3 {Human (Homo | 95.36 | |
| d1ibia2 | 31 | Cysteine-rich (intestinal) protein, CRP, CRIP {Jap | 95.32 | |
| d1rutx4 | 33 | LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10 | 95.3 | |
| d2cura1 | 31 | Four and a half LIM domains protein 1, FHL-1 {Huma | 95.25 | |
| d1x61a2 | 32 | Thyroid receptor interacting protein 6, TRIP6 {Hum | 95.06 | |
| d1a7ia1 | 28 | Cysteine-rich (intestinal) protein, CRP, CRIP {Jap | 95.05 | |
| d2cupa3 | 27 | Four and a half LIM domains protein 1, FHL-1 {Huma | 94.88 | |
| d1x62a1 | 31 | PDZ and LIM domain protein 1 Elfin {Human (Homo sa | 94.86 | |
| d1rutx4 | 33 | LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10 | 94.82 | |
| d1x6aa2 | 34 | Lim domain kinase 2 {Human (Homo sapiens) [TaxId: | 94.77 | |
| d1ibia1 | 28 | Cysteine-rich (intestinal) protein, CRP, CRIP {Jap | 94.18 | |
| d1x68a1 | 29 | Four and a half LIM domains protein 5, FHL-5 {Huma | 94.18 | |
| d1x62a2 | 35 | PDZ and LIM domain protein 1 Elfin {Human (Homo sa | 94.03 | |
| d1x68a2 | 34 | Four and a half LIM domains protein 5, FHL-5 {Huma | 93.74 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.66 | |
| d1x6aa1 | 34 | Lim domain kinase 2 {Human (Homo sapiens) [TaxId: | 93.35 | |
| d1u5sb2 | 35 | Pinch (particularly interesting new Cys-His) prote | 92.81 | |
| d1x64a1 | 45 | PDZ and LIM domain protein 3, PDLIM3 {Mouse (Mus m | 92.54 | |
| d1wiga1 | 32 | Actin-binding LIM protein 2, abLIM2 {Human (Homo s | 92.25 | |
| d1x63a2 | 32 | Four and a half LIM domains protein 1, FHL-1 {Huma | 92.21 | |
| d1g47a1 | 35 | Pinch (particularly interesting new Cys-His) prote | 91.87 | |
| d1jm7b_ | 97 | bard1 RING domain {Human (Homo sapiens) [TaxId: 96 | 91.82 | |
| d1x3ha2 | 32 | Leupaxin {Human (Homo sapiens) [TaxId: 9606]} | 91.23 | |
| d1g47a1 | 35 | Pinch (particularly interesting new Cys-His) prote | 90.63 | |
| d2cora2 | 35 | Pinch (particularly interesting new Cys-His) prote | 90.05 | |
| d2d8xa1 | 32 | Pinch (particularly interesting new Cys-His) prote | 89.83 | |
| d1wiga2 | 41 | Actin-binding LIM protein 2, abLIM2 {Human (Homo s | 88.45 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 87.41 | |
| d1x4la2 | 30 | Four and a half LIM domains protein 2, FHL2 {Human | 86.92 | |
| d1v6ga2 | 40 | Actin-binding LIM protein 2, abLIM2 {Human (Homo s | 86.38 | |
| d1b8ta4 | 49 | Cysteine-rich (intestinal) protein, CRP, CRIP {Chi | 86.25 | |
| d1wyha1 | 32 | Four and a half LIM domains 3, FHL3 {Human (Homo s | 86.21 | |
| d1x4ka1 | 32 | Four and a half LIM domains protein 2, FHL2 {Human | 85.86 | |
| d2cora2 | 35 | Pinch (particularly interesting new Cys-His) prote | 85.67 | |
| d1a7ia2 | 32 | Cysteine-rich (intestinal) protein, CRP, CRIP {Jap | 85.13 | |
| d1imla2 | 48 | Cysteine-rich (intestinal) protein, CRP, CRIP {Rat | 82.24 | |
| d2dara1 | 32 | PDZ and LIM domain protein 5, Enigma {Human (Homo | 81.85 | |
| d2d8ya2 | 42 | Eplin, LIMA1 {Human (Homo sapiens) [TaxId: 9606]} | 81.41 | |
| d2c2la2 | 80 | STIP1 homology and U box-containing protein 1, STU | 80.41 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-51 Score=373.31 Aligned_cols=240 Identities=28% Similarity=0.449 Sum_probs=194.6
Q ss_pred ccccccCCeeeeeccCCCcchhhhhcc------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeE
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 175 (433)
.|.+..+++.+.+.+|+|+||+||++. +|+++|++++||||+++++++. ++.+++
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l 80 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI 80 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEE
Confidence 456677778888899999999998722 6999999999999999999864 567899
Q ss_pred EEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCC
Q psy6593 176 VTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
||||++||+|.+++...+..+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999999999876667999999999999999999999999999999999999999999999999999865432211
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecC---CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG---QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL 332 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~ 332 (433)
. ......||+.|+|||++.+ ..++.++||||||+++|||++|.+||............
T Consensus 161 ~-------------------~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~ 221 (276)
T d1uwha_ 161 H-------------------QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM 221 (276)
T ss_dssp ------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH
T ss_pred c-------------------cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH
Confidence 1 1125679999999999864 35789999999999999999999998654332211111
Q ss_pred chhh----hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 333 DQTD----FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 333 ~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
.... .....+..+|+++.+|+.+||+.||++|||+++|++.|+.+.+
T Consensus 222 ~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 222 VGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp HHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111 1223457789999999999999999999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-51 Score=370.55 Aligned_cols=228 Identities=23% Similarity=0.365 Sum_probs=194.5
Q ss_pred cccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeee
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 174 (433)
|..+++.+.+.+|+|+||+||++. +|+++|++++||||+++++++.+++..|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 456778889999999999998622 6999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCC
Q psy6593 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 83 ivmEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp EEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred EEEeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 9999999999999997643 59999999999999999999999999999999999999999999999999997654321
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCch
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQ 334 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~ 334 (433)
.....||+.|+|||++.+..++.++|||||||++|||++|.+||.......... ..
T Consensus 161 ----------------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~--~i 216 (263)
T d2j4za1 161 ----------------------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK--RI 216 (263)
T ss_dssp ----------------------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--HH
T ss_pred ----------------------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHH--HH
Confidence 125679999999999999999999999999999999999999986532211111 11
Q ss_pred hhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 335 TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 335 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
......++..+|+++.+|+.+||+.||++|||++++++ ||..
T Consensus 217 ~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 217 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 12223456778999999999999999999999999985 7764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-50 Score=372.17 Aligned_cols=240 Identities=28% Similarity=0.517 Sum_probs=201.7
Q ss_pred cccccccCCeeeeeccCCCcchhhhhcc------------------------chHHHHhhcCCcceeeEEEEEEeCCeee
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 174 (433)
++|.+..+++.+.+++|+|+||+||++. +|+++|++++|||||++++++.+++..+
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 4566777889999999999999999732 7999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 175 LVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
|||||+++|+|.+++.+ ....+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999999999864 44579999999999999999999999999999999999999999999999999998764432
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcC-CCCCCCCCCCCCCCCC
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGR-VPADPDYLPRSPDFGL 332 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~-~~~~~~~~~~~~~~~~ 332 (433)
... .....||+.|+|||.+.+..++.++||||||+++|||+++ .|++.... .......
T Consensus 170 ~~~--------------------~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~~~~ 228 (287)
T d1opja_ 170 YTA--------------------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYEL 228 (287)
T ss_dssp SEE--------------------ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHH
T ss_pred cee--------------------eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHHHHHH
Confidence 211 1134688999999999999999999999999999999975 55543321 1111112
Q ss_pred chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 333 DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 333 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
.........+..+|+++.+|+.+||+.||++|||+++|+++|+.+..
T Consensus 229 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 22334455667899999999999999999999999999999998754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-50 Score=366.23 Aligned_cols=234 Identities=24% Similarity=0.400 Sum_probs=187.9
Q ss_pred ccCCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEecc
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYI 180 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 180 (433)
..+++.+.+++|+|+||+||++. +|+++|++++||||+++++++..++..++||||+
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 34567788889999999998722 7999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcccc
Q psy6593 181 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260 (433)
Q Consensus 181 ~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 260 (433)
++|+|.+++......+++..++.|+.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~---- 158 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS---- 158 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee----
Confidence 9999999998777779999999999999999999999999999999999999999999999999998765432221
Q ss_pred ccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhcc
Q psy6593 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRN 339 (433)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~ 339 (433)
.....||+.|+|||++.+..++.++||||||+++|||++ |.||+...... ............
T Consensus 159 ----------------~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-~~~~~i~~~~~~ 221 (263)
T d1sm2a_ 159 ----------------STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVEDISTGFRL 221 (263)
T ss_dssp ----------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-HHHHHHHHTCCC
T ss_pred ----------------ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-HHHHHHHhcCCC
Confidence 114578999999999999999999999999999999997 56666442211 111111223334
Q ss_pred ccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 340 KFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 340 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
..+..+++++.+|+.+||+.||++|||+++|++.|+++.
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 456778999999999999999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=376.80 Aligned_cols=238 Identities=29% Similarity=0.444 Sum_probs=201.9
Q ss_pred ccccccCCeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhc-CCcceeeEEEEE
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSL-HHHNVIRFIGVL 167 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l-~h~~iv~~~~~~ 167 (433)
+|.+..+++.+.+.+|+|+||+||++. +|+.+|+++ +|||||++++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 455677889999999999999998621 699999999 899999999999
Q ss_pred EeCCeeeEEEeccCCCCHHHHhcCCC----------------------CCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 168 YKDRKLNLVTEYIAGGTLKELLQDPG----------------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 168 ~~~~~~~lv~e~~~g~sL~~~l~~~~----------------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
.+.+.+++||||++||+|.+++++.. ..+++..++.++.||+.||+|||++||+||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 99999999999999999999997642 24889999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEe
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFS 305 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 305 (433)
||+||+++.++.+||+|||+++......... ......||+.|+|||++.+..++.++||||
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~-------------------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS 251 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYV-------------------VRGNARLPVKWMAPESLFEGIYTIKSDVWS 251 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSE-------------------EETTEEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred chhccccccCCeEEEeeccccccccCCCcee-------------------eeccccCCCccCChHHHcCCCCCcceeccc
Confidence 9999999999999999999998765433221 111456899999999999999999999999
Q ss_pred hhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHh
Q psy6593 306 YGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376 (433)
Q Consensus 306 lG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 376 (433)
||+++|||++ |.+||...........+.....+...+..+|+++.+||.+||+.||++|||+++|++.|..
T Consensus 252 ~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 252 YGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 9999999996 8998876544333233333444556678899999999999999999999999999998863
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=367.69 Aligned_cols=231 Identities=23% Similarity=0.383 Sum_probs=188.7
Q ss_pred CCeeeeeccCCCcchhhhhcc--------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
+++.+.+.+|+|+||+||++. +|+++|++++||||+++++++.+++..||||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 456777888899999888622 799999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccc
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+++........
T Consensus 85 ~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~---- 159 (271)
T d1nvra_ 85 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE---- 159 (271)
T ss_dssp CTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE----
T ss_pred cCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc----
Confidence 99999999997644 6999999999999999999999999999999999999999999999999999876433211
Q ss_pred cccchhhhhhhcccccceeeeccCccccccceecCCCC-CcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC-Cchhhh
Q psy6593 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY-DETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG-LDQTDF 337 (433)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~-~~~~~~ 337 (433)
......+||+.|+|||++.+..+ +.++||||||+++|||++|.+||........... ......
T Consensus 160 ---------------~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~ 224 (271)
T d1nvra_ 160 ---------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 224 (271)
T ss_dssp ---------------CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT
T ss_pred ---------------ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Confidence 11125689999999999988776 5789999999999999999998864332211110 011111
Q ss_pred ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 338 RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 338 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
.......+++++.+|+.+||+.||++|||++++++ ||++
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 11222567899999999999999999999999974 6543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.5e-50 Score=371.16 Aligned_cols=239 Identities=27% Similarity=0.453 Sum_probs=188.4
Q ss_pred ccCCeeeeeccCCCcchhhhhcc-----------------------------chHHHHhhcCCcceeeEEEEEEeCCeee
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC-----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~-----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 174 (433)
..+.+.+.+.+|+|+||+||++. +|+++|++++|||||++++++.+++..+
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 34556777788999999998621 7999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCC
Q psy6593 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
+||||+++|+|.+++......+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 99999999999999988767799999999999999999999999999999999999999999999999999987654322
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCc
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~ 333 (433)
.... .......||+.|+|||.+.+..++.++||||||+++|||++ |.+||.......... ..
T Consensus 184 ~~~~----------------~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~-~i 246 (299)
T d1jpaa_ 184 DPTY----------------TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN-AI 246 (299)
T ss_dssp ----------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-HH
T ss_pred ccee----------------eecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHH-HH
Confidence 1110 11123568999999999999999999999999999999997 888886543221111 11
Q ss_pred hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 334 QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 334 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
....+...+..+|+.+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 247 EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1223344567889999999999999999999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-50 Score=369.20 Aligned_cols=228 Identities=26% Similarity=0.430 Sum_probs=191.1
Q ss_pred CCeeeeeccCCCcchhhhhcc-------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEecc
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYI 180 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 180 (433)
+.+.+.+++|+|+||+||++. +|+++|++++||||+++++++.+++.+||||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 347778889999999999732 7999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcccc
Q psy6593 181 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260 (433)
Q Consensus 181 ~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 260 (433)
+||+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 100 ~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~----- 172 (293)
T d1yhwa1 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK----- 172 (293)
T ss_dssp TTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-----
T ss_pred CCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccc-----
Confidence 99999999876 45999999999999999999999999999999999999999999999999999876443221
Q ss_pred ccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh-hhcc
Q psy6593 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT-DFRN 339 (433)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~-~~~~ 339 (433)
.....||+.|+|||++.+..++.++||||||+++|+|++|.+||...........+... ....
T Consensus 173 ----------------~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~ 236 (293)
T d1yhwa1 173 ----------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 236 (293)
T ss_dssp ----------------BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC
T ss_pred ----------------ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 12567999999999999999999999999999999999999998653221111111101 1112
Q ss_pred ccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 340 KFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 340 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
..+..+++.+.+||.+||+.||++|||++++++ ||+.
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 234667899999999999999999999999974 6653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=366.88 Aligned_cols=239 Identities=23% Similarity=0.406 Sum_probs=198.6
Q ss_pred cccccCCeeeee-ccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCC
Q psy6593 121 WYFEKDGLLFCK-EDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDR 171 (433)
Q Consensus 121 ~~~~~~~~~~~~-~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~ 171 (433)
.+++.+++.+.. ++|+|+||+||++. +|+++|++++|||||++++++.. +
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence 456677777776 58999999998731 79999999999999999999864 5
Q ss_pred eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
.+||||||++||+|.+++...+..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 68999999999999999877667799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDF 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~ 330 (433)
...... ......||+.|+|||++.+..++.++||||||+++|||++ |.+||....... ..
T Consensus 162 ~~~~~~------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-~~ 222 (285)
T d1u59a_ 162 DDSYYT------------------ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VM 222 (285)
T ss_dssp CSCEEC------------------CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-HH
T ss_pred cccccc------------------cccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-HH
Confidence 322111 1114468999999999999999999999999999999997 888886543221 11
Q ss_pred CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 331 GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
.......+...+..+|+++.+||.+||+.||++||++.+|.+.|+....
T Consensus 223 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 223 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1122233445678899999999999999999999999999998887543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=368.00 Aligned_cols=230 Identities=25% Similarity=0.430 Sum_probs=188.5
Q ss_pred cCCeeeeeccCCCcchhhhhcc-------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
.+.+.+.+++|+|+||+||++. +|+++|++++|||||++++++.+++..++||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 3456777889999999998722 799999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccc
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
++||+|.+++.+.++++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~------ 164 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI------ 164 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH------
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc------
Confidence 99999999987655679999999999999999999999999999999999999999999999999987543210
Q ss_pred cccchhhhhhhcccccceeeeccCccccccceec-----CCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCch
Q psy6593 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMT-----GQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQ 334 (433)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~ 334 (433)
.......||+.|+|||++. +..++.++|||||||++|||++|.+||...........+..
T Consensus 165 ---------------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~ 229 (288)
T d2jfla1 165 ---------------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK 229 (288)
T ss_dssp ---------------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHH
T ss_pred ---------------ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence 0112567999999999984 45688999999999999999999999865433221111111
Q ss_pred hh-hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHH
Q psy6593 335 TD-FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLE 375 (433)
Q Consensus 335 ~~-~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~ 375 (433)
.. .....+..+++++.+||.+||+.||++|||++++++ ||+
T Consensus 230 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~ 273 (288)
T d2jfla1 230 SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273 (288)
T ss_dssp SCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGC
T ss_pred CCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 11 111223567899999999999999999999999975 553
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=363.40 Aligned_cols=238 Identities=28% Similarity=0.515 Sum_probs=196.0
Q ss_pred cccccccCCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCCcceeeEEEEEEeCCeeeE
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 175 (433)
+.|.+..+++.+.+++|+|+||+||++. +|+++|++++|||||++++++. ++..++
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~i 84 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEE
Confidence 4566677889999999999999999732 8999999999999999999874 567899
Q ss_pred EEeccCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCC
Q psy6593 176 VTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
||||+++|+|.+++... +.++++..++.|+.||+.||.|||+.||+||||||+|||+++++.+||+|||+++.......
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 99999999999987653 23599999999999999999999999999999999999999999999999999987654322
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCc
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLD 333 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~ 333 (433)
... ....||+.|+|||.+.+..++.++||||||+++|||++ |.|++...... ......
T Consensus 165 ~~~--------------------~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~~i 223 (272)
T d1qpca_ 165 TAR--------------------EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNL 223 (272)
T ss_dssp ECC--------------------TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHH
T ss_pred ccc--------------------cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HHHHHH
Confidence 111 14568999999999998899999999999999999997 55655432211 111111
Q ss_pred hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 334 QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 334 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
........+..+|+++.+|+.+||+.||++|||+++|++.|+++.
T Consensus 224 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 224 ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 222334456789999999999999999999999999999988754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=363.45 Aligned_cols=225 Identities=24% Similarity=0.400 Sum_probs=176.3
Q ss_pred CCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEe--CCeeeEE
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYK--DRKLNLV 176 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 176 (433)
+++.+.+.+|+|+||+||+.. +|+++|++++||||+++++++.+ ++.+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 457777888888888888622 79999999999999999999864 4568999
Q ss_pred EeccCCCCHHHHhcC---CCCCCChHHHHHHHHHHHHHHhhhhcCC-----ccccCCCCcceEEccCCceEEeccccchh
Q psy6593 177 TEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMN-----LIHRDLNSQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
|||++||+|.+++.+ .+..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999854 3456999999999999999999999876 99999999999999999999999999988
Q ss_pred ccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCC
Q psy6593 249 IHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~ 328 (433)
....... .....||+.|+|||++.+..++.++||||||+++|||++|.+||........
T Consensus 164 ~~~~~~~---------------------~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~ 222 (269)
T d2java1 164 LNHDTSF---------------------AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 222 (269)
T ss_dssp C--------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccCCCc---------------------cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH
Confidence 6543221 1256899999999999999999999999999999999999999865322111
Q ss_pred CCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 329 DFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
...+ .......++..+++++.+||.+||+.||++|||+++|++
T Consensus 223 ~~~i-~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 223 AGKI-REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHH-HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHH-HcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1111 111223455778999999999999999999999999874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=365.70 Aligned_cols=226 Identities=19% Similarity=0.297 Sum_probs=188.3
Q ss_pred cCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEE
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 176 (433)
.+++.+.+.+|+|+||+||++. +|+++|++++||||+++++++.+++.+|+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 3568888899999999998622 799999999999999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCC
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
|||++||+|.+++...+ .+++..++.++.|++.||+|||+.||+||||||+|||+++++.+||+|||+++.+.......
T Consensus 87 mEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 99999999999987644 59999999999999999999999999999999999999999999999999998764322111
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD 336 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~ 336 (433)
......||+.|+|||++.+..++.++|||||||++|||++|.+||........... ...
T Consensus 166 -------------------~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~--i~~ 224 (288)
T d1uu3a_ 166 -------------------RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK--IIK 224 (288)
T ss_dssp -----------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHT
T ss_pred -------------------ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHH--HHc
Confidence 11256799999999999999999999999999999999999999865322111111 111
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
....++..+++++.+||.+||+.||++|||++|+++
T Consensus 225 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 225 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp TCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 223456788999999999999999999999999753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-48 Score=363.28 Aligned_cols=228 Identities=22% Similarity=0.383 Sum_probs=179.9
Q ss_pred CCeeeeeccCCCcchhhhhcc--------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
+.+.+.+.+|+|+||+||++. +|+++|++++||||+++++++.+++.+||||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 447788899999999999722 699999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEc---cCCceEEeccccchhccCCCCCC
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
++||+|.+++.+.+ .+++..+..++.||+.||+|||+.||+||||||+||++. .++.+||+|||+++.......
T Consensus 89 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~-- 165 (307)
T d1a06a_ 89 VSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV-- 165 (307)
T ss_dssp CCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred cCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe--
Confidence 99999999997744 599999999999999999999999999999999999995 578999999999986543221
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh-
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT- 335 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~- 335 (433)
.....||+.|+|||++.+..++.++|||||||++|||++|.+||...........+...
T Consensus 166 --------------------~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 225 (307)
T d1a06a_ 166 --------------------LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 225 (307)
T ss_dssp ---------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTC
T ss_pred --------------------eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccC
Confidence 12567999999999999999999999999999999999999998653221111111111
Q ss_pred -hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 336 -DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 336 -~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
.........+|+++.+||.+||+.||++|||++|+++ ||..
T Consensus 226 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 1112233678999999999999999999999999986 6653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=367.75 Aligned_cols=231 Identities=22% Similarity=0.369 Sum_probs=188.7
Q ss_pred ccCCeeeeeccCCCcchhhhhcc--------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEE
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVT 177 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 177 (433)
..+++.+.+++|+|+||+||++. +|+.+|++++|||||++++++.+++++||||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45668888899999999999722 7999999999999999999999999999999
Q ss_pred eccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcC-CccccCCCCcceEEccCCceEEeccccchhccCCCCCC
Q psy6593 178 EYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 178 e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
||++||+|.+++.+.+ .+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+|+......
T Consensus 84 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--- 159 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 159 (322)
T ss_dssp ECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT---
T ss_pred EcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc---
Confidence 9999999999997644 599999999999999999999975 89999999999999999999999999998764321
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC------
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF------ 330 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~------ 330 (433)
..+.+||+.|+|||++.+..++.++||||+||++|||++|.+||..........
T Consensus 160 --------------------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 219 (322)
T d1s9ja_ 160 --------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219 (322)
T ss_dssp --------------------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----
T ss_pred --------------------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence 125689999999999999999999999999999999999988875432110000
Q ss_pred ---------------------------CCchh----hhc----cccC-CCCcHHHHHHHHHhcccCCCCCCChhHHHH--
Q psy6593 331 ---------------------------GLDQT----DFR----NKFC-ASCPEPFVRIAFLCCDLNPDQRPPFEVLEV-- 372 (433)
Q Consensus 331 ---------------------------~~~~~----~~~----~~~~-~~~~~~l~~li~~~l~~~p~~RPs~~~i~~-- 372 (433)
..... ... ...+ ..++.++.+|+.+||+.||++|||++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hp 299 (322)
T d1s9ja_ 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299 (322)
T ss_dssp --------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCH
Confidence 00000 000 0011 235789999999999999999999999984
Q ss_pred HHHhhc
Q psy6593 373 WLEGLS 378 (433)
Q Consensus 373 ~l~~~~ 378 (433)
||++..
T Consensus 300 f~~~~~ 305 (322)
T d1s9ja_ 300 FIKRSD 305 (322)
T ss_dssp HHHHHH
T ss_pred hhCcCC
Confidence 887643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-48 Score=370.65 Aligned_cols=231 Identities=17% Similarity=0.281 Sum_probs=192.7
Q ss_pred CCeeeeeccCCCcchhhhhcc-------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEecc
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYI 180 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 180 (433)
+++.+.+.+|+|+||+||++. +|+++|++++|||||++++++.+++.+||||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 457788899999999999722 7999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEc--cCCceEEeccccchhccCCCCCCcc
Q psy6593 181 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR--EDKTVVVADFGLARIIHQGPRAPTT 258 (433)
Q Consensus 181 ~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~--~~~~~kl~Dfg~~~~~~~~~~~~~~ 258 (433)
+||+|.+++.+....+++..++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+++......
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~----- 180 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----- 180 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-----
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-----
Confidence 99999999977666799999999999999999999999999999999999996 46789999999998764322
Q ss_pred ccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh--
Q psy6593 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD-- 336 (433)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~-- 336 (433)
......||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+....
T Consensus 181 -----------------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 243 (350)
T d1koaa2 181 -----------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN 243 (350)
T ss_dssp -----------------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred -----------------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 1236789999999999999999999999999999999999999986532211111111111
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
........+++++.+||.+||+.||++|||++++++ ||....
T Consensus 244 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 111222567899999999999999999999999986 676543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=356.33 Aligned_cols=219 Identities=26% Similarity=0.398 Sum_probs=178.9
Q ss_pred eeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEe----CCeeeEEE
Q psy6593 129 LFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYK----DRKLNLVT 177 (433)
Q Consensus 129 ~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~ 177 (433)
.+..++|+|+||+||++. +|+++|++++||||+++++++.. +..+|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 345578999999999722 79999999999999999999875 34689999
Q ss_pred eccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCC--ccccCCCCcceEEc-cCCceEEeccccchhccCCCC
Q psy6593 178 EYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN--LIHRDLNSQNCLVR-EDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 178 e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
||++||+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+|||++ +++.+||+|||+++.....
T Consensus 92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-- 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-- 168 (270)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC--
Confidence 9999999999997643 5999999999999999999999998 99999999999997 5789999999999754321
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC-CCc
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF-GLD 333 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~-~~~ 333 (433)
......||+.|+|||++.+ .++.++||||||+++|||++|.+||.......... .+.
T Consensus 169 ---------------------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~ 226 (270)
T d1t4ha_ 169 ---------------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 226 (270)
T ss_dssp ---------------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred ---------------------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHH
Confidence 1125689999999999876 69999999999999999999999886432211110 111
Q ss_pred hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH
Q psy6593 334 QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV 372 (433)
Q Consensus 334 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 372 (433)
.......++...++++.+||.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 227 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111122334567889999999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=358.02 Aligned_cols=225 Identities=23% Similarity=0.393 Sum_probs=184.9
Q ss_pred eccCCCcchhhhhcc-----------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCC
Q psy6593 132 KEDYNGKYGEACQNC-----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAG 182 (433)
Q Consensus 132 ~~~~~g~fg~v~~~~-----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 182 (433)
+++|+|+||+||++. +|+++|++++|||||++++++.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 457888888887621 79999999999999999999864 567899999999
Q ss_pred CCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcccccc
Q psy6593 183 GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAK 262 (433)
Q Consensus 183 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 262 (433)
|+|.+++.+.. .+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~------ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY------ 164 (277)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE------
T ss_pred CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc------
Confidence 99999997644 59999999999999999999999999999999999999999999999999998764432211
Q ss_pred chhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhcccc
Q psy6593 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKF 341 (433)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (433)
.......||+.|+|||.+.+..++.++||||||+++|||++ |.+||........ ........+...
T Consensus 165 ------------~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~-~~~i~~~~~~~~ 231 (277)
T d1xbba_ 165 ------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TAMLEKGERMGC 231 (277)
T ss_dssp ------------EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HHHHHTTCCCCC
T ss_pred ------------ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH-HHHHHcCCCCCC
Confidence 11124578999999999999999999999999999999996 8888875432211 111122334456
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 342 CASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 342 ~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
+..+|+++.+|+.+||+.||++|||+++|.+.|+..
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 688999999999999999999999999998887764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=357.58 Aligned_cols=234 Identities=29% Similarity=0.476 Sum_probs=185.8
Q ss_pred CeeeeeccCCCcchhhhhc------------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeEE
Q psy6593 127 GLLFCKEDYNGKYGEACQN------------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~------------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 176 (433)
.+...+.+|+|+||+||++ .+|+++|++++|||||++++++.+.+..++|
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v 87 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 87 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence 3555566777777777752 1799999999999999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCC
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
|||+.+++|.+++.+....+++..++.++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 88 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~ 167 (283)
T d1mqba_ 88 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 167 (283)
T ss_dssp EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred EEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccc
Confidence 99999999999887766779999999999999999999999999999999999999999999999999998765432211
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchh
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~ 335 (433)
. ......||+.|+|||.+.+..++.++||||||+++|||++ +.|++..... .........
T Consensus 168 ~------------------~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~ 228 (283)
T d1mqba_ 168 Y------------------TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAIND 228 (283)
T ss_dssp ------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHT
T ss_pred e------------------EeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHHHhc
Confidence 0 1114568999999999999999999999999999999997 4555443221 111112223
Q ss_pred hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 336 DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 336 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
..+...+..+|+++.+|+.+||+.||++||++.+|++.|+.+..
T Consensus 229 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 34445667899999999999999999999999999999998764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-48 Score=357.27 Aligned_cols=241 Identities=30% Similarity=0.512 Sum_probs=194.7
Q ss_pred ccccccccCCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCCcceeeEEEEEEeCCeee
Q psy6593 118 LDNWYFEKDGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 118 l~~~~~~~~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 174 (433)
.+.|-+..+++.+.+++|+|+||+||++. +|+.+|++++|+|||++++++. ++..+
T Consensus 9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~ 87 (285)
T d1fmka3 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 87 (285)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred CcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeE
Confidence 35677788899999999999999999732 8999999999999999999985 56789
Q ss_pred EEEeccCCCCHHHHhcC-CCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 175 LVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
+||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 99999999999998864 23469999999999999999999999999999999999999999999999999998664332
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCC
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGL 332 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~ 332 (433)
... .....||+.|+|||.+.+..++.++||||||+++|||++ |.|++..... ......
T Consensus 168 ~~~--------------------~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~ 226 (285)
T d1fmka3 168 YTA--------------------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQ 226 (285)
T ss_dssp ----------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHH
T ss_pred cee--------------------eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHH
Confidence 211 124578999999999999999999999999999999997 5555543221 111111
Q ss_pred chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccc
Q psy6593 333 DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMH 380 (433)
Q Consensus 333 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~ 380 (433)
.........+..+|+++.++|.+||+.||++||++++|+++|++....
T Consensus 227 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 227 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 222334456688999999999999999999999999999999986643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-48 Score=369.03 Aligned_cols=231 Identities=16% Similarity=0.289 Sum_probs=195.0
Q ss_pred CCeeeeeccCCCcchhhhhcc-------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEecc
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC-------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYI 180 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~-------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 180 (433)
+.+.+.+.+|+|+||+||++. +|+.+|++++||||+++++++.+++.+||||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 457788899999999999722 6999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEc--cCCceEEeccccchhccCCCCCCcc
Q psy6593 181 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR--EDKTVVVADFGLARIIHQGPRAPTT 258 (433)
Q Consensus 181 ~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~--~~~~~kl~Dfg~~~~~~~~~~~~~~ 258 (433)
+||+|.+++...+.++++.+++.|+.||+.||+|||+.||+||||||+|||++ .++.+||+|||+++......
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~----- 183 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----- 183 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-----
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC-----
Confidence 99999998887666799999999999999999999999999999999999998 67899999999998764322
Q ss_pred ccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh--h
Q psy6593 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT--D 336 (433)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~--~ 336 (433)
......||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+... .
T Consensus 184 -----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 246 (352)
T d1koba_ 184 -----------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE 246 (352)
T ss_dssp -----------------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC
T ss_pred -----------------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 223678999999999999999999999999999999999999998654322111111111 1
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
+.......+++++.+||.+||+.||.+|||++++++ ||+...
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 122234678999999999999999999999999985 776543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-48 Score=361.86 Aligned_cols=223 Identities=30% Similarity=0.452 Sum_probs=185.4
Q ss_pred eeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 128 LLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
+...+++|+|+||+||++. +|+++|++++|||||++++++.+++..|+||||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 6778899999999999722 699999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccc
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
++||+|..++... .++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~------- 168 (309)
T d1u5ra_ 97 CLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------- 168 (309)
T ss_dssp CSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-------
T ss_pred cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC-------
Confidence 9999987766543 46999999999999999999999999999999999999999999999999999764321
Q ss_pred cccchhhhhhhcccccceeeeccCccccccceecC---CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh
Q psy6593 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG---QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD 336 (433)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~ 336 (433)
....||+.|+|||++.+ ..++.++|||||||++|||++|.+||...........+....
T Consensus 169 ------------------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~ 230 (309)
T d1u5ra_ 169 ------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 230 (309)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred ------------------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence 14579999999999864 458999999999999999999999886532211111111111
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
........+|+++.+||.+||+.||++|||++++++ ||..
T Consensus 231 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp CCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred CCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 112223568899999999999999999999999984 7764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=354.80 Aligned_cols=237 Identities=22% Similarity=0.389 Sum_probs=189.3
Q ss_pred cccccCCeeeeeccCCCcchhhhhcc-----------------------------chHHHHhhcCCcceeeEEEEEEeCC
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQNC-----------------------------GQVAVLRSLHHHNVIRFIGVLYKDR 171 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~~-----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~ 171 (433)
|.+..+++.+.+.+|+|+||+||++. +|+++|++++||||+++++++. ++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 45666788889999999999998621 7999999999999999999985 56
Q ss_pred eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
.+++||||+++|+|.+++......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 89999999999999998876666799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDF 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~ 330 (433)
..... .....||+.|+|||.+.+..++.++||||||+++|||++ |.+|+..........
T Consensus 161 ~~~~~--------------------~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~ 220 (273)
T d1mp8a_ 161 STYYK--------------------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 220 (273)
T ss_dssp ------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred Cccee--------------------ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 32221 114568999999999999999999999999999999996 888886543322111
Q ss_pred CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 331 GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
. .........+..+|+++.+||.+||+.||++|||+++|++.|+.+..
T Consensus 221 ~-i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 221 R-IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp H-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-HHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1 12223345668899999999999999999999999999999987653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=351.31 Aligned_cols=230 Identities=25% Similarity=0.426 Sum_probs=194.7
Q ss_pred CCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCC
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAG 182 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 182 (433)
+++.+.+++|+|+||+||+.. +|++++++++||||+++++++.+++.+++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 456777888888888888622 799999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcccccc
Q psy6593 183 GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAK 262 (433)
Q Consensus 183 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 262 (433)
|+|.+++......+++..+++++.|+++||+|||+.||+||||||+||++++++.+||+|||+++..........
T Consensus 84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~----- 158 (258)
T d1k2pa_ 84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----- 158 (258)
T ss_dssp EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC-----
T ss_pred CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceee-----
Confidence 999999877666799999999999999999999999999999999999999999999999999986654322211
Q ss_pred chhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchhhhcccc
Q psy6593 263 VPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKF 341 (433)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (433)
....||+.|+|||.+.+..++.++||||||+++|||++ |.+||.......... ......+...
T Consensus 159 ---------------~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~-~i~~~~~~~~ 222 (258)
T d1k2pa_ 159 ---------------VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-HIAQGLRLYR 222 (258)
T ss_dssp ---------------CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH-HHHTTCCCCC
T ss_pred ---------------cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHH-HHHhCCCCCC
Confidence 14568999999999999999999999999999999997 788876543222111 1122334456
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHh
Q psy6593 342 CASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEG 376 (433)
Q Consensus 342 ~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 376 (433)
+...|+++.+||.+||+.||++|||+++|++.|.+
T Consensus 223 p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 67889999999999999999999999999998865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=360.11 Aligned_cols=230 Identities=19% Similarity=0.237 Sum_probs=194.0
Q ss_pred ccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeE
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 175 (433)
..+++.+.+.+|+|+||.|++.. +|+.+|++++||||+++++++.+++.+|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 44668888999999999998622 79999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCC
Q psy6593 176 VTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++........
T Consensus 83 v~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred ceeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence 999999999999987744 5999999999999999999999999999999999999999999999999999865432221
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~ 335 (433)
....+||+.|+|||++.+..++.++|||||||++|||++|.+||......... ....
T Consensus 162 ---------------------~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~~i~ 218 (337)
T d1o6la_ 162 ---------------------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF--ELIL 218 (337)
T ss_dssp ---------------------BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHH
T ss_pred ---------------------cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH--HHHh
Confidence 12578999999999999999999999999999999999999988654321111 1111
Q ss_pred hhccccCCCCcHHHHHHHHHhcccCCCCCCC-----hhHHHH--HHHhh
Q psy6593 336 DFRNKFCASCPEPFVRIAFLCCDLNPDQRPP-----FEVLEV--WLEGL 377 (433)
Q Consensus 336 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~i~~--~l~~~ 377 (433)
.....++..+++++.+||.+||+.||.+|++ +++|++ ||+++
T Consensus 219 ~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 219 MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred cCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 2223456889999999999999999999995 778874 55543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.3e-47 Score=353.64 Aligned_cols=227 Identities=22% Similarity=0.386 Sum_probs=192.5
Q ss_pred ccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeE
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 175 (433)
..+++.+.+.+|+|+||+||++. +|+.+|++++||||+++++++.+++.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 44668888999999999998622 69999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCC
Q psy6593 176 VTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
||||++|++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 82 vmE~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-- 158 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 158 (316)
T ss_dssp EECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred EeeecCCccccccccccc-cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccc--
Confidence 999999999999987644 58999999999999999999999999999999999999999999999999998754321
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~ 335 (433)
....||+.|+|||++.+..++.++||||||+++|+|++|.+||........... ..
T Consensus 159 ----------------------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~--i~ 214 (316)
T d1fota_ 159 ----------------------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK--IL 214 (316)
T ss_dssp ----------------------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--HH
T ss_pred ----------------------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHH--HH
Confidence 256799999999999999999999999999999999999999865322111111 11
Q ss_pred hhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHHH--HHHhh
Q psy6593 336 DFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLEV--WLEGL 377 (433)
Q Consensus 336 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~~--~l~~~ 377 (433)
.....++..+++++.+++.+||+.||.+|+ ++++|++ ||+++
T Consensus 215 ~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 215 NAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred cCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 112345677899999999999999999996 8999984 67654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=351.93 Aligned_cols=236 Identities=25% Similarity=0.393 Sum_probs=190.6
Q ss_pred cccCCeeeeeccCCCcchhhhhc-------------------------------cchHHHHhhcCCcceeeEEEEEEeCC
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQN-------------------------------CGQVAVLRSLHHHNVIRFIGVLYKDR 171 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~-------------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~ 171 (433)
+..+++.+.+++|+|+||+||++ .+|+.+|++++||||+++++++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 45566888889999999999862 179999999999999999999965 5
Q ss_pred eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
..++||||+++++|.+.+......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 78899999999999998876556799999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDF 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~ 330 (433)
...... ......|+..|+|||.+.+..++.++||||||+++|||++ |.+||..........
T Consensus 164 ~~~~~~------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~ 225 (273)
T d1u46a_ 164 NDDHYV------------------MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 225 (273)
T ss_dssp -CCEEE------------------C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CCCcce------------------ecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH
Confidence 332111 1124457889999999999999999999999999999997 888886543322222
Q ss_pred CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhh
Q psy6593 331 GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGL 377 (433)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~ 377 (433)
.+.........+..+|+.+.+|+.+||+.||++|||+.+|.++|+++
T Consensus 226 ~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 226 KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 22223334445678899999999999999999999999999999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=354.98 Aligned_cols=229 Identities=16% Similarity=0.251 Sum_probs=191.5
Q ss_pred CeeeeeccCCCcchhhhhcc------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCC
Q psy6593 127 GLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAG 182 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 182 (433)
.+.+.+.+|+|+||+||++. +|+++|++++||||+++++++.+++.+||||||++|
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence 46778899999999999722 899999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc--CCceEEeccccchhccCCCCCCcccc
Q psy6593 183 GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE--DKTVVVADFGLARIIHQGPRAPTTVM 260 (433)
Q Consensus 183 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~ 260 (433)
++|.+++.+.+..+++.+++.|+.||+.||+|||+.||+||||||+|||++. ...+||+|||+++......
T Consensus 86 g~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~------- 158 (321)
T d1tkia_ 86 LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD------- 158 (321)
T ss_dssp CBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-------
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC-------
Confidence 9999999876667999999999999999999999999999999999999985 4589999999998653321
Q ss_pred ccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh--hc
Q psy6593 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD--FR 338 (433)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~--~~ 338 (433)
......+|+.|+|||.+.+..++.++|||||||++|+|++|.+||...........+.... +.
T Consensus 159 ---------------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~ 223 (321)
T d1tkia_ 159 ---------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD 223 (321)
T ss_dssp ---------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC
T ss_pred ---------------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 1236679999999999999999999999999999999999999986543221111111111 11
Q ss_pred cccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 339 NKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 339 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
......+++++.+||.+||+.||++|||++++++ ||+.-
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 1222568899999999999999999999999985 88753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=354.26 Aligned_cols=242 Identities=27% Similarity=0.403 Sum_probs=191.9
Q ss_pred cccccccCCeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhc-CCcceeeEEEE
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSL-HHHNVIRFIGV 166 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l-~h~~iv~~~~~ 166 (433)
++|.+..+++.+.+.+|+|+||+||++. +|+.++.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 4556777889999999999999998621 566777777 68999999999
Q ss_pred EEeC-CeeeEEEeccCCCCHHHHhcCC---------------CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcce
Q psy6593 167 LYKD-RKLNLVTEYIAGGTLKELLQDP---------------GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 230 (433)
Q Consensus 167 ~~~~-~~~~lv~e~~~g~sL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Ni 230 (433)
+... ..+++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 8765 4689999999999999998542 23589999999999999999999999999999999999
Q ss_pred EEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHH
Q psy6593 231 LVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310 (433)
Q Consensus 231 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 310 (433)
|++.++.+||+|||+++.......... .....||+.|+|||.+.+..++.++||||||+++
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~-------------------~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil 226 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVR-------------------KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 226 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCC-------------------TTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred eECCCCcEEEccCcchhhccccccccc-------------------cCceeeCccccchhHhhcCCCCcccceeehHHHH
Confidence 999999999999999987654332211 1145799999999999999999999999999999
Q ss_pred HHHhcC-CCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 311 CEIIGR-VPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 311 ~ell~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
|||+++ .+|+.....................+..+++++.+++.+||+.||++|||+++|++.|++++.
T Consensus 227 ~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 227 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 999965 566654332222222223334455667889999999999999999999999999999998754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=352.58 Aligned_cols=236 Identities=22% Similarity=0.351 Sum_probs=194.1
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc------------------------------chHHHHhhcCCcceeeEEEEEEeCC
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC------------------------------GQVAVLRSLHHHNVIRFIGVLYKDR 171 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~------------------------------~E~~~l~~l~h~~iv~~~~~~~~~~ 171 (433)
++..+++...+.+|+|+||+||++. +|+++|++++|||||++++++.++
T Consensus 5 ~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred cCCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 3455668888999999999998621 799999999999999999999764
Q ss_pred eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
..++++|++.+++|.+.+......+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 56788899999999998887677899999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDF 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~ 330 (433)
...... .....||+.|+|||.+.+..++.++||||||+++|||++ |.+|+....... ..
T Consensus 164 ~~~~~~-------------------~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-~~ 223 (317)
T d1xkka_ 164 EEKEYH-------------------AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-IS 223 (317)
T ss_dssp TCC---------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-HH
T ss_pred cccccc-------------------ccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-HH
Confidence 332211 114568999999999999999999999999999999997 788876533221 11
Q ss_pred CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 331 GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
.......+...+..+|+++.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 224 ~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp HHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 122223344556788999999999999999999999999998887764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=352.02 Aligned_cols=227 Identities=21% Similarity=0.353 Sum_probs=188.2
Q ss_pred CCeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhcCCcceeeEEEEEEeCCeee
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 174 (433)
+.+.+.+.+|+|+||+||++. +|+++|++++|||||++++++.+++.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 447777889999999998622 6999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCC----ceEEeccccchhcc
Q psy6593 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDK----TVVVADFGLARIIH 250 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~ 250 (433)
|||||++||+|.+++.+.+ .+++..++.++.|++.||+|||+.||+||||||+||+++.++ .+||+|||++....
T Consensus 90 iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 9999999999999997644 599999999999999999999999999999999999998766 59999999998764
Q ss_pred CCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC
Q psy6593 251 QGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF 330 (433)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~ 330 (433)
.... .....||+.|+|||++.+..++.++||||||+++|||++|.+||..........
T Consensus 169 ~~~~----------------------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~ 226 (293)
T d1jksa_ 169 FGNE----------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 226 (293)
T ss_dssp TSCB----------------------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCcc----------------------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHH
Confidence 3321 125678999999999999999999999999999999999999886532211111
Q ss_pred CCchh--hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHH
Q psy6593 331 GLDQT--DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLE 375 (433)
Q Consensus 331 ~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~ 375 (433)
.+... .+....+..+|+.+.+||++||+.||++|||++++++ ||+
T Consensus 227 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 275 (293)
T d1jksa_ 227 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275 (293)
T ss_dssp HHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTC
T ss_pred HHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 11111 1112233678899999999999999999999999985 554
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-47 Score=343.76 Aligned_cols=234 Identities=28% Similarity=0.472 Sum_probs=190.2
Q ss_pred ccccccCCeeeeeccCCCcchhhhhcc---------------------chHHHHhhcCCcceeeEEEEEEe-CCeeeEEE
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQNC---------------------GQVAVLRSLHHHNVIRFIGVLYK-DRKLNLVT 177 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~~---------------------~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 177 (433)
+|.+..+++.+.+.+|+|+||+||++. +|+++|++++||||+++++++.+ ++.+++||
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 356677778888999999999999732 79999999999999999999865 45689999
Q ss_pred eccCCCCHHHHhcCCC-CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCC
Q psy6593 178 EYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 178 e~~~g~sL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
||+++|+|.+++.+.+ ..+++..++.|+.||+.||.|||+.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~-- 158 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-- 158 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCCc--
Confidence 9999999999986532 3589999999999999999999999999999999999999999999999999986543211
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc-CCCCCCCCCCCCCCCCCchh
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG-RVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-~~~~~~~~~~~~~~~~~~~~ 335 (433)
...+|+.|+|||.+.+..++.++||||||+++|||++ |.+|+.......... ....
T Consensus 159 ----------------------~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~-~i~~ 215 (262)
T d1byga_ 159 ----------------------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-RVEK 215 (262)
T ss_dssp -------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH-HHTT
T ss_pred ----------------------cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHH-HHHc
Confidence 4467889999999999999999999999999999996 788765432221111 1122
Q ss_pred hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 336 DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 336 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
..+..++..+++++.+|+.+||+.||.+|||+.+|+++|+.+.
T Consensus 216 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 3445567888999999999999999999999999999998864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=350.13 Aligned_cols=241 Identities=28% Similarity=0.437 Sum_probs=204.3
Q ss_pred ccccccCCeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhc-CCcceeeEEEEE
Q psy6593 120 NWYFEKDGLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSL-HHHNVIRFIGVL 167 (433)
Q Consensus 120 ~~~~~~~~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l-~h~~iv~~~~~~ 167 (433)
+|.+..+++.+.+.+|+|+||+||++. +|+.+++++ +|||||++++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 466778889999999999999998631 799999999 799999999999
Q ss_pred EeCCeeeEEEeccCCCCHHHHhcCCC-----------------CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcce
Q psy6593 168 YKDRKLNLVTEYIAGGTLKELLQDPG-----------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 230 (433)
Q Consensus 168 ~~~~~~~lv~e~~~g~sL~~~l~~~~-----------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Ni 230 (433)
.+++..++||||+++|+|.++++... ..+++..++.++.||+.||+|||++|++||||||+||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccc
Confidence 99999999999999999999986421 2589999999999999999999999999999999999
Q ss_pred EEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHH
Q psy6593 231 LVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVL 310 (433)
Q Consensus 231 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 310 (433)
+++.++.++|+|||+++.......... .....||+.|+|||.+.+..++.++||||||+++
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l 237 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVV-------------------KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEE-------------------CSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred cccccCcccccccchheeccCCCcceE-------------------eeecccChHHcCHHHhcCCCCCCcccccchHHHH
Confidence 999999999999999987654332211 1145789999999999999999999999999999
Q ss_pred HHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 311 CEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 311 ~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
|||++ |.|++...........+.....+...+..+|+.+.+||.+||+.||++|||+++|+++|++...
T Consensus 238 ~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 238 WELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 99996 7777755443333333444455556667889999999999999999999999999999987654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=348.42 Aligned_cols=233 Identities=28% Similarity=0.395 Sum_probs=193.9
Q ss_pred ccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhc-CCcceeeEEEEEEeCCeee
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSL-HHHNVIRFIGVLYKDRKLN 174 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 174 (433)
..+++.+.+.+|+|+||+||++. +|+++|+++ +||||+++++++.+++.++
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 44667778889999999998621 799999999 7999999999999999999
Q ss_pred EEEeccCCCCHHHHhcCC---------------CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceE
Q psy6593 175 LVTEYIAGGTLKELLQDP---------------GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVV 239 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~k 239 (433)
+||||++||+|.++++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+|
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceE
Confidence 999999999999998653 35699999999999999999999999999999999999999999999
Q ss_pred EeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcC-CC
Q psy6593 240 VADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGR-VP 318 (433)
Q Consensus 240 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~-~~ 318 (433)
|+|||+++........ ....||..|+|||.+.+..++.++||||||+++|||++| .+
T Consensus 168 l~DfG~a~~~~~~~~~----------------------~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~ 225 (309)
T d1fvra_ 168 IADFGLSRGQEVYVKK----------------------TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225 (309)
T ss_dssp ECCTTCEESSCEECCC--------------------------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred Eccccccccccccccc----------------------cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCC
Confidence 9999999765432211 144689999999999999999999999999999999975 55
Q ss_pred CCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 319 ADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
|+.......... ......+...+..+|+++.+||.+||+.||++|||+++|++.|+++..
T Consensus 226 p~~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 226 PYCGMTCAELYE-KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp TTTTCCHHHHHH-HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHH-HHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 665432211111 112233445567889999999999999999999999999999998764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-46 Score=345.47 Aligned_cols=241 Identities=30% Similarity=0.467 Sum_probs=198.5
Q ss_pred cccccccCCeeeeeccCCCcchhhhhcc---------------------------------chHHHHhhc-CCcceeeEE
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQNC---------------------------------GQVAVLRSL-HHHNVIRFI 164 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~~---------------------------------~E~~~l~~l-~h~~iv~~~ 164 (433)
.+|.+..+++.+.+.+|+|+||+||++. +|+..+.++ +||||++++
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 4566788899999999999999998621 688889888 799999999
Q ss_pred EEEEeCCeeeEEEeccCCCCHHHHhcCCC---------------CCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcc
Q psy6593 165 GVLYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 229 (433)
Q Consensus 165 ~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~N 229 (433)
+++.+++..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 99999999999999999999999996532 458999999999999999999999999999999999
Q ss_pred eEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHH
Q psy6593 230 CLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIV 309 (433)
Q Consensus 230 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 309 (433)
||++.++.+||+|||+++.......... .....||+.|+|||.+.+..++.++||||||++
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~-------------------~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvv 226 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKK-------------------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCC-------------------CTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred eeecCCCCeEeccchhhccccccccccc-------------------cccCCCChhhhhhhHhcCCCCCchhhhHHhHHH
Confidence 9999999999999999997765433221 114578999999999999999999999999999
Q ss_pred HHHHhc-CCCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcc
Q psy6593 310 LCEIIG-RVPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSM 379 (433)
Q Consensus 310 l~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~ 379 (433)
+|||++ |.+|+........ ............+..+++++.+||.+||+.||++|||+.+|++.|+++..
T Consensus 227 l~ell~~g~~p~~~~~~~~~-~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 227 LWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHTTSCCSSTTCCHHHH-HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhccCCCCCCCCCCHHHH-HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 999996 7888765332211 11122234445667889999999999999999999999999999998753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-46 Score=349.16 Aligned_cols=238 Identities=27% Similarity=0.460 Sum_probs=196.7
Q ss_pred cccccCCeeeeeccCCCcchhhhhc-------------------------------cchHHHHhhcCCcceeeEEEEEEe
Q psy6593 121 WYFEKDGLLFCKEDYNGKYGEACQN-------------------------------CGQVAVLRSLHHHNVIRFIGVLYK 169 (433)
Q Consensus 121 ~~~~~~~~~~~~~~~~g~fg~v~~~-------------------------------~~E~~~l~~l~h~~iv~~~~~~~~ 169 (433)
+.+..+++.+.+++|+|+||+||++ .+|+++|++++||||+++++++..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 4556778999999999999999853 189999999999999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhcCC-----------------------CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 170 DRKLNLVTEYIAGGTLKELLQDP-----------------------GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 170 ~~~~~lv~e~~~g~sL~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
.+..++||||+++|+|.+++... ...+++..++.|+.|++.||+|||+.+|+|||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 99999999999999999998532 1248899999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEeh
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSY 306 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 306 (433)
|+|||++.++.+||+|||+++......... ......||+.|+|||.+.+..++.++|||||
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~ 228 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYK-------------------ADGNDAIPIRWMPPESIFYNRYTTESDVWAY 228 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC-----------------------CCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ccceEECCCCcEEEccchhheeccCCcccc-------------------ccCCCCcCcCcCCHHHHccCCCChhhhhccc
Confidence 999999999999999999998664322111 1124568899999999999999999999999
Q ss_pred hHHHHHHhcC-CCCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 307 GIVLCEIIGR-VPADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 307 G~il~ell~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
|+++|||+++ .+|+........... .........+..+|+++.+|+.+||+.+|++|||+.+|+++|+++.
T Consensus 229 Gvvl~ell~~~~~p~~~~~~~e~~~~-v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 229 GVVLWEIFSYGLQPYYGMAHEEVIYY-VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHTTTCCTTTTSCHHHHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hhhHHHHHccCCCCCCCCCHHHHHHH-HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 9999999966 566655332221111 1122234456789999999999999999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6e-46 Score=353.99 Aligned_cols=229 Identities=18% Similarity=0.250 Sum_probs=189.0
Q ss_pred ccCCeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhcCCcceeeEEEEEEeCCe
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSLHHHNVIRFIGVLYKDRK 172 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~ 172 (433)
..+++.+.+.+|+|+||+||++. +|+++++.++||||+++++++.+++.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 34668888899999999999622 23667777789999999999999999
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
+|+||||++||+|.+++.+.. .+++..++.++.||+.||+|||+.||+||||||+|||++.+|.+||+|||+++.....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 999999999999999997643 5899999999999999999999999999999999999999999999999999876443
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCC
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFG 331 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~ 331 (433)
.. ....||+.|+|||++.. ..++.++|||||||++|||++|.+||......... .
T Consensus 161 ~~-----------------------~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~ 216 (364)
T d1omwa3 161 KP-----------------------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-E 216 (364)
T ss_dssp CC-----------------------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-H
T ss_pred cc-----------------------cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH-H
Confidence 22 14579999999999875 56899999999999999999999998654322111 1
Q ss_pred Cch--hhhccccCCCCcHHHHHHHHHhcccCCCCCCC-----hhHHH--HHHHhh
Q psy6593 332 LDQ--TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPP-----FEVLE--VWLEGL 377 (433)
Q Consensus 332 ~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~i~--~~l~~~ 377 (433)
+.. ......++..+++++.+||.+||+.||++||+ +++|+ .||+.+
T Consensus 217 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 217 IDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 111 11223345778999999999999999999999 68887 466654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-46 Score=348.93 Aligned_cols=229 Identities=22% Similarity=0.342 Sum_probs=184.5
Q ss_pred CCeeeee-ccCCCcchhhhhcc--------------------chHHHHhhc-CCcceeeEEEEEEe----CCeeeEEEec
Q psy6593 126 DGLLFCK-EDYNGKYGEACQNC--------------------GQVAVLRSL-HHHNVIRFIGVLYK----DRKLNLVTEY 179 (433)
Q Consensus 126 ~~~~~~~-~~~~g~fg~v~~~~--------------------~E~~~l~~l-~h~~iv~~~~~~~~----~~~~~lv~e~ 179 (433)
+++.+.. .+|+|+||.||++. +|++++.++ +||||++++++|.+ +..+||||||
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy 90 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 90 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEEC
Confidence 3455554 48999999999743 799997766 89999999999975 4679999999
Q ss_pred cCCCCHHHHhcCC-CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc---CCceEEeccccchhccCCCCC
Q psy6593 180 IAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE---DKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 180 ~~g~sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
++||+|.+++.+. ...+++.+++.|+.||+.||+|||+.||+||||||+|||++. ++.+||+|||+++........
T Consensus 91 ~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~ 170 (335)
T d2ozaa1 91 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170 (335)
T ss_dssp CCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCC
T ss_pred CCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCcc
Confidence 9999999999764 356999999999999999999999999999999999999985 567999999999876543221
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~ 335 (433)
....||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+...
T Consensus 171 ----------------------~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~ 228 (335)
T d2ozaa1 171 ----------------------TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 228 (335)
T ss_dssp ----------------------CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------C
T ss_pred ----------------------ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHH
Confidence 1567999999999999999999999999999999999999998654332221111111
Q ss_pred ----h--hccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 336 ----D--FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 336 ----~--~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
. +.......+++++.+||.+||+.||++|||++++++ ||.+
T Consensus 229 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 1 111111357889999999999999999999999985 7764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=351.41 Aligned_cols=228 Identities=21% Similarity=0.322 Sum_probs=190.0
Q ss_pred CCeeeeeccCCCcchhhhhcc----------------------------chHHHHh-hcCCcceeeEEEEEEeCCeeeEE
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLR-SLHHHNVIRFIGVLYKDRKLNLV 176 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 176 (433)
+++.+.+.+|+|+||+||++. .|+.++. .++||||+++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 568888899999999999622 4666655 67999999999999999999999
Q ss_pred EeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCC
Q psy6593 177 TEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 177 ~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
|||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+++........
T Consensus 82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~- 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK- 159 (320)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC-
T ss_pred EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccc-
Confidence 99999999999997644 5999999999999999999999999999999999999999999999999999865433221
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhh
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTD 336 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~ 336 (433)
.....||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+ ..
T Consensus 160 --------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i--~~ 217 (320)
T d1xjda_ 160 --------------------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RM 217 (320)
T ss_dssp --------------------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HH
T ss_pred --------------------ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH--Hc
Confidence 12467999999999999999999999999999999999999998653222111111 12
Q ss_pred hccccCCCCcHHHHHHHHHhcccCCCCCCChh-HHH--HHHHhh
Q psy6593 337 FRNKFCASCPEPFVRIAFLCCDLNPDQRPPFE-VLE--VWLEGL 377 (433)
Q Consensus 337 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~-~i~--~~l~~~ 377 (433)
....++..+|+++.+||.+||+.||++||++. +|+ .||+++
T Consensus 218 ~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 218 DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred CCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 22345677899999999999999999999996 776 477654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.4e-46 Score=352.41 Aligned_cols=227 Identities=21% Similarity=0.337 Sum_probs=193.2
Q ss_pred ccCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeE
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNL 175 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 175 (433)
..+++.+.+.+|+|+||+||++. +|+.+|++++||||+++++++.+.+..++
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 34678889999999999999722 79999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCC
Q psy6593 176 VTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRA 255 (433)
Q Consensus 176 v~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 255 (433)
||||+.||+|.+++.+.+ .+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++......
T Consensus 119 v~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-- 195 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-- 195 (350)
T ss_dssp EEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred ccccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc--
Confidence 999999999999987644 59999999999999999999999999999999999999999999999999998764321
Q ss_pred CccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh
Q psy6593 256 PTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT 335 (433)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~ 335 (433)
....||+.|+|||++.+..++.++|||||||++|||++|.+||.......... ...
T Consensus 196 ----------------------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--~i~ 251 (350)
T d1rdqe_ 196 ----------------------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE--KIV 251 (350)
T ss_dssp ----------------------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHH
T ss_pred ----------------------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHH--HHh
Confidence 15679999999999999999999999999999999999999986532111111 111
Q ss_pred hhccccCCCCcHHHHHHHHHhcccCCCCCC-----ChhHHHH--HHHhh
Q psy6593 336 DFRNKFCASCPEPFVRIAFLCCDLNPDQRP-----PFEVLEV--WLEGL 377 (433)
Q Consensus 336 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~~--~l~~~ 377 (433)
.....++..+++++.+||++||+.||.+|+ ++++|++ ||+..
T Consensus 252 ~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 252 SGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred cCCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 122344578899999999999999999994 8999984 66543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.1e-46 Score=342.78 Aligned_cols=207 Identities=20% Similarity=0.340 Sum_probs=171.7
Q ss_pred chHHHHhhcC-CcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCC
Q psy6593 147 GQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 225 (433)
Q Consensus 147 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dl 225 (433)
+|+.+|++++ ||||+++++++.+++..||||||++||+|.++++..+ ++++..++.++.||+.||+|||++||+||||
T Consensus 58 ~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~ivHrDl 136 (277)
T d1phka_ 58 KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDL 136 (277)
T ss_dssp HHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCccccc
Confidence 6999999996 9999999999999999999999999999999997644 6999999999999999999999999999999
Q ss_pred CCcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC------CCCCc
Q psy6593 226 NSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG------QEYDE 299 (433)
Q Consensus 226 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ 299 (433)
||+||+++.++.+||+|||+++.+..... .....||+.|+|||.+.+ ..++.
T Consensus 137 kp~Nill~~~~~~kl~DFG~a~~~~~~~~----------------------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~ 194 (277)
T d1phka_ 137 KPENILLDDDMNIKLTDFGFSCQLDPGEK----------------------LREVCGTPSYLAPEIIECSMNDNHPGYGK 194 (277)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCTTCC----------------------BCCCCSCGGGCCHHHHHHHHCTTSCCBCT
T ss_pred ccceEEEcCCCCeEEccchheeEccCCCc----------------------eeeeeccCCCCCHHHhhccccccCCCCCc
Confidence 99999999999999999999987644221 125679999999999864 35688
Q ss_pred ccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhh--ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHH
Q psy6593 300 TVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDF--RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLE 375 (433)
Q Consensus 300 ~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~ 375 (433)
++||||+|+++|+|++|.+||...........+..... ......++|+++.+|+.+||+.||++|||+++|++ ||+
T Consensus 195 ~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~ 274 (277)
T d1phka_ 195 EVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274 (277)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred hheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHH
Confidence 99999999999999999999875432211111111111 11122478899999999999999999999999974 565
Q ss_pred h
Q psy6593 376 G 376 (433)
Q Consensus 376 ~ 376 (433)
+
T Consensus 275 ~ 275 (277)
T d1phka_ 275 Q 275 (277)
T ss_dssp T
T ss_pred H
Confidence 4
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=341.07 Aligned_cols=233 Identities=23% Similarity=0.388 Sum_probs=189.3
Q ss_pred eeccCCCcchhhhhcc-----------------------------chHHHHhhcCCcceeeEEEEEEeC-CeeeEEEecc
Q psy6593 131 CKEDYNGKYGEACQNC-----------------------------GQVAVLRSLHHHNVIRFIGVLYKD-RKLNLVTEYI 180 (433)
Q Consensus 131 ~~~~~~g~fg~v~~~~-----------------------------~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~ 180 (433)
...+|+|+||+||++. +|+++|++++||||+++++++.+. +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4567899999998621 899999999999999999998764 5899999999
Q ss_pred CCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcccc
Q psy6593 181 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260 (433)
Q Consensus 181 ~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 260 (433)
++++|.+++......+++..++.++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++...........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~-- 189 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH-- 189 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT--
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccce--
Confidence 999999999887777889999999999999999999999999999999999999999999999999876543322111
Q ss_pred ccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchhhhccc
Q psy6593 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQTDFRNK 340 (433)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (433)
......||+.|+|||.+....++.++||||||+++|||+++..|+.................+..
T Consensus 190 ---------------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~ 254 (311)
T d1r0pa_ 190 ---------------NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 254 (311)
T ss_dssp ---------------CTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC
T ss_pred ---------------ecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 11145689999999999999999999999999999999975444433222211111112223444
Q ss_pred cCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhccc
Q psy6593 341 FCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMH 380 (433)
Q Consensus 341 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~ 380 (433)
.+..+++++.+||.+||+.||++||++.+|++.|+.+...
T Consensus 255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 5678899999999999999999999999999999988653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-45 Score=339.98 Aligned_cols=208 Identities=22% Similarity=0.330 Sum_probs=167.8
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
+|+.+|++++||||+++++++.+++++||||||+.|+++..+... +..+++..+..++.||+.||+|||++||+|||||
T Consensus 49 ~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiK 127 (299)
T d1ua2a_ 49 REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLK 127 (299)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhccceecccCC
Confidence 799999999999999999999999999999999988766665544 4569999999999999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEe
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFS 305 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws 305 (433)
|+|||++.++.+||+|||+++........ ....+||+.|+|||++.+ ..++.++||||
T Consensus 128 p~NIli~~~~~~KL~DFG~a~~~~~~~~~---------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS 186 (299)
T d1ua2a_ 128 PNNLLLDENGVLKLADFGLAKSFGSPNRA---------------------YTHQVVTRWYRAPELLFGARMYGVGVDMWA 186 (299)
T ss_dssp GGGEEECTTCCEEECCCGGGSTTTSCCCC---------------------CCCSCCCCTTCCHHHHTTCSCCCHHHHHHH
T ss_pred cceEEecCCCccccccCccccccCCCccc---------------------ccceecChhhccHHHHccCCCCChhhhhhh
Confidence 99999999999999999999876543221 125579999999999865 46799999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCC--------------CCCC----CC----ch----hhhccccCCCCcHHHHHHHHHhccc
Q psy6593 306 YGIVLCEIIGRVPADPDYLPR--------------SPDF----GL----DQ----TDFRNKFCASCPEPFVRIAFLCCDL 359 (433)
Q Consensus 306 lG~il~ell~~~~~~~~~~~~--------------~~~~----~~----~~----~~~~~~~~~~~~~~l~~li~~~l~~ 359 (433)
|||++|||++|.+||...... .... .. .. ..........+++++.+||.+||+.
T Consensus 187 lGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~ 266 (299)
T d1ua2a_ 187 VGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLF 266 (299)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCS
T ss_pred cchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccC
Confidence 999999999999988543210 0000 00 00 0000112246788999999999999
Q ss_pred CCCCCCChhHHHH--HHHh
Q psy6593 360 NPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 360 ~p~~RPs~~~i~~--~l~~ 376 (433)
||++|||++|+++ ||++
T Consensus 267 dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 267 NPCARITATQALKMKYFSN 285 (299)
T ss_dssp STTTSCCHHHHHTSGGGTS
T ss_pred ChhhCcCHHHHhCCHhhCC
Confidence 9999999999984 5543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.7e-46 Score=341.40 Aligned_cols=232 Identities=20% Similarity=0.295 Sum_probs=181.0
Q ss_pred CeeeeeccCCCcchhhhhcc----------------------------chHHHHhhcCCcceeeEEEEEEeCC----eee
Q psy6593 127 GLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSLHHHNVIRFIGVLYKDR----KLN 174 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l~h~~iv~~~~~~~~~~----~~~ 174 (433)
.+.+.+.+|+|+||+||++. +|+++|++++||||+++++++...+ .+|
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 46677788888888888622 7999999999999999999998654 389
Q ss_pred EEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCC
Q psy6593 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
|||||++|++|.+++...+ .+++.+++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||.+........
T Consensus 88 lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~ 166 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166 (277)
T ss_dssp EEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred EEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence 9999999999999887644 599999999999999999999999999999999999999999999999999876543321
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCch
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQ 334 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~ 334 (433)
.. .......||+.|+|||++.+..++.++||||||+++|||++|.+||..............
T Consensus 167 ~~------------------~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~ 228 (277)
T d1o6ya_ 167 SV------------------TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228 (277)
T ss_dssp ------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cc------------------cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh
Confidence 11 122356899999999999999999999999999999999999999865322111110000
Q ss_pred h--hhccccCCCCcHHHHHHHHHhcccCCCCCC-ChhHHHHHHHhh
Q psy6593 335 T--DFRNKFCASCPEPFVRIAFLCCDLNPDQRP-PFEVLEVWLEGL 377 (433)
Q Consensus 335 ~--~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-s~~~i~~~l~~~ 377 (433)
. .........+|+++.++|.+||+.||++|| |+++++.-|.++
T Consensus 229 ~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 229 EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 0 111223467899999999999999999999 889998777664
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=335.77 Aligned_cols=231 Identities=22% Similarity=0.365 Sum_probs=183.4
Q ss_pred CCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCCeeeEEEe
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTE 178 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 178 (433)
|++...+.+|+|+||+||++. +|+++|++++||||+++++++.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 456777888888888888622 79999999999999999999999999999999
Q ss_pred ccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcc
Q psy6593 179 YIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTT 258 (433)
Q Consensus 179 ~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 258 (433)
|+.++.+..........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~--- 158 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--- 158 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC---
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc---
Confidence 99654444444555567999999999999999999999999999999999999999999999999999876543221
Q ss_pred ccccchhhhhhhcccccceeeeccCccccccceecCCC-CCcccCeEehhHHHHHHhcCCCCCCCCCC------------
Q psy6593 259 VMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE-YDETVDVFSYGIVLCEIIGRVPADPDYLP------------ 325 (433)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~~~~~~~~~~~------------ 325 (433)
.....||+.|+|||.+.... ++.++||||||+++|+|++|.+||.....
T Consensus 159 ------------------~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~ 220 (298)
T d1gz8a_ 159 ------------------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220 (298)
T ss_dssp ------------------TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ------------------ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence 11557999999999877755 57899999999999999999998854211
Q ss_pred --CCCCCCC--chhhh-----------ccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 326 --RSPDFGL--DQTDF-----------RNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 326 --~~~~~~~--~~~~~-----------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
....... ..... .......+++++.+|+.+||+.||++|||++|+++ ||+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 221 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp CCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0000000 00000 01112467789999999999999999999999985 77654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=335.61 Aligned_cols=219 Identities=18% Similarity=0.296 Sum_probs=181.0
Q ss_pred CeeeeeccCCCcchhhhhcc-------------------------------chHHHHhhcC--CcceeeEEEEEEeCCee
Q psy6593 127 GLLFCKEDYNGKYGEACQNC-------------------------------GQVAVLRSLH--HHNVIRFIGVLYKDRKL 173 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~~-------------------------------~E~~~l~~l~--h~~iv~~~~~~~~~~~~ 173 (433)
++.+.+.+|+|+||+||++. +|+.+|++++ ||||+++++++.+++..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 35666777888888887511 6999999996 89999999999999999
Q ss_pred eEEEeccCC-CCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc-CCceEEeccccchhccC
Q psy6593 174 NLVTEYIAG-GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE-DKTVVVADFGLARIIHQ 251 (433)
Q Consensus 174 ~lv~e~~~g-~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~ 251 (433)
++||||+.+ +++.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 85 ~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp EEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence 999999976 5788887654 35999999999999999999999999999999999999985 57999999999976433
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCC-CcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEY-DETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~ 330 (433)
... ....||+.|+|||++.+..+ +.++|||||||++|||++|.+||....
T Consensus 164 ~~~-----------------------~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------ 214 (273)
T d1xwsa_ 164 TVY-----------------------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 214 (273)
T ss_dssp SCB-----------------------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------
T ss_pred ccc-----------------------cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------
Confidence 211 15679999999999987665 577999999999999999999885421
Q ss_pred CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 331 GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
........++..+|+++.+||.+||+.||++|||++++++ ||+++
T Consensus 215 --~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 215 --EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp --HHHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred --HHhhcccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1111223345778999999999999999999999999985 67653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.6e-44 Score=331.85 Aligned_cols=253 Identities=16% Similarity=0.226 Sum_probs=208.2
Q ss_pred CCeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCC-cceeeEEEEEEeCCeeeEEEeccC
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHH-HNVIRFIGVLYKDRKLNLVTEYIA 181 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~ 181 (433)
+.+.+.+.+|+|+||+||++. +|+++++.|+| +||+.+++++..+...++||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 346778899999999999732 79999999965 89999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEcc-----CCceEEeccccchhccCCCCCC
Q psy6593 182 GGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE-----DKTVVVADFGLARIIHQGPRAP 256 (433)
Q Consensus 182 g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~-----~~~~kl~Dfg~~~~~~~~~~~~ 256 (433)
+++|.+++...+..++...+..++.|++.||+|||++||+||||||+||+++. ++.+||+|||+++.........
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (293)
T d1csna_ 84 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 163 (293)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCC
T ss_pred CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcccc
Confidence 78999999877778999999999999999999999999999999999999974 5789999999999875433221
Q ss_pred ccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCc---
Q psy6593 257 TTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLD--- 333 (433)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~--- 333 (433)
.. .........||+.|+|||++.+..++.++||||||+++|||++|.+||.............
T Consensus 164 ~~--------------~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~ 229 (293)
T d1csna_ 164 HI--------------PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229 (293)
T ss_dssp BC--------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred ce--------------eecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH
Confidence 10 1112336689999999999999999999999999999999999999986543332211110
Q ss_pred ---hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccccCCCCCCCchhh
Q psy6593 334 ---QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPLPSDLEA 393 (433)
Q Consensus 334 ---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~~~~~~~~~~~~ 393 (433)
.......++.++|+++.+++..|++.+|++||+++.+.+.|+++..........+++|+.
T Consensus 230 ~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~ 292 (293)
T d1csna_ 230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 292 (293)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred hccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCc
Confidence 111122345788999999999999999999999999999999988877777778888863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-45 Score=339.73 Aligned_cols=240 Identities=25% Similarity=0.437 Sum_probs=198.7
Q ss_pred cccccccCCeeeeeccCCCcchhhhhc-------------------------------cchHHHHhhcCCcceeeEEEEE
Q psy6593 119 DNWYFEKDGLLFCKEDYNGKYGEACQN-------------------------------CGQVAVLRSLHHHNVIRFIGVL 167 (433)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~g~fg~v~~~-------------------------------~~E~~~l~~l~h~~iv~~~~~~ 167 (433)
+.|.+..+++.+.+++|+|+||+||++ .+|++++++++||||+++++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 556678889999999999999999851 1899999999999999999999
Q ss_pred EeCCeeeEEEeccCCCCHHHHhcCC---------CCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCce
Q psy6593 168 YKDRKLNLVTEYIAGGTLKELLQDP---------GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTV 238 (433)
Q Consensus 168 ~~~~~~~lv~e~~~g~sL~~~l~~~---------~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~ 238 (433)
..++..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 9999999999999999999987531 1347899999999999999999999999999999999999999999
Q ss_pred EEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcC-C
Q psy6593 239 VVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGR-V 317 (433)
Q Consensus 239 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~-~ 317 (433)
||+|||+++......... ......||+.|+|||.+.+..++.++||||||+++|||+++ .
T Consensus 173 Kl~DFGla~~~~~~~~~~-------------------~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~ 233 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYR-------------------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233 (308)
T ss_dssp EECCTTCCCGGGGGGCEE-------------------GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSC
T ss_pred EEeecccceeccCCccee-------------------eccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCC
Confidence 999999998764432211 11134689999999999999999999999999999999976 5
Q ss_pred CCCCCCCCCCCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhc
Q psy6593 318 PADPDYLPRSPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLS 378 (433)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~ 378 (433)
+|+.......... ..........+..+|+.+.++|.+||+.+|++|||+++|++.|++..
T Consensus 234 ~p~~~~~~~~~~~-~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 234 QPYQGLSNEQVLR-FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp CTTTTSCHHHHHH-HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CCCCCCCHHHHHH-HHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 6665432211111 11122234455788999999999999999999999999999998754
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-43 Score=329.81 Aligned_cols=254 Identities=17% Similarity=0.214 Sum_probs=201.5
Q ss_pred CeeeeeccCCCcchhhhhcc-----------------------chHHHHhhcCCcc-eeeEEEEEEeCCeeeEEEeccCC
Q psy6593 127 GLLFCKEDYNGKYGEACQNC-----------------------GQVAVLRSLHHHN-VIRFIGVLYKDRKLNLVTEYIAG 182 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~~-----------------------~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~g 182 (433)
.+.+.+.+|+|+||+||++. .|++++++++|+| |+.+..++.+++..++||||+ +
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~ 86 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 86 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-C
Confidence 47778899999999999732 6999999997665 566667778888999999999 6
Q ss_pred CCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEc---cCCceEEeccccchhccCCCCCCccc
Q psy6593 183 GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR---EDKTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 183 ~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
++|.+.+......+++..+..++.|++.||+|||++||+||||||+|||++ .+..++|+|||+++...........
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~- 165 (299)
T d1ckia_ 87 PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI- 165 (299)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBC-
T ss_pred CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccce-
Confidence 688877766666799999999999999999999999999999999999986 4567999999999987654322110
Q ss_pred cccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCCchh----
Q psy6593 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGLDQT---- 335 (433)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~~~~---- 335 (433)
.........||+.|+|||.+.+..++.++||||||+++|||++|.+||...............
T Consensus 166 -------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ckia_ 166 -------------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232 (299)
T ss_dssp -------------CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH
T ss_pred -------------eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc
Confidence 111223568999999999999999999999999999999999999998765544433322111
Q ss_pred --hhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccccCCCCCCCchhhhh
Q psy6593 336 --DFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHLSVDKPLPSDLEADI 395 (433)
Q Consensus 336 --~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~~~~~~~~~~~~~~~ 395 (433)
........++|+++.+++.+||+.+|++||++++|.+.|+.+..........+++|+...
T Consensus 233 ~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~~ 294 (299)
T d1ckia_ 233 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 294 (299)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHGG
T ss_pred CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchhhc
Confidence 111233478899999999999999999999999999999988776677777788887654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-44 Score=332.76 Aligned_cols=232 Identities=28% Similarity=0.378 Sum_probs=185.8
Q ss_pred cCCeeeeeccCCCcchhhhhcc----------------------------chHHHHhhc---CCcceeeEEEEEEe----
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC----------------------------GQVAVLRSL---HHHNVIRFIGVLYK---- 169 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~----------------------------~E~~~l~~l---~h~~iv~~~~~~~~---- 169 (433)
.+++.+.+++|+|+||+||++. +|+++|+.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 3557778888999999888621 688888877 79999999999863
Q ss_pred -CCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchh
Q psy6593 170 -DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 170 -~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
...++++||+++++++..........+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 2468999999988777666655566799999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCC
Q psy6593 249 IHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP 328 (433)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~ 328 (433)
..... ......||+.|+|||++.+..++.++|||||||++|||++|.+||........
T Consensus 166 ~~~~~----------------------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 223 (305)
T d1blxa_ 166 YSFQM----------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 223 (305)
T ss_dssp CCGGG----------------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred hcccc----------------------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH
Confidence 43211 12256799999999999999999999999999999999999999864321000
Q ss_pred ------------------CC-------CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 329 ------------------DF-------GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 329 ------------------~~-------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
.. ..........+...+++.+.+||.+||+.||++|||++|+++ ||+++.
T Consensus 224 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 224 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 00 000111122334678899999999999999999999999984 777653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.5e-43 Score=324.52 Aligned_cols=227 Identities=23% Similarity=0.357 Sum_probs=177.2
Q ss_pred CeeeeeccCCCcchhhhhc--------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEecc
Q psy6593 127 GLLFCKEDYNGKYGEACQN--------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYI 180 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~--------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 180 (433)
++...+++|+|+||+||++ .+|+.+|++++||||+++++++..++..++|||++
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 4556667777777777751 17999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCcccc
Q psy6593 181 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTVM 260 (433)
Q Consensus 181 ~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 260 (433)
.++.+..+... .+.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 83 ~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~----- 156 (286)
T d1ob3a_ 83 DQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK----- 156 (286)
T ss_dssp SEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred hhhhHHHHHhh-cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc-----
Confidence 77655555544 456999999999999999999999999999999999999999999999999999886543221
Q ss_pred ccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeEehhHHHHHHhcCCCCCCCCCCC-------------
Q psy6593 261 AKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVPADPDYLPR------------- 326 (433)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~~~~~~~~~~~~------------- 326 (433)
.....+++.|+|||.+.+. .++.++||||||+++|||++|.+||......
T Consensus 157 ----------------~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~ 220 (286)
T d1ob3a_ 157 ----------------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP 220 (286)
T ss_dssp ---------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ----------------cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence 1145789999999998764 5689999999999999999999998543110
Q ss_pred -CCCC-------------CCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHH--HHHH
Q psy6593 327 -SPDF-------------GLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLE--VWLE 375 (433)
Q Consensus 327 -~~~~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~--~~l~ 375 (433)
.... ..............+++.+.+|+++||+.||++|||++|++ .||+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred ChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 0000 00001111223466789999999999999999999999998 3554
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=329.45 Aligned_cols=237 Identities=24% Similarity=0.314 Sum_probs=180.8
Q ss_pred CCeeeeeccCCCcchhhhhcc----------------------chHHHHhhcCCcceeeEEEEEEeCC----eeeEEEec
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC----------------------GQVAVLRSLHHHNVIRFIGVLYKDR----KLNLVTEY 179 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~----------------------~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~ 179 (433)
..++..+++|+|+||+||++- .|+..+.+++||||+++++++.+++ .+|+||||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 346777888999999998622 3445556789999999999998654 58999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhc--------CCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS--------MNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~--------~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
+++|+|.+++++ ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 83 HEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp CTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred ccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 999999999987 359999999999999999999996 5999999999999999999999999999987754
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCC------CCcccCeEehhHHHHHHhcCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE------YDETVDVFSYGIVLCEIIGRVPADPDYLP 325 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~ell~~~~~~~~~~~ 325 (433)
...... .......||+.|+|||++.+.. ++.++||||||+++|||++|.+|+.....
T Consensus 161 ~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~ 223 (303)
T d1vjya_ 161 ATDTID-----------------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223 (303)
T ss_dssp TTTEEC-----------------C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCC
T ss_pred CCccee-----------------ccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccc
Confidence 332111 1112567999999999987642 56789999999999999999877643221
Q ss_pred CCCCCC-C-----ch---------hhhccccC-----CCCcHHHHHHHHHhcccCCCCCCChhHHHHHHHhhcccc
Q psy6593 326 RSPDFG-L-----DQ---------TDFRNKFC-----ASCPEPFVRIAFLCCDLNPDQRPPFEVLEVWLEGLSMHL 381 (433)
Q Consensus 326 ~~~~~~-~-----~~---------~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~~~~~~ 381 (433)
...... . .. ...++.++ ...+..+.+|+.+||+.||++|||+.+|++.|+++....
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 224 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 111100 0 00 01111111 112345899999999999999999999999999876543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=328.03 Aligned_cols=229 Identities=24% Similarity=0.368 Sum_probs=179.4
Q ss_pred eeeeeccCCCcchhhhhcc---------------------chHHHHhhcCCcceeeEEEEEEeC------CeeeEEEecc
Q psy6593 128 LLFCKEDYNGKYGEACQNC---------------------GQVAVLRSLHHHNVIRFIGVLYKD------RKLNLVTEYI 180 (433)
Q Consensus 128 ~~~~~~~~~g~fg~v~~~~---------------------~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~ 180 (433)
+...+.+|+|+||+||++. +|+++|++++|+||+++++++... .+++|||||+
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~ 101 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECC
T ss_pred cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEecc
Confidence 5566789999999999722 799999999999999999999643 3579999999
Q ss_pred CCCCHHHHhc--CCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCC-ceEEeccccchhccCCCCCCc
Q psy6593 181 AGGTLKELLQ--DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDK-TVVVADFGLARIIHQGPRAPT 257 (433)
Q Consensus 181 ~g~sL~~~l~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~ 257 (433)
+++.+..+.. .....+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||+|||+++........
T Consensus 102 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~-- 179 (350)
T d1q5ka_ 102 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-- 179 (350)
T ss_dssp SEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCC--
T ss_pred CCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCccc--
Confidence 7654333321 2345699999999999999999999999999999999999999765 8999999999876443221
Q ss_pred cccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCC---------
Q psy6593 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRS--------- 327 (433)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~--------- 327 (433)
....||+.|+|||.+.+ ..++.++||||+||++|||++|.+||.......
T Consensus 180 --------------------~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~ 239 (350)
T d1q5ka_ 180 --------------------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239 (350)
T ss_dssp --------------------CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred --------------------ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHh
Confidence 15579999999998765 578999999999999999999999885432110
Q ss_pred ------------------CCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 328 ------------------PDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 328 ------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
.........+........++++.+||.+||+.||++|||+.|+++ ||+++.
T Consensus 240 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred CCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 000001111112223567889999999999999999999999984 887764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-42 Score=322.54 Aligned_cols=233 Identities=18% Similarity=0.289 Sum_probs=190.6
Q ss_pred cccCCeeeeeccCCCcchhhhhcc--------------------------------chHHHHhhcCC-cceeeEEEEEEe
Q psy6593 123 FEKDGLLFCKEDYNGKYGEACQNC--------------------------------GQVAVLRSLHH-HNVIRFIGVLYK 169 (433)
Q Consensus 123 ~~~~~~~~~~~~~~g~fg~v~~~~--------------------------------~E~~~l~~l~h-~~iv~~~~~~~~ 169 (433)
...+++.+.+++|+|+||+||++. +|+++|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 345778999999999999998621 79999999976 899999999999
Q ss_pred CCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhc
Q psy6593 170 DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARII 249 (433)
Q Consensus 170 ~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 249 (433)
....++||||+.|++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred CCceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 999999999999999999987644 4889999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC--CCCcccCeEehhHHHHHHhcCCCCCCCCCCCC
Q psy6593 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ--EYDETVDVFSYGIVLCEIIGRVPADPDYLPRS 327 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~~~~~~~~~~~~~ 327 (433)
...... ......|++.|+|||.+.+. .++.++|||||||+||+|++|.+||.......
T Consensus 180 ~~~~~~--------------------~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~ 239 (322)
T d1vzoa_ 180 VADETE--------------------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239 (322)
T ss_dssp CGGGGG--------------------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred cccccc--------------------cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 432211 11256799999999999764 46889999999999999999999986654333
Q ss_pred CCCCCchhh--hccccCCCCcHHHHHHHHHhcccCCCCCCC-----hhHHHH--HHHh
Q psy6593 328 PDFGLDQTD--FRNKFCASCPEPFVRIAFLCCDLNPDQRPP-----FEVLEV--WLEG 376 (433)
Q Consensus 328 ~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~i~~--~l~~ 376 (433)
....+.... ....++..+++++.+|+.+||+.||++||+ ++|+++ ||+.
T Consensus 240 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 240 SQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 322222222 223345678999999999999999999995 677763 6654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-42 Score=325.90 Aligned_cols=227 Identities=23% Similarity=0.323 Sum_probs=179.1
Q ss_pred cCCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeCC------
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKDR------ 171 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~~------ 171 (433)
.+.+.+.+++|+|+||+||++. +|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4457888899999999999722 7999999999999999999998654
Q ss_pred eeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccC
Q psy6593 172 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQ 251 (433)
Q Consensus 172 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 251 (433)
++|+||||+ +.+|.++++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 579999999 6788888865 4699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCC
Q psy6593 252 GPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDF 330 (433)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~ 330 (433)
.. ....||+.|+|||.+.+ ..++.++||||+||++|+|++|.+||..........
T Consensus 174 ~~------------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~ 229 (346)
T d1cm8a_ 174 EM------------------------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 229 (346)
T ss_dssp SC------------------------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred cc------------------------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHH
Confidence 22 15579999999999876 456899999999999999999999886532110000
Q ss_pred C-----------------------------CchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 331 G-----------------------------LDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 331 ~-----------------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
. .............+++.+.+||.+||..||.+|||++++++ ||+.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 230 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0 00000011223567889999999999999999999999985 787654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-41 Score=320.18 Aligned_cols=229 Identities=20% Similarity=0.281 Sum_probs=183.2
Q ss_pred ccCCeeeeeccCCCcchhhhhcc----------------------chHHHHhhcC-CcceeeEEEEEEeC--CeeeEEEe
Q psy6593 124 EKDGLLFCKEDYNGKYGEACQNC----------------------GQVAVLRSLH-HHNVIRFIGVLYKD--RKLNLVTE 178 (433)
Q Consensus 124 ~~~~~~~~~~~~~g~fg~v~~~~----------------------~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e 178 (433)
+.+++.+.+++|+|+||+||++. +|+++|++++ ||||+++++++... ..+++|||
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 55678999999999999999732 7999999995 99999999999854 56999999
Q ss_pred ccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccC-CceEEeccccchhccCCCCCCc
Q psy6593 179 YIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRED-KTVVVADFGLARIIHQGPRAPT 257 (433)
Q Consensus 179 ~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~ 257 (433)
|+.+++|.++.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++........
T Consensus 113 ~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~-- 186 (328)
T d3bqca1 113 HVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-- 186 (328)
T ss_dssp CCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC--
T ss_pred ecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcc--
Confidence 999999987753 49999999999999999999999999999999999999865 46999999999876443221
Q ss_pred cccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCC-------
Q psy6593 258 TVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPD------- 329 (433)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~------- 329 (433)
....+|+.|+|||.+.+. .++.++||||+|+++|+|++|.+|+.........
T Consensus 187 --------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~ 246 (328)
T d3bqca1 187 --------------------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246 (328)
T ss_dssp --------------------CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH
T ss_pred --------------------cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHH
Confidence 155789999999998775 4799999999999999999888877543211000
Q ss_pred ----------------------------CCCc-hhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 330 ----------------------------FGLD-QTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 330 ----------------------------~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
.... ...........+++++.+||++||+.||++|||++|+++ ||+.+.
T Consensus 247 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred HCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 0000 000011112446789999999999999999999999985 776644
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-41 Score=311.08 Aligned_cols=228 Identities=23% Similarity=0.269 Sum_probs=181.5
Q ss_pred CeeeeeccCCCcchhhhhc---------------------------cchHHHHhhcCCcceeeEEEEEEeCCeeeEEEec
Q psy6593 127 GLLFCKEDYNGKYGEACQN---------------------------CGQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 179 (433)
Q Consensus 127 ~~~~~~~~~~g~fg~v~~~---------------------------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 179 (433)
.+.+.+++|+|+||+||++ .+|+.+|++++||||+++++++.+....++|+|+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 4666777888888887761 2899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCCCCccc
Q psy6593 180 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPRAPTTV 259 (433)
Q Consensus 180 ~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 259 (433)
+.|++|..++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++.........
T Consensus 83 ~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~--- 158 (292)
T d1unla_ 83 CDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--- 158 (292)
T ss_dssp CSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC---
T ss_pred ccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccc---
Confidence 9998888887664 469999999999999999999999999999999999999999999999999998765433221
Q ss_pred cccchhhhhhhcccccceeeeccCccccccceecCCC-CCcccCeEehhHHHHHHhcCCCCCCCCCC-C-----------
Q psy6593 260 MAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQE-YDETVDVFSYGIVLCEIIGRVPADPDYLP-R----------- 326 (433)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~~~~~~~~~~~-~----------- 326 (433)
....+++.|+|||.+.+.. ++.++|||||||++|||++|..|+..... .
T Consensus 159 ------------------~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 220 (292)
T d1unla_ 159 ------------------SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220 (292)
T ss_dssp ------------------CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHC
T ss_pred ------------------eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcC
Confidence 1345778899999987754 68999999999999999976655421110 0
Q ss_pred ----------------CCCCCCchhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHh
Q psy6593 327 ----------------SPDFGLDQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEG 376 (433)
Q Consensus 327 ----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~ 376 (433)
..................+++.+.+|+.+||+.||.+|||++|+++ ||++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred CCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 0000001111122233567889999999999999999999999985 7765
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=312.81 Aligned_cols=233 Identities=19% Similarity=0.282 Sum_probs=176.3
Q ss_pred cCCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEe--------
Q psy6593 125 KDGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYK-------- 169 (433)
Q Consensus 125 ~~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~-------- 169 (433)
.+.+.+.+++|+|+||+||++. +|+++|++++|+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 3557788899999999998622 79999999999999999999865
Q ss_pred CCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhc
Q psy6593 170 DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARII 249 (433)
Q Consensus 170 ~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 249 (433)
++..|+||||+.++++. ........+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp --CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 34689999999765544 44454567999999999999999999999999999999999999999999999999999866
Q ss_pred cCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeEehhHHHHHHhcCCCCCCCCCCCC-
Q psy6593 250 HQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVPADPDYLPRS- 327 (433)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~~~~~~~~~~~~~- 327 (433)
........ .......||+.|+|||.+.+. .++.++||||||+++|||++|.+||.......
T Consensus 168 ~~~~~~~~-----------------~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~ 230 (318)
T d3blha1 168 SLAKNSQP-----------------NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 230 (318)
T ss_dssp CC-----C-----------------CCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccc-----------------ccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH
Confidence 53322111 122256799999999998764 68999999999999999999999885321100
Q ss_pred --------------CCCCCchhhhcc------ccC---------CCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHH
Q psy6593 328 --------------PDFGLDQTDFRN------KFC---------ASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLE 375 (433)
Q Consensus 328 --------------~~~~~~~~~~~~------~~~---------~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~ 375 (433)
............ ... ...++.+.+||.+||+.||++|||++|+++ ||+
T Consensus 231 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~ 309 (318)
T d3blha1 231 LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309 (318)
T ss_dssp HHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred HHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhc
Confidence 000000000000 000 112567789999999999999999999984 665
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-41 Score=317.59 Aligned_cols=231 Identities=24% Similarity=0.370 Sum_probs=176.9
Q ss_pred CCeeeeeccCCCcchhhhhcc--------------------------chHHHHhhcCCcceeeEEEEEEeCC-----eee
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC--------------------------GQVAVLRSLHHHNVIRFIGVLYKDR-----KLN 174 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~--------------------------~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 174 (433)
+.+.+.+++|+|+||+||++. +|+++|++++||||+++++++.... .++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 347788899999999998722 7999999999999999999997653 345
Q ss_pred EEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCCC
Q psy6593 175 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGPR 254 (433)
Q Consensus 175 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 254 (433)
+|+ ++.|++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 88 l~~-~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 88 LVT-HLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEE-ECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEE-eecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 555 5568999999976 3599999999999999999999999999999999999999999999999999986544322
Q ss_pred CCccccccchhhhhhhcccccceeeeccCccccccceecC-CCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC-
Q psy6593 255 APTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTG-QEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL- 332 (433)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~- 332 (433)
.. ......+||+.|+|||.+.. ..++.++||||+|+++|+|++|.+||............
T Consensus 165 ~~------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~ 226 (345)
T d1pmea_ 165 HT------------------GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 226 (345)
T ss_dssp BC------------------CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cc------------------eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHh
Confidence 11 01125679999999999854 56789999999999999999999988543210000000
Q ss_pred ----------------------------chhhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 333 ----------------------------DQTDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 333 ----------------------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
............+++++.+|+.+||+.||.+|||++++++ ||+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 227 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 0000001123567789999999999999999999999985 66643
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-41 Score=318.56 Aligned_cols=227 Identities=22% Similarity=0.302 Sum_probs=178.3
Q ss_pred CCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeC-----Cee
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKD-----RKL 173 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 173 (433)
+.+...+++|+|+||+||++. +|+++|++++||||+++++++... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 568888999999999999722 799999999999999999999743 334
Q ss_pred eEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCCC
Q psy6593 174 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQGP 253 (433)
Q Consensus 174 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 253 (433)
++||+++.|++|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++......
T Consensus 98 ~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~- 174 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE- 174 (348)
T ss_dssp CEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG-
T ss_pred EEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc-
Confidence 666677779999999976 46999999999999999999999999999999999999999999999999998754321
Q ss_pred CCCccccccchhhhhhhcccccceeeeccCccccccceecCC-CCCcccCeEehhHHHHHHhcCCCCCCCCCCCCCCCCC
Q psy6593 254 RAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQ-EYDETVDVFSYGIVLCEIIGRVPADPDYLPRSPDFGL 332 (433)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~~~~~ 332 (433)
.....||+.|+|||.+.+. .++.++||||||+++|+|++|.+||...........+
T Consensus 175 -----------------------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i 231 (348)
T d2gfsa1 175 -----------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231 (348)
T ss_dssp -----------------------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred -----------------------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 1256789999999987765 4688999999999999999999988543210000000
Q ss_pred ------------------ch-----------hhhccccCCCCcHHHHHHHHHhcccCCCCCCChhHHHH--HHHhhc
Q psy6593 333 ------------------DQ-----------TDFRNKFCASCPEPFVRIAFLCCDLNPDQRPPFEVLEV--WLEGLS 378 (433)
Q Consensus 333 ------------------~~-----------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~--~l~~~~ 378 (433)
.. .........++++++.+||.+||+.||++|||++|+++ ||+.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 232 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 00 00000112467889999999999999999999999995 887654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-40 Score=315.05 Aligned_cols=226 Identities=23% Similarity=0.332 Sum_probs=169.6
Q ss_pred CCeeeeeccCCCcchhhhhcc---------------------------chHHHHhhcCCcceeeEEEEEEeC------Ce
Q psy6593 126 DGLLFCKEDYNGKYGEACQNC---------------------------GQVAVLRSLHHHNVIRFIGVLYKD------RK 172 (433)
Q Consensus 126 ~~~~~~~~~~~g~fg~v~~~~---------------------------~E~~~l~~l~h~~iv~~~~~~~~~------~~ 172 (433)
+.+.+.+++|+|+||+||++. +|+.+|++++||||++++++|... .+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 458888899999999999722 799999999999999999999643 68
Q ss_pred eeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCCCcceEEccCCceEEeccccchhccCC
Q psy6593 173 LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREDKTVVVADFGLARIIHQG 252 (433)
Q Consensus 173 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 252 (433)
+|+||||+.+ +|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||+++.....
T Consensus 97 ~~iv~Ey~~~-~l~~~~~~---~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEeccch-HHHHhhhc---CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 8999999965 55555533 5999999999999999999999999999999999999999999999999998865432
Q ss_pred CCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhcCCCCCCCCCCCCC----
Q psy6593 253 PRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIGRVPADPDYLPRSP---- 328 (433)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~~~~~~~~~~~~~~---- 328 (433)
.. .....+|+.|+|||++.+..++.++||||+||++|+|++|.+||........
T Consensus 173 ~~----------------------~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i 230 (355)
T d2b1pa1 173 FM----------------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230 (355)
T ss_dssp ------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cc----------------------cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHH
Confidence 21 1256789999999999999999999999999999999999998864321000
Q ss_pred ----------------------------CCCCchhh-hcccc-------CCCCcHHHHHHHHHhcccCCCCCCChhHHH-
Q psy6593 329 ----------------------------DFGLDQTD-FRNKF-------CASCPEPFVRIAFLCCDLNPDQRPPFEVLE- 371 (433)
Q Consensus 329 ----------------------------~~~~~~~~-~~~~~-------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~- 371 (433)
........ ..... ....++++.+||++||+.||++|||++|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000 00000 012356789999999999999999999998
Q ss_pred -HHHHhh
Q psy6593 372 -VWLEGL 377 (433)
Q Consensus 372 -~~l~~~ 377 (433)
.||+..
T Consensus 311 Hpw~~~~ 317 (355)
T d2b1pa1 311 HPYINVW 317 (355)
T ss_dssp STTTGGG
T ss_pred CcccCCC
Confidence 477653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-35 Score=280.40 Aligned_cols=232 Identities=14% Similarity=0.233 Sum_probs=171.1
Q ss_pred ccccCCeeeeeccCCCcchhhhhcc------------------------chHHHHhhcC-----------CcceeeEEEE
Q psy6593 122 YFEKDGLLFCKEDYNGKYGEACQNC------------------------GQVAVLRSLH-----------HHNVIRFIGV 166 (433)
Q Consensus 122 ~~~~~~~~~~~~~~~g~fg~v~~~~------------------------~E~~~l~~l~-----------h~~iv~~~~~ 166 (433)
.+....+.+.+++|+|+||+||++. +|+.+|++++ |+||++++++
T Consensus 9 ~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 9 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 3444458889999999999999732 5888888885 4789999999
Q ss_pred EEeC--CeeeEEEeccCCCCH-H-HHhcCCCCCCChHHHHHHHHHHHHHHhhhhc-CCccccCCCCcceEEccCC-----
Q psy6593 167 LYKD--RKLNLVTEYIAGGTL-K-ELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCLVREDK----- 236 (433)
Q Consensus 167 ~~~~--~~~~lv~e~~~g~sL-~-~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~~~----- 236 (433)
+... ...+++|++...+.. . .........+++..+..++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 8653 456666666544432 2 2233344569999999999999999999997 8999999999999998654
Q ss_pred -ceEEeccccchhccCCCCCCccccccchhhhhhhcccccceeeeccCccccccceecCCCCCcccCeEehhHHHHHHhc
Q psy6593 237 -TVVVADFGLARIIHQGPRAPTTVMAKVPRKAAQRRGARKKRYTVVGNPYWMAPEMMTGQEYDETVDVFSYGIVLCEIIG 315 (433)
Q Consensus 237 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 315 (433)
.++++|||.+....... ....||+.|+|||++.+..++.++||||+|+++++|++
T Consensus 169 ~~~kl~dfg~s~~~~~~~------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 224 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY------------------------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 224 (362)
T ss_dssp EEEEECCCTTCEETTBCC------------------------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHH
T ss_pred ceeeEeeccccccccccc------------------------ccccccccccChhhccccCCCccccccchHHHHHHHHH
Confidence 49999999987654322 15579999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCC-------------------------------------Cch------h---hhccccCCCCcHHH
Q psy6593 316 RVPADPDYLPRSPDFG-------------------------------------LDQ------T---DFRNKFCASCPEPF 349 (433)
Q Consensus 316 ~~~~~~~~~~~~~~~~-------------------------------------~~~------~---~~~~~~~~~~~~~l 349 (433)
|.+||........... ... . ..........++.+
T Consensus 225 g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (362)
T d1q8ya_ 225 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 304 (362)
T ss_dssp SSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHH
T ss_pred CCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHH
Confidence 9988764322110000 000 0 00011112346789
Q ss_pred HHHHHHhcccCCCCCCChhHHHH--HHHhh
Q psy6593 350 VRIAFLCCDLNPDQRPPFEVLEV--WLEGL 377 (433)
Q Consensus 350 ~~li~~~l~~~p~~RPs~~~i~~--~l~~~ 377 (433)
.+|+.+||..||.+|||++|+++ ||++.
T Consensus 305 ~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 305 SDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999984 77643
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.78 E-value=1.8e-20 Score=161.06 Aligned_cols=91 Identities=18% Similarity=0.186 Sum_probs=76.6
Q ss_pred chHHHHhhcCCcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhcCCccccCCC
Q psy6593 147 GQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 226 (433)
Q Consensus 147 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~dlk 226 (433)
.|...|.++.|.+++..+++. ..++||||+++..+.+ ++...+..++.|++.+|.+||+.||+|||||
T Consensus 63 ~e~~~l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiK 130 (191)
T d1zara2 63 NEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLS 130 (191)
T ss_dssp HHHHHHHHTTTSSSCCEEEEE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHHHHHccCCCcceEEEec----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCC
Confidence 578899999999999988763 2379999998765533 4556678899999999999999999999999
Q ss_pred CcceEEccCCceEEeccccchhcc
Q psy6593 227 SQNCLVREDKTVVVADFGLARIIH 250 (433)
Q Consensus 227 p~Nil~~~~~~~kl~Dfg~~~~~~ 250 (433)
|+|||++++ .++|+|||++....
T Consensus 131 P~NILv~~~-~~~liDFG~a~~~~ 153 (191)
T d1zara2 131 QYNVLVSEE-GIWIIDFPQSVEVG 153 (191)
T ss_dssp TTSEEEETT-EEEECCCTTCEETT
T ss_pred hhheeeeCC-CEEEEECCCcccCC
Confidence 999999865 48999999987653
|
| >d1x3ha1 g.39.1.3 (A:8-42) Leupaxin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Leupaxin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=3.7e-13 Score=77.78 Aligned_cols=35 Identities=26% Similarity=0.673 Sum_probs=33.9
Q ss_pred cccccccccccccccccccCCeEEecCcccCCCCc
Q psy6593 53 EDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECF 87 (433)
Q Consensus 53 ~~~~~~~~~~C~~C~~~i~~~~~~~~~~~~h~~cf 87 (433)
.||.++|+|+|.+|+++|.+.+|+|.++.||++||
T Consensus 1 ~DY~~~fapkC~~C~~~I~g~~v~Al~~~wHpeCF 35 (35)
T d1x3ha1 1 KDFLAMFSPKCGGCNRPVLENYLSAMDTVWHPECF 35 (35)
T ss_dssp CCCCCCCSCBCTTTCCBCCSSCEEETTEEECTTTC
T ss_pred CcHHHHhChhhhhcCCcccchheeecCCccCcccC
Confidence 48999999999999999999999999999999998
|
| >d1b8ta4 g.39.1.3 (A:144-192) Cysteine-rich (intestinal) protein, CRP, CRIP {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.01 E-value=4.8e-11 Score=73.16 Aligned_cols=41 Identities=29% Similarity=0.591 Sum_probs=37.7
Q ss_pred cccccccccCCc-eEeeCCeeeeccccccccccccccccccc
Q psy6593 30 GCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQNCGQMM 70 (433)
Q Consensus 30 ~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~C~~~i 70 (433)
+|..|++.|++. .+++|++|||+.||.++|+||+.+.++.-
T Consensus 1 KC~~C~k~Lds~t~~ehdg~~YCk~CY~k~fGPKG~g~G~ga 42 (49)
T d1b8ta4 1 RCAKCGKSLESTTLADKDGEIYCKGCYAKNFGPKGFGFGQGA 42 (49)
T ss_dssp BCTTTCCBCCSSSEEEETTEEEEHHHHHHHTCCCCCCCCCCC
T ss_pred ChhhcCCccCCCcccccCCcccchhhhhhccCCCccCcccCc
Confidence 699999999887 99999999999999999999999888654
|
| >d1g47a2 g.39.1.3 (A:36-70) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.00 E-value=3.3e-11 Score=69.31 Aligned_cols=33 Identities=18% Similarity=0.533 Sum_probs=31.2
Q ss_pred ccccccccccCCc-eEeeCCeeeecccccccccc
Q psy6593 29 SGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGE 61 (433)
Q Consensus 29 f~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~ 61 (433)
|+|+.|+++|.+. |+++||++||+.||+++|+|
T Consensus 1 F~C~~C~~~f~~~~F~e~~G~pYCe~~Y~~lFAP 34 (35)
T d1g47a2 1 FVCAQCFQQFPEGLFYEFEGRKYCEHDFQMLFAP 34 (35)
T ss_dssp CCCTTTCCCCGGGCSEEETTEEECHHHHHHHCCC
T ss_pred CCCCCCcCCCCCCCeEEECCEecChHhHHhhcCC
Confidence 8999999999766 99999999999999999987
|
| >d2dj7a1 g.39.1.3 (A:44-74) Actin-binding LIM protein 3, abLIM-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 3, abLIM-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.92 E-value=1.9e-10 Score=61.70 Aligned_cols=31 Identities=39% Similarity=1.048 Sum_probs=29.7
Q ss_pred cccccccccCCceEeeCCeeeeccccccccc
Q psy6593 30 GCSACDVMLDNWYFEKDGLLFCKEDYNGKYG 60 (433)
Q Consensus 30 ~C~~C~~~l~~~~~~~~~~~~C~~~~~~~~~ 60 (433)
+|..|++.|+++|..+||.|||+.||+..||
T Consensus 1 kC~~C~~vL~gEYm~kdG~PyCe~DY~~~FG 31 (31)
T d2dj7a1 1 KCQTCSVILTGEYISKDGVPYCESDYHAQFG 31 (31)
T ss_dssp BCSSSCCBCSSCCEEETTEEECTTHHHHHTT
T ss_pred CccccCccccceeecCCCCcccHHHHHHhcC
Confidence 6999999999999999999999999999986
|
| >d1v6ga1 g.39.1.3 (A:1-41) Actin-binding LIM protein 2, abLIM2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 2, abLIM2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.89 E-value=3.2e-10 Score=66.07 Aligned_cols=34 Identities=35% Similarity=0.871 Sum_probs=33.0
Q ss_pred cccccccccccccccccccCCeEEecCcccCCCC
Q psy6593 53 EDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPEC 86 (433)
Q Consensus 53 ~~~~~~~~~~C~~C~~~i~~~~~~~~~~~~h~~c 86 (433)
.||+++|+.+|..|++.|++.+|++.+++|||+|
T Consensus 8 ~DYq~~fG~~C~~C~~~ItG~V~~Ag~~~yHP~C 41 (41)
T d1v6ga1 8 LDYQRLYGTRCFSCDQFIEGEVVSALGKTYHPDC 41 (41)
T ss_dssp SCGGGSCCCBCTTTCCBCCSCCEEETTEEECTTT
T ss_pred ccHHHHhCcccccccCEeeeeeeEecCcccCCCC
Confidence 5899999999999999999999999999999998
|
| >d2cuqa2 g.39.1.3 (A:8-42) Four and a half LIM domains 3, FHL3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains 3, FHL3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.88 E-value=3.3e-10 Score=62.79 Aligned_cols=35 Identities=23% Similarity=0.634 Sum_probs=33.2
Q ss_pred cccccccccccccccccccCCeEEecCcccCCCCc
Q psy6593 53 EDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECF 87 (433)
Q Consensus 53 ~~~~~~~~~~C~~C~~~i~~~~~~~~~~~~h~~cf 87 (433)
.||+++|+++|..|+++|+..=+.+++..||.+||
T Consensus 1 PCyE~kfa~~C~~Ckk~It~GGvtY~dqpWHkeCF 35 (35)
T d2cuqa2 1 PCYENKFAPRCARCSKTLTQGGVTYRDQPWHRECL 35 (35)
T ss_dssp CCCCCCSSCCCTTTCCCCCSCCEESSSSEECTTTC
T ss_pred CchHHHHHHHHhhcCCccccCceeecCCcchhhhC
Confidence 49999999999999999988888999999999998
|
| >d1x63a1 g.39.1.3 (A:8-44) Four and a half LIM domains protein 1, FHL-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 1, FHL-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.76 E-value=1.6e-09 Score=62.35 Aligned_cols=35 Identities=14% Similarity=0.373 Sum_probs=32.2
Q ss_pred ccccccccccccccccccc--CCeEEecCcccCCCCc
Q psy6593 53 EDYNGKYGEACQNCGQMMS--GPVMVVGDHKFHPECF 87 (433)
Q Consensus 53 ~~~~~~~~~~C~~C~~~i~--~~~~~~~~~~~h~~cf 87 (433)
.||.+.|+++|.+|+++|. .+.|++.+++||..||
T Consensus 1 kCy~~~~a~~C~~C~k~I~~G~k~veykg~~WHe~CF 37 (37)
T d1x63a1 1 KCTTREDSPKCKGCFKAIVAGDQNVEYKGTVWHKDCF 37 (37)
T ss_dssp CCCSCCCSCBCSSSCCBCCSSSCEEECSSCEEETTTC
T ss_pred CccccccCcccccCCCccCCCCeEeEeCCccchhccC
Confidence 4899999999999999994 4599999999999998
|
| >d1x6aa1 g.39.1.3 (A:8-41) Lim domain kinase 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Lim domain kinase 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.71 E-value=2.1e-09 Score=58.56 Aligned_cols=34 Identities=56% Similarity=1.304 Sum_probs=32.5
Q ss_pred cccccccccccccccccccCCeEEecCcccCCCC
Q psy6593 53 EDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPEC 86 (433)
Q Consensus 53 ~~~~~~~~~~C~~C~~~i~~~~~~~~~~~~h~~c 86 (433)
.||..+|+..|++|++.|+|.+|.+++..||++|
T Consensus 1 kdYw~kfge~C~~C~~~itGpvMvAG~~K~HPEC 34 (34)
T d1x6aa1 1 KDYWGKFGEFCHGCSLLMTGPFMVAGEFKYHPEC 34 (34)
T ss_dssp CCSSCCSSCBCTTTCCBCCSCCBCCTTCCBCTTS
T ss_pred CcHHHHHHHHhhhhHhhcccceeeecccccCCCC
Confidence 4799999999999999999999999999999998
|
| >d1ibia2 g.39.1.3 (A:145-175) Cysteine-rich (intestinal) protein, CRP, CRIP {Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]
Probab=98.69 E-value=1.6e-09 Score=56.59 Aligned_cols=30 Identities=30% Similarity=0.644 Sum_probs=27.4
Q ss_pred ccccccccccCCc-eEeeCCeeeeccccccc
Q psy6593 29 SGCSACDVMLDNW-YFEKDGLLFCKEDYNGK 58 (433)
Q Consensus 29 f~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~ 58 (433)
|+|+.|++.|.+. ...+||.+||+.||.++
T Consensus 1 frca~cgk~lestt~adkdgeiyck~cyak~ 31 (31)
T d1ibia2 1 FRCAKCGKSLESTTLTEKEGEIYCKGCYAKN 31 (31)
T ss_dssp EECSSSCCEECSSCSEEETTEEECHHHHHHC
T ss_pred CccccccCccccceeeccCCcEEEeeeeecC
Confidence 8999999999777 89999999999999763
|
| >d1imla2 g.39.1.3 (A:29-76) Cysteine-rich (intestinal) protein, CRP, CRIP {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Rat (Rattus rattus) [TaxId: 10117]
Probab=98.65 E-value=4.9e-09 Score=63.11 Aligned_cols=34 Identities=24% Similarity=0.541 Sum_probs=31.3
Q ss_pred cccccccccCCc-eEeeCCeeee-cccccccccccc
Q psy6593 30 GCSACDVMLDNW-YFEKDGLLFC-KEDYNGKYGEAC 63 (433)
Q Consensus 30 ~C~~C~~~l~~~-~~~~~~~~~C-~~~~~~~~~~~C 63 (433)
+|..|++.|+.. ..++|++||| +.||.++|+||=
T Consensus 1 kC~~C~K~L~sg~~aeHdg~pYC~k~CY~~~FGPkG 36 (48)
T d1imla2 1 KCEKCGKTLTSGGHAEHEGKPYCNHPCYSAMFGPKG 36 (48)
T ss_dssp BCTTTCCBCCTTTEEEETTEEEETTTHHHHHSSCCC
T ss_pred CchhcCcCcCCCChhhcCCcccccccchhhccCCCc
Confidence 699999999776 9999999999 889999999974
|
| >d2dloa1 g.39.1.3 (A:8-42) Thyroid receptor interacting protein 6, TRIP6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Thyroid receptor interacting protein 6, TRIP6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.56 E-value=1.6e-08 Score=56.29 Aligned_cols=35 Identities=26% Similarity=0.642 Sum_probs=31.5
Q ss_pred ccccccccccccccccccccCCeEEecCcccCCCCc
Q psy6593 52 KEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECF 87 (433)
Q Consensus 52 ~~~~~~~~~~~C~~C~~~i~~~~~~~~~~~~h~~cf 87 (433)
+.||.... .||..|+++|.+++++|.++.|||.||
T Consensus 1 E~Cy~~tl-EkC~~C~~~I~driLrA~Gk~yHP~CF 35 (35)
T d2dloa1 1 EGCYVATL-EKCATCSQPILDRILRAMGKAYHPGCF 35 (35)
T ss_dssp CCCCCSSC-CBCTTTCCBCCSCCEEETTEEECTTTC
T ss_pred ChhHHHHH-HHHHHhchHHHHHHHHHhCCCCCCCCC
Confidence 36787655 899999999999999999999999998
|
| >d1x61a1 g.39.1.3 (A:8-34) Thyroid receptor interacting protein 6, TRIP6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Thyroid receptor interacting protein 6, TRIP6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.54 E-value=1.2e-08 Score=50.79 Aligned_cols=27 Identities=15% Similarity=-0.065 Sum_probs=26.4
Q ss_pred cCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 3 FGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
||||+|+++-++..+.|+++.||..||
T Consensus 1 cggcgedvvgdgagvvaldrvfhvgcf 27 (27)
T d1x61a1 1 CGGCGEDVVGDGAGVVALDRVFHVGCF 27 (27)
T ss_dssp CSSSCSCCCSSSCCEECSSSEECTTTC
T ss_pred CCCcccccccCCcceEEEeeeEEeccC
Confidence 899999999999999999999999998
|
| >d2dara2 g.39.1.3 (A:8-52) PDZ and LIM domain protein 5, Enigma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: PDZ and LIM domain protein 5, Enigma species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.51 E-value=2.2e-08 Score=59.36 Aligned_cols=30 Identities=37% Similarity=0.799 Sum_probs=28.0
Q ss_pred ccccccccccccccCCeEEecCcccCCCCc
Q psy6593 58 KYGEACQNCGQMMSGPVMVVGDHKFHPECF 87 (433)
Q Consensus 58 ~~~~~C~~C~~~i~~~~~~~~~~~~h~~cf 87 (433)
..+|+|..|+++|.++++.+.++.||++||
T Consensus 16 ~r~P~C~~C~~pI~g~~vtAlgk~WHPEhF 45 (45)
T d2dara2 16 KRTPMCAHCNQVIRGPFLVALGKSWHPEEF 45 (45)
T ss_dssp TCCCBBSSSCCBCCSCEEEETTEEECTTTC
T ss_pred CCCeeccccCCcccCceeeecCCccCcCCC
Confidence 356899999999999999999999999998
|
| >d2d8za2 g.39.1.3 (A:33-64) Four and a half LIM domains protein 2, FHL2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 2, FHL2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.51 E-value=8.4e-09 Score=56.22 Aligned_cols=31 Identities=23% Similarity=0.600 Sum_probs=28.6
Q ss_pred cccccccccCCc-eEeeCCeeeeccccccccc
Q psy6593 30 GCSACDVMLDNW-YFEKDGLLFCKEDYNGKYG 60 (433)
Q Consensus 30 ~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~ 60 (433)
.|..|+++|.|. |..||++|||-.||..+|+
T Consensus 1 ~C~~C~~~L~GQry~~rd~~PyC~~Cf~~lfA 32 (32)
T d2d8za2 1 VCTACRKQLSGQRFTARDDFAYCLNCFCDLYA 32 (32)
T ss_dssp BCSSSCCBCTTSCCEESSSSEECHHHHHHHTC
T ss_pred CcccCCccccCceeeecCCCeehHHhhHhhcC
Confidence 489999999887 9999999999999999885
|
| >d1b8ta2 g.39.1.3 (A:36-100) Cysteine-rich (intestinal) protein, CRP, CRIP {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.48 E-value=1.7e-08 Score=65.41 Aligned_cols=40 Identities=28% Similarity=0.462 Sum_probs=34.6
Q ss_pred cccccccccCCc-eEeeCCeeeecccccccccccccccccc
Q psy6593 30 GCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQNCGQM 69 (433)
Q Consensus 30 ~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~C~~~ 69 (433)
.|..|++.|++. ..++++++||+.||.++|+||=.+-+..
T Consensus 1 ~C~~C~K~LdS~~~~eh~~e~YCk~CY~k~fGPkG~G~G~g 41 (65)
T d1b8ta2 1 LCMVCKKNLDSTTVAVHGDEIYCKSCYGKKYGPKGKGKGMG 41 (65)
T ss_dssp BCTTTCCBCCSSSEEEETTEEEEHHHHHHHHSCCCCCCCCC
T ss_pred CchhcCCccCCCccccCCCcccchhhhccccCCCccccccc
Confidence 489999999887 9999999999999999999986554443
|
| >d1x3ha2 g.39.1.3 (A:43-74) Leupaxin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Leupaxin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=2.4e-08 Score=54.80 Aligned_cols=31 Identities=32% Similarity=0.706 Sum_probs=27.7
Q ss_pred cccccccccCCc-eEeeCCeeeeccccccccc
Q psy6593 30 GCSACDVMLDNW-YFEKDGLLFCKEDYNGKYG 60 (433)
Q Consensus 30 ~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~ 60 (433)
+|..|.+|+.+. ||+.||+|||+.+|+++.|
T Consensus 1 VC~~C~~PF~~~~Fy~~~g~PyCe~HyH~~~G 32 (32)
T d1x3ha2 1 VCGDCFTSFSTGSFFELDGRPFCELHYHHRRG 32 (32)
T ss_dssp BCSSSCCBSCSSCCEESSSCEECHHHHHHHHS
T ss_pred CcCccCCcCCCCCeEeECCccchHHhhhhhcC
Confidence 599999999766 9999999999999998754
|
| >d1u5sb2 g.39.1.3 (B:103-137) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.38 E-value=4.4e-08 Score=53.06 Aligned_cols=33 Identities=27% Similarity=0.746 Sum_probs=30.8
Q ss_pred ccccccccccCCc-eEeeCCeeeecccccccccc
Q psy6593 29 SGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGE 61 (433)
Q Consensus 29 f~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~ 61 (433)
|+|+.|.+|+-+. .++++|..||+.+|+++||.
T Consensus 1 FvCA~CekPF~G~rhyE~~g~ayCe~Hy~qLfg~ 34 (35)
T d1u5sb2 1 FVCAKCEKPFLGHRHYERKGLAYCETHYNQLFGD 34 (35)
T ss_dssp CBCTTTCCBCSSSCCEEETTEEECHHHHHHHCSC
T ss_pred CcccccCCccCCchhhhhcCchHHHHHHHHHhcc
Confidence 8999999999776 99999999999999999974
|
| >d2cuqa1 g.39.1.3 (A:43-74) Four and a half LIM domains 3, FHL3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains 3, FHL3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.37 E-value=4.2e-08 Score=52.45 Aligned_cols=31 Identities=16% Similarity=0.484 Sum_probs=28.5
Q ss_pred cccccccccCCc-eEeeCCeeeeccccccccc
Q psy6593 30 GCSACDVMLDNW-YFEKDGLLFCKEDYNGKYG 60 (433)
Q Consensus 30 ~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~ 60 (433)
.|+.|+++|.|. |-.+|+++||.+||..+|+
T Consensus 1 vCt~Ck~~LaGqrFTSrde~pYC~~Cfg~LfA 32 (32)
T d2cuqa1 1 VCTGCQTPLAGQQFTSRDEDPYCVACFGELFA 32 (32)
T ss_dssp BCSSSCCBCTTCCEEECSSSEEEHHHHHHHTT
T ss_pred CccccCccccCCccccCCCCccHHHHhHhhcC
Confidence 489999999987 9999999999999988874
|
| >d1u5sb1 g.39.1.3 (B:72-102) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.35 E-value=5.2e-08 Score=52.32 Aligned_cols=30 Identities=20% Similarity=0.338 Sum_probs=27.6
Q ss_pred cccccccccccccccCCeEEecCcccCCCC
Q psy6593 57 GKYGEACQNCGQMMSGPVMVVGDHKFHPEC 86 (433)
Q Consensus 57 ~~~~~~C~~C~~~i~~~~~~~~~~~~h~~c 86 (433)
+.+.|+|+.|+++|.++++.+.++.||+++
T Consensus 2 kmg~p~C~~C~~PI~~~~vtAlgk~WHpEH 31 (31)
T d1u5sb1 2 SMGVPICGACRRPIEGRVVNAMGKQWHVEH 31 (31)
T ss_dssp CCCCCEETTTTEECCSCEECCTTSBEETTT
T ss_pred CcCCcchhhcCCchhhhHhhhhccccCCCC
Confidence 467899999999999999999999999984
|
| >d1x4ka1 g.39.1.3 (A:35-66) Four and a half LIM domains protein 2, FHL2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 2, FHL2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.21 E-value=2.2e-07 Score=50.04 Aligned_cols=31 Identities=23% Similarity=0.478 Sum_probs=28.3
Q ss_pred cccccccccCCc-eEeeCCeeeeccccccccc
Q psy6593 30 GCSACDVMLDNW-YFEKDGLLFCKEDYNGKYG 60 (433)
Q Consensus 30 ~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~ 60 (433)
.|..|.+||..+ |+.+++..||..||+++|+
T Consensus 1 ~C~~C~qPIGtksfipk~~~~yCvpCyE~kfA 32 (32)
T d1x4ka1 1 ICHRCQQPIGTKSFIPKDNQNFCVPCYEKQHA 32 (32)
T ss_dssp CCSSSCCCCCSSSEEEETTEEEEHHHHHHHTS
T ss_pred CcccccCcccccccccCCCCceEeecchhhcC
Confidence 389999999777 9999999999999999885
|
| >d2dj7a2 g.39.1.3 (A:8-43) Actin-binding LIM protein 3, abLIM-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 3, abLIM-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.20 E-value=2.1e-07 Score=51.17 Aligned_cols=27 Identities=11% Similarity=-0.070 Sum_probs=25.6
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
.|+||++... .++.+.|+++.||..||
T Consensus 10 ~CagCg~eik-~gQaL~ALdkqWH~~CF 36 (36)
T d2dj7a2 10 HCAGCKEEIK-HGQSLLALDKQWHVSCF 36 (36)
T ss_dssp CCTTTCCCCS-SSCCEEETTEEECTTTC
T ss_pred cccccchhhh-CCceeeeeecceeeeeC
Confidence 6999999988 89999999999999998
|
| >d2d8ya2 g.39.1.3 (A:44-85) Eplin, LIMA1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Eplin, LIMA1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.18 E-value=9.2e-08 Score=56.34 Aligned_cols=33 Identities=27% Similarity=0.592 Sum_probs=30.6
Q ss_pred cccccccccCCc-eEeeCCeeeeccccccccccc
Q psy6593 30 GCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEA 62 (433)
Q Consensus 30 ~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~ 62 (433)
+|+.|++.|+.. |...+|.+||+.||.++|.+|
T Consensus 1 rC~~C~~~Ls~~~yas~~G~lYCkpHf~qLF~~k 34 (42)
T d2d8ya2 1 RCSYCNNKLSLGTYASLHGRIYCKPHFNQLFKSK 34 (42)
T ss_dssp BCTTTCCBCCTTTCCCSSSCCCCHHHHHHHSCCC
T ss_pred CcCcCCCCccCCcchhhCCEeccHHHHHHHHHhh
Confidence 699999999776 999999999999999999876
|
| >d1a7ia2 g.39.1.3 (A:36-67) Cysteine-rich (intestinal) protein, CRP, CRIP {Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]
Probab=98.15 E-value=2.5e-07 Score=49.04 Aligned_cols=30 Identities=37% Similarity=0.709 Sum_probs=27.8
Q ss_pred ccccccccCCc-eEeeCCeeeeccccccccc
Q psy6593 31 CSACDVMLDNW-YFEKDGLLFCKEDYNGKYG 60 (433)
Q Consensus 31 C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~ 60 (433)
|-.|++.|++. -..+++.+||+.||.++||
T Consensus 2 C~~C~K~LdStTva~h~~eiYCKsCygkkyg 32 (32)
T d1a7ia2 2 CMVCRKNLDSTTVAIHDAEVYCKSCYGKKYG 32 (32)
T ss_dssp CSSSCCEECSSCCEEETTEEECSHHHHHHCC
T ss_pred chhhhhccCcceeeeecceEEehhhccccCC
Confidence 78999999887 8999999999999999875
|
| >d1x3ha1 g.39.1.3 (A:8-42) Leupaxin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Leupaxin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.13 E-value=3.6e-07 Score=52.22 Aligned_cols=26 Identities=8% Similarity=-0.197 Sum_probs=23.1
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
.|++|++- |+++.|+|+|+.||++||
T Consensus 10 kC~~C~~~--I~g~~v~Al~~~wHpeCF 35 (35)
T d1x3ha1 10 KCGGCNRP--VLENYLSAMDTVWHPECF 35 (35)
T ss_dssp BCTTTCCB--CCSSCEEETTEEECTTTC
T ss_pred hhhhcCCc--ccchheeecCCccCcccC
Confidence 48899874 578999999999999998
|
| >d2cu8a2 g.39.1.3 (A:38-70) Cysteine-rich (intestinal) protein, CRP, CRIP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.13 E-value=4.7e-07 Score=48.73 Aligned_cols=31 Identities=32% Similarity=0.629 Sum_probs=27.7
Q ss_pred cccccccccCCc-eEeeCCeeeecc-ccccccc
Q psy6593 30 GCSACDVMLDNW-YFEKDGLLFCKE-DYNGKYG 60 (433)
Q Consensus 30 ~C~~C~~~l~~~-~~~~~~~~~C~~-~~~~~~~ 60 (433)
+|..|++.|+.. ..++||++||.. ||..+||
T Consensus 1 kCekC~ktL~~G~HaEH~gkPYC~~PCY~aLFG 33 (33)
T d2cu8a2 1 KCERCSKTLTPGGHAEHDGKPFCHKPCYATLFG 33 (33)
T ss_dssp BCSSSCCBCCTTSCEEETTEEECTTTHHHHHSC
T ss_pred CchhcccccCCCCccccCCCcCcCcchHHhhcC
Confidence 689999999765 999999999987 9998885
|
| >d1wyha1 g.39.1.3 (A:35-66) Four and a half LIM domains 3, FHL3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains 3, FHL3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.12 E-value=4e-07 Score=48.90 Aligned_cols=31 Identities=26% Similarity=0.665 Sum_probs=28.2
Q ss_pred cccccccccCCc-eEeeCCeeeeccccccccc
Q psy6593 30 GCSACDVMLDNW-YFEKDGLLFCKEDYNGKYG 60 (433)
Q Consensus 30 ~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~ 60 (433)
.|..|.+|+..+ |+.+++..||..||+++|+
T Consensus 1 ~C~~C~qPIGtkSFip~~~~~yCvpCYE~kfA 32 (32)
T d1wyha1 1 LCSGCEQPLGSRSFVPDKGAHYCVPCYENKFA 32 (32)
T ss_dssp BCTTTCCBTTTSCEEEETTEEEEHHHHHHHTS
T ss_pred CcccccCcccccccccCCCcEEEEeccccccC
Confidence 389999999776 9999999999999999885
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.10 E-value=5.5e-06 Score=72.60 Aligned_cols=98 Identities=19% Similarity=0.179 Sum_probs=69.0
Q ss_pred hccchHHHHhhcC-CcceeeEEEEEEeCCeeeEEEeccCCCCHHHHhcCCCCCCChHHHHHHHHHHHHHHhhhhc-----
Q psy6593 144 QNCGQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS----- 217 (433)
Q Consensus 144 ~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~----- 217 (433)
...+|+.+|+.+. +--+++++.+...++..++||++++|.++.+..... .....++.++...|+.||+
T Consensus 55 ~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~ 128 (263)
T d1j7la_ 55 DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISD 128 (263)
T ss_dssp CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTT
T ss_pred hHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccc
Confidence 3447888888884 555788999988889999999999998886554221 1112223333333333332
Q ss_pred ------------------------------------------------------CCccccCCCCcceEEccCCceEEecc
Q psy6593 218 ------------------------------------------------------MNLIHRDLNSQNCLVREDKTVVVADF 243 (433)
Q Consensus 218 ------------------------------------------------------~~i~H~dlkp~Nil~~~~~~~kl~Df 243 (433)
..++|+|+.|.||++++++.+-|+||
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDw 208 (263)
T d1j7la_ 129 CPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDL 208 (263)
T ss_dssp CSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCC
T ss_pred cccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeec
Confidence 13789999999999998776779999
Q ss_pred ccch
Q psy6593 244 GLAR 247 (433)
Q Consensus 244 g~~~ 247 (433)
+.+.
T Consensus 209 e~a~ 212 (263)
T d1j7la_ 209 GRSG 212 (263)
T ss_dssp TTCE
T ss_pred hhcc
Confidence 9875
|
| >d1x62a2 g.39.1.3 (A:8-42) PDZ and LIM domain protein 1 Elfin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: PDZ and LIM domain protein 1 Elfin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.03 E-value=9.3e-07 Score=47.96 Aligned_cols=27 Identities=33% Similarity=0.866 Sum_probs=26.2
Q ss_pred cccccccccccCCeEEecCcccCCCCc
Q psy6593 61 EACQNCGQMMSGPVMVVGDHKFHPECF 87 (433)
Q Consensus 61 ~~C~~C~~~i~~~~~~~~~~~~h~~cf 87 (433)
|.|..|+.+|.+.++.++++.+|++||
T Consensus 9 p~CdkCg~GIVG~~VK~rDk~rHPeCf 35 (35)
T d1x62a2 9 PMCDKCGTGIVGVFVKLRDRHRHPECY 35 (35)
T ss_dssp CCCSSSCCCCCSSCEECSSCEECTTTT
T ss_pred ccccccCCCcEeEEEEeccccCCCCCC
Confidence 789999999999999999999999998
|
| >d2dara2 g.39.1.3 (A:8-52) PDZ and LIM domain protein 5, Enigma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: PDZ and LIM domain protein 5, Enigma species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.98 E-value=9.8e-07 Score=52.17 Aligned_cols=26 Identities=12% Similarity=-0.098 Sum_probs=23.2
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
.|+.|+. +|.+..|.|+|+.||++||
T Consensus 20 ~C~~C~~--pI~g~~vtAlgk~WHPEhF 45 (45)
T d2dara2 20 MCAHCNQ--VIRGPFLVALGKSWHPEEF 45 (45)
T ss_dssp BBSSSCC--BCCSCEEEETTEEECTTTC
T ss_pred eccccCC--cccCceeeecCCccCcCCC
Confidence 4999985 5679999999999999998
|
| >d1x64a1 g.39.1.3 (A:8-52) PDZ and LIM domain protein 3, PDLIM3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: PDZ and LIM domain protein 3, PDLIM3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.87 E-value=2.4e-06 Score=49.70 Aligned_cols=27 Identities=41% Similarity=0.898 Sum_probs=26.2
Q ss_pred cccccccccccCCeEEecCcccCCCCc
Q psy6593 61 EACQNCGQMMSGPVMVVGDHKFHPECF 87 (433)
Q Consensus 61 ~~C~~C~~~i~~~~~~~~~~~~h~~cf 87 (433)
|.|..|+.+|.|.++.++++.+|++||
T Consensus 19 P~CdkCg~GIVG~~VK~rDK~rHPeCf 45 (45)
T d1x64a1 19 PLCDKCGSGIVGAVVKARDKYRHPECF 45 (45)
T ss_dssp CBCTTTCCBCCSCCEESSSCEECTTTC
T ss_pred ccccccCCCcEEEEEEeccccCCCCCC
Confidence 689999999999999999999999998
|
| >d2dara1 g.39.1.3 (A:53-84) PDZ and LIM domain protein 5, Enigma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: PDZ and LIM domain protein 5, Enigma species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.84 E-value=1.9e-06 Score=46.21 Aligned_cols=31 Identities=23% Similarity=0.670 Sum_probs=27.5
Q ss_pred cccccccccCCc-eEeeCCeeeeccccccccc
Q psy6593 30 GCSACDVMLDNW-YFEKDGLLFCKEDYNGKYG 60 (433)
Q Consensus 30 ~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~ 60 (433)
.|+.|+.+|... |.+.+|.+||+.||.+.|+
T Consensus 1 nCa~C~~sL~d~gFVEE~g~lYCe~Cye~ffA 32 (32)
T d2dara1 1 NCAHCKNTMAYIGFVEEKGALYCELCYEKFFA 32 (32)
T ss_dssp BCSSSCCBCSSSCBEESSSCEECHHHHHHHTS
T ss_pred CcccccccHhhcceeeecCcEeHHHHHHHhcC
Confidence 489999999776 9999999999999998764
|
| >d1x4la1 g.39.1.3 (A:8-36) Four and a half LIM domains protein 2, FHL2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 2, FHL2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.75 E-value=5.7e-06 Score=43.06 Aligned_cols=25 Identities=28% Similarity=0.850 Sum_probs=22.6
Q ss_pred cccccccccCC----eEEecCcccCCCCc
Q psy6593 63 CQNCGQMMSGP----VMVVGDHKFHPECF 87 (433)
Q Consensus 63 C~~C~~~i~~~----~~~~~~~~~h~~cf 87 (433)
|..|.+||++. ++...++.||..||
T Consensus 1 C~~C~kPItg~gg~kyisFE~R~WH~~CF 29 (29)
T d1x4la1 1 CAGCTNPISGLGGTKYISFEERQWHNDCF 29 (29)
T ss_dssp BTTTTBCCCCSSSCSCEECSSCEECTTTC
T ss_pred CCccCCcccccCCceEEEeecccccccCC
Confidence 89999999654 99999999999998
|
| >d1wiga1 g.39.1.3 (A:1-32) Actin-binding LIM protein 2, abLIM2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 2, abLIM2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.75 E-value=3.5e-06 Score=44.31 Aligned_cols=26 Identities=31% Similarity=1.037 Sum_probs=24.6
Q ss_pred cccccccccccCCeEEecCcccCCCC
Q psy6593 61 EACQNCGQMMSGPVMVVGDHKFHPEC 86 (433)
Q Consensus 61 ~~C~~C~~~i~~~~~~~~~~~~h~~c 86 (433)
.-|..|.+.|++.++++++++|||.|
T Consensus 6 sgC~~C~~~ItGkVLEAG~khYHP~C 31 (32)
T d1wiga1 6 SGCDSCEKYITGRVLEAGEKHYHPSC 31 (32)
T ss_dssp CSCSSSCCCCSSCCBCCSSCCBCTTT
T ss_pred chhhhhhhhhhhhhhhccccccCCCC
Confidence 46999999999999999999999997
|
| >d2dloa2 g.39.1.3 (A:43-75) Thyroid receptor interacting protein 6, TRIP6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Thyroid receptor interacting protein 6, TRIP6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.75 E-value=3e-06 Score=46.27 Aligned_cols=31 Identities=26% Similarity=0.614 Sum_probs=26.8
Q ss_pred cccccccccCCc-eEe-eCCeeeeccccccccc
Q psy6593 30 GCSACDVMLDNW-YFE-KDGLLFCKEDYNGKYG 60 (433)
Q Consensus 30 ~C~~C~~~l~~~-~~~-~~~~~~C~~~~~~~~~ 60 (433)
.|..|++.|+|. |.. .++++||-.||+++|+
T Consensus 1 tCvvC~~~LDGvPFtvD~~n~i~Cv~DyHrkfA 33 (33)
T d2dloa2 1 TCVVCHRGLDGIPFTVDATSQIHCIEDFHRKFA 33 (33)
T ss_dssp BCSSSCCBCTTSCEECCTTCCCEEHHHHHHHTT
T ss_pred CeeEcCcccCCCcEEEcCCCCEeehhhhhhhcC
Confidence 489999999998 655 4779999999999985
|
| >d1rutx3 g.39.1.3 (X:83-113) LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: LIM only 4 (Lmo4) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.73 E-value=4.3e-06 Score=45.19 Aligned_cols=27 Identities=37% Similarity=0.819 Sum_probs=23.9
Q ss_pred cccccccccccC--CeEEecCcccCCCCc
Q psy6593 61 EACQNCGQMMSG--PVMVVGDHKFHPECF 87 (433)
Q Consensus 61 ~~C~~C~~~i~~--~~~~~~~~~~h~~cf 87 (433)
-.|.+|++.|.. .+|++++.+||.+||
T Consensus 3 g~Ca~C~~~I~~~e~VmRA~~~VyHl~CF 31 (31)
T d1rutx3 3 GACSACGQSIPASELVMRAQGNVYHLKCF 31 (31)
T ss_dssp EECTTTCCEECTTSEEEEETTEEECGGGC
T ss_pred cccccccCcCChhHhheecccceeeeccC
Confidence 469999999954 488999999999998
|
| >d1rutx1 g.39.1.3 (X:19-48) LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: LIM only 4 (Lmo4) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.72 E-value=6.1e-06 Score=44.29 Aligned_cols=27 Identities=22% Similarity=0.706 Sum_probs=24.2
Q ss_pred cccccccccccCC-eEEecCcccCCCCc
Q psy6593 61 EACQNCGQMMSGP-VMVVGDHKFHPECF 87 (433)
Q Consensus 61 ~~C~~C~~~i~~~-~~~~~~~~~h~~cf 87 (433)
.+|++|+++|.++ .+.+.++.||..|.
T Consensus 3 ~~CaGC~~~I~DRflL~v~dr~WH~~CL 30 (30)
T d1rutx1 3 KRCAGCGGKIADRFLLYAMDSYWHSRCL 30 (30)
T ss_dssp CBBTTTCCBCCCSEEEEETTEEECGGGC
T ss_pred cccCCCCCccchhhhhccchhhhhhhhC
Confidence 4799999999999 66899999999884
|
| >d2dj7a2 g.39.1.3 (A:8-43) Actin-binding LIM protein 3, abLIM-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 3, abLIM-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.66 E-value=9.1e-06 Score=44.54 Aligned_cols=27 Identities=26% Similarity=0.772 Sum_probs=24.6
Q ss_pred cccccccccc-cCCeEEecCcccCCCCc
Q psy6593 61 EACQNCGQMM-SGPVMVVGDHKFHPECF 87 (433)
Q Consensus 61 ~~C~~C~~~i-~~~~~~~~~~~~h~~cf 87 (433)
..|++|++.| .++.+.+.++.||.+||
T Consensus 9 ~~CagCg~eik~gQaL~ALdkqWH~~CF 36 (36)
T d2dj7a2 9 SHCAGCKEEIKHGQSLLALDKQWHVSCF 36 (36)
T ss_dssp SCCTTTCCCCSSSCCEEETTEEECTTTC
T ss_pred ccccccchhhhCCceeeeeecceeeeeC
Confidence 4699999999 67799999999999998
|
| >d2cura1 g.39.1.3 (A:33-63) Four and a half LIM domains protein 1, FHL-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 1, FHL-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.66 E-value=7.8e-06 Score=43.01 Aligned_cols=28 Identities=18% Similarity=0.523 Sum_probs=25.2
Q ss_pred cccccccccCCc-eEeeCCeeeecccccc
Q psy6593 30 GCSACDVMLDNW-YFEKDGLLFCKEDYNG 57 (433)
Q Consensus 30 ~C~~C~~~l~~~-~~~~~~~~~C~~~~~~ 57 (433)
.|..|.++|.+. |-..+++.||-+||..
T Consensus 1 vC~~C~K~Lag~rFTa~eDq~yCVdCYK~ 29 (31)
T d2cura1 1 VCVTCSKKLAGQRFTAVEDQYYCVDCYKN 29 (31)
T ss_dssp BCTTTCCBCTTSCEEECSSCEEEHHHHHH
T ss_pred CcccccchhcCceeEEecceEEEeeeecc
Confidence 489999999887 9999999999999953
|
| >d1j2oa1 g.39.1.3 (A:1-30) Rhombotin-2 (Lmo2) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Rhombotin-2 (Lmo2) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.64 E-value=1.3e-05 Score=42.84 Aligned_cols=26 Identities=23% Similarity=0.586 Sum_probs=23.5
Q ss_pred cccccccccccCC-eEEecCcccCCCC
Q psy6593 61 EACQNCGQMMSGP-VMVVGDHKFHPEC 86 (433)
Q Consensus 61 ~~C~~C~~~i~~~-~~~~~~~~~h~~c 86 (433)
..|++|+++|.++ .+.+.++.||..|
T Consensus 4 ~~CaGC~~~I~DRflL~a~Dr~WH~~C 30 (30)
T d1j2oa1 4 LTCGGCQQNIGDRYFLKAIDQYWHEDC 30 (30)
T ss_dssp BCBSSSCSCBCSSEEEECSSSEECTTT
T ss_pred cccCCCCCcchHHHHHHHHHHHHhcCC
Confidence 4699999999999 6689999999987
|
| >d1j2oa1 g.39.1.3 (A:1-30) Rhombotin-2 (Lmo2) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Rhombotin-2 (Lmo2) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.60 E-value=1e-05 Score=43.21 Aligned_cols=26 Identities=8% Similarity=-0.127 Sum_probs=23.9
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCC
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFT 28 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~c 28 (433)
.|+||+..+. |...+.|+++.||..|
T Consensus 5 ~CaGC~~~I~-DRflL~a~Dr~WH~~C 30 (30)
T d1j2oa1 5 TCGGCQQNIG-DRYFLKAIDQYWHEDC 30 (30)
T ss_dssp CBSSSCSCBC-SSEEEECSSSEECTTT
T ss_pred ccCCCCCcch-HHHHHHHHHHHHhcCC
Confidence 6999999877 8999999999999988
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.60 E-value=5.5e-05 Score=65.61 Aligned_cols=40 Identities=18% Similarity=0.115 Sum_probs=32.0
Q ss_pred chHHHHhhcC--CcceeeEEEEEEeCCeeeEEEeccCCCCHH
Q psy6593 147 GQVAVLRSLH--HHNVIRFIGVLYKDRKLNLVTEYIAGGTLK 186 (433)
Q Consensus 147 ~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~ 186 (433)
.|+.+|+.|. .-.+++++.+..+++..++||++++|.++.
T Consensus 53 ~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 53 DEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp HHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred HHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 6888888884 344788898888888899999999886653
|
| >d2dloa1 g.39.1.3 (A:8-42) Thyroid receptor interacting protein 6, TRIP6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Thyroid receptor interacting protein 6, TRIP6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.60 E-value=1.1e-05 Score=44.76 Aligned_cols=26 Identities=15% Similarity=-0.020 Sum_probs=22.5
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
.|..|++ +|.+..|+|+|+.||+.||
T Consensus 10 kC~~C~~--~I~driLrA~Gk~yHP~CF 35 (35)
T d2dloa1 10 KCATCSQ--PILDRILRAMGKAYHPGCF 35 (35)
T ss_dssp BCTTTCC--BCCSCCEEETTEEECTTTC
T ss_pred HHHHhch--HHHHHHHHHhCCCCCCCCC
Confidence 4777877 4678999999999999998
|
| >d1x68a1 g.39.1.3 (A:8-36) Four and a half LIM domains protein 5, FHL-5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 5, FHL-5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.58 E-value=8.7e-06 Score=42.25 Aligned_cols=25 Identities=36% Similarity=0.926 Sum_probs=22.5
Q ss_pred cccccccccCC----eEEecCcccCCCCc
Q psy6593 63 CQNCGQMMSGP----VMVVGDHKFHPECF 87 (433)
Q Consensus 63 C~~C~~~i~~~----~~~~~~~~~h~~cf 87 (433)
|..|.+||++. ++...+++||.+||
T Consensus 1 C~~C~kPItg~gG~k~isFedR~WH~~CF 29 (29)
T d1x68a1 1 CVACSKPISGLTGAKFICFQDSQWHSECF 29 (29)
T ss_dssp CTTTCCCCCTTTTCCEEEETTEEEEGGGC
T ss_pred CccccccccccCCceEEEeehhhcccccC
Confidence 88999999654 89999999999998
|
| >d1x61a2 g.39.1.3 (A:35-66) Thyroid receptor interacting protein 6, TRIP6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Thyroid receptor interacting protein 6, TRIP6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.54 E-value=1.5e-05 Score=42.02 Aligned_cols=28 Identities=21% Similarity=0.589 Sum_probs=25.6
Q ss_pred cccccccccCCc-eEeeCCeeeecccccc
Q psy6593 30 GCSACDVMLDNW-YFEKDGLLFCKEDYNG 57 (433)
Q Consensus 30 ~C~~C~~~l~~~-~~~~~~~~~C~~~~~~ 57 (433)
.|..|+..|.|. |+..+.+.||+.||-.
T Consensus 1 vC~tC~~kLRGqpFYAvekkayCE~CYi~ 29 (32)
T d1x61a2 1 VCSTCRAQLRGQHFYAVERRAYCEGCYVA 29 (32)
T ss_dssp BCSSSCCBCTTSCEEESSSCEEEHHHHHH
T ss_pred CeeEeCceecCCcceEeeccccccceeee
Confidence 489999999998 9999999999999954
|
| >d1x63a2 g.39.1.3 (A:45-76) Four and a half LIM domains protein 1, FHL-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 1, FHL-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.51 E-value=1.9e-05 Score=41.04 Aligned_cols=31 Identities=23% Similarity=0.587 Sum_probs=27.0
Q ss_pred cccccccccCC-ceEeeCCeeeeccccccccc
Q psy6593 30 GCSACDVMLDN-WYFEKDGLLFCKEDYNGKYG 60 (433)
Q Consensus 30 ~C~~C~~~l~~-~~~~~~~~~~C~~~~~~~~~ 60 (433)
.|+.|++.+.. +||.++...||-.|++.+|+
T Consensus 1 tcs~ckq~igsgsffpkg~d~ycvtche~kfa 32 (32)
T d1x63a2 1 TCSNCKQVIGTGSFFPKGEDFYCVTCHETKFA 32 (32)
T ss_dssp CCSSSCCCCTTSCEEEETTEEEEHHHHHHHTS
T ss_pred CcchhhhhcccccccCCCCcEEEEEeeccccC
Confidence 48999999955 49999999999999988774
|
| >d1rutx1 g.39.1.3 (X:19-48) LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: LIM only 4 (Lmo4) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.34 E-value=2.2e-05 Score=42.07 Aligned_cols=27 Identities=4% Similarity=-0.324 Sum_probs=24.3
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
.|+||+..+. |...+.++++.||..|.
T Consensus 4 ~CaGC~~~I~-DRflL~v~dr~WH~~CL 30 (30)
T d1rutx1 4 RCAGCGGKIA-DRFLLYAMDSYWHSRCL 30 (30)
T ss_dssp BBTTTCCBCC-CSEEEEETTEEECGGGC
T ss_pred ccCCCCCccc-hhhhhccchhhhhhhhC
Confidence 4999999877 99999999999999984
|
| >d1u5sb1 g.39.1.3 (B:72-102) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.33 E-value=2.6e-05 Score=41.69 Aligned_cols=25 Identities=8% Similarity=0.125 Sum_probs=21.3
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCC
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFT 28 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~c 28 (433)
.||.|. -+|.++.|.|+||+||+++
T Consensus 7 ~C~~C~--~PI~~~~vtAlgk~WHpEH 31 (31)
T d1u5sb1 7 ICGACR--RPIEGRVVNAMGKQWHVEH 31 (31)
T ss_dssp EETTTT--EECCSCEECCTTSBEETTT
T ss_pred chhhcC--CchhhhHhhhhccccCCCC
Confidence 377786 4788999999999999985
|
| >d1x63a1 g.39.1.3 (A:8-44) Four and a half LIM domains protein 1, FHL-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 1, FHL-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.33 E-value=3e-05 Score=44.19 Aligned_cols=28 Identities=4% Similarity=-0.198 Sum_probs=25.9
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
.|-+|+..+....+.|.+.|+.||..||
T Consensus 10 ~C~~C~k~I~~G~k~veykg~~WHe~CF 37 (37)
T d1x63a1 10 KCKGCFKAIVAGDQNVEYKGTVWHKDCF 37 (37)
T ss_dssp BCSSSCCBCCSSSCEEECSSCEEETTTC
T ss_pred ccccCCCccCCCCeEeEeCCccchhccC
Confidence 4889999998889999999999999998
|
| >d1x4ka2 g.39.1.3 (A:8-34) Four and a half LIM domains protein 2, FHL2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 2, FHL2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.31 E-value=5.2e-05 Score=38.39 Aligned_cols=25 Identities=28% Similarity=0.680 Sum_probs=22.4
Q ss_pred cccccccccC--CeEEecCcccCCCCc
Q psy6593 63 CQNCGQMMSG--PVMVVGDHKFHPECF 87 (433)
Q Consensus 63 C~~C~~~i~~--~~~~~~~~~~h~~cf 87 (433)
|..|++.|.+ +.|++.+..||..||
T Consensus 1 C~~C~ktiMPGsrKme~kG~~WHEtCF 27 (27)
T d1x4ka2 1 CQECKKTIMPGTRKMEYKGSSWHETCF 27 (27)
T ss_dssp BSSSCCCCCSSSCEEEETTEEEETTTT
T ss_pred CccccccccCCceeecccCCccccccC
Confidence 8899999954 499999999999998
|
| >d1rutx2 g.39.1.3 (X:49-82) LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: LIM only 4 (Lmo4) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.15 E-value=4.2e-05 Score=41.30 Aligned_cols=31 Identities=32% Similarity=0.888 Sum_probs=26.9
Q ss_pred cccccccccCC---ceEeeCCeeeeccccccccc
Q psy6593 30 GCSACDVMLDN---WYFEKDGLLFCKEDYNGKYG 60 (433)
Q Consensus 30 ~C~~C~~~l~~---~~~~~~~~~~C~~~~~~~~~ 60 (433)
+|+.|+..|.. ++|.+.|.+.|+.||.++||
T Consensus 1 KCscC~~~LgeiG~s~ytk~~mILCk~DY~rlFG 34 (34)
T d1rutx2 1 KCSSCQAQLGDIGTSSYTKSGMILCRNDYIRLFG 34 (34)
T ss_dssp BCTTTCCBHHHHCSEEEEETTEEECHHHHHHHHS
T ss_pred CCcchhcChhhccchheecCCEEEEchhHHHhcC
Confidence 58899999933 39999999999999999886
|
| >d1wyha2 g.39.1.3 (A:8-34) Four and a half LIM domains 3, FHL3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains 3, FHL3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.01 E-value=9.2e-05 Score=37.36 Aligned_cols=25 Identities=28% Similarity=0.832 Sum_probs=22.1
Q ss_pred cccccccccC--CeEEecCcccCCCCc
Q psy6593 63 CQNCGQMMSG--PVMVVGDHKFHPECF 87 (433)
Q Consensus 63 C~~C~~~i~~--~~~~~~~~~~h~~cf 87 (433)
|..|.+.|.+ +.|++.+..||..||
T Consensus 1 C~~C~ktiMPGsrKmey~G~sWHE~CF 27 (27)
T d1wyha2 1 CSACGETVMPGSRKLEYGGQTWHEHCF 27 (27)
T ss_dssp CSSSCCBCCSSSCEECSTTCCEETTTC
T ss_pred CccccceecCCcccccccCcccccccC
Confidence 7899999954 499999999999998
|
| >d1zfoa_ g.39.1.4 (A:) LASP-1 {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LASP-1 domain: LASP-1 species: Pig (Sus scrofa) [TaxId: 9823]
Probab=96.98 E-value=9e-05 Score=38.71 Aligned_cols=27 Identities=7% Similarity=-0.103 Sum_probs=22.2
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
.|+.|+-.+- --|.|.-+|+.||+.||
T Consensus 4 ~CaRC~k~VY-p~Ekl~ClDk~WHK~CF 30 (30)
T d1zfoa_ 4 NCARCGKIVY-PTEKVNCLDKFWHKACF 30 (30)
T ss_dssp BCSSSCSBCC-GGGCCCSSSSCCCGGGC
T ss_pred cccccCCccc-cHHHhhhhHHHHhhccC
Confidence 3788887665 45679999999999998
|
| >d2cuqa2 g.39.1.3 (A:8-42) Four and a half LIM domains 3, FHL3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains 3, FHL3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.97 E-value=0.00017 Score=39.58 Aligned_cols=26 Identities=4% Similarity=-0.115 Sum_probs=21.8
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
.|..|+.+ |+...|.+.++.||++||
T Consensus 10 ~C~~Ckk~--It~GGvtY~dqpWHkeCF 35 (35)
T d2cuqa2 10 RCARCSKT--LTQGGVTYRDQPWHRECL 35 (35)
T ss_dssp CCTTTCCC--CCSCCEESSSSEECTTTC
T ss_pred HHhhcCCc--cccCceeecCCcchhhhC
Confidence 57788876 667789999999999998
|
| >d1wyha2 g.39.1.3 (A:8-34) Four and a half LIM domains 3, FHL3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains 3, FHL3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.84 E-value=0.00018 Score=36.25 Aligned_cols=27 Identities=7% Similarity=-0.068 Sum_probs=21.9
Q ss_pred cCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 3 FGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
|-+|...+---..++...|++||..||
T Consensus 1 C~~C~ktiMPGsrKmey~G~sWHE~CF 27 (27)
T d1wyha2 1 CSACGETVMPGSRKLEYGGQTWHEHCF 27 (27)
T ss_dssp CSSSCCBCCSSSCEECSTTCCEETTTC
T ss_pred CccccceecCCcccccccCcccccccC
Confidence 556776665556889999999999998
|
| >d1b8ta3 g.39.1.3 (A:101-143) Cysteine-rich (intestinal) protein, CRP, CRIP {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.82 E-value=0.00021 Score=42.45 Aligned_cols=26 Identities=4% Similarity=-0.266 Sum_probs=22.7
Q ss_pred cCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 3 FGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
|..|+..|-+.+ .+.+.|+.||+.||
T Consensus 18 C~~C~k~VY~~E-~~~~~g~~~Hk~CF 43 (43)
T d1b8ta3 18 CPRCGQAVYAAE-KVIGAGKSWHKSCF 43 (43)
T ss_dssp CTTTSCEECSSS-CEEETTEEECTTTC
T ss_pred CccCCCEeeHHH-HhhcCCCccccCCC
Confidence 888998888665 58999999999998
|
| >d2cupa3 g.39.1.3 (A:8-34) Four and a half LIM domains protein 1, FHL-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 1, FHL-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.75 E-value=0.00035 Score=35.09 Aligned_cols=25 Identities=20% Similarity=0.607 Sum_probs=21.3
Q ss_pred cccccccccCC--eEEecCcccCCCCc
Q psy6593 63 CQNCGQMMSGP--VMVVGDHKFHPECF 87 (433)
Q Consensus 63 C~~C~~~i~~~--~~~~~~~~~h~~cf 87 (433)
|.-|.+||... -+.+.++.||..||
T Consensus 1 c~ecrkpigad~ke~h~knr~wh~~cf 27 (27)
T d2cupa3 1 CVECRKPIGADSKEVHYKNRFWHDTCF 27 (27)
T ss_dssp CSSSCCBCCSSSCEEEETTEEEETTTC
T ss_pred CccccCCcCcchHHhhccccccccccC
Confidence 78899999544 77899999999998
|
| >d1zfoa_ g.39.1.4 (A:) LASP-1 {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LASP-1 domain: LASP-1 species: Pig (Sus scrofa) [TaxId: 9823]
Probab=96.67 E-value=0.00016 Score=37.71 Aligned_cols=28 Identities=25% Similarity=0.647 Sum_probs=24.1
Q ss_pred ccccccccccccCC-eEEecCcccCCCCc
Q psy6593 60 GEACQNCGQMMSGP-VMVVGDHKFHPECF 87 (433)
Q Consensus 60 ~~~C~~C~~~i~~~-~~~~~~~~~h~~cf 87 (433)
.+.|++|++.+-+. .+.-.++.||..||
T Consensus 2 n~~CaRC~k~VYp~Ekl~ClDk~WHK~CF 30 (30)
T d1zfoa_ 2 NPNCARCGKIVYPTEKVNCLDKFWHKACF 30 (30)
T ss_dssp CCBCSSSCSBCCGGGCCCSSSSCCCGGGC
T ss_pred CCcccccCCccccHHHhhhhHHHHhhccC
Confidence 37899999999654 77889999999998
|
| >d2cora1 g.39.1.3 (A:43-73) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.63 E-value=0.0004 Score=36.20 Aligned_cols=29 Identities=24% Similarity=0.367 Sum_probs=25.9
Q ss_pred cccccccccCCceEeeCCeeeeccccccc
Q psy6593 30 GCSACDVMLDNWYFEKDGLLFCKEDYNGK 58 (433)
Q Consensus 30 ~C~~C~~~l~~~~~~~~~~~~C~~~~~~~ 58 (433)
.|+.|++.|+..--+.+|.+||..|+.+.
T Consensus 1 nC~~CgkeltadArEl~geLyCLpChdKm 29 (31)
T d2cora1 1 NCANCGKELTADARELKGELYCLPCHDKM 29 (31)
T ss_dssp BCSSSCCBCCTTCEEETTEEECHHHHHTT
T ss_pred CccccccccchhHHHhcCCEEEEeccccc
Confidence 48999999998888999999999998763
|
| >d1rutx3 g.39.1.3 (X:83-113) LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: LIM only 4 (Lmo4) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.60 E-value=0.00021 Score=38.49 Aligned_cols=28 Identities=4% Similarity=-0.143 Sum_probs=25.7
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
-|.+|+....-++-.++|.++.||..||
T Consensus 4 ~Ca~C~~~I~~~e~VmRA~~~VyHl~CF 31 (31)
T d1rutx3 4 ACSACGQSIPASELVMRAQGNVYHLKCF 31 (31)
T ss_dssp ECTTTCCEECTTSEEEEETTEEECGGGC
T ss_pred ccccccCcCChhHhheecccceeeeccC
Confidence 3899999998888899999999999998
|
| >d1b8ta3 g.39.1.3 (A:101-143) Cysteine-rich (intestinal) protein, CRP, CRIP {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.60 E-value=0.00043 Score=41.04 Aligned_cols=27 Identities=26% Similarity=0.781 Sum_probs=23.8
Q ss_pred ccccccccccc-CCeEEecCcccCCCCc
Q psy6593 61 EACQNCGQMMS-GPVMVVGDHKFHPECF 87 (433)
Q Consensus 61 ~~C~~C~~~i~-~~~~~~~~~~~h~~cf 87 (433)
++|..|++.+- ...+.+.++.||..||
T Consensus 16 ~kC~~C~k~VY~~E~~~~~g~~~Hk~CF 43 (43)
T d1b8ta3 16 DGCPRCGQAVYAAEKVIGAGKSWHKSCF 43 (43)
T ss_dssp EECTTTSCEECSSSCEEETTEEECTTTC
T ss_pred CcCccCCCEeeHHHHhhcCCCccccCCC
Confidence 68999999994 4478899999999998
|
| >d1x6aa2 g.39.1.3 (A:42-75) Lim domain kinase 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Lim domain kinase 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.50 E-value=0.0004 Score=37.42 Aligned_cols=30 Identities=43% Similarity=1.000 Sum_probs=26.1
Q ss_pred ccccCCccccCCCCcccccCCcc-ccccccc
Q psy6593 87 FKCTSCSCCIGDGESYALVERSI-LCSACDV 116 (433)
Q Consensus 87 f~C~~C~~~l~~g~~~~~~~~~~-~C~~c~~ 116 (433)
|.|..|+.-+++|++|++++... +|..|+.
T Consensus 1 F~C~~C~~fIgdgdsyaLVerskLYCG~Cy~ 31 (34)
T d1x6aa2 1 FACMSCKVIIEDGDAYALVQHATLYCGKCHN 31 (34)
T ss_dssp CBCTTTCCBCCTTSCEEECSSSCEEEHHHHH
T ss_pred CcccccccEEecCceEEEEeeceeeeecchh
Confidence 78999999999999999887664 5999975
|
| >d2cu8a1 g.39.1.3 (A:8-37) Cysteine-rich (intestinal) protein, CRP, CRIP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.47 E-value=0.00072 Score=35.85 Aligned_cols=28 Identities=14% Similarity=0.452 Sum_probs=23.7
Q ss_pred cccccccccccc-CCeEEecCcccCCCCc
Q psy6593 60 GEACQNCGQMMS-GPVMVVGDHKFHPECF 87 (433)
Q Consensus 60 ~~~C~~C~~~i~-~~~~~~~~~~~h~~cf 87 (433)
.++|.+|++++- ...+...|+.||..|.
T Consensus 2 ~~~CprC~K~VYfaEk~~~lgk~WHk~Cl 30 (30)
T d2cu8a1 2 ASKCPKCDKTVYFAEKVSSLGKDWHKFCL 30 (30)
T ss_dssp CCBCTTTCCBCCTTTEEEETTEEEETTTC
T ss_pred CCcCCCCCCceeeHHhhccCCcccccccC
Confidence 479999999995 4588889999999884
|
| >d2cu8a1 g.39.1.3 (A:8-37) Cysteine-rich (intestinal) protein, CRP, CRIP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.47 E-value=0.00031 Score=37.28 Aligned_cols=27 Identities=11% Similarity=0.011 Sum_probs=22.0
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
.|..|+..|-.. |.+.++|+.||+.|.
T Consensus 4 ~CprC~K~VYfa-Ek~~~lgk~WHk~Cl 30 (30)
T d2cu8a1 4 KCPKCDKTVYFA-EKVSSLGKDWHKFCL 30 (30)
T ss_dssp BCTTTCCBCCTT-TEEEETTEEEETTTC
T ss_pred cCCCCCCceeeH-HhhccCCcccccccC
Confidence 488898877754 569999999999984
|
| >d2d8ya1 g.39.1.3 (A:9-43) Eplin, LIMA1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Eplin, LIMA1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.45 E-value=0.00034 Score=39.21 Aligned_cols=27 Identities=11% Similarity=-0.239 Sum_probs=22.2
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
.|.-|+..+-+. |.+.|.|+.||+.||
T Consensus 9 kC~~C~K~VY~~-E~~~a~g~~~Hk~CF 35 (35)
T d2d8ya1 9 TCVECQKTVYPM-ERLLANQQVFHISCF 35 (35)
T ss_dssp BCTTTCCBCCTT-SEEECSSSEEETTTC
T ss_pred ccccCCCEEeee-eeEecCCeehhhccC
Confidence 477888877755 459999999999998
|
| >d2d8za2 g.39.1.3 (A:33-64) Four and a half LIM domains protein 2, FHL2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 2, FHL2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.44 E-value=0.0003 Score=38.00 Aligned_cols=29 Identities=21% Similarity=0.521 Sum_probs=25.7
Q ss_pred cccCCccccCCCCcccccCCcccccccccc
Q psy6593 88 KCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 88 ~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
.|..|..+| .|++|..+++.++|..|+..
T Consensus 1 ~C~~C~~~L-~GQry~~rd~~PyC~~Cf~~ 29 (32)
T d2d8za2 1 VCTACRKQL-SGQRFTARDDFAYCLNCFCD 29 (32)
T ss_dssp BCSSSCCBC-TTSCCEESSSSEECHHHHHH
T ss_pred CcccCCccc-cCceeeecCCCeehHHhhHh
Confidence 478899999 69999999999999999754
|
| >d2d8ya1 g.39.1.3 (A:9-43) Eplin, LIMA1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Eplin, LIMA1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.43 E-value=0.00069 Score=37.93 Aligned_cols=28 Identities=25% Similarity=0.663 Sum_probs=24.6
Q ss_pred ccccccccccccC-CeEEecCcccCCCCc
Q psy6593 60 GEACQNCGQMMSG-PVMVVGDHKFHPECF 87 (433)
Q Consensus 60 ~~~C~~C~~~i~~-~~~~~~~~~~h~~cf 87 (433)
..+|..|++.+-. ..+.+.+..||..||
T Consensus 7 ~~kC~~C~K~VY~~E~~~a~g~~~Hk~CF 35 (35)
T d2d8ya1 7 RETCVECQKTVYPMERLLANQQVFHISCF 35 (35)
T ss_dssp SCBCTTTCCBCCTTSEEECSSSEEETTTC
T ss_pred CcccccCCCEEeeeeeEecCCeehhhccC
Confidence 4689999999954 588999999999998
|
| >d1x4ka2 g.39.1.3 (A:8-34) Four and a half LIM domains protein 2, FHL2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 2, FHL2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.34 E-value=0.00056 Score=34.53 Aligned_cols=27 Identities=4% Similarity=-0.164 Sum_probs=21.0
Q ss_pred cCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 3 FGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
|-+|...+---..++.+.|..||..||
T Consensus 1 C~~C~ktiMPGsrKme~kG~~WHEtCF 27 (27)
T d1x4ka2 1 CQECKKTIMPGTRKMEYKGSSWHETCF 27 (27)
T ss_dssp BSSSCCCCCSSSCEEEETTEEEETTTT
T ss_pred CccccccccCCceeecccCCccccccC
Confidence 456666555456789999999999998
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.33 E-value=0.0025 Score=58.63 Aligned_cols=28 Identities=32% Similarity=0.394 Sum_probs=24.8
Q ss_pred CccccCCCCcceEEccCCceEEeccccch
Q psy6593 219 NLIHRDLNSQNCLVREDKTVVVADFGLAR 247 (433)
Q Consensus 219 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 247 (433)
.++|+|+.|.|||+++++ ++|+||..+.
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcc
Confidence 689999999999998765 8999998865
|
| >d2co8a2 g.39.1.3 (A:8-43) Nedd9 interacting protein with calponin homology, NICAL (MICAL1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Nedd9 interacting protein with calponin homology, NICAL (MICAL1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.18 E-value=0.00073 Score=37.96 Aligned_cols=27 Identities=7% Similarity=-0.264 Sum_probs=22.1
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
.|.-|+..+-+.+ .+.|.|+.||+.||
T Consensus 10 ~C~~C~K~VY~~E-rl~a~g~~yHk~CF 36 (36)
T d2co8a2 10 LCALCGEHLYVLE-RLCVNGHFFHRSCF 36 (36)
T ss_dssp BCSSSCCBCCTTT-BCCBTTBCCBTTTC
T ss_pred cccccCCEEeeee-EEEecCcEeccccC
Confidence 4778887777654 58999999999998
|
| >d2co8a2 g.39.1.3 (A:8-43) Nedd9 interacting protein with calponin homology, NICAL (MICAL1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Nedd9 interacting protein with calponin homology, NICAL (MICAL1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.11 E-value=0.00099 Score=37.40 Aligned_cols=28 Identities=36% Similarity=0.835 Sum_probs=24.4
Q ss_pred ccccccccccccC-CeEEecCcccCCCCc
Q psy6593 60 GEACQNCGQMMSG-PVMVVGDHKFHPECF 87 (433)
Q Consensus 60 ~~~C~~C~~~i~~-~~~~~~~~~~h~~cf 87 (433)
+.+|..|++.+-. ..+.+.++.||..||
T Consensus 8 ~~~C~~C~K~VY~~Erl~a~g~~yHk~CF 36 (36)
T d2co8a2 8 GDLCALCGEHLYVLERLCVNGHFFHRSCF 36 (36)
T ss_dssp SCBCSSSCCBCCTTTBCCBTTBCCBTTTC
T ss_pred CCcccccCCEEeeeeEEEecCcEeccccC
Confidence 4699999999954 478999999999998
|
| >d1x4la1 g.39.1.3 (A:8-36) Four and a half LIM domains protein 2, FHL2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 2, FHL2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.09 E-value=0.0011 Score=34.26 Aligned_cols=16 Identities=13% Similarity=-0.139 Sum_probs=13.9
Q ss_pred ccceeecCCCcCcCCc
Q psy6593 14 NENLRFLCRSSLIFTS 29 (433)
Q Consensus 14 ~~~~~~~~~~~h~~cf 29 (433)
..+|.+.++.||..||
T Consensus 14 ~kyisFE~R~WH~~CF 29 (29)
T d1x4la1 14 TKYISFEERQWHNDCF 29 (29)
T ss_dssp CSCEECSSCEECTTTC
T ss_pred ceEEEeecccccccCC
Confidence 4788899999999998
|
| >d1b8ta1 g.39.1.3 (A:1-35) Cysteine-rich (intestinal) protein, CRP, CRIP {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.07 E-value=0.0012 Score=35.21 Aligned_cols=27 Identities=11% Similarity=-0.138 Sum_probs=21.7
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
.||-|+..+- -.|.++-.|+.||+.||
T Consensus 9 kcg~c~ktvy-~aeevqc~g~sfhk~cf 35 (35)
T d1b8ta1 9 KCGVCQKAVY-FAEEVQCEGSSFHKSCF 35 (35)
T ss_dssp ECTTTCCEEC-SSCCEEETTEEECTTTC
T ss_pred eeccccceEe-eeeeeeecCcccccccC
Confidence 3888887666 44559999999999998
|
| >d1x64a2 g.39.1.3 (A:53-83) PDZ and LIM domain protein 3, PDLIM3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: PDZ and LIM domain protein 3, PDLIM3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.98 E-value=0.0016 Score=34.03 Aligned_cols=26 Identities=31% Similarity=0.764 Sum_probs=22.4
Q ss_pred cccccccccCCc-eEeeCCeeeecccc
Q psy6593 30 GCSACDVMLDNW-YFEKDGLLFCKEDY 55 (433)
Q Consensus 30 ~C~~C~~~l~~~-~~~~~~~~~C~~~~ 55 (433)
.|+.|+.-|-.+ +|..++++||+.+-
T Consensus 1 vC~dCg~NLKqrG~Ffv~~~lyCE~HA 27 (31)
T d1x64a2 1 VCADCNLNLKQKGYFFVEGELYCETHA 27 (31)
T ss_dssp CCSSSCCCTTTSCCEEETTEEECHHHH
T ss_pred CccccccChhhcceEEeccEEeehhhh
Confidence 489999999777 88899999998653
|
| >d1v6ga1 g.39.1.3 (A:1-41) Actin-binding LIM protein 2, abLIM2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 2, abLIM2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.77 E-value=0.002 Score=37.06 Aligned_cols=25 Identities=12% Similarity=-0.056 Sum_probs=21.4
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCC
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFT 28 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~c 28 (433)
.|-+|++. |+++.|.|.++.||+.|
T Consensus 17 ~C~~C~~~--ItG~V~~Ag~~~yHP~C 41 (41)
T d1v6ga1 17 RCFSCDQF--IEGEVVSALGKTYHPDC 41 (41)
T ss_dssp BCTTTCCB--CCSCCEEETTEEECTTT
T ss_pred ccccccCE--eeeeeeEecCcccCCCC
Confidence 37778765 58999999999999998
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.64 E-value=0.0041 Score=57.24 Aligned_cols=38 Identities=18% Similarity=0.314 Sum_probs=27.5
Q ss_pred hccchHHHHhhcC-CcceeeEEEEEEeCCeeeEEEeccCCCCH
Q psy6593 144 QNCGQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTL 185 (433)
Q Consensus 144 ~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g~sL 185 (433)
.+.+|..+++.+. +.-.+++++++.+ .+|+||++|.+|
T Consensus 90 dr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 90 HLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp HHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 3458999999994 4445688887642 689999987544
|
| >d1g47a2 g.39.1.3 (A:36-70) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.61 E-value=0.00073 Score=38.04 Aligned_cols=30 Identities=20% Similarity=0.265 Sum_probs=25.7
Q ss_pred ccccCCccccCCCCcccccCCcccccccccc
Q psy6593 87 FKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 87 f~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
|+|+.|+++++ +..|+..++.++|..++..
T Consensus 1 F~C~~C~~~f~-~~~F~e~~G~pYCe~~Y~~ 30 (35)
T d1g47a2 1 FVCAQCFQQFP-EGLFYEFEGRKYCEHDFQM 30 (35)
T ss_dssp CCCTTTCCCCG-GGCSEEETTEEECHHHHHH
T ss_pred CCCCCCcCCCC-CCCeEEECCEecChHhHHh
Confidence 78999999996 6678999999999888753
|
| >d1a7ia1 g.39.1.3 (A:8-35) Cysteine-rich (intestinal) protein, CRP, CRIP {Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]
Probab=95.58 E-value=0.0019 Score=32.50 Aligned_cols=27 Identities=15% Similarity=-0.020 Sum_probs=21.8
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
.||-|+..+- ..+.|+-.|+.||+.||
T Consensus 2 kcg~c~ktvy-~aeevqc~grsfhk~cf 28 (28)
T d1a7ia1 2 KCGACGRTVY-HAEEVQCDGRSFHRCCF 28 (28)
T ss_dssp BCSSSCCBCS-STTEEEETTEEEESSSE
T ss_pred ccccccceEe-eeeeeeecCceeccccC
Confidence 4788876554 56679999999999998
|
| >d2cuqa1 g.39.1.3 (A:43-74) Four and a half LIM domains 3, FHL3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains 3, FHL3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.56 E-value=0.0013 Score=34.91 Aligned_cols=29 Identities=24% Similarity=0.564 Sum_probs=25.6
Q ss_pred cccCCccccCCCCcccccCCcccccccccc
Q psy6593 88 KCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 88 ~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
+|+.|+.+| .|++|..++..+||..|+-.
T Consensus 1 vCt~Ck~~L-aGqrFTSrde~pYC~~Cfg~ 29 (32)
T d2cuqa1 1 VCTGCQTPL-AGQQFTSRDEDPYCVACFGE 29 (32)
T ss_dssp BCSSSCCBC-TTCCEEECSSSEEEHHHHHH
T ss_pred CccccCccc-cCCccccCCCCccHHHHhHh
Confidence 489999999 69999999999999999743
|
| >d1b8ta1 g.39.1.3 (A:1-35) Cysteine-rich (intestinal) protein, CRP, CRIP {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.49 E-value=0.0034 Score=33.43 Aligned_cols=28 Identities=25% Similarity=0.647 Sum_probs=24.2
Q ss_pred ccccccccccc-cCCeEEecCcccCCCCc
Q psy6593 60 GEACQNCGQMM-SGPVMVVGDHKFHPECF 87 (433)
Q Consensus 60 ~~~C~~C~~~i-~~~~~~~~~~~~h~~cf 87 (433)
+.||..|.+.+ ...-++..++.||..||
T Consensus 7 g~kcg~c~ktvy~aeevqc~g~sfhk~cf 35 (35)
T d1b8ta1 7 GKKCGVCQKAVYFAEEVQCEGSSFHKSCF 35 (35)
T ss_dssp CEECTTTCCEECSSCCEEETTEEECTTTC
T ss_pred CceeccccceEeeeeeeeecCcccccccC
Confidence 46999999988 45578999999999998
|
| >d2cupa2 g.39.1.3 (A:35-65) Four and a half LIM domains protein 1, FHL-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 1, FHL-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.49 E-value=0.0034 Score=32.60 Aligned_cols=26 Identities=27% Similarity=0.540 Sum_probs=22.7
Q ss_pred cccccccccCCc-eEeeCCeeeecccc
Q psy6593 30 GCSACDVMLDNW-YFEKDGLLFCKEDY 55 (433)
Q Consensus 30 ~C~~C~~~l~~~-~~~~~~~~~C~~~~ 55 (433)
+|..|=.||... |..+|+++.|..|-
T Consensus 1 RCaKC~hpLA~E~F~aKd~kI~C~Kc~ 27 (31)
T d2cupa2 1 RCAKCLHPLANETFVAKDNKILCNKCT 27 (31)
T ss_dssp CCSSSCCCTTSSCCEEETTEEECHHHH
T ss_pred CchhhccccccCcccccCCeEeecccc
Confidence 689999999777 99999999997664
|
| >d1ibia1 g.39.1.3 (A:117-144) Cysteine-rich (intestinal) protein, CRP, CRIP {Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]
Probab=95.41 E-value=0.0033 Score=32.05 Aligned_cols=26 Identities=4% Similarity=-0.215 Sum_probs=20.9
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCC
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFT 28 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~c 28 (433)
+|--|+..+. ..|+|...|+.||+.|
T Consensus 3 ~CpRC~~~Vy-aAEkviGaG~~WHk~C 28 (28)
T d1ibia1 3 KCSRCGDSVY-AAEKVIGAGKPWHKNC 28 (28)
T ss_dssp ECTTTSSEES-SSSCEESSSSEECSSC
T ss_pred cCcccchhHH-HHHHHhcCCCccccCC
Confidence 4677877665 6678889999999988
|
| >d1x61a1 g.39.1.3 (A:8-34) Thyroid receptor interacting protein 6, TRIP6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Thyroid receptor interacting protein 6, TRIP6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.38 E-value=0.0041 Score=30.52 Aligned_cols=25 Identities=40% Similarity=0.868 Sum_probs=21.0
Q ss_pred cccccccccC--CeEEecCcccCCCCc
Q psy6593 63 CQNCGQMMSG--PVMVVGDHKFHPECF 87 (433)
Q Consensus 63 C~~C~~~i~~--~~~~~~~~~~h~~cf 87 (433)
|.+|++-+.+ .-+.+.++.||..||
T Consensus 1 cggcgedvvgdgagvvaldrvfhvgcf 27 (27)
T d1x61a1 1 CGGCGEDVVGDGAGVVALDRVFHVGCF 27 (27)
T ss_dssp CSSSCSCCCSSSCCEECSSSEECTTTC
T ss_pred CCCcccccccCCcceEEEeeeEEeccC
Confidence 7899998854 467888999999997
|
| >d2dj7a1 g.39.1.3 (A:44-74) Actin-binding LIM protein 3, abLIM-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 3, abLIM-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.36 E-value=0.0014 Score=34.72 Aligned_cols=30 Identities=40% Similarity=1.095 Sum_probs=21.4
Q ss_pred cccccccccccccccCCeeeeeccCCCcch
Q psy6593 111 CSACDVMLDNWYFEKDGLLFCKEDYNGKYG 140 (433)
Q Consensus 111 C~~c~~~l~~~~~~~~~~~~~~~~~~g~fg 140 (433)
|..|..+|..+|+.+++..+|.++++..||
T Consensus 2 C~~C~~vL~gEYm~kdG~PyCe~DY~~~FG 31 (31)
T d2dj7a1 2 CQTCSVILTGEYISKDGVPYCESDYHAQFG 31 (31)
T ss_dssp CSSSCCBCSSCCEEETTEEECTTHHHHHTT
T ss_pred ccccCccccceeecCCCCcccHHHHHHhcC
Confidence 555666666777888888888877776665
|
| >d1ibia2 g.39.1.3 (A:145-175) Cysteine-rich (intestinal) protein, CRP, CRIP {Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]
Probab=95.32 E-value=0.0017 Score=33.52 Aligned_cols=29 Identities=24% Similarity=0.715 Sum_probs=24.5
Q ss_pred ccccCCccccCCCCcccccCCccccccccc
Q psy6593 87 FKCTSCSCCIGDGESYALVERSILCSACDV 116 (433)
Q Consensus 87 f~C~~C~~~l~~g~~~~~~~~~~~C~~c~~ 116 (433)
|+|..|++.| ..-+.+-+++..+|+.|+.
T Consensus 1 frca~cgk~l-estt~adkdgeiyck~cya 29 (31)
T d1ibia2 1 FRCAKCGKSL-ESTTLTEKEGEIYCKGCYA 29 (31)
T ss_dssp EECSSSCCEE-CSSCSEEETTEEECHHHHH
T ss_pred CccccccCcc-ccceeeccCCcEEEeeeee
Confidence 6899999999 5677788899999998873
|
| >d1rutx4 g.39.1.3 (X:114-146) LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: LIM only 4 (Lmo4) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.30 E-value=0.0039 Score=32.74 Aligned_cols=29 Identities=17% Similarity=0.572 Sum_probs=25.8
Q ss_pred cccCCccccCCCCcccccCCccccccccc
Q psy6593 88 KCTSCSCCIGDGESYALVERSILCSACDV 116 (433)
Q Consensus 88 ~C~~C~~~l~~g~~~~~~~~~~~C~~c~~ 116 (433)
.|++|..+|.+|++|...++..+|.....
T Consensus 1 tC~tC~n~LVPGDRFHyvNG~lfCE~D~p 29 (33)
T d1rutx4 1 TCSTCRNRLVPGDRFHYINGSLFCEHDRP 29 (33)
T ss_dssp BCTTTCCBCCTTCEEEEETTEEEEGGGCC
T ss_pred CcccccccccCCceeEEecCEEEEecCCc
Confidence 48999999999999999999999987653
|
| >d2cura1 g.39.1.3 (A:33-63) Four and a half LIM domains protein 1, FHL-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 1, FHL-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.25 E-value=0.0027 Score=33.22 Aligned_cols=28 Identities=29% Similarity=0.689 Sum_probs=25.1
Q ss_pred cccCCccccCCCCcccccCCccccccccc
Q psy6593 88 KCTSCSCCIGDGESYALVERSILCSACDV 116 (433)
Q Consensus 88 ~C~~C~~~l~~g~~~~~~~~~~~C~~c~~ 116 (433)
.|.+|+++| .|.+|...+.+.+|..|+.
T Consensus 1 vC~~C~K~L-ag~rFTa~eDq~yCVdCYK 28 (31)
T d2cura1 1 VCVTCSKKL-AGQRFTAVEDQYYCVDCYK 28 (31)
T ss_dssp BCTTTCCBC-TTSCEEECSSCEEEHHHHH
T ss_pred Ccccccchh-cCceeEEecceEEEeeeec
Confidence 488999999 6899999999999999875
|
| >d1x61a2 g.39.1.3 (A:35-66) Thyroid receptor interacting protein 6, TRIP6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Thyroid receptor interacting protein 6, TRIP6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.06 E-value=0.0034 Score=32.85 Aligned_cols=28 Identities=32% Similarity=0.827 Sum_probs=25.0
Q ss_pred cccCCccccCCCCcccccCCccccccccc
Q psy6593 88 KCTSCSCCIGDGESYALVERSILCSACDV 116 (433)
Q Consensus 88 ~C~~C~~~l~~g~~~~~~~~~~~C~~c~~ 116 (433)
.|.+|+..| .|+.|+.++...+|..|+.
T Consensus 1 vC~tC~~kL-RGqpFYAvekkayCE~CYi 28 (32)
T d1x61a2 1 VCSTCRAQL-RGQHFYAVERRAYCEGCYV 28 (32)
T ss_dssp BCSSSCCBC-TTSCEEESSSCEEEHHHHH
T ss_pred CeeEeCcee-cCCcceEeeccccccceee
Confidence 488999999 6899999999999999975
|
| >d1a7ia1 g.39.1.3 (A:8-35) Cysteine-rich (intestinal) protein, CRP, CRIP {Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]
Probab=95.05 E-value=0.0056 Score=30.79 Aligned_cols=26 Identities=27% Similarity=0.730 Sum_probs=22.6
Q ss_pred ccccccccc-cCCeEEecCcccCCCCc
Q psy6593 62 ACQNCGQMM-SGPVMVVGDHKFHPECF 87 (433)
Q Consensus 62 ~C~~C~~~i-~~~~~~~~~~~~h~~cf 87 (433)
||..|.+.+ ...-++..++.||..||
T Consensus 2 kcg~c~ktvy~aeevqc~grsfhk~cf 28 (28)
T d1a7ia1 2 KCGACGRTVYHAEEVQCDGRSFHRCCF 28 (28)
T ss_dssp BCSSSCCBCSSTTEEEETTEEEESSSE
T ss_pred ccccccceEeeeeeeeecCceeccccC
Confidence 799999988 45688999999999997
|
| >d2cupa3 g.39.1.3 (A:8-34) Four and a half LIM domains protein 1, FHL-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 1, FHL-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.88 E-value=0.0046 Score=30.92 Aligned_cols=27 Identities=4% Similarity=-0.138 Sum_probs=19.6
Q ss_pred cCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 3 FGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
|.+|..-+-.|...+...++.||..||
T Consensus 1 c~ecrkpigad~ke~h~knr~wh~~cf 27 (27)
T d2cupa3 1 CVECRKPIGADSKEVHYKNRFWHDTCF 27 (27)
T ss_dssp CSSSCCBCCSSSCEEEETTEEEETTTC
T ss_pred CccccCCcCcchHHhhccccccccccC
Confidence 456655555567778888888888887
|
| >d1x62a1 g.39.1.3 (A:43-73) PDZ and LIM domain protein 1 Elfin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: PDZ and LIM domain protein 1 Elfin species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.86 E-value=0.002 Score=33.78 Aligned_cols=26 Identities=19% Similarity=0.525 Sum_probs=22.0
Q ss_pred cccccccccCCc-eEeeCCeeeecccc
Q psy6593 30 GCSACDVMLDNW-YFEKDGLLFCKEDY 55 (433)
Q Consensus 30 ~C~~C~~~l~~~-~~~~~~~~~C~~~~ 55 (433)
.|+.|+.-|-.+ +|..++++||+.+-
T Consensus 1 vC~dCg~NLKqrG~Ffve~~lyCE~HA 27 (31)
T d1x62a1 1 VCTDCGTNLKQKGHFFVEDQIYCEKHA 27 (31)
T ss_dssp SCSSSCCCHHHHCCEESSSCEECHHHH
T ss_pred CccccccChhhcceEEeccEEehhhhh
Confidence 489999999776 88889999998653
|
| >d1rutx4 g.39.1.3 (X:114-146) LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: LIM only 4 (Lmo4) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=94.82 E-value=0.014 Score=30.54 Aligned_cols=26 Identities=35% Similarity=0.680 Sum_probs=21.6
Q ss_pred cccccccccCC--ceEeeCCeeeecccc
Q psy6593 30 GCSACDVMLDN--WYFEKDGLLFCKEDY 55 (433)
Q Consensus 30 ~C~~C~~~l~~--~~~~~~~~~~C~~~~ 55 (433)
.|+.|...|-. +|...+|.+||+.|.
T Consensus 1 tC~tC~n~LVPGDRFHyvNG~lfCE~D~ 28 (33)
T d1rutx4 1 TCSTCRNRLVPGDRFHYINGSLFCEHDR 28 (33)
T ss_dssp BCTTTCCBCCTTCEEEEETTEEEEGGGC
T ss_pred CcccccccccCCceeEEecCEEEEecCC
Confidence 48999999933 388899999999875
|
| >d1x6aa2 g.39.1.3 (A:42-75) Lim domain kinase 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Lim domain kinase 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.77 E-value=0.0053 Score=32.96 Aligned_cols=29 Identities=24% Similarity=0.555 Sum_probs=22.9
Q ss_pred ccccccccccCC-c-eEee-CCeeeecccccc
Q psy6593 29 SGCSACDVMLDN-W-YFEK-DGLLFCKEDYNG 57 (433)
Q Consensus 29 f~C~~C~~~l~~-~-~~~~-~~~~~C~~~~~~ 57 (433)
|.|..|+.-+.. . |... ..++||-.||.+
T Consensus 1 F~C~~C~~fIgdgdsyaLVerskLYCG~Cy~~ 32 (34)
T d1x6aa2 1 FACMSCKVIIEDGDAYALVQHATLYCGKCHNE 32 (34)
T ss_dssp CBCTTTCCBCCTTSCEEECSSSCEEEHHHHHH
T ss_pred CcccccccEEecCceEEEEeeceeeeecchhc
Confidence 789999999944 4 7665 458999999965
|
| >d1ibia1 g.39.1.3 (A:117-144) Cysteine-rich (intestinal) protein, CRP, CRIP {Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]
Probab=94.18 E-value=0.01 Score=30.16 Aligned_cols=26 Identities=23% Similarity=0.695 Sum_probs=19.9
Q ss_pred cccccccccccC-CeEEecCcccCCCC
Q psy6593 61 EACQNCGQMMSG-PVMVVGDHKFHPEC 86 (433)
Q Consensus 61 ~~C~~C~~~i~~-~~~~~~~~~~h~~c 86 (433)
.+|.+|++.+.. ..+--.++.||..|
T Consensus 2 d~CpRC~~~VyaAEkviGaG~~WHk~C 28 (28)
T d1ibia1 2 EKCSRCGDSVYAAEKVIGAGKPWHKNC 28 (28)
T ss_dssp EECTTTSSEESSSSCEESSSSEECSSC
T ss_pred CcCcccchhHHHHHHHhcCCCccccCC
Confidence 579999998844 35555678899887
|
| >d1x68a1 g.39.1.3 (A:8-36) Four and a half LIM domains protein 5, FHL-5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 5, FHL-5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.18 E-value=0.0044 Score=31.93 Aligned_cols=15 Identities=7% Similarity=-0.292 Sum_probs=11.2
Q ss_pred cceeecCCCcCcCCc
Q psy6593 15 ENLRFLCRSSLIFTS 29 (433)
Q Consensus 15 ~~~~~~~~~~h~~cf 29 (433)
.+|.+.++.||.+||
T Consensus 15 k~isFedR~WH~~CF 29 (29)
T d1x68a1 15 KFICFQDSQWHSECF 29 (29)
T ss_dssp CEEEETTEEEEGGGC
T ss_pred eEEEeehhhcccccC
Confidence 567777777887776
|
| >d1x62a2 g.39.1.3 (A:8-42) PDZ and LIM domain protein 1 Elfin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: PDZ and LIM domain protein 1 Elfin species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.03 E-value=0.013 Score=31.47 Aligned_cols=26 Identities=4% Similarity=-0.199 Sum_probs=21.5
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
.|..||.-++ +..+.+.+|..|++||
T Consensus 10 ~CdkCg~GIV--G~~VK~rDk~rHPeCf 35 (35)
T d1x62a2 10 MCDKCGTGIV--GVFVKLRDRHRHPECY 35 (35)
T ss_dssp CCSSSCCCCC--SSCEECSSCEECTTTT
T ss_pred cccccCCCcE--eEEEEeccccCCCCCC
Confidence 4778887654 6689999999999998
|
| >d1x68a2 g.39.1.3 (A:37-70) Four and a half LIM domains protein 5, FHL-5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 5, FHL-5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.74 E-value=0.035 Score=29.04 Aligned_cols=26 Identities=23% Similarity=0.609 Sum_probs=22.1
Q ss_pred cccccccccCCc-eEeeCCeeeecccc
Q psy6593 30 GCSACDVMLDNW-YFEKDGLLFCKEDY 55 (433)
Q Consensus 30 ~C~~C~~~l~~~-~~~~~~~~~C~~~~ 55 (433)
.|..|+.+|-++ |...+..++|..|-
T Consensus 1 ncgkcsvslvg~gfltq~~~i~c~~cg 27 (34)
T d1x68a2 1 NCGKCSVSLVGKGFLTQNKEIFCQKCG 27 (34)
T ss_dssp BCTTTCCBCSSSCEEEETTEEEETTTT
T ss_pred CCccceEEEEeeeeeeccCcEEehhcC
Confidence 378899999887 99999999997764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.66 E-value=0.02 Score=50.42 Aligned_cols=30 Identities=30% Similarity=0.354 Sum_probs=27.3
Q ss_pred CCccccCCCCcceEEccCCceEEeccccch
Q psy6593 218 MNLIHRDLNSQNCLVREDKTVVVADFGLAR 247 (433)
Q Consensus 218 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 247 (433)
.|++|+|+.+.|++++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 489999999999999988878999999875
|
| >d1x6aa1 g.39.1.3 (A:8-41) Lim domain kinase 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Lim domain kinase 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.35 E-value=0.018 Score=30.91 Aligned_cols=25 Identities=8% Similarity=-0.395 Sum_probs=21.6
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCC
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFT 28 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~c 28 (433)
.|-+|++ .|++..|.|-+..||++|
T Consensus 10 ~C~~C~~--~itGpvMvAG~~K~HPEC 34 (34)
T d1x6aa1 10 FCHGCSL--LMTGPFMVAGEFKYHPEC 34 (34)
T ss_dssp BCTTTCC--BCCSCCBCCTTCCBCTTS
T ss_pred HhhhhHh--hcccceeeecccccCCCC
Confidence 4778988 567999999999999998
|
| >d1u5sb2 g.39.1.3 (B:103-137) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.81 E-value=0.0089 Score=32.00 Aligned_cols=24 Identities=21% Similarity=0.372 Sum_probs=14.7
Q ss_pred ccccCCccccCCCCcccccCCcccc
Q psy6593 87 FKCTSCSCCIGDGESYALVERSILC 111 (433)
Q Consensus 87 f~C~~C~~~l~~g~~~~~~~~~~~C 111 (433)
|+|+.|.+++ -|...+.+.+..+|
T Consensus 1 FvCA~CekPF-~G~rhyE~~g~ayC 24 (35)
T d1u5sb2 1 FVCAKCEKPF-LGHRHYERKGLAYC 24 (35)
T ss_dssp CBCTTTCCBC-SSSCCEEETTEEEC
T ss_pred CcccccCCcc-CCchhhhhcCchHH
Confidence 6899999888 45444444444444
|
| >d1x64a1 g.39.1.3 (A:8-52) PDZ and LIM domain protein 3, PDLIM3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: PDZ and LIM domain protein 3, PDLIM3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=92.54 E-value=0.027 Score=32.40 Aligned_cols=26 Identities=0% Similarity=-0.271 Sum_probs=20.9
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
.|..||.-++ +..+.+.||.+|++||
T Consensus 20 ~CdkCg~GIV--G~~VK~rDK~rHPeCf 45 (45)
T d1x64a1 20 LCDKCGSGIV--GAVVKARDKYRHPECF 45 (45)
T ss_dssp BCTTTCCBCC--SCCEESSSCEECTTTC
T ss_pred cccccCCCcE--EEEEEeccccCCCCCC
Confidence 3677776544 6689999999999998
|
| >d1wiga1 g.39.1.3 (A:1-32) Actin-binding LIM protein 2, abLIM2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 2, abLIM2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.25 E-value=0.031 Score=29.05 Aligned_cols=24 Identities=4% Similarity=-0.198 Sum_probs=19.7
Q ss_pred cCCCCCeeEeeccceeecCCCcCcCC
Q psy6593 3 FGTRSEVTSMENENLRFLCRSSLIFT 28 (433)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~h~~c 28 (433)
|-+|. -+|++..+.|-++.||+.|
T Consensus 8 C~~C~--~~ItGkVLEAG~khYHP~C 31 (32)
T d1wiga1 8 CDSCE--KYITGRVLEAGEKHYHPSC 31 (32)
T ss_dssp CSSSC--CCCSSCCBCCSSCCBCTTT
T ss_pred hhhhh--hhhhhhhhhccccccCCCC
Confidence 45554 3688999999999999988
|
| >d1x63a2 g.39.1.3 (A:45-76) Four and a half LIM domains protein 1, FHL-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 1, FHL-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.21 E-value=0.018 Score=29.64 Aligned_cols=28 Identities=29% Similarity=0.757 Sum_probs=22.6
Q ss_pred cccCCccccCCCCcccccCCccccccccc
Q psy6593 88 KCTSCSCCIGDGESYALVERSILCSACDV 116 (433)
Q Consensus 88 ~C~~C~~~l~~g~~~~~~~~~~~C~~c~~ 116 (433)
.|+.|.+.++.| +|..+....+|..|+.
T Consensus 1 tcs~ckq~igsg-sffpkg~d~ycvtche 28 (32)
T d1x63a2 1 TCSNCKQVIGTG-SFFPKGEDFYCVTCHE 28 (32)
T ss_dssp CCSSSCCCCTTS-CEEEETTEEEEHHHHH
T ss_pred Ccchhhhhcccc-cccCCCCcEEEEEeec
Confidence 488999999765 4778888899998875
|
| >d1g47a1 g.39.1.3 (A:1-35) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.87 E-value=0.044 Score=29.51 Aligned_cols=26 Identities=15% Similarity=0.572 Sum_probs=22.0
Q ss_pred cccccccccccC--CeEEecCcccCCCC
Q psy6593 61 EACQNCGQMMSG--PVMVVGDHKFHPEC 86 (433)
Q Consensus 61 ~~C~~C~~~i~~--~~~~~~~~~~h~~c 86 (433)
..|.+|+.++.+ ..+...+..||..|
T Consensus 8 ~~C~RC~~gF~p~EkiVNSnGEl~H~qC 35 (35)
T d1g47a1 8 ATCERCKGGFAPAEKIVNSNGELYHEQC 35 (35)
T ss_dssp CBCSSSCCBCCSTTTCEEETTEEECTTT
T ss_pred HHHHHHccCCCchHHhhcCCCccccccC
Confidence 579999999955 47789999999987
|
| >d1jm7b_ g.44.1.1 (B:) bard1 RING domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: bard1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.82 E-value=0.044 Score=38.89 Aligned_cols=46 Identities=20% Similarity=0.304 Sum_probs=36.5
Q ss_pred CccccccccccCCc-eEeeCCeeeeccccccccccccccccccccCC
Q psy6593 28 TSGCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQNCGQMMSGP 73 (433)
Q Consensus 28 cf~C~~C~~~l~~~-~~~~~~~~~C~~~~~~~~~~~C~~C~~~i~~~ 73 (433)
-+.|..|...+..- ....-|..||..|..+.+..+|..|+..+...
T Consensus 22 ~l~C~IC~~~~~~pv~~~~CgH~fC~~Ci~~~~~~~CP~Cr~~~~~~ 68 (97)
T d1jm7b_ 22 LLRCSRCTNILREPVCLGGCEHIFCSNCVSDCIGTGCPVCYTPAWIQ 68 (97)
T ss_dssp TTSCSSSCSCCSSCBCCCSSSCCBCTTTGGGGTTTBCSSSCCBCSCS
T ss_pred cCCCccCCchhhcCceeCCCCCchhHHHHHHHHhccccccCCcCchh
Confidence 47899999999655 44578999999999888887888888776443
|
| >d1x3ha2 g.39.1.3 (A:43-74) Leupaxin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Leupaxin species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.23 E-value=0.051 Score=29.24 Aligned_cols=27 Identities=15% Similarity=0.352 Sum_probs=22.1
Q ss_pred cccCCccccCCCCcccccCCcccccccc
Q psy6593 88 KCTSCSCCIGDGESYALVERSILCSACD 115 (433)
Q Consensus 88 ~C~~C~~~l~~g~~~~~~~~~~~C~~c~ 115 (433)
+|.+|.+++ .++.|++.++.++|..-+
T Consensus 1 VC~~C~~PF-~~~~Fy~~~g~PyCe~Hy 27 (32)
T d1x3ha2 1 VCGDCFTSF-STGSFFELDGRPFCELHY 27 (32)
T ss_dssp BCSSSCCBS-CSSCCEESSSCEECHHHH
T ss_pred CcCccCCcC-CCCCeEeECCccchHHhh
Confidence 589999999 567799999999987644
|
| >d1g47a1 g.39.1.3 (A:1-35) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.63 E-value=0.054 Score=29.15 Aligned_cols=28 Identities=0% Similarity=-0.352 Sum_probs=22.2
Q ss_pred CCcCCCCCeeEeeccceeecCCCcCcCC
Q psy6593 1 MVFGTRSEVTSMENENLRFLCRSSLIFT 28 (433)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~~~h~~c 28 (433)
|.|--|++--.-.+..|+..|..||..|
T Consensus 8 ~~C~RC~~gF~p~EkiVNSnGEl~H~qC 35 (35)
T d1g47a1 8 ATCERCKGGFAPAEKIVNSNGELYHEQC 35 (35)
T ss_dssp CBCSSSCCBCCSTTTCEEETTEEECTTT
T ss_pred HHHHHHccCCCchHHhhcCCCccccccC
Confidence 6677888777767788888888888877
|
| >d2cora2 g.39.1.3 (A:8-42) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.05 E-value=0.052 Score=29.28 Aligned_cols=26 Identities=23% Similarity=0.779 Sum_probs=23.5
Q ss_pred ccccccccccCCeEEecCcccCCCCc
Q psy6593 62 ACQNCGQMMSGPVMVVGDHKFHPECF 87 (433)
Q Consensus 62 ~C~~C~~~i~~~~~~~~~~~~h~~cf 87 (433)
.|+.|...|.+.-+.+++..||+..|
T Consensus 10 vC~KCh~iIdd~pL~Fr~d~YHp~HF 35 (35)
T d2cora2 10 ICQKCHAIIDEQPLIFKNDPYHPDHF 35 (35)
T ss_dssp BCTTTCCBCCSCCCCCSSSCCCTTTS
T ss_pred HHHHHHhhhhcCcceecCCCCCCCCC
Confidence 69999999999988999999999876
|
| >d2d8xa1 g.39.1.3 (A:33-64) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.83 E-value=0.068 Score=27.89 Aligned_cols=28 Identities=21% Similarity=0.578 Sum_probs=24.1
Q ss_pred cccccccccCCc-eEeeCCeeeecccccc
Q psy6593 30 GCSACDVMLDNW-YFEKDGLLFCKEDYNG 57 (433)
Q Consensus 30 ~C~~C~~~l~~~-~~~~~~~~~C~~~~~~ 57 (433)
+|..|+..|... |.--.|...|..|+.+
T Consensus 1 rC~~C~~~LAD~GFvKnagR~LCrpch~r 29 (32)
T d2d8xa1 1 RCDLCQEVLADIGFVKNAGRHLCRPCHNR 29 (32)
T ss_dssp BCSSSCCBCSSSCCEEETTEEECHHHHHH
T ss_pred CchHHHhHHHHhhhhhcccccccchhhhh
Confidence 689999999665 8888899999999865
|
| >d1wiga2 g.39.1.3 (A:33-73) Actin-binding LIM protein 2, abLIM2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 2, abLIM2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.45 E-value=0.086 Score=29.47 Aligned_cols=26 Identities=42% Similarity=0.971 Sum_probs=14.3
Q ss_pred ccccccccc-CCeEE-ecCcccCCCCcc
Q psy6593 63 CQNCGQMMS-GPVMV-VGDHKFHPECFK 88 (433)
Q Consensus 63 C~~C~~~i~-~~~~~-~~~~~~h~~cf~ 88 (433)
|.+|++.+. |.-|- -++..|||.|-.
T Consensus 2 C~rC~~mF~EGEEMYLQGs~IWHP~C~~ 29 (41)
T d1wiga2 2 CVRCGQMFAEGEEMYLQGSSIWHPACRQ 29 (41)
T ss_dssp CSSSCCCCCSSCCCEEETTEEECTTHHH
T ss_pred cchhhccccccceeeecCCceeCCcccc
Confidence 667777663 33332 345667776543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=87.41 E-value=0.19 Score=44.15 Aligned_cols=29 Identities=28% Similarity=0.316 Sum_probs=23.7
Q ss_pred CCccccCCCCcceEEccCCceEEeccccchh
Q psy6593 218 MNLIHRDLNSQNCLVREDKTVVVADFGLARI 248 (433)
Q Consensus 218 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 248 (433)
.+++|+|+.|.|||++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 479999999999999743 45899998763
|
| >d1x4la2 g.39.1.3 (A:37-66) Four and a half LIM domains protein 2, FHL2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 2, FHL2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.92 E-value=0.13 Score=25.95 Aligned_cols=25 Identities=16% Similarity=0.575 Sum_probs=19.6
Q ss_pred cccccccccCCc-eEeeCCeeeeccc
Q psy6593 30 GCSACDVMLDNW-YFEKDGLLFCKED 54 (433)
Q Consensus 30 ~C~~C~~~l~~~-~~~~~~~~~C~~~ 54 (433)
.|..|..+|-++ |....+.+.|.+|
T Consensus 1 nc~kcsvslvgrgflterddilc~dc 26 (30)
T d1x4la2 1 NCKKCSLSLVGRGFLTERDDILCPDC 26 (30)
T ss_dssp BCSSSCCBCTTSCCEECSSSEECHHH
T ss_pred CcceeeEEEEeeeccccccceecccc
Confidence 378899999887 8777777887665
|
| >d1v6ga2 g.39.1.3 (A:42-81) Actin-binding LIM protein 2, abLIM2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 2, abLIM2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.38 E-value=0.14 Score=28.22 Aligned_cols=31 Identities=19% Similarity=0.610 Sum_probs=26.3
Q ss_pred ccccCCccccCCCCcccccCCcccccccccc
Q psy6593 87 FKCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 87 f~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
|+|+.|.+++..|++.......-.|..|...
T Consensus 1 FvC~vCr~pFP~GDRVTFnGKeC~CQ~Cs~p 31 (40)
T d1v6ga2 1 FVCAVCRLPFPPGDRVTFNGKECMCQKCSLP 31 (40)
T ss_dssp SSCSSSCCCCCSSSCEEEETTEEEEHHHHSC
T ss_pred CcccccCCCCCCCCeEEEcCceeehhhcCCC
Confidence 7899999999989988888888888888764
|
| >d1b8ta4 g.39.1.3 (A:144-192) Cysteine-rich (intestinal) protein, CRP, CRIP {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=86.25 E-value=0.097 Score=31.27 Aligned_cols=29 Identities=21% Similarity=0.575 Sum_probs=23.8
Q ss_pred cccCCccccCCCCcccccCCcccccccccc
Q psy6593 88 KCTSCSCCIGDGESYALVERSILCSACDVM 117 (433)
Q Consensus 88 ~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~ 117 (433)
+|..|++.|. .-.....++.+||..|+..
T Consensus 1 KC~~C~k~Ld-s~t~~ehdg~~YCk~CY~k 29 (49)
T d1b8ta4 1 RCAKCGKSLE-STTLADKDGEIYCKGCYAK 29 (49)
T ss_dssp BCTTTCCBCC-SSSEEEETTEEEEHHHHHH
T ss_pred ChhhcCCccC-CCcccccCCcccchhhhhh
Confidence 4889999994 5577889999999999863
|
| >d1wyha1 g.39.1.3 (A:35-66) Four and a half LIM domains 3, FHL3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains 3, FHL3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.21 E-value=0.09 Score=27.78 Aligned_cols=27 Identities=22% Similarity=0.602 Sum_probs=21.9
Q ss_pred ccCCccccCCCCcccccCCccccccccc
Q psy6593 89 CTSCSCCIGDGESYALVERSILCSACDV 116 (433)
Q Consensus 89 C~~C~~~l~~g~~~~~~~~~~~C~~c~~ 116 (433)
|..|.++++ ..+|..++...+|..|+.
T Consensus 2 C~~C~qPIG-tkSFip~~~~~yCvpCYE 28 (32)
T d1wyha1 2 CSGCEQPLG-SRSFVPDKGAHYCVPCYE 28 (32)
T ss_dssp CTTTCCBTT-TSCEEEETTEEEEHHHHH
T ss_pred cccccCccc-ccccccCCCcEEEEeccc
Confidence 778889995 466888888899988874
|
| >d1x4ka1 g.39.1.3 (A:35-66) Four and a half LIM domains protein 2, FHL2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 2, FHL2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.86 E-value=0.095 Score=27.74 Aligned_cols=27 Identities=26% Similarity=0.636 Sum_probs=22.3
Q ss_pred ccCCccccCCCCcccccCCccccccccc
Q psy6593 89 CTSCSCCIGDGESYALVERSILCSACDV 116 (433)
Q Consensus 89 C~~C~~~l~~g~~~~~~~~~~~C~~c~~ 116 (433)
|..|.+++++ .+|..+++..+|..|+.
T Consensus 2 C~~C~qPIGt-ksfipk~~~~yCvpCyE 28 (32)
T d1x4ka1 2 CHRCQQPIGT-KSFIPKDNQNFCVPCYE 28 (32)
T ss_dssp CSSSCCCCCS-SSEEEETTEEEEHHHHH
T ss_pred cccccCcccc-cccccCCCCceEeecch
Confidence 7789999964 56889999999998874
|
| >d2cora2 g.39.1.3 (A:8-42) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.67 E-value=0.21 Score=26.88 Aligned_cols=26 Identities=8% Similarity=-0.000 Sum_probs=20.7
Q ss_pred CcCCCCCeeEeeccceeecCCCcCcCCc
Q psy6593 2 VFGTRSEVTSMENENLRFLCRSSLIFTS 29 (433)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~h~~cf 29 (433)
+|-+|-++ ||++-+.+.|.+||+.+|
T Consensus 10 vC~KCh~i--Idd~pL~Fr~d~YHp~HF 35 (35)
T d2cora2 10 ICQKCHAI--IDEQPLIFKNDPYHPDHF 35 (35)
T ss_dssp BCTTTCCB--CCSCCCCCSSSCCCTTTS
T ss_pred HHHHHHhh--hhcCcceecCCCCCCCCC
Confidence 56777654 678889999999999887
|
| >d1a7ia2 g.39.1.3 (A:36-67) Cysteine-rich (intestinal) protein, CRP, CRIP {Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]
Probab=85.13 E-value=0.13 Score=26.81 Aligned_cols=26 Identities=23% Similarity=0.703 Sum_probs=22.4
Q ss_pred ccCCccccCCCCcccccCCcccccccc
Q psy6593 89 CTSCSCCIGDGESYALVERSILCSACD 115 (433)
Q Consensus 89 C~~C~~~l~~g~~~~~~~~~~~C~~c~ 115 (433)
|..|.+.| +.-+.+..+...+|+.|+
T Consensus 2 C~~C~K~L-dStTva~h~~eiYCKsCy 27 (32)
T d1a7ia2 2 CMVCRKNL-DSTTVAIHDAEVYCKSCY 27 (32)
T ss_dssp CSSSCCEE-CSSCCEEETTEEECSHHH
T ss_pred chhhhhcc-CcceeeeecceEEehhhc
Confidence 77788898 778888999999999886
|
| >d1imla2 g.39.1.3 (A:29-76) Cysteine-rich (intestinal) protein, CRP, CRIP {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Rat (Rattus rattus) [TaxId: 10117]
Probab=82.24 E-value=0.24 Score=29.13 Aligned_cols=29 Identities=24% Similarity=0.463 Sum_probs=23.4
Q ss_pred cccCCccccCCCCcccccCCcccc-cccccc
Q psy6593 88 KCTSCSCCIGDGESYALVERSILC-SACDVM 117 (433)
Q Consensus 88 ~C~~C~~~l~~g~~~~~~~~~~~C-~~c~~~ 117 (433)
+|..|++.| +....+..++.++| ..|+..
T Consensus 1 kC~~C~K~L-~sg~~aeHdg~pYC~k~CY~~ 30 (48)
T d1imla2 1 KCEKCGKTL-TSGGHAEHEGKPYCNHPCYSA 30 (48)
T ss_dssp BCTTTCCBC-CTTTEEEETTEEEETTTHHHH
T ss_pred CchhcCcCc-CCCChhhcCCcccccccchhh
Confidence 488899999 45668899999999 778864
|
| >d2dara1 g.39.1.3 (A:53-84) PDZ and LIM domain protein 5, Enigma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: PDZ and LIM domain protein 5, Enigma species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.85 E-value=0.25 Score=26.03 Aligned_cols=27 Identities=15% Similarity=0.492 Sum_probs=22.1
Q ss_pred ccCCccccCCCCcccccCCccccccccc
Q psy6593 89 CTSCSCCIGDGESYALVERSILCSACDV 116 (433)
Q Consensus 89 C~~C~~~l~~g~~~~~~~~~~~C~~c~~ 116 (433)
|+.|.++|. .-.|+...++.+|..|+.
T Consensus 2 Ca~C~~sL~-d~gFVEE~g~lYCe~Cye 28 (32)
T d2dara1 2 CAHCKNTMA-YIGFVEEKGALYCELCYE 28 (32)
T ss_dssp CSSSCCBCS-SSCBEESSSCEECHHHHH
T ss_pred cccccccHh-hcceeeecCcEeHHHHHH
Confidence 778999995 455888899999998875
|
| >d2d8ya2 g.39.1.3 (A:44-85) Eplin, LIMA1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Eplin, LIMA1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.41 E-value=0.18 Score=28.99 Aligned_cols=30 Identities=27% Similarity=0.544 Sum_probs=24.6
Q ss_pred cccCCccccCCCCcccccCCccccccccccc
Q psy6593 88 KCTSCSCCIGDGESYALVERSILCSACDVML 118 (433)
Q Consensus 88 ~C~~C~~~l~~g~~~~~~~~~~~C~~c~~~l 118 (433)
+|..|+..|..| .|+..++..+|+.++.+|
T Consensus 1 rC~~C~~~Ls~~-~yas~~G~lYCkpHf~qL 30 (42)
T d2d8ya2 1 RCSYCNNKLSLG-TYASLHGRIYCKPHFNQL 30 (42)
T ss_dssp BCTTTCCBCCTT-TCCCSSSCCCCHHHHHHH
T ss_pred CcCcCCCCccCC-cchhhCCEeccHHHHHHH
Confidence 488999999654 689999999998888654
|
| >d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: STIP1 homology and U box-containing protein 1, STUB1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=80.41 E-value=0.42 Score=32.04 Aligned_cols=48 Identities=6% Similarity=-0.014 Sum_probs=36.9
Q ss_pred cCCccccccccccCCceEeeCCeeeecccccccc---ccccccccccccCC
Q psy6593 26 IFTSGCSACDVMLDNWYFEKDGLLFCKEDYNGKY---GEACQNCGQMMSGP 73 (433)
Q Consensus 26 ~~cf~C~~C~~~l~~~~~~~~~~~~C~~~~~~~~---~~~C~~C~~~i~~~ 73 (433)
++.|.|..|...+..=.....|..||+.|-.+.+ +..|..|++.+...
T Consensus 5 P~~l~CpIc~~l~~dPv~~~cGhtfc~~ci~~~l~~~~~~cP~c~~~l~~~ 55 (80)
T d2c2la2 5 PDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQE 55 (80)
T ss_dssp CSTTBCTTTCSBCSSEEECSSCCEEETTHHHHHHHHTCSSCTTTCCCCCGG
T ss_pred CccccCcCcCchhhhhcccCCcCeecHHHHHHHHhcCCccCCCcccccccc
Confidence 6789999999999665667899999999986644 34577777777543
|